Citrus Sinensis ID: 040763

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360
Protein Sequence
TISTSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIKN
Secondary Structure (PSIPRED)
cEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHcccccccccEEEEcHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEccccccHHHHHHHHHHHHHHHHHHHcccccccccEEccccccccEEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEcccccccccccccccEEEEEcccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccccccHHHHccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEcccccHHHEEEcccccEEEccccccEEccccccEEEEEEEEccccccHHHHHccccccHHHHHHHHHHHHHHHccccccccccccccHHccHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
TISTSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSydgsvidrcklfsskeldkatnhfnvnrilgqggqgtvykgrledgriiavkksklavddeELYKLEEFINEIFILSQINHRNVVKLLGccletefpllvyefipngtlyqhlhdrhqneeypltWEMRFRVAIEVAGALAYlhsgasspiyhrdikstniLLDERYRAkvadfgtskfiamDQTHVTTKIqgtfgyldpeyhqssqltdksdvYSFGVVLVELLtgkkpifstgntsqenVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLdlngkkrptmEEVSMELNGIRGSIKN
Flexible Loop (DISEMBL)
TISTSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKAtnhfnvnrilgqggqgtvykgrledgriiavkksklavddeELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHsgasspiyhrDIKSTNILLDERYRAKVADFGTskfiamdqtHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGkkpifstgntsqenVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERcldlngkkrptmeevsmelngirgsikn
Low Complexity Region (SEG)
TISTSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKqngglllqqmlnSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIKN
Disordered region (IsUnstruct)
****SLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDL************************
Disordered Region (DISOPRED)
TISTSLVFLFQVIGRILFRII**************************************LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLA*****LYK*EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF*********VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN*IRG****
Disordered Region (DISEMBL)
TISTSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIKN
Disordered Region (DISPRO)
TISTSLVFLFQVIGRILFRIIRKKRM*****************************DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT*EEVSMELN********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
TISTSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIKN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	360	2.2.26 [Sep-21-2011]
Q7X8C5	748	Wall-associated receptor	yes	no	0.952	0.458	0.6	1e-120
Q9C9L5	792	Wall-associated receptor	no	no	0.944	0.429	0.606	1e-119
Q9S9M2	761	Wall-associated receptor	no	no	0.952	0.450	0.585	1e-116
Q9LMT9	764	Putative wall-associated	no	no	0.938	0.442	0.601	1e-115
Q8RY17	751	Wall-associated receptor	no	no	0.883	0.423	0.617	1e-115
Q9LN59	788	Putative wall-associated	no	no	0.966	0.441	0.595	1e-115
Q9S9M5	730	Wall-associated receptor	no	no	0.958	0.472	0.582	1e-114
Q8VYA3	769	Wall-associated receptor	no	no	0.938	0.439	0.597	1e-113
Q9S9M3	730	Wall-associated receptor	no	no	0.880	0.434	0.606	1e-113
Q9S9M1	731	Wall-associated receptor	no	no	0.947	0.466	0.573	1e-110

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  431 bits (1109), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 213/355 (60%), Positives = 286/355 (80%), Gaps = 12/355 (3%)

Query: 3   STSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFS 62
           S  L+F F + G  L++ ++K+R  IR++ KFF++NGG+LL+Q L   +G+V +  ++FS
Sbjct: 350 SALLLFAFGIFG--LYKFVQKRRKLIRMR-KFFRRNGGMLLKQQLARKEGNV-EMSRIFS 405

Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           S EL+KAT++FN NR+LGQGGQGTVYKG L DGRI+AVK+SK AVD++   ++EEFINE+
Sbjct: 406 SHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSK-AVDED---RVEEFINEV 461

Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            +L+QINHRN+VKLLGCCLETE P+LVYEF+PNG L + LHD  ++++Y +TWE+R  +A
Sbjct: 462 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHD--ESDDYTMTWEVRLHIA 519

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           IE+AGAL+YLHS AS PIYHRDIK+TNILLDER RAKV+DFGTS+ + +DQTH+TT++ G
Sbjct: 520 IEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAG 579

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           TFGY+DPEY QSS+ T+KSDVYSFGVVLVELLTG+KP  S+   S+EN  LAA+FV +++
Sbjct: 580 TFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKP--SSRVRSEENRGLAAHFVEAVK 637

Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
           +NR+  I+DD++      +Q+++ ANLA RCL+  GKKRP M EVS+EL  IR S
Sbjct: 638 ENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1

 Score =  429 bits (1103), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 213/351 (60%), Positives = 279/351 (79%), Gaps = 11/351 (3%)

Query: 5   SLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSK 64
           SL+F+  +   +L++ I+K+R  +  K+KFFK+NGGLLLQQ L S  G ++++  +FSS+
Sbjct: 383 SLIFVVGIY--LLYKFIKKQR-KLNQKKKFFKRNGGLLLQQQLISTVG-MVEKTIVFSSR 438

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           EL+KAT +F+ NRILGQGGQGTVYKG L DGRI+AVKKSK+  +D    KLEEFINE+ I
Sbjct: 439 ELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDED----KLEEFINEVVI 494

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           LSQINHRN+VKLLGCCLET+ P+LVYEFIPNG L++HLHD   +E    TW +R R+AI+
Sbjct: 495 LSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEF-DENIMATWNIRLRIAID 553

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +AGAL+YLHS ASSPIYHRD+KSTNI+LDE+YRAKV+DFGTS+ + +D TH+TT + GT 
Sbjct: 554 IAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTV 613

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
           GY+DPEY QSSQ TDKSDVYSFGVVLVEL+TG+K I  +   SQEN +LA YF+ +M++N
Sbjct: 614 GYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSI--SFLRSQENRTLATYFILAMKEN 671

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
           +L+ I+D ++      +Q+ A A +A +CL+L G+KRP+M EVSMEL+ IR
Sbjct: 672 KLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  419 bits (1078), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 208/355 (58%), Positives = 279/355 (78%), Gaps = 12/355 (3%)

Query: 3   STSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFS 62
           S  L+F F + G  L++ I+K+R   R++  FF++NGG+LL+Q L   +G+V +  K+FS
Sbjct: 358 SALLLFAFGIFG--LYKFIKKQRRSSRMR-VFFRRNGGMLLKQQLARKEGNV-EMSKIFS 413

Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           S EL+KAT++FN NR+LGQGGQGTVYKG L DGRI+AVK+SK A+D++   K+EEFINE+
Sbjct: 414 SNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSK-AMDED---KVEEFINEV 469

Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            +L+QINHRN+VKLLGCCLETE P+LVYEF+PNG L + L D  + ++Y +TWE+R  +A
Sbjct: 470 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRD--ECDDYIMTWEVRLHIA 527

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           IE+AGAL+YLHS AS PIYHRDIK+TNILLDE+Y+ KV+DFGTS+ + +DQTH+TT++ G
Sbjct: 528 IEIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAG 587

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           TFGY+DPEY QSS+ TDKSDVYSFGVVLVEL+TGK P  S+   S+EN   AA+FV +++
Sbjct: 588 TFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNP--SSRVQSEENRGFAAHFVAAVK 645

Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
           +NR   I+D+++      +Q++A A LA+RCL+  GKKRP M EVS+EL  IR S
Sbjct: 646 ENRFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSS 700

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1

 Score =  416 bits (1070), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 210/349 (60%), Positives = 266/349 (76%), Gaps = 11/349 (3%)

Query: 8   FLFQVIGRILF--RIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKE 65
           F+  V G I +  +++RK+RM  R K KFFK+NGGLLLQQ LN+  G V ++ KLFSS+E
Sbjct: 389 FVLIVGGGIWWWRKLLRKRRMTNR-KRKFFKRNGGLLLQQQLNTTQGRV-EKTKLFSSRE 446

Query: 66  LDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFIL 125
           L+KAT++FN NR++GQGGQGTVYKG L DGR +AVKKS +  +D    KL+EFINE+ IL
Sbjct: 447 LEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDED----KLQEFINEVIIL 502

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           SQINHR+VVKLLGCCLETE P+LVYEFIPNG L+QHLH+    ++Y   W +R R+A+++
Sbjct: 503 SQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEF--DDYTALWGVRMRIAVDI 560

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
           +GA +YLH+ A SPIYHRDIKSTNILLDE+YRAKV+DFGTS+ +++D TH TT I GT G
Sbjct: 561 SGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVG 620

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           Y+DPEY+ SS  T+KSDVYSFGVVLVEL+TG+KP+ +   T QE   LA YF  +MR+NR
Sbjct: 621 YVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSET-QEITGLADYFRLAMRENR 679

Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
           L+ I+D ++    K  Q++A ANLA RCL   GK RP M EVS  L  I
Sbjct: 680 LFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1

 Score =  416 bits (1069), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 202/327 (61%), Positives = 263/327 (80%), Gaps = 9/327 (2%)

Query: 34  FFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLE 93
           FFK+NGGLLL+Q L +  G+V    K+FSSKEL+KAT++FN+NR+LGQGGQGTVYKG L 
Sbjct: 383 FFKRNGGLLLKQQLTTRGGNV-QSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLV 441

Query: 94  DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFI 153
           DGRI+AVK+SK+  +D    K+EEFINE+ +LSQINHRN+VKL+GCCLETE P+LVYE I
Sbjct: 442 DGRIVAVKRSKVLDED----KVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHI 497

Query: 154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD 213
           PNG L++ LH  H +++Y +TW++R R+++E+AGALAYLHS AS+P+YHRD+K+TNILLD
Sbjct: 498 PNGDLFKRLH--HDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLD 555

Query: 214 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 273
           E+YRAKV+DFGTS+ I +DQTH+TT + GTFGYLDPEY Q+SQ TDKSDVYSFGVVLVEL
Sbjct: 556 EKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVEL 615

Query: 274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERC 333
           +TG+KP FS     +EN  L ++F  +M++NR+  I+D ++ +     Q++A A LA RC
Sbjct: 616 ITGEKP-FSVMR-PEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRC 673

Query: 334 LDLNGKKRPTMEEVSMELNGIRGSIKN 360
           L L GKKRP M EVS+EL  IR S ++
Sbjct: 674 LSLKGKKRPNMREVSVELERIRSSPED 700

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2

 Score =  414 bits (1065), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 212/356 (59%), Positives = 271/356 (76%), Gaps = 8/356 (2%)

Query: 2   ISTSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLF 61
           + ++   L  V+G    R   KKR   + K KFFK+NGGLLLQQ LN+  G+V ++ ++F
Sbjct: 381 VGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNV-EKTRIF 439

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS+EL+KAT++F+ +RILGQGGQGTVYKG L DGR +AVKKSK+  +D    KLEEFINE
Sbjct: 440 SSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDED----KLEEFINE 495

Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
           + ILSQINHR+VVKLLGCCLETE P LVYEFIPNG L+QH+H+  ++++Y  TW MR R+
Sbjct: 496 VVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHE--ESDDYTKTWGMRLRI 553

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A+++AGAL+YLHS ASSPIYHRDIKSTNILLDE+YR KV+DFGTS+ + +D TH TT I 
Sbjct: 554 AVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVIS 613

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
           GT GY+DPEY+ SSQ TDKSDVYSFGVVLVEL+TG+KP+ +  N SQE   LA +F  +M
Sbjct: 614 GTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSN-SQEIRGLADHFRVAM 672

Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
           ++NR + I+D ++    K  Q++A ANLA RCL+  GKKRP M +V  +L  I  S
Sbjct: 673 KENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1

 Score =  412 bits (1058), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 208/357 (58%), Positives = 278/357 (77%), Gaps = 12/357 (3%)

Query: 4   TSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSS 63
           + LVF   +    LF++I+K+R +I   +KFFK+NGGLLL+Q L + DG+V +  K+FSS
Sbjct: 364 SGLVFFVGLF--WLFKLIKKRR-NINRSKKFFKRNGGLLLKQQLTTKDGNV-EMSKIFSS 419

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           KEL KAT++F+++R+LGQGGQGTVYKG L DG I+AVK+SK+  +D    K+EEFINEI 
Sbjct: 420 KELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDED----KMEEFINEIV 475

Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +LSQINHRN+VKLLGCCLETE P+LVYE+IPNG L++ LHD  ++++Y +TWE+R R+AI
Sbjct: 476 LLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHD--ESDDYTMTWEVRLRIAI 533

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           E+AGAL Y+HS AS PI+HRDIK+TNILLDE+YRAKV+DFGTS+ + +DQTH+TT + GT
Sbjct: 534 EIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGT 593

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
           FGY+DPEY  SSQ T KSDVYSFGVVLVEL+TG+KP+      S+E   LA +F+ +M++
Sbjct: 594 FGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRV--RSEEGRGLATHFLEAMKE 651

Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIKN 360
           NR+  I+D ++    K  Q++A A LA +CL+  GK RP M+EVS EL  IR S ++
Sbjct: 652 NRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPED 708

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1

 Score =  409 bits (1052), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 212/355 (59%), Positives = 281/355 (79%), Gaps = 17/355 (4%)

Query: 4   TSLVFLFQVIGRI--LFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLF 61
           ++LVF    IG I  L++ IR++R  +  K+KFFK+NGGLLLQQ L + +G+V D  ++F
Sbjct: 368 STLVF----IGGIYWLYKFIRRQRR-LNQKKKFFKRNGGLLLQQQLTTTEGNV-DSTRVF 421

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           +S+EL+KAT +F++ RILG+GGQGTVYKG L DGRI+AVKKSK+  +D    KLEEFINE
Sbjct: 422 NSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDED----KLEEFINE 477

Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLT-WEMRFR 180
           + ILSQINHRN+VKLLGCCLET+ P+LVYEFIPNG L++HLHD   +++Y +T WE+R R
Sbjct: 478 VVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHD--DSDDYTMTTWEVRLR 535

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
           +A+++AGAL+YLHS ASSPIYHRDIKSTNI+LDE++RAKV+DFGTS+ + +D TH+TT +
Sbjct: 536 IAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVV 595

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
            GT GY+DPEY QSSQ TDKSDVYSFGVVL EL+TG+K +  +   SQE  +LA YF  +
Sbjct: 596 SGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSV--SFLRSQEYRTLATYFTLA 653

Query: 301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
           M++NRL  I+D ++    K NQ+ A A +A +CL++ G+KRP+M +VSMEL  IR
Sbjct: 654 MKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2

 Score =  409 bits (1050), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 199/328 (60%), Positives = 261/328 (79%), Gaps = 11/328 (3%)

Query: 33  KFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL 92
           KFFK+NGGLLL+Q L + DGSV +  K+FSS+EL+KAT++F+++R+LGQGGQGTVYK  L
Sbjct: 389 KFFKRNGGLLLKQQLTTKDGSV-EMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRML 447

Query: 93  EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEF 152
            DG I+AVK+SK+  +D    K+EEFINEI +LSQINHRN+VKLLGCCLETE P+LVYE+
Sbjct: 448 VDGSIVAVKRSKVVDED----KMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEY 503

Query: 153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL 212
           IPNG L++ LHD +  ++Y +TWE+R R+A+E+AGAL+Y+HS AS PI+HRDIK+TNILL
Sbjct: 504 IPNGDLFKRLHDEY--DDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILL 561

Query: 213 DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE 272
           DE+YRAK++DFGTS+ +A DQTH+TT + GTFGY+DPEY  SSQ T KSDVYSFGVVLVE
Sbjct: 562 DEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVE 621

Query: 273 LLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAER 332
           L+TG+KP+      S+E + LA YF+ +M++NR   I+D ++    K  Q++A A LA R
Sbjct: 622 LITGEKPMSRV--RSEEGIGLATYFLEAMKENRAVDIIDIRIKDESK--QVMAVAKLARR 677

Query: 333 CLDLNGKKRPTMEEVSMELNGIRGSIKN 360
           CL+  G KRP M EVS++L  IR S K+
Sbjct: 678 CLNRKGNKRPNMREVSIKLERIRSSPKD 705

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2

 Score =  399 bits (1025), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 200/349 (57%), Positives = 267/349 (76%), Gaps = 8/349 (2%)

Query: 12  VIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATN 71
           V+G +   I  KKR  I    KFFK+NGGLLL+Q L + +   +D  +LFSS+EL KAT+
Sbjct: 371 VVGTLGLIIFIKKRRRIISSRKFFKRNGGLLLKQQLTTTNDGNVDMSRLFSSEELKKATD 430

Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           +F+V R+LG+G QGTVYKG + DG+IIAVK+SK+  +D    KLE+FINEI +LSQINHR
Sbjct: 431 NFSVKRVLGKGSQGTVYKGMMVDGKIIAVKRSKVVDED----KLEKFINEIILLSQINHR 486

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           N+VKL+GCCLETE P+LVYE+IPNG +++ LHD  ++++Y +TWE+R R+AIE+AGAL Y
Sbjct: 487 NIVKLIGCCLETEVPILVYEYIPNGDMFKRLHD--ESDDYAMTWEVRLRIAIEIAGALTY 544

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           +HS AS PIYHRDIK+TNILLDE+Y AKV+DFGTS+ + +DQTH+TT + GTFGY+DPEY
Sbjct: 545 MHSAASFPIYHRDIKTTNILLDEKYGAKVSDFGTSRSVTIDQTHLTTMVAGTFGYMDPEY 604

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD 311
             SSQ TDKSDVYSFGVVLVEL+TG+KP+      S+E   LA +F+ +M++NR+  I+D
Sbjct: 605 FLSSQYTDKSDVYSFGVVLVELITGEKPLSRI--RSEEGRGLATHFLEAMKENRVIDIID 662

Query: 312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIKN 360
            ++ +  K +Q++A A LA +CL   G KRP M E S+EL  IR S ++
Sbjct: 663 IRIKEESKLDQLMAVAKLARKCLSRKGIKRPNMREASLELERIRSSPED 711

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	360
359475620	822	PREDICTED: wall-associated receptor kina	0.930	0.407	0.681	1e-132
147852023	413	hypothetical protein VITISV_028337 [Viti	0.927	0.808	0.674	1e-131
359475622	867	PREDICTED: wall-associated receptor kina	0.95	0.394	0.663	1e-131
255545828	694	kinase, putative [Ricinus communis] gi|2	0.944	0.489	0.660	1e-130
255545824	727	kinase, putative [Ricinus communis] gi|2	0.916	0.453	0.667	1e-129
147765961	679	hypothetical protein VITISV_007744 [Viti	0.95	0.503	0.658	1e-128
255541802	743	kinase, putative [Ricinus communis] gi|2	0.963	0.467	0.665	1e-127
225455808	718	PREDICTED: wall-associated receptor kina	0.916	0.459	0.664	1e-126
224075946	729	predicted protein [Populus trichocarpa]	0.908	0.448	0.679	1e-126
297734146	1029	unnamed protein product [Vitis vinifera]	0.916	0.320	0.664	1e-125

>gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera]

 Score =  478 bits (1229), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 235/345 (68%), Positives = 286/345 (82%), Gaps = 10/345 (2%)

Query: 7   VFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKEL 66
             L  +    L++++ K+R  I+ KEK FK+NGGLLL+Q L+S +G+V D+ KLF+SKEL
Sbjct: 465 TLLLVICAWWLYKVL-KRRQKIKYKEKCFKRNGGLLLEQQLSSSEGNV-DKTKLFTSKEL 522

Query: 67  DKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           +KAT+ +N NR++GQGGQGTVYKG L DGRI+AVKK K+  D     K+E+FINE+ ILS
Sbjct: 523 EKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDG----KVEQFINEVVILS 578

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           QINHRNVVKLLGCCLET  PLLVYEFIPNGTL +H+HD  QNEE+P+TWEMR R+AIEVA
Sbjct: 579 QINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHD--QNEEFPITWEMRLRIAIEVA 636

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           GAL+YLHS AS PIYHRDIKSTNILLD++YRAKVADFGTSK +A+DQTH+TT++QGTFGY
Sbjct: 637 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTFGY 696

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
           LDPEY QSSQ T+KSDVYSFG+VL+ELLTGKKPI ST   S+E  SLA+YF+ SM ++RL
Sbjct: 697 LDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTA--SEEGKSLASYFILSMNEDRL 754

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
             +LD QV+K GKK +I A A LA RC++LNGKKRPTM EV+MEL
Sbjct: 755 SDLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMEL 799

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera]

 Score =  475 bits (1222), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 232/344 (67%), Positives = 289/344 (84%), Gaps = 10/344 (2%)

Query: 12  VIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATN 71
           +   +L+R+++++R  I+ KEK FK+NGGLLL+Q L+S +G+V D+ KLF+SKEL+KAT+
Sbjct: 24  ICAWLLYRVLKRRR-KIKHKEKCFKRNGGLLLEQQLSSSEGNV-DKTKLFTSKELEKATD 81

Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
            +N NR++GQGGQGTVYKG L DGRI+AVKK K+  D     KLE+FINE+ ILSQINHR
Sbjct: 82  RYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDG----KLEQFINEVVILSQINHR 137

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           NVVKLLGCCLE E PLLVYE+IPNGTL +H+HD  QNEE+P+TW+MR ++A EVAGAL+Y
Sbjct: 138 NVVKLLGCCLEIEVPLLVYEYIPNGTLSEHIHD--QNEEFPITWKMRLQIATEVAGALSY 195

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS AS PIYHRDIKSTNILLD++YRAKVADFGTSK +A+DQTH+TTK+QGTFGYLDPEY
Sbjct: 196 LHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTKVQGTFGYLDPEY 255

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD 311
            QSSQ T+KSDVYSFG+VL+ELLTGKKPI S G  S E  SLA+YF+ SM+++RL  +LD
Sbjct: 256 FQSSQFTEKSDVYSFGIVLIELLTGKKPILSIG--SGEGKSLASYFIMSMKEDRLSDLLD 313

Query: 312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
            +V+K G+K +I A A LA+RC++LNGKKRPTM EV+MEL  IR
Sbjct: 314 ARVVKEGRKEEINAIAFLAKRCINLNGKKRPTMMEVAMELERIR 357

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera]

 Score =  473 bits (1218), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 233/351 (66%), Positives = 284/351 (80%), Gaps = 9/351 (2%)

Query: 5   SLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSK 64
           +L  L  V+      I+ K+R  I+ KEK F +NGGLLL+Q L+S +G+ ID+ KLF+SK
Sbjct: 306 ALGTLLLVLCAWWLYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGN-IDKTKLFTSK 364

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           EL+KAT+ +N NR++GQGG+GTVYKG L DGRI+AVKK K+  D     KLE+FINE+ I
Sbjct: 365 ELEKATDRYNENRVIGQGGEGTVYKGMLMDGRIVAVKKLKIMSDS----KLEQFINEVVI 420

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           L QINHRNVVKLLGCCLETE PLLVYEFIPNGTL +H+H   QNEE+P+TWE+R R+A E
Sbjct: 421 LCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHG--QNEEFPITWEIRLRIATE 478

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           VAGAL+YLHS AS PIYHRDIKSTNILLD++YRAKVADFG SKF+A+DQTH+TT++QGTF
Sbjct: 479 VAGALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGTF 538

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
           GYLDPEY QSSQ T+KSDVYSFG+VL+ELLTGKKPI ST   S+E  SLA+YF+ SM ++
Sbjct: 539 GYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTA--SEEGKSLASYFILSMNED 596

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
           RL  +LD QV+K  +K +I A A LA RC++LNGKKRPTM EV+MEL  IR
Sbjct: 597 RLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIR 647

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis]

 Score =  471 bits (1213), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 232/351 (66%), Positives = 294/351 (83%), Gaps = 11/351 (3%)

Query: 8   FLFQVIG-RILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKEL 66
           FL  +IG   L++II+++R  ++LK+ FFK+NGGLLL+Q L+S + + +++ K+F+SKEL
Sbjct: 336 FLLLLIGIWSLYKIIKRRRA-MKLKQNFFKRNGGLLLEQQLSSTE-NYVEQTKVFTSKEL 393

Query: 67  DKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           +KAT+ ++ NRILGQGGQGTVYKG L DGR++A+KKSK+  +D    KL++FINE+ ILS
Sbjct: 394 EKATDDYHTNRILGQGGQGTVYKGMLIDGRVVAIKKSKVVDED----KLDQFINEVVILS 449

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           QINHRNVVKL+GCCLETE PLLVYEFIPNGTLYQ++H+   NEE+P+TWEMR R+A EVA
Sbjct: 450 QINHRNVVKLIGCCLETEVPLLVYEFIPNGTLYQYIHN--PNEEFPVTWEMRLRIATEVA 507

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           GALAYLH+ AS PIYHRDIKS+NILLDE+YRAKVADFGTSK I++DQTHVTT++QGTFGY
Sbjct: 508 GALAYLHAAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGY 567

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
           LDPEY QSSQ T+KSDVYSFGVVLVELLTG+KPI S    S E  SLA YF+ +M ++RL
Sbjct: 568 LDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSY--RSVEERSLATYFLMTMEESRL 625

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
           + ILD +V+K G + +I+A A LAE+CL+LNGKKRP M+ V++EL GIR S
Sbjct: 626 FEILDARVLKEGGREEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSS 676

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis]

 Score =  466 bits (1199), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 227/340 (66%), Positives = 286/340 (84%), Gaps = 10/340 (2%)

Query: 18  FRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNR 77
           ++II+++R   +LK+KFFK+NGGLLL+Q L+S + S +++ K+F+SKEL+KAT++++ +R
Sbjct: 342 YKIIKRRRA-TKLKQKFFKRNGGLLLEQQLSSTE-SHVEQTKVFTSKELEKATDNYHTSR 399

Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           ILGQGGQGTVYKG L DGR++A+KKSKL  +D    KL++FINE+ ILSQINHRNVVKL 
Sbjct: 400 ILGQGGQGTVYKGMLTDGRVVAIKKSKLVDED----KLDQFINEVVILSQINHRNVVKLT 455

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           GCCLETE PLLVYEFIPNGTL+Q++ +   N+E+P+TWEMR R+A EVAGALAYLHS AS
Sbjct: 456 GCCLETEVPLLVYEFIPNGTLFQYIQN--PNKEFPITWEMRLRIATEVAGALAYLHSAAS 513

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
            PIYHRDIKS+NILLDE+YRAKVADFGTSK IA++QTHVTT +QGTFGYLDPEY QSSQ 
Sbjct: 514 MPIYHRDIKSSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQF 573

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
           T+KSDVYSFGVVLVELLTG+KPI S    S E  SLA YF+ +M +NRL+ ILD +V+K 
Sbjct: 574 TEKSDVYSFGVVLVELLTGQKPISSL--RSVEERSLATYFLMTMEENRLFEILDARVLKE 631

Query: 318 GKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
           G + +I+A A +AE+CL+LNGKKRP M+ V++EL GIR S
Sbjct: 632 GGREEIIAMAKMAEKCLNLNGKKRPKMKTVAIELEGIRSS 671

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera]

 Score =  464 bits (1195), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 231/351 (65%), Positives = 279/351 (79%), Gaps = 9/351 (2%)

Query: 5   SLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSK 64
           SL  L  V+      I  K+R  I+ KEK F +NGGLLL+Q L+S +G+ ID+ KLF+SK
Sbjct: 291 SLGTLLLVLCAWWLYIXLKRRKKIKYKEKCFNRNGGLLLEQQLSSSEGN-IDKTKLFTSK 349

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           EL+KAT+ +N NR++GQG QGT YKG L DGRI+AVKK K+  D     KLE+FINE+ I
Sbjct: 350 ELEKATDRYNENRVIGQGXQGTXYKGMLMDGRIVAVKKLKIMSDS----KLEQFINEVVI 405

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           L QINHRNVVKLLGCCLETE PLLVYEFIPNGTL +H+H   QNEE+P+TWEMR R+A E
Sbjct: 406 LCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHG--QNEEFPITWEMRLRIATE 463

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           V GAL+YLHS AS PIYHRDIKSTNILLB++YRAKVADFG SKF+A+DQTH+TT++QGTF
Sbjct: 464 VXGALSYLHSXASIPIYHRDIKSTNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGTF 523

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
           GYLDPEY QSSQ T+KSDVYSFG+VL+ELLTGKKPI S    S+E  SLA+YF+ SM ++
Sbjct: 524 GYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIA--SEEGKSLASYFILSMNED 581

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
           RL  +LD QV+K  +K +I A A LA RC++LNGKKRPTM EV+MEL  IR
Sbjct: 582 RLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIR 632

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis]

 Score =  460 bits (1184), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 237/356 (66%), Positives = 287/356 (80%), Gaps = 9/356 (2%)

Query: 2   ISTSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLF 61
           +S  L   F +IG      ++K+R D +L+++FFK+NGGLLLQQ L+S + S I++  +F
Sbjct: 332 LSAGLGIPFLLIGTWWLYKVQKRRKDAKLRQRFFKRNGGLLLQQQLSSSE-SSIEKTNMF 390

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           ++KEL+KAT+H+N NRILGQGGQGTVYKG L DG+++A+KKSK+A  DE   K E+FINE
Sbjct: 391 TAKELEKATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKIA--DES--KTEQFINE 446

Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
           + ILSQINHRNVVKLLGCCLETE PLLVYEFIPNGTLYQHLHD   +EE+P+TWEMR R+
Sbjct: 447 VVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHD--PSEEFPITWEMRLRI 504

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           AIE   AL+YLHS AS PIYHRDIKSTNILLD++YRAKV+DFGTSK IA+DQTHVTT++Q
Sbjct: 505 AIETGSALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQ 564

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
           GTFGYLDPEY QSSQ T+KSDVYSFGVVLVELLTG+KPI S    + E  SLA YF+ SM
Sbjct: 565 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSA--RAVEERSLAMYFLLSM 622

Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
            +NRL+ ILD +V+K G K +I+A A LA RCL+LNGKKRPTM  V  E+  IR S
Sbjct: 623 EQNRLFEILDARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRAS 678

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera]

 Score =  458 bits (1178), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 226/340 (66%), Positives = 286/340 (84%), Gaps = 10/340 (2%)

Query: 18  FRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNR 77
           ++++RK+ +DIR+K++FFK+NGGLLLQQ ++S D    ++ K+F+S EL+KAT++FN NR
Sbjct: 334 YKVVRKQ-LDIRVKKRFFKRNGGLLLQQQISS-DKIAFEKTKIFTSDELEKATDNFNKNR 391

Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           ILGQGGQGTVYKG L DGRI+AVKKSK+ VD+ +L   E FINEI ILSQINHRNVV +L
Sbjct: 392 ILGQGGQGTVYKGMLNDGRIVAVKKSKI-VDENQL---EHFINEIVILSQINHRNVVGIL 447

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           GCCLETE PLLVYEFI NGTL+Q +HD  QN E+PL+WEMR R+A+EV+GAL+YLHS  S
Sbjct: 448 GCCLETEVPLLVYEFISNGTLFQLIHD--QNSEFPLSWEMRLRIALEVSGALSYLHSACS 505

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
            PIYHRDIKSTNILLD++Y+AKV+DFGTS+ I++DQTH+TT +QGTFGYLDPEY QSSQ 
Sbjct: 506 IPIYHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQF 565

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
           T+KSDVYSFGVVLVELLTG+KPI ST   S E  SLA +F+ S++++RL+ ILD +V+K 
Sbjct: 566 TEKSDVYSFGVVLVELLTGQKPISST--RSPEEKSLATHFILSLQESRLFDILDARVVKE 623

Query: 318 GKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
           G+K  I+ FA LA RCL+LNG+KRPTM+EV+ E++ IR S
Sbjct: 624 GRKEDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVS 663

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075946|ref|XP_002304841.1| predicted protein [Populus trichocarpa] gi|222842273|gb|EEE79820.1| predicted protein [Populus trichocarpa]

 Score =  457 bits (1177), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 227/334 (67%), Positives = 276/334 (82%), Gaps = 7/334 (2%)

Query: 21  IRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILG 80
           + KKR +I LK KFFK+NGGLLLQQ L+S  GSV  + K+F+SKEL+ AT+ FN NRILG
Sbjct: 343 LAKKRKNIELKRKFFKRNGGLLLQQQLSSNHGSV-QKTKIFTSKELETATDRFNENRILG 401

Query: 81  QGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCC 140
           QGGQGTVYKG LEDGRI+AVK+S +  ++    KLEEFINE+ ILSQINHRNVVKL GCC
Sbjct: 402 QGGQGTVYKGMLEDGRIVAVKRSTIVGEE----KLEEFINEVVILSQINHRNVVKLFGCC 457

Query: 141 LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPI 200
           LETE PLLVYEFI NG L+Q+LH+ +QNE++ L+WEMR ++AIEVAGAL+YLHS AS PI
Sbjct: 458 LETEVPLLVYEFISNGNLFQYLHNFYQNEDFILSWEMRLQIAIEVAGALSYLHSAASIPI 517

Query: 201 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK 260
           YHRDIKS NILLD++YRAKV+DFG+S+ +A+DQTH+TT +QGTFGYLDPEY QSSQ TDK
Sbjct: 518 YHRDIKSANILLDDKYRAKVSDFGSSRSMAIDQTHLTTNVQGTFGYLDPEYFQSSQFTDK 577

Query: 261 SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKK 320
           SDVYSFGVVLVELL+GKKPI S+  TSQE  SLA +F+  M +NRL+ ILD QV +   +
Sbjct: 578 SDVYSFGVVLVELLSGKKPIISS--TSQETRSLATHFIVLMEENRLFDILDVQVKEDCLE 635

Query: 321 NQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
            +I+A ANLA+RCL+++ K RPTM+EVS EL  I
Sbjct: 636 EEIMAVANLAKRCLNVSRKHRPTMKEVSAELERI 669

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera]

 Score =  454 bits (1168), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 226/340 (66%), Positives = 286/340 (84%), Gaps = 10/340 (2%)

Query: 18  FRIIRKKRMDIRLKEKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNR 77
           ++++RK+ +DIR+K++FFK+NGGLLLQQ ++S D    ++ K+F+S EL+KAT++FN NR
Sbjct: 214 YKVVRKQ-LDIRVKKRFFKRNGGLLLQQQISS-DKIAFEKTKIFTSDELEKATDNFNKNR 271

Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           ILGQGGQGTVYKG L DGRI+AVKKSK+ VD+ +L   E FINEI ILSQINHRNVV +L
Sbjct: 272 ILGQGGQGTVYKGMLNDGRIVAVKKSKI-VDENQL---EHFINEIVILSQINHRNVVGIL 327

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           GCCLETE PLLVYEFI NGTL+Q +HD  QN E+PL+WEMR R+A+EV+GAL+YLHS  S
Sbjct: 328 GCCLETEVPLLVYEFISNGTLFQLIHD--QNSEFPLSWEMRLRIALEVSGALSYLHSACS 385

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
            PIYHRDIKSTNILLD++Y+AKV+DFGTS+ I++DQTH+TT +QGTFGYLDPEY QSSQ 
Sbjct: 386 IPIYHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQF 445

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
           T+KSDVYSFGVVLVELLTG+KPI ST   S E  SLA +F+ S++++RL+ ILD +V+K 
Sbjct: 446 TEKSDVYSFGVVLVELLTGQKPISST--RSPEEKSLATHFILSLQESRLFDILDARVVKE 503

Query: 318 GKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
           G+K  I+ FA LA RCL+LNG+KRPTM+EV+ E++ IR S
Sbjct: 504 GRKEDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVS 543

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	360
TAIR|locus:2200562	748	WAKL2 "wall associated kinase-	0.952	0.458	0.580	1.1e-105
TAIR|locus:2205040	792	AT1G69730 [Arabidopsis thalian	0.944	0.429	0.584	2.5e-104
TAIR|locus:2019893	751	RFO1 "RESISTANCE TO FUSARIUM O	0.941	0.451	0.585	4.1e-104
TAIR|locus:2019843	769	WAKL10 "WALL ASSOCIATED KINASE	0.952	0.446	0.574	6e-103
TAIR|locus:2200552	730	WAKL1 "wall associated kinase-	0.919	0.453	0.580	1.6e-102
TAIR|locus:2016377	788	AT1G19390 [Arabidopsis thalian	0.963	0.440	0.571	1.8e-101
TAIR|locus:2030988	764	AT1G17910 [Arabidopsis thalian	0.908	0.428	0.586	1.2e-99
TAIR|locus:2126316	786	AT4G31100 [Arabidopsis thalian	0.916	0.419	0.571	1.3e-98
TAIR|locus:2126271	793	AT4G31110 [Arabidopsis thalian	0.916	0.416	0.571	5.8e-98
TAIR|locus:2032875	720	AT1G16260 [Arabidopsis thalian	0.966	0.483	0.545	1.1e-96

TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1046 (373.3 bits), Expect = 1.1e-105, P = 1.1e-105
 Identities = 206/355 (58%), Positives = 276/355 (77%)

Query:     3 STSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCKLFS 62
             S  L+F F + G  L++ ++K+R  IR++ KFF+              +G+V +  ++FS
Sbjct:   350 SALLLFAFGIFG--LYKFVQKRRKLIRMR-KFFRRNGGMLLKQQLARKEGNV-EMSRIFS 405

Query:    63 SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
             S EL+KAT++FN NR+LGQGGQGTVYKG L DGRI+AVK+SK AVD++   ++EEFINE+
Sbjct:   406 SHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSK-AVDED---RVEEFINEV 461

Query:   123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
              +L+QINHRN+VKLLGCCLETE P+LVYEF+PNG L + LHD  ++++Y +TWE+R  +A
Sbjct:   462 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHD--ESDDYTMTWEVRLHIA 519

Query:   183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
             IE+AGAL+YLHS AS PIYHRDIK+TNILLDER RAKV+DFGTS+ + +DQTH+TT++ G
Sbjct:   520 IEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAG 579

Query:   243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
             TFGY+DPEY QSS+ T+KSDVYSFGVVLVELLTG+KP  S+   S+EN  LAA+FV +++
Sbjct:   580 TFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKP--SSRVRSEENRGLAAHFVEAVK 637

Query:   303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
             +NR+  I+DD++      +Q+++ ANLA RCL+  GKKRP M EVS+EL  IR S
Sbjct:   638 ENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1033 (368.7 bits), Expect = 2.5e-104, P = 2.5e-104
 Identities = 205/351 (58%), Positives = 270/351 (76%)

Query:     5 SLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCKLFSSK 64
             SL+F+  +   +L++ I+K+R  +  K+KFFK            S  G ++++  +FSS+
Sbjct:   383 SLIFVVGIY--LLYKFIKKQRK-LNQKKKFFKRNGGLLLQQQLISTVG-MVEKTIVFSSR 438

Query:    65 ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
             EL+KAT +F+ NRILGQGGQGTVYKG L DGRI+AVKKSK+ VD++   KLEEFINE+ I
Sbjct:   439 ELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKV-VDED---KLEEFINEVVI 494

Query:   125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
             LSQINHRN+VKLLGCCLET+ P+LVYEFIPNG L++HLHD   +E    TW +R R+AI+
Sbjct:   495 LSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEF-DENIMATWNIRLRIAID 553

Query:   185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
             +AGAL+YLHS ASSPIYHRD+KSTNI+LDE+YRAKV+DFGTS+ + +D TH+TT + GT 
Sbjct:   554 IAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTV 613

Query:   245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
             GY+DPEY QSSQ TDKSDVYSFGVVLVEL+TG+K I      SQEN +LA YF+ +M++N
Sbjct:   614 GYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFL--RSQENRTLATYFILAMKEN 671

Query:   305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
             +L+ I+D ++      +Q+ A A +A +CL+L G+KRP+M EVSMEL+ IR
Sbjct:   672 KLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1031 (368.0 bits), Expect = 4.1e-104, P = 4.1e-104
 Identities = 205/350 (58%), Positives = 267/350 (76%)

Query:     9 LFQVIGRI-LFRIIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCKLFSSKELD 67
             LF V+G   L + ++K+R  IR K  FFK            +  G+V    K+FSSKEL+
Sbjct:   358 LFLVLGIWGLIKFVKKRRKIIR-KRMFFKRNGGLLLKQQLTTRGGNV-QSSKIFSSKELE 415

Query:    68 KATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
             KAT++FN+NR+LGQGGQGTVYKG L DGRI+AVK+SK+   DE+  K+EEFINE+ +LSQ
Sbjct:   416 KATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVL--DED--KVEEFINEVGVLSQ 471

Query:   128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
             INHRN+VKL+GCCLETE P+LVYE IPNG L++ LH  H +++Y +TW++R R+++E+AG
Sbjct:   472 INHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLH--HDSDDYTMTWDVRLRISVEIAG 529

Query:   188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
             ALAYLHS AS+P+YHRD+K+TNILLDE+YRAKV+DFGTS+ I +DQTH+TT + GTFGYL
Sbjct:   530 ALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYL 589

Query:   248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
             DPEY Q+SQ TDKSDVYSFGVVLVEL+TG+KP FS     +EN  L ++F  +M++NR+ 
Sbjct:   590 DPEYFQTSQFTDKSDVYSFGVVLVELITGEKP-FSVMRP-EENRGLVSHFNEAMKQNRVL 647

Query:   308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
              I+D ++ +     Q++A A LA RCL L GKKRP M EVS+EL  IR S
Sbjct:   648 DIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009620 "response to fungus" evidence=IMP

TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1020 (364.1 bits), Expect = 6.0e-103, P = 6.0e-103
 Identities = 205/357 (57%), Positives = 272/357 (76%)

Query:     2 ISTSLVFLFQVIGRI--LFRIIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCK 59
             +STS   L   IG I  L++ IR++R  +  K+KFFK            + +G+V D  +
Sbjct:   363 LSTSFSTLV-FIGGIYWLYKFIRRQRR-LNQKKKFFKRNGGLLLQQQLTTTEGNV-DSTR 419

Query:    60 LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFI 119
             +F+S+EL+KAT +F++ RILG+GGQGTVYKG L DGRI+AVKKSK+ VD++   KLEEFI
Sbjct:   420 VFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKV-VDED---KLEEFI 475

Query:   120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLT-WEMR 178
             NE+ ILSQINHRN+VKLLGCCLET+ P+LVYEFIPNG L++HLHD   +++Y +T WE+R
Sbjct:   476 NEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHD--DSDDYTMTTWEVR 533

Query:   179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
              R+A+++AGAL+YLHS ASSPIYHRDIKSTNI+LDE++RAKV+DFGTS+ + +D TH+TT
Sbjct:   534 LRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTT 593

Query:   239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV 298
              + GT GY+DPEY QSSQ TDKSDVYSFGVVL EL+TG+K +      SQE  +LA YF 
Sbjct:   594 VVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFL--RSQEYRTLATYFT 651

Query:   299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
              +M++NRL  I+D ++    K NQ+ A A +A +CL++ G+KRP+M +VSMEL  IR
Sbjct:   652 LAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006182 "cGMP biosynthetic process" evidence=IDA

GO:0006952 "defense response" evidence=IEP

GO:0009617 "response to bacterium" evidence=IEP

GO:0009620 "response to fungus" evidence=IEP

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009723 "response to ethylene stimulus" evidence=RCA

TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1016 (362.7 bits), Expect = 1.6e-102, P = 1.6e-102
 Identities = 198/341 (58%), Positives = 263/341 (77%)

Query:    17 LFRIIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCKLFSSKELDKATNHFNVN 76
             LF++I+K+R +I   +KFFK            + DG+V +  K+FSSKEL KAT++F+++
Sbjct:   375 LFKLIKKRR-NINRSKKFFKRNGGLLLKQQLTTKDGNV-EMSKIFSSKELRKATDNFSID 432

Query:    77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
             R+LGQGGQGTVYKG L DG I+AVK+SK+ VD++   K+EEFINEI +LSQINHRN+VKL
Sbjct:   433 RVLGQGGQGTVYKGMLVDGSIVAVKRSKV-VDED---KMEEFINEIVLLSQINHRNIVKL 488

Query:   137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
             LGCCLETE P+LVYE+IPNG L++ LHD  ++++Y +TWE+R R+AIE+AGAL Y+HS A
Sbjct:   489 LGCCLETEVPILVYEYIPNGDLFKRLHD--ESDDYTMTWEVRLRIAIEIAGALTYMHSAA 546

Query:   197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
             S PI+HRDIK+TNILLDE+YRAKV+DFGTS+ + +DQTH+TT + GTFGY+DPEY  SSQ
Sbjct:   547 SFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQ 606

Query:   257 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMK 316
              T KSDVYSFGVVLVEL+TG+KP+      S+E   LA +F+ +M++NR+  I+D ++  
Sbjct:   607 YTHKSDVYSFGVVLVELITGEKPLSRV--RSEEGRGLATHFLEAMKENRVIDIIDIRIKD 664

Query:   317 LGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
               K  Q++A A LA +CL+  GK RP M+EVS EL  IR S
Sbjct:   665 ESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)]

 Score = 1006 (359.2 bits), Expect = 1.8e-101, P = 1.8e-101
 Identities = 204/357 (57%), Positives = 265/357 (74%)

Query:     2 ISTSLVFLFQVIGRILFR-IIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCKL 60
             + ++   L  V+G    R  ++K+RM  R K KFFK            +  G+V ++ ++
Sbjct:   381 VGSAFGILVLVVGIWWLRKFLKKRRMSKR-KRKFFKRNGGLLLQQQLNTNKGNV-EKTRI 438

Query:    61 FSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFIN 120
             FSS+EL+KAT++F+ +RILGQGGQGTVYKG L DGR +AVKKSK+ VD++   KLEEFIN
Sbjct:   439 FSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKV-VDED---KLEEFIN 494

Query:   121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
             E+ ILSQINHR+VVKLLGCCLETE P LVYEFIPNG L+QH+H+  ++++Y  TW MR R
Sbjct:   495 EVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHE--ESDDYTKTWGMRLR 552

Query:   181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
             +A+++AGAL+YLHS ASSPIYHRDIKSTNILLDE+YR KV+DFGTS+ + +D TH TT I
Sbjct:   553 IAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVI 612

Query:   241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
              GT GY+DPEY+ SSQ TDKSDVYSFGVVLVEL+TG+KP+ +  N SQE   LA +F  +
Sbjct:   613 SGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSN-SQEIRGLADHFRVA 671

Query:   301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
             M++NR + I+D ++    K  Q++A ANLA RCL+  GKKRP M +V  +L  I  S
Sbjct:   672 MKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)]

 Score = 989 (353.2 bits), Expect = 1.2e-99, P = 1.2e-99
 Identities = 197/336 (58%), Positives = 251/336 (74%)

Query:    19 RIIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCKLFSSKELDKATNHFNVNRI 78
             +++RK+RM  R K KFFK            +  G V ++ KLFSS+EL+KAT++FN NR+
Sbjct:   402 KLLRKRRMTNR-KRKFFKRNGGLLLQQQLNTTQGRV-EKTKLFSSRELEKATDNFNDNRV 459

Query:    79 LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
             +GQGGQGTVYKG L DGR +AVKKS + VD++   KL+EFINE+ ILSQINHR+VVKLLG
Sbjct:   460 IGQGGQGTVYKGMLVDGRSVAVKKSNV-VDED---KLQEFINEVIILSQINHRHVVKLLG 515

Query:   139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
             CCLETE P+LVYEFIPNG L+QHLH+    ++Y   W +R R+A++++GA +YLH+ A S
Sbjct:   516 CCLETEVPILVYEFIPNGNLFQHLHEEF--DDYTALWGVRMRIAVDISGAFSYLHTAACS 573

Query:   199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
             PIYHRDIKSTNILLDE+YRAKV+DFGTS+ +++D TH TT I GT GY+DPEY+ SS  T
Sbjct:   574 PIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFT 633

Query:   259 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLG 318
             +KSDVYSFGVVLVEL+TG+KP+ +   T QE   LA YF  +MR+NRL+ I+D ++    
Sbjct:   634 EKSDVYSFGVVLVELITGEKPVITLSET-QEITGLADYFRLAMRENRLFEIIDARIRNDC 692

Query:   319 KKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
             K  Q++A ANLA RCL   GK RP M EVS  L  I
Sbjct:   693 KLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)]

 Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
 Identities = 193/338 (57%), Positives = 254/338 (75%)

Query:    17 LFRIIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCKLFSSKELDKATNHFNVN 76
             L + + K+RM  R K+KFFK            +  G V+++ ++F+SKEL+KAT +F+ N
Sbjct:   390 LRKFLVKRRMAKR-KKKFFKRNGGLLLQQELNTRQG-VVEKARIFTSKELEKATENFSEN 447

Query:    77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
             R+LG GGQGTVYKG L DGR +AVKKSK+ +D++   KL+EFINE+ ILSQINHR+VVKL
Sbjct:   448 RVLGHGGQGTVYKGMLVDGRTVAVKKSKV-IDED---KLQEFINEVVILSQINHRHVVKL 503

Query:   137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
             LGCCLETE P+LVYEFI NG L++H+H+  + ++Y + W MR R+A+++AGAL+YLHS A
Sbjct:   504 LGCCLETEVPILVYEFIINGNLFKHIHEE-EADDYTMIWGMRLRIAVDIAGALSYLHSAA 562

Query:   197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
             SSPIYHRDIKSTNILLDE+YRAKVADFGTS+ + +DQTH TT I GT GY+DPEY++SSQ
Sbjct:   563 SSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQ 622

Query:   257 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMK 316
              T+KSDVYSFGV+L EL+TG KP+    NT QE ++LA +F  +M++ RL  I+D ++  
Sbjct:   623 YTEKSDVYSFGVILAELITGDKPVIMVQNT-QEIIALAEHFRVAMKERRLSDIMDARIRD 681

Query:   317 LGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
               K  Q++A ANLA +CL   G+ RP M EV  EL  I
Sbjct:   682 DSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERI 719

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)]

 Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
 Identities = 193/338 (57%), Positives = 255/338 (75%)

Query:    17 LFRIIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCKLFSSKELDKATNHFNVN 76
             L + + K+R+  R K+KFFK            + +G V ++ ++F+S+EL+KAT +F+ N
Sbjct:   399 LRKFLIKRRITKR-KKKFFKRNGGLLLLQELNTREGYV-EKTRVFNSRELEKATENFSEN 456

Query:    77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
             R+LG GGQGTVYKG L DGR +AVKKSK+ +D++   KL+EFINE+ ILSQINHR+VVKL
Sbjct:   457 RVLGHGGQGTVYKGMLVDGRTVAVKKSKV-IDED---KLQEFINEVVILSQINHRHVVKL 512

Query:   137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
             LGCCLETE P+LVYEFI NG L++H+H+  ++++Y + W MR R+A+++AGAL+YLHS A
Sbjct:   513 LGCCLETEVPMLVYEFIINGNLFKHIHEE-ESDDYTMLWGMRLRIAVDIAGALSYLHSSA 571

Query:   197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
             SSPIYHRDIKSTNILLDE+YRAKVADFGTS+ + +DQTH TT I GT GY+DPEY+QSSQ
Sbjct:   572 SSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQ 631

Query:   257 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMK 316
              T+KSDVYSFGV+L EL+TG KP+    NT QE V+LA +F  +M++ RL  I+D ++  
Sbjct:   632 YTEKSDVYSFGVILAELITGDKPVIMVQNT-QEIVALAEHFRVAMKEKRLTDIIDARIRN 690

Query:   317 LGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
               K  Q++A A +A +CL   GKKRP M EV  EL  I
Sbjct:   691 DCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERI 728

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)]

 Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
 Identities = 196/359 (54%), Positives = 257/359 (71%)

Query:     1 TISTSLVFLFQVIGRILFRIIRKKRMDIRLKEKFFKXXXXXXXXXXXXSYDGSVIDRCKL 60
             T+S+ L+ L  + G  L     +KR   + K KFF+               GSV +R K+
Sbjct:   321 TLSSGLLLL--IFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSV-NRTKV 377

Query:    61 FSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFIN 120
             FSS +L+ AT+ FN +RILGQGGQGTVYKG LEDG I+AVKKSK A+ +E L   EEFIN
Sbjct:   378 FSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSK-ALKEENL---EEFIN 433

Query:   121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
             EI +LSQINHRNVVK+LGCCLETE P+LVYEFIPN  L+ HLH+   +E++P++WE+R  
Sbjct:   434 EIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHN--PSEDFPMSWEVRLC 491

Query:   181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
             +A EVA AL+YLHS  S PIYHRD+KSTNILLDE++RAKV+DFG S+ +A+D TH+TT +
Sbjct:   492 IACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIV 551

Query:   241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
             QGT GY+DPEY QS+  T KSDVYSFGV+L+ELLTG+KP+       QE   L AYF+ +
Sbjct:   552 QGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRR--QEVRMLGAYFLEA 609

Query:   301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK 359
             MR +RL+ ILD ++ +   + +++A A LA RCL LN + RPTM +V +EL+ ++   K
Sbjct:   610 MRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRK 668

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00005799001 SubName- Full=Chromosome chr3 scaffold_158, whole genome shotgun sequence; (970 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	360
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-45
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-42
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-31
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-29
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-29
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-27
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-26
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-25
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-24
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-22
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-21
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-19
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-18
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-17
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-15
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-12
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.003
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  172 bits (438), Expect = 2e-52
 Identities = 72/198 (36%), Positives = 105/198 (53%), Gaps = 14/198 (7%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+GG GTVY  R  + G+ +A+K  K    ++    LEE + EI IL ++NH N+VKL 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK---EDSSSLLEELLREIEILKKLNHPNIVKLY 57

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G   +     LV E+   G+L   L +        L+ +   R+ +++   L YLH   S
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLH---S 110

Query: 198 SPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSS 255
           + I HRD+K  NILLD    + K+ADFG SK +      +   I GT  Y+ PE      
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKG 169

Query: 256 QLTDKSDVYSFGVVLVEL 273
             ++KSD++S GV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  169 bits (431), Expect = 8e-51
 Identities = 81/278 (29%), Positives = 119/278 (42%), Gaps = 33/278 (11%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + +   LG+G  G VY  R  + G+++A+K  K     +     E  + EI IL ++ H 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK---DRERILREIKILKKLKHP 57

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           N+V+L     + +   LV E+   G L+  L  R +  E     E RF    ++  AL Y
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED----EARF-YLRQILSALEY 112

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH   S  I HRD+K  NILLDE    K+ADFG ++   +D     T   GT  Y+ PE 
Sbjct: 113 LH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEV 167

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD 311
                     D++S GV+L ELLTGK P                 F    +   L+  + 
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGKPP-----------------FPGDDQLLELFKKIG 210

Query: 312 DQVMKLGKKNQIV--AFANLAERCLDLNGKKRPTMEEV 347
                       +     +L  + L  + +KR T EE 
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  169 bits (430), Expect = 1e-50
 Identities = 88/277 (31%), Positives = 129/277 (46%), Gaps = 25/277 (9%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + + R LG G  GTVYK +    G+I+AVK  K   +  +  K +    EI IL +++H 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHP 58

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           N+V+L+    + +   LV E+   G L+ +L         PL+ +   ++A+++   L Y
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEY 113

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     I HRD+K  NILLDE    K+ADFG +K +    + +TT   GT  Y+ PE 
Sbjct: 114 LHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEV 169

Query: 252 HQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
                    K DV+S GV+L ELLTGK P        Q    L                 
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ----LQLIRRILGPPLEFDEPK 225

Query: 311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                +  K         L ++CL+ +  KRPT EE+
Sbjct: 226 WSSGSEEAKD--------LIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  157 bits (400), Expect = 4e-46
 Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 49/286 (17%)

Query: 76  NRILGQGGQGTVYKGRLEDG-----RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
            + LG+G  G VYKG L+         +AVK  K    ++++   EEF+ E  I+ +++H
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI---EEFLREARIMRKLDH 60

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+VKLLG C E E  ++V E++P G L  +L     N    L+       A+++A  + 
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK---NRPKELSLSDLLSFALQIARGME 117

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YL S       HRD+ + N L+ E    K++DFG S+ +  D  +     +    ++ PE
Sbjct: 118 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
             +  + T KSDV+SFGV+L E+ T G++P                Y            +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP----------------Y----------PGM 208

Query: 310 LDDQVMKLGKKNQIV--------AFANLAERCLDLNGKKRPTMEEV 347
            + +V++  KK   +            L  +C   + + RPT  E+
Sbjct: 209 SNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  157 bits (399), Expect = 6e-46
 Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 32/277 (11%)

Query: 76  NRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
            + LG+G  G VYKG+L+         +AVK  K    ++++   EEF+ E  I+ +++H
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI---EEFLREARIMRKLDH 60

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            NVVKLLG C E E   +V E++  G L  +L          L+       A+++A  + 
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGME 116

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YL S       HRD+ + N L+ E    K++DFG S+ +  D  +     +    ++ PE
Sbjct: 117 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
             +  + T KSDV+SFGV+L E       IF+ G      +S      +     RL    
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWE-------IFTLGEQPYPGMSNEEVLEYLKNGYRLPQPP 226

Query: 311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +                +L  +C   + + RPT  E+
Sbjct: 227 NCPP----------ELYDLMLQCWAEDPEDRPTFSEL 253

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  154 bits (393), Expect = 4e-45
 Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 21/213 (9%)

Query: 76  NRILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
            + LG+G  G VYKG L          +AVK  K    +EE    EEF+ E  I+ +++H
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER---EEFLEEASIMKKLSH 60

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+V+LLG C + E   +V E++P G L   L          LT +   ++A+++A  + 
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH----GEKLTLKDLLQMALQIAKGME 116

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG---YL 247
           YL    S    HRD+ + N L+ E    K++DFG S+ I  D  +      G      ++
Sbjct: 117 YLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWM 171

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            PE  +  + T KSDV+SFGV+L E+ T G++P
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  154 bits (392), Expect = 6e-45
 Identities = 83/288 (28%), Positives = 128/288 (44%), Gaps = 40/288 (13%)

Query: 77  RILGQGGQGTVYKGRLEDG----RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           + LG+G  G VYKG+L+        +AVK  K    +EE    ++F+ E  ++ ++ H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER---KDFLKEARVMKKLGHPN 57

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHL----HDRHQNEEYPLTWEMRFRVAIEVAGA 188
           VV+LLG C E E   LV E++  G L  +L          E+  L+ +     AI++A  
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GY 246
           + YL S       HRD+ + N L+ E    K++DFG S+ +  D  +      G     +
Sbjct: 118 MEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRW 173

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
           + PE  +    T KSDV+SFGV+L E       IF+ G T    +S      +  +  RL
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWE-------IFTLGATPYPGLSNEEVLEYLRKGYRL 226

Query: 307 Y---HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
               +  D+                L   C  L+ + RPT  E+   L
Sbjct: 227 PKPEYCPDE-------------LYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  154 bits (391), Expect = 7e-45
 Identities = 84/281 (29%), Positives = 129/281 (45%), Gaps = 44/281 (15%)

Query: 77  RILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
            +LG+G  G+VY    +D G ++AVK  +L+ D EE  +LE    EI ILS + H N+V+
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE--ELEALEREIRILSSLQHPNIVR 63

Query: 136 LLGCCLETE--FPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYL 192
             G   + E     +  E++  G+L   L       E       +R +   ++   LAYL
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-----VIR-KYTRQILEGLAYL 117

Query: 193 HS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLDPE 250
           HS G    I HRDIK  NIL+D     K+ADFG +K +  ++    T  ++GT  ++ PE
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
             +  +    +D++S G  ++E+ TGK P    GN                    LY I 
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA----------------LYKI- 216

Query: 311 DDQVMKLGKKNQIVAFA-----NLAERCLDLNGKKRPTMEE 346
                  G+  +I         +   +CL  + KKRPT +E
Sbjct: 217 ----GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  146 bits (372), Expect = 5e-42
 Identities = 84/270 (31%), Positives = 122/270 (45%), Gaps = 32/270 (11%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+GG G VYK R    G+ +A+K     +  E   K E+ INEI IL +  H N+VK  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKV----IKLESKEKKEKIINEIQILKKCKHPNIVKYY 63

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G  L+ +   +V EF   G+L   L   +Q     LT      V  E+   L YLH   S
Sbjct: 64  GSYLKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLH---S 116

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
           + I HRDIK+ NILL      K+ DFG S  ++   T     + GT  ++ PE       
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKPY 174

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K+D++S G+  +EL  GK P                  +  M+   L+ I  +    L
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSE---------------LPPMK--ALFKIATNGPPGL 217

Query: 318 -GKKNQIVAFANLAERCLDLNGKKRPTMEE 346
              +     F +  ++CL  N +KRPT E+
Sbjct: 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 1e-34
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 36/279 (12%)

Query: 72  HFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           ++ +  ++G+G  G VYKG  LE G  +A+K+  L    EE   L+  + EI +L  + H
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE--ALKSIMQEIDLLKNLKH 58

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI---EVAG 187
            N+VK +G    ++   ++ E+  NG+L Q +  +       L       VA+   +V  
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPESL-------VAVYVYQVLQ 110

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
            LAYLH      + HRDIK+ NIL  +    K+ADFG +  +  D +     + GT  ++
Sbjct: 111 GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWM 166

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE  + S  +  SD++S G  ++ELLTG  P +           +AA          L+
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAA----------LF 209

Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
            I+ D    L  +       +   +C   +   RPT ++
Sbjct: 210 RIVQDDHPPL-PEGISPELKDFLMQCFQKDPNLRPTAKQ 247

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (310), Expect = 5e-33
 Identities = 69/204 (33%), Positives = 102/204 (50%), Gaps = 8/204 (3%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           + +G+G  G VY  R   DG++  +K+  L+   E+  + E+ +NE+ IL ++NH N++K
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK--EREDALNEVKILKKLNHPNIIK 63

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
                 E     +V E+   G L Q +  + +  + P   E      +++  AL YLHS 
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGK-PFPEEQILDWFVQLCLALKYLHS- 121

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
               I HRDIK  NI L      K+ DFG SK ++       T + GT  YL PE  Q+ 
Sbjct: 122 --RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNK 178

Query: 256 QLTDKSDVYSFGVVLVELLTGKKP 279
               KSD++S G VL EL T K P
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  119 bits (300), Expect = 2e-31
 Identities = 78/281 (27%), Positives = 118/281 (41%), Gaps = 34/281 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +     ++LGQG  G VYK R    G+I A+KK  +  D+E   +L     E+  L    
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCE 57

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
              VVK  G   +     +V E++  G+L     D  +     +   +   +A ++   L
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSL----ADLLKKVG-KIPEPVLAYIARQILKGL 112

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI----AMDQTHVTTKIQGTFG 245
            YLH+     I HRDIK +N+L++ +   K+ADFG SK +        T V     GT  
Sbjct: 113 DYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVT 165

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           Y+ PE  Q    +  +D++S G+ L+E   GK P    G  S     L            
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF--FEL------------ 211

Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           +  I D     L  +     F +    CL  + KKRP+  E
Sbjct: 212 MQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  117 bits (295), Expect = 5e-31
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 38/281 (13%)

Query: 73  FNVNRILGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F V + LG+G  G+VYK  RL D +  A+K+  L    ++  + E+ +NEI IL+ +NH 
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK--EREDAVNEIRILASVNHP 59

Query: 132 NVVK-----LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N++      L G  L      +V E+ P G L + +  R +  +  +  +  +R+ I++ 
Sbjct: 60  NIISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRK-LIPEQEIWRIFIQLL 113

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
             L  LH      I HRD+KS NILL      K+ D G SK   + +    T+I GT  Y
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPHY 167

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
           + PE  +    + KSD++S G +L E+ T   P      + Q+      Y V   +   +
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF--EARSMQD----LRYKVQRGKYPPI 221

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             I    +         +         L +  K RP  +++
Sbjct: 222 PPIYSQDL------QNFIRS------MLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  117 bits (294), Expect = 8e-31
 Identities = 69/208 (33%), Positives = 109/208 (52%), Gaps = 10/208 (4%)

Query: 73  FNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F +   +G+G  G V+K  R  D R+ A+K+  L+  +    + EE I+E  +L++++  
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR--EREEAIDEARVLAKLDSS 59

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +++     L+     +V E+  NG L++ L  +      PL  +  +R  I++   LA+
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAH 116

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     I HRDIKS N+ LD     K+ D G +K ++ D T+    I GT  YL PE 
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPEL 172

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            +     +KSDV++ GVVL E  TGK P
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (299), Expect = 1e-30
 Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 24/285 (8%)

Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH- 130
            + + R LG+G  G VY  R  D +++A+K     ++ +    +E F+ EI IL+ +NH 
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKE-VERFLREIQILASLNHP 57

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+VKL     +     LV E++  G+L   L    +  + PL+      +  ++  AL 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGR--KGPLSESEALFILAQILSALE 115

Query: 191 YLHSGASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMDQTHV-----TTKIQGTF 244
           YLHS     I HRDIK  NILLD      K+ DFG +K +    +        +   GT 
Sbjct: 116 YLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 245 GYLDPEYHQSSQL---TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
           GY+ PE      L   +  SD++S G+ L ELLTG  P     N+S  +          +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ------TLKI 226

Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
                   L   +     +    A ++L ++ L  + K R +   
Sbjct: 227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271

Length = 384

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  114 bits (288), Expect = 1e-29
 Identities = 77/275 (28%), Positives = 127/275 (46%), Gaps = 32/275 (11%)

Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G VY    L+ G ++AVK+  + + D +   ++E  +E+ +L  + H N+VK  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKE--IRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G  +  E   +  E+   GTL + L      +E      +     +++   LAYLHS   
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDE-----HVIRVYTLQLLEGLAYLHS--- 117

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG---YLDPEYHQS 254
             I HRDIK  NI LD     K+ DFG +  +  + T +  ++Q   G   Y+ PE    
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 255 SQLTDK---SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD 311
            +       +D++S G V++E+ TGK+P +S      +N     + V +  K  +     
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP-WS----ELDNEFQIMFHVGAGHKPPIPD--S 230

Query: 312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
            Q+   GK        +  +RCL+ + KKRPT  E
Sbjct: 231 LQLSPEGK--------DFLDRCLESDPKKRPTASE 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (288), Expect = 1e-29
 Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 35/233 (15%)

Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           R LG+G  G V+ G         D  ++AVK  K    ++     ++F  E  +L+   H
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND---ARKDFEREAELLTNFQH 67

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL--HDRH-------QNEEYPLTWEMRFRV 181
            N+VK  G C E + P++V+E++ +G L + L  H           +    LT     ++
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--- 238
           A+++A  + YL   AS    HRD+ + N L+      K+ DFG S+ +       TT   
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYY 178

Query: 239 KIQGT----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 286
           ++ G       ++ PE     + T +SDV+SFGVVL E+ T GK+P +   N 
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  112 bits (281), Expect = 6e-29
 Identities = 79/275 (28%), Positives = 127/275 (46%), Gaps = 34/275 (12%)

Query: 77  RILGQG--GQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV 134
           R+LG+G  G+ T+Y+ R ED  ++  K+  L    E+  +    +NEI ILS + H N++
Sbjct: 6   RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQHPNII 62

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEVAGALAYL 192
                 ++    L+  E+   GTLY  +  +     EE  + W +      ++  A++Y+
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-----FQIVSAVSYI 117

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
           H      I HRDIK+ NI L +    K+ DFG SK +  + +   T + GT  Y+ PE  
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELC 173

Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD 312
           Q  +   KSD+++ G VL ELLT K+  F   N     V +       ++ N  Y  +  
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKR-TFDATNPLNLVVKI-------VQGN--YTPVVS 223

Query: 313 QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                          +L    L  + +KRPT +EV
Sbjct: 224 VYSS--------ELISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  111 bits (281), Expect = 8e-29
 Identities = 79/211 (37%), Positives = 108/211 (51%), Gaps = 23/211 (10%)

Query: 79  LGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQINHRNVV 134
           LG+G  G V   R +D G++ A+K   K K+    E  +     + E  ILS+INH  +V
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH----TLTERNILSRINHPFIV 56

Query: 135 KLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQ-NEEYPLTWEMRFRVAIEVAGALAYL 192
           KL     +TE  L LV E+ P G L+ HL    + +EE       RF  A E+  AL YL
Sbjct: 57  KLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFYAA-EIVLALEYL 109

Query: 193 HS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           HS G    I +RD+K  NILLD     K+ DFG +K ++ + +   T   GT  YL PE 
Sbjct: 110 HSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEV 164

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
                     D +S GV+L E+LTGK P ++
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 4e-28
 Identities = 76/293 (25%), Positives = 129/293 (44%), Gaps = 32/293 (10%)

Query: 73  FNVNRILGQGGQGTVYKGRL--EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
             + +ILG+G  G+V +G+L  +DG  + V    + +D     ++EEF++E   +   +H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 131 RNVVKLLGCCLETE------FPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAI 183
            NV+KL+G C E         P+++  F+ +G L+  L + R       L  +   +  +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QG 242
           ++A  + YL   ++    HRD+ + N +L E     VADFG SK I     +   +I + 
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSM 301
              ++  E       T KSDV++FGV + E+ T G+ P     N    +     Y  H  
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD-----YLRHGN 232

Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
           R  +    LD+               +L   C   + K RPT  ++   L  I
Sbjct: 233 RLKQPEDCLDE-------------LYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  107 bits (270), Expect = 5e-27
 Identities = 73/283 (25%), Positives = 120/283 (42%), Gaps = 40/283 (14%)

Query: 70  TNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              +     +G+G  G VYK      G+ +A+KK +L   ++EL      INEI I+   
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL-----IINEILIMKDC 72

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTL----YQHLHDRHQNEEYPLTWEMRFRVAIE 184
            H N+V      L  +   +V E++  G+L     Q+           +       V  E
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--------FVRMNEPQIAYVCRE 124

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           V   L YLHS     + HRDIKS NILL +    K+ADFG +  +  +++   + + GT 
Sbjct: 125 VLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTP 180

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
            ++ PE  +      K D++S G++ +E+  G+ P                Y      + 
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP----------------YLREPPLR- 223

Query: 305 RLYHILDDQVMKLGKKNQIVA-FANLAERCLDLNGKKRPTMEE 346
            L+ I    +  L    +    F +   +CL  + +KRP+ EE
Sbjct: 224 ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  106 bits (266), Expect = 1e-26
 Identities = 71/216 (32%), Positives = 110/216 (50%), Gaps = 23/216 (10%)

Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD-----EELYKLEEFINEIFILSQINHRN 132
           +LG+G  GTVY G    G++IAVK+ +L   +     +E  KL+E   E+ +L  + H N
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQE---EVDLLKSLKHVN 63

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF-RVAIEVAGALAY 191
           +V+ LG CL+     +  EF+P G++   L     N   PL  E  F +   ++   +AY
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLP-EPVFCKYTKQILDGVAY 117

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT-----TKIQGTFGY 246
           LH+     + HRDIK  N++L      K+ DFG ++ +A    H T       + GT  +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           + PE    S    KSD++S G  + E+ TGK P+ S
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 7e-26
 Identities = 73/286 (25%), Positives = 126/286 (44%), Gaps = 37/286 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
               +   +G+G  G V  G    G+ +AVK  K     ++    + F+ E  +++ + H
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLK-----DDSTAAQAFLAEASVMTTLRH 59

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+V+LLG  L+     +V E++  G+L  +L  R       +T   +   A++V   + 
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGME 116

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YL         HRD+ + N+L+ E   AKV+DFG +K  +  Q      ++ T     PE
Sbjct: 117 YLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APE 169

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY--H 308
             +  + + KSDV+SFG++L E       I+S G      + L     H  +  R+    
Sbjct: 170 ALREKKFSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVVPHVEKGYRMEAPE 222

Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
               +V K+ K             C +L+  KRPT +++  +L  I
Sbjct: 223 GCPPEVYKVMKD------------CWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  103 bits (258), Expect = 1e-25
 Identities = 75/211 (35%), Positives = 112/211 (53%), Gaps = 18/211 (8%)

Query: 77  RILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           R++G+G  G VY G L   DG+ I  AVK      D EE+   E+F+ E  I+   +H N
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV---EQFLKEGIIMKDFSHPN 57

Query: 133 VVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           V+ LLG CL +E  PL+V  ++ +G L   +    ++E +  T +      ++VA  + Y
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGTFGYLD 248
           L   AS    HRD+ + N +LDE +  KVADFG ++ I        H  T  +    ++ 
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            E  Q+ + T KSDV+SFGV+L EL+T   P
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  103 bits (260), Expect = 1e-25
 Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 57/306 (18%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL-EDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           + F   +I+G+G   TV   +  E  +  A+K   K +L     +  K++    E  +L+
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI----KEKKVKYVKIEKEVLT 56

Query: 127 QIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           ++N H  ++KL     + E    V E+ PNG L Q++  ++ + +   T   RF  A E+
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCT---RFYAA-EI 111

Query: 186 AGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ--- 241
             AL YLHS G    I HRD+K  NILLD+    K+ DFGT+K +  + +  + K     
Sbjct: 112 LLALEYLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 242 ----------------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
                           GT  Y+ PE          SD+++ G ++ ++LTGK P F   N
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP-FRGSN 226

Query: 286 TSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME 345
                     Y          Y             N      +L E+ L L+ + R  + 
Sbjct: 227 E---------YLTFQKILKLEYSFP---------PNFPPDAKDLIEKLLVLDPQDRLGVN 268

Query: 346 EVSMEL 351
           E   EL
Sbjct: 269 EGYDEL 274

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (256), Expect = 2e-25
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 19/214 (8%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G G  G V+ G   + R +A+K  +     EE     +FI E  ++ +++H  +V+L G
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-----DFIEEAQVMMKLSHPKLVQLYG 66

Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
            C E     LV+EF+ +G L  +L    + +    + E    + ++V   +AYL S   S
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLES---S 119

Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
            + HRD+ + N L+ E    KV+DFG ++F+  DQ   +T  +    +  PE    S+ +
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179

Query: 259 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
            KSDV+SFGV++ E       +FS G T  EN S
Sbjct: 180 SKSDVWSFGVLMWE-------VFSEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  102 bits (257), Expect = 2e-25
 Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 50/297 (16%)

Query: 76  NRILGQGGQGTVYKG---RLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
            R +G+G  G VY+G     E+ +I +AVK  K           E+F+ E +I+ Q +H 
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS---VREKFLQEAYIMRQFDHP 67

Query: 132 NVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
           ++VKL+G    TE P+ +V E  P G L  +L    Q  +Y L        + +++ ALA
Sbjct: 68  HIVKLIGVI--TENPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALA 121

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YL S       HRDI + N+L+      K+ DFG S+++  +  +  +K +    ++ PE
Sbjct: 122 YLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
                + T  SDV+ FGV + E+L  G KP     N                        
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN------------------------ 214

Query: 310 LDDQVMKLGKKNQI-------VAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK 359
            +D + ++    ++           +L  +C   +  KRP   E+  +L+ I    K
Sbjct: 215 -NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEEK 270

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  101 bits (254), Expect = 5e-25
 Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 33/276 (11%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F++   LG+G  G+VYK    E G+++A+K   + V+++    L+E I EI IL Q +  
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEED----LQEIIKEISILKQCDSP 58

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +VK  G   +     +V E+   G+    + D  +     LT E    +  +    L Y
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEY 114

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH   S+   HRDIK+ NILL+E  +AK+ADFG S  +        T I GT  ++ PE 
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEV 170

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD 311
            Q     +K+D++S G+  +E+  GK P                  +H MR   ++ I +
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSD---------------IHPMRA--IFMIPN 213

Query: 312 DQVMKLGKKNQIV-AFANLAERCLDLNGKKRPTMEE 346
                L    +    F +  ++CL  + ++RP+  +
Sbjct: 214 KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (255), Expect = 5e-25
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 21/209 (10%)

Query: 77  RILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + LG+G  G V   R +      G  +AVK   L    EE +   +F  EI IL  ++H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKS--LNHSGEEQH-RSDFEREIEILRTLDHE 66

Query: 132 NVVKLLGCCLETEF--PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+VK  G C +       L+ E++P+G+L  +L  RH+++   +  +     + ++   +
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQ---INLKRLLLFSSQICKGM 122

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGY 246
            YL S       HRD+ + NIL++     K++DFG +K +  D+ +   K  G    F Y
Sbjct: 123 DYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             PE  ++S+ +  SDV+SFGV L EL T
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-24
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 18/217 (8%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
             +G+G  G VYKG L+    +AVK  +  +  +   K   F+ E  IL Q +H N+VKL
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK---FLQEAEILKQYDHPNIVKL 57

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
           +G C++ +   +V E +P G+L   L  R +     +   ++   +++ A  + YL    
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQM--SLDAAAGMEYLE--- 110

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSS 255
           S    HRD+ + N L+ E    K++DFG S+        V+  + Q    +  PE     
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
           + T +SDV+S+G++L E        FS G+T    +S
Sbjct: 171 RYTSESDVWSYGILLWE-------TFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-24
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)

Query: 79  LGQGGQGTVYKG--RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           LG G  G+V KG   ++ G+ + V    L   +      +EF+ E  +++Q++H  +V+L
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           +G C      +LV E  P G L ++L   R                A +VA  +AYL S 
Sbjct: 62  IGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES- 113

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPE--- 250
                 HRD+ + N+LL  R++AK++DFG S+ +     +      G +   +  PE   
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           Y + S    KSDV+S+GV L E  + G KP
Sbjct: 172 YGKFSS---KSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 67/213 (31%), Positives = 110/213 (51%), Gaps = 19/213 (8%)

Query: 78  ILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYK-----LEEFINEIFILSQINHR 131
           ++G G  G+VY G     G ++AVK+ +L              L+    EI +L ++ H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           N+V+ LG  L+ +   +  E++P G++   L + +   E  L   +R  V   + G L Y
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETL---VRNFVRQILKG-LNY 121

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-----IQGTFGY 246
           LH+     I HRDIK  NIL+D +   K++DFG SK +  +     T      +QG+  +
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           + PE  + +  T K+D++S G ++VE+LTGK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 3e-24
 Identities = 62/222 (27%), Positives = 112/222 (50%), Gaps = 26/222 (11%)

Query: 75  VNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           + +++G G  G V +GRL    +    +A+K  K    D++     +F+ E  I+ Q +H
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL---DFLTEASIMGQFDH 64

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+++L G   ++   +++ E++ NG+L + L  R  + +   T      +   +A  + 
Sbjct: 65  PNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGK--FTVGQLVGMLRGIASGMK 120

Query: 191 YLHSGASSPIY-HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-----IQGTF 244
           YL    S   Y HRD+ + NIL++     KV+DFG S+ +   +   TTK     I+ T 
Sbjct: 121 YL----SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT- 175

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
               PE     + T  SDV+SFG+V+ E+++ G++P +   N
Sbjct: 176 ---APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 99.1 bits (247), Expect = 5e-24
 Identities = 86/298 (28%), Positives = 127/298 (42%), Gaps = 52/298 (17%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           E +   +      +LG+G  G VY  R L     IA+K+     D   +  L E   EI 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHE---EIA 57

Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR----HQNEEYPLTWEMRF 179
           + S + HRN+V+ LG   E  F  +  E +P G+L   L  +      NE+      + F
Sbjct: 58  LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-----TIIF 112

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVT 237
               ++   L YLH    + I HRDIK  N+L++  Y    K++DFGTSK +A      T
Sbjct: 113 YTK-QILEGLKYLH---DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLA-GINPCT 166

Query: 238 TKIQGTFGYLDPEYHQSSQLTDK--------SDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
               GT  Y+ PE      + DK        +D++S G  +VE+ TGK P    G     
Sbjct: 167 ETFTGTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-- 218

Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
               AA F   M K    H    + +    KN I+       RC + +  KR +  ++
Sbjct: 219 ----AAMFKVGMFKI---HPEIPESLSAEAKNFIL-------RCFEPDPDKRASAHDL 262

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 99.1 bits (247), Expect = 5e-24
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 12/210 (5%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G+      +A+K  +     E+     +FI E  ++ +++H N+V+L G
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-----DFIEEAKVMMKLSHPNLVQLYG 66

Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
            C +     +V E++ NG L  +L +R          +M      +V  A+ YL    S+
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM----CSDVCEAMEYLE---SN 119

Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
              HRD+ + N L+ E    KV+DFG ++++  DQ   +   +    +  PE    S+ +
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 259 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            KSDV+SFGV++ E+ +  K  +   + S+
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 6e-24
 Identities = 60/213 (28%), Positives = 111/213 (52%), Gaps = 24/213 (11%)

Query: 77  RILGQGGQGTVYKG----RLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           ++LG G  GTVYKG      E  +I +A+K  +   ++      +E ++E ++++ ++H 
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR---EETSPKANKEILDEAYVMASVDHP 69

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE---EYPLTWEMRFRVAIEVAGA 188
           +VV+LLG CL +    L+ + +P G L  ++ + H++    +Y L W       +++A  
Sbjct: 70  HVVRLLGICL-SSQVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNW------CVQIAKG 121

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT-FGYL 247
           ++YL       + HRD+ + N+L+      K+ DFG +K + +D+     +       ++
Sbjct: 122 MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             E       T KSDV+S+GV + EL+T G KP
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.4 bits (245), Expect = 9e-24
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 14/199 (7%)

Query: 79  LGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +     +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 138 GCC-LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
           G C  E  F  ++ EF+  G L  +L + ++ E   +       +A +++ A+ YL    
Sbjct: 69  GVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE--- 121

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
                HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 257 LTDKSDVYSFGVVLVELLT 275
            + KSDV++FGV+L E+ T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.7 bits (241), Expect = 3e-23
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 16/219 (7%)

Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           F + R LG G  G V++G  ++   +A+K  K     ++L K ++F  E+  L ++ H++
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILK----SDDLLKQQDFQKEVQALKRLRHKH 63

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           ++ L   C   E   ++ E +  G+L   L      E   L       +A +VA  +AYL
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYL 120

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD-QTHVTTKIQGTFGYLDPEY 251
                    HRD+ + NIL+ E    KVADFG ++ I  D       KI   + +  PE 
Sbjct: 121 EE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEA 175

Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQE 289
                 + KSDV+SFG++L E+ T G+ P    G  + E
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPY--PGMNNHE 212

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 81/276 (29%), Positives = 118/276 (42%), Gaps = 38/276 (13%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G VYK R +  G ++A+K  KL   D+     E    EI +L +  H N+V   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD----FEIIQQEISMLKECRHPNIVAYF 66

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G  L  +   +V E+   G+L     D +Q    PL+      V  E    LAYLH    
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSL----QDIYQVTRGPLSELQIAYVCRETLKGLAYLHE--- 119

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ---GTFGYLDPEYHQS 254
           +   HRDIK  NILL E    K+ADFG S  +    T    K +   GT  ++ PE    
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAV 175

Query: 255 SQLTD---KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD 311
            +      K D+++ G+  +EL   + P+F                +H MR   L    +
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFD---------------LHPMRALFLISKSN 220

Query: 312 DQVMKLGKKNQ-IVAFANLAERCLDLNGKKRPTMEE 346
               KL  K +    F +  ++CL  + KKRPT  +
Sbjct: 221 FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 96.3 bits (240), Expect = 6e-23
 Identities = 81/290 (27%), Positives = 122/290 (42%), Gaps = 44/290 (15%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           + + +  ++G G    VY    L +   +A+K+  L      +   +E   E+  +SQ N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCN 57

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLY---QHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           H NVVK     +  +   LV  ++  G+L    +  + R   +E  +   ++     EV 
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----EVL 112

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA--MDQTHVTTK-IQGT 243
             L YLHS       HRDIK+ NILL E    K+ADFG S  +A   D+T    K   GT
Sbjct: 113 KGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Query: 244 FGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGK------KPIFSTGNTSQENVSLAAY 296
             ++ PE   Q      K+D++SFG+  +EL TG        P+     T Q +      
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP---- 225

Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
              S+     Y        K  K     +F  +   CL  +  KRPT EE
Sbjct: 226 ---SLETGADYK-------KYSK-----SFRKMISLCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 6e-23
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 12/204 (5%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           R LG G  G V++G   +   +AVK  K    D +     +F+ E  I+ ++ H  +++L
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-----DFLAEAQIMKKLRHPKLIQL 66

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
              C   E   +V E +  G+L ++L          L       +A +VA  +AYL   A
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLE--A 121

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
            + I HRD+ + N+L+ E    KVADFG ++ I  D        +    +  PE    ++
Sbjct: 122 QNYI-HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR 180

Query: 257 LTDKSDVYSFGVVLVELLT-GKKP 279
            + KSDV+SFG++L E++T G+ P
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.0 bits (239), Expect = 7e-23
 Identities = 87/278 (31%), Positives = 133/278 (47%), Gaps = 40/278 (14%)

Query: 77  RILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDD----EELYKLEEFINEIFILSQINHR 131
            +LG G  G+VY+G  L+DG   AVK+  LA D     E + +LE+   EI +LS++ H 
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ---EIALLSKLQHP 62

Query: 132 NVVKLLGCCLETEFPLLVY-EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
           N+V+ LG   E +  L ++ E +P G+L + L  ++ +   P+   +  R   ++   L 
Sbjct: 63  NIVQYLGTEREED-NLYIFLELVPGGSLAK-LLKKYGSFPEPVI-RLYTR---QILLGLE 116

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLDP 249
           YLH        HRDIK  NIL+D     K+ADFG +K +         K  +G+  ++ P
Sbjct: 117 YLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAP 170

Query: 250 EY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           E   Q       +D++S G  ++E+ TGK P +S      E V  AA F    R   L  
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPP-WS----QLEGV--AAVF-KIGRSKELPP 222

Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           I D   +    K+ I+       +CL  +   RPT  E
Sbjct: 223 IPDH--LSDEAKDFIL-------KCLQRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 96.4 bits (241), Expect = 7e-23
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 14/206 (6%)

Query: 78  ILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
            LG+G  G VYK R  + G I+A+KK +L  ++E +      + EI +L ++ H N+VKL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS--TALREISLLKELKHPNIVKL 63

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
           L          LV+E+     L ++L  R      PL+  +   +  ++   LAY HS  
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRPG----PLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              I HRD+K  NIL++     K+ADFG ++   +     T ++  T  Y  PE    S+
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSK 174

Query: 257 LTDKS-DVYSFGVVLVELLTGKKPIF 281
               + D++S G +  E++TG KP+F
Sbjct: 175 HYSTAVDIWSVGCIFAEMITG-KPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.5 bits (238), Expect = 9e-23
 Identities = 67/209 (32%), Positives = 97/209 (46%), Gaps = 12/209 (5%)

Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           HF + R++G+G  G V   +  D + +   K        E   +   +NE  IL ++NH 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            +V L     + E   LV + +  G L  HL      +EE     +++F +  E+  AL 
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-----QVKFWIC-EIVLALE 114

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YLHS     I HRDIK  NILLDE+    + DF  +  +  D   +TT   GT GY+ PE
Sbjct: 115 YLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
                  +   D +S GV   E L GK+P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.0 bits (239), Expect = 9e-23
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 27/227 (11%)

Query: 79  LGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHR 131
           LG+G  G VYKG L           +A+K     + +    K+ +EF  E  ++S + H 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIK----TLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR-----------FR 180
           N+V LLG C + +   +++E++ +G L++ L     + +                     
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTK 239
           +AI++A  + YL   +S    HRD+ + N L+ E    K++DFG S+ I + D   V +K
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE     + T +SD++SFGVVL E+ + G +P +   N
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQINHR 131
             +G+G  G VYK R  + G ++A+KK ++  ++E+    E F    I EI +L ++ H 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEK----EGFPITAIREIKLLQKLRHP 58

Query: 132 NVVKLLGCCLETEFP--LLVYEFIPNGTLYQHLHDR---HQNEEYPLTWEMRFRVAIEVA 186
           N+V+L             +V+E++         HD      + E   T         ++ 
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMD--------HDLTGLLDSPEVKFTESQIKCYMKQLL 110

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
             L YLHS   + I HRDIK +NIL++     K+ADFG ++      +   T    T  Y
Sbjct: 111 EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167

Query: 247 LDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---------------- 289
             PE    +++   + D++S G +L EL  G KPIF  G+T  E                
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIF-QGSTELEQLEKIFELCGSPTDEN 225

Query: 290 --NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              VS   +F +   K      L +      K     +  +L ++ L L+ KKR + ++ 
Sbjct: 226 WPGVSKLPWFENLKPKKPYKRRLREFF----KHLIDPSALDLLDKLLTLDPKKRISADQA 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 16/209 (7%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYK-LEEFINEIFILSQINHRNVV 134
           ++LGQG  G VY    ++ GR +AVK+     D  E  K +     EI +L  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY-PLTWEMRFRVAIEVAGALAYLH 193
           +  GC  + E   +  E++P G++   L      + Y  LT  +  +   ++   + YLH
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQL------KAYGALTETVTRKYTRQILEGVEYLH 121

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLDPE 250
           S   + I HRDIK  NIL D     K+ DFG SK    I    T + + + GT  ++ PE
Sbjct: 122 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPE 177

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
                    K+DV+S G  +VE+LT K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 94.9 bits (236), Expect = 2e-22
 Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 19/217 (8%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKL----AVDDEELYKLEEFINEIFILS 126
            +   + LG G   + Y+ R ++ G ++AVK+       + + EE+   E    EI +++
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVV--EALRKEIRLMA 58

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           ++NH +++++LG   E     L  E++  G++   L      +E      +      ++ 
Sbjct: 59  RLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-----AVIINYTEQLL 113

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQT---HVTTKIQG 242
             L+YLH    + I HRD+K  N+L+D    R ++ADFG +  +A   T       ++ G
Sbjct: 114 RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           T  ++ PE  +  Q     DV+S G V++E+ T K P
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 95.1 bits (236), Expect = 2e-22
 Identities = 82/292 (28%), Positives = 136/292 (46%), Gaps = 35/292 (11%)

Query: 75  VNRILGQGGQGTVYKGRL-EDGRI--IAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + + LG+G  G+V +G+L +D  I  +AVK  K+A+      ++E+F++E   + + +H 
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHP 60

Query: 132 NVVKLLGCCLETE------FPLLVYEFIPNGTLYQH-LHDRHQNEEYPLTWEMRFRVAIE 184
           NV++L+G CL+T        P+++  F+ +G L+   L+ R  +    L  +M  +   +
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGT 243
           +A  + YL   +S    HRD+ + N +L+E     VADFG SK I     +   +I +  
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMR 302
             ++  E       T KSDV+SFGV + E+ T G+ P         EN  +  Y     R
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLRQGNR 232

Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
             +    LD                +L   C  LN K RP+ E +  EL   
Sbjct: 233 LKQPPDCLD-------------GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 49/278 (17%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK       +++A+K   L   ++E+   E+   EI  LSQ     + K  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI---EDIQQEIQFLSQCRSPYITKYY 65

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI---EVAGALAYLHS 194
           G  L+     ++ E+   G+    L     +E Y         +A    EV   L YLH 
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY---------IAFILREVLLGLEYLHE 116

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 254
                  HRDIK+ NILL E    K+ADFG S  +    +   T + GT  ++ PE  + 
Sbjct: 117 EGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQ 172

Query: 255 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR------KNRLYH 308
           S   +K+D++S G+  +EL  G+ P             L+    H MR      KN    
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP-------------LSDL--HPMRVLFLIPKNNPPS 217

Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           +  ++  K  K        +    CL+ + K+RP+ +E
Sbjct: 218 LEGNKFSKPFK--------DFVSLCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 94.7 bits (236), Expect = 3e-22
 Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 33/282 (11%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKLEEFINEIFILSQINHRN 132
           R LGQG  G VY+G L  G +    ++++A+    ++  + +  EF+NE  ++ + N  +
Sbjct: 12  RELGQGSFGMVYEG-LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY-----PLTWEMRFRVAIEVAG 187
           VV+LLG     +  L+V E +  G L  +L  R    E      P T +   ++A E+A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGY 246
            +AYL   A+    HRD+ + N ++ E    K+ DFG ++ I   D      K      +
Sbjct: 131 GMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           + PE  +    T KSDV+SFGVVL E+ T  ++P     N   E V              
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEV-------------- 230

Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           L  ++D   + L  +N       L   C   N K RPT  E+
Sbjct: 231 LKFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.0 bits (234), Expect = 3e-22
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 79  LGQGGQGTVYKGRLED--GRII--AVKKSKLAVDDEELYK-LEEFINEIFILSQINHRNV 133
           LG G  G V +G      G++I  AVK     +  ++L   +++F+ E  I+  ++H N+
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVK----CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 134 VKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           ++L G  L    PL +V E  P G+L   L        + ++    +  A+++A  + YL
Sbjct: 59  IRLYGVVLTH--PLMMVTELAPLGSLLDRLRKDALGH-FLISTLCDY--AVQIANGMRYL 113

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT--FGYLDPE 250
            S       HRD+ + NILL    + K+ DFG  + +  ++ H   +      F +  PE
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             ++   +  SDV+ FGV L E+ T G++P
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 4e-22
 Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 31/272 (11%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V K      G+I+AVK  +L +++    ++   + E+ IL + N   +V   
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI---LRELDILHKCNSPYIVGFY 65

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
           G         +  E++  G+L + L + + +  E  L      ++A+ V   L YLH   
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKH 120

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYHQS 254
              I HRD+K +NIL++ R + K+ DFG S  +  ++ +T V     GT  Y+ PE  Q 
Sbjct: 121 K--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQG 173

Query: 255 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV 314
           +  + KSD++S G+ L+EL TG+ P     +       L            L +I+++  
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL------------LQYIVNEPP 221

Query: 315 MKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
            +L        F +    CL  + ++RP+ +E
Sbjct: 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.1 bits (231), Expect = 5e-22
 Identities = 79/276 (28%), Positives = 126/276 (45%), Gaps = 31/276 (11%)

Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +LG+G  G V+KG L+D   +AVK  K  +  E   K   F++E  IL Q +H N+VKL+
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK---FLSEARILKQYDHPNIVKLI 58

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C + +   +V E +P G     L  R + +E      ++F  A++ A  +AYL    S
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKF--ALDAAAGMAYLE---S 111

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSSQ 256
               HRD+ + N L+ E    K++DFG S+    D  + ++ + Q    +  PE     +
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGR 170

Query: 257 LTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM 315
            + +SDV+S+G++L E  + G  P     N          Y +   +K        D V 
Sbjct: 171 YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQK------CPDDVY 224

Query: 316 KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
           K            + +RC D   + RP   E+  EL
Sbjct: 225 K------------VMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 7e-22
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 20/214 (9%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
               + R LG G  G V+ G       +AVK  K           E F+ E  I+ ++ H
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK-----PGTMSPEAFLQEAQIMKKLRH 60

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
             +V+L   C E E   +V E++  G+L   L      E   L       +A ++A  +A
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMA 117

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--IQGTFGY 246
           YL S       HRD+ + NIL+ E    K+ADFG ++ I  D+       K  I+ T   
Sbjct: 118 YLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT--- 171

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             PE     + T KSDV+SFG++L E++T G+ P
Sbjct: 172 -APEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.7 bits (233), Expect = 7e-22
 Identities = 79/255 (30%), Positives = 117/255 (45%), Gaps = 37/255 (14%)

Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK  L     E   L +F  EI IL 
Sbjct: 5   HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKK--LQHSTAE--HLRDFEREIEILK 60

Query: 127 QINHRNVVKLLGCCLETEFP--LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            + H N+VK  G C         LV E++P G+L  +L    Q     L        A +
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQ 116

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG-- 242
           +   + YL    S    HRD+ + NIL++   R K+ DFG +K +  D+ +   +  G  
Sbjct: 117 ICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173

Query: 243 -TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
             F Y  PE    S+ +  SDV+SFGVVL EL T           S ++ S  A F+  M
Sbjct: 174 PIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YSDKSCSPPAEFMRMM 222

Query: 302 RKNR-----LYHILD 311
             ++     +YH+++
Sbjct: 223 GNDKQGQMIVYHLIE 237

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.1 bits (232), Expect = 9e-22
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 27/274 (9%)

Query: 78  ILGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
            +G+G  GTV K  R  DG+I+  K+       E+  + ++ ++E+ IL ++ H N+V+ 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--EKQQLVSEVNILRELKHPNIVRY 64

Query: 137 LGCCLETEFPLL--VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
               ++     L  V E+   G L Q L  + + E   +  E  +R+  ++  AL   H+
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 195 G--ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
                + + HRD+K  NI LD     K+ DFG +K +  D +   T + GT  Y+ PE  
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQL 182

Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD 312
                 +KSD++S G ++ EL     P F+  N     + LA+  +   +  R+ +    
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP-FTARN----QLQLASK-IKEGKFRRIPYRYSS 236

Query: 313 QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           ++      N+++         L+++  KRP+ EE
Sbjct: 237 EL------NEVIKS------MLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 70/271 (25%), Positives = 118/271 (43%), Gaps = 22/271 (8%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G+V K +      +  KK         + K  + + E+ I+ +     +V   G
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK--QILRELQIMHECRSPYIVSFYG 70

Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
             L      +  EF+  G+L     DR   +  P+  E+  ++A+ V   L YL++    
Sbjct: 71  AFLNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VH 123

Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
            I HRDIK +NIL++ R + K+ DFG S  +  ++  T V     GT  Y+ PE  Q  +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGK 178

Query: 257 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMK 316
            T KSDV+S G+ ++EL  GK P   +                    + L  I+ +   +
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL------DLLQQIVQEPPPR 232

Query: 317 LGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           L   +      +  + CL  +  +RPT +++
Sbjct: 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 92.2 bits (229), Expect = 2e-21
 Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 37/283 (13%)

Query: 78  ILGQGGQGTVYKG-RLEDGRIIAVKKSKL----AVDDEELYK--LEEFINEIFILSQINH 130
           ++G+G  G VY    +  G ++AVK+ +L    A   +   K  ++   +EI  L  ++H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+V+ LG     E+  +  E++P G++   L   +   E  L    RF    +V   LA
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR-TYGRFEEQLV---RF-FTEQVLEGLA 122

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK----FIAMDQTHVTTKIQGTFGY 246
           YLHS     I HRD+K+ N+L+D     K++DFG SK        DQ      +QG+  +
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMSMQGSVFW 176

Query: 247 LDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
           + PE   S     + K D++S G V++E+  G++P       S E    A + + + R  
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP------WSDEEAIAAMFKLGNKRSA 230

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
               I  D  M L          +    C  +N   RPT  E+
Sbjct: 231 P--PIPPDVSMNLSP-----VALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 95.3 bits (237), Expect = 2e-21
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 46/288 (15%)

Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI--LSQINHRNV 133
             ++ +G +G  YKG+     +  V K    V+          I    I  + ++ H N+
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNI 745

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           VKL+G C   +   L++E+I    L + L +        L+WE R ++AI +A AL +LH
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLH 797

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
              S  +   ++    I++D +    +        +  D     +       Y+ PE  +
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRE 851

Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKP----------IFSTGNTSQENVSLAAYFVHSMRK 303
           +  +T+KSD+Y FG++L+ELLTGK P          I         +  L  +   S+R 
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911

Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
           +   +           +N+IV   NLA  C   +   RP   +V   L
Sbjct: 912 DVSVN-----------QNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 92.3 bits (229), Expect = 3e-21
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 31/270 (11%)

Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  GTVY    +  G+ +A+K+  L    ++  K E  INEI ++ +  H N+V  L
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNL----QQQPKKELIINEILVMRENKHPNIVNYL 82

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V E++  G+L   + +   +E           V  E   AL +LHS   
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 133

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
           + + HRDIKS NILL      K+ DFG    I  +Q+  +T + GT  ++ PE       
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K D++S G++ +E++ G+ P  +      EN   A Y + +     L +         
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTPELQN--------- 237

Query: 318 GKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             +     F +   RCL+++ +KR + +E+
Sbjct: 238 -PEKLSAIFRDFLNRCLEMDVEKRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 74/296 (25%), Positives = 127/296 (42%), Gaps = 49/296 (16%)

Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           R +GQG  G V++ R       E   ++AVK  K   ++       +F  E  ++++ +H
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDH 67

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR--HQNEEY---------------PL 173
            N+VKLLG C   +   L++E++  G L + L  R                       PL
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMD 232
           +   +  +A +VA  +AYL   +     HRD+ + N L+ E    K+ADFG S+ I + D
Sbjct: 128 SCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184

Query: 233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV 291
               +        ++ PE    ++ T +SDV+++GVVL E+ + G +P +   +   E V
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---EEV 241

Query: 292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                         +Y++ D  V+     N  +   NL   C       RP+   +
Sbjct: 242 --------------IYYVRDGNVLSC-PDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 92.6 bits (230), Expect = 5e-21
 Identities = 79/246 (32%), Positives = 114/246 (46%), Gaps = 47/246 (19%)

Query: 48  NSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLA 106
           +S  GS     K  S  EL++      VNRI G G  GTVYK      GR+ A+K   + 
Sbjct: 60  SSASGSAPSAAKSLS--ELER------VNRI-GSGAGGTVYKVIHRPTGRLYALK---VI 107

Query: 107 VDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-----EFPLLVYEFIPNGTLYQH 161
             + E     +   EI IL  +NH NVVK    C +      E  +L+ EF+  G+L   
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL--- 159

Query: 162 LHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA 221
               H  +E  L       VA ++   +AYLH      I HRDIK +N+L++     K+A
Sbjct: 160 -EGTHIADEQFLA-----DVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIA 210

Query: 222 DFGTSKFIA--MDQTHVTTKIQGTFGYLDPEYHQSSQLTD------KSDVYSFGVVLVEL 273
           DFG S+ +A  MD  + +    GT  Y+ PE   ++ L          D++S GV ++E 
Sbjct: 211 DFGVSRILAQTMDPCNSSV---GTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEF 266

Query: 274 LTGKKP 279
             G+ P
Sbjct: 267 YLGRFP 272

Length = 353

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 91.5 bits (228), Expect = 5e-21
 Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 20/214 (9%)

Query: 73  FNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQI 128
           F   + LG G  G V   R +  G+  A+K   K+K+     +L ++E  +NE  IL  I
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV----KLKQVEHVLNEKRILQSI 58

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H  +V L G   +     LV E++P G L+ HL    +  E       RF  A +V  A
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP----VARFYAA-QVVLA 113

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L YLHS     I +RD+K  N+LLD     K+ DFG +K +   +T+    + GT  YL 
Sbjct: 114 LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYT---LCGTPEYLA 166

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           PE   S       D ++ G+++ E+L G  P F 
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 91.2 bits (226), Expect = 6e-21
 Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 25/226 (11%)

Query: 79  LGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           LG+G  G V+          +D  ++AVK  K A +        +F  E  +L+ + H++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ----DFQREAELLTVLQHQH 68

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLH----DRHQNEEY------PLTWEMRFRVA 182
           +V+  G C E    L+V+E++ +G L + L     D              LT      +A
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQ 241
            ++A  + YL   AS    HRD+ + N L+ +    K+ DFG S+ I + D   V  +  
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 286
               ++ PE     + T +SD++SFGVVL E+ T GK+P +   NT
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 90.6 bits (225), Expect = 7e-21
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 38/287 (13%)

Query: 78  ILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
            LG+G  G V+  +      E G  + + K+     DE L    EF  E+ +  +++H+N
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKLSHKN 69

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY----PLTWEMRFRVAIEVAGA 188
           VV+LLG C E E   ++ E+   G L Q L      +E     PL+ + +  +  ++A  
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           + +L   +++   HRD+ + N L+  +   KV+    SK +   + +          +L 
Sbjct: 130 MDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYF---VHSMRKN 304
           PE  Q    + KSDV+SFGV++ E+ T G+ P +   +    N   A      V     +
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPS 246

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
           RLY ++                     RC  +N K RP+  E+   L
Sbjct: 247 RLYKLM--------------------TRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.4 bits (224), Expect = 1e-20
 Identities = 80/310 (25%), Positives = 132/310 (42%), Gaps = 53/310 (17%)

Query: 75  VNRILGQGGQGTVYKG---RLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           + + LG+G  G V K    RL+ GR     +AVK  K      EL  L   ++E  +L Q
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLK-GRAGYTTVAVKMLKENASSSELRDL---LSEFNLLKQ 59

Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL--------------------HDRHQ 167
           +NH +V+KL G C +    LL+ E+   G+L   L                    +  + 
Sbjct: 60  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK 227
           +E   LT       A +++  + YL   A   + HRD+ + N+L+ E  + K++DFG S+
Sbjct: 120 DER-ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 228 FIAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
            +  + ++V  +K +    ++  E       T +SDV+SFGV+L E++T           
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------- 224

Query: 287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
                 L       +   RL+++L         +N      NL   C      KRPT  +
Sbjct: 225 ------LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFAD 278

Query: 347 VSMELNGIRG 356
           +S EL  +  
Sbjct: 279 ISKELEKMMV 288

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 17/215 (7%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           N + V  ++G+G  G V K R    G I+A+KK K + DDE++ K    + E+ +L Q+ 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLR 58

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVAIEVAG 187
           H N+V L           LV+E++   TL + L      E  P  L  +       ++  
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVER-TLLELL------EASPGGLPPDAVRSYIWQLLQ 111

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           A+AY HS     I HRDIK  NIL+ E    K+ DFG ++ +        T    T  Y 
Sbjct: 112 AIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168

Query: 248 DPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 281
            PE         K  DV++ G ++ ELL G +P+F
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 79/318 (24%), Positives = 132/318 (41%), Gaps = 55/318 (17%)

Query: 67  DKATNHFNVNRILGQGGQGTVY------------KGRLEDG-----RIIAVKKSKLAVDD 109
           +      N    LG+G  G V+            K   E+       ++AVK  +    D
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 110 EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE 169
                 E+F+ E+ ILS+++  N+ +LLG C       ++ E++ NG L Q L  +H  E
Sbjct: 61  NAR---EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ-KHVAE 116

Query: 170 E-------YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD 222
                     L++     +A ++A  + YL    S    HRD+ + N L+ + Y  K+AD
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIAD 173

Query: 223 FGTSKFIAMDQTHVTTKIQGT----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GK 277
           FG S+ +    +    ++QG       ++  E     + T KSDV++FGV L E+LT  +
Sbjct: 174 FGMSRNL---YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230

Query: 278 KPIFSTGNTSQ--ENVSLAAYFVHSMRKNRLYHILDDQVMKLGK-KNQIVAFANLAERCL 334
           +  +      Q  EN   A +F             D + + L +  N       L   C 
Sbjct: 231 EQPYEHLTDQQVIEN---AGHF----------FRDDGRQIYLPRPPNCPKDIYELMLECW 277

Query: 335 DLNGKKRPTMEEVSMELN 352
             + + RPT  E+ + L 
Sbjct: 278 RRDEEDRPTFREIHLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 23/227 (10%)

Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + R LG+G  G V+          +D  ++AVK  K A D+      ++F  E  +L+ +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR----KDFHREAELLTNL 64

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR--------HQNEEYPLTWEMRFR 180
            H ++VK  G C+E +  ++V+E++ +G L + L             N    LT      
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTK 239
           +A ++A  + YL   AS    HRD+ + N L+ E    K+ DFG S+ + + D   V   
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE     + T +SDV+S GVVL E+ T GK+P +   N
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 17/213 (7%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKK-SKLAVDDEELYKLEEFI-NEIFILSQINHRNVVK 135
           LG GG G V   +++   R  A+K   K  + +      +E I +E  IL + NH  +VK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE---TGQQEHIFSEKEILEECNHPFIVK 57

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           L     + ++  ++ E+   G L+  L DR   +EY      RF +A  V  A  YLH+ 
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEY----TARFYIA-CVVLAFEYLHNR 112

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
               I +RD+K  N+LLD     K+ DFG +K +   Q   T    GT  Y+ PE   + 
Sbjct: 113 G---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNK 167

Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
                 D +S G++L ELLTG+ P F   +   
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPP-FGEDDEDP 199

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 83/295 (28%), Positives = 122/295 (41%), Gaps = 46/295 (15%)

Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKK----SKLAVDDEELYK 114
           LFS  + +K    F   R +G G  G VY  R +    ++A+KK     K + +     K
Sbjct: 7   LFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-----K 58

Query: 115 LEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLT 174
            ++ I E+  L Q+ H N ++  GC L      LV E+         + + H+    PL 
Sbjct: 59  WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSA--SDILEVHKK---PLQ 113

Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
                 +       LAYLHS       HRDIK+ NILL E    K+ADFG++  ++   +
Sbjct: 114 EVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170

Query: 235 HVTTKIQGTFGYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
            V     GT  ++ PE        Q   K DV+S G+  +EL   K P+F+    S    
Sbjct: 171 FV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--- 222

Query: 292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
                         LYHI  +    L   +    F N  + CL    + RP+ EE
Sbjct: 223 --------------LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE 263

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 37/282 (13%)

Query: 79  LGQGGQGTVYKGRLEDG--RIIAVKK-----SKLAVDDEELYK-LEEFINEI-FILSQIN 129
           LG G  G VYK R ++    ++A+K+          D  E  K + + ++E+  I  Q+ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 130 HRNVVKLLGCCLETEFPLLVYEFI---PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           H N+V+     LE +   +V + I   P G  +  L ++ Q       W +     +++ 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI----FVQMV 123

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
            AL YLH      I HRD+   NI+L E  +  + DFG +K          T + GT  Y
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
             PE  ++    +K+DV++FG +L ++ T + P +ST       +SLA   V       +
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIV-----EAV 229

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS 348
           Y  L + +      ++ V    +   CL  + + RP + +VS
Sbjct: 230 YEPLPEGMY-----SEDVTD--VITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.4 bits (220), Expect = 7e-20
 Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 33/216 (15%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFIN-----EIFILSQINHRN 132
           LG+G    VYK R  E GRI+A+KK KL     E  + ++ IN     EI +L ++ H N
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELKHPN 63

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA------IEVA 186
           ++ LL          LV+EF+    L + + D+           +    A      +   
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDK----------SIVLTPADIKSYMLMTL 112

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
             L YLHS   + I HRD+K  N+L+      K+ADFG ++        +T ++  T  Y
Sbjct: 113 RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWY 168

Query: 247 LDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
             PE    +       D++S G +  ELL    P  
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFL 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 88.2 bits (218), Expect = 9e-20
 Identities = 81/278 (29%), Positives = 118/278 (42%), Gaps = 41/278 (14%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           R +G G  G VY  R +    ++A+KK   +   +   K ++ I E+  L +I H N ++
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL---AYL 192
             GC L      LV E+           D  +  + PL       +A    GAL   AYL
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSA-----SDLLEVHKKPL---QEVEIAAITHGALQGLAYL 141

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY- 251
           HS     + HRDIK+ NILL E  + K+ADFG++   +   + V     GT  ++ PE  
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193

Query: 252 --HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
                 Q   K DV+S G+  +EL   K P+F+    S                  LYHI
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------------LYHI 236

Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             ++   L        F N  + CL    + RPT EE+
Sbjct: 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 14/205 (6%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R    G I+A+KK KL  + E + K    + EI +L ++NH N++KLL
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA--LREIKLLKELNHPNIIKLL 64

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                     LV+EF+ +  LY+ + DR    +  L   +      ++   LA+ HS   
Sbjct: 65  DVFRHKGDLYLVFEFM-DTDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHG- 118

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQ 256
             I HRD+K  N+L++     K+ADFG ++         T  +  T  Y  PE       
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKG 175

Query: 257 LTDKSDVYSFGVVLVELLTGKKPIF 281
            +   D++S G +  ELL+  +P+F
Sbjct: 176 YSTPVDIWSVGCIFAELLSR-RPLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 18/207 (8%)

Query: 78  ILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH---RNV 133
           ++G+G  G VY+G+ +  GR++A+K   L   D+++    +   E+ +LSQ+      N+
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV---SDIQREVALLSQLRQSQPPNI 64

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
            K  G  L+     ++ E+   G++   +      E+Y ++  +R     EV  AL Y+H
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY-ISVIIR-----EVLVALKYIH 118

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
                 + HRDIK+ NIL+      K+ DFG +  +  + +  +T + GT  ++ PE   
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVIT 174

Query: 254 SSQLTD-KSDVYSFGVVLVELLTGKKP 279
             +  D K+D++S G+ + E+ TG  P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 87.2 bits (216), Expect = 1e-19
 Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 22/219 (10%)

Query: 77  RILGQGGQGTVYKGRLED------GRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
             LG G  G VY+G   D      G I +AVK  +    D+E    +EF+ E  ++S  N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK---KEFLKEAHLMSNFN 57

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVAIEVAG 187
           H N+VKLLG CL  E   ++ E +  G L  +L D       P  LT +    + ++VA 
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDE-----RYRAKVADFGTSKFI-AMDQTHVTTKIQ 241
              YL         HRD+ + N L+ E         K+ DFG ++ I   D      +  
Sbjct: 118 GCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               ++ PE     + T +SDV+SFGV++ E+LT G++P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 61/222 (27%), Positives = 115/222 (51%), Gaps = 17/222 (7%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           +H    +++G G  G V++G L+  GR    +A+K  K    +++    ++F++E  I+ 
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           Q +H N+++L G   + +  +++ E++ NG L ++L D H  E          R    +A
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLR---GIA 117

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD--QTHVTTKIQGTF 244
             + YL   +     HRD+ + NIL++     KV+DFG S+ +  D   T+ T+  +   
Sbjct: 118 AGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +  PE     + T  SDV+SFG+V+ E+++ G++P +   N
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 30/233 (12%)

Query: 75  VNRILGQGGQGTVYKGR------LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + R LG+G  G V+          +D  ++AVK    A+ D  L   ++F  E  +L+ +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNL 64

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-------------HDRHQNEEYPLTW 175
            H ++VK  G C + +  ++V+E++ +G L + L               R    E  L+ 
Sbjct: 65  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS- 123

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQT 234
                +A ++A  + YL   AS    HRD+ + N L+      K+ DFG S+ + + D  
Sbjct: 124 -QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179

Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 286
            V         ++ PE     + T +SDV+SFGV+L E+ T GK+P F   NT
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.2 bits (213), Expect = 2e-19
 Identities = 61/211 (28%), Positives = 109/211 (51%), Gaps = 23/211 (10%)

Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
              +  I+G+G  G V +G    G+ +AVK  K  V        + F+ E  ++++++H+
Sbjct: 7   KLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV------TAQAFLEETAVMTKLHHK 59

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           N+V+LLG  L      +V E +  G L   L  R +     +   ++F  +++VA  + Y
Sbjct: 60  NLVRLLGVILHNGL-YIVMELMSKGNLVNFLRTRGR-ALVSVIQLLQF--SLDVAEGMEY 115

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTTKIQGTFGYLDP 249
           L S     + HRD+ + NIL+ E   AKV+DFG ++   + +D + +  K      +  P
Sbjct: 116 LES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAP 166

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           E  +  + + KSDV+S+GV+L E+ + G+ P
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 81/298 (27%), Positives = 129/298 (43%), Gaps = 40/298 (13%)

Query: 73  FNVNRILGQGGQGTVYKGRL--EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           F + R+LG+G  G+V + +L  EDG    V    L  D      +EEF+ E   + + +H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 131 RNVVKLLGCCLETE------FPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAI 183
            NV+KL+G  L +        P+++  F+ +G L+  L   R   E + L  +   R  I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++A  + YL   +S    HRD+ + N +L+E     VADFG SK I     +     QG 
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR----QGC 173

Query: 244 FGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYF 297
              L  ++     L D      SDV++FGV + E++T G+ P         EN  +  Y 
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYL 228

Query: 298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
           +   R  +    L+D                L  +C     K RP+ + +  +L  I 
Sbjct: 229 IKGNRLKQPPDCLED-------------VYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 86/298 (28%), Positives = 129/298 (43%), Gaps = 47/298 (15%)

Query: 66  LDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           L   T  F +  ++G+G  G VYK R  + G+++A+K   +  D+EE  K E   N +  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE--YNILRK 58

Query: 125 LSQINHRNVVKLLGCCLETEFPL------LVYEFIPNGT---LYQHLHDRHQN-EEYPLT 174
            S  NH N+    G  ++   P       LV E    G+   L + L  + +  +E  + 
Sbjct: 59  YS--NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116

Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
           + +R     E    LAYLH    + + HRDIK  NILL +    K+ DFG S  +     
Sbjct: 117 YILR-----ETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG 168

Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
              T I GT  ++ PE     +  D     +SDV+S G+  +EL  GK P+         
Sbjct: 169 RRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD------- 220

Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKL-GKKNQIVAFANLAERCLDLNGKKRPTMEE 346
                   +H MR   L+ I  +    L   +N    F +    CL  N ++RP MEE
Sbjct: 221 --------MHPMRA--LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE 268

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 86.7 bits (214), Expect = 3e-19
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 16/209 (7%)

Query: 77  RILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLE-EFINEIFILSQINHRNVV 134
           ++LG G  GTVYKG  + +G  + +  +   +++    K   EF++E  I++ ++H ++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEVAGALAYL 192
           +LLG CL      LV + +P+G L  ++H+   N   +  L W       +++A  + YL
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLDPEY 251
                  + HRD+ + N+L+      K+ DFG ++ +  D+        +    ++  E 
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + T +SDV+S+GV + EL+T G KP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFI-----NEIFILSQINHRN 132
           +G+G  G V+K +  E G  +A+KK  L        +LE  I      EI  L    H  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALR-------RLEGGIPNQALREIKALQACQHPY 60

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           VVKLL         +LV E++P+      L +  ++EE PL           +   +AY+
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
           H+   + I HRD+K  N+L+      K+ADFG ++  + ++  + +    T  Y  PE  
Sbjct: 116 HA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 253 QSSQLTDKS-DVYSFGVVLVELLTGKKPIFS 282
             ++  D   D+++ G +  ELL G  P+F 
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNG-SPLFP 202

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 86.1 bits (213), Expect = 3e-19
 Identities = 80/279 (28%), Positives = 119/279 (42%), Gaps = 26/279 (9%)

Query: 77  RILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           R+LG+G  G V     +      G ++AVK  K    +        +  EI IL  + H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK---RECGQQNTSGWKKEINILKTLYHE 66

Query: 132 NVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+VK  GCC E   +   L+ E++P G+L  +L     N    L   + F  A ++   +
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN----LAQLLLF--AQQICEGM 120

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGY 246
           AYLH   S    HRD+ + N+LLD     K+ DFG +K +     +   +  G    F Y
Sbjct: 121 AYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
              E  + ++ +  SDV+SFGV L ELLT      S     +E +         M   RL
Sbjct: 178 A-VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ---GQMTVVRL 233

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME 345
             +L+  +     KN       L + C +   K RPT  
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 85.3 bits (211), Expect = 4e-19
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 16/206 (7%)

Query: 77  RILGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEF--INEIFILSQINHRNV 133
           R++G+G  G V+   R  D +++ +K+    +  E++ K E     NE  +L  ++H N+
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQ----IPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           ++     LE +  ++V E+ P GTL +++  R  N        + F V I +A     LH
Sbjct: 62  IEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLA-----LH 115

Query: 194 SGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
              +  I HRD+K+ NILLD+     K+ DFG SK ++      T  + GT  Y+ PE  
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELC 173

Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKK 278
           +      KSD+++ G VL EL + K+
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 38/279 (13%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
             LG+G  G+V K RL++  +I   K+     + +L K  + + E+ I        +VK 
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK--QILRELEINKSCKSPYIVKY 64

Query: 137 LGCCL---ETEFPLLVYEFIPNGTL---YQHLHDR-HQNEEYPLTWEMRFRVAIEVAGAL 189
            G  L    +   + + E+   G+L   Y+ +  R  +  E  L      ++A  V   L
Sbjct: 65  YGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGL 118

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFI-AMDQTHVTTKIQGTFGYL 247
           +YLHS     I HRDIK +NILL  + + K+ DFG S + + ++  T       GT  Y+
Sbjct: 119 SYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYM 170

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE  Q    +  SDV+S G+ L+E+   + P    G      + L +Y V+        
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM------- 223

Query: 308 HILDDQVMKLGKKNQIV---AFANLAERCLDLNGKKRPT 343
               +  +K    N I     F +  ++CL+ +  +RPT
Sbjct: 224 ---PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 85.3 bits (211), Expect = 4e-19
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 13/210 (6%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           + LG G  G V+ G+      +A+K    A+++  + + E+FI E  ++ +++H  +V+L
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIK----AINEGAMSE-EDFIEEAKVMMKLSHPKLVQL 64

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            G C + +   +V EF+ NG L  +L  R       L+ +M   +  +V   + YL    
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLE--- 117

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
            +   HRD+ + N L+      KV+DFG ++++  D+   ++  +    +  PE    S+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 257 LTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            + KSDV+SFGV++ E+ T GK P     N
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 78/226 (34%), Positives = 118/226 (52%), Gaps = 27/226 (11%)

Query: 77  RILGQGGQGTVYKGR----LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQIN 129
           ++LGQG  G V+  R     + G++ A+K   K+ L V D    K+E  I     L+++N
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI-----LAEVN 56

Query: 130 HRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE-MRFRVAIEVAG 187
           H  +VKL     +TE  L L+ +F+  G L+  L     ++E   T E ++F +A E+A 
Sbjct: 57  HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLA-ELAL 109

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL +LHS     I +RD+K  NILLDE    K+ DFG SK  ++D         GT  Y+
Sbjct: 110 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 165

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
            PE       T  +D +SFGV++ E+LTG  P    G   +E +++
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF--QGKDRKETMTM 209

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.2 bits (211), Expect = 6e-19
 Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 7/213 (3%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
             +F + + +G+G    VYK   L DGR++A+KK ++  +  +    ++ + EI +L Q+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQI-FEMMDAKARQDCLKEIDLLKQL 59

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           +H NV+K L   +E     +V E    G L   +    + ++  +     ++  +++  A
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L ++H   S  I HRDIK  N+ +      K+ D G  +F +   T   + + GT  Y+ 
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           PE    +    KSD++S G +L E+   + P +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.5 bits (209), Expect = 7e-19
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 15/203 (7%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V  G+      +A+K  K     E+     EFI E  ++ +++H  +V+L G
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMKLSHEKLVQLYG 66

Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
            C   + P+ +V E++ NG L  +L +  +  +     EM      +V   +AYL    S
Sbjct: 67  VC-TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM----CKDVCEGMAYLE---S 118

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+D++   KV+DFG S+++  D+   +   +    +  PE    S+ 
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178

Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV++ E+ + GK P
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 85.5 bits (211), Expect = 7e-19
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 15/205 (7%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V   R +  GR +AVK     +D  +  + E   NE+ I+    H+NVV++ 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK----MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  E   ++ EF+  G L   +     NEE   T      V   V  AL YLHS   
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT------VCESVLQALCYLHSQG- 137

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRDIKS +ILL    R K++DFG    I+ D     + + GT  ++ PE    +  
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPY 194

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFS 282
             + D++S G++++E++ G+ P FS
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFS 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.4 bits (208), Expect = 1e-18
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 18/211 (8%)

Query: 77  RILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYK-LEEFINEIFILSQINHRNVV 134
           ++LGQG  G VY    ++ GR +A K+ +   +  E  K +     EI +L  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 135 KLLGCCLE-TEFPLLVY-EFIPNGTLYQHLHDRHQNEEY-PLTWEMRFRVAIEVAGALAY 191
           +  GC  +  E  L ++ E++P G++      + Q + Y  LT  +  +   ++   ++Y
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSV------KDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGTFGYLD 248
           LHS     I HRDIK  NIL D     K+ DFG SK    I M  T + + + GT  ++ 
Sbjct: 122 LHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMS 177

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           PE         K+DV+S G  +VE+LT K P
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 21/226 (9%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFILSQINH 130
           R LG G  G VY+G     R       +L V  + L +        +F+ E  I+S+ NH
Sbjct: 12  RALGHGAFGEVYEGLY---RGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDR-HQNEEYPLTWEMRFRVAIEVAGA 188
           +N+V+L+G   E     ++ E +  G L   L  +R        LT +     A +VA  
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDER---YRAKVADFGTSKFI-AMDQTHVTTKIQGTF 244
             YL     +   HRDI + N LL  +     AK+ADFG ++ I          +     
Sbjct: 129 CKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQE 289
            ++ PE       T K+DV+SFGV+L E+ + G  P    G T+QE
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY--PGRTNQE 229

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 67/260 (25%), Positives = 121/260 (46%), Gaps = 26/260 (10%)

Query: 73  FNVNRILGQGGQGTVY--KGRLEDGR--IIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + + + +G+G  G +Y  K + +     I  +  +K+ V ++E  K      E+ +L+++
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-----KEVILLAKM 56

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ---NEEYPLTWEMRFRVAIEV 185
            H N+V       E     +V E+   G L + ++ +     +E+  L+W       +++
Sbjct: 57  KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQI 110

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYR-AKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  L ++H      I HRDIKS NI L +    AK+ DFG ++ +  D   +     GT 
Sbjct: 111 SLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTP 166

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
            YL PE  Q+    +K+D++S G VL EL T K P F   N  Q  + +   +   +  N
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKICQGYFAPISPN 225

Query: 305 --RLYHILDDQVMKLGKKNQ 322
             R    L  Q+ K+  +++
Sbjct: 226 FSRDLRSLISQLFKVSPRDR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 14/209 (6%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKLEEFINEIFILSQINHRN 132
           R LGQG  G VY+G +  G +    ++++A+    +   + +  EF+NE  ++ + N  +
Sbjct: 12  RELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE-----YPLTWEMRFRVAIEVAG 187
           VV+LLG   + +  L++ E +  G L  +L       E      P + +   ++A E+A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGY 246
            +AYL+   ++   HRD+ + N ++ E +  K+ DFG ++ I   D      K      +
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
           + PE  +    T  SDV+SFGVVL E+ T
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 84.0 bits (207), Expect = 2e-18
 Identities = 81/288 (28%), Positives = 126/288 (43%), Gaps = 42/288 (14%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH- 130
           F +  ++G G  G VYKGR ++ G++ A+K   +  D+EE     E   EI +L + +H 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-----EIKQEINMLKKYSHH 62

Query: 131 RNVVKLLGCCLETEFP------LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           RN+    G  ++   P       LV EF   G++   + +   N    L  E    +  E
Sbjct: 63  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT---LKEEWIAYICRE 119

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +   L++LH      + HRDIK  N+LL E    K+ DFG S  +        T I GT 
Sbjct: 120 ILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 175

Query: 245 GYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
            ++ PE     +  D     KSD++S G+  +E+  G  P+                 +H
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD---------------MH 220

Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            MR   L+ I  +   +L  K     F +  E CL  N  +RPT E++
Sbjct: 221 PMRA--LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 61/234 (26%), Positives = 117/234 (50%), Gaps = 27/234 (11%)

Query: 79  LGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           LG+   G +YKG L     +  +++A+K  K   D     +  EF  E  ++++++H N+
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK---DINNPQQWGEFQQEASLMAELHHPNI 69

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR------------FRV 181
           V LLG   + +   +++E++  G L++ L  R  + +   + +                +
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKI 240
           AI++A  + YL   +S    H+D+ + NIL+ E+   K++D G S+ I + D   V  K 
Sbjct: 130 AIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSL 293
                ++ PE     + +  SD++SFGVVL E+ + G +P +  G ++QE + +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY--GFSNQEVIEM 238

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 17/207 (8%)

Query: 79  LGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           LG G  GTV KG  +     + +AVK  K   +D  L   +E + E  ++ Q+++  +V+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALK--DELLREANVMQQLDNPYIVR 60

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           ++G C E E  +LV E    G L + L       E  +T      +  +V+  + YL   
Sbjct: 61  MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLEE- 113

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYHQ 253
             +   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   K  G +   +  PE   
Sbjct: 114 --TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171

Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKP 279
             + + KSDV+SFGV++ E  + G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 18/216 (8%)

Query: 72  HFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYK-LEEFINEIFILSQIN 129
           ++ + ++LG+G  G VY     D GR +AVK+     D +E  K +     EI +L  + 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 130 HRNVVKLLGCCLE-TEFPLLVY-EFIPNGTLYQHLHDRHQNEEY-PLTWEMRFRVAIEVA 186
           H  +V+  GC  +  E  L ++ E++P G++      + Q + Y  LT  +  R   ++ 
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI------KDQLKAYGALTENVTRRYTRQIL 116

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGT 243
             ++YLHS     I HRDIK  NIL D     K+ DFG SK    I M  T + + + GT
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGT 172

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
             ++ PE         K+DV+S    +VE+LT K P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 22/215 (10%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFIN--EIFILSQIN 129
           + V + LG G  G+VY  R  E G ++A+KK K     ++ Y  EE +N  E+  L ++N
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECMNLREVKSLRKLN 55

Query: 130 -HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+VKL     E +    V+E++  G LYQ + DR      P +  +   +  ++   
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK---PFSESVIRSIIYQILQG 111

Query: 189 LAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           LA++H  G     +HRD+K  N+L+      K+ADFG ++ I     + T  +  T  Y 
Sbjct: 112 LAHIHKHG----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYR 165

Query: 248 DPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
            PE   +S+  +   D+++ G ++ EL T  +P+F
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTL-RPLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.4 bits (206), Expect = 3e-18
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 19/208 (9%)

Query: 77  RILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           R LG+G  G V   R +      G  +AVK  K       +  L++   EI IL  + H 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHE 66

Query: 132 NVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+VK  G C E       L+ EF+P+G+L ++L  R++N+   +  + + + A+++   +
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNK---INLKQQLKYAVQICKGM 122

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYL 247
            YL    S    HRD+ + N+L++  ++ K+ DFG +K I  D+ + T K  +     + 
Sbjct: 123 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLT 275
            PE    S+    SDV+SFGV L ELLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 82.4 bits (203), Expect = 5e-18
 Identities = 82/274 (29%), Positives = 116/274 (42%), Gaps = 33/274 (12%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G VYK R L  G + AVK  KL   D+  + L +   EIF++ +  H N+V   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD--FSLIQ--QEIFMVKECKHCNIVAYF 72

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G  L  E   +  E+   G+L    H      E  + +  R     E    LAYLHS   
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGK 127

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE---YHQS 254
               HRDIK  NILL +    K+ADFG +  I        + I GT  ++ PE     ++
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKN 183

Query: 255 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV 314
                  D+++ G+  +EL   + P+F                +H MR   L    + Q 
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFD---------------LHPMRALFLMSKSNFQP 228

Query: 315 MKLGKKNQ-IVAFANLAERCLDLNGKKRPTMEEV 347
            KL  K +    F N  +  L  N KKRPT E +
Sbjct: 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 82.6 bits (204), Expect = 5e-18
 Identities = 62/224 (27%), Positives = 115/224 (51%), Gaps = 27/224 (12%)

Query: 75  VNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +  ++G G  G V +GRL+  G+    +A+K  K    +++     +F++E  I+ Q +H
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDH 64

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N++ L G   ++   +++ EF+ NG L   L    QN+        +F V I++ G L 
Sbjct: 65  PNIIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDG-------QFTV-IQLVGMLR 113

Query: 191 YLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--VTTKIQGTF 244
            + +G    +     HRD+ + NIL++     KV+DFG S+F+  D +    T+ + G  
Sbjct: 114 GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Query: 245 G--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
              +  PE     + T  SDV+S+G+V+ E+++ G++P +   N
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 25/217 (11%)

Query: 78  ILGQGGQGTVYKGRL-----EDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQI-NH 130
            LG+G  G V K         +    +AVK  K    +++L    + ++E+ ++  I  H
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL---SDLVSEMEMMKMIGKH 75

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY-----------PLTWEMRF 179
           +N++ LLG C +     +V E+  +G L   L  R    EY            LT +   
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTT 238
             A +VA  + +L   AS    HRD+ + N+L+ E +  K+ADFG ++ I  +D    TT
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             +    ++ PE       T +SDV+SFGV+L E+ T
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.0 bits (202), Expect = 6e-18
 Identities = 73/276 (26%), Positives = 119/276 (43%), Gaps = 31/276 (11%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V+ GRL  D   +AVK  +  +  +   K   F+ E  IL Q +H N+V+L+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK---FLQEARILKQYSHPNIVRLI 59

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C + +   +V E +  G     L    + E   L  +   ++    A  + YL S   
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLESKHC 115

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
               HRD+ + N L+ E+   K++DFG S+    D  + +T    Q    +  PE     
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM 315
           + + +SDV+SFG++L E        FS G     N+S            +    ++  V 
Sbjct: 172 RYSSESDVWSFGILLWE-------AFSLGAVPYANLS----------NQQTREAIEQGVR 214

Query: 316 KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
               +    A   L ERC + +  +RP+   V  EL
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 82.5 bits (203), Expect = 7e-18
 Identities = 75/271 (27%), Positives = 127/271 (46%), Gaps = 33/271 (12%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  GTVY    +  G+ +A+++  L    ++  K E  INEI ++ +  + N+V  L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V E++  G+L   + +   +E           V  E   AL +LHS   
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 134

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
           + + HRDIKS NILL      K+ DFG    I  +Q+   + + GT  ++ PE       
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAY 193

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K D++S G++ +E++ G+ P  +      EN   A           LY I  +   +L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLN------ENPLRA-----------LYLIATNGTPEL 236

Query: 318 GKKNQIVA-FANLAERCLDLNGKKRPTMEEV 347
               ++ A F +   RCLD++ +KR + +E+
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 82.3 bits (203), Expect = 9e-18
 Identities = 62/218 (28%), Positives = 111/218 (50%), Gaps = 26/218 (11%)

Query: 73  FNVNRILGQGGQGTVYKGRL----EDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           F   ++LG G  GTVYKG      E  +I +A+K+ + A   +     +E ++E ++++ 
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK---ANKEILDEAYVMAS 65

Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEV 185
           +++ +V +LLG CL T    L+ + +P G L  ++ +   N   +Y L W       +++
Sbjct: 66  VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQI 118

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---KIQG 242
           A  + YL       + HRD+ + N+L+      K+ DFG +K +  D+        K+  
Sbjct: 119 AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 176 KWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V        GR +AVKK    +D  +  + E   NE+ I+    H N+V++ 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKK----MDLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE   T      V + V  AL++LH+   
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFLHAQG- 135

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 136 --VIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190

Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFN 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 77/274 (28%), Positives = 115/274 (41%), Gaps = 41/274 (14%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           R +G G  G VY  R + +  ++A+KK   +   +   K ++ I E+  L ++ H N ++
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL---AYL 192
             GC L      LV E+           D  +  + PL       +A    GAL   AYL
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSA-----SDLLEVHKKPL---QEVEIAAVTHGALQGLAYL 131

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY- 251
           HS     + HRD+K+ NILL E    K+ DFG++  +A     V     GT  ++ PE  
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183

Query: 252 --HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
                 Q   K DV+S G+  +EL   K P+F+    S                  LYHI
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------------LYHI 226

Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT 343
             ++   L   +    F N  + CL    + RPT
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 81.7 bits (201), Expect = 1e-17
 Identities = 75/271 (27%), Positives = 127/271 (46%), Gaps = 33/271 (12%)

Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  GTVY    +  G+ +A+K+  L    ++  K E  INEI ++ +  + N+V  L
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 82

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V E++  G+L   + +   +E           V  E   AL +LHS   
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALDFLHS--- 133

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
           + + HRDIKS NILL      K+ DFG    I  +Q+  +T + GT  ++ PE       
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K D++S G++ +E++ G+ P  +      EN   A           LY I  +   +L
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRA-----------LYLIATNGTPEL 235

Query: 318 GKKNQIVA-FANLAERCLDLNGKKRPTMEEV 347
               ++ A F +   RCL+++  +R + +E+
Sbjct: 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 18/216 (8%)

Query: 72  HFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYK-LEEFINEIFILSQIN 129
           ++ + ++LGQG  G VY     D GR +AVK+ +   +  E  K +     EI +L  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 130 HRNVVKLLGCCLET-EFPLLVY-EFIPNGTLYQHLHDRHQNEEY-PLTWEMRFRVAIEVA 186
           H  +V+  GC  +  E  L ++ E +P G++      + Q + Y  LT  +  +   ++ 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSI------KDQLKSYGALTENVTRKYTRQIL 116

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK---FIAMDQTHVTTKIQGT 243
             ++YLHS     I HRDIK  NIL D     K+ DFG SK    I +  T + + + GT
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGT 172

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
             ++ PE         K+D++S G  +VE+LT K P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)

Query: 79  LGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V    ++  G+++AVKK    +D  +  + E   NE+ I+    H NVV++ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKK----MDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE          V + V  AL+ LH+   
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLKALSVLHAQG- 136

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRL 191

Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFN 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 58/174 (33%), Positives = 77/174 (44%), Gaps = 19/174 (10%)

Query: 124 ILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
           ILSQ     VVKL     + +  L LV E++P G L   L +    +E       R  +A
Sbjct: 46  ILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED----VARIYIA 100

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV------ 236
            E+  AL YLHS     I HRD+K  NIL+D     K+ DFG SK   + +         
Sbjct: 101 -EIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156

Query: 237 -TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
              +I GT  Y+ PE       +   D +S G +L E L G  P    G T +E
Sbjct: 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH--GETPEE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 19/205 (9%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           + +G+G  G V  G    G  +AVK  K   +D      + F+ E  +++Q+ H N+V+L
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIK---NDA---TAQAFLAEASVMTQLRHSNLVQL 64

Query: 137 LGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           LG  +E +  L +V E++  G+L  +L  R ++    L  +   + +++V  A+ YL + 
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
                 HRD+ + N+L+ E   AKV+DFG +K  +  Q      ++ T     PE  +  
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 174

Query: 256 QLTDKSDVYSFGVVLVELLT-GKKP 279
           + + KSDV+SFG++L E+ + G+ P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 71/208 (34%), Positives = 98/208 (47%), Gaps = 18/208 (8%)

Query: 77  RILGQGGQGTVYKGRL-EDGRIIAVKKSKLAV---DDEELYKLEEFINEIFILSQINHRN 132
           R+LG+G  G V   RL E GR+ AVK  K  V   DD+    +E  + E  ILS   +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD----VECTMTEKRILSLARNHP 56

Query: 133 VVKLLGCCLET-EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +  L CC +T +    V EF+  G L  H+    + +E       RF  A E+  AL +
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARFYAA-EITSALMF 111

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH      I +RD+K  N+LLD     K+ADFG  K   +     T+   GT  Y+ PE 
Sbjct: 112 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEI 167

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Q        D ++ GV+L E+L G  P
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.3 bits (200), Expect = 2e-17
 Identities = 72/271 (26%), Positives = 128/271 (47%), Gaps = 33/271 (12%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  GTV+    +  G+ +A+K+  L    ++  K E  INEI ++ ++ + N+V  L
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINL----QKQPKKELIINEILVMKELKNPNIVNFL 82

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V E++  G+L   + +   +E           V  E   AL +LH+   
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA------VCRECLQALEFLHA--- 133

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
           + + HRDIKS N+LL      K+ DFG    I  +Q+  +T + GT  ++ PE       
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K D++S G++ +E++ G+ P  +      EN   A           LY I  +   +L
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRA-----------LYLIATNGTPEL 235

Query: 318 GKKNQIVA-FANLAERCLDLNGKKRPTMEEV 347
               ++   F +   RCL+++ +KR + +E+
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 73/257 (28%), Positives = 109/257 (42%), Gaps = 16/257 (6%)

Query: 73  FNVNRILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           F + R+LG G  G V+     G  + G++ A+K  K A   ++    E    E  +L  +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 129 NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +  L    +T+  L L+ +++  G L+ HL+ R    E     E+R  +A E+  
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES----EVRVYIA-EIVL 116

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL +LH      I +RDIK  NILLD      + DFG SK    ++        GT  Y+
Sbjct: 117 ALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 248 DPEY--HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG-NTSQENVSLAAYFVHSMRKN 304
            PE     S       D +S GV+  ELLTG  P    G   SQ  +S            
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK 233

Query: 305 RLYHILDDQVMKLGKKN 321
            +     D + KL +K+
Sbjct: 234 TMSAEARDFIQKLLEKD 250

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 69/225 (30%), Positives = 103/225 (45%), Gaps = 40/225 (17%)

Query: 75  VNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI---NH 130
           +  I G+G  GTVYK R L  GR +A+KK ++ + +E +      + EI +L Q+    H
Sbjct: 4   LAEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI--PLSTLREIALLKQLESFEH 60

Query: 131 RNVVKLLGCC----LETEFPL-LVYEFIPNGTLYQHLHDRHQN------EEYPLTWEMRF 179
            N+V+LL  C     + E  L LV+E +      Q L                +   MR 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMR- 114

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVT 237
               ++   + +LHS     I HRD+K  NIL+    + K+ADFG ++     M  T V 
Sbjct: 115 ----QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV 167

Query: 238 TKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
                T  Y  PE   QSS  T   D++S G +  EL   ++P+F
Sbjct: 168 V----TLWYRAPEVLLQSSYAT-PVDMWSVGCIFAELFR-RRPLF 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 40/287 (13%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F +  ++G G  G VYKGR ++ G++ A+K   +  D+EE  KLE  IN +   S  +HR
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE--INMLKKYS--HHR 73

Query: 132 NVVKLLGCCLETEFP------LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           N+    G  ++   P       LV EF   G++   + +   N    L  +    +  E+
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA---LKEDWIAYICREI 130

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
              LA+LH+     + HRDIK  N+LL E    K+ DFG S  +        T I GT  
Sbjct: 131 LRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 186

Query: 246 YLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
           ++ PE     +  D     +SD++S G+  +E+  G  P+                 +H 
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD---------------MHP 231

Query: 301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           MR   L+ I  +   KL  K     F +  E CL  N   RP+ E++
Sbjct: 232 MRA--LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)

Query: 77  RILGQGGQGTVYKG-RLEDGRIIAVKKS-KLAVDDEELYKLEEFINEIFILSQINHRNVV 134
           ++LG G  GTVYKG  + DG  + +  + K+  ++      +E ++E ++++ +    V 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ--NEEYPLTWEMRFRVAIEVAGALAYL 192
           +LLG CL T    LV + +P G L  ++ +       +  L W       +++A  ++YL
Sbjct: 73  RLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---KIQGTFGYLDP 249
                  + HRD+ + N+L+      K+ DFG ++ + +D+T       K+   +  L+ 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             H+  + T +SDV+S+GV + EL+T G KP
Sbjct: 183 ILHR--RFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 18/208 (8%)

Query: 77  RILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           ++LG+G  G V     KG+ E   + A+KK  + +DD+    +E  + E  +L+      
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD----VECTMVEKRVLALAWENP 56

Query: 133 VVKLLGCCLET-EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +  L C  +T E    V EF+  G L  H+ D+ + + Y  T+      A E+   L +
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQF 111

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     I +RD+K  N++LD     K+ADFG  K         +T   GT  Y+ PE 
Sbjct: 112 LHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEI 167

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Q  + T   D +SFGV+L E+L G+ P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 21/218 (9%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           T    +NRI G+G  G VY+ R    G I+A+KK ++  D+E        + EI +L  +
Sbjct: 7   TEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISSLREITLLLNL 63

Query: 129 NHRNVVKLL----GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            H N+V+L     G  L++ F  LV E+       Q L     N   P +      + ++
Sbjct: 64  RHPNIVELKEVVVGKHLDSIF--LVMEYCE-----QDLASLLDNMPTPFSESQVKCLMLQ 116

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +   L YLH    + I HRD+K +N+LL ++   K+ADFG ++   +    +T K+  T 
Sbjct: 117 LLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TL 172

Query: 245 GYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 281
            Y  PE          + D+++ G +L ELL   KP+ 
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLL 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 22/209 (10%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G VYK + ++  + A  K      +EEL   E+F+ EI ILS+  H N+V L  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL---EDFMVEIDILSECKHPNIVGLYE 69

Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNE-EYPLTW-EMRFRVAIEVAGALAYLHSGA 196
                    ++ EF   G L     D    E E  LT  ++R+ V  ++  AL +LHS  
Sbjct: 70  AYFYENKLWILIEFCDGGAL-----DSIMLELERGLTEPQIRY-VCRQMLEALNFLHS-- 121

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
              + HRD+K+ NILL      K+ADFG S K  +  Q   T    GT  ++ PE     
Sbjct: 122 -HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE 178

Query: 256 QLTD-----KSDVYSFGVVLVELLTGKKP 279
              D     K+D++S G+ L+EL   + P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 75/234 (32%), Positives = 117/234 (50%), Gaps = 37/234 (15%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEF----INEIFIL 125
           + F++   +G+G  G VYK R +D G ++A+KK +L  D+E+    E F    I EI IL
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEK----EGFPITAIREIKIL 60

Query: 126 SQINHRNVVKLLGCCLETEFPL----------LVYEFIPN---GTLYQHLHDRHQNEEYP 172
            Q+NHRN+V L     + +  L          LV+E++ +   G L   L   H +E++ 
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL--VHFSEDHI 118

Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 232
            ++ M+     ++   L Y H        HRDIK +NILL+ + + K+ADFG ++    +
Sbjct: 119 KSF-MK-----QLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Query: 233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGN 285
           ++   T    T  Y  PE     +    + DV+S G +L EL T KKPIF    
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQ 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.5 bits (198), Expect = 4e-17
 Identities = 77/276 (27%), Positives = 114/276 (41%), Gaps = 41/276 (14%)

Query: 79  LGQGGQGTVY-KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G VY         ++AVKK   +   +   K ++ I E+  L Q+ H N ++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYS-GKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL---AYLHS 194
           GC L+     LV E+           D  +  + PL       +A    GAL   AYLHS
Sbjct: 88  GCYLKEHTAWLVMEYCLGSA-----SDLLEVHKKPL---QEVEIAAITHGALQGLAYLHS 139

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY--- 251
                + HRDIK+ NILL E  + K+ADFG++   +   + V     GT  ++ PE    
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILA 191

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD 311
               Q   K DV+S G+  +EL   K P+F+    S                  LYHI  
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------------LYHIAQ 234

Query: 312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +    L       +F    + CL    ++RP   E+
Sbjct: 235 NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAEL 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 78/273 (28%), Positives = 125/273 (45%), Gaps = 38/273 (13%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V+KG   D R   V   K+   +E   ++E+   EI +LSQ +   V K  G
Sbjct: 12  IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI---EVAGALAYLHSG 195
             L+     ++ E++  G+    L     +E         F++A    E+   L YLHS 
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAGPFDE---------FQIATMLKEILKGLDYLHSE 120

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
                 HRDIK+ N+LL E+   K+ADFG +  +   Q    T + GT  ++ PE  Q S
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176

Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM 315
               K+D++S G+  +EL  G+ P     N+           +H MR   L+ I  +   
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP-----NSD----------MHPMRV--LFLIPKNNPP 219

Query: 316 KL-GKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            L G+ ++   F    + CL+ +   RPT +E+
Sbjct: 220 TLTGEFSK--PFKEFIDACLNKDPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.2 bits (195), Expect = 5e-17
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 17/207 (8%)

Query: 79  LGQGGQGTVYKG--RLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G V KG  ++   +I +A+K  K   ++ E    +E + E  I+ Q+++  +V+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           ++G C E E  +LV E    G L + L  +       +T      +  +V+  + YL   
Sbjct: 60  MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLEG- 113

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYHQ 253
                 HRD+ + N+LL  ++ AK++DFG SK +  D ++   +  G +   +  PE   
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171

Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKP 279
             + + +SDV+S+G+ + E  + G+KP
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 18/208 (8%)

Query: 77  RILGQGGQGTVYKGRL-EDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           ++LG+G  G V    L     + AVK  K  + + D+++   E  + E  +L+       
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV---ECTMTEKRVLALAGKHPF 57

Query: 134 VKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +  L  C +T+  L  V E++  G L  H+    + +E       RF  A E+   L +L
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP----RARF-YAAEIVLGLQFL 112

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLDPEY 251
           H      I +RD+K  N+LLD     K+ADFG  K  I    T  T+   GT  Y+ PE 
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEI 167

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
                     D ++ GV+L E+L G+ P
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.2 bits (195), Expect = 6e-17
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 25/222 (11%)

Query: 75  VNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           + +++G G  G V  GRL+    R I V    L     E  +  +F++E  I+ Q +H N
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPN 66

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVAIEVAGALA 190
           ++ L G   +++  ++V E++ NG+L   L  HD              F V I++ G L 
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ------------FTV-IQLVGMLR 113

Query: 191 YLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG- 245
            + SG    +     HRD+ + NIL++     KV+DFG S+ +  D     T   G    
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173

Query: 246 -YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +  PE     + T  SDV+S+G+V+ E+++ G++P +   N
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 79.7 bits (196), Expect = 7e-17
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 79  LGQGGQGTV-YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V        G+ +AVKK    +D  +  + E   NE+ I+   +H NVV + 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKK----MDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE   T      V + V  AL+YLH+   
Sbjct: 86  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHNQG- 138

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 139 --VIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLVGTPYWMAPEVISRL 193

Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPYFN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 79.6 bits (196), Expect = 8e-17
 Identities = 51/170 (30%), Positives = 87/170 (51%), Gaps = 17/170 (10%)

Query: 117 EFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-------HQNE 169
           +F+ EI I+S++ + N+++LLG C+  +   ++ E++ NG L Q L  R       H N 
Sbjct: 63  DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122

Query: 170 EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 229
              ++      +A+++A  + YL   AS    HRD+ + N L+   Y  K+ADFG S+ +
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 230 AMDQTHVTTKIQG----TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
                +   +IQG       ++  E     + T  SDV++FGV L E+ T
Sbjct: 180 YSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 49/294 (16%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL-----EDGRI-IAVKKSKLAVDDEELYKLEEFINEIFI 124
           N+ +  + LG G  G V +         D  + +AVK  K      E    E  ++E+ I
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER---EALMSELKI 91

Query: 125 LSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +S + NH N+V LLG C      L++ E+   G L   L    +  E  LT E     + 
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSY 148

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           +VA  +A+L   AS    HRD+ + N+LL      K+ DFG ++ I  D  +V   ++G 
Sbjct: 149 QVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGN 202

Query: 244 ----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
                 ++ PE   +   T +SDV+S+G++L E       IFS G+     + + + F  
Sbjct: 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWE-------IFSLGSNPYPGMPVDSKF-- 253

Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFA-----NLAERCLDLNGKKRPTMEEVS 348
                  Y ++ +     G +      A     ++ + C D +  KRPT +++ 
Sbjct: 254 -------YKLIKE-----GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 75/271 (27%), Positives = 124/271 (45%), Gaps = 34/271 (12%)

Query: 79  LGQGGQGTVYKGRLEDGR-IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYKG     + ++A+K   L   ++E+   E+   EI +LSQ +   + +  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEI---EDIQQEITVLSQCDSPYITRYY 68

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G  L+     ++ E++  G+    L      E Y  T      +  E+   L YLHS   
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYLHSERK 122

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRDIK+ N+LL E+   K+ADFG +  +   Q    T + GT  ++ PE  + S  
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K+D++S G+  +EL  G+ P                  +H MR   L+ I  +    L
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSD---------------LHPMRV--LFLIPKNSPPTL 221

Query: 318 -GKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            G+ ++   F    E CL+ + + RPT +E+
Sbjct: 222 EGQYSK--PFKEFVEACLNKDPRFRPTAKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 24/196 (12%)

Query: 105 LAVDDEELYKLEEFINEIFILSQINHRNVVKLL--GCCLETEFPLLVYEFIPNGTLYQHL 162
            A ++E       F  E  + +++ H N+V LL  G          V+E++P  TL + L
Sbjct: 14  DAPEEEHQRA--RFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL 70

Query: 163 HDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAK 219
                 +   L      R+ ++V  ALA  H+     I HRD+K  NI++     R  AK
Sbjct: 71  ----AADG-ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAK 122

Query: 220 VADFGTSKFI----AMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 273
           V DFG    +      D   +T  T++ GT  Y  PE  +   +T  SD+Y++G++ +E 
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLEC 182

Query: 274 LTGKKPIFSTGNTSQE 289
           LTG++ +   G +  E
Sbjct: 183 LTGQRVV--QGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 31/284 (10%)

Query: 74  NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKLEEFINEIFILSQIN 129
            + R LGQG  G VY+G   D  I    ++++AV    +   L +  EF+NE  ++    
Sbjct: 9   TLLRELGQGSFGMVYEGNARD-IIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 67

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLH----DRHQNEEYPL-TWEMRFRVAIE 184
             +VV+LLG   + +  L+V E + +G L  +L     +   N   P  T +   ++A E
Sbjct: 68  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGT 243
           +A  +AYL+   +    HRD+ + N ++   +  K+ DFG ++ I   D      K    
Sbjct: 128 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
             ++ PE  +    T  SD++SFGVVL E+ +  +  +     S E V            
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ--GLSNEQV------------ 230

Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             L  ++D   +     N      +L   C   N K RPT  E+
Sbjct: 231 --LKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 9/212 (4%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +F + + +G+G    VY+   L DG  +A+KK ++  D  +     + I EI +L Q+NH
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNH 61

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR-FRVAIEVAGAL 189
            NV+K     +E     +V E    G L + +  +H  ++  L  E   ++  +++  AL
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
            ++HS     + HRDIK  N+ +      K+ D G  +F +  +T     + GT  Y+ P
Sbjct: 120 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSP 175

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           E    +    KSD++S G +L E+   + P +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 77.2 bits (190), Expect = 3e-16
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 78  ILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           ILG G  GTVYK   L   RI+AVK   L +   EL K  + ++E+ IL + +   ++  
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQK--QIMSELEILYKCDSPYIIGF 64

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            G         +  EF+  G+L     D ++     +      R+A+ V   L YL S  
Sbjct: 65  YGAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLG----RIAVAVVKGLTYLWS-- 113

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYHQS 254
              I HRD+K +N+L++ R + K+ DFG S  +  ++ +T+V     GT  Y+ PE    
Sbjct: 114 -LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISG 167

Query: 255 SQLTDKSDVYSFGVVLVELLTGKKP 279
            Q    SDV+S G+  +EL  G+ P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 14/206 (6%)

Query: 78  ILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           ++G+G  G V K +  E G+I+A+KK   + DD+ + K+   + EI +L Q+ H N+V L
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA--MREIRMLKQLRHENLVNL 65

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
           +      +   LV+EF+ +  L     D  +     L      +   ++   + + HS  
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHS-- 118

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              I HRDIK  NIL+ +    K+ DFG ++ +A     V T    T  Y  PE      
Sbjct: 119 -HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDT 176

Query: 257 LTDKS-DVYSFGVVLVELLTGKKPIF 281
              ++ D+++ G ++ E+LTG +P+F
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG-EPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 30/211 (14%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLE-------EFINEIFILSQINHR 131
           LG G  G V K + +   +I  +K         L  LE       + I E+ +L + N  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARK---------LIHLEIKPAIRNQIIRELQVLHECNSP 63

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +V   G         +  E +  G+L Q L +  +  E     E+  +V+I V   LAY
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-----EILGKVSIAVLRGLAY 118

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDP 249
           L       I HRD+K +NIL++ R   K+ DFG S  +  +M  + V     GT  Y+ P
Sbjct: 119 LRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSP 171

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
           E  Q +  + +SD++S G+ LVEL  G+ PI
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 76.8 bits (189), Expect = 4e-16
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 15/203 (7%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +A+K  K     +     E F+ E  ++ Q+ H  +V+L  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-----QGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      E   LT      +A ++A  +A++     
Sbjct: 69  VV--TQEPIYIITEYMENGSLVDFLK---TPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 124 ---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)

Query: 79  LGQGGQGTVYKGRLEDGR-IIAVKKSKLAVDDEELYKLEEFI-NEIFILSQINHRNVVKL 136
           +G G  G V+  R        A+K   +A+ +    K E+ + NE  +L +++H  +++L
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKV--MAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
                +  F  ++ E++P G L+ +L +  +      +       A E+  AL YLHS  
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVCALEYLHS-- 119

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              I +RD+K  NILLD+    K+ DFG +K +  D+T     + GT  YL PE  QS  
Sbjct: 120 -KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLAPEVIQSKG 174

Query: 257 LTDKSDVYSFGVVLVELLTGKKPIF 281
                D ++ G+++ E+L G  P F
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.0 bits (189), Expect = 6e-16
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G VYK + ++   +A  K      +EEL   E+++ EI IL+  NH  +VKLLG
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76

Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                    ++ EF P G +   + +  +    P   +++  +  ++  AL YLHS    
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---M 129

Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
            I HRD+K+ N+LL      K+ADFG S K +   Q        GT  ++ PE      +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCETM 187

Query: 258 TD-----KSDVYSFGVVLVELLTGKKP 279
            D     K+D++S G+ L+E+   + P
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 76.2 bits (187), Expect = 6e-16
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 69  VV--SEEPIYIVTEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVER--- 120

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 76.2 bits (187), Expect = 8e-16
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           E F+ E  I+ ++ H  +V+L  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-----MSPESFLEEAQIMKKLRHDKLVQLYA 68

Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
               +E P+ +V E++  G+L   L D   +  + P   +M    A +VA  +AY+    
Sbjct: 69  VV--SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM----AAQVAAGMAYIER-- 120

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
                HRD++S NIL+ +    K+ADFG ++ I  ++       +    +  PE     +
Sbjct: 121 -MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 257 LTDKSDVYSFGVVLVELLT-GKKP 279
            T KSDV+SFG++L EL+T G+ P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 83/302 (27%), Positives = 129/302 (42%), Gaps = 50/302 (16%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL-EDGRII--AVKKSK-LAVDDEELYKLEEFINEIFILS 126
           N      ++G+G  G V K R+ +DG  +  A+K+ K  A  D+      +F  E+ +L 
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAGELEVLC 62

Query: 127 QIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP-----------LT 174
           ++  H N++ LLG C    +  L  E+ P+G L   L      E  P           L+
Sbjct: 63  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            +     A +VA  + YL   +     HRD+ + NIL+ E Y AK+ADFG S+     Q 
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE 175

Query: 235 HVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
               K  G     ++  E    S  T  SDV+S+GV+L E       I S G T    ++
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE-------IVSLGGTPYCGMT 228

Query: 293 LAAYFVHSMRKNRLYHIL--DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
            A  +    +  RL   L  DD+V             +L  +C      +RP+  ++ + 
Sbjct: 229 CAELYEKLPQGYRLEKPLNCDDEVY------------DLMRQCWREKPYERPSFAQILVS 276

Query: 351 LN 352
           LN
Sbjct: 277 LN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 18/173 (10%)

Query: 117 EFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE------- 169
           +F+ E+ ILS++   N+++LLG C++ +   ++ E++ NG L Q L   H ++       
Sbjct: 65  DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124

Query: 170 ----EYPL---TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD 222
                + L   ++     VA+++A  + YL   +S    HRD+ + N L+ E    K+AD
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 223 FGTSK-FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 274
           FG S+   A D   +  +      ++  E     + T  SDV++FGV L E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE----LYKLEEFINEIFILSQINHRNV 133
           +G G  G VYK R +  G ++AVK+ +   + EE    L  L+       +L   +   +
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD------VVLKSHDCPYI 76

Query: 134 VKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           VK  G    T+  + +  E +   T    L  R Q    P+  ++  ++ + +  AL YL
Sbjct: 77  VKCYGY-FITDSDVFICMELM--STCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYL 130

Query: 193 ---HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
              H      + HRD+K +NILLD     K+ DFG S  +   +    T+  G   Y+ P
Sbjct: 131 KEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAP 183

Query: 250 EYHQSSQLTDK----SDVYSFGVVLVELLTGKKP 279
           E         K    +DV+S G+ LVEL TG+ P
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 50/170 (29%), Positives = 89/170 (52%), Gaps = 18/170 (10%)

Query: 117 EFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           +F+ EI I+S++   N+++LL  C+ ++   ++ E++ NG L Q L  RH+ +E     +
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL-SRHEPQEAAEKAD 123

Query: 177 MRF-------RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 229
           +          +A ++A  + YL   +S    HRD+ + N L+ + Y  K+ADFG S+ +
Sbjct: 124 VVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 230 AMDQTHVTTKIQG----TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
                +   +IQG       ++  E     + T  SDV++FGV L E+LT
Sbjct: 181 YSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 12/201 (5%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V+KG   D R   V   K+   +E   ++E+   EI +LSQ +   V K  G
Sbjct: 12  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
             L+     ++ E++  G+    L      E  PL       +  E+   L YLHS    
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSEKK- 122

Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
              HRDIK+ N+LL E    K+ADFG +  +   Q    T + GT  ++ PE  + S   
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 179

Query: 259 DKSDVYSFGVVLVELLTGKKP 279
            K+D++S G+  +EL  G+ P
Sbjct: 180 SKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 70/250 (28%), Positives = 104/250 (41%), Gaps = 48/250 (19%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQI 128
           F V +++G+G  G V+  R  + G++ A+K   KS +   ++  +       E  IL+  
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILADA 58

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           +   +VKL     + E   LV E++P G L   L  +    E       RF +A E+  A
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE----TARFYIA-ELVLA 113

Query: 189 LAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSK-------------------F 228
           L  +H  G      HRDIK  NIL+D     K+ADFG  K                   F
Sbjct: 114 LDSVHKLG----FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 229 IAMDQTHVTTKIQ---------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
                       Q         GT  Y+ PE  + +    + D +S GV+L E+L G  P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Query: 280 IFSTGNTSQE 289
            +S  +T QE
Sbjct: 230 FYS--DTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 44/273 (16%)

Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 71

Query: 123 FILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE-EY--------- 171
            ++  I  H+N++ LLG C +     ++ E+   G L ++L  R     EY         
Sbjct: 72  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131

Query: 172 -PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ + 
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 241

Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 242 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 274

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 23/227 (10%)

Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKS-KLAVDDEELYKLE 116
           ++    EL K        ++LG G  GTV+KG  + +G  I +  + K   D       +
Sbjct: 2   RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54

Query: 117 EFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ--NEEYPLT 174
           E  + +  +  ++H  +V+LLG C      L V +  P G+L  H+       + +  L 
Sbjct: 55  EITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLN 113

Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQ 233
           W       +++A  + YL       + HR++ + NILL      ++ADFG +  +   D+
Sbjct: 114 W------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164

Query: 234 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            +  ++ +    ++  E     + T +SDV+S+GV + E+++ G +P
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 12/205 (5%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYKGR  + G+I+A+KK +L  ++E +      I EI +L ++ H N+V L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              ++     L++EF+ +  L ++L    + +         +   I     + + H   S
Sbjct: 66  DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQI--LQGILFCH---S 119

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRD+K  N+L+D +   K+ADFG ++   +    V T    T  Y  PE    S  
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGSPR 178

Query: 258 -TDKSDVYSFGVVLVELLTGKKPIF 281
            +   D++S G +  E+ T KKP+F
Sbjct: 179 YSTPVDIWSIGTIFAEMAT-KKPLF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 18/208 (8%)

Query: 77  RILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           ++LG+G  G V     KG  E   I A+KK  +  DD+    +E  + E  +L+      
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD----VECTMVERRVLALAWEHP 56

Query: 133 VVKLLGCCLETEFPLL-VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +  L C  +T+  L  V E++  G L  H+    + +E       RF  A E+   L +
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA----RARFYAA-EIICGLQF 111

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH      I +RD+K  N+LLD+    K+ADFG  K   M+     +   GT  Y+ PE 
Sbjct: 112 LHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYIAPEI 167

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            +  +  +  D +SFGV+L E+L G+ P
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 73.9 bits (181), Expect = 5e-15
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 12/204 (5%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           + LG G  G V+ G   +   +AVK  K          ++ F+ E  ++  + H  +V+L
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRL 66

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
                + E   ++ E++  G+L   L     +E   +        + ++A  +AY+    
Sbjct: 67  YAVVTKEEPIYIITEYMAKGSLLDFLK---SDEGGKVLLPKLIDFSAQIAEGMAYIER-- 121

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
                HRD+++ N+L+ E    K+ADFG ++ I  ++       +    +  PE      
Sbjct: 122 -KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180

Query: 257 LTDKSDVYSFGVVLVELLT-GKKP 279
            T KSDV+SFG++L E++T GK P
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 16/229 (6%)

Query: 72  HFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           +F + ++LG G  G V+  R     + G++ A+K  K A   ++    E    E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           I     +  L    +T+  L L+ ++I  G L+ HL  R + +E     E++     E+ 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ----EVQIYSG-EIV 115

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
            AL +LH      I +RDIK  NILLD      + DFG SK    D+        GT  Y
Sbjct: 116 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 247 LDPEYHQSSQLT-DKS-DVYSFGVVLVELLTGKKPIFSTGN-TSQENVS 292
           + P+  +      DK+ D +S GV++ ELLTG  P    G   SQ  +S
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 74/263 (28%), Positives = 116/263 (44%), Gaps = 40/263 (15%)

Query: 79  LGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHR 131
           LG+G  G V         + +  R+  V    L  D  E   L + I+E+ ++  I  H+
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 84

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWEMRFR 180
           N++ LLG C +     ++ E+   G L ++L  R            Q  E  L+++    
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTK 239
            A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I  +D    TT 
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV- 298
            +    ++ PE       T +SDV+SFGV+L E       IF+ G +    V +   F  
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPVEELFKL 254

Query: 299 ----HSMRK-----NRLYHILDD 312
               H M K     N LY ++ D
Sbjct: 255 LKEGHRMDKPSNCTNELYMMMRD 277

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 28/212 (13%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G VYK + ++  ++A  K    +D +   +LE+++ EI IL+  +H N+VKLL 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAK---VIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69

Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                    ++ EF   G +   + +     E PLT      V  +   AL YLH    +
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLH---EN 122

Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ------GTFGYLDPEYH 252
            I HRD+K+ NIL       K+ADFG S          T  IQ      GT  ++ PE  
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRTIQRRDSFIGTPYWMAPEVV 175

Query: 253 QSSQLTD-----KSDVYSFGVVLVELLTGKKP 279
                 D     K+DV+S G+ L+E+   + P
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 75.2 bits (185), Expect = 9e-15
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 32/234 (13%)

Query: 72  HFNVNRILGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            +++ R++G+GG G VY     D    R +A+KK +  + +  L K + F+ E  I + +
Sbjct: 3   RYDIIRLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLK-KRFLREAKIAADL 59

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR------FRVA 182
            H  +V +   C + +       +I   TL   L    Q E        +        + 
Sbjct: 60  IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH------- 235
            ++   + Y+HS     + HRD+K  NILL       + D+G + F  +++         
Sbjct: 120 HKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 236 ----------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
                     +  KI GT  Y+ PE       ++ +D+Y+ GV+L ++LT   P
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 68/209 (32%), Positives = 97/209 (46%), Gaps = 14/209 (6%)

Query: 77  RILGQGGQGTVY-KGRLEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           +++G+G  G V    R  DG+  AVK  + K+ ++ +E   +    N   +L  + H  +
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFL 58

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           V L      TE    V +F+  G L+ HL    Q E        RF  A E+A AL YLH
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAA-EIASALGYLH 113

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     I +RD+K  NILLD +    + DFG  K   + Q+  TT   GT  YL PE  +
Sbjct: 114 S---INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIR 169

Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
                +  D +  G VL E+L G  P + 
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 71/230 (30%), Positives = 103/230 (44%), Gaps = 36/230 (15%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEE---FINEIFILS 126
             F +   +GQGG G V+  + +D G I+A+K+ K       L+KL E    + E  IL+
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMK----KSLLFKLNEVRHVLTERDILT 56

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNG---TLYQH---LHDRHQNEEYPLTWEMRFR 180
                 +VKLL    + E+  L  E++P G   TL  +   L + H           RF 
Sbjct: 57  TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA----------RFY 106

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTK 239
           +A E+  A+  LH        HRD+K  N L+D     K+ DFG SK  +    + V   
Sbjct: 107 MA-EMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV--- 159

Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
             G+  Y+ PE  +        D +S G +L E L G  P FS G+T  E
Sbjct: 160 --GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP-FS-GSTPNE 205

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 9/103 (8%)

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFI-AMDQTHVT 237
           +++I V   L YL       I HRD+K +NIL++ R   K+ DFG S + I +M  + V 
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 159

Query: 238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
               GT  Y+ PE  Q +  T +SD++S G+ LVE+  G+ PI
Sbjct: 160 ----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 13/214 (6%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F + + +G+G    VY+   L D + +A+KK ++  +  +    ++ + EI +L Q+NH 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI-FEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYP--LTWEMRFRVAIEVAGA 188
           NV+K L   +E     +V E    G L Q + + + Q    P    W    +  +++  A
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW----KYFVQLCSA 118

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           + ++H   S  + HRDIK  N+ +      K+ D G  +F +  +T     + GT  Y+ 
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           PE    +    KSD++S G +L E+   + P + 
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 15/227 (6%)

Query: 73  FNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           F + ++LG G  G V+  R     + G++ A+K  + A   ++   +E    E  +L  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 129 NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +  L    +TE  L L+ +++  G ++ HL+ R    E     E+RF    E+  
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED----EVRFYSG-EIIL 116

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL +LH      I +RDIK  NILLD      + DFG SK    ++   T    GT  Y+
Sbjct: 117 ALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 248 DPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGN-TSQENVS 292
            PE  +      K+ D +S G+++ ELLTG  P    G   +Q  VS
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 82/276 (29%), Positives = 121/276 (43%), Gaps = 33/276 (11%)

Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEE--FINEIFILSQINH 130
           F+V +++G+G  G V   R +  +   V   KL    E + + +   F  E  I++  N 
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSK--QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
             +V+L     + ++  +V E++P G L   +     N + P  W  RF  A EV  AL 
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWA-RFYTA-EVVLALD 156

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---HVTTKIQGTFGYL 247
            +HS       HRD+K  N+LLD+    K+ADFGT   + MD        T + GT  Y+
Sbjct: 157 AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRCDTAV-GTPDYI 210

Query: 248 DPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM-R 302
            PE  +S         + D +S GV L E+L G  P ++         SL   +   M  
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSKIMDH 262

Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNG 338
           KN L    DD  +    K+ I AF    E  L  NG
Sbjct: 263 KNSL-TFPDDIEISKQAKDLICAFLTDREVRLGRNG 297

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 42/286 (14%)

Query: 79  LGQGGQGTVYKGRLEDG----RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV 134
           +G G  G V  G    G    R++  +    A  DE+L     F+ E+    ++NH NV+
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL----LFLQEVQPYRELNHPNVL 58

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
           + LG C+E+   LLV EF P G L  +L             ++  R+A EVA  L +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH- 117

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEYH 252
              +   H D+   N  L      K+ D+G +      + +  TK        +L PE  
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV 174

Query: 253 QSSQ-------LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           +           T KS+++S GV + EL T     +   + S E V              
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP--DLSDEQV-------------- 218

Query: 306 LYHILDDQVMKLGKKNQIVAFAN----LAERCLDLNGKKRPTMEEV 347
           L  ++ +Q +KL K    + +++    + + C  L+ + RPT EEV
Sbjct: 219 LKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 14/202 (6%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R    G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 65

Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
              + TE  L LV+EF+ +  L + + D       PL     +    ++   LA+ HS  
Sbjct: 66  DV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSY--LFQLLQGLAFCHS-- 118

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE     +
Sbjct: 119 -HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 176

Query: 257 L-TDKSDVYSFGVVLVELLTGK 277
             +   D++S G +  E++T +
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 15/203 (7%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  I+ ++ H  +V L  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V EF+  G+L   L    + +   L       +A ++A  +AY+     
Sbjct: 69  VV--SEEPIYIVTEFMGKGSLLDFLK---EGDGKYLKLPQLVDMAAQIADGMAYIER--- 120

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE     + 
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL+T G+ P
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 68/224 (30%), Positives = 106/224 (47%), Gaps = 30/224 (13%)

Query: 79  LGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-N 129
           LG+G  G V         K +      +AVK  K   DD     L + ++E+ ++  I  
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK---DDATDKDLSDLVSEMEMMKMIGK 76

Query: 130 HRNVVKLLGCCLETEFPLLVY-EFIPNGTLYQHLHDRH-----------QNEEYPLTWEM 177
           H+N++ LLG C + + PL V  E+   G L ++L  R            +  E  LT++ 
Sbjct: 77  HKNIINLLGACTQ-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 178 RFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHV 236
               A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ +  +D    
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           TT  +    ++ PE       T +SDV+SFGV+L E+ T G  P
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 30/224 (13%)

Query: 79  LGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN- 129
           LG+G  G V         K R +    +AVK  K    D++L  L   I+E+ ++  I  
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL---ISEMELMKLIGK 76

Query: 130 HRNVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRH-----------QNEEYPLTWEM 177
           H+N++ LLG C + E PL V  E+   G L + L  R            +  E  L+++ 
Sbjct: 77  HKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 178 RFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHV 236
               A +VA  + YL    S    HRD+ + N+L+ E    K+ADFG ++ +  +D    
Sbjct: 136 LVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           T+  +    ++ PE       T +SDV+SFG+++ E+ T G  P
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 46/303 (15%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYK--LEEFINEIFILSQI 128
            + + + +G G  G V        GR +A+KK     DD    K  L E    I +L  +
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE----IKLLRHL 56

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPN-GTLY--QHL--HDRHQ--NEEYPLTWE-MRFR 180
            H N++ LL         +L      +   +Y    L   D H+      PLT + +++ 
Sbjct: 57  RHENIIGLLD--------ILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY- 107

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
              ++   L YLHS     + HRD+K +NIL++     K+ DFG ++ +  D+       
Sbjct: 108 FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 241 QG--TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
           +   T  Y  PE   SS    K+ D++S G +  ELLT  KP+F  G    + ++L    
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPLFP-GRDYIDQLNLIVEV 222

Query: 298 VHSMRKNRLYHILDDQVMK----LGKK-----NQIVAFAN-----LAERCLDLNGKKRPT 343
           + +  +  L  I  ++       L KK     +++   A+     L E+ L  + KKR T
Sbjct: 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282

Query: 344 MEE 346
            +E
Sbjct: 283 ADE 285

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 13/206 (6%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R    G I+A+KK +L  +DE +      I EI +L ++NH N+V+LL
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                     LV+EF+ +  L +++ D        L   +      ++   +AY H   S
Sbjct: 65  DVVHSENKLYLVFEFL-DLDLKKYM-DSSP--LTGLDPPLIKSYLYQLLQGIAYCH---S 117

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQ 256
             + HRD+K  N+L+D     K+ADFG ++   +     T ++  T  Y  PE    S Q
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQ 176

Query: 257 LTDKSDVYSFGVVLVELLTGKKPIFS 282
            +   D++S G +  E++  ++P+F 
Sbjct: 177 YSTPVDIWSIGCIFAEMVN-RRPLFP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 85/311 (27%), Positives = 134/311 (43%), Gaps = 41/311 (13%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKK--SKLAVDDEELYKLEE---F 118
           ++L      ++V +++G+G  G V   R +  + +   K  SK      E+ K  +   F
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF-----EMIKRSDSAFF 90

Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
             E  I++  N   VV+L     + ++  +V E++P G L   +     N + P  W  +
Sbjct: 91  WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWA-K 145

Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---H 235
           F  A EV  AL  +HS     + HRD+K  N+LLD+    K+ADFGT   + MD+T    
Sbjct: 146 FYTA-EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVR 199

Query: 236 VTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
             T + GT  Y+ PE  +S         + D +S GV L E+L G  P ++         
Sbjct: 200 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-------- 250

Query: 292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNG----KKRPTMEEV 347
           SL   +   M      +  +D  +    KN I AF    E  L  NG    K+ P  +  
Sbjct: 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310

Query: 348 SMELNGIRGSI 358
               + IR + 
Sbjct: 311 QWNWDNIRETA 321

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           +++G+G  G V   +   DG+  AVK   K  +    E+ + + E      +L  + H  
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAE---RNVLLKNVKHPF 57

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +V L       +    V +++  G L+ HL    Q E        RF  A E+A AL YL
Sbjct: 58  LVGLHYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAA-EIASALGYL 112

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
           HS     I +RD+K  NILLD +    + DFG  K   ++ +  T+   GT  YL PE  
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 253 QSSQLTDKS-DVYSFGVVLVELLTGKKPIFS 282
           +  Q  D++ D +  G VL E+L G  P +S
Sbjct: 169 R-KQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 70.4 bits (172), Expect = 6e-14
 Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 21/213 (9%)

Query: 73  FNVNRILGQG--GQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +NV R++G+G  G+  + +    D +  A+K+ +L      +   E+   E  +L+++ H
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAV---EDSRKEAVLLAKMKH 57

Query: 131 RNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVA 186
            N+V       E +  L +V E+   G L Q +  +      E+  L W ++  + ++  
Sbjct: 58  PNIVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ-- 114

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               ++H      + HRDIKS NI L +  + K+ DFG+++ +     +  T + GT  Y
Sbjct: 115 ----HIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYY 166

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           + PE  ++    +KSD++S G +L EL T K P
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 76/263 (28%), Positives = 115/263 (43%), Gaps = 24/263 (9%)

Query: 77  RILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           +++G+G  G V   R + + +  AVK   K  +    EE + + E      +L  + H  
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE---RNVLLKNVKHPF 57

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +V L       +    V ++I  G L+ HL    Q E   L    RF  A E+A AL YL
Sbjct: 58  LVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAA-EIASALGYL 112

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
           HS     I +RD+K  NILLD +    + DFG  K   ++    T+   GT  YL PE  
Sbjct: 113 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVL 168

Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAYFVHSMRKNRLYHIL 310
                    D +  G VL E+L G  P +S  NT++  +N+      +     N   H+L
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-NTAEMYDNILNKPLQLKPNITNSARHLL 227

Query: 311 D-----DQVMKLGKKNQIVAFAN 328
           +     D+  +LG K+  +   N
Sbjct: 228 EGLLQKDRTKRLGAKDDFMEIKN 250

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 57/233 (24%), Positives = 105/233 (45%), Gaps = 24/233 (10%)

Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKS--KLAVDDEEL 112
           I R +  +  +L +            +G  G ++ G L D +    ++   K   D    
Sbjct: 3   ISRDR-VTLSDLLQ------------EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE 49

Query: 113 YKLEEFINEIFILSQINHRNVVKLLGCCLE-TEFPLLVYEFIPNGTLYQHLHD-RHQNEE 170
            ++   + E  +L  ++H+N++ +L  C+E  E P ++Y ++  G L   L   R     
Sbjct: 50  IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN 109

Query: 171 YPLTWEMRFRV--AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK- 227
            P     +  V  AI++A  ++YLH      + H+DI + N ++DE  + K+ D   S+ 
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRD 166

Query: 228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              MD   +         ++  E   + + +  SDV+SFGV+L EL+T G+ P
Sbjct: 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.5 bits (172), Expect = 7e-14
 Identities = 77/280 (27%), Positives = 114/280 (40%), Gaps = 33/280 (11%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F + + +G G  G VYK R +  G + A+K  KL   ++          EI ++    H 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED----FAVVQQEIIMMKDCKHS 66

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           N+V   G  L  +   +  EF   G+L    H      E  + +  R     E    L Y
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYY 121

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE- 250
           LHS       HRDIK  NILL +    K+ADFG S  I        + I GT  ++ PE 
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEV 177

Query: 251 --YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
               +        D+++ G+  +EL   + P+F                +H MR   L  
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFD---------------LHPMRALFLMT 222

Query: 309 ILDDQVMKLGKKNQIV-AFANLAERCLDLNGKKRPTMEEV 347
             + Q  KL  K +   +F +  +  L  N KKRPT E++
Sbjct: 223 KSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 37/218 (16%)

Query: 79  LGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  GTV K   +  G I+AVK+ +  VD++E  +L   ++   ++   +   +VK  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD--VVMRSSDCPYIVKFY 69

Query: 138 G-------C--CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           G       C  C+E    L+          Y+++++       P   E+  ++A+    A
Sbjct: 70  GALFREGDCWICME----LMDISL---DKFYKYVYE-VLKSVIP--EEILGKIAVATVKA 119

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF----IAMDQTHVTTKIQGTF 244
           L YL       I HRD+K +NILLD     K+ DFG S      IA       T+  G  
Sbjct: 120 LNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA------KTRDAGCR 171

Query: 245 GYLDPEYHQSSQLTD---KSDVYSFGVVLVELLTGKKP 279
            Y+ PE    S       +SDV+S G+ L E+ TGK P
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 65/235 (27%), Positives = 110/235 (46%), Gaps = 18/235 (7%)

Query: 77  RILGQGGQGTVYKGRLED-GRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           R++G+G    V   RL+   RI A+K  K +L  DDE++  ++    E  +  Q ++   
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASNHPF 57

Query: 134 VKLLGCCLETEFPLL-VYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +  L  C +TE  L  V E++  G L  H+   R   EE+      RF  A E++ AL Y
Sbjct: 58  LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-----RFYSA-EISLALNY 111

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH      I +RD+K  N+LLD     K+ D+G  K   +     T+   GT  Y+ PE 
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEI 167

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
            +        D ++ GV++ E++ G+ P    G++   + +   Y    + + ++
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 25/215 (11%)

Query: 79  LGQG--GQGTVYKGRLEDGRIIAVKK---SKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           +G+G  G+  + K + EDG+   +K+   SK++  + E     E   E+ +LS + H N+
Sbjct: 8   IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKERE-----ESRKEVAVLSNMKHPNI 61

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ---NEEYPLTWEMRFRVAIEVAGALA 190
           V+      E     +V ++   G LY+ ++ +      E+  L W       +++  AL 
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALK 115

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           ++H      I HRDIKS NI L +    K+ DFG ++ +        T I GT  YL PE
Sbjct: 116 HVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
             ++    +KSD+++ G VL E+ T K   F  GN
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHA-FEAGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 66/212 (31%), Positives = 90/212 (42%), Gaps = 17/212 (8%)

Query: 73  FNVNRILGQGGQGTV----YKGRLEDGRIIAVKKSKLAVDDE-ELYKLEEFINEIFILSQ 127
           F    +LG+G  G V    YK   E   I A+KK  +   DE E    E+ I E    + 
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET--ANS 58

Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
             H  +V L  C    +    V E+   G L  H+H    +E         F  A  V  
Sbjct: 59  ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAA-CVVL 112

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
            L YLH    + I +RD+K  N+LLD     K+ADFG  K   M     T+   GT  +L
Sbjct: 113 GLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFL 168

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            PE    +  T   D +  GV++ E+L G+ P
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 30/211 (14%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLE-------EFINEIFILSQINHR 131
           LG G  G V+K   +   +I  +K         L  LE       + I E+ +L + N  
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARK---------LIHLEIKPAIRNQIIRELQVLHECNSP 63

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +V   G         +  E +  G+L Q L    +  E  L      +V+I V   L Y
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 118

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDP 249
           L       I HRD+K +NIL++ R   K+ DFG S  +  +M  + V     GT  Y+ P
Sbjct: 119 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSP 171

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
           E  Q +  + +SD++S G+ LVE+  G+ PI
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 78/258 (30%), Positives = 111/258 (43%), Gaps = 38/258 (14%)

Query: 46  MLNSYDGSVIDRCKLFSSK-ELDKAT-----NHFNVNRILGQGGQGTV-YKGRLEDGRII 98
           M+ S D  +   C+ F      D+AT       + ++R+LG G  GTV    R+ DG   
Sbjct: 1   MMASGDAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPF 60

Query: 99  AVKKSKLAVDDEELYKLEEFIN----EIFILSQINHRNVVKLLGCCLE------------ 142
           AVK     V D E    E   N    E+  L   +  ++VK    C E            
Sbjct: 61  AVK-----VVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVK----CHEDFAKKDPRNPEN 110

Query: 143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
                LV ++   G L Q +  R +             + I+V  A+ ++HS     + H
Sbjct: 111 VLMIALVLDYANAGDLRQEIKSRAKTNR-TFREHEAGLLFIQVLLAVHHVHS---KHMIH 166

Query: 203 RDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RDIKS NILL      K+ DFG SK + A     V     GT  Y+ PE  +    + K+
Sbjct: 167 RDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA 226

Query: 262 DVYSFGVVLVELLTGKKP 279
           D++S GV+L ELLT K+P
Sbjct: 227 DMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 79/281 (28%), Positives = 116/281 (41%), Gaps = 25/281 (8%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEE--FINE 121
           ++L      + V +++G+G  G V   R +  R   V   KL    E + + +   F  E
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR--KVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
             I++  N   VV+L     +  +  +V E++P G L   +     N + P  W  RF  
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA-RFYT 148

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A EV  AL  +HS       HRD+K  N+LLD+    K+ADFGT   +  +         
Sbjct: 149 A-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 242 GTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
           GT  Y+ PE  +S         + D +S GV L E+L G  P ++         SL   +
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTY 256

Query: 298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNG 338
              M         DD  +    KN I AF    E  L  NG
Sbjct: 257 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG 297

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 65/207 (31%), Positives = 91/207 (43%), Gaps = 17/207 (8%)

Query: 79  LGQGGQGTVYKGRLEDGRII----AVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV 134
           +G+G  G V + R  D + I     ++K+ +    E  + L E      +L+Q+N   +V
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT----VLAQVNCPFIV 56

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
            L       E   LV  FI  G L+ HL    Q E        RF  A E+  AL  LH 
Sbjct: 57  PLKFSFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTA-ELLCALENLHK 111

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 254
                + +RD+K  NILLD +    + DFG  K + M     T    GT  YL PE    
Sbjct: 112 ---FNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLG 167

Query: 255 SQLTDKSDVYSFGVVLVELLTGKKPIF 281
              T   D ++ GV+L E+LTG  P +
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPPFY 194

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 66/210 (31%), Positives = 93/210 (44%), Gaps = 16/210 (7%)

Query: 77  RILGQGGQGTVY-KGRLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           +++G+G  G V    R  DG   AVK   K  +    E+ + + E      +L  + H  
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAE---RNVLLKNLKHPF 57

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +V L       E    V +++  G L+ HL    Q E   L    RF  A EVA A+ YL
Sbjct: 58  LVGLHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAA-EVASAIGYL 112

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
           HS     I +RD+K  NILLD +    + DFG  K   ++    T+   GT  YL PE  
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVL 168

Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           +        D +  G VL E+L G  P +S
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 15/209 (7%)

Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
             + + LG G  G V+         +AVK  K          +E F+ E  ++  + H  
Sbjct: 8   LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDK 62

Query: 133 VVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +VKL      T+ P+ ++ EF+  G+L   L     +++ PL   + F  + ++A  +A+
Sbjct: 63  LVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDF--SAQIAEGMAF 117

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           +         HRD+++ NIL+      K+ADFG ++ I  ++       +    +  PE 
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174

Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                 T KSDV+SFG++L+E++T G+ P
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 49/284 (17%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH-RNVVKL 136
           LG+G  G V K R    G I+AVK+ +  V+ +E  +L   + ++ I  +       V  
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRL---LMDLDISMRSVDCPYTVTF 65

Query: 137 LGC---------CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
            G          C+E     L  +F      Y+ ++D+       +  ++    A+ +  
Sbjct: 66  YGALFREGDVWICMEVMDTSL-DKF------YKKVYDKGLTIPEDILGKI----AVSIVK 114

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL YLHS  S  + HRD+K +N+L++   + K+ DFG S ++ +D    T    G   Y+
Sbjct: 115 ALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA-GCKPYM 170

Query: 248 DPEY---HQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
            PE      + +  D KSDV+S G+ ++EL TG+ P  S     Q+              
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-------------- 216

Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             L  ++++   +L  +     F +   +CL  N K+RP   E+
Sbjct: 217 --LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPEL 258

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 78  ILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           I+G+GG G VY  R  D G++ A+K   K ++ +   E   L    NE  +LS ++  + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLSLVSTGDC 56

Query: 134 VKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
             ++  C+   F        + + +  G L+ HL       E     EMRF  A E+   
Sbjct: 57  PFIV--CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK----EMRF-YATEIILG 109

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L ++H+     + +RD+K  NILLDE    +++D G +   +  + H +    GT GY+ 
Sbjct: 110 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163

Query: 249 PEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           PE  Q     D S D +S G +L +LL G  P
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 77  RILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           ++LG+G  G V+    KG  +   I A+KK  + +DD+    +E  + E  +LS      
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD----VECTMVEKRVLSLAWEHP 56

Query: 133 VVKLLGCCLET-EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +  L C  +T E    V E++  G L  H+   H+ +    T+      A E+   L +
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-----YAAEIICGLQF 111

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     I +RD+K  NILLD     K+ADFG  K   +     T    GT  Y+ PE 
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEI 167

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
               +     D +SFGV+L E+L G+ P
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 53/220 (24%), Positives = 104/220 (47%), Gaps = 25/220 (11%)

Query: 79  LGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           LG+   G VYKG L      E  + +A+K  K   D  E    EEF +E  + S++ H N
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK---DKAEGPLREEFKHEAMMRSRLQHPN 69

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR-----------FRV 181
           +V LLG   + +   +++ +  +  L++ L  R  + +   T + +             +
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKI 240
             ++A  + +L   +S  + H+D+ + N+L+ ++   K++D G  + + A D   +    
Sbjct: 130 VTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                ++ PE     + +  SD++S+GVVL E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 67/244 (27%), Positives = 99/244 (40%), Gaps = 53/244 (21%)

Query: 69  ATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIF 123
               + +   LG+G  G VYK R ++ GR++A+KK  + + +E+    + F    + EI 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKK--ILMHNEK----DGFPITALREIK 59

Query: 124 ILSQINHRNVVKLLGCCLE-----TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           IL ++ H NVV L+   +E           VY   P    Y   HD     E P      
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP----YMD-HDLSGLLENP------ 108

Query: 179 FRVAIEVAGA----------LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG---- 224
             V +  +            + YLH    + I HRDIK+ NIL+D +   K+ADFG    
Sbjct: 109 -SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164

Query: 225 ------TSKFIAMDQTHVTTKIQGTFGYLDPEY-HQSSQLTDKSDVYSFGVVLVELLTGK 277
                   K      T   T +  T  Y  PE      + T   D++  G V  E+ T  
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR- 223

Query: 278 KPIF 281
           +PI 
Sbjct: 224 RPIL 227

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 27/215 (12%)

Query: 78  ILGQGGQGTVYKGRLE-DGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNV 133
           ++G+G  G V +  ++ DG  +  A+K  K    + +     +F  E+ +L ++ +H N+
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH---RDFAGELEVLCKLGHHPNI 65

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP-----------LTWEMRFRVA 182
           + LLG C    +  +  E+ P G L   L      E  P           LT +   + A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            +VA  + YL   +     HRD+ + N+L+ E   +K+ADFG S+    ++ +V  K  G
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMG 178

Query: 243 TFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
                ++  E    S  T KSDV+SFGV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  GTV+K +  E   I+A+K+ +L  DDE +      + EI +L ++ H+N+V+L 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLY 65

Query: 138 GCCLETEFPLLVYEFIP----------NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                 +   LV+E+            NG +     D    + +            ++  
Sbjct: 66  DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-----DPEIVKSFMF----------QLLK 110

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
            LA+ H   S  + HRD+K  N+L+++    K+ADFG ++   +     + ++  T  Y 
Sbjct: 111 GLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYR 166

Query: 248 DPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 281
            P+    ++L   S D++S G +  EL    +P+F
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 22/222 (9%)

Query: 77  RILGQGGQGTVYKGRLE-DGRIIAVK--KSKLAVDDEEL--YKLEEFINEIFILSQINHR 131
           R++G+G    V    L+   RI A+K  K +L  DDE++   + E+ + E    +  NH 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFE----TASNHP 56

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALA 190
            +V L  C         V EF+  G L  H+   R   EE+      RF  A E++ AL 
Sbjct: 57  FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHA-----RFYSA-EISLALN 110

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           +LH      I +RD+K  N+LLD     K+ D+G  K   +     T+   GT  Y+ PE
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPE 166

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKP--IFSTGNTSQEN 290
             +        D ++ GV++ E++ G+ P  I    +   +N
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 56/239 (23%), Positives = 105/239 (43%), Gaps = 34/239 (14%)

Query: 115 LEEFINEIFILSQINHRNVVKLLGCCLETEFPL----LVYEFIPNGTLYQHLHDRHQNEE 170
           ++   NEI  L +I+  N++K+ G  ++    L    L+ E+   G L + L     ++E
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKE 116

Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
             L+++ +  +AI+    L  L+   + P  ++++ S + L+ E Y+ K+   G  K ++
Sbjct: 117 KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILS 174

Query: 231 MDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
                   K      Y   +      S+ T K D+YS GVVL E+ TGK P         
Sbjct: 175 SP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-------- 222

Query: 289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           EN++    +   + KN    +  D  +++           + E C   +  KRP ++E+
Sbjct: 223 ENLTTKEIYDLIINKNNSLKLPLDCPLEI---------KCIVEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 24/215 (11%)

Query: 73  FNVNRILGQGGQGTV----YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           F +   LG G  G V    +KG  E   I  +KK ++     ++ +++    E  IL ++
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL----KMKQVQHVAQEKSILMEL 75

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD--RHQNEEYPLTWEMRFRVAIEVA 186
           +H  +V ++    +      + EF+  G L+ HL    R  N+        +F  A E+ 
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV------AKFYHA-ELV 128

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
            A  YLHS     I +RD+K  N+LLD +   KV DFG +K +       T  + GT  Y
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEY 181

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           L PE  QS       D ++ GV+L E + G  P F
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216

Length = 329

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 14/206 (6%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R       IA+KK +L  +DE +      I EI +L ++ H N+V+L 
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVRLQ 67

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                 +   LV+E++ +  L +H+     + ++     +      ++   +AY HS   
Sbjct: 68  DVVHSEKRLYLVFEYL-DLDLKKHMD---SSPDFAKNPRLIKTYLYQILRGIAYCHS--- 120

Query: 198 SPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSS 255
             + HRD+K  N+L+D R  A K+ADFG ++   +     T ++  T  Y  PE    S 
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSR 179

Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIF 281
             +   D++S G +  E++  +KP+F
Sbjct: 180 HYSTPVDIWSVGCIFAEMVN-QKPLF 204

Length = 294

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 47/242 (19%)

Query: 75  VNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFIN----------EIF 123
               LG+G  G V K      G+I+A+KK K+     ++ K  + +           E+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           I+++I H N++ L+   +E +F  LV + I    L + +  + +     LT      + +
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRKIR-----LTESQVKCILL 126

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG-------------TSKFIA 230
           ++   L  LH        HRD+   NI ++ +   K+ADFG              SK   
Sbjct: 127 QILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 231 MDQTHVTTKIQGTFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 283
           M +    T    T  Y  PE       YH +       D++S G +  ELLTG KP+F  
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFA------VDMWSVGCIFAELLTG-KPLFPG 236

Query: 284 GN 285
            N
Sbjct: 237 EN 238

Length = 335

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 78  ILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           I+G+GG G VY  R  D G++ A+K   K ++ +   E   L    NE  +LS ++  + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLSLVSTGDC 56

Query: 134 VKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
             ++  C+   F        + + +  G L+ HL       E     EMRF  A E+   
Sbjct: 57  PFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----EMRF-YAAEIILG 109

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L ++H+     + +RD+K  NILLDE    +++D G +   +  + H +    GT GY+ 
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163

Query: 249 PEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           PE  Q     D S D +S G +L +LL G  P
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 14/204 (6%)

Query: 79  LGQGGQGTVYKGRLED-GRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           LG+GG G V   +++  G++ A KK  K  +   +  ++   +NE  IL +++ R +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58

Query: 137 LGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
                ET+  L LV   +  G L  H+++      +P      F  A ++   L +LH  
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEA-RAIFYAA-QIICGLEHLHQ- 113

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
               I +RD+K  N+LLD+    +++D G +  + +          GT GY+ PE  Q  
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGE 169

Query: 256 QLTDKSDVYSFGVVLVELLTGKKP 279
                 D ++ G  L E++ G+ P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 18/208 (8%)

Query: 77  RILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           ++LG+G  G V     KG  E   I  +KK  +  DD+    ++  + E  IL+      
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD----VDCTMTEKRILALAAKHP 56

Query: 133 VVKLLGCCLETEFPLL-VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +  L CC +T+  L  V E++  G L   +    + +E       RF  A EV  AL +
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP----RSRFYAA-EVTLALMF 111

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH      + +RD+K  NILLD     K+ADFG  K   +     TT   GT  Y+ PE 
Sbjct: 112 LHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEI 167

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Q  +     D ++ GV++ E++ G+ P
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 18/208 (8%)

Query: 77  RILGQGGQGTVYKGRLE-DGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           R++G+G    V   RL+ + +I A+K  K +L  DDE++  ++    E  +  Q +    
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQ---TEKHVFEQASSNPF 57

Query: 134 VKLLGCCLETEFPL-LVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +  L  C +T   L LV E++  G L  H+   R   EE+      RF  A E+  AL +
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA-----RFYAA-EICIALNF 111

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH      I +RD+K  N+LLD     K+ D+G  K   +     T+   GT  Y+ PE 
Sbjct: 112 LHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEI 167

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            +  +     D ++ GV++ E++ G+ P
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 30/225 (13%)

Query: 72  HFNVNRILGQGGQGTV----YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
            + + + LGQG  G V         E+  + A+KK       + L K    + E+ +L  
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETV-AIKKITNVFSKKILAK--RALRELKLLRH 57

Query: 128 I-NHRNVVKLLGCCLETEFPLLVYEFIPNGT-LYQHL--HDRHQ--NEEYPLTWEMRFRV 181
              H+N+  L    ++  FP     F  N   LY+ L   D HQ      PLT +  F+ 
Sbjct: 58  FRGHKNITCLYD--MDIVFP---GNF--NELYLYEELMEADLHQIIRSGQPLT-DAHFQS 109

Query: 182 AI-EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
            I ++   L Y+HS   + + HRD+K  N+L++     K+ DFG ++  + +       +
Sbjct: 110 FIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166

Query: 241 QG---TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 281
                T  Y  PE   S Q   K+ DV+S G +L ELL G+KP+F
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 72/260 (27%), Positives = 119/260 (45%), Gaps = 38/260 (14%)

Query: 77  RILGQGGQGTVYKGRLEDG----RIIAVK---KSKLAVDDEELYKLEEFINEIFILSQIN 129
           ++LG+GG G V++ R   G    +I A+K   K+ +  + ++    +   N   IL  + 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN---ILEAVK 58

Query: 130 HRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           H  +V L+    +T   L L+ E++  G L+ HL    + E   +     F ++ E++ A
Sbjct: 59  HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHL----EREGIFMEDTACFYLS-EISLA 112

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L +LH      I +RD+K  NILLD +   K+ DFG  K  ++ +  VT    GT  Y+ 
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMA 168

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-------NVSLAAYFVHSM 301
           PE    S      D +S G ++ ++LTG  P F+  N  +         ++L  Y     
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP-FTAENRKKTIDKILKGKLNLPPYLTPEA 227

Query: 302 RKNRLYHILDDQVMKLGKKN 321
           R         D + KL K+N
Sbjct: 228 R---------DLLKKLLKRN 238

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 46/159 (28%), Positives = 66/159 (41%), Gaps = 19/159 (11%)

Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFR 180
           ++ Q     V KL       ++  LV E++  G   +L + L         P  W  ++ 
Sbjct: 50  MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG------GLPEDWAKQY- 102

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
              EV   +  LH      I HRDIK  N+L+D+    K+ DFG S+    ++     K 
Sbjct: 103 -IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KF 153

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            GT  YL PE          SD +S G V+ E L G  P
Sbjct: 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 14/210 (6%)

Query: 73  FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEF-INEIFILSQINH 130
           F   R+LG+GG G V   ++   G++ A KK  L     +  K E   +NE  IL ++N 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 131 RNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           R VV L     ET+  L LV   +  G L  H++  H  E         F  A E+   L
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY--HMGEAGFEEGRAVFYAA-EICCGL 115

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
             LH      I +RD+K  NILLD+    +++D G +  +   QT +  ++ GT GY+ P
Sbjct: 116 EDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAP 170

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           E  ++ + T   D ++ G +L E++ G+ P
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 13/200 (6%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V+K R  E G+I+A+KK   + DD  + K+   + EI +L Q+ H N+V L+
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVNLI 66

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                     LV+E+  +  L  +  +++      +   +  ++  +   A+ + H    
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVL--NELEKNPRG---VPEHLIKKIIWQTLQAVNFCHK--- 118

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH-QSSQ 256
               HRD+K  NIL+ ++ + K+ DFG ++ +       T  +  T  Y  PE     +Q
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQ 177

Query: 257 LTDKSDVYSFGVVLVELLTG 276
                DV++ G V  ELLTG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 20/225 (8%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQI 128
             F+V  ++G+G  G V   R +  G I A+K   K  +  +E   +  F  E  ILS  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQE--TVSFFEEERDILSIS 58

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM-RFRVAIEVAG 187
           N   + +L     + +   LV E+ P G L   L +R+++       +M +F +A E+  
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYED---QFDEDMAQFYLA-ELVL 113

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           A+  +H        HRDIK  N+L+D     K+ADFG++  +  ++   +    GT  Y+
Sbjct: 114 AIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170

Query: 248 DPEYHQSSQLTDKS------DVYSFGVVLVELLTGKKPIFSTGNT 286
            PE   +     K       D +S GV+  E++ G+ P F  G +
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-FHEGTS 214

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 16/214 (7%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+G   TVYKGR    G I+A+K+  L   D E       I EI ++ ++ H N+V+L 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHL---DAEEGTPSTAIREISLMKELKHENIVRLH 64

Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
              + TE  L LV+E++ +  L +++                F    ++   +A+ H   
Sbjct: 65  DV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSF--TYQLLKGIAFCHE-- 118

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
            + + HRD+K  N+L+++R   K+ADFG ++   +     + ++  T  Y  P+    S+
Sbjct: 119 -NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSR 176

Query: 257 LTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
               S D++S G ++ E++TG +P+F  G  +++
Sbjct: 177 TYSTSIDIWSVGCIMAEMITG-RPLF-PGTNNED 208

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 41/171 (23%), Positives = 77/171 (45%), Gaps = 14/171 (8%)

Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP--NGTLYQHLHDRHQNEEYPLTWEMR 178
           E  +L  +NH +V+++    +      +V   +P  +  LY +L         PL  +  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL----TKRSRPLPIDQA 159

Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
             +  ++   L YLH+     I HRD+K+ NI +++  +  + D G ++F  +    +  
Sbjct: 160 LIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-- 214

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            + GT     PE     +   K+D++S G+VL E+L     IF    ++ E
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265

Length = 357

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 21/215 (9%)

Query: 78  ILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEEL--YKLEEFINEIFILSQINHRNVV 134
            +G+G  G VYK R    G+++A+KK++L +D+E +    L E I+ + +LS+  +  +V
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE-ISLLQMLSESIY--IV 64

Query: 135 KLLGCCLETEFPL------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           +LL      E         LV+E++ +  L + +    +    PL  +       ++   
Sbjct: 65  RLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 189 LAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           +A+ H      + HRD+K  N+L+D ++   K+AD G  +  ++     T +I  T  Y 
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178

Query: 248 DPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
            PE    S+  +   D++S G +  E+   K+P+F
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 21/212 (9%)

Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR-NVVKL 136
           ++G+G  G V K R++   +      K   +        +F  E+ +L ++ H  N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP-----------LTWEMRFRVAIEV 185
           LG C    +  L  E+ P+G L   L      E  P           L+ +     A +V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
           A  + YL   +     HRD+ + NIL+ E Y AK+ADFG S+     + +V  K  G   
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRLP 174

Query: 246 --YLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             ++  E    S  T  SDV+S+GV+L E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 37/227 (16%)

Query: 78  ILGQGGQGT---VYKGRL---EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           I G  G+GT   VYK +    +DG+  A+KK K   +            EI +L ++ H 
Sbjct: 4   IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLRELKHE 62

Query: 132 NVVKLLGCCLETEFPL--LVYEFIPNGTLYQ--HLHDRHQNEEYP------LTWEMRFRV 181
           NVV L+   LE       L++++  +  L+Q    H + +    P      L W      
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLW------ 115

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTS-KFIAMDQTHV 236
             ++   + YLH   S+ + HRD+K  NIL+     ER   K+ D G +  F A  +   
Sbjct: 116 --QILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 237 T-TKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIF 281
               +  T  Y  PE    ++  T   D+++ G +  ELLT  +PIF
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.9 bits (159), Expect = 9e-12
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 36/184 (19%)

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTH---VTTKIQGT 243
           AL Y+HSG    + HRD+K +NILL+   R K+ADFG ++ ++ +++     V T    T
Sbjct: 119 ALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 244 FGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF--------------STGNTSQ 288
             Y  PE    S    K  D++S G +L E+L G KP+F                G  S 
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEKIIEVIGPPSA 234

Query: 289 ENV-SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFAN-----LAERCLDLNGKKRP 342
           E++ S+ + F  +M    L  +       L   ++++  A+     L ++ L  N  KR 
Sbjct: 235 EDIESIKSPFAATM----LDSLPSRPRKPL---DELLPKASDDALDLLKKLLVFNPNKRL 287

Query: 343 TMEE 346
           T EE
Sbjct: 288 TAEE 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 33/219 (15%)

Query: 75  VNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQIN 129
           +NRI  +G  G VY+ R  + G I+A+KK K+   ++E    E F    + EI IL ++ 
Sbjct: 10  LNRI-EEGTYGVVYRARDKKTGEIVALKKLKM---EKEK---EGFPITSLREINILLKLQ 62

Query: 130 HRNVVKL----LGCCLETEFPLLVYEFIPNG--TLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           H N+V +    +G  L+  +  +V E++ +   +L + +          L  E++  + +
Sbjct: 63  HPNIVTVKEVVVGSNLDKIY--MVMEYVEHDLKSLMETMKQPF------LQSEVKCLM-L 113

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++   +A+LH      I HRD+K++N+LL+ R   K+ DFG ++          T++  T
Sbjct: 114 QLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVT 169

Query: 244 FGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
             Y  PE    + + +   D++S G +  ELLT KKP+F
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLF 207

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 25/219 (11%)

Query: 79  LGQGGQGTVYKGR-LEDG-RIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN---HRNV 133
           +G+G  G V+K R L++G R +A+K+ ++   +E +      I E+ +L  +    H NV
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--STIREVAVLRHLETFEHPNV 66

Query: 134 VKLLGCCL------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L   C       ET+  L V+E + +  L  +L D+      P   E    +  ++  
Sbjct: 67  VRLFDVCTVSRTDRETKLTL-VFEHV-DQDLTTYL-DKVPEPGVPT--ETIKDMMFQLLR 121

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
            L +LHS     + HRD+K  NIL+    + K+ADFG ++  +       T +  T  Y 
Sbjct: 122 GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 176

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
            PE    S      D++S G +  E+   +KP+F  G++
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR-GSS 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 26/224 (11%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFIL---SQINHRNVV 134
           +G G  GTVYK R    G  +A+K  ++  +++ L      + E+ +L      +H N+V
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL--STVREVALLKRLEAFDHPNIV 65

Query: 135 KLLGCCL------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP-LTWEMRFRVAIEVAG 187
           +L+  C       ET+  L V+E +      Q L         P L  E    +  +   
Sbjct: 66  RLMDVCATSRTDRETKVTL-VFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
            L +LH+     I HRD+K  NIL+    + K+ADFG ++  +       T +  T  Y 
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYR 174

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
            PE    S      D++S G +  E+   +KP+F  GN+  + +
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF-CGNSEADQL 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 51/223 (22%), Positives = 81/223 (36%), Gaps = 27/223 (12%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           +         + K +     ++AVKK  L    +E  KL     EI    Q+ H N++  
Sbjct: 8   KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKL--LQQEIITSRQLQHPNILPY 64

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI-----EVAGALAY 191
           +   +      +V   +  G+    L   H  E  P        +AI     +V  AL Y
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLP-------ELAIAFILKDVLNALDY 116

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHV-----TTKIQGTFG 245
           +HS       HR +K+++ILL    +  ++    S   I   +                 
Sbjct: 117 IHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 246 YLDPEYHQSSQL--TDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
           +L PE  Q +     +KSD+YS G+   EL  G  P      T
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 19/211 (9%)

Query: 77  RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAV---DDEELYKLEEFINEIFILSQINHRN 132
           ++LG+G  G V   R +  G+  A+K  K  V    DE  + L     E  +L    H  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL----TESRVLQNTRHPF 56

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +  L       +    V E+   G L+ HL  +R  +E+       RF  A E+  AL Y
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGA-EIVSALGY 110

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     + +RD+K  N++LD+    K+ DFG  K    D   + T   GT  YL PE 
Sbjct: 111 LHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEV 166

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
            + +      D +  GVV+ E++ G+ P ++
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 42/286 (14%)

Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKL---AVDDEELYKLEEFINEIFILSQINHRNVV 134
           LGQG    ++KG R E G    + K+++    +D       E F     ++SQ++H+++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY-LH 193
              G C+  +  ++V E++  G+L  +L          ++W++      EVA  LA+ LH
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISWKL------EVAKQLAWALH 114

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD----- 248
                 + H ++ + N+LL    R +    G   FI +    ++  +      L+     
Sbjct: 115 FLEDKGLTHGNVCAKNVLL---IREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171

Query: 249 -PE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
            PE       L+  +D +SFG  L E       IFS G+       L+A    S +K + 
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWE-------IFSGGDK-----PLSAL--DSQKKLQF 217

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
           Y   D   +   K  ++   ANL  +C+D     RP+   +  +LN
Sbjct: 218 YE--DRHQLPAPKWTEL---ANLINQCMDYEPDFRPSFRAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 68/233 (29%), Positives = 101/233 (43%), Gaps = 28/233 (12%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           + L   T+ + +   +G+G  G VYK    +DG + AVK      D +E     E   E 
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-----EIEAEY 69

Query: 123 FILSQI-NHRNVVKLLGCCLETEFPL-----LVYEFIPNGT---LYQHLHDRHQNEEYPL 173
            IL  + NH NVVK  G   + +  +     LV E    G+   L + L    Q  +  +
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129

Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 233
                  ++  + GAL  L    ++ I HRD+K  NILL      K+ DFG S  +   +
Sbjct: 130 -------ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182

Query: 234 THVTTKIQGTFGYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIF 281
               T + GT  ++ PE     Q  D S     DV+S G+  +EL  G  P+F
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 30/208 (14%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEF----IN---------EIFIL 125
           LG+G  GTVY           + K K AV +E L  L+E     +N         E  +L
Sbjct: 8   LGKGSFGTVY-----------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLL 56

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           S+++H  +VK     LE +   ++ E+     L   L +     +  L+        I++
Sbjct: 57  SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-TLSENQVCEWFIQL 115

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
              + Y+H      I HRD+K+ NI L      K+ DFG S+ + M    + T   GT  
Sbjct: 116 LLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPY 170

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVEL 273
           Y+ PE  +      KSD++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 20/213 (9%)

Query: 73  FNVNRILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           FN   +LG+G  G V     KG  E   I  +KK  +  DD+    +E  + E  +L+  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD----VECTMVEKRVLALS 57

Query: 129 NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +  L  C +T   L  V E++  G L   +    + +E    +      A E+A 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-----YAAEIAI 112

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGY 246
            L +LHS     I +RD+K  N++LD     K+ADFG  K    D   VTTK   GT  Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDY 167

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           + PE           D ++FGV+L E+L G+ P
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 62.6 bits (152), Expect = 3e-11
 Identities = 51/226 (22%), Positives = 100/226 (44%), Gaps = 17/226 (7%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEFIN 120
           ELD  +    + RILG G  G + +G L+   +    +A+   +    D++      F+ 
Sbjct: 1   ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR---RGFLA 55

Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E   L Q +H N+V+L G        ++V E++ NG L   L  +H+ +   L       
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQ---LVAGQLMG 111

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
           +   +A  + YL   +     H+ + +  +L++     K++ F   +    +  + T   
Sbjct: 112 MLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG 168

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
           +    +  PE  Q    +  SDV+SFG+V+ E+++ G++P +    
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 73  FNVNRILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           FN   +LG+G  G V     KG  E   I  +KK  +  DD+    +E  + E  +L+  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD----VECTMVEKRVLALP 57

Query: 129 NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +  L  C +T   L  V E++  G L  H+    + +E    +      A E+A 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-----YAAEIAI 112

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGY 246
            L +LHS     I +RD+K  N++LD     K+ADFG  K         TT+   GT  Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDY 167

Query: 247 LDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           + PE   + Q   KS D ++FGV+L E+L G+ P
Sbjct: 168 IAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)

Query: 73  FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEF-INEIFILSQINH 130
           F   R+LG+GG G V   ++   G++ A KK  L     +  K E   +NE  IL ++N 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 59

Query: 131 RNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQ---NEEYPLTWEMRFRVAIEVA 186
           R VV L     ET+  L LV   +  G L  H+++      +EE  + +      A E+ 
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY------AAEIT 112

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
             L  LH      I +RD+K  NILLD+    +++D G +  I   +T +  ++ GT GY
Sbjct: 113 CGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGY 167

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           + PE  ++ + T   D +  G ++ E++ GK P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 19/211 (9%)

Query: 77  RILGQGGQGTVYKGRLE-DGRIIA---VKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           ++LG+G  G V   R +  G+  A   +KK  +   DE  + L     E  +L    H  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL----TESRVLKNTRHPF 56

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +  L       +    V E++  G L+ HL  +R  +E+       RF  A E+  AL Y
Sbjct: 57  LTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED-----RTRFYGA-EIVSALDY 110

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHSG    I +RD+K  N++LD+    K+ DFG  K    D   + T   GT  YL PE 
Sbjct: 111 LHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEV 166

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
            + +      D +  GVV+ E++ G+ P ++
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           R++G+G  G V   R   DG+   +KK  L        K  E   E  +LSQ+ H N+V 
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIVA 63

Query: 136 LLGCCLETEFPLL--VYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALA 190
                 E E  LL  V  F   G LY  L ++      E   + W       +++A AL 
Sbjct: 64  YRES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQ 116

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YLH      I HRD+K+ N+ L      KV D G ++ +  +Q  + + + GT  Y+ PE
Sbjct: 117 YLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPE 172

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGK 277
              +     KSDV++ G  + E+ T K
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 37/220 (16%)

Query: 77  RILGQGGQGT---VYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFIN--EIFILSQIN- 129
           +ILG+ G+GT   V K +  + G+  A+K  K          LE+  N  EI  L +++ 
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-----LEQVNNLREIQALRRLSP 56

Query: 130 HRNVVKLLGCCLE--TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI-EVA 186
           H N+++L+    +  T    LV+E + +  LY+ +  R      PL  E R +  + ++ 
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRK----RPLP-EKRVKSYMYQLL 110

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
            +L ++H    + I+HRDIK  NIL+ +    K+ADFG+ + I     +  T+   T  Y
Sbjct: 111 KSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYISTRWY 164

Query: 247 LDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIF 281
             PE      LTD     K D+++ G V  E+L+   P+F
Sbjct: 165 RAPE----CLLTDGYYGPKMDIWAVGCVFFEILS-LFPLF 199

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 68/231 (29%), Positives = 116/231 (50%), Gaps = 30/231 (12%)

Query: 65  ELDKATNH-FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +++++ N  + +  I+G G  G VY+   ++    +A+KK    V  +  YK  E +   
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELL--- 111

Query: 123 FILSQINHRNVVKL-----LGCCLETE---FPLLVYEFIPNGTLYQHL-HDRHQNEEYPL 173
            I+  +NH N++ L       C  + E   F  +V EFIP  T+++++ H    N   PL
Sbjct: 112 -IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPL 169

Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMD 232
                +  + ++  ALAY+HS     I HRD+K  N+L+D   +  K+ DFG++K +   
Sbjct: 170 FLVKLY--SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224

Query: 233 QTHVTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           Q  V+  I   F Y  PE    ++  T   D++S G ++ E++ G  PIFS
Sbjct: 225 QRSVSY-ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFS 272

Length = 440

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 72/273 (26%), Positives = 103/273 (37%), Gaps = 78/273 (28%)

Query: 77  RILGQGGQGTVYK------GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-N 129
           + LG+G  G V +       +    R +AVK  K      E   L   + E+ IL  I +
Sbjct: 13  KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKAL---MTELKILIHIGH 69

Query: 130 HRNVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDR----------------------- 165
           H NVV LLG C +   PL+V  E+   G L  +L  +                       
Sbjct: 70  HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129

Query: 166 --------------------------HQNEEY-------PLTWEMRFRVAIEVAGALAYL 192
                                      + +E        PLT E     + +VA  + +L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEY 251
              AS    HRD+ + NILL E    K+ DFG ++ I  D  +V     +    ++ PE 
Sbjct: 190 ---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
                 T +SDV+SFGV+L E       IFS G
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWE-------IFSLG 272

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 53/200 (26%), Positives = 102/200 (51%), Gaps = 14/200 (7%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+G   TVYKG+ + +G+++A+K  +L  ++   +     I E  +L  + H N+V L 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---IREASLLKGLKHANIVLLH 69

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                 E   LV+E++ +  L Q++ D+H    +P   ++      ++   L+Y+H    
Sbjct: 70  DIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKL---FLFQLLRGLSYIHQ--- 121

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQ 256
             I HRD+K  N+L+ +    K+ADFG ++  ++  +H  +    T  Y  P+    S++
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 257 LTDKSDVYSFGVVLVELLTG 276
            +   D++  G + VE++ G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 20/213 (9%)

Query: 73  FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEF-INEIFILSQINH 130
           F   R+LG+GG G V   ++   G++ A KK  L     +  K E   +NE  IL ++N 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKRILEKVNS 59

Query: 131 RNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQ---NEEYPLTWEMRFRVAIEVA 186
           R VV L     ET+  L LV   +  G L  H+++      +E+  + +      A E+ 
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY------AAELC 112

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
             L  L       I +RD+K  NILLD+R   +++D G +  I   +T V  ++ GT GY
Sbjct: 113 CGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGY 167

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           + PE   + + T   D +  G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 33/224 (14%)

Query: 72  HFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
            +     +G+G  G V        G  +A+KK  ++  + + +     + EI IL +  H
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--ISPFEHQTFCQRT-LREIKILRRFKH 62

Query: 131 RNVVKLLGCCLETEFP-----LLVYEFIPNGTLY-----QHLHDRHQNEEYPLTWEMRFR 180
            N++ +L       F       +V E +    LY     QHL + H   +Y L   +R  
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHI--QYFLYQILR-- 117

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM--DQTHVTT 238
                   L Y+HS   + + HRD+K +N+LL+     K+ DFG ++      D T   T
Sbjct: 118 -------GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167

Query: 239 KIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 281
           +   T  Y  PE   +S+   K+ D++S G +L E+L+  +P+F
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 79  LGQGGQGTVYKGRLED-GRIIAVKK--SKLAVDDEEL-YKLEEFINEIFILSQINHRNVV 134
           +G+G  G VY+ R +D  RI A+K    K  V  +E+ + + E    I + + ++    +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGE--RNILVRTLLDESPFI 58

Query: 135 KLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
             L    +T+  L LV +++  G L+ HL    +  E       +F +A E+  AL +LH
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED----RAKFYIA-ELVLALEHLH 113

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YH 252
                 I +RD+K  NILLD      + DFG SK   +     T    GT  YL PE   
Sbjct: 114 K---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLL 169

Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
                T   D +S GV++ E+  G  P ++
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 15/211 (7%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           LG+GG G V   ++   G++ A KK +K  +   + Y  E  + E  IL++++ R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY--EGAMVEKRILAKVHSRFIVSL 58

Query: 137 LGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIEVAGALAYLH 193
                +T+  L LV   +  G L  H+++   +EE P   E R  F  A  ++G L +LH
Sbjct: 59  -AYAFQTKTDLCLVMTIMNGGDLRYHIYN--VDEENPGFPEPRACFYTAQIISG-LEHLH 114

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
                 I +RD+K  N+LLD     +++D G +  +   Q+  T    GT G++ PE  Q
Sbjct: 115 Q---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQ 170

Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
             +     D ++ GV L E++  + P  + G
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARG 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 62.1 bits (150), Expect = 2e-10
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 36/201 (17%)

Query: 117 EFINEIFILSQINHRNVVKLLGCCLE--TEFPLLVYEFIPNGTLYQHLHDRHQN----EE 170
           + + E+ ++ ++ H+N+V+ +   L    +   ++ EF   G L +++   ++     EE
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSP----IYHRDIKSTNILLDERYR--------- 217
           + +       +  ++  ALAY H+    P    + HRD+K  NI L    R         
Sbjct: 118 HAIV-----DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172

Query: 218 --------AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY--HQSSQLTDKSDVYSFG 267
                   AK+ DFG SK I ++   +     GT  Y  PE   H++    DKSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 268 VVLVELLTGKKPIFSTGNTSQ 288
            ++ EL +GK P     N SQ
Sbjct: 231 CIIYELCSGKTPFHKANNFSQ 251

Length = 1021

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 20/213 (9%)

Query: 73  FNVNRILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           FN   +LG+G  G V     KG  E   I  +KK  +  DD+    +E  + E  +L+  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD----VECTMVEKRVLALQ 57

Query: 129 NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           +    +  L  C +T   L  V E++  G L  H+    + +E    +      A E++ 
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-----YAAEISV 112

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGY 246
            L +LH      I +RD+K  N++LD     K+ADFG  K   +D   VTT+   GT  Y
Sbjct: 113 GLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDY 167

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           + PE           D +++GV+L E+L G+ P
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)

Query: 73  FNVNRILGQGGQGTVYKGRLEDGRI--IAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
           FN  R LG G  G V     ++     +A+K   KSK+    +    ++   +E  IL+ 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ----VDHVFSERKILNY 87

Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           INH   V L G   +  +  LV EF+  G  +  L    +N+ +P   ++    A ++  
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPN--DVGCFYAAQIVL 142

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
              YL S     I +RD+K  N+LLD+    K+ DFG +K +       T  + GT  Y+
Sbjct: 143 IFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYI 195

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
            PE   +      +D ++ G+ + E+L G  P ++
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230

Length = 340

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 12/212 (5%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           N F V  ++G+G  G V K R  E   I+A+KK K + ++EE+   E  + E+ +L  + 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK--ETTLRELKMLRTLK 58

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
             N+V+L           LV+E++    L   L +   N   P       +V   +   +
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPE------KVRSYIYQLI 110

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
             +H    + I HRDIK  N+L+      K+ DFG ++ ++       T+   T  Y  P
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           E    +      D++S G +L EL  G +P+F
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDG-QPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 75/293 (25%), Positives = 126/293 (43%), Gaps = 46/293 (15%)

Query: 79  LGQGGQGTVYKGRLEDGRI---IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +G G  G V  G +  G     + VK+ +++   +E  K   F+ E      + H N+++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK---FLEEAQPYRSLQHSNLLQ 59

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF--RVAIEVAGALAYLH 193
            LG C E    LLV EF P G L  +L  R   +   +T +     R+A E+A  L +LH
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQRMACEIALGLLHLH 117

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-------FIAMDQTHVTTKIQGTFGY 246
               +   H D+   N LL      K+ D+G S        ++  DQ  V   ++     
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPE 172

Query: 247 LDPEYHQSSQLTDK---SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
           L  E H +  + D+   S+V+S GV + EL       F  G+           + H   +
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL-------FELGSQP---------YRHLSDE 216

Query: 304 NRLYHILDDQVMKLGKKNQIVAFAN----LAERCLDLNGKKRPTMEEVSMELN 352
             L + + +Q +KL K    +  ++    + + C  L  ++RP+ EEV + L+
Sbjct: 217 QVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+G  G+VYK      G  +A+K+ +L +D+    K  + I E+ IL +     +V   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES---KFNQIIMELDILHKAVSPYIVDFY 65

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E++  G+L   L+      E      +R R+   V   L +L    +
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKEEHN 123

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K TN+L++   + K+ DFG S    +  +   T I G   Y+ PE  +S   
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNI-GCQSYMAPERIKSGGP 178

Query: 258 TD------KSDVYSFGVVLVELLTGKKP 279
                   +SDV+S G+ ++E+  G+ P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 47/240 (19%)

Query: 78  ILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQINHRN 132
            +GQG  G V+K R  +  +I+A+KK  + +++E+    E F    + EI IL  + H N
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKK--VLMENEK----EGFPITALREIKILQLLKHEN 72

Query: 133 VVKLLGCCLETEFP--------LLVYEFIPNGTLYQHLHDRH---QNEEYPLTWEMRFRV 181
           VV L+  C     P         LV+EF          HD      N+    T     +V
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKV 124

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM---DQTHVTT 238
              +   L Y+H    + I HRD+K+ NIL+ +    K+ADFG ++  ++    + +  T
Sbjct: 125 MKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 239 KIQGTFGYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
               T  Y  PE      L ++      D++  G ++ E+ T + PI   GNT Q  ++L
Sbjct: 182 NRVVTLWYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQ-GNTEQHQLTL 235

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 21/173 (12%)

Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLV---YEFIPNGTLYQHLHDRH-QNEEYPLTW 175
           NEI  L ++NH N++K+           ++   Y+F     LY  ++D     ++ PL  
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLK 267

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
           + R  +  ++  A+ Y+H      + HRDIK  NI L+   +  + DFGT+     ++  
Sbjct: 268 QTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT---------GKKP 279
                 GT     PE        + +D++S G++L+++L+         G KP
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376

Length = 501

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 11/164 (6%)

Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           +E+  L+  +H  +VK        +  LL+ E+   G L + +  R + E  P       
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK-EHLPFQEYEVG 172

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK----FIAMDQTH 235
            +  ++  AL  +HS     + HRD+KS NI L      K+ DFG SK     +++D   
Sbjct: 173 LLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD--- 226

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           V +   GT  YL PE  +  + + K+D++S GV+L ELLT  +P
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 52/175 (29%), Positives = 74/175 (42%), Gaps = 24/175 (13%)

Query: 121 EIFILSQINHRNVVKLLGC-------CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPL 173
           EI IL  I+HR ++ L+         C+     +  Y+      L+ ++ DR      PL
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCM----VMPKYKC----DLFTYV-DRSG----PL 182

Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMD 232
             E    +   +  ALAYLH      I HRD+K+ NI LDE   A + DFG + K  A  
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239

Query: 233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 287
            T       GT     PE         K+D++S G+VL E+      +F     S
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294

Length = 392

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 64/219 (29%), Positives = 115/219 (52%), Gaps = 20/219 (9%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+G   TV+KGR +    ++A+K+ +L  + EE       I E+ +L  + H N+V L 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTA-IREVSLLKNLKHANIVTLH 69

Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI-EVAGALAYLHSG 195
              + TE  L LV+E++ +  L Q+L D   N    L      ++ + ++   L+Y H  
Sbjct: 70  DI-IHTERCLTLVFEYLDS-DLKQYL-DNCGN----LMSMHNVKIFMFQLLRGLSYCHK- 121

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-YHQS 254
               I HRD+K  N+L++E+   K+ADFG ++  ++     + ++  T  Y  P+    S
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 178

Query: 255 SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
           ++ +   D++  G +L E+ TG +P+F  G+T +E + L
Sbjct: 179 TEYSTPIDMWGVGCILYEMATG-RPMFP-GSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 68/247 (27%), Positives = 106/247 (42%), Gaps = 56/247 (22%)

Query: 72  HFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEEL---YKLEEFINEIFILSQ 127
           HF   ++LG+G  G V+  RL+  G++ A+K     +D +E+    K++  + E  IL+ 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALK----VLDKKEMIKRNKVKRVLTEQEILAT 57

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           ++H  +  L     +TE  L LV ++ P G L++ L  + Q  +       RF  A EV 
Sbjct: 58  LDHPFLPTLY-ASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAA-EVL 113

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ----- 241
            AL YLH      +Y RD+K  NILL E     ++DF  SK     +    +K       
Sbjct: 114 LALEYLH--LLGIVY-RDLKPENILLHESGHIMLSDFDLSKQSD-VEPPPVSKALRKGSR 169

Query: 242 ------------------------GTFGYLDPEY-----HQSSQLTDKSDVYSFGVVLVE 272
                                   GT  Y+ PE      H S+      D ++ G++L E
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-----VDWWTLGILLYE 224

Query: 273 LLTGKKP 279
           +L G  P
Sbjct: 225 MLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 19/211 (9%)

Query: 77  RILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           ++LG+G  G V   R +  GR  A+K   K  +   DE    +   + E  +L    H  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQNTRHPF 56

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +  L       +    V E+   G L+ HL  +R   EE       RF  A E+  AL Y
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA-EIVSALEY 110

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     + +RDIK  N++LD+    K+ DFG  K    D   + T   GT  YL PE 
Sbjct: 111 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEV 166

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
            + +      D +  GVV+ E++ G+ P ++
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 30/222 (13%)

Query: 79  LGQGGQGTVYKGR--LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           LG+G   TVYKGR  L D  ++A+K+ +L  + EE       I E+ +L  + H N+V L
Sbjct: 14  LGEGTYATVYKGRSKLTDN-LVALKEIRL--EHEEGAPCTA-IREVSLLKDLKHANIVTL 69

Query: 137 LGCCLETEFPL-LVYEFIPNGTLYQHLHD-----RHQNEEYPLTWEMRFRVAIEVAGALA 190
               + TE  L LV+E++ +  L Q+L D        N +  L   +R          L 
Sbjct: 70  HDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR---------GLN 118

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           Y H      + HRD+K  N+L++ER   K+ADFG ++  ++     + ++  T  Y  P+
Sbjct: 119 YCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPD 174

Query: 251 -YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
               S+  + + D++  G +  E+ TG +P+F  G+T +E +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFP-GSTVEEQL 214

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 68/243 (27%), Positives = 105/243 (43%), Gaps = 44/243 (18%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIF----IL 125
             F   +++  G  G VY  R ++ R   A+KK    ++ + L  L   I ++F    IL
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKK----INKQNLI-LRNQIQQVFVERDIL 55

Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNG---TLYQHLHDRHQNEEYPLTWEM-RFR 180
           +   +  VV +  C  ET+  L +V E++  G   TL +++          L  +M R  
Sbjct: 56  TFAENPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIG--------ALPVDMARMY 106

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT------ 234
            A E   AL YLH+     I HRD+K  N+L+      K+ DFG SK   M  T      
Sbjct: 107 FA-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162

Query: 235 --------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
                    +  ++ GT  Y+ PE           D ++ G++L E L G  P F  G+T
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF--GDT 220

Query: 287 SQE 289
            +E
Sbjct: 221 PEE 223

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 20/213 (9%)

Query: 73  FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEF-INEIFILSQINH 130
           F   R+LG+GG G V   ++   G++ A K+  L     +  K E   +NE  IL ++N 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKR--LEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 131 RNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQ---NEEYPLTWEMRFRVAIEVA 186
           + VV L     ET+  L LV   +  G L  H+++       EE  L +      A E+ 
Sbjct: 60  QFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY------AAEIL 112

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
             L  LH        +RD+K  NILLD+    +++D G +  + + +        GT GY
Sbjct: 113 CGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGY 167

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           + PE   + + T   D +  G ++ E++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 43/136 (31%), Positives = 67/136 (49%), Gaps = 10/136 (7%)

Query: 148 LVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
            V E+   G L+ HL  +R  +E+       RF  A E+  AL YLH  +   + +RD+K
Sbjct: 72  FVMEYANGGELFFHLSRERVFSED-----RARFYGA-EIVSALDYLH--SEKNVVYRDLK 123

Query: 207 STNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSF 266
             N++LD+    K+ DFG  K    D   + T   GT  YL PE  + +      D +  
Sbjct: 124 LENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGL 182

Query: 267 GVVLVELLTGKKPIFS 282
           GVV+ E++ G+ P ++
Sbjct: 183 GVVMYEMMCGRLPFYN 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 30/220 (13%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKK----SKLAVDDEELYKLEEFINEIFI 124
           TN +   + +G G  G V   R    G+ +A+KK        V  +  Y+      E+ +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR------ELKL 62

Query: 125 LSQINHRNVVKLLGCCLE-TEFPLLVYEFIPNGT-LYQHLHDRHQNEEYPLTWEMRFRVA 182
           L  + H N++ L    +   E    V E +  GT L++ L  R      PL  +      
Sbjct: 63  LKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR------PLEKQFIQYFL 114

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            ++   L Y+HS     + HRD+K +NIL++E    K+ DFG ++     Q    T    
Sbjct: 115 YQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVS 167

Query: 243 TFGYLDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIF 281
           T  Y  PE   + Q  D + D++S G +  E+L G KP+F
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLF 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 60/222 (27%), Positives = 110/222 (49%), Gaps = 26/222 (11%)

Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+G   TV+KGR +    ++A+K+ +L  + EE       I E+ +L  + H N+V L 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTA-IREVSLLKDLKHANIVTLH 70

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHD-----RHQNEEYPLTWEMRFRVAIEVAGALAYL 192
                 +   LV+E++ +  L Q++ D        N +  L   +R          LAY 
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR---------GLAYC 120

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE-Y 251
           H      + HRD+K  N+L++ER   K+ADFG ++  ++     + ++  T  Y  P+  
Sbjct: 121 HR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVL 176

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             SS+ + + D++  G +  E+ +G +P+F  G+T ++ + L
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASG-RPLFP-GSTVEDELHL 216

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 41/221 (18%)

Query: 77  RILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
             +G G  G V      + GR +A+KK           K      E+ +L  ++H NV+ 
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK--RTYRELRLLKHMDHENVIG 78

Query: 136 LLGCCLETEFPL-------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           LL         L       LV   +    L   +  +  +++      ++F V  ++   
Sbjct: 79  LLDVFTPAS-SLEDFQDVYLVTHLM-GADLNNIVKCQKLSDD-----HIQFLV-YQILRG 130

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYL 247
           L Y+HS     I HRD+K +NI ++E    K+ DFG ++    + T +V T+      Y 
Sbjct: 131 LKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 182

Query: 248 DPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
            PE       Y+Q+       D++S G ++ ELLTG K +F
Sbjct: 183 APEIMLNWMHYNQT------VDIWSVGCIMAELLTG-KTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.9 bits (135), Expect = 5e-09
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 45/288 (15%)

Query: 79  LGQGGQGTVYKGRL-EDGRIIAVKKSK-----LAVDDEELYKLEEFINEIFILSQINHRN 132
           LGQG    +YKG L     +  V   +     L V   +      F     ++SQ++H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +VKL G C+  E  ++V E++  G L   LH     E+  ++   +  VA ++A AL YL
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLH----REKNNVSLHWKLDVAKQLASALHYL 117

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI------QGTFGY 246
                  + H ++   NIL+  RY     + G   FI +    +   +           +
Sbjct: 118 E---DKKLVHGNVCGKNILV-ARYG---LNEGYVPFIKLSDPGIPITVLSREERVERIPW 170

Query: 247 LDPEYHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
           + PE  +   + LT  +D +SFG  L+E       I S G      +S +        K 
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLE-------ICSNGEEPLSTLSSS-------EKE 216

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
           R Y   D   + +    ++   ANL  +C   +  KRP+   +  +LN
Sbjct: 217 RFYQ--DQHRLPMPDCAEL---ANLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 61/253 (24%), Positives = 112/253 (44%), Gaps = 41/253 (16%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEF---------INEIFILSQIN 129
           +G+G  G VYK + +DG+            DE+ Y L++            EI +L ++ 
Sbjct: 9   VGRGTYGHVYKAKRKDGK------------DEKEYALKQIEGTGISMSACREIALLRELK 56

Query: 130 HRNVVKLLGCCL--ETEFPLLVYEFIPNGTLYQ---HLHDRHQNEEYPLTWEMRFRVAIE 184
           H NV+ L    L        L++++  +   +    H   +   +   L   M   +  +
Sbjct: 57  HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFI--AMDQTHVTT 238
           +   + YLH+     + HRD+K  NIL+     ER R K+AD G ++     +       
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 239 KIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
            +  TF Y  PE    ++   K+ D+++ G +  ELLT  +PIF   +  QE++  +  F
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIF---HCRQEDIKTSNPF 229

Query: 298 VHSMRKNRLYHIL 310
            H  + +R++ ++
Sbjct: 230 HHD-QLDRIFSVM 241

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 57/185 (30%), Positives = 81/185 (43%), Gaps = 39/185 (21%)

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT---TKIQGTF 244
           AL Y+H+     ++HRD+K  NIL +   + K+ DFG ++ +A + T      T    T 
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATR 170

Query: 245 GYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFS--------------TGNTSQ 288
            Y  PE   S  S+ T   D++S G +  E+LTG KP+F                G  S 
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSP 229

Query: 289 ENVSL-----AAYFVHSMRKNRLYHILDDQVMKLGKK--NQIVAFANLAERCLDLNGKKR 341
           E +S      A  ++ SMRK         Q +   +K  N       L ER L  + K R
Sbjct: 230 ETISRVRNEKARRYLSSMRKK--------QPVPFSQKFPNADPLALRLLERLLAFDPKDR 281

Query: 342 PTMEE 346
           PT EE
Sbjct: 282 PTAEE 286

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.6 bits (134), Expect = 7e-09
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 37/234 (15%)

Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVAIEV 185
           + H N+++ LG C+E    LLV+E+   G L  +L     H+     L  +   R+A E+
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEI 108

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGT 243
           A  + ++H        H D+   N  L      KV D+G        + ++ T       
Sbjct: 109 AAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVP 164

Query: 244 FGYLDPE----YHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY 296
             +L PE    +H    +++ T  S+V++ GV L EL       +S  + S   V     
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS--HLSDREV----- 217

Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLD---LNGKKRPTMEEV 347
                    L H++ DQ +KL K    + ++      L    L+ +KR T EEV
Sbjct: 218 ---------LNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 24/219 (10%)

Query: 69  ATNHFNVNRILGQGGQGTVYKG--RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           AT++ N+ + LG+G   TVYKG  R+ +G+++A+K   +++  EE       I E  +L 
Sbjct: 4   ATSYLNLEK-LGEGSYATVYKGISRI-NGQLVALKV--ISMKTEEGVPFTA-IREASLLK 58

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            + H N+V L       E    V+E++ +  L Q++  +H    +P    +      ++ 
Sbjct: 59  GLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHPYNVRL---FMFQLL 113

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGTFG 245
             LAY+H      I HRD+K  N+L+      K+ADFG ++  ++  QT+ +  +  T  
Sbjct: 114 RGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLW 168

Query: 246 YLDPEYHQSSQLTDKS---DVYSFGVVLVELLTGKKPIF 281
           Y  P+    +  TD S   D++  G + +E+L G +P F
Sbjct: 169 YRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 66/265 (24%), Positives = 106/265 (40%), Gaps = 65/265 (24%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYK--LEEFINEIFI 124
           + F   +++G+G  G V   RL    + G I A+KK + +   E L K  +     E  I
Sbjct: 1   DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKS---EMLEKEQVAHVRAERDI 54

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM-RFRVAI 183
           L++ ++  VVKL     +  +  L+ E++P G +   L  +        T E  RF +A 
Sbjct: 55  LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-----FTEEETRFYIA- 108

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-- 241
           E   A+  +H        HRDIK  N+LLD +   K++DFG      + ++H T   +  
Sbjct: 109 ETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRIL 163

Query: 242 -------------------------------------GTFGYLDPEYHQSSQLTDKSDVY 264
                                                GT  Y+ PE    +    + D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 265 SFGVVLVELLTGKKPIFSTGNTSQE 289
           S GV++ E+L G  P  S  +  QE
Sbjct: 224 SLGVIMYEMLVGYPPFCS--DNPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 11/132 (8%)

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
           PLT E     + +VA  + +L   AS    HRD+ + NILL E    K+ DFG ++ I  
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226

Query: 232 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
           D  +V     +    ++ PE       T +SDV+SFGV+L E       IFS G +    
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE-------IFSLGASPYPG 279

Query: 291 VSLAAYFVHSMR 302
           V +   F   ++
Sbjct: 280 VQINEEFCQRLK 291

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 36/202 (17%)

Query: 160 QHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAK 219
               +    + +PL  +   R + +VA  + +L   AS    HRD+ + N+LL +   AK
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAK 252

Query: 220 VADFGTSKFIAMDQTHVTTKIQGT----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
           + DFG ++ I  D  +V   ++G       ++ PE       T +SDV+S+G++L E   
Sbjct: 253 ICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE--- 306

Query: 276 GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFA-----NLA 330
               IFS G +    +         +  ++ Y     +++K G +     FA     ++ 
Sbjct: 307 ----IFSLGKSPYPGI---------LVNSKFY-----KMVKRGYQMSRPDFAPPEIYSIM 348

Query: 331 ERCLDLNGKKRPTMEEVSMELN 352
           + C +L   +RPT  ++S  + 
Sbjct: 349 KMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 22/222 (9%)

Query: 77  RILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           R LG G  G V+     D  + +AVKK  + + D +   ++  + EI I+ +++H N+VK
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKK--IVLTDPQ--SVKHALREIKIIRRLDHDNIVK 66

Query: 136 L---LGCCLETEFPLLVYEFIPNGTLY--QHLHD---RHQNEEYPLTWEMRFRVAIEVAG 187
           +   LG    ++    V       ++Y  Q   +    +  E+ PL+ E       ++  
Sbjct: 67  VYEVLGPS-GSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQG--TF 244
            L Y+HS   + + HRD+K  N+ ++ E    K+ DFG ++ +    +H     +G  T 
Sbjct: 126 GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 245 GYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            Y  P      +  T   D+++ G +  E+LTG KP+F+  +
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAH 223

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 67/305 (21%), Positives = 129/305 (42%), Gaps = 60/305 (19%)

Query: 77  RILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
             +G G  G V        G+ +A+KK   A D   L K    + E+ IL    H N++ 
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK--RTLRELKILRHFKHDNIIA 68

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLH--------DRHQ--NEEYPLTWE-MRFRVAIE 184
           +                 P G  ++ ++        D H   + + PLT E +R+ +   
Sbjct: 69  IRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQ 241
           + G L Y+HS   + + HRD+K +N+L++E    ++ DFG ++ ++    +  +  T+  
Sbjct: 117 LRG-LKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 242 GTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY---- 296
            T  Y  PE   S  + T   D++S G +  E+L G++ +F  G      + L       
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP-GKNYVHQLKLILSVLGS 230

Query: 297 ----FVHSMRKNRLYHILDDQVMKLGKKNQIVAFA-----------NLAERCLDLNGKKR 341
                ++ +  +R+   + +    L +K Q V ++           +L  + L  + ++R
Sbjct: 231 PSEEVLNRIGSDRVRKYIQN----LPRK-QPVPWSKIFPKASPEALDLLSQMLQFDPEER 285

Query: 342 PTMEE 346
            T+E+
Sbjct: 286 ITVEQ 290

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 78/311 (25%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEE--------------------- 117
           LGQG +  +Y GRL       V+      +DE   +                        
Sbjct: 3   LGQGTRTNIYDGRLR------VEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH 56

Query: 118 ------FINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 F     ++SQ++H ++  + G C+     ++V EF+ +G L   L  R +    
Sbjct: 57  RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRV 114

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
           P+ W  +  VA ++A AL+YL       + H ++ + NILL    R  +A+ GTS FI +
Sbjct: 115 PVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLA---RLGLAE-GTSPFIKL 165

Query: 232 DQTHVTTKIQG------TFGYLDPEYHQS-SQLTDKSDVYSFGVVLVEL-LTGKKPIFST 283
               V+              ++ PE     + L+  +D +SFG  L+E+   G+ P+   
Sbjct: 166 SDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL--K 223

Query: 284 GNTSQENVSLAAYFVHSMRKNRLY---HILDDQVMKLGKKNQIVAFANLAERCLDLNGKK 340
             T  E             K R Y   H L +   K          A L  +CL     +
Sbjct: 224 ERTPSE-------------KERFYEKKHRLPEPSCK--------ELATLISQCLTYEPTQ 262

Query: 341 RPTMEEVSMEL 351
           RP+   +  +L
Sbjct: 263 RPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 17/167 (10%)

Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP--NGTLYQHLHDRHQNEEYPLTWE 176
             E  IL  INH ++++L G     +F  L+   +P     LY +L  +       +  +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN---IAIC-D 183

Query: 177 MRFRVAIE--VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
           +   +AIE  V  A+ YLH      I HRDIK+ NI ++      + DFG + F      
Sbjct: 184 I---LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237

Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           +      GT     PE           D++S G+VL E+ T    +F
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284

Length = 391

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 76/294 (25%), Positives = 120/294 (40%), Gaps = 46/294 (15%)

Query: 70  TNHFNVNRILGQGGQGTVYK-GRLEDGRIIAVKKSKLAVD-DEELYKLEEFINEIFILSQ 127
           ++ + +   +G+G  G V+K    ++G   AVK      D DEE+   E   N +  LS 
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI---EAEYNILKALS- 72

Query: 128 INHRNVVKLLGCCLETEFP-----LLVYEFIPNGT---LYQHLHDRHQNEEYPLTWEMRF 179
            +H NVVK  G   + +        LV E    G+   L +    R +  E P+      
Sbjct: 73  -DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI------ 125

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
            +A  +  AL  L     +   HRD+K  NILL      K+ DFG S  +   +    T 
Sbjct: 126 -IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184

Query: 240 IQGTFGYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           + GT  ++ PE     Q  D +     DV+S G+  +EL  G  P+              
Sbjct: 185 V-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD------------ 231

Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVA-FANLAERCLDLNGKKRPTMEEV 347
              +H MR   L+ I  +    L +       F +   +CL  + +KRPT+ ++
Sbjct: 232 ---LHPMRA--LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 41/133 (30%), Positives = 62/133 (46%), Gaps = 11/133 (8%)

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT E     + +VA  + +L   AS    HRD+ + NILL E    K+ DFG ++ I  
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 232 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
           D  +V     +    ++ PE       T +SDV+SFGV+L E       IFS G +    
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPG 284

Query: 291 VSLAAYFVHSMRK 303
           V +   F   +++
Sbjct: 285 VKIDEEFCRRLKE 297

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 59/253 (23%), Positives = 112/253 (44%), Gaps = 41/253 (16%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEF---------INEIFILSQIN 129
           +G+G  G VYK + +DG+            D+  Y L++            EI +L ++ 
Sbjct: 9   VGRGTYGHVYKAKRKDGK------------DDRDYALKQIEGTGISMSACREIALLRELK 56

Query: 130 HRNVVKLLGCCLE--TEFPLLVYEFIPNGTLYQ---HLHDRHQNEEYPLTWEMRFRVAIE 184
           H NV+ L    L        L++++  +   +    H   +   +   L   M   +  +
Sbjct: 57  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFI--AMDQTHVTT 238
           +   + YLH+     + HRD+K  NIL+     ER R K+AD G ++     +       
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 239 KIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
            +  TF Y  PE    ++   K+ D+++ G +  ELLT  +PIF   +  QE++  +  +
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIF---HCRQEDIKTSNPY 229

Query: 298 VHSMRKNRLYHIL 310
            H  + +R+++++
Sbjct: 230 HHD-QLDRIFNVM 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 26/222 (11%)

Query: 73  FNVNRILGQGGQGTVYKGRLEDG-RIIAVKKSKLAVDDEELYKLEE---FINEIFILSQI 128
           F + +++G+G  G V   +L++  ++ A+K     ++  E+ K  E   F  E  +L   
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMK----ILNKWEMLKRAETACFREERDVLVNG 58

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           +++ +  L     +     LV ++   G   TL     DR   E+    +     +AI+ 
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP-EDMARFYLAEMVIAIDS 117

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
              L Y+H         RDIK  NIL+D     ++ADFG+   +  D T  ++   GT  
Sbjct: 118 VHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168

Query: 246 YLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           Y+ PE  Q+      +   + D +S GV + E+L G+ P ++
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 28/223 (12%)

Query: 73  FNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEE---FINEIFILSQI 128
           F + +++G+G  G V   ++++ G++ A+K     ++  E+ K  E   F  E  +L   
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMK----ILNKWEMLKRAETACFREERDVLVNG 58

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEM-RFRVAIE 184
           + R +  L     +     LV ++   G   TL     DR       L  +M RF +A E
Sbjct: 59  DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-------LPEDMARFYLA-E 110

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  A+  +H        HRDIK  N+LLD+    ++ADFG+   +  D T  +    GT 
Sbjct: 111 MVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167

Query: 245 GYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFS 282
            Y+ PE  Q+      +   + D +S GV + E+L G+ P ++
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 69/306 (22%), Positives = 119/306 (38%), Gaps = 78/306 (25%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF--------------- 123
           LG+G +  +Y G L        K      D+++ Y  E+ I  I                
Sbjct: 3   LGRGTRTQIYAGILNY------KDD----DEDDGYSYEKEIKVILKVLDPSHRDISLAFF 52

Query: 124 ----ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
               ++ Q++H+++V L G C+     ++V EF+  G L   +H +       LT   +F
Sbjct: 53  ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD----VLTTPWKF 108

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILL-----DERYRA--KVADFGTSKFIAMD 232
           +VA ++A AL+YL       + H ++ + NILL     D       K++D G    +   
Sbjct: 109 KVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165

Query: 233 QTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           Q  V         ++ PE    S  L+  +D +SFG  L E       I   G    ++ 
Sbjct: 166 QECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWE-------ICYNGEIPLKDK 213

Query: 292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVA-----FANLAERCLDLNGKKRPTMEE 346
           +LA        K R Y            +  +V       A+L   C++ +  +RP    
Sbjct: 214 TLA-------EKERFY----------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRA 256

Query: 347 VSMELN 352
           +  ++N
Sbjct: 257 IMRDIN 262

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 4/90 (4%)

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L YLHS     I HRDIK  N+L++     K+ DFG ++    D++   T+   T  Y  
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 249 PEYHQSSQ-LTDKSDVYSFGVVLVELLTGK 277
           PE    S+  T   D++S G +  ELL  +
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 5/86 (5%)

Query: 202 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQ 256
           HRDIK  N+LLD     ++ADFG+   +  D T  ++   GT  Y+ PE  Q+      +
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK 184

Query: 257 LTDKSDVYSFGVVLVELLTGKKPIFS 282
              + D +S GV + E+L G+ P ++
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 50.6 bits (122), Expect = 4e-07
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 26/158 (16%)

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           ++ N +KL       +  +L+ ++I +G L+  L    + E      E++  +  ++  A
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKK-IIRQLVEA 121

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           L  LH      I H DIK  N+L D  + R  + D+G  K I     +      GT  Y 
Sbjct: 122 LNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYF 173

Query: 248 DPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            PE      Y  S       D ++ GV+  ELLTGK P
Sbjct: 174 SPEKIKGHNYDVSF------DWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 52/214 (24%), Positives = 100/214 (46%), Gaps = 34/214 (15%)

Query: 79  LGQGGQGTVYKGRLED-GRIIAVKK-----------SKLAVDDEELYKLEEFINEIFILS 126
           LG+GG G V   ++++ G++ A KK            K+A+ ++E+    E +N  FI++
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL---EKVNSPFIVN 57

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
                     L    E++  L LV   +  G L  H+++  +     L  E     + ++
Sbjct: 58  ----------LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG---LEMERVIHYSAQI 104

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
              + +LHS     I +RD+K  N+LLD++   +++D G +  + +      T+  GT G
Sbjct: 105 TCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNG 159

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           Y+ PE  +    +   D ++ G  + E++ G+ P
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.5 bits (118), Expect = 6e-07
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 14/147 (9%)

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAIEVAGALA 190
           N+V L    +  +   LV +    G L+ H+    +  EE    W      A E+  AL 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRW------AAEMVVALD 99

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
            LH      I  RD+   NILLD+R   ++  F   ++  ++ +     ++    Y  PE
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPE 152

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGK 277
               S+ T+  D +S G +L ELLTGK
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 16/160 (10%)

Query: 71  NHFNVNRILGQGGQGTV-YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFIN---EIFILS 126
             F+  +++G+G  G V    + + G+I A+K     +   E++K ++  +   E  +L+
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK----TLLKSEMFKKDQLAHVKAERDVLA 56

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           + +   VV L     + ++  L+ EF+P G L   L  ++      +T   RF +A E  
Sbjct: 57  ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-IKYDTFSEDVT---RFYMA-ECV 111

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS 226
            A+  +H        HRDIK  NIL+D     K++DFG S
Sbjct: 112 LAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 15/139 (10%)

Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK 227
           NE   L++      + +VA  + +L   AS    HRD+ + N+L+ E    K+ DFG ++
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 228 FIAMDQTHVTTKIQGTF---GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
            I  D  +++     TF    ++ PE   ++  T  SDV+SFG++L E       IF+ G
Sbjct: 288 DIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE-------IFTLG 338

Query: 285 NTSQENVSLAAYFVHSMRK 303
            T    + +   F +++++
Sbjct: 339 GTPYPELPMNEQFYNAIKR 357

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.9 bits (119), Expect = 9e-07
 Identities = 46/185 (24%), Positives = 85/185 (45%), Gaps = 26/185 (14%)

Query: 167 QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS 226
           + +E  L  E     + +VA  +++L   AS    HRD+ + NILL      K+ DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 261

Query: 227 KFIAMDQTHVTTKIQGT----FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           + I  D  +V   ++G       ++ PE   +   T +SDV+S+G++L E       IFS
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE-------IFS 311

Query: 283 TGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP 342
            G++    + + + F         Y ++ +    L  +       ++ + C D +  KRP
Sbjct: 312 LGSSPYPGMPVDSKF---------YKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRP 362

Query: 343 TMEEV 347
           T +++
Sbjct: 363 TFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 32/226 (14%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           + +G G QG V     +    I V   KL+   +     +    E+ +L  +NH+N++ L
Sbjct: 27  KPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85

Query: 137 LGC-----CLETEFP--LLVYEFIPNGTLYQ--HLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           L        LE EF    LV E + +  L Q  H+   H+   Y L          ++  
Sbjct: 86  LNVFTPQKSLE-EFQDVYLVMELM-DANLCQVIHMELDHERMSYLL---------YQMLC 134

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTF 244
            + +LHS     I HRD+K +NI++      K+ DFG ++      M   +V T+     
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY---- 187

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
            Y  PE        +  D++S G ++ EL+ G      T +  Q N
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V   +  E    +A+KK   A D+    K    + EI +L  ++H NV+ + 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAK--RTLREIKLLRHLDHENVIAIK 70

Query: 138 GCC---LETEFP--LLVYEFIPNGTLYQHLHDRHQ--NEEYPLTWEMRFRVAIEVAGALA 190
                     F    +VYE +          D HQ       L+ +       ++   L 
Sbjct: 71  DIMPPPHREAFNDVYIVYELMDT--------DLHQIIRSSQTLSDDHCQYFLYQLLRGLK 122

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           Y+HS   + + HRD+K +N+LL+     K+ DFG ++    ++    T+   T  Y  PE
Sbjct: 123 YIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPE 178

Query: 251 -YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
                S+ T   DV+S G +  ELL G+KP+F
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPLF 209

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 43/234 (18%)

Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEE 117
           KL + K+LDK          LG+G   TVYKGR +  G+++A+K+ +L  + EE      
Sbjct: 3   KLETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRL--EHEEGAPFTA 50

Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM 177
            I E  +L  + H N+V L       +   LV+E++ +  L Q++      ++      M
Sbjct: 51  -IREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYM------DDCGGGLSM 102

Query: 178 RFRVAI---EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
              V +   ++   LAY H      + HRD+K  N+L+ ER   K+ADFG ++  ++  +
Sbjct: 103 H-NVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV-PS 157

Query: 235 HVTTKIQGTFGYLDP-------EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
              +    T  Y  P       EY  S+ L    D++  G +  E+ TG +P+F
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEY--STSL----DMWGVGCIFYEMATG-RPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 32/222 (14%)

Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 83  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPE--- 250
              + I HRD+K +N+ ++E    K+ DFG ++    + T +V T+      Y  PE   
Sbjct: 139 ---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIML 190

Query: 251 ----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
               Y+Q+       D++S G ++ ELLTG+     T +  Q
Sbjct: 191 NWMHYNQT------VDIWSVGCIMAELLTGRTLFPGTDHIDQ 226

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 15/106 (14%)

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           +VA  + +L   AS    HRD+ + N+LL +    K+ DFG ++ I  D  +V+     T
Sbjct: 245 QVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--ST 299

Query: 244 F---GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
           F    ++ PE    +  T  SDV+S+G++L E       IFS G T
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWE-------IFSLGGT 338

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 26/221 (11%)

Query: 73  FNVNRILGQGGQGTVYKGRLED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           F ++R L  G +G V++    D   R++ VK    A            ++E  +L +++H
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVV-VKAGWYASS----------VHEARLLRRLSH 219

Query: 131 RNVVKLLGCCLETEFPLLVYEFIP--NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
             V+ LL   +      LV   +P     LY +L  R +    PL       VA ++  A
Sbjct: 220 PAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLR----PLGLAQVTAVARQLLSA 272

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYL 247
           + Y+H      I HRDIK+ N+L++      + DFG + F      T     I GT    
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            PE       T   D++S G+V+ E       +FS     +
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370

Length = 461

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 64/252 (25%), Positives = 99/252 (39%), Gaps = 46/252 (18%)

Query: 73  FNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F   +++G+G  G V   + +D G I A+K  + A D  E  ++     E  IL + +  
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA-DMLEKEQVAHIRAERDILVEADGA 61

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            VVK+     +     L+ EF+P G +   L  +    E       +F +A E   A+  
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----ATQFYIA-ETVLAIDA 116

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFG--------------------------- 224
           +H        HRDIK  N+LLD +   K++DFG                           
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 225 ---TSKFIA----MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 277
               SK  A     ++  +     GT  Y+ PE    +      D +S GV++ E+L G 
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 278 KPIFSTGNTSQE 289
            P  S   T QE
Sbjct: 234 PPFCS--ETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 28/165 (16%)

Query: 73  FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F + + + +G  G VY GR + + ++ AVK  K A          + IN+  +      R
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA----------DMINKNMVHQVQAER 55

Query: 132 NVVKLLGC--CLETEFPL-------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
           + + L      +   + L       LV E++  G +   LH     +E     EM  +  
Sbjct: 56  DALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE-----EMAVKYI 110

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK 227
            EVA AL YLH      I HRD+K  N+L+      K+ DFG SK
Sbjct: 111 SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 51/261 (19%), Positives = 102/261 (39%), Gaps = 46/261 (17%)

Query: 75  VNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS-------- 126
           +++++G GG G VY+ +           S   ++++ + K+E   NE  ++         
Sbjct: 16  IDKLIGCGGFGCVYETQ---------CASDHCINNQAVAKIENLENETIVMETLVYNNIY 66

Query: 127 ------------QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQH---LHDRHQNEEY 171
                        I+H  + K  GC    +   + Y FI    L ++   +  R + +  
Sbjct: 67  DIDKIALWKNIHNIDHLGIPKYYGCG-SFKRCRMYYRFILLEKLVENTKEIFKRIKCKNK 125

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            L       +  ++   L Y+H      I H DIK  NI++D   R  + D+G +    +
Sbjct: 126 KLIKN----IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFII 178

Query: 232 DQTHVT-TKIQ-----GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
              H+  +K Q     GT  Y   + H  + +T + D+ S G  +++    K P    G+
Sbjct: 179 HGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238

Query: 286 TSQENVSLAAYFVHSMRKNRL 306
                 +    F+  + + ++
Sbjct: 239 NGNLIHAAKCDFIKRLHEGKI 259

Length = 294

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 24/207 (11%)

Query: 79  LGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +G G QG V   Y   LE  R +A+KK      ++   K      E+ ++  +NH+N++ 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAK--RAYRELVLMKCVNHKNIIG 87

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRH--QNEEYPLTWEMRFRVAIEVAGALAYLH 193
           LL        P    E   +  +   L D +  Q  +  L  E    +  ++   + +LH
Sbjct: 88  LLNVFT----PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTFGYLDPE 250
           S     I HRD+K +NI++      K+ DFG ++      M   +V T+      Y  PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPE 195

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGK 277
                   +  D++S G ++ E++ G 
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 18/204 (8%)

Query: 79  LGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +G G QG V   Y   L+  R +A+KK      ++   K      E+ ++  +NH+N++ 
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAK--RAYRELVLMKCVNHKNIIS 80

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRH--QNEEYPLTWEMRFRVAIEVAGALAYLH 193
           LL        P    E   +  L   L D +  Q  +  L  E    +  ++   + +LH
Sbjct: 81  LLNVFT----PQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     I HRD+K +NI++      K+ DFG ++      + + T    T  Y  PE   
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 254 SSQLTDKSDVYSFGVVLVELLTGK 277
                +  D++S G ++ E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 64/252 (25%), Positives = 100/252 (39%), Gaps = 46/252 (18%)

Query: 73  FNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F   +++G+G  G V   + +D G + A+K  + A D  E  ++     E  IL + +  
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA-DMLEKEQVGHIRAERDILVEADSL 61

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            VVK+     +     L+ EF+P G +   L  +    E     E +F +A E   A+  
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----ETQFYIA-ETVLAIDS 116

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFG--------------------------- 224
           +H        HRDIK  N+LLD +   K++DFG                           
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173

Query: 225 ---TSKFIA----MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 277
               SK  A     ++  +     GT  Y+ PE    +      D +S GV++ E+L G 
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 278 KPIFSTGNTSQE 289
            P  S   T QE
Sbjct: 234 PPFCS--ETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 27/208 (12%)

Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V        G  +A+KK       E   K      E+ +L  + H NV+ LL
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAK--RAYRELTLLKHMQHENVIGLL 80

Query: 138 GCCLETEFPLL-----VYEFIP-NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
              + T           Y  +P   T  Q +     +E+     ++++ V   + G L Y
Sbjct: 81  D--VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED-----KVQYLVYQMLCG-LKY 132

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPE 250
           +HS   + I HRD+K  N+ ++E    K+ DFG ++    + T +V T+      Y  PE
Sbjct: 133 IHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPE 184

Query: 251 YHQS-SQLTDKSDVYSFGVVLVELLTGK 277
              +        D++S G ++ E+LTGK
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 15/97 (15%)

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFG 245
           L Y+H+     I HRD+K  N+ ++E    K+ DFG ++          +++ G   T  
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRW 180

Query: 246 YLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIF 281
           Y  PE   +    T   D++S G ++ E+LTG KP+F
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 59/250 (23%), Positives = 87/250 (34%), Gaps = 50/250 (20%)

Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
            F   + +G G  G V   R  D   +   K+    D     +      E  IL++ ++ 
Sbjct: 2   MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            VVKL     + +    V ++IP G +   L      EE       RF +A E+  A+  
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED----LARFYIA-ELTCAIES 116

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFG---------TSKFI------------- 229
           +H        HRDIK  NIL+D     K+ DFG          SK+              
Sbjct: 117 VHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173

Query: 230 -------------------AMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVV 269
                                         + GT  Y+ PE    +  T   D +S GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233

Query: 270 LVELLTGKKP 279
           L E+L G+ P
Sbjct: 234 LYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 52/241 (21%)

Query: 61  FSSKELDKAT----NHFNVNRILGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELY 113
           F  +EL+K        +     +G G  G+V   Y  RL   + +AVKK  L+   + L 
Sbjct: 1   FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKK--LSRPFQSLI 56

Query: 114 KLEEFINEIFILSQINHRNVVKLL-----GCCLE--TEFPL---LVYEFIPNGTLYQHLH 163
                  E+ +L  + H NV+ LL        +E   E  L   L+   + N    Q L 
Sbjct: 57  HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLS 116

Query: 164 DRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF 223
           D H          ++F +   + G L Y+HS     I HRD+K +N+ ++E    ++ DF
Sbjct: 117 DEH----------VQFLIYQLLRG-LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162

Query: 224 GTSKFIAMDQTHVTTKIQGTFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTG 276
           G    +A       T    T  Y  PE       Y+Q+       D++S G ++ ELL G
Sbjct: 163 G----LARQADDEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLKG 212

Query: 277 K 277
           K
Sbjct: 213 K 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 53/212 (25%), Positives = 80/212 (37%), Gaps = 54/212 (25%)

Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           IL++ ++  VVKL     + +    V ++IP G +   L    + E +P     RF +A 
Sbjct: 54  ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLA-RFYIA- 108

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG---------TSKF------ 228
           E+  A+  +H        HRDIK  NIL+D     K+ DFG          SK+      
Sbjct: 109 ELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH 165

Query: 229 IAMD-------------------------------QTHVTTKIQGTFGYLDPEYHQSSQL 257
           I  D                               Q  +   + GT  Y+ PE       
Sbjct: 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           T   D +S GV+L E+L G+ P  +   T  +
Sbjct: 226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ 257

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 38.9 bits (91), Expect = 0.002
 Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 40/217 (18%)

Query: 77  RILGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           + +G G QG V   Y      G+ +A+KK  L+   + +   +    E+ ++  +NH+N+
Sbjct: 22  KPIGSGAQGIVCAAYDTVT--GQNVAIKK--LSRPFQNVTHAKRAYRELVLMKLVNHKNI 77

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTL--YQHL--------HDRHQNEEYPLTWEMRFRVAI 183
           + LL              F P  +L  +Q +         +  Q  +  L  E    +  
Sbjct: 78  IGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLY 125

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG---TSKFIAMDQTHVTTKI 240
           ++   + +LHS   + I HRD+K +NI++      K+ DFG   T+    M   +V T+ 
Sbjct: 126 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 277
                Y  PE        +  D++S G ++ E++ G 
Sbjct: 183 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 33/128 (25%), Positives = 61/128 (47%), Gaps = 12/128 (9%)

Query: 48  NSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYK------GRLEDGRIIAVK 101
           N+Y  + ID  +L  +++ +   ++    + LG G  G V +      G+ ++   +AVK
Sbjct: 17  NNY--TFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK 74

Query: 102 KSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQ 160
             K +   +E    E  ++E+ ILS +  H+N+V LLG C      L++ E+   G L  
Sbjct: 75  MLKASAHTDER---EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN 131

Query: 161 HLHDRHQN 168
            L  + + 
Sbjct: 132 FLRKKAET 139

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 29/114 (25%), Positives = 46/114 (40%), Gaps = 22/114 (19%)

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD----------------ERYRAKVADF 223
           ++  +   AL Y H+     + H D+K  NIL++                +  R ++ D 
Sbjct: 235 QIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 277
           G       D+ H  T I  T  Y  PE          +D++S G ++ EL TGK
Sbjct: 293 GG----CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 39/129 (30%), Positives = 57/129 (44%), Gaps = 13/129 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           +   + + LG+G  G V +       +    R +AVK  K      E   L   ++E+ I
Sbjct: 7   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL---MSELKI 63

Query: 125 LSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYPL-TWEMRFRV 181
           L  I H  NVV LLG C +   PL+V  EF   G L  +L  + + E  P  T + RFR 
Sbjct: 64  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSK-RGEFVPYKTKDARFRQ 122

Query: 182 AIEVAGALA 190
                G ++
Sbjct: 123 GKSGYGDIS 131

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	360
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
PRK10345	210	hypothetical protein; Provisional	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
smart00090	237	RIO RIO-like kinase.	99.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG1243	690	consensus Protein kinase [General function predict	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
COG4248	637	Uncharacterized protein with protein kinase and he	99.28
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.28
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.1
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.02
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.0
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.7
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.68
PRK09902	216	hypothetical protein; Provisional	98.66
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.61
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.52
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.52
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.44
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.34
PF01636	239	APH: Phosphotransferase enzyme family This family	98.23
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.2
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.16
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.08
PLN02876	822	acyl-CoA dehydrogenase	98.05
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.98
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.95
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.81
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.74
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.71
PRK10593	297	hypothetical protein; Provisional	97.67
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.58
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.52
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.41
KOG2270	520	consensus Serine/threonine protein kinase involved	97.37
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.29
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.25
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.24
PRK05231	319	homoserine kinase; Provisional	97.17
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.06
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.04
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.94
PLN02236	344	choline kinase	96.71
PLN02756	418	S-methyl-5-thioribose kinase	96.61
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.48
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.41
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.89
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.74
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.62
COG2334	331	Putative homoserine kinase type II (protein kinase	95.36
PRK06148	1013	hypothetical protein; Provisional	95.2
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.83
PTZ00384	383	choline kinase; Provisional	94.73
PRK11768	325	serine/threonine protein kinase; Provisional	94.45
PRK12396	409	5-methylribose kinase; Reviewed	94.4
PRK10271	188	thiK thiamine kinase; Provisional	93.8
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.46
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.04
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	92.88

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-55  Score=392.04  Aligned_cols=289  Identities=46%  Similarity=0.775  Sum_probs=249.5

Q ss_pred             cccccChHHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceee
Q 040763           57 RCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL  136 (360)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~  136 (360)
                      ..+.|+++++..++++|...+.||+|+||+||+|...++..||||++.......    ..+|.+|+.++.+++|||++++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~L  136 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKL  136 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccE
Confidence            567899999999999999999999999999999999998999999776543321    3458999999999999999999


Q ss_pred             eeEEeeCC-cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC
Q 040763          137 LGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       137 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~  215 (360)
                      +|+|.+.+ ..++|+||+++|+|.+.|......   +++|..+++|+.++|+||+|||....++|+||||||+|||+|++
T Consensus       137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             EEEEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            99999988 499999999999999999764322   78999999999999999999999988889999999999999999


Q ss_pred             CcEEEeecCCccccCCCCceeeecc-cccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH
Q 040763          216 YRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~  294 (360)
                      +++||+|||+|+...... ...... .||.+|+|||++..+..+.|+||||||++++||+||+.|.....  ......+.
T Consensus       214 ~~aKlsDFGLa~~~~~~~-~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~  290 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEGD-TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLV  290 (361)
T ss_pred             CCEEccCccCcccCCccc-cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHH
Confidence            999999999996654311 111222 79999999999999999999999999999999999998876554  22333477


Q ss_pred             HHHHHHhhccccccccchHHh-hhccH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          295 AYFVHSMRKNRLYHILDDQVM-KLGKK-NQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      .+....+....+.+++|+.+. ...+. .....+..++.+|++.+|.+||+|.+++++|+.+.
T Consensus       291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            777888888899999999876 44453 57778999999999999999999999999997665

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-54  Score=366.25  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=211.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc-ceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF-PLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~-~~l  148 (360)
                      .+.+..+.||+|..|+||++.++ ++..+|+|.+....+.   ...+++.+|+++++..+||+||++||+|..+.. .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~---~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP---ALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH---HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            35667788999999999999998 6788999998655444   456788999999999999999999999999985 999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||++|||.+++...+     .+++...-.++.++++||.|||+ .+   |+||||||+||||+..|++||||||.+.
T Consensus       156 ~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             ehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccH
Confidence            999999999999997643     59999999999999999999996 67   9999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .+...   .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||............+...           
T Consensus       228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~-----------  293 (364)
T KOG0581|consen  228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA-----------  293 (364)
T ss_pred             Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH-----------
Confidence            76543   4466789999999999999999999999999999999999999997653222222222211           


Q ss_pred             cccchHHhhhccH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKK-NQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       +++.. ....|. .++++|++++..||++||.+|||++|+++
T Consensus       294 -Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 -IVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -HhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             22211 122334 48889999999999999999999999974

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-52  Score=371.83  Aligned_cols=263  Identities=34%  Similarity=0.548  Sum_probs=216.6

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC-cceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE-FPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~lv  149 (360)
                      ..+.+.+.+|+|+||+||+|.++....+|+|.+.........  .+.|.+|+.++.+++|||||+++|++.+.. ...+|
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            344555669999999999999986555999998875544433  778999999999999999999999999988 78999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cEEEeecCCccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADFGTSKF  228 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~  228 (360)
                      |||+++|+|.+++...   ....+++..++.++.|||.|+.|||++++  |+||||||+|||++.++ ++||+|||+++.
T Consensus       119 tEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcccee
Confidence            9999999999999774   23379999999999999999999999884  99999999999999998 999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhc--cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ..... ...+...||+.|||||++.  ...++.|+||||||+++|||+||+.||.+...        .+....       
T Consensus       194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~-------  257 (362)
T KOG0192|consen  194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASA-------  257 (362)
T ss_pred             ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHH-------
Confidence            65422 2233357999999999999  56999999999999999999999999975442        010111       


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                        ......+...+..+++.+..|+.+||+.||+.||++.+++..|+.+...+
T Consensus       258 --v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  258 --VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             --HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence              11122233334446778999999999999999999999999999987654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-53  Score=374.35  Aligned_cols=257  Identities=30%  Similarity=0.457  Sum_probs=223.3

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ..+...+.||+|.||.||.|.++....||+|.++...     ...+.|.+|+.+|++|+|+|||+++++|..++..||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            3455677899999999999999987899999987642     23467889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||++.|+|.++|...   ....+.....+.++.|||.|++||++++   +|||||.+.||||+++..+||+|||+|+...
T Consensus       281 E~m~~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EecccCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC
Confidence            999999999999872   3336888999999999999999999999   9999999999999999999999999999766


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ++.........-+..|.|||.+..+.++.||||||||++||||+| |+.||.+...                  ....+.
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------------------~ev~~~  416 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------------------EEVLEL  416 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------------------HHHHHH
Confidence            665555555556889999999999999999999999999999999 9999865431                  122334


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      ++...+.+.|..+++++.+++..||..+|++|||++.+...|+.+..
T Consensus       417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            55566667788899999999999999999999999999999988764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-53  Score=361.47  Aligned_cols=257  Identities=26%  Similarity=0.358  Sum_probs=206.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHH---hHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELY---KLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~---~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||++..........   ......+|+++|++++|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4467889999999999999999875 78999999977654332111   2223568999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC---CcEEEe
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER---YRAKVA  221 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~  221 (360)
                      ..|+||||++||+|.+.+-.+.     .+.+.....++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence            9999999999999999998755     3566667889999999999999999   9999999999999876   789999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCC---CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL---TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      |||+|+..+  ....+.+.|||+.|.|||++.+...   ..++|+||+||+||-+++|.+||.+.....    .+    .
T Consensus       322 DFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----sl----~  391 (475)
T KOG0615|consen  322 DFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----SL----K  391 (475)
T ss_pred             ccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----cH----H
Confidence            999999886  3455677899999999999988653   347899999999999999999997654322    01    1


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..+..+....      -+..-...+++..+||.+||..||++|||+.|+++
T Consensus       392 eQI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  392 EQILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            1111111100      01112345778999999999999999999999864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-52  Score=372.20  Aligned_cols=250  Identities=27%  Similarity=0.402  Sum_probs=213.0

Q ss_pred             cCCCccceecccCcEEEEEEEe-cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|...+.||+|+|+.||.+++ .+|+.||+|++....-.+. ...+...+|+++.+.|+|||||+++++|++.+..|+|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-chHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            5699999999999999999998 6899999999776432222 3456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      .|+|..++|..+++++.     ++++..++.++.||+.||.|||+++   |+|||||..|+|++++.++||+|||+|..+
T Consensus        97 LELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL  168 (592)
T ss_pred             EEecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence            99999999999998544     6999999999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..+. ....+.+|||.|.|||++....++..+||||+||++|-|+.|++||....        +...+.....       
T Consensus       169 e~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------vkety~~Ik~-------  232 (592)
T KOG0575|consen  169 EYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------VKETYNKIKL-------  232 (592)
T ss_pred             cCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------HHHHHHHHHh-------
Confidence            7543 33456799999999999999999999999999999999999999996432        1111111110       


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ..-..|...+.+..+||.++|+.||.+|||+++|+.
T Consensus       233 ----~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  233 ----NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                011234566778999999999999999999999974

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-52  Score=343.12  Aligned_cols=260  Identities=24%  Similarity=0.421  Sum_probs=210.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeee-EEeeCC-cce
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG-CCLETE-FPL  147 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~-~~~~~~-~~~  147 (360)
                      .+|++.++||+|+||.||++... +|..+|.|.++...  -+....+....|+.++++++|||||++++ .+..+. ..+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~--md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM--MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh--ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            56889999999999999999864 78999999988433  33355677889999999999999999999 444444 489


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS-SPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||+|.+|+|...+..... ....+++..+++++.|++.||.++|++-+ ..|.||||||.||+|+.+|.+||+|||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            99999999999999976653 34479999999999999999999999431 24999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      +.+...... ....+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+..-     ..+    ...+.... 
T Consensus       176 r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-----~~L----~~KI~qgd-  244 (375)
T KOG0591|consen  176 RFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-----LSL----CKKIEQGD-  244 (375)
T ss_pred             hHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-----HHH----HHHHHcCC-
Confidence            988765433 3457899999999999999999999999999999999999999976530     001    11111111 


Q ss_pred             ccccchHHhhhcc-HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          307 YHILDDQVMKLGK-KNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       307 ~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                              -.+.| ..++.++..|+..|+..||+.||+...++..+.
T Consensus       245 --------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  245 --------YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             --------CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                    11233 678889999999999999999998655544443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-51  Score=349.42  Aligned_cols=202  Identities=33%  Similarity=0.525  Sum_probs=179.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..+|.+.+.||+|+||+||+|+++ ++..||||.+....-..  ...+-...|+.+++.++|||||.+++++..++..|+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~--k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK--KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH--HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            367888899999999999999987 57899999987653222  234556789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC------CcEEEee
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER------YRAKVAD  222 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~------~~~kl~D  222 (360)
                      |||||.||+|.+|+..+.     .+++.+...++.|++.||++||+++   |+||||||+||||+.+      -.+||+|
T Consensus        87 VMEyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecc
Confidence            999999999999998765     5899999999999999999999999   9999999999999865      5689999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST  283 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~  283 (360)
                      ||+|+.+...  ....+.+|++.|||||++..+.|+.|+|+||+|+++|+|++|+.||...
T Consensus       159 FGfAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  159 FGFARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             cchhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9999988643  3345679999999999999999999999999999999999999999643

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-50  Score=376.74  Aligned_cols=264  Identities=28%  Similarity=0.464  Sum_probs=223.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE  142 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~  142 (360)
                      ...+....+.||+|+||.||+|...      +...||||.++.....   ....+|.+|++++..++|||||+++|+|..
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~---~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN---QARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH---HHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            3455677889999999999999743      3567999998875444   356789999999999999999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEE---------YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      ++..++|+|||..|+|.++|..+.+...         .+++..+.+.||.|||.|+.||.++.   +|||||..+|+||.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence            9999999999999999999987654322         23888999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCceeee-cccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV  291 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~  291 (360)
                      ++..|||+|||+++.....+.+... ...-+.+|||||.+..+++|++||||||||+|||+++ |+-||.+...      
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------  711 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------  711 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------
Confidence            9999999999999887665554433 4456889999999999999999999999999999999 9999976542      


Q ss_pred             chHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                         +.+...+..+.+         .+.|++++.++++|+..||+.+|.+||+++||-..|+..-.
T Consensus       712 ---~EVIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  712 ---QEVIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             ---HHHHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence               112333333322         45688889999999999999999999999999999987643

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-50  Score=339.14  Aligned_cols=247  Identities=29%  Similarity=0.405  Sum_probs=205.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ...+|++.+.||+|+||.|+.++.+ +++.+|+|+++...-... ...+....|..++..++||.||+++-.|++.+..|
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            3578999999999999999999876 588999998876543322 34566788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +|+||+.||.|...|.+.+     .+++..+.-++.+|+.||.|||+++   |+||||||+|||+|.+|+++|+|||+++
T Consensus       102 lVld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             EEEeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccch
Confidence            9999999999999997543     5888888889999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..... ...+.+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||.+.....         +...+....  
T Consensus       174 ~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~---------~~~~I~~~k--  241 (357)
T KOG0598|consen  174 EDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK---------MYDKILKGK--  241 (357)
T ss_pred             hcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH---------HHHHHhcCc--
Confidence            64332 233455799999999999999999999999999999999999999997654211         111111111  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT  343 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  343 (360)
                             ....+...+++.++++.+.|..||++|..
T Consensus       242 -------~~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  242 -------LPLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             -------CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence                   12233446778999999999999999973

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-49  Score=328.94  Aligned_cols=265  Identities=24%  Similarity=0.319  Sum_probs=207.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +.|+...++|+|+||.|++++++ +|+.||||++....++.  ...+-.++|++++++++|+|+|.++++|......++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~--~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP--VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH--HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            45778889999999999999987 59999999988654443  3445678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +|||+. ++.+.|.....    .++...+.+++.|++.|+.|+|+++   ++||||||+||||+.++.+||||||+|+.+
T Consensus        80 FE~~dh-TvL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPN----GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             eeecch-HHHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhh
Confidence            999976 44455554332    4888999999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH--------HHH
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF--------VHS  300 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~  300 (360)
                      .. .....+.++.|.+|+|||.+.+ .+|...+||||+||++.||++|.+-|.+.++.++.  ......        ...
T Consensus       152 ~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL--y~I~ktLG~L~prhq~i  228 (396)
T KOG0593|consen  152 SA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL--YLIRKTLGNLIPRHQSI  228 (396)
T ss_pred             cC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH--HHHHHHHcccCHHHHHH
Confidence            75 3344566788999999998888 68999999999999999999999999776643322  111111        111


Q ss_pred             hhcccc------ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          301 MRKNRL------YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       301 ~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                      ......      .+.-+....+..-+..+.-+.+++..||+.||++|++.++++
T Consensus       229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence            111111      111111111111223455789999999999999999999986

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=345.51  Aligned_cols=255  Identities=28%  Similarity=0.383  Sum_probs=211.4

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCC
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETE  144 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~  144 (360)
                      ....++|...+.||+|+|++|++|+.+ .++.||||++....-.++ ...+-+..|-.+|.+| .||.|++++..|.++.
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike-~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE-KKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh-cccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            345578999999999999999999876 688999998766443322 2233456788889999 8999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      .+|+|+||+++|+|.++|...+     .+++...+.++.+|+.||+|||++|   ||||||||+|||+|.|+++||+|||
T Consensus       148 sLYFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecc
Confidence            9999999999999999998865     4888999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCce----------e--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 040763          225 TSKFIAMDQTH----------V--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS  292 (360)
Q Consensus       225 ~~~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~  292 (360)
                      .|+.+......          .  ....+||..|.+||++.++..+..+|+|+||||||+|+.|.+||.+..+      .
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------y  293 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------Y  293 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------H
Confidence            99988653221          1  1347899999999999999999999999999999999999999976553      1


Q ss_pred             hHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          293 LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +.  +...+           .+.-..++..++...+|+.+.|..||.+|+|+++|.+
T Consensus       294 li--FqkI~-----------~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  294 LI--FQKIQ-----------ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HH--HHHHH-----------HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            11  01110           1122345556678999999999999999999988864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-49  Score=342.57  Aligned_cols=262  Identities=24%  Similarity=0.337  Sum_probs=211.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCC-c
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETE-F  145 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~-~  145 (360)
                      ..++|.++++||.|+||.||+|+.+ ++..||||+++......   ....-++|+..+++++ ||||+++.+++.+.+ .
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~---ee~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH---HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            3478999999999999999999865 68899999988765552   2233568999999998 999999999999888 8


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .|+||||| ..+|+++++++    +.++++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+
T Consensus        85 L~fVfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   85 LYFVFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             EeeeHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccc
Confidence            99999999 67999999875    337999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      |+.+....  ..+.++.|.+|+|||++.. +.|+.+.|+||+|||++|+.+-++-|.+..+.++-.     -+...+...
T Consensus       157 ARev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~-----KIc~VLGtP  229 (538)
T KOG0661|consen  157 AREVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY-----KICEVLGTP  229 (538)
T ss_pred             ccccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH-----HHHHHhCCC
Confidence            98775433  3466788999999997654 678999999999999999999999887766432211     112222222


Q ss_pred             cccc-----------------ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYH-----------------ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....                 .....+....+ ++++++.+++.+|+++||++||||.+.++
T Consensus       230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             ccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            1111                 11112222233 37889999999999999999999999875

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=331.32  Aligned_cols=265  Identities=24%  Similarity=0.346  Sum_probs=215.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ......|++.+.||.|..++||+|+.. .+..||||++.......   ..+.+.+|+..|+.++||||++++.+|..+..
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            344578999999999999999999864 67999999998865553   36778899999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .|+||.||.+||+.+.+...-+.   .+++..+..|.+++++||.|||++|   .+|||+|+.||||+.+|.+||+|||.
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCcee
Confidence            99999999999999999876543   3889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCc---eeeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          226 SKFIAMDQT---HVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       226 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      +..+.....   ......+||++|||||++..  ..|+.|+||||||++..||.+|..||.......        .....
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--------vLl~t  244 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--------VLLLT  244 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--------HHHHH
Confidence            877654322   12255689999999998554  478999999999999999999999996543111        11111


Q ss_pred             hhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +.. ............+....++..|.+++..||+.||.+|||++++++
T Consensus       245 Lqn-~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  245 LQN-DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hcC-CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111 111111223333445556678999999999999999999999974

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-48  Score=346.35  Aligned_cols=249  Identities=26%  Similarity=0.428  Sum_probs=209.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..|....+||+|+.|.||.+... +++.||||++......    ..+-+++|+.+|+..+|+|||++++.|...+..++|
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP----KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC----chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            45777789999999999999865 6889999998775544    345678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||++||+|.+.+...      .+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+
T Consensus       349 MEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI  419 (550)
T ss_pred             EeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence            9999999999999764      4889999999999999999999999   999999999999999999999999999877


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... .....+||+.|||||++....|.+|+||||||++++||+.|++||....  .     +...+  .+......  
T Consensus       420 ~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~--P-----lrAly--LIa~ng~P--  487 (550)
T KOG0578|consen  420 SEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN--P-----LRALY--LIATNGTP--  487 (550)
T ss_pred             ccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC--h-----HHHHH--HHhhcCCC--
Confidence            65433 4566789999999999999999999999999999999999999996422  1     11111  11111111  


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ....+...+++|.+++.+||+.||++|+|+.|+++
T Consensus       488 -----~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  488 -----KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             -----CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence                 11234567889999999999999999999999975

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-48  Score=316.79  Aligned_cols=239  Identities=29%  Similarity=0.380  Sum_probs=205.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++.... -....+.+...+|..+++.+.||.++++++.+.+.+..|+|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            56888999999999999999987 58899999877642 22334566778999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||++||.|.+++++.+     ++++...+.++.||+.||+|||+++   |++|||||+|||+|.+|.+||+|||+|+.+
T Consensus       123 meyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            99999999999998755     5888899999999999999999999   999999999999999999999999999877


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...    +.+.||||.|+|||.+...++..++|.||||+++|||+.|.+||.+...        .+.+.         .+
T Consensus       195 ~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~---------KI  253 (355)
T KOG0616|consen  195 SGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYE---------KI  253 (355)
T ss_pred             cCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHH---------HH
Confidence            542    4567999999999999999999999999999999999999999987653        11111         11


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCC
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKR  341 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  341 (360)
                      +...  -..|...+.++.+|+...|+.|-.+|
T Consensus       254 ~~~~--v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 LEGK--VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HhCc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            1111  12466677789999999999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-48  Score=333.30  Aligned_cols=254  Identities=30%  Similarity=0.440  Sum_probs=203.1

Q ss_pred             hcCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC--cc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE--FP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~  146 (360)
                      ..++...+.||+|+||+||++...+ |...|+|.+......    ..+...+|+.++.+++|||||+++|......  .+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~----~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP----TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch----hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence            3557778899999999999999764 889999987764211    1556778999999999999999999855444  58


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEeecCC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVADFGT  225 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~  225 (360)
                      ++.|||+++|+|.+++.....    .+++..+..+++|+++||.|||+++   ++||||||+|||++. ++.+||+|||+
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence            899999999999999987432    5899999999999999999999999   999999999999999 79999999999


Q ss_pred             ccccCC--CCceeeecccccCCccchhhhccCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          226 SKFIAM--DQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       226 ~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      +.....  ..........||+.|||||++..+. ...++||||+||++.||+||+.||....       .......    
T Consensus       165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-------~~~~~~~----  233 (313)
T KOG0198|consen  165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-------EEAEALL----  233 (313)
T ss_pred             ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-------chHHHHH----
Confidence            987663  2222344567999999999999643 3359999999999999999999996530       0000000    


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                           .+......+..+...+++..+++..|++.||++||||.++++-
T Consensus       234 -----~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  234 -----LIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             -----HHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence                 0111111224566677899999999999999999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-48  Score=337.77  Aligned_cols=270  Identities=26%  Similarity=0.329  Sum_probs=210.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--C
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--E  144 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~  144 (360)
                      .....|+.+++||+|+||.||++++. +|+.||+|+++.......  ......+|+.+|++++||||+++.+...+.  .
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~--~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG--FPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc--chHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            34456888899999999999999865 789999999887654432  334567999999999999999999998876  6


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..|+|+|||++ +|.-++..    ..-.+++.++..++.|++.||.|||+++   |.|||||..|||||++|.+||+|||
T Consensus       192 siYlVFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             eEEEEEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccc
Confidence            88999999965 77777754    2336899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +|.++........+..+-|.+|+|||.+.+ ..|+.++|+||.|||+.||++|++.|.+..+..+...  .-........
T Consensus       264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k--IfklcGSP~e  341 (560)
T KOG0600|consen  264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK--IFKLCGSPTE  341 (560)
T ss_pred             ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH--HHHHhCCCCh
Confidence            999887766666677778999999998888 4789999999999999999999999877654322211  1111111111


Q ss_pred             cccc--ccc-----c-----hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLY--HIL-----D-----DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~--~~~-----~-----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..|.  .+.     .     .....+.....++...+|+..+|..||.+|.|+.+.++
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1111  000     0     01111113344667889999999999999999998864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.5e-47  Score=311.14  Aligned_cols=264  Identities=25%  Similarity=0.307  Sum_probs=207.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|...+.+|+|.||.||+|++. +|+.||||+++.....+.  -.-...+|++.++.++|+||+.++++|...+...+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG--i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG--INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC--ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence            46788899999999999999865 799999999887644321  123567999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||++ .+|...++++.    -.++...+..++.++++|++|||+++   |.||||||+|+||+.+|.+||+|||+++..
T Consensus        80 fEfm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             EEecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhcc
Confidence            99994 69999997643    36888999999999999999999999   999999999999999999999999999998


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc---c
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN---R  305 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  305 (360)
                      ......... .+-|.+|+|||.+.| ..|+..+|+||.||++.||+-|.+-|.+..+.++...     +...+..+   .
T Consensus       152 ~~p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~-----If~~LGTP~~~~  225 (318)
T KOG0659|consen  152 GSPNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK-----IFRALGTPTPDQ  225 (318)
T ss_pred             CCCCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH-----HHHHcCCCCccc
Confidence            765543333 367999999998877 5789999999999999999988766655543222221     22222221   1


Q ss_pred             cccccc---h--------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          306 LYHILD---D--------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       306 ~~~~~~---~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                      |.++..   -        ......-...+++..+|+..|+..||.+|+|++|.++.
T Consensus       226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            111111   0        00111223456678999999999999999999998753

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=336.19  Aligned_cols=259  Identities=25%  Similarity=0.337  Sum_probs=208.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHH-HhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCC
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEEL-YKLEEFINEIFILSQIN-HRNVVKLLGCCLETE  144 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~-~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~  144 (360)
                      ...+.|.+.+.||+|+||+|+.|.+. ++..||+|.+......... ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34578999999999999999999865 6899999976653111111 22345568999999998 999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC-CcEEEeec
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-YRAKVADF  223 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Df  223 (360)
                      ..|+||||+.+|+|.+++....     ++.+.....+++|++.|++|||+++   |+||||||+|+|++.+ +++||+||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence            9999999999999999998743     5788999999999999999999999   9999999999999999 99999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhccCC-CC-CccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ-LT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      |++.... .........+||+.|+|||++.+.. |+ .++||||+|++||-|++|+.||.+...        ...+.. +
T Consensus       166 G~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~~k-i  235 (370)
T KOG0583|consen  166 GLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLYRK-I  235 (370)
T ss_pred             ccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHHHH-H
Confidence            9998774 2223445678999999999999977 75 689999999999999999999976321        111111 1


Q ss_pred             hccccccccchHHhhhccHHH-HHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQ-IVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      ...          .-..+... ++++..|+.+||..||.+|+|+.+|+ .-.-++
T Consensus       236 ~~~----------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  236 RKG----------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             hcC----------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence            111          01122333 67899999999999999999999998 444333

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-46  Score=339.74  Aligned_cols=264  Identities=27%  Similarity=0.399  Sum_probs=205.9

Q ss_pred             hcCCCccceecccCcEEEEEEEe------cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEee
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLE  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~  142 (360)
                      .++|++.+.||+|+||.||+|.+      .++..||+|.++.....   .....+.+|+.++..+ +||||+++++++..
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA---SEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch---HHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            36789999999999999999974      23467999988753322   2345688999999999 89999999998876


Q ss_pred             C-CcceEEEEecCCCChhHHhhhhccC-----------------------------------------------------
Q 040763          143 T-EFPLLVYEFIPNGTLYQHLHDRHQN-----------------------------------------------------  168 (360)
Q Consensus       143 ~-~~~~lv~e~~~~~~L~~~l~~~~~~-----------------------------------------------------  168 (360)
                      . ...+++|||+++|+|.+++......                                                     
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 4578999999999999999753210                                                     


Q ss_pred             ----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCce-eeeccccc
Q 040763          169 ----EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGT  243 (360)
Q Consensus       169 ----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt  243 (360)
                          ...++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......... ......++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                0135778889999999999999999999   999999999999999999999999999765432221 12223457


Q ss_pred             CCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHH
Q 040763          244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQ  322 (360)
Q Consensus       244 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (360)
                      +.|+|||++.+..++.++||||||+++|||++ |..||.+.....        .+......+..         ...+...
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~---------~~~~~~~  302 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--------EFCQRLKDGTR---------MRAPENA  302 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--------HHHHHHhcCCC---------CCCCCCC
Confidence            78999999999999999999999999999997 999986533110        01111111111         1112344


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          323 IVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       323 ~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      ++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            5679999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=366.90  Aligned_cols=263  Identities=28%  Similarity=0.475  Sum_probs=218.6

Q ss_pred             cCCCccceecccCcEEEEEEEecC--Cc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED--GR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .+....+.||+|.||.||.|...+  +.    .||+|.++.....   ....+|++|..+|..++||||++++|++.+..
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~---~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE---QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH---HHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            455677889999999999998653  32    4899988776554   56778999999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNE--EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                      ..++++|||++|+|..+|++...+.  ...++....+.++.|||+|+.||++++   +|||||..+|+|++....+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence            9999999999999999998864333  345888999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceee-ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHH
Q 040763          223 FGTSKFIAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       223 fg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      ||+|+.......+.. .+..-+..|||||.+..+.++.|+|||||||++||++| |..||.+.....     .   ....
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-----v---~~~~  917 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-----V---LLDV  917 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-----H---HHHH
Confidence            999996655444332 22244678999999999999999999999999999999 999997654211     1   1111


Q ss_pred             hhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..         .. +.+.|..++..++++|..||+.+|++||++..|++.+..+.+.
T Consensus       918 ~~---------gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  918 LE---------GG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             Hh---------CC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            11         11 4455788888999999999999999999999999998887654

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=330.80  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=209.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..|...+.||+|+||.||+|.+. .++.||+|++......+   .++.+.+|+.++.+++++||.++|+.+..+..++++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d---eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED---EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch---hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            45667789999999999999875 68899999988866553   456677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||||.||++.+.+.....     +.+..+.-++++++.|+.|||.++   .+|||||+.|||+..+|.+|++|||++-..
T Consensus        90 Mey~~gGsv~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             HHHhcCcchhhhhccCCC-----CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeee
Confidence            999999999999976543     345555568899999999999999   999999999999999999999999999877


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ....... .+.+||+.|||||++....|+.|+||||||++.+||++|.+|+.....                  .+..-+
T Consensus       162 ~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------mrvlfl  222 (467)
T KOG0201|consen  162 TNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------MRVLFL  222 (467)
T ss_pred             echhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------------ceEEEe
Confidence            6544333 678999999999999988999999999999999999999999854321                  111222


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +-...++.....+++.|++++..||.+||+.||||.++++
T Consensus       223 Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  223 IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            2233333444578889999999999999999999999975

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-47  Score=337.89  Aligned_cols=272  Identities=27%  Similarity=0.480  Sum_probs=216.4

Q ss_pred             cChHHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEE
Q 040763           61 FSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCC  140 (360)
Q Consensus        61 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~  140 (360)
                      .+.++.+...+++.+...||+|.||+||+|.+.  ..||||.++......+  ..+.|++|+..+++-+|.||+-|.|+|
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~--qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE--QLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHH--HHHHHHHHHHHHhhcchhhheeeehhh
Confidence            334555666677888899999999999999985  3599999998776654  788999999999999999999999999


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                      ..... .+|+.+|+|.+|+.++....    ..++..+.+.|++|+++|+.|||.++   |+|||||..||++.+++.|||
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkI  529 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKI  529 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEE
Confidence            98887 99999999999999997643    25888999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCc-eeeecccccCCccchhhhcc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 040763          221 ADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  296 (360)
                      +|||++.....-.. .......|...|||||++..   .+|+..+||||||+++|||++|..||....   .++....  
T Consensus       530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~---~dqIifm--  604 (678)
T KOG0193|consen  530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN---RDQIIFM--  604 (678)
T ss_pred             ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC---hhheEEE--
Confidence            99999976433211 11222347889999998875   468999999999999999999999997221   1111110  


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                          ...+..  ..+   ......+++.++.+|+..||.+++++||++.+|+..|+.+...+
T Consensus       605 ----VGrG~l--~pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  605 ----VGRGYL--MPD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             ----eccccc--Ccc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence                000000  000   01112345668999999999999999999999999898887643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-46  Score=337.95  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=208.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .-|+..+.||+|+.|.|-+|++. +|+..|||++.......+ .....+.+|+.+|+.+.|||++.+++++.+..++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~-s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSS-SQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeecccccccc-ccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            45788899999999999999975 799999999876532221 2233566899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      .||+++|.|.+++-.++     ++++.....+++||+.|+.|||..+   |+||||||+|+|+|..+++||+|||+|...
T Consensus        91 lEyv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EEecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc
Confidence            99999999999998765     5888899999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ..+.  ...+.||++.|.|||.+.+.+|+ .++||||.|||||.|+||+.||++.+.     ..+    ....+.     
T Consensus       163 ~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-----r~L----LlKV~~-----  226 (786)
T KOG0588|consen  163 VPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-----RVL----LLKVQR-----  226 (786)
T ss_pred             cCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-----HHH----HHHHHc-----
Confidence            5433  34556999999999999999884 689999999999999999999975431     000    000111     


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           -.-++|.+.+++..+|+.+|+..||+.|.|++||++
T Consensus       227 -----G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  227 -----GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             -----CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                 112345667778999999999999999999999975

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-46  Score=336.71  Aligned_cols=264  Identities=27%  Similarity=0.419  Sum_probs=211.7

Q ss_pred             hcCCCccceecccCcEEEEEEEecC--C--cE-EEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED--G--RI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .++....++||+|+||.||+|..+.  +  .. ||+|..+... ........++++|+++|++++||||++++|+.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            3455566899999999999998653  2  23 8999877522 122356788999999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..++|||+|.||+|.++|.....    .++...++.++.+.|.||+|||+++   ++||||.++|+|++.++.+||+|||
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence            99999999999999999987543    5899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ++......... .....-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....     .    .....  
T Consensus       308 Ls~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~----v~~kI--  375 (474)
T KOG0194|consen  308 LSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----E----VKAKI--  375 (474)
T ss_pred             cccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----H----HHHHH--
Confidence            98754311111 111235788999999999999999999999999999999 88998765421     1    11111  


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                            .....+...+...+.++..++.+||..+|++||||.++.+.|+.+.+...
T Consensus       376 ------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  376 ------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                  01122223344556688899999999999999999999999999876543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.9e-45  Score=321.03  Aligned_cols=265  Identities=23%  Similarity=0.326  Sum_probs=207.5

Q ss_pred             CcccccChHHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCcee
Q 040763           56 DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK  135 (360)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~  135 (360)
                      ...+..+.++++.     .....||+|++|.||+|.. +|+.||+|.++...... ....+.+.+|+.++.+++||||++
T Consensus        10 ~~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~   82 (283)
T PHA02988         10 NDIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGH-KVLIDITENEIKNLRRIDSNNILK   82 (283)
T ss_pred             CcceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEecccccccc-HHHHHHHHHHHHHHHhcCCCCEEE
Confidence            4445556666532     2224699999999999998 57899999987643221 123467789999999999999999


Q ss_pred             eeeEEee----CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCe
Q 040763          136 LLGCCLE----TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNI  210 (360)
Q Consensus       136 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Ni  210 (360)
                      +++++.+    ....+++|||+++|+|.+++....     .+++.....++.|++.||.|||+. +   ++||||||+||
T Consensus        83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~ni  154 (283)
T PHA02988         83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSF  154 (283)
T ss_pred             EeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhE
Confidence            9999876    346789999999999999997532     578889999999999999999985 6   88999999999


Q ss_pred             EEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcc
Q 040763          211 LLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ  288 (360)
Q Consensus       211 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~  288 (360)
                      ++++++.+||+|||++.......    ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||.....   
T Consensus       155 ll~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---  227 (283)
T PHA02988        155 LVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---  227 (283)
T ss_pred             EECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---
Confidence            99999999999999987654321    22357889999999876  6789999999999999999999999965421   


Q ss_pred             cccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                           ...........         .....+..+++++.+++.+||+.||++|||+.++++.|+.++.
T Consensus       228 -----~~~~~~i~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        228 -----KEIYDLIINKN---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -----HHHHHHHHhcC---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                 01111111111         0111233456689999999999999999999999999998874

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.2e-45  Score=320.20  Aligned_cols=257  Identities=21%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .++|++.+.||+|+||.||+|..+    .+..+|+|.++.....   .....+.+|+.++..++||||+++++++...+.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD---KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            356889999999999999999753    3568999988765333   234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++||||+++++|.+++....    ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcc
Confidence            999999999999999997532    25889999999999999999999999   99999999999999999999999998


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      +...............++..|+|||.+.+..++.++||||||+++||+++ |..||......         .....+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---------~~~~~~~~~  224 (266)
T cd05064         154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---------DVIKAVEDG  224 (266)
T ss_pred             cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---------HHHHHHHCC
Confidence            76543222111222335678999999999999999999999999999775 99998654310         011111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                               .....+..++..+.+++.+||+.+|++|||+.+|.+.|+.+
T Consensus       225 ---------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ---------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                     01112344566799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.3e-46  Score=329.80  Aligned_cols=248  Identities=29%  Similarity=0.461  Sum_probs=209.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|-+.+.||+|+||.||+|+-+ +.+.||+|.+......+  ..+....+|+++++.++||||+.++++|.+..+.++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~--k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE--KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch--HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            56888899999999999999876 57899999876544332  3456678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      .||+.| +|..++....     .++++.+..++.+++.||.|||+++   |.|||+||.|||++.++.+|+||||+|+..
T Consensus        80 te~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             ehhhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhc
Confidence            999966 9999997643     5999999999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      +.. ....+...|||-|||||+..++.|+..+|.||+||++||+++|++||....        ..+... .+..      
T Consensus       151 ~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~-~I~~------  214 (808)
T KOG0597|consen  151 STN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVK-SILK------  214 (808)
T ss_pred             ccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHH-HHhc------
Confidence            653 445566789999999999999999999999999999999999999996432        111111 1111      


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        +..  ..+...+..|.+++...|.+||.+|.|-.+++.
T Consensus       215 --d~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  215 --DPV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             --CCC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence              111  124467788999999999999999999888753

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-45  Score=325.06  Aligned_cols=250  Identities=25%  Similarity=0.342  Sum_probs=202.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|+++..||+|+||.||+++-+ +|..+|+|+++.. ......+.+.++.|-.+|...++|.||+++-.|++.+++|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS-~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS-EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHH-HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            5578999999999999999999876 6899999998874 3333456677888999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||++||++..+|....     .+++.....++.+++.||..+|+.|   ++||||||+|+|||..|++||+|||++.
T Consensus       218 LiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             EEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence            9999999999999997654     6888999999999999999999999   9999999999999999999999999984


Q ss_pred             ccCC-----------------------CCce----ee-------------------ecccccCCccchhhhccCCCCCcc
Q 040763          228 FIAM-----------------------DQTH----VT-------------------TKIQGTFGYLDPEYHQSSQLTDKS  261 (360)
Q Consensus       228 ~~~~-----------------------~~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~  261 (360)
                      -+..                       +...    ..                   ...+|||.|+|||++.+..|+...
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            3211                       0000    00                   024699999999999999999999


Q ss_pred             chhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCC
Q 040763          262 DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKR  341 (360)
Q Consensus       262 DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  341 (360)
                      |.||||||+|||+.|.+||.+...  .+.-.....+...+.             .+.....+.+..+||.+|+. ||++|
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp--~~T~rkI~nwr~~l~-------------fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETP--QETYRKIVNWRETLK-------------FPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhhhcc-------------CCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            999999999999999999976542  211111111111111             11122334689999999999 99999


Q ss_pred             CC
Q 040763          342 PT  343 (360)
Q Consensus       342 pt  343 (360)
                      ..
T Consensus       434 LG  435 (550)
T KOG0605|consen  434 LG  435 (550)
T ss_pred             cC
Confidence            86

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-47  Score=347.54  Aligned_cols=259  Identities=23%  Similarity=0.417  Sum_probs=218.4

Q ss_pred             cCCCccceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      +...+.++||.|.||.|+.|..+-    ...||||.++.....   .+..+|+.|+.||-+++||||+++.|+.......
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte---kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE---KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH---HHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            456778899999999999998752    347999999987666   4566899999999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      .+|.|||++|+|+.+|+.+.    ..+.+.+..-++++|+.|+.||.+.+   +|||||.++|||++.+..+|++|||++
T Consensus       706 MIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence            99999999999999998743    35888899999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecc--cccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          227 KFIAMDQTHVTTKI--QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       227 ~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +.+.++.....+..  .-+.+|.|||.+...+++.+|||||||+++||.++ |..||-+..     +....         
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----NQdVI---------  844 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVI---------  844 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----hHHHH---------
Confidence            98866553322222  23678999999999999999999999999999887 999985433     11111         


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                          .-++...+.+.|-.++..|.+|+.+||++|-.+||++.+|+..|.++..+
T Consensus       845 ----kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  845 ----KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ----HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                12233334444667888999999999999999999999999999988653

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.4e-45  Score=323.48  Aligned_cols=266  Identities=24%  Similarity=0.383  Sum_probs=203.4

Q ss_pred             hcCCCccceecccCcEEEEEEEecC-----------------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED-----------------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN  132 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~n  132 (360)
                      .++|.+.+.||+|+||.||++.+++                 +..+|+|.+......   .....+.+|+.++..++|||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK---NARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH---HHHHHHHHHHHHHhhcCCCC
Confidence            3578899999999999999997532                 236999988764332   33557889999999999999


Q ss_pred             ceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 040763          133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--------------EEYPLTWEMRFRVAIEVAGALAYLHSGASS  198 (360)
Q Consensus       133 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~  198 (360)
                      |+++++++...+..+++|||+++++|.+++......              ....+++..++.++.|++.||.|||+.+  
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--  158 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--  158 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence            999999999999999999999999999998654211              1124678889999999999999999999  


Q ss_pred             CeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh--
Q 040763          199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--  275 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--  275 (360)
                       ++||||||+|||++.++.+||+|||++......... ......++..|+|||++.++.++.++||||||+++|||++  
T Consensus       159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             -ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence             999999999999999999999999998765433222 2223446788999999998899999999999999999987  


Q ss_pred             CCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          276 GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       276 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      +..||.....  .   ................      .....+..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       238 ~~~p~~~~~~--~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         238 KEQPYGELTD--E---QVIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCCcCCH--H---HHHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            5567654321  0   0111111111111000      001112234567999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=334.42  Aligned_cols=245  Identities=29%  Similarity=0.487  Sum_probs=206.1

Q ss_pred             CccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           74 NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      ..++-||.|+.|.||+|+.+ ++.||||+++.-.           ..+++-|++|+||||+.|.|+|....-++||||||
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhh-----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence            34567999999999999987 5789999865321           15788999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      ..|.|++.|+..+     ++......++..+||.|+.|||.+.   |||||||.-||||..+..+||+|||-++..... 
T Consensus       195 a~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-  265 (904)
T KOG4721|consen  195 AQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-  265 (904)
T ss_pred             ccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence            9999999998754     5888899999999999999999999   999999999999999999999999998766543 


Q ss_pred             ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchH
Q 040763          234 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQ  313 (360)
Q Consensus       234 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (360)
                      .+ .-.++||..|||||++...+-++|+|||||||+||||+||..||.+....                 -.+...-...
T Consensus       266 ST-kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----------------AIIwGVGsNs  327 (904)
T KOG4721|consen  266 ST-KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----------------AIIWGVGSNS  327 (904)
T ss_pred             hh-hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----------------eeEEeccCCc
Confidence            22 12357999999999999999999999999999999999999999654310                 1122222334


Q ss_pred             HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          314 VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       314 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      +....|..++..|.-|++.||+..|.+||++.+|+.-|.-...+
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            44556777888899999999999999999999999888755443

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.8e-45  Score=333.86  Aligned_cols=262  Identities=26%  Similarity=0.402  Sum_probs=205.0

Q ss_pred             hcCCCccceecccCcEEEEEEEe------cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEee
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLE  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~  142 (360)
                      .++|++.+.||+|+||.||++..      .++..||+|+++.....   ...+.+.+|+.++..+ +||||+++++++..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc---HHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            45799999999999999999963      23568999988754332   2345678899999999 89999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccC------------------------------------------------------
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQN------------------------------------------------------  168 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------  168 (360)
                      .+..++||||+++|+|.+++......                                                      
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            99999999999999999999653210                                                      


Q ss_pred             ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCC
Q 040763          169 ----------------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD  232 (360)
Q Consensus       169 ----------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  232 (360)
                                      ....+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                            1124788899999999999999999999   999999999999999999999999999765443


Q ss_pred             Ccee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          233 QTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       233 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      .... .....++..|+|||++.+..++.++||||||+++|||++ |..||......        ..+........     
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~-----  334 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--------SKFYKMIKEGY-----  334 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--------HHHHHHHHhCc-----
Confidence            2211 122335678999999999999999999999999999998 88888543211        01111111110     


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                          ....+...+.++.+|+.+||+.||++|||+.++++.|+..
T Consensus       335 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 ----RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                0111222345799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.1e-45  Score=333.38  Aligned_cols=264  Identities=26%  Similarity=0.410  Sum_probs=206.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEe
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCL  141 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~  141 (360)
                      ..++|++.+.||+|+||.||++...      ++..||+|.++.....   ...+.+.+|+.+++.+ +|+||+++++++.
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT---DEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH---HHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            3457899999999999999998742      2357999998754333   2345678899999999 8999999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhcc------------------------------------------------------
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQ------------------------------------------------------  167 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  167 (360)
                      .....+++|||+++|+|.+++.....                                                      
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            99999999999999999999864321                                                      


Q ss_pred             -----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCcee
Q 040763          168 -----------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV  236 (360)
Q Consensus       168 -----------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  236 (360)
                                 ....++++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++..........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                       01235788889999999999999999999   9999999999999999999999999987654332221


Q ss_pred             -eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          237 -TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       237 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                       .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......        .........         .
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--------~~~~~~~~~---------~  332 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--------KFYKMVKRG---------Y  332 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--------HHHHHHHcc---------c
Confidence             122235678999999998899999999999999999997 999986532110        011111110         0


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      ....+...++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         333 QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            11112223568999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=308.24  Aligned_cols=263  Identities=22%  Similarity=0.262  Sum_probs=206.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--CCcce
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--TEFPL  147 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~  147 (360)
                      ++|+.++.|++|+||.||+|+++ +++.||+|+++......... + ..++|+.++.+.+|||||.+..+...  .+..|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP-I-tsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP-I-TSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc-c-hhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            56888999999999999999987 67899999999875443221 1 34689999999999999999998764  45689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +|||||++ +|.+++....    +++....+.-++.|++.|++|||+++   |+||||||+|+|+++.|.+||+|||+|+
T Consensus       154 ~VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhh
Confidence            99999965 8999987643    47888999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc--
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN--  304 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  304 (360)
                      .++.+ ....+..+-|.+|+|||.+.+ ..|++..|+||+|||+.||+++++-|.+.++..+...     +...+..+  
T Consensus       226 ~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~-----If~llGtPte  299 (419)
T KOG0663|consen  226 EYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK-----IFKLLGTPSE  299 (419)
T ss_pred             hhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH-----HHHHhCCCcc
Confidence            87764 334556678999999998887 5689999999999999999999999987765433222     11122111  


Q ss_pred             -ccccccch--------------HHhhhccHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 -RLYHILDD--------------QVMKLGKKN-QIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 -~~~~~~~~--------------~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       .|..+...              .+....+.. .++.-.+|+..+|..||.+|.|+++.++
T Consensus       300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             11111111              111111111 4467789999999999999999999764

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-44  Score=319.38  Aligned_cols=260  Identities=27%  Similarity=0.444  Sum_probs=208.9

Q ss_pred             cCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      ++|++.+.||+|+||.||+|....      ...+++|.+......   .....+.+|+.++..++||||+++++++....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP---KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH---HHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            468889999999999999998643      257899987654332   33456789999999999999999999999988


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEE-----------YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      ..+++|||+++++|.+++........           ..+++..++.++.|++.||.|||+++   ++|+||||+||+++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVG  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEc
Confidence            99999999999999999976532222           45788899999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV  291 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~  291 (360)
                      +++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+...      
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------  232 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------  232 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999876533221 12233456788999999998889999999999999999998 9999865431      


Q ss_pred             chHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                         ......+....         ....+..++.++.+|+.+||+.||++|||+.+|++.|+++
T Consensus       233 ---~~~~~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 ---QEVIEMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ---HHHHHHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence               01111111111         1123445677899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.7e-45  Score=321.06  Aligned_cols=269  Identities=23%  Similarity=0.251  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++.++ +++.+|+|++.......  ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE--EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc--cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            46899999999999999999986 57889999876543221  2345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||++++.+..+...     ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        79 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          79 FEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            999988766554322     125888999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc------h-HHHHHHHhh
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS------L-AAYFVHSMR  302 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~------~-~~~~~~~~~  302 (360)
                      ............|++.|+|||++.+..++.++|||||||++|||++|+.||.+..........      . .........
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         151 SEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             cccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            443332333456899999999999988999999999999999999999999754321100000      0 000000000


Q ss_pred             cccccccc------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRLYHIL------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ........      ............+.++.+|+.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000      000011112235668999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.6e-44  Score=317.55  Aligned_cols=253  Identities=24%  Similarity=0.288  Sum_probs=201.1

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |+..+.||+|+||.||++... +++.+|+|.+....... ......+.+|+.++..++|+|++++++++.+.+..+++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            677889999999999999875 68899999876532221 1223456789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+++|+|.+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.....
T Consensus        81 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          81 IMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             ecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            999999998886432   225788999999999999999999999   99999999999999999999999999876533


Q ss_pred             CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                      ..  ......||..|+|||++.+..++.++|||||||++|+|++|+.||........     ..........        
T Consensus       155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~--------  219 (285)
T cd05631         155 GE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRVKE--------  219 (285)
T ss_pred             CC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHhhc--------
Confidence            22  22344689999999999999999999999999999999999999975432111     0011111110        


Q ss_pred             hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 040763          312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVSM  349 (360)
Q Consensus       312 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~~  349 (360)
                        .....+...++++.+|+.+||+.||++|||     +.++++
T Consensus       220 --~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         220 --DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              011223445668999999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=294.85  Aligned_cols=270  Identities=21%  Similarity=0.323  Sum_probs=212.9

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEe-cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      .+....++|.+.+.||+|+|+.|++++. .++..+|+|++.....    ...+..++|++..++++|||+++++++...+
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~----~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ----EDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch----HHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            3445568999999999999999999984 4678899999876542    3466788999999999999999999987644


Q ss_pred             C-----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcE
Q 040763          144 E-----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA  218 (360)
Q Consensus       144 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~  218 (360)
                      .     ..|++++|...|+|.+.++.... ++..+++..++.++.++++||.+||+.. ++++||||||.|||+.+.+.+
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~  168 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLP  168 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCce
Confidence            4     37999999999999999987643 4447999999999999999999999987 579999999999999999999


Q ss_pred             EEeecCCccccCCCCceee--------ecccccCCccchhhhcc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 040763          219 KVADFGTSKFIAMDQTHVT--------TKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS  287 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~  287 (360)
                      +|.|||.++...-.-....        .....|..|+|||.+.-   ...++++|||||||+||+|+.|..||...-...
T Consensus       169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G  248 (302)
T KOG2345|consen  169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG  248 (302)
T ss_pred             EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence            9999999875432111000        01236889999997764   456889999999999999999999995432211


Q ss_pred             ccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          288 QENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      . .              -...+...+...+-...+++.+.+++.+||+.||.+||++.+++..+..+.
T Consensus       249 g-S--------------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 G-S--------------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             C-e--------------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1 1              111122222222223337889999999999999999999999999988764

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-45  Score=339.29  Aligned_cols=261  Identities=25%  Similarity=0.368  Sum_probs=214.1

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEecCC-cEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEE-ee-
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLEDG-RIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCC-LE-  142 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~-~~-  142 (360)
                      .....++++.+.|.+|+|+.||++.+..+ ..+|+|++-.. +.   ..++.+.+|+.+|++|+ |+|||.+++.. .. 
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de---~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DE---EALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CH---HHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            34456778889999999999999998765 99999987654 22   56778889999999995 99999999942 21 


Q ss_pred             --C---CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc
Q 040763          143 --T---EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR  217 (360)
Q Consensus       143 --~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~  217 (360)
                        .   -..++.||||.+|+|-++++.+...   .+++..+++|+.|+++|+++||... +||||||||-+||||+.+++
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~  184 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGN  184 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCC
Confidence              1   2357899999999999999986543   3899999999999999999999987 78999999999999999999


Q ss_pred             EEEeecCCccccCCCCceee--------ecccccCCccchhhh---ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 040763          218 AKVADFGTSKFIAMDQTHVT--------TKIQGTFGYLDPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT  286 (360)
Q Consensus       218 ~kl~Dfg~~~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~  286 (360)
                      .||||||.++-.........        ....-|+.|+|||++   .+..+++|+|||||||+||-|+....||...+. 
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-  263 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-  263 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-
Confidence            99999999975432221000        012368999999965   467889999999999999999999999976642 


Q ss_pred             cccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                                          ..++.....-+..+.++..|.+||..||+.||++||++.++++++-.+.+
T Consensus       264 --------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  264 --------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                                23445555555557889999999999999999999999999999988764

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=319.44  Aligned_cols=264  Identities=26%  Similarity=0.373  Sum_probs=204.9

Q ss_pred             cChHHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChH----------HHHhHHHHHHHHHHHhhcC
Q 040763           61 FSSKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDE----------ELYKLEEFINEIFILSQIN  129 (360)
Q Consensus        61 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~----------~~~~~~~~~~e~~~~~~l~  129 (360)
                      +...+-.+..++|++.+.||+|.||.|-+|+.. +++.||+|++.......          ....++...+|+.+|++++
T Consensus        87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            334444556689999999999999999999976 68899999876543211          1112457889999999999


Q ss_pred             CCCceeeeeEEee--CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 040763          130 HRNVVKLLGCCLE--TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKS  207 (360)
Q Consensus       130 h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~  207 (360)
                      |||||+++++..+  .+..|||+|||..|.+...=..     ...+.+.+.++++++++.||.|||.++   |+||||||
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKP  238 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKP  238 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccch
Confidence            9999999999865  5678999999998888654322     112889999999999999999999999   99999999


Q ss_pred             CCeEEcCCCcEEEeecCCccccCCC----CceeeecccccCCccchhhhccCC----CCCccchhhhHHHHHHHHhCCCC
Q 040763          208 TNILLDERYRAKVADFGTSKFIAMD----QTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKP  279 (360)
Q Consensus       208 ~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~p  279 (360)
                      .|+||+++|++||+|||.+......    ........+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.|
T Consensus       239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P  318 (576)
T KOG0585|consen  239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP  318 (576)
T ss_pred             hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence            9999999999999999999765321    111123468999999999887743    24578999999999999999999


Q ss_pred             CCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          280 IFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      |.+.....            .     ...++...+.-...+...+++.+||.++|++||+.|.+..+|..
T Consensus       319 F~~~~~~~------------l-----~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  319 FFDDFELE------------L-----FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             cccchHHH------------H-----HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            97654200            0     11222333333333456678999999999999999999998853

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.1e-44  Score=326.25  Aligned_cols=260  Identities=20%  Similarity=0.282  Sum_probs=197.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|++.+.||+|+||.||++.+. +++.||+|....          ..+.+|+.+++.++||||+++++++......+++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            67999999999999999999875 678899996432          2356899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +|++ .++|..++....     .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++...
T Consensus       162 ~e~~-~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        162 LPRY-KTDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             EecC-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            9998 578888886532     4788999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc--cchHHHHHHHhhccc--
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN--VSLAAYFVHSMRKNR--  305 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~--  305 (360)
                      ............||+.|+|||++.+..++.++|||||||++|||++|..||..........  ...............  
T Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            3322223334579999999999999999999999999999999999998876543211110  000010111000000  


Q ss_pred             c----ccccchHH---------------hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 L----YHILDDQV---------------MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~----~~~~~~~~---------------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .    ...+....               ........+.++.+|+.+||+.||++|||++|+++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0    00000000               00001234568999999999999999999999974

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=320.84  Aligned_cols=247  Identities=25%  Similarity=0.355  Sum_probs=200.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++..+ +++.+|+|.+..... ......+.+.+|+.+++.++||||+++++++.+....+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            36889999999999999999986 688999998764321 1123345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .+++.....++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        80 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          80 MEYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             EeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence            99999999999997543     5788899999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        .... .......    
T Consensus       152 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~-~~i~~~~----  214 (291)
T cd05612         152 RDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIY-EKILAGK----  214 (291)
T ss_pred             cCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHHhCC----
Confidence            332    1234689999999999998899999999999999999999999965321        0011 1111110    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~~  349 (360)
                            ...+...+..+.+|+.+||+.||.+||+     +.++++
T Consensus       215 ------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 ------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                  1123334567899999999999999995     777753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3e-44  Score=313.21  Aligned_cols=256  Identities=23%  Similarity=0.396  Sum_probs=206.6

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|++|.||+|...++..+++|.+.....     ..+.+.+|+.+++.++|+||+++++.+......+++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            367899999999999999999988888899998764321     245678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....   ...+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++...
T Consensus        80 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          80 TEYMAKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             EecCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceec
Confidence            99999999999987532   225788889999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||......         ..........   
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---------~~~~~~~~~~---  221 (261)
T cd05072         154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---------DVMSALQRGY---  221 (261)
T ss_pred             CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---------HHHHHHHcCC---
Confidence            4432222223345678999999998889999999999999999998 99998543210         0111111110   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                            ..+.....+.++.+++.+||..+|++|||++++.+.|+.+
T Consensus       222 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 ------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                  0111223455789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.9e-44  Score=312.26  Aligned_cols=255  Identities=26%  Similarity=0.419  Sum_probs=205.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|.+.+.||+|++|.||+|..+ .++.+++|.+....     .....+.+|+.+++.++||||+++++++...+..+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            45788899999999999999876 47889999876432     2245678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....   ...+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~  154 (263)
T cd05052          81 TEFMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  154 (263)
T ss_pred             EEeCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence            99999999999986532   235889999999999999999999999   999999999999999999999999999766


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..||.+...        ...+ ......    
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~-~~~~~~----  221 (263)
T cd05052         155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVY-ELLEKG----  221 (263)
T ss_pred             ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH-HHHHCC----
Confidence            5433222222334678999999999999999999999999999998 8899854321        0111 111110    


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                           .....+...+.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       222 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 -----YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 11122334566899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-45  Score=324.59  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=215.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc-ceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF-PLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~-~~l  148 (360)
                      .+|..++.+|+|+||.+++.+++ ++..+++|.+........  .......|+.++++++|||||.+.+.|..++. .++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~--~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP--ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch--hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            57889999999999999999877 577899999877654432  23356789999999999999999999998888 899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|+||+||++.+.+.+..   ...++++.+..++.|++.|+.|||++.   |.|||||+.||+++.++.+||+|||+|+.
T Consensus        82 vm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             EEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhh
Confidence            999999999999998754   346899999999999999999999888   99999999999999999999999999999


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      +..+.. ......||+.|++||.+.+.+|..|+|||||||.+|||++-+++|.+..-        ......         
T Consensus       156 l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~k---------  217 (426)
T KOG0589|consen  156 LNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILK---------  217 (426)
T ss_pred             cCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHH---------
Confidence            877652 23456899999999999999999999999999999999999999976541        000110         


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                      + ......+.+..++.++..++..||+.+|+.||++.+++..
T Consensus       218 i-~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  218 I-NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             H-hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1 1112345677889999999999999999999999999876

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-44  Score=323.97  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=203.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++...... .......+.+|+.++..++||||+++++++...+..++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence            36889999999999999999986 5789999987653221 112345678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        80 ~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          80 MEYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             EeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            99999999999996532     5788899999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..    ......||+.|+|||.+.+..++.++|||||||++|||++|..||.....  .      ..+.......   ..
T Consensus       152 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~------~~~~~i~~~~---~~  216 (333)
T cd05600         152 VT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--N------ETWENLKYWK---ET  216 (333)
T ss_pred             cc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--H------HHHHHHHhcc---cc
Confidence            33    22345689999999999999999999999999999999999999965431  0      0011100000   00


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .............++++.+++.+||+.+|++|||+.++++
T Consensus       217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            0000000001234668999999999999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.7e-44  Score=322.46  Aligned_cols=262  Identities=28%  Similarity=0.415  Sum_probs=203.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.++ ++..+|+|.+......   ...+.+.+|+.++..++||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH---HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            367999999999999999999986 5788999987754332   234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +|||+++++|.+++....     .+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++.
T Consensus        81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  152 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (331)
T ss_pred             EeecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccc
Confidence            999999999999997533     478899999999999999999985 5   9999999999999999999999999987


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc----
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK----  303 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  303 (360)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     +..........    
T Consensus       153 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~  224 (331)
T cd06649         153 QLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-----LEAIFGRPVVDGEEG  224 (331)
T ss_pred             ccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhcccccccccC
Confidence            55322   1233468999999999999899999999999999999999999996432100     00000000000    


Q ss_pred             --------------------------cccccccc----hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          304 --------------------------NRLYHILD----DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       304 --------------------------~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                                                ....+..+    ...........++++.+|+.+||+.||++|||+.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                      00000000    000011112356789999999999999999999999753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-44  Score=324.97  Aligned_cols=247  Identities=26%  Similarity=0.336  Sum_probs=200.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||.||++.++ +++.+|+|.+...... .....+.+.+|+.++..++||||+++++++...+..++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            367899999999999999999986 5789999987643211 11334567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|||+++++|.+++....     .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++..
T Consensus        96 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEcCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            999999999999997532     4788888999999999999999999   99999999999999999999999999976


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      .....    ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...        ... ........   
T Consensus       168 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~-~~~i~~~~---  231 (329)
T PTZ00263        168 VPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRI-YEKILAGR---  231 (329)
T ss_pred             cCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHH-HHHHhcCC---
Confidence            54322    234689999999999999999999999999999999999999965321        000 11111111   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVS  348 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~  348 (360)
                             ...+...+.++.+|+.+||+.||.+||+     +.+++
T Consensus       232 -------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        232 -------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             -------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence                   0112224557899999999999999997     56665

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-44  Score=311.89  Aligned_cols=256  Identities=26%  Similarity=0.398  Sum_probs=206.2

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|++|.||++...+++.+|+|.++....     ..+.+.+|+.++++++||||+++++++......+++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            356889999999999999999987788899998765322     234577899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....   ...+++..+..++.|++.|+.|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          80 TELMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             eecccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            99999999999997632   235889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      .............+..|+|||.+.+..++.++||||||+++|||++ |+.||.+...        .. ....+....   
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~-~~~~~~~~~---  221 (261)
T cd05068         154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AE-VLQQVDQGY---  221 (261)
T ss_pred             cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HH-HHHHHHcCC---
Confidence            5322221122223457999999998899999999999999999999 9999864321        00 011111110   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                            ....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       222 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         222 ------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                  0112233456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.6e-44  Score=323.08  Aligned_cols=244  Identities=24%  Similarity=0.300  Sum_probs=196.5

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPN  155 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  155 (360)
                      +.||+|+||.||++..+ +++.+|+|+++..... .......+.+|+.++..++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 6889999987753221 112345677899999999999999999999999999999999999


Q ss_pred             CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCce
Q 040763          156 GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH  235 (360)
Q Consensus       156 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  235 (360)
                      ++|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++...... ..
T Consensus        80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~  150 (323)
T cd05571          80 GELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GA  150 (323)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CC
Confidence            99999987533     5789999999999999999999999   999999999999999999999999998753221 11


Q ss_pred             eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHh
Q 040763          236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM  315 (360)
Q Consensus       236 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (360)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||.....        ... ........          
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~-~~~~~~~~----------  211 (323)
T cd05571         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKL-FELILMEE----------  211 (323)
T ss_pred             cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHH-HHHHHcCC----------
Confidence            22335689999999999999999999999999999999999999965321        000 11111110          


Q ss_pred             hhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          316 KLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       316 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                      ...+...++++.+++.+||+.||++||     ++.++++
T Consensus       212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            112334566899999999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=319.97  Aligned_cols=264  Identities=25%  Similarity=0.365  Sum_probs=214.3

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +...++++||+|.||.|.++....+..||+|.++.....   ....+|.+|+++|.+++||||+.++|+|..++..++|+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~---~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK---NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccch---hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            345778999999999999999988899999999876555   34678999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++|+|.+++.++...   .+......+|+.||+.|++||.+.+   ++||||.++|+|++.++++||+|||+++-+.
T Consensus       615 EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence            999999999999875321   1345566779999999999999999   9999999999999999999999999998665


Q ss_pred             CCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh--CCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          231 MDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       231 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ....+. ..+.+-+.+|||||.+..++++.++|||+||+++||+++  ...||....+.     .............   
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~~~~~~---  760 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGEFFRDQ---  760 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhhhcCCC---
Confidence            544443 345667899999999999999999999999999999876  66787543211     1111111111111   


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                         ........|.-++.++.+++.+||+.|.++|||++++-..|...
T Consensus       761 ---~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 ---GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               12222334666777899999999999999999999998887654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.4e-44  Score=316.62  Aligned_cols=267  Identities=21%  Similarity=0.266  Sum_probs=198.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|++.+.||+|+||.||+|..+ +++.||+|.++.....   .....+.+|+.+++.++||||+++++++......++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC---CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            56899999999999999999876 6789999987654322   1234566899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||++ ++|.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        82 ~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          82 FEYLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             EeCCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            99996 59999886532    24788899999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch-------HHHHHHHh
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL-------AAYFVHSM  301 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~~  301 (360)
                      ..... ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+...........       ...+....
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         154 SVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             cCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            33221 1223457899999998866 568899999999999999999999996543211000000       00000000


Q ss_pred             hccccccccchHHh----hhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNRLYHILDDQVM----KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..........+...    .......++++.+|+.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000000000000    0011123567899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=310.46  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=211.5

Q ss_pred             hcCCCccceecccCcEEEEEEEe-cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..+|++.+.||+|.||.|-+++. ..|+.||||.++...-.+ ...+-.+.+|+++|..++||||+.++++|...+...+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-eqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            46799999999999999999986 679999999988754433 3456678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||..+|.|++|+.+++     .+++...+.|++||+.|+.|+|.++   ++|||||.+|||+|+|+++||+|||++..
T Consensus       131 vMEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL  202 (668)
T ss_pred             EEEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence            999999999999998765     4889999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      +....  ...++||++-|.+||.+.+.+| .+.+|.||||++||-|+.|..||++..-         ......+..+...
T Consensus       203 y~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---------k~lvrQIs~GaYr  271 (668)
T KOG0611|consen  203 YADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---------KRLVRQISRGAYR  271 (668)
T ss_pred             hcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---------HHHHHHhhccccc
Confidence            65433  3466799999999999999888 4789999999999999999999976531         1223333333222


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                      +           +..+.+..-||.+||..||++|-|+.+|..-
T Consensus       272 E-----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  272 E-----------PETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             C-----------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            1           1122357789999999999999999999754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.8e-44  Score=310.52  Aligned_cols=252  Identities=26%  Similarity=0.415  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ++|++.+.||+|+||.||++..+++..+|+|.+.....     ..+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            45888899999999999999988888899998764322     2345778999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....    ..+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.+||+|||.+....
T Consensus        79 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          79 EFMENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             EcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            9999999999986532    25789999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....     .   . ..........   
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~---~-~~~~i~~~~~---  219 (256)
T cd05114         152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----Y---E-VVEMISRGFR---  219 (256)
T ss_pred             CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----H---H-HHHHHHCCCC---
Confidence            332222222345678999999998889999999999999999999 8999854321     0   0 0111111110   


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                            ...+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       220 ------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 ------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  0112223457899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.5e-44  Score=322.95  Aligned_cols=255  Identities=25%  Similarity=0.299  Sum_probs=199.7

Q ss_pred             CCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      +|++.+.||+|+||.||++...    +++.+|+|++............+.+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999998753    57889999876533222223345677899999999 599999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      +++|||+++|+|.+++..+.     .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence            99999999999999996533     4788999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ...............||+.|+|||++.+. .++.++|||||||++|||++|..||........    ... +....... 
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~-~~~~~~~~-  226 (332)
T cd05614         153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSE-VSRRILKC-  226 (332)
T ss_pred             ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHH-HHHHHhcC-
Confidence            76543333333345799999999998875 478899999999999999999999965432111    111 11111100 


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                               ....+...++++.+++.+||+.||++||     +++++++
T Consensus       227 ---------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 ---------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                     0112233456789999999999999999     6667753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=329.21  Aligned_cols=247  Identities=27%  Similarity=0.333  Sum_probs=204.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEF  145 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~  145 (360)
                      ....+|...++||+|+||+|+++..+ +++.+|||.++...--. ....+..+.|-+++... +||.+++++.+|++.++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            34477999999999999999999987 57899999988754221 13455667788888877 59999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .|+||||+.||++......      ..+++....-++..|+.||+|||+++   |++||||.+|||+|.+|++||+|||+
T Consensus       444 l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             EEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccc
Confidence            9999999999995444322      25888889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ++.... ....+++.+|||.|+|||++.+..|+.++|.|||||++|||+.|+.||.+..+...        +. .+... 
T Consensus       515 cKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~--------Fd-sI~~d-  583 (694)
T KOG0694|consen  515 CKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV--------FD-SIVND-  583 (694)
T ss_pred             ccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH--------HH-HHhcC-
Confidence            986432 23356778999999999999999999999999999999999999999987653111        11 11111 


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                               ...+|...+.+..+++.++|.++|++|..+
T Consensus       584 ---------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 ---------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                     123467778899999999999999999866

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-44  Score=313.48  Aligned_cols=250  Identities=36%  Similarity=0.573  Sum_probs=194.4

Q ss_pred             ccceecccCcEEEEEEEec-----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           75 VNRILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~-----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.....   ...+.+.+|+..+++++||||++++|++...+..++|
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE---EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH---HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc---ccceeeeeccccccccccccccccccccccccccccc
Confidence            4578999999999999876     2567999998653333   3467788999999999999999999999988889999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+++|+|.+++...   ....+++..+..++.|++.||.|||+++   ++|+||+++||++++++.+||+|||++...
T Consensus        80 ~e~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             EE--TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             cccccccccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999999999875   2235899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          230 AMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       230 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..... .......+...|+|||.+.+..++.++||||||+++|||++ |+.||.....         ..+......... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---------~~~~~~~~~~~~-  223 (259)
T PF07714_consen  154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---------EEIIEKLKQGQR-  223 (259)
T ss_dssp             TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---------HHHHHHHHTTEE-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------cccccccccccc-
Confidence            33222 22233456788999999999989999999999999999999 7788754321         111111111111 


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                              ...+..++..+.+++.+||..||++|||+.+++++|
T Consensus       224 --------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 --------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                    112334556799999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.4e-44  Score=326.41  Aligned_cols=265  Identities=24%  Similarity=0.352  Sum_probs=207.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEe
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCL  141 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~  141 (360)
                      ..++|.+.+.||+|+||.||+|....      +..||+|++......   ...+.+.+|+.++..++ ||||+++++++.
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS---SEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            35678999999999999999998531      346999998754332   23457889999999996 999999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccC-----------------------------------------------------
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQN-----------------------------------------------------  168 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------------------------------------------  168 (360)
                      .....++||||+++|+|.+++......                                                     
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999998653210                                                     


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 040763          169 --------------------------------------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNI  210 (360)
Q Consensus       169 --------------------------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Ni  210 (360)
                                                            ....+++..+..++.|++.||.|||+.+   ++||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence                                                  0124778888999999999999999999   99999999999


Q ss_pred             EEcCCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcc
Q 040763          211 LLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ  288 (360)
Q Consensus       211 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~  288 (360)
                      +++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......  
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--  346 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--  346 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence            9999999999999998765432221 1222346788999999999899999999999999999997 99998643210  


Q ss_pred             cccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                            ..........         .....+...+.++.+++.+||+.||++|||+.++.+.|+.+..
T Consensus       347 ------~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 ------STFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ------HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                  0011111111         0111233456689999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.1e-44  Score=313.39  Aligned_cols=258  Identities=26%  Similarity=0.452  Sum_probs=206.1

Q ss_pred             cCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .+|.+.+.||+|+||.||+|...+      +..+|+|.++.....   ...+.+.+|+.++..++|+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN---DARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH---HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            568888999999999999998643      468999988754332   23467889999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQ---------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~  215 (360)
                      ..+++|||+++++|.+++.....         .....+++..+..++.|++.|+.|||+++   ++||||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCC
Confidence            99999999999999999976532         22335788899999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccch
Q 040763          216 YRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSL  293 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~  293 (360)
                      +.++|+|||++.......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.......      
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------  232 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------  232 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            999999999987543322211 222345788999999999999999999999999999998 999986543210      


Q ss_pred             HHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                         .......+..         ...+...+.++.+++.+||+.||++|||+.|+++.|+
T Consensus       233 ---~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 ---VIECITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               1111111111         1112334567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-43  Score=308.71  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=206.1

Q ss_pred             hcCCCccceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .++|++.+.||+|+||.||+|.++.    ...+++|..+.....   .....+.+|+.++..++||||+++++.+.....
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD---KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh---HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            3568899999999999999998752    357899987754333   234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+++++|.+++....    ..+++..++.++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          80 VMIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccch
Confidence            999999999999999996532    25889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCC-ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....         .........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---------~~~~~~~~~  223 (266)
T cd05033         153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---------QDVIKAVED  223 (266)
T ss_pred             hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---------HHHHHHHHc
Confidence            98765222 122222345678999999998899999999999999999998 9999854321         001111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      ..         ..+.+..+++.+.+++.+||+.+|++||++.++++.|+.+
T Consensus       224 ~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 GY---------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10         0011223456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-43  Score=315.51  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=197.7

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|.+......   .....+.+|+.+++.++||||+++++++.+....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            367999999999999999999986 6889999987654322   122345689999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+ .++|.+++....    ..++...+..++.|++.||.|||+++   |+||||||+||++++++.+||+|||++..
T Consensus        81 v~e~~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          81 VFEYV-HTDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             EEECC-CcCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCccee
Confidence            99999 478888886532    24788889999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc--
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR--  305 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  305 (360)
                      ..... .......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+..+...    .............  
T Consensus       153 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~  227 (303)
T cd07869         153 KSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD----QLERIFLVLGTPNED  227 (303)
T ss_pred             ccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhCCCChh
Confidence            43222 12233467899999998865 4578899999999999999999999975432110    0000000000000  


Q ss_pred             -cc------cc--------cchHHhhh-ccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 -LY------HI--------LDDQVMKL-GKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 -~~------~~--------~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       +.      ..        ........ .....+.++.+|+.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00      00        00000000 00112357889999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.4e-43  Score=317.57  Aligned_cols=258  Identities=23%  Similarity=0.431  Sum_probs=202.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .+|++.+.||+|+||.||+|.+. ++.    .+|+|.++.....   ...+++.+|+.+++.++||||+++++++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            56899999999999999999864 333    3899987643222   2345678899999999999999999998764 5


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++++|+++|+|.+++....    ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccc
Confidence            689999999999999997642    24788889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+...        .. +......
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~-~~~~~~~  226 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SE-ISSILEK  226 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHHHhC
Confidence            98765433222 122234678999999999999999999999999999998 9999864321        00 1111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..         ....+..++.++.+++.+||+.+|++|||+.+++..|..+.++
T Consensus       227 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         227 GE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            10         0111223345789999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.5e-44  Score=302.34  Aligned_cols=267  Identities=23%  Similarity=0.303  Sum_probs=206.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCC-ceeeeeEEeeCC----
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN-VVKLLGCCLETE----  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~n-iv~~~~~~~~~~----  144 (360)
                      ..|..+++||+|+||+||+|..+ +|+.||+|+++.....+  ..-....+|+.+++.++|+| |+++++++.+..    
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E--G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE--GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc--CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            45677788999999999999976 68899999988765531  12234568999999999999 999999998877    


Q ss_pred             --cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          145 --FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       145 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                        ..++|+||+ ..+|..++....... ..++...+..++.|++.||+|||+++   |+||||||+||||+++|.+||+|
T Consensus        89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   89 IGKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             cceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeec
Confidence              789999999 679999998765322 34667889999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||+|...+-+... .+..++|.+|+|||++.+. .|+...||||+|||+.||++++..|.+..+.     .+...+...+
T Consensus       164 FGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-----~ql~~If~~l  237 (323)
T KOG0594|consen  164 FGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-----DQLFRIFRLL  237 (323)
T ss_pred             cchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-----HHHHHHHHHc
Confidence            9999866543322 3445789999999999886 7899999999999999999999999877642     1222222222


Q ss_pred             hcc---ccccccch-----HHhhhc-cH-------HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          302 RKN---RLYHILDD-----QVMKLG-KK-------NQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       302 ~~~---~~~~~~~~-----~~~~~~-~~-------~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                      ..+   .|.....-     .+.... +.       ...++..+++.+||+.+|.+|.|+...++.
T Consensus       238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            222   11111100     000000 11       112478899999999999999999998864

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-43  Score=308.50  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .+|.+.+.||+|+||.||.+...++..+|+|.+.....     ..+.+.+|+.++..++||||+++++++...+..+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            45788899999999999999887777799998764322     2345778999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+.+++|.+++.....    .+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||.+....
T Consensus        79 e~~~~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          79 EYMSNGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             EcCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecC
Confidence            99999999999975321    5889999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++ |..||......        . ..........   
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~-~~~~~~~~~~---  219 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------E-TVEKVSQGLR---  219 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------H-HHHHHhcCCC---
Confidence            433222222345678999999998889999999999999999999 99998543210        0 1111111110   


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                            ...+...++.+.+++.+||+.||++|||+.++++.|+
T Consensus       220 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                  0111223567999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7e-44  Score=310.89  Aligned_cols=256  Identities=26%  Similarity=0.412  Sum_probs=208.0

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..+|++.+.||.|+||.||+|...++..+++|.+.....    .....+.+|+.+++.++||||+++++++......+++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch----hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            456888999999999999999998889999998765432    2344677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....   ...+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.+||+|||.+...
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          81 TELMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             EeecccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence            99999999999997532   235789999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ...... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....        ...+. ....     
T Consensus       155 ~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~-~~~~-----  219 (261)
T cd05148         155 KEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYD-QITA-----  219 (261)
T ss_pred             CCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHH-HHHh-----
Confidence            432211 223345778999999998889999999999999999998 8999854321        00011 1111     


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                          ......+...++++.+++.+||+.||++|||+.++++.|+++
T Consensus       220 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 ----GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                111122344556899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.7e-43  Score=311.65  Aligned_cols=262  Identities=27%  Similarity=0.434  Sum_probs=207.8

Q ss_pred             cCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .+|.+.+.||+|+||.||++...      ++..+++|.+.....    ...+.+.+|+.++.+++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD----NARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            56888999999999999999752      245688888764321    23456788999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhcc--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQ--------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY  216 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~  216 (360)
                      ..+++|||+++++|.+++.....        .....+++..++.++.|++.||+|||+++   ++||||||+||++++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            99999999999999999975432        12235899999999999999999999999   99999999999999999


Q ss_pred             cEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchH
Q 040763          217 RAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       217 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~  294 (360)
                      .++|+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......        
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------  229 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------  229 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            9999999998765432221 1223345778999999998889999999999999999998 89998544310        


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                       ........+...         ..+...+.++.+++.+||+.||.+|||+.++.+.|+.+.+.
T Consensus       230 -~~~~~i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         230 -EVIECITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence             011111111111         11223455799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.1e-44  Score=322.14  Aligned_cols=248  Identities=24%  Similarity=0.321  Sum_probs=200.1

Q ss_pred             hcCCCccceecccCcEEEEEEEecC--CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||+|..++  +..+|+|.+...... .....+.+.+|+.++..++||||+++++++.+....+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3569999999999999999998653  358999987543211 1123456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++|||+++|+|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++.
T Consensus       108 lv~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            9999999999999997543     5888999999999999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||++|..||.+....        . ....+....  
T Consensus       180 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~-~~~~i~~~~--  244 (340)
T PTZ00426        180 VVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------L-IYQKILEGI--  244 (340)
T ss_pred             ecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------H-HHHHHhcCC--
Confidence            65432    22346899999999999988999999999999999999999999654310        0 011111111  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                              ...+...++.+.+++.+||+.||++|+     |++++++
T Consensus       245 --------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        245 --------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                    011233455788999999999999995     7888764

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-46  Score=307.37  Aligned_cols=246  Identities=26%  Similarity=0.387  Sum_probs=210.4

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |.++++||+|+||.||++.++ +|+.+|||.+...      ..++++.+|+.++.+.+.|++|++||.+.....+++|||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            667889999999999999876 6999999988764      346788899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      ||.-|+..+.++.++.    ++.+..+..++++.+.||+|||...   =+|||||+.|||++.+|++||+|||.+-.+..
T Consensus       109 YCGAGSiSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             hcCCCcHHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            9999999999987543    7999999999999999999999987   78999999999999999999999999976543


Q ss_pred             CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                       .....++..||+.|||||++..-.|+.++||||||++..||..|++||.+.-.  ..               .+.-+..
T Consensus       182 -TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP--MR---------------AIFMIPT  243 (502)
T KOG0574|consen  182 -TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP--MR---------------AIFMIPT  243 (502)
T ss_pred             -hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc--cc---------------eeEeccC
Confidence             34445667899999999999999999999999999999999999999976431  00               0111111


Q ss_pred             -hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          312 -DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       312 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       ++..-..|+.++.+|.+++.+||.++|++|-|+.++++
T Consensus       244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence             11112247789999999999999999999999999875

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-44  Score=302.12  Aligned_cols=265  Identities=25%  Similarity=0.352  Sum_probs=204.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee----
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE----  142 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----  142 (360)
                      .....|...+.||+|+||.|+.+.++ +|..||||++.......  ...++..+|+.+++.++|+||+.+.+.+..    
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~--~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ--IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch--HHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            34456766789999999999999876 68999999988554443  345677899999999999999999999865    


Q ss_pred             -CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          143 -TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       143 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                       -...|+|+|+| +.+|...++...     .++......++.|++.||.|+|+.+   ++||||||.|++++.+..+||+
T Consensus        97 ~f~DvYiV~elM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEec
Confidence             34679999999 678988887643     4888889999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCC-CceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          222 DFGTSKFIAMD-QTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       222 Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |||+|+..... .....+..+.|.+|.|||.+.. ..|+.+.||||.|||+.||++|++-|.+.....+-     ..+..
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql-----~lI~~  242 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL-----QLILE  242 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH-----HHHHH
Confidence            99999877542 1223466778999999996654 68999999999999999999999998765432221     11111


Q ss_pred             Hhhcc---ccccccc---------------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRKN---RLYHILD---------------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~~---~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....+   .+..+..               ..+... -++..+...+|+.+||.+||.+|+|++|.++
T Consensus       243 ~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~-fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  243 LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSI-FPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             hcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHH-cCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11111   0111110               011111 1245667899999999999999999999874

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-42  Score=313.31  Aligned_cols=200  Identities=30%  Similarity=0.446  Sum_probs=173.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.++ ++..+|+|.+......   ...+.+.+|+.++..++||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH---HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            367999999999999999999987 5778899987654332   234567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +|||+++++|.+++....     .+++..+..++.|++.||.|||+. +   ++|+||||+||++++++.+||+|||++.
T Consensus        81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~  152 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (333)
T ss_pred             EEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcch
Confidence            999999999999996532     478888999999999999999974 6   9999999999999999999999999986


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST  283 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~  283 (360)
                      .....   ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       153 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         153 QLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            54322   122346899999999999888999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=324.17  Aligned_cols=264  Identities=26%  Similarity=0.431  Sum_probs=230.5

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee
Q 040763           64 KELDKATNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE  142 (360)
Q Consensus        64 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~  142 (360)
                      ++.+-...+..+..+||-|.||.||.|.++. ...||||.++.+     ....++|+.|..+|+.++|||+|+++|+|..
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            3444444567788899999999999999874 667999987753     2567899999999999999999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                      ....|||+|||..|+|.+||++....   .++....++++.||..|+.||..++   +|||||..+|+|+.++..+|++|
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvAD  408 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVAD  408 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeec
Confidence            99999999999999999999885432   4677788999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||+++++..+.........-+..|.|||.+..+.++.|+|||+|||+|||+.| |..||.+..        +        
T Consensus       409 FGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------l--------  472 (1157)
T KOG4278|consen  409 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------L--------  472 (1157)
T ss_pred             cchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------H--------
Confidence            99999988877666666666889999999999999999999999999999999 999987653        1        


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                        ..+.++++...+...++.|++..++|+..||+++|.+||++.|+-+.++.+-.
T Consensus       473 --SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  473 --SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             --HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence              22345666777777889999999999999999999999999999999988754

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-43  Score=306.91  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=201.1

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .+|++.+.||+|+||.||++.++++..+++|.+......     ...+.+|+.+++.++||||+++++++...+..+++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC-----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            357888999999999999999887778999987643221     235678999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++..+.    ..+++..++.++.|++.|++|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        79 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          79 EYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             ecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence            9999999999997532    25889999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||......        .. .......     
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~-~~~~~~~-----  217 (256)
T cd05059         152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EV-VESVSAG-----  217 (256)
T ss_pred             cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HH-HHHHHcC-----
Confidence            322221222234567999999999899999999999999999999 88898643210        00 1111111     


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                          .....+...+.++.+++.+||+.+|++|||+.++++.|
T Consensus       218 ----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 ----YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                01112233566899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=316.39  Aligned_cols=240  Identities=26%  Similarity=0.300  Sum_probs=192.5

Q ss_pred             ecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCC
Q 040763           79 LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        79 lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  157 (360)
                      ||+|+||.||++... +++.+|+|.+...... .......+.+|+.++..++||||+++++++...+..++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            699999999999976 5788999987643211 12334567789999999999999999999999999999999999999


Q ss_pred             hhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceee
Q 040763          158 LYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT  237 (360)
Q Consensus       158 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  237 (360)
                      |.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....... ...
T Consensus        80 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  150 (312)
T cd05585          80 LFHHLQREG-----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKT  150 (312)
T ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccc
Confidence            999996532     5788999999999999999999999   9999999999999999999999999987543222 223


Q ss_pred             ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhh
Q 040763          238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL  317 (360)
Q Consensus       238 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (360)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...        ...+......           ...
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~-----------~~~  211 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQE-----------PLR  211 (312)
T ss_pred             ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcC-----------CCC
Confidence            345689999999999999999999999999999999999999965321        1111111111           011


Q ss_pred             ccHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 040763          318 GKKNQIVAFANLAERCLDLNGKKRPTMEEV  347 (360)
Q Consensus       318 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei  347 (360)
                      .+...++++.+++.+||+.||++||++..+
T Consensus       212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             CCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence            233456689999999999999999864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-43  Score=312.69  Aligned_cols=263  Identities=24%  Similarity=0.338  Sum_probs=193.8

Q ss_pred             cCCCccceecccCcEEEEEEEec--CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc---CCCCceeeeeEEe----
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI---NHRNVVKLLGCCL----  141 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l---~h~niv~~~~~~~----  141 (360)
                      ++|++.+.||+|+||.||++.+.  +++.+|+|.++.......  ....+.+|+.++..+   +||||+++++++.    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--chHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            36899999999999999999873  467899998765433221  122344566666655   6999999999885    


Q ss_pred             -eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          142 -ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       142 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                       .....+++|||+. ++|.+++....   ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEE
Confidence             2446789999995 69999986532   225789999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      +|||++......  .......||+.|+|||.+.+..++.++|||||||++|||++|..||.+......     .......
T Consensus       152 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-----~~~i~~~  224 (290)
T cd07862         152 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-----LGKILDV  224 (290)
T ss_pred             ccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHHHH
Confidence            999999765432  223344689999999999988999999999999999999999999976442111     0111111


Q ss_pred             hhcc---cccc---ccch-------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          301 MRKN---RLYH---ILDD-------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       301 ~~~~---~~~~---~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....   .+..   ....       .......+..++.+.+++.+||+.||++|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         225 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000   0000   0000       0000111234567889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.4e-43  Score=306.87  Aligned_cols=264  Identities=22%  Similarity=0.361  Sum_probs=209.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||+|..+ +++.+|+|.+...... .......+.+|+.+++.++|||++++++++...+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            47889999999999999999876 6889999976542221 123345678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+++++|.+++..... ....++...+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          81 LELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            999999999998865332 2235788899999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||.......      .. ..........   
T Consensus       157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------~~-~~~~~~~~~~---  225 (267)
T cd08228         157 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------FS-LCQKIEQCDY---  225 (267)
T ss_pred             cchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH------HH-HHHHHhcCCC---
Confidence            43221 1123457889999999998889999999999999999999999986533111      01 1111111110   


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                           ........+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus       226 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 -----PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                 11112345567999999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.8e-43  Score=309.95  Aligned_cols=259  Identities=25%  Similarity=0.440  Sum_probs=204.5

Q ss_pred             cCCCccceecccCcEEEEEEEe-----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ..|++.+.||+|+||.||+|..     .++..+++|.+......   .....+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP---QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH---HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            4578889999999999999974     24578999988753332   344567789999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQN------------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      .+++|||+++++|.+++......            ....+++...+.++.|++.||.|||+++   ++|+||||+||+++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIG  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEc
Confidence            99999999999999998643211            1234788899999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV  291 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~  291 (360)
                      +++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.+...      
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------  232 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------  232 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999976543221 11223345678999999988889999999999999999998 8889865331      


Q ss_pred             chHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                         ............         ...+..+++++.+++.+||+.||++||++.++.+.|.+
T Consensus       233 ---~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 ---QEVIEMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               001111111111         11223345679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.8e-43  Score=309.86  Aligned_cols=261  Identities=27%  Similarity=0.392  Sum_probs=205.4

Q ss_pred             CCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           72 HFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      +|++.+.||+|+||.||+|....      ...+++|.+......   .....+.+|+.++..++||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS---SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH---HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence            47788999999999999998532      246888887654333   234668889999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhcc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQ-------------------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK  206 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  206 (360)
                      .++++||+.+++|.+++.....                   ....++++..++.++.|++.||.|||+.+   ++|||||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dik  154 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLA  154 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhh
Confidence            9999999999999999865321                   11235788999999999999999999999   9999999


Q ss_pred             CCCeEEcCCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 040763          207 STNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG  284 (360)
Q Consensus       207 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~  284 (360)
                      |+||++++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999998765332211 1222345678999999988889999999999999999998 999985432


Q ss_pred             CCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      .         ..........         .....+...+.++.+++.+||+.+|++||++.++++.|+++..
T Consensus       235 ~---------~~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         235 P---------ERLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             H---------HHHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1         0111111111         1111233455689999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6e-43  Score=314.79  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=193.0

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++..+ +++.+|+|.++...... ......+..|+.++.++ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            46999999999999976 57889999887543221 12345567788888776 89999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|..++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....... 
T Consensus        80 ~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-  150 (329)
T cd05618          80 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  150 (329)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence            999998886532     5889999999999999999999999   9999999999999999999999999986532211 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........................         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------  221 (329)
T cd05618         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------  221 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------
Confidence            12233568999999999999999999999999999999999999996433211111111111111111111         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                       ...+...+.++.+++.+||+.||++|||+
T Consensus       222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 -IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             11234456678999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-43  Score=304.01  Aligned_cols=255  Identities=27%  Similarity=0.312  Sum_probs=205.9

Q ss_pred             hcCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|+.++.||+|.-|+||++..++ +..+|+|++....-.. .....+...|-+||..++||.++.+|+.+..+...++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            3567888999999999999999874 5899999977643322 2345567789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +||||+||+|.....+.   .+..+++..++.++.+++-||+|||..|   ||.|||||+||||.++|++.|+||.++..
T Consensus       155 ~meyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             EEecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999998887653   3446899999999999999999999999   99999999999999999999999998744


Q ss_pred             cCCC----------------------------------C---------------------ceeeecccccCCccchhhhc
Q 040763          229 IAMD----------------------------------Q---------------------THVTTKIQGTFGYLDPEYHQ  253 (360)
Q Consensus       229 ~~~~----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~  253 (360)
                      +...                                  .                     ...+...+||..|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            3210                                  0                     01112356999999999999


Q ss_pred             cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHh
Q 040763          254 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERC  333 (360)
Q Consensus       254 ~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  333 (360)
                      +...+.++|.|+||+++|||+.|..||.+.+...-                 +..++...+.-......+..+.+||.+.
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-----------------l~NIv~~~l~Fp~~~~vs~~akDLIr~L  371 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-----------------LRNIVGQPLKFPEEPEVSSAAKDLIRKL  371 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-----------------HHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence            99999999999999999999999999987763111                 1112222222222335667899999999


Q ss_pred             hcCCCCCCCC----HHHHH
Q 040763          334 LDLNGKKRPT----MEEVS  348 (360)
Q Consensus       334 l~~dp~~Rpt----~~ei~  348 (360)
                      |.+||.+|..    +.||.
T Consensus       372 LvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             hccChhhhhccccchHHhh
Confidence            9999999998    66654

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.5e-43  Score=305.63  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=203.8

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+.|++.+.||+|+||.||++..++++.+|+|.+.....     ..+.+.+|+.+++.++|+|++++++++. .+..+++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            467889999999999999999988889999998765332     2346778999999999999999999864 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        79 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          79 TEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             EEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeec
Confidence            99999999999986532   235888999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ............++..|+|||.+....++.++||||||+++|||++ |+.||.+....        . ....+...    
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~-~~~~~~~~----  219 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------E-VIQNLERG----  219 (260)
T ss_pred             CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------H-HHHHHHcC----
Confidence            4322222222345678999999998889999999999999999999 99998643310        0 11111111    


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                           .....+...+.++.+++.+||+.+|++|||++++.+.|+.
T Consensus       220 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 -----YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 0111223345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.3e-43  Score=316.56  Aligned_cols=263  Identities=27%  Similarity=0.400  Sum_probs=204.9

Q ss_pred             cCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLET  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~  143 (360)
                      .+|++.+.||+|+||.||+|...      +++.||+|+++.....   ...+.+.+|+.++.++ +|+||+++++++...
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA---SEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH---HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            57899999999999999999642      2468999988754322   2345677899999999 899999999988654


Q ss_pred             -CcceEEEEecCCCChhHHhhhhccC------------------------------------------------------
Q 040763          144 -EFPLLVYEFIPNGTLYQHLHDRHQN------------------------------------------------------  168 (360)
Q Consensus       144 -~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------  168 (360)
                       ...+++|||+++++|.+++......                                                      
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             5678999999999999998643210                                                      


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCcee-eecccccCC
Q 040763          169 --EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFG  245 (360)
Q Consensus       169 --~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~  245 (360)
                        ...++++..+..++.|++.||+|||+++   |+||||||+||++++++.++|+|||++..+....... .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence              0126789999999999999999999999   9999999999999999999999999998754322211 222345778


Q ss_pred             ccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHH
Q 040763          246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIV  324 (360)
Q Consensus       246 y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (360)
                      |+|||++.+..++.++|||||||++|||++ |..||.+.....        .....+....         ....+...++
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~---------~~~~~~~~~~  303 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--------EFCRRLKEGT---------RMRAPEYATP  303 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--------HHHHHHhccC---------CCCCCccCCH
Confidence            999999999999999999999999999998 999986532110        1111111111         1111234456


Q ss_pred             HHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          325 AFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       325 ~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      ++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            79999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.1e-43  Score=314.46  Aligned_cols=248  Identities=24%  Similarity=0.342  Sum_probs=193.0

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++.++ +++.+|+|.++...... ......+..|..++..+ +||||+++++++.+....++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            36999999999999876 57899999987532221 12345577889999888 79999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....... 
T Consensus        80 ~g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  150 (329)
T cd05588          80 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-  150 (329)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-
Confidence            999998886532     5899999999999999999999999   9999999999999999999999999986422111 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.....................         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------  221 (329)
T cd05588         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---------  221 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---------
Confidence            12234568999999999999999999999999999999999999996433211111111111111111111         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                       ...+...+.++.+++.+||+.||.+|||+
T Consensus       222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         222 -IRIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence             11233445679999999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.3e-43  Score=304.65  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=203.0

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ++|++.+.||+|+||.||+|...++..+++|.+.....     ..+.+.+|+.+++.++||||+++++.+.. ...+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   79 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence            56899999999999999999887777899998875322     23457789999999999999999998754 5679999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....   ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||.+....
T Consensus        80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          80 EYMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             EcCCCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            9999999999997532   225788999999999999999999999   9999999999999999999999999997664


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...........++..|+|||...+..++.++||||||+++|+|++ |..||.+....        . ........     
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~-~~~~~~~~-----  219 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------E-VLDQVERG-----  219 (262)
T ss_pred             ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------H-HHHHHhcC-----
Confidence            433222223346778999999988889999999999999999999 88888543210        0 00111000     


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                          .....+...++.+.+++.+||+.||++|||+.++++.|+..
T Consensus       220 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ----CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                01112334566899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.4e-43  Score=309.33  Aligned_cols=260  Identities=27%  Similarity=0.400  Sum_probs=202.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE  142 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~  142 (360)
                      ..++|++.+.||+|+||.||+|.++      .+..+|+|.+......   ....++.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4567999999999999999998753      2457999987643222   234567889999999999999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNE-----EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR  217 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~  217 (360)
                      ....+++|||+++++|.+++.......     ....++..++.++.|++.||.|||+.+   ++|+||||+||++++++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCC
Confidence            999999999999999999997533211     224678889999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHH
Q 040763          218 AKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       218 ~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~  295 (360)
                      ++|+|||++.......... .....+++.|+|||.+.++.++.++||||||+++|||++ |..||.+...  .       
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~-------  228 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--E-------  228 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H-------
Confidence            9999999987554322211 112245778999999999889999999999999999999 7888854321  0       


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ............         ..+...+.++.+++.+||+.||++|||+.|+++.|+
T Consensus       229 ~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         229 QVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            011111111111         112234557999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.8e-43  Score=314.77  Aligned_cols=244  Identities=25%  Similarity=0.313  Sum_probs=196.0

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPN  155 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  155 (360)
                      +.||+|+||.||++... +++.+|+|++....... ......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA-KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999876 68899999876532211 12345677899999999999999999999999999999999999


Q ss_pred             CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCce
Q 040763          156 GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH  235 (360)
Q Consensus       156 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  235 (360)
                      ++|..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....... .
T Consensus        80 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~  150 (328)
T cd05593          80 GELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-A  150 (328)
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-c
Confidence            99998886532     5889999999999999999999999   9999999999999999999999999987532221 1


Q ss_pred             eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHh
Q 040763          236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM  315 (360)
Q Consensus       236 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (360)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......        .. .......          .
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~-~~~~~~~----------~  211 (328)
T cd05593         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KL-FELILME----------D  211 (328)
T ss_pred             ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HH-HHHhccC----------C
Confidence            223356899999999999989999999999999999999999999653210        00 0111000          0


Q ss_pred             hhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          316 KLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       316 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                      ...+...++++.+++.+||+.||++||     ++.++++
T Consensus       212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            112334566799999999999999997     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-43  Score=316.88  Aligned_cols=261  Identities=25%  Similarity=0.353  Sum_probs=194.8

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC-----c
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE-----F  145 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~  145 (360)
                      +|++.+.||+|+||.||+|... +++.||+|.+.......  .....+.+|+.+++.++||||+++++++....     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV--SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc--hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            4788999999999999999876 68899999876432221  23346788999999999999999999875432     4


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+ +++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+
T Consensus        79 ~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          79 IYVVFELM-ESDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             EEEEEecC-CCCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcc
Confidence            69999999 578998886532     4889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCc--eeeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          226 SKFIAMDQT--HVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       226 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      +........  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+......     ........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-----~~~~~~~~  224 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-----LDLITDLL  224 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-----HHHHHHHh
Confidence            975432221  11234568999999999876  6788999999999999999999999965432100     00000000


Q ss_pred             h-----------ccccccccc-------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 R-----------KNRLYHILD-------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~-----------~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .           .........       ..... ..+..++++.+++.+||+.||++|||+.++++
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQ-KFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHH-hcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0           000000000       00000 01123457889999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-43  Score=332.47  Aligned_cols=260  Identities=27%  Similarity=0.329  Sum_probs=205.8

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           66 LDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        66 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .....++|.+.+.||+|+||+||++... +++.||+|.+.......  .....+.+|+..+..++|+|++++++.+...+
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE--ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH--HHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            3445579999999999999999999865 68899999976543322  33456778999999999999999988765432


Q ss_pred             --------cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC
Q 040763          145 --------FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY  216 (360)
Q Consensus       145 --------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~  216 (360)
                              ..++||||+++|+|.+++..+.. ...++++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG  180 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence                    25799999999999999976432 2336889999999999999999999999   99999999999999999


Q ss_pred             cEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          217 RAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       217 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      .+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+...        ..
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~  252 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------EE  252 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HH
Confidence            999999999876543221 122345699999999999999999999999999999999999999964321        11


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .. .......         ....+...++++.+++.+||+.||++|||+.++++
T Consensus       253 ~~-~~~~~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        253 VM-HKTLAGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HH-HHHhcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            11 1111111         11123445678999999999999999999999875

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.2e-43  Score=304.38  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=202.6

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ++|++.+.||+|++|.||++..+++..+++|.+......     .+.+.+|+.+++.++|+|++++++++. ....+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC-----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            568899999999999999999888888999987753322     245778999999999999999999875 45679999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          80 EYMSKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            9999999999986532   235789999999999999999999999   9999999999999999999999999997654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+...     ..    ....+...     
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~----~~~~~~~~-----  219 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----RE----VLEQVERG-----  219 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HH----HHHHHHcC-----
Confidence            332222222335678999999988889999999999999999999 8889854321     00    11111111     


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                          .....+...+.++.+++.+||+.+|++|||+.++.+.|+.
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 ----YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                1112233456689999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-43  Score=316.80  Aligned_cols=245  Identities=27%  Similarity=0.338  Sum_probs=194.8

Q ss_pred             ceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEe
Q 040763           77 RILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      +.||+|+||.||++...    +++.+|+|.++.............+..|+.+++.++||||+++++++..++..|++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999753    57889999876532222223344567899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCC
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD  232 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  232 (360)
                      +++++|.+++....     .+.+..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            99999999986533     4778888889999999999999999   999999999999999999999999998643222


Q ss_pred             CceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccch
Q 040763          233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD  312 (360)
Q Consensus       233 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (360)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....        .... .......       
T Consensus       154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~-~~~~~~~-------  216 (323)
T cd05584         154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTI-DKILKGK-------  216 (323)
T ss_pred             C-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHH-HHHHcCC-------
Confidence            1 122335689999999999998899999999999999999999999965431        0111 1111110       


Q ss_pred             HHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          313 QVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       313 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                         ...+...++++.+++.+||+.||++||     ++.++++
T Consensus       217 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 ---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               112233456789999999999999999     7777754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-43  Score=323.02  Aligned_cols=255  Identities=24%  Similarity=0.298  Sum_probs=200.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..+|++.+.||+|+||.||++..+ ++..+|+|.+...... .......+.+|+.+++.++||||+++++++.+....++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            467999999999999999999876 5789999987642111 11223456789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++...      .++...+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            99999999999998642      3778888889999999999999999   99999999999999999999999999976


Q ss_pred             cCCCCceeeecccccCCccchhhhccC----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      .............||+.|+|||++.+.    .++.++|||||||++|||++|..||.+...        ...+.......
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~  263 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHK  263 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCC
Confidence            543332223345799999999988653    378899999999999999999999965431        11111111110


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKK--RPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ei~~  349 (360)
                      ...       ..+.....+.++.+++.+||+.+|++  |||+.++++
T Consensus       264 ~~~-------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         264 NSL-------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CcC-------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            000       00111234668999999999999988  999999964

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.6e-43  Score=306.99  Aligned_cols=258  Identities=22%  Similarity=0.381  Sum_probs=200.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .+|++.+.||+|+||.||+|... +++    .+++|........   ....++..|+..+..++||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR---QTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch---HHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence            46788899999999999999874 344    4777776532221   234566778888899999999999998754 45


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++++||+++|+|.+++....    ..+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||+
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~  155 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGV  155 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcc
Confidence            689999999999999997532    25889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +......... ......++..|+|||.+.++.++.++||||||+++|||++ |..||.+...  .       ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~-------~~~~~~~~  226 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--H-------EVPDLLEK  226 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--H-------HHHHHHHC
Confidence            9765433221 2233456778999999998899999999999999999998 9999865321  0       01111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ....         ..+..++.++.+++.+||..||++|||+.|+++.|..+.++
T Consensus       227 ~~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         227 GERL---------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            1110         11112344688999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-44  Score=323.31  Aligned_cols=254  Identities=26%  Similarity=0.314  Sum_probs=202.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|.+.+.||+|+||+||++... +++.+|+|++...... .......+..|+.++..++||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence            46889999999999999999976 6889999987653211 112345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        80 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          80 MEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             EcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            9999999999999764     25889999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCC----------------------------ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 040763          230 AMDQ----------------------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF  281 (360)
Q Consensus       230 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~  281 (360)
                      ....                            ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence            4432                            111233468999999999999999999999999999999999999996


Q ss_pred             CCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 040763          282 STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-MEEVSM  349 (360)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ei~~  349 (360)
                      .....        ..........       ...........++++.+++.+||+ ||.+||+ +.++++
T Consensus       232 ~~~~~--------~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         232 SDTLQ--------ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCCHH--------HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            54310        0111111100       000000111146689999999998 9999999 999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.2e-43  Score=316.96  Aligned_cols=244  Identities=26%  Similarity=0.317  Sum_probs=195.3

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPN  155 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  155 (360)
                      +.||+|+||.||++... ++..||+|.++...... ......+.+|+.++..++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999875 68899999876532211 12345667899999999999999999999999999999999999


Q ss_pred             CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCce
Q 040763          156 GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH  235 (360)
Q Consensus       156 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  235 (360)
                      ++|..++....     .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++....... .
T Consensus        80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~  150 (323)
T cd05595          80 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A  150 (323)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-C
Confidence            99998886532     5889999999999999999999999   9999999999999999999999999986532221 1


Q ss_pred             eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHh
Q 040763          236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM  315 (360)
Q Consensus       236 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (360)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......        ... .......          
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~-~~~~~~~----------  211 (323)
T cd05595         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLF-ELILMEE----------  211 (323)
T ss_pred             ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHH-HHHhcCC----------
Confidence            123346899999999999999999999999999999999999999653210        000 0110000          


Q ss_pred             hhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          316 KLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       316 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                      ...+...++++.+++.+||+.||++||     ++.++++
T Consensus       212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            012334566899999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.9e-43  Score=308.79  Aligned_cols=262  Identities=25%  Similarity=0.406  Sum_probs=208.3

Q ss_pred             cCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .+|.+.+.||+|+||.||++...      ++..+++|.+.....    ...+.+.+|+.+++.++|+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL----AARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH----HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            45788899999999999999753      245688888764322    23456778999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQ-----------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      ..+++|||+++++|.+++.....           .....+++..++.++.|++.||+|||+++   ++||||||+||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence            99999999999999999976432           11234789999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV  291 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~  291 (360)
                      .++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......     
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----  232 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-----  232 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence            9999999999999765433221 1223446788999999999899999999999999999999 99998654311     


Q ss_pred             chHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                          ............         ..+...+.++.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus       233 ----~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         233 ----EVIECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ----HHHHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                011111111111         11223456799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=318.57  Aligned_cols=255  Identities=29%  Similarity=0.467  Sum_probs=221.4

Q ss_pred             CCccceecccCcEEEEEEEecC---Cc--EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           73 FNVNRILGQGGQGTVYKGRLED---GR--IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~~---~~--~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ....++||.|.||.||.|.+.+   |.  .||||.++.....   ...+.|+.|..+|++++||||++++|+|.+. ..+
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~---d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP---DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh---hhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            3556789999999999997643   33  5899988876554   3477899999999999999999999999875 569


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +|||.++-|.|..||..+.    ..++..+...++.|++.||+|||++.   +|||||..+|||+.....+||+|||+++
T Consensus       467 ivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             EEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence            9999999999999998743    25888889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .+..+..+..+...-+..|||||.+.-..++.++|||.||+.+||+++ |..||++...                  ...
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN------------------sDV  601 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN------------------SDV  601 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc------------------cce
Confidence            988877666666667889999999999999999999999999999988 9999976542                  233


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      ...++.+-+.++|+++++.++.|+.+||..+|.+||++.++...|+.+..
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            34455666777899999999999999999999999999999999988765

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.6e-43  Score=330.05  Aligned_cols=253  Identities=23%  Similarity=0.290  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-C-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-D-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..|.+.+.||+|++|.||++... + +..+++|.+.....    .....+.+|+.++..++||||+++++++...+..++
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~----~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE----RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            34899999999999999999765 3 56788887644321    233456789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++..... ...++++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       143 v~E~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEECCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence            9999999999998865422 2336888999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..... ....... 
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~-~~~~~~~-  288 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQ-QVLYGKY-  288 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH-HHHhCCC-
Confidence            543322 123345699999999999999999999999999999999999999964321        01111 1111110 


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                              ...+...+.++.+++.+||+.||++|||+.+++.
T Consensus       289 --------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 --------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                    0122345568999999999999999999999864

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.1e-43  Score=307.39  Aligned_cols=265  Identities=22%  Similarity=0.383  Sum_probs=209.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEecC-----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee-
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE-  142 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-  142 (360)
                      ..++|++.+.||+|+||.||+|.+.+     +..+++|.+......   ...+.+.+|+.+++.++|||++++++++.. 
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE---IQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            34678999999999999999999765     678999987643322   345667889999999999999999998765 


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEE
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAK  219 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~k  219 (360)
                      ....+++++|+++++|.+++......   ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEE
Confidence            56789999999999999999764321   1246889999999999999999999999   99999999999999999999


Q ss_pred             EeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHH
Q 040763          220 VADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      |+|||+++......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.....  .      . .
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~------~-~  228 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--F------E-M  228 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--H------H-H
Confidence            99999997654332221 122345778999999998889999999999999999999 9999864321  0      0 1


Q ss_pred             HHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ........         ....+..+++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       229 ~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         229 AAYLKDGY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHHcCC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            11111110         0011122355799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.3e-43  Score=310.59  Aligned_cols=265  Identities=26%  Similarity=0.381  Sum_probs=208.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeE
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGC  139 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~  139 (360)
                      ....++|++.+.||+|+||.||++....      ...+++|.+......   .....+.+|+.++..+ +|+||++++++
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH---HHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            3344678899999999999999998642      357899987754332   2345678899999999 89999999999


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQ-----------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKST  208 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~  208 (360)
                      +...+..+++|||+++++|.+++..+..           .....+++..++.++.|++.||.|||+++   ++||||||+
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~  161 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAAR  161 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cccccccee
Confidence            9999999999999999999999975421           22346889999999999999999999999   999999999


Q ss_pred             CeEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCC
Q 040763          209 NILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT  286 (360)
Q Consensus       209 Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~  286 (360)
                      ||++++++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... 
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-  240 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-  240 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-
Confidence            9999999999999999997654332211 222235678999999998899999999999999999998 8899854321 


Q ss_pred             cccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                             ... ........         ....+...+.++.+|+.+||+.||++|||+.++++.|+++.
T Consensus       241 -------~~~-~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 -------EEL-FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -------HHH-HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                   011 11111111         11122334567999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.8e-43  Score=308.36  Aligned_cols=268  Identities=28%  Similarity=0.377  Sum_probs=202.1

Q ss_pred             CCccceecccCcEEEEEEEe-----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--Cc
Q 040763           73 FNVNRILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EF  145 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~  145 (360)
                      |+..+.||+|+||+||++..     .++..+|+|.++.....   .....+.+|+.+++.++||||+++++++...  ..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ---QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            48889999999999988653     35778999988754322   2345677899999999999999999987653  35


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+++++|.+++...      .+++..++.++.|++.||.|||+++   ++|+||||+||++++++.++|+|||+
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccc
Confidence            78999999999999998642      4889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +..........  .....++..|+|||.+.+..++.++||||||+++|||++|..||........+....   .......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~  230 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP---KQGQMTV  230 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc---cccccch
Confidence            87654322111  112235667999999988889999999999999999999999985433211100000   0000000


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      ..+....+.......+...+.++.+++.+||+.+|++|||++++++.|+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0111111111112223445678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-42  Score=301.16  Aligned_cols=248  Identities=28%  Similarity=0.428  Sum_probs=198.0

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCC
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNG  156 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  156 (360)
                      +.||+|+||.||+|...++..+|+|.+......   .....+.+|+.++..++||||+++++++......+++|||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ---ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCH---HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            368999999999999888889999987764433   23346778999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCcee
Q 040763          157 TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV  236 (360)
Q Consensus       157 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  236 (360)
                      +|.+++....    ..+++..+..++.|++.||.|+|+++   ++|+||+|+||+++.++.+||+|||++..........
T Consensus        78 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (250)
T cd05085          78 DFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS  150 (250)
T ss_pred             cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc
Confidence            9999986532    24789999999999999999999999   9999999999999999999999999986543222111


Q ss_pred             eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHh
Q 040763          237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM  315 (360)
Q Consensus       237 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (360)
                      .....++..|+|||++.++.++.++||||||+++|++++ |..||......        . .........         .
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~-~~~~~~~~~---------~  212 (250)
T cd05085         151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------Q-AREQVEKGY---------R  212 (250)
T ss_pred             CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------H-HHHHHHcCC---------C
Confidence            112234667999999998889999999999999999998 99998643210        0 011111110         1


Q ss_pred             hhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          316 KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       316 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ...+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1112234568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-42  Score=302.38  Aligned_cols=263  Identities=24%  Similarity=0.402  Sum_probs=210.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|++|.||+|... +++.+++|.++...... ....+.+.+|+.++++++|+|++++++.+...+..+++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            57889999999999999999987 78899999876422221 23355678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++.... .....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          81 LELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeec
Confidence            99999999999986532 22335889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......      ... .........    
T Consensus       157 ~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~----  224 (267)
T cd08224         157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYS-LCKKIEKCD----  224 (267)
T ss_pred             cCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHH-HHhhhhcCC----
Confidence            432211 22235788999999999888999999999999999999999998643311      000 011111111    


Q ss_pred             cchHHhhhcc-HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          310 LDDQVMKLGK-KNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       310 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                           ....+ ...+..+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus       225 -----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 -----YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 11112 245668999999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-42  Score=304.14  Aligned_cols=259  Identities=29%  Similarity=0.458  Sum_probs=199.1

Q ss_pred             CCccceecccCcEEEEEEEecCCc---EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC------
Q 040763           73 FNVNRILGQGGQGTVYKGRLEDGR---IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET------  143 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~~~~---~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~------  143 (360)
                      |.+.+.||+|+||.||+|...++.   .+|+|.++......  ...+.+..|+.+++.++|+||+++++.+...      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR--SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            356788999999999999876432   58999877543222  3456778899999999999999999986432      


Q ss_pred             CcceEEEEecCCCChhHHhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRH-QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                      ...+++|||+++++|.+++.... ......+++.....++.|++.||+|||+++   ++||||||+||+++.++.+||+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECC
Confidence            24689999999999999885332 122335889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceee-ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHH
Q 040763          223 FGTSKFIAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       223 fg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      ||++........... ....+++.|+|||...+..++.++||||||+++|||++ |..||.....  .      . ....
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~------~-~~~~  226 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--S------E-IYDY  226 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--H------H-HHHH
Confidence            999987644322111 12235678999999999999999999999999999999 7888854321  0      0 1111


Q ss_pred             hhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      .......         ..+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       227 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 LRQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111110         11223455789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-44  Score=304.08  Aligned_cols=259  Identities=25%  Similarity=0.343  Sum_probs=197.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC-----
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE-----  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----  144 (360)
                      -.|...+++|.|+||.||.|... +++.+|||+.-....-.        -+|+.+|+.++|||||++.-+|....     
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            34677889999999999999876 46899999876543321        26999999999999999998886432     


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC-CcEEEeec
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-YRAKVADF  223 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Df  223 (360)
                      ...+||||++ .+|.++++.... .+..++...+.-++.|+++||.|||+.+   |+||||||.|+|+|.+ |.+|||||
T Consensus        96 ~lnlVleymP-~tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   96 YLNLVLEYMP-ETLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             HHHHHHHhch-HHHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccC
Confidence            3357999995 699999986422 2335777777889999999999999999   9999999999999976 89999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      |.|+.+...+...  ....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.....+     ...+...+.
T Consensus       171 GSAK~L~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ-----L~eIik~lG  243 (364)
T KOG0658|consen  171 GSAKVLVKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ-----LVEIIKVLG  243 (364)
T ss_pred             CcceeeccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH-----HHHHHHHhC
Confidence            9999987655543  3356889999998887 5789999999999999999999999977543222     122222222


Q ss_pred             cccc---------------ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRL---------------YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .+..               ..+....+........+++..+|+.++|+.+|.+|.|+.|++.
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            2111               1111111111233455678999999999999999999999863

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.8e-43  Score=302.37  Aligned_cols=248  Identities=27%  Similarity=0.403  Sum_probs=195.7

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPN  155 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  155 (360)
                      +.||+|+||.||++... +++.+|+|.+......   .....+.+|+.+++.++||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP---DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            36899999999999875 6888999987643322   2345678999999999999999999999999999999999999


Q ss_pred             CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCce
Q 040763          156 GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH  235 (360)
Q Consensus       156 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  235 (360)
                      ++|.+++....    ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.+||+|||++.........
T Consensus        78 ~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          78 GDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             CcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            99999986532    25789999999999999999999999   999999999999999999999999998754322111


Q ss_pred             ee-ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccccchH
Q 040763          236 VT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQ  313 (360)
Q Consensus       236 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (360)
                      .. .....+..|+|||.+.++.++.++||||||+++|||++ |..||.....         .........         .
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---------~~~~~~~~~---------~  212 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---------QQTREAIEQ---------G  212 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---------HHHHHHHHc---------C
Confidence            11 11123457999999999889999999999999999998 8888753221         000111111         0


Q ss_pred             HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          314 VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       314 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      .....+...+..+.+++.+||+.+|++|||+.++.+.|.
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         213 VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            111223344568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.7e-43  Score=319.30  Aligned_cols=254  Identities=24%  Similarity=0.293  Sum_probs=195.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||++... +++.+|+|++...... .......+..|+.++..++|+||+++++.+.+....++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence            36889999999999999999876 5789999987643211 123345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        80 ~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          80 MEFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             EcCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            99999999999997532     5889999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCc----------------------------------eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh
Q 040763          230 AMDQT----------------------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT  275 (360)
Q Consensus       230 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t  275 (360)
                      .....                                  ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence            32110                                  00123469999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCC---CCCCHHHHHH
Q 040763          276 GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGK---KRPTMEEVSM  349 (360)
Q Consensus       276 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~---~Rpt~~ei~~  349 (360)
                      |+.||.+...        ...+.........  .     ........++++.+++.+++. +|.   .||++.|+++
T Consensus       232 G~~Pf~~~~~--------~~~~~~i~~~~~~--~-----~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~  292 (363)
T cd05628         232 GYPPFCSETP--------QETYKKVMNWKET--L-----IFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCCCCCCCCH--------HHHHHHHHcCcCc--c-----cCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence            9999965431        0111111100000  0     000011245578888888665 444   4689999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.7e-43  Score=316.07  Aligned_cols=255  Identities=25%  Similarity=0.307  Sum_probs=202.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|.+.+.||+|+||.||++... +++.+|+|.++..... .....+.+.+|+.++..++|+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            46889999999999999999876 6889999988754221 112345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....    ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        80 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          80 MEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             ECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            99999999999997642    25889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhc------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQ------SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ............||+.|+|||++.      ...++.++|||||||++|||++|..||.....        ...+......
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~  224 (330)
T cd05601         153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNF  224 (330)
T ss_pred             CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcC
Confidence            544333333446899999999887      45678899999999999999999999965331        0111111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......       +.....+.++.+|+..||+ +|.+|||+.++++
T Consensus       225 ~~~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 QRFLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            111100       1112345679999999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-43  Score=318.79  Aligned_cols=254  Identities=23%  Similarity=0.315  Sum_probs=199.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++... +++.||+|++...... .......+.+|+.++..++||||+++++++.+....++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence            46889999999999999999986 5889999998653211 113345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.++|+|||++...
T Consensus        80 ~E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          80 MEYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             ECCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence            99999999999997532     5889999999999999999999999   999999999999999999999999998654


Q ss_pred             CCCCce-------------------------------------eeecccccCCccchhhhccCCCCCccchhhhHHHHHH
Q 040763          230 AMDQTH-------------------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE  272 (360)
Q Consensus       230 ~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e  272 (360)
                      ......                                     .....+||+.|+|||++.+..++.++|||||||++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence            321100                                     0112358999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 040763          273 LLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT---MEEVSM  349 (360)
Q Consensus       273 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~ei~~  349 (360)
                      |++|..||......        .............       ........++++.+++.+|+. +|.+|++   +.++++
T Consensus       232 l~~G~~Pf~~~~~~--------~~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         232 MLVGYPPFCSDNPQ--------ETYRKIINWKETL-------QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hhcCCCCCCCCCHH--------HHHHHHHcCCCcc-------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999999654310        0111111000000       000111345678999999997 9999998   888764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-42  Score=303.69  Aligned_cols=264  Identities=23%  Similarity=0.368  Sum_probs=209.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|++.+.||+|++|.||++... ++..+++|.+...... +.....++.+|+.+++.++||||+++++++...+..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            46888899999999999999864 7889999976643222 223446788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++..... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          81 LELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            999999999999875332 2336889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... ......++..|+|||++.+..++.++|+||||+++|+|++|..||.+......      . .........    
T Consensus       157 ~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~----  224 (267)
T cd08229         157 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------S-LCKKIEQCD----  224 (267)
T ss_pred             ccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH------H-HhhhhhcCC----
Confidence            43322 12234588899999999988899999999999999999999999865331100      0 000000000    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                          .........++++.+++.+||+.||++|||+.+|++.++.+.
T Consensus       225 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         225 ----YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ----CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                011112345668999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.5e-43  Score=320.63  Aligned_cols=255  Identities=24%  Similarity=0.304  Sum_probs=198.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++... +++.+|+|.+...... .......+.+|+.+++.++||||+++++++.+....++
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            467999999999999999999986 5788999987542111 11223456789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++...      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       121 v~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence            99999999999998642      3778888999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhccCC----CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      .............||+.|+|||++.+..    ++.++||||+||++|+|++|..||.+...        ...+.......
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~  263 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHK  263 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence            6443332334457999999999987643    78899999999999999999999965431        11111111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKK--RPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ei~~  349 (360)
                      ....       .+.....+..+.+++.+||+.+|.+  |||+.++++
T Consensus       264 ~~~~-------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         264 NSLN-------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             cccC-------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            0000       0111234567889999999865544  889999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.9e-43  Score=319.30  Aligned_cols=248  Identities=26%  Similarity=0.344  Sum_probs=193.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|+..+.||+|+||.||++.+. +++.||+|.+......   .....+.+|+.+++.++|+||+++++++...+..+++
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED---TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH---HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            45777889999999999999876 6889999987543322   2345678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+..         ...+..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++...
T Consensus       151 ~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~  218 (353)
T PLN00034        151 LEFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL  218 (353)
T ss_pred             EecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceec
Confidence            9999999986532         2456777889999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhcc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      .... .......||..|+|||++..     ...+.++|||||||++|||++|+.||.......     ....... ....
T Consensus       219 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~-~~~~  291 (353)
T PLN00034        219 AQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCA-ICMS  291 (353)
T ss_pred             cccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHH-Hhcc
Confidence            4321 11233468999999998753     223568999999999999999999996322110     1100000 0000


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                               .....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       292 ---------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        292 ---------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     011123345668999999999999999999999975

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.7e-43  Score=306.77  Aligned_cols=250  Identities=22%  Similarity=0.292  Sum_probs=196.2

Q ss_pred             ecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCC
Q 040763           79 LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        79 lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  157 (360)
                      ||+|+||+||++.++ +++.+|+|.+...... .....+.+..|+.+++.++|+||+++.+++......+++|||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            699999999999876 6789999987643221 11234566789999999999999999999999999999999999999


Q ss_pred             hhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceee
Q 040763          158 LYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT  237 (360)
Q Consensus       158 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  237 (360)
                      |.+++..... ....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++........ ..
T Consensus        80 L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~  154 (280)
T cd05608          80 LRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KT  154 (280)
T ss_pred             HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cc
Confidence            9988754321 2336889999999999999999999999   99999999999999999999999999876543222 12


Q ss_pred             ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhh
Q 040763          238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL  317 (360)
Q Consensus       238 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (360)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........    .. ........          ...
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~-~~~~~~~~----------~~~  219 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KE-LKQRILND----------SVT  219 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HH-HHHhhccc----------CCC
Confidence            3346899999999999999999999999999999999999999654321110    00 00000000          011


Q ss_pred             ccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          318 GKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       318 ~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                      .+...++++.+++.+||+.||++||     |++++++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            2334566899999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-42  Score=310.67  Aligned_cols=266  Identities=26%  Similarity=0.370  Sum_probs=208.5

Q ss_pred             hcCCCccceecccCcEEEEEEEec--------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE--------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCC  140 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~  140 (360)
                      ..+|.+.+.||+|+||.||++...        ++..+|+|.+......   .....+..|+.++..+ +||||+++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh---HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            357999999999999999999753        2346999988754322   2345677899999999 799999999999


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN  209 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~N  209 (360)
                      ...+..+++|||+++++|.+++......           ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence            9999999999999999999999765321           1235888999999999999999999999   9999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCc
Q 040763          210 ILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTS  287 (360)
Q Consensus       210 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~  287 (360)
                      |+++.++.+||+|||.+.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....  
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--  248 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  248 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence            999999999999999987654322111 111234568999999998889999999999999999998 8888854321  


Q ss_pred             ccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          288 QENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                            .. .........         ....+...+.++.+++.+||+.+|++|||+.++++.|..+...-+
T Consensus       249 ------~~-~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         249 ------EE-LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             ------HH-HHHHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence                  11 111111111         111233445689999999999999999999999999999876644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.8e-42  Score=349.58  Aligned_cols=263  Identities=27%  Similarity=0.445  Sum_probs=202.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ...+...+.||+|+||.||+|... ++..||+|.+......        ...|++.+++++||||+++++++.+.+..++
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence            355777889999999999999974 7889999987643221        1245788899999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++..        ++|..+..++.|++.|++|||....++++|||+||+||+++.++..++. ||.+..
T Consensus       761 v~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        761 IHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             EEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            9999999999999953        7899999999999999999996543449999999999999999888875 665433


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ....     ....+|+.|+|||++.+..++.++|||||||++|||+||+.||......   ......+............
T Consensus       832 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  903 (968)
T PLN00113        832 LCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV---HGSIVEWARYCYSDCHLDM  903 (968)
T ss_pred             cccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC---CCcHHHHHHHhcCccchhh
Confidence            2211     1235789999999999999999999999999999999999998543211   1122222222222222222


Q ss_pred             ccchHHhh--hccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          309 ILDDQVMK--LGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       309 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      +.++....  ..+.....++.+++.+||+.||++||||.|+++.|+.+.+.
T Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            33332221  23345566889999999999999999999999999988653

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-42  Score=309.57  Aligned_cols=265  Identities=24%  Similarity=0.373  Sum_probs=208.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEec--------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeE
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE--------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGC  139 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~  139 (360)
                      ...+|.+.+.||+|+||.||++...        ++..+++|........   .....+.+|+.++..+ +||||++++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch---HHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3467888999999999999999742        2447899987643322   3345678899999999 89999999999


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKST  208 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~  208 (360)
                      +......+++|||+++++|.+++......           ....+++..+..++.|++.||.|||+++   ++||||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence            99999999999999999999999764321           1235788899999999999999999999   999999999


Q ss_pred             CeEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCC
Q 040763          209 NILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT  286 (360)
Q Consensus       209 Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~  286 (360)
                      ||++++++.+||+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||....  
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--  244 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--  244 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--
Confidence            9999999999999999997664432221 222345678999999998889999999999999999998 788875432  


Q ss_pred             cccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                            .... ........         ....+..++.++.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       245 ------~~~~-~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         245 ------VEEL-FKLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ------HHHH-HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                  1111 11111111         1112234566899999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.4e-43  Score=308.52  Aligned_cols=259  Identities=21%  Similarity=0.344  Sum_probs=203.7

Q ss_pred             cCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      ..|.+.+.||+|+||.||+|...+      +..+|+|.++.....   ...+.+..|+.++..++||||+++++.+....
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG---PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            347778899999999999998642      468999998754332   23456778999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQ-----------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      ..++++||+.+++|.+++.....           .....+++..+..++.|++.||.|||+.+   ++||||||+||+++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence            99999999999999999854221           11235788889999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV  291 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~  291 (360)
                      +++.+||+|||++........ .......+++.|+|||.+.++.++.++||||||+++|||++ |..||.+...      
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------  232 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------  232 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999876543222 11223345778999999988889999999999999999998 8888754321      


Q ss_pred             chHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                        .. ..........         ...+..++..+.+++.+||+.+|++|||+.+|+..|+.
T Consensus       233 --~~-~~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 --QD-VIEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HH-HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              01 1111111111         11234456679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.6e-43  Score=320.08  Aligned_cols=254  Identities=21%  Similarity=0.245  Sum_probs=195.9

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .|+.++.||+|+||+||+|... +++.+|+|++...... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            5888999999999999999875 5789999987653211 1133456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++|+|.+++....     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        81 E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~  152 (381)
T cd05626          81 DYIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR  152 (381)
T ss_pred             ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence            9999999999987533     4788888999999999999999999   9999999999999999999999999975331


Q ss_pred             CCCc----------------------------------------------eeeecccccCCccchhhhccCCCCCccchh
Q 040763          231 MDQT----------------------------------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVY  264 (360)
Q Consensus       231 ~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  264 (360)
                      ....                                              ......+||+.|+|||.+.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (381)
T cd05626         153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW  232 (381)
T ss_pred             cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence            1000                                              001234699999999999998899999999


Q ss_pred             hhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhh--cCCCCCCC
Q 040763          265 SFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCL--DLNGKKRP  342 (360)
Q Consensus       265 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dp~~Rp  342 (360)
                      ||||++|||++|..||........        .........       ..........++++.+|+.+|+  ..+|..||
T Consensus       233 SlG~il~elltG~~Pf~~~~~~~~--------~~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         233 SVGVILFEMLVGQPPFLAPTPTET--------QLKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             ehhhHHHHHHhCCCCCcCCCHHHH--------HHHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            999999999999999965431100        000000000       0001111234567889998854  45566699


Q ss_pred             CHHHHHH
Q 040763          343 TMEEVSM  349 (360)
Q Consensus       343 t~~ei~~  349 (360)
                      |+.++++
T Consensus       298 ~~~~~l~  304 (381)
T cd05626         298 GADDIKA  304 (381)
T ss_pred             CHHHHhc
Confidence            9999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-42  Score=307.83  Aligned_cols=261  Identities=25%  Similarity=0.400  Sum_probs=202.6

Q ss_pred             cCCCccceecccCcEEEEEEEecC-Cc--EEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-GR--IIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      ++|++.+.||+|+||.||+|..++ +.  .+++|.++.....   ...+.+.+|+.++.++ +||||+++++++......
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE---NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH---HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            468899999999999999998753 32  4688876643222   2345678899999999 799999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~  215 (360)
                      ++++||+++++|.+++......           ....+++..++.++.|++.||+|||+.+   ++||||||+||+++++
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~  155 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGEN  155 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCC
Confidence            9999999999999999654311           1125788999999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchH
Q 040763          216 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~  294 (360)
                      +.+||+|||++......  ........+..|+|||++.+..++.++||||||+++|||++ |..||.....        .
T Consensus       156 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~  225 (297)
T cd05089         156 LASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------A  225 (297)
T ss_pred             CeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence            99999999998532211  11111223567999999998889999999999999999998 9999864321        0


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ... ......         .....+..++.++.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       226 ~~~-~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         226 ELY-EKLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HHH-HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            001 111110         01112234556899999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.7e-43  Score=314.56  Aligned_cols=247  Identities=26%  Similarity=0.322  Sum_probs=192.7

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHH---hhcCCCCceeeeeEEeeCCcceE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFIL---SQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~---~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      |++.+.||+|+||.||++.+. +++.+|+|.++...... ....+.+.+|..++   ..++||||+++++++...+..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            667889999999999999876 58899999986532111 12234455555544   56689999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|...+...      .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        80 v~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          80 VMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             EEcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            99999999998887531      5889999999999999999999999   99999999999999999999999999865


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.+....        .. ...+....   
T Consensus       151 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~-~~~i~~~~---  217 (324)
T cd05589         151 GMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EV-FDSIVNDE---  217 (324)
T ss_pred             CCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HH-HHHHHhCC---
Confidence            32221 1223456899999999999999999999999999999999999999654310        00 11111110   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                             ...+...++++.+++.+||+.||++||     ++.++++
T Consensus       218 -------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 -------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                   112334456789999999999999999     4555543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-42  Score=309.39  Aligned_cols=261  Identities=26%  Similarity=0.419  Sum_probs=202.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCc--EEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGR--IIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      ++|++.+.||+|+||.||+|.++ ++.  .+++|..+.....   .....+.+|+.++.++ +||||+++++++...+..
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH---HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            57888999999999999999875 343  4577765542222   3345677899999999 899999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~  215 (360)
                      +++|||+++++|.+++......           ....+++..++.++.|++.||+|||+++   ++||||||+||+++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCC
Confidence            9999999999999999764321           1235789999999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchH
Q 040763          216 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~  294 (360)
                      +.+||+|||++......  .......++..|+|||.+.+..++.++||||||+++|||+| |..||......        
T Consensus       161 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------  230 (303)
T cd05088         161 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------  230 (303)
T ss_pred             CcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------
Confidence            99999999998532211  11111234667999999988889999999999999999998 99998643210        


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ... .......         ....+...++++.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       231 ~~~-~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         231 ELY-EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HHH-HHHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111 1111110         0111223455789999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-42  Score=303.16  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=202.4

Q ss_pred             CCccceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc---
Q 040763           73 FNVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF---  145 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~---  145 (360)
                      |.+.+.||+|+||.||.|....    +..+|+|.++......  .....+.+|+..++.++||||+++++.+.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY--SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            5678899999999999998652    3679999877543321  335678899999999999999999998866554   


Q ss_pred             ---ceEEEEecCCCChhHHhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          146 ---PLLVYEFIPNGTLYQHLHDRHQ-NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       146 ---~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                         .++++||+++++|..++..... .....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEEC
Confidence               7899999999999999865422 22336889999999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHH
Q 040763          222 DFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+...        ... ..
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~-~~  226 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEI-YD  226 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHH-HH
Confidence            999987654332211 111235678999999988889999999999999999999 8888854321        011 11


Q ss_pred             HhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      ......         ....+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       227 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         227 YLRHGN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHcCC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111111         1112334566899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-42  Score=316.96  Aligned_cols=262  Identities=23%  Similarity=0.273  Sum_probs=198.3

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC-----c
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE-----F  145 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~  145 (360)
                      +|++.+.||+|+||.||++.+. +++.||+|.+.......  .....+.+|+.+++.++||||+++++++....     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL--VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch--HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            4788899999999999999875 68899999876533221  23456789999999999999999999998766     7


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .|+++||+. ++|.+.+...     ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccc
Confidence            899999985 6788877542     25889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      +...............++..|+|||.+.+. .++.++||||+||++|||++|+.||.+......     ...+.......
T Consensus       150 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~g~~  224 (372)
T cd07853         150 ARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-----LDLITDLLGTP  224 (372)
T ss_pred             eeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHHHcCCC
Confidence            976543333333344678999999998874 478999999999999999999999965432110     00011000000


Q ss_pred             ccc------------------cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLY------------------HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...                  ...............++++.+|+.+||+.||++|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            000                  000000000112233668899999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-44  Score=285.73  Aligned_cols=251  Identities=28%  Similarity=0.352  Sum_probs=206.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|-||.||.|+.+ ++..+|+|++-... -.......++.+|+++.+.++||||++++++|.+....|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            467899999999999999999976 67789999865432 2222234567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ++||..+|++...|....   ...+++.....++.|+|.|+.|+|.++   ++||||||+|+|++..+.+||+|||-+..
T Consensus       100 ilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             EEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence            999999999999998532   224667777889999999999999999   99999999999999999999999999865


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ..   .......+||..|++||+..+..++..+|+|++|++.||++.|.+||.....        ...+....       
T Consensus       174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~-------  235 (281)
T KOG0580|consen  174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIR-------  235 (281)
T ss_pred             cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHH-------
Confidence            43   3345667999999999999999999999999999999999999999965331        11111111       


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ...-..|...+.+..++|.+|+..+|.+|.+..|+++
T Consensus       236 ----k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  236 ----KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ----HccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                1112234556668999999999999999999999875

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.2e-43  Score=319.72  Aligned_cols=267  Identities=23%  Similarity=0.364  Sum_probs=207.5

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeee
Q 040763           66 LDKATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLG  138 (360)
Q Consensus        66 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~  138 (360)
                      .....++|.+.+.||+|+||.||+|.+.      .+..||+|+++.....   ...+.+.+|+.++..+. ||||+++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS---SEKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh---hHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            3344466888899999999999999853      2457999998764333   22346788999999997 999999999


Q ss_pred             EEeeCCcceEEEEecCCCChhHHhhhhcc---------------------------------------------------
Q 040763          139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQ---------------------------------------------------  167 (360)
Q Consensus       139 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------  167 (360)
                      ++......++||||+++|+|.+++.....                                                   
T Consensus       109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence            99999999999999999999999975421                                                   


Q ss_pred             ------------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 040763          168 ------------------------------------------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDI  205 (360)
Q Consensus       168 ------------------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl  205 (360)
                                                                .....+++..++.++.|++.||+|||+.+   ++||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdl  265 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDL  265 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccC
Confidence                                                      01123677788999999999999999998   999999


Q ss_pred             CCCCeEEcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 040763          206 KSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFST  283 (360)
Q Consensus       206 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~  283 (360)
                      ||+|||+++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999976533221 11222346788999999998889999999999999999998 88898543


Q ss_pred             CCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          284 GNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      ....        ........+         .....+...+.++.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       346 ~~~~--------~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         346 PMNE--------QFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CchH--------HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            2100        011111111         011122334568999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-42  Score=300.98  Aligned_cols=248  Identities=26%  Similarity=0.385  Sum_probs=197.0

Q ss_pred             eecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           78 ILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      .||+|+||.||+|.++   ++..+|+|+++.....  ....+++..|+.++..++||||+++++++. .+..+++|||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc--HHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            5899999999999653   5678999987654332  234567889999999999999999999875 456789999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||.||++++++.+||+|||++........
T Consensus        79 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~  150 (257)
T cd05116          79 LGPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN  150 (257)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence            999999996532     5888999999999999999999999   99999999999999999999999999977654332


Q ss_pred             eee--ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          235 HVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       235 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                      ...  ....++..|+|||.+....++.++|+||||+++|||++ |..||......     .    .........      
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~----~~~~i~~~~------  215 (257)
T cd05116         151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----E----VTQMIESGE------  215 (257)
T ss_pred             eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----H----HHHHHHCCC------
Confidence            211  12234578999999988888999999999999999998 99998653210     0    111111111      


Q ss_pred             hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       312 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                         ....+...++++.+++.+||+.||++|||+.+|.+.|++.
T Consensus       216 ---~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 ---RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence               1122334566899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-43  Score=306.38  Aligned_cols=259  Identities=29%  Similarity=0.389  Sum_probs=204.9

Q ss_pred             hcCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      .++|.+.+.||+|+||.||+|..++      +..+++|........   .....+.+|+.++..++||||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH---HHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            3578899999999999999998652      367999987654322   2345677899999999999999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcE
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNE-----EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA  218 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~  218 (360)
                      ...+++|||+++++|.+++.......     ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCE
Confidence            99999999999999999997643221     224788899999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHH
Q 040763          219 KVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  296 (360)
                      ||+|||++........ .......++..|+|||.+.++.++.++||||||+++||+++ |..||.....  .      . 
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~------~-  229 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--E------E-  229 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--H------H-
Confidence            9999999876543322 12223346788999999988889999999999999999998 8889854321  0      0 


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ..........         ...+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       230 ~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         230 VLKFVIDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111111111         1112234668999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=320.38  Aligned_cols=247  Identities=31%  Similarity=0.467  Sum_probs=204.5

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .|+-++.||.|+||.||.+++. +.+.||||++..... ........+++|+..++++.|||++.+.|||......|+||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            3666788999999999999875 678999999776433 23456778999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||| -||-.+.+.-...    ++.+..+..|+.+.++||+|||+++   .||||||+.|||+++.|.|||+|||.|....
T Consensus       106 EYC-lGSAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHH-hccHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence            999 6788888865433    7889999999999999999999999   9999999999999999999999999997654


Q ss_pred             CCCceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .     .+.++|||.|||||++.   .+.|+-++||||||++..||...++|++..+.       ....+          
T Consensus       178 P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALY----------  235 (948)
T KOG0577|consen  178 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALY----------  235 (948)
T ss_pred             c-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHH----------
Confidence            3     34468999999999875   47899999999999999999999999875441       11111          


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .+-...-+-...+.|+..|++++..||++-|.+|||..+++.
T Consensus       236 HIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  236 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            111111111225778999999999999999999999999864

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-42  Score=301.01  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .+|.+.+.||+|++|.||++...++..+++|.+.....     ..+.+.+|+.+++.++|+|++++++++. ....+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            55888899999999999999988777899998764322     2345778999999999999999999875 45679999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          80 EFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             EcCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            9999999999997532   225788999999999999999999999   9999999999999999999999999997654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...........++..|+|||...+..++.++||||||+++|+|++ |..||.+...  .      . ....+....    
T Consensus       154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~------~-~~~~~~~~~----  220 (260)
T cd05069         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--R------E-VLEQVERGY----  220 (260)
T ss_pred             CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--H------H-HHHHHHcCC----
Confidence            332222222345678999999998889999999999999999999 8999865321  0      0 011111110    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                           ....+...+..+.+++.+||+.||++|||++++++.|+.
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 -----RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 111233456689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=306.12  Aligned_cols=254  Identities=25%  Similarity=0.296  Sum_probs=201.0

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|+||.||++... +++.+|+|.+....... ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            4788899999999999999875 68899999876532221 122345678999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....   ...+++..+..++.|++.||.|||+++   ++||||||+||++++++.++|+|||++....
T Consensus        80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          80 TLMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             eccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999999998886432   225889999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ....  .....|+..|+|||++.+..++.++||||+|+++|||++|..||.+.....     ...........       
T Consensus       154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~-------  219 (285)
T cd05605         154 EGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKE-------  219 (285)
T ss_pred             CCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhh-------
Confidence            3221  223468999999999998889999999999999999999999996533110     00001111110       


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                         .....+...+..+.+|+.+||+.||++||     ++.++++
T Consensus       220 ---~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         220 ---DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ---cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence               01122344666899999999999999999     7888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.5e-42  Score=300.37  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=195.9

Q ss_pred             eecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           78 ILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      .||+|+||.||+|.+.   ++..+|+|.+......   ...+.+.+|+.+++.++||||+++++++.. +..++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~---~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK---SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh---HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            3899999999999764   3456999988754332   334568899999999999999999998754 56799999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++....    ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++........
T Consensus        78 ~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          78 GGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            999999986432    25889999999999999999999999   99999999999999999999999999876544332


Q ss_pred             eeee--cccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          235 HVTT--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       235 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                      ....  ...++..|+|||.+.+..++.++||||||+++|++++ |..||......        . ........       
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~-~~~~~~~~-------  214 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------E-VMSFIEQG-------  214 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------H-HHHHHHCC-------
Confidence            2211  1223578999999988889999999999999999996 99998654210        0 11111111       


Q ss_pred             hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       312 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                        .....+..+++++.+++.+||+.||++||++.++.+.|+.+
T Consensus       215 --~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 --KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              11123344567899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.1e-42  Score=304.20  Aligned_cols=259  Identities=26%  Similarity=0.378  Sum_probs=202.3

Q ss_pred             hcCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      .++|.+.+.||+|++|.||+|.+.+      +..+++|........   .....+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE---QDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3668999999999999999998753      467889987654332   2234678899999999999999999999998


Q ss_pred             CcceEEEEecCCCChhHHhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC---cE
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY---RA  218 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~---~~  218 (360)
                      ...+++|||+++++|.+++......  ....+++..++.++.|++.||+|||+++   ++|+||||+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcce
Confidence            8999999999999999999765321  1235889999999999999999999999   99999999999998754   59


Q ss_pred             EEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHH
Q 040763          219 KVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  296 (360)
                      ||+|||++.......... ......+..|+|||++.+..++.++|||||||++|||++ |..||.....  ..       
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~~-------  229 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QE-------  229 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HH-------
Confidence            999999997653322111 112223567999999999899999999999999999997 9999864321  00       


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ........         .....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       230 ~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         230 VMEFVTGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            01111110         011123334567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.7e-42  Score=308.93  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=206.7

Q ss_pred             cCCCccceecccCcEEEEEEEec--------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEe
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE--------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCL  141 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~  141 (360)
                      .+|.+.+.||+|+||.||++...        ....+|+|.++.....   .....+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD---KDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh---HHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            56888999999999999999742        2456899987754332   3355678899999999 6999999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQ-----------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNI  210 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Ni  210 (360)
                      .....+++|||+++++|.+++.....           .....+++..+..++.|++.||.|||+++   ++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            98999999999999999999976432           11235888999999999999999999999   99999999999


Q ss_pred             EEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcc
Q 040763          211 LLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ  288 (360)
Q Consensus       211 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~  288 (360)
                      ++++++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---  242 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---  242 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence            99999999999999997654322111 111234567999999998889999999999999999999 8888854321   


Q ss_pred             cccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                           .. ..........         ...+...+.++.+++.+||+.+|++|||+.++++.|..+....
T Consensus       243 -----~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         243 -----EE-LFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             -----HH-HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence                 01 1111111111         1122334557899999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=302.34  Aligned_cols=254  Identities=29%  Similarity=0.404  Sum_probs=203.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccCh-HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ++|.+.+.||+|++|.||.+... +++.+++|.+...... ........+.+|+.+++.++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56889999999999999999865 5889999987654322 122345567889999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ++||+++++|.+++....     .++......++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            999999999999987542     4788889999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCceee--ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          229 IAMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       229 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .........  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....       . ..........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~-~~~~~~~~~~--  223 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------M-AAIFKIATQP--  223 (263)
T ss_pred             ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------H-HHHHHHhccC--
Confidence            543221111  234578899999999998899999999999999999999999864321       0 0001110000  


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             .....+...+.++.+++.+||+.+|++|||+.++++
T Consensus       224 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         224 -------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             -------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence                   111223445567899999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.6e-43  Score=312.14  Aligned_cols=243  Identities=25%  Similarity=0.347  Sum_probs=190.3

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||+|... +++.||+|.++....... ...+....|..++... +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36999999999999876 577899998775322111 2233445566666654 89999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++....     .++...+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++....... 
T Consensus        80 gg~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-  150 (316)
T cd05592          80 GGDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-  150 (316)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence            999999886532     4788899999999999999999999   9999999999999999999999999987543222 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|||||||++|||++|..||.+...        ..... .+...          
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~-~i~~~----------  211 (316)
T cd05592         151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFD-SILND----------  211 (316)
T ss_pred             CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHH-HHHcC----------
Confidence            223345689999999999998999999999999999999999999965431        01111 11110          


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTME-EVS  348 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ei~  348 (360)
                      ....+...+.++.+++.+||+.||++||++. +++
T Consensus       212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            0112333456789999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.5e-42  Score=304.15  Aligned_cols=259  Identities=23%  Similarity=0.407  Sum_probs=202.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .++|++.+.||+|+||+||+|.+. ++.    .||+|.++.....   .....+.+|+.++..++||||+++++.+.. .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP---KANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH---HHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            356888999999999999999854 344    4799987654333   234567789999999999999999999875 4


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..+++++|+++|+|.+++....    ..+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCC
Confidence            5689999999999999986532    25889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          225 TSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       225 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ++.......... .....++..|+|||...+..++.++||||||+++|||++ |..||.....     ...    .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~----~~~~~  225 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REI----PDLLE  225 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHH----HHHHH
Confidence            998664332221 112234678999999998899999999999999999998 8889854321     001    11111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ...         ....+...+.++.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       226 ~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         226 KGE---------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             CCC---------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            110         0111223456789999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.1e-43  Score=315.61  Aligned_cols=244  Identities=24%  Similarity=0.302  Sum_probs=194.6

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPN  155 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  155 (360)
                      +.||+|+||.||++... ++..+|+|.+....... ......+..|+.++..++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999875 68899999876532211 12345667899999999999999999999999999999999999


Q ss_pred             CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          156 GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       156 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      ++|..++....     .+++..+..++.|++.||.|||+ ++   ++||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-  150 (325)
T cd05594          80 GELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-  150 (325)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-
Confidence            99998886532     58899999999999999999997 68   9999999999999999999999999986532221 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||......        . .........         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~-~~~~i~~~~---------  212 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------K-LFELILMEE---------  212 (325)
T ss_pred             cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------H-HHHHHhcCC---------
Confidence            1223346899999999999999999999999999999999999999653210        0 011111100         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                       ...+...++++.+++.+||+.||++|+     ++.++++
T Consensus       213 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         213 -IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence             012233456799999999999999997     8888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-43  Score=289.72  Aligned_cols=256  Identities=26%  Similarity=0.405  Sum_probs=204.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHH----hHHHHHHHHHHHhhc-CCCCceeeeeEEee
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELY----KLEEFINEIFILSQI-NHRNVVKLLGCCLE  142 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~----~~~~~~~e~~~~~~l-~h~niv~~~~~~~~  142 (360)
                      ..+.|...+.+|.|..++|.++.++ +|+.+|+|++..........    -.+.-.+|+.+++++ .||+|+.+.+++.+
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3466888899999999999888776 68889999876554333222    234456799999998 79999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                      +...++|+|.|+.|.|.++|...-     .++++..+.|++|++.|+.|||.++   |+||||||+|||++++.++||+|
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            999999999999999999997654     5889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhcc------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  296 (360)
                      ||+++.+...  ......+|||+|+|||.+..      ..|+..+|+||+|+|+|-|+.|.+||-...     +......
T Consensus       167 FGFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----QmlMLR~  239 (411)
T KOG0599|consen  167 FGFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QMLMLRM  239 (411)
T ss_pred             cceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHHHHHH
Confidence            9999987643  34566799999999997764      357778999999999999999999984321     1111111


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +.     +.-.++..+.+     .+.+++..+|+.+||+.||.+|.|++|.++
T Consensus       240 Im-----eGkyqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  240 IM-----EGKYQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HH-----hcccccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            11     11111111111     234667899999999999999999999874

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-42  Score=306.10  Aligned_cols=262  Identities=27%  Similarity=0.383  Sum_probs=203.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE  142 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~  142 (360)
                      ...+|++.+.||+|+||.||+|..++      +..+|+|.+......   .....+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL---RERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            35679999999999999999997542      447999987644322   233457789999999999999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNE-----EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR  217 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~  217 (360)
                      ....+++|||+++|+|.+++.......     ....++..+..++.|++.||.|||+++   ++||||||+||++++++.
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~  157 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCc
Confidence            999999999999999999997643211     234567788999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHH
Q 040763          218 AKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       218 ~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~  295 (360)
                      ++|+|||++.......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||.+...        ..
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~  229 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQ  229 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence            9999999987553322111 122235678999999998889999999999999999998 7888854321        01


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                       ...........         ..+...++++.+++.+||+.||++|||+.++++.|...
T Consensus       230 -~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         230 -VLKFVMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence             11111111110         11223356899999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-42  Score=301.73  Aligned_cols=255  Identities=28%  Similarity=0.439  Sum_probs=205.3

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|.+.+.||+|+||.||++..++++.+++|.+.....     ..+.+.+|+.+++.++|+|++++++++......+++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            467899999999999999999988888899998775332     234677899999999999999999999988899999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....   ...+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||++...
T Consensus        80 ~e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          80 TEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             EeccCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceec
Confidence            99999999999997632   235889999999999999999999999   999999999999999999999999998766


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ............++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+...  .      . ........    
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~------~-~~~~~~~~----  220 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--R------E-VLEQVERG----  220 (261)
T ss_pred             cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H------H-HHHHHHcC----
Confidence            4322221222234668999999998889999999999999999999 9999854321  0      0 01111100    


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                           .....+...+.++.+++.+||+.+|++|||+.++.+.|+.
T Consensus       221 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 -----YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                 0011122235579999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.9e-43  Score=319.99  Aligned_cols=253  Identities=21%  Similarity=0.256  Sum_probs=195.3

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .|+.++.||+|+||.||++... +++.+|+|.+..... ........+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            5888999999999999999875 578899998764321 11234556788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        81 E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~  152 (382)
T cd05625          81 DYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (382)
T ss_pred             eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence            9999999999986532     4788888999999999999999999   9999999999999999999999999974321


Q ss_pred             CCC----------------------------------------------ceeeecccccCCccchhhhccCCCCCccchh
Q 040763          231 MDQ----------------------------------------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVY  264 (360)
Q Consensus       231 ~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  264 (360)
                      ...                                              .......+||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (382)
T cd05625         153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  232 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence            000                                              0001124689999999999999999999999


Q ss_pred             hhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-
Q 040763          265 SFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-  343 (360)
Q Consensus       265 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-  343 (360)
                      ||||++|||++|+.||.+....        ..........       .....+.....++++.+++.+|+ .+|++|++ 
T Consensus       233 SlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         233 SVGVILYEMLVGQPPFLAQTPL--------ETQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             echHHHHHHHhCCCCCCCCCHH--------HHHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            9999999999999999654310        0000110000       00001111234567888998876 59999997 


Q ss_pred             --HHHHHH
Q 040763          344 --MEEVSM  349 (360)
Q Consensus       344 --~~ei~~  349 (360)
                        +.++++
T Consensus       297 ~~~~ei~~  304 (382)
T cd05625         297 NGADEIKA  304 (382)
T ss_pred             CCHHHHhc
Confidence              777653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.4e-43  Score=324.39  Aligned_cols=260  Identities=23%  Similarity=0.322  Sum_probs=193.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC----
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET----  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----  143 (360)
                      ...+|.+.+.||+|+||.||+|... +++.||+|++.....        ...+|+.+++.++||||+++++++...    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ--------YKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            3467999999999999999999875 578999998754221        223689999999999999998876432    


Q ss_pred             ----CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cE
Q 040763          144 ----EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RA  218 (360)
Q Consensus       144 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~  218 (360)
                          ...++||||++ ++|.+++..... ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+
T Consensus       136 ~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        136 NEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             CCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCce
Confidence                23568999996 578777754322 2336889999999999999999999999   99999999999999664 79


Q ss_pred             EEeecCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 040763          219 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      ||+|||++.......  ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+......     ....
T Consensus       211 kL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-----~~~i  283 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-----LVRI  283 (440)
T ss_pred             eeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHH
Confidence            999999998654322  12234689999999988764 689999999999999999999999975432110     0001


Q ss_pred             HHHhhcc---------------ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          298 VHSMRKN---------------RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       298 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                      .......               .........+....+...++++.+|+.+||+.||.+|||+.|++
T Consensus       284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l  349 (440)
T PTZ00036        284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL  349 (440)
T ss_pred             HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            1111000               01111112222233444567899999999999999999999987

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.8e-42  Score=307.04  Aligned_cols=260  Identities=27%  Similarity=0.391  Sum_probs=205.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEe
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCL  141 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~  141 (360)
                      ..++|.+.+.||+|+||.||++...      .+..+|+|.++.....   ...+.+.+|+.+++++ +||||+++++++.
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS---SEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh---HHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3457899999999999999999742      2447899987754332   2345678999999999 7999999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                      ..+..+++|||+.+++|.+++....   ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++++
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEEC
Confidence            9999999999999999999996532   123789999999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHH
Q 040763          222 DFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       222 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |||++......... ......++..|+|||.+.+..++.++||||+|+++|||++ |..||.......        .+..
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~~~~  255 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYK  255 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------HHHH
Confidence            99998765433221 1222345778999999999889999999999999999998 999986543110        0111


Q ss_pred             HhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      .....         .....+...++++.+++.+||+.+|++|||+.++++.|+.+
T Consensus       256 ~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 LIKEG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            11111         01111223355799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.5e-42  Score=304.48  Aligned_cols=265  Identities=27%  Similarity=0.395  Sum_probs=204.3

Q ss_pred             cCCCccceecccCcEEEEEEEecC-----------------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-----------------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV  133 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni  133 (360)
                      ++|++.+.||+|+||.||++....                 +..+|+|.+......   ...+.+.+|+.++..++|||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD---NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhcCCCCE
Confidence            578999999999999999987642                 235789987754333   345678899999999999999


Q ss_pred             eeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 040763          134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE------EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKS  207 (360)
Q Consensus       134 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~  207 (360)
                      +++++++...+..+++||++++++|.+++.......      ...+++..++.++.|++.||+|||+.+   ++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence            999999999999999999999999999997654222      226899999999999999999999999   99999999


Q ss_pred             CCeEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh--CCCCCCCCC
Q 040763          208 TNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSTG  284 (360)
Q Consensus       208 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~p~~~~~  284 (360)
                      +||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99999999999999999987654332211 223346778999999988889999999999999999998  667774322


Q ss_pred             CCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      .  .   .............      ........+...++++.+++.+||+.||++|||+.+|++.|+
T Consensus       239 ~--~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 D--Q---QVIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             h--H---HHHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1  0   0001111110000      000111122334568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.7e-43  Score=312.93  Aligned_cols=240  Identities=28%  Similarity=0.361  Sum_probs=188.4

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHH-HHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIF-ILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~-~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++.+. +++.+|+|.+........ .....+..|.. +++.++||||+++++.+...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            36999999999999986 688999998765322111 12233444544 5577899999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-  150 (323)
T cd05575          80 GGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-  150 (323)
T ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-
Confidence            999999986532     5788899999999999999999999   9999999999999999999999999986532211 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...        ........ ...         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~-~~~---------  212 (323)
T cd05575         151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNIL-NKP---------  212 (323)
T ss_pred             CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHH-cCC---------
Confidence            122345689999999999999999999999999999999999999965321        11111111 110         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTME  345 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  345 (360)
                       ...+...+.++.+++.+||+.||.+||++.
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 -LRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             011223456799999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.9e-42  Score=314.93  Aligned_cols=257  Identities=24%  Similarity=0.297  Sum_probs=199.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ...++|++.+.||+|+||.||++.++ +++.+|+|.+...... .......+.+|+.+++.++||||+++++++......
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            34578999999999999999999987 5788999987542211 112234567899999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++|+|.+++...      .++...+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       119 ~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            9999999999999998642      3778888889999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCC----CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ...............||+.|+|||++.+..    ++.++|||||||++|||++|..||.+...        ...+.....
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~  261 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMN  261 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHHc
Confidence            866443333334457999999999987643    78899999999999999999999965331        111111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKK--RPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ei~~  349 (360)
                      .....       ........+.++.+++..||+.++.+  ||++.++++
T Consensus       262 ~~~~~-------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         262 HKNSL-------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             CCCcc-------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence            11100       01112345668999999999844433  678888875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4e-42  Score=300.86  Aligned_cols=256  Identities=24%  Similarity=0.423  Sum_probs=203.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-C---CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-D---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.++.....   ...+.+.+|+.++..++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE---KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            56888999999999999999864 2   337899987654332   2345778899999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      +++|||+++++|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcc
Confidence            99999999999999997532    25788999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeee--cccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          227 KFIAMDQTHVTT--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       227 ~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ............  ...++..|+|||.+.+..++.++|+||||+++||+++ |..||.......         ....+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---------~~~~~~~  224 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---------VIKAIEE  224 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---------HHHHHhC
Confidence            876543222211  1223567999999998889999999999999999887 999986543110         0111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      ..         ..+.+...++.+.+++.+||+.+|++|||+.++++.|..+
T Consensus       225 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 GY---------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CC---------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            10         0111223456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.8e-42  Score=299.73  Aligned_cols=251  Identities=22%  Similarity=0.348  Sum_probs=202.5

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|+||.||++... +++.+++|.++.....   ...+.+.+|+.+++.++|+|++++++.+......+++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS---SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            4788899999999999999876 6888999987654322   23456778999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....   ...++......++.|++.||.|||+++   ++|+||+|+||++++++.++++|||.+....
T Consensus        78 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          78 EYCDGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             eeCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            9999999999886532   235788899999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      .... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....        .. ..........    
T Consensus       152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~-~~~~~~~~~~----  217 (255)
T cd08219         152 SPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KN-LILKVCQGSY----  217 (255)
T ss_pred             cccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HH-HHHHHhcCCC----
Confidence            3221 12234688999999999998899999999999999999999999964321        00 0111111111    


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                           ...+...+..+.+++.+||+.||++|||+.+++.+
T Consensus       218 -----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 -----KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 11223355678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.6e-43  Score=320.16  Aligned_cols=254  Identities=22%  Similarity=0.263  Sum_probs=196.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +.|++.+.||+|+||.||++... +++.+|+|.+...... .......+.+|+.++..++|+||+++++.+.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            36899999999999999999876 5889999987643211 112345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .++...+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        80 ~E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          80 MDYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            99999999999997533     4788888899999999999999999   999999999999999999999999997532


Q ss_pred             CCCC------------------------------------------ceeeecccccCCccchhhhccCCCCCccchhhhH
Q 040763          230 AMDQ------------------------------------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFG  267 (360)
Q Consensus       230 ~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  267 (360)
                      ....                                          ........||+.|+|||++.+..++.++||||||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  231 (376)
T cd05598         152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence            1000                                          0001124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC---CH
Q 040763          268 VVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP---TM  344 (360)
Q Consensus       268 ~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---t~  344 (360)
                      |++|||++|+.||.+......        ... .....      ...........++++.+++.+|+ .+|++|+   |+
T Consensus       232 vilyell~G~~Pf~~~~~~~~--------~~~-i~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         232 VILYEMLVGQPPFLADTPAET--------QLK-VINWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             ceeeehhhCCCCCCCCCHHHH--------HHH-HhccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            999999999999965431100        000 00000      00000111234557888999876 5999999   88


Q ss_pred             HHHHH
Q 040763          345 EEVSM  349 (360)
Q Consensus       345 ~ei~~  349 (360)
                      .++++
T Consensus       296 ~ell~  300 (376)
T cd05598         296 DEIKA  300 (376)
T ss_pred             HHHhC
Confidence            88864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.5e-42  Score=304.00  Aligned_cols=265  Identities=25%  Similarity=0.379  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-----------------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-----------------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV  133 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni  133 (360)
                      ++|++.+.||+|+||.||++...                 ++..+|+|.+......   .....+.+|+.+++.++|+||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK---NARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCc
Confidence            56899999999999999998532                 2346899987754322   334577899999999999999


Q ss_pred             eeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 040763          134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE------EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKS  207 (360)
Q Consensus       134 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~  207 (360)
                      +++++++...+..+++|||+++++|.+++.......      ...+++..+..++.|++.||+|||+.+   ++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCh
Confidence            999999999999999999999999999997643221      124778889999999999999999999   99999999


Q ss_pred             CCeEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh--CCCCCCCCC
Q 040763          208 TNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSTG  284 (360)
Q Consensus       208 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~p~~~~~  284 (360)
                      +||+++.++.++|+|||++.......... .....++..|+|||...++.++.++||||||+++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            99999999999999999987654332211 122334678999999888889999999999999999998  667875432


Q ss_pred             CCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      .  ..   ..............      ......+..+++.+.+++.+||+.||++|||+.+|.+.|+
T Consensus       239 ~--~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         239 D--EQ---VIENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             h--HH---HHHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1  00   00000011100000      0001112334567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-42  Score=311.80  Aligned_cols=244  Identities=25%  Similarity=0.307  Sum_probs=193.5

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC-CCceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH-RNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~lv  149 (360)
                      +|++.+.||+|+||.||+|..+ +++.+|+|++....... ....+.+..|..++..++| ++|+++++++...+..|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            4788999999999999999876 46789999876532211 1234566788889988866 5688899999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        80 ~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          80 MEYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            99999999999986533     4788899999999999999999999   999999999999999999999999998643


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+...        ..... .....     
T Consensus       152 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~-~i~~~-----  216 (324)
T cd05587         152 IFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQ-SIMEH-----  216 (324)
T ss_pred             CCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHH-HHHcC-----
Confidence            2211 122345689999999999999999999999999999999999999965331        01111 11111     


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                           ....+...++++.+++.+||..||.+|++.
T Consensus       217 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 -----NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                 011223345678999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.2e-42  Score=306.94  Aligned_cols=247  Identities=24%  Similarity=0.330  Sum_probs=193.4

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++... +++.+|+|+++...... ....+.+.+|..++.++ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            36999999999999876 57889999987543221 23345677899988888 69999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|..++....     .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++....... 
T Consensus        80 ~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-  150 (327)
T cd05617          80 GGDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-  150 (327)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-
Confidence            999998886532     5889999999999999999999999   9999999999999999999999999987432211 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|..||..........  .............         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~---------  219 (327)
T cd05617         151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TEDYLFQVILEKP---------  219 (327)
T ss_pred             CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--cHHHHHHHHHhCC---------
Confidence            12234568999999999999999999999999999999999999996543211111  1111111111111         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTME  345 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  345 (360)
                       ...+...+..+.+++.+||+.||++||++.
T Consensus       220 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         220 -IRIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence             112333456789999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=318.92  Aligned_cols=254  Identities=23%  Similarity=0.310  Sum_probs=196.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|.+.+.||+|+||.||++... +++.+|+|++...... .....+.+.+|+.++..++||||+++++++.+....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence            36889999999999999999875 6889999987543211 123455678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        80 ~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          80 MEFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999999986532     5788889999999999999999999   999999999999999999999999998632


Q ss_pred             CCCCc-------------e---------------------------------eeecccccCCccchhhhccCCCCCccch
Q 040763          230 AMDQT-------------H---------------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDV  263 (360)
Q Consensus       230 ~~~~~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  263 (360)
                      .....             .                                 .....+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence            11000             0                                 0012468999999999999999999999


Q ss_pred             hhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCC--
Q 040763          264 YSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKR--  341 (360)
Q Consensus       264 wslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R--  341 (360)
                      |||||++|||++|..||.+...  .      ..+...........+       ......+.++.+++.+||. +|.+|  
T Consensus       232 wSlGvil~elltG~~Pf~~~~~--~------~~~~~i~~~~~~~~~-------p~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENS--H------ETYRKIINWRETLYF-------PDDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCH--H------HHHHHHHccCCccCC-------CCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            9999999999999999965331  0      001111100000000       0111245678999999998 67765  


Q ss_pred             -CCHHHHHH
Q 040763          342 -PTMEEVSM  349 (360)
Q Consensus       342 -pt~~ei~~  349 (360)
                       +|+.++++
T Consensus       296 r~~~~~~l~  304 (377)
T cd05629         296 RGGAHEIKS  304 (377)
T ss_pred             CCCHHHHhc
Confidence             59988875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.9e-42  Score=303.24  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=193.1

Q ss_pred             ecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCC
Q 040763           79 LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        79 lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  157 (360)
                      ||+|+||.||++..+ +|+.+|+|.+........ .....+..|+.++..++||||+++++.+......+++|||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            699999999999876 588999998764221111 122344569999999999999999999999999999999999999


Q ss_pred             hhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceee
Q 040763          158 LYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT  237 (360)
Q Consensus       158 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  237 (360)
                      |.+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        80 L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~  151 (277)
T cd05607          80 LKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TI  151 (277)
T ss_pred             HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--ee
Confidence            998886532   224788889999999999999999999   9999999999999999999999999987654322  22


Q ss_pred             ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhh
Q 040763          238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL  317 (360)
Q Consensus       238 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (360)
                      ....|+..|+|||++.+..++.++||||+||++|||++|+.||........    ......... ....         ..
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~---------~~  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTL-EDEV---------KF  217 (277)
T ss_pred             eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhh-cccc---------cc
Confidence            334689999999999998899999999999999999999999865332110    000001000 0000         00


Q ss_pred             ccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          318 GKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       318 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                      .....++++.+++.+||+.||++||++.|+++.
T Consensus       218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            112356679999999999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.2e-42  Score=298.11  Aligned_cols=251  Identities=29%  Similarity=0.432  Sum_probs=203.2

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|.+.+.||+|++|.||++..+ ++..+++|.+......  ......+.+|+.+++.++|||++++++++...+..+++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN--RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC--HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence            4778889999999999999876 5788999987643222  134557888999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        79 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          79 EYAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EeCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            9999999999997642   236889999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ..... .....|++.|+|||+..+..++.++|+||||+++|+|++|+.||.....         ...........     
T Consensus       153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~-----  217 (256)
T cd08529         153 DNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---------GALILKIIRGV-----  217 (256)
T ss_pred             Cccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHcCC-----
Confidence            43221 2234578899999999998899999999999999999999999964431         00111111111     


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ....+...+.++.+++.+||+.+|++||++.++++
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         218 ----FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence                11122245567999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.3e-42  Score=299.44  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=203.8

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..+|++.+.||+|+||.||++...++..+++|.+....     ...+.+.+|+.+++.++|+|++++++.+.. ...+++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            46789999999999999999988777889999876431     234567889999999999999999999887 778999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....   ....++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||.+...
T Consensus        79 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          79 TEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             EEeCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeec
Confidence            99999999999997532   225788889999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ............++..|+|||.+..+.++.++|+||||+++|++++ |..||.......         .........   
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---------~~~~~~~~~---  220 (260)
T cd05073         153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------VIRALERGY---  220 (260)
T ss_pred             cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHhCCC---
Confidence            4332222222345678999999998889999999999999999999 899986432100         011111110   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                            ....+...+.++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       221 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         221 ------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                  1111233455799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-42  Score=312.77  Aligned_cols=244  Identities=27%  Similarity=0.336  Sum_probs=188.9

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHH-HHHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEI-FILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~-~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++.+. +++.+|+|++........ .....+..|. .+++.++||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            36999999999999976 567899998764322111 1122333443 35677899999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++....     .++......++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-  150 (325)
T cd05602          80 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  150 (325)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-
Confidence            999999986532     4677888889999999999999999   9999999999999999999999999987532221 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||......        ..+.... ...         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~-~~~---------  212 (325)
T cd05602         151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNIL-NKP---------  212 (325)
T ss_pred             CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHH-hCC---------
Confidence            1223456899999999999999999999999999999999999999653310        1111111 110         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       ...+...+.++.+++.+||+.||.+||++.+.+.
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         213 -LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             -cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence             0112234567899999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-42  Score=311.08  Aligned_cols=244  Identities=25%  Similarity=0.307  Sum_probs=193.9

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +|.+.+.||+|+||.||++... +++.+|+|.+....... .........|..++..+ +|++|+++++++...+..++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            4788899999999999999876 56789999877532211 12334456677777777 689999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++...
T Consensus        80 ~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          80 MEYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             EcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            99999999999886532     4788999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...        .... ..+....    
T Consensus       152 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~-~~i~~~~----  217 (323)
T cd05616         152 MWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELF-QSIMEHN----  217 (323)
T ss_pred             CCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHH-HHHHhCC----
Confidence            3221 122345689999999999999999999999999999999999999965331        0011 1111110    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                            ...+...++++.+++.+||+.||++|++.
T Consensus       218 ------~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                  11233456688999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-42  Score=303.82  Aligned_cols=265  Identities=25%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             cCCCccceecccCcEEEEEEEecC---------------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCcee
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED---------------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK  135 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~  135 (360)
                      ++|++.+.||+|+||.||++....               ...+|+|.++.....   .....+.+|++++.+++|+|+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK---TARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCcCe
Confidence            579999999999999999987542               235899988754332   23456889999999999999999


Q ss_pred             eeeEEeeCCcceEEEEecCCCChhHHhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040763          136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN-------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKST  208 (360)
Q Consensus       136 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~  208 (360)
                      +++++......+++|||+++++|.+++......       ....+++..++.++.|++.||+|||+.+   ++|+||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChh
Confidence            999999999999999999999999999653211       1123678889999999999999999999   999999999


Q ss_pred             CeEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh--CCCCCCCCCC
Q 040763          209 NILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT--GKKPIFSTGN  285 (360)
Q Consensus       209 Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~p~~~~~~  285 (360)
                      ||++++++.+||+|||++.......... .....++..|+|||.+.++.++.++||||||+++|+|++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9999999999999999987654322211 222345778999999998889999999999999999998  5567654321


Q ss_pred             CcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          286 TSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                        ..   .............      .......+...++.+.+|+.+||+.||++|||+.+|++.|.
T Consensus       239 --~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 --EQ---VIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HH---HHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              00   0000011010000      00001112224457999999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-42  Score=304.39  Aligned_cols=265  Identities=27%  Similarity=0.416  Sum_probs=201.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--C
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--T  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~  143 (360)
                      .+|++.+.||+|+||.||++..+     ++..+++|.+.....    ...+.+.+|+.++..++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            57888999999999999999742     477899998765322    234567889999999999999999998754  3


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...+++|||+++++|.+++....    ..+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+||
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence            46789999999999999996532    25789999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc-------cchH
Q 040763          224 GTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN-------VSLA  294 (360)
Q Consensus       224 g~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~-------~~~~  294 (360)
                      |++..........  .....++..|+|||.+.+..++.++||||||+++|||++|..|+..........       ....
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05081         153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV  232 (284)
T ss_pred             cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence            9998764432211  111223456999999998889999999999999999999887754332110000       0000


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      ......         +........+...+.++.+++.+||+.+|++|||+.++++.|+.++
T Consensus       233 ~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         233 YHLIEL---------LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHHHHH---------HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            000000         1111111122334567999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.4e-42  Score=299.30  Aligned_cols=257  Identities=24%  Similarity=0.422  Sum_probs=203.5

Q ss_pred             hcCCCccceecccCcEEEEEEEecC-C---cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED-G---RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .++|+..+.||+|+||.||+|..+. +   ..+++|........   ...+.+..|+.++..++|||++++.+++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE---KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH---HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            3568888999999999999998752 3   36899987654332   234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+++++|.+++....    ..+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.+||+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence            999999999999999986532    25889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeee--cccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          226 SKFIAMDQTHVTT--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       226 ~~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      +............  ....+..|+|||++.+..++.++||||||+++|||++ |..||.....         ......+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---------~~~~~~i~  224 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---------HEVMKAIN  224 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---------HHHHHHHh
Confidence            8765432221111  1223457999999998889999999999999999998 9999854321         01111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      ...         ..+.+...+.++.+++.+||+.+|++||++.++++.|+++
T Consensus       225 ~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 DGF---------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             cCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            110         1111223455789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.4e-42  Score=309.11  Aligned_cols=244  Identities=25%  Similarity=0.317  Sum_probs=192.6

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||+|..+ +++.+|+|.+....... ....+.+..|..++..+ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            36999999999999876 47899999876532211 12344566788888766 89999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|..++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....... 
T Consensus        80 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-  150 (321)
T cd05591          80 GGDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-  150 (321)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence            999999886533     4788889999999999999999999   9999999999999999999999999987533222 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....        ......... ..         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~-~~---------  212 (321)
T cd05591         151 VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILH-DD---------  212 (321)
T ss_pred             ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CC---------
Confidence            122335689999999999998999999999999999999999999965431        011111111 10         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCC-------CHHHHHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRP-------TMEEVSM  349 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-------t~~ei~~  349 (360)
                       ...+...++++.+++.+||+.||++||       ++.++++
T Consensus       213 -~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 -VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence             011223456789999999999999999       7777753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.9e-42  Score=303.64  Aligned_cols=259  Identities=27%  Similarity=0.435  Sum_probs=203.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      .++|++.+.||+|+||.||++...      ++..+|+|.+......   .....+.+|+.+++.++|||++++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH---HHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            356889999999999999999864      3578999987754332   2345678899999999999999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhcc-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQ-----------------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK  206 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  206 (360)
                      +..+++|||+++++|.+++.....                 .....+++..++.++.|++.||+|||+++   ++||||+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~  157 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLA  157 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eeccccc
Confidence            999999999999999999975421                 11224788889999999999999999999   9999999


Q ss_pred             CCCeEEcCCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 040763          207 STNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG  284 (360)
Q Consensus       207 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~  284 (360)
                      |+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999998754332211 1122234667999999998899999999999999999998 888885432


Q ss_pred             CCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      .  .      . ...........         ..+...+.++.+++.+||+.||++|||+.|+++.|+
T Consensus       238 ~--~------~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         238 H--E------E-VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H--H------H-HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1  0      0 11111111111         122334568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.9e-43  Score=314.25  Aligned_cols=240  Identities=29%  Similarity=0.312  Sum_probs=192.5

Q ss_pred             ceecccCcEEEEEEEe----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEe
Q 040763           77 RILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      +.||+|+||.||++..    .+++.+|+|++......  ......+..|+.++.+++||||+++++++...+..|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            5799999999999875    25789999987653221  12234566899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCC
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD  232 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  232 (360)
                      +++++|.+++....     .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        80 ~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          80 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            99999999986532     5889999999999999999999999   999999999999999999999999998765432


Q ss_pred             CceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccch
Q 040763          233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD  312 (360)
Q Consensus       233 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (360)
                      . .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        .... .......       
T Consensus       152 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~-~~i~~~~-------  214 (318)
T cd05582         152 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETM-TMILKAK-------  214 (318)
T ss_pred             C-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHH-HHHHcCC-------
Confidence            2 122345689999999999988899999999999999999999999964321        0001 1111110       


Q ss_pred             HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 040763          313 QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE  346 (360)
Q Consensus       313 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e  346 (360)
                         ...+...++++.+++.+||+.||++|||+.+
T Consensus       215 ---~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 ---LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence               0123334567899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.4e-41  Score=297.78  Aligned_cols=256  Identities=25%  Similarity=0.360  Sum_probs=192.5

Q ss_pred             ceecccCcEEEEEEEecC---CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           77 RILGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~---~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      +.||+|+||.||+|...+   +..+++|.++.....   .....+.+|+.+++.++||||+++++++.+....+++|||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV---QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            358999999999998653   357899987654332   22346778999999999999999999999989999999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      ++++|.+++...........++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9999999997654333335677788889999999999999999   9999999999999999999999999987543322


Q ss_pred             cee-eecccccCCccchhhhccC-------CCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          234 THV-TTKIQGTFGYLDPEYHQSS-------QLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       234 ~~~-~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ... .....++..|+|||++.+.       .++.++|+||||+++|||++ |..||.......     .   ...... .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~---~~~~~~-~  225 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----V---LTYTVR-E  225 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----H---HHHHhh-c
Confidence            211 1223567889999988642       35789999999999999996 999995432110     0   000000 1


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      .......+.    .....++.+.+++..|| .+|++|||+.+|...|+
T Consensus       226 ~~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQLKLPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCCCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            011111111    11123456889999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-42  Score=297.75  Aligned_cols=251  Identities=27%  Similarity=0.431  Sum_probs=204.3

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||.|++|.||++... ++.+++|.+.....     ..+++.+|+.+++.++|+|++++++++......+++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            357888999999999999999876 78899998875432     356778899999999999999999999988999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++.....   ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+...
T Consensus        79 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             EEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccc
Confidence            999999999999976431   25889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      .....    ....+..|+|||.+..+.++.++||||||+++|+|++ |..||.....        .. ........    
T Consensus       153 ~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~-~~~~~~~~----  215 (256)
T cd05039         153 SQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KD-VVPHVEKG----  215 (256)
T ss_pred             ccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HH-HHHHHhcC----
Confidence            32211    2234667999999988889999999999999999997 9999854321        00 11111111    


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                           .....+...++++.+++.+||..+|++|||+.+++++|+.+
T Consensus       216 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         216 -----YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -----CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                 01112233456899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.3e-42  Score=309.72  Aligned_cols=244  Identities=25%  Similarity=0.319  Sum_probs=193.8

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++.+. +++.+|+|.++...... ......+..|..++..+ +||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999876 57889999877532211 12344566788888877 79999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|..++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....... 
T Consensus        80 ~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  150 (318)
T cd05570          80 GGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-  150 (318)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence            999999886532     5889999999999999999999999   9999999999999999999999999986432211 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...        .. .........         
T Consensus       151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~-~~~~i~~~~---------  212 (318)
T cd05570         151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DE-LFQSILEDE---------  212 (318)
T ss_pred             CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HH-HHHHHHcCC---------
Confidence            122334689999999999999999999999999999999999999964331        01 111111110         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTM-----EEVSM  349 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~ei~~  349 (360)
                       ...+...++++.+++.+||+.||++|||+     .++++
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         213 -VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             11223345679999999999999999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.9e-42  Score=300.29  Aligned_cols=259  Identities=28%  Similarity=0.427  Sum_probs=204.9

Q ss_pred             hcCCCccceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ..+|.+.+.||+|+||.||+|.+.+    ...+++|........   ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP---SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH---HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            3568888999999999999998643    246899987654432   334577889999999999999999998875 45


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+++++|.+++....    ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCce
Confidence            689999999999999996532    24789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      +...............++..|+|||.+....++.++||||||+++||+++ |..||......        ... ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~-~~~~~~  224 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------DVI-GRIENG  224 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHH-HHHHcC
Confidence            87665433222222334568999999988889999999999999999986 99998654311        000 111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .         ....+...+.++.+++.+||..+|++|||+.++++.|+++.+.
T Consensus       225 ~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         225 E---------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             C---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0         0012233456899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8e-42  Score=331.28  Aligned_cols=265  Identities=22%  Similarity=0.346  Sum_probs=205.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....... ....+++.+|+.++..++||||+++++++.+.+..+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~-e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN-PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC-HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            57999999999999999999876 58899999987543322 12345688999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          150 YEFIPNGTLYQHLHDRHQN------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      |||+++++|.+++......      .....++..++.++.|++.||+|||+++   |+||||||+||+++.++.++|+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEec
Confidence            9999999999998653211      1124567788899999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCC-----------------ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 040763          224 GTSKFIAMDQ-----------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT  286 (360)
Q Consensus       224 g~~~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~  286 (360)
                      |++.......                 ........||+.|+|||++.+..++.++|||||||++|||+||..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652111                 00112246899999999999999999999999999999999999999653210


Q ss_pred             cccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHhH
Q 040763          287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-TMEEVSMELNGIR  355 (360)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ei~~~L~~l~  355 (360)
                      ..   .    .....         ............++.+.+++.+||+.||++|| +++++.+.|+...
T Consensus       238 ki---~----~~~~i---------~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        238 KI---S----YRDVI---------LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hh---h----hhhhc---------cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            00   0    00000         00000001123456789999999999999996 6777887777654

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=309.81  Aligned_cols=255  Identities=26%  Similarity=0.376  Sum_probs=211.9

Q ss_pred             HHhcCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEF  145 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~  145 (360)
                      .....|++.+.||+|.||.||.+..+. |+.+|+|.+........ ...+.+.+|+.+|+++. ||||+.+++.+.+...
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            345679999999999999999999875 99999999776544322 13467789999999998 9999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC----CcEEEe
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVA  221 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~----~~~kl~  221 (360)
                      .++|||++.||.|.+.+...      .+++.....++.|++.++.|||+.|   ++|||+||+|+|+...    +.+|++
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEe
Confidence            99999999999999999875      2889999999999999999999999   9999999999999643    579999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      |||++.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+..+.....         .+
T Consensus       182 DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------~i  250 (382)
T KOG0032|consen  182 DFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------AI  250 (382)
T ss_pred             eCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---------HH
Confidence            9999998765  445666789999999999999999999999999999999999999997765321111         11


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....+      .+..+.-...++.+.+++..|+..||..|+|+.++++
T Consensus       251 ~~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  251 LRGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HcCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            11111      1112222345678999999999999999999999986

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.9e-42  Score=303.00  Aligned_cols=257  Identities=25%  Similarity=0.416  Sum_probs=201.7

Q ss_pred             cCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .+|...+.||+|+||.||++...      ++..+++|.+.....    .....+.+|+.++..++|+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE----SARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH----HHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            56788899999999999999642      345788887664322    23456888999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQN----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE  214 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~  214 (360)
                      ..+++|||+++++|.+++......          ....+++..++.++.|++.|++|||+.+   ++|+||||+||++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence            999999999999999999764321          1135788999999999999999999999   999999999999999


Q ss_pred             CCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccc
Q 040763          215 RYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVS  292 (360)
Q Consensus       215 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~  292 (360)
                      ++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.......     
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----  232 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-----  232 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----
Confidence            9999999999987554322211 122335778999999999899999999999999999998 899985432110     


Q ss_pred             hHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          293 LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                          .........         ....+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus       233 ----~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 ----AIECITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----HHHHHHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                011111100         11112334567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-42  Score=303.52  Aligned_cols=265  Identities=27%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             cCCCccceecccCcEEEEEEEe-----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--
Q 040763           71 NHFNVNRILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--  143 (360)
                      ..|++.+.||+|+||.||++..     .++..+++|.++.....   .....+.+|+.+++.++|||++++++++...  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG---NHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH---HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            4578899999999999999974     24778999998754332   3345688999999999999999999998775  


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...+++|||+++++|.+++....    ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+||
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~df  153 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDF  153 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCC
Confidence            56789999999999999986532    25789999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCce--eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc------ccchHH
Q 040763          224 GTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE------NVSLAA  295 (360)
Q Consensus       224 g~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~------~~~~~~  295 (360)
                      |++.........  ......++..|+|||.+.+..++.++||||||+++|||++++.|+.........      ......
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05079         154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT  233 (284)
T ss_pred             ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence            999866443221  122345677899999998888999999999999999999987765332111000      000000


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      ..........         ....+..++.++.+|+.+||+.||++|||+.++++.|+.+
T Consensus       234 ~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         234 RLVRVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0011111110         1111233566899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4e-42  Score=308.36  Aligned_cols=239  Identities=28%  Similarity=0.362  Sum_probs=190.3

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++..+ +++.+|+|.+....... ....+.+..|..++..+ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            36999999999999986 57899999876432111 12344566788888776 79999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....... 
T Consensus        80 ~g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-  150 (320)
T cd05590          80 GGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-  150 (320)
T ss_pred             CchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-
Confidence            999999886543     4888999999999999999999999   9999999999999999999999999986532221 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        .. ....+....         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~-~~~~i~~~~---------  212 (320)
T cd05590         151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DD-LFEAILNDE---------  212 (320)
T ss_pred             CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HH-HHHHHhcCC---------
Confidence            122335689999999999998999999999999999999999999965431        01 111111111         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                       ...+...+.++.+++.+||+.||++||++
T Consensus       213 -~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 -VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence             01122345678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-41  Score=298.54  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=197.0

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|+||.||++.+. +++.+|+|........   .....+.+|+.++.+++||||+++++.+......+++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV---ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh---HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            5788899999999999999865 6788999987654222   23456888999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|..+.         .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        79 e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          79 EFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             ecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            999999996542         3678888899999999999999999   9999999999999999999999999987553


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ..   ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||.......... ..... .........    
T Consensus       147 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~----  217 (279)
T cd06619         147 NS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQL-LQCIVDEDP----  217 (279)
T ss_pred             cc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHH-HHHHhccCC----
Confidence            22   1223468999999999999899999999999999999999999996533211111 00010 111111100    


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ........++++.+++.+||+.||++||+++++++
T Consensus       218 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         218 ----PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                00011224557899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.6e-42  Score=307.35  Aligned_cols=243  Identities=26%  Similarity=0.358  Sum_probs=190.4

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||+|.+. +++.+|+|.++......+ ........|..++... +||||+++++++.+.+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            36999999999999976 478899998765321111 1233455677777754 99999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +|+|.+++....     .+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        80 ~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  150 (316)
T cd05619          80 GGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-  150 (316)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-
Confidence            999999987532     4788889999999999999999999   9999999999999999999999999986532211 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|||||||++|||++|..||.+...        ... ........         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~-~~~i~~~~---------  212 (316)
T cd05619         151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EEL-FQSIRMDN---------  212 (316)
T ss_pred             CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHH-HHHHHhCC---------
Confidence            122345689999999999998999999999999999999999999965331        010 11111100         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTME-EVS  348 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ei~  348 (360)
                       ...+...+.++.+++.+||+.||++||++. ++.
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         213 -PCYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             -CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence             111223455789999999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.6e-42  Score=298.13  Aligned_cols=254  Identities=33%  Similarity=0.534  Sum_probs=198.8

Q ss_pred             CCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |++.+.||+|+||+||++.... ++.+|+|.+.......  .......+|+.++..++||||+++++++......+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE--EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH--HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc--cccchhhhhhhcccccccccccccccccccccccccccc
Confidence            5678899999999999999874 5689999987654332  222334569999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      ++++++|.+++....     .+++..+..++.|++.||.+||+.+   ++|+||||+||+++.++.++|+|||.+.... 
T Consensus        79 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-  149 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-  149 (260)
T ss_dssp             EETTEBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-
T ss_pred             ccccccccccccccc-----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-
Confidence            999999999998332     5889999999999999999999999   9999999999999999999999999987542 


Q ss_pred             CCceeeecccccCCccchhhhc-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ..........++..|+|||++. +..++.++||||+|+++|+|++|..||.....  ...   ............     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~---~~~~~~~~~~~~-----  219 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQ---LEIIEKILKRPL-----  219 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHH---HHHHHHHHHTHH-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--hhh---hhhhhhcccccc-----
Confidence            2223344556899999999998 78889999999999999999999999875410  000   000000000000     


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..  .........+++.+++.+||+.||++|||+.++++
T Consensus       220 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  220 PS--SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HH--HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cc--cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  00000111268999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=306.41  Aligned_cols=257  Identities=22%  Similarity=0.292  Sum_probs=196.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++... +++.+|+|.+..... ......+.+.+|..++..++|+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence            46889999999999999999976 588999998764211 1112345577899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....    ..+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++...
T Consensus        80 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             EecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            99999999999996532    25888899999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhcc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ............||+.|+|||++..     ..++.++|||||||++|+|++|+.||.+...        ...........
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~~~  224 (331)
T cd05597         153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHK  224 (331)
T ss_pred             CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHcCC
Confidence            4433222233468999999999873     4578899999999999999999999965321        11111111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKK--RPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ei~~  349 (360)
                      ....+      .......++++.+++.+|+..++++  ||++.++++
T Consensus       225 ~~~~~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         225 EHFQF------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             CcccC------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            10110      0111225667899999988654443  788888864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.9e-42  Score=297.87  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=201.0

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .+|++.+.||+|+||.||++.+.++..+++|.+......     ...+.+|+.+++.++|||++++++++......+++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            467888999999999999998877788999987653322     245778999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....    ..+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        79 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          79 EFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             EcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            9999999999986532    25788999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...........++..|+|||.+.++.++.++||||||+++|||++ |..||.....         ......+....    
T Consensus       152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~~~----  218 (256)
T cd05112         152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---------SEVVETINAGF----  218 (256)
T ss_pred             cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---------HHHHHHHhCCC----
Confidence            332222222335678999999998889999999999999999998 8999854321         00111111110    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                           ....+...+.++.+++.+||+.+|++|||+.+++++|
T Consensus       219 -----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         219 -----RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 0011122346799999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=297.91  Aligned_cols=253  Identities=27%  Similarity=0.418  Sum_probs=195.4

Q ss_pred             ceecccCcEEEEEEEecC-Cc--EEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEe
Q 040763           77 RILGQGGQGTVYKGRLED-GR--IIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~-~~--~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      +.||+|+||.||+|..++ +.  .+++|..+.....   ...+.+.+|+.++.++ +||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH---HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            368999999999998764 33  4688877643222   2345677899999999 899999999999999999999999


Q ss_pred             cCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          153 IPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                      +++++|.+++......           ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEEC
Confidence            9999999999764321           1234788999999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHH
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      |||++......  ........+..|+|||++....++.++||||||+++|||++ |..||.+...        ..... .
T Consensus       155 dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~-~  223 (270)
T cd05047         155 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYE-K  223 (270)
T ss_pred             CCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHH-H
Confidence            99997532211  11111223567999999988889999999999999999997 9999854321        01111 1


Q ss_pred             hhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      .....         ....+...+.++.+++.+||+.||.+|||+.+++..|+.+.
T Consensus       224 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HhCCC---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11110         01112234457899999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=288.72  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=202.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++-+.||+|.|+.|+++.+. +|+.+|+|.+....-..  ...+++.+|+.+.+.++||||+++.+.+.+....|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            466888899999999999998764 68889988766543222  245677899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEEEeecCC
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAKVADFGT  225 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~  225 (360)
                      |+|+++|++|..-+-.+.     .+++...--.++||+.+|.|+|.++   |+|||+||+|+++..   ..-+||+|||+
T Consensus        88 vFe~m~G~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVARE-----FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             EEecccchHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccce
Confidence            999999999988776652     4677777788999999999999999   999999999999953   45689999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      |..++  ....-...+|||.|||||++...+|+..+|||+.|++||-|+.|++||.+....        ..+.+.+. +.
T Consensus       160 Ai~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------rlye~I~~-g~  228 (355)
T KOG0033|consen  160 AIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYEQIKA-GA  228 (355)
T ss_pred             EEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------HHHHHHhc-cc
Confidence            99887  233334568999999999999999999999999999999999999999763310        11111111 10


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                      .      ......-.+.+++..+|+.+||..||.+|.|+.|.+
T Consensus       229 y------d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  229 Y------DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             c------CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence            0      001111234566899999999999999999999875

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.1e-42  Score=299.23  Aligned_cols=256  Identities=25%  Similarity=0.448  Sum_probs=202.0

Q ss_pred             cCCCccceecccCcEEEEEEEecC-C---cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-G---RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      +.|++.+.||+|+||.||+|.... +   ..+++|.+......   .....+..|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE---KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            457888999999999999998753 2   36999988754332   3456788999999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      +++|||+++++|.+++....    ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~  153 (269)
T cd05065          81 MIITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccc
Confidence            99999999999999987532    25788999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCcee--eecc--cccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 040763          227 KFIAMDQTHV--TTKI--QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       227 ~~~~~~~~~~--~~~~--~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ..........  ....  ..+..|+|||.+.+..++.++||||||+++|||++ |..||......         ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---------~~~~~i  224 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------DVINAI  224 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---------HHHHHH
Confidence            7654322111  1111  12457999999999999999999999999999887 99998643210         011111


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      ....         ....+..++..+.+++.+||+.+|++||++.+++..|+.+
T Consensus       225 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 EQDY---------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HcCC---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1100         0111233456789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=295.92  Aligned_cols=249  Identities=27%  Similarity=0.389  Sum_probs=196.8

Q ss_pred             ceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEe
Q 040763           77 RILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      +.||+|+||.||+|.+..    +..+++|.+......   ...+.+.+|+.+++.++|+|++++++++. .+..+++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            469999999999997542    268999987754433   23456788999999999999999999876 4567999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCC
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD  232 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  232 (360)
                      +++++|.+++....     .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        77 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          77 APLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            99999999997543     5789999999999999999999999   999999999999999999999999998766443


Q ss_pred             Cceeee--cccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          233 QTHVTT--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       233 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ......  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.....     .   . .........    
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~---~-~~~~~~~~~----  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----A---E-VIAMLESGE----  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----H---H-HHHHHHcCC----
Confidence            322111  1223567999999998899999999999999999998 9999854321     0   0 111111111    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                           ....+..++..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       216 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 -----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                 11223345568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.3e-42  Score=307.75  Aligned_cols=262  Identities=22%  Similarity=0.293  Sum_probs=197.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|.+.+.||+|+||.||+|..+ +++.+|+|.++......   ....+.+|+.+++.++||||+++++++...+..+++
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC---cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            56899999999999999999876 57789999876543321   223466899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||++ ++|.+++....    ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        83 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          83 FEYLD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             EeCCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceec
Confidence            99996 58888886532    24788889999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc---c
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN---R  305 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  305 (360)
                      ..... ......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||.+.......     ..........   .
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~  228 (309)
T cd07872         155 SVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL-----HLIFRLLGTPTEET  228 (309)
T ss_pred             CCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHHHhCCCCHHH
Confidence            33221 1223357899999998865 46789999999999999999999999654321110     0000000000   0


Q ss_pred             ccccc------chHHh-------hhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHIL------DDQVM-------KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~------~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +..+.      +....       .......++++.+++.+||+.||.+|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000      00000       0011234567899999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-41  Score=298.27  Aligned_cols=255  Identities=25%  Similarity=0.335  Sum_probs=190.3

Q ss_pred             eecccCcEEEEEEEecC---CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           78 ILGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~~---~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      .||+|+||.||+|...+   ...+++|.+......   .....+.+|+.+++.++|+||+++++.+......+++|||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP---DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh---HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            58999999999997543   346788876543322   234567789999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++...........++.....++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh
Confidence            999999997754333334567888899999999999999999   99999999999999999999999999865433221


Q ss_pred             ee-eecccccCCccchhhhcc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          235 HV-TTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       235 ~~-~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      .. .....++..|+|||++..       ..++.++||||||+++|||++ |..||.....  .      ......... .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~------~~~~~~~~~-~  226 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--E------QVLKQVVRE-Q  226 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--H------HHHHHHhhc-c
Confidence            11 122345678999998643       356789999999999999999 7788754321  0      001111111 1


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ...+..+    ..+..++..+.+++..|| .||++|||+.+|++.|+
T Consensus       227 ~~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 DIKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111111    122345567888999999 59999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.1e-42  Score=307.72  Aligned_cols=243  Identities=26%  Similarity=0.363  Sum_probs=190.6

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++.++ ++..+|+|.++....... ........|..++... +||||+++++++.+.+..|+||||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence            46999999999999986 578999998875322111 1234455677777654 89999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|..++....     .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++....... 
T Consensus        80 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  150 (316)
T cd05620          80 GGDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-  150 (316)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence            999999986532     4788889999999999999999999   9999999999999999999999999986432111 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|||||||++|||++|..||.+....        . .........         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~-~~~~~~~~~---------  212 (316)
T cd05620         151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------E-LFESIRVDT---------  212 (316)
T ss_pred             CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------H-HHHHHHhCC---------
Confidence            1233456899999999999999999999999999999999999999654310        0 111111110         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTME-EVS  348 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ei~  348 (360)
                       ...+...+.++.+++.+||+.||++||++. ++.
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 -PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             111223456789999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.1e-41  Score=308.65  Aligned_cols=266  Identities=23%  Similarity=0.289  Sum_probs=196.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC---
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE---  144 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~---  144 (360)
                      ..++|++.+.||+|+||.||++.+. ++..+|+|.+.......  .....+.+|+.++..++||||+++++++....   
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ--THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch--hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            4578999999999999999999875 58899999986543222  33456778999999999999999999986543   


Q ss_pred             ---cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          145 ---FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       145 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                         ..+++|||++ ++|.+.+..       .++...+..++.|++.||.|||+++   |+||||||+||+++.++.+||+
T Consensus        97 ~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          97 EFQDVYLVMELMD-ANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             ccceeEEEEeCCC-cCHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEe
Confidence               4689999996 466666632       3778888899999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc---------
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS---------  292 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~---------  292 (360)
                      |||++......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..........         
T Consensus       166 Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  243 (359)
T cd07876         166 DFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA  243 (359)
T ss_pred             cCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence            99998754322  1223346899999999999999999999999999999999999999754311000000         


Q ss_pred             -----hHHHHHHHhhcc-ccccccchHH--------hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          293 -----LAAYFVHSMRKN-RLYHILDDQV--------MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       293 -----~~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ............ ......-...        ........++++.+|+.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                 000000000000 0000000000        00011123467899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.4e-42  Score=308.36  Aligned_cols=263  Identities=25%  Similarity=0.372  Sum_probs=206.1

Q ss_pred             hcCCCccceecccCcEEEEEEEecC--------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED--------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCC  140 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~  140 (360)
                      ..+|.+.+.||+|+||.||++....        +..+|+|........   ...+++.+|+.++.++ +||||+++++++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD---KDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH---HHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            3568999999999999999997421        236899987653322   3456788899999999 899999999999


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQ-----------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN  209 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~N  209 (360)
                      ......++++||+++++|.+++.....           ..+..+++..++.++.|++.||.|||+++   ++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence            999999999999999999999976432           12335788999999999999999999999   9999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCc
Q 040763          210 ILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTS  287 (360)
Q Consensus       210 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~  287 (360)
                      |+++.++.+||+|||++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.+...  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            999999999999999987654322111 122234567999999999999999999999999999998 8888854321  


Q ss_pred             ccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          288 QENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                            .. .........         ....+...+.++.+++.+||+.+|++|||+.++++.|..+..
T Consensus       243 ------~~-~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 ------EE-LFKLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             ------HH-HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                  11 111111111         111223345579999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-41  Score=300.59  Aligned_cols=253  Identities=26%  Similarity=0.312  Sum_probs=199.6

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |+..+.||+|+||.||++.+. +++.+|+|.+....... ......+..|+.+++.++|+|++++++.+...+..+++||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            667789999999999999876 67899999876432221 1223456789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+++++|.+++....   ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.....
T Consensus        81 ~~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          81 LMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             ecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            999999999886532   225888999999999999999999999   99999999999999999999999999875433


Q ss_pred             CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                      ...  .....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........     .........         
T Consensus       155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-----~~~~~~~~~---------  218 (285)
T cd05630         155 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVERLVK---------  218 (285)
T ss_pred             Ccc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-----HHHHHhhhh---------
Confidence            221  2234689999999999999999999999999999999999999965432110     000000000         


Q ss_pred             hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 040763          312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVSM  349 (360)
Q Consensus       312 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~~  349 (360)
                       ......+...++++.+|+.+||+.||++|||     +.|+++
T Consensus       219 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         219 -EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             0011123345567899999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.9e-42  Score=309.08  Aligned_cols=264  Identities=26%  Similarity=0.370  Sum_probs=202.7

Q ss_pred             hcCCCccceecccCcEEEEEEEe------cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEee
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLE  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~  142 (360)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|.++.....   .....+.+|+.++..+ +||||+++++++..
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh---HHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            35799999999999999999973      24678999998754332   2345677899999999 78999999998765


Q ss_pred             C-CcceEEEEecCCCChhHHhhhhccC-----------------------------------------------------
Q 040763          143 T-EFPLLVYEFIPNGTLYQHLHDRHQN-----------------------------------------------------  168 (360)
Q Consensus       143 ~-~~~~lv~e~~~~~~L~~~l~~~~~~-----------------------------------------------------  168 (360)
                      . ...+++|||+++|+|.+++......                                                     
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 4568999999999999998653210                                                     


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc-eeee
Q 040763          169 ---------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTT  238 (360)
Q Consensus       169 ---------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~  238 (360)
                               ....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++........ ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                     0123678888999999999999999999   99999999999999999999999999876533221 1122


Q ss_pred             cccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhh
Q 040763          239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL  317 (360)
Q Consensus       239 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (360)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......        ...........         ..
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~---------~~  302 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------EFCRRLKEGTR---------MR  302 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--------HHHHHHhccCC---------CC
Confidence            2345678999999988889999999999999999997 899985432110        01111111111         11


Q ss_pred             ccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          318 GKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       318 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      .+...++++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            122234578999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-41  Score=313.56  Aligned_cols=261  Identities=23%  Similarity=0.327  Sum_probs=196.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ...|.+.+.||+|+||.||++.+. .++.||+|....          ..+.+|+.++++++|+||+++++++...+..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            346999999999999999999986 477899995322          234579999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +||++ .++|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       238 v~e~~-~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~  309 (461)
T PHA03211        238 VLPKY-RSDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF  309 (461)
T ss_pred             EEEcc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCcee
Confidence            99999 578988886532    25899999999999999999999999   99999999999999999999999999976


Q ss_pred             cCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc---
Q 040763          229 IAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN---  304 (360)
Q Consensus       229 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  304 (360)
                      ....... ......||..|+|||++.+..++.++|||||||++|||++|..|++.............+ ....+...   
T Consensus       310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~-l~~~i~~~~~~  388 (461)
T PHA03211        310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ-ILRIIRQAQVH  388 (461)
T ss_pred             cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHH-HHHHHHhhccc
Confidence            5432211 122356999999999999999999999999999999999988776554322211111111 11111100   


Q ss_pred             --ccccccchHHhhh-------------------ccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 --RLYHILDDQVMKL-------------------GKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 --~~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        .........+...                   .-.....++.+|+.+||+.||.+|||+.|+++
T Consensus       389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence              0000000000000                   00012347889999999999999999999985

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-41  Score=295.99  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=198.6

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe-eCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL-ETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~~~lv  149 (360)
                      .+|.+.+.||+|+||.||++... +..+++|..+...      ..+.+.+|+.+++.++|+|++++++++. .....+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            46888999999999999999775 6788999876432      2345778999999999999999999764 45678999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....   ...+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++...
T Consensus        79 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          79 TEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             EECCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceec
Confidence            99999999999987532   224788999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ....    ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.....        .. .........   
T Consensus       153 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~-~~~~~~~~~---  216 (256)
T cd05082         153 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KD-VVPRVEKGY---  216 (256)
T ss_pred             cccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHhcCC---
Confidence            3221    12234667999999998889999999999999999998 9999854321        11 111111110   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                            ....+..+++.+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       217 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 ------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  1112234456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.7e-42  Score=307.76  Aligned_cols=240  Identities=26%  Similarity=0.340  Sum_probs=187.4

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHH-HHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIF-ILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~-~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++... +++.+|+|.+........ .....+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK-KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36999999999999986 578899998764322111 12233445544 5778899999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|...+....     .++...+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....... 
T Consensus        80 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  150 (321)
T cd05603          80 GGELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-  150 (321)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence            999988886432     4778888899999999999999999   9999999999999999999999999986532221 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||.+.+..++.++|||||||++|||++|..||.....        ........ ...         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~-~~~---------  212 (321)
T cd05603         151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNIL-HKP---------  212 (321)
T ss_pred             CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHh-cCC---------
Confidence            122345689999999999998899999999999999999999999965321        11111111 110         


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTME  345 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  345 (360)
                       ...+...+.++.+++.+||+.||.+||++.
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 -LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             112333456799999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.1e-42  Score=309.11  Aligned_cols=244  Identities=27%  Similarity=0.370  Sum_probs=189.7

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHH-HHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIF-ILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~-~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+||.||++... +++.+|+|++........ .....+..|.. +++.++||||+++++.+...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence            36999999999999875 688999998765322111 22234445544 4677899999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|..++....     .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  150 (325)
T cd05604          80 GGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-  150 (325)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-
Confidence            999998886532     5889999999999999999999999   9999999999999999999999999986532211 


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ...+..... ...        
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~-~~~--------  213 (325)
T cd05604         151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILH-KPL--------  213 (325)
T ss_pred             CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHc-CCc--------
Confidence            122345689999999999999999999999999999999999999965321        111111111 100        


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        ..++..+.++.+++.+||+.||.+||++.+.++
T Consensus       214 --~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         214 --VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             --cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence              112234557889999999999999999864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-41  Score=303.47  Aligned_cols=199  Identities=26%  Similarity=0.386  Sum_probs=160.1

Q ss_pred             cceecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--CCcceEEE
Q 040763           76 NRILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--TEFPLLVY  150 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~lv~  150 (360)
                      .+.||+|+||.||+|..+   +++.+|+|.+.....      ...+.+|+.+++.++||||+++++++..  ....+++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            357999999999999865   457899998764322      2235689999999999999999998854  44578999


Q ss_pred             EecCCCChhHHhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----cCCCcEEEee
Q 040763          151 EFIPNGTLYQHLHDRHQN----EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVAD  222 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~D  222 (360)
                      ||+ +++|.+++......    ....+++..+..++.|++.||.|||+++   |+||||||+|||+    +.++.+||+|
T Consensus        80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            998 46888887643211    1235888999999999999999999999   9999999999999    4567899999


Q ss_pred             cCCccccCCCCc--eeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 040763          223 FGTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTG  284 (360)
Q Consensus       223 fg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~  284 (360)
                      ||++........  .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            999976543221  122345689999999998774 57899999999999999999999997554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=317.41  Aligned_cols=256  Identities=24%  Similarity=0.421  Sum_probs=214.8

Q ss_pred             CccceecccCcEEEEEEEe-cCCc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           74 NVNRILGQGGQGTVYKGRL-EDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~-~~~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ...++||+|+||+||+|.+ ..++    +||+|++......   ....++++|+-+|.+++|||++++++++.... +.+
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~---~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP---KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc---hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            3456899999999999975 3343    6788876554333   34668899999999999999999999998776 789


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      |++|++.|+|.+|++..+.    .+.....+.+..|||+|+.|||.+.   ++||||..+|||+..-.++||.|||+++.
T Consensus       775 vtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             HHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            9999999999999987443    5888899999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCceeee-cccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          229 IAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       229 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      +..+...... ...-.+.|||=|.+....++.++|||||||++||++| |..|+++...                  ..+
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------------------~eI  909 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------------------EEI  909 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------------------HHh
Confidence            8765543322 2234678999999999999999999999999999999 9999977542                  223


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      .+++....+...|+.++-++..++.+||..|+..||+++++.++++.+-++.
T Consensus       910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            3444555556678888889999999999999999999999999999887654

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-41  Score=303.52  Aligned_cols=261  Identities=28%  Similarity=0.417  Sum_probs=199.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++.+. ++..+++|.+......   .....+.+|++++..++||||+++++++..++..+++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP---AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            36889999999999999999876 5778888887654322   2345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      |||+++++|.+++....     .+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~ey~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (308)
T cd06615          78 MEHMDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  149 (308)
T ss_pred             eeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccc
Confidence            99999999999997532     57889999999999999999998 47   99999999999999999999999999865


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc---
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR---  305 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  305 (360)
                      ....   ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........     ...+........   
T Consensus       150 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~  221 (308)
T cd06615         150 LIDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-----EAMFGRPVSEGEAKE  221 (308)
T ss_pred             cccc---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-----HHhhcCccccccccC
Confidence            4322   12334688999999999888899999999999999999999999854321100     000000000000   


Q ss_pred             -----------------cccccch----HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          306 -----------------LYHILDD----QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       306 -----------------~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                                       ..+..+.    ..........+.++.+++.+||+.||++|||+.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             0000000    00000011256679999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-41  Score=308.70  Aligned_cols=267  Identities=20%  Similarity=0.258  Sum_probs=197.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC--
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE--  144 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--  144 (360)
                      ...++|++.+.||+|+||.||++.+. .++.+|+|.+.......  .....+.+|+.+++.++||||+++++++....  
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh--HHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            34578999999999999999999875 57889999877543322  23456778999999999999999999886433  


Q ss_pred             ----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          145 ----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       145 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                          ..+++|||++ +++.+.+..       .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||
T Consensus        92 ~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          92 EEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             cccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEE
Confidence                4689999995 467676643       3778888999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH------
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA------  294 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~------  294 (360)
                      +|||++......  .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+............      
T Consensus       161 ~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (355)
T cd07874         161 LDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_pred             eeCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999765332  222345689999999999998999999999999999999999999965431110000000      


Q ss_pred             -H-------HHHHHhhcc-ccccccchHH--------hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          295 -A-------YFVHSMRKN-RLYHILDDQV--------MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       295 -~-------~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       .       ......... ..........        ....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence             0       000000000 0000000000        00111223457899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=295.13  Aligned_cols=269  Identities=24%  Similarity=0.360  Sum_probs=202.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhh--cCCCCceeeeeEEeeCC
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ--INHRNVVKLLGCCLETE  144 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~--l~h~niv~~~~~~~~~~  144 (360)
                      .....+..+.+.||+|.||.||+|.++ |..||||++....       ...+.+|.++++.  ++|+||+.|++....+.
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            345577889999999999999999997 7889999987532       2345577777765  59999999999876543


Q ss_pred             ----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCeEEcCC
Q 040763          145 ----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-----GASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       145 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-----~~~~~i~H~dlk~~Nill~~~  215 (360)
                          .+++|++|.+.|||.|||.+.      +++.+..++++..+|.||++||.     +|++.|.|||||+.|||+..+
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence                468999999999999999763      58899999999999999999995     578889999999999999999


Q ss_pred             CcEEEeecCCccccCCCCce---eeecccccCCccchhhhccCCC------CCccchhhhHHHHHHHHh----C------
Q 040763          216 YRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSSQL------TDKSDVYSFGVVLVELLT----G------  276 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwslG~il~el~t----g------  276 (360)
                      +.+.|+|+|+|-....+...   ..+..+||.+|||||++...-.      -..+||||||+++||++-    |      
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            99999999999765443222   1344679999999999887421      236899999999999863    2      


Q ss_pred             CCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          277 KKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       277 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      +.||.+.-..+..    .+..............+..   .....+....+.+++..||..+|..|.|+-.+.+.|..+.+
T Consensus       433 ~~Pyyd~Vp~DPs----~eeMrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  433 QLPYYDVVPSDPS----FEEMRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCcccCCCCCCC----HHHHhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            3677554321111    0011111111111111111   11223455678999999999999999999999999988874

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.4e-41  Score=295.05  Aligned_cols=252  Identities=30%  Similarity=0.438  Sum_probs=192.0

Q ss_pred             ceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe-eCCcceEEEE
Q 040763           77 RILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL-ETEFPLLVYE  151 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~~~lv~e  151 (360)
                      +.||+|+||.||+|...+    ...+|+|.+......   ...+.+.+|+.+++.++|||++++++++. .+...+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL---EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH---HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            368999999999998542    357899987543222   33556778999999999999999999765 4556789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+.+++|.+++.....    ..++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus        78 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~  150 (262)
T cd05058          78 YMKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYD  150 (262)
T ss_pred             cCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccC
Confidence            9999999999975322    3567778889999999999999999   99999999999999999999999999875533


Q ss_pred             CCcee---eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          232 DQTHV---TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG-KKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       232 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .....   .....++..|+|||.+.+..++.++||||||+++|||++| .+||.....     ....    .......  
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~----~~~~~~~--  219 (262)
T cd05058         151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FDIT----VYLLQGR--  219 (262)
T ss_pred             CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH----HHHhcCC--
Confidence            22111   1123457789999999888899999999999999999995 455533210     0011    1111100  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                             ....+...+..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus       220 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 -------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                   011122334579999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-41  Score=296.58  Aligned_cols=253  Identities=30%  Similarity=0.401  Sum_probs=198.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|++.+.||+|+||.||+|... +++.+|+|+.......    ....+.+|+.++..++||||+++++.+......+++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD----DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc----hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            56999999999999999999975 6788999987653222    234567899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     ++++..+..++.|++.||.|||+.+   ++|+|++|+||+++.++.++|+|||++...
T Consensus        85 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          85 MEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceee
Confidence            99999999999986432     5788999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .... .......++..|+|||.+.   ...++.++|+||||+++|||++|+.||..........         .+.....
T Consensus       157 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---------~~~~~~~  226 (267)
T cd06646         157 TATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---------LMSKSNF  226 (267)
T ss_pred             cccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---------eeecCCC
Confidence            3221 1122345788999999874   3457789999999999999999999985432110000         0000000


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                         ....  ......++.++.+++.+||+.+|++|||+.++++.
T Consensus       227 ---~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         227 ---QPPK--LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             ---CCCC--CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence               0000  00122345689999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-41  Score=294.71  Aligned_cols=252  Identities=32%  Similarity=0.483  Sum_probs=203.9

Q ss_pred             ceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEe
Q 040763           77 RILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      +.||+|+||.||++....    +..+++|.+.......   ..+.+.+|+..+..++|+|++++++++......+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh---HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            469999999999998764    7789999987654432   456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          153 IPNGTLYQHLHDRHQN----EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +++++|.+++......    ....+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccc
Confidence            9999999999775211    1246899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          229 IAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       229 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ...... .......++..|+|||.+....++.++||||+|+++|+|++ |..||.....         ..........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~~~~--  223 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---------EEVLEYLRKG--  223 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHHcC--
Confidence            654321 11233457889999999998889999999999999999999 6899865421         0011111111  


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                             .....+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       224 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 -------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   111223444678999999999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-41  Score=305.91  Aligned_cols=244  Identities=24%  Similarity=0.315  Sum_probs=193.3

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~lv  149 (360)
                      +|+..+.||+|+||.||++..+ +++.||+|++....... ....+.+..|..++..+. |++|+++++++...+..|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence            3677889999999999999876 58899999876532211 123445667888888875 57888999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        80 ~Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          80 MEYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence            99999999999986532     5889999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... .......||+.|+|||++.+..++.++||||+|+++|+|++|..||.+...        .... ..+....    
T Consensus       152 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~-~~i~~~~----  217 (323)
T cd05615         152 MVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELF-QSIMEHN----  217 (323)
T ss_pred             CCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHH-HHHHhCC----
Confidence            3222 112334689999999999998999999999999999999999999965431        0001 1111110    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                            ...+...+.++.+++.+||+.+|.+|++.
T Consensus       218 ------~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ------VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                  11233455678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-41  Score=305.62  Aligned_cols=258  Identities=21%  Similarity=0.276  Sum_probs=197.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++..+ +++.+|+|.+...... .......+..|+.++..++|+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence            36889999999999999999976 4678999987542111 112334577889999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        80 ~ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             EeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheec
Confidence            99999999999997532    25888899999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ............||+.|+|||++.     ...++.++|||||||++|||++|+.||.....        ...+.......
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~  224 (332)
T cd05623         153 MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHK  224 (332)
T ss_pred             ccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCC
Confidence            433333333456999999999886     34678899999999999999999999964321        11111111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKK--RPTMEEVSME  350 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ei~~~  350 (360)
                      ....      ........++++.+|+.+|++.++.+  |+++.++++.
T Consensus       225 ~~~~------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         225 ERFQ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cccc------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0000      00111234668899999999765544  6788888654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.6e-42  Score=304.30  Aligned_cols=271  Identities=23%  Similarity=0.330  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|.+.+.||+|+||.||++..+ +++.+|+|.+.......   ....+.+|+.++..++||||+++++++......+++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC---chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            56899999999999999999876 57889999876543321   233456899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||++ ++|.+++....    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          83 FEYLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             Eeccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            99996 68988886532    24788899999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc---cc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK---NR  305 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~  305 (360)
                      ...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......  +.   ..........   ..
T Consensus       155 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~---~~~~~~~~~~~~~~~  228 (301)
T cd07873         155 SIPTKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQ---LHFIFRILGTPTEET  228 (301)
T ss_pred             CCCCCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HH---HHHHHHHcCCCChhh
Confidence            332211 122346889999998766 45788999999999999999999999654311  00   0001110000   00


Q ss_pred             cccccc---------hHH----hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHHhHhhc
Q 040763          306 LYHILD---------DQV----MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM--ELNGIRGSI  358 (360)
Q Consensus       306 ~~~~~~---------~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~--~L~~l~~~~  358 (360)
                      +..+..         +..    ........++++.+|+.+||+.||.+|||+.|+++  -++.+..++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~  296 (301)
T cd07873         229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI  296 (301)
T ss_pred             chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence            000000         000    00111234557899999999999999999999986  444444443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.5e-42  Score=311.43  Aligned_cols=202  Identities=30%  Similarity=0.407  Sum_probs=173.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-C-----CCceeeeeEE
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-H-----RNVVKLLGCC  140 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h-----~niv~~~~~~  140 (360)
                      ....+|.+.+.||+|+||.|.+|.+. +++.||||+++....     ...+...|+.+|..++ |     -|+|+++++|
T Consensus       183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            34458899999999999999999875 689999999886432     3455668999999986 3     4999999999


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC--CCcE
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE--RYRA  218 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~--~~~~  218 (360)
                      ...++.++|+|.+ ..+|.++++.+.   ...++...++.|+.||+.||.+||..+   |||+||||+||||.+  ...+
T Consensus       258 ~fr~HlciVfELL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  258 YFRNHLCIVFELL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             ccccceeeeehhh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCce
Confidence            9999999999988 689999998754   346899999999999999999999999   999999999999974  3479


Q ss_pred             EEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 040763          219 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN  285 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~  285 (360)
                      |++|||.++.....-.    ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+..+
T Consensus       331 KVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  331 KVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             eEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            9999999987643222    44568889999999999999999999999999999999877766654

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.8e-41  Score=305.55  Aligned_cols=257  Identities=22%  Similarity=0.293  Sum_probs=197.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|.+.+.||+|+||.||++..+ +++.+|+|.+..... ........+.+|..++..++|+||+++++++.+.+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            46889999999999999999976 578899998764211 1112344567889999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....    ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++...
T Consensus        80 ~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             EeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            99999999999997632    25788899999999999999999999   999999999999999999999999999766


Q ss_pred             CCCCceeeecccccCCccchhhhcc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ............||+.|+|||++.+     +.++.++||||||+++|+|++|+.||.....        ...........
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~  224 (331)
T cd05624         153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHE  224 (331)
T ss_pred             cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcCC
Confidence            5443333334569999999998876     4678899999999999999999999964321        11111111110


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKK--RPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~ei~~  349 (360)
                      ....     . .......++++.+++.+|++.++.+  |+++.++++
T Consensus       225 ~~~~-----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         225 ERFQ-----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             Cccc-----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            0000     0 0011224567999999999876544  457777754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=296.92  Aligned_cols=248  Identities=27%  Similarity=0.392  Sum_probs=202.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||.|++|.||++... +++.+++|.+......   .....+.+|+.+++.++|+|++++++.+......+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE---DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc---hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            36888899999999999999876 5889999987654322   2345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+++++|.+++...      ++++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        78 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          78 MEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             EEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceee
Confidence            9999999999998653      5889999999999999999999999   999999999999999999999999999776


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......        . .........    
T Consensus       149 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~-~~~~~~~~~----  214 (274)
T cd06609         149 TSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------R-VLFLIPKNN----  214 (274)
T ss_pred             cccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------H-HHHHhhhcC----
Confidence            5432 1223345788999999999988999999999999999999999999643310        0 001111110    


Q ss_pred             cchHHhhhccHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKN-QIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ....+.. +++++.+++.+||..+|++|||++++++
T Consensus       215 -----~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         215 -----PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -----CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 1111111 5667999999999999999999999964

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4e-42  Score=313.50  Aligned_cols=253  Identities=24%  Similarity=0.306  Sum_probs=195.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++..+ +++.+|+|.++..... .......+..|+.++..++||||+++++.+.+.+..++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            36888999999999999999876 5889999987643211 123345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++|+|||++...
T Consensus        80 ~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          80 MEFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            99999999999996532     5788999999999999999999999   999999999999999999999999998654


Q ss_pred             CCCCc----------------------------------eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh
Q 040763          230 AMDQT----------------------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT  275 (360)
Q Consensus       230 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t  275 (360)
                      .....                                  ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            22110                                  00113468999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC---HHHHH
Q 040763          276 GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT---MEEVS  348 (360)
Q Consensus       276 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~ei~  348 (360)
                      |+.||.+....        ..+...........     ..  .....++++.+++.+|+. ||.+|++   +.+++
T Consensus       232 G~~Pf~~~~~~--------~~~~~i~~~~~~~~-----~p--~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~  291 (360)
T cd05627         232 GYPPFCSETPQ--------ETYRKVMNWKETLV-----FP--PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK  291 (360)
T ss_pred             CCCCCCCCCHH--------HHHHHHHcCCCcee-----cC--CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence            99999654310        00111110000000     00  011245678899999774 9999996   45554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.2e-41  Score=294.83  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=202.2

Q ss_pred             CCCccceecccCcEEEEEEEecCCcEEEEEecccccCh--HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD--EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +|.+.+.||+|+||.||+|...+++.+|+|.+......  ........+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47788999999999999999888899999987654322  1223345688899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+++++|.+++....     ++++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            99999999999996532     4788889999999999999999999   999999999999999999999999998764


Q ss_pred             CCCC-----ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          230 AMDQ-----THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       230 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ....     ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.......       . ........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~-~~~~~~~~  224 (265)
T cd06631         153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-------A-MFYIGAHR  224 (265)
T ss_pred             hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-------H-HHHhhhcc
Confidence            3211     111223458899999999998889999999999999999999999996432100       0 00000000


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .        .....+..++.++.+++.+||+.+|++|||+.++++
T Consensus       225 ~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 G--------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             C--------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0        011123345668999999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-41  Score=291.35  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=198.2

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCC
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNG  156 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  156 (360)
                      +.||+|++|.||++...+++.+++|........   .....+.+|+.++++++|+||+++++++......+++|||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            369999999999999877899999987764433   23456788999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCcee
Q 040763          157 TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV  236 (360)
Q Consensus       157 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  236 (360)
                      +|.+++....    ..+++..+..++.+++.||.|||+++   ++||||+|+||+++.++.++|+|||++..........
T Consensus        78 ~l~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          78 SLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            9999986532    25788899999999999999999999   9999999999999999999999999987654222111


Q ss_pred             e-ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          237 T-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       237 ~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                      . ....++..|+|||.+.++.++.++|+||||+++|+|++ |..||.......         ........         .
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---------~~~~~~~~---------~  212 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---------TRERIESG---------Y  212 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---------HHHHHhcC---------C
Confidence            1 11223567999999988889999999999999999999 888885443100         01111110         0


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ....+...+.++.+++.+||+.+|++|||+.|+++.|.
T Consensus       213 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            11123344568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2e-41  Score=299.21  Aligned_cols=268  Identities=25%  Similarity=0.328  Sum_probs=198.0

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|++|.||+|..+ +++.+++|.++......  .....+.+|+.++..++|||++++++++..+...++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE--GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC--CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence            4788899999999999999976 68899999876543221  22345678999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||++ ++|.+++.....  ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus        79 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          79 EFLS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             ecCC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            9996 689888865332  236889999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH------HHHHhh-
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY------FVHSMR-  302 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~------~~~~~~-  302 (360)
                      ... .......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||.+..............      ...... 
T Consensus       153 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         153 IPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             CCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence            322 112233568899999988664 56889999999999999999999996543211000000000      000000 


Q ss_pred             ----ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 ----KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          .......... .........++++.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         232 LPDYKNTFPKWKKG-SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hHHHHhhccccCcc-hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                0000000000 001112235668899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.5e-41  Score=300.57  Aligned_cols=262  Identities=23%  Similarity=0.316  Sum_probs=191.4

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc---CCCCceeeeeEEee-----
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI---NHRNVVKLLGCCLE-----  142 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l---~h~niv~~~~~~~~-----  142 (360)
                      +|++.+.||+|+||.||++.++ +++.+|+|.++.......  ....+.+|+.++..+   +||||+++++++..     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG--LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC--CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            4888999999999999999876 588999998765322211  112334566655554   79999999998764     


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                      ....+++||++. ++|.+++....   ...+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|
T Consensus        79 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          79 ETKVTLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             CceEEEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence            234689999996 58988886532   224889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ||++.......  ......||..|+|||++.+..++.++||||+||++|+|++|..||........    + ........
T Consensus       152 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~----~-~~~~~~~~  224 (288)
T cd07863         152 FGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----L-GKIFDLIG  224 (288)
T ss_pred             cCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH----H-HHHHHHhC
Confidence            99987654322  12334678999999999988899999999999999999999999854332110    0 00111100


Q ss_pred             c---cccccc-------cc---hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 K---NRLYHI-------LD---DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~---~~~~~~-------~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .   ..+...       ..   ........+..++++.+++.+||+.||++|||+.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0   000000       00   00001112234567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.1e-41  Score=297.52  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=203.6

Q ss_pred             cCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .+|++.+.||+|+||.||++..+      +.+.+++|.+......   ...+.+.+|+.++.+++|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE---NLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch---HHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            56888999999999999999864      2457888876543221   24567889999999999999999999999989


Q ss_pred             cceEEEEecCCCChhHHhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNE----EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                      ..+++|||+++++|.+++.......    ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEE
Confidence            9999999999999999997643211    125889999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      +|||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......        . ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--------~-~~~  229 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--------E-VLN  229 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--------H-HHH
Confidence            9999986543332222333346778999999988888999999999999999999 78888543210        0 111


Q ss_pred             HhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ........        ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       230 ~~~~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 RLQAGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHcCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11111110        1112234557999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.3e-41  Score=298.63  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=200.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|++.+.||+|++|.||++... +++.+++|.+......    ..+.+.+|+.+++.++|+|++++++.+......++|
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            57899999999999999999865 6789999987653322    235577899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++...      .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        96 ~e~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             ecccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            9999999999998542      4788899999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....  ..     . ........ ..  
T Consensus       167 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--~~-----~-~~~~~~~~-~~--  234 (296)
T cd06654         167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LR-----A-LYLIATNG-TP--  234 (296)
T ss_pred             ccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--HH-----h-HHHHhcCC-CC--
Confidence            33221 12234688899999999988889999999999999999999999965431  00     0 00010000 00  


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ....+...+..+.+++.+||..||++|||+.++++
T Consensus       235 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         235 -----ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -----CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                 01113345567999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=296.90  Aligned_cols=267  Identities=28%  Similarity=0.403  Sum_probs=198.7

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhh--cCCCCceeeeeEEeeCC----
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ--INHRNVVKLLGCCLETE----  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~--l~h~niv~~~~~~~~~~----  144 (360)
                      ...+..+.+|+|.||.||+|... ++.||||++..       ...+.+..|-.+...  +.|+||++|++.-....    
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            44566788999999999999986 48999999875       334556666666654  58999999999876544    


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCCeEEcCCCcE
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG------ASSPIYHRDIKSTNILLDERYRA  218 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~------~~~~i~H~dlk~~Nill~~~~~~  218 (360)
                      .+++|++|.+.|+|.+||..+      .++|.....++..+++||+|||+.      .+++|+|||||+.||||.+|+++
T Consensus       282 eywLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            678999999999999999874      599999999999999999999974      25689999999999999999999


Q ss_pred             EEeecCCccccCCCC-ceeeecccccCCccchhhhccCC-CC-----CccchhhhHHHHHHHHhCCCCCCCCCCCcc---
Q 040763          219 KVADFGTSKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQ-LT-----DKSDVYSFGVVLVELLTGKKPIFSTGNTSQ---  288 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~el~tg~~p~~~~~~~~~---  288 (360)
                      .|+|||+|..+.... .......+||.+|||||++.+.- ..     .+.||||+|.++|||++....++. +..+.   
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yql  434 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQL  434 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccC
Confidence            999999998876433 22233468999999999998742 22     267999999999999986654431 11111   


Q ss_pred             -------cccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          289 -------ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       289 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                             ....+.+...-.........+.+. +...   ....-+++.+..||..||+.|.|+.=+.+++..+..
T Consensus       435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~-W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDA-WRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             chhHHhcCCCCHHHHHHHHHhhccCCCChhh-hhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence                   111112211222222222222221 1111   234468999999999999999999999888887753

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-41  Score=304.67  Aligned_cols=267  Identities=18%  Similarity=0.231  Sum_probs=194.2

Q ss_pred             ccceeccc--CcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           75 VNRILGQG--GQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        75 ~~~~lg~G--~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      +.++||+|  +|++||++..+ +++.||+|.+.......  ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN--EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            45789999  78999999875 68899999987643332  234456679999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+++++|.+++..+..   ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++++||+.......
T Consensus        80 ~~~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          80 FMAYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             ccCCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999999965321   24788999999999999999999999   99999999999999999999999986543321


Q ss_pred             CCc-e-----eeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH-------
Q 040763          232 DQT-H-----VTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY-------  296 (360)
Q Consensus       232 ~~~-~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------  296 (360)
                      ... .     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||................       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence            110 0     0111246778999999876  458899999999999999999999996532111000000000       


Q ss_pred             ---HHHHhhccc-----cccc------------cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          297 ---FVHSMRKNR-----LYHI------------LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       297 ---~~~~~~~~~-----~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         .........     ....            ............+++++.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence               000000000     0000            0000011123345678999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.7e-41  Score=292.32  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=199.8

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee-CCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE-TEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~lv  149 (360)
                      +|++.+.||+|++|.||++..+ +++.+++|.+.......  ...+.+.+|+.+++.++|+|++++++.+.. ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR--RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH--HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence            4888999999999999999876 57789999876433221  234567789999999999999999998764 4457899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....   ...+++..+..++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        79 ~e~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          79 MGFCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             ecccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            99999999999997532   235889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.....        ... .........   
T Consensus       153 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~-~~~~~~~~~---  219 (257)
T cd08223         153 ENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSL-VYRIIEGKL---  219 (257)
T ss_pred             cccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHH-HHHHHhcCC---
Confidence            4322 222334688999999999999999999999999999999999999854321        000 011111111   


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ...+...++++.+++.+||+.||++|||+.++++
T Consensus       220 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  1223446678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-41  Score=310.58  Aligned_cols=266  Identities=20%  Similarity=0.274  Sum_probs=196.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC----
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET----  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----  143 (360)
                      ..++|++.+.||+|+||.||++.+. .++.+|+|++.......  .....+.+|+.+++.++||||+++++++...    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc--hhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            4578999999999999999999875 57889999887543322  2345677899999999999999999987543    


Q ss_pred             --CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          144 --EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       144 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                        ...|+||||++ ++|.+.+..       .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875         100 EFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             ccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEE
Confidence              34699999995 577777743       3778888999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch-------H
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL-------A  294 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~-------~  294 (360)
                      |||++......  .......+|..|+|||++.+..++.++|||||||++|+|++|+.||.+...........       .
T Consensus       169 DfG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (364)
T cd07875         169 DFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  246 (364)
T ss_pred             eCCCccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99999765332  12233468999999999999999999999999999999999999996543211000000       0


Q ss_pred             HH-------HHHHhhccc-cccccchHH--------hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          295 AY-------FVHSMRKNR-LYHILDDQV--------MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       295 ~~-------~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..       ......... .........        ........+.++.+|+.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00       000000000 000000000        00011112457899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-41  Score=295.44  Aligned_cols=258  Identities=24%  Similarity=0.419  Sum_probs=203.7

Q ss_pred             cCCCccceecccCcEEEEEEEecC-Cc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-GR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .+|++.+.||+|+||.||+|..++ +.    .+++|........   .....+.+|+.++..++|||++++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP---KANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            568888999999999999998653 32    5888887654332   345667889999999999999999999887 77


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+++++|.+++....    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcc
Confidence            899999999999999997532    24889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +.......... .....++..|+|||.+....++.++|+||||+++||+++ |..||.+...         .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~  226 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---------VEIPDLLEK  226 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---------HHHHHHHhC
Confidence            98765332211 111224568999999988889999999999999999998 9999865321         011111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..         ....+..++..+.+++.+||..||++|||+.++++.|+.+.++
T Consensus       227 ~~---------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         227 GE---------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            11         0111222345688999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-41  Score=305.29  Aligned_cols=261  Identities=21%  Similarity=0.356  Sum_probs=192.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ...+|.+.+.||+|+||.||+|... ++..+|+|.....          ....|+.++..++||||+++++++......+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            3467999999999999999999976 4678999974432          1235888999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++||++ .++|.+++....    .++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       134 lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        134 MVLPHY-SSDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             EEEEcc-CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccc
Confidence            999998 568888886532    26889999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc--cchHHHHHHHhhc--
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN--VSLAAYFVHSMRK--  303 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~--  303 (360)
                      ......  ......||..|+|||++.+..++.++|||||||++|||+++..|++.........  .............  
T Consensus       206 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~  283 (357)
T PHA03209        206 FPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK  283 (357)
T ss_pred             ccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence            533221  1223468999999999999999999999999999999999665554332111110  0000011110000  


Q ss_pred             ---cccccccchHH------------------hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 ---NRLYHILDDQV------------------MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ---~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         ...........                  ........+.++.+++.+||+.||++|||+.|+++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence               00000000000                  00001123446778999999999999999999874

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-41  Score=298.28  Aligned_cols=266  Identities=24%  Similarity=0.398  Sum_probs=206.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--C
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--T  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~  143 (360)
                      ..|+..+.||+|+||.||++...     ++..+|+|.+......   ...+.+.+|+.+++.++|+||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            45778899999999999999853     3678999998764433   345678899999999999999999999877  5


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...+++|||+++++|.+++.....    .+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.++|+||
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df  153 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDF  153 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccc
Confidence            578999999999999999975432    4889999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccc------chHH
Q 040763          224 GTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV------SLAA  295 (360)
Q Consensus       224 g~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~------~~~~  295 (360)
                      |.+..........  .....++..|+|||.+.+..++.++||||||+++|||++|..|+...........      ....
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            9998765322211  1122345679999999888899999999999999999999999865432111000      0001


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      .....+...         .....+..++.++.+++.+||+.+|++|||+.+++++|+.++
T Consensus       234 ~~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         234 RLLELLKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHHHHHHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            111111111         111112334568999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.1e-41  Score=296.60  Aligned_cols=253  Identities=23%  Similarity=0.286  Sum_probs=197.9

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |+..+.||+|+||+||++.+. +++.+|+|.+....... ......+.+|+.+++.++|+|++.+.+.+..++..+++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            667788999999999999875 68899999876532221 1223456789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+++++|.+++....   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.....
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          81 IMNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             eccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            999999998886532   225899999999999999999999999   99999999999999999999999999865432


Q ss_pred             CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                      ..  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........     ...........       
T Consensus       155 ~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-----~~~~~~~~~~~-------  220 (285)
T cd05632         155 GE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-----REEVDRRVLET-------  220 (285)
T ss_pred             CC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhhhcc-------
Confidence            21  12234689999999999988999999999999999999999999965431100     00000000000       


Q ss_pred             hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 040763          312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVSM  349 (360)
Q Consensus       312 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~~  349 (360)
                         ....+...++++.+|+.+||+.||++|||     +.+++.
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 ---EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence               00112334557899999999999999999     556654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=312.84  Aligned_cols=251  Identities=24%  Similarity=0.429  Sum_probs=210.4

Q ss_pred             CCccceecccCcEEEEEEEec--CCc--EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE--DGR--IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ....++||+|+||.|++|.++  +|+  .||||+++.....   .....|++|+.+|.+|+|+|++++||+..+ ....+
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            455678999999999999876  343  6899998876544   367789999999999999999999999988 67789


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      |||+++.|+|.+.|++.   ....+.......++.|||.|+.||.+++   +|||||..+|+|+...-.+||+|||+.+.
T Consensus       188 V~ELaplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             HhhhcccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceec
Confidence            99999999999999872   2336778888999999999999999999   99999999999999999999999999988


Q ss_pred             cCCCCce-ee-ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          229 IAMDQTH-VT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       229 ~~~~~~~-~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ++..+.. .+ ....-...|+|||.+....++.++|||+|||++|||+| |+.||.+-..                  ..
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------------~q  323 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------------IQ  323 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------------HH
Confidence            7654322 22 22335678999999999999999999999999999999 8999965431                  12


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                      +.+.+|..-+..-++.+++++++++.+||..+|++|||+..|.+.+
T Consensus       324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            3334555555566888999999999999999999999999997544

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.6e-41  Score=292.41  Aligned_cols=249  Identities=25%  Similarity=0.409  Sum_probs=198.4

Q ss_pred             ceecccCcEEEEEEEecC--C--cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEe
Q 040763           77 RILGQGGQGTVYKGRLED--G--RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~--~--~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      +.||+|++|.||+|.+.+  +  ..+|+|.+......   ...+.+.+|+.++++++||||+++++.+.. ...+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            368999999999998753  2  26899988765443   445678899999999999999999999988 888999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCC
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD  232 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  232 (360)
                      +++++|.+++.....   ..+++..++.++.|++.||+|||+++   ++|+||+|+||+++.++.+||+|||++......
T Consensus        77 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          77 APLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             cCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence            999999999976432   35889999999999999999999999   999999999999999999999999999876543


Q ss_pred             Ccee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          233 QTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       233 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ....  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....        ............    
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~----  218 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEGE----  218 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcCC----
Confidence            2211  112346788999999999899999999999999999999 9999854321        000111110000    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                           ....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       219 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 -----RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -----cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                 01112234567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.4e-41  Score=290.98  Aligned_cols=252  Identities=29%  Similarity=0.416  Sum_probs=203.2

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|+..+.||.|+||.||.++.. +++.+++|.+.......  .....+.+|+.++++++|+||+++++++.+....+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE--KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch--hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            5888999999999999998865 57889999876543222  33456789999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          79 EYANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EecCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            9999999999997642   235789999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      .... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....        ...... ......    
T Consensus       153 ~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~-~~~~~~----  218 (256)
T cd08221         153 SEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVK-IVQGNY----  218 (256)
T ss_pred             cccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH-HHcCCC----
Confidence            4332 22334689999999999888889999999999999999999999854321        011111 111111    


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                           ...+...+.++.+++.+||+.+|++|||+.++++.
T Consensus       219 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         219 -----TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -----CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                 01123445679999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.2e-41  Score=294.70  Aligned_cols=251  Identities=29%  Similarity=0.438  Sum_probs=196.4

Q ss_pred             eecccCcEEEEEEEecC-------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           78 ILGQGGQGTVYKGRLED-------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~~-------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .||+|+||.||+|...+       +..+++|.+......   .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD---QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccch---hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            58999999999998653       257888987543221   23456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-----cEEEeec
Q 040763          151 EFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-----RAKVADF  223 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-----~~kl~Df  223 (360)
                      ||+++++|.+++......  ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++     .++|+||
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCc
Confidence            999999999999764321  2234788999999999999999999999   99999999999999887     8999999


Q ss_pred             CCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 040763          224 GTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       224 g~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      |++.......... .....++..|+|||.+.++.++.++||||||+++|+|++ |..||.....     .   . .....
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~---~-~~~~~  226 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----Q---E-VLQHV  226 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----H---H-HHHHH
Confidence            9987654322111 122245678999999999999999999999999999998 9999854321     0   0 01111


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ....         ....+...+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       227 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 TAGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             hcCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1110         11123345668999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.9e-41  Score=290.71  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=202.6

Q ss_pred             cCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|++|.||++...+ ++.+++|.+....      ..+.+.+|+.+++.++|||++++++.+......+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            678999999999999999999874 7889999876431      156788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+++++|.+++....    ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        77 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~  149 (256)
T cd06612          77 MEYCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQL  149 (256)
T ss_pred             EecCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhc
Confidence            99999999999986532    26889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........         ..........  
T Consensus       150 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---------~~~~~~~~~~--  217 (256)
T cd06612         150 TDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---------IFMIPNKPPP--  217 (256)
T ss_pred             ccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---------hhhhccCCCC--
Confidence            43321 22234578899999999998899999999999999999999999864321110         0000000000  


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ....+...+.++.+++.+||+.||++|||+.++++
T Consensus       218 -----~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         218 -----TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -----CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                 01123345568999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.8e-41  Score=293.65  Aligned_cols=254  Identities=22%  Similarity=0.311  Sum_probs=187.1

Q ss_pred             eecccCcEEEEEEEecCCc---EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           78 ILGQGGQGTVYKGRLEDGR---IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~---~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      .||+|+||.||++...++.   .+++|.+......   ...+.+.+|+.+++.++||||+++++.+......+++|||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS---KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh---HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            5999999999999754432   4566665543222   234678899999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC-
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ-  233 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-  233 (360)
                      +++|.+++...... ....+...+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++....... 
T Consensus        79 ~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          79 LGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            99999999764322 224667778889999999999999999   9999999999999999999999999975432211 


Q ss_pred             ceeeecccccCCccchhhhcc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          234 THVTTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       234 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ........++..|+|||++..       ..++.++||||||+++|||++ |..||.....        ...+...... .
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~-~  225 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKD-Q  225 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhh-c
Confidence            111223457889999998753       235779999999999999997 5667643221        0111111111 1


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ......+    ..+..+++.+.+++..|| .+|++|||++++++.|.
T Consensus       226 ~~~~~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         226 QVKLFKP----QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccccCCC----ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1111111    112234567889999999 67999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-41  Score=297.08  Aligned_cols=252  Identities=29%  Similarity=0.437  Sum_probs=195.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeC---
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLET---  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~---  143 (360)
                      ..+.|++.+.||+|+||.||+|... +++.+|+|.+......     ...+..|+.++..+ +|+|++++++.+...   
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            4567888899999999999999876 5788999987653222     24566889999888 799999999998753   


Q ss_pred             ---CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          144 ---EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       144 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                         ...+++|||+++++|.+++....   ...+++..+..++.|++.|++|||+++   ++|+||+|+||++++++.++|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l  152 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL  152 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEE
Confidence               35789999999999999997632   235889999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      +|||++....... .......|+..|+|||++.     +..++.++|||||||++|||++|..||......       ..
T Consensus       153 ~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~  224 (272)
T cd06637         153 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RA  224 (272)
T ss_pred             ccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HH
Confidence            9999987653321 1223346889999999886     335788999999999999999999998543210       00


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      . . .......        ........+.++.+|+.+||+.||++|||+.++++
T Consensus       225 ~-~-~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         225 L-F-LIPRNPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             H-H-HHhcCCC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0 0 0001100        11112234557999999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.7e-41  Score=292.34  Aligned_cols=252  Identities=27%  Similarity=0.476  Sum_probs=200.4

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChH-----HHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDE-----ELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~-----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      +|.+.+.||+|++|.||+|... +++.+++|.+.......     .....+.+.+|+.++..++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999875 57889999876543221     11234567889999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence            999999999999999997532     4788888999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCce-----eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          226 SKFIAMDQTH-----VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       226 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      +.........     ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.....       . ..... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~-~~~~~-  223 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------L-QAIFK-  223 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------H-HHHHH-
Confidence            8766432111     11223578899999999988899999999999999999999999964321       0 00000 


Q ss_pred             hhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...         ......+...+..+.+++.+||+.||++||++.++++
T Consensus       224 ~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 IGE---------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             Hhc---------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            000         0111223345668999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.4e-41  Score=308.14  Aligned_cols=260  Identities=23%  Similarity=0.308  Sum_probs=196.7

Q ss_pred             hcCCCccceecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ..+|.+.+.||+|+||.||++...   .+..+++|.+....         ...+|+.+++.++||||+++++++......
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            457999999999999999999753   35678999765421         234799999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      +++||++ .++|.+++...     ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.++|+|||++
T Consensus       162 ~lv~e~~-~~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a  232 (392)
T PHA03207        162 CMVMPKY-KCDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA  232 (392)
T ss_pred             EEEehhc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccc
Confidence            9999998 47888888432     25899999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          227 KFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       227 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... ..+ ......+....
T Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~l-~~i~~~~~~~~  310 (392)
T PHA03207        233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS-SQL-RSIIRCMQVHP  310 (392)
T ss_pred             cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH-HHH-HHHHHHhccCc
Confidence            765443221 223456899999999999999999999999999999999999999765432110 000 00111111000


Q ss_pred             cc--cc-----------cchHHhh-------hccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LY--HI-----------LDDQVMK-------LGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~--~~-----------~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..  ..           .......       .....++.++.+++.+||+.||++|||+.+++.
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            00  00           0000000       001123557889999999999999999999974

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.3e-41  Score=304.31  Aligned_cols=260  Identities=22%  Similarity=0.290  Sum_probs=194.4

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC---
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET---  143 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---  143 (360)
                      ...++|++.+.||+|+||.||++... +++.||+|.+......  ......+.+|+.+++.++||||+++++++...   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh--hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            34578999999999999999999875 6788999987653222  23345677899999999999999999987543   


Q ss_pred             ---CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          144 ---EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       144 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                         ...+++++++ +++|.+++...      .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEE
Confidence               3458899987 78998877532      4889999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      +|||++......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....     .......
T Consensus       160 ~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~  230 (343)
T cd07878         160 LDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-----QLKRIME  230 (343)
T ss_pred             cCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHH
Confidence            999998765332    233468999999999877 568899999999999999999999996532110     0000000


Q ss_pred             Hhhccc------------------cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRKNR------------------LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......                  +.......+ .......++.+.+|+.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDL-KKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HhCCCCHHHHHhcchhhHHHHhhccccccchhH-HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000                  000000000 0000112346789999999999999999999974

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.3e-41  Score=299.07  Aligned_cols=258  Identities=24%  Similarity=0.440  Sum_probs=200.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ++|+..+.||+|+||.||++.+. ++.    .+|+|.+......   ....++.+|+.++..++||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP---KANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            56788899999999999999864 343    4788877654332   2234677899999999999999999998754 4


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++++||+++|+|.+++....    ..+++..++.++.|++.||.|||+++   ++|+||||+||++++++.+||+|||+
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccc
Confidence            678999999999999987532    24788899999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+...         .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~  226 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEK  226 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHC
Confidence            9865432221 1222345678999999998889999999999999999997 8999854321         001111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ....         ..+..++..+.+++.+||..+|++||++.++++.|+.+..+
T Consensus       227 ~~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         227 GERL---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1100         11122345789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-41  Score=295.29  Aligned_cols=257  Identities=25%  Similarity=0.382  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||++... +++.+|+|.+......   ...+.+.+|+.+++.++||||+++++.+......++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS---SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc---hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            56888899999999999999876 5788999987653222   2345678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      |||+++++|.+++....     ++++..+..++.+++.||.|||+ .+   ++|+||+|+||++++++.++|+|||++..
T Consensus        82 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          82 MEFMDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             EecCCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            99999999999886532     58899999999999999999997 47   99999999999999999999999999865


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc---hHHHHHHHhhccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS---LAAYFVHSMRKNR  305 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~  305 (360)
                      .....   .....|+..|+|||++.+..++.++|+|||||++|+|++|..||............   .......... ..
T Consensus       154 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  229 (284)
T cd06620         154 LINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EP  229 (284)
T ss_pred             hhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-cc
Confidence            42211   12346899999999998888999999999999999999999999754432111100   0111111111 00


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                      ..        .......+.++.+|+.+||+.||++|||+.|+++.
T Consensus       230 ~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         230 PP--------RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CC--------CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00        00112255679999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-40  Score=289.90  Aligned_cols=252  Identities=31%  Similarity=0.487  Sum_probs=201.1

Q ss_pred             CCccceecccCcEEEEEEEecC-----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           73 FNVNRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      +++.+.||.|+||.||++...+     +..+|+|.+......   ...+.+..|+..+..++|+||+++++++...+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE---QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh---HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            3567889999999999998764     378999998765433   14567788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++|||+++++|.+++.....   ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCce
Confidence            99999999999999976432   12889999999999999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ..............+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.....        .. ..........
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~-~~~~~~~~~~  222 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EE-VLEYLKKGYR  222 (258)
T ss_pred             ecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHhcCCC
Confidence            765443222222336789999999988889999999999999999998 7888754221        11 1111111111


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                               ...+...+.++.+++.+||+.||++|||+.++++.|
T Consensus       223 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ---------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                     111223566899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.2e-41  Score=325.59  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=198.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--CC
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--TE  144 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~  144 (360)
                      ...++|.+.+.||+|+||+||++.+. ++..+|+|.+.......  .....+..|+.++..++||||+++++++..  ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e--~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE--REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH--HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            34478999999999999999999986 46788999876543222  234568889999999999999999998864  35


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCeEEcC------
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS----SPIYHRDIKSTNILLDE------  214 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~----~~i~H~dlk~~Nill~~------  214 (360)
                      ..|+||||+++++|.++|..... ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            68999999999999999976432 22368999999999999999999998431    23999999999999964      


Q ss_pred             -----------CCcEEEeecCCccccCCCCceeeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCCC
Q 040763          215 -----------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIF  281 (360)
Q Consensus       215 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~  281 (360)
                                 .+.+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||++|+|++|..||.
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                       3458999999997654322  2234468999999998864  457899999999999999999999996


Q ss_pred             CCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          282 STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....       .... ...+.....          ......+.++.+||..||+.+|++|||+.+++.
T Consensus       245 ~~~~-------~~ql-i~~lk~~p~----------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KANN-------FSQL-ISELKRGPD----------LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCCc-------HHHH-HHHHhcCCC----------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            4321       1111 111111110          001123567999999999999999999999983

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-40  Score=297.92  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=186.7

Q ss_pred             ceecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--CCcceEEEE
Q 040763           77 RILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--TEFPLLVYE  151 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~lv~e  151 (360)
                      ..||+|+||.||+|..+   ++..+|+|.+.....      ...+.+|+.+++.++||||+++++++..  ....+++||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            57999999999999865   346899998764321      2245689999999999999999998854  456789999


Q ss_pred             ecCCCChhHHhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----cCCCcEEEeec
Q 040763          152 FIPNGTLYQHLHDRHQ----NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADF  223 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~Df  223 (360)
                      |++ ++|.+++.....    .....+++..+..++.|++.||.|||+.+   ++||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            985 588887754321    12235788999999999999999999999   9999999999999    56679999999


Q ss_pred             CCccccCCCCc--eeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch-HHH---
Q 040763          224 GTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL-AAY---  296 (360)
Q Consensus       224 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~-~~~---  296 (360)
                      |++........  .......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||....+........ ...   
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            99986643321  12233468999999999876 457899999999999999999999996543321111100 000   


Q ss_pred             HHHHhhcc---cccc---------ccc---------hH---HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          297 FVHSMRKN---RLYH---------ILD---------DQ---VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       297 ~~~~~~~~---~~~~---------~~~---------~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....+...   .+..         ...         ..   ............+.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            00000000   0000         000         00   000011112346889999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.1e-40  Score=291.48  Aligned_cols=249  Identities=27%  Similarity=0.382  Sum_probs=201.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..|+..+.||.|+||.||+|.+. ++..+|+|.+......   .....+.+|+.++..++||||+++++++.+....++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            45777889999999999999875 5788999987653322   3356778899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++...      ++++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~  151 (277)
T cd06640          81 MEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             EecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceec
Confidence            9999999999988642      4778888999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... ......++..|+|||.+.+..++.++|+||||+++|||++|..||.......         ......       
T Consensus       152 ~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---------~~~~~~-------  214 (277)
T cd06640         152 TDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---------VLFLIP-------  214 (277)
T ss_pred             cCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---------Hhhhhh-------
Confidence            43221 1222357889999999988889999999999999999999999986432100         000000       


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                        .......+...+..+.+++.+||+.+|++|||+.+++..
T Consensus       215 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 --KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence              011122344566789999999999999999999999654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-42  Score=310.37  Aligned_cols=244  Identities=30%  Similarity=0.450  Sum_probs=200.5

Q ss_pred             eecccCcEEEEEEEecCC-cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCC
Q 040763           78 ILGQGGQGTVYKGRLEDG-RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNG  156 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~-~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  156 (360)
                      +||+|.||+||.|++.+. ..+|||.+.....    ...+....|+.+.+.++|.|||+++|++..++..-+.||.++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds----r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS----REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc----hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            599999999999998754 4689997765322    34566788999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc-CCCcEEEeecCCccccCCCC
Q 040763          157 TLYQHLHDRHQNEEYPL--TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       157 ~L~~~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      ||.++++..=.    ++  .+.++-.+.+||++||.|||++.   |||||||-+||||+ -.|.+||+|||-++.+..-.
T Consensus       658 SLSsLLrskWG----PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  658 SLSSLLRSKWG----PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             cHHHHHHhccC----CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            99999986421    44  66777788999999999999999   99999999999997 47899999999998876533


Q ss_pred             ceeeecccccCCccchhhhccC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          234 THVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       234 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                      . .+.+..||..|||||++..+  .|..++|||||||+..||.||++||...+.      .....+.-.          -
T Consensus       731 P-~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs------pqAAMFkVG----------m  793 (1226)
T KOG4279|consen  731 P-CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS------PQAAMFKVG----------M  793 (1226)
T ss_pred             c-cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC------hhHhhhhhc----------c
Confidence            2 23456799999999999886  578899999999999999999999965442      111111111          1


Q ss_pred             hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       312 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      -+.-++.|.+.+++..++|.+|+.+||.+||+++++++
T Consensus       794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            12234568889999999999999999999999999874

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=288.88  Aligned_cols=253  Identities=28%  Similarity=0.411  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||.|++|.||++... ++..+++|.+......    ..+.+.+|+.+++.++||||+++++.+......+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            57889999999999999999875 5778999987654222    356778899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....    ..++...+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++...
T Consensus        79 ~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          79 MEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             EeCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhh
Confidence            99999999999987632    25889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .... .......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||........        .. .......
T Consensus       152 ~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--------~~-~~~~~~~  221 (262)
T cd06613         152 TATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--------LF-LISKSNF  221 (262)
T ss_pred             hhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--------HH-HHHhccC
Confidence            4321 112234578899999998776   788999999999999999999999865331000        00 0000000


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .   .  .........+.++.+++.+||+.+|.+|||+.+++.
T Consensus       222 ~---~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         222 P---P--PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             C---C--ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0   0  001123445678999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.7e-41  Score=296.77  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=196.4

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|++|.||++.+. +|..+++|.+.......  .....+.+|+.+++.++|||++++++++.+....++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc--cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence            4788899999999999999986 68899999876532221  12345667999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||++ ++|.+++....    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        79 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          79 EYCD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             ecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            9996 58888776432    25889999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc------
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK------  303 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  303 (360)
                      ..... .....++..|+|||++.+. .++.++||||||+++|+|+||..|+.........   + .........      
T Consensus       151 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~---~-~~~~~~~~~~~~~~~  225 (284)
T cd07839         151 IPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---L-KRIFRLLGTPTEESW  225 (284)
T ss_pred             CCCCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH---H-HHHHHHhCCCChHHh
Confidence            32211 2233578899999988764 4689999999999999999999887543321110   0 000000000      


Q ss_pred             ------cc---cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 ------NR---LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ------~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ..   .................++++.+++.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                  00   00000000001112335678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-40  Score=290.54  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=196.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccCh-HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--CCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVKLLGCCLE--TEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~  146 (360)
                      .+|+..+.||+|+||.||++... ++..+++|.+...... ........+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999875 5889999987644322 122344567889999999999999999998865  3567


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++++||+++++|.+++....     .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            89999999999999996532     4788888999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCc--eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          227 KFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       227 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ........  .......++..|+|||.+.+..++.++||||||+++|||++|+.||.....        ...........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~~~~~~~~~~~  225 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------MAAIFKIATQP  225 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------HHHHHHHhcCC
Confidence            75532111  111224578899999999998899999999999999999999999864321        00011110000


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                               .....+...++.+.+++ +||..+|++|||++|+++
T Consensus       226 ---------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 ---------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                     01122334455677787 788899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-40  Score=291.64  Aligned_cols=252  Identities=29%  Similarity=0.430  Sum_probs=197.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|.+.+.||+|+||.||++... ++..+++|.++.....    ....+.+|+.+++.++||||+++++.+...+..+++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE----DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            46888889999999999999875 5788999987654222    234567899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          85 MEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             EeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            99999999999986532     5889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .... .......|+..|+|||++.   ...++.++|+|||||++|+|++|..||........    .   ..  ......
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~----~---~~--~~~~~~  226 (267)
T cd06645         157 TATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----L---FL--MTKSNF  226 (267)
T ss_pred             cCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh----H---Hh--hhccCC
Confidence            4321 1223346899999999874   45678899999999999999999999864331100    0   00  000000


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .   ....  .....+++.+.+++.+||+.+|++|||+.++++
T Consensus       227 ~---~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         227 Q---PPKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             C---CCcc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0   0000  001124457899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3e-40  Score=288.08  Aligned_cols=240  Identities=23%  Similarity=0.367  Sum_probs=185.1

Q ss_pred             ceecccCcEEEEEEEecC-------------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           77 RILGQGGQGTVYKGRLED-------------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~-------------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      +.||+|+||.||+|....             ...+++|.+.....    .....+.+|+.++..++||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR----DISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh----hHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            368999999999997532             12578887654321    2344677889999999999999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc------
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR------  217 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~------  217 (360)
                      ...+++|||+++++|..++....    .++++..++.++.|++.||+|||+++   ++||||||+|||++.++.      
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~  149 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGP  149 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCc
Confidence            99999999999999998876432    25888999999999999999999999   999999999999987654      


Q ss_pred             -EEEeecCCccccCCCCceeeecccccCCccchhhhc-cCCCCCccchhhhHHHHHHHH-hCCCCCCCCCCCcccccchH
Q 040763          218 -AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-SSQLTDKSDVYSFGVVLVELL-TGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       218 -~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~-tg~~p~~~~~~~~~~~~~~~  294 (360)
                       ++++|||++......     ....++..|+|||.+. +..++.++||||||+++|||+ +|..||.......     . 
T Consensus       150 ~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~-  218 (262)
T cd05077         150 FIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----K-  218 (262)
T ss_pred             eeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----H-
Confidence             899999998654321     2235788899999887 466889999999999999998 4888875432100     0 


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                         .... .... .         .....++++.+|+.+||+.||++||++.+|++.|+
T Consensus       219 ---~~~~-~~~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 ---ERFY-EGQC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ---HHHH-hcCc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence               0000 0000 0         01122457899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-41  Score=316.04  Aligned_cols=274  Identities=20%  Similarity=0.259  Sum_probs=189.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEecC--CcEEEEEeccc-------------ccChHHHHhHHHHHHHHHHHhhcCCCCc
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLED--GRIIAVKKSKL-------------AVDDEELYKLEEFINEIFILSQINHRNV  133 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vaik~~~~-------------~~~~~~~~~~~~~~~e~~~~~~l~h~ni  133 (360)
                      ...+|++.+.||+|+||.||++..+.  +...+.|.+..             ............+.+|+.++..++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987542  22222221000             0000111233457789999999999999


Q ss_pred             eeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       134 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      +++++++...+..|++++++ .++|.+++..................++.|++.||.|||+++   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            99999999999999999998 567877775432221222345667789999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCC-CCCCCCCcccccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP-IFSTGNTSQENVS  292 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p-~~~~~~~~~~~~~  292 (360)
                      .++.+||+|||++...............||..|+|||++.+..++.++|||||||++|||++|..+ +..........  
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~--  379 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ--  379 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH--
Confidence            999999999999987654433333345799999999999999999999999999999999998754 43322111100  


Q ss_pred             hHHHHHHHhh--cccc-------ccccch--------HHhhh-ccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          293 LAAYFVHSMR--KNRL-------YHILDD--------QVMKL-GKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       293 ~~~~~~~~~~--~~~~-------~~~~~~--------~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +... .....  ....       ...+..        ..... .....+.++.+++.+||+.||.+|||+.|+++
T Consensus       380 ~~~~-~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKI-IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHH-HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000 00000  0000       000000        00000 00112346788999999999999999999975

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.6e-42  Score=307.45  Aligned_cols=247  Identities=23%  Similarity=0.400  Sum_probs=196.9

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc--ceEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF--PLLV  149 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~--~~lv  149 (360)
                      .....+||+|+|-+||+|.+. +|-.||--.++...-......++++..|+++|+.|+||||++++.+|.+...  ..+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            355678999999999999976 4556665444444444444567889999999999999999999999987665  6789


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEeecCCccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKF  228 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~  228 (360)
                      +|.+..|+|..|..+.+     .+....+..|++||++||.|||++. +||+|||||-+||+|+. .|.|||+|+|+|..
T Consensus       122 TEL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHH
Confidence            99999999999998765     4788899999999999999999987 78999999999999985 58999999999988


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc---cc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK---NR  305 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~  305 (360)
                      ......   ....|||.|||||+.. ..|++.+||||||+.++||+|+..||..=.       .-++.+......   ..
T Consensus       196 ~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------n~AQIYKKV~SGiKP~s  264 (632)
T KOG0584|consen  196 LRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-------NPAQIYKKVTSGIKPAA  264 (632)
T ss_pred             hhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-------CHHHHHHHHHcCCCHHH
Confidence            754332   2368999999999988 679999999999999999999999984321       112222222211   11


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +..+-            -++.+++|.+||.. ..+|||+.|++.
T Consensus       265 l~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  265 LSKVK------------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hhccC------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            11111            23688999999999 999999999974

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-40  Score=295.02  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=201.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..+|++.+.||+|++|.||++... +++.+|+|.+......    ..+.+.+|+.+++.++|+|++++++.+...+..++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            367999999999999999999874 6889999987653322    23456789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++...      .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        94 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~  164 (297)
T cd06656          94 VMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (297)
T ss_pred             eecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceE
Confidence            99999999999998542      4788899999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........         ...     
T Consensus       165 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---------~~~-----  229 (297)
T cd06656         165 ITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------IAT-----  229 (297)
T ss_pred             ccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---------ecc-----
Confidence            543221 12234578899999999998899999999999999999999999965432110000         000     


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        ........+...+..+.+++.+||+.+|++|||+.++++
T Consensus       230 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         230 --NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000001112334567899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.7e-41  Score=294.70  Aligned_cols=247  Identities=28%  Similarity=0.402  Sum_probs=198.6

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .|+..+.||+|+||.||+|.+. ++..+|+|.+......   ...+.+.+|+.+++.++||||+++++++......++||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch---HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            3666778999999999999865 5778999987644322   23456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++...      .+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          82 EYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EccCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccccc
Confidence            999999999988531      4788999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      .... ......++..|+|||.+.+..++.++|+||||+++|||++|..||.......         ........      
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---------~~~~~~~~------  216 (277)
T cd06642         153 DTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---------VLFLIPKN------  216 (277)
T ss_pred             Ccch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---------HHhhhhcC------
Confidence            3221 1122357889999999999889999999999999999999999985432100         00001111      


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         .....+...+.++.+++.+||+.+|++|||+.++++
T Consensus       217 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         217 ---SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence               011122334567899999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-40  Score=291.51  Aligned_cols=260  Identities=28%  Similarity=0.450  Sum_probs=199.4

Q ss_pred             CCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           73 FNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      |.+.+.||+|+||.||+|..+    +++.+|+|.+.......  ...+++.+|+.+++.++||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS--SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            567788999999999999754    36789999887644332  23566788999999999999999999876532    


Q ss_pred             --cceEEEEecCCCChhHHhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          145 --FPLLVYEFIPNGTLYQHLHDRH-QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       145 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                        ..+++++|+.+++|.+++.... ......+++.....++.|++.||+|||+++   ++||||||+||++++++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEEC
Confidence              2368889999999998875432 122235788899999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHH
Q 040763          222 DFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |||++.......... .....+++.|++||.+....++.++||||||+++|+|++ |..||.....        ......
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~  227 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNY  227 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHH
Confidence            999987654332211 122335678999999998889999999999999999999 8888754321        000111


Q ss_pred             HhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      .......          ..+...+.++.+++.+||+.+|++|||+.++++.|++++
T Consensus       228 ~~~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         228 LIKGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             HHcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            1111100          111234457999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=312.93  Aligned_cols=265  Identities=20%  Similarity=0.249  Sum_probs=188.8

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC------CCCceeee
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN------HRNVVKLL  137 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~------h~niv~~~  137 (360)
                      ++....++|++.+.||+|+||+||++.+. .++.||+|+++....     .......|+.++..++      |.++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~  197 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-----YTRDAKIEIQFMEKVRQADPADRFPLMKIQ  197 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-----hHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence            34445678999999999999999999875 578899999864221     1223344566655554      45688888


Q ss_pred             eEEeeC-CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCC
Q 040763          138 GCCLET-EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       138 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~  215 (360)
                      +++... ...++||+++ +++|.+++....     .+++..+..++.|++.||.|||+ .+   |+||||||+|||++.+
T Consensus       198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~  268 (467)
T PTZ00284        198 RYFQNETGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETS  268 (467)
T ss_pred             EEEEcCCceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecC
Confidence            888754 4678899987 788988886532     58889999999999999999998 48   9999999999999876


Q ss_pred             C----------------cEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCC
Q 040763          216 Y----------------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP  279 (360)
Q Consensus       216 ~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p  279 (360)
                      +                .+||+|||.+.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            5                499999998754221    22345789999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccchHHH--------HHH---------Hhhc-cccccccchHHhh-------hccHHHHHHHHHHHHHhh
Q 040763          280 IFSTGNTSQENVSLAAY--------FVH---------SMRK-NRLYHILDDQVMK-------LGKKNQIVAFANLAERCL  334 (360)
Q Consensus       280 ~~~~~~~~~~~~~~~~~--------~~~---------~~~~-~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl  334 (360)
                      |.+.....  .......        +..         .... .......+.....       .......+.+++|+.+||
T Consensus       345 f~~~~~~~--~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  422 (467)
T PTZ00284        345 YDTHDNLE--HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL  422 (467)
T ss_pred             CCCCChHH--HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence            97543211  0000000        000         0000 0000000000000       000112456889999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 040763          335 DLNGKKRPTMEEVSM  349 (360)
Q Consensus       335 ~~dp~~Rpt~~ei~~  349 (360)
                      +.||++|||+.|+++
T Consensus       423 ~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        423 HYDRQKRLNARQMTT  437 (467)
T ss_pred             CcChhhCCCHHHHhc
Confidence            999999999999985

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-40  Score=291.41  Aligned_cols=258  Identities=25%  Similarity=0.416  Sum_probs=201.7

Q ss_pred             CCCccceecccCcEEEEEEEecC--CcEEEEEecccccCh------HHHHhHHHHHHHHHHHhh-cCCCCceeeeeEEee
Q 040763           72 HFNVNRILGQGGQGTVYKGRLED--GRIIAVKKSKLAVDD------EELYKLEEFINEIFILSQ-INHRNVVKLLGCCLE  142 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vaik~~~~~~~~------~~~~~~~~~~~e~~~~~~-l~h~niv~~~~~~~~  142 (360)
                      +|++.+.||+|+||.||++..+.  ++.+++|.+......      .......++..|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999765  678999976543211      111234556778887765 699999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                      .+..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEe
Confidence            9999999999999999998865321 23368889999999999999999996 67   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      |||++.......  ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......         ......
T Consensus       157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~  225 (269)
T cd08528         157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---------SLATKI  225 (269)
T ss_pred             cccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---------HHHHHH
Confidence            999997654432  223446889999999999888999999999999999999999998543210         001111


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ......        .......++++.+++.+||+.||++|||+.|+.++++
T Consensus       226 ~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 VEAVYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hhccCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111110        0011234567999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-40  Score=294.17  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=198.8

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|+||.||++... ++..+|+|.+......   .....+.+|+.++.+++||||+++++.+......+++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE---SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH---HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            5888999999999999999976 6889999987654322   23456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||+++++|.+++....  ....+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        79 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          79 EYMDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             eecCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999999999886531  12358899999999999999999997 47   999999999999999999999999998654


Q ss_pred             CCCCceeeecccccCCccchhhhccCC------CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQ------LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ...   ......+++.|+|||.+.+..      ++.++|+|||||++|+|++|+.||.....  .   ...... .....
T Consensus       154 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~---~~~~~~-~~~~~  224 (286)
T cd06622         154 VAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--A---NIFAQL-SAIVD  224 (286)
T ss_pred             cCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--h---hHHHHH-HHHhh
Confidence            322   122335788999999886543      47899999999999999999999954321  0   000000 00000


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .         .....+..++.++.+++.+||+.+|++||++.+++.
T Consensus       225 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         225 G---------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             c---------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            0         011223446778999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9.2e-41  Score=290.05  Aligned_cols=247  Identities=27%  Similarity=0.458  Sum_probs=196.6

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ++|++.+.||+|+||.||.+.. +++.+++|..+...      ..+.+.+|+.+++.++|||++++++++... ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            4588899999999999999875 57789999876432      234677899999999999999999998764 469999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....   ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        78 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          78 ELMSKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             ECCCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            9999999999997532   225788999999999999999999999   9999999999999999999999999986543


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..    ......+..|+|||.+.++.++.++|+||||+++|+|++ |..||.....        .. ........     
T Consensus       152 ~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~-~~~~~~~~-----  213 (254)
T cd05083         152 MG----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KE-VKECVEKG-----  213 (254)
T ss_pred             cc----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HH-HHHHHhCC-----
Confidence            21    112234567999999988889999999999999999998 9999854321        00 11111111     


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                          .....+...+.++.+++.+||+.+|++|||+.++++.|+.
T Consensus       214 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 ----YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                0111223455689999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.1e-40  Score=287.97  Aligned_cols=257  Identities=28%  Similarity=0.392  Sum_probs=204.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||.|++|+||++... ++..+++|++......   .....+.+|+..++.++|+|++++++.+......+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ---TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc---hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence            46889999999999999999865 5778999987653322   2456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +|++++++|.+++.....  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        78 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999976432  125889999999999999999999999   999999999999999999999999998776


Q ss_pred             CCCCce---eeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          230 AMDQTH---VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       230 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ......   ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||.......        ......... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~-  223 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQND-  223 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhcCC-
Confidence            543322   12334588999999998877 78999999999999999999999986443210        011111110 


Q ss_pred             cccccchHHhhhc-cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLG-KKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..     ...... ....++++.+++.+||+.||++|||+.++++
T Consensus       224 ~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 PP-----SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CC-----CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00     000000 1245678999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-40  Score=289.95  Aligned_cols=262  Identities=25%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--Ccce
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFPL  147 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~  147 (360)
                      ++|...+.||.|++|.||++.+. +++.+|+|.+......   .....+.+|+++++.++||||+++++++...  ...+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP---DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch---HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            35788899999999999999985 5788999987654332   3345678899999999999999999988654  3679


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++|||+++++|.+++..... ....++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        78 lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccc
Confidence            99999999999998865332 3345788899999999999999999999   9999999999999999999999999986


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .......   ....++..|+|||.+.+..++.++||||||+++|+|++|..||.............    ..........
T Consensus       154 ~~~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~  226 (287)
T cd06621         154 ELVNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL----LSYIVNMPNP  226 (287)
T ss_pred             ccccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH----HHHHhcCCch
Confidence            5432211   23357889999999999899999999999999999999999997653211111111    1111111111


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .....   ......+++++.+++.+||+.+|++|||+.|+++
T Consensus       227 ~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         227 ELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hhccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00000   0111235678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=305.28  Aligned_cols=242  Identities=26%  Similarity=0.306  Sum_probs=185.0

Q ss_pred             ecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc---CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           79 LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI---NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        79 lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l---~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      ||+|+||+||++... +++.+|+|++........ ........|..++...   +||||+++++++......++||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh-hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence            699999999999876 588999998754321111 1233444566666554   69999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-  150 (330)
T cd05586          80 GGELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-  150 (330)
T ss_pred             CChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence            999999886532     5889999999999999999999999   9999999999999999999999999986533221 


Q ss_pred             eeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQ  313 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (360)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....        .... ..+..... .+    
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~-~~i~~~~~-~~----  216 (330)
T cd05586         151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMY-RNIAFGKV-RF----  216 (330)
T ss_pred             CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHH-HHHHcCCC-CC----
Confidence            122345689999999998764 478999999999999999999999965321        1111 11111110 00    


Q ss_pred             HhhhccHHHHHHHHHHHHHhhcCCCCCCCC----HHHHH
Q 040763          314 VMKLGKKNQIVAFANLAERCLDLNGKKRPT----MEEVS  348 (360)
Q Consensus       314 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt----~~ei~  348 (360)
                          .....++++.+++.+||+.||++||+    +.+++
T Consensus       217 ----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll  251 (330)
T cd05586         217 ----PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELK  251 (330)
T ss_pred             ----CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHh
Confidence                01124557889999999999999995    55554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.9e-40  Score=289.78  Aligned_cols=252  Identities=26%  Similarity=0.395  Sum_probs=202.2

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|+..+.||+|++|.||++.++ +++.+++|.+......   ....++.+|+.+++.++||||+++++.+......++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh---HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            5778889999999999999987 5888999987764433   34456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||+++++|.+++....    ..++...+..++.|++.|++|||+ .+   ++|+||+|+||++++++.++|+|||.+...
T Consensus        79 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          79 EYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             EecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            9999999999997642    368889999999999999999999 88   999999999999999999999999998655


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ......   ...++..|+|||.+.+..++.++||||||+++|+|++|..||..........   .... ........   
T Consensus       152 ~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~-~~~~~~~~---  221 (265)
T cd06605         152 VNSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI---FELL-QYIVNEPP---  221 (265)
T ss_pred             HHHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH---HHHH-HHHhcCCC---
Confidence            332211   1567889999999999899999999999999999999999986543211111   1111 11111110   


Q ss_pred             cchHHhhhccHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKN-QIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ...+.. .+.++.+++.+||..||++|||+.+++.
T Consensus       222 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 ------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                  111122 5667999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.7e-40  Score=293.03  Aligned_cols=251  Identities=26%  Similarity=0.343  Sum_probs=198.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +.|++.+.||+|+||.||+|... ++..+++|.+....    ....+.+.+|+.+++.++|||++++++.+..+...+++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            56899999999999999999986 47889999876532    13456678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|..++....    ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++...
T Consensus        88 ~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          88 IEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             EecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            99999999988876532    25889999999999999999999999   999999999999999999999999998654


Q ss_pred             CCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      .... .......+++.|+|||++.     ...++.++|+||||+++|+|++|..||.....        ......... .
T Consensus       161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~-~  230 (292)
T cd06644         161 VKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAK-S  230 (292)
T ss_pred             cccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhc-C
Confidence            3221 1122345788999999875     34567899999999999999999999854321        001111111 0


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...       ....+...+.++.+++.+||+.||++||++.++++
T Consensus       231 ~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 EPP-------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCc-------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000       01123345567999999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-40  Score=292.89  Aligned_cols=249  Identities=27%  Similarity=0.352  Sum_probs=195.7

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |++.+.||+|+||.||++... ++..+++|.+.....    ...+.+.+|+.+++.++|||++++++.+......++++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH----HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            577788999999999999876 467788888754321    235567889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+++++|..++...    ..++++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          83 FCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             ecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence            99999999887642    226889999999999999999999999   99999999999999999999999999865432


Q ss_pred             CCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .. .......++..|+|||++.     +..++.++|||||||++|+|++|+.||.....        .......... ..
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~-~~  225 (282)
T cd06643         156 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKS-EP  225 (282)
T ss_pred             cc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhc-CC
Confidence            21 1223346889999999874     34577899999999999999999999854321        0001111110 00


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .       ....+..++.++.+++.+||+.||++|||+.++++
T Consensus       226 ~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         226 P-------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             C-------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0       00122335568999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-40  Score=295.05  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=200.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|++.+.||.|++|.||++... +++.+++|.+.....    ...+.+.+|+.+++.++|||++++++.+......+++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            46899999999999999999864 688999998764322    2345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+++++|.+++...      .+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        95 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          95 MEYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             EEecCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            9999999999988542      4789999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......       .. . ........  
T Consensus       166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~~-~-~~~~~~~~--  233 (296)
T cd06655         166 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------AL-Y-LIATNGTP--  233 (296)
T ss_pred             ccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HH-H-HHHhcCCc--
Confidence            43322 1223468889999999998889999999999999999999999996543100       00 0 00000000  


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ....+...++.+.+++.+||+.||++|||+.+++.
T Consensus       234 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         234 -----ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -----ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                 01112334567999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.5e-40  Score=293.75  Aligned_cols=262  Identities=24%  Similarity=0.311  Sum_probs=199.9

Q ss_pred             hHHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE
Q 040763           63 SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCC  140 (360)
Q Consensus        63 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~  140 (360)
                      .+.+....++|++.+.||+|+||.||++... +++.+++|........     ...+..|+.++..+ +||||+++++++
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-----DEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-----HHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            3455566789999999999999999999875 5788999986542211     23456788899998 799999999987


Q ss_pred             e-----eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC
Q 040763          141 L-----ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       141 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~  215 (360)
                      .     .+...+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~  160 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTE  160 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCC
Confidence            4     34567999999999999998864322 2336888899999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCccccCCCCceeeecccccCCccchhhhcc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 040763          216 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN  290 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~  290 (360)
                      +.++|+|||++........ ......|++.|+|||.+..     ..++.++||||+||++|||++|+.||.......   
T Consensus       161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---  236 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---  236 (286)
T ss_pred             CCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---
Confidence            9999999999876543221 1223458999999998753     447889999999999999999999986432100   


Q ss_pred             cchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          291 VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                           .... ........       ...+..++.++.+++.+||+.||++|||+.|+++.
T Consensus       237 -----~~~~-~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         237 -----ALFK-IPRNPPPT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -----HHhh-ccccCCCc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                 0000 00000000       01122245579999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-40  Score=293.61  Aligned_cols=267  Identities=23%  Similarity=0.322  Sum_probs=198.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|+..+.||+|++|.||++..+ +++.+|+|.+.......  ...+.+.+|+.+++.++|||++++++.+......+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP--VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc--cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence            36888999999999999999986 58899999876432221  1234567899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|..++...     ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        79 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          79 FEYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EeccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceec
Confidence            9999988887776432     14889999999999999999999999   999999999999999999999999999766


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH-------HHh
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV-------HSM  301 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~~~  301 (360)
                      ..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+........ .......       ...
T Consensus       151 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhc
Confidence            44321 1223357889999998876 457889999999999999999999996543211000 0000000       000


Q ss_pred             hccccc---cccchH---HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNRLY---HILDDQ---VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~---~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......   ......   .........+..+.+++.+||+.||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000000   000000   000011223567999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.4e-40  Score=287.66  Aligned_cols=257  Identities=26%  Similarity=0.382  Sum_probs=198.6

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChH------HHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDE------ELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      +|...+.||+|++|.||+|... +++.+|+|.++......      .....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999865 68899999875432211      1122456778999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..++||||+++++|.+++...     .++++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence            999999999999999999764     25888889999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCce-eeecccccCCccchhhhccCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          225 TSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       225 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ++......... ......++..|+|||.+....  ++.++|+||||+++|++++|..||......        .......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~  225 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------AAMFKLG  225 (272)
T ss_pred             ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--------HHHHHhh
Confidence            98754322111 122345788999999987754  788999999999999999999998532210        0000000


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ... .    ............+.++.+++.+||..+|++|||+.++++
T Consensus       226 ~~~-~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         226 NKR-S----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ccc-c----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            000 0    001111122334668999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.3e-40  Score=289.37  Aligned_cols=253  Identities=26%  Similarity=0.385  Sum_probs=198.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccCh-HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--Ccc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~  146 (360)
                      .+|++.+.||+|+||.||.+... ++..+++|.+...... ......+.+.+|+.++..++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999875 5789999987543221 1123456778899999999999999999988763  457


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      +++|||+++++|.+++....     .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence            89999999999999986532     4778888999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCc--eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          227 KFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       227 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ........  .......++..|+|||++.+..++.++||||||+++|+|++|+.||.....       . ........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~-~~~~~~~~--  223 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------M-AAIFKIAT--  223 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------H-HHHHHHhc--
Confidence            75432111  112234588899999999888899999999999999999999999854311       0 00111100  


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             .......+...+..+.+++.+||. +|++|||+.++++
T Consensus       224 -------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         224 -------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                   011122345566678999999995 9999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.3e-40  Score=287.91  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=201.1

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|+||.+|.+... +++.+++|.+.......  ....++.+|+.+++.++||||+++++++...+..++++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP--KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh--HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence            4788999999999999999875 67899999876432221  23456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....   ...+++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        79 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          79 DYCEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             ecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            9999999999987532   224788899999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      .... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....        ........ .+.     
T Consensus       153 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~-~~~-----  217 (256)
T cd08218         153 STVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKII-RGS-----  217 (256)
T ss_pred             cchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHh-cCC-----
Confidence            3221 12234578899999999988899999999999999999999999854321        01111111 111     


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ....+...+.++.+++.+||+.+|++||++.++++
T Consensus       218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 ----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ----CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                01123345667999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-40  Score=293.27  Aligned_cols=258  Identities=28%  Similarity=0.415  Sum_probs=198.0

Q ss_pred             hHHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE
Q 040763           63 SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCC  140 (360)
Q Consensus        63 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~  140 (360)
                      ..+.....+.|++.+.||+|+||.||+|.+. +++.+|+|......     .....+..|+.++..+ +|+|++++++++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            3344445678999999999999999999875 57889999865432     1234566788888888 799999999998


Q ss_pred             ee------CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC
Q 040763          141 LE------TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE  214 (360)
Q Consensus       141 ~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~  214 (360)
                      ..      ....+++|||+++++|.+++....   ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~  156 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE  156 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence            53      456799999999999999987532   225778888999999999999999999   999999999999999


Q ss_pred             CCcEEEeecCCccccCCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 040763          215 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE  289 (360)
Q Consensus       215 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~  289 (360)
                      ++.++|+|||++........ ......|+..|+|||.+.     ...++.++|+||||+++|||++|..||........ 
T Consensus       157 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-  234 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-  234 (282)
T ss_pred             CCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-
Confidence            99999999999875432211 122345889999999876     34578899999999999999999999864321000 


Q ss_pred             ccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            .. . .....        ........++.++.+++.+||+.||.+|||+.++++
T Consensus       235 ------~~-~-~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 ------LF-L-IPRNP--------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ------hh-h-HhhCC--------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                  00 0 00000        011112345668999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.9e-40  Score=288.41  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=202.0

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--CCcceE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--TEFPLL  148 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~l  148 (360)
                      +|++.+.||.|+||.||++... +++.+++|.+......  ....+.+..|+.+++.++|||++++++.+..  ....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT--EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC--HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence            4788899999999999999865 6788999987653322  1334567889999999999999999998764  445789


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH-----SGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-----~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      +|||+++++|.+++.... ....++++..++.++.|++.||.|||     +.+   ++|+||+|+||++++++.+||+||
T Consensus        79 ~~e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EehhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecc
Confidence            999999999999997643 22346899999999999999999999     767   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      |++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....         .........
T Consensus       155 g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~  224 (265)
T cd08217         155 GLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---------LQLASKIKE  224 (265)
T ss_pred             cccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---------HHHHHHHhc
Confidence            999876543321 2234689999999999998899999999999999999999999865321         011111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..         ....+...+.++.+++.+||+.+|++|||+.+|++
T Consensus       225 ~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         225 GK---------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CC---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            11         11233455678999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.8e-40  Score=288.43  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=201.9

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccCh--HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDD--EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      +|+..+.||+|++|.||++... +++.+|+|.+......  ......+.+.+|+.+++.++|+|++++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999864 6889999987654322  112235678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~  227 (360)
                      ++||+++++|.+++....     ++++..+..++.|++.||.|||+++   ++|+||+|+||+++.++ .++|+|||.+.
T Consensus        81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            999999999999986532     5788999999999999999999999   99999999999998775 59999999987


Q ss_pred             ccCCCCce---eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          228 FIAMDQTH---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       228 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ........   ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......     .........   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~---  224 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-----HLALIFKIA---  224 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-----hHHHHHHHh---
Confidence            66432111   1123457889999999988889999999999999999999999985432110     001010000   


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ........+...++++.+++.+||+.+|++|||+.+++.
T Consensus       225 ------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 ------SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ------ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                  001112234456678999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=293.67  Aligned_cols=267  Identities=25%  Similarity=0.324  Sum_probs=202.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|++|.||+|.++ +++.+++|.++......  ...+.+.+|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE--DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc--cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            36889999999999999999876 57899999876543321  2345678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||++++.+..+....     ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        79 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          79 FEYVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            9999876666555331     24788999999999999999999999   999999999999999999999999998876


Q ss_pred             CCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH--------HHH
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF--------VHS  300 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~  300 (360)
                      ............++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.....  ........        ...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07833         151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQEL  228 (288)
T ss_pred             CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhhh
Confidence            55433233345678899999999887 78999999999999999999999986543210  00000000        000


Q ss_pred             hhcc------ccccccc-hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          301 MRKN------RLYHILD-DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       301 ~~~~------~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....      ....... .......+...++++.+++.+||+.+|++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000      0000000 01111223334778999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=294.94  Aligned_cols=250  Identities=22%  Similarity=0.322  Sum_probs=208.7

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..-|...+.||+|-|+.|-++++- +|..||||++....-+.  .....++.|+..|+.++|||||++|++...+...|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~--~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT--LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch--hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            455788889999999999999875 79999999987654332  345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc-CCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~  227 (360)
                      |+|.-++|+|.+|+.....    .+.+....+++.||+.|+.|+|+..   +|||||||+||... .-|-+||.|||++.
T Consensus        95 iLELGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             EEEecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccc
Confidence            9999999999999987543    5889999999999999999999999   99999999998764 66899999999986


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .+...  ....+.+|+..|-|||.+.+..|+ +++||||||||||.|++|++||....+..                 .+
T Consensus       168 kf~PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------------TL  228 (864)
T KOG4717|consen  168 KFQPG--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------------TL  228 (864)
T ss_pred             cCCCc--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------------hh
Confidence            65433  345567899999999999998886 57899999999999999999997654311                 11


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .-++|-  .-..|...+.+..+||.+||+.||.+|.|.++|..
T Consensus       229 TmImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  229 TMIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            112222  22346677889999999999999999999999863

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=295.65  Aligned_cols=255  Identities=27%  Similarity=0.365  Sum_probs=200.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|+..+.||+|++|+||++... +++.+|+|.+....... ......+..|+.++..++|+||+++++.+......+++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            36888899999999999999886 48899999877543221 12455678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+.+++|.+++....   ...+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          80 MDYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EEecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            99999999999986532   235889999999999999999999999   999999999999999999999999998654


Q ss_pred             CCCCce----------------------------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 040763          230 AMDQTH----------------------------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF  281 (360)
Q Consensus       230 ~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~  281 (360)
                      ......                            ......|+..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            321110                            1112357889999999999889999999999999999999999996


Q ss_pred             CCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC----HHHHHH
Q 040763          282 STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT----MEEVSM  349 (360)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt----~~ei~~  349 (360)
                      +....        ..+.......         .........+.++.+++.+||+.||++|||    +.+++.
T Consensus       234 ~~~~~--------~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         234 GSNRD--------ETFSNILKKE---------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCchH--------HHHHHHhcCC---------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            54311        1111111100         000111124668999999999999999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.9e-40  Score=291.54  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=193.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHH-HhhcCCCCceeeeeEEeeCCcceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFI-LSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~-~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ++|++.+.||+|+||.||++.++ +|..||+|.++......   ....+..|+.. ++..+|||++++++++......++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ---EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH---HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            36888999999999999999876 68999999877543322   12344456554 556699999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +|||++ ++|.+++..... ....+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++.
T Consensus        78 v~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999995 789888865432 224689999999999999999999997 7   9999999999999999999999999987


Q ss_pred             ccCCCCceeeecccccCCccchhhhcc----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ......  ......++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||.......       ........ 
T Consensus       153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~-  222 (283)
T cd06617         153 YLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-------QQLKQVVE-  222 (283)
T ss_pred             cccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-------HHHHHHHh-
Confidence            653221  1122457889999998865    446889999999999999999999985322100       00111111 


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......        ....+++++.+++.+||..+|++|||+.++++
T Consensus       223 ~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 EPSPQL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCCCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000        11235668999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.1e-40  Score=287.68  Aligned_cols=252  Identities=28%  Similarity=0.414  Sum_probs=195.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .+++.....||+|+||.||+|.+. ++..+++|.+.....    ...+.+.+|+.+++.++|+||+++++++...+..++
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH----HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            344555568999999999999866 567899998765322    234567889999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEeecCC
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPL--TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVADFGT  225 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~  225 (360)
                      ++||+++++|.+++.....    .+  +...+..++.|++.||+|||+.+   ++||||||+||+++. ++.++|+|||+
T Consensus        83 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             EEecCCCCCHHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence            9999999999999975321    23  67788889999999999999999   999999999999976 67999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +........ ......++..|+|||.+.+..  ++.++||||||+++|+|++|..||.........      .+....  
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~------~~~~~~--  226 (268)
T cd06624         156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA------MFKVGM--  226 (268)
T ss_pred             heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh------Hhhhhh--
Confidence            876543221 122235788999999987643  788999999999999999999998643211000      000000  


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                              .......+...++++.+++.+||+.+|++|||+.++++
T Consensus       227 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         227 --------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                    00011223445667999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-40  Score=293.78  Aligned_cols=263  Identities=23%  Similarity=0.295  Sum_probs=200.7

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|++|.||+|.+. +++.+++|.+.......  ...+.+.+|+.+++.++|||++++++++......++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG--GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc--hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence            4788899999999999999975 68899999877543222  23456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+ +++|.+++....    .++++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        79 e~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          79 EYM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             ccc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            999 999999986533    36899999999999999999999999   9999999999999999999999999987765


Q ss_pred             CCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc-----
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN-----  304 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  304 (360)
                      ...........++..|+|||.+.+. .++.++||||+|+++|+|++|.+||.+..+...     ...........     
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  225 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-----LAIVFRTLGTPNEETW  225 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-----HHHHHHHcCCCChHHH
Confidence            4332223344688999999988654 468899999999999999999877754332100     00000000000     


Q ss_pred             -------ccccccc----hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 -------RLYHILD----DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 -------~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             .+..+..    ...........+.++.+++.+||+.+|++|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                   0000000    00001111233578999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-40  Score=294.73  Aligned_cols=268  Identities=24%  Similarity=0.333  Sum_probs=198.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++..+ +++.+|+|.+.......  ...+.+.+|+.++..++||||+++++++......+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK--MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc--hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence            36888999999999999999986 57899999876533322  2345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+++++|.++....     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        79 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          79 FEFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            9999998888776432     14789999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc------hHHHHHHHhh
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS------LAAYFVHSMR  302 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~  302 (360)
                      .... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............      +.........
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         151 AAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             cCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence            4332 22233457889999998876 44678999999999999999999988643311000000      0000000000


Q ss_pred             ccc------cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNR------LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...      ..............+..+..+.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000      00000000001112345678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.7e-40  Score=286.45  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=200.2

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|+..+.||+|++|.||++... +++.+++|.+.......  .....+.+|+.+++.++|||++++++.+...+..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc--HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence            4788899999999999999875 67889999876543222  33567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC-CcEEEeecCCcccc
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFI  229 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~  229 (360)
                      ||+++++|.+++....   ...+++..+..++.|++.|+.|||+++   ++|+||+|+||+++++ +.++|+|||++...
T Consensus        79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          79 EYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             ecCCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            9999999999997642   225789999999999999999999999   9999999999999855 46899999999866


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ....  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......        ....... ...    
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~-~~~----  217 (256)
T cd08220         153 SSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIM-SGT----  217 (256)
T ss_pred             CCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHH-hcC----
Confidence            4332  122345788999999999888899999999999999999999998543210        0011111 000    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ....+...++++.+++.+||+.+|++|||+.++++
T Consensus       218 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 -----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -----CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 01122335667999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=291.89  Aligned_cols=252  Identities=27%  Similarity=0.346  Sum_probs=200.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||.|++|.||++... ++..+++|.+.....    ...+.+..|+.+++.++|||++++++.+......++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE----EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH----HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            356889999999999999999875 578999998764321    345677889999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|||+++++|.+++....    .++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        80 v~e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~  152 (280)
T cd06611          80 LIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK  152 (280)
T ss_pred             EeeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence            999999999999987532    25889999999999999999999999   99999999999999999999999999865


Q ss_pred             cCCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ...... ......+++.|+|||.+.     ...++.++|+||||+++|+|++|+.||......        ... .....
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~-~~~~~  222 (280)
T cd06611         153 NKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVL-LKILK  222 (280)
T ss_pred             hccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHH-HHHhc
Confidence            433221 122345889999999875     345678999999999999999999998643210        000 11111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....       ....+..++.++.+++.+||+.+|.+|||+.++++
T Consensus       223 ~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         223 SEPP-------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CCCC-------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            1000       00112345567999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.3e-40  Score=292.20  Aligned_cols=246  Identities=28%  Similarity=0.375  Sum_probs=199.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|++|.||++.+. +++.+|+|.+...... .....+.+.+|+.++++++||||+++++++......+++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence            46888999999999999999876 5789999987643211 123356678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .++...+..++.|++.||.|||+.+   ++|+||+|.||++++++.+||+|||++...
T Consensus        80 ~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~  151 (290)
T cd05580          80 MEYVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV  151 (290)
T ss_pred             EecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence            99999999999997642     5889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...    .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....        ....... ....    
T Consensus       152 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~-~~~~----  214 (290)
T cd05580         152 KGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKI-LEGK----  214 (290)
T ss_pred             CCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-hcCC----
Confidence            433    2334688999999999888889999999999999999999999864331        0001111 1110    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVS  348 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~  348 (360)
                            ...+...+..+.+++.+||+.||.+||     ++.+++
T Consensus       215 ------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         215 ------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                  112233456789999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-40  Score=287.45  Aligned_cols=251  Identities=27%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccCh-HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +|+..+.||+|++|.||+|... ++..+++|.+...... ......+.+.+|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999876 7889999987653321 1123456788899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             EEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence            99999999999996532     4788899999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ....  ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.....        ............   
T Consensus       153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~---  219 (258)
T cd06632         153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKE---  219 (258)
T ss_pred             cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhccc---
Confidence            4332  223345889999999988766 89999999999999999999999854321        000011000000   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ....+...++++.+++.+||+.+|++|||+.+++.
T Consensus       220 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 ------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                  01122334567899999999999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-40  Score=290.52  Aligned_cols=239  Identities=23%  Similarity=0.367  Sum_probs=183.9

Q ss_pred             eecccCcEEEEEEEecC-------------------------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCC
Q 040763           78 ILGQGGQGTVYKGRLED-------------------------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN  132 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~~-------------------------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~n  132 (360)
                      .||+|+||.||+|....                         ...+++|.+.....    .....+.+|+.+++.++|||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR----DIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH----HHHHHHHHHHHHHhcCCCCC
Confidence            59999999999997421                         12578887754321    23356778899999999999


Q ss_pred             ceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 040763          133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL  212 (360)
Q Consensus       133 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill  212 (360)
                      |+++++++......++||||+++++|..++...    ...+++..+..++.|++.||+|||+++   ++||||||+||++
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill  150 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL  150 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence            999999999999999999999999999988642    225788999999999999999999999   9999999999999


Q ss_pred             cCCC-------cEEEeecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHH-hCCCCCCCC
Q 040763          213 DERY-------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELL-TGKKPIFST  283 (360)
Q Consensus       213 ~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~-tg~~p~~~~  283 (360)
                      +..+       .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||...
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             eccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            7643       3899999987543221     12346788999998866 56789999999999999995 689998643


Q ss_pred             CCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          284 GNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      .....     ...    ....           ...+....+++.+++.+||+.+|++|||+.++++.|+
T Consensus       226 ~~~~~-----~~~----~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         226 TPSEK-----ERF----YEKK-----------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ChHHH-----HHH----HHhc-----------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            21110     000    0000           0011122346899999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-40  Score=286.98  Aligned_cols=253  Identities=28%  Similarity=0.430  Sum_probs=200.7

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|++|.||++... +++.+++|.++.....  ....+.+.+|+.+++.++|+||+++++.+...+..++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence            5788899999999999999865 6889999987754433  235667889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....     .+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        79 e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          79 EYCSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             ecCCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            9999999999986532     4778889999999999999999999   9999999999999999999999999988765


Q ss_pred             CCCceee---ecccccCCccchhhhccCC---CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          231 MDQTHVT---TKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       231 ~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      .......   ....++..|+|||.+.+..   .+.++||||||+++|++++|+.||......      ......  ....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~------~~~~~~--~~~~  222 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE------FQIMFH--VGAG  222 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch------HHHHHH--HhcC
Confidence            4332221   1345788999999988766   788999999999999999999999643210      000000  0000


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....+       +.....++.+.+++.+||+.+|++|||+.+++.
T Consensus       223 ~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 HKPPI-------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCC-------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000       001123567889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-40  Score=289.44  Aligned_cols=240  Identities=23%  Similarity=0.378  Sum_probs=185.4

Q ss_pred             ceecccCcEEEEEEEecC-C-------cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           77 RILGQGGQGTVYKGRLED-G-------RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~-~-------~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      +.||+|+||.||+|..+. +       ..+++|.....    .....+.+.+|+.+++.++|||++++++++......++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence            369999999999998642 2       23677765432    12334567789999999999999999999999899999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc--------EEE
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR--------AKV  220 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~--------~kl  220 (360)
                      ||||+++|+|.+++.....    .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.        +++
T Consensus        77 v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l  149 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKL  149 (258)
T ss_pred             EEecCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEe
Confidence            9999999999999975432    5788999999999999999999999   999999999999987765        699


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCC-CCCCCCCCCcccccchHHHHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGK-KPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      +|||++......     ....++..|+|||++.+. .++.++||||||+++|+|++|. .||..... .    .    ..
T Consensus       150 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~----~----~~  215 (258)
T cd05078         150 SDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-Q----K----KL  215 (258)
T ss_pred             cccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-H----H----HH
Confidence            999988654321     223578889999998874 5789999999999999999985 55432211 0    0    00


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      .....           ....+...+.++.+++.+||+.||++|||+.++++.|+
T Consensus       216 ~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         216 QFYED-----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHc-----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00000           01122233457899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.4e-40  Score=291.13  Aligned_cols=256  Identities=25%  Similarity=0.337  Sum_probs=194.1

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~lv  149 (360)
                      +|...+.||+|+||.||++.+. +++.+|+|.+......   .....+.+|+.++.++. |+||+++++++......+++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            4556678999999999999876 5789999987754333   23456778999999995 99999999999988899999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      |||+. +++.++...........+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.++|+|||++..
T Consensus        82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            99985 5666554322112234689999999999999999999975 7   99999999999999999999999999876


Q ss_pred             cCCCCceeeecccccCCccchhhhccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ......  .....|+..|+|||.+.+.   .++.++||||||+++|+|++|+.||.....       .......... ..
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~-~~  227 (288)
T cd06616         158 LVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVK-GD  227 (288)
T ss_pred             hccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcC-CC
Confidence            543221  1233578899999998876   688999999999999999999999854320       0011111111 00


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .     .......+..++.++.+|+.+||+.||++|||+.++++
T Consensus       228 ~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         228 P-----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             C-----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0     01111122346678999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-39  Score=288.06  Aligned_cols=263  Identities=26%  Similarity=0.353  Sum_probs=201.5

Q ss_pred             cChHHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeee
Q 040763           61 FSSKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLG  138 (360)
Q Consensus        61 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~  138 (360)
                      +...++....++|.+.+.||+|+||.||++... +++.+|+|.+.....     ....+.+|+.++..+ +|||++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~~h~ni~~~~~   86 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-----VDEEIEAEYNILQSLPNHPNVVKFYG   86 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-----HHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence            444555666789999999999999999999875 678899998764321     123456788888888 8999999999


Q ss_pred             EEeeC-----CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          139 CCLET-----EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       139 ~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      ++...     ...+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++
T Consensus        87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~  162 (291)
T cd06639          87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLT  162 (291)
T ss_pred             EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEc
Confidence            98754     357999999999999998865322 2235889999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcc
Q 040763          214 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ  288 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~  288 (360)
                      .++.+||+|||++........ ......|+..|+|||.+...     .++.++||||||+++|||++|+.||......  
T Consensus       163 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--  239 (291)
T cd06639         163 TEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--  239 (291)
T ss_pred             CCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--
Confidence            999999999999876543221 12234578899999987653     3678999999999999999999998643210  


Q ss_pred             cccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ..... .........       ..+...+.++.+++.+||+.+|++|||+.++++
T Consensus       240 ------~~~~~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 ------KTLFK-IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ------HHHHH-HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                  00111 111111111       112334557999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-39  Score=290.14  Aligned_cols=258  Identities=24%  Similarity=0.278  Sum_probs=199.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++... +++.|++|.+..... ........+.+|+.+++.++||||+++++.+...+..+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            36888999999999999999876 578899998764321 1123345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~  151 (305)
T cd05609          80 MEYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIG  151 (305)
T ss_pred             EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence            99999999999996532     5788999999999999999999999   999999999999999999999999988642


Q ss_pred             CCCCc--------------eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          230 AMDQT--------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       230 ~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      .....              .......++..|+|||.+.+..++.++|+||||+++|||++|..||.+...        .+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~  223 (305)
T cd05609         152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EE  223 (305)
T ss_pred             CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH
Confidence            11000              011123478889999999888899999999999999999999999964321        01


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                      ... ........   .    .......+.++.+++.+||+.||++|||+.++.+.|+.
T Consensus       224 ~~~-~~~~~~~~---~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         224 LFG-QVISDDIE---W----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHH-HHHhcccC---C----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111 11111000   0    00112345678999999999999999997666655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.7e-41  Score=277.72  Aligned_cols=274  Identities=22%  Similarity=0.257  Sum_probs=207.2

Q ss_pred             hcCCCccceecccCcEEEEEEEecC-----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee-C
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE-T  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~  143 (360)
                      -..|+....||+|.||.||++.-++     +..+|+|+++...+...  -.....+|+.+++.++|||++.+..++.+ +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG--iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG--ISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC--cCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            3568999999999999999995432     23689999887543221  12345689999999999999999999987 7


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC----CcEE
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAK  219 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~----~~~k  219 (360)
                      ...++++||.++ +|...+..........++..++.+|++||+.|+.|||++.   |.||||||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            788999999865 8989887766555567899999999999999999999999   9999999999999887    9999


Q ss_pred             EeecCCccccCCCC--ceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc----cc
Q 040763          220 VADFGTSKFIAMDQ--THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN----VS  292 (360)
Q Consensus       220 l~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~----~~  292 (360)
                      |+|||+++.....-  .......+-|.+|+|||.+.+. .||.+.||||.|||..||+|-.+-|.+..+.....    ..
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            99999998876532  2334566789999999998885 67889999999999999999998887765433332    12


Q ss_pred             hHHHHHHHhhccccccccchHHhhhc-----------------------cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          293 LAAYFVHSMRKNRLYHILDDQVMKLG-----------------------KKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....+...+..+....+.+-...++.                       ...-++...+|+.++|..||.+|.|+++.++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            22233333332222111111111110                       0001223789999999999999999999875

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=289.23  Aligned_cols=263  Identities=18%  Similarity=0.279  Sum_probs=185.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEecCC----cEEEEEecccccChHHHHh-------HHHHHHHHHHHhhcCCCCceeee
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLEDG----RIIAVKKSKLAVDDEELYK-------LEEFINEIFILSQINHRNVVKLL  137 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vaik~~~~~~~~~~~~~-------~~~~~~e~~~~~~l~h~niv~~~  137 (360)
                      ..++|++.+.||+|+||+||+|...++    ..+++|.............       ......+...+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346899999999999999999987643    4566665433222110000       01122334455667899999999


Q ss_pred             eEEeeCC----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          138 GCCLETE----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       138 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      +++....    ..+++++++ ..++.+.+....     ..++..+..++.|++.||+|||+++   ++||||||+|||++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~  160 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVD  160 (294)
T ss_pred             EeeeEecCCceEEEEEEehh-ccCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence            9766543    335677766 446666664422     2567788899999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCce------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 040763          214 ERYRAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS  287 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~  287 (360)
                      .++.++|+|||++.........      ......||+.|+|||+..+..++.++|||||||++|||++|..||.+.....
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999765432111      1122358999999999999999999999999999999999999997653211


Q ss_pred             ccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          288 QENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                      .........+...+..+        ..   .....++++.+++..||..+|++||++.++.+.|
T Consensus       241 ~~~~~~~~~~~~~~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKCDFIKRLHEG--------KI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHHHHHHHhhhh--------hh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11000000011111111        00   1122356799999999999999999999999876

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=315.39  Aligned_cols=266  Identities=24%  Similarity=0.355  Sum_probs=216.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec----C----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeee
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE----D----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLL  137 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~  137 (360)
                      +...++..+.+.+|+|.||.|++|...    .    ...||||..+.....   ...+.+..|+.+|..+ +|+||+.++
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            333445566679999999999999743    1    457899988865554   4566788999999999 699999999


Q ss_pred             eEEeeCCcceEEEEecCCCChhHHhhhhc---------cCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 040763          138 GCCLETEFPLLVYEFIPNGTLYQHLHDRH---------QNEEY--PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK  206 (360)
Q Consensus       138 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  206 (360)
                      |++......++|+||+..|+|.++++.+.         .....  .++....+.++.|||.|++||++..   ++||||.
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA  445 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA  445 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence            99999999999999999999999998876         11122  3889999999999999999999998   9999999


Q ss_pred             CCCeEEcCCCcEEEeecCCccccCCCCceeeeccc--ccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 040763          207 STNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ--GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFST  283 (360)
Q Consensus       207 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~  283 (360)
                      .+|||+..+..+||+|||+++..............  -+..|||||.+....++.++||||||++||||+| |..||.+.
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999876655544433333  3456999999999999999999999999999999 99998652


Q ss_pred             CCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          284 GNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      ..       ...          +.+.+.+..+...|..+++++.+++..||+.+|++||++.++.+.++...
T Consensus       526 ~~-------~~~----------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  526 PP-------TEE----------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             Cc-------HHH----------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            20       000          11122233344557778889999999999999999999999999999864

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-39  Score=286.80  Aligned_cols=247  Identities=28%  Similarity=0.402  Sum_probs=199.1

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      -|+..+.||+|+||.||+|... ++..+|+|........   .....+.+|+.++..++||||+++++++..+...++||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            4677889999999999999865 6789999987543222   23456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++...      .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          82 EYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             EeCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            999999999998532      4789999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......         ..........     
T Consensus       153 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~-----  217 (277)
T cd06641         153 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---------KVLFLIPKNN-----  217 (277)
T ss_pred             cchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---------HHHHHHhcCC-----
Confidence            3221 112235788999999998888899999999999999999999998543210         0011111110     


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ....+...+.++.+++.+||+.+|++||++.++++
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         218 ----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ----CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                11122334567899999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-39  Score=290.89  Aligned_cols=248  Identities=30%  Similarity=0.437  Sum_probs=196.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..|+..+.||+|+||.||+|... +++.+++|.+...... .......+.+|+.+++.++|||++++.+++...+..++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            55888899999999999999875 6889999987543222 123345678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+. |++.+++....    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        94 ~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          94 MEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             HHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence            99996 67777775422    25889999999999999999999999   999999999999999999999999998654


Q ss_pred             CCCCceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ...     ....++..|+|||++.   ...++.++||||||+++|||++|..||.......        ... .......
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~~-~~~~~~~  231 (307)
T cd06607         166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALY-HIAQNDS  231 (307)
T ss_pred             CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HHH-HHhcCCC
Confidence            322     2235788999999874   3567889999999999999999999986432100        000 0000000


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                              ....+..++.++.+++.+||+.||++|||+.+++.
T Consensus       232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         232 --------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             --------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                    11112345678999999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-39  Score=282.16  Aligned_cols=238  Identities=25%  Similarity=0.402  Sum_probs=186.2

Q ss_pred             ceecccCcEEEEEEEecCCc-----------EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           77 RILGQGGQGTVYKGRLEDGR-----------IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~-----------~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      +.||+|+||.||+|...+..           .+++|.......     ....+.+|+.+++.++||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh-----hHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence            36899999999999986433           467776554321     14567789999999999999999999888 77


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-------cE
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-------RA  218 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-------~~  218 (360)
                      .+++|||+++++|.+++.....    .+++..+..++.|++.||+|||+++   ++||||||+||+++.++       .+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~  147 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFI  147 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeE
Confidence            8999999999999999976432    5788999999999999999999999   99999999999999887       79


Q ss_pred             EEeecCCccccCCCCceeeecccccCCccchhhhccC--CCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHH
Q 040763          219 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~  295 (360)
                      ||+|||++.....     .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||.......     .  
T Consensus       148 kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-----~--  215 (259)
T cd05037         148 KLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-----K--  215 (259)
T ss_pred             EeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-----H--
Confidence            9999999876543     1223467789999998876  78899999999999999999 577765432100     0  


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                        .........           .+......+.+++.+||..+|++|||+.++++.|+
T Consensus       216 --~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 --ERFYQDQHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --HHHHhcCCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              000000000           00111157899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=289.27  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=195.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|++|.||+|..+ +++.+|+|.+.......   ....+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            67889999999999999999976 67899999876543221   123456899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+. ++|.+++....    ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++...
T Consensus        82 ~e~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          82 FEYLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             EecCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            99997 59999886532    15788999999999999999999999   999999999999999999999999998654


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc---c
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN---R  305 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  305 (360)
                      ...... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... +   ........+...   .
T Consensus       154 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~  228 (291)
T cd07844         154 SVPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-D---QLHKIFRVLGTPTEET  228 (291)
T ss_pred             CCCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-H---HHHHHHHhcCCCChhh
Confidence            322111 122346888999998875 457899999999999999999999996543110 0   000000000000   0


Q ss_pred             c-------------ccccchHHhhhccHHH--HHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 L-------------YHILDDQVMKLGKKNQ--IVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~-------------~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +             ................  ..++.+++.+||+.+|++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0             0000000000000111  257889999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1e-39  Score=284.89  Aligned_cols=252  Identities=28%  Similarity=0.426  Sum_probs=205.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|++|.||++... +++.+++|.+......   .....+.+|+..+..++|+|++++++++......+++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            36888999999999999999987 4889999987764332   3456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      |||+++++|.+++...     .+++...+..++.|++.|+.|||+ .+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~  149 (264)
T cd06623          78 LEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKV  149 (264)
T ss_pred             EEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCcccee
Confidence            9999999999999764     258899999999999999999999 99   99999999999999999999999999876


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....     ........ .......  
T Consensus       150 ~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~-~~~~~~~--  220 (264)
T cd06623         150 LENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQ-AICDGPP--  220 (264)
T ss_pred             cccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHH-HHhcCCC--
Confidence            6433222 1234578899999999998899999999999999999999999865542     01111111 1111111  


Q ss_pred             ccchHHhhhccHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKN-QIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             ...+.. ++..+.+++.+||..+|++|||+.++++
T Consensus       221 -------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         221 -------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             -------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                   111222 5668999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=291.90  Aligned_cols=273  Identities=22%  Similarity=0.306  Sum_probs=199.4

Q ss_pred             CCCccceecccCcEEEEEEEecC---CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--Ccc
Q 040763           72 HFNVNRILGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFP  146 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~~---~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~  146 (360)
                      +|++.+.||+|++|.||+|..+.   +..+|+|.+....... ....+.+.+|+.++..++||||+++++++...  ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-TGISQSACREIALLRELKHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc-cCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence            47888999999999999999754   6899999887633111 11234566899999999999999999999887  788


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC----CCcEEEee
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE----RYRAKVAD  222 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~----~~~~kl~D  222 (360)
                      ++||||++ +++.+.+..........++...+..++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+|
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          80 YLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECC
Confidence            99999996 57877776544333346889999999999999999999999   999999999999999    99999999


Q ss_pred             cCCccccCCCCc--eeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch----HH
Q 040763          223 FGTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL----AA  295 (360)
Q Consensus       223 fg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~----~~  295 (360)
                      ||++........  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+...........    ..
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999886543322  112334678899999987764 57899999999999999999999997654322111000    00


Q ss_pred             HHHHHhhcc------------cccc---------ccchHHhhhccH--HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKN------------RLYH---------ILDDQVMKLGKK--NQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~------------~~~~---------~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .....+...            ....         ............  ..+.++.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000            0000         000000011111  34557899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.3e-40  Score=290.01  Aligned_cols=262  Identities=24%  Similarity=0.334  Sum_probs=197.3

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|+..+.||.|++|.||+|..+ +++.+++|.+.......  .....+.+|+.++++++||||+++++++.+.+..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE--GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc--ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence            4788899999999999999876 68899999876543221  22346778999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+. ++|.+++....   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        79 e~~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          79 EFLH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             eccc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9995 68988886532   235889999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc-----
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN-----  304 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  304 (360)
                      .... ......++..|+|||.+.+.. ++.++||||||+++|+|+||+.||........    ..... ......     
T Consensus       152 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~  225 (284)
T cd07860         152 VPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ----LFRIF-RTLGTPDEVVW  225 (284)
T ss_pred             cCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHH-HHhCCCChhhh
Confidence            3221 122234688899999887644 58899999999999999999999965432110    00000 000000     


Q ss_pred             -----------ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 -----------RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                                 ......... .....+..++++.+++.+||+.||++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         226 PGVTSLPDYKPSFPKWARQD-FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhHHHHHHhhcccccccC-HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                       000000000 01112234567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=286.76  Aligned_cols=248  Identities=25%  Similarity=0.429  Sum_probs=197.0

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC---CCCceeeeeEEeeCCcce
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN---HRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~---h~niv~~~~~~~~~~~~~  147 (360)
                      .|+..+.||+|+||.||+|.+. +++.+++|.+......   ...+++.+|+.+++.++   |||++++++++......+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD---DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            4778889999999999999974 6889999987654333   23456678899988886   999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++|||+++++|.+++...      ++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        79 lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          79 IIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             EEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence            999999999999988542      5889999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ........ .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||........         .........
T Consensus       150 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---------~~~~~~~~~  219 (277)
T cd06917         150 LLNQNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---------MMLIPKSKP  219 (277)
T ss_pred             ecCCCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---------hhccccCCC
Confidence            76543321 2334688899999988754 468899999999999999999999965321000         000000000


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..+        .....+.++.+++.+||+.||++|||+.++++
T Consensus       220 ~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         220 PRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            000        01114567999999999999999999999964

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-40  Score=294.95  Aligned_cols=254  Identities=26%  Similarity=0.336  Sum_probs=200.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~  147 (360)
                      ....|++.+.||.|+.+.||++...+.+.+|+|++.....+.  ..+.-+..|+..|.++ .|.+|+.++++-..++..|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~--qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN--QTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH--HHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            446799999999999999999998888889998876544443  4577899999999999 6999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ||||+- ..+|...|..+...    ++...+..+..|++.++.++|+.|   |||.||||.|+|+-. |.+||+|||.|.
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~----~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSI----DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIAN  507 (677)
T ss_pred             EEeecc-cccHHHHHHhccCC----CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhc
Confidence            999964 78999999875432    332367788999999999999999   999999999999876 489999999999


Q ss_pred             ccCCCCcee-eecccccCCccchhhhccCC-----------CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          228 FIAMDQTHV-TTKIQGTFGYLDPEYHQSSQ-----------LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       228 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      .+..+.... ....+||+.||+||.+....           .+.++||||+|||||+|+.|++||.....          
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------  577 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------  577 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------
Confidence            988776555 34467999999999776432           45789999999999999999999954321          


Q ss_pred             HHHHHhhccccccccchHHhhhccHHH-HHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQ-IVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          .+  ..+..+.++...-+++..- ..++.+++..||..||.+|||..++++
T Consensus       578 ----~~--aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 ----QI--AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ----HH--HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                11  1122233332211111110 113999999999999999999999975

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.6e-40  Score=290.02  Aligned_cols=268  Identities=24%  Similarity=0.294  Sum_probs=198.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--Ccce
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFPL  147 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~  147 (360)
                      ++|++.+.||+|++|.||+|..+ +++.+++|.++......  .....+.+|+.++..++||||+++++++...  ...+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE--GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc--cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            56888999999999999999986 57889999887543321  2233456899999999999999999998877  8899


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++|||++ ++|.+++.....    .+++.....++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 lv~e~~~-~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          83 MVMEYVE-HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             EEehhcC-cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCcee
Confidence            9999996 599998875332    5889999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch-------HHHHHH
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL-------AAYFVH  299 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~  299 (360)
                      ....... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.............       ...+..
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         155 EYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             eccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence            6654321 12233578899999988764 46889999999999999999999986543210000000       000000


Q ss_pred             H-----hhccccccccchHHhhhccHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 S-----MRKNRLYHILDDQVMKLGKKN-QIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~-----~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .     ..................+.. .++.+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0     000000111111111222222 4667899999999999999999999974

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-40  Score=287.65  Aligned_cols=255  Identities=29%  Similarity=0.422  Sum_probs=198.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCC--
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETE--  144 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~--  144 (360)
                      ..++|++.+.||+|++|.||+|..+ +++.+++|.+.....     ..+.+.+|+.+++.+ +|+||+++++++....  
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            4578999999999999999999986 577899998765322     235677899999998 7999999999997654  


Q ss_pred             ----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          145 ----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       145 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                          ..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEE
Confidence                47999999999999999865331 1236889999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhcc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      +|||++....... .......|+..|+|||.+..     ..++.++||||||+++|+|++|+.||......        .
T Consensus       155 ~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~  225 (275)
T cd06608         155 VDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------R  225 (275)
T ss_pred             CCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------H
Confidence            9999987653322 12233458889999998754     34678999999999999999999999643210        0


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .... +.......       ...+..++.++.+++.+||..||++|||+.++++
T Consensus       226 ~~~~-~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         226 ALFK-IPRNPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHHH-hhccCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0111 11111100       1112346678999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.3e-39  Score=286.54  Aligned_cols=267  Identities=21%  Similarity=0.296  Sum_probs=196.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCc---
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEF---  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~---  145 (360)
                      ++|++.+.||+|+||.||++.+. +++.||+|.........  .....+.+|+.++..+ +||||+++++++...+.   
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE--GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc--CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            36888999999999999999976 68899999876543221  1234567899999999 56999999999887665   


Q ss_pred             --ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEee
Q 040763          146 --PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVAD  222 (360)
Q Consensus       146 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~D  222 (360)
                        .|++|||+++ +|.+++..........+++..+..++.|++.||.|||+++   ++||||+|+||+++. ++.+||+|
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEee
Confidence              7999999975 8988887654332346899999999999999999999999   999999999999998 89999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+......    .. ......
T Consensus       155 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~-~~~~~~  228 (295)
T cd07837         155 LGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ----LL-HIFKLL  228 (295)
T ss_pred             cccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH----HH-HHHHHh
Confidence            999875533211 1122346788999998765 4578999999999999999999999965432110    00 000000


Q ss_pred             hccc---ccccc-----------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNR---LYHIL-----------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~---~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....   +....           .........+..+.++.+++.+||+.||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000   00000           000001111235667999999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.7e-40  Score=286.25  Aligned_cols=250  Identities=28%  Similarity=0.346  Sum_probs=202.3

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||.|+||.||++.+. ++..+++|.+....... ....+.+.+|+.++++++||||+++++.+......++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            4888999999999999999986 58899999876532211 124567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+.+++|.+++...     .+++...+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++....
T Consensus        80 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          80 DLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             eCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            999999999999764     25888999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ...  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......      ....+......       
T Consensus       152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~-------  216 (258)
T cd05578         152 PDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET-------  216 (258)
T ss_pred             CCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc-------
Confidence            332  223345788999999999888999999999999999999999998654321      11111111110       


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH--HHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM--EEVS  348 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~--~ei~  348 (360)
                         .....+...+..+.+++.+||+.||.+||++  +|++
T Consensus       217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence               1122333455789999999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.5e-39  Score=286.88  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=200.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|.+.+.||+|+||.||++... ++..+++|.+.....    ...+.+.+|+.+++.++|||++++++.+......++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            67899999999999999999865 578899998754322    2245677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||+++++|.+++...      .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus        95 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          95 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             EecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence            9999999999998642      3678889999999999999999999   999999999999999999999999988655


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... ......+++.|+|||.+.+..++.++|+||||+++|++++|+.||.........  ..      ....+     
T Consensus       166 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~------~~~~~-----  231 (293)
T cd06647         166 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL------IATNG-----  231 (293)
T ss_pred             ccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--ee------hhcCC-----
Confidence            43222 222345888999999998888999999999999999999999999654321110  00      00000     


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                         ......+...+..+.+++.+||+.+|++||++.+++..
T Consensus       232 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         232 ---TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ---CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00011123345578999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.3e-39  Score=286.92  Aligned_cols=264  Identities=20%  Similarity=0.254  Sum_probs=193.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||.||+|... ++..+++|.+.......   ....+.+|+.+++.++|+||+++++++......++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            467999999999999999999875 58899999876543221   12345689999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|||+. +++.+++....    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        81 v~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  152 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARA  152 (291)
T ss_pred             EEeccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccc
Confidence            999995 78877765422    24677888889999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh-----
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR-----  302 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  302 (360)
                      ...... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||........   .+... .....     
T Consensus       153 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~-~~~~~~~~~~  227 (291)
T cd07870         153 KSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE---QLEKI-WTVLGVPTED  227 (291)
T ss_pred             cCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH---HHHHH-HHHcCCCChh
Confidence            432211 12223578899999988764 578899999999999999999999965432100   00000 00000     


Q ss_pred             -------ccc-cccccchHHhhhc-----cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 -------KNR-LYHILDDQVMKLG-----KKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 -------~~~-~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             ... .............     ....+.++.+++.+|++.||++|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                   000 0000000000000     0012457889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.7e-39  Score=288.77  Aligned_cols=264  Identities=27%  Similarity=0.304  Sum_probs=198.1

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH-HHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE-LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +|++.+.||+|++|.||+|... +++.+++|.+........ ......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999876 688999999876433211 11234566899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+ +++|.+++....    ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            9999 899999996532    25889999999999999999999999   999999999999999999999999999766


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc----
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN----  304 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  304 (360)
                      ..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+......    . ..........    
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~----~-~~~~~~~~~~~~~~  226 (298)
T cd07841         153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ----L-GKIFEALGTPTEEN  226 (298)
T ss_pred             cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH----H-HHHHHHcCCCchhh
Confidence            44321 1222346788999998865 4578899999999999999999777754332110    0 0000000000    


Q ss_pred             -----ccccccc-----hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 -----RLYHILD-----DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 -----~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           .......     ...........+.++.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                 0000000     00001112234668999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.7e-40  Score=289.32  Aligned_cols=247  Identities=26%  Similarity=0.408  Sum_probs=195.1

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |.....||+|+||.||++... ++..+|+|.+.....    ...+.+.+|+.+++.++|+|++++++.+...+..+++||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ----QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH----HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            333467999999999999875 578999998754321    234567889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+++++|.+++...      .+++..+..++.|++.||.|||+++   ++||||+|+||++++++.++|+|||++.....
T Consensus       100 ~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         100 FLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            99999999987431      4788899999999999999999999   99999999999999999999999999865433


Q ss_pred             CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                      ... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||......        ... ...... .    .
T Consensus       171 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~-~~~~~~-~----~  235 (292)
T cd06658         171 EVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAM-RRIRDN-L----P  235 (292)
T ss_pred             ccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH-HHHHhc-C----C
Confidence            221 122345889999999998888999999999999999999999998643210        000 001000 0    0


Q ss_pred             hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       312 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...  ......+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         236 PRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             Ccc--ccccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            000  011234557889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.3e-39  Score=283.30  Aligned_cols=251  Identities=23%  Similarity=0.369  Sum_probs=199.4

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|.+.+.||+|+||.||++..+ ++..+++|.+.......  ...+.+.+|+.+++.++|+|++++++.+......++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV--KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc--hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence            4788899999999999999876 57889999876532111  23346678999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cEEEeecCCcccc
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFI  229 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~  229 (360)
                      ||+++++|.+++....   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++ .++|+|||.+...
T Consensus        79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          79 EYCDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             ecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            9999999999997532   225789999999999999999999999   99999999999999885 4699999998766


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... ......|++.|+|||+..+..++.++|+||||+++|+|++|..||.....        ...... ......   
T Consensus       153 ~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~---  219 (257)
T cd08225         153 NDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLK-ICQGYF---  219 (257)
T ss_pred             cCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHH-HhcccC---
Confidence            43221 12234588899999999888899999999999999999999999854321        111111 111111   


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            .......+.++.+++.+||+.+|++|||+.++++
T Consensus       220 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 ------APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                  1112334567999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.8e-39  Score=291.53  Aligned_cols=266  Identities=21%  Similarity=0.290  Sum_probs=196.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC----
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET----  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----  143 (360)
                      ..++|++.+.||+|+||.||++... +++.+|+|.+.......  .....+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV--THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh--hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            4578999999999999999999876 68899999876433221  2345567899999999999999999988644    


Q ss_pred             --CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          144 --EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       144 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                        ...++||||+. ++|.+.+..       .++...+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          92 EFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             ccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence              34699999995 588887754       2778888899999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc---------
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS---------  292 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~---------  292 (360)
                      |||++.......  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||............         
T Consensus       161 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (353)
T cd07850         161 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD  238 (353)
T ss_pred             cCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            999997654322  123345788999999999999999999999999999999999999654311000000         


Q ss_pred             -hHH----HHHHHhhccc------cccccchHH----hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          293 -LAA----YFVHSMRKNR------LYHILDDQV----MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       293 -~~~----~~~~~~~~~~------~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       ...    ..........      .........    ........++++.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             000    0000000000      000000000    00001234567899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.2e-39  Score=286.63  Aligned_cols=259  Identities=26%  Similarity=0.308  Sum_probs=201.1

Q ss_pred             CCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      +|++.+.||+|++|.||++...    ++..+|+|.++...........+.+..|+.++..+ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999998743    46789999876533222223445677899999999 699999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++++|.+++....     .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~  152 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS  152 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence            99999999999999986532     5788889999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ...............|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||........    ... ........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~-~~~~~~~~  227 (288)
T cd05583         153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSE-ISRRILKS  227 (288)
T ss_pred             cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHH-HHHHHHcc
Confidence            765443322223345889999999987754  78899999999999999999999864321110    001 11111000


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                                ....+...+.++.+++.+||+.||++|||+.++.+.|+-
T Consensus       228 ----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 ----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                      011233345678999999999999999999888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.7e-39  Score=283.96  Aligned_cols=267  Identities=22%  Similarity=0.312  Sum_probs=199.0

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||.|++|.||+|... ++..+|+|.++.....   ...+.+.+|+.+++.++|+||+++++.+...+..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence            4888999999999999999986 5889999987754332   22345668999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||++ ++|.+++.....  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        78 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          78 EYMD-KDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             ecCC-ccHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            9997 588888865432  236899999999999999999999999   9999999999999999999999999987554


Q ss_pred             CCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch-------HHHHHHHhh
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL-------AAYFVHSMR  302 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~~~  302 (360)
                      .... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+...........       ...+.....
T Consensus       152 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         152 IPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             CCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence            3221 11223568899999988664 56889999999999999999999986543211000000       000000000


Q ss_pred             cc----ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KN----RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..    ........ ......+..+.++.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         231 LPEYKPTFPRYPPQ-DLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CchhcccccCCChH-HHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00    00000000 111122334668999999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=300.09  Aligned_cols=250  Identities=27%  Similarity=0.388  Sum_probs=198.7

Q ss_pred             CCCccceecccCcEEEEEEEecCCcEE-EEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLEDGRII-AVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~~~~~v-aik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .+.++..||.|+||.||++..++.... |.|++..    .+...++.++-|++|+..++||+|+++++.|...+.+++..
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            355667799999999999988754443 4454433    23356788999999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      |||.||.....+-....    ++.+..+..++.|++.||.|||++.   |+|||||+.|||++-+|.++|+|||.+....
T Consensus       109 EFC~GGAVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             eecCCchHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch
Confidence            99999999998876543    6899999999999999999999999   9999999999999999999999999975322


Q ss_pred             CCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      . .......+.|||.|||||+..     ..+|+.++||||||++|.||..+.+|-....       .......  +... 
T Consensus       182 ~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllK--iaKS-  250 (1187)
T KOG0579|consen  182 S-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLK--IAKS-  250 (1187)
T ss_pred             h-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHH--Hhhc-
Confidence            1 122244568999999999754     4679999999999999999999999853221       1111111  1111 


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            .+.....|..|+..|.+++.+||.+||..||++.++++
T Consensus       251 ------ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  251 ------EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ------CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                  11112246778889999999999999999999999874

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.6e-39  Score=284.33  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=202.0

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .+.|+..+.||+|++|.||++.++ ++..+++|.+.....     ..+.+.+|+..++.++|+|++++++.+......++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            466888889999999999999987 688899998765432     34567789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ++||+++++|.+++....    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        93 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             EEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            999999999999998743    25889999999999999999999999   99999999999999999999999999865


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......       ..  ...........
T Consensus       166 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~--~~~~~~~~~~~  235 (286)
T cd06614         166 LTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RA--LFLITTKGIPP  235 (286)
T ss_pred             hccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HH--HHHHHhcCCCC
Confidence            543221 122234788999999998888999999999999999999999998543210       00  00111111111


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .       ..+..++.++.+++.+||+.+|.+|||+.++++
T Consensus       236 ~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         236 L-------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             C-------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0       012224567999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.6e-39  Score=281.14  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=203.3

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|++|.||++... +++.+++|.+.......  .....+.+|+.+++.++|+||+++++++......++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ--KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH--HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence            4788899999999999999865 67889999876533222  23456678999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++..... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          79 EYAPFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             hhcCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            99999999999876432 2236889999999999999999999999   9999999999999999999999999997765


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ..   ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......         ..........     
T Consensus       155 ~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---------~~~~~~~~~~-----  217 (256)
T cd08530         155 KN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---------DLRYKVQRGK-----  217 (256)
T ss_pred             cC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhcCC-----
Confidence            43   122235788999999999988999999999999999999999998643310         0111111111     


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ....+...+.++.+++.+||+.+|++|||+.++++
T Consensus       218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         218 ----YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ----CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                11223356678999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.1e-39  Score=285.38  Aligned_cols=245  Identities=29%  Similarity=0.406  Sum_probs=194.7

Q ss_pred             ccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           75 VNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      ....||+|+||.||++... +++.+++|.+.....    ...+.+.+|+.++..++|||++++++.+...+..++++||+
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            3447999999999999875 688999998754322    22355778999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      ++++|.+++...      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus       101 ~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659         101 QGGALTDIVSQT------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             CCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            999999877442      4788999999999999999999999   9999999999999999999999999986543322


Q ss_pred             ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchH
Q 040763          234 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQ  313 (360)
Q Consensus       234 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (360)
                      . ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......        ... ..+.......     
T Consensus       172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~-~~~~~~~~~~-----  236 (297)
T cd06659         172 P-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAM-KRLRDSPPPK-----  236 (297)
T ss_pred             c-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH-HHHhccCCCC-----
Confidence            1 122346889999999999888999999999999999999999999643210        000 0111110000     


Q ss_pred             HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          314 VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       314 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        .......+.++.+++.+||+.+|++|||+.++++
T Consensus       237 --~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         237 --LKNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             --ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence              0011223457899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.1e-39  Score=279.36  Aligned_cols=253  Identities=30%  Similarity=0.433  Sum_probs=204.7

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|.+.+.||.|++|.||++.+. +++.+++|.+.......  .....+.+|+++++.++|+|++++.+.+......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE--KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh--HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence            4788899999999999999976 58899999877543321  33456778999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      |++++++|.+++..... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        79 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          79 EYADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             EecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecc
Confidence            99999999999976532 2246899999999999999999999999   9999999999999999999999999997665


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ... .......|++.|+|||...+..++.++|+||+|+++|+|++|..||.....        .. ..........    
T Consensus       155 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~-~~~~~~~~~~----  220 (258)
T cd08215         155 STV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LE-LALKILKGQY----  220 (258)
T ss_pred             cCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HH-HHHHHhcCCC----
Confidence            433 222334688899999999888899999999999999999999999854321        01 1111111111    


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ...+...+.++.+++.+||..+|++|||+.++++
T Consensus       221 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 -----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 1122244567999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.5e-40  Score=314.01  Aligned_cols=256  Identities=30%  Similarity=0.421  Sum_probs=192.9

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--  143 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--  143 (360)
                      ..-.++|+..+.||+|+||.||+++.+ ||+.||||++......   .....+.+|+..+.+++|||||+++..|.+.  
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~---~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASD---KLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHH---HHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            345577899999999999999999988 8999999998886522   3456788999999999999999988543210  


Q ss_pred             --------------------------------------------------------------------------------
Q 040763          144 --------------------------------------------------------------------------------  143 (360)
Q Consensus       144 --------------------------------------------------------------------------------  143 (360)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------------------CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHH
Q 040763          144 -------------------------------------EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA  186 (360)
Q Consensus       144 -------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~  186 (360)
                                                           ...|+=||||+...+.+++.++..+.    .....+.++++|+
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREIL  707 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHH
Confidence                                                 01267788998888888887654321    4567889999999


Q ss_pred             HHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC-----------------CCCceeeecccccCCccch
Q 040763          187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-----------------MDQTHVTTKIQGTFGYLDP  249 (360)
Q Consensus       187 ~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~gt~~y~aP  249 (360)
                      .||+|+|+.|   +|||||||.||+++++..|||+|||+|+...                 .......+..+||.-|+||
T Consensus       708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            9999999999   9999999999999999999999999998721                 0011123446799999999


Q ss_pred             hhhccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHH
Q 040763          250 EYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAF  326 (360)
Q Consensus       250 E~~~~~---~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (360)
                      |++.+.   .|+.|+|+||||++++||+.   ||...++        .......++.+.+..-      .....+..+.=
T Consensus       785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--------Ra~iL~~LR~g~iP~~------~~f~~~~~~~e  847 (1351)
T KOG1035|consen  785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--------RASILTNLRKGSIPEP------ADFFDPEHPEE  847 (1351)
T ss_pred             HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH--------HHHHHHhcccCCCCCC------cccccccchHH
Confidence            998875   49999999999999999996   5643321        1122233333322221      11112222335


Q ss_pred             HHHHHHhhcCCCCCCCCHHHHHH
Q 040763          327 ANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       327 ~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..+|.++++.||.+||||.|++.
T Consensus       848 ~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  848 ASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHhcCCCccCCCHHHHhh
Confidence            68999999999999999999974

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.5e-39  Score=280.72  Aligned_cols=245  Identities=27%  Similarity=0.307  Sum_probs=195.1

Q ss_pred             ecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCC
Q 040763           79 LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        79 lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  157 (360)
                      ||.|++|.||++... +++.+++|.+....... ....+.+.+|+.+++.++||||+++++.+.+....++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            689999999999986 47899999876533221 1234568899999999999999999999999999999999999999


Q ss_pred             hhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceee
Q 040763          158 LYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT  237 (360)
Q Consensus       158 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  237 (360)
                      |.+++....     .++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        80 L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~  149 (262)
T cd05572          80 LWTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KT  149 (262)
T ss_pred             HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cc
Confidence            999996532     4788899999999999999999999   9999999999999999999999999997765432  22


Q ss_pred             ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhh
Q 040763          238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL  317 (360)
Q Consensus       238 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (360)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......      .........         ......
T Consensus       150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~  214 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILK---------GNGKLE  214 (262)
T ss_pred             ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhc---------cCCCCC
Confidence            23457889999999988889999999999999999999999996543200      111111110         000111


Q ss_pred             ccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 040763          318 GKKNQIVAFANLAERCLDLNGKKRPT-----MEEVSM  349 (360)
Q Consensus       318 ~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~~  349 (360)
                      .+...++++.+++.+||+.+|++|||     +.|+++
T Consensus       215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            22233568999999999999999999     777764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.8e-39  Score=286.28  Aligned_cols=249  Identities=31%  Similarity=0.447  Sum_probs=195.4

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .|...+.||+|+||.||++... ++..+++|.+....... ......+.+|+.+++.++|||++++++++......+++|
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc-hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3777889999999999999875 57899999876432221 133456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+. |++.+.+....    .++++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus       105 e~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         105 EYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             eCCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            9996 57877775432    25889999999999999999999999   9999999999999999999999999886543


Q ss_pred             CCCceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..     ....++..|+|||.+.   .+.++.++||||||+++|||++|+.||......        ..... .....  
T Consensus       177 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~-~~~~~--  240 (317)
T cd06635         177 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYH-IAQNE--  240 (317)
T ss_pred             Cc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHH-HHhcc--
Confidence            21     2235788999999874   456889999999999999999999998643210        00000 00000  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                            ........+++.+.+++.+||+.+|.+|||+.++++..
T Consensus       241 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         241 ------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                  01111233556799999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.1e-40  Score=294.30  Aligned_cols=252  Identities=25%  Similarity=0.337  Sum_probs=209.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ......|.+...||+|.|+.|.++++. ++..||+|.+....-..  ..+..+.+|+.+|..++|||||+++.+......
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~--~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP--SKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh--HHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            344577999999999999999999976 68899999877654432  334557899999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      +|+||||+.+|.+.+|+.....     .........+.|+..+++|||+++   |+|||||++|+|++.+.++||+|||+
T Consensus       130 lylV~eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgf  201 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGF  201 (596)
T ss_pred             eEEEEEeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccc
Confidence            9999999999999999987654     445777889999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      +..+..  .......+|++.|.|||++.+..| .+.+|+||+|+++|-|+.|..||.+..-.......+..         
T Consensus       202 S~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g---------  270 (596)
T KOG0586|consen  202 STFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG---------  270 (596)
T ss_pred             ceeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee---------
Confidence            988763  344556789999999999999776 57999999999999999999999765422221111110         


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                                .-..+...+-+..++++++|..+|.+|++++++.+
T Consensus       271 ----------k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  271 ----------KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ----------eecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                      01123444557889999999999999999999853

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.1e-39  Score=281.79  Aligned_cols=262  Identities=24%  Similarity=0.291  Sum_probs=192.2

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeC--CcceE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLET--EFPLL  148 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--~~~~l  148 (360)
                      |++.+.||+|+||.||++... +++.+|+|.++.......   .....+|+.++.++ +|+|++++++++.+.  +..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE---QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch---hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            567889999999999999875 588999998775433221   12334788888888 499999999999887  88899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||++ +++.+.+....    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++. +.+||+|||++..
T Consensus        78 v~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~  148 (282)
T cd07831          78 VFELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRG  148 (282)
T ss_pred             EEecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccc
Confidence            999996 58888876532    25899999999999999999999999   999999999999999 9999999999976


Q ss_pred             cCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc------hHHHHHHHh
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS------LAAYFVHSM  301 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~  301 (360)
                      .......  ....++..|+|||.+.. +.++.++|||||||++|||++|..||.+..........      ....+....
T Consensus       149 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         149 IYSKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             cccCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            5433221  23457889999997654 55688999999999999999999999654321000000      000000000


Q ss_pred             hccccc-----cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNRLY-----HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......     ....... .......+.++.+++.+||+.+|++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000     0000000 1112345778999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-39  Score=290.96  Aligned_cols=264  Identities=25%  Similarity=0.324  Sum_probs=195.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--Ccc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~  146 (360)
                      ..+|++.+.||+|+||.||+|.++ +++.||+|.++......  .....+.+|+.++.+++|+|++++++++...  +..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            467999999999999999999976 58899999876543221  1122345799999999999999999998755  457


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+. ++|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          84 FLVMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             EEEEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcccee
Confidence            99999995 58888886532    35889999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc-
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN-  304 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  304 (360)
                      ........ ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........     ........... 
T Consensus       156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-----~~~~~~~~~~~~  229 (309)
T cd07845         156 RTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-----LDLIIQLLGTPN  229 (309)
T ss_pred             eecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcCCCC
Confidence            76644321 1222345788999998866 4578999999999999999999999965432110     00001100000 


Q ss_pred             -c------------cccccchHH--hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 -R------------LYHILDDQV--MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 -~------------~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       .            .........  ........++++.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             0            000000000  00001124667899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.4e-39  Score=284.45  Aligned_cols=255  Identities=27%  Similarity=0.329  Sum_probs=197.3

Q ss_pred             CCCccceecccCcEEEEEEEe----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           72 HFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      +|++.+.||+|+||.||.+..    .+|..+|+|.+............+.+.+|+.++..+ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999986    367899999876533222223345677899999999 699999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      +++|||+++++|.+++....     ++++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  152 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  152 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence            99999999999999997532     4778888999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCceeeecccccCCccchhhhccC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ...............|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...+..    ............. 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~-  227 (290)
T cd05613         153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRILKS-  227 (290)
T ss_pred             eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHhhcc-
Confidence            76544332223344688999999988753  4678999999999999999999998543211    0111111111100 


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                                ....+...++.+.+++.+||+.||++||     ++.++++
T Consensus       228 ----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 ----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                      0112333456789999999999999997     6666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=293.25  Aligned_cols=263  Identities=22%  Similarity=0.310  Sum_probs=194.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.+......   .....+.+|+.++..++||||+++++++....    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc---hhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            468999999999999999999875 6889999987642222   23455678999999999999999998865443    


Q ss_pred             -cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          145 -FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       145 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                       ..++++||+. ++|.+.+...      .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+||
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~df  150 (336)
T cd07849          81 NDVYIVQELME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDF  150 (336)
T ss_pred             ceEEEEehhcc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcc
Confidence             4789999995 5887777532      5889999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCce--eeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          224 GTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       224 g~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      |++.........  ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.....     ........
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~  225 (336)
T cd07849         151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGV  225 (336)
T ss_pred             cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHH
Confidence            998765432211  1123467899999998655 568899999999999999999999996532100     00000000


Q ss_pred             hhcc---ccccccchH-----------H---hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          301 MRKN---RLYHILDDQ-----------V---MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       301 ~~~~---~~~~~~~~~-----------~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                      ....   .+..+....           .   .....+..++++.+++.+||+.||++|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000   000000000           0   000112245679999999999999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=324.88  Aligned_cols=253  Identities=26%  Similarity=0.340  Sum_probs=202.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      +-+++-..+||.|.||.||.+... +|...|+|-++.....  ........+|+.++..++|||+|+++|+-...+..++
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            345667788999999999998754 6888899987765444  3445667899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      .||||++|+|.+.+....     -.++....-+..|++.|++|||++|   |||||+||.||+++.+|.+|++|||.|..
T Consensus      1312 FMEyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence            999999999999997543     2444555567889999999999999   99999999999999999999999999987


Q ss_pred             cCCCCc---eeeecccccCCccchhhhccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          229 IAMDQT---HVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       229 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      +.....   .......||+.|||||++.+.   ....++||||+||++.||+||+.||.....     .     | .   
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e-----~-a--- 1449 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----E-----W-A--- 1449 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----h-----h-H---
Confidence            765421   123456799999999999874   355689999999999999999999954321     0     0 0   


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         +...+.-.-.+..|...+.+-.+++..||..||+.|.++.|+++
T Consensus      1450 ---IMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1450 ---IMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ---HHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence               11111111223356668889999999999999999999998875

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=285.61  Aligned_cols=262  Identities=26%  Similarity=0.331  Sum_probs=196.2

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |++.+.||.|++|.||+|... +|..+++|++.......  .....+.+|+.+++.++|||++++++++...+..+++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE--GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc--cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence            677889999999999999875 68899999876543221  123456789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+ +++|.+++.....   ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          79 FL-DLDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             cc-CcCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            99 4689998865431   35889999999999999999999999   99999999999999999999999999875533


Q ss_pred             CCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc------
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN------  304 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  304 (360)
                      .... .....++..|+|||++.+. .++.++|+||||+++|+|++|+.||........    ... ........      
T Consensus       152 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~-~~~~~~~~~~~~~~  225 (283)
T cd07835         152 PVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ----LFR-IFRTLGTPDEDVWP  225 (283)
T ss_pred             Cccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH-HHHHhCCCChHHhh
Confidence            2211 1223468899999987664 568899999999999999999999965432110    000 00000000      


Q ss_pred             ---cccccc------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 ---RLYHIL------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ---~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         ...+..      ............+.++.+++.+||+.||++|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               000000      000001112234467899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-39  Score=278.95  Aligned_cols=253  Identities=27%  Similarity=0.388  Sum_probs=198.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccC-hHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--Ccc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVD-DEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~  146 (360)
                      .+|.+.+.||+|++|.||++... ++..+++|.+..... .........+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999875 588999998653221 11223456788899999999999999999998764  457


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++++||+++++|.+++....     .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence            89999999999999986532     4778889999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCC--ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          227 KFIAMDQ--THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       227 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      .......  ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....       . .......   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~-~~~~~~~---  222 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------M-AAIFKIA---  222 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------H-HHHHHHH---
Confidence            7653211  1112234588899999999988889999999999999999999999864321       0 0011111   


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ........+...++++.+++.+||+ +|..|||+.+++.
T Consensus       223 ------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 ------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                  1111223455667789999999999 5799999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.3e-39  Score=288.47  Aligned_cols=264  Identities=20%  Similarity=0.290  Sum_probs=192.5

Q ss_pred             eeccc--CcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           78 ILGQG--GQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        78 ~lg~G--~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      .||+|  +||+||++.+. +++.||+|.........  ...+.+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE--EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            46666  99999999975 68999999977543332  345677889999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      ++++.+++.....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+........
T Consensus        83 ~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          83 YGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             CCCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            9999999876432   24788899999999999999999999   99999999999999999999999986533221110


Q ss_pred             ee------eecccccCCccchhhhccC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccc-------------ch
Q 040763          235 HV------TTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV-------------SL  293 (360)
Q Consensus       235 ~~------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~-------------~~  293 (360)
                      ..      .....++..|+|||++.+.  .++.++||||||+++|+|++|..||...........             ..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence            00      0112346679999998764  478899999999999999999999965431110000             00


Q ss_pred             HHHHHH---------------HhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          294 AAYFVH---------------SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       294 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......               ......................++..+.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            000000               00000000111111222234557788999999999999999999999963

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7e-39  Score=282.94  Aligned_cols=247  Identities=26%  Similarity=0.393  Sum_probs=196.0

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |...+.||+|++|.||++... +++.+++|.+.....    ...+.+.+|+.+++.++|||++++++++...+..++++|
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            444568999999999999865 678899998754322    234457789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+++++|.+++...      ++++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||.+.....
T Consensus        97 ~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          97 FLEGGALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             ccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            99999999998651      4788899999999999999999999   99999999999999999999999998865543


Q ss_pred             CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                      ... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....     .   ... ...........  
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~---~~~-~~~~~~~~~~~--  235 (285)
T cd06648         168 EVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----L---QAM-KRIRDNLPPKL--  235 (285)
T ss_pred             CCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----H---HHH-HHHHhcCCCCC--
Confidence            221 12234588999999999888899999999999999999999999864321     0   000 01111100000  


Q ss_pred             hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       312 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       236 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         236 -----KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -----cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                 011224567999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-39  Score=278.90  Aligned_cols=246  Identities=25%  Similarity=0.273  Sum_probs=187.5

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHH-HhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFI-LSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~-~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|++|.||+|... +++.+|+|.+........ .....+..|..+ ....+|+|++++++++...+..++++||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            46899999999999875 578999998764322111 122233344444 344589999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++....     .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....   
T Consensus        81 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---  149 (260)
T cd05611          81 GGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---  149 (260)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence            999999986532     5788899999999999999999999   99999999999999999999999999865432   


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHH
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQV  314 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (360)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|..||.....        ...+ .........      .
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~-~~~~~~~~~------~  212 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVF-DNILSRRIN------W  212 (260)
T ss_pred             --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHH-HHHHhcccC------C
Confidence              2233578899999999888889999999999999999999999954321        0111 111111000      0


Q ss_pred             hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          315 MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       315 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                      ........+.++.+++.+||+.+|++|||+.++.+.|
T Consensus       213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            1111223456799999999999999999887665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-39  Score=291.74  Aligned_cols=268  Identities=23%  Similarity=0.307  Sum_probs=198.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC-----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-----  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----  143 (360)
                      .++|.+.+.||+|+||+||++... ++..+|+|.+.......  .....+.+|+.+++.++|+||+++++++...     
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR--IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            467999999999999999999875 68899999876532221  2234566899999999999999999987644     


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...++++||+. ++|.+++....     ++++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+||
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcC
Confidence            24799999995 78988886432     5889999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      |++....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.+...  ..   ..........
T Consensus       153 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~---~~~~~~~~~~  226 (337)
T cd07858         153 GLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VH---QLKLITELLG  226 (337)
T ss_pred             ccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HH---HHHHHHHHhC
Confidence            9997654322 12233457889999998765 4688999999999999999999999964321  00   0000000000


Q ss_pred             c---cccccccchH--------------HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHh
Q 040763          303 K---NRLYHILDDQ--------------VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME--LNGI  354 (360)
Q Consensus       303 ~---~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~--L~~l  354 (360)
                      .   ..+..+.+..              ......+..++++.+++.+||+.+|++|||+.++++-  ++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            0   0000000000              0011122456789999999999999999999999865  4443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-40  Score=298.41  Aligned_cols=271  Identities=28%  Similarity=0.405  Sum_probs=207.2

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee------CCc
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE------TEF  145 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------~~~  145 (360)
                      +...+.||+|+||.||+|+++ +|+.||||.++.....   ...+...+|++++++++|+|||+++++-.+      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~---r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL---RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhccc---chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            455678999999999999965 7999999998875533   335567799999999999999999998654      345


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC----CCcEEEe
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE----RYRAKVA  221 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~----~~~~kl~  221 (360)
                      ..++||||.+|||...+++.  .+-..+++...+.+..+++.||.|||.++   |+||||||.||++-.    ....||+
T Consensus        92 ~vlvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeee
Confidence            68999999999999999763  34456999999999999999999999999   999999999999842    2346999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      |||.|+.+..+.  .....+||..|++||+... +.|+..+|.|||||++|+.+||..||...+.......   ..+...
T Consensus       167 DfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~---~~~~~~  241 (732)
T KOG4250|consen  167 DFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE---IMWHII  241 (732)
T ss_pred             cccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch---hhhhhh
Confidence            999999776544  5566789999999999985 7889999999999999999999999976654321100   001111


Q ss_pred             hhcc-cccccc----c--------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCC--CHHHHHHHHHHhHh
Q 040763          301 MRKN-RLYHIL----D--------DQVMKLGKKNQIVAFANLAERCLDLNGKKRP--TMEEVSMELNGIRG  356 (360)
Q Consensus       301 ~~~~-~~~~~~----~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--t~~ei~~~L~~l~~  356 (360)
                      .+.. ...-..    .        -+............+..++..+|..+|.+|.  ...+...++..+.+
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            1110 000000    0        0112223344555678899999999999999  88888888777654

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-39  Score=283.79  Aligned_cols=262  Identities=25%  Similarity=0.317  Sum_probs=197.5

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--CcceEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFPLLV  149 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~lv  149 (360)
                      |++.+.||.|++|.||+|... +++.+++|.+.......  .....+.+|+.+++.++|+|++++++++...  ...+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE--GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence            567889999999999999877 47899999987653121  2334577899999999999999999999887  789999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||++ ++|.+++....    ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        79 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          79 FEYMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             ecccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            99996 58888886532    25889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh---ccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR---KNR  305 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  305 (360)
                      ............++..|+|||.+.+ ..++.++||||||+++|||++|+.||........    .. .......   ...
T Consensus       151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~----~~-~~~~~~~~~~~~~  225 (287)
T cd07840         151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ----LE-KIFELCGSPTDEN  225 (287)
T ss_pred             cCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HH-HHHHHhCCCchhh
Confidence            5443222233456888999997765 4578999999999999999999999865432100    00 0000000   000


Q ss_pred             cc--------------cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LY--------------HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~--------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +.              ..............+++++.+++.+||+.+|++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00              000011111111113678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.5e-39  Score=281.17  Aligned_cols=244  Identities=23%  Similarity=0.276  Sum_probs=186.2

Q ss_pred             eecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHH---HHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           78 ILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIF---ILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~---~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      .||+|+||.||++... +++.+|+|.+........ .....+.+|..   .+...+|||++.+++.+...+..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence            4899999999999875 578999998765322211 11122233433   333447999999999999999999999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      ++++|.+++....     .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        80 ~~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          80 NGGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            9999999886532     5899999999999999999999999   9999999999999999999999999986543221


Q ss_pred             ceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccch
Q 040763          234 THVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD  312 (360)
Q Consensus       234 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (360)
                         .....|+..|+|||.+.+ ..++.++||||+|+++|+|++|..||.........      .......          
T Consensus       152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~----------  212 (279)
T cd05633         152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRMTL----------  212 (279)
T ss_pred             ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH------HHHHHhh----------
Confidence               122358999999998864 55789999999999999999999999654321110      0000000          


Q ss_pred             HHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          313 QVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       313 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                      ......+...+.++.+++.+||+.||++||     |++++++
T Consensus       213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         213 TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            011123445667899999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-38  Score=276.58  Aligned_cols=252  Identities=30%  Similarity=0.416  Sum_probs=204.6

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--CcceE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFPLL  148 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~l  148 (360)
                      +|...+.||+|++|.||+|... ++..+++|........  ....+.+.+|+..+++++||||+++++.+...  ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence            4677889999999999999987 6889999987664432  23456788999999999999999999999988  88999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ++||+++++|.+++....     .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        79 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             EEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            999999999999997643     5889999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ....... ......++..|+|||.+.+...+.++||||||+++|+|++|..||.....       .........      
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~------  217 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIG------  217 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhcc------
Confidence            6544321 12334588899999999888899999999999999999999999865431       000111110      


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         ........+...+.++.+++.+||+.||++|||+.+++.
T Consensus       218 ---~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 ---SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               011111233344678999999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.6e-38  Score=272.31  Aligned_cols=249  Identities=33%  Similarity=0.476  Sum_probs=201.3

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .|...+.||+|++|.||++... ++..+++|+......    .....+.+|+..++.++|+|++++++++......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            3777889999999999999986 678899998876433    23456778999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....    ..+++..+..++.|++.||.+||+.+   ++|+||+|+||++++++.++|+|||.+....
T Consensus        77 e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  149 (253)
T cd05122          77 EFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS  149 (253)
T ss_pred             ecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence            9999999999987642    35899999999999999999999999   9999999999999999999999999987765


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ....  .....++..|+|||.+.+...+.++|+||||+++|+|++|..||......       ..  .............
T Consensus       150 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~--~~~~~~~~~~~~~  218 (253)
T cd05122         150 DTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------KA--LFKIATNGPPGLR  218 (253)
T ss_pred             cccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HH--HHHHHhcCCCCcC
Confidence            4332  23346788999999999888899999999999999999999998643210       00  0000001111110


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             .+..++..+.+++.+||+.||++|||+.++++
T Consensus       219 -------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 -------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -------cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   01113567999999999999999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.8e-39  Score=281.54  Aligned_cols=247  Identities=23%  Similarity=0.275  Sum_probs=192.9

Q ss_pred             ecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCC
Q 040763           79 LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        79 lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  157 (360)
                      ||+|+||+||++... +++.+++|.+....... ......+..|+.+++.++|||++++++.+...+..++||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            689999999999865 58899999876432111 1233456689999999999999999999999999999999999999


Q ss_pred             hhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceee
Q 040763          158 LYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT  237 (360)
Q Consensus       158 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  237 (360)
                      |.+++.....   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+......  ...
T Consensus        80 L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~  151 (277)
T cd05577          80 LKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKI  151 (277)
T ss_pred             HHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccc
Confidence            9999976432   25889999999999999999999999   999999999999999999999999998765432  122


Q ss_pred             ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhh
Q 040763          238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL  317 (360)
Q Consensus       238 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (360)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|+.||........    ... ......          .....
T Consensus       152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~-~~~~~~----------~~~~~  216 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEE-LKRRTL----------EMAVE  216 (277)
T ss_pred             ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHH-HHhccc----------ccccc
Confidence            234578899999999888899999999999999999999999965432111    000 000000          00111


Q ss_pred             ccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          318 GKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       318 ~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                      .+...++.+.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            2334466899999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.4e-39  Score=286.48  Aligned_cols=262  Identities=20%  Similarity=0.246  Sum_probs=192.0

Q ss_pred             ccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           75 VNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.+.+|.|+++.|+++.. +++.+|+|++.......  ...+.+.+|+.+++.++|+||+++++++...+..+++|||++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSK--EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccch--hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            344455555555555544 58899999987542222  345678899999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      +++|.+++.....   ..+++.....++.|++.||.|||+++   |+||||||+||+++.++.+||+|||.+........
T Consensus        83 ~~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          83 YGSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             CCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            9999999976432   24788889999999999999999999   99999999999999999999999998865432111


Q ss_pred             ------eeeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh----
Q 040763          235 ------HVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR----  302 (360)
Q Consensus       235 ------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----  302 (360)
                            .......++..|+|||.+.+  ..++.++|+||||+++|||++|..||........    ..........    
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~  232 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM----LLEKVRGTVPCLLD  232 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCccccc
Confidence                  01122346778999999876  3578899999999999999999999965321110    0000000000    


Q ss_pred             -------cccc--------ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 -------KNRL--------YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 -------~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             ....        ................+.++.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                   0000        0000111122234456778999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.4e-39  Score=285.03  Aligned_cols=264  Identities=23%  Similarity=0.325  Sum_probs=195.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|++|.||+|..+ +++.+++|.+.......  ...+.+.+|+.+++.++|||++++++++......++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE--GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc--cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            46889999999999999999876 67899999876543221  2234567899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEeecCCccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKF  228 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~  228 (360)
                      |||++ ++|.+++....   ....++..+..++.|++.||+|||+++   ++|+||+|+||+++. ++.+||+|||++..
T Consensus        80 ~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             Eeccc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            99995 58888875432   223578888899999999999999999   999999999999985 56799999999976


Q ss_pred             cCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc---
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN---  304 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  304 (360)
                      ..... .......+++.|+|||.+.+. .++.++||||+|+++|+|+||+.||........    ... ........   
T Consensus       153 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~----~~~-~~~~~~~~~~~  226 (294)
T PLN00009        153 FGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE----LFK-IFRILGTPNEE  226 (294)
T ss_pred             cCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH-HHHHhCCCChh
Confidence            54321 112233568899999988764 578899999999999999999999965431100    000 00000000   


Q ss_pred             cccc---cc---------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYH---IL---------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~---~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .+..   ..         .........+..++++.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000   00         000000112234567899999999999999999999875

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.5e-39  Score=286.08  Aligned_cols=266  Identities=27%  Similarity=0.345  Sum_probs=196.4

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC--
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE--  144 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--  144 (360)
                      ...++|++.+.||+|+||.||+|..+ +++.+++|.++......  .....+.+|+.+++.++|||++++++++.+..  
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE--GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc--CchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            44578999999999999999999986 57899999876543221  12235568999999999999999999987654  


Q ss_pred             --------cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC
Q 040763          145 --------FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY  216 (360)
Q Consensus       145 --------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~  216 (360)
                              ..++++||+++ ++...+...    ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~  153 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKG  153 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence                    78999999965 777777543    225889999999999999999999999   99999999999999999


Q ss_pred             cEEEeecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          217 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       217 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      .+||+|||++...............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......    .+ .
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~----~~-~  228 (302)
T cd07864         154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA----QL-E  228 (302)
T ss_pred             cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HH-H
Confidence            99999999997664433222222345778999998865 356889999999999999999999986432110    00 0


Q ss_pred             HHHHHhhcc---ccccccc--------------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKN---RLYHILD--------------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .........   .+..+..              ...... ....+..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            001100000   0000000              000011 1123567999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=279.70  Aligned_cols=261  Identities=26%  Similarity=0.338  Sum_probs=199.5

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |++.+.||+|++|.||++... +++.+++|.+.......  .....+.+|+.+++.++|+||+++++.+......++++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE--GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence            567789999999999999875 68889999876543321  234567789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |++ +++.+++....    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          79 FMD-TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             ccC-CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            996 48888886632    25889999999999999999999999   99999999999999999999999999877654


Q ss_pred             CCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc---cccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK---NRLY  307 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  307 (360)
                      .. .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........     ..........   ..+.
T Consensus       151 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  224 (283)
T cd05118         151 PV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-----LFKIFRTLGTPDPEVWP  224 (283)
T ss_pred             Cc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHcCCCchHhcc
Confidence            33 122233578889999998876 789999999999999999999999865432110     0000000000   0000


Q ss_pred             cccc-------------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILD-------------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....             ........+..+.++.+++.+||+.||.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000             00011122346778999999999999999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-40  Score=267.04  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=196.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~l  148 (360)
                      ++.+.+..||.|+.|.||+++++ +|...|||.+......   +..++++..+.++... ++|.||+.+|+|..+...++
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk---ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH---HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            34556677999999999999987 4788999998875444   4566778888887766 48999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      .||.| ...+..++...    ..++++...-.+...++.||.||..+..  |+|||+||+|||+|+.|++|+||||.+-.
T Consensus       169 cMelM-s~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  169 CMELM-STCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             HHHHH-HHHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccce
Confidence            99987 44555555542    2368999999999999999999988653  99999999999999999999999999977


Q ss_pred             cCCCCceeeecccccCCccchhhhccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      +-+..  ..++..|-+.|||||.+.-.   .|+.++||||||++++||.||+.||.+-......   +    ......++
T Consensus       242 lvdSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~---l----tkvln~eP  312 (391)
T KOG0983|consen  242 LVDSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV---L----TKVLNEEP  312 (391)
T ss_pred             eeccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH---H----HHHHhcCC
Confidence            64432  33455788999999988753   6888999999999999999999999764321111   0    11111110


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            +.++  ....+++.|++++..||++|+.+||...++++
T Consensus       313 ------P~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  313 ------PLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ------CCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                  0111  12237889999999999999999999999875

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.6e-39  Score=289.96  Aligned_cols=264  Identities=21%  Similarity=0.307  Sum_probs=196.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee----CC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE----TE  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~~  144 (360)
                      ..+|++.+.||+|++|.||++..+ ++..|++|++.......  .....+.+|+.+++.++||||+++++++..    ..
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP--TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc--cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            367999999999999999999876 58899999876543221  234566789999999999999999998753    34


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..++||||+. ++|.+++....     .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccc
Confidence            6789999995 68988885432     4889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCce---eeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          225 TSKFIAMDQTH---VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       225 ~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      ++.........   ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+......     .......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-----~~~~~~~  227 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-----LKLILSV  227 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-----HHHHHHH
Confidence            98765432211   1223468899999998766 4678999999999999999999999965432110     0000000


Q ss_pred             hh-----------ccccccccch------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          301 MR-----------KNRLYHILDD------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       301 ~~-----------~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..           ...+......      .......+..++++.+++.+||+.+|++|||+.+++.
T Consensus       228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00           0000000000      0000111234678999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.7e-38  Score=282.62  Aligned_cols=268  Identities=24%  Similarity=0.306  Sum_probs=192.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc---
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF---  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~---  145 (360)
                      .++|++.+.||+|+||.||++... +++.+|+|.+.......  .....+.+|+.+++.++||||+++++++.....   
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC--CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            357999999999999999999876 58899999876433221  112345579999999999999999999876543   


Q ss_pred             -----ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          146 -----PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       146 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                           .+++|||+. ++|.+++....    ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.+||
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEE
Confidence                 499999995 58888875432    25889999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCce---eeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 040763          221 ADFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  296 (360)
                      +|||++.........   ......++..|+|||.+.+. .++.++||||||+++|+|++|..||.+...  .........
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~~~~  238 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTLISQ  238 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence            999999765432211   11223567889999988664 468899999999999999999999865431  110000000


Q ss_pred             HHHHhhccccccc--------------cchHHhhh-ccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          297 FVHSMRKNRLYHI--------------LDDQVMKL-GKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       297 ~~~~~~~~~~~~~--------------~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .......+.....              ........ .+...+..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000000000000              00000000 00112346789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1e-37  Score=272.80  Aligned_cols=243  Identities=23%  Similarity=0.292  Sum_probs=188.2

Q ss_pred             hcCCCcccee--cccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRIL--GQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~  145 (360)
                      .++|.+.+.+  |+|+||.||++..+ ++..+++|........    .     .|+.....+ +|||++++++.+...+.
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----A-----IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----h-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            4566776666  99999999999875 5778899987643211    1     122222222 79999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cEEEeecC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADFG  224 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg  224 (360)
                      .++||||+++++|.+++....     ++++..+..++.|++.||.|||+.+   ++||||+|+||+++.++ .++|+|||
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999997532     6899999999999999999999999   99999999999999998 99999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++.......     ...++..|+|||++.+..++.++||||+|+++|+|++|..||.......   ...... .... ..
T Consensus       156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~-~~~~-~~  225 (267)
T PHA03390        156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESL-LKRQ-QK  225 (267)
T ss_pred             cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHH-HHhh-cc
Confidence            987654321     2357899999999999889999999999999999999999997433211   111111 1000 00


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-MEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ei~~  349 (360)
                                .....+..++.+.+++.+||+.+|.+||+ ++++++
T Consensus       226 ----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 ----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                      11122346668999999999999999996 588763

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-38  Score=287.56  Aligned_cols=270  Identities=27%  Similarity=0.344  Sum_probs=196.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeC--C
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLET--E  144 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--~  144 (360)
                      ..++|++.+.||+|+||.||+|.+. +++.+++|++.......  .....+.+|+.++.++ +||||+++++++...  .
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA--TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc--hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            3467889999999999999999876 57889999875432221  2234566899999999 999999999988653  3


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..++||||++ ++|.+++...      .+++..+..++.|++.||+|||+++   ++|+||+|+||+++.++.+||+|||
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeecc
Confidence            5799999996 5998888542      4778888899999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCce----eeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH----
Q 040763          225 TSKFIAMDQTH----VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA----  295 (360)
Q Consensus       225 ~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~----  295 (360)
                      ++.........    ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.............    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99766443221    2233468899999998765 45788999999999999999999999654321110000000    


Q ss_pred             --HHHHHhhccccccccc------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          296 --YFVHSMRKNRLYHILD------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       296 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                        .....+.......+++      ........+..+.++.+++.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              0000000000000000      000011112246689999999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=273.73  Aligned_cols=249  Identities=27%  Similarity=0.441  Sum_probs=202.0

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|++.+.||+|++|.||++... +++.+++|.+.......  ...+.+.+|++++..++|+|++++++++.+....+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH--HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence            4778899999999999999876 57889999877654321  34567889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++...     ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        79 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          79 EYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             ecCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            999999999998754     25889999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ..... .....++..|+|||...+..++.++|+||+|+++|+|++|..||.....       ...... . ....     
T Consensus       151 ~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~-~-~~~~-----  215 (254)
T cd06627         151 DVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFR-I-VQDD-----  215 (254)
T ss_pred             CCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHH-H-hccC-----
Confidence            43321 2234578899999998888889999999999999999999999864321       000010 0 0000     


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ....+...+.++.+++.+||..+|++|||+.+++.
T Consensus       216 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 ----HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                01122334567999999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-38  Score=277.93  Aligned_cols=245  Identities=27%  Similarity=0.353  Sum_probs=194.5

Q ss_pred             ecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCC
Q 040763           79 LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        79 lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  157 (360)
                      ||.|+||.||++... +++.+++|.+....... ....+.+.+|+.++..++|||++++++.+......++++||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999987 48899999876543221 2345677889999999999999999999999999999999999999


Q ss_pred             hhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc---
Q 040763          158 LYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---  234 (360)
Q Consensus       158 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---  234 (360)
                      |.+++....     .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........   
T Consensus        80 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          80 LASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            999997532     5889999999999999999999999   99999999999999999999999999876443211   


Q ss_pred             ----eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          235 ----HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       235 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                          .......++..|+|||...+...+.++|+||||+++|++++|..||.....        .... ........    
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~-~~~~~~~~----  218 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIF-QNILNGKI----  218 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHhcCCc----
Confidence                122334578899999999888889999999999999999999999854321        0111 11111000    


Q ss_pred             chHHhhhccHH--HHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          311 DDQVMKLGKKN--QIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       311 ~~~~~~~~~~~--~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                            ..+..  .+..+.+++.+||+.+|++|||+.++.+.|
T Consensus       219 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 ------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                  00111  256789999999999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-38  Score=281.05  Aligned_cols=251  Identities=28%  Similarity=0.389  Sum_probs=201.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~l  148 (360)
                      ++|.+.+.||+|++|.||++... +++.+++|++........ .....+.+|..++..++ ||||+++++++...+..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch-HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence            46889999999999999999876 688999998765322111 22356778999999998 9999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +||++++++|.+++....     .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++..
T Consensus        80 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~  151 (280)
T cd05581          80 VLEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV  151 (280)
T ss_pred             EEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence            999999999999997643     5899999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCc-------------------eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 040763          229 IAMDQT-------------------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE  289 (360)
Q Consensus       229 ~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~  289 (360)
                      ......                   .......++..|+|||...+..++.++|+||||+++|++++|..||.....    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----  227 (280)
T cd05581         152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----  227 (280)
T ss_pred             cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----
Confidence            644322                   112234578899999999888899999999999999999999999865431    


Q ss_pred             ccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH----HHHHH
Q 040763          290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM----EEVSM  349 (360)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~----~ei~~  349 (360)
                          ...+.....           .....+...++.+.+++.+||+.+|++|||+    .++++
T Consensus       228 ----~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 ----YLTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ----HHHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                000111110           0111233345679999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-38  Score=282.64  Aligned_cols=249  Identities=30%  Similarity=0.426  Sum_probs=193.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..|...+.||+|++|.||+|... ++..+++|.+....... .....++.+|+.+++.++|+|++++.+++......++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            33667788999999999999976 57789999875422211 12345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+. +++.+.+....    .++++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        94 ~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          94 MEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceee
Confidence            99996 68877775422    25788999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ...     ....++..|+|||.+.   ...++.++||||||+++|+|++|..||.......         ..........
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~  231 (308)
T cd06634         166 APA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------ALYHIAQNES  231 (308)
T ss_pred             cCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---------HHHHHhhcCC
Confidence            322     2235788999999874   3567889999999999999999999985432100         0000010000


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                              .......++..+.+++.+||+.+|++|||+.++++.
T Consensus       232 --------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 --------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             --------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                    111123456679999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.5e-38  Score=280.88  Aligned_cols=246  Identities=29%  Similarity=0.416  Sum_probs=192.2

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |...+.||+|+||.||+|... ++..+++|.+...... .......+.+|+.+++.++|||++++++++.+....+++||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            566678999999999999875 5788999987643222 11334567789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |+. +++.+++....    .++++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus       102 ~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633         102 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             cCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence            995 67878775432    25889999999999999999999999   99999999999999999999999999854321


Q ss_pred             CCceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                           .....|+..|+|||++.   .+.++.++||||||+++|+|++|..||........     .   . .......  
T Consensus       174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----~---~-~~~~~~~--  237 (313)
T cd06633         174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----L---Y-HIAQNDS--  237 (313)
T ss_pred             -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----H---H-HHHhcCC--
Confidence                 22346788999999874   45678899999999999999999999865421000     0   0 0000000  


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            .......++..+.+++.+||+.+|++|||+.+++.
T Consensus       238 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         238 ------PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  01112234456899999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.4e-38  Score=275.78  Aligned_cols=244  Identities=23%  Similarity=0.276  Sum_probs=186.1

Q ss_pred             eecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHH---HHHHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           78 ILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINE---IFILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e---~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      .||+|+||.||++... +++.||+|.+........ .....+..|   +..+...+||||+++++.+...+..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence            3899999999999875 578999998765322211 111112233   33444568999999999999999999999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      .+++|.+++....     .+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        80 ~g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          80 NGGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence            9999999886432     5899999999999999999999999   9999999999999999999999999987543221


Q ss_pred             ceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccch
Q 040763          234 THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD  312 (360)
Q Consensus       234 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (360)
                         .....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.........     . .......         
T Consensus       152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~-~~~~~~~---------  213 (278)
T cd05606         152 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----E-IDRMTLT---------  213 (278)
T ss_pred             ---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----H-HHHHhhc---------
Confidence               1234689999999998754 6889999999999999999999999654321110     0 0000000         


Q ss_pred             HHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          313 QVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       313 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                       .....+...+.++.+++.+||+.+|.+||     ++.++++
T Consensus       214 -~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 -MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             01112233456899999999999999999     9999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-38  Score=277.17  Aligned_cols=261  Identities=26%  Similarity=0.336  Sum_probs=193.9

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc---CCCCceeeeeEEeeCCc---
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI---NHRNVVKLLGCCLETEF---  145 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l---~h~niv~~~~~~~~~~~---  145 (360)
                      |++.+.||+|+||.||++..+ +++.+|+|.++......  .....+.+|+.++..+   +|+|++++++++...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE--GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc--hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            567889999999999999987 48899999987543322  1223455677666655   69999999999988776   


Q ss_pred             --ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          146 --PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       146 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                        .+++|||+. ++|.+++.....   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        79 ~~~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          79 LKLTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             ceeEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEecc
Confidence              899999996 589888865322   25889999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      |++........  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+......    . ..+......
T Consensus       152 g~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~----~-~~~~~~~~~  224 (287)
T cd07838         152 GLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ----L-DKIFDVIGL  224 (287)
T ss_pred             CcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH----H-HHHHHHcCC
Confidence            99876543221  1233478899999999998899999999999999999999999865332110    0 001110000


Q ss_pred             c---ccc----------cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 N---RLY----------HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~---~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .   .+.          ...............++.+.+++.+||+.||++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0   000          000000011112344677899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-38  Score=287.66  Aligned_cols=262  Identities=26%  Similarity=0.352  Sum_probs=200.0

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC-----c
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE-----F  145 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~  145 (360)
                      +|++.+.||.|++|.||++... +++.+++|.+......  ....+.+.+|+.+++.++|+||+++.+++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD--LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc--chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            5788999999999999999976 4889999987754321  133456788999999999999999999988765     7


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .|++|||++ ++|.+++....     ++++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCc
Confidence            899999996 58888886432     6889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCc--eeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          226 SKFIAMDQT--HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       226 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      +........  .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+......     .........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~~  224 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-----LNLIVEVLG  224 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHHHhcC
Confidence            987654321  112334578899999999887 789999999999999999999999966542110     000000000


Q ss_pred             cc-----------ccccccc------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KN-----------RLYHILD------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~-----------~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..           .....+.      ........+..+.++.+++.+||+.+|++|||+.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            00           0000000      00001112234668999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.9e-38  Score=278.63  Aligned_cols=252  Identities=24%  Similarity=0.391  Sum_probs=191.9

Q ss_pred             hcCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|++|.||++.+++ ++.+|+|.++.....   .....+..|+.++... +||||+++++++......+
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh---HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            3668889999999999999999874 889999998654322   2234556677766666 5999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++|||+ ++++.+++....    .++++..+..++.|++.|++|||+ .+   ++||||+|+||++++++.+||+|||++
T Consensus        91 ~v~e~~-~~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          91 ICMELM-STCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             EEeecc-CcCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccc
Confidence            999998 457777765532    268899999999999999999997 47   999999999999999999999999998


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCC----CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ........  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......       .........
T Consensus       163 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~  233 (296)
T cd06618         163 GRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQ  233 (296)
T ss_pred             hhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhc
Confidence            76533221  12234788999999987653    788999999999999999999998542110       000111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .. ....       .....+++++.+++.+||+.||++|||+.++++
T Consensus       234 ~~-~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         234 EE-PPSL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             CC-CCCC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            10 0000       001124567999999999999999999999964

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=279.98  Aligned_cols=253  Identities=24%  Similarity=0.279  Sum_probs=204.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..+.|..-++||+|+||.|+-+..+ +|+.+|.|++....... .......+.|-.++.+++.+.||.+--.|.+.+.++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            3466788899999999999999876 68899998765432211 122334678899999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +|+..|.||+|.-.|...+.   ..+++..++.++.+|+.||++||+.+   ||.|||||+|||+|+.|+++|+|+|+|.
T Consensus       262 lVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             EEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence            99999999999988876432   35889999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .+.....  ....+||.+|||||++.++.|+...|.||+||+||||+.|+.||....+......     +.+        
T Consensus       336 ei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE-----vdr--------  400 (591)
T KOG0986|consen  336 EIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE-----VDR--------  400 (591)
T ss_pred             ecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH-----HHH--------
Confidence            8765443  3334899999999999999999999999999999999999999976543211100     000        


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME  345 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  345 (360)
                        ........++..++++..++....|.+||++|....
T Consensus       401 --r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  401 --RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             --HHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence              011123345678889999999999999999997543

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.4e-38  Score=276.53  Aligned_cols=243  Identities=26%  Similarity=0.415  Sum_probs=192.8

Q ss_pred             ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCC
Q 040763           77 RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPN  155 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  155 (360)
                      ..||+|+||.||++..+ +++.+++|.+.....    .....+.+|+.+++.++|+|++++++.+...+..+++|||+++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch----hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            57999999999999875 688999998754322    2345678899999999999999999999999999999999999


Q ss_pred             CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCce
Q 040763          156 GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH  235 (360)
Q Consensus       156 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  235 (360)
                      ++|.+++...      .+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus       102 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657         102 GALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            9999887432      4788899999999999999999999   99999999999999999999999999865543221 


Q ss_pred             eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHh
Q 040763          236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM  315 (360)
Q Consensus       236 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (360)
                      ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+....     ..    ....... ..    ... 
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----~~----~~~~~~~-~~----~~~-  236 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KA----MKMIRDN-LP----PKL-  236 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH----HHHHHhh-CC----ccc-
Confidence            122345789999999998888899999999999999999999998643210     00    0011000 00    000 


Q ss_pred             hhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          316 KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       316 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       ......+..+.+++.+||+.||.+||++.++++
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         237 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence             001223456889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=275.20  Aligned_cols=265  Identities=25%  Similarity=0.349  Sum_probs=194.8

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcceEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~lv~  150 (360)
                      |.+.+.||+|++|.||+|... +++.+++|.+.......   ......+|+..+..++ |+|++++++.+...+..+++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   77 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF   77 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch---hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence            567889999999999999986 47889999876543321   1223446888999998 999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+ +++|.+++....   ...+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++....
T Consensus        78 e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          78 EYM-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             ecC-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence            999 889999887643   235889999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccc-------chHHHHHHHhh
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV-------SLAAYFVHSMR  302 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~-------~~~~~~~~~~~  302 (360)
                      ...  ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........       .....+.....
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         151 SRP--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCC--CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            322  1233457889999998754 4578999999999999999999999865432111000       00000000000


Q ss_pred             -ccccccccchHH---hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 -KNRLYHILDDQV---MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 -~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       ............   ........+.++.+++.+||+.||++|||++|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             000000000000   00011112467999999999999999999999874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-38  Score=283.83  Aligned_cols=267  Identities=23%  Similarity=0.290  Sum_probs=197.0

Q ss_pred             ChHHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEE
Q 040763           62 SSKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCC  140 (360)
Q Consensus        62 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~  140 (360)
                      ...++....++|.+.+.||+|+||.||++... +++.||+|++.......  ...+.+.+|+.++..++||||+++++++
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh--HHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            34456667789999999999999999999864 68899999876532221  2345677899999999999999999987


Q ss_pred             eeC------CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC
Q 040763          141 LET------EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE  214 (360)
Q Consensus       141 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~  214 (360)
                      ...      ...+++++++ +++|.+++...      .+++..+..++.|++.||+|||+.+   ++||||||+||+++.
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~  155 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE  155 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence            643      2357788876 78998877532      4788999999999999999999999   999999999999999


Q ss_pred             CCcEEEeecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch
Q 040763          215 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL  293 (360)
Q Consensus       215 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~  293 (360)
                      ++.+||+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........    .
T Consensus       156 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~  227 (345)
T cd07877         156 DCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----L  227 (345)
T ss_pred             CCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence            999999999998754321    223457889999998866 5678899999999999999999999854321100    0


Q ss_pred             HHHHHHHhh--cccc-ccccch---HH----h-------hhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          294 AAYFVHSMR--KNRL-YHILDD---QV----M-------KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       294 ~~~~~~~~~--~~~~-~~~~~~---~~----~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       ........  .... ..+.+.   ..    .       .......++++.+++.+||+.||++|||+.++++
T Consensus       228 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         228 -KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             -HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence             00000000  0000 000000   00    0       0000123567899999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.8e-38  Score=282.62  Aligned_cols=264  Identities=22%  Similarity=0.317  Sum_probs=192.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      .++|.+.+.||+|+||.||+|... +++.+|+|.+.......  .....+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc--cchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            478999999999999999999875 68899999876533221  22345678999999999999999999987543    


Q ss_pred             --cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          145 --FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       145 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                        ..++++||+. .+|..+...       .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~d  160 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILD  160 (342)
T ss_pred             CceEEEEecccc-cCHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEee
Confidence              3489999985 467665421       4788999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH---
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV---  298 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---  298 (360)
                      ||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+...  ..  .......   
T Consensus       161 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~--~~~~~~~~~~  232 (342)
T cd07879         161 FGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LD--QLTQILKVTG  232 (342)
T ss_pred             CCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HH--HHHHHHHhcC
Confidence            9998754321    123356888999998876 4678899999999999999999999965321  00  0000000   


Q ss_pred             -------HHhhccccccccc------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHh
Q 040763          299 -------HSMRKNRLYHILD------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME--LNGI  354 (360)
Q Consensus       299 -------~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~--L~~l  354 (360)
                             .............      ..-.....+..+.++.+++.+||+.||++|||+.+++..  ++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                   0000000000000      000000011234578999999999999999999999843  4444

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.8e-38  Score=279.42  Aligned_cols=264  Identities=25%  Similarity=0.296  Sum_probs=191.7

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      .++|++.+.||+|++|.||++..+ +++.+++|.+.......  .....+.+|+.+++.++||||+++++.+....    
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            478999999999999999999876 57889999876533221  11234568999999999999999999875433    


Q ss_pred             ----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          145 ----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       145 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                          ..++++||+. +++...+...    ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|
T Consensus        85 ~~~~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          85 RKRGSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             ccCceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence                3589999985 4677766542    225899999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCcee----------eecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 040763          221 ADFGTSKFIAMDQTHV----------TTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE  289 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~  289 (360)
                      +|||++..........          .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||.+...... 
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-  235 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-  235 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            9999987654322111          1223467889999987654 578899999999999999999999865432110 


Q ss_pred             ccchHHHHHHHhhc---cc------ccc--------ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          290 NVSLAAYFVHSMRK---NR------LYH--------ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       290 ~~~~~~~~~~~~~~---~~------~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ..........   ..      ...        ........ ......+++.+++.+||+.||++|||+.+++.
T Consensus       236 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         236 ----LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             ----HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                0000000000   00      000        00000000 11123367899999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6e-38  Score=273.35  Aligned_cols=254  Identities=22%  Similarity=0.280  Sum_probs=194.1

Q ss_pred             CCCccceecccCcEEEEEEEecC-CcEEEEEecccccChH-HHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDE-ELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +|.+.+.||+|+||.||++.... +..+++|..+...... .......+..|+.++..++||||+++++.+......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998753 3445555544322111 111223455788999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++..... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++ +.++|+|||++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence            999999999998865322 2336899999999999999999999999   999999999999986 46999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....        ........ ..     
T Consensus       156 ~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~-~~-----  220 (260)
T cd08222         156 MGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIV-EG-----  220 (260)
T ss_pred             CCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHH-cC-----
Confidence            4322 122234578899999999888889999999999999999999999853221        01111111 01     


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          .....+..++.++.+++.+||+.+|++||++.++++
T Consensus       221 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         221 ----PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                011123456678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=269.31  Aligned_cols=245  Identities=25%  Similarity=0.316  Sum_probs=200.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|..+++||+|.||.|.+++.+ +++.+|+|+++...--.. .....-+.|-.++...+||.+..+.-.|+..+..+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak-dEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK-DEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh-HHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            4477999999999999999999977 688999999876543211 22334567888999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||..||.|.-.|.+..     .+++...+.+-..|+.||.|||+++   |+.||||.+|.|+|.+|++||+|||+++
T Consensus       245 FVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             EEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccch
Confidence            9999999999998886533     4777777778889999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .--. ........+|||.|+|||++....|..++|.|.+|+++|||++|+.||.....     ..+-..+    ..+   
T Consensus       317 E~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----~kLFeLI----l~e---  383 (516)
T KOG0690|consen  317 EEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----EKLFELI----LME---  383 (516)
T ss_pred             hccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----hHHHHHH----Hhh---
Confidence            5322 23445678999999999999999999999999999999999999999975431     1111100    000   


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP  342 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  342 (360)
                             ....|...+++...|+...|.+||.+|.
T Consensus       384 -------d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 -------DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -------hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence                   1123566677899999999999999996

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-37  Score=278.34  Aligned_cols=267  Identities=23%  Similarity=0.292  Sum_probs=196.0

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           66 LDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        66 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      +....++|++.+.||+|+||.||++... ++..||+|.+.......  .....+.+|+.+++.++||||+++++++....
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            4445678999999999999999999865 68899999876432221  23446778999999999999999999987654


Q ss_pred             c------ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcE
Q 040763          145 F------PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA  218 (360)
Q Consensus       145 ~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~  218 (360)
                      .      .++||||+ +++|.+++...      .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~  157 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCEL  157 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence            3      48999998 77998887531      4889999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch----
Q 040763          219 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL----  293 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~----  293 (360)
                      +|+|||++......    .....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.............    
T Consensus       158 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~  233 (343)
T cd07880         158 KILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG  233 (343)
T ss_pred             EEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999998754322    123357889999998876 457889999999999999999999996543110000000    


Q ss_pred             --HHHHHHHhhcccccccc------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          294 --AAYFVHSMRKNRLYHIL------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       294 --~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                        ...+...+.........      ............++++.+++.+|++.||++|||+.+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence              00000000000000000      00000111123455789999999999999999999987

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=245.20  Aligned_cols=265  Identities=22%  Similarity=0.313  Sum_probs=198.5

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|.-.++||+|.||+|++++.+ +++.||+|.++....++  ..-...++|+-+++.++|.||++++++..++....+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde--gvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC--CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            4556678999999999999876 57899999988765543  23346779999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||| +.+|..|....+.    .++...+.+++.|+++||.++|+++   +.|||+||.|.||+.+|++|++|||+++..+
T Consensus        81 e~c-dqdlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   81 EFC-DQDLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             HHh-hHHHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            999 6789888876433    5889999999999999999999999   9999999999999999999999999998776


Q ss_pred             CCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      -+-...+. .+-|.+|.+|.++.+. .|++..|+||.||++.|+.. |++.|.+..-  .++.............+.+..
T Consensus       153 ipvrcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  153 IPVRCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             CceEeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCc
Confidence            54332222 3469999999998884 57899999999999999999 5554544321  111111111111111122222


Q ss_pred             cc---chHHhhhc---------cHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 IL---DDQVMKLG---------KKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~---~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +.   |-...+..         -+.....-++|+.+.|.-+|.+|.++++.++
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11   11111111         1222334578999999999999999998764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-39  Score=303.98  Aligned_cols=259  Identities=26%  Similarity=0.336  Sum_probs=211.4

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      ++.....+|.++++||+|+||-|.+++.+ +++.||.|++.....- .......|..|-.+|..-+.+-|+.++-.|.+.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-KRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            34445578999999999999999999987 5788999987652111 112345677888898888999999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      .++|+||||++||+|..++....     ++++...+.++..|+.||..+|+.|   +|||||||+|||||..|++||+||
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence            99999999999999999997643     5899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhcc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      |.+-.+..+..-.....+|||.|.+||++..     +.|+...|.||+||++|||+.|..||+...        +...+.
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY~  291 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETYG  291 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHHH
Confidence            9998888777667777899999999998763     468889999999999999999999997543        333444


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC---HHHHH
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT---MEEVS  348 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~ei~  348 (360)
                      ..+.......+.+       ....|++..+||.+.+. +|+.|..   ++++.
T Consensus       292 KIm~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  292 KIMNHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             HHhchhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            4443332222221       13367889999999998 8888987   66653

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-37  Score=280.50  Aligned_cols=266  Identities=23%  Similarity=0.311  Sum_probs=194.7

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee-CC
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE-TE  144 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~  144 (360)
                      ..++++|++.+.||.|+||.||++... +++.+|+|++.......  ...+.+..|+.++..++|||++++.+++.. ..
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP--VLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            345688999999999999999999876 68899999875432221  233556789999999999999999999865 55


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..++++||+ +++|.+++...      +++......++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccc
Confidence            788999998 67898887532      4778888899999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH-------H
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA-------Y  296 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~-------~  296 (360)
                      .+......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... .....       .
T Consensus       154 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~  228 (328)
T cd07856         154 LARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF-SIITDLLGTPPDD  228 (328)
T ss_pred             cccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHH
Confidence            98754321    122356888999998766 56889999999999999999999998643210000 00000       0


Q ss_pred             HHHHhhccccccccc------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          297 FVHSMRKNRLYHILD------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +..............      ........+..++++.+++.+||+.+|++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000000000      00000011124568999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.2e-37  Score=279.71  Aligned_cols=265  Identities=23%  Similarity=0.281  Sum_probs=194.7

Q ss_pred             cCCC-ccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHH----------hHHHHHHHHHHHhhcCCCCceeeee
Q 040763           71 NHFN-VNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELY----------KLEEFINEIFILSQINHRNVVKLLG  138 (360)
Q Consensus        71 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~----------~~~~~~~e~~~~~~l~h~niv~~~~  138 (360)
                      ++|. +.+.||.|+||.||++.+. +++.+|+|.++.........          ....+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            5565 4567999999999999876 68899999876543221100          0124668999999999999999999


Q ss_pred             EEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcE
Q 040763          139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA  218 (360)
Q Consensus       139 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~  218 (360)
                      ++...+..+++|||+. ++|.+++....     .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence            9999999999999996 69999886532     4788999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccCCCC-------------ceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 040763          219 KVADFGTSKFIAMDQ-------------THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTG  284 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~  284 (360)
                      +|+|||++.......             ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999987654111             1111223467889999988764 46889999999999999999999996544


Q ss_pred             CCcccccchHHHHHHHhhccc---ccccc-----------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          285 NTSQENVSLAAYFVHSMRKNR---LYHIL-----------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...     .............   +....           .+..........+.++.+++.+||+.+|++|||+.+++.
T Consensus       239 ~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        239 EID-----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHH-----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            211     0011111110000   00000           000001112234567899999999999999999999974

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-37  Score=282.27  Aligned_cols=263  Identities=24%  Similarity=0.306  Sum_probs=190.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC-----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-----  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----  143 (360)
                      ..+|.+.+.||.|+||.||+|... ++..+++|.+.....    ...+.+.+|+.+++.++||||+++++++...     
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            367999999999999999999875 578999998765432    2345677899999999999999999876543     


Q ss_pred             ---------CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc-
Q 040763          144 ---------EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-  213 (360)
Q Consensus       144 ---------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~-  213 (360)
                               ...+++|||++ ++|.+++...      .+++..+..++.|++.||.|||+.+   ++||||||+||+++ 
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~  149 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT  149 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence                     34689999996 5888887532      4788999999999999999999999   99999999999997 


Q ss_pred             CCCcEEEeecCCccccCCCCce--eeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN  290 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~  290 (360)
                      .++.++|+|||++.........  ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..........
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~  229 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ  229 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            4567899999998765332111  1122357889999997654 567889999999999999999999996543211100


Q ss_pred             cchHH--------------HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          291 VSLAA--------------YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       291 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .....              ...........  ..... ........+.++.+++.+||+.||++|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         230 LILESVPVVREEDRNELLNVIPSFVRNDGG--EPRRP-LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhccc--ccCCC-HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000              00000000000  00000 00011234567899999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-38  Score=283.89  Aligned_cols=265  Identities=23%  Similarity=0.302  Sum_probs=195.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc--
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF--  145 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~--  145 (360)
                      ..++|++.+.||+|++|.||+|... +++.+|+|.+.......  .....+.+|+.+++.++|||++++.+++...+.  
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA--IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh--hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            4578999999999999999999986 57899999876532221  234556789999999999999999998766554  


Q ss_pred             ----ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          146 ----PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       146 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                          .++++||+ +++|.+++..      .++++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEc
Confidence                79999998 6799988864      25889999999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH------
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA------  294 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~------  294 (360)
                      |||++......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+............      
T Consensus       161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~  236 (343)
T cd07851         161 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD  236 (343)
T ss_pred             ccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence            99998765332    223457889999998765 3678899999999999999999999965431100000000      


Q ss_pred             HHHHHHhhccccccccch------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          295 AYFVHSMRKNRLYHILDD------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..+...+........+..      ..........++++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            000000000000000000      0000001123668999999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=274.10  Aligned_cols=265  Identities=27%  Similarity=0.338  Sum_probs=196.9

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |+..+.||+|.+|.||+|... +++.+++|.+.......  ...+.+..|+.+++.++|+|++++++++.+.+..++++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE--GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc--cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence            556788999999999999976 48899999887653221  223456689999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |++ ++|.+++....    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        79 ~~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          79 YCD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             CcC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            996 69999997642    25889999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc-------hHHHHHHHhh-
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS-------LAAYFVHSMR-  302 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~-------~~~~~~~~~~-  302 (360)
                      ... ......++..|+|||.+.+. .++.++||||||+++|||++|..||............       ....+..... 
T Consensus       151 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         151 PLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             Ccc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence            221 22223457789999988776 7889999999999999999999998654311000000       0000000000 


Q ss_pred             ---ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 ---KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         .............. ..+..+..+.+++.+||+.||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence               00000000000101 11123567999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6e-37  Score=276.50  Aligned_cols=265  Identities=24%  Similarity=0.282  Sum_probs=189.5

Q ss_pred             CCCccceecccCcEEEEEEEec-C--CcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeC----
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-D--GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLET----  143 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~----  143 (360)
                      +|.+.+.||+|+||.||++... .  +..+|+|.+.......  ...+.+.+|+.++..+ +||||+++++.+...    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK--ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            4778899999999999999876 3  6789999876433221  2244567899999998 699999999875432    


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...+++++++. ++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+||
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcC
Confidence            34678888884 68988885432     5889999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCce---eeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc-------
Q 040763          224 GTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS-------  292 (360)
Q Consensus       224 g~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~-------  292 (360)
                      |++.........   ......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||............       
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP  229 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence            999765432211   1223468999999998766 46889999999999999999999998653311000000       


Q ss_pred             hHHHHHHHhhccccc-------cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          293 LAAYFVHSMRKNRLY-------HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       293 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...... .+......       ......+. ......+..+.+++.+||+.||++|||+.+++.
T Consensus       230 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         230 DEETLS-RIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CHHHHH-hhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000 00000000       00000000 001113557999999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=265.86  Aligned_cols=239  Identities=32%  Similarity=0.361  Sum_probs=192.2

Q ss_pred             ecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCC
Q 040763           79 LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        79 lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  157 (360)
                      ||+|++|.||++... +++.+++|.+...... .......+..|+.+++.++|||++++++.+......+++|||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            689999999999876 4889999987654322 11345577889999999999999999999999999999999999999


Q ss_pred             hhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceee
Q 040763          158 LYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT  237 (360)
Q Consensus       158 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  237 (360)
                      |.+++....     .+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        80 L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~  150 (250)
T cd05123          80 LFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRT  150 (250)
T ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-Ccc
Confidence            999997543     4788999999999999999999999   9999999999999999999999999987654322 122


Q ss_pred             ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhh
Q 040763          238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL  317 (360)
Q Consensus       238 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (360)
                      ....++..|+|||...+...+.++|+||||+++|++++|..||.....        ....... ...          ...
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~-~~~----------~~~  211 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKI-LKD----------PLR  211 (250)
T ss_pred             cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH-hcC----------CCC
Confidence            334578899999999888889999999999999999999999954321        0111111 100          011


Q ss_pred             ccHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 040763          318 GKKNQIVAFANLAERCLDLNGKKRPTMEE  346 (360)
Q Consensus       318 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~e  346 (360)
                      .+...+.++.+++.+||..||++|||+.+
T Consensus       212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         212 FPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            22233567899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=264.44  Aligned_cols=258  Identities=22%  Similarity=0.287  Sum_probs=194.1

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +.+-...||.|+||+|++-.++ .|+..|||+++.....   ....+++.|.+...+- +.||||+++|.+..+..+|+.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~---keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE---KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch---HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            3445567999999999998876 6899999998876553   2345677787766555 789999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||.| ..|+..+...-..-....+++..+..|+.-.+.||.||...-+  |+|||+||+|||++..|.+||||||.+-.+
T Consensus       142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhH
Confidence            9998 5677665544333334468999999999999999999987643  999999999999999999999999998654


Q ss_pred             CCCCceeeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..  +...+...|-..|||||.+..  ..|+.+|||||||++|+|+.||..||..-..      .+.+.-.-...+.+..
T Consensus       219 v~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  219 VD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQVVIGDPPIL  290 (361)
T ss_pred             HH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHHHcCCCCee
Confidence            32  222344567788999998875  3588999999999999999999999854221      1111111111111111


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        ..    ....-+++..+..++.-||-+|...||+..++.+
T Consensus       291 --~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  291 --LF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             --cC----cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence              00    0112346778999999999999999999998864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=267.54  Aligned_cols=265  Identities=23%  Similarity=0.319  Sum_probs=201.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-C-C----CceeeeeE
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-H-R----NVVKLLGC  139 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h-~----niv~~~~~  139 (360)
                      +...++|.++..+|+|.||.|..+.+. .+..+|+|+++...     ...+..+-|+.++.++. + |    -++.+.++
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            344789999999999999999999865 46889999987642     34456677999999993 2 2    35677788


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-----
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-----  214 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-----  214 (360)
                      |...++.++|+|.+ |.|+.+++..+   +..+++...+..++.|+++++++||+.+   ++|.||||+|||+.+     
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence            99999999999987 77999999874   4447899999999999999999999999   999999999999832     


Q ss_pred             ---------------CCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCC
Q 040763          215 ---------------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP  279 (360)
Q Consensus       215 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p  279 (360)
                                     +..++++|||.|.......    ...+.|..|.|||++.+-+|+.+.||||+||||.|+.||..-
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                           4568999999998765443    345678999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccchHHHHHHHhhccccc----------------cccchH----H---------hhhccHHHHHHHHHHH
Q 040763          280 IFSTGNTSQENVSLAAYFVHSMRKNRLY----------------HILDDQ----V---------MKLGKKNQIVAFANLA  330 (360)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~----~---------~~~~~~~~~~~l~~li  330 (360)
                      |+...+..  .....+.+.+..+..-+.                +.....    .         ..........+|.+|+
T Consensus       309 FqtHen~E--HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  309 FQTHENLE--HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             cccCCcHH--HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            98766322  112222221111100000                000000    0         0001223344699999


Q ss_pred             HHhhcCCCCCCCCHHHHHH
Q 040763          331 ERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       331 ~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .+||..||.+|+|+.|++.
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999874

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=287.80  Aligned_cols=254  Identities=27%  Similarity=0.411  Sum_probs=206.8

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEee--
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLE--  142 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--  142 (360)
                      ...+.-|++.+.||.|.+|.||+++.+ +++..|+|+.....+.++     ++..|..+++.. +|||++.++|++..  
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de-----EiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE-----EIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH-----HHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            334567899999999999999999865 688889998877655532     334577788887 79999999999864  


Q ss_pred             ---CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEE
Q 040763          143 ---TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAK  219 (360)
Q Consensus       143 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~k  219 (360)
                         ++.+++|||||.+||..++++...   ...+.|..+..|++.++.|+++||.+.   ++|||+|-.|||++.++.+|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence               567899999999999999998754   447999999999999999999999998   99999999999999999999


Q ss_pred             EeecCCccccCCCCceeeecccccCCccchhhhccC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH
Q 040763          220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~  294 (360)
                      |+|||++..+.. ......+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+.+...         
T Consensus       164 LvDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---------  233 (953)
T KOG0587|consen  164 LVDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---------  233 (953)
T ss_pred             Eeeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------
Confidence            999999987654 23345667899999999988764     366789999999999999999999866431         


Q ss_pred             HHHHHHhhccccccccc-hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          295 AYFVHSMRKNRLYHILD-DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         .     ..+..+.- ++.....+..++++|.++|..||.+|-++||++.++++
T Consensus       234 ---m-----raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  234 ---M-----RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---h-----hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence               0     11111111 11222237889999999999999999999999999874

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=256.15  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=195.0

Q ss_pred             HhcCCCcc-ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEee---
Q 040763           69 ATNHFNVN-RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLE---  142 (360)
Q Consensus        69 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~---  142 (360)
                      .+.+|++. ++||-|-.|.|..+.++ +++.+|+|++...         ....+|++..-.. .|||||.+++++..   
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            34556553 57999999999999876 6889999987642         2344777766555 79999999998764   


Q ss_pred             -CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcE
Q 040763          143 -TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRA  218 (360)
Q Consensus       143 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~  218 (360)
                       ..-+.+|||.++||.|.+.+.+++   ...+++..+-.|++||..|+.|||+.+   |.||||||+|+|...   |..+
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcce
Confidence             334578999999999999998754   346899999999999999999999999   999999999999964   5679


Q ss_pred             EEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          219 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      ||+|||+|+....  .....+-+-|+.|.|||++....|+...|+||+||++|-|++|.+||...........     ..
T Consensus       204 KLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg-----Mk  276 (400)
T KOG0604|consen  204 KLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MK  276 (400)
T ss_pred             EecccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh-----HH
Confidence            9999999986543  2233445779999999999999999999999999999999999999976432111111     11


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..+..+ -.++.++.+     .+.+++..++|+.+|..+|++|.|+.++++
T Consensus       277 ~rI~~g-qy~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  277 RRIRTG-QYEFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hHhhcc-CccCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            111111 111222211     346778999999999999999999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=278.46  Aligned_cols=239  Identities=23%  Similarity=0.273  Sum_probs=192.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~  147 (360)
                      ...|.....+|.|+|+.|..+.+. +++..++|++.....+        ..+|+.++... +|||++++.+.+.+....|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc--------cccccchhhhhcCCCcceeecceecCCceee
Confidence            467888888999999999888765 5788899987764222        12566566555 8999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE-cCCCcEEEeecCCc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL-DERYRAKVADFGTS  226 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill-~~~~~~kl~Dfg~~  226 (360)
                      +|||.+.++-+.+.+....      .....+..|+.+++.++.|||++|   ++||||||+|||+ ++.++++|+|||.+
T Consensus       393 ~v~e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a  463 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW  463 (612)
T ss_pred             eeehhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence            9999999998888776532      222667789999999999999999   9999999999999 69999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      +.....    ..+-+-|..|.|||++....+++++|+||||++||+|++|+.||......        ......+..   
T Consensus       464 ~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~---  528 (612)
T KOG0603|consen  464 SELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQM---  528 (612)
T ss_pred             hhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcC---
Confidence            876544    22234588999999999999999999999999999999999999765432        001111111   


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                               .......|++.++|+.+||+.||.+||++.++..
T Consensus       529 ---------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 ---------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ---------CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                     1122567778999999999999999999999853

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-36  Score=261.04  Aligned_cols=219  Identities=22%  Similarity=0.201  Sum_probs=175.1

Q ss_pred             cCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCChhH
Q 040763           82 GGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQ  160 (360)
Q Consensus        82 G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~  160 (360)
                      |.+|.||++.+. +++.+|+|.++....         ...|...+....|||++++++++...+..+++|||+++++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh---------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999876 678999998865321         1233444445679999999999999999999999999999999


Q ss_pred             HhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeecc
Q 040763          161 HLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI  240 (360)
Q Consensus       161 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  240 (360)
                      ++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++++|||.+......    ....
T Consensus        75 ~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~  142 (237)
T cd05576          75 HISKFL-----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGE  142 (237)
T ss_pred             HHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccC
Confidence            987543     4889999999999999999999999   999999999999999999999999987654322    1223


Q ss_pred             cccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccH
Q 040763          241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKK  320 (360)
Q Consensus       241 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (360)
                      .++..|+|||.+.+..++.++|+||+|+++|||++|..|+.........                       ......+.
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~-----------------------~~~~~~~~  199 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-----------------------HTTLNIPE  199 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc-----------------------ccccCCcc
Confidence            4567899999998888899999999999999999999886432210000                       00011233


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          321 NQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       321 ~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                      ..++.+.+++.+||+.||++|||+
T Consensus       200 ~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         200 WVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCHHHHHHHHHHccCCHHHhcCC
Confidence            345679999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.3e-36  Score=289.90  Aligned_cols=148  Identities=30%  Similarity=0.361  Sum_probs=130.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|+++...... ......+..|+.++..++||||+++++++......|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN-KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC-HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            67899999999999999999987 68899999876532211 12345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      |||+.+++|.+++....     .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999996532     4788889999999999999999999   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=275.97  Aligned_cols=245  Identities=24%  Similarity=0.274  Sum_probs=201.4

Q ss_pred             cCCCccceecccCcEEEEEEEecCCc-EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGR-IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+++.+..||-|+||.|=++..++.. .+|+|+++...--+ ..+.+.+..|-.+|...+.|.||++|..|.++.+.|+.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            55677788999999999998876544 37888776543222 23456778899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||-|-||.++..+++++.     ++..+...++..++.|++|||+++   |+.|||||+|.+++.+|-+||.|||+|+.+
T Consensus       499 mEaClGGElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             HHhhcCchhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence            999999999999988764     666667778889999999999999   999999999999999999999999999988


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ....  .+.+.+||+.|.|||.+.+...+.++|.||||+++|||++|.+||.+...  +..      +.         .+
T Consensus       571 ~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp--mkt------Yn---------~I  631 (732)
T KOG0614|consen  571 GSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP--MKT------YN---------LI  631 (732)
T ss_pred             ccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch--HHH------HH---------HH
Confidence            6544  44567999999999999999999999999999999999999999976542  111      11         01


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT  343 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  343 (360)
                      +..--....|........+|+.+.+..+|.+|..
T Consensus       632 LkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  632 LKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             HhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            1111123345666668899999999999999976

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=267.57  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=202.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHH---HhHHHHHHHHHHHhhcCCCCceeeeeEEe-eC
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEEL---YKLEEFINEIFILSQINHRNVVKLLGCCL-ET  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~  143 (360)
                      ...+|-++.+||+|+|+.||++.+- ..+.||+|+-.....+.+.   ...+...+|-.|.+.++||.||++++++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3467888999999999999999864 4678999986554443322   23456778999999999999999999986 55


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEEE
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAKV  220 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~kl  220 (360)
                      +..+-|+|||+|.+|.-||..+.     .+++...++|+.||+.||.||.... +||+|-||||.|||+.+   -|.+||
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence            67788999999999999998755     4889999999999999999999876 78999999999999954   578999


Q ss_pred             eecCCccccCCCCce------eeecccccCCccchhhhccC----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 040763          221 ADFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSS----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN  290 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~  290 (360)
                      +|||+++.+..+...      .+....||++|++||++.-+    ..+.|+||||+|||+|..+.|+.||.....     
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-----  689 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-----  689 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-----
Confidence            999999998664432      23456799999999976533    468899999999999999999999954321     


Q ss_pred             cchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          291 VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                            -...+....+....+-.++  ..+-.+.+..++|.+||+.--++|....++.
T Consensus       690 ------QQdILqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  690 ------QQDILQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ------HHHHHhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                  0111122222222222111  1234566889999999999999998888775

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=266.44  Aligned_cols=247  Identities=26%  Similarity=0.328  Sum_probs=197.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEF  145 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~  145 (360)
                      ....+|..+.+||+|+||.|.++..+ +.+.+|||+++...--.+ ...+--+.|-+++... +-|.++.++.+|++.+.
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            33467888999999999999999876 467899998877543221 1222334567777766 56899999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      +|+||||+.||+|...+...+.     +.+.....++.+|+-||-+||+++   |+.||||.+||+++.+|++||+|||+
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccc
Confidence            9999999999999999877653     555666778999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ++.--.+ ...+.+.+||+.|+|||.+..++|+..+|.||||++||||+.|++||.+..+..        .+..      
T Consensus       497 cKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------lF~a------  561 (683)
T KOG0696|consen  497 CKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQA------  561 (683)
T ss_pred             ccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHH------
Confidence            9753222 222456789999999999999999999999999999999999999997754311        1111      


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT  343 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  343 (360)
                         +.+.  ...+|+..+.+...++...|.+.|.+|..
T Consensus       562 ---I~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  562 ---IMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ---HHHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence               1111  12357778889999999999999999964

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=259.58  Aligned_cols=268  Identities=23%  Similarity=0.329  Sum_probs=210.4

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEE
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCC  140 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~  140 (360)
                      .....+++....+-+|.||.||.|.+.      +.+.+.+|.++.....   .+...++.|.-.+..+.|||+..+.+++
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~---iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ---IQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH---HHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            334456777788999999999999543      3445666765543222   4566788888888999999999999987


Q ss_pred             e-eCCcceEEEEecCCCChhHHhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC
Q 040763          141 L-ETEFPLLVYEFIPNGTLYQHLHDRHQ---NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY  216 (360)
Q Consensus       141 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~  216 (360)
                      . +...+++++.++.-|+|..++...+.   ..-+.++..+...++.|++.|++|||+++   ++|.||..+|++|++..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            5 45678899999999999999984322   22345677788889999999999999999   99999999999999999


Q ss_pred             cEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchH
Q 040763          217 RAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       217 ~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~  294 (360)
                      .+||+|=.+++.+-..+.+- ...-..+..||+||.+....|+.++||||||+++|||+| |+.|+.......       
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------  506 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------  506 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------
Confidence            99999999987754433222 122234678999999999999999999999999999999 999986554211       


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                                 +...+.++.+...|.+++.++..++.-||..+|++||+++++..-|+.+...+
T Consensus       507 -----------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  507 -----------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             -----------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence                       11222333344567788999999999999999999999999999998876544

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-37  Score=269.87  Aligned_cols=245  Identities=25%  Similarity=0.326  Sum_probs=194.2

Q ss_pred             cceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           76 NRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      .+.||.|.||+||-|.++ +|+.||||++.......  ...+.+.+|+.|+.+++||.||.+...|.+.+..++|||-+ 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-  645 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-  645 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-
Confidence            478999999999999986 79999999865533222  22356778999999999999999999999999999999999 


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEEEeecCCccccCC
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKFIAM  231 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~  231 (360)
                      +|+..+.+-.   .+..++++..-..+..||+.||.|||.++   |+|+||||+|||+.+   -..+||||||+|+.++.
T Consensus       646 ~GDMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  646 HGDMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             cchHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            5566565543   23446888777788999999999999999   999999999999964   35799999999999876


Q ss_pred             CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccc
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD  311 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (360)
                      ...  ....+||+.|+|||++..+.|+..-|+||.|+|+|--++|..||....+    -....++..-..+..+|.    
T Consensus       720 ksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----IndQIQNAaFMyPp~PW~----  789 (888)
T KOG4236|consen  720 KSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----INDQIQNAAFMYPPNPWS----  789 (888)
T ss_pred             hhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hhHHhhccccccCCCchh----
Confidence            433  3346899999999999999999999999999999999999999965432    111122111122222222    


Q ss_pred             hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          312 DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       312 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                               +.+++..+||...|+..-.+|-|.+.-+
T Consensus       790 ---------eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  790 ---------EISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ---------hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence                     2355788999999999999999987653

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-36  Score=249.74  Aligned_cols=255  Identities=23%  Similarity=0.343  Sum_probs=194.6

Q ss_pred             ceecccCcEEEEEEE-ecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~-~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      +.||+|+|+.|-.+. +.+|..+|||++.....    ....+..+|++++.+. .|+||+.++++|.++...|+|||-+.
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCc----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            569999999998875 56899999999876532    4567788999999998 69999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc---EEEeecCCccccCC
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAM  231 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~  231 (360)
                      ||+|.+.+..+.     .+++.....+.++|+.||.+||++|   |.|||+||+|||-.+...   +|||||.+..-...
T Consensus       160 GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  160 GGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             CchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccccc
Confidence            999999997754     5888899999999999999999999   999999999999976544   79999988754322


Q ss_pred             CC------ceeeecccccCCccchhhhcc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc-ccc-----cchH
Q 040763          232 DQ------THVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS-QEN-----VSLA  294 (360)
Q Consensus       232 ~~------~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~-~~~-----~~~~  294 (360)
                      ..      .-...+.+|+..|||||+..-     ..|+.+.|.||||+++|-|++|.+||.+.-... ...     ...-
T Consensus       232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ  311 (463)
T KOG0607|consen  232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ  311 (463)
T ss_pred             CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence            11      111223468999999996542     357889999999999999999999997764311 100     0111


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......+.++ -.++.+..+     ...+.+..+++...|..|+.+|.++.+++.
T Consensus       312 ~~LFesIQEG-kYeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  312 NKLFESIQEG-KYEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHhcc-CCcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            1111222221 122222222     234667899999999999999999888754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=282.45  Aligned_cols=245  Identities=29%  Similarity=0.391  Sum_probs=187.5

Q ss_pred             CCccceecccCcEE-EEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEE
Q 040763           73 FNVNRILGQGGQGT-VYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        73 ~~~~~~lg~G~~g~-V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      |...+.+|.|+.|+ ||+|... ++.||||++-..       ..+.+.+|+..++.- +||||+++++.-.+.+..|+..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            45567799999988 5899886 789999987653       233456899999988 6999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-----CCcEEEeecCC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-----RYRAKVADFGT  225 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~  225 (360)
                      |.| ..+|++++.... .+.....-...+.+..|++.||++||+.+   |+||||||.||||+.     ...++|+|||+
T Consensus       583 ELC-~~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             hHh-hhhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccc
Confidence            999 689999998741 11111111345678899999999999999   999999999999975     25789999999


Q ss_pred             ccccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          226 SKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       226 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ++.+..+....  .....||.+|+|||++.....+.++||||+||++|+.++ |..||.+.-..  +...+.       .
T Consensus       658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~-------~  728 (903)
T KOG1027|consen  658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILT-------G  728 (903)
T ss_pred             ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhc-------C
Confidence            99887654332  345679999999999999888889999999999999999 58898654321  000000       0


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                      ...+..+      .. ...+  +..+||.+|+.++|..||++.+|+
T Consensus       729 ~~~L~~L------~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  729 NYTLVHL------EP-LPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ccceeee------cc-CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            0001100      00 1111  688999999999999999999995

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.9e-35  Score=278.24  Aligned_cols=260  Identities=20%  Similarity=0.243  Sum_probs=168.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEecC-----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeE----
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGC----  139 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~----  139 (360)
                      ..++|++.+.||+|+||.||+|.+.+     +..+|+|++......      +....+  .+....+.++..+...    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~------e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV------EIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh------HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            35789999999999999999999764     588999986542211      111111  1112222222222211    


Q ss_pred             --EeeCCcceEEEEecCCCChhHHhhhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 040763          140 --CLETEFPLLVYEFIPNGTLYQHLHDRHQN---------------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH  202 (360)
Q Consensus       140 --~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  202 (360)
                        .......++++||+.+++|.+++......               .........+..++.|++.||.|||+++   |+|
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiH  278 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVH  278 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence              23456789999999999999998653210               0001123345679999999999999999   999


Q ss_pred             cCCCCCCeEEcC-CCcEEEeecCCccccCCCCceeeecccccCCccchhhhccC----------------------CCCC
Q 040763          203 RDIKSTNILLDE-RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS----------------------QLTD  259 (360)
Q Consensus       203 ~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~  259 (360)
                      |||||+|||+++ ++.+||+|||++...............+++.|+|||.+...                      .++.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            999999999985 68999999999986544333344456789999999965432                      2344


Q ss_pred             ccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc-----ccccccchHHhh------hccHHHHHHHHH
Q 040763          260 KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN-----RLYHILDDQVMK------LGKKNQIVAFAN  328 (360)
Q Consensus       260 ~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~------~~~~~~~~~l~~  328 (360)
                      ++|||||||++|||+++..|+...         .... ...+...     .+..........      ........+..+
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~~---------~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d  428 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDSN---------LIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE  428 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCchH---------HHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence            679999999999999976654211         0000 0000000     000000000000      000111234568


Q ss_pred             HHHHhhcCCCCCCCCHHHHHH
Q 040763          329 LAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       329 li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      |+.+||+.||++|||+.++++
T Consensus       429 Li~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        429 LLKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHHHHccCCcccCCCHHHHhC
Confidence            999999999999999999975

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-37  Score=251.60  Aligned_cols=267  Identities=24%  Similarity=0.332  Sum_probs=195.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee-------
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE-------  142 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-------  142 (360)
                      +.|.-..++|+|.||.||+++.+ .++.||+|+.........  .-...++|+.++..+.|+|++.+++.|..       
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG--fpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG--FPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC--CcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            44556678999999999999876 477789887554322211  12345689999999999999999988753       


Q ss_pred             -CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          143 -TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       143 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                       ....|+||++|++ +|.-.+..    ....++...+..++.++..||.|+|...   |+|||+||.|+||+.++.+||+
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEee
Confidence             2347999999965 77777754    3336888999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCcee---eecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 040763          222 DFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      |||+++.+.......   .+..+-|.+|++||.+.+ ..|+++.|||+.||++.||+|+.+-+.+..  .+.+..+....
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~L  244 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQL  244 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHH
Confidence            999997665433222   233456999999998877 578999999999999999999987765543  23333333333


Q ss_pred             HHHhhccccccccchHHhhhc-----c-------HHH------HHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          298 VHSMRKNRLYHILDDQVMKLG-----K-------KNQ------IVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~-----~-------~~~------~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......+.|...-.-.+....     +       ++.      .++.++|+..++..||.+|+++++++.
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            333333333222221111111     1       011      226789999999999999999998863

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-34  Score=249.28  Aligned_cols=239  Identities=32%  Similarity=0.414  Sum_probs=190.8

Q ss_pred             CcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCChhHH
Q 040763           83 GQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQH  161 (360)
Q Consensus        83 ~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~  161 (360)
                      +||.||++... +++.+++|.+.......   ..+.+.+|+..+++++|+|++++++.+......++++|++++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK---KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc---HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            58999999987 48899999987643331   156788999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeeccc
Q 040763          162 LHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ  241 (360)
Q Consensus       162 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  241 (360)
                      +....     .+++..+..++.+++.++.+||+.+   ++|+||+|.||++++++.++|+|||.+.......  ......
T Consensus        78 ~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  147 (244)
T smart00220       78 LKKRG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFV  147 (244)
T ss_pred             HHhcc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--cccccc
Confidence            87532     2788999999999999999999999   9999999999999999999999999998765432  233446


Q ss_pred             ccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHH
Q 040763          242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKN  321 (360)
Q Consensus       242 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (360)
                      ++..|+|||...+..++.++||||||+++|+|++|..||......        ...............       .....
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~-------~~~~~  212 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--------LELFKKIGKPKPPFP-------PPEWK  212 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHhccCCCCc-------ccccc
Confidence            788999999998888899999999999999999999998653110        011111111111000       00000


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          322 QIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       322 ~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .+.++.+++.+||..+|++||++.++++
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            4557999999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.1e-34  Score=264.96  Aligned_cols=269  Identities=19%  Similarity=0.199  Sum_probs=180.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEe-----------------cCCcEEEEEecccccChHHHH----------hHHHHHHH
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRL-----------------EDGRIIAVKKSKLAVDDEELY----------KLEEFINE  121 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vaik~~~~~~~~~~~~----------~~~~~~~e  121 (360)
                      ..++|.+.++||+|+||.||+|..                 ..++.||+|++..........          ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999963                 235679999976543221000          11223446


Q ss_pred             HHHHhhcCCCCc-----eeeeeEEee--------CCcceEEEEecCCCChhHHhhhhccC-------------------C
Q 040763          122 IFILSQINHRNV-----VKLLGCCLE--------TEFPLLVYEFIPNGTLYQHLHDRHQN-------------------E  169 (360)
Q Consensus       122 ~~~~~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~  169 (360)
                      +.++.+++|.++     ++++++|..        ....++||||+++++|.+++......                   .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766544     667776643        34579999999999999998643110                   1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccch
Q 040763          170 EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP  249 (360)
Q Consensus       170 ~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP  249 (360)
                      ....++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            123567788999999999999999999   99999999999999999999999999876543222212222357899999


Q ss_pred             hhhccCCC----------------------CCccchhhhHHHHHHHHhCCC-CCCCCCCCccc---ccchHHHHHHHhhc
Q 040763          250 EYHQSSQL----------------------TDKSDVYSFGVVLVELLTGKK-PIFSTGNTSQE---NVSLAAYFVHSMRK  303 (360)
Q Consensus       250 E~~~~~~~----------------------~~~~DvwslG~il~el~tg~~-p~~~~~~~~~~---~~~~~~~~~~~~~~  303 (360)
                      |.+.....                      ..+.||||+||++++|++|.. ||........+   .......+.. ...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~  458 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKG  458 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcc
Confidence            98754321                      234799999999999999875 66432110000   0000011110 000


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCC---CCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNG---KKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rpt~~ei~~  349 (360)
                      .        ..........+++..+|+.++|..+|   .+|+|+.|+++
T Consensus       459 ~--------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 Q--------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             c--------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0        00111122345678999999999866   68999999874

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=241.91  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=198.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~l  148 (360)
                      ++|..+++||+|+|+.|..+.++ +.+.+|+|+++.....++ +.++-...|-.+..+- +||.+|.++.+|.+....++
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-edidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-ccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            57899999999999999999876 578899998776543322 2344455677777665 79999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      |.||++||+|.-.+.+..     .++++..+.+..+|..||.|||+.|   |+.||||.+|+|+|..|++||+|+|+++.
T Consensus       329 vieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence            999999999988776543     5888999999999999999999999   99999999999999999999999999975


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      --. ....+++.+|||.|.|||.+.+..|...+|.|++|++++||+.|+.||.-.+....+ ........+.+...    
T Consensus       401 ~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-~ntedylfqvilek----  474 (593)
T KOG0695|consen  401 GLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-MNTEDYLFQVILEK----  474 (593)
T ss_pred             CCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-cchhHHHHHHHhhh----
Confidence            322 233456689999999999999999999999999999999999999999754421111 11112222222111    


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT  343 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  343 (360)
                          +  ...|...+-....++..-|.+||.+|..
T Consensus       475 ----q--iriprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  475 ----Q--IRIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ----c--ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence                1  1134555556778999999999999864

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.3e-34  Score=229.67  Aligned_cols=257  Identities=22%  Similarity=0.328  Sum_probs=194.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEe-cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEee--CC
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLE--TE  144 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~--~~  144 (360)
                      ...+|++.+++|+|.++.|+.|.. .+.+.++||.++..       ..+.+.+|+.+++.+. ||||+++++...+  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            346799999999999999999974 46788999998873       4556789999999995 9999999999875  44


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEeec
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVADF  223 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Df  223 (360)
                      .+.+|+|++.+.+...+...        ++...+...+.+++.||.|||+.|   |.|||+||.|++||. .-.++|+||
T Consensus       109 tpaLiFE~v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             CchhHhhhhccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeec
Confidence            67899999998888776643        666778889999999999999999   999999999999996 457999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      |+|.+.......  +-.+.+..|--||.+-. ..|+..-|+|||||++..|+..+.||+...+..+.    ...+...+.
T Consensus       178 GLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ----LVkIakVLG  251 (338)
T KOG0668|consen  178 GLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ----LVKIAKVLG  251 (338)
T ss_pred             chHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH----HHHHHHHhC
Confidence            999887654332  22356777899997766 56888999999999999999999998754432221    111111111


Q ss_pred             cccc---------------ccccchH----H---hhhccHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRL---------------YHILDDQ----V---MKLGKKN-QIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~---------------~~~~~~~----~---~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...+               ..+++..    +   ....+.. .+++..+|+.+.|..|-.+|||++|...
T Consensus       252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1111               1111110    0   0111111 2478999999999999999999999853

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-34  Score=255.98  Aligned_cols=247  Identities=23%  Similarity=0.266  Sum_probs=188.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .-|..++.||-|+||.|.+++-. +...+|.|.++.... -........+.|-.||..-+.+-||+++-.|.+.+.+|+|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            45777889999999999998643 456788887665321 1123445567888999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |+|++||++.++|.+.+     .+++...+.++.++..|+++.|..|   +|||||||+|||||.+|++||+|||++.-+
T Consensus       708 MdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence            99999999999998755     4788888888999999999999999   999999999999999999999999998432


Q ss_pred             C---------C-CCc--------------------------ee-----eecccccCCccchhhhccCCCCCccchhhhHH
Q 040763          230 A---------M-DQT--------------------------HV-----TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGV  268 (360)
Q Consensus       230 ~---------~-~~~--------------------------~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  268 (360)
                      .         . +..                          ..     ....+||+.|+|||++....++...|.||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            1         0 000                          00     01246999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC
Q 040763          269 VLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP  342 (360)
Q Consensus       269 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  342 (360)
                      |||||+.|+.||.+.......  ....         .|...+    .-....+.+++..++|.+.++ +++.|.
T Consensus       860 il~em~~g~~pf~~~tp~~tq--~kv~---------nw~~~l----~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQ--YKVI---------NWRNFL----HIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcce--eeee---------ehhhcc----ccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            999999999999765422211  1111         111111    122334456677777777655 566665

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=226.36  Aligned_cols=210  Identities=25%  Similarity=0.376  Sum_probs=168.9

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeC
Q 040763           66 LDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLET  143 (360)
Q Consensus        66 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~  143 (360)
                      ++...+.......||+|++|.|-+-++. +|...|+|.++.....   ...++.+.|+.+..+. .+|.+|.|+|.....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~---q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re  117 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS---QEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE  117 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh---HHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence            3344455556677999999999887764 7999999998876664   3345667888877665 789999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...++.||.| ..||..+-..-- ..+..+++..+-+|+..+..||.|||++-.  ++|||+||+||||+.+|.+|+|||
T Consensus       118 gdvwIcME~M-~tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  118 GDVWICMELM-DTSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             ccEEEeHHHh-hhhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEccc
Confidence            9999999988 567766654432 345579999999999999999999999754  999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhcc----CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS----SQLTDKSDVYSFGVVLVELLTGKKPIFSTG  284 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~p~~~~~  284 (360)
                      |.+-.+.+.-  ..+-..|-..|||||.+..    ..|+.++||||||+++.||.+++.||..-+
T Consensus       194 GIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  194 GISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             ccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            9986654321  1122346678999997764    368899999999999999999999986543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=240.87  Aligned_cols=263  Identities=24%  Similarity=0.306  Sum_probs=194.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-----C---CCceeeeeEEe
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-----H---RNVVKLLGCCL  141 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-----h---~niv~~~~~~~  141 (360)
                      .+|.+.++||-|-|+|||++.+. +.+.||+|+.+..     ....+..+.|+.++++++     |   ..||++++.|.
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            68899999999999999999875 5778999987642     245677889999999983     2   47999999986


Q ss_pred             e----CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---
Q 040763          142 E----TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---  214 (360)
Q Consensus       142 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---  214 (360)
                      .    +.+.+||+|++ |.+|..+|....   -..++...+.+|++||+.||.|||..+.  |+|.||||+|||+..   
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~  226 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEI  226 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeecccc
Confidence            4    56889999998 778888887643   2258899999999999999999999864  999999999999800   


Q ss_pred             --------------------------------------------------------------------------------
Q 040763          215 --------------------------------------------------------------------------------  214 (360)
Q Consensus       215 --------------------------------------------------------------------------------  214 (360)
                                                                                                      
T Consensus       227 ~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~  306 (590)
T KOG1290|consen  227 DPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNE  306 (590)
T ss_pred             chhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 040763          215 --------------------------------------------------------------------------------  214 (360)
Q Consensus       215 --------------------------------------------------------------------------------  214 (360)
                                                                                                      
T Consensus       307 ~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~  386 (590)
T KOG1290|consen  307 PRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPL  386 (590)
T ss_pred             cCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCC
Confidence                                                                                            


Q ss_pred             ---CCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc--cc
Q 040763          215 ---RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS--QE  289 (360)
Q Consensus       215 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~--~~  289 (360)
                         +-.+||+|||-|+.....    .+....|..|+|||++.+..|++.+||||++|++|||+||...|.......  .+
T Consensus       387 ~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD  462 (590)
T KOG1290|consen  387 PECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD  462 (590)
T ss_pred             CccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence               001566777766654322    222345778999999999999999999999999999999999886654221  11


Q ss_pred             ccchHHHHHHHhhccc---------cccccch----------H---------HhhhccHHHHHHHHHHHHHhhcCCCCCC
Q 040763          290 NVSLAAYFVHSMRKNR---------LYHILDD----------Q---------VMKLGKKNQIVAFANLAERCLDLNGKKR  341 (360)
Q Consensus       290 ~~~~~~~~~~~~~~~~---------~~~~~~~----------~---------~~~~~~~~~~~~l~~li~~cl~~dp~~R  341 (360)
                      ... ...+...+..-+         ..++++.          +         -.-..+.....+|.+++.-||+++|++|
T Consensus       463 EDH-iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR  541 (590)
T KOG1290|consen  463 EDH-IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR  541 (590)
T ss_pred             HHH-HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence            111 112222211110         0111111          0         0122456778889999999999999999


Q ss_pred             CCHHHHHH
Q 040763          342 PTMEEVSM  349 (360)
Q Consensus       342 pt~~ei~~  349 (360)
                      |||.+.++
T Consensus       542 ~tA~~cl~  549 (590)
T KOG1290|consen  542 PTAAQCLK  549 (590)
T ss_pred             ccHHHHhc
Confidence            99999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=233.71  Aligned_cols=262  Identities=23%  Similarity=0.304  Sum_probs=193.0

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC-----c
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE-----F  145 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~  145 (360)
                      +.+..+-||.|+||.||..++. +|+.+++|++......  ...-+.+.+|++++..++|.|++..++...-..     .
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~--L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN--LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH--HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            3455678999999999999875 7999999998765444  345567889999999999999999888765433     3


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .|+++|.+ ..+|...+-.     .++++...+.-+..||++||.|||+.+   |.||||||.|.|++.|..+||||||+
T Consensus       132 iYV~TELm-QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  132 LYVLTELM-QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHHHH-Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccc
Confidence            46778877 3466655533     336777777789999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++.-..+....++..+-|..|.|||.+.+. .|+.+.||||.|||..|++..+.-|...+...+     .+.+...+...
T Consensus       203 ARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ-----L~lItdLLGTP  277 (449)
T KOG0664|consen  203 ARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ-----LQMIIDLLGTP  277 (449)
T ss_pred             ccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH-----HHHHHHHhCCC
Confidence            987666655555666678899999998884 689999999999999999988888865442111     11122222211


Q ss_pred             cccc-----------ccchHHh---------hhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYH-----------ILDDQVM---------KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~-----------~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....           ++-...+         ...+...-.+...+...++.+||+.|.+..+.+.
T Consensus       278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence            1100           0000000         0011223446778999999999999999887654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-33  Score=230.69  Aligned_cols=264  Identities=22%  Similarity=0.289  Sum_probs=193.2

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      ..+|.-++.+|.|.- .|..+.+. .+++||+|+.......  .....+..+|+..+..++|+|+++++.++.-..    
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--CccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            466777788899988 56666554 5889999987765443  234556779999999999999999999987443    


Q ss_pred             --cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          145 --FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       145 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                        ..|+|||++ ..+|...+.-       .++-..+..+..|++.|+.|||+.+   |+||||||+||++..+..+||.|
T Consensus        93 ~~e~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   93 FQEVYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             HHhHHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeecc
Confidence              468999999 6788888752       3666788899999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccc-------chHH
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV-------SLAA  295 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~-------~~~~  295 (360)
                      ||++..-..+  ...+..+.|..|.|||++.+-.+.+.+||||+||++.||++|..-|.+....++-..       ....
T Consensus       162 fg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  162 FGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             chhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            9999754433  456777889999999999998899999999999999999999988864322111100       0000


Q ss_pred             HHHHHhhccc-------------ccccc-chHHh--hhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKNR-------------LYHIL-DDQVM--KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~~-------------~~~~~-~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +..+......             ..+.+ |.-+.  .+.++-...-+.+++.+||..||++|.|+++++.
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            0000000000             00000 00000  0011122335789999999999999999999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=8.8e-31  Score=220.08  Aligned_cols=211  Identities=37%  Similarity=0.598  Sum_probs=181.9

Q ss_pred             ecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCC
Q 040763           79 LGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        79 lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  157 (360)
                      ||+|++|.||++.... ++.+++|.........   ..+.+.+|+..+..++|++++++++++......++++|++++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            6899999999999864 8899999987654321   34567899999999999999999999999899999999999999


Q ss_pred             hhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEeecCCccccCCCCcee
Q 040763          158 LYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFIAMDQTHV  236 (360)
Q Consensus       158 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~  236 (360)
                      |.+++....    ..+++..+..++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus        78 l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~  149 (215)
T cd00180          78 LKDLLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-L  149 (215)
T ss_pred             HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-h
Confidence            999987642    25788999999999999999999999   999999999999999 89999999999876544321 1


Q ss_pred             eecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHh
Q 040763          237 TTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM  315 (360)
Q Consensus       237 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (360)
                      .....+...|++||..... ..+.++|+|++|+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            2223578889999998887 788999999999999999                                          


Q ss_pred             hhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          316 KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       316 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                              ..+.+++.+|++.+|++||++.++++.
T Consensus       188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                    258899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=245.85  Aligned_cols=200  Identities=22%  Similarity=0.340  Sum_probs=168.0

Q ss_pred             cCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHh----HHHHHHHHHHHhhcC---CCCceeeeeEEee
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYK----LEEFINEIFILSQIN---HRNVVKLLGCCLE  142 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~----~~~~~~e~~~~~~l~---h~niv~~~~~~~~  142 (360)
                      ..|...+.+|+|+||.|+++.++. ...|++|.+....--.+.+-    +-....|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            568999999999999999999874 56788887665432222221    112456999999996   9999999999999


Q ss_pred             CCcceEEEEec-CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          143 TEFPLLVYEFI-PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       143 ~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                      +++.|++||-- ++.+|.+++..+.     .+++.....|++|++.|+++||+++   |+|||||-+|+.++.+|-+||+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence            99999999964 4788999997754     4788888999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCCC-CccchhhhHHHHHHHHhCCCCCC
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIF  281 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~p~~  281 (360)
                      |||.+.....   ......+||..|.|||++.+..|- ...|||++|++||-++....||.
T Consensus       713 dfgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999876533   234456899999999999998874 56799999999999999888885

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.3e-32  Score=241.42  Aligned_cols=208  Identities=25%  Similarity=0.268  Sum_probs=174.4

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC------CCCceee
Q 040763           64 KELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN------HRNVVKL  136 (360)
Q Consensus        64 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~------h~niv~~  136 (360)
                      .-.+....+|.+....|+|-|++|..|.+. .|+.||||+++.....     .+.=+.|+++|.+|+      .-|.+++
T Consensus       425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-----~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-----HKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-----hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            334555688999999999999999999876 4789999998764222     223357999999995      3589999


Q ss_pred             eeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC-
Q 040763          137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-  215 (360)
Q Consensus       137 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~-  215 (360)
                      +..|...++++||+|.+ ..+|.+.|...+.+-  .+....+..++.|++.||..|-.-+   |+|.||||+|||++++ 
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nv--GL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNV--GLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCccc--ceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence            99999999999999987 789999999876554  4778899999999999999999999   9999999999999865 


Q ss_pred             CcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCC
Q 040763          216 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN  285 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~  285 (360)
                      ..+||||||.|...+...   .+.+.-+..|.|||.+.+..|+...|+||.||+||||.||+..|.+...
T Consensus       574 ~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             ceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            567999999998765443   2333456689999999999999999999999999999999999976543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=246.52  Aligned_cols=252  Identities=30%  Similarity=0.413  Sum_probs=200.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+|.....+|.|++|.||+++++ ++...|+|.++....++    ..-...|+-+++..+||||+.++|.+...+..++.
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd----~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc----ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            67889999999999999999976 68889999988866543    33455789999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||||.+|+|++...-..     ++++.++-..++..++|+.|||+.+   =+|||||-.||++++.|.+|+.|||.+..+
T Consensus        91 MEycgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             EEecCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh
Confidence            99999999999765433     6888888899999999999999999   789999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhh---ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ... ........||+.|||||+.   ..+.|..++|||++|++.-|+-.-+.|.++...       ...  ...+.... 
T Consensus       163 tat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~--l~LmTkS~-  231 (829)
T KOG0576|consen  163 TAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRA--LFLMTKSG-  231 (829)
T ss_pred             hhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHH--HHHhhccC-
Confidence            432 2234456799999999954   456789999999999999999888888543220       000  01111110 


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         .++ ........+++.|.+|++.|+-++|.+|||++.++.
T Consensus       232 ---~qp-p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  232 ---FQP-PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ---CCC-CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence               011 111124557888999999999999999999988753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=7.6e-30  Score=217.00  Aligned_cols=200  Identities=37%  Similarity=0.537  Sum_probs=170.7

Q ss_pred             CCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      |.+.+.||.|++|.||++...+ ++.+++|........   ...+.+.+|+..+..++|+|++++++.+......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence            4567889999999999999875 789999998764333   235677889999999999999999999999899999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      ++++++|.+++.....    .+++.....++.+++.++.+||+.+   ++|+|++|.||+++.++.++|+|||.+.....
T Consensus        78 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       78 YCEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             ccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            9999999999876431    1788899999999999999999998   99999999999999999999999999987654


Q ss_pred             CCceeeecccccCCccchhhh-ccCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 040763          232 DQTHVTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFS  282 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~p~~~  282 (360)
                      ..........++..|++||.. ....++.++|+||||+++++|++|+.||..
T Consensus       151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            321122334578889999988 666778899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-31  Score=216.04  Aligned_cols=253  Identities=19%  Similarity=0.298  Sum_probs=185.2

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeE-EeeCCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGC-CLETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~-~~~~~~~  146 (360)
                      .+.|.+.+.+|+|.||.+.++.++ +.+.+++|.+.....     ...+|.+|...--.| .|.||+.-+++ |++.+..
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            367899999999999999999987 467888897765433     356788888776666 58999987765 6777777


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc--CCCcEEEeecC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFG  224 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg  224 (360)
                      ++++||++.|+|.+-+...+      +.+.....++.|++.||.|+|+++   +||||||.+||||-  +...+|+||||
T Consensus        98 vF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             EEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence            88999999999999887643      667777889999999999999999   99999999999994  44589999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      .....+..    .....-+..|.+||.....     ...+.+|+|.||+++|.++||+.||+...  .++.....  +..
T Consensus       169 ~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~~Y~~--~~~  240 (378)
T KOG1345|consen  169 LTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDKPYWE--WEQ  240 (378)
T ss_pred             cccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCchHHH--HHH
Confidence            98654321    1222346679999965542     23567899999999999999999997433  22222111  111


Q ss_pred             HhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                      +. .......      +..-...++.+..+..+-|..+|++|-...+..+.-
T Consensus       241 w~-~rk~~~~------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  241 WL-KRKNPAL------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             Hh-cccCccC------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            11 1111110      111233566788999999999999996555554443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=5e-31  Score=228.04  Aligned_cols=266  Identities=26%  Similarity=0.395  Sum_probs=196.4

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEe
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCL  141 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~  141 (360)
                      ....+.|..+++||+|.|++||++.+.    ....||+|.+.....      ..++..|++.+..+ .+.||+++.+++.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~------p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS------PSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC------chHHHHHHHHHHHhccchhhhcchhhhc
Confidence            344567899999999999999999754    356899998776533      34577899999999 6999999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEE
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKV  220 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl  220 (360)
                      .++...+|+||+++....++...        ++...+...++.++.||.++|.+|   |+|||+||.|+|.+. .+.-.|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence            99999999999999999999875        668888899999999999999999   999999999999974 567899


Q ss_pred             eecCCccccCCC---------------------------------C----------ceeeecccccCCccchhhhcc-CC
Q 040763          221 ADFGTSKFIAMD---------------------------------Q----------THVTTKIQGTFGYLDPEYHQS-SQ  256 (360)
Q Consensus       221 ~Dfg~~~~~~~~---------------------------------~----------~~~~~~~~gt~~y~aPE~~~~-~~  256 (360)
                      +|||+|......                                 .          ........||++|.|||++.. +.
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            999999621100                                 0          000112359999999998876 45


Q ss_pred             CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH-HHHhh-----ccc--c---------------cccc--c
Q 040763          257 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF-VHSMR-----KNR--L---------------YHIL--D  311 (360)
Q Consensus       257 ~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~-----~~~--~---------------~~~~--~  311 (360)
                      .++++||||.|+|++-++++..||+...+...........+ ...+.     .+.  +               .+-+  .
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~  334 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE  334 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence            68999999999999999999999976543222111110000 00000     000  0               0000  0


Q ss_pred             hH--------HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          312 DQ--------VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       312 ~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..        .........+..+.+|+.+|+..||.+|.|+++.++
T Consensus       335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            00        011112234557899999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.6e-30  Score=256.60  Aligned_cols=195  Identities=21%  Similarity=0.226  Sum_probs=136.5

Q ss_pred             hcCC-CCceeeeeEE-------eeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 040763          127 QINH-RNVVKLLGCC-------LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS  198 (360)
Q Consensus       127 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~  198 (360)
                      .++| +||.++++++       ......+.++|++ +++|.+++...    ...+++..+..++.||+.||.|||+++  
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g--  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG--  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            3445 5777777776       2334567788877 67999999642    235889999999999999999999999  


Q ss_pred             CeEecCCCCCCeEEcCCC-------------------cEEEeecCCccccCCCC---------------ceeeecccccC
Q 040763          199 PIYHRDIKSTNILLDERY-------------------RAKVADFGTSKFIAMDQ---------------THVTTKIQGTF  244 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~---------------~~~~~~~~gt~  244 (360)
                       |+||||||+||||+..+                   .+|++|||++.......               ........||+
T Consensus       101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence             99999999999996544                   45556666554321100               00011135788


Q ss_pred             CccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHH
Q 040763          245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIV  324 (360)
Q Consensus       245 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (360)
                      .|+|||++.+..++.++|||||||++|||++|..|+.....       .    .......    ......     ....+
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-------~----~~~~~~~----~~~~~~-----~~~~~  239 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-------T----MSSLRHR----VLPPQI-----LLNWP  239 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-------H----HHHHHHh----hcChhh-----hhcCH
Confidence            99999999999999999999999999999998888642110       0    0000000    000100     11123


Q ss_pred             HHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          325 AFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       325 ~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +..+++.+||+.+|.+|||+.|+++
T Consensus       240 ~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        240 KEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHHHhCCCChhhCcChHHHhh
Confidence            4668899999999999999999964

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=6.4e-29  Score=203.40  Aligned_cols=169  Identities=24%  Similarity=0.268  Sum_probs=127.2

Q ss_pred             CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCce
Q 040763          156 GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH  235 (360)
Q Consensus       156 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  235 (360)
                      |+|.+++..+.    .++++..++.++.|++.||.|||+++         ||+||+++.++.+|+  ||++.......  
T Consensus         1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--   63 (176)
T smart00750        1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--   63 (176)
T ss_pred             CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence            68899997532    25899999999999999999999965         999999999999999  99987654321  


Q ss_pred             eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHh
Q 040763          236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVM  315 (360)
Q Consensus       236 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (360)
                          ..||+.|+|||++.+..++.++|||||||++|||+||+.||........    ...............       .
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~-------~  128 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA----ILEILLNGMPADDPR-------D  128 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH----HHHHHHHHhccCCcc-------c
Confidence                2588999999999999999999999999999999999999864332111    111111111111000       0


Q ss_pred             hhccHHHHH--HHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          316 KLGKKNQIV--AFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       316 ~~~~~~~~~--~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      ...+...+.  ++.+++.+||+.||++|||+.++++.+..+..
T Consensus       129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            011223333  69999999999999999999999998876653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-26  Score=185.28  Aligned_cols=266  Identities=18%  Similarity=0.256  Sum_probs=208.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEe-cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC-CCceeeeeEEeeCCcc
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH-RNVVKLLGCCLETEFP  146 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~  146 (360)
                      ..+.|.+++.||.|+||.+|.|.. .+|..||||.-......      .+...|..+...+++ ..|..+..+..+..+-
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h------pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH------PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC------cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            347799999999999999999974 57999999985544332      345578899999975 7888888888888899


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEEEeec
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAKVADF  223 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Df  223 (360)
                      .+||+.+ |.||.++++-...    .++..+++-++-|++.-++|+|.++   ++||||||+|+|..-   ...+.++||
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDF  158 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDF  158 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEec
Confidence            9999988 8999999876433    5889999999999999999999999   999999999999863   456899999


Q ss_pred             CCccccCCCCcee------eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 040763          224 GTSKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       224 g~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      |+++...+.....      .....||.+|.+-....+...+.+.|+=|+|.+|.+.--|..||++.......+       
T Consensus       159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-------  231 (341)
T KOG1163|consen  159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-------  231 (341)
T ss_pred             cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-------
Confidence            9998875543322      223569999999998888888999999999999999999999998765322111       


Q ss_pred             HHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                          +.+.+.+.--....+.....+|.+|.-.+.-|-..--++-|...-+.+.+..+-.+++
T Consensus       232 ----KyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  232 ----KYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             ----HHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence                1111111111122333456677899999999999999999999888888877766653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-25  Score=198.55  Aligned_cols=261  Identities=23%  Similarity=0.277  Sum_probs=194.1

Q ss_pred             CCCccceecccCcEEEEEEEecCC--cEEEEEecccccChHHHHhHHHHHHHHHHHhhcC----CCCceeeeeEE-eeCC
Q 040763           72 HFNVNRILGQGGQGTVYKGRLEDG--RIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN----HRNVVKLLGCC-LETE  144 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~----h~niv~~~~~~-~~~~  144 (360)
                      +|.+.+.||+|+||.||.+.....  ..+|+|.........    ...+..|..++..+.    .+++..+++.. ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence            799999999999999999997654  478888755432221    113456777777775    26888888888 5777


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC-----CcEE
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-----YRAK  219 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~-----~~~k  219 (360)
                      ..++||+.+ |.+|.++.....   ...++..+.+.++.|++.+|.++|+.|   ++||||||.|+++...     ..+.
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~  167 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY  167 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence            889999987 899999876543   346899999999999999999999999   9999999999999865     4699


Q ss_pred             EeecCCcc--ccCCCCce------e-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 040763          220 VADFGTSK--FIAMDQTH------V-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN  290 (360)
Q Consensus       220 l~Dfg~~~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~  290 (360)
                      |.|||+++  ........      . .....||..|+++.+..+...+.+.|+||++.++.++..|..||........  
T Consensus       168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--  245 (322)
T KOG1164|consen  168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--  245 (322)
T ss_pred             EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--
Confidence            99999998  32222111      1 1234599999999999999999999999999999999999999965442211  


Q ss_pred             cchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          291 VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                         ...+...........         .....+.++.++...+-..+...+|....+...|+.....
T Consensus       246 ---~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  246 ---KSKFEKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             ---HHHHHHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence               111111111100000         1222344677777777779999999999999888776543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.4e-25  Score=186.50  Aligned_cols=266  Identities=15%  Similarity=0.240  Sum_probs=207.4

Q ss_pred             HHhcCCCccceecccCcEEEEEEEe-cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEF  145 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~  145 (360)
                      ...-+|.+.++||+|+||..+.|+. -+++.||||.-.....      ..++..|....+.| ..++|...+-+-..+.+
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~   98 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE------APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY   98 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCC------cchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence            3456799999999999999999974 4789999997554322      23456788888888 56999998888888888


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-----CCcEEE
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-----RYRAKV  220 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-----~~~~kl  220 (360)
                      -.+|+|.+ |.||.+++.-...    .++.+++..+|.|++.-++|+|++.   +|.|||||+|+||..     ...+.|
T Consensus        99 NiLVidLL-GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             hhhhhhhh-CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEE
Confidence            89999988 8899998865443    6999999999999999999999999   999999999999963     346899


Q ss_pred             eecCCccccCCCCcee------eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH
Q 040763          221 ADFGTSKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~  294 (360)
                      +|||+|+...++....      .....||.+||+-....+...+.+-|.=|+|-++++.+-|..||.+-......     
T Consensus       171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-----  245 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-----  245 (449)
T ss_pred             EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----
Confidence            9999999886654433      33467999999999999999999999999999999999999999875432111     


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      +.      .+.+.+.--.........+++.+|...+.-.-+.+-++-|..+-+...+.++..++
T Consensus       246 ~k------YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  246 EK------YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             HH------HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            00      01111111111223345567778888888888888888899888888777776554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.5e-25  Score=200.02  Aligned_cols=173  Identities=20%  Similarity=0.132  Sum_probs=130.2

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEec--CCcEEEEEecccccCh-HHHHhHHHHHHHHHHHhhcCCCCcee-eeeE
Q 040763           64 KELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVK-LLGC  139 (360)
Q Consensus        64 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaik~~~~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~-~~~~  139 (360)
                      +.......+|.+.+.||+|+||+||+|.++  +++.+|+|+....... ........+.+|+.++..++|+|++. +++.
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            334456688999999999999999999875  4677899975432110 11123456889999999999999985 4432


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEEcCCCcE
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDI-KSTNILLDERYRA  218 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-k~~Nill~~~~~~  218 (360)
                          ...++||||+++++|.. +.   .     ..   ...++.|++.+|.|||+++   |+|||| ||+|||++.++.+
T Consensus        91 ----~~~~LVmE~~~G~~L~~-~~---~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHL-AR---P-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             ----CCcEEEEEccCCCCHHH-hC---c-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence                45799999999999962 21   0     11   1357889999999999999   999999 9999999999999


Q ss_pred             EEeecCCccccCCCCcee-------eecccccCCccchhhhccC
Q 040763          219 KVADFGTSKFIAMDQTHV-------TTKIQGTFGYLDPEYHQSS  255 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~  255 (360)
                      ||+|||++..........       .....++..|+|||.+...
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999999998765432111       1245678889999987653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.3e-27  Score=192.37  Aligned_cols=252  Identities=21%  Similarity=0.321  Sum_probs=190.3

Q ss_pred             CccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           74 NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      ....+|.+.-.|..|+|+++. ..++.|++....-.  ......|..|.-.++-+.||||+.++|.|.....+.++..|+
T Consensus       193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t--~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVT--ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhccCCCcccccccccC-cchhhhhhhhhhcc--hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            445568888999999999974 44566765543221  122335667887888889999999999999999999999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      +.|+|++.+...   .+..++..+..+++.++++|++|||+..+ -|..--|.+..++||++.+++|+- +-+++     
T Consensus       270 p~gslynvlhe~---t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf-----  339 (448)
T KOG0195|consen  270 PFGSLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF-----  339 (448)
T ss_pred             cchHHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee-----
Confidence            999999999763   33356777889999999999999999873 244446899999999999888752 11111     


Q ss_pred             ceeeecccccCCccchhhhccCCCC---CccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          234 THVTTKIQGTFGYLDPEYHQSSQLT---DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       234 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      +.......-.+.||+||.++..+-+   .++|+|||++++||+.|...||.+-..  .               +--..+-
T Consensus       340 sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp--m---------------ecgmkia  402 (448)
T KOG0195|consen  340 SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP--M---------------ECGMKIA  402 (448)
T ss_pred             eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc--h---------------hhhhhhh
Confidence            1111112346889999999886543   478999999999999999999965431  0               0111222


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      -+.++...|+..+..+++|+.-|+..||.+||.+..|+-.|+.++
T Consensus       403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            344556677888889999999999999999999999999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.8e-26  Score=219.10  Aligned_cols=257  Identities=23%  Similarity=0.275  Sum_probs=187.0

Q ss_pred             CccceecccCcEEEEEEEec-CCcEEEEEecccc--cChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           74 NVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLA--VDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~--~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      .....+|.|++|.|+..... .....+.|..+..  ....+......+..|+-+-..+.|+|++.....+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977776644 2333444443311  11111122222667887888899999988887777666666669


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      |||++ +|...+....     .+....+-.++.|++.|+.|+|+.|   +.|||+|++|++++.+|.+||+|||.+....
T Consensus       401 E~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence            99999 9999997642     4677778889999999999999999   9999999999999999999999999997765


Q ss_pred             CCCc---eeeecccccCCccchhhhccCCCCC-ccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          231 MDQT---HVTTKIQGTFGYLDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       231 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .+..   ......+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||..........        ........
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~  543 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQ  543 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccc
Confidence            4332   3455678999999999999999876 5799999999999999999997654322211        00111111


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......  ........+.+-+.++.+||+.||.+|.|+++|++
T Consensus       544 ~~~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            111111  11122334557789999999999999999999974

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=3e-26  Score=218.72  Aligned_cols=253  Identities=22%  Similarity=0.228  Sum_probs=185.3

Q ss_pred             CCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      ++...+.||.+.|=.|.+++++.|. |++|++-.....-......+-+.|++ ...+++||.+++..+...+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777889999999999999998877 88998766554444444445555666 566699999999999888888899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc--
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI--  229 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~--  229 (360)
                      |.. -+|.+.+..+.     .+...+..-|+.|++.||.-+|..|   |+|+|||.+||||+..+.+.|+||..-+..  
T Consensus       102 yvk-hnLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen  102 YVK-HNLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL  172 (1431)
T ss_pred             HHh-hhhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence            884 48888887654     3566667779999999999999999   999999999999999999999999876543  


Q ss_pred             CCCCceeee----cccccCCccchhhhccCC-----------CCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccch
Q 040763          230 AMDQTHVTT----KIQGTFGYLDPEYHQSSQ-----------LTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSL  293 (360)
Q Consensus       230 ~~~~~~~~~----~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~  293 (360)
                      ..+.....+    +...-.+|.|||.+....           .+++.||||+||+++||++ |++||.-+.         
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---------  243 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---------  243 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---------
Confidence            223322222    222345799999765421           4678899999999999999 777773211         


Q ss_pred             HHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                            ......-...-.....+.++   ...+++++..|++.||.+|.++++.++...+
T Consensus       244 ------L~aYr~~~~~~~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  244 ------LLAYRSGNADDPEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             ------HHhHhccCccCHHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence                  11111000001111111111   1258899999999999999999999987554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=3.5e-23  Score=186.23  Aligned_cols=264  Identities=29%  Similarity=0.410  Sum_probs=195.8

Q ss_pred             CCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCC-CceeeeeEEeeCCcceEEEE
Q 040763           73 FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~-niv~~~~~~~~~~~~~lv~e  151 (360)
                      |.+.+.||.|+||.||.+...  ..+++|.+........ .....+.+|+.++..+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            667788999999999999876  7788888776544432 2356788899999999887 79999999977777899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cEEEeecCCccccC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIA  230 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~  230 (360)
                      ++.++++.+++......  ..+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.+....
T Consensus        79 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             cCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999999776553211  25788899999999999999999999   99999999999999988 79999999997554


Q ss_pred             CCCce-----eeecccccCCccchhhhcc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          231 MDQTH-----VTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       231 ~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      .....     ......|+..|+|||.+.+   ...+...|+||+|++++++++|..||......    ..... ....+.
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~-~~~~~~  228 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQ-TLKIIL  228 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHH-HHHHHH
Confidence            43322     2345679999999999988   57888999999999999999999996544321    00000 111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                      ..... .................+.+++..|+..+|..|.+..+....
T Consensus       229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         229 ELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             hcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            10000 000000000002223468899999999999999998877653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=2.9e-23  Score=172.60  Aligned_cols=176  Identities=13%  Similarity=0.135  Sum_probs=134.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHH------HHHHHHHHhhcCCCCceeeeeEEe
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEE------FINEIFILSQINHRNVVKLLGCCL  141 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~------~~~e~~~~~~l~h~niv~~~~~~~  141 (360)
                      ...++|...+.+|.|+||.||+... ++..+|+|.++......+ .....      +.+|+..+.++.|++|..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~-~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTE-RFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchH-HHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3568999999999999999999766 567899999876544332 12222      578999999999999999988865


Q ss_pred             eC--------CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          142 ET--------EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       142 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      ..        ...+++|||++|.+|.++..         ++.    ....+++.++..+|+.+   ++|||++|.||+++
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~  169 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVS  169 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEe
Confidence            33        35789999999999987732         222    24569999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh
Q 040763          214 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT  275 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t  275 (360)
                      .++ ++|+|||.......+...             ........+..++|+||||+++.....
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            988 999999987543221111             113444456789999999998776543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=4.7e-23  Score=176.47  Aligned_cols=238  Identities=20%  Similarity=0.250  Sum_probs=151.5

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC----------CCceeeeeEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH----------RNVVKLLGCC  140 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h----------~niv~~~~~~  140 (360)
                      .+...+.||.|+++.||.+++. +++.+|+|+..... .......+.+.+|.-....+.+          -.++.-++..
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            3456678999999999999987 58999999876654 3333456667666544444322          1122112211


Q ss_pred             e---------eC---C-----cceEEEEecCCCChhHHhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 040763          141 L---------ET---E-----FPLLVYEFIPNGTLYQHLHDRHQNE--EYPLTWEMRFRVAIEVAGALAYLHSGASSPIY  201 (360)
Q Consensus       141 ~---------~~---~-----~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~  201 (360)
                      .         ..   .     ..+++|+-+ .++|.+++.......  ........++.+..|+++.+++||+.|   ++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence            1         11   1     124567766 678888765321111  223455667888899999999999999   99


Q ss_pred             ecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccC--------CCCCccchhhhHHHHHHH
Q 040763          202 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS--------QLTDKSDVYSFGVVLVEL  273 (360)
Q Consensus       202 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslG~il~el  273 (360)
                      |+||+|+|++++.+|.++|+||+.....+..  .  .....+..|.+||.....        .++.+.|.|++|+++|.|
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR--Y--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEE--E--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCce--e--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999999877654321  1  113356789999966442        467889999999999999


Q ss_pred             HhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCC
Q 040763          274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKR  341 (360)
Q Consensus       274 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  341 (360)
                      ++|..||.........                      ...-..+. +.++.+..||..+|+.||++|
T Consensus       244 WC~~lPf~~~~~~~~~----------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADP----------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTS----------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccc----------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999654321111                      00122344 778899999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.8e-23  Score=178.16  Aligned_cols=197  Identities=21%  Similarity=0.283  Sum_probs=143.2

Q ss_pred             CCCCceeeeeEEee---------------------------CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHH
Q 040763          129 NHRNVVKLLGCCLE---------------------------TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV  181 (360)
Q Consensus       129 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i  181 (360)
                      .|||||+++++|.+                           ....|+||..+ ..+|..|+..+.      .+.....-+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~------~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH------RSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC------CchHHHHHH
Confidence            59999999988753                           22358899877 569999997653      455566678


Q ss_pred             HHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc--CCC--cEEEeecCCccccCCCC-----ceeeecccccCCccchhhh
Q 040763          182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERY--RAKVADFGTSKFIAMDQ-----THVTTKIQGTFGYLDPEYH  252 (360)
Q Consensus       182 ~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~--~~~--~~kl~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~  252 (360)
                      +.|+++|+.|||.+|   +.|||+|++|||+.  +|+  .+.++|||++.......     ....-..-|...-||||..
T Consensus       347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            899999999999999   99999999999993  443  46899999875433211     1111122377789999976


Q ss_pred             ccCC------CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHH
Q 040763          253 QSSQ------LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAF  326 (360)
Q Consensus       253 ~~~~------~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  326 (360)
                      ...+      ...|+|.|+.|.+.||+++...||+..++...+...        ..         +......+..+++.+
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--------Yq---------e~qLPalp~~vpp~~  486 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--------YQ---------ESQLPALPSRVPPVA  486 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh--------hh---------hhhCCCCcccCChHH
Confidence            6532      235899999999999999999999875543322211        11         111223455667789


Q ss_pred             HHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          327 ANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       327 ~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      .+++...|+.||.+|++..-....|+
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhHHH
Confidence            99999999999999999876665554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=2.3e-22  Score=165.46  Aligned_cols=144  Identities=18%  Similarity=0.146  Sum_probs=108.3

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHH----------------------HhHHHHHHHHHHHhhcCCCCc
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL----------------------YKLEEFINEIFILSQINHRNV  133 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~----------------------~~~~~~~~e~~~~~~l~h~ni  133 (360)
                      .+.||+|++|.||+|...+|+.||+|+++........                      ........|+..+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998764321100                      001123458899999987776


Q ss_pred             eeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCeEE
Q 040763          134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL-HSGASSPIYHRDIKSTNILL  212 (360)
Q Consensus       134 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dlk~~Nill  212 (360)
                      ........  ...++||||++++++......     ..+++......++.|++.+|.++ |+.+   |+||||||+||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli  151 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY  151 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence            44333222  223899999988776554322     12578889999999999999999 6888   9999999999999


Q ss_pred             cCCCcEEEeecCCccccC
Q 040763          213 DERYRAKVADFGTSKFIA  230 (360)
Q Consensus       213 ~~~~~~kl~Dfg~~~~~~  230 (360)
                      ++ +.++|+|||++....
T Consensus       152 ~~-~~v~LiDFG~a~~~~  168 (190)
T cd05147         152 HD-GKLYIIDVSQSVEHD  168 (190)
T ss_pred             EC-CcEEEEEccccccCC
Confidence            84 789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=6.4e-22  Score=161.08  Aligned_cols=192  Identities=17%  Similarity=0.077  Sum_probs=141.3

Q ss_pred             CccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcceEEEEe
Q 040763           74 NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      .+...|++|+||+|+.+.. .+.+++.+.+..............+.+|++++.+++ |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3456899999999997766 567777776665544322222335778999999995 5889999886    346999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEEcCCCcEEEeecCCccccCC
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDI-KSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      +.|.+|...+..            ....++.|++.+|.++|++|   |+|||| ||+|||++.++.++|+|||++.....
T Consensus        80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            999888654311            01346789999999999999   999999 79999999999999999999985443


Q ss_pred             CCce----e--------eecccccCCccchhhhccC-CCC-CccchhhhHHHHHHHHhCCCCCCCCCC
Q 040763          232 DQTH----V--------TTKIQGTFGYLDPEYHQSS-QLT-DKSDVYSFGVVLVELLTGKKPIFSTGN  285 (360)
Q Consensus       232 ~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~el~tg~~p~~~~~~  285 (360)
                      ....    .        ......++.|++|+...-- ..+ ...+.++-|..+|.++|+..|..++++
T Consensus       145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            2210    0        0011257889999843332 223 466888999999999999988766554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=1.4e-21  Score=161.37  Aligned_cols=144  Identities=23%  Similarity=0.206  Sum_probs=110.6

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHH----------------------HHhHHHHHHHHHHHhhcCCCCc
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEE----------------------LYKLEEFINEIFILSQINHRNV  133 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~----------------------~~~~~~~~~e~~~~~~l~h~ni  133 (360)
                      .+.||+|++|.||+|...+|+.||+|+++.......                      .........|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            467999999999999987899999999776532100                      0011223578899999999887


Q ss_pred             eeeeeEEeeCCcceEEEEecCCCChhHH-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeE
Q 040763          134 VKLLGCCLETEFPLLVYEFIPNGTLYQH-LHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNIL  211 (360)
Q Consensus       134 v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nil  211 (360)
                      .....+...  ..++||||++++++... +..      ..++......++.|++.++.++|+ .|   ++||||||+||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl  150 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL  150 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence            554444332  24899999988755433 322      146778889999999999999999 99   999999999999


Q ss_pred             EcCCCcEEEeecCCccccCC
Q 040763          212 LDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       212 l~~~~~~kl~Dfg~~~~~~~  231 (360)
                      ++ ++.++|+|||++.....
T Consensus       151 l~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EE-CCCEEEEEcccceecCC
Confidence            99 78999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=3.9e-22  Score=181.43  Aligned_cols=219  Identities=24%  Similarity=0.419  Sum_probs=162.3

Q ss_pred             HhhcCCCCceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 040763          125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD  204 (360)
Q Consensus       125 ~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~d  204 (360)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..    ....+++.....++++++.||+|+|+-..  ..|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeee
Confidence            3568999999999999999999999999999999999976    34468899999999999999999998651  39999


Q ss_pred             CCCCCeEEcCCCcEEEeecCCccccCCC-CceeeecccccCCccchhhhccCC-------CCCccchhhhHHHHHHHHhC
Q 040763          205 IKSTNILLDERYRAKVADFGTSKFIAMD-QTHVTTKIQGTFGYLDPEYHQSSQ-------LTDKSDVYSFGVVLVELLTG  276 (360)
Q Consensus       205 lk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~tg  276 (360)
                      +++.|++++..+.+||+|||+....... .........-..-|.|||.+.+..       .+.++||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999998766421 111111122355699999887742       35679999999999999999


Q ss_pred             CCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          277 KKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       277 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      ..||......... ......... .........+..      .....+++..++.+||..+|++||++..+...++.+.+
T Consensus       155 ~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~~------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  155 SGPFDLRNLVEDP-DEIILRVKK-GGSNPFRPSIEL------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cCccccccccCCh-HHHHHHHHh-cCCCCcCcchhh------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9999764432221 111111111 000001000000      01334479999999999999999999999999888776


Q ss_pred             h
Q 040763          357 S  357 (360)
Q Consensus       357 ~  357 (360)
                      .
T Consensus       227 ~  227 (484)
T KOG1023|consen  227 G  227 (484)
T ss_pred             c
Confidence            4

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.3e-21  Score=190.07  Aligned_cols=202  Identities=20%  Similarity=0.278  Sum_probs=164.1

Q ss_pred             ChHHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC---CCCceeeee
Q 040763           62 SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN---HRNVVKLLG  138 (360)
Q Consensus        62 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~---h~niv~~~~  138 (360)
                      +..+.+.....|.+.+.+|+|+||+||.|...+|+.+|+|+-+....++-.       --..++.+|+   -+.|..+..
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY-------I~~q~~~RLk~~~~~~~~~~~~  761 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY-------ICLQVMERLKPQMLPSIMHISS  761 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee-------ehHHHHHhhchhhhcchHHHHH
Confidence            344556667789999999999999999999988999999998776544211       1122333443   356666677


Q ss_pred             EEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc-----
Q 040763          139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-----  213 (360)
Q Consensus       139 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~-----  213 (360)
                      ++...+..++|+||.+.|+|.++++.     ...+++..+..++.|++..+.+||..+   |||+||||+|.||.     
T Consensus       762 a~~~~~~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~  833 (974)
T KOG1166|consen  762 AHVFQNASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICA  833 (974)
T ss_pred             HHccCCcceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCC
Confidence            77778888999999999999999973     235889999999999999999999999   99999999999994     


Q ss_pred             --CCCcEEEeecCCccccCC-CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCC
Q 040763          214 --ERYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKK  278 (360)
Q Consensus       214 --~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~  278 (360)
                        ++..++|+|||.+..+.. .........++|-.+-.+|+..+..|+.++|-|.++.+++-|+.|+.
T Consensus       834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence              345689999999976543 22344556678999999999999999999999999999999999863

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.3e-23  Score=187.25  Aligned_cols=227  Identities=27%  Similarity=0.273  Sum_probs=177.0

Q ss_pred             eecccCcEEEEEEE----ecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcceEEEEe
Q 040763           78 ILGQGGQGTVYKGR----LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        78 ~lg~G~~g~V~~~~----~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      .+|+|+||.|+++.    .+.+..+|.|..+.......  .......|-.++...+ ||.++++.-.+..+...++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~--~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR--DRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccc--cccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            37899999998764    23466778777554332211  1113345777888886 99999999999999999999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCC
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD  232 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  232 (360)
                      ..+|.|...+....     .+.+.........++-+++++|+.+   ++|||+|++||+++.+|++++.|||+++..-..
T Consensus        79 ~rgg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             cccchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence            99999988775432     3556666667789999999999999   999999999999999999999999999765432


Q ss_pred             CceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccch
Q 040763          233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD  312 (360)
Q Consensus       233 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (360)
                      +..     +||..|||||.+.  .....+|.||||++.+||+||..||...             ....+          .
T Consensus       151 ~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-------------~~~~I----------l  200 (612)
T KOG0603|consen  151 KIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-------------TMKRI----------L  200 (612)
T ss_pred             hhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-------------HHHHH----------h
Confidence            222     8999999999988  5678999999999999999999999650             01110          1


Q ss_pred             HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          313 QVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       313 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                      ......|...+..+.+++..++..+|.+|...
T Consensus       201 ~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  201 KAELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            11223477788889999999999999999865

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=9e-20  Score=151.39  Aligned_cols=136  Identities=18%  Similarity=0.215  Sum_probs=103.0

Q ss_pred             CccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-----CCCCceeeeeEEeeCC---c
Q 040763           74 NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-----NHRNVVKLLGCCLETE---F  145 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~~~---~  145 (360)
                      .-.+.||+|+||.||.  ++.....+||+.......    ..+.+.+|+.+++.+     +||||++++|++.++.   .
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccc----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            3346799999999996  543333478887653222    235678999999999     5799999999998864   3


Q ss_pred             -ceEEEEe--cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCeEEcC----CCc
Q 040763          146 -PLLVYEF--IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL-AYLHSGASSPIYHRDIKSTNILLDE----RYR  217 (360)
Q Consensus       146 -~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~lh~~~~~~i~H~dlk~~Nill~~----~~~  217 (360)
                       ..+|+||  +.+++|.+++...      .+++.  ..++.+++.++ .|||+++   |+||||||+||+++.    +..
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCc
Confidence             2378999  5579999999652      24444  34677888777 8999999   999999999999973    347


Q ss_pred             EEEee-cCCc
Q 040763          218 AKVAD-FGTS  226 (360)
Q Consensus       218 ~kl~D-fg~~  226 (360)
                      ++|+| ||..
T Consensus       148 ~~LiDg~G~~  157 (210)
T PRK10345        148 PVVCDNIGES  157 (210)
T ss_pred             EEEEECCCCc
Confidence            99999 5543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=3.9e-21  Score=171.92  Aligned_cols=173  Identities=23%  Similarity=0.367  Sum_probs=130.8

Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      .++|+.|++|.-.+|.+++..+.....  .++.....++.|++.|+.|   ++   .+|+|+||.||+...+..+||.||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~--~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEE--RSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccc--cchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhh
Confidence            357899999999999999987654443  5677888999999999999   77   899999999999999999999999


Q ss_pred             CCccccCCCC-----ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHH
Q 040763          224 GTSKFIAMDQ-----THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       224 g~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      |+........     ....+...||..||+||.+.+..|+.|+||||||++|+|++. =..++....            .
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------------t  468 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------------T  468 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------------h
Confidence            9998765543     334556779999999999999999999999999999999997 222321111            1


Q ss_pred             HHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 040763          298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME  345 (360)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  345 (360)
                      ...++++.+.    +......|     +=..|+.+++.+.|.+||++.
T Consensus       469 ~~d~r~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  469 LTDIRDGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hhhhhcCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence            1112222111    11111112     235799999999999999443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.5e-18  Score=146.21  Aligned_cols=138  Identities=21%  Similarity=0.315  Sum_probs=112.8

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccCh----HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEe
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD----EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      +.||+|++|.||+|.. .+..+++|........    ........+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 5677888875543221    1112234577899999999999988777777777888999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ++|++|.+++...        .. ....++.+++.+|.++|+.+   ++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998642        12 77889999999999999999   99999999999999 78999999998753

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=1.2e-18  Score=148.16  Aligned_cols=148  Identities=18%  Similarity=0.128  Sum_probs=110.6

Q ss_pred             cCCCccceecccCcEEEEEEE--ecCCcEEEEEecccccChHH------------------H--HhHHHHHHHHHHHhhc
Q 040763           71 NHFNVNRILGQGGQGTVYKGR--LEDGRIIAVKKSKLAVDDEE------------------L--YKLEEFINEIFILSQI  128 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~--~~~~~~vaik~~~~~~~~~~------------------~--~~~~~~~~e~~~~~~l  128 (360)
                      .-|.+.+.||+|++|.||+|.  ..+|+.||+|.++.......                  .  .....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357889999999999999998  45799999998775431100                  0  0112356799999999


Q ss_pred             CCC--CceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 040763          129 NHR--NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK  206 (360)
Q Consensus       129 ~h~--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  206 (360)
                      .+.  .+.+.++.    ...++||||+++.++.......     ..........++.|++.++.+||+.++  ++|+|||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik  176 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS  176 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence            753  33444432    2348999999988886654221     134555677899999999999999874  9999999


Q ss_pred             CCCeEEcCCCcEEEeecCCccccC
Q 040763          207 STNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       207 ~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      |+||+++ ++.++|+|||.+....
T Consensus       177 p~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      177 EYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999 8899999999986543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=7.5e-20  Score=175.13  Aligned_cols=210  Identities=27%  Similarity=0.359  Sum_probs=143.9

Q ss_pred             hcCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..+|..++.+..|++|.||..+++. .+.+|+|.-+.   .       -+.+-  ++..-..|.+|              
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~-------lilRn--ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---N-------LILRN--ILTFAGNPFVV--------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc---c-------hhhhc--cccccCCccee--------------
Confidence            4679999999999999999999873 56777743221   0       00111  22222333332              


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                             |+=...+...+     +++.        +++.+++|||+.+   |+|||+||+|.+|+.-|++|++|||+.+.
T Consensus       136 -------gDc~tllk~~g-----~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 -------GDCATLLKNIG-----PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             -------chhhhhcccCC-----CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence                   22223332211     3433        2378999999999   99999999999999999999999999865


Q ss_pred             cCCCC--------------ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH
Q 040763          229 IAMDQ--------------THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       229 ~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~  294 (360)
                      .....              .......+||+.|.|||++....|...+|.|++|+|+||.+-|+.||++...+..      
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------  266 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------  266 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------
Confidence            42211              1112346899999999999999999999999999999999999999987642111      


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                        +...+.+        .....+.....+++..+++.+.|+.+|..|.-.
T Consensus       267 --fg~visd--------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  267 --FGQVISD--------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             --Hhhhhhh--------hccccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence              1111111        111112234455689999999999999999643

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=2.7e-18  Score=143.27  Aligned_cols=134  Identities=21%  Similarity=0.338  Sum_probs=106.6

Q ss_pred             eecccCcEEEEEEEecCCcEEEEEeccccc-Ch---HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           78 ILGQGGQGTVYKGRLEDGRIIAVKKSKLAV-DD---EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~vaik~~~~~~-~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      .||+|++|.||+|.. ++..+++|...... ..   ......+++.+|+.++..++|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 46788999754322 11   11123456778999999998887665555555667779999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|++|.+.+....      .      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998875421      0      68899999999999999   99999999999999 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=4.7e-18  Score=141.55  Aligned_cols=143  Identities=20%  Similarity=0.167  Sum_probs=108.6

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHH------------------HhHHHHHHHHHHHhhcCCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL------------------YKLEEFINEIFILSQINHR  131 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~------------------~~~~~~~~e~~~~~~l~h~  131 (360)
                      ...|.+.+.||+|+||.||++..++|+.+|+|++.........                  ........|..++..+.|+
T Consensus        14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            3347788899999999999999888999999986543211000                  0112356788888888777


Q ss_pred             C--ceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 040763          132 N--VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN  209 (360)
Q Consensus       132 n--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~N  209 (360)
                      +  +...++    ....+++|||+++++|......           .....++.+++.++.++|+.+   ++|+||+|.|
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N  155 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN  155 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence            4  444443    2455899999999998765321           223568889999999999999   9999999999


Q ss_pred             eEEcCCCcEEEeecCCccccC
Q 040763          210 ILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       210 ill~~~~~~kl~Dfg~~~~~~  230 (360)
                      |++++++.++|+|||++....
T Consensus       156 ill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEEcCCCcEEEEECCccccCC
Confidence            999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=5.9e-18  Score=161.61  Aligned_cols=140  Identities=21%  Similarity=0.295  Sum_probs=110.8

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEe-cccccCh---HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKK-SKLAVDD---EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~-~~~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ..|...+.||+|+||+||++.+.... +++|+ .......   ......+.+.+|+.++..++|++++....++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            44566789999999999999876443 33333 2211111   1112345678999999999999998887777777778


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++++|.+++.             ....++.+++.+|.+||+.+   ++|||+||+||++ +++.++|+|||++
T Consensus       412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            99999999999999884             23568899999999999999   9999999999999 6779999999998


Q ss_pred             cc
Q 040763          227 KF  228 (360)
Q Consensus       227 ~~  228 (360)
                      ..
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            64

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=3.9e-19  Score=169.26  Aligned_cols=255  Identities=22%  Similarity=0.264  Sum_probs=185.6

Q ss_pred             hcCCCccceecccCcEEEEEEEecC--CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~  146 (360)
                      ...|...+.||+|+|+.|-......  ...+|.|.+....  ......+....|..+-..+. |+|++.+++.....+..
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            4668888899999999998776533  3345666555433  12223344445777777776 99999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeEEcCCC-cEEEeecC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH-SGASSPIYHRDIKSTNILLDERY-RAKVADFG  224 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg  224 (360)
                      ++++++..++++.+.+....   ....+....-..+.|+..++.|+| ..+   +.|+|+||+|.+++..+ ..+++|||
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             ccccCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCch
Confidence            99999999999988883211   102333445568899999999999 888   99999999999999999 99999999


Q ss_pred             CccccCC--CCceeeecccc-cCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          225 TSKFIAM--DQTHVTTKIQG-TFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       225 ~~~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      +|.....  .........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+...........         
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~---------  241 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS---------  241 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce---------
Confidence            9988765  22333455678 9999999998884 446788999999999999999999866543221110         


Q ss_pred             hhccccccccchHH--hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          301 MRKNRLYHILDDQV--MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       301 ~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                             .+.+...  ....-........+++.+++..+|..|.+.+++.
T Consensus       242 -------~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  242 -------SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -------eecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence                   0011100  0011122233577889999999999999988774

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=3e-16  Score=129.57  Aligned_cols=139  Identities=23%  Similarity=0.201  Sum_probs=97.0

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhH--------------------HHHHHHHHHHhhcCCC--Cc
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL--------------------EEFINEIFILSQINHR--NV  133 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~--------------------~~~~~e~~~~~~l~h~--ni  133 (360)
                      .+.||+|+||+||++...+++.||+|+++...........                    .....|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999987653222110000                    0112455556565433  24


Q ss_pred             eeeeeEEeeCCcceEEEEecCCCChhH-HhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeE
Q 040763          134 VKLLGCCLETEFPLLVYEFIPNGTLYQ-HLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNIL  211 (360)
Q Consensus       134 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nil  211 (360)
                      .+.+++    ...+++|||++++++.. .+....      .. .....++.+++.++.++|. .+   ++|+||+|+||+
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil  147 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL  147 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence            444433    24589999998854432 121110      11 4567889999999999999 88   999999999999


Q ss_pred             EcCCCcEEEeecCCcccc
Q 040763          212 LDERYRAKVADFGTSKFI  229 (360)
Q Consensus       212 l~~~~~~kl~Dfg~~~~~  229 (360)
                      ++ ++.++++|||.+...
T Consensus       148 i~-~~~~~liDfg~a~~~  164 (187)
T cd05119         148 VD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             EE-CCcEEEEECcccccc
Confidence            99 889999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=1.5e-15  Score=120.59  Aligned_cols=135  Identities=23%  Similarity=0.228  Sum_probs=110.0

Q ss_pred             ccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC--CCceeeeeEEeeCCcceEEEEe
Q 040763           75 VNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH--RNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h--~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      +.+.+|.|.++.||++...+ ..+++|.......      ...+.+|+..+..++|  .+++++++.....+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            45679999999999999865 6789998765322      3456688999999976  5888998888877889999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +++.++..+            +......++.+++.+++++|......++|+|++|+||++++++.++++|||.+..
T Consensus        75 ~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            988766543            3455667889999999999986333499999999999999999999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=1.7e-15  Score=129.23  Aligned_cols=138  Identities=20%  Similarity=0.293  Sum_probs=102.6

Q ss_pred             ceec-ccCcEEEEEEEecCCcEEEEEecccccC-----hH----HHHhHHHHHHHHHHHhhcCCCCc--eeeeeEEeeCC
Q 040763           77 RILG-QGGQGTVYKGRLEDGRIIAVKKSKLAVD-----DE----ELYKLEEFINEIFILSQINHRNV--VKLLGCCLETE  144 (360)
Q Consensus        77 ~~lg-~G~~g~V~~~~~~~~~~vaik~~~~~~~-----~~----~~~~~~~~~~e~~~~~~l~h~ni--v~~~~~~~~~~  144 (360)
                      ..|| .|+.|+||.+... +..+++|.+.....     ..    .......+.+|+.++..++|+++  +..++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4577 8888999988775 67788887753210     00    01233467789999999988775  66666543322


Q ss_pred             ----cceEEEEecCC-CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEE
Q 040763          145 ----FPLLVYEFIPN-GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAK  219 (360)
Q Consensus       145 ----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~k  219 (360)
                          ..++|||++++ .+|.+++...      +++..    .+.+++.++.+||+.|   |+|+||||.|||++.++.++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence                23599999997 6898887542      24443    3568999999999999   99999999999999999999


Q ss_pred             EeecCCccc
Q 040763          220 VADFGTSKF  228 (360)
Q Consensus       220 l~Dfg~~~~  228 (360)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=1e-14  Score=123.61  Aligned_cols=202  Identities=20%  Similarity=0.301  Sum_probs=138.8

Q ss_pred             HHHhhcCCCCceeeeeEEeeCC-----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 040763          123 FILSQINHRNVVKLLGCCLETE-----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS  197 (360)
Q Consensus       123 ~~~~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~  197 (360)
                      ..+.++-|.|+++++.++.+..     ...++.||+..|++..+|++...... .+......+++-||+.||.|||+-. 
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~-a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK-ALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh-hhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            3445567999999999987544     35789999999999999987654332 5667778899999999999999966 


Q ss_pred             CCeEecCCCCCCeEEcCCCcEEEeecCCccccCCC----CceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHH
Q 040763          198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD----QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL  273 (360)
Q Consensus       198 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el  273 (360)
                      ++|+|+++..+.|++..++-+|++--.-. .....    .......-.+-++|.|||.-.....+.++|||+||+-..||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            78999999999999999999998532111 11100    01111122467889999977666777899999999999999


Q ss_pred             HhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       274 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                      .-|..--....    .........     ...+...-++ +           =+.++..|++..|..||+|.+++
T Consensus       276 ailEiq~tnse----S~~~~ee~i-----a~~i~~len~-l-----------qr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  276 AILEIQSTNSE----SKVEVEENI-----ANVIIGLENG-L-----------QRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             HHheeccCCCc----ceeehhhhh-----hhheeeccCc-c-----------ccCcCcccccCCCCCCcchhhhh
Confidence            88765421111    011000000     0111111111 0           12578899999999999999875

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=8.7e-15  Score=133.87  Aligned_cols=249  Identities=22%  Similarity=0.261  Sum_probs=180.2

Q ss_pred             cCCCccceecc--cCcEEEEEEEe---cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQ--GGQGTVYKGRL---EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~  144 (360)
                      ..+.+.+.+|.  |.+|.||.+..   .++..+|+|..+.......  ....-.+|+.....+ .|+|.++.+..+...+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~--~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL--DSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc--ccccccchhhcccccCccccccccCcccccCC
Confidence            55677788999  99999999876   3577899998555443211  112223566666666 5999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCeEEcCC-CcEE
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG----ALAYLHSGASSPIYHRDIKSTNILLDER-YRAK  219 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~lh~~~~~~i~H~dlk~~Nill~~~-~~~k  219 (360)
                      ..++-+|+| +.+|.++......    .++....+....+...    |+.++|+..   ++|-|+||.||+...+ ...+
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             cceeeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceee
Confidence            999999998 5788888766433    3666677777777777    999999999   9999999999999999 8999


Q ss_pred             EeecCCccccCCCCcee----eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          220 VADFGTSKFIAMDQTHV----TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      ++|||+...++......    .....|...|++||...+ .++..+|+||+|.+..+..+|..+......          
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----------  332 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN----------  332 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC----------
Confidence            99999998876644211    223357888999998765 568899999999999999887765432200          


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                              ..|.++-......+....-+.++...+..+++.+|-.|++.+.+.
T Consensus       333 --------~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  333 --------SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             --------CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence                    000000000011122222333566699999999999999987764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=1.1e-13  Score=128.10  Aligned_cols=145  Identities=20%  Similarity=0.205  Sum_probs=100.0

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHh--------------------------HH----------HHHH
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYK--------------------------LE----------EFIN  120 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~--------------------------~~----------~~~~  120 (360)
                      +.||.|++|.||+|+.++|+.||||+.+......-...                          .+          .+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            57999999999999999999999999876532211000                          00          2344


Q ss_pred             HHHHHhhc----CCCCceeeeeEE-eeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 040763          121 EIFILSQI----NHRNVVKLLGCC-LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG-ALAYLHS  194 (360)
Q Consensus       121 e~~~~~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~-~l~~lh~  194 (360)
                      |...+.++    +|.+-+.+-..+ ......++||||++|++|.+.......    ..+   ...++.+++. .+..+|.
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CCC---HHHHHHHHHHHHHHHHHh
Confidence            55555554    233333333332 224456999999999999887653211    122   2346666665 4678899


Q ss_pred             CCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       195 ~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      .|   ++|+|++|.||+++.++.++++|||++..+..
T Consensus       276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            89   99999999999999999999999999876643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.48  E-value=1.6e-12  Score=120.53  Aligned_cols=164  Identities=19%  Similarity=0.184  Sum_probs=121.7

Q ss_pred             CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCC
Q 040763           94 DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPL  173 (360)
Q Consensus        94 ~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  173 (360)
                      ++.++.+...+....    ...+...+-++.++.++||||+++++.+......|+|+|.+.  .|..++.+..       
T Consensus        36 ~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------  102 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------  102 (690)
T ss_pred             cCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------
Confidence            567777776665433    223345567888899999999999999999999999999874  7888887632       


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhc
Q 040763          174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ  253 (360)
Q Consensus       174 ~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  253 (360)
                       ...+-.-+.||+.||.+||+.+.  ++|+++....|+++..|+.||++|-++.....-.. .......-..|..|+.+.
T Consensus       103 -~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 -KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcC
Confidence             44455578899999999997664  99999999999999999999999988754332111 001111223466776554


Q ss_pred             cCCCCCccchhhhHHHHHHHHhC
Q 040763          254 SSQLTDKSDVYSFGVVLVELLTG  276 (360)
Q Consensus       254 ~~~~~~~~DvwslG~il~el~tg  276 (360)
                      ...  -..|.|-||+++|+++.|
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCc
Confidence            432  346999999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=4.6e-13  Score=125.56  Aligned_cols=149  Identities=17%  Similarity=0.156  Sum_probs=95.0

Q ss_pred             cCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHH--------------------------H----HhHH---
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEE--------------------------L----YKLE---  116 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~--------------------------~----~~~~---  116 (360)
                      ..|+. +.||.|++|.||+|..++ |+.||||+.+......-                          .    +..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 689999999999999987 99999999876432110                          0    0001   


Q ss_pred             ---HHHHHHHHHhhc----CCCCceeeeeEEee-CCcceEEEEecCCCChhHHh--hhhccCCCCCCCHHHHHHHHHHHH
Q 040763          117 ---EFINEIFILSQI----NHRNVVKLLGCCLE-TEFPLLVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVAIEVA  186 (360)
Q Consensus       117 ---~~~~e~~~~~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~~i~~~i~  186 (360)
                         .+.+|+..+.++    .+.+.+.+-.++.+ ....++||||++|+++.+.-  ...+. ....+....+..++.|+ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHHH-
Confidence               133444444444    23333443333322 45568999999999998743  22110 00112222333334443 


Q ss_pred             HHHHHHHhCCCCCeEecCCCCCCeEEcCCC----cEEEeecCCccccCC
Q 040763          187 GALAYLHSGASSPIYHRDIKSTNILLDERY----RAKVADFGTSKFIAM  231 (360)
Q Consensus       187 ~~l~~lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~~~~~~~  231 (360)
                            ...|   ++|+|++|.||+++.++    .+++.|||++..++.
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  3567   99999999999999888    999999999977654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=3.9e-12  Score=103.17  Aligned_cols=129  Identities=22%  Similarity=0.131  Sum_probs=93.0

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCce-eeeeEEeeCCcceEEEEecCC
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV-KLLGCCLETEFPLLVYEFIPN  155 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~  155 (360)
                      +.++.|.++.||++... +..+++|........     ...+..|+.++..+.+.+++ +++...  ....++||||+++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~-----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL-----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc-----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            46889999999999875 678999986543211     11345788888888654443 444443  2345899999999


Q ss_pred             CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          156 GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA--SSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       156 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      .++.+.-         ..    ....+.+++.+|+.||+.+  ...++|+|++|.||+++ ++.++++||+.+.
T Consensus        76 ~~l~~~~---------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          76 SELLTED---------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             Ccccccc---------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            8775430         01    1235678999999999987  22359999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=3.6e-11  Score=94.94  Aligned_cols=135  Identities=24%  Similarity=0.318  Sum_probs=101.5

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEe-cccccChHHH---HhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEe
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKK-SKLAVDDEEL---YKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~-~~~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      ..+++|+-+.++.+.+.+ ..+++|. ++......+.   -..++-.+|+.++..+.--.|....=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            357899999999997653 3355553 3333333222   2334567899999988765555555555666777899999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ++|..|.+.+...            ...++..+-.-+.-||..+   |+|+||.++||++.++. +.++|||++.+
T Consensus        81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999998763            2457778888899999999   99999999999999875 99999999864

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.35  E-value=4.7e-11  Score=97.54  Aligned_cols=141  Identities=18%  Similarity=0.164  Sum_probs=98.0

Q ss_pred             cceecccCcEEEEEEEecC-------CcEEEEEecccccCh---H------H---------HHhHHH----HHHHHHHHh
Q 040763           76 NRILGQGGQGTVYKGRLED-------GRIIAVKKSKLAVDD---E------E---------LYKLEE----FINEIFILS  126 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~-------~~~vaik~~~~~~~~---~------~---------~~~~~~----~~~e~~~~~  126 (360)
                      ...||.|.-+.||.|...+       +..+|+|+.+.....   .      +         ......    ..+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997543       478999976543210   0      0         000112    337899998


Q ss_pred             hcCC--CCceeeeeEEeeCCcceEEEEecCCCChh-HHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEe
Q 040763          127 QINH--RNVVKLLGCCLETEFPLLVYEFIPNGTLY-QHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL-HSGASSPIYH  202 (360)
Q Consensus       127 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H  202 (360)
                      ++..  -++...+++    ...++||||+.+..+. ..+..      ..++......+..+++.+|..+ |+.+   ++|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH  148 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVH  148 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            8843  566666654    4568999999764332 22221      1234455667789999999998 8888   999


Q ss_pred             cCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          203 RDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       203 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      +||++.||++++ +.+.|+|||.+....
T Consensus       149 GDLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         149 ADLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            999999999974 689999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=3.8e-12  Score=116.78  Aligned_cols=256  Identities=19%  Similarity=0.234  Sum_probs=176.5

Q ss_pred             ccChHH-HHHHhcCCCccceecccCcEEEEEEEec--CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCcee
Q 040763           60 LFSSKE-LDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVK  135 (360)
Q Consensus        60 ~~~~~~-~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~  135 (360)
                      .+...+ ......+|..+..||.|.|+.|+....+  ++..|++|...........  ...-+.|+.+...+ .|.++++
T Consensus       253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~--di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS--DIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh--hhcchhhhhHhhHhhcccccCC
Confidence            333333 3444567888999999999999887643  5788999876655443221  11223566566666 6899999


Q ss_pred             eeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC
Q 040763          136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       136 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~  215 (360)
                      ++..+......|+-.|||+++++........     -+....++.+..|++.++.++|+..   ++|+|++|+||++..+
T Consensus       331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~-----~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~  402 (524)
T KOG0601|consen  331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQ-----MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISND  402 (524)
T ss_pred             CCCCccccccccCchhhhcCcchhhhhHHHH-----hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccc
Confidence            9988888888899999999988877663322     3566677889999999999999998   9999999999999886


Q ss_pred             -CcEEEeecCCccccCCCCceeeecccccCCcc--chhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 040763          216 -YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL--DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS  292 (360)
Q Consensus       216 -~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~  292 (360)
                       +..+++|||++..+.-..    ......-++.  +|+......+-.++|+||||....+.++|..- ...+.  +    
T Consensus       403 ~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l-s~~~~--~----  471 (524)
T KOG0601|consen  403 GFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL-SESGV--Q----  471 (524)
T ss_pred             hhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCccc-Ccccc--c----
Confidence             888999999986432111    1111233344  55555666778899999999999999987643 11110  0    


Q ss_pred             hHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          293 LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                           ...+..+....          .......+..+...+...++..||.+.++....
T Consensus       472 -----~~~i~~~~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  472 -----SLTIRSGDTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             -----ceeeecccccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence                 00001111111          111224677888999999999999998875433

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.28  E-value=9.1e-11  Score=103.40  Aligned_cols=272  Identities=15%  Similarity=0.142  Sum_probs=164.8

Q ss_pred             CccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE------ee-CCc
Q 040763           74 NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCC------LE-TEF  145 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~------~~-~~~  145 (360)
                      ...+.||+|+-+.+|..-.-.++  +.|++.....--    ..   +.+..|... .||-+-.-+.+=      -+ +..
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~--VAKIYh~Pppa~----~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQ--VAKIYHAPPPAA----QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchhhch--hheeecCCCchH----HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            34567999999999965332222  335444332221    11   122333333 565443311110      01 112


Q ss_pred             ceEEEEecCCC-ChhHHhhhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          146 PLLVYEFIPNG-TLYQHLHDR-HQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       146 ~~lv~e~~~~~-~L~~~l~~~-~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      .-+.|..+.+. ....+++-. ...+-....|...+..++.++.+.+.||..|   .+-+|+.++|+|+.+++.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence            44666666543 222333221 1122335789999999999999999999999   899999999999999999999986


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCCcccccchHHHH
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTG-KKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      ..-....  .......-+|.+.|.+||.-.     +..-+...|-|.||+++++++.| +.||.+..............+
T Consensus       162 Dsfqi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         162 DSFQINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             cceeecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            6544332  223333446899999999533     34557789999999999999885 999987754444333332221


Q ss_pred             HHHhhcccccc-ccchHHhhhcc-HHHHHHHHHHHHHhhcC--CCCCCCCHHHHHHHHHHhHhhcc
Q 040763          298 VHSMRKNRLYH-ILDDQVMKLGK-KNQIVAFANLAERCLDL--NGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       298 ~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~l~~li~~cl~~--dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      ........... .-........+ .-.++++..+..+|+..  ++.-|||++.++..|..+.+.|.
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            11100000000 00000011111 12345678888999865  46789999999999999988775

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.28  E-value=2.5e-10  Score=103.14  Aligned_cols=218  Identities=20%  Similarity=0.255  Sum_probs=151.4

Q ss_pred             CcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe----eCCcceEEEEecCC-C
Q 040763           83 GQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL----ETEFPLLVYEFIPN-G  156 (360)
Q Consensus        83 ~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-~  156 (360)
                      ...+.|++... +|..|++|++......    .......-++.++++.|+|+|++.+++.    .+...++|++|.++ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~----~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQ----STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeecccccc----CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            34667888765 7999999998332111    1112234577889999999999999886    34567899999874 6


Q ss_pred             ChhHHhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          157 TLYQHLHDRHQN----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       157 ~L~~~l~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      +|.++.-...+.          .+...++..+|.++.|+..||.++|+.|   +..+-|.|.+|+++++..++|+..|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccce
Confidence            777765443222          2234678999999999999999999999   999999999999999999999999987


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ..+..+..               |.+.+   -.+-|.=.||.+++.|.||..---   .....                 
T Consensus       441 Dvl~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~---~~d~~-----------------  482 (655)
T KOG3741|consen  441 DVLQEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSN---RTDST-----------------  482 (655)
T ss_pred             eeecCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccc---cccch-----------------
Confidence            66544331               11111   125688899999999999864310   00000                 


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                          -..-....-..++.++++++.-....++++ -++.+++..
T Consensus       483 ----~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  483 ----QSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ----HHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                000012234456667888888888888876 677776544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=3.1e-10  Score=89.31  Aligned_cols=147  Identities=19%  Similarity=0.209  Sum_probs=105.5

Q ss_pred             ccceecccCcEEEEEEEecCCcEEEEEe-cccccChHH---HHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           75 VNRILGQGGQGTVYKGRLEDGRIIAVKK-SKLAVDDEE---LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~vaik~-~~~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ....+-+|+-+.|+++.+. |+...||. +........   .-...+.++|+..+.++.--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999886 66666664 333222221   123446678999998886555554444556666678999


Q ss_pred             EecCC-CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC---cEEEeecCCc
Q 040763          151 EFIPN-GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY---RAKVADFGTS  226 (360)
Q Consensus       151 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~  226 (360)
                      ||+++ .++.+++......   .........++..+-..+.-||+++   ++|+||..+||++..++   .+.++|||++
T Consensus        90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence            99966 4778888664322   2222333678999999999999999   99999999999997554   3589999998


Q ss_pred             cc
Q 040763          227 KF  228 (360)
Q Consensus       227 ~~  228 (360)
                      ..
T Consensus       164 ~~  165 (229)
T KOG3087|consen  164 SV  165 (229)
T ss_pred             hc
Confidence            54

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.22  E-value=2.5e-12  Score=124.31  Aligned_cols=253  Identities=21%  Similarity=0.239  Sum_probs=166.9

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      .....+.+.+-+-.|+++.++.+.-. .|...+++.......-.. ...+....+-.++-...+|-++...-.+.-....
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            44566777778889999999877543 233333333222111000 1111222222232333456666665555667788


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      +++++|..+++|...+....     ..+.+........+.++.+|||...   +.|+|++|.|.++..+++.+++|||..
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccc
Confidence            99999999999999987644     2334444556677889999999977   899999999999999999999999843


Q ss_pred             cccCCC------------------------------CceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhC
Q 040763          227 KFIAMD------------------------------QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG  276 (360)
Q Consensus       227 ~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg  276 (360)
                      ...+.-                              .........||+.|.+||...+......+|.|++|+.++|.++|
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence            222110                              00011124589999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 040763          277 KKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME  345 (360)
Q Consensus       277 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  345 (360)
                      ..||.......         ..+.+....       ......+...+.+..+++...+..+|.+|..+.
T Consensus      1032 ~pp~na~tpq~---------~f~ni~~~~-------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQ---------IFENILNRD-------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCcchhh---------hhhccccCC-------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99996543210         111111100       001122344556788999999999999998775

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=2.8e-10  Score=96.45  Aligned_cols=142  Identities=23%  Similarity=0.253  Sum_probs=104.4

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC--CCceeeeeEEeeCC---cceEEEE
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH--RNVVKLLGCCLETE---FPLLVYE  151 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h--~niv~~~~~~~~~~---~~~lv~e  151 (360)
                      +.++.|..+.+|++...+|..+++|........   .....+..|..++..+.+  .++.+++.+.....   ..+++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            468999999999998876688999986653221   123355688999998865  44567777766542   5689999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA-----------------------------------  196 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----------------------------------  196 (360)
                      |++|.++.+.+..      ..++......++.+++++|..||+..                                   
T Consensus        81 ~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (223)
T cd05154          81 RVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP  154 (223)
T ss_pred             EeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence            9999888775531      13566666677777888887777421                                   


Q ss_pred             ------------------CCCeEecCCCCCCeEEcC--CCcEEEeecCCcc
Q 040763          197 ------------------SSPIYHRDIKSTNILLDE--RYRAKVADFGTSK  227 (360)
Q Consensus       197 ------------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~  227 (360)
                                        ...++|+|+.|.||+++.  ++.+.|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                              134899999999999998  6678999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.10  E-value=1.7e-09  Score=88.09  Aligned_cols=130  Identities=24%  Similarity=0.224  Sum_probs=82.0

Q ss_pred             EEEEEEecCCcEEEEEecccccC----------------------hHHHHhHHHHHHHHHHHhhcCCC--CceeeeeEEe
Q 040763           86 TVYKGRLEDGRIIAVKKSKLAVD----------------------DEELYKLEEFINEIFILSQINHR--NVVKLLGCCL  141 (360)
Q Consensus        86 ~V~~~~~~~~~~vaik~~~~~~~----------------------~~~~~~~~~~~~e~~~~~~l~h~--niv~~~~~~~  141 (360)
                      .||.|...+|..+|+|..+....                      ...........+|...|..+...  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48899888899999997654311                      01111223467899999999765  56666644  


Q ss_pred             eCCcceEEEEecC--CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCeEEcCCCcE
Q 040763          142 ETEFPLLVYEFIP--NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY-LHSGASSPIYHRDIKSTNILLDERYRA  218 (360)
Q Consensus       142 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~-lh~~~~~~i~H~dlk~~Nill~~~~~~  218 (360)
                        ....+||||++  |..+..+....       ++......++.+++..+.. +|..|   ++|+||++.||+++++ .+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence              24489999998  55554433221       1122334567777775555 57888   9999999999999988 99


Q ss_pred             EEeecCCccccC
Q 040763          219 KVADFGTSKFIA  230 (360)
Q Consensus       219 kl~Dfg~~~~~~  230 (360)
                      .|+|||.+....
T Consensus       146 ~iIDf~qav~~~  157 (188)
T PF01163_consen  146 YIIDFGQAVDSS  157 (188)
T ss_dssp             EE--GTTEEETT
T ss_pred             EEEecCcceecC
Confidence            999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.02  E-value=5e-09  Score=87.94  Aligned_cols=139  Identities=22%  Similarity=0.181  Sum_probs=98.5

Q ss_pred             CCccceecccCcEEEEEEEecCCcEEEEEecccccChH------------------HHHhHHHHHHHHHHHhhcCCC--C
Q 040763           73 FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDE------------------ELYKLEEFINEIFILSQINHR--N  132 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~------------------~~~~~~~~~~e~~~~~~l~h~--n  132 (360)
                      ..+...||-|.-+.||.|....|.++++|.-+.....-                  .........+|.+.|..+...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45667899999999999999999999999544321110                  011223467899999999654  6


Q ss_pred             ceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 040763          133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL  212 (360)
Q Consensus       133 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill  212 (360)
                      +.+.+++    +...+|||+++|-.|...=          +.....-.++..|+.-+.-+-..|   ++|+|+++-||++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV  235 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV  235 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence            7666654    4558999999886654321          112222334555555555555778   9999999999999


Q ss_pred             cCCCcEEEeecCCccc
Q 040763          213 DERYRAKVADFGTSKF  228 (360)
Q Consensus       213 ~~~~~~kl~Dfg~~~~  228 (360)
                      +++|.+.++||.-+..
T Consensus       236 ~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         236 TEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ecCCCEEEEeCccccc
Confidence            9999999999987643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=1.2e-10  Score=108.74  Aligned_cols=149  Identities=24%  Similarity=0.295  Sum_probs=103.5

Q ss_pred             HHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeee--------cccccCCccchhhhccC
Q 040763          184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--------KIQGTFGYLDPEYHQSS  255 (360)
Q Consensus       184 ~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~~  255 (360)
                      +++.|+.|+|..-+  +||+++.|++|.++.++.+||+.|+++............        -..-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            55699999998653  999999999999999999999999987544332111111        11245679999999998


Q ss_pred             CCCCccchhhhHHHHHHHHhCCCCC-CCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhh
Q 040763          256 QLTDKSDVYSFGVVLVELLTGKKPI-FSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCL  334 (360)
Q Consensus       256 ~~~~~~DvwslG~il~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  334 (360)
                      ..+.++|+||+|+++|.+..|..+. ...+....      ...         ....++........+.+.++.+=+.+++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~------~~~---------~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS------YSF---------SRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcch------hhh---------hhcccccccccccccCcHHHHHHHHHHh
Confidence            8889999999999999999655443 22221000      000         0011111111223556678999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 040763          335 DLNGKKRPTMEEVSM  349 (360)
Q Consensus       335 ~~dp~~Rpt~~ei~~  349 (360)
                      ..++..||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877743

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=2.3e-08  Score=86.36  Aligned_cols=143  Identities=15%  Similarity=0.101  Sum_probs=94.9

Q ss_pred             eecccCcEEEEEEEecCCcEEEEEecccccChHHHHh-------HHHHHHHHHHHhhcCCCC--ceeeeeEEee-----C
Q 040763           78 ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYK-------LEEFINEIFILSQINHRN--VVKLLGCCLE-----T  143 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~-------~~~~~~e~~~~~~l~h~n--iv~~~~~~~~-----~  143 (360)
                      .+-......|.+... +|+.+.+|.........-...       ...+.+|...+..+...+  .+..+++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344333344556554 467899997643221100000       113567888877774322  2333444332     2


Q ss_pred             CcceEEEEecCCC-ChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-------C
Q 040763          144 EFPLLVYEFIPNG-TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-------R  215 (360)
Q Consensus       144 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-------~  215 (360)
                      ...++|+|++++. +|.+++....   ..+.+......++.+++..+.-||+.|   ++|+|+++.|||++.       +
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence            3468999999876 8988885421   113556677789999999999999999   999999999999975       4


Q ss_pred             CcEEEeecCCcc
Q 040763          216 YRAKVADFGTSK  227 (360)
Q Consensus       216 ~~~kl~Dfg~~~  227 (360)
                      ..+.++||+.+.
T Consensus       182 ~~~~LIDl~r~~  193 (268)
T PRK15123        182 LKLSVIDLHRAQ  193 (268)
T ss_pred             ceEEEEECCccc
Confidence            689999999874

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=3.2e-07  Score=76.62  Aligned_cols=105  Identities=24%  Similarity=0.276  Sum_probs=79.6

Q ss_pred             HHHHHHHHHHhhcCC--CCceeeeeEEeeC----CcceEEEEecCCC-ChhHHhhhhccCCCCCCCHHHHHHHHHHHHHH
Q 040763          116 EEFINEIFILSQINH--RNVVKLLGCCLET----EFPLLVYEFIPNG-TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA  188 (360)
Q Consensus       116 ~~~~~e~~~~~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~  188 (360)
                      ....+|...+..+..  -.+.+.+++....    ...++|+|++++. +|.+++.....     .+......++.+++..
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARL  130 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHH
Confidence            345678777777743  3344555554442    2348999999874 78888865321     4455677899999999


Q ss_pred             HHHHHhCCCCCeEecCCCCCCeEEcCCC---cEEEeecCCccc
Q 040763          189 LAYLHSGASSPIYHRDIKSTNILLDERY---RAKVADFGTSKF  228 (360)
Q Consensus       189 l~~lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~  228 (360)
                      +.-||+.|   ++|+|+++.|||++.+.   .+.++||+-+..
T Consensus       131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999   99999999999999887   899999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.68  E-value=2.3e-07  Score=87.00  Aligned_cols=146  Identities=16%  Similarity=0.155  Sum_probs=91.9

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHH------------------------------------HHHH
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLE------------------------------------EFIN  120 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~------------------------------------~~~~  120 (360)
                      +-|+.++-|.||+|..++|+.||||+.+......-...+.                                    .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            4688999999999999999999999888754332111110                                    1234


Q ss_pred             HHHHHhhc----C-CCCceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 040763          121 EIFILSQI----N-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG  195 (360)
Q Consensus       121 e~~~~~~l----~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~  195 (360)
                      |...+.++    + .+++.--.=++.-.....++|||++|-.+.+...-...    ..+.+.+.....++.  +..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~k~ia~~~~~~f--~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GIDRKELAELLVRAF--LRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCCHHHHHHHHHHHH--HHHHHhc
Confidence            44444443    2 23332222223335566899999999988887432211    233222222211111  1222234


Q ss_pred             CCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       196 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |   +.|.|..|.||+++.++.+.+.|||+......
T Consensus       285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             C---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            6   99999999999999999999999999876654

>PRK09902 hypothetical protein; Provisional

Probab=98.66  E-value=8.8e-07  Score=72.76  Aligned_cols=142  Identities=18%  Similarity=0.124  Sum_probs=97.8

Q ss_pred             ecccCcEEEEEEEecCCcEEEEEecccccChH-H-HHhHHHHHHHHHHHhhcCC--CCceeeeeEEee----CCcceEEE
Q 040763           79 LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDE-E-LYKLEEFINEIFILSQINH--RNVVKLLGCCLE----TEFPLLVY  150 (360)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~-~-~~~~~~~~~e~~~~~~l~h--~niv~~~~~~~~----~~~~~lv~  150 (360)
                      -|+|+-+.|+..... |+.+.+|....-.... - ......|.+|+..+..+..  -.+.+.......    .-..++|+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            466888889887665 4478888754111110 0 1234567889999988843  224444422111    12357899


Q ss_pred             EecCC-CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc--EEEeecCCcc
Q 040763          151 EFIPN-GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR--AKVADFGTSK  227 (360)
Q Consensus       151 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~  227 (360)
                      |-+++ -+|.+++....   ..+.+...+..+..+++..+.-||+.|   +.|+|+.+.||+++.++.  ++++||--+.
T Consensus       105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97743 68888875432   114567777889999999999999999   999999999999986666  9999998654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.61  E-value=1.4e-06  Score=71.90  Aligned_cols=140  Identities=16%  Similarity=0.213  Sum_probs=92.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHH------HHHHHHHHhhcCC---CCceeeeeE
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEE------FINEIFILSQINH---RNVVKLLGC  139 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~------~~~e~~~~~~l~h---~niv~~~~~  139 (360)
                      ..++|.+.+.+.......|.+...+ |..+++|..+......+ .....      ..+.+..+..+..   .....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~e-r~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPE-RRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHH-HHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4577888888888888888777765 67889998776443321 11111      2334444444422   222232222


Q ss_pred             E-----eeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC
Q 040763          140 C-----LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE  214 (360)
Q Consensus       140 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~  214 (360)
                      .     .-....+++|||++|..|.+...         ++.    .++..+.+++.-+|+.|   +.|+|..|.|+++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~  170 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN  170 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence            2     22334468999999988866542         222    24456778899999999   999999999999996


Q ss_pred             CCcEEEeecCCcc
Q 040763          215 RYRAKVADFGTSK  227 (360)
Q Consensus       215 ~~~~kl~Dfg~~~  227 (360)
                      + .+++.||+...
T Consensus       171 ~-~i~iID~~~k~  182 (229)
T PF06176_consen  171 N-GIRIIDTQGKR  182 (229)
T ss_pred             C-cEEEEECcccc
Confidence            6 49999998653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.52  E-value=3.1e-06  Score=71.68  Aligned_cols=141  Identities=16%  Similarity=0.161  Sum_probs=82.1

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCC--CceeeeeEEeeCCcceEEEEecC
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR--NVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~--niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      ..||+|..+.||+.   .+..+++|.......      .....+|.+++..+..-  .+.+.+++....+...++||+++
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCC------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            46899999999984   245677887664332      22346788888888543  34667777777777789999998


Q ss_pred             CCC-hhHHh--------------hh----hccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeEe
Q 040763          155 NGT-LYQHL--------------HD----RHQNEEYPLTWEMRFR-VAI----------EVAG-ALAYLHSG-ASSPIYH  202 (360)
Q Consensus       155 ~~~-L~~~l--------------~~----~~~~~~~~~~~~~~~~-i~~----------~i~~-~l~~lh~~-~~~~i~H  202 (360)
                      |.+ +...+              ..    -+...-.......... +..          .+.. ...+|... ....++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 21111              00    1110000011111000 000          0111 11222211 2234789


Q ss_pred             cCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          203 RDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       203 ~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +|+.|.||++++++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999988 9999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.52  E-value=4.5e-06  Score=69.70  Aligned_cols=140  Identities=21%  Similarity=0.225  Sum_probs=93.3

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHH--------------------hHHHHHHHHHHHhhcC--CCCce
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELY--------------------KLEEFINEIFILSQIN--HRNVV  134 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~--------------------~~~~~~~e~~~~~~l~--h~niv  134 (360)
                      ..|++|.-+.||+|...++..+|+|+++.........                    ...-..+|...|.++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            3577888899999998888999999877643221110                    0011245666666663  33444


Q ss_pred             eeeeEEeeCCcceEEEEecCCC-ChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEE
Q 040763          135 KLLGCCLETEFPLLVYEFIPNG-TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILL  212 (360)
Q Consensus       135 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill  212 (360)
                      +-+++.    .-.++|||+... .-...|      ...++.......+..++++.+.-|-. .+   +||+||+.-|||+
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L------kDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~  200 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRL------KDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILV  200 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCc------ccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEE
Confidence            444432    337999998543 122222      22233333566677888888888877 56   9999999999999


Q ss_pred             cCCCcEEEeecCCccccC
Q 040763          213 DERYRAKVADFGTSKFIA  230 (360)
Q Consensus       213 ~~~~~~kl~Dfg~~~~~~  230 (360)
                      . ++.+.|+|||-|....
T Consensus       201 ~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         201 H-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             E-CCeEEEEECccccccC
Confidence            9 7899999999876544

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=4.3e-06  Score=78.31  Aligned_cols=142  Identities=17%  Similarity=0.206  Sum_probs=88.9

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHH---------------------------------HHHHHHH
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLE---------------------------------EFINEIF  123 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~---------------------------------~~~~e~~  123 (360)
                      +-||..+.|.||+++.++|+.||||+.+..........+.                                 .|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            4699999999999999999999999887754332111100                                 2344444


Q ss_pred             HHhh----cCCCC------ceeeeeEEeeCCcceEEEEecCCCChhHH--hhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 040763          124 ILSQ----INHRN------VVKLLGCCLETEFPLLVYEFIPNGTLYQH--LHDRHQNEEYPLTWEMRFRVAIEVAGALAY  191 (360)
Q Consensus       124 ~~~~----l~h~n------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~  191 (360)
                      ...+    +.|-+      |.+++-.  ......++|||++|..+.+.  +.+.      .++...+..-+.+...-.-+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~------gi~~~~i~~~l~~~~~~qIf  318 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR------GISPHDILNKLVEAYLEQIF  318 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc------CCCHHHHHHHHHHHHHHHHH
Confidence            3333    34544      3333222  23455899999999888665  3332      24443332222222221112


Q ss_pred             HHhCCCCCeEecCCCCCCeEEcC----CCcEEEeecCCccccCC
Q 040763          192 LHSGASSPIYHRDIKSTNILLDE----RYRAKVADFGTSKFIAM  231 (360)
Q Consensus       192 lh~~~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg~~~~~~~  231 (360)
                        ..|   ++|.|-.|.||++..    ++.+.+-|||+......
T Consensus       319 --~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 --KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             --hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence              235   999999999999983    67899999999876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.34  E-value=7.3e-08  Score=89.65  Aligned_cols=183  Identities=21%  Similarity=0.167  Sum_probs=128.2

Q ss_pred             ccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCC-ceeeeeEEeeCCcceEEEEec
Q 040763           75 VNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN-VVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~n-iv~~~~~~~~~~~~~lv~e~~  153 (360)
                      ...-+++++++.+++.+..-.+....+.+...         ....-++++|.+++||| .+..++-+..+++.++.++++
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc---------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            33447889999988876433333333333221         12235788999999999 777888888888899999998


Q ss_pred             CCC-ChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCC
Q 040763          154 PNG-TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD  232 (360)
Q Consensus       154 ~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  232 (360)
                      .++ +.......    .+-.+...+...+.+.-+.+++++|+..   =+|+|    ||+..+ +..+..||+....+...
T Consensus       317 s~~rs~~~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  317 STGRSSALEMTV----SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             cCCccccccCCh----hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            766 22221111    1112333344556667788999999854   47888    776655 68999999998766543


Q ss_pred             CceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCC
Q 040763          233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI  280 (360)
Q Consensus       233 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~  280 (360)
                      .  ......+++.|+|||+...+.+..+.|.|++|.-.-++.-|-+|-
T Consensus       385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            2  334457899999999999999999999999998877887777664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.23  E-value=3.3e-05  Score=65.77  Aligned_cols=144  Identities=25%  Similarity=0.274  Sum_probs=80.2

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCC--CceeeeeEEee---CCcceEEEE
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR--NVVKLLGCCLE---TEFPLLVYE  151 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~--niv~~~~~~~~---~~~~~lv~e  151 (360)
                      +.++.|..+.||.....+ ..+++|.....      .....+..|..++..+...  .+.+++.....   ....+++|+
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            568999999999999877 58899986543      1234555788888777422  35566654432   334688999


Q ss_pred             ecCCCChhH----------------HhhhhccC--CCCCCCHHH---------HHHH------------HHHHHH-HHHH
Q 040763          152 FIPNGTLYQ----------------HLHDRHQN--EEYPLTWEM---------RFRV------------AIEVAG-ALAY  191 (360)
Q Consensus       152 ~~~~~~L~~----------------~l~~~~~~--~~~~~~~~~---------~~~i------------~~~i~~-~l~~  191 (360)
                      ++++.++..                .+......  ...+.....         ....            ...+.. .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            999888877                11111111  111111110         0000            111222 2333


Q ss_pred             HHh----CCCCCeEecCCCCCCeEEc-CCCcEEEeecCCcc
Q 040763          192 LHS----GASSPIYHRDIKSTNILLD-ERYRAKVADFGTSK  227 (360)
Q Consensus       192 lh~----~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~  227 (360)
                      ++.    .....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            332    1234499999999999999 56666799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.20  E-value=3.9e-05  Score=66.01  Aligned_cols=141  Identities=17%  Similarity=0.129  Sum_probs=82.4

Q ss_pred             ecccCc-EEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcceEEEEecCCC
Q 040763           79 LGQGGQ-GTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNG  156 (360)
Q Consensus        79 lg~G~~-g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  156 (360)
                      |..|.+ ..||+.... +..+.+|......       .....+|+.++..+. +--+.+++++....+..++||++++|.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            444555 788988765 4678888765432       123446888887773 445667777777666789999999988


Q ss_pred             ChhHHhh----------------hhccCC--CCCCCH--HHHHHHHH--------------------HHHHHHHHHHhC-
Q 040763          157 TLYQHLH----------------DRHQNE--EYPLTW--EMRFRVAI--------------------EVAGALAYLHSG-  195 (360)
Q Consensus       157 ~L~~~l~----------------~~~~~~--~~~~~~--~~~~~i~~--------------------~i~~~l~~lh~~-  195 (360)
                      ++.....                ..+...  ..++..  ........                    .....+..|-.. 
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            7764321                001100  001110  00000000                    011112222111 


Q ss_pred             ---CCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          196 ---ASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       196 ---~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                         ..+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence               12349999999999999998778899999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.16  E-value=1.6e-05  Score=65.03  Aligned_cols=104  Identities=25%  Similarity=0.399  Sum_probs=80.2

Q ss_pred             HHHHHHhhcCC-CCceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 040763          120 NEIFILSQINH-RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS  198 (360)
Q Consensus       120 ~e~~~~~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~  198 (360)
                      .|.-++..+++ +++.+++|+|-.    +++.|+...+++...-..  ...-...+|..+.+++.++++.+.++++....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            47778888865 699999999833    678999976665422000  00111468999999999999999999985433


Q ss_pred             CeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          199 PIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      .+.-.|++|+|+-+++++.+|+.|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            4889999999999999999999999887544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.08  E-value=0.00013  Score=60.10  Aligned_cols=136  Identities=21%  Similarity=0.265  Sum_probs=89.8

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChH------------HHHhHHHHHHHHHHHhhcC------CCCceeee
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDE------------ELYKLEEFINEIFILSQIN------HRNVVKLL  137 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~------------~~~~~~~~~~e~~~~~~l~------h~niv~~~  137 (360)
                      ...||+|+.-.||.  ++++....||+........            ......+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45699999999884  5556667888877654000            0011334555666555554      88999999


Q ss_pred             eEEeeCCcceEEEEecC------CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 040763          138 GCCLETEFPLLVYEFIP------NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNIL  211 (360)
Q Consensus       138 ~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nil  211 (360)
                      |+..++...-+|+|.+.      ..+|.+++...      .++. .   +...+-.-..||-+.+   |+.+|++|.||+
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv  150 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIV  150 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence            99999999999999864      24567777432      2443 2   2333334455777777   999999999999


Q ss_pred             EcCC---C-cEEEee-cCCc
Q 040763          212 LDER---Y-RAKVAD-FGTS  226 (360)
Q Consensus       212 l~~~---~-~~kl~D-fg~~  226 (360)
                      +..+   . .+.|+| ||..
T Consensus       151 ~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EEecCCCceEEEEEeCCCCc
Confidence            9633   2 567776 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=9.5e-05  Score=74.75  Aligned_cols=80  Identities=14%  Similarity=0.252  Sum_probs=54.5

Q ss_pred             cceecccCcEEEEEEEecCC---cEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCc--eeeeeEEeeC---Ccc
Q 040763           76 NRILGQGGQGTVYKGRLEDG---RIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNV--VKLLGCCLET---EFP  146 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~---~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~ni--v~~~~~~~~~---~~~  146 (360)
                      .+.++.|.+..+|+....++   ..+++|+.......   .....+.+|..+++.+. |.++  .+++.++.+.   ...
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            56788999999998876543   35777765432211   11235668999999885 6654  7777777654   467


Q ss_pred             eEEEEecCCCCh
Q 040763          147 LLVYEFIPNGTL  158 (360)
Q Consensus       147 ~lv~e~~~~~~L  158 (360)
                      ++||||++|..+
T Consensus       120 flVME~v~G~~~  131 (822)
T PLN02876        120 FYIMEYLEGRIF  131 (822)
T ss_pred             eEEEEecCCccc
Confidence            899999987643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.98  E-value=9.6e-05  Score=58.57  Aligned_cols=129  Identities=18%  Similarity=0.182  Sum_probs=85.7

Q ss_pred             CccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCcee-eeeEEeeCCcceEEEEe
Q 040763           74 NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK-LLGCCLETEFPLLVYEF  152 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~-~~~~~~~~~~~~lv~e~  152 (360)
                      ...+.|++|.+|.||+|.+.+ ..+|+|+-+.+...      ..+..|++++..+.-.++.+ ++.+-    ...+.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds~r------~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRRDSPR------RNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC-ceEEEEEecCCcch------hhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhh
Confidence            445679999999999999874 57899987665433      34557888888887666554 33332    22455999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC-CCeEEcCCCcEEEeecCCccc
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKS-TNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~-~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +.|-+|.+.-...        +-.    -...++..-.-|-..|   |-|+.|.- ...+|.+++.+.|+||..|+.
T Consensus        94 i~G~~L~~~~~~~--------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIGG--------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhcc--------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9888887766431        112    2234444433455557   88998864 444444444999999999874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.98  E-value=0.00015  Score=59.25  Aligned_cols=129  Identities=29%  Similarity=0.451  Sum_probs=89.3

Q ss_pred             cCCCccceecccCc-EEEEEEEecCCcEEEEEeccc---cc--------ChHHH------HhHHHHHHHHHHHhhcC---
Q 040763           71 NHFNVNRILGQGGQ-GTVYKGRLEDGRIIAVKKSKL---AV--------DDEEL------YKLEEFINEIFILSQIN---  129 (360)
Q Consensus        71 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vaik~~~~---~~--------~~~~~------~~~~~~~~e~~~~~~l~---  129 (360)
                      ..++..+.||.|.- |.||++.+. |+.+|+|.++.   ..        ...+.      ...+.|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67889999999999 999999986 67999998222   11        11111      23345777888777774   


Q ss_pred             CCCc--eeeeeEEeeCC------------------cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 040763          130 HRNV--VKLLGCCLETE------------------FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL  189 (360)
Q Consensus       130 h~ni--v~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l  189 (360)
                      +.++  ++.+|+..-..                  ...||.||.+...              .+.    ..-+.++.+-+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~dl  177 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRDL  177 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHHH
Confidence            4566  88888874221                  1246777665322              112    22345778888


Q ss_pred             HHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       190 ~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ..+|..|   |+-+|+++.|..     .-+|+|||.+
T Consensus       178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            9999999   999999999986     5689999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.95  E-value=4.5e-05  Score=76.28  Aligned_cols=192  Identities=20%  Similarity=0.201  Sum_probs=132.1

Q ss_pred             HHHHHHhhcCCCCceeeeeEEeeCCcc----eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 040763          120 NEIFILSQINHRNVVKLLGCCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG  195 (360)
Q Consensus       120 ~e~~~~~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~  195 (360)
                      .|+..+....|+|++.++.+.......    .+..++|..-++...+....     .++..+.+.+..+...|+.|+|+.
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-----~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-----SIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-----ccCHHHHHHHHHHHhhhHHHHHHh
Confidence            467777888999999999887654322    33446777777776665432     588899999999999999999998


Q ss_pred             CCCCeEecCCCCC---CeEEcCCCcEEEe--ecCCccccCCCCceeeecccccCCccchhhhccCCCCC--ccchhhhHH
Q 040763          196 ASSPIYHRDIKST---NILLDERYRAKVA--DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD--KSDVYSFGV  268 (360)
Q Consensus       196 ~~~~i~H~dlk~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwslG~  268 (360)
                      .   ..|.-+...   +--.+..+.+.++  ||+.............  ...+..|.+||.......+.  ..|+|.+|.
T Consensus       306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence            6   666666555   5555677778877  9988876654332222  23455688888777765554  469999999


Q ss_pred             HHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          269 VLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       269 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                      ....+..|..+-.....                    ...+++        .....+..+....|+..++++|+++.+++
T Consensus       381 l~~~~~~~~~i~~~~~~--------------------~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV--------------------PVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHhhhhhcCcccccccc--------------------hhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhh
Confidence            99999987655211110                    000000        00001467888999999999999999987


Q ss_pred             H
Q 040763          349 M  349 (360)
Q Consensus       349 ~  349 (360)
                      .
T Consensus       433 ~  433 (1351)
T KOG1035|consen  433 T  433 (1351)
T ss_pred             h
Confidence            5

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.81  E-value=0.00045  Score=58.97  Aligned_cols=74  Identities=20%  Similarity=0.212  Sum_probs=45.8

Q ss_pred             ceecccCcEEEEEEEecC--CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCc-eeeeeEEeeCCcceEEEEec
Q 040763           77 RILGQGGQGTVYKGRLED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV-VKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~--~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-v~~~~~~~~~~~~~lv~e~~  153 (360)
                      +.|..|-...+|+....+  +..+++|........     .-...+|+.++..+...++ .++++.+.    ..++|||+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-----~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i   74 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-----IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFI   74 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-----eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEee
Confidence            457778888999987664  567888876532111     1112367888888754333 34444322    24899999


Q ss_pred             CCCChh
Q 040763          154 PNGTLY  159 (360)
Q Consensus       154 ~~~~L~  159 (360)
                      +|.++.
T Consensus        75 ~G~~l~   80 (235)
T cd05157          75 PGRTLE   80 (235)
T ss_pred             CCCcCC
Confidence            887663

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.74  E-value=5e-05  Score=65.96  Aligned_cols=138  Identities=18%  Similarity=0.167  Sum_probs=94.1

Q ss_pred             CCccceecccCcEEEEEEEecCCcEEEEEecccccChH----------------HHHh--HHHHHHHHHHHhhcC-C-CC
Q 040763           73 FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDE----------------ELYK--LEEFINEIFILSQIN-H-RN  132 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~----------------~~~~--~~~~~~e~~~~~~l~-h-~n  132 (360)
                      +.+.+.||-|.-+.+|.+-+..|++.++|.-+.....-                ....  .-...+|...|..+. | --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            57788999999999999999999999988544322110                0001  113457888888884 3 33


Q ss_pred             ceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 040763          133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL  212 (360)
Q Consensus       133 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill  212 (360)
                      +.+.+++    +..++|||++.+-+|...-.-        ...   ..+...+..-+.-|..+|   +||+|+.--||++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--------~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv  235 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV--------EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMV  235 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeec--------CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence            4444443    445789999888777543211        111   224444555566778888   9999999999999


Q ss_pred             cCCCcEEEeecCCccc
Q 040763          213 DERYRAKVADFGTSKF  228 (360)
Q Consensus       213 ~~~~~~kl~Dfg~~~~  228 (360)
                      ++++.++++||.-...
T Consensus       236 ~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQMVS  251 (465)
T ss_pred             ecCCCEEEeechHhhc
Confidence            9999999999975543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.71  E-value=0.00065  Score=58.03  Aligned_cols=29  Identities=28%  Similarity=0.481  Sum_probs=25.3

Q ss_pred             CeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          199 PIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      .++|+|+.|.||+++++...-|.||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            48999999999999977666799999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.67  E-value=0.0011  Score=58.79  Aligned_cols=76  Identities=9%  Similarity=0.015  Sum_probs=53.0

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC---CCceeeeeEEee---CCcceEE
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH---RNVVKLLGCCLE---TEFPLLV  149 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h---~niv~~~~~~~~---~~~~~lv  149 (360)
                      .+.||.|..+.||.....++ .+.+|..+....      ...+..|...++.+..   ..+.++++++..   .+..++|
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARSFST------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEeccccc------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            45699999999999876555 456666432101      1355678888888743   467788887754   3568999


Q ss_pred             EEecCCCCh
Q 040763          150 YEFIPNGTL  158 (360)
Q Consensus       150 ~e~~~~~~L  158 (360)
                      ||++++.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999988765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.58  E-value=0.00077  Score=58.38  Aligned_cols=139  Identities=16%  Similarity=0.177  Sum_probs=74.1

Q ss_pred             ecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCc-eeeeeEEeeCCcceEEEEecCCCC
Q 040763           79 LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV-VKLLGCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~~  157 (360)
                      +..|-...+|+... ++..+++|.........   .. ...+|..+++.+....+ .+++....    .++||||++|..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~---~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL---GV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccc---cC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            45677788888874 46678888654321110   01 12467778887754333 33333321    378999998866


Q ss_pred             hhHH--------------hhhhccC--CCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEecCCC
Q 040763          158 LYQH--------------LHDRHQN--EEYPLTWEMR-FRVAIE---------VAGALAYLHSG-----ASSPIYHRDIK  206 (360)
Q Consensus       158 L~~~--------------l~~~~~~--~~~~~~~~~~-~~i~~~---------i~~~l~~lh~~-----~~~~i~H~dlk  206 (360)
                      +...              +.+.+..  ...+++.... .....+         +...+..+-..     .+..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            5421              1111111  1112222211 111101         11112222211     12348999999


Q ss_pred             CCCeEEcCCCcEEEeecCCcc
Q 040763          207 STNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       207 ~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      |.||++++++ +.++||..+.
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccC
Confidence            9999999877 7899999874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.52  E-value=0.0021  Score=58.82  Aligned_cols=79  Identities=22%  Similarity=0.228  Sum_probs=52.0

Q ss_pred             ceecccCcEEEEEEEecCC-cEEEEEecccccC--hHH-HHhHHHHHHHHHHHhhcC---CCCceeeeeEEeeCCcceEE
Q 040763           77 RILGQGGQGTVYKGRLEDG-RIIAVKKSKLAVD--DEE-LYKLEEFINEIFILSQIN---HRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~-~~vaik~~~~~~~--~~~-~~~~~~~~~e~~~~~~l~---h~niv~~~~~~~~~~~~~lv  149 (360)
                      +.||.|.+..||++...+| +.++||.-.....  ... ....++...|.+.|..+.   ..++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999998776 4899997432111  000 123345566777777662   3456677766  33557899


Q ss_pred             EEecCCCC
Q 040763          150 YEFIPNGT  157 (360)
Q Consensus       150 ~e~~~~~~  157 (360)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99987643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.41  E-value=0.0023  Score=56.74  Aligned_cols=144  Identities=19%  Similarity=0.158  Sum_probs=79.6

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCC--CceeeeeE------EeeCCcce
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR--NVVKLLGC------CLETEFPL  147 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~--niv~~~~~------~~~~~~~~  147 (360)
                      .+.+..|....+|+....+ ..+++|.... ..      .+....|+.++..+.+.  .+.+.+..      ....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~-~~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK-VS------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC-CC------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            3457778778899887654 4688887654 11      12334566666666332  24444332      12344568


Q ss_pred             EEEEecCCCChhH----Hh-------hhhc----cCC-----CCCCCHHHHH----------HHHHHHHHHHHHHHhC--
Q 040763          148 LVYEFIPNGTLYQ----HL-------HDRH----QNE-----EYPLTWEMRF----------RVAIEVAGALAYLHSG--  195 (360)
Q Consensus       148 lv~e~~~~~~L~~----~l-------~~~~----~~~-----~~~~~~~~~~----------~i~~~i~~~l~~lh~~--  195 (360)
                      +++++++|.++..    ..       ...+    ...     .....|....          .....+..++.++...  
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999998876532    01       0000    000     0011111110          0111123344444431  


Q ss_pred             --CCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          196 --ASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       196 --~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                        .+..++|+|+.|.|+++++++.+.|.||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence              12349999999999999998778899999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.37  E-value=0.0033  Score=55.98  Aligned_cols=143  Identities=21%  Similarity=0.234  Sum_probs=95.8

Q ss_pred             CccceecccCcEEEEEEEecCCcEEEEEecccccC---hHH-----------------HHh--HHHHHHHHHHHhhcCCC
Q 040763           74 NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVD---DEE-----------------LYK--LEEFINEIFILSQINHR  131 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~---~~~-----------------~~~--~~~~~~e~~~~~~l~h~  131 (360)
                      .+..+|..|.-+.||-+...+|..+|||+++...-   +.+                 +..  .--...|+.-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            45678999999999999999999999997665321   000                 000  11133577777777654


Q ss_pred             CceeeeeEEeeCCcceEEEEecCC-CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 040763          132 NVVKLLGCCLETEFPLLVYEFIPN-GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNI  210 (360)
Q Consensus       132 niv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Ni  210 (360)
                      .|...--...  ....+||+|+.. |-....|      ....++...+..+-.|++.-+.-|.+.++  +||.||+--|+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkL------Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~  296 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKL------KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL  296 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCccc------ccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence            4432211111  123789999852 2222223      23356667778888889888888888775  99999999999


Q ss_pred             EEcCCCcEEEeecCCcc
Q 040763          211 LLDERYRAKVADFGTSK  227 (360)
Q Consensus       211 ll~~~~~~kl~Dfg~~~  227 (360)
                      |+.+ |.+.|+|-+-+.
T Consensus       297 Lyhd-G~lyiIDVSQSV  312 (520)
T KOG2270|consen  297 LYHD-GKLYIIDVSQSV  312 (520)
T ss_pred             eEEC-CEEEEEEccccc
Confidence            9876 488999987654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.29  E-value=0.0045  Score=54.14  Aligned_cols=31  Identities=29%  Similarity=0.520  Sum_probs=25.6

Q ss_pred             CCeEecCCCCCCeEEcCCCc-EEEeecCCccc
Q 040763          198 SPIYHRDIKSTNILLDERYR-AKVADFGTSKF  228 (360)
Q Consensus       198 ~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~  228 (360)
                      ..++|+|+.|.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997555 46999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.25  E-value=0.0033  Score=55.92  Aligned_cols=75  Identities=28%  Similarity=0.338  Sum_probs=45.1

Q ss_pred             ceecccCcEEEEEEEecC-------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCC-ceeeeeEEeeCCcceE
Q 040763           77 RILGQGGQGTVYKGRLED-------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN-VVKLLGCCLETEFPLL  148 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~-------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~n-iv~~~~~~~~~~~~~l  148 (360)
                      +.+..|-...+|+....+       ++.+++|........     .....+|..++..+...+ ..++++.+.    ...
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-----~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~   74 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-----LIDRERELVVFARLSERNLGPKLYGIFP----NGR   74 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-----eechHHHHHHHHHHHhCCCCCceEEEeC----CCc
Confidence            345667777888887654       477888886543211     122346777777774332 334455443    245


Q ss_pred             EEEecCCCChhH
Q 040763          149 VYEFIPNGTLYQ  160 (360)
Q Consensus       149 v~e~~~~~~L~~  160 (360)
                      |++|++|.++..
T Consensus        75 v~e~i~G~~l~~   86 (302)
T cd05156          75 IEEFIPSRTLTT   86 (302)
T ss_pred             hhheeCCCcCCH
Confidence            899988876643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.24  E-value=0.016  Score=51.71  Aligned_cols=145  Identities=18%  Similarity=0.189  Sum_probs=77.3

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC--CCceeeeeEE------eeCCcce
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH--RNVVKLLGCC------LETEFPL  147 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h--~niv~~~~~~------~~~~~~~  147 (360)
                      .+.++.|....+|.....++ .+++|........      +....|.+++..+..  -.+.+.+...      ...+..+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKA------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCCH------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            44577777788998876544 5777876542111      122345556655532  2234443321      1234568


Q ss_pred             EEEEecCCCChhH-----------Hhhhhcc-CCCC---------CCCHHHHH------------HHHHHHHHHHHHHHh
Q 040763          148 LVYEFIPNGTLYQ-----------HLHDRHQ-NEEY---------PLTWEMRF------------RVAIEVAGALAYLHS  194 (360)
Q Consensus       148 lv~e~~~~~~L~~-----------~l~~~~~-~~~~---------~~~~~~~~------------~i~~~i~~~l~~lh~  194 (360)
                      ++++|++|.++..           .+...+. ....         .-.|....            .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            9999998755421           1110000 0000         01111100            011123344555542


Q ss_pred             ----CCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          195 ----GASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       195 ----~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                          .....++|+|+.+.|+++++++.+.+.||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                112349999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.17  E-value=0.028  Score=50.33  Aligned_cols=29  Identities=21%  Similarity=0.275  Sum_probs=25.5

Q ss_pred             CeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          199 PIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      .++|+|+.|.||+++++...-++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            49999999999999977666899999874

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.06  E-value=7.7e-05  Score=76.64  Aligned_cols=155  Identities=12%  Similarity=-0.026  Sum_probs=111.1

Q ss_pred             HHhhcCCCCceeeeeEEee--CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCCC
Q 040763          124 ILSQINHRNVVKLLGCCLE--TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG--ASSP  199 (360)
Q Consensus       124 ~~~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~~~  199 (360)
                      -.+...|+++.....-...  ....+..++++.+|.+.+.+..... +..++....+.....+.+....-+|+.  +...
T Consensus      1282 e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e-e~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T 1360 (2724)
T KOG1826|consen 1282 ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE-ESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNT 1360 (2724)
T ss_pred             hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc-cCCcchhchHHHHHHHHHhccchhhhcccCCcc
Confidence            3444578888776655432  3355789999999999999876432 233344444443444435555555543  2345


Q ss_pred             eEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCC
Q 040763          200 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP  279 (360)
Q Consensus       200 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p  279 (360)
                      .+|+++|+-|.+|..+..+|++++|+.+..... ....+...+++-|++|+....-.++.++|+|..|+-+|+...|..+
T Consensus      1361 ~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred             chhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHH
Confidence            889999999999999999999999999844332 2223334578889999988888888889999999999999988887


Q ss_pred             C
Q 040763          280 I  280 (360)
Q Consensus       280 ~  280 (360)
                      |
T Consensus      1440 f 1440 (2724)
T KOG1826|consen 1440 F 1440 (2724)
T ss_pred             H
Confidence            6

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.04  E-value=0.0073  Score=52.99  Aligned_cols=73  Identities=22%  Similarity=0.210  Sum_probs=44.1

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc---CCCCceeeeeEEeeCCcceEEEEe
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI---NHRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l---~h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      .+.++.|....+|... .+++.+.+|.-...       ....+..|.+-|+.|   ..-.+.+.+++....+..+++|||
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~-------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES-------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG-------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecChh-------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            4568889899999887 56778999975522       122345666666666   345677888888877788999999


Q ss_pred             cCCC
Q 040763          153 IPNG  156 (360)
Q Consensus       153 ~~~~  156 (360)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.94  E-value=0.023  Score=50.34  Aligned_cols=139  Identities=17%  Similarity=0.251  Sum_probs=79.3

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC--CCceeeeeEEeeCC--cceEEEEe
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH--RNVVKLLGCCLETE--FPLLVYEF  152 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h--~niv~~~~~~~~~~--~~~lv~e~  152 (360)
                      +.+..|..-.+|..... ++.+++.........   .......+|..++..+.-  .-+...++.|.++.  .++.||+|
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~---~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPV---ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEecCCccccc---hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            33433433334444333 677777722111111   233445578888877743  44555677777666  77999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCHHHHHHHHH-HHHHHHH-----------------------------------------
Q 040763          153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI-EVAGALA-----------------------------------------  190 (360)
Q Consensus       153 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~-~i~~~l~-----------------------------------------  190 (360)
                      ++|..+.+.+....      .  .  .+++. .++..|+                                         
T Consensus       107 veGe~~~~~~~~~~------~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~  176 (321)
T COG3173         107 VEGEVVWSALPPES------L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR  176 (321)
T ss_pred             ecceeccCcCCccc------c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence            98743332221100      0  0  11111 2333333                                         


Q ss_pred             ---------HHHhCC-----CCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          191 ---------YLHSGA-----SSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       191 ---------~lh~~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                               |++.+-     ++.++|+|+.+.|++++++.-+=+.||+++..-
T Consensus       177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                     333322     234999999999999999988999999998653

>PLN02236 choline kinase

Probab=96.71  E-value=0.031  Score=50.61  Aligned_cols=142  Identities=21%  Similarity=0.262  Sum_probs=76.4

Q ss_pred             ceecccCcEEEEEEEecC-----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCce-eeeeEEeeCCcceEEE
Q 040763           77 RILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV-KLLGCCLETEFPLLVY  150 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~-----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv-~~~~~~~~~~~~~lv~  150 (360)
                      ..+..|-.-.+|+....+     ++.+++|.......    ..+++ ..|..++..+...++. ++++.+...    .|.
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~----~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE----LFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC----eeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            345557778888886532     35788887654321    11111 3688888888543333 455555332    578


Q ss_pred             EecCCCChhHH--------------hhhhccCC----CCCCCHHHHHHHHHHH-----------------HHHHHHH---
Q 040763          151 EFIPNGTLYQH--------------LHDRHQNE----EYPLTWEMRFRVAIEV-----------------AGALAYL---  192 (360)
Q Consensus       151 e~~~~~~L~~~--------------l~~~~~~~----~~~~~~~~~~~i~~~i-----------------~~~l~~l---  192 (360)
                      +|+++.++...              +.+.+...    ..+..+..+..+..++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99877666421              11111100    1011222222222111                 1112222   


Q ss_pred             -Hh-CCCCCeEecCCCCCCeEEcC-CCcEEEeecCCcc
Q 040763          193 -HS-GASSPIYHRDIKSTNILLDE-RYRAKVADFGTSK  227 (360)
Q Consensus       193 -h~-~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~  227 (360)
                       .. .....++|+|+++.||++++ ++.+.++||..+.
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             21 11234899999999999986 4689999998874

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.61  E-value=0.047  Score=50.06  Aligned_cols=84  Identities=15%  Similarity=0.091  Sum_probs=51.6

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccCh-HH--HHhHHHHHHHHHHHhhcC---CCCceeeeeEEeeCCcceEE
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD-EE--LYKLEEFINEIFILSQIN---HRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~-~~--~~~~~~~~~e~~~~~~l~---h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+.+|.|....||+.... +..++||.-...... .+  .....+...|...|..+.   ...+.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            456899999999998874 456889875421110 00  012233344566665553   357778888776  446889


Q ss_pred             EEecCC--CChhHHh
Q 040763          150 YEFIPN--GTLYQHL  162 (360)
Q Consensus       150 ~e~~~~--~~L~~~l  162 (360)
                      ||++++  ..+.+.+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999966  3444433

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.48  E-value=0.0092  Score=55.46  Aligned_cols=49  Identities=18%  Similarity=0.255  Sum_probs=38.1

Q ss_pred             HHHHHHHHHhhcCCCCceeeeeEEee-CCcceEEEEecCCCChhHHhhhhc
Q 040763          117 EFINEIFILSQINHRNVVKLLGCCLE-TEFPLLVYEFIPNGTLYQHLHDRH  166 (360)
Q Consensus       117 ~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~  166 (360)
                      +++-...+++.+.|+|...++.+-.. .....+|+|++ +.||.+.+..+.
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            44566778888999999999887653 33467899998 789999987643

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.41  E-value=0.017  Score=51.52  Aligned_cols=104  Identities=16%  Similarity=0.196  Sum_probs=69.2

Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                      ..+.|++|++- |+++ ..+.        ...+++...|+++.+..++-+..+-  +.-|||+.-.||||+ +|++.|+|
T Consensus       298 ~~y~yl~~kdh-gt~i-s~ik--------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLID  364 (488)
T COG5072         298 TLYLYLHFKDH-GTPI-SIIK--------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLID  364 (488)
T ss_pred             ceEEEEEEecC-Ccee-eeee--------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEE
Confidence            33556677753 3343 3332        2568888999999998888888765  389999999999999 99999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSF  266 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  266 (360)
                      |-+++..... .-...     ...--|-.+.| .-+.+=|||-+
T Consensus       365 fklsRl~~~q-~~isy-----~rldhp~lF~G-~dd~QFeIYrl  401 (488)
T COG5072         365 FKLSRLSYSQ-GIISY-----NRLDHPDLFNG-VDDYQFEIYRL  401 (488)
T ss_pred             eeeeecccCC-ceeec-----cccCchhhhcC-ccceeeeHHHH
Confidence            9999843322 21111     12234444543 33666677654

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.89  E-value=0.11  Score=46.95  Aligned_cols=76  Identities=21%  Similarity=0.177  Sum_probs=45.9

Q ss_pred             eecccCcEEEEEEEecCC-cEEEEEecccccCh---HHHHhHHHHHHHHHHHhhcC--CC-CceeeeeEEeeCCcceEEE
Q 040763           78 ILGQGGQGTVYKGRLEDG-RIIAVKKSKLAVDD---EELYKLEEFINEIFILSQIN--HR-NVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~-~~vaik~~~~~~~~---~~~~~~~~~~~e~~~~~~l~--h~-niv~~~~~~~~~~~~~lv~  150 (360)
                      .||-|....||++...+| +.++||.-..-...   .-....++..-|...|....  -| .+.+++.+  +.+...++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478999999999997654 57999963321111   11123344556777776653  24 44455443  444557899


Q ss_pred             EecCC
Q 040763          151 EFIPN  155 (360)
Q Consensus       151 e~~~~  155 (360)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            98853

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.74  E-value=0.14  Score=46.13  Aligned_cols=29  Identities=28%  Similarity=0.387  Sum_probs=25.3

Q ss_pred             CeEecCCCCCCeEEcC-CCcEEEeecCCcc
Q 040763          199 PIYHRDIKSTNILLDE-RYRAKVADFGTSK  227 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~  227 (360)
                      .++|+|+.+.||++++ ++.++++||..|.
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            4899999999999974 5789999999874

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.62  E-value=0.22  Score=41.79  Aligned_cols=74  Identities=23%  Similarity=0.263  Sum_probs=49.3

Q ss_pred             eecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc---CCCCceeeeeEEeeCCcceEEEEecC
Q 040763           78 ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI---NHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l---~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      .+.-|.--..|...+ +...+.+|+-..       .....|..|+.-|..+   +.-.+.+++.+-.+..+.|+|+||++
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n~~-------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCNQR-------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEecch-------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            344444444444433 356788886433       2345566677666666   44668888888889999999999998


Q ss_pred             CCChh
Q 040763          155 NGTLY  159 (360)
Q Consensus       155 ~~~L~  159 (360)
                      .+.+.
T Consensus        95 ~~~~d   99 (286)
T COG3001          95 TGPLD   99 (286)
T ss_pred             CCCCC
Confidence            76665

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.36  E-value=0.44  Score=42.73  Aligned_cols=141  Identities=21%  Similarity=0.320  Sum_probs=76.8

Q ss_pred             ecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-C--CC---ceeeeeE----EeeCCcceE
Q 040763           79 LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-H--RN---VVKLLGC----CLETEFPLL  148 (360)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h--~n---iv~~~~~----~~~~~~~~l  148 (360)
                      |.+ .-..+|.....+|+. ++|........      .+...|+..+..+. +  +-   +...-|-    ........-
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~~~~------~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~  105 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPGWTR------AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA  105 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCCCCH------HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence            444 456678888777666 88887765222      23334666666662 1  11   2222221    111236677


Q ss_pred             EEEecCCCChhH------------Hhhh-------h---ccCCCCCCCHHH-------------HHHHHHHHHHHHHHHH
Q 040763          149 VYEFIPNGTLYQ------------HLHD-------R---HQNEEYPLTWEM-------------RFRVAIEVAGALAYLH  193 (360)
Q Consensus       149 v~e~~~~~~L~~------------~l~~-------~---~~~~~~~~~~~~-------------~~~i~~~i~~~l~~lh  193 (360)
                      +++|++|..+..            .+.+       .   +++......|..             ......++...+..+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            899999888772            1100       0   011111122320             0112233444444444


Q ss_pred             hC----CCC---CeEecCCCCCCeEEcCCCc-EEEeecCCcc
Q 040763          194 SG----ASS---PIYHRDIKSTNILLDERYR-AKVADFGTSK  227 (360)
Q Consensus       194 ~~----~~~---~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~  227 (360)
                      +.    -+.   .+||+|+.|.||+++.+.. +-+.||+-+.
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            32    122   2899999999999999885 8999999874

>PRK06148 hypothetical protein; Provisional

Probab=95.20  E-value=0.61  Score=48.69  Aligned_cols=31  Identities=32%  Similarity=0.546  Sum_probs=25.8

Q ss_pred             CCeEecCCCCCCeEEcCCC--cEE-EeecCCccc
Q 040763          198 SPIYHRDIKSTNILLDERY--RAK-VADFGTSKF  228 (360)
Q Consensus       198 ~~i~H~dlk~~Nill~~~~--~~k-l~Dfg~~~~  228 (360)
                      ..+||+|+.+.||+++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3499999999999999875  555 999998753

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.83  E-value=0.21  Score=41.69  Aligned_cols=118  Identities=16%  Similarity=0.134  Sum_probs=66.0

Q ss_pred             cCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecCCCChhHH
Q 040763           82 GGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQH  161 (360)
Q Consensus        82 G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~  161 (360)
                      |+.++...++.+-|.. .+|+++...-.   -...-+..+.+++.+++  .|+++..  ......-++.|+|..      
T Consensus        73 ~gNsTl~~~kt~iG~L-~lKKi~slp~~---~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~------  138 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGPL-FLKKIRSLPCC---INDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYK------  138 (308)
T ss_pred             CCceEEEEeccccchh-hhhhccCCCcc---cchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccC------
Confidence            4555555555444443 34443322211   01223456677777664  3445441  122344588898842      


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          162 LHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       162 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                                 +..... .++.-=+.+|.-.|+.. ....|+|..|+||+-|..|.+||.|-+..
T Consensus       139 -----------~~i~~~-N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  139 -----------IKINFS-NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -----------cccchh-HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence                       111101 11111245677778532 33999999999999999999999998764

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=94.73  E-value=0.15  Score=46.81  Aligned_cols=28  Identities=29%  Similarity=0.229  Sum_probs=23.5

Q ss_pred             CeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          199 PIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ..+|.|+-+.||+.+++ .+.++||-.|.
T Consensus       228 VfCHNDL~~gNIL~~~~-~l~lID~EYA~  255 (383)
T PTZ00384        228 LFCHNDLFFTNILDFNQ-GIYFIDFDFAG  255 (383)
T ss_pred             eeeeccCCcccEEecCC-CEEEEEecccc
Confidence            48999999999987654 69999998763

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.45  E-value=2.8  Score=37.64  Aligned_cols=27  Identities=22%  Similarity=0.310  Sum_probs=23.1

Q ss_pred             CeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          199 PIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      .++|+|+.+.||+++ + .+.++||+.+.
T Consensus       197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            389999999999995 4 57899999874

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.40  E-value=0.25  Score=45.23  Aligned_cols=78  Identities=18%  Similarity=0.113  Sum_probs=48.0

Q ss_pred             cceecccCcEEEEEEEecC-CcEEEEEecccccC--hHHHHhHHHHHHHHHHHhhcC--CC-CceeeeeEEeeCCcceEE
Q 040763           76 NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVD--DEELYKLEEFINEIFILSQIN--HR-NVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~--~~~~~~~~~~~~e~~~~~~l~--h~-niv~~~~~~~~~~~~~lv  149 (360)
                      .+.||-|.-..||++...+ ++.++||.-..-..  ..-....++..-|.+.|+...  .| .+.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4568999999999998753 56799986322111  111223455666777777663  24 45555544  34455788


Q ss_pred             EEecCC
Q 040763          150 YEFIPN  155 (360)
Q Consensus       150 ~e~~~~  155 (360)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888743

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.80  E-value=0.056  Score=43.97  Aligned_cols=28  Identities=14%  Similarity=0.255  Sum_probs=25.1

Q ss_pred             CeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          199 PIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ..+|+|+.|.|+++++++ ++++||+.+.
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            479999999999998887 8999999885

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.46  E-value=0.33  Score=44.33  Aligned_cols=58  Identities=17%  Similarity=0.173  Sum_probs=39.6

Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeEEc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH-SGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~H~dlk~~Nill~  213 (360)
                      .++=+|..|.++..++....      .++..+..++.-.++|+.-+- -.+   ++|.|+.|.||++.
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~------~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlir  379 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS------QPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeeccccccHHhhhhccc------ChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEE
Confidence            34556778888888886532      344556666666666665433 234   99999999999994

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.04  E-value=0.11  Score=45.98  Aligned_cols=53  Identities=21%  Similarity=0.226  Sum_probs=33.1

Q ss_pred             HHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCC------------------CcEEEeecCCccccC
Q 040763          178 RFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDER------------------YRAKVADFGTSKFIA  230 (360)
Q Consensus       178 ~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~------------------~~~kl~Dfg~~~~~~  230 (360)
                      +.-++.|+|.-.--.... +....+|.||||+||||-+.                  -.++|.||.++...+
T Consensus       277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence            444566765433223222 23449999999999999443                  236778888876543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=92.88  E-value=0.073  Score=39.98  Aligned_cols=31  Identities=29%  Similarity=0.430  Sum_probs=27.6

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEeccccc
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAV  107 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~  107 (360)
                      +-||.|+.|.||+|+.++|+.||||+.+...
T Consensus        17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i   47 (119)
T PF03109_consen   17 EPLASASIAQVHRARLKDGEEVAVKVQRPGI   47 (119)
T ss_pred             chhhheehhhheeeeecccchhhhhhcchHH
Confidence            4599999999999999999999999987643

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	360
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-47
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-47
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-33
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-33
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-32
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-31
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-30
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-27
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-26
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-26
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-24
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-23
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-23
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-23
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-23
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-23
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-23
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-23
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-22
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-22
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-22
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-22
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-22
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-22
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-22
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-22
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-22
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-21
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-21
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-21
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-21
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-21
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-21
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-21
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-21
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-21
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-21
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-21
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-21
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-21
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-21
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-21
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-21
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-21
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-21
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-21
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-20
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-20
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-19
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-19
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-19
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-19
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-19
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-18
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-07
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-07
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-07
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-07
3soa_A	444	Full-Length Human Camkii Length = 444		3e-07
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-07
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-07
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-07
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-07
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-07
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-07
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-07
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-07
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-07
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-07
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-07
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 106/301 (35%), Positives = 172/301 (57%), Gaps = 8/301 (2%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYK 114
           + + K FS +EL  A+++F+   ILG+GG G VYKGRL DG ++AVK+ K     EE  +
Sbjct: 22  LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK-----EERXQ 76
Query: 115 LEE--FINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
             E  F  E+ ++S   HRN+++L G C+     LLVY ++ NG++   L +R +++  P
Sbjct: 77  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-P 135
Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 232
           L W  R R+A+  A  LAYLH      I HRD+K+ NILLDE + A V DFG +K +   
Sbjct: 136 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 195
Query: 233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
             HV   ++GT G++ PEY  + + ++K+DV+ +GV+L+EL+TG++        + ++V 
Sbjct: 196 DXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 255
Query: 293 LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
           L  +    +++ +L  ++D  +    K  ++     +A  C   +  +RP M EV   L 
Sbjct: 256 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315
Query: 353 G 353
           G
Sbjct: 316 G 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  184 bits (468), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 170/300 (56%), Gaps = 6/300 (2%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYK 114
           + + K FS +EL  A+++F    ILG+GG G VYKGRL DG ++AVK+ K    +E    
Sbjct: 14  LGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLK----EERTQG 69
Query: 115 LE-EFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPL 173
            E +F  E+ ++S   HRN+++L G C+     LLVY ++ NG++   L +R +++  PL
Sbjct: 70  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PL 128
Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 233
            W  R R+A+  A  LAYLH      I HRD+K+ NILLDE + A V DFG +K +    
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 234 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
            HV   ++G  G++ PEY  + + ++K+DV+ +GV+L+EL+TG++        + ++V L
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG 353
             +    +++ +L  ++D  +    K  ++     +A  C   +  +RP M EV   L G
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 114/291 (39%), Positives = 168/291 (57%), Gaps = 17/291 (5%)
Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           +L++ATN+F+   ++G G  G VYKG L DG  +A+K+       E    +EEF  EI  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT----PESSQGIEEFETEIET 88
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP---LTWEMRFRV 181
           LS   H ++V L+G C E    +L+Y+++ NG L +HL+      + P   ++WE R  +
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY----GSDLPTMSMSWEQRLEI 144
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKI 240
            I  A  L YLH+ A   I HRD+KS NILLDE +  K+ DFG SK    +DQTH+   +
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
           +GT GY+DPEY    +LT+KSDVYSFGVVL E+L  +  I  +    +E V+LA + V S
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS--LPREMVNLAEWAVES 259
Query: 301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
               +L  I+D  +    +   +  F + A +CL L+ + RP+M +V  +L
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 113/291 (38%), Positives = 167/291 (57%), Gaps = 17/291 (5%)
Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           +L++ATN+F+   ++G G  G VYKG L DG  +A+K+       E    +EEF  EI  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT----PESSQGIEEFETEIET 88
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP---LTWEMRFRV 181
           LS   H ++V L+G C E    +L+Y+++ NG L +HL+      + P   ++WE R  +
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY----GSDLPTMSMSWEQRLEI 144
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKI 240
            I  A  L YLH+ A   I HRD+KS NILLDE +  K+ DFG SK    + QTH+   +
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
           +GT GY+DPEY    +LT+KSDVYSFGVVL E+L  +  I  +    +E V+LA + V S
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS--LPREMVNLAEWAVES 259
Query: 301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
               +L  I+D  +    +   +  F + A +CL L+ + RP+M +V  +L
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 106/309 (34%), Positives = 161/309 (52%), Gaps = 28/309 (9%)
Query: 61  FSSKELDKATNHFNVNRI------LGQGGQGTVYKGRLEDGRIIAVKKSKLAVD--DEEL 112
           FS  EL   TN+F+   I      +G+GG G VYKG + +   +AVKK    VD   EEL
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 113 YKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
              ++F  EI ++++  H N+V+LLG   + +   LVY ++PNG+L   L     +   P
Sbjct: 74  K--QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPP 129
Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG----TSKF 228
           L+W MR ++A   A  + +LH        HRDIKS NILLDE + AK++DFG    + KF
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
               QT + ++I GT  Y+ PE  +  ++T KSD+YSFGVVL+E++TG   +    +  +
Sbjct: 187 A---QTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV----DEHR 238
Query: 289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS 348
           E   L         + +      D+ M       + A  ++A +CL     KRP +++V 
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 349 MELNGIRGS 357
             L  +  S
Sbjct: 299 QLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 106/309 (34%), Positives = 160/309 (51%), Gaps = 28/309 (9%)
Query: 61  FSSKELDKATNHFNVNRI------LGQGGQGTVYKGRLEDGRIIAVKKSKLAVD--DEEL 112
           FS  EL   TN+F+   I      +G+GG G VYKG + +   +AVKK    VD   EEL
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 113 YKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
              ++F  EI ++++  H N+V+LLG   + +   LVY ++PNG+L   L     +   P
Sbjct: 74  K--QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPP 129
Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG----TSKF 228
           L+W MR ++A   A  + +LH        HRDIKS NILLDE + AK++DFG    + KF
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
               QT +  +I GT  Y+ PE  +  ++T KSD+YSFGVVL+E++TG   +    +  +
Sbjct: 187 A---QTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV----DEHR 238
Query: 289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS 348
           E   L         + +      D+ M       + A  ++A +CL     KRP +++V 
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 349 MELNGIRGS 357
             L  +  S
Sbjct: 299 QLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 105/309 (33%), Positives = 159/309 (51%), Gaps = 28/309 (9%)
Query: 61  FSSKELDKATNHFNVNRI------LGQGGQGTVYKGRLEDGRIIAVKKSKLAVD--DEEL 112
           FS  EL   TN+F+   I      +G+GG G VYKG + +   +AVKK    VD   EEL
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 113 YKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
              ++F  EI ++++  H N+V+LLG   + +   LVY ++PNG+L   L     +   P
Sbjct: 68  K--QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPP 123
Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG----TSKF 228
           L+W MR ++A   A  + +LH        HRDIKS NILLDE + AK++DFG    + KF
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
               Q  +  +I GT  Y+ PE  +  ++T KSD+YSFGVVL+E++TG   +    +  +
Sbjct: 181 A---QXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAV----DEHR 232
Query: 289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS 348
           E   L         + +      D+ M       + A  ++A +CL     KRP +++V 
Sbjct: 233 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 292
Query: 349 MELNGIRGS 357
             L  +  S
Sbjct: 293 QLLQEMTAS 301

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 96/297 (32%), Positives = 151/297 (50%), Gaps = 41/297 (13%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEE---LYKLEEFINEIFI 124
           A N     + +G+GG G V+KGRL +D  ++A+K   L   + E   + K +EF  E+FI
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           +S +NH N+VKL G  L    P +V EF+P G LY  L D+     +P+ W ++ R+ ++
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLD 130
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNIL---LDERYR--AKVADFGTSKFIAMDQTHVTTK 239
           +A  + Y+ +  + PI HRD++S NI    LDE     AKVADFGTS+       H  + 
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSG 185
Query: 240 IQGTFGYLDPEY--HQSSQLTDKSDVYSFGVVLVELLTGKKPI--FSTGNTSQENVSLAA 295
           + G F ++ PE    +    T+K+D YSF ++L  +LTG+ P   +S G           
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-------- 237
Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
            F++ +R+  L   + +               N+ E C   + KKRP    +  EL+
Sbjct: 238 -FINMIREEGLRPTIPEDCPP--------RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 95/297 (31%), Positives = 150/297 (50%), Gaps = 41/297 (13%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEE---LYKLEEFINEIFI 124
           A N     + +G+GG G V+KGRL +D  ++A+K   L   + E   + K +EF  E+FI
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           +S +NH N+VKL G  L    P +V EF+P G LY  L D+     +P+ W ++ R+ ++
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLD 130
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNIL---LDERYR--AKVADFGTSKFIAMDQTHVTTK 239
           +A  + Y+ +  + PI HRD++S NI    LDE     AKVADFG S+       H  + 
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSG 185
Query: 240 IQGTFGYLDPEY--HQSSQLTDKSDVYSFGVVLVELLTGKKPI--FSTGNTSQENVSLAA 295
           + G F ++ PE    +    T+K+D YSF ++L  +LTG+ P   +S G           
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-------- 237
Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
            F++ +R+  L   + +               N+ E C   + KKRP    +  EL+
Sbjct: 238 -FINMIREEGLRPTIPEDCPP--------RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 94/297 (31%), Positives = 149/297 (50%), Gaps = 41/297 (13%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEE---LYKLEEFINEIFI 124
           A N     + +G+GG G V+KGRL +D  ++A+K   L   + E   + K +EF  E+FI
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           +S +NH N+VKL G  L    P +V EF+P G LY  L D+     +P+ W ++ R+ ++
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLD 130
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNIL---LDERYR--AKVADFGTSKFIAMDQTHVTTK 239
           +A  + Y+ +  + PI HRD++S NI    LDE     AKVADF  S+       H  + 
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSG 185
Query: 240 IQGTFGYLDPEY--HQSSQLTDKSDVYSFGVVLVELLTGKKPI--FSTGNTSQENVSLAA 295
           + G F ++ PE    +    T+K+D YSF ++L  +LTG+ P   +S G           
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-------- 237
Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
            F++ +R+  L   + +               N+ E C   + KKRP    +  EL+
Sbjct: 238 -FINMIREEGLRPTIPEDCPP--------RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 125/225 (55%), Gaps = 18/225 (8%)
Query: 61  FSSKELDKATNHFNVNRI------LGQGGQGTVYKGRLEDGRIIAVKKSKLAVD--DEEL 112
           FS  EL   TN+F+   I       G+GG G VYKG + +   +AVKK    VD   EEL
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 113 YKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
              ++F  EI + ++  H N+V+LLG   + +   LVY + PNG+L   L     +   P
Sbjct: 65  K--QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL--SCLDGTPP 120
Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-M 231
           L+W  R ++A   A  + +LH        HRDIKS NILLDE + AK++DFG ++     
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG 276
            Q    ++I GT  Y  PE  +  ++T KSD+YSFGVVL+E++TG
Sbjct: 178 AQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITG 221

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 79/234 (33%), Positives = 125/234 (53%), Gaps = 12/234 (5%)
Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           ++D      N+   +G G  GTV++     G  +AVK   L   D    ++ EF+ E+ I
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKI--LMEQDFHAERVNEFLREVAI 87
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           + ++ H N+V  +G   +     +V E++  G+LY+ LH     E+  L    R  +A +
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYD 145
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGT 243
           VA  + YLH+  + PI HR++KS N+L+D++Y  KV DFG S+  A   T +++K   GT
Sbjct: 146 VAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGT 202
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
             ++ PE  +     +KSDVYSFGV+L EL T ++P    GN +   V  A  F
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP---WGNLNPAQVVAAVGF 253

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/233 (33%), Positives = 121/233 (51%), Gaps = 10/233 (4%)
Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           ++D      N+   +G G  GTV++     G  +AVK   L   D    ++ EF+ E+ I
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKI--LMEQDFHAERVNEFLREVAI 87
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           + ++ H N+V  +G   +     +V E++  G+LY+ LH     E+  L    R  +A +
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYD 145
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           VA  + YLH+  + PI HRD+KS N+L+D++Y  KV DFG S+  A      +    GT 
Sbjct: 146 VAKGMNYLHN-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-SXFLXSKXAAGTP 203
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
            ++ PE  +     +KSDVYSFGV+L EL T ++P    GN +   V  A  F
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP---WGNLNPAQVVAAVGF 253

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 32/274 (11%)
Query: 75  VNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV 134
           V  ++G+G  G V K +    + +A+K+    ++ E   K   FI E+  LS++NH N+V
Sbjct: 13  VEEVVGRGAFGVVCKAKWR-AKDVAIKQ----IESESERK--AFIVELRQLSRVNHPNIV 65
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
           KL G CL      LV E+   G+LY  LH       Y     M +   ++ +  +AYLHS
Sbjct: 66  KLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW--CLQCSQGVAYLHS 121
Query: 195 GASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
                + HRD+K  N+LL       K+ DFGT+  I   QTH+T   +G+  ++ PE  +
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFE 177
Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQ 313
            S  ++K DV+S+G++L E++T +KP    G  +   +    + VH+  +  L       
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAVHNGTRPPLI------ 227
Query: 314 VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                 KN      +L  RC   +  +RP+MEE+
Sbjct: 228 ------KNLPKPIESLMTRCWSKDPSQRPSMEEI 255

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 32/274 (11%)
Query: 75  VNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV 134
           V  ++G+G  G V K +    + +A+K+    ++ E   K   FI E+  LS++NH N+V
Sbjct: 12  VEEVVGRGAFGVVCKAKWR-AKDVAIKQ----IESESERK--AFIVELRQLSRVNHPNIV 64
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
           KL G CL      LV E+   G+LY  LH       Y     M +   ++ +  +AYLHS
Sbjct: 65  KLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW--CLQCSQGVAYLHS 120
Query: 195 GASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
                + HRD+K  N+LL       K+ DFGT+  I   QTH+T   +G+  ++ PE  +
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFE 176
Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQ 313
            S  ++K DV+S+G++L E++T +KP    G  +   +    + VH+  +  L       
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAVHNGTRPPLI------ 226
Query: 314 VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                 KN      +L  RC   +  +RP+MEE+
Sbjct: 227 ------KNLPKPIESLMTRCWSKDPSQRPSMEEI 254

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 138/300 (46%), Gaps = 41/300 (13%)
Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           E+D A     +  I+G GG G VY+     G  +AVK ++   D++    +E    E  +
Sbjct: 3   EIDFA--ELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            + + H N++ L G CL+     LV EF   G L + L  +    +  + W      A++
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQ 113
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYR--------AKVADFGTSKFIAMDQTHV 236
           +A  + YLH  A  PI HRD+KS+NIL+ ++           K+ DFG ++     + H 
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHR 168
Query: 237 TTKIQ--GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           TTK+   G + ++ PE  ++S  +  SDV+S+GV+L ELLTG+ P       +       
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------- 221
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
               + +  N+L   +     +         FA L E C + +   RP+   +  +L  I
Sbjct: 222 --VAYGVAMNKLALPIPSTCPE--------PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 31  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 85
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 86  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 141
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGT 243
             + +L   AS    HRD+ + N +LDE++  KVADFG ++ +     D  H  T  +  
Sbjct: 142 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 198
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 199 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 248

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 38  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 92
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 93  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 148
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGT 243
             + +L   AS    HRD+ + N +LDE++  KVADFG ++ +     D  H  T  +  
Sbjct: 149 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 205
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 206 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 255

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 117/223 (52%), Gaps = 20/223 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 34  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 88
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 89  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 144
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGT 243
             + +L   AS    HRD+ + N +LDE++  KVADFG ++ +     D  H  T  +  
Sbjct: 145 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLP 201
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT
Sbjct: 202 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 244

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 117/223 (52%), Gaps = 20/223 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 34  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 88
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 89  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 144
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGT 243
             + +L   AS    HRD+ + N +LDE++  KVADFG ++ +     D  H  T  +  
Sbjct: 145 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 201
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT
Sbjct: 202 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 244

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 87
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 88  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 143
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGT 243
             + +L   AS    HRD+ + N +LDE++  KVADFG ++ +     D  H  T  +  
Sbjct: 144 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 87
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 88  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 143
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGT 243
             + +L   AS    HRD+ + N +LDE++  KVADFG ++ +     D  H  T  +  
Sbjct: 144 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 117/223 (52%), Gaps = 20/223 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 92  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 146
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 202
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGT 243
             + +L   AS    HRD+ + N +LDE++  KVADFG ++ +     D  H  T  +  
Sbjct: 203 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 116/223 (52%), Gaps = 20/223 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 32  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 86
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 87  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 142
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +        H  T  +  
Sbjct: 143 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLP 199
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT
Sbjct: 200 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 242

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 84
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 85  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 140
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ---THVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +   +    H  T  +  
Sbjct: 141 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 197
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 25  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 79
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 80  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 135
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ---THVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +   +    H  T  +  
Sbjct: 136 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 192
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 193 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 242

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 117/223 (52%), Gaps = 20/223 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 87
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 88  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 143
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ---THVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +   +    H  T  +  
Sbjct: 144 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 200
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 243

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 117/223 (52%), Gaps = 20/223 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 52  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 106
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 107 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 162
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ---THVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +   +    H  T  +  
Sbjct: 163 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 219
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT
Sbjct: 220 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 262

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 28  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 82
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 83  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 138
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ---THVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +   +    H  T  +  
Sbjct: 139 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 117/223 (52%), Gaps = 20/223 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 51  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 105
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 106 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 161
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ---THVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +   +    H  T  +  
Sbjct: 162 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 218
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT
Sbjct: 219 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 261

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 32  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 86
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 87  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 142
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ---THVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +   +    H  T  +  
Sbjct: 143 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 199
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 200 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 249

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 31  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 85
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 86  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 141
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ---THVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +   +    H  T  +  
Sbjct: 142 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 198
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 199 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 248

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           HFN   ++G+G  G VY G L   DG+ I  AVK      D  E+    +F+ E  I+  
Sbjct: 33  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 87
Query: 128 INHRNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +H NV+ LLG CL +E  PL+V  ++ +G L   +    +NE +  T +      ++VA
Sbjct: 88  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVA 143
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ---THVTTKIQGT 243
             + YL   AS    HRD+ + N +LDE++  KVADFG ++ +   +    H  T  +  
Sbjct: 144 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 200
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
             ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT    V L
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 117
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S  +    +  TT + G
Sbjct: 118 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCG 171
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 220
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 221 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 257

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 123/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 119
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S      +    T + G
Sbjct: 120 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCG 173
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 222
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 223 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 259

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 123/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 115
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S      +    T + G
Sbjct: 116 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCG 169
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 218
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 219 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 255

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 114/231 (49%), Gaps = 16/231 (6%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS + +       V + +G G  GTVYKG+      +AVK   L V      +L+ F NE
Sbjct: 3   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNE 58
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
           + +L +  H N++  +G   + +   +V ++    +LY HLH      E     +    +
Sbjct: 59  VGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLH----ASETKFEMKKLIDI 113
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKI 240
           A + A  + YLH+ +   I HRD+KS NI L E    K+ DFG +   +    +H   ++
Sbjct: 114 ARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQL 170
Query: 241 QGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            G+  ++ PE      S+  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 171 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 221

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 119
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S  +    +  TT + G
Sbjct: 120 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCG 173
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 222
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 223 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 117
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S  +    +  TT + G
Sbjct: 118 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCG 171
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 220
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 221 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 257

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 119
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S  +    +  TT + G
Sbjct: 120 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCG 173
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 174 TLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 222
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 223 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPXLREV 259

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 122/284 (42%), Gaps = 30/284 (10%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           K+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYIT 116
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S       +   T + GT
Sbjct: 117 ELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGT 170
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
             YL PE  +     +K D++S GV+  E L GK P     NT QE            R 
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RI 219
Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 220 SRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 255

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 114/231 (49%), Gaps = 16/231 (6%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS + +       V + +G G  GTVYKG+      +AVK   L V      +L+ F NE
Sbjct: 15  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNE 70
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
           + +L +  H N++  +G   + +   +V ++    +LY HLH      E     +    +
Sbjct: 71  VGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLH----ASETKFEMKKLIDI 125
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG-TSKFIAMDQTHVTTKI 240
           A + A  + YLH+ +   I HRD+KS NI L E    K+ DFG  ++      +H   ++
Sbjct: 126 ARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 241 QGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            G+  ++ PE      S+  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 120
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +    T++ GT  YL 
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTLDYLP 174
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 223
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 224 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 17  SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 76
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 77  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 131
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S  +    +  TT + G
Sbjct: 132 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCG 185
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 186 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 234
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 235 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 271

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 119
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +    T + GT  YL 
Sbjct: 120 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 173
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 222
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 223 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 253

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 124/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P G +Y+ L    + +E     +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE-----QRTATYI 119
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S  +    +  TT + G
Sbjct: 120 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCG 173
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 222
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 223 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 259

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 26  SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 85
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 86  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 140
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S  +    +  TT + G
Sbjct: 141 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCG 194
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 243
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 244 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 280

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 120
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +    T + GT  YL 
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTLDYLP 174
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 223
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 224 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 254

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 124
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +    T + GT  YL 
Sbjct: 125 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 178
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 227
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 228 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 122/285 (42%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 117
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S      +      + G
Sbjct: 118 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCG 171
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 220
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 221 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 257

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 120
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +    T + GT  YL 
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLP 174
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 223
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 224 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 254

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 123/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 117
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+A+FG S      +    T + G
Sbjct: 118 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCG 171
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 220
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 221 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 257

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 122/279 (43%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 120
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S  +    +  TT + GT  YL 
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLP 174
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 223
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 224 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 254

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 122/284 (42%), Gaps = 30/284 (10%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           K+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYIT 115
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S      +    T + GT
Sbjct: 116 ELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGT 169
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
             YL PE  +     +K D++S GV+  E L GK P     NT QE            R 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RI 218
Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 219 SRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 254

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 125/285 (43%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 116
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+A+FG S  +    +  TT + G
Sbjct: 117 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCG 170
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 219
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 220 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 256

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 122/285 (42%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 116
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S      +      + G
Sbjct: 117 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCG 170
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 219
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 220 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 256

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 122/285 (42%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 115
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S      +      + G
Sbjct: 116 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT---LCG 169
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 218
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 219 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 255

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 117
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +    T + GT  YL 
Sbjct: 118 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 171
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 220
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 221 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 251

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 121/285 (42%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P G +Y+ L    + +E     +      
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE-----QRTATYI 119
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S      +      + G
Sbjct: 120 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLXG 173
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 222
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 223 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 120
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +      + GT  YL 
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLP 174
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 223
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 224 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 254

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R ++ + I   K       E+     +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   ++    L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 120
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +      + GT  YL 
Sbjct: 121 LSYCHSKK---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLP 174
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT Q+            R +R+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQDTYK---------RISRVEF 223
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 224 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 254

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 116/241 (48%), Gaps = 32/241 (13%)
Query: 52  GSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEE 111
           GSVID  +L   +E+             G G  G V+ G   +   +A+K  +     EE
Sbjct: 1   GSVIDPSELTFVQEI-------------GSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE 47
Query: 112 LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                +FI E  ++ +++H  +V+L G CLE     LV+EF+ +G L  +L  R Q   +
Sbjct: 48  -----DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLF 100
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
               E    + ++V   +AYL   +   + HRD+ + N L+ E    KV+DFG ++F+  
Sbjct: 101 AA--ETLLGMCLDVCEGMAYLEEAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 155
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           DQ   +T  +    +  PE    S+ + KSDV+SFGV++ E       +FS G    EN 
Sbjct: 156 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE-------VFSEGKIPYENR 208
Query: 292 S 292
           S
Sbjct: 209 S 209

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 123
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +      + GT  YL 
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLP 177
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 226
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 227 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 120
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +      + GT  YL 
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLP 174
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 223
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 224 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 254

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 20/223 (8%)
Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
              V + +G G  GTVYKG+      +AVK   L V      +L+ F NE+ +L +  H 
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIEVAGAL 189
           N++  +G     +   +V ++    +LY HLH           +EM+    +A + A  +
Sbjct: 81  NILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETK------FEMKKLIDIARQTARGM 133
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG-TSKFIAMDQTHVTTKIQGTFGYLD 248
            YLH+ +   I HRD+KS NI L E    K+ DFG  ++      +H   ++ G+  ++ 
Sbjct: 134 DYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 249 PE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           PE      S+  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS + +       V + +G G  GTVYKG+      +AVK   L V      +L+ F NE
Sbjct: 26  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNE 81
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR- 180
           + +L +  H N++  +G   + +  + V ++    +LY HLH            E +F  
Sbjct: 82  VGVLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH----------IIETKFEM 130
Query: 181 -----VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQT 234
                +A + A  + YLH+ +   I HRD+KS NI L E    K+ DFG +   +    +
Sbjct: 131 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 187
Query: 235 HVTTKIQGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           H   ++ G+  ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 188 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 244

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 32/241 (13%)
Query: 52  GSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEE 111
           GSVID  +L   +E+             G G  G V+ G   +   +A+K  +     EE
Sbjct: 1   GSVIDPSELTFVQEI-------------GSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE 47
Query: 112 LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                +FI E  ++ +++H  +V+L G CLE     LV+EF+ +G L  +L  R Q   +
Sbjct: 48  -----DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLF 100
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
               E    + ++V   +AYL       + HRD+ + N L+ E    KV+DFG ++F+  
Sbjct: 101 AA--ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 155
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           DQ   +T  +    +  PE    S+ + KSDV+SFGV++ E       +FS G    EN 
Sbjct: 156 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE-------VFSEGKIPYENR 208
Query: 292 S 292
           S
Sbjct: 209 S 209

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS + +       V + +G G  GTVYKG+      +AVK   L V      +L+ F NE
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNE 82
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR- 180
           + +L +  H N++  +G   + +  + V ++    +LY HLH            E +F  
Sbjct: 83  VGVLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH----------IIETKFEM 131
Query: 181 -----VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQT 234
                +A + A  + YLH+ +   I HRD+KS NI L E    K+ DFG +   +    +
Sbjct: 132 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 188
Query: 235 HVTTKIQGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           H   ++ G+  ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 189 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 245

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 122/285 (42%), Gaps = 30/285 (10%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           SK+   A   F + R LG+G  G VY  R +  + I   K       E+     +   E+
Sbjct: 26  SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 85
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            I S + H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +      
Sbjct: 86  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYI 140
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL+Y HS     + HRDIK  N+LL      K+ADFG S      +      + G
Sbjct: 141 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCG 194
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +     +K D++S GV+  E L GK P     NT QE            R
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------R 243
Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +R+     D V +  +        +L  R L  N  +RP + EV
Sbjct: 244 ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 280

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS + +       V + +G G  GTVYKG+      +AVK   L V      +L+ F NE
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNE 59
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR- 180
           + +L +  H N++  +G   + +  + V ++    +LY HLH            E +F  
Sbjct: 60  VGVLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH----------IIETKFEM 108
Query: 181 -----VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQT 234
                +A + A  + YLH+ +   I HRD+KS NI L E    K+ DFG +   +    +
Sbjct: 109 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 165
Query: 235 HVTTKIQGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           H   ++ G+  ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 166 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 222

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS + +       V + +G G  GTVYKG+      +AVK   L V      +L+ F NE
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNE 56
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR- 180
           + +L +  H N++  +G   + +  + V ++    +LY HLH            E +F  
Sbjct: 57  VGVLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH----------IIETKFEM 105
Query: 181 -----VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQT 234
                +A + A  + YLH+ +   I HRD+KS NI L E    K+ DFG +   +    +
Sbjct: 106 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 162
Query: 235 HVTTKIQGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           H   ++ G+  ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 163 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 219

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           A   F + R LG+G  G VY  R +  + I   K       E+     +   E+ I S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A A
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANA 123
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S      +      + GT  YL 
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLP 177
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE  +     +K D++S GV+  E L GK P     NT QE            R +R+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK---------RISRVEF 226
Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              D V +  +        +L  R L  N  +RP + EV
Sbjct: 227 TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 257

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS + +       V + +G G  GTVYKG+      +AVK   L V      +L+ F NE
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNE 59
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR- 180
           + +L +  H N++  +G   + +  + V ++    +LY HLH            E +F  
Sbjct: 60  VGVLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH----------IIETKFEM 108
Query: 181 -----VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQT 234
                +A + A  + YLH+ +   I HRD+KS NI L E    K+ DFG +   +    +
Sbjct: 109 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 165
Query: 235 HVTTKIQGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           H   ++ G+  ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 166 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 222

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G G  G V+ G   +   +A+K  +     EE     +FI E  ++ +++H  +V+L G
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 67
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
            CLE     LV+EF+ +G L  +L  R Q   +    E    + ++V   +AYL      
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAA--ETLLGMCLDVCEGMAYLEEAC-- 121
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
            + HRD+ + N L+ E    KV+DFG ++F+  DQ   +T  +    +  PE    S+ +
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 259 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
            KSDV+SFGV++ E       +FS G    EN S
Sbjct: 181 SKSDVWSFGVLMWE-------VFSEGKIPYENRS 207

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G G  G V+ G   +   +A+K  +     EE     +FI E  ++ +++H  +V+L G
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 72
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
            CLE     LV+EF+ +G L  +L  R Q   +    E    + ++V   +AYL      
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAA--ETLLGMCLDVCEGMAYLEEAC-- 126
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
            + HRD+ + N L+ E    KV+DFG ++F+  DQ   +T  +    +  PE    S+ +
Sbjct: 127 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 259 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
            KSDV+SFGV++ E       +FS G    EN S
Sbjct: 186 SKSDVWSFGVLMWE-------VFSEGKIPYENRS 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS + +       V + +G G  GTVYKG+      +AVK   L V      +L+ F NE
Sbjct: 19  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNE 74
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR- 180
           + +L +  H N++  +G   + +  + V ++    +LY HLH            E +F  
Sbjct: 75  VGVLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH----------IIETKFEM 123
Query: 181 -----VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG-TSKFIAMDQT 234
                +A + A  + YLH+ +   I HRD+KS NI L E    K+ DFG  ++      +
Sbjct: 124 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS 180
Query: 235 HVTTKIQGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           H   ++ G+  ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 181 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 237

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 114/237 (48%), Gaps = 28/237 (11%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           SS + +       V + +G G  GTVYKG+      +AVK   L V      +L+ F NE
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNE 82
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR- 180
           + +L +  H N++  +G   + +  + V ++    +LY HLH            E +F  
Sbjct: 83  VGVLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH----------IIETKFEM 131
Query: 181 -----VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG-TSKFIAMDQT 234
                +A + A  + YLH+ +   I HRD+KS NI L E    K+ DFG  ++      +
Sbjct: 132 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS 188
Query: 235 HVTTKIQGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           H   ++ G+  ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 189 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 245

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 127/282 (45%), Gaps = 31/282 (10%)
Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILS 126
           ++ + +  ILG GG   V+  R L D R +AVK  ++ LA D     +   F  E    +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR---FRREAQNAA 67
Query: 127 QINHRNVVKLLGCC-LETE---FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            +NH  +V +      ET     P +V E++   TL   +H      E P+T +    V 
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 122
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKI 240
            +   AL + H      I HRD+K  NIL+      KV DFG ++ IA     V  T  +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH- 299
            GT  YL PE  +   +  +SDVYS G VL E+LTG+ P   TG++    VS+A   V  
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSP---VSVAYQHVRE 234
Query: 300 -----SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDL 336
                S R   L   LD  V+K   KN    +   AE   DL
Sbjct: 235 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G G  G V+ G   +   +A+K  K     E+     +FI E  ++ +++H  +V+L G
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED-----DFIEEAEVMMKLSHPKLVQLYG 89
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
            CLE     LV+EF+ +G L  +L  R Q   +    E    + ++V   +AYL      
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAA--ETLLGMCLDVCEGMAYLEEAC-- 143
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
            + HRD+ + N L+ E    KV+DFG ++F+  DQ   +T  +    +  PE    S+ +
Sbjct: 144 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 259 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
            KSDV+SFGV++ E       +FS G    EN S
Sbjct: 203 SKSDVWSFGVLMWE-------VFSEGKIPYENRS 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 127/282 (45%), Gaps = 31/282 (10%)
Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILS 126
           ++ + +  ILG GG   V+  R L D R +AVK  ++ LA D     +   F  E    +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR---FRREAQNAA 67
Query: 127 QINHRNVVKLLGCC-LETE---FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            +NH  +V +      ET     P +V E++   TL   +H      E P+T +    V 
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 122
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT--TKI 240
            +   AL + H      I HRD+K  NI++      KV DFG ++ IA     VT    +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH- 299
            GT  YL PE  +   +  +SDVYS G VL E+LTG+ P   TG++    VS+A   V  
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSP---VSVAYQHVRE 234
Query: 300 -----SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDL 336
                S R   L   LD  V+K   KN    +   AE   DL
Sbjct: 235 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G G  G V+ G   +   +A+K  +     EE     +FI E  ++ +++H  +V+L G
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 70
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
            CLE     LV EF+ +G L  +L  R Q   +    E    + ++V   +AYL      
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAA--ETLLGMCLDVCEGMAYLEEAC-- 124
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
            + HRD+ + N L+ E    KV+DFG ++F+  DQ   +T  +    +  PE    S+ +
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 259 DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
            KSDV+SFGV++ E       +FS G    EN S
Sbjct: 184 SKSDVWSFGVLMWE-------VFSEGKIPYENRS 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 138 GCC-LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
           G C LE  F  +V E++P G L  +L + ++ E   +T  +   +A +++ A+ YL    
Sbjct: 95  GVCTLEPPF-YIVTEYMPYGNLLDYLRECNREE---VTAVVLLYMATQISSAMEYLE--- 147
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
                HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    + 
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNT 207
Query: 257 LTDKSDVYSFGVVLVELLT-GKKP 279
            + KSDV++FGV+L E+ T G  P
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 28/227 (12%)
Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
              V + +G G  GTVYKG+      +AVK   L V      +L+ F NE+ +L +  H 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR------VAIEV 185
           N++  +G   + +  + V ++    +LY HLH            E +F       +A + 
Sbjct: 65  NILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQT 113
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTF 244
           A  + YLH+ +   I HRD+KS NI L E    K+ DFG +   +    +H   ++ G+ 
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 245 GYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 28/227 (12%)
Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
              V + +G G  GTVYKG+      +AVK   L V      +L+ F NE+ +L +  H 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR------VAIEV 185
           N++  +G     +  + V ++    +LY HLH            E +F       +A + 
Sbjct: 65  NILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQT 113
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTF 244
           A  + YLH+ +   I HRD+KS NI L E    K+ DFG +   +    +H   ++ G+ 
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 245 GYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 28/227 (12%)
Query: 72  HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
              V + +G G  GTVYKG+      +AVK   L V      +L+ F NE+ +L +  H 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD--VAVKM--LNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR------VAIEV 185
           N++  +G   + +  + V ++    +LY HLH            E +F       +A + 
Sbjct: 65  NILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQT 113
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG-TSKFIAMDQTHVTTKIQGTF 244
           A  + YLH+ +   I HRD+KS NI L E    K+ DFG  ++      +H   ++ G+ 
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 170
Query: 245 GYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            ++ PE       +  + +SDVY+FG+VL EL+TG+ P  +  N  Q
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 126/282 (44%), Gaps = 31/282 (10%)
Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILS 126
           ++ + +  ILG GG   V+  R L D R +AVK  ++ LA D     +   F  E    +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR---FRREAQNAA 67
Query: 127 QINHRNVVKLLGCC-LETE---FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            +NH  +V +      ET     P +V E++   TL   +H      E P+T +    V 
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 122
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT--TKI 240
            +   AL + H      I HRD+K  NI++      KV DFG ++ IA     VT    +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH- 299
            GT  YL PE  +   +  +SDVYS G VL E+LTG+ P   TG++     S+A   V  
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSPD---SVAYQHVRE 234
Query: 300 -----SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDL 336
                S R   L   LD  V+K   KN    +   AE   DL
Sbjct: 235 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 118/275 (42%), Gaps = 30/275 (10%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           F++ R LG+G  G VY  R    + I   K       E+     +   E+ I S + H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A AL+Y 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE-----QRTATYITELANALSYC 128
Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
           HS     + HRDIK  N+LL      K+ADFG S      +    T + GT  YL PE  
Sbjct: 129 HSKR---VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMI 182
Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD 312
           +     +K D++S GV+  E L G  P     +T QE            R +R+     D
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPF--EAHTYQETYR---------RISRVEFTFPD 231
Query: 313 QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            V +  +        +L  R L  N  +R T+ EV
Sbjct: 232 FVTEGAR--------DLISRLLKHNASQRLTLAEV 258

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 113/216 (52%), Gaps = 16/216 (7%)
Query: 75  VNRILGQGGQGTVYKGRLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +NRILG+G  G VY+G   + +     +AVK  K    D  L   E+F++E  I+  ++H
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDH 84
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            ++VKL+G  +E E   ++ E  P G L  +L +R++N    LT  +    ++++  A+A
Sbjct: 85  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVL---YSLQICKAMA 139
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YL S       HRDI   NIL+      K+ DFG S++I  +  +  +  +    ++ PE
Sbjct: 140 YLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 196
Query: 251 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                + T  SDV+ F V + E+L+ GK+P F   N
Sbjct: 197 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 114/232 (49%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD +     + R++G G  G V  GRL+    R +AV    L V   E  +  +F+ 
Sbjct: 37  AKELDASC--IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR-RDFLC 93
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H NVV L G     +  ++V EF+ NG L   L  +H  +         F 
Sbjct: 94  EASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLR-KHDGQ---------FT 143
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
           V I++ G L  + +G    A     HRD+ + NIL++     KV+DFG S+ I  D   V
Sbjct: 144 V-IQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV 202
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE  Q  + T  SDV+S+G+V+ E+++ G++P +   N
Sbjct: 203 YTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 254

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 113/216 (52%), Gaps = 16/216 (7%)
Query: 75  VNRILGQGGQGTVYKGRLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +NRILG+G  G VY+G   + +     +AVK  K    D  L   E+F++E  I+  ++H
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDH 68
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            ++VKL+G  +E E   ++ E  P G L  +L +R++N    LT  +    ++++  A+A
Sbjct: 69  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVL---YSLQICKAMA 123
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YL S       HRDI   NIL+      K+ DFG S++I  +  +  +  +    ++ PE
Sbjct: 124 YLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 180
Query: 251 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                + T  SDV+ F V + E+L+ GK+P F   N
Sbjct: 181 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 113/216 (52%), Gaps = 16/216 (7%)
Query: 75  VNRILGQGGQGTVYKGRLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +NRILG+G  G VY+G   + +     +AVK  K    D  L   E+F++E  I+  ++H
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDH 72
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            ++VKL+G  +E E   ++ E  P G L  +L +R++N    LT  +    ++++  A+A
Sbjct: 73  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVL---YSLQICKAMA 127
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YL S       HRDI   NIL+      K+ DFG S++I  +  +  +  +    ++ PE
Sbjct: 128 YLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184
Query: 251 YHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                + T  SDV+ F V + E+L+ GK+P F   N
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 76  NRILGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           +R++G+G  G VY G   D    RI    KS   +   E+ ++E F+ E  ++  +NH N
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPN 83
Query: 133 VVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           V+ L+G  L  E  P ++  ++ +G L Q +    +N     T +      ++VA  + Y
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP----TVKDLISFGLQVARGMEY 139
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD------QTHVTTKIQGTFG 245
           L   A     HRD+ + N +LDE +  KVADFG ++ I +D      Q H   ++   + 
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKWT 195
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
            L  E  Q+ + T KSDV+SFGV+L ELLT   P +
Sbjct: 196 AL--ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   ++  +   +A +++ A+ YL     
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEK--- 127
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 132/303 (43%), Gaps = 40/303 (13%)
Query: 71  NHFNVNRILGQGGQGTVYKGRL--EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
             F + R+LG+G  G+V + +L  EDG  + V    L  D      +EEF+ E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 129 NHRNVVKLLGCCLET------EFPLLVYEFIPNGTLYQH-LHDRHQNEEYPLTWEMRFRV 181
           +H +V KL+G  L +        P+++  F+ +G L+   L  R     + L  +   R 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
            +++A  + YL   +S    HRD+ + N +L E     VADFG S+ I     +     Q
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----Q 195
Query: 242 GTFGYLDPEYHQSSQLTDK-----SDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA 295
           G    L  ++     L D      SDV++FGV + E++T G+ P         EN  +  
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-----ENAEIYN 250
Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
           Y +   R  +    +++               +L  +C   + K+RP+   + MEL  I 
Sbjct: 251 YLIGGNRLKQPPECMEE-------------VYDLMYQCWSADPKQRPSFTCLRMELENIL 297
Query: 356 GSI 358
           G +
Sbjct: 298 GHL 300

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN- 133
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKF 191
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 126/282 (44%), Gaps = 31/282 (10%)
Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILS 126
           ++ + +  ILG GG   V+  R L   R +AVK  ++ LA D     +   F  E    +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR---FRREAQNAA 67
Query: 127 QINHRNVVKLLGCC-LETE---FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            +NH  +V +      ET     P +V E++   TL   +H      E P+T +    V 
Sbjct: 68  ALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 122
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT--TKI 240
            +   AL + H      I HRD+K  NI++      KV DFG ++ IA     VT    +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH- 299
            GT  YL PE  +   +  +SDVYS G VL E+LTG+ P   TG++    VS+A   V  
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSP---VSVAYQHVRE 234
Query: 300 -----SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDL 336
                S R   L   LD  V+K   KN    +   AE   DL
Sbjct: 235 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN- 132
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 133 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKF 190
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSP 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 143/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    R LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 14  HLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 69
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ EF+P G+L ++L    +  ++   L +  +    
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 130 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 181 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 229
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 230 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 289
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 290 DQIRDNM 296

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   ++  +   +A +++ A+ YL     
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLE---K 129
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN- 132
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 133 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 190
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN- 136
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 194
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 49/288 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G G  GTVYKG+      +AVK   L V D    + + F NE+ +L +  H N++  +G
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKI--LKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR------VAIEVAGALAYL 192
              +    + V ++    +LY+HLH +          E +F+      +A + A  + YL
Sbjct: 100 YMTKDNLAI-VTQWCEGSSLYKHLHVQ----------ETKFQMFQLIDIARQTAQGMDYL 148
Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFG----TSKFIAMDQTHVTTKIQGTFGYLD 248
           H+     I HRD+KS NI L E    K+ DFG     S++    Q    T   G+  ++ 
Sbjct: 149 HA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT---GSVLWMA 202
Query: 249 PE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           PE      ++  + +SDVYS+G+VL EL+TG+ P +S  N   + + +      S   ++
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP-YSHINNRDQIIFMVGRGYASPDLSK 261
Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV--SMEL 351
           LY            KN   A   L   C+    ++RP   ++  S+EL
Sbjct: 262 LY------------KNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   ++  +   +A +++ A+ YL     
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLE---K 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   ++  +   +A +++ A+ YL     
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLE---K 129
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 23/227 (10%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + R LG+G  G V+          +D  ++AVK  K A D+      ++F  E  +L+ +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR----KDFHREAELLTNL 72
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR--------HQNEEYPLTWEMRFR 180
            H ++VK  G C+E +  ++V+E++ +G L + L             N    LT      
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTK 239
           +A ++A  + YL   AS    HRD+ + N L+ E    K+ DFG S+ + + D   V   
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE     + T +SDV+S GVVL E+ T GK+P +   N
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   ++  +   +A +++ A+ YL     
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEK--- 127
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   ++  +   +A +++ A+ YL     
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLE---K 129
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   ++  +   +A +++ A+ YL     
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLE---K 129
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   ++  +   +A +++ A+ YL     
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLE---K 127
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKF 187
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN- 131
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLE---K 142
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 143 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 202
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 203 SIKSDVWAFGVLLWEIATYGMSP 225

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN- 131
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN- 136
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLE---K 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN- 135
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 136 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSP 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 119/286 (41%), Gaps = 41/286 (14%)
Query: 67  DKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFIL 125
           D     F+  R +G G  G VY  R + +  ++A+KK   +   +   K ++ I E+  L
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFL 69
Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            ++ H N ++  GC L      LV E+           D  +  + PL       +A   
Sbjct: 70  QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA-----SDLLEVHKKPLQ---EVEIAAVT 121
Query: 186 AGAL---AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            GAL   AYLHS     + HRD+K+ NILL E    K+ DFG++  +A     V     G
Sbjct: 122 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----G 173
Query: 243 TFGYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
           T  ++ PE        Q   K DV+S G+  +EL   K P+F+    S            
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------- 222
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME 345
                 LYHI  ++   L   +    F N  + CL    + RPT E
Sbjct: 223 ------LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN- 136
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 117/275 (42%), Gaps = 30/275 (10%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           F++ R LG+G  G VY  R    + I   K       E+     +   E+ I S + H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +++L G   +     L+ E+ P GT+Y+ L    + +E     +       E+A AL+Y 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE-----QRTATYITELANALSYC 128
Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
           HS     + HRDIK  N+LL      K+ADFG S      +      + GT  YL PE  
Sbjct: 129 HSKR---VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT---LCGTLDYLPPEMI 182
Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD 312
           +     +K D++S GV+  E L G  P     +T QE            R +R+     D
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPF--EAHTYQETYR---------RISRVEFTFPD 231
Query: 313 QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            V +  +        +L  R L  N  +R T+ EV
Sbjct: 232 FVTEGAR--------DLISRLLKHNASQRLTLAEV 258

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLE---K 131
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLE---K 131
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 126/282 (44%), Gaps = 31/282 (10%)
Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILS 126
           ++ + +  ILG GG   V+  R L   R +AVK  ++ LA D     +   F  E    +
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR---FRREAQNAA 67
Query: 127 QINHRNVVKLLGCC-LETE---FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            +NH  +V +      ET     P +V E++   TL   +H      E P+T +    V 
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 122
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT--TKI 240
            +   AL + H      I HRD+K  NI++      KV DFG ++ IA     VT    +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH- 299
            GT  YL PE  +   +  +SDVYS G VL E+LTG+ P   TG++    VS+A   V  
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSP---VSVAYQHVRE 234
Query: 300 -----SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDL 336
                S R   L   LD  V+K   KN    +   AE   DL
Sbjct: 235 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 123/282 (43%), Gaps = 31/282 (10%)
Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILS 126
           ++ + +  ILG GG   V+  R L   R +AVK  ++ LA D     +   F  E    +
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR---FRREAQNAA 84
Query: 127 QINHRNVVKLLGCC-LETE---FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            +NH  +V +      ET     P +V E++   TL   +H      E P+T +    V 
Sbjct: 85  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 139
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT--TKI 240
            +   AL + H      I HRD+K  NI++      KV DFG ++ IA     VT    +
Sbjct: 140 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 196
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH- 299
            GT  YL PE  +   +  +SDVYS G VL E+LTG+ P      T    VS+A   V  
Sbjct: 197 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSVAYQHVRE 251
Query: 300 -----SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDL 336
                S R   L   LD  V+K   KN    +   AE   DL
Sbjct: 252 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 293

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAV---DDEELYKLEEFINEIFILSQINHRNVVK 135
           LG GG  TVY   L +  I+ +K +  A+     E+   L+ F  E+   SQ++H+N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           ++    E +   LV E+I   TL +++         PL+ +       ++   + + H  
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDM 130
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
               I HRDIK  NIL+D     K+ DFG +K ++      T  + GT  Y  PE  +  
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 256 QLTDKSDVYSFGVVLVELLTGKKP 279
              + +D+YS G+VL E+L G+ P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 119/286 (41%), Gaps = 41/286 (14%)
Query: 67  DKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFIL 125
           D     F+  R +G G  G VY  R + +  ++A+KK   +   +   K ++ I E+  L
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFL 108
Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            ++ H N ++  GC L      LV E+           D  +  + PL       +A   
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA-----SDLLEVHKKPLQ---EVEIAAVT 160
Query: 186 AGAL---AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            GAL   AYLHS     + HRD+K+ NILL E    K+ DFG++  +A     V     G
Sbjct: 161 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----G 212
Query: 243 TFGYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
           T  ++ PE        Q   K DV+S G+  +EL   K P+F+    S            
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------- 261
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME 345
                 LYHI  ++   L   +    F N  + CL    + RPT E
Sbjct: 262 ------LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 301

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 118/258 (45%), Gaps = 34/258 (13%)
Query: 52  GSVIDRCKLFSSKELDKATNHFNVNRI-----LGQGGQGTVYKGRL------EDGRIIAV 100
           G +I+  + FS    D   +H     I     LG+G  G V+          +D  ++AV
Sbjct: 21  GHIIENPQYFS----DACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAV 76
Query: 101 KKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQ 160
           K  K A +       ++F  E  +L+ + H+++V+  G C E    L+V+E++ +G L +
Sbjct: 77  KALKEASESAR----QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 132
Query: 161 HLHDRHQNEEY----------PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNI 210
            L     + +           PL       VA +VA  + YL   A     HRD+ + N 
Sbjct: 133 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNC 189
Query: 211 LLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVV 269
           L+ +    K+ DFG S+ I + D   V  +      ++ PE     + T +SDV+SFGVV
Sbjct: 190 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249
Query: 270 LVELLT-GKKPIFSTGNT 286
           L E+ T GK+P +   NT
Sbjct: 250 LWEIFTYGKQPWYQLSNT 267

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 121/252 (48%), Gaps = 18/252 (7%)
Query: 71  NHFNVNRILGQGGQGTVYKGRL--EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           N   + +ILG+G  G+V +G L  EDG  + V    + +D+    ++EEF++E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 129 NHRNVVKLLGCCLETEF-----PLLVYEFIPNGTLYQH-LHDRHQNEEYPLTWEMRFRVA 182
           +H NV++LLG C+E        P+++  F+  G L+ + L+ R +     +  +   +  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-Q 241
           +++A  + YL   ++    HRD+ + N +L +     VADFG SK I     +   +I +
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHS 300
               ++  E       T KSDV++FGV + E+ T G  P         +N  +  Y +H 
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-----PGVQNHEMYDYLLHG 265
Query: 301 MRKNRLYHILDD 312
            R  +    LD+
Sbjct: 266 HRLKQPEDCLDE 277

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 27  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 83
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  +H         + +F 
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KH---------DAQFT 133
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
           V I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 134 V-IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 244

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 119/232 (51%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 39  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 95
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  R  + ++         
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQF--------- 144
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
             I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 10  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 66
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  +H         + +F 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KH---------DAQFT 116
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
           V I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 117 V-IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 77  RILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLE-EFINEIFILSQINHRNVV 134
           ++LG G  GTVYKG  + +G  + +  +   +++    K   EF++E  I++ ++H ++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEVAGALAYL 192
           +LLG CL      LV + +P+G L +++H+   N   +  L W       +++A  + YL
Sbjct: 104 RLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 156
Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLDPEY 251
                  + HRD+ + N+L+      K+ DFG ++ +  D+        +    ++  E 
Sbjct: 157 EERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + T +SDV+S+GV + EL+T G KP
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 33/271 (12%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  GTVY    +  G+ +A+++  L    ++  K E  INEI ++ +  + N+V  L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V E++  G+L   + +   +E           V  E   AL +LHS   
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSNQ- 136
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRDIKS NILL      K+ DFG    I  +Q+  +T + GT  ++ PE       
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K D++S G++ +E++ G+ P  +      EN   A           LY I  +   +L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLN------ENPLRA-----------LYLIATNGTPEL 236
Query: 318 GKKNQIVA-FANLAERCLDLNGKKRPTMEEV 347
               ++ A F +   RCLD++ +KR + +E+
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 119/232 (51%), Gaps = 27/232 (11%)
Query: 71  NHFNVNRILGQGGQGTVY----KGRLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIF 123
           +HF + ++LGQG  G V+      R + G + A+K   K+ L V D    K+E  I    
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI---- 83
Query: 124 ILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE-MRFRV 181
            L+ +NH  VVKL     +TE  L L+ +F+  G L+  L     ++E   T E ++F +
Sbjct: 84  -LADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYL 136
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A E+A  L +LHS     I +RD+K  NILLDE    K+ DFG SK  A+D         
Sbjct: 137 A-ELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAYSFC 191
Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
           GT  Y+ PE       +  +D +S+GV++ E+LTG  P    G   +E ++L
Sbjct: 192 GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF--QGKDRKETMTL 241

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 77  RILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLE-EFINEIFILSQINHRNVV 134
           ++LG G  GTVYKG  + +G  + +  +   +++    K   EF++E  I++ ++H ++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEVAGALAYL 192
           +LLG CL      LV + +P+G L +++H+   N   +  L W       +++A  + YL
Sbjct: 81  RLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 133
Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGYLDPEY 251
                  + HRD+ + N+L+      K+ DFG ++ +  D+        +    ++  E 
Sbjct: 134 EERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + T +SDV+S+GV + EL+T G KP
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 119/232 (51%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 39  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 95
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  R  + ++         
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQF--------- 144
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
             I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 37  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 93
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  +H         + +F 
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KH---------DAQFT 143
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
           V I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 144 V-IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 254

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 119/232 (51%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 39  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 95
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  R  + ++         
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQF--------- 144
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
             I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 119/232 (51%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 39  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 95
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  R  + ++         
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQF--------- 144
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
             I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   ++  +   +A +++ A+ YL     
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKN- 338
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HR++ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSP 419

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 39  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 95
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  +H         + +F 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KH---------DAQFT 145
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
           V I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 146 V-IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 79  LGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           LG+G  G V+          +D  ++AVK  K A +       ++F  E  +L+ + H++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTMLQHQH 75
Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY----------PLTWEMRFRVA 182
           +V+  G C E    L+V+E++ +G L + L     + +           PL       VA
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQ 241
            +VA  + YL   A     HRD+ + N L+ +    K+ DFG S+ I + D   V  +  
Sbjct: 136 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 286
               ++ PE     + T +SDV+SFGVVL E+ T GK+P +   NT
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 238

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 79  LGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           LG+G  G V+          +D  ++AVK  K A +       ++F  E  +L+ + H++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTMLQHQH 81
Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY----------PLTWEMRFRVA 182
           +V+  G C E    L+V+E++ +G L + L     + +           PL       VA
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQ 241
            +VA  + YL   A     HRD+ + N L+ +    K+ DFG S+ I + D   V  +  
Sbjct: 142 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 286
               ++ PE     + T +SDV+SFGVVL E+ T GK+P +   NT
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 244

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 119/232 (51%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 39  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 95
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  R  + ++         
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQF--------- 144
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
             I++ G L  + SG    +     HRD+ + NIL++     KV+DFG ++ +  D    
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 10  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 66
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E + NG+L   L  +H         + +F 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-KH---------DAQFT 116
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
           V I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 117 V-IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 227

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  ++ +I H N+V+LL
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C       ++ EF+  G L  +L + ++ E   +   +   +A +++ A+ YL     
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKN- 377
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HR++ + N L+ E +  KVADFG S+ +  D        +    +  PE    ++ 
Sbjct: 378 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 435
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           + KSDV++FGV+L E+ T G  P
Sbjct: 436 SIKSDVWAFGVLLWEIATYGMSP 458

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 30/233 (12%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + R LG+G  G V+          +D  ++AVK    A+ D  L   ++F  E  +L+ +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNL 74
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-------------HDRHQNEEYPLTW 175
            H ++VK  G C + +  ++V+E++ +G L + L               R    E  L+ 
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS- 133
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQT 234
                +A ++A  + YL   AS    HRD+ + N L+      K+ DFG S+ + + D  
Sbjct: 134 -QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT 286
            V         ++ PE     + T +SDV+SFGV+L E+ T GK+P F   NT
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 118/232 (50%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 39  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 95
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E + NG+L   L  R  + ++         
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQF--------- 144
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
             I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 113/226 (50%), Gaps = 14/226 (6%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + A     ++R LGQG  G VY+G +  G +    ++++A+    +   + + 
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 66
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPL- 173
            EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R + E  P+ 
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 174 ---TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
              +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG ++ I 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIX 183
Query: 231 -MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 184 ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 41/292 (14%)
Query: 78  ILGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           +LG+G  G   K    E G ++ +K+  L   DEE  +   F+ E+ ++  + H NV+K 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQR--TFLKEVKVMRCLEHPNVLKF 72
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
           +G   + +    + E+I  GTL   +  +  + +YP  W  R   A ++A  +AYLHS  
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYP--WSQRVSFAKDIASGMAYLHSMN 128
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT-------------KIQGT 243
              I HRD+ S N L+ E     VADFG ++ +  ++T                  + G 
Sbjct: 129 ---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
             ++ PE        +K DV+SFG+VL E       I    N   + +     F  ++R 
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCE-------IIGRVNADPDYLPRTMDFGLNVRG 238
Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
                 LD    +    N   +F  +  RC DL+ +KRP+  ++   L  +R
Sbjct: 239 -----FLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 113/226 (50%), Gaps = 14/226 (6%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           +F   E + A     ++R LGQG  G VY+G +  G +    ++++A+    +   + + 
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 63
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPL- 173
            EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R + E  P+ 
Sbjct: 64  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 174 ---TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
              +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG ++ I 
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 118/232 (50%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 39  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 95
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L  R  + ++         
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQF--------- 144
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
             I++ G L  + SG    +     HRD+ + NIL++     KV+DFG  + +  D    
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 111/221 (50%), Gaps = 14/221 (6%)
Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKLEEFIN 120
           E + A     ++R LGQG  G VY+G +  G +    ++++A+    +   + +  EF+N
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPL----TW 175
           E  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R + E  P+    + 
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQT 234
               ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG ++ I   D  
Sbjct: 123 SKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
               K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 127/271 (46%), Gaps = 33/271 (12%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  GTVY    +  G+ +A+++  L    ++  K E  INEI ++ +  + N+V  L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V E++  G+L   + +   +E           V  E   AL +LHS   
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSNQ- 136
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRDIKS NILL      K+ DFG    I  +Q+   +++ GT  ++ PE       
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSEMVGTPYWMAPEVVTRKAY 193
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K D++S G++ +E++ G+ P  +      EN   A           LY I  +   +L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLN------ENPLRA-----------LYLIATNGTPEL 236
Query: 318 GKKNQIVA-FANLAERCLDLNGKKRPTMEEV 347
               ++ A F +   RCLD++ +KR + +E+
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 18  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 73
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 134 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 184
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 185 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 233
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 234 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 293
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 294 DQIRDNM 300

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 15  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 70
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 131 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 181
Query: 243 ---TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 182 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 230
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 231 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 290
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 291 DQIRDNM 297

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 17  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 72
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 133 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 183
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 184 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 232
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 233 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 292
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 293 DQIRDNM 299

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 66
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 127 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 178 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 226
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 287 DQIRDNM 293

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 84
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 145 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 243 ---TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 196 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 244
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 245 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 304
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 305 DQIRDNM 311

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 42/288 (14%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH- 130
           F +  ++G G  G VYKGR ++ G++ A+K   +  D+EE     E   EI +L + +H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-----EIKQEINMLKKYSHH 80
Query: 131 RNVVKLLGCCLETEFP------LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           RN+    G  ++   P       LV EF   G++   + +   N    L  E    +  E
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT---LKEEWIAYICRE 137
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +   L++LH      + HRDIK  N+LL E    K+ DFG S  +        T I GT 
Sbjct: 138 ILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 193
Query: 245 GYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
            ++ PE     +  D     KSD++S G+  +E+  G  P+                 +H
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD---------------MH 238
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            MR   L+ I  +   +L  K     F +  E CL  N  +RP  E++
Sbjct: 239 PMRA--LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 118/232 (50%), Gaps = 23/232 (9%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFIN 120
           +KELD ATN  ++++++G G  G V  GRL+    + I+V    L V   E  +  +F+ 
Sbjct: 39  AKELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLG 95
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E  I+ Q +H N+++L G   +++  ++V E + NG+L   L  R  + ++         
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQF--------- 144
Query: 181 VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
             I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D    
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 237 TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            T   G     +  PE     + T  SDV+S+G+VL E+++ G++P +   N
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 16  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 71
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 132 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 182
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 183 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 231
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 232 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 291
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 292 DQIRDNM 298

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 10  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 65
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 126 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 176
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 177 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 225
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 226 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 285
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 286 DQIRDNM 292

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 66
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 127 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 243 ---TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 178 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 226
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 287 DQIRDNM 293

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 84
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 145 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 243 ---TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 196 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 244
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 245 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 304
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 305 DQIRDNM 311

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 69
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 130 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 181 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 229
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 230 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 289
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 290 DQIRDNM 296

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 66
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 127 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 178 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 226
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 287 DQIRDNM 293

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 141/307 (45%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 42  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 97
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 158 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 208
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 209 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 257
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 258 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317
Query: 352 NGIRGSI 358
           + IR  +
Sbjct: 318 DQIRDQM 324

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 115/232 (49%), Gaps = 14/232 (6%)
Query: 54  VIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DD 109
           ++    ++   E + A     ++R LGQG  G VY+G +  G +    ++++A+    + 
Sbjct: 1   MVSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA 59
Query: 110 EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQN 168
             + +  EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R + 
Sbjct: 60  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 119
Query: 169 EEYPL----TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG 224
           E  P+    +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG
Sbjct: 120 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFG 176
Query: 225 TSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
            ++ I   D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 177 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 115/232 (49%), Gaps = 14/232 (6%)
Query: 54  VIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DD 109
           ++    ++   E + A     ++R LGQG  G VY+G +  G +    ++++A+    + 
Sbjct: 1   MVSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA 59
Query: 110 EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQN 168
             + +  EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R + 
Sbjct: 60  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 119
Query: 169 EEYPL----TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG 224
           E  P+    +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG
Sbjct: 120 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFG 176
Query: 225 TSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
            ++ I   D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 177 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 117/243 (48%), Gaps = 25/243 (10%)
Query: 50  YDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGR----IIAVKKSKL 105
           + G  I+       KE     ++F V R LG G  G V   + ++G     I  +KKS+ 
Sbjct: 16  FQGIAINPGMYVRKKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQF 74
Query: 106 -----AVDDEELYKL-EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLY 159
                + D++ + K  EE  NEI +L  ++H N++KL     + ++  LV EF   G L+
Sbjct: 75  DKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF 134
Query: 160 QHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER---Y 216
           + + +RH+ +E      M+     ++   + YLH      I HRDIK  NILL+ +    
Sbjct: 135 EQIINRHKFDECDAANIMK-----QILSGICYLH---KHNIVHRDIKPENILLENKNSLL 186
Query: 217 RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG 276
             K+ DFG S F + D  +      GT  Y+ PE  +  +  +K DV+S GV++  LL G
Sbjct: 187 NIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243
Query: 277 KKP 279
             P
Sbjct: 244 YPP 246

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 141/307 (45%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 9   HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 64
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 125 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 175
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 176 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 224
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 225 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 284
Query: 352 NGIRGSI 358
           + IR  +
Sbjct: 285 DQIRDQM 291

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 111/235 (47%), Gaps = 44/235 (18%)
Query: 78  ILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           +LGQG  G V K R   D R  A+KK +     EE  KL   ++E+ +L+ +NH+ VV+ 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR---HTEE--KLSTILSEVMLLASLNHQYVVRY 67
Query: 137 LGCCLETEF---PL----------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
               LE      P+          +  E+  NGTLY  +H  + N++    W + FR  +
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-FRQIL 126
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-------FIAMDQTHV 236
           E   AL+Y+HS     I HRD+K  NI +DE    K+ DFG +K        + +D  ++
Sbjct: 127 E---ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 237 T------TKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
                  T   GT  Y+  E    +    +K D+YS G++  E++      FSTG
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----FSTG 231

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 69
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         RD+ + NIL++   R K+ DFG +K +  D+     K  G
Sbjct: 130 MEYLGTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 181 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 229
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 230 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 289
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 290 DQIRDNM 296

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 118/232 (50%), Gaps = 27/232 (11%)
Query: 71  NHFNVNRILGQGGQGTVY---KGRLEDGRII----AVKKSKLAVDDEELYKLEEFINEIF 123
           + F + ++LGQG  G V+   K    D R +     +KK+ L V D    K+E  I    
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI---- 79
Query: 124 ILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE-MRFRV 181
            L ++NH  +VKL     +TE  L L+ +F+  G L+  L     ++E   T E ++F +
Sbjct: 80  -LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYL 132
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A E+A AL +LHS     I +RD+K  NILLDE    K+ DFG SK  ++D         
Sbjct: 133 A-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC 187
Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
           GT  Y+ PE       T  +D +SFGV++ E+LTG  P    G   +E +++
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF--QGKDRKETMTM 237

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 113/226 (50%), Gaps = 14/226 (6%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + A     ++R LGQG  G VY+G +  G +    ++++A+    +   + + 
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 66
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPL- 173
            EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R + E  P+ 
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 174 ---TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
              +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG ++ I 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 183
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 184 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 118/232 (50%), Gaps = 27/232 (11%)
Query: 71  NHFNVNRILGQGGQGTVY---KGRLEDGRII----AVKKSKLAVDDEELYKLEEFINEIF 123
           + F + ++LGQG  G V+   K    D R +     +KK+ L V D    K+E  I    
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI---- 80
Query: 124 ILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE-MRFRV 181
            L ++NH  +VKL     +TE  L L+ +F+  G L+  L     ++E   T E ++F +
Sbjct: 81  -LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYL 133
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A E+A AL +LHS     I +RD+K  NILLDE    K+ DFG SK  ++D         
Sbjct: 134 A-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC 188
Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
           GT  Y+ PE       T  +D +SFGV++ E+LTG  P    G   +E +++
Sbjct: 189 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF--QGKDRKETMTM 238

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 143/307 (46%), Gaps = 44/307 (14%)
Query: 72  HFNVNRILGQGGQGTVYKGR---LED--GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H    + LG+G  G+V   R   L+D  G ++AVKK + + ++     L +F  EI IL 
Sbjct: 12  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILK 67
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVA 182
            + H N+VK  G C         L+ E++P G+L  +L    +  ++   L +  +    
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +E  G   Y+H         R++ + NIL++   R K+ DFG +K +  D+ +   K  G
Sbjct: 128 MEYLGTKRYIH---------RNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 178
Query: 243 T---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
               F Y  PE    S+ +  SDV+SFGVVL EL T            +++ S  A F+ 
Sbjct: 179 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMR 227
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFAN--------LAERCLDLNGKKRPTMEEVSMEL 351
            +  ++   ++   +++L K N  +   +        +   C + N  +RP+  ++++ +
Sbjct: 228 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 287
Query: 352 NGIRGSI 358
           + IR ++
Sbjct: 288 DQIRDNM 294

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQIN 129
           F + R LG G  G V+  R   +GR  A+K  K ++ V    L ++E   +E  +LS + 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV---RLKQVEHTNDERLMLSIVT 64
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H  ++++ G   + +   ++ ++I  G L+  L  + Q    P+    +F  A EV  AL
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVA---KFYAA-EVCLAL 119
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
            YLHS     I +RD+K  NILLD+    K+ DFG +K++      VT  + GT  Y+ P
Sbjct: 120 EYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYXLCGTPDYIAP 172
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 283
           E   +       D +SFG+++ E+L G  P + +
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 118/232 (50%), Gaps = 27/232 (11%)
Query: 71  NHFNVNRILGQGGQGTVY---KGRLEDGRII----AVKKSKLAVDDEELYKLEEFINEIF 123
           + F + ++LGQG  G V+   K    D R +     +KK+ L V D    K+E  I    
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI---- 79
Query: 124 ILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE-MRFRV 181
            L ++NH  +VKL     +TE  L L+ +F+  G L+  L     ++E   T E ++F +
Sbjct: 80  -LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYL 132
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A E+A AL +LHS     I +RD+K  NILLDE    K+ DFG SK  ++D         
Sbjct: 133 A-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC 187
Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
           GT  Y+ PE       T  +D +SFGV++ E+LTG  P    G   +E +++
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF--QGKDRKETMTM 237

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 113/226 (50%), Gaps = 14/226 (6%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + A     ++R LGQG  G VY+G +  G +    ++++A+    +   + + 
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 94
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPL- 173
            EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R + E  P+ 
Sbjct: 95  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 154
Query: 174 ---TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
              +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG ++ I 
Sbjct: 155 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 211
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 212 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V  G+      +A+K  K     E+     EFI E  ++  ++H  +V+L G
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQLYG 66
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
            C +     ++ E++ NG L  +L + RH+ +   L       +  +V  A+ YL    S
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE---S 118
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L++++   KV+DFG S+++  D+   +   +    +  PE    S+ 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 258 TDKSDVYSFGVVLVELLT-GKKPI--FSTGNTSQ 288
           + KSD+++FGV++ E+ + GK P   F+   T++
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V  G+      +A+K  K     E+     EFI E  ++  ++H  +V+L G
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQLYG 71
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
            C +     ++ E++ NG L  +L + RH+ +   L       +  +V  A+ YL    S
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE---S 123
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L++++   KV+DFG S+++  D+   +   +    +  PE    S+ 
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 258 TDKSDVYSFGVVLVELLT-GKKPI--FSTGNTSQ 288
           + KSD+++FGV++ E+ + GK P   F+   T++
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 217

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 114/239 (47%), Gaps = 23/239 (9%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V  G+      +A+K  K     E+     EFI E  ++  ++H  +V+L G
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQLYG 86
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
            C +     ++ E++ NG L  +L + RH+ +   L       +  +V  A+ YL S   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLES--- 138
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L++++   KV+DFG S+++  D+   +   +    +  PE    S+ 
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKF 198
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY--HILDDQV 314
           + KSD+++FGV++ E       I+S G    E  + +    H  +  RLY  H+  ++V
Sbjct: 199 SSKSDIWAFGVLMWE-------IYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V  G+      +A+K  K     E+     EFI E  ++  ++H  +V+L G
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQLYG 70
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
            C +     ++ E++ NG L  +L + RH+ +   L       +  +V  A+ YL    S
Sbjct: 71  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE---S 122
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L++++   KV+DFG S+++  D+   +   +    +  PE    S+ 
Sbjct: 123 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 258 TDKSDVYSFGVVLVELLT-GKKPI--FSTGNTSQ 288
           + KSD+++FGV++ E+ + GK P   F+   T++
Sbjct: 183 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 216

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 113/226 (50%), Gaps = 14/226 (6%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + A     ++R LGQG  G VY+G +  G +    ++++A+    +   + + 
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 72
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPL- 173
            EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R + E  P+ 
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 132
Query: 174 ---TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
              +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG ++ I 
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 115/234 (49%), Gaps = 22/234 (9%)
Query: 52  GSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV---- 107
           GSV D        E + A     ++R LGQG  G VY+G +  G +    ++++A+    
Sbjct: 1   GSVPD--------EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN 51
Query: 108 DDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RH 166
           +   + +  EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R 
Sbjct: 52  EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 111
Query: 167 QNEEYPL----TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD 222
           + E  P+    +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ D
Sbjct: 112 EMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 168
Query: 223 FGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
           FG ++ I   D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 169 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V  G+      +A+K  K     E+     EFI E  ++  ++H  +V+L G
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQLYG 77
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
            C +     ++ E++ NG L  +L + RH+ +   L       +  +V  A+ YL    S
Sbjct: 78  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE---S 129
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L++++   KV+DFG S+++  D+   +   +    +  PE    S+ 
Sbjct: 130 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKPI--FSTGNTSQ 288
           + KSD+++FGV++ E+ + GK P   F+   T++
Sbjct: 190 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 223

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 116/234 (49%), Gaps = 27/234 (11%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEF 118
           +KE+D +     + +++G G  G V  GRL+  G+    +A+K  K    D++     +F
Sbjct: 23  AKEIDASC--IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDF 77
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++E  I+ Q +H N++ L G   + +  +++ E++ NG+L   L             + R
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN----------DGR 127
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
           F V I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D  
Sbjct: 128 FTV-IQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 235 HVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
              T   G     +  PE     + T  SDV+S+G+V+ E+++ G++P +   N
Sbjct: 187 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 240

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 116/234 (49%), Gaps = 27/234 (11%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEF 118
           +KE+D +     + +++G G  G V  GRL+  G+    +A+K  K    D++     +F
Sbjct: 8   AKEIDASC--IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDF 62
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++E  I+ Q +H N++ L G   + +  +++ E++ NG+L   L             + R
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN----------DGR 112
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
           F V I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D  
Sbjct: 113 FTV-IQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 171
Query: 235 HVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
              T   G     +  PE     + T  SDV+S+G+V+ E+++ G++P +   N
Sbjct: 172 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 225

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 114/239 (47%), Gaps = 23/239 (9%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V  G+      +A+K  K     E+     EFI E  ++  ++H  +V+L G
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQLYG 86
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
            C +     ++ E++ NG L  +L + RH+ +   L       +  +V  A+ YL    S
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE---S 138
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L++++   KV+DFG S+++  D+   +   +    +  PE    S+ 
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY--HILDDQV 314
           + KSD+++FGV++ E       I+S G    E  + +    H  +  RLY  H+  ++V
Sbjct: 199 SSKSDIWAFGVLMWE-------IYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 116/234 (49%), Gaps = 27/234 (11%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEF 118
           +KE+D +     + +++G G  G V  GRL+  G+    +A+K  K    D++     +F
Sbjct: 2   AKEIDASC--IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDF 56
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++E  I+ Q +H N++ L G   + +  +++ E++ NG+L   L             + R
Sbjct: 57  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN----------DGR 106
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
           F V I++ G L  + SG    +     HRD+ + NIL++     KV+DFG S+ +  D  
Sbjct: 107 FTV-IQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 165
Query: 235 HVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
              T   G     +  PE     + T  SDV+S+G+V+ E+++ G++P +   N
Sbjct: 166 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 219

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V  G+      +A+K  K     E+     EFI E  ++  ++H  +V+L G
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHEKLVQLYG 71
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
            C +     ++ E++ NG L  +L + RH+ +   L       +  +V  A+ YL    S
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE---S 123
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L++++   KV+DFG S+++  D+   +   +    +  PE    S+ 
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKF 183
Query: 258 TDKSDVYSFGVVLVELLT-GKKPI--FSTGNTSQ 288
           + KSD+++FGV++ E+ + GK P   F+   T++
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 217

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 33/271 (12%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  GTVY    +  G+ +A+++  L    ++  K E  INEI ++ +  + N+V  L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V E++  G+L   + +   +E           V  E   AL +LHS   
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSNQ- 137
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HR+IKS NILL      K+ DFG    I  +Q+  +T + GT  ++ PE       
Sbjct: 138 --VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 194
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K D++S G++ +E++ G+ P  +      EN   A           LY I  +   +L
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLN------ENPLRA-----------LYLIATNGTPEL 237
Query: 318 GKKNQIVA-FANLAERCLDLNGKKRPTMEEV 347
               ++ A F +   RCL+++ +KR + +E+
Sbjct: 238 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 268

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 33/271 (12%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  GTVY    +  G+ +A+++  L    ++  K E  INEI ++ +  + N+V  L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V E++  G+L   + +   +E           V  E   AL +LHS   
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSNQ- 136
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRDIKS NILL      K+ DFG    I  +Q+  +  + GT  ++ PE       
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAY 193
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K D++S G++ +E++ G+ P  +      EN   A           LY I  +   +L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLN------ENPLRA-----------LYLIATNGTPEL 236
Query: 318 GKKNQIVA-FANLAERCLDLNGKKRPTMEEV 347
               ++ A F +   RCL+++ +KR + +E+
Sbjct: 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 33/271 (12%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  GTVY    +  G+ +A+++  L    ++  K E  INEI ++ +  + N+V  L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V E++  G+L   + +   +E           V  E   AL +LHS   
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHSNQ- 137
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRDIKS NILL      K+ DFG    I  +Q+  +  + GT  ++ PE       
Sbjct: 138 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAY 194
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K D++S G++ +E++ G+ P  +      EN   A           LY I  +   +L
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLN------ENPLRA-----------LYLIATNGTPEL 237
Query: 318 GKKNQIVA-FANLAERCLDLNGKKRPTMEEV 347
               ++ A F +   RCL+++ +KR + +E+
Sbjct: 238 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 268

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 33/281 (11%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V+ GRL  D  ++AVK  +  +  +   K   F+ E  IL Q +H N+V+L+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK---FLQEARILKQYSHPNIVRLI 178
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C + +   +V E +  G     L    + E   L  +   ++  + A  + YL S   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSSQ 256
               HRD+ + N L+ E+   K++DFG S+  A      +  + Q    +  PE     +
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 257 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS--LAAYFVHSMRKNRLYHILDDQV 314
            + +SDV+SFG++L E        FS G +   N+S      FV    +     +  D V
Sbjct: 292 YSSESDVWSFGILLWE-------TFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV 344
Query: 315 MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
            +            L E+C      +RP+   +  EL  IR
Sbjct: 345 FR------------LMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 124/271 (45%), Gaps = 33/271 (12%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V   R +  GR +AVK     +D  +  + E   NE+ I+    H NVV++ 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK----MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  E   ++ EF+  G L   +     NEE   T      V   V  ALAYLH+   
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT------VCEAVLQALAYLHAQG- 161
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRDIKS +ILL    R K++DFG    I+ D       + GT  ++ PE    S  
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSLY 218
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             + D++S G++++E++ G+ P FS               V +M++ R     D    KL
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSP------------VQAMKRLR-----DSPPPKL 261
Query: 318 GKKNQI-VAFANLAERCLDLNGKKRPTMEEV 347
              +++     +  ER L  + ++R T +E+
Sbjct: 262 KNSHKVSPVLRDFLERMLVRDPQERATAQEL 292

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 112/226 (49%), Gaps = 14/226 (6%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + A     ++R LGQG  G VY+G +  G +    ++++A+    +   + + 
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 59
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD-RHQNEEYPL- 173
            EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L   R + E  P+ 
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 174 ---TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
              +     ++A E+A  +AYL++       HRD+ + N  + E +  K+ DFG ++ I 
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIY 176
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 31/298 (10%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           +F   E + +     + R LGQG  G VY+G   D  I    ++++AV    +   L + 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARD-IIKGEAETRVAVKTVNESASLRER 64
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE----- 170
            EF+NE  ++      +VV+LLG   + +  L+V E + +G L  +L       E     
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
            P T +   ++A E+A  +AYL++       HRD+ + N ++   +  K+ DFG ++ I 
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 181
Query: 231 -MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
             D      K      ++ PE  +    T  SD++SFGVVL E+                
Sbjct: 182 ETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------- 225
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             SLA      +   ++   + D        N      +L   C   N K RPT  E+
Sbjct: 226 -TSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 31/298 (10%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           +F   E + +     + R LGQG  G VY+G   D  I    ++++AV    +   L + 
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARD-IIKGEAETRVAVKTVNESASLRER 61
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE----- 170
            EF+NE  ++      +VV+LLG   + +  L+V E + +G L  +L       E     
Sbjct: 62  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 121
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
            P T +   ++A E+A  +AYL++       HRD+ + N ++   +  K+ DFG ++ I 
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 178
Query: 231 -MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
             D      K      ++ PE  +    T  SD++SFGVVL E+                
Sbjct: 179 ETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------- 222
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             SLA      +   ++   + D        N      +L   C   N K RPT  E+
Sbjct: 223 -TSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 279

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 33/281 (11%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V+ GRL  D  ++AVK  +  +  +   K   F+ E  IL Q +H N+V+L+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK---FLQEARILKQYSHPNIVRLI 178
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G C + +   +V E +  G     L    + E   L  +   ++  + A  + YL S   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI-QGTFGYLDPEYHQSSQ 256
               HRD+ + N L+ E+   K++DFG S+  A      +  + Q    +  PE     +
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 257 LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS--LAAYFVHSMRKNRLYHILDDQV 314
            + +SDV+SFG++L E        FS G +   N+S      FV    +     +  D V
Sbjct: 292 YSSESDVWSFGILLWE-------TFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV 344
Query: 315 MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
            +            L E+C      +RP+   +  EL  IR
Sbjct: 345 FR------------LMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 114/222 (51%), Gaps = 26/222 (11%)
Query: 76  NRILGQGGQGTVYKGRLEDGR-----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
            +++G G  G VYKG L+         +A+K  K    +++     +F+ E  I+ Q +H
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV---DFLGEAGIMGQFSH 105
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+++L G   + +  +++ E++ NG L + L  R ++ E+ +         +++ G L 
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSV---------LQLVGMLR 154
Query: 191 YLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTKIQGTF 244
            + +G    A+    HRD+ + NIL++     KV+DFG S+ +  D   T+ T+  +   
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +  PE     + T  SDV+SFG+V+ E++T G++P +   N
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V  G+ +    +AVK  K     E+     EF  E   + +++H  +VK  G
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-----EFFQEAQTMMKLSHPKLVKFYG 70
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
            C   E+P+ +V E+I NG L  +L    +  E     EM +    +V   +A+L S   
Sbjct: 71  VC-SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY----DVCEGMAFLESHQ- 124
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + N L+D     KV+DFG ++++  DQ   +   +    +  PE     + 
Sbjct: 125 --FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY--HILDDQVM 315
           + KSDV++FG+++ E       +FS G    +  + +   +   + +RLY  H+  D + 
Sbjct: 183 SSKSDVWAFGILMWE-------VFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIY 235
Query: 316 KLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
           +            +   C     +KRPT +++   +  +R
Sbjct: 236 Q------------IMYSCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 77  RILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           R LG+G  G V   R +      G  +AVK  K       +  L++   EI IL  + H 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHE 83
Query: 132 NVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+VK  G C E       L+ EF+P+G+L ++L  +++N+   +  + + + A+++   +
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNK---INLKQQLKYAVQICKGM 139
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK---IQGTFGY 246
            YL    S    HRD+ + N+L++  ++ K+ DFG +K I  D+   T K       F Y
Sbjct: 140 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 196
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             PE    S+    SDV+SFGV L ELLT
Sbjct: 197 A-PECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 23/210 (10%)
Query: 79  LGQGGQGTVYKG--RLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G+V +G  R+   +I +A+K  K   +  +    EE + E  I+ Q+++  +V+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVR 74
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI---EVAGALAYL 192
           L+G C + E  +LV E    G L++ L  +   EE P++      VA    +V+  + YL
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVS-----NVAELLHQVSMGMKYL 126
Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPE 250
                    HRD+ + N+LL  R+ AK++DFG SK +  D ++ T +  G +   +  PE
Sbjct: 127 EE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 251 YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                + + +SDV+S+GV + E L+ G+KP
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 77  RILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           R LG+G  G V   R +      G  +AVK  K       +  L++   EI IL  + H 
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHE 71
Query: 132 NVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+VK  G C E       L+ EF+P+G+L ++L  +++N+   +  + + + A+++   +
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNK---INLKQQLKYAVQICKGM 127
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK---IQGTFGY 246
            YL    S    HRD+ + N+L++  ++ K+ DFG +K I  D+   T K       F Y
Sbjct: 128 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 184
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             PE    S+    SDV+SFGV L ELLT
Sbjct: 185 A-PECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 73  FNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F+V   LG+G  G+VYK    E G+I+A+K+  +  D      L+E I EI I+ Q +  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSP 84
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +VVK  G   +     +V E+   G++   +  R++     LT +    +       L Y
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEY 140
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH        HRDIK+ NILL+    AK+ADFG +  +  D       + GT  ++ PE 
Sbjct: 141 LHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTPFWMAPEV 196
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Q       +D++S G+  +E+  GK P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 119/237 (50%), Gaps = 31/237 (13%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEF 118
           +KE+D   ++  +  ++G G  G V +GRL+  G+    +A+K  K    + +     EF
Sbjct: 8   AKEID--VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR---REF 62
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++E  I+ Q  H N+++L G    +   +++ EF+ NG L   L  R  + ++       
Sbjct: 63  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQF------- 113
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AM 231
               I++ G L  + SG    A     HRD+ + NIL++     KV+DFG S+F+   + 
Sbjct: 114 --TVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS 171
Query: 232 DQTHVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
           D T+ T+ + G     +  PE     + T  SD +S+G+V+ E+++ G++P +   N
Sbjct: 172 DPTY-TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 31/298 (10%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           +F   E + +     + R LGQG  G VY+G   D  I    ++++AV    +   L + 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARD-IIKGEAETRVAVKTVNESASLRER 64
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE----- 170
            EF+NE  ++      +VV+LLG   + +  L+V E + +G L  +L       E     
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
            P T +   ++A E+A  +AYL++       HRD+ + N ++   +  K+ DFG ++ I 
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
             D      K      ++ PE  +    T  SD++SFGVVL E+                
Sbjct: 182 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------- 225
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             SLA      +   ++   + D        N      +L   C   N K RPT  E+
Sbjct: 226 -TSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 110/235 (46%), Gaps = 44/235 (18%)
Query: 78  ILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           +LGQG  G V K R   D R  A+KK +     EE  KL   ++E+ +L+ +NH+ VV+ 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR---HTEE--KLSTILSEVMLLASLNHQYVVRY 67
Query: 137 LGCCLETEF---PL----------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
               LE      P+          +  E+  N TLY  +H  + N++    W + FR  +
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL-FRQIL 126
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-------FIAMDQTHV 236
           E   AL+Y+HS     I HRD+K  NI +DE    K+ DFG +K        + +D  ++
Sbjct: 127 E---ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 237 T------TKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
                  T   GT  Y+  E    +    +K D+YS G++  E++      FSTG
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----FSTG 231

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 109/226 (48%), Gaps = 14/226 (6%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + A     ++R LGQG  G VY+G +  G +    ++++A+    +   + + 
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 62
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE----- 170
            EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L             
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
            P +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG ++ I 
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 179
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 122/236 (51%), Gaps = 29/236 (12%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEF 118
           +KE+D +     + +++G G  G V  G L+  G+    +A+K  K    +++     +F
Sbjct: 27  AKEIDISC--VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR---RDF 81
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++E  I+ Q +H NV+ L G   ++   +++ EF+ NG+L   L    QN+        +
Sbjct: 82  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG-------Q 131
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
           F V I++ G L  + +G    A     HRD+ + NIL++     KV+DFG S+F+  D +
Sbjct: 132 FTV-IQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 190
Query: 235 HV--TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
               T+ + G     +  PE  Q  + T  SDV+S+G+V+ E+++ G++P +   N
Sbjct: 191 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 246

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 118/261 (45%), Gaps = 31/261 (11%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +  N+ + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 77  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 132
Query: 173 --------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG 224
                   LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+ DFG
Sbjct: 133 YKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFG 189
Query: 225 TSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 283
            ++ I  D  +V     +    ++ PE       T +SDV+SFGV+L E       IFS 
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSL 242
Query: 284 GNTSQENVSLAAYFVHSMRKN 304
           G +    V +   F   +++ 
Sbjct: 243 GASPYPGVKIDEEFCRRLKEG 263

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGR-IIAVK---KSKLAVDDEELYKLEEFINEIFILSQI 128
           F++ R LG+G  G VY  R +  + I+A+K   KS+L  +  E     +   EI I S +
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE----HQLRREIEIQSHL 72
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVAIEVA 186
            H N++++     + +   L+ EF P G LY+ L  H R   +      E       E+A
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-------ELA 125
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT----KIQG 242
            AL Y H      + HRDIK  N+L+  +   K+ADFG S        H  +     + G
Sbjct: 126 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCG 175
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
           T  YL PE  +     +K D++  GV+  E L G  P  S  +T
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 219

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 74
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 127
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 128 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 184
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 185 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 109/226 (48%), Gaps = 14/226 (6%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + A     ++R LGQG  G VY+G +  G +    ++++A+    +   + + 
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRER 72
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE----- 170
            EF+NE  ++ + N  +VV+LLG   + +  L++ E +  G L  +L             
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
            P +     ++A E+A  +AYL++       HRD+ + N ++ E +  K+ DFG ++ I 
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             D      K      ++ PE  +    T  SDV+SFGVVL E+ T
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 118/261 (45%), Gaps = 31/261 (11%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +  N+ + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 77  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 132
Query: 173 --------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG 224
                   LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+ DFG
Sbjct: 133 YKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFG 189
Query: 225 TSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 283
            ++ I  D  +V     +    ++ PE       T +SDV+SFGV+L E       IFS 
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSL 242
Query: 284 GNTSQENVSLAAYFVHSMRKN 304
           G +    V +   F   +++ 
Sbjct: 243 GASPYPGVKIDEEFXRRLKEG 263

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 126
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 127 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 184 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 124
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 125 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 182 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 33/299 (11%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           +F   E + +     + R LGQG  G VY+G   D  I    ++++AV    +   L + 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARD-IIKGEAETRVAVKTVNESASLRER 64
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE----- 170
            EF+NE  ++      +VV+LLG   + +  L+V E + +G L  +L       E     
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
            P T +   ++A E+A  +AYL++       HRD+ + N ++   +  K+ DFG ++ I 
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDI- 180
Query: 231 MDQTHVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            +  +     +G     ++ PE  +    T  SD++SFGVVL E+               
Sbjct: 181 YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI--------------- 225
Query: 289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              SLA      +   ++   + D        N      +L   C   N K RPT  E+
Sbjct: 226 --TSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 110/217 (50%), Gaps = 20/217 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQI 128
             F   ++LG G  GTVYKG  + +G  + +  + + + +    K  +E ++E ++++ +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEVA 186
           ++ +V +LLG CL T    L+ + +P G L  ++ +   N   +Y L W       +++A
Sbjct: 109 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 161
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---KIQGT 243
             + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K+   
Sbjct: 162 KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 219 WMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 74
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 127
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 128 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 185 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 118/237 (49%), Gaps = 31/237 (13%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEF 118
           +KE+D   ++  +  ++G G  G V +GRL+  G+    +A+K  K    + +     EF
Sbjct: 10  AKEID--VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR---REF 64
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++E  I+ Q  H N+++L G    +   +++ EF+ NG L   L  R  + ++       
Sbjct: 65  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQF------- 115
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AM 231
               I++ G L  + SG    A     HRD+ + NIL++     KV+DFG S+F+   + 
Sbjct: 116 --TVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS 173
Query: 232 DQTHVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
           D T  T+ + G     +  PE     + T  SD +S+G+V+ E+++ G++P +   N
Sbjct: 174 DPTE-TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN 229

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 80
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 133
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 134 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 191 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------C 124
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 125 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 182 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 131 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 188 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 117
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 118 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 175 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 126
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 127 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 184 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL T    L+ + +P G L  ++ +   N   +Y L W       
Sbjct: 78  MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 131 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 188 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 126
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 127 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 184 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 126
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 127 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 184 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 110/230 (47%), Gaps = 19/230 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYK---LEEFINEIFILSQI 128
           F V  +LG+G    VY+   +  G  +A+K     +D + +YK   ++   NE+ I  Q+
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIK----MIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H ++++L     ++ +  LV E   NG + ++L +R +    P +         ++   
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIITG 124
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD-QTHVTTKIQGTFGYL 247
           + YLHS     I HRD+  +N+LL      K+ADFG +  + M  + H T  + GT  Y+
Sbjct: 125 MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS-TGNTSQENVSLAAY 296
            PE    S    +SDV+S G +   LL G+ P  + T   +   V LA Y
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 76
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 129
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 130 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 187 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 67
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 120
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 121 VQIAEGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 178 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGR-IIAVK---KSKLAVDDEELYKLEEFINEIFILSQI 128
           F++ R LG+G  G VY  R +  + I+A+K   KS+L  +  E     +   EI I S +
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE----HQLRREIEIQSHL 71
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVAIEVA 186
            H N++++     + +   L+ EF P G LY+ L  H R   +      E       E+A
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-------ELA 124
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT----KIQG 242
            AL Y H      + HRDIK  N+L+  +   K+ADFG S        H  +     + G
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCG 174
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
           T  YL PE  +     +K D++  GV+  E L G  P  S  +T
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 95
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 148
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 149 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 205
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 206 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 113/234 (48%), Gaps = 27/234 (11%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEF 118
           ++E++ +  H  + +I+G G  G V  GRL    +    +A+K  K    + +     +F
Sbjct: 43  TREIEASRIH--IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDF 97
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++E  I+ Q +H N+++L G        ++V E++ NG+L   L  R  + ++ +     
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTI----- 150
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
               +++ G L  + +G    +     HRD+ + N+L+D     KV+DFG S+ +  D  
Sbjct: 151 ----MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 235 HVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
              T   G     +  PE       +  SDV+SFGVV+ E+L  G++P ++  N
Sbjct: 207 AAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKLEEFINEIFILSQINHRN 132
           R LGQG  G VY+G   D  I    ++++AV    +   L +  EF+NE  ++      +
Sbjct: 22  RELGQGSFGMVYEGNARD-IIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 80
Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE-----YPLTWEMRFRVAIEVAG 187
           VV+LLG   + +  L+V E + +G L  +L       E      P T +   ++A E+A 
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGY 246
            +AYL+   +    HRD+ + N ++   +  K+ DFG ++ I   D      K      +
Sbjct: 141 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
           + PE  +    T  SD++SFGVVL E+                  SLA      +   ++
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEI-----------------TSLAEQPYQGLSNEQV 240
Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              + D        N      +L   C   N K RPT  E+
Sbjct: 241 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 281

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++LG G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW------C 123
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEF 118
           ++E++ +  H  + +I+G G  G V  GRL    +    +A+K  K    + +     +F
Sbjct: 43  TREIEASRIH--IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDF 97
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++E  I+ Q +H N+++L G        ++V E++ NG+L   L  R  + ++ +     
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTI----- 150
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA--MD 232
               +++ G L  + +G    +     HRD+ + N+L+D     KV+DFG S+ +    D
Sbjct: 151 ----MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
             + TT  +    +  PE       +  SDV+SFGVV+ E+L  G++P ++  N
Sbjct: 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 34/291 (11%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYK----LEEFINEIFILS 126
           + + +  ++G G    V           A KK K+A+    L K    ++E + EI  +S
Sbjct: 10  DDYELQEVIGSGATAVV------QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS 63
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGT---LYQHLHDRHQNEEYPLTWEMRFRVAI 183
           Q +H N+V      +  +   LV + +  G+   + +H+  + +++   L       +  
Sbjct: 64  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 123
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           EV   L YLH        HRD+K+ NILL E    ++ADFG S F+A        K++ T
Sbjct: 124 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 244 F----GYLDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV 298
           F     ++ PE  +  +  D K+D++SFG+  +EL TG  P           ++L     
Sbjct: 181 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL----- 235
Query: 299 HSMRKNRLYHILDDQVM--KLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                  L   + D+ M  K GK     +F  +   CL  + +KRPT  E+
Sbjct: 236 -QNDPPSLETGVQDKEMLKKYGK-----SFRKMISLCLQKDPEKRPTAAEL 280

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 117/264 (44%), Gaps = 34/264 (12%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +  N+ + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 18  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 78  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 133
Query: 173 -----------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA 221
                      LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+ 
Sbjct: 134 YKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 222 DFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
           DFG ++ I  D   V     +    ++ PE       T +SDV+SFGV+L E       I
Sbjct: 191 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------I 243
Query: 281 FSTGNTSQENVSLAAYFVHSMRKN 304
           FS G +    V +   F   +++ 
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEG 267

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 34/291 (11%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYK----LEEFINEIFILS 126
           + + +  ++G G    V           A KK K+A+    L K    ++E + EI  +S
Sbjct: 15  DDYELQEVIGSGATAVV------QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS 68
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGT---LYQHLHDRHQNEEYPLTWEMRFRVAI 183
           Q +H N+V      +  +   LV + +  G+   + +H+  + +++   L       +  
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           EV   L YLH        HRD+K+ NILL E    ++ADFG S F+A        K++ T
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 244 F----GYLDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV 298
           F     ++ PE  +  +  D K+D++SFG+  +EL TG  P           ++L     
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL----- 240
Query: 299 HSMRKNRLYHILDDQVM--KLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                  L   + D+ M  K GK     +F  +   CL  + +KRPT  E+
Sbjct: 241 -QNDPPSLETGVQDKEMLKKYGK-----SFRKMISLCLQKDPEKRPTAAEL 285

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 121/236 (51%), Gaps = 29/236 (12%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEF 118
           SKE+D +     + +++G G  G V  G L+  G+    +A+K  K    +++     +F
Sbjct: 1   SKEIDISC--VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR---RDF 55
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++E  I+ Q +H NV+ L G   ++   +++ EF+ NG+L   L    QN+        +
Sbjct: 56  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL---RQNDG-------Q 105
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
           F V I++ G L  + +G    A     HR + + NIL++     KV+DFG S+F+  D +
Sbjct: 106 FTV-IQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTS 164
Query: 235 HV--TTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
               T+ + G     +  PE  Q  + T  SDV+S+G+V+ E+++ G++P +   N
Sbjct: 165 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 220

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/321 (25%), Positives = 140/321 (43%), Gaps = 48/321 (14%)
Query: 49  SYDG---SVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL-----EDGRI-IA 99
           SY+G   + ID  +L  +++ +   N+    + LG G  G V +        ED  + +A
Sbjct: 13  SYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVA 72
Query: 100 VKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTL 158
           VK  K     +E    E  ++E+ I+S +  H N+V LLG C      L++ E+   G L
Sbjct: 73  VKMLKSTAHADEK---EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 159 YQHLH-----DRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD 213
              L      D  + +  PL        + +VA  +A+L   AS    HRD+ + N+LL 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 186
Query: 214 ERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE 272
             + AK+ DFG ++ I  D  + V    +    ++ PE       T +SDV+S+G++L E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 273 LLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFA----- 327
                  IFS G      +         +  ++ Y ++ D     G +    AFA     
Sbjct: 247 -------IFSLGLNPYPGI---------LVNSKFYKLVKD-----GYQMAQPAFAPKNIY 285
Query: 328 NLAERCLDLNGKKRPTMEEVS 348
           ++ + C  L    RPT +++ 
Sbjct: 286 SIMQACWALEPTHRPTFQQIC 306

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 22/232 (9%)
Query: 68  KATNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           +    + +   LG GG G V +   +D G  +A+K+ +  +  +     E +  EI I+ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMK 67
Query: 127 QINHRNVVKL------LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           ++NH NVV        L      + PLL  E+   G L ++L+   Q E      E   R
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN---QFENCCGLKEGPIR 124
Query: 181 VAI-EVAGALAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHV 236
             + +++ AL YLH      I HRD+K  NI+L    +R   K+ D G +K   +DQ  +
Sbjct: 125 TLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGEL 179
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            T+  GT  YL PE  +  + T   D +SFG +  E +TG +P        Q
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 31/298 (10%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + +     + R LGQG  G VY+G   D  I    ++++AV    +   L + 
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARD-IIKGEAETRVAVKTVNESASLRER 64
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE----- 170
            EF+NE  ++      +VV+LLG   + +  L+V E + +G L  +L       E     
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
            P T +   ++A E+A  +AYL++       HRD+ + N ++   +  K+ DFG ++ I 
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 181
Query: 231 -MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
             D      K      ++ PE  +    T  SD++SFGVVL E+                
Sbjct: 182 ETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------- 225
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             SLA      +   ++   + D        N      +L   C   N   RPT  E+
Sbjct: 226 -TSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 22/232 (9%)
Query: 68  KATNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           +    + +   LG GG G V +   +D G  +A+K+ +  +  +     E +  EI I+ 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMK 68
Query: 127 QINHRNVVKL------LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           ++NH NVV        L      + PLL  E+   G L ++L+   Q E      E   R
Sbjct: 69  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN---QFENCCGLKEGPIR 125
Query: 181 VAI-EVAGALAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHV 236
             + +++ AL YLH      I HRD+K  NI+L    +R   K+ D G +K   +DQ  +
Sbjct: 126 TLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGEL 180
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            T+  GT  YL PE  +  + T   D +SFG +  E +TG +P        Q
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 232

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 79  LGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G V +G  +   G+ ++V    L  D   +   +++FI E+  +  ++HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           L G  L     + V E  P G+L   L  +HQ      T     R A++VA  + YL S 
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLS---RYAVQVAEGMGYLESK 130
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQ 253
                 HRD+ + N+LL  R   K+ DFG  + +  +  H   +   +  F +  PE  +
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ 288
           +   +  SD + FGV L E+ T G++P     N SQ
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQ 222

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 79  LGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G V +G  +   G+ ++V    L  D   +   +++FI E+  +  ++HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           L G  L     + V E  P G+L   L  +HQ      T     R A++VA  + YL S 
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLS---RYAVQVAEGMGYLESK 140
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQ 253
                 HRD+ + N+LL  R   K+ DFG  + +  +  H   +   +  F +  PE  +
Sbjct: 141 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ 288
           +   +  SD + FGV L E+ T G++P     N SQ
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQ 232

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKM-----LN 63
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 118
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 175
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 79  LGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G V +G  +   G+ ++V    L  D   +   +++FI E+  +  ++HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           L G  L     + V E  P G+L   L  +HQ      T     R A++VA  + YL S 
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLS---RYAVQVAEGMGYLESK 130
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQ 253
                 HRD+ + N+LL  R   K+ DFG  + +  +  H   +   +  F +  PE  +
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ 288
           +   +  SD + FGV L E+ T G++P     N SQ
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQ 222

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +       E         R   ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 71  NHFNVNRILGQGGQGTVYKGRL-EDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQ 127
           ++F   R+LG+G  G V   R+ E G + AVK  K  + + D+++   E  + E  ILS 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV---ECTMTEKRILSL 79
Query: 128 INHRNVVKLLGCCLETEFPLL-VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
             +   +  L CC +T   L  V EF+  G L  H+    + +E       RF  A E+ 
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARFYAA-EII 134
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
            AL +LH      I +RD+K  N+LLD     K+ADFG  K   +     T    GT  Y
Sbjct: 135 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDY 190
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           + PE  Q        D ++ GV+L E+L G  P
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQE 216

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 22/231 (9%)
Query: 78  ILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           +LG+G  G VY GR L +   IA+K+    + + +    +    EI +   + H+N+V+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRH---QNEEYPLTWEMRFRVAIEVAGALAYLH 193
           LG   E  F  +  E +P G+L   L  +    ++ E  + +  +     ++   L YLH
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLH 139
Query: 194 SGASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
                 I HRDIK  N+L++  Y    K++DFGTSK +A      T    GT  Y+ PE 
Sbjct: 140 DNQ---IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEI 194
Query: 252 HQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
                      +D++S G  ++E+ TGK P +  G        +  + VH 
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/321 (25%), Positives = 140/321 (43%), Gaps = 48/321 (14%)
Query: 49  SYDG---SVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL-----EDGRI-IA 99
           SY+G   + ID  +L  +++ +   N+    + LG G  G V +        ED  + +A
Sbjct: 21  SYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 100 VKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTL 158
           VK  K     +E    E  ++E+ I+S +  H N+V LLG C      L++ E+   G L
Sbjct: 81  VKMLKSTAHADEK---EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 159 YQHLH-----DRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD 213
              L      D  + +  PL        + +VA  +A+L   AS    HRD+ + N+LL 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 194
Query: 214 ERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE 272
             + AK+ DFG ++ I  D  + V    +    ++ PE       T +SDV+S+G++L E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 273 LLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFA----- 327
                  IFS G      +         +  ++ Y ++ D     G +    AFA     
Sbjct: 255 -------IFSLGLNPYPGI---------LVNSKFYKLVKD-----GYQMAQPAFAPKNIY 293
Query: 328 NLAERCLDLNGKKRPTMEEVS 348
           ++ + C  L    RPT +++ 
Sbjct: 294 SIMQACWALEPTHRPTFQQIC 314

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K      EI I + +N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-----KEICINAMLN 63
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +       E         R   ++   +
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGV 118
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 79  LGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G V +G  +   G+ ++V    L  D   +   +++FI E+  +  ++HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           L G  L     + V E  P G+L   L  +HQ      T     R A++VA  + YL S 
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLS---RYAVQVAEGMGYLESK 134
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQ 253
                 HRD+ + N+LL  R   K+ DFG  + +  +  H   +   +  F +  PE  +
Sbjct: 135 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ 288
           +   +  SD + FGV L E+ T G++P     N SQ
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQ 226

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 79  LGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G V +G  +   G+ ++V    L  D   +   +++FI E+  +  ++HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           L G  L     + V E  P G+L   L  +HQ      T     R A++VA  + YL S 
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLS---RYAVQVAEGMGYLESK 130
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQ 253
                 HRD+ + N+LL  R   K+ DFG  + +  +  H   +   +  F +  PE  +
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ 288
           +   +  SD + FGV L E+ T G++P     N SQ
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQ 222

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 79  LGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G V +G  +   G+ ++V    L  D   +   +++FI E+  +  ++HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           L G  L     + V E  P G+L   L  +HQ      T     R A++VA  + YL S 
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLS---RYAVQVAEGMGYLESK 134
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQ 253
                 HRD+ + N+LL  R   K+ DFG  + +  +  H   +   +  F +  PE  +
Sbjct: 135 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ 288
           +   +  SD + FGV L E+ T G++P     N SQ
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQ 226

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 79  LGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G V +G  +   G+ ++V    L  D   +   +++FI E+  +  ++HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           L G  L     + V E  P G+L   L  +HQ      T     R A++VA  + YL S 
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLS---RYAVQVAEGMGYLESK 140
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQ 253
                 HRD+ + N+LL  R   K+ DFG  + +  +  H   +   +  F +  PE  +
Sbjct: 141 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQ 288
           +   +  SD + FGV L E+ T G++P     N SQ
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQ 232

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 63
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 118
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 61
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 116
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 117 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 63
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +       E         R   ++   +
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGV 118
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +       E         R   ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 63
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 118
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 63
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 118
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 63
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 118
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 20/230 (8%)
Query: 78  ILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           +LG+G  G VY GR L +   IA+K+    + + +    +    EI +   + H+N+V+ 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRH---QNEEYPLTWEMRFRVAIEVAGALAYLH 193
           LG   E  F  +  E +P G+L   L  +    ++ E  + +  +     ++   L YLH
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEGLKYLH 125
Query: 194 SGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
                 I HRDIK  N+L++      K++DFGTSK +A      T    GT  Y+ PE  
Sbjct: 126 DNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEII 181
Query: 253 QSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
                     +D++S G  ++E+ TGK P +  G        +  + VH 
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 231

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +       E         R   ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 79  LGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V    +   G+++AVKK    +D  +  + E   NE+ I+    H NVV++ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKK----MDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE          V + V  AL+ LH+   
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG- 136
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRL 191
Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFN 218

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 63
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 118
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 79  LGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V    +   G+++AVKK    +D  +  + E   NE+ I+    H NVV++ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKK----MDLRKQQRRELLFNEVVIMRDYQHENVVEMY 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE          V + V  AL+ LH+   
Sbjct: 88  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG- 140
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 141 --VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRL 195
Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 196 PYGPEVDIWSLGIMVIEMVDGEPPYFN 222

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++L  G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L++ + +P G L  ++ +   N   +Y L W       
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 131 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 188 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 79  LGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V    +   G+++AVKK    +D  +  + E   NE+ I+    H NVV++ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKK----MDLRKQQRRELLFNEVVIMRDYQHENVVEMY 92
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE          V + V  AL+ LH+   
Sbjct: 93  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG- 145
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 146 --VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRL 200
Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 201 PYGPEVDIWSLGIMVIEMVDGEPPYFN 227

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +       E         R   ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 79  LGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V    +   G+++AVKK    +D  +  + E   NE+ I+    H NVV++ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKK----MDLRKQQRRELLFNEVVIMRDYQHENVVEMY 94
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE          V + V  AL+ LH+   
Sbjct: 95  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG- 147
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 148 --VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRL 202
Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 203 PYGPEVDIWSLGIMVIEMVDGEPPYFN 229

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 73  FNVNRILGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +++ + LG+G  G V        E+   + +   K AVD  E  K E  IN++     +N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----LN 62
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +     +   P     RF    ++   +
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRF--FHQLMAGV 117
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +  F   ++  +  K+ GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 79  LGQGGQGTV-YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V        G+ +AVKK    +D  +  + E   NE+ I+   +H NVV + 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKK----MDLRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE   T      V + V  AL+YLH+   
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHNQG- 161
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 162 --VIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKXLVGTPYWMAPEVISRL 216
Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPPYFN 243

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++L  G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 28/221 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL------EEFINEIFI 124
             F   ++L  G  GTVYKG      I   +K K+ V  +EL +       +E ++E ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLW----IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVA 182
           ++ +++ +V +LLG CL +   L+  + +P G L  ++ +   N   +Y L W       
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT---K 239
           +++A  + YL       + HRD+ + N+L+      K+ DFG +K +  ++        K
Sbjct: 131 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +   +  L+   H+    T +SDV+S+GV + EL+T G KP
Sbjct: 188 VPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 79  LGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V    +   G+++AVKK    +D  +  + E   NE+ I+    H NVV++ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKK----MDLRKQQRRELLFNEVVIMRDYQHENVVEMY 137
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE          V + V  AL+ LH+   
Sbjct: 138 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG- 190
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 191 --VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRL 245
Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 246 PYGPEVDIWSLGIMVIEMVDGEPPYFN 272

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 117/234 (50%), Gaps = 27/234 (11%)
Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGR---IIAVKKSKLAVDDEELYKLEEF 118
           +KE++ +     + R++G G  G V  GRL+  G+    +A+K  K+   +++     +F
Sbjct: 16  AKEIEASC--ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR---RDF 70
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           + E  I+ Q +H N++ L G   +++  ++V E++ NG+L   L             + +
Sbjct: 71  LGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKN----------DGQ 120
Query: 179 FRVAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
           F V I++ G L  + +G    +     HRD+ + NIL++     KV+DFG S+ +  D  
Sbjct: 121 FTV-IQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 235 HVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
              T   G     +  PE     + T  SDV+S+G+V+ E+++ G++P +   N
Sbjct: 180 AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTN 233

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 116/263 (44%), Gaps = 33/263 (12%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 79  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 134
Query: 173 ----------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD 222
                     LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+ D
Sbjct: 135 YKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICD 191
Query: 223 FGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           FG ++ I  D   V     +    ++ PE       T +SDV+SFGV+L E       IF
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IF 244
Query: 282 STGNTSQENVSLAAYFVHSMRKN 304
           S G +    V +   F   +++ 
Sbjct: 245 SLGASPYPGVKIDEEFCRRLKEG 267

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 117/265 (44%), Gaps = 35/265 (13%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 77  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 132
Query: 173 ------------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
                       LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 221 ADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            DFG ++ I  D  +V     +    ++ PE       T +SDV+SFGV+L E       
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 242
Query: 280 IFSTGNTSQENVSLAAYFVHSMRKN 304
           IFS G +    V +   F   +++ 
Sbjct: 243 IFSLGASPYPGVKIDEEFCRRLKEG 267

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 77  RILGQGGQGTVYKG-RLEDGRIIAVKKS-KLAVDDEELYKLEEFINEIFILSQINHRNVV 134
           ++LG G  GTVYKG  + DG  + +  + K+  ++      +E ++E ++++ +    V 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHD---RHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +LLG CL T    LV + +P G L  H+ +   R  +++  L W M      ++A  ++Y
Sbjct: 83  RLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDL-LNWCM------QIAKGMSY 134
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPE 250
           L       + HRD+ + N+L+      K+ DFG ++ + +D+T       +    ++  E
Sbjct: 135 LEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 251 YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                + T +SDV+S+GV + EL+T G KP
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 21/209 (10%)
Query: 79  LGQGGQGTVYKG--RLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G+V +G  R+   +I +A+K  K   +  +    EE + E  I+ Q+++  +V+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVR 400
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLT--WEMRFRVAIEVAGALAYLH 193
           L+G C + E  +LV E    G L++ L  +   EE P++   E+  +V++     + YL 
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSM----GMKYLE 453
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
                   HR++ + N+LL  R+ AK++DFG SK +  D ++ T +  G +   +  PE 
Sbjct: 454 EKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + +SDV+S+GV + E L+ G+KP
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 117/265 (44%), Gaps = 35/265 (13%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 114 L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 169
Query: 173 ------------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
                       LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+
Sbjct: 170 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 226
Query: 221 ADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            DFG ++ I  D  +V     +    ++ PE       T +SDV+SFGV+L E       
Sbjct: 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 279
Query: 280 IFSTGNTSQENVSLAAYFVHSMRKN 304
           IFS G +    V +   F   +++ 
Sbjct: 280 IFSLGASPYPGVKIDEEFCRRLKEG 304

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 79  LGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V    +   G+++AVKK    +D  +  + E   NE+ I+    H NVV++ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKK----MDLRKQQRRELLFNEVVIMRDYQHENVVEMY 214
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  +   +V EF+  G L   +     NEE          V + V  AL+ LH+   
Sbjct: 215 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLQALSVLHAQG- 267
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQGTFGYLDPEYHQSS 255
             + HRDIKS +ILL    R K++DFG   F A     V  +  + GT  ++ PE     
Sbjct: 268 --VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRL 322
Query: 256 QLTDKSDVYSFGVVLVELLTGKKPIFS 282
               + D++S G++++E++ G+ P F+
Sbjct: 323 PYGPEVDIWSLGIMVIEMVDGEPPYFN 349

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 117/265 (44%), Gaps = 35/265 (13%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLVY-EFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 68  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSK-RNEFVP 123
Query: 173 ------------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
                       LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 180
Query: 221 ADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            DFG ++ I  D  +V     +    ++ PE       T +SDV+SFGV+L E       
Sbjct: 181 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 233
Query: 280 IFSTGNTSQENVSLAAYFVHSMRKN 304
           IFS G +    V +   F   +++ 
Sbjct: 234 IFSLGASPYPGVKIDEEFCRRLKEG 258

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKG----RLEDGRIIAVKKSKLAVDDEELYKLEE 117
           S+++ +       + R +G+G  G V++G           +A+K  K    D      E+
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS---VREK 57
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           F+ E   + Q +H ++VKL+G  + TE P+ ++ E    G L   L  R    +Y L   
Sbjct: 58  FLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVR----KYSLDLA 111
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++     + 
Sbjct: 112 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 168
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 117/265 (44%), Gaps = 35/265 (13%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLVY-EFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 68  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSK-RNEFVP 123
Query: 173 ------------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
                       LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 180
Query: 221 ADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            DFG ++ I  D  +V     +    ++ PE       T +SDV+SFGV+L E       
Sbjct: 181 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 233
Query: 280 IFSTGNTSQENVSLAAYFVHSMRKN 304
           IFS G +    V +   F   +++ 
Sbjct: 234 IFSLGASPYPGVKIDEEFCRRLKEG 258

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 117/265 (44%), Gaps = 35/265 (13%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 79  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 134
Query: 173 ------------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
                       LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+
Sbjct: 135 YKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 191
Query: 221 ADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            DFG ++ I  D  +V     +    ++ PE       T +SDV+SFGV+L E       
Sbjct: 192 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 244
Query: 280 IFSTGNTSQENVSLAAYFVHSMRKN 304
           IFS G +    V +   F   +++ 
Sbjct: 245 IFSLGASPYPGVKIDEEFCRRLKEG 269

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 35/265 (13%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLVY-EFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 68  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSK-RNEFVP 123
Query: 173 ------------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
                       LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 180
Query: 221 ADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            DFG ++ I  D   V     +    ++ PE       T +SDV+SFGV+L E       
Sbjct: 181 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 233
Query: 280 IFSTGNTSQENVSLAAYFVHSMRKN 304
           IFS G +    V +   F   +++ 
Sbjct: 234 IFSLGASPYPGVKIDEEFCRRLKEG 258

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 35/265 (13%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 68  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 123
Query: 173 ------------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
                       LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 180
Query: 221 ADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            DFG ++ I  D   V     +    ++ PE       T +SDV+SFGV+L E       
Sbjct: 181 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 233
Query: 280 IFSTGNTSQENVSLAAYFVHSMRKN 304
           IFS G +    V +   F   +++ 
Sbjct: 234 IFSLGASPYPGVKIDEEFCRRLKEG 258

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 129/302 (42%), Gaps = 50/302 (16%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRII--AVKKSK-LAVDDEELYKLEEFINEIFILS 126
           N      ++G+G  G V K R++ DG  +  A+K+ K  A  D+      +F  E+ +L 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAGELEVLC 80
Query: 127 QINHR-NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP-----------LT 174
           ++ H  N++ LLG C    +  L  E+ P+G L   L      E  P           L+
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            +     A +VA  + YL   +     HRD+ + NIL+ E Y AK+ADFG S+     Q 
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE 193
Query: 235 HVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
               K  G     ++  E    S  T  SDV+S+GV+L E       I S G T    ++
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE-------IVSLGGTPYCGMT 246
Query: 293 LAAYFVHSMRKNRLYHIL--DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
            A  +    +  RL   L  DD+V             +L  +C      +RP+  ++ + 
Sbjct: 247 CAELYEKLPQGYRLEKPLNCDDEVY------------DLMRQCWREKPYERPSFAQILVS 294
Query: 351 LN 352
           LN
Sbjct: 295 LN 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 35/265 (13%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 77  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 132
Query: 173 ------------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
                       LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 221 ADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            DFG ++ I  D   V     +    ++ PE       T +SDV+SFGV+L E       
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 242
Query: 280 IFSTGNTSQENVSLAAYFVHSMRKN 304
           IFS G +    V +   F   +++ 
Sbjct: 243 IFSLGASPYPGVKIDEEFCRRLKEG 267

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 18/230 (7%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKG---RLEDGRI-IAVKKSKLAVDDEELYKLEE 117
           S+++ +       + R +G+G  G V++G     E+  + +A+K  K    D      E+
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS---VREK 57
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           F+ E   + Q +H ++VKL+G  + TE P+ ++ E    G L   L  R    +Y L   
Sbjct: 58  FLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVR----KYSLDLA 111
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++     + 
Sbjct: 112 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 168
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/326 (25%), Positives = 141/326 (43%), Gaps = 54/326 (16%)
Query: 49  SYDG---SVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL-----EDGRI-IA 99
           SY+G   + ID  +L  +++ +   N+    + LG G  G V +        ED  + +A
Sbjct: 21  SYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 100 VKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTL 158
           VK  K     +E    E  ++E+ I+S +  H N+V LLG C      L++ E+   G L
Sbjct: 81  VKMLKSTAHADEK---EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 159 YQHL-----------HDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKS 207
              L           ++   N E  L+       + +VA  +A+L   AS    HRD+ +
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 194
Query: 208 TNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSF 266
            N+LL   + AK+ DFG ++ I  D  + V    +    ++ PE       T +SDV+S+
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 254
Query: 267 GVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAF 326
           G++L E       IFS G      +         +  ++ Y ++ D     G +    AF
Sbjct: 255 GILLWE-------IFSLGLNPYPGI---------LVNSKFYKLVKD-----GYQMAQPAF 293
Query: 327 A-----NLAERCLDLNGKKRPTMEEV 347
           A     ++ + C  L    RPT +++
Sbjct: 294 APKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 18/230 (7%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKG---RLEDGRI-IAVKKSKLAVDDEELYKLEE 117
           S+++ +       + R +G+G  G V++G     E+  + +A+K  K    D      E+
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS---VREK 59
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           F+ E   + Q +H ++VKL+G  + TE P+ ++ E    G L   L  R    +Y L   
Sbjct: 60  FLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVR----KYSLDLA 113
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++     + 
Sbjct: 114 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 170
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 171 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 220

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 18/230 (7%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKG---RLEDGRI-IAVKKSKLAVDDEELYKLEE 117
           S+++ +       + R +G+G  G V++G     E+  + +A+K  K    D      E+
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS---VREK 62
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           F+ E   + Q +H ++VKL+G  + TE P+ ++ E    G L   L  R    +Y L   
Sbjct: 63  FLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVR----KYSLDLA 116
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++     + 
Sbjct: 117 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 129/302 (42%), Gaps = 50/302 (16%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRII--AVKKSK-LAVDDEELYKLEEFINEIFILS 126
           N      ++G+G  G V K R++ DG  +  A+K+ K  A  D+      +F  E+ +L 
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAGELEVLC 70
Query: 127 QINHR-NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP-----------LT 174
           ++ H  N++ LLG C    +  L  E+ P+G L   L      E  P           L+
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            +     A +VA  + YL   +     HRD+ + NIL+ E Y AK+ADFG S+     Q 
Sbjct: 131 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE 183
Query: 235 HVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
               K  G     ++  E    S  T  SDV+S+GV+L E       I S G T    ++
Sbjct: 184 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE-------IVSLGGTPYCGMT 236
Query: 293 LAAYFVHSMRKNRLYHIL--DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
            A  +    +  RL   L  DD+V             +L  +C      +RP+  ++ + 
Sbjct: 237 CAELYEKLPQGYRLEKPLNCDDEVY------------DLMRQCWREKPYERPSFAQILVS 284
Query: 351 LN 352
           LN
Sbjct: 285 LN 286

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 18/230 (7%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKG---RLEDGRI-IAVKKSKLAVDDEELYKLEE 117
           S+++ +       + R +G+G  G V++G     E+  + +A+K  K    D      E+
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS---VREK 60
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           F+ E   + Q +H ++VKL+G  + TE P+ ++ E    G L   L  R    +Y L   
Sbjct: 61  FLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVR----KYSLDLA 114
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++     + 
Sbjct: 115 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 171
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 172 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 221

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 18/230 (7%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKG---RLEDGRI-IAVKKSKLAVDDEELYKLEE 117
           S+++ +       + R +G+G  G V++G     E+  + +A+K  K    D      E+
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS---VREK 85
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           F+ E   + Q +H ++VKL+G  + TE P+ ++ E    G L   L  R    +Y L   
Sbjct: 86  FLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVR----KYSLDLA 139
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++     + 
Sbjct: 140 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 196
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 197 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 246

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 35/265 (13%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYP 172
           L   ++E+ IL  I H  NVV LLG C +   PL+V  EF   G L  +L  + +NE  P
Sbjct: 77  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVP 132
Query: 173 ------------LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
                       LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 221 ADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            DFG ++ I  D   V     +    ++ PE       T +SDV+SFGV+L E       
Sbjct: 190 CDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 242
Query: 280 IFSTGNTSQENVSLAAYFVHSMRKN 304
           IFS G +    V +   F   +++ 
Sbjct: 243 IFSLGASPYPGVKIDEEFCRRLKEG 267

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 106/228 (46%), Gaps = 16/228 (7%)
Query: 73  FNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           F + ++LG G  G V+  R     + G++ A+K  K A   ++    E    E  +L  I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 129 NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +  L    +TE  L L+ ++I  G L+ HL  R +  E+    E++  V  E+  
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH----EVQIYVG-EIVL 170
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL +LH      I +RDIK  NILLD      + DFG SK    D+T       GT  Y+
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 248 DPEYHQSSQLT-DKS-DVYSFGVVLVELLTGKKPIFSTGN-TSQENVS 292
            P+  +      DK+ D +S GV++ ELLTG  P    G   SQ  +S
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 143/290 (49%), Gaps = 37/290 (12%)
Query: 78  ILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           ++G+G  G V K R +D GRI+A+KK   + DD+ + K+   + EI +L Q+ H N+V L
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQLRHENLVNL 89
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP--LTWEMRFRVAIEVAGALAYLHS 194
           L  C + +   LV+EF+ + T+   L      E +P  L +++  +   ++   + + H 
Sbjct: 90  LEVCKKKKRWYLVFEFV-DHTILDDL------ELFPNGLDYQVVQKYLFQIINGIGFCH- 141
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 254
             S  I HRDIK  NIL+ +    K+ DFG ++ +A        ++  T  Y  PE    
Sbjct: 142 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVG 198
Query: 255 SQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENV--------SLAAYFVHSMRKN- 304
                K+ DV++ G ++ E+  G +P+F  G++  + +        +L         KN 
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMFMG-EPLFP-GDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 305 -----RLYHILDDQVM--KLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                RL  I + + +  +  K +++V   +LA++CL ++  KRP   E+
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVV--IDLAKKCLHIDPDKRPFCAEL 304

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 136/301 (45%), Gaps = 45/301 (14%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKK--SKLAVDDEELYKLEE---FINEIFILSQ 127
           ++V +++G+G  G V   R +  + +   K  SK      E+ K  +   F  E  I++ 
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKF-----EMIKRSDSAFFWEERDIMAF 131
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
            N   VV+L     + ++  +V E++P G L   +     N + P  W  +F  A EV  
Sbjct: 132 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKW-AKFYTA-EVVL 185
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---HVTTKIQGTF 244
           AL  +HS     + HRD+K  N+LLD+    K+ADFGT   + MD+T   H  T + GT 
Sbjct: 186 ALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAV-GTP 239
Query: 245 GYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
            Y+ PE  + SQ  D     + D +S GV L E+L G  P ++         SL   +  
Sbjct: 240 DYISPEVLK-SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD--------SLVGTYSK 290
Query: 300 SM-RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNG----KKRPTMEEVSMELNGI 354
            M  KN L    D ++ K   KN I AF    E  L  NG    K+ P  +      + I
Sbjct: 291 IMDHKNSLCFPEDAEISKHA-KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNI 349
Query: 355 R 355
           R
Sbjct: 350 R 350

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 44/235 (18%)
Query: 78  ILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           +LGQG  G V K R   D R  A+KK +     EE  KL   ++E+ +L+ +NH+ VV+ 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR---HTEE--KLSTILSEVXLLASLNHQYVVRY 67
Query: 137 LGCCLE-------------TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
               LE                  +  E+  N TLY  +H  + N++    W + FR  +
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL-FRQIL 126
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-------FIAMDQTHV 236
           E   AL+Y+HS     I HR++K  NI +DE    K+ DFG +K        + +D  ++
Sbjct: 127 E---ALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 237 T------TKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
                  T   GT  Y+  E    +    +K D YS G++  E +      FSTG
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYP----FSTG 231

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 124/298 (41%), Gaps = 31/298 (10%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + +     + R LGQG  G VY+G   D  I    ++++AV    +   L + 
Sbjct: 7   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARD-IIKGEAETRVAVKTVNESASLRER 65
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE----- 170
            EF+NE  ++      +VV+LLG   + +  L+V E + +G L  +L       E     
Sbjct: 66  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 125
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
            P T +   ++A E+A  +AYL++       HR++ + N ++   +  K+ DFG ++ I 
Sbjct: 126 PPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIY 182
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
             D      K      ++ PE  +    T  SD++SFGVVL E+                
Sbjct: 183 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------- 226
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             SLA      +   ++   + D        N      +L   C   N   RPT  E+
Sbjct: 227 -TSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 283

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 124/298 (41%), Gaps = 31/298 (10%)
Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV----DDEELYKL 115
           ++   E + +     + R LGQG  G VY+G   D  I    ++++AV    +   L + 
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARD-IIKGEAETRVAVKTVNESASLRER 64
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE----- 170
            EF+NE  ++      +VV+LLG   + +  L+V E + +G L  +L       E     
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
            P T +   ++A E+A  +AYL++       HR++ + N ++   +  K+ DFG ++ I 
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
             D      K      ++ PE  +    T  SD++SFGVVL E+                
Sbjct: 182 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------- 225
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             SLA      +   ++   + D        N      +L   C   N   RPT  E+
Sbjct: 226 -TSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 113/226 (50%), Gaps = 19/226 (8%)
Query: 58  CKLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYK-L 115
            ++F   EL K        ++LG G  GTV+KG  + +G  I +      ++D+   +  
Sbjct: 25  ARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 77
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           +   + +  +  ++H ++V+LLG C  +    LV +++P G+L  H+  +H+    P   
Sbjct: 78  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVR-QHRGALGP--- 132
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
           ++     +++A  + YL       + HR++ + N+LL    + +VADFG +  +  D   
Sbjct: 133 QLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 236 VT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +  ++ +    ++  E     + T +SDV+S+GV + EL+T G +P
Sbjct: 190 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 126/278 (45%), Gaps = 37/278 (13%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+G  G V K R +  G+I+AVK+ +  V+ +E  +L   ++    +  ++    V   
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL--LMDLDISMRTVDCPFTVTFY 72
Query: 138 GCCLETEFPLLVYEFIPNG--TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           G         +  E +       Y+ + D+ Q     +  ++  ++A+ +  AL +LHS 
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQT----IPEDILGKIAVSIVKALEHLHSK 128
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGYL-----DP 249
            S  + HRD+K +N+L++   + K+ DFG S ++  D   V   I  G   Y+     +P
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINP 183
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
           E +Q    + KSD++S G+ ++EL   + P  S G   Q+                L  +
Sbjct: 184 ELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ----------------LKQV 226
Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +++   +L        F +   +CL  N K+RPT  E+
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 18/217 (8%)
Query: 75  VNRILGQGGQGTVYKG---RLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           + R +G+G  G V++G     E+  + +A+K  K    D      E+F+ E   + Q +H
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS---VREKFLQEALTMRQFDH 67
Query: 131 RNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
            ++VKL+G  + TE P+ ++ E    G L   L  R    +Y L        A +++ AL
Sbjct: 68  PHIVKLIG--VITENPVWIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTAL 121
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
           AYL S       HRDI + N+L+      K+ DFG S+++     +  +K +    ++ P
Sbjct: 122 AYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
           E     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 40/267 (14%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + + LG+G  G V           +  R+  V    L  D  E   L + I+E+ ++  I
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMI 90
Query: 129 N-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L  R             N E  L+ +
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 235
                A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I  +D   
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            TT  +    ++ PE       T +SDV+SFGV+L E       IF+ G +    V +  
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPVEE 260
Query: 296 YFV-----HSMRK-----NRLYHILDD 312
            F      H M K     N LY ++ D
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRD 287

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 70  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 122
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  PE 
Sbjct: 123 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 179
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 113/226 (50%), Gaps = 19/226 (8%)
Query: 58  CKLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYK-L 115
            ++F   EL K        ++LG G  GTV+KG  + +G  I +      ++D+   +  
Sbjct: 7   ARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           +   + +  +  ++H ++V+LLG C  +    LV +++P G+L  H+  +H+    P   
Sbjct: 60  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVR-QHRGALGP--- 114
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
           ++     +++A  + YL       + HR++ + N+LL    + +VADFG +  +  D   
Sbjct: 115 QLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 236 VT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +  ++ +    ++  E     + T +SDV+S+GV + EL+T G +P
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 18/230 (7%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKG----RLEDGRIIAVKKSKLAVDDEELYKLEE 117
           S+++ +       + R +G+G  G V++G           +A+K  K    D      E+
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS---VREK 57
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           F+ E   + Q +H ++VKL+G  + TE P+ ++ E    G L   L  R    ++ L   
Sbjct: 58  FLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVR----KFSLDLA 111
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++       
Sbjct: 112 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXK 168
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 124
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  PE 
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 92/166 (55%), Gaps = 12/166 (7%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLT 174
           + F+ E  +++Q+ H N+V+LLG  +E +  L +V E++  G+L  +L  R ++    L 
Sbjct: 50  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LG 106
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            +   + +++V  A+ YL     +   HRD+ + N+L+ E   AKV+DFG +K  +  Q 
Sbjct: 107 GDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 163
Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                ++ T     PE  + +  + KSDV+SFG++L E+ + G+ P
Sbjct: 164 TGKLPVKWT----APEALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 79  LGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G V+K R  + G +IAVK+ + + + EE  ++   ++   +L   +   +V+  
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI--LMDLDVVLKSHDCPYIVQCF 90
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G  +      +  E +  GT  + L  R Q    P+   +  ++ + +  AL YL     
Sbjct: 91  GTFITNTDVFIAMELM--GTCAEKLKKRMQG---PIPERILGKMTVAIVKALYYLKEKHG 145
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRD+K +NILLDER + K+ DFG S  +  D+     +  G   Y+ PE       
Sbjct: 146 --VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDP 201
Query: 258 TD-----KSDVYSFGVVLVELLTGKKP 279
           T      ++DV+S G+ LVEL TG+ P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 92/166 (55%), Gaps = 12/166 (7%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLT 174
           + F+ E  +++Q+ H N+V+LLG  +E +  L +V E++  G+L  +L  R ++    L 
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LG 115
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            +   + +++V  A+ YL     +   HRD+ + N+L+ E   AKV+DFG +K  +  Q 
Sbjct: 116 GDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172
Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                ++ T     PE  +  + + KSDV+SFG++L E+ + G+ P
Sbjct: 173 TGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 128
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  PE 
Sbjct: 129 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 185
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 134
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  PE 
Sbjct: 135 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 261
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 35/277 (12%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+G  G V K R +  G+I+AVK+ +  V+ +E  +L   ++    +  ++    V   
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL--LMDLDISMRTVDCPFTVTFY 116
Query: 138 GCCLETEFPLLVYEFIPNG--TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           G         +  E +       Y+ + D+ Q     +  ++  ++A+ +  AL +LHS 
Sbjct: 117 GALFREGDVWICMELMDTSLDKFYKQVIDKGQT----IPEDILGKIAVSIVKALEHLHSK 172
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL-----DPE 250
            S  + HRD+K +N+L++   + K+ DFG S ++    +   T   G   Y+     +PE
Sbjct: 173 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DSVAKTIDAGCKPYMAPERINPE 228
Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
            +Q    + KSD++S G+ ++EL   + P  S G   Q+                L  ++
Sbjct: 229 LNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ----------------LKQVV 271
Query: 311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           ++   +L        F +   +CL  N K+RPT  E+
Sbjct: 272 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 308

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKG----RLEDGRIIAVKKSKLAVDDEELYKLEE 117
           S+++ +       + R +G+G  G V++G           +A+K  K    D      E+
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS---VREK 57
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           F+ E   + Q +H ++VKL+G  + TE P+ ++ E    G L   L  R    ++ L   
Sbjct: 58  FLQEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVR----KFSLDLA 111
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++     + 
Sbjct: 112 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYK 168
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
            +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 62  SSKELDKATNHFNVN-----RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLE 116
           SS   D  T HF ++     R LG+G  G VY  R +    I   K       E+     
Sbjct: 9   SSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEH 68
Query: 117 EFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           +   EI I + ++H N+++L     +     L+ E+ P G LY+ L      +E     +
Sbjct: 69  QLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDE-----Q 123
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
               +  E+A AL Y H      + HRDIK  N+LL  +   K+ADFG S        H 
Sbjct: 124 RTATIMEELADALMYCHGKK---VIHRDIKPENLLLGLKGELKIADFGWS-------VHA 173
Query: 237 TT----KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            +     + GT  YL PE  +     +K D++  GV+  ELL G  P  S  +
Sbjct: 174 PSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASH 226

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 261
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 113/241 (46%), Gaps = 28/241 (11%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLT 174
           + F+ E  +++Q+ H N+V+LLG  +E +  L +V E++  G+L  +L  R ++    L 
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LG 287
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            +   + +++V  A+ YL     +   HRD+ + N+L+ E   AKV+DFG +K  +  Q 
Sbjct: 288 GDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344
Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
                ++ T     PE  +  + + KSDV+SFG++L E       I+S G      + L 
Sbjct: 345 TGKLPVKWT----APEALREKKFSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLK 393
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
              V  + K       D             A  ++ + C  L+   RPT  ++  +L  I
Sbjct: 394 D-VVPRVEKGYKMDAPD---------GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
Query: 355 R 355
           R
Sbjct: 444 R 444

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 92/166 (55%), Gaps = 12/166 (7%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLT 174
           + F+ E  +++Q+ H N+V+LLG  +E +  L +V E++  G+L  +L  R ++    L 
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LG 100
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            +   + +++V  A+ YL     +   HRD+ + N+L+ E   AKV+DFG +K  +  Q 
Sbjct: 101 GDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157
Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                ++ T     PE  +  + + KSDV+SFG++L E+ + G+ P
Sbjct: 158 TGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 90  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 142
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  PE 
Sbjct: 143 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 199
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 18/236 (7%)
Query: 56  DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKG----RLEDGRIIAVKKSKLAVDDEE 111
           D   + S+++ +       + R +G+G  G V++G           +A+K  K    D  
Sbjct: 375 DTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS- 433
Query: 112 LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEE 170
               E+F+ E   + Q +H ++VKL+G    TE P+ ++ E    G L   L  R    +
Sbjct: 434 --VREKFLQEALTMRQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVR----K 485
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
           + L        A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++ 
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
               +  +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 144
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  PE 
Sbjct: 145 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 144
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  PE 
Sbjct: 145 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +A+K  K           E F+ E  I+ ++ H  +V+L  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGT-----MSPESFLEEAQIMKKLKHDKLVQLYA 71
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L D    E   L       +A +VA  +AY+     
Sbjct: 72  VV--SEEPIYIVTEYMNKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIERMN- 125
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD++S NIL+      K+ADFG ++ I  ++       +    +  PE     + 
Sbjct: 126 --YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 183
Query: 258 TDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
           T KSDV+SFG++L EL+T G+ P     N
Sbjct: 184 TIKSDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 129/302 (42%), Gaps = 50/302 (16%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRII--AVKKSK-LAVDDEELYKLEEFINEIFILS 126
           N      ++G+G  G V K R++ DG  +  A+K+ K  A  D+      +F  E+ +L 
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAGELEVLC 77
Query: 127 QINHR-NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP-----------LT 174
           ++ H  N++ LLG C    +  L  E+ P+G L   L      E  P           L+
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            +     A +VA  + YL   +     HR++ + NIL+ E Y AK+ADFG S+     Q 
Sbjct: 138 SQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQE 190
Query: 235 HVTTKIQGTFG--YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
               K  G     ++  E    S  T  SDV+S+GV+L E       I S G T    ++
Sbjct: 191 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE-------IVSLGGTPYCGMT 243
Query: 293 LAAYFVHSMRKNRLYHIL--DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
            A  +    +  RL   L  DD+V             +L  +C      +RP+  ++ + 
Sbjct: 244 CAELYEKLPQGYRLEKPLNCDDEVY------------DLMRQCWREKPYERPSFAQILVS 291
Query: 351 LN 352
           LN
Sbjct: 292 LN 293

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+V+RI+G+GG G VY  R  D G++ A+K   K ++ +   E   L    NE  +LS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLS 244
Query: 127 QINHRNVVKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
            ++  +   ++  C+   F        + + +  G L+ HL       E     +MRF  
Sbjct: 245 LVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYA 298
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A E+   L ++H+     + +RD+K  NILLDE    +++D G +   +  + H +    
Sbjct: 299 A-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           GT GY+ PE  Q     D S D +S G +L +LL G  P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+V+RI+G+GG G VY  R  D G++ A+K   K ++ +   E   L    NE  +LS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLS 244
Query: 127 QINHRNVVKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
            ++  +   ++  C+   F        + + +  G L+ HL       E     +MRF  
Sbjct: 245 LVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYA 298
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A E+   L ++H+     + +RD+K  NILLDE    +++D G +   +  + H +    
Sbjct: 299 A-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           GT GY+ PE  Q     D S D +S G +L +LL G  P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 18/236 (7%)
Query: 56  DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKG----RLEDGRIIAVKKSKLAVDDEE 111
           D   + S+++ +       + R +G+G  G V++G           +A+K  K    D  
Sbjct: 375 DTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS- 433
Query: 112 LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEE 170
               E+F+ E   + Q +H ++VKL+G    TE P+ ++ E    G L   L  R    +
Sbjct: 434 --VREKFLQEALTMRQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVR----K 485
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
           + L        A +++ ALAYL S       HRDI + N+L+      K+ DFG S+++ 
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYME 542
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
               +  +K +    ++ PE     + T  SDV+ FGV + E+L  G KP     N
Sbjct: 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+V+RI+G+GG G VY  R  D G++ A+K   K ++ +   E   L    NE  +LS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLS 244
Query: 127 QINHRNVVKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
            ++  +   ++  C+   F        + + +  G L+ HL       E     +MRF  
Sbjct: 245 LVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRF-Y 297
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A E+   L ++H+     + +RD+K  NILLDE    +++D G +   +  + H +    
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           GT GY+ PE  Q     D S D +S G +L +LL G  P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 127/285 (44%), Gaps = 31/285 (10%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           F ++++LG+G  G V+    +       I A+KK  + +DD+    +E  + E  +LS  
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD----VECTMVEKRVLSLA 75
Query: 129 NHRNVVKLLGCCLET-EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +  + C  +T E    V E++  G L  H+   H+ +    T+      A E+  
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-----YAAEIIL 130
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
            L +LHS     I +RD+K  NILLD+    K+ADFG  K   +     T +  GT  Y+
Sbjct: 131 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGTPDYI 186
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE     +     D +SFGV+L E+L G+ P    G   +E         HS+R +  +
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF--HGQDEEE-------LFHSIRMDNPF 237
Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNG--KKRPTMEEVSME 350
           +     + K  K   +  F    E+ L + G  ++ P   E++ E
Sbjct: 238 Y--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 280

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 123/290 (42%), Gaps = 40/290 (13%)
Query: 52  GSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKL 105
           G+ +   +L      +   +   + + LG+G  G V           +  R+  V    L
Sbjct: 1   GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 60
Query: 106 AVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD 164
             D  E   L + I+E+ ++  I  H+N++ LLG C +     ++ E+   G L ++L  
Sbjct: 61  KSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 119
Query: 165 RH-----------QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD 213
           R             N E  L+ +     A +VA  + YL   AS    HRD+ + N+L+ 
Sbjct: 120 RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVT 176
Query: 214 ERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE 272
           E    K+ADFG ++ I  +D    TT  +    ++ PE       T +SDV+SFGV+L E
Sbjct: 177 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 236
Query: 273 LLTGKKPIFSTGNTSQENVSLAAYFV-----HSMRK-----NRLYHILDD 312
                  IF+ G +    V +   F      H M K     N LY ++ D
Sbjct: 237 -------IFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD 279

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+V+RI+G+GG G VY  R  D G++ A+K   K ++ +   E   L    NE  +LS
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLS 243
Query: 127 QINHRNVVKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
            ++  +   ++  C+   F        + + +  G L+ HL       E     +MRF  
Sbjct: 244 LVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRF-Y 296
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A E+   L ++H+     + +RD+K  NILLDE    +++D G +   +  + H +    
Sbjct: 297 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 350
Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           GT GY+ PE  Q     D S D +S G +L +LL G  P
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 34/271 (12%)
Query: 79  LGQGGQGTVYKGRLEDGR-IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYKG     + ++A+K   L   ++E+  +++   EI +LSQ +   + +  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYF 83
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G  L++    ++ E++  G+    L      E Y  T      +  E+   L YLHS   
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYLHSERK 137
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRDIK+ N+LL E+   K+ADFG +  +   Q      + GT  ++ PE  + S  
Sbjct: 138 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAY 193
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             K+D++S G+  +EL  G+ P          N  L     H MR   L+ I  +    L
Sbjct: 194 DFKADIWSLGITAIELAKGEPP----------NSDL-----HPMR--VLFLIPKNSPPTL 236
Query: 318 -GKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            G+ ++   F    E CL+ + + RPT +E+
Sbjct: 237 EGQHSK--PFKEFVEACLNKDPRFRPTAKEL 265

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEEDLSDLVSEM 91
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 261
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
              E     +V E++  G+L   L  + +  +Y L       +A ++A  +AY+      
Sbjct: 71  VVSEEPI-XIVTEYMSKGSLLDFL--KGETGKY-LRLPQLVDMAAQIASGMAYVERMN-- 124
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
              HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + T
Sbjct: 125 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 183
Query: 259 DKSDVYSFGVVLVELLT-GKKP 279
            KSDV+SFG++L EL T G+ P
Sbjct: 184 IKSDVWSFGILLTELTTKGRVP 205

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 128
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+     +  G +   +  PE 
Sbjct: 129 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPEC 185
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 92  EMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 261
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 18/230 (7%)
Query: 73  FNVNRILGQGGQGTVYKGRLED-GRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQIN 129
           F++ R++G+G    V   RL+   RI A+K  K +L  DDE++  ++    E  +  Q +
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQAS 78
Query: 130 HRNVVKLLGCCLETEFPLL-VYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAG 187
           +   +  L  C +TE  L  V E++  G L  H+   R   EE+      RF  A E++ 
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSA-EISL 132
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL YLH      I +RD+K  N+LLD     K+ D+G  K   +     T+   GT  Y+
Sbjct: 133 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 188
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
            PE  +        D ++ GV++ E++ G+ P    G++   + +   Y 
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 238

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 96
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL  C  + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 151
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 152 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 243

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 261
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 40/267 (14%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + + LG+G  G V           +  R+  V    L  D  E   L + I+E+ ++  I
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMI 90
Query: 129 N-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L  R             N E  L+ +
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 235
                A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I  +D   
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            TT  +    ++ PE       T +SDV+SFGV+L E       IF+ G +    V +  
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPVEE 260
Query: 296 YFV-----HSMRK-----NRLYHILDD 312
            F      H M K     N LY ++ D
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRD 287

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 40/267 (14%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + + LG+G  G V           +  R+  V    L  D  E   L + I+E+ ++  I
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMI 90
Query: 129 N-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L  R             N E  L+ +
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 235
                A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I  +D   
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            TT  +    ++ PE       T +SDV+SFGV+L E       IF+ G +    V +  
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPVEE 260
Query: 296 YFV-----HSMRK-----NRLYHILDD 312
            F      H M K     N LY ++ D
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRD 287

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 92  EMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 261
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 18/230 (7%)
Query: 73  FNVNRILGQGGQGTVYKGRLED-GRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQIN 129
           F++ R++G+G    V   RL+   RI A+K  K +L  DDE++  ++    E  +  Q +
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQAS 63
Query: 130 HRNVVKLLGCCLETEFPLL-VYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAG 187
           +   +  L  C +TE  L  V E++  G L  H+   R   EE+      RF  A E++ 
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSA-EISL 117
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL YLH      I +RD+K  N+LLD     K+ D+G  K   +     T+   GT  Y+
Sbjct: 118 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 173
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
            PE  +        D ++ GV++ E++ G+ P    G++   + +   Y 
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 434 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 486
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  PE 
Sbjct: 487 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 543
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +F + + +G+G    VY+   L DG  +A+KK ++  D  +     + I EI +L Q+NH
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNH 91
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYP--LTWEMRFRVAIEVAG 187
            NV+K     +E     +V E    G L + + H + Q    P    W    +  +++  
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCS 147
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL ++HS     + HRDIK  N+ +      K+ D G  +F +  +T     + GT  Y+
Sbjct: 148 ALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYM 203
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
            PE    +    KSD++S G +L E+   + P +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 40/267 (14%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + + LG+G  G V           +  R+  V    L  D  E   L + I+E+ ++  I
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMI 90
Query: 129 N-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L  R             N E  L+ +
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 235
                A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I  +D   
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            TT  +    ++ PE       T +SDV+SFGV+L E       IF+ G +    V +  
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPVEE 260
Query: 296 YFV-----HSMRK-----NRLYHILDD 312
            F      H M K     N LY ++ D
Sbjct: 261 LFKLLKEGHRMDKPSNCTNELYMMMRD 287

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 40/267 (14%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + + LG+G  G V           +  R+  V    L  D  E   L + I+E+ ++  I
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMI 79
Query: 129 N-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L  R             N E  L+ +
Sbjct: 80  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 235
                A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I  +D   
Sbjct: 140 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            TT  +    ++ PE       T +SDV+SFGV+L E       IF+ G +    V +  
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPVEE 249
Query: 296 YFV-----HSMRK-----NRLYHILDD 312
            F      H M K     N LY ++ D
Sbjct: 250 LFKLLKEGHRMDKPSNCTNELYMMMRD 276

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 40/267 (14%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + + LG+G  G V           +  R+  V    L  D  E   L + I+E+ ++  I
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMI 83
Query: 129 N-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L  R             N E  L+ +
Sbjct: 84  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 235
                A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I  +D   
Sbjct: 144 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            TT  +    ++ PE       T +SDV+SFGV+L E       IF+ G +    V +  
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPVEE 253
Query: 296 YFV-----HSMRK-----NRLYHILDD 312
            F      H M K     N LY ++ D
Sbjct: 254 LFKLLKEGHRMDKPSNCTNELYMMMRD 280

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 54/281 (19%)
Query: 79  LGQGGQGTVYKGRLEDGR---IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +G+G  G V+KG   D R   ++A+K   L   ++E+  +++   EI +LSQ +   V K
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSSYVTK 85
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI---EVAGALAYL 192
             G  L+     ++ E++  G+    L     +E         F++A    E+   L YL
Sbjct: 86  YYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDE---------FQIATMLKEILKGLDYL 136
Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
           HS       HRDIK+ N+LL E+   K+ADFG +  +   Q    T + GT  ++ PE  
Sbjct: 137 HSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 192
Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR------KNRL 306
           Q S    K+D++S G+  +EL  G+ P     N+           +H MR      KN  
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPP-----NSD----------MHPMRVLFLIPKNNP 237
Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             ++ D            +F    + CL+ +   RPT +E+
Sbjct: 238 PTLVGDFTK---------SFKEFIDACLNKDPSFRPTAKEL 269

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 40/267 (14%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + + LG+G  G V           +  R+  V    L  D  E   L + I+E+ ++  I
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMI 75
Query: 129 N-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L  R             N E  L+ +
Sbjct: 76  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 235
                A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I  +D   
Sbjct: 136 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            TT  +    ++ PE       T +SDV+SFGV+L E       IF+ G +    V +  
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPVEE 245
Query: 296 YFV-----HSMRK-----NRLYHILDD 312
            F      H M K     N LY ++ D
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRD 272

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 76  NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKL-EEFINEIFILSQINHRNVV 134
           ++ LG G  GTV KG  +  +++     K+  ++     L +E + E  ++ Q+++  +V
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           +++G C E E  +LV E    G L ++L  +RH  ++  +       +  +V+  + YL 
Sbjct: 435 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYLE 487
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG--YLDPEY 251
               S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  PE 
Sbjct: 488 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 544
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               + + KSDV+SFGV++ E  + G+KP
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 40/267 (14%)
Query: 75  VNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + + LG+G  G V           +  R+  V    L  D  E   L + I+E+ ++  I
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMI 131
Query: 129 N-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L  R             N E  L+ +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTH 235
                A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I  +D   
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            TT  +    ++ PE       T +SDV+SFGV+L E       IF+ G +    V +  
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE-------IFTLGGSPYPGVPVEE 301
Query: 296 YFV-----HSMRK-----NRLYHILDD 312
            F      H M K     N LY ++ D
Sbjct: 302 LFKLLKEGHRMDKPSNCTNELYMMMRD 328

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 18/230 (7%)
Query: 73  FNVNRILGQGGQGTVYKGRLED-GRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQIN 129
           F++ R++G+G    V   RL+   RI A+K  K +L  DDE++  ++    E  +  Q +
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQAS 67
Query: 130 HRNVVKLLGCCLETEFPLL-VYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAG 187
           +   +  L  C +TE  L  V E++  G L  H+   R   EE+      RF  A E++ 
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSA-EISL 121
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL YLH      I +RD+K  N+LLD     K+ D+G  K   +     T+   GT  Y+
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 177
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
            PE  +        D ++ GV++ E++ G+ P    G++   + +   Y 
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 140/324 (43%), Gaps = 52/324 (16%)
Query: 49  SYDG---SVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL-----EDGRI-IA 99
           SY+G   + ID  +L  +++ +   N+    + LG G  G V +        ED  + +A
Sbjct: 21  SYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 100 VKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTL 158
           VK  K     +E    E  ++E+ I+S +  H N+V LLG C      L++ E+   G L
Sbjct: 81  VKMLKSTAHADEK---EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 159 YQHLHDRHQNEEYPLTWEMRFRVAI---------EVAGALAYLHSGASSPIYHRDIKSTN 209
              L  + +  E    + +    A          +VA  +A+L   AS    HRD+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 210 ILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGV 268
           +LL   + AK+ DFG ++ I  D  + V    +    ++ PE       T +SDV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 269 VLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFA- 327
           +L E       IFS G      +         +  ++ Y ++ D     G +    AFA 
Sbjct: 255 LLWE-------IFSLGLNPYPGI---------LVNSKFYKLVKD-----GYQMAQPAFAP 293
Query: 328 ----NLAERCLDLNGKKRPTMEEV 347
               ++ + C  L    RPT +++
Sbjct: 294 KNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ +I H  +V+L  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 81  VV--SEEPIYIVTEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K      E      F+ E  ++ ++ H  +V+L  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-----AFLQEAQVMKKLRHEKLVQLYA 73
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
             + +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 74  --VVSEEPIYIVTEYMSKGSLLDFL--KGETGKY-LRLPQLVDMAAQIASGMAYVERMN- 127
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 128 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 185
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 186 TIKSDVWSFGILLTELTTKGRVP 208

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 80
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 81  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 140
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 141 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 250
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 251 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 283

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 83
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 84  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 143
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 200
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 253
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 254 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 286

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 247 VV--SEEPIYIVTEYMSKGSLLDFL--KGETGKY-LRLPQLVDMAAQIASGMAYVERMN- 300
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP 381

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 137
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 307
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 308 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 340

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 247 VV--SEEPIYIVTEYMSKGSLLDFL--KGETGKY-LRLPQLVDMAAQIASGMAYVERMN- 300
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP 381

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 81  VV--SEEPIYIVIEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 192
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    ++ADFG ++ I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 261
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 140/324 (43%), Gaps = 52/324 (16%)
Query: 49  SYDG---SVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL-----EDGRI-IA 99
           SY+G   + ID  +L  +++ +   N+    + LG G  G V +        ED  + +A
Sbjct: 21  SYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 100 VKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTL 158
           VK  K     +E    E  ++E+ I+S +  H N+V LLG C      L++ E+   G L
Sbjct: 81  VKMLKSTAHADEK---EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 159 YQHLHDRHQNEEYPLTWEMR---------FRVAIEVAGALAYLHSGASSPIYHRDIKSTN 209
              L  + +  E    + +             + +VA  +A+L   AS    HRD+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 210 ILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGV 268
           +LL   + AK+ DFG ++ I  D  + V    +    ++ PE       T +SDV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 269 VLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFA- 327
           +L E       IFS G      +         +  ++ Y ++ D     G +    AFA 
Sbjct: 255 LLWE-------IFSLGLNPYPGI---------LVNSKFYKLVKD-----GYQMAQPAFAP 293
Query: 328 ----NLAERCLDLNGKKRPTMEEV 347
               ++ + C  L    RPT +++
Sbjct: 294 KNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 78
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L           +D ++  E
Sbjct: 79  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 138
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 248
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 249 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 281

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 31/285 (10%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           F ++++LG+G  G V+    +       I A+KK  + +DD+    +E  + E  +LS  
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD----VECTMVEKRVLSLA 74
Query: 129 NHRNVVKLLGCCLET-EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +  + C  +T E    V E++  G L  H+   H+ +    T+      A E+  
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-----YAAEIIL 129
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
            L +LHS     I +RD+K  NILLD+    K+ADFG  K   +     T    GT  Y+
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYI 185
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE     +     D +SFGV+L E+L G+ P    G   +E         HS+R +  +
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF--HGQDEEE-------LFHSIRMDNPF 236
Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNG--KKRPTMEEVSME 350
           +     + K  K   +  F    E+ L + G  ++ P   E++ E
Sbjct: 237 Y--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 43/314 (13%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVD 108
           ID  +L    + +   N  +  + LG G  G V +       + +    +AVK  K    
Sbjct: 30  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---P 86
Query: 109 DEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
              L + E  ++E+ +LS + NH N+V LLG C      L++ E+   G L   L  +  
Sbjct: 87  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 146
Query: 168 N----EEYPLTWEMRF---------RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE 214
           +    +  P   E              + +VA  +A+L   AS    HRD+ + NILL  
Sbjct: 147 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTH 203
Query: 215 RYRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 273
               K+ DFG ++ I  D  +V     +    ++ PE   +   T +SDV+S+G+ L EL
Sbjct: 204 GRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263
Query: 274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERC 333
                  FS G++    + + + F         Y ++ +    L  ++      ++ + C
Sbjct: 264 -------FSLGSSPYPGMPVDSKF---------YKMIKEGFRMLSPEHAPAEMYDIMKTC 307
Query: 334 LDLNGKKRPTMEEV 347
            D +  KRPT +++
Sbjct: 308 WDADPLKRPTFKQI 321

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
              E     +V E++  G+L   L  + +  +Y L       +A ++A  +AY+      
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFL--KGETGKY-LRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
              HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + T
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 259 DKSDVYSFGVVLVELLT-GKKP 279
            KSDV+SFG++L EL T G+ P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVP 464

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 14/225 (6%)
Query: 69  ATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           +++ F     LG G   TVYKG     G  +A+K+ KL   D E       I EI ++ +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL---DSEEGTPSTAIREISLMKE 59
Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRH-QNEEYPLTWEMRFRVAIEV 185
           + H N+V+L    + TE  L LV+EF+ N  L +++  R   N    L   +      ++
Sbjct: 60  LKHENIVRLYDV-IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
              LA+ H      I HRD+K  N+L+++R + K+ DFG ++   +     ++++  T  
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           Y  P+    S+    S D++S G +L E++TG KP+F   N  ++
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEEQ 217

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/334 (24%), Positives = 140/334 (41%), Gaps = 61/334 (18%)
Query: 49  SYDG---SVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL-----EDGRI-IA 99
           SY+G   + ID  +L  +++ +   N+    + LG G  G V +        ED  + +A
Sbjct: 6   SYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVA 65
Query: 100 VKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTL 158
           VK  K     +E    E  ++E+ I+S +  H N+V LLG C      L++ E+   G L
Sbjct: 66  VKMLKSTAHADEK---EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 159 YQHLHDRHQ------------------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPI 200
              L  + +                   +  PL        + +VA  +A+L   AS   
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNC 179
Query: 201 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTD 259
            HRD+ + N+LL   + AK+ DFG ++ I  D  + V    +    ++ PE       T 
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 260 KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGK 319
           +SDV+S+G++L E       IFS G      +         +  ++ Y ++ D     G 
Sbjct: 240 QSDVWSYGILLWE-------IFSLGLNPYPGI---------LVNSKFYKLVKD-----GY 278
Query: 320 KNQIVAFA-----NLAERCLDLNGKKRPTMEEVS 348
           +    AFA     ++ + C  L    RPT +++ 
Sbjct: 279 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 312

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 247 VV--SEEPIYIVGEYMSKGSLLDFL--KGETGKY-LRLPQLVDMAAQIASGMAYVERMN- 300
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP 381

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
             + +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 81  --VVSEEPIYIVCEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G VYK + ++  ++A  K    +D +   +LE+++ EI IL+  +H N+VKLL 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAK---VIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                    ++ EF   G +   + +     E PLT      V  +   AL YLH     
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK-- 155
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ------GTFGYLDPEYH 252
            I HRD+K+ NIL       K+ADFG S          T  IQ      GT  ++ PE  
Sbjct: 156 -IIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRXIQRRDSFIGTPYWMAPEVV 207
Query: 253 QSSQLTD-----KSDVYSFGVVLVELLTGKKP 279
                 D     K+DV+S G+ L+E+   + P
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G VYK + ++  ++A  K    +D +   +LE+++ EI IL+  +H N+VKLL 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAK---VIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                    ++ EF   G +   + +     E PLT      V  +   AL YLH     
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK-- 155
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ------GTFGYLDPEYH 252
            I HRD+K+ NIL       K+ADFG S          T  IQ      GT  ++ PE  
Sbjct: 156 -IIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRXIQRRDXFIGTPYWMAPEVV 207
Query: 253 QSSQLTD-----KSDVYSFGVVLVELLTGKKP 279
                 D     K+DV+S G+ L+E+   + P
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G VYK + ++  ++A  K    +D +   +LE+++ EI IL+  +H N+VKLL 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAK---VIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                    ++ EF   G +   + +     E PLT      V  +   AL YLH     
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK-- 155
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ------GTFGYLDPEYH 252
            I HRD+K+ NIL       K+ADFG S          T  IQ      GT  ++ PE  
Sbjct: 156 -IIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRTIQRRDSFIGTPYWMAPEVV 207
Query: 253 QSSQLTD-----KSDVYSFGVVLVELLTGKKP 279
                 D     K+DV+S G+ L+E+   + P
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 81  VV--SEEPIYIVIEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 131/291 (45%), Gaps = 56/291 (19%)
Query: 72  HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEEL--YKLEEFINEIFIL 125
           H    R+L   G+G   K +L      GR +A+K     +D  +L    L++   E+ I+
Sbjct: 10  HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK----IIDKTQLNPTSLQKLFREVRIM 65
Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVA 182
             +NH N+VKL    +ETE  L L+ E+   G ++ +L  H R + +E       +FR  
Sbjct: 66  KILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA----RSKFR-- 118
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ- 241
            ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S     ++  V  K+  
Sbjct: 119 -QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFS-----NEFTVGGKLDT 169
Query: 242 --GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAY 296
             G+  Y  PE  Q  +      DV+S GV+L  L++G  P F   N  +  E V    Y
Sbjct: 170 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLRGKY 228
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +        Y   D +              NL +R L LN  KR T+E++
Sbjct: 229 RIP------FYMSTDCE--------------NLLKRFLVLNPIKRGTLEQI 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
             + +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 72  --VVSEEPIYIVTEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 125
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 126 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 183
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 184 TIKSDVWSFGILLTELTTKGRVP 206

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 81  VV--SEEPIYIVTEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K      E      F+ E  ++ ++ H  +V+L  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-----AFLQEAQVMKKLRHEKLVQLYA 69
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
             + +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 70  --VVSEEPIYIVTEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 123
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 124 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 181
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 182 TIKSDVWSFGILLTELTTKGRVP 204

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 122/257 (47%), Gaps = 24/257 (9%)
Query: 52  GSVIDRCK-LFSSKELDKATNH-----FNVNRILGQGGQGTVYKGRLED-GRIIAVK--K 102
           GS I+  K   +++E  KA++      F++ R++G+G    V   RL+   RI A++  K
Sbjct: 27  GSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK 86
Query: 103 SKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL-VYEFIPNGTLYQH 161
            +L  DDE++  ++    E  +  Q ++   +  L  C +TE  L  V E++  G L  H
Sbjct: 87  KELVNDDEDIDWVQ---TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143
Query: 162 LH-DRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
           +   R   EE+      RF  A E++ AL YLH      I +RD+K  N+LLD     K+
Sbjct: 144 MQRQRKLPEEH-----ARFYSA-EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKL 194
Query: 221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
            D+G  K   +     T+   GT  Y+ PE  +        D ++ GV++ E++ G+ P 
Sbjct: 195 TDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253
Query: 281 FSTGNTSQENVSLAAYF 297
              G++   + +   Y 
Sbjct: 254 DIVGSSDNPDQNTEDYL 270

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
             + +E P+ +V E++  G L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 81  --VVSEEPIYIVMEYMSKGCLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 130/291 (44%), Gaps = 56/291 (19%)
Query: 72  HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEEL--YKLEEFINEIFIL 125
           H    R+L   G+G   K +L      GR +A+K     +D  +L    L++   E+ I+
Sbjct: 13  HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK----IIDKTQLNPTSLQKLFREVRIM 68
Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVA 182
             +NH N+VKL    +ETE  L L+ E+   G ++ +L  H R + +E       +FR  
Sbjct: 69  KILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA----RSKFR-- 121
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S     ++  V  K+  
Sbjct: 122 -QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFS-----NEFTVGGKLDA 172
Query: 243 TFG---YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAY 296
             G   Y  PE  Q  +      DV+S GV+L  L++G  P F   N  +  E V    Y
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLRGKY 231
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +        Y   D +              NL +R L LN  KR T+E++
Sbjct: 232 RIP------FYMSTDCE--------------NLLKRFLVLNPIKRGTLEQI 262

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 77  RILGQGGQGTVY--KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV 134
            +LG G    V+  K RL  G++ A+K     +     ++     NEI +L +I H N+V
Sbjct: 15  EVLGSGAFSEVFLVKQRL-TGKLFALK----CIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
            L      T    LV + +  G L+  + +R    E   +      V  +V  A+ YLH 
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-----LVIQQVLSAVKYLHE 124
Query: 195 GASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
                I HRD+K  N+L    +E  +  + DFG SK   M+Q  + +   GT GY+ PE 
Sbjct: 125 NG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPGYVAPEV 178
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
                 +   D +S GV+   LL G  P +
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILLCGYPPFY 208

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 134/314 (42%), Gaps = 43/314 (13%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVD 108
           ID  +L    + +   N  +  + LG G  G V +       + +    +AVK  K +  
Sbjct: 7   IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA- 65
Query: 109 DEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
              L + E  ++E+ +LS + NH N+V LLG C      L++ E+   G L   L  +  
Sbjct: 66  --HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 168 N----EEYPLTWEMRF---------RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE 214
           +    +  P   E              + +VA  +A+L   AS    HRD+ + NILL  
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTH 180
Query: 215 RYRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 273
               K+ DFG ++ I  D  +V     +    ++ PE   +   T +SDV+S+G+ L EL
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERC 333
                  FS G++    + + + F         Y ++ +    L  ++      ++ + C
Sbjct: 241 -------FSLGSSPYPGMPVDSKF---------YKMIKEGFRMLSPEHAPAEMYDIMKTC 284
Query: 334 LDLNGKKRPTMEEV 347
            D +  KRPT +++
Sbjct: 285 WDADPLKRPTFKQI 298

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 134/314 (42%), Gaps = 43/314 (13%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVD 108
           ID  +L    + +   N  +  + LG G  G V +       + +    +AVK  K +  
Sbjct: 23  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA- 81
Query: 109 DEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
              L + E  ++E+ +LS + NH N+V LLG C      L++ E+   G L   L  +  
Sbjct: 82  --HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 139
Query: 168 N----EEYPLTWEMRF---------RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE 214
           +    +  P   E              + +VA  +A+L   AS    HRD+ + NILL  
Sbjct: 140 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTH 196
Query: 215 RYRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 273
               K+ DFG ++ I  D  +V     +    ++ PE   +   T +SDV+S+G+ L EL
Sbjct: 197 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 256
Query: 274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERC 333
                  FS G++    + + + F         Y ++ +    L  ++      ++ + C
Sbjct: 257 -------FSLGSSPYPGMPVDSKF---------YKMIKEGFRMLSPEHAPAEMYDIMKTC 300
Query: 334 LDLNGKKRPTMEEV 347
            D +  KRPT +++
Sbjct: 301 WDADPLKRPTFKQI 314

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 134/314 (42%), Gaps = 43/314 (13%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVD 108
           ID  +L    + +   N  +  + LG G  G V +       + +    +AVK  K +  
Sbjct: 30  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA- 88
Query: 109 DEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
              L + E  ++E+ +LS + NH N+V LLG C      L++ E+   G L   L  +  
Sbjct: 89  --HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 146
Query: 168 N----EEYPLTWEMRF---------RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE 214
           +    +  P   E              + +VA  +A+L   AS    HRD+ + NILL  
Sbjct: 147 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTH 203
Query: 215 RYRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 273
               K+ DFG ++ I  D  +V     +    ++ PE   +   T +SDV+S+G+ L EL
Sbjct: 204 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263
Query: 274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERC 333
                  FS G++    + + + F         Y ++ +    L  ++      ++ + C
Sbjct: 264 -------FSLGSSPYPGMPVDSKF---------YKMIKEGFRMLSPEHAPAEMYDIMKTC 307
Query: 334 LDLNGKKRPTMEEV 347
            D +  KRPT +++
Sbjct: 308 WDADPLKRPTFKQI 321

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 72  HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEEL--YKLEEFINEIFIL 125
           H    R+L   G+G   K +L      G+ +AVK     +D  +L    L++   E+ I+
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREVRIM 67
Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVA 182
             +NH N+VKL    +ETE  L LV E+   G ++ +L  H R + +E       +FR  
Sbjct: 68  KVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA----RAKFR-- 120
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S          T    G
Sbjct: 121 -QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCG 174
Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           +  Y  PE  Q  +      DV+S GV+L  L++G  P
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
             + +E P+ +V E++  G L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 81  --VVSEEPIYIVTEYMSKGCLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 134/314 (42%), Gaps = 43/314 (13%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVD 108
           ID  +L    + +   N  +  + LG G  G V +       + +    +AVK  K +  
Sbjct: 25  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA- 83
Query: 109 DEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
              L + E  ++E+ +LS + NH N+V LLG C      L++ E+   G L   L  +  
Sbjct: 84  --HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 141
Query: 168 N----EEYPLTWEMRF---------RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE 214
           +    +  P   E              + +VA  +A+L   AS    HRD+ + NILL  
Sbjct: 142 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTH 198
Query: 215 RYRAKVADFGTSKFIAMDQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 273
               K+ DFG ++ I  D  +V     +    ++ PE   +   T +SDV+S+G+ L EL
Sbjct: 199 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 258
Query: 274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERC 333
                  FS G++    + + + F         Y ++ +    L  ++      ++ + C
Sbjct: 259 -------FSLGSSPYPGMPVDSKF---------YKMIKEGFRMLSPEHAPAEMYDIMKTC 302
Query: 334 LDLNGKKRPTMEEV 347
            D +  KRPT +++
Sbjct: 303 WDADPLKRPTFKQI 316

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 119/285 (41%), Gaps = 33/285 (11%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKK--SKLAVDDEELYKLEE---F 118
           ++L      + V +++G+G  G V   R +  R +   K  SK      E+ K  +   F
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF-----EMIKRSDSAFF 121
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
             E  I++  N   VV+L     +  +  +V E++P G L   +     N + P  W  R
Sbjct: 122 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKW-AR 176
Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
           F  A EV  AL  +HS       HRD+K  N+LLD+    K+ADFGT   +  +      
Sbjct: 177 FYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 232
Query: 239 KIQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
              GT  Y+ PE  + SQ  D     + D +S GV L E+L G  P ++         SL
Sbjct: 233 TAVGTPDYISPEVLK-SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SL 283
Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNG 338
              +   M         DD  +    KN I AF    E  L  NG
Sbjct: 284 VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG 328

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 72  HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEEL--YKLEEFINEIFIL 125
           H    R+L   G+G   K +L      G+ +AVK     +D  +L    L++   E+ I+
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREVRIM 67
Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVA 182
             +NH N+VKL    +ETE  L LV E+   G ++ +L  H R + +E       +FR  
Sbjct: 68  KVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA----RAKFR-- 120
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S          T    G
Sbjct: 121 -QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCG 174
Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           +  Y  PE  Q  +      DV+S GV+L  L++G  P
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 119/285 (41%), Gaps = 33/285 (11%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKK--SKLAVDDEELYKLEE---F 118
           ++L      + V +++G+G  G V   R +  R +   K  SK      E+ K  +   F
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF-----EMIKRSDSAFF 121
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
             E  I++  N   VV+L     +  +  +V E++P G L   +     N + P  W  R
Sbjct: 122 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKW-AR 176
Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
           F  A EV  AL  +HS       HRD+K  N+LLD+    K+ADFGT   +  +      
Sbjct: 177 FYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 232
Query: 239 KIQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
              GT  Y+ PE  + SQ  D     + D +S GV L E+L G  P ++         SL
Sbjct: 233 TAVGTPDYISPEVLK-SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SL 283
Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNG 338
              +   M         DD  +    KN I AF    E  L  NG
Sbjct: 284 VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG 328

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++  +   G L ++L           +D ++  E
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 261
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEEL--YKLEEFINEIFILSQI 128
           ++ + + +G+G    V   R +  GR +AVK     +D  +L    L++   E+ I+  +
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVK----IIDKTQLNPTSLQKLFREVRIMKIL 71
Query: 129 NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVAIEV 185
           NH N+VKL    +ETE  L LV E+   G ++ +L  H R + +E       +FR   ++
Sbjct: 72  NHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA----RAKFR---QI 123
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             A+ Y H      I HRD+K+ N+LLD     K+ADFG S    +     T    G+  
Sbjct: 124 VSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPP 178
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           Y  PE  Q  +      DV+S GV+L  L++G  P
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 79  LGQGGQGTVYKGRLEDGR---IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +G+G  G V+KG   D R   ++A+K   L   ++E+  +++   EI +LSQ +   V K
Sbjct: 35  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTK 89
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
             G  L+     ++ E++  G+    L      E  PL       +  E+   L YLHS 
Sbjct: 90  YYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSE 143
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
                 HRDIK+ N+LL E    K+ADFG +  +   Q    T + GT  ++ PE  + S
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 199
Query: 256 QLTDKSDVYSFGVVLVELLTGKKP 279
               K+D++S G+  +EL  G+ P
Sbjct: 200 AYDSKADIWSLGITAIELARGEPP 223

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 119/285 (41%), Gaps = 33/285 (11%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKK--SKLAVDDEELYKLEE---F 118
           ++L      + V +++G+G  G V   R +  R +   K  SK      E+ K  +   F
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF-----EMIKRSDSAFF 116
Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
             E  I++  N   VV+L     +  +  +V E++P G L   +     N + P  W  R
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKW-AR 171
Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
           F  A EV  AL  +HS       HRD+K  N+LLD+    K+ADFGT   +  +      
Sbjct: 172 FYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227
Query: 239 KIQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
              GT  Y+ PE  + SQ  D     + D +S GV L E+L G  P ++         SL
Sbjct: 228 TAVGTPDYISPEVLK-SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SL 278
Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNG 338
              +   M         DD  +    KN I AF    E  L  NG
Sbjct: 279 VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG 323

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 79  LGQGGQGTVYKGRLEDGR---IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +G+G  G V+KG   D R   ++A+K   L   ++E+  +++   EI +LSQ +   V K
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTK 69
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
             G  L+     ++ E++  G+    L      E  PL       +  E+   L YLHS 
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSE 123
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
                 HRDIK+ N+LL E    K+ADFG +  +   Q    T + GT  ++ PE  + S
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 179
Query: 256 QLTDKSDVYSFGVVLVELLTGKKP 279
               K+D++S G+  +EL  G+ P
Sbjct: 180 AYDSKADIWSLGITAIELARGEPP 203

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G VYK +   GRI+A+K+ +L  +DE +      I EI +L +++H N+V L+ 
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKELHHPNIVSLID 86
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI-EVAGALAYLHSGAS 197
                    LV+EF+    L + L +     +     + + ++ + ++   +A+ H    
Sbjct: 87  VIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-----DSQIKIYLYQLLRGVAHCHQHR- 139
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  P+    S+ 
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKK 196
Query: 258 TDKS-DVYSFGVVLVELLTGKKPIFS 282
              S D++S G +  E++TG KP+F 
Sbjct: 197 YSTSVDIWSIGCIFAEMITG-KPLFP 221

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G VYK +   GRI+A+K+ +L  +DE +      I EI +L +++H N+V L+ 
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKELHHPNIVSLID 86
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI-EVAGALAYLHSGAS 197
                    LV+EF+    L + L +     +     + + ++ + ++   +A+ H    
Sbjct: 87  VIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-----DSQIKIYLYQLLRGVAHCHQHR- 139
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  P+    S+ 
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKK 196
Query: 258 TDKS-DVYSFGVVLVELLTGKKPIFS 282
              S D++S G +  E++TG KP+F 
Sbjct: 197 YSTSVDIWSIGCIFAEMITG-KPLFP 221

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 21/270 (7%)
Query: 79  LGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K      G ++A K   L +         + I E+ +L + N   +V   
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFY 70
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E +  G+L Q L    +  E     ++  +V+I V   L YL     
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLREKHK 125
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K +NIL++ R   K+ DFG S  +      +     GT  Y+ PE  Q +  
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHY 180
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
           + +SD++S G+ LVE+  G+ PI            +A +         L +I+++   KL
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIF-------ELLDYIVNEPPPKL 233
Query: 318 GKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                 + F +   +CL  N  +R  ++++
Sbjct: 234 PSGVFSLEFQDFVNKCLIKNPAERADLKQL 263

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       ++ ++A  +AY+     
Sbjct: 78  VV--SEEPIYIVTEYMNKGSLLDFL--KGETGKY-LRLPQLVDMSAQIASGMAYVERMN- 131
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVP 212

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 44/273 (16%)
Query: 71  NHFNVNRILGQGGQGTVY--------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V         K + ++   +AVK  K   DD     L + ++E+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 123 FILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEE 170
            ++  I  H+N++ LLG C +     ++  +   G L ++L           +D ++  E
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI- 229
             +T++       ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            +D    TT  +    ++ PE       T +SDV+SFGV++ E       IF+ G +   
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE-------IFTLGGSPYP 261
Query: 290 NVSLAAYFV-----HSMRK-----NRLYHILDD 312
            + +   F      H M K     N LY ++ D
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 72  HFNVNRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H      LG+G  G+V   R +      G ++AVK+ + +  D++     +F  EI IL 
Sbjct: 8   HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILK 63
Query: 127 QINHRNVVKLLGCCLETEFP--LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            ++   +VK  G       P   LV E++P+G L   L  RH+     L        + +
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQ-RHRAR---LDASRLLLYSSQ 119
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT- 243
           +   + YL    S    HRD+ + NIL++     K+ADFG +K + +D+     +  G  
Sbjct: 120 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 244 --FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
             F Y  PE    +  + +SDV+SFGVVL EL T
Sbjct: 177 PIFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 81  VV--SEEPIYIVTEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+ + NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 135 --YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 130/301 (43%), Gaps = 53/301 (17%)
Query: 71  NHFNVNRILGQGGQGTVYKGRL------EDGRIIAVK--KSKLAVDDEELYKLEEFINEI 122
           N+    R +G+G  G V++ R       E   ++AVK  K + + D +      +F  E 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-----DFQREA 101
Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE------------- 169
            ++++ ++ N+VKLLG C   +   L++E++  G L + L     +              
Sbjct: 102 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 170 ------EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF 223
                   PL+   +  +A +VA  +AYL   +     HRD+ + N L+ E    K+ADF
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 224 GTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           G S+ I + D             ++ PE    ++ T +SDV+++GVVL E       IFS
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE-------IFS 271
Query: 283 TGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP 342
            G        L  Y+  +  +  +Y++ D  ++    +N  +   NL   C       RP
Sbjct: 272 YG--------LQPYYGMA-HEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRP 321
Query: 343 T 343
           +
Sbjct: 322 S 322

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       ++ ++A  +AY+     
Sbjct: 78  VV--SEEPIYIVTEYMNKGSLLDFL--KGETGKY-LRLPQLVDMSAQIASGMAYVERMN- 131
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE     + 
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVP 212

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 27/280 (9%)
Query: 73  FNVNRILGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + V   +G G  G   K  R  DG+I+  K+       E   ++   ++E+ +L ++ H 
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHP 65
Query: 132 NVVKLLGCCLETEFPLL--VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+V+     ++     L  V E+   G L   +    +  +Y L  E   RV  ++  AL
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLAL 124
Query: 190 AYLH--SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
              H  S     + HRD+K  N+ LD +   K+ DFG ++ +  D +   T + GT  Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE        +KSD++S G +L EL     P      T+     LA   +   +  R+ 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGK-IREGKFRRIP 237
Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +   D++      N+I+       R L+L    RP++EE+
Sbjct: 238 YRYSDEL------NEIIT------RMLNLKDYHRPSVEEI 265

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 27/270 (10%)
Query: 79  LGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K      G ++A K   L +         + I E+ +L + N   +V   
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFY 89
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E +  G+L Q L    +  E  L      +V+I V   L YL     
Sbjct: 90  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE--K 142
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K +NIL++ R   K+ DFG S  +      +     GT  Y+ PE  Q +  
Sbjct: 143 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHY 199
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
           + +SD++S G+ LVE+  G+ PI  +G+ S     L  Y            I+++   KL
Sbjct: 200 SVQSDIWSMGLSLVEMAVGRYPI-GSGSGSMAIFELLDY------------IVNEPPPKL 246
Query: 318 GKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                 + F +   +CL  N  +R  ++++
Sbjct: 247 PSGVFSLEFQDFVNKCLIKNPAERADLKQL 276

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 44/253 (17%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL--EDGR----IIAVKKSKLAVD 108
           +D  K+    + +    +  + + LG+G  G V K       GR     +AVK  K    
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 109 DEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ- 167
             EL    + ++E  +L Q+NH +V+KL G C +    LL+ E+   G+L   L +  + 
Sbjct: 67  PSEL---RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 168 ------------------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN 209
                              +E  LT       A +++  + YL   A   + HRD+ + N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARN 180
Query: 210 ILLDERYRAKVADFGTSK-------FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSD 262
           IL+ E  + K++DFG S+       ++   Q  +  K        D  Y      T +SD
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY------TTQSD 234
Query: 263 VYSFGVVLVELLT 275
           V+SFGV+L E++T
Sbjct: 235 VWSFGVLLWEIVT 247

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 91
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC----TRFYTA-EIVSALE 146
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E       +  SD+++ G ++ +L+ G  P F  GN
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPP-FRAGN 238

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 72  HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEEL--YKLEEFINEIFIL 125
           H    R+L   G+G   K +L      G+ +AV+     +D  +L    L++   E+ I+
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVR----IIDKTQLNSSSLQKLFREVRIM 67
Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVA 182
             +NH N+VKL    +ETE  L LV E+   G ++ +L  H R + +E       +FR  
Sbjct: 68  KVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA----RAKFR-- 120
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S          T    G
Sbjct: 121 -QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCG 174
Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           +  Y  PE  Q  +      DV+S GV+L  L++G  P
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 14/221 (6%)
Query: 68  KATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFIL 125
           K    F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVM 62
Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           S+++H   VKL     + E       +  NG L +++      +E       RF  A E+
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EI 117
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTF 244
             AL YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT 
Sbjct: 118 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            Y+ PE          SD+++ G ++ +L+ G  P F  GN
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 214

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 14/221 (6%)
Query: 68  KATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFIL 125
           K    F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVM 61
Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           S+++H   VKL     + E       +  NG L +++      +E       RF  A E+
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EI 116
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTF 244
             AL YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT 
Sbjct: 117 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            Y+ PE          SD+++ G ++ +L+ G  P F  GN
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 14/221 (6%)
Query: 68  KATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFIL 125
           K    F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVM 63
Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           S+++H   VKL     + E       +  NG L +++      +E       RF  A E+
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EI 118
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTF 244
             AL YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT 
Sbjct: 119 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            Y+ PE          SD+++ G ++ +L+ G  P F  GN
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 72  HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEEL--YKLEEFINEIFIL 125
           H    R+L   G+G   K +L      G+ +AV+     +D  +L    L++   E+ I+
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVR----IIDKTQLNSSSLQKLFREVRIM 67
Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVA 182
             +NH N+VKL    +ETE  L LV E+   G ++ +L  H R + +E       +FR  
Sbjct: 68  KVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA----RAKFR-- 120
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S            +  G
Sbjct: 121 -QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCG 174
Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           +  Y  PE  Q  +      DV+S GV+L  L++G  P
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 72  HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEEL--YKLEEFINEIFIL 125
           H    R+L   G+G   K +L      G+ +AVK     +D  +L    L++   E+ I+
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREVRIM 67
Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVA 182
             +NH N+VKL    +ETE  L LV E+   G ++ +L  H R + +E       +FR  
Sbjct: 68  KVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA----RAKFR-- 120
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S               G
Sbjct: 121 -QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDAFCG 174
Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
              Y  PE  Q  +      DV+S GV+L  L++G  P
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 15/223 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR----LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           F + R+LG+GG G V++ R       G+I A+K  K A+             E  IL ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H  +V L+          L+ E++  G L+  L    + E   +     F +A E++ A
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLA-EISMA 133
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L +LH      I +RD+K  NI+L+ +   K+ DFG  K    D T VT    GT  Y+ 
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMA 189
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           PE    S      D +S G ++ ++LTG  P   TG   ++ +
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPF--TGENRKKTI 230

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 14/221 (6%)
Query: 68  KATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFIL 125
           K    F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVM 64
Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           S+++H   VKL     + E       +  NG L +++      +E       RF  A E+
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTA-EI 119
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTF 244
             AL YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT 
Sbjct: 120 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            Y+ PE          SD+++ G ++ +L+ G  P F  GN
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 41/280 (14%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV---- 133
           LG+G  G V K R +  G+I AVK+ +  V+ +E  +L   ++       I+ R V    
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLD-------ISXRTVDCPF 94
Query: 134 -VKLLGCCLETEFPLLVYEFIPNG--TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            V   G         +  E         Y+ + D+ Q     +  ++  ++A+ +  AL 
Sbjct: 95  TVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQT----IPEDILGKIAVSIVKALE 150
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD---QTHVTTKIQGTFGYL 247
           +LHS  S  + HRD+K +N+L++   + K  DFG S ++  D         K       +
Sbjct: 151 HLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERI 208
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
           +PE +Q    + KSD++S G+  +EL   + P  S G   Q+                L 
Sbjct: 209 NPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQ----------------LK 251
Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            ++++   +L        F +   +CL  N K+RPT  E+
Sbjct: 252 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LGQG  G V+ G       +A+K  K           E F+ E  ++ ++ H  +V+L  
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGN-----MSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               +E P+ +V E++  G+L   L  + +  +Y L       +A ++A  +AY+     
Sbjct: 248 VV--SEEPIYIVTEYMSKGSLLDFL--KGEMGKY-LRLPQLVDMAAQIASGMAYVERMN- 301
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ E    KVADFG  + I  ++       +    +  PE     + 
Sbjct: 302 --YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRF 359
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L EL T G+ P
Sbjct: 360 TIKSDVWSFGILLTELTTKGRVP 382

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 15/223 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR----LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           F + R+LG+GG G V++ R       G+I A+K  K A+             E  IL ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H  +V L+          L+ E++  G L+  L    + E   +     F +A E++ A
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLA-EISMA 133
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L +LH      I +RD+K  NI+L+ +   K+ DFG  K    D T VT    GT  Y+ 
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMA 189
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           PE    S      D +S G ++ ++LTG  P   TG   ++ +
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPF--TGENRKKTI 230

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 114/259 (44%), Gaps = 23/259 (8%)
Query: 95  GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP--LLVYEF 152
           G ++AVK  K     +     ++   EI IL  + H +++K  GCC +       LV E+
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL 212
           +P G+L  +L  RH      +        A ++   +AYLH+       HRD+ + N+LL
Sbjct: 117 VPLGSLRDYL-PRHS-----IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLL 167
Query: 213 DERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEYHQSSQLTDKSDVYSFGVV 269
           D     K+ DFG +K +         +  G    F Y  PE  +  +    SDV+SFGV 
Sbjct: 168 DNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA-PECLKEYKFYYASDVWSFGVT 226
Query: 270 LVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVA-FAN 328
           L ELLT      S      E + +A      M   RL  +L ++  +L + ++  A   +
Sbjct: 227 LYELLTHCDSSQSPPTKFLELIGIAQ---GQMTVLRLTELL-ERGERLPRPDKCPAEVYH 282
Query: 329 LAERCLDLNGKKRPTMEEV 347
           L + C +     RPT E +
Sbjct: 283 LMKNCWETEASFRPTFENL 301

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 73
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 128
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 129 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 220

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 88
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 143
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 235

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 92
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 147
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 239

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 27/280 (9%)
Query: 73  FNVNRILGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + V   +G G  G   K  R  DG+I+  K+       E   ++   ++E+ +L ++ H 
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHP 65
Query: 132 NVVKLLGCCLETEFPLL--VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+V+     ++     L  V E+   G L   +    +  +Y L  E   RV  ++  AL
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLAL 124
Query: 190 AYLH--SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
              H  S     + HRD+K  N+ LD +   K+ DFG ++ +  D T       GT  Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYM 183
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE        +KSD++S G +L EL     P      T+     LA   +   +  R+ 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGK-IREGKFRRIP 237
Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +   D++      N+I+       R L+L    RP++EE+
Sbjct: 238 YRYSDEL------NEIIT------RMLNLKDYHRPSVEEI 265

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 88
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 143
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 235

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 26/239 (10%)
Query: 52  GSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYK------GRLEDGRIIAVKKSKL 105
           G  + R   F      K +++++V   LG+G    V +      G     +II  KK   
Sbjct: 10  GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--- 66
Query: 106 AVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR 165
            +   +  KLE    E  I  ++ H N+V+L     E  F  LV++ +  G L++ +  R
Sbjct: 67  -LSARDFQKLER---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 166 HQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA---KVAD 222
               E   +  ++     ++  ++AY HS     I HR++K  N+LL  + +    K+AD
Sbjct: 123 EFYSEADASHCIQ-----QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           FG +  I ++ +       GT GYL PE  +    +   D+++ GV+L  LL G  P +
Sbjct: 175 FGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 89
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 144
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 236

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 91
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 146
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 238

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 89
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 144
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 236

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLE-------EFINEIFILSQINHR 131
           LG G  G V K +     +I  +K         L  LE       + I E+ +L + N  
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARK---------LIHLEIKPAIRNQIIRELQVLHECNSP 74
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +V   G         +  E +  G+L Q L +  +  E     E+  +V+I V   LAY
Sbjct: 75  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-----EILGKVSIAVLRGLAY 129
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           L       I HRD+K +NIL++ R   K+ DFG S  +      +     GT  Y+ PE 
Sbjct: 130 LREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMAPER 184
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
            Q +  + +SD++S G+ LVEL  G+ PI
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 89
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 144
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 236

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 76  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 129
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 34/248 (13%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL--EDGR----IIAVKKSKLAVD 108
           +D  K+    + +    +  + + LG+G  G V K       GR     +AVK  K    
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 109 DEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ- 167
             EL    + ++E  +L Q+NH +V+KL G C +    LL+ E+   G+L   L +  + 
Sbjct: 67  PSEL---RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 168 ------------------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN 209
                              +E  LT       A +++  + YL   A   + HRD+ + N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARN 180
Query: 210 ILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG--TFGYLDPEYHQSSQLTDKSDVYSFG 267
           IL+ E  + K++DFG S+ +  + + V  + QG     ++  E       T +SDV+SFG
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 268 VVLVELLT 275
           V+L E++T
Sbjct: 240 VLLWEIVT 247

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 79  LGQGGQGTVYKG---RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +G+G  G V+KG   R +  +++A+K   L   ++E+  +++   EI +LSQ +   V K
Sbjct: 30  IGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTK 84
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
             G  L+     ++ E++  G+    L      E  PL       +  E+   L YLHS 
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSE 138
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
                 HRDIK+ N+LL E    K+ADFG +  +   Q      + GT  ++ PE  + S
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQS 194
Query: 256 QLTDKSDVYSFGVVLVELLTGKKP 279
               K+D++S G+  +EL  G+ P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 79  LGQGGQGTVYKGRLEDGR---IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +G+G  G V+KG   D R   ++A+K   L   ++E+  +++   EI +LSQ +   V K
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTK 69
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
             G  L+     ++ E++  G+    L      E  PL       +  E+   L YLHS 
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSE 123
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
                 HRDIK+ N+LL E    K+ADFG +  +   Q      + GT  ++ PE  + S
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQS 179
Query: 256 QLTDKSDVYSFGVVLVELLTGKKP 279
               K+D++S G+  +EL  G+ P
Sbjct: 180 AYDSKADIWSLGITAIELARGEPP 203

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 91
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 146
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 238

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S++N
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKLN 92
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 153 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 205
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 91
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 146
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 238

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 77  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 130
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 131 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 188
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 189 TIKSDVWSFGILLTEIVTHGRIP 211

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 94
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 149
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 150 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 241

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 91
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 146
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 238

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 92
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 147
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 239

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S++N
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKLN 106
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 107 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 167 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 219
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 266

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEEL--YKLEEFINEI 122
           A  H    R+L   G+G   K +L      G+ +AVK     +D  +L    L++   E+
Sbjct: 2   ADLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREV 57
Query: 123 FILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRF 179
            I+  +NH N+VKL    +ETE  L LV E+   G ++ +L  H   + +E       +F
Sbjct: 58  RIMKVLNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEA----RAKF 112
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
           R   ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S          T  
Sbjct: 113 R---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-- 164
Query: 240 IQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKP 279
             G+  Y  PE  Q  +    + DV+S GV+L  L++G  P
Sbjct: 165 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 78  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 131
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 132 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 190 TIKSDVWSFGILLTEIVTHGRIP 212

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 34/248 (13%)
Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL--EDGR----IIAVKKSKLAVD 108
           +D  K+    + +    +  + + LG+G  G V K       GR     +AVK  K    
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 109 DEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ- 167
             EL    + ++E  +L Q+NH +V+KL G C +    LL+ E+   G+L   L +  + 
Sbjct: 67  PSEL---RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 168 ------------------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN 209
                              +E  LT       A +++  + YL   A   + HRD+ + N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARN 180
Query: 210 ILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG--TFGYLDPEYHQSSQLTDKSDVYSFG 267
           IL+ E  + K++DFG S+ +  + + V  + QG     ++  E       T +SDV+SFG
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 268 VVLVELLT 275
           V+L E++T
Sbjct: 240 VLLWEIVT 247

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K     +     + F+ E  ++ Q+ H+ +V+L  
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 76  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 129
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I   +       +    +  PE       
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 76  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 129
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   TV   R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 91
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 146
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAGLPP-FRAGN 238

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 85  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 138
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 139 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 196
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 197 TIKSDVWSFGILLTEIVTHGRIP 219

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K     +     + F+ E  ++ Q+ H+ +V+L  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLYA 70
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 71  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEE--- 122
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 123 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 182
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 183 TIKSDVWSFGILLTEIVTHGRIP 205

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 72  HFNVNRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H      LG+G  G+V   R +      G ++AVK+ + +  D++     +F  EI IL 
Sbjct: 11  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILK 66
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            ++   +VK  G       +   LV E++P+G L   L  RH+     L        + +
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRAR---LDASRLLLYSSQ 122
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--VTTKIQG 242
           +   + YL    S    HRD+ + NIL++     K+ADFG +K + +D+ +  V    Q 
Sbjct: 123 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 179
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
              +  PE    +  + +SDV+SFGVVL EL T
Sbjct: 180 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 68  KATNHFNVNRILGQGGQGTVYK------GRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           K +++++V   LG+G    V +      G     +II  KK    +   +  KLE    E
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK----LSARDFQKLE---RE 55
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
             I  ++ H N+V+L     E  F  LV++ +  G L++ +  R    E   +  ++   
Sbjct: 56  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ--- 112
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA---KVADFGTSKFIAMDQTHVTT 238
             ++  ++AY HS     I HR++K  N+LL  + +    K+ADFG +  I ++ +    
Sbjct: 113 --QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH 165
Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
              GT GYL PE  +    +   D+++ GV+L  LL G  P +
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 68  KATNHFNVNRILGQGGQGTVYK------GRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           K +++++V   LG+G    V +      G     +II  KK    +   +  KLE    E
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK----LSARDFQKLE---RE 55
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
             I  ++ H N+V+L     E  F  LV++ +  G L++ +  R    E   +       
Sbjct: 56  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-----HC 110
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA---KVADFGTSKFIAMDQTHVTT 238
             ++  ++AY HS     I HR++K  N+LL  + +    K+ADFG +  I ++ +    
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH 165
Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
              GT GYL PE  +    +   D+++ GV+L  LL G  P +
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 68  KATNHFNVNRILGQGGQGTVYK------GRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           K +++++V   LG+G    V +      G     +II  KK    +   +  KLE    E
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK----LSARDFQKLE---RE 54
Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
             I  ++ H N+V+L     E  F  LV++ +  G L++ +  R    E   +  ++   
Sbjct: 55  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ--- 111
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA---KVADFGTSKFIAMDQTHVTT 238
             ++  ++AY HS     I HR++K  N+LL  + +    K+ADFG +  I ++ +    
Sbjct: 112 --QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH 164
Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
              GT GYL PE  +    +   D+++ GV+L  LL G  P +
Sbjct: 165 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 207

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 82  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 135
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 136 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 193
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 72  HFNVNRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H      LG+G  G+V   R +      G ++AVK+ + +  D++     +F  EI IL 
Sbjct: 24  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILK 79
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            ++   +VK  G       +   LV E++P+G L   L  RH+     L        + +
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRAR---LDASRLLLYSSQ 135
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--VTTKIQG 242
           +   + YL    S    HRD+ + NIL++     K+ADFG +K + +D+ +  V    Q 
Sbjct: 136 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
              +  PE    +  + +SDV+SFGVVL EL T
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 98
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 99  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 158
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 159 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 211
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 212 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 258

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G VYK + ++   +A  K      +EEL   E++I EI IL+  +H  +VKLLG
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPYIVKLLG 83
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                    ++ EF P G +   + +  +     LT      V  ++  AL +LHS    
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKR-- 137
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
            I HRD+K+ N+L+      ++ADFG S    +          GT  ++ PE      + 
Sbjct: 138 -IIHRDLKAGNVLMTLEGDIRLADFGVSAK-NLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 259 D-----KSDVYSFGVVLVELLTGKKP 279
           D     K+D++S G+ L+E+   + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 84  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 137
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 138 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 195
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 196 TIKSDVWSFGILLTEIVTHGRIP 218

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 92
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 153 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MAQDIYRASYYRKGGC 205
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 76  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 129
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 118
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 119 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 178
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 179 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 231
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 232 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 278

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 110/247 (44%), Gaps = 19/247 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G   +   +AVK  K          ++ F+ E  ++  + H  +V+L  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
              + E   ++ EF+  G+L   L     +E   +        + ++A  +AY+      
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLK---SDEGGKVLLPKLIDFSAQIAEGMAYIER---K 128
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
              HRD+++ N+L+ E    K+ADFG ++ I  ++       +    +  PE       T
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 259 DKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD--QVM 315
            KS+V+SFG++L E++T GK P    G T   N  + +      R  R+ +  D+   +M
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIPY--PGRT---NADVMSALSQGYRMPRMENCPDELYDIM 243
Query: 316 KLGKKNQ 322
           K+  K +
Sbjct: 244 KMCWKEK 250

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 27/280 (9%)
Query: 73  FNVNRILGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + V   +G G  G   K  R  DG+I+  K+       E   ++   ++E+ +L ++ H 
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHP 65
Query: 132 NVVKLLGCCLETEFPLL--VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+V+     ++     L  V E+   G L   +    +  +Y L  E   RV  ++  AL
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLAL 124
Query: 190 AYLH--SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
              H  S     + HRD+K  N+ LD +   K+ DFG ++ +  D+     +  GT  Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED-FAKEFVGTPYYM 183
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE        +KSD++S G +L EL     P      T+     LA   +   +  R+ 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGK-IREGKFRRIP 237
Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +   D++      N+I+       R L+L    RP++EE+
Sbjct: 238 YRYSDEL------NEIIT------RMLNLKDYHRPSVEEI 265

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 116/259 (44%), Gaps = 23/259 (8%)
Query: 95  GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-EFPL-LVYEF 152
           G ++AVK  K     +     ++   EI IL  + H +++K  GCC +  E  L LV E+
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL 212
           +P G+L  +L  RH      +        A ++   +AYLHS       HR++ + N+LL
Sbjct: 100 VPLGSLRDYL-PRHS-----IGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLL 150
Query: 213 DERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEYHQSSQLTDKSDVYSFGVV 269
           D     K+ DFG +K +     +   +  G    F Y  PE  +  +    SDV+SFGV 
Sbjct: 151 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKEYKFYYASDVWSFGVT 209
Query: 270 LVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVA-FAN 328
           L ELLT      S      E + +A      M   RL  +L ++  +L + ++      +
Sbjct: 210 LYELLTHCDSSQSPPTKFLELIGIAQ---GQMTVLRLTELL-ERGERLPRPDKCPCEVYH 265
Query: 329 LAERCLDLNGKKRPTMEEV 347
           L + C +     RPT E +
Sbjct: 266 LMKNCWETEASFRPTFENL 284

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 108
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 109 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 168
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 169 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 221
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 222 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 268

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 72  HFNVNRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           H      LG+G  G+V   R +      G ++AVK+ + +  D++     +F  EI IL 
Sbjct: 12  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILK 67
Query: 127 QINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            ++   +VK  G       +   LV E++P+G L   L  RH+     L        + +
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRAR---LDASRLLLYSSQ 123
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--VTTKIQG 242
           +   + YL    S    HRD+ + NIL++     K+ADFG +K + +D+ +  V    Q 
Sbjct: 124 ICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 180
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT 275
              +  PE    +  + +SDV+SFGVVL EL T
Sbjct: 181 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 91
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 152 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 204
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 82  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 135
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 136 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 193
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIP 216

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 72  HFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEEL--YKLEEFINEIFIL 125
           H    R+L   G+G   K +L      G+ +AVK     +D  +L    L++   E+ I 
Sbjct: 12  HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVK----IIDKTQLNSSSLQKLFREVRIX 67
Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVA 182
             +NH N+VKL    +ETE  L LV E+   G ++ +L  H R + +E       +FR  
Sbjct: 68  KVLNHPNIVKLFEV-IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEA----RAKFR-- 120
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S               G
Sbjct: 121 -QIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK--LDAFCG 174
Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
              Y  PE  Q  +      DV+S GV+L  L++G  P
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 106
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 107 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 167 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 219
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 266

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 81  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 134
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 135 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 192
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 193 TIKSDVWSFGILLTEIVTHGRIP 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G VYK + ++   +A  K      +EEL   E++I EI IL+  +H  +VKLLG
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPYIVKLLG 75
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                    ++ EF P G +   + +  +     LT      V  ++  AL +LHS    
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKR-- 129
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
            I HRD+K+ N+L+      ++ADFG S    +          GT  ++ PE      + 
Sbjct: 130 -IIHRDLKAGNVLMTLEGDIRLADFGVSAK-NLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 259 D-----KSDVYSFGVVLVELLTGKKP 279
           D     K+D++S G+ L+E+   + P
Sbjct: 188 DTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 91
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 92  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 152 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 204
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 92
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 153 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 205
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 28  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 83
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 84  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 143
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
              YL         HRDI + N LL        AK+ DFG    +A D    +   +G  
Sbjct: 144 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGC 196
Query: 245 G-----YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 197 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 243

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 28/228 (12%)
Query: 69  ATNH-FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
            +NH + ++ ILGQG    V++GR  + G + A+K   +  +   L  ++  + E  +L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLK 62
Query: 127 QINHRNVVKLLGCCLE--TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI- 183
           ++NH+N+VKL     E  T   +L+ EF P G+LY  L +       P   E  F + + 
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLR 119
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTK 239
           +V G + +L       I HR+IK  NI+     D +   K+ DFG ++ +  D+  V+  
Sbjct: 120 DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-- 174
Query: 240 IQGTFGYLDPEYHQSSQLTDKS--------DVYSFGVVLVELLTGKKP 279
           + GT  YL P+ ++ + L            D++S GV      TG  P
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 19/247 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G   +   +AVK  K          ++ F+ E  ++  + H  +V+L  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                E   ++ E++  G+L   L     +E   +        + ++A  +AY+      
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLK---SDEGGKVLLPKLIDFSAQIAEGMAYIER---K 129
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT 258
              HRD+++ N+L+ E    K+ADFG ++ I  ++       +    +  PE       T
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 259 DKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD--QVM 315
            KSDV+SFG++L E++T GK P    G T   N  +        R  R+ +  D+   +M
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPY--PGRT---NADVMTALSQGYRMPRVENCPDELYDIM 244
Query: 316 KLGKKNQ 322
           K+  K +
Sbjct: 245 KMCWKEK 251

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K           + F+ E  ++ Q+ H+ +V+L  
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 86  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERN- 139
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 140 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 197
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 198 TIKSDVWSFGILLTEIVTHGRIP 220

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 14/216 (6%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK-KSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   +ILG+G   T    R L   R  A+K   K  +  E   K+     E  ++S+++H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDH 89
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
              VKL     + E       +  NG L +++      +E       RF  A E+  AL 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTA-EIVSALE 144
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDP 249
           YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           E          SD+++ G ++ +L+ G  P F  GN
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN 236

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 21/223 (9%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 109
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 110 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 169
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQG-T 243
              YL         HRDI + N LL        AK+ DFG ++ I     +         
Sbjct: 170 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 226
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
             ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 269

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 78  ILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           ++G GG G V+K +   DG+   +K+ K        Y  E+   E+  L++++H N+V  
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAEREVKALAKLDHVNIVHY 69
Query: 137 LGCC----------------LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
            GC                  +T+   +  EF   GTL Q +  R   +   L   +   
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---LDKVLALE 126
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
           +  ++   + Y+HS     + +RD+K +NI L +  + K+ DFG    +  D     +K 
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK- 182
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 274
            GT  Y+ PE   S     + D+Y+ G++L ELL
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 28/228 (12%)
Query: 69  ATNH-FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
            +NH + ++ ILGQG    V++GR  + G + A+K   +  +   L  ++  + E  +L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLK 62
Query: 127 QINHRNVVKLLGCCLE--TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI- 183
           ++NH+N+VKL     E  T   +L+ EF P G+LY  L +       P   E  F + + 
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLR 119
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTK 239
           +V G + +L       I HR+IK  NI+     D +   K+ DFG ++ +  D+  V   
Sbjct: 120 DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX-- 174
Query: 240 IQGTFGYLDPEYHQSSQLTDKS--------DVYSFGVVLVELLTGKKP 279
           + GT  YL P+ ++ + L            D++S GV      TG  P
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 115/263 (43%), Gaps = 24/263 (9%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGRII-AVK---KSKLAVDDEELYKLEEFINEIFILSQI 128
           F+  +++G+G  G V   R +   +  AVK   K  +    EE + + E      +L  +
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE---RNVLLKNV 96
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H  +V L       +    V ++I  G L+ HL    Q E   L    RF  A E+A A
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAA-EIASA 151
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L YLHS     I +RD+K  NILLD +    + DFG  K   ++    T+   GT  YL 
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLA 207
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAYFVHSMRKNRL 306
           PE           D +  G VL E+L G  P +S  NT++  +N+      +     N  
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-NTAEMYDNILNKPLQLKPNITNSA 266
Query: 307 YHILD-----DQVMKLGKKNQIV 324
            H+L+     D+  +LG K+  +
Sbjct: 267 RHLLEGLLQKDRTKRLGAKDDFM 289

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 21/223 (9%)
Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
           R LG G  G VY+G++           +AVK   ++  + +EL    +F+ E  I+S+ N
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFN 132
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAG 187
           H+N+V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A 
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQG-T 243
              YL         HRDI + N LL        AK+ DFG ++ I     +         
Sbjct: 193 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 249
Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
             ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD-EELYKLEE---FINEIFILSQINHRN 132
           R LG G  G VY+G++  G        ++AV    E+Y  ++   F+ E  I+S+ NH+N
Sbjct: 51  RGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQN 109
Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM--RFRVAIEVAGALA 190
           +V+ +G  L++    ++ E +  G L   L +       P +  M     VA ++A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 191 YLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG-- 245
           YL         HRDI + N LL        AK+ DFG    +A D    +   +G     
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAML 222
Query: 246 ---YLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
              ++ PE       T K+D +SFGV+L E+ + G  P  S  N
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 266

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 116/259 (44%), Gaps = 23/259 (8%)
Query: 95  GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-EFPL-LVYEF 152
           G ++AVK  K     +     ++   EI IL  + H +++K  GCC +  E  L LV E+
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL 212
           +P G+L  +L  RH      +        A ++   +AYLH+       HR++ + N+LL
Sbjct: 100 VPLGSLRDYL-PRHS-----IGLAQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLL 150
Query: 213 DERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEYHQSSQLTDKSDVYSFGVV 269
           D     K+ DFG +K +     +   +  G    F Y  PE  +  +    SDV+SFGV 
Sbjct: 151 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKEYKFYYASDVWSFGVT 209
Query: 270 LVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVA-FAN 328
           L ELLT      S      E + +A      M   RL  +L ++  +L + ++      +
Sbjct: 210 LYELLTHCDSSQSPPTKFLELIGIAQ---GQMTVLRLTELL-ERGERLPRPDKCPCEVYH 265
Query: 329 LAERCLDLNGKKRPTMEEV 347
           L + C +     RPT E +
Sbjct: 266 LMKNCWETEASFRPTFENL 284

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+ G       +AVK  K     +     + F+ E  ++ Q+ H+ +V+L  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ E++ NG+L   L      +   LT      +A ++A  +A++     
Sbjct: 72  VV--TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEE--- 123
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HR++++ NIL+ +    K+ADFG ++ I  ++       +    +  PE       
Sbjct: 124 RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 183
Query: 258 TDKSDVYSFGVVLVELLT-GKKP 279
           T KSDV+SFG++L E++T G+ P
Sbjct: 184 TIKSDVWSFGILLTEIVTHGRIP 206

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 79  LGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K      G ++A K   L +         + I E+ +L + N   +V   
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFY 70
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E +  G+L Q L    +  E     ++  +V+I V   L YL     
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLRE--K 123
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K +NIL++ R   K+ DFG S  +      +     GT  Y+ PE  Q +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHY 180
Query: 258 TDKSDVYSFGVVLVELLTGKKPI 280
           + +SD++S G+ LVE+  G+ PI
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 79  LGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K      G ++A K   L +         + I E+ +L + N   +V   
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFY 70
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E +  G+L Q L    +  E     ++  +V+I V   L YL     
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLRE--K 123
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K +NIL++ R   K+ DFG S  +      +     GT  Y+ PE  Q +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHY 180
Query: 258 TDKSDVYSFGVVLVELLTGKKPI 280
           + +SD++S G+ LVE+  G+ PI
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 13/213 (6%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  GTV+K +  E   I+A+K+ +L  DDE +      + EI +L ++ H+N+V+L 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVRLH 67
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                 +   LV+EF       Q L     +    L  E+      ++   L + HS   
Sbjct: 68  DVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRD+K  N+L++     K+ADFG ++   +     + ++  T  Y  P+    ++L
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 178
Query: 258 TDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
              S D++S G +  EL    +P+F   +   +
Sbjct: 179 YSTSIDMWSAGCIFAELANAARPLFPGNDVDDQ 211

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 79  LGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K      G ++A K   L +         + I E+ +L + N   +V   
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFY 70
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E +  G+L Q L    +  E     ++  +V+I V   L YL     
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLRE--K 123
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K +NIL++ R   K+ DFG S  +      +     GT  Y+ PE  Q +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHY 180
Query: 258 TDKSDVYSFGVVLVELLTGKKPI 280
           + +SD++S G+ LVE+  G+ PI
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 53  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 103
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 161
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+        Y
Sbjct: 162 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 210
Query: 247 LDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 211 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 252

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + +G G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   KVADFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 14/203 (6%)
Query: 79  LGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K      G ++A K   L +         + I E+ +L + N   +V   
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFY 97
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E +  G+L Q L    +  E  L      +V+I V   L YL     
Sbjct: 98  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE--K 150
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K +NIL++ R   K+ DFG S  +      +     GT  Y+ PE  Q +  
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHY 207
Query: 258 TDKSDVYSFGVVLVELLTGKKPI 280
           + +SD++S G+ LVE+  G+ PI
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 79  LGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K      G ++A K   L +         + I E+ +L + N   +V   
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFY 70
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E +  G+L Q L    +  E     ++  +V+I V   L YL     
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLRE--K 123
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K +NIL++ R   K+ DFG S  +      +     GT  Y+ PE  Q +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHY 180
Query: 258 TDKSDVYSFGVVLVELLTGKKPI 280
           + +SD++S G+ LVE+  G+ PI
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 109
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 167
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+        Y
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 216
Query: 247 LDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 61  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 111
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 169
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+        Y
Sbjct: 170 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 218
Query: 247 LDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 219 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 260

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 30  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 80
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 138
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+        Y
Sbjct: 139 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 187
Query: 247 LDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 188 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 229

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 88
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 146
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+        Y
Sbjct: 147 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 195
Query: 247 LDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 196 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 237

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 39/226 (17%)
Query: 73  FNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINH 130
           +   +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDH 110
Query: 131 RNVVKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            N+V+L       G   +  +  LV +++P        H     +  P+ +   +    +
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 168
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGT 243
           +  +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+      
Sbjct: 169 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS------ 219
Query: 244 FGYLDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
             Y+   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 220 --YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 262

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 75
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 133
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+        Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 182
Query: 247 LDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 79  LGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K      G ++A K   L +         + I E+ +L + N   +V   
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFY 73
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E +  G+L Q L    +  E     ++  +V+I V   L YL     
Sbjct: 74  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLRE--K 126
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K +NIL++ R   K+ DFG S  + +D+  +  +  GT  Y+ PE  Q +  
Sbjct: 127 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDE--MANEFVGTRSYMSPERLQGTHY 183
Query: 258 TDKSDVYSFGVVLVELLTGKKP 279
           + +SD++S G+ LVE+  G+ P
Sbjct: 184 SVQSDIWSMGLSLVEMAVGRYP 205

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 104 TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 154
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 212
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+        Y
Sbjct: 213 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 261
Query: 247 LDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 262 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 303

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQGKAFKNRELQIMRKLDHCNI 75
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 133
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+        Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 182
Query: 247 LDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + +G G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   KVADFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQGKAFKNRELQIMRKLDHCNI 75
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 133
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+        Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 182
Query: 247 LDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   Y+++ +L       T   DV+S G VL ELL G +PIF 
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 79  LGQGGQGTVYK-GRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K      G ++A K   L +   +     + I E+ +L + N   +V   
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 132
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
           G         +  E +  G+L Q L    +  E     ++  +V+I V   L YL     
Sbjct: 133 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLREKHK 187
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRD+K +NIL++ R   K+ DFG S  +      +     GT  Y+ PE  Q +  
Sbjct: 188 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHY 242
Query: 258 TDKSDVYSFGVVLVELLTGKKPI 280
           + +SD++S G+ LVE+  G+ PI
Sbjct: 243 SVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + +G G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   KVADFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 79  LGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V+K R  D G+I+A+KK   + DD  + K+   + EI +L Q+ H N+V LL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHPNLVNLL 68
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                     LV+E+  +  L  H  DR+Q     +   +   +  +   A+ + H    
Sbjct: 69  EVFRRKRRLHLVFEYCDHTVL--HELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH-QSSQ 256
               HRD+K  NIL+ +    K+ DFG ++ +     +   ++  T  Y  PE     +Q
Sbjct: 124 ---IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDTQ 179
Query: 257 LTDKSDVYSFGVVLVELLTG 276
                DV++ G V  ELL+G
Sbjct: 180 YGPPVDVWAIGCVFAELLSG 199

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           LG G  G V+         +AVK  K          +E F+ E  ++  + H  +VKL  
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHA 77
Query: 139 CCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
               T+ P+ ++ EF+  G+L   L     +++ PL   + F  + ++A  +A++     
Sbjct: 78  VV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDF--SAQIAEGMAFIEQRN- 131
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+++ NIL+      K+ADFG ++ I  ++       +    +  PE       
Sbjct: 132 --YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 258 TDKSDVYSFGVVLVELLT-GKKPIFSTGNT 286
           T KSDV+SFG++L+E++T G+ P     N 
Sbjct: 190 TIKSDVWSFGILLMEIVTYGRIPYPGMSNP 219

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 19/224 (8%)
Query: 62  SSKELDKAT-NHFNVNRILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLE 116
            S  LD+     FN   +LG+G  G V     KG  E   I  +KK  +  DD+    +E
Sbjct: 9   PSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDD----VE 64
Query: 117 EFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
             + E  +L+ ++    +  L  C +T   L  V E++  G L  H+    + +E    +
Sbjct: 65  CTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 124
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
                 A E++  L +LH      I +RD+K  N++LD     K+ADFG  K   MD   
Sbjct: 125 -----YAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV- 175
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            T +  GT  Y+ PE           D +++GV+L E+L G+ P
Sbjct: 176 TTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 219

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 75
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 76  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 127
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 128 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 69
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 70  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 121
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 122 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 177
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 68  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 68  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 113/261 (43%), Gaps = 27/261 (10%)
Query: 95  GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFPLLVYEF 152
           G ++AVK  K     +       +  EI IL  + H ++VK  GCC +   +   LV E+
Sbjct: 37  GEMVAVKALKEGCGPQ---LRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 93
Query: 153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL 212
           +P G+L  +L  RH      +        A ++   +AYLH+       HR + + N+LL
Sbjct: 94  VPLGSLRDYL-PRHC-----VGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLL 144
Query: 213 DERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEYHQSSQLTDKSDVYSFGVV 269
           D     K+ DFG +K +     +   +  G    F Y  PE  +  +    SDV+SFGV 
Sbjct: 145 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKECKFYYASDVWSFGVT 203
Query: 270 LVELLTGKKPIFSTGNTSQEN--VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQI-VAF 326
           L ELLT     +   N S       L  +    M   RL  +L ++  +L + ++     
Sbjct: 204 LYELLT-----YCDSNQSPHTKFTELIGHTQGQMTVLRLTELL-ERGERLPRPDRCPCEI 257
Query: 327 ANLAERCLDLNGKKRPTMEEV 347
            +L + C +     RPT + +
Sbjct: 258 YHLMKNCWETEASFRPTFQNL 278

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
             + + LG G  G V+         +AVK  K          +E F+ E  ++  + H  
Sbjct: 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDK 244
Query: 133 VVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +VKL      T+ P+ ++ EF+  G+L   L     +++ PL   + F  + ++A  +A+
Sbjct: 245 LVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDF--SAQIAEGMAF 299
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           +         HRD+++ NIL+      K+ADFG ++ I  ++       +    +  PE 
Sbjct: 300 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 T KSDV+SFG++L+E++T G+ P     N
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 113/261 (43%), Gaps = 27/261 (10%)
Query: 95  GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFPLLVYEF 152
           G ++AVK  K     +       +  EI IL  + H ++VK  GCC +   +   LV E+
Sbjct: 38  GEMVAVKALKEGCGPQ---LRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 94
Query: 153 IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL 212
           +P G+L  +L  RH      +        A ++   +AYLH+       HR + + N+LL
Sbjct: 95  VPLGSLRDYL-PRHC-----VGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLL 145
Query: 213 DERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEYHQSSQLTDKSDVYSFGVV 269
           D     K+ DFG +K +     +   +  G    F Y  PE  +  +    SDV+SFGV 
Sbjct: 146 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKECKFYYASDVWSFGVT 204
Query: 270 LVELLTGKKPIFSTGNTSQEN--VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQI-VAF 326
           L ELLT     +   N S       L  +    M   RL  +L ++  +L + ++     
Sbjct: 205 LYELLT-----YCDSNQSPHTKFTELIGHTQGQMTVLRLTELL-ERGERLPRPDRCPCEI 258
Query: 327 ANLAERCLDLNGKKRPTMEEV 347
            +L + C +     RPT + +
Sbjct: 259 YHLMKNCWETEASFRPTFQNL 279

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 75
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 133
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 188
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 72
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 73  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 124
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 125 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 180
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 75
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 76  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 127
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 128 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 114/244 (46%), Gaps = 44/244 (18%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL----------- 112
           KE DK  N + + R L QG    +     +D +  A+KK + ++ +++            
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKIS 82
Query: 113 --YKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE 170
              K ++F NE+ I++ I +   +   G     +   ++YE++ N ++ +        +E
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF-------DE 135
Query: 171 YPLTWEMRFRVAI----------EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV 220
           Y    +  +   I           V  + +Y+H+  +  I HRD+K +NIL+D+  R K+
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKL 193
Query: 221 ADFGTSKFIAMDQTHVTTKIQ---GTFGYLDPEY--HQSSQLTDKSDVYSFGVVLVELLT 275
           +DFG S+++      V  KI+   GT+ ++ PE+  ++SS    K D++S G+ L  +  
Sbjct: 194 SDFGESEYM------VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
Query: 276 GKKP 279
              P
Sbjct: 248 NVVP 251

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF---INEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL+E    +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKEIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E+ P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+++D++   KV DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 87
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 145
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 146 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 200
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 236

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 46/227 (20%)
Query: 78  ILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           ++G GG G V+K +   DG+   +++ K        Y  E+   E+  L++++H N+V  
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVK--------YNNEKAEREVKALAKLDHVNIVHY 70
Query: 137 LGC-------------CLE----------------TEFPLLVYEFIPNGTLYQHLHDRHQ 167
            GC              LE                T+   +  EF   GTL Q +  R  
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK 227
            +   L   +   +  ++   + Y+HS     + HRD+K +NI L +  + K+ DFG   
Sbjct: 131 EK---LDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 274
            +  D     T+ +GT  Y+ PE   S     + D+Y+ G++L ELL
Sbjct: 185 SLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 83  GQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           G+G+  K  L    EDGR   +K+  ++    +  + EE   E+ +L+ + H N+V+   
Sbjct: 33  GEGSFGKAILVKSTEDGRQYVIKEINISRMSSK--EREESRREVAVLANMKHPNIVQYRE 90
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQ---NEEYPLTWEMRFRVAIEVAGALAYLHSG 195
              E     +V ++   G L++ ++ +      E+  L W       +++  AL ++H  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD- 143
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS 255
               I HRDIKS NI L +    ++ DFG ++ +      +     GT  YL PE  ++ 
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENK 200
Query: 256 QLTDKSDVYSFGVVLVELLTGK 277
              +KSD+++ G VL EL T K
Sbjct: 201 PYNNKSDIWALGCVLYELCTLK 222

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 94
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 152
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 153 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 207
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 83
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 141
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 142 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 196
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 87
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 145
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 146 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 200
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 236

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 70  TNHFNVNRILGQGGQGTVY------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           ++ +   R+LG+G  G V        G+    ++I+ ++ K   D E L      + E+ 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL------LREVQ 84
Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +L Q++H N++KL     +  +  LV E    G L+  +  R +  E         R+  
Sbjct: 85  LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIR 139
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQTHVTTKI 240
           +V   + Y+H    + I HRD+K  N+LL+ + +    ++ DFG S      +  +  KI
Sbjct: 140 QVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI 195
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            GT  Y+ PE    +   +K DV+S GV+L  LL+G  P F+  N
Sbjct: 196 -GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGAN 237

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNE-----EYPLTWEMRFRVAIEVAGALAY 191
              + TE  L LV+EF     L+Q L D            PL     F    ++   LA+
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKDFMDASALTGIPLPLIKSYLF----QLLQGLAF 118
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
            HS     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE 
Sbjct: 119 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEI 174
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLT 275
               +    + D++S G +  E++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 79
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 137
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 138 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 192
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 228

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 75
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 133
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 188
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 109
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 167
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 222
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 258

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 76
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 134
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 135 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 189
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 225

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           NEI +L +I H N+V L           L+ + +  G L+  + ++    E   +     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNIL---LDERYRAKVADFGTSKFIAMDQTHV 236
           R+  +V  A+ YLH      I HRD+K  N+L   LDE  +  ++DFG SK    D   V
Sbjct: 120 RLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSV 174
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
            +   GT GY+ PE       +   D +S GV+   LL G  P +   + 
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 15/225 (6%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +HF + R +G+G  G V   +  D + +   K        E  ++     E+ I+  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI-EVAGAL 189
             +V L     + E   +V + +  G L  HL    QN  +    E   ++ I E+  AL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFK---EETVKLFICELVMAL 128
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
            YL +     I HRD+K  NILLDE     + DF  +  +   +T +TT + GT  Y+ P
Sbjct: 129 DYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITT-MAGTKPYMAP 183
Query: 250 EYHQSSQLTDKS---DVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           E   S +    S   D +S GV   ELL G++P     +TS + +
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNI 75
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 133
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 188
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           NEI +L +I H N+V L           L+ + +  G L+  + ++    E   +     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNIL---LDERYRAKVADFGTSKFIAMDQTHV 236
           R+  +V  A+ YLH      I HRD+K  N+L   LDE  +  ++DFG SK    D   V
Sbjct: 120 RLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSV 174
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
            +   GT GY+ PE       +   D +S GV+   LL G  P +   + 
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 70  TNHFNVNRILGQGGQGTVY------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           ++ +   R+LG+G  G V        G+    ++I+ ++ K   D E L      + E+ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL------LREVQ 78
Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +L Q++H N++KL     +  +  LV E    G L+  +  R +  E         R+  
Sbjct: 79  LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIR 133
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQTHVTTKI 240
           +V   + Y+H    + I HRD+K  N+LL+ + +    ++ DFG S      +  +  KI
Sbjct: 134 QVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKI 189
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            GT  Y+ PE    +   +K DV+S GV+L  LL+G  P F+  N
Sbjct: 190 -GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGAN 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 152
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEY 205
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           NEI +L +I H N+V L           L+ + +  G L+  + ++    E   +     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNIL---LDERYRAKVADFGTSKFIAMDQTHV 236
           R+  +V  A+ YLH      I HRD+K  N+L   LDE  +  ++DFG SK    D   V
Sbjct: 120 RLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSV 174
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
            +   GT GY+ PE       +   D +S GV+   LL G  P +   + 
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 152
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 13/213 (6%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  GTV+K +  E   I+A+K+ +L  DDE +      + EI +L ++ H+N+V+L 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVRLH 67
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                 +   LV+EF       Q L     +    L  E+      ++   L + HS   
Sbjct: 68  DVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRD+K  N+L++     K+A+FG ++   +     + ++  T  Y  P+    ++L
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 178
Query: 258 TDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
              S D++S G +  EL    +P+F   +   +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           NEI +L +I H N+V L           L+ + +  G L+  + ++    E   +     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNIL---LDERYRAKVADFGTSKFIAMDQTHV 236
           R+  +V  A+ YLH      I HRD+K  N+L   LDE  +  ++DFG SK    D   V
Sbjct: 120 RLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSV 174
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
            +   GT GY+ PE       +   D +S GV+   LL G  P +   + 
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 131/294 (44%), Gaps = 43/294 (14%)
Query: 79  LGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           LG+   G VYKG L      E  + +A+K  K   D  E    EEF +E  + +++ H N
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73
Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR-----------FRV 181
           VV LLG   + +   +++ +  +G L++ L  R  + +   T + R             +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKI 240
             ++A  + YL   +S  + H+D+ + N+L+ ++   K++D G  + + A D   +    
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVH 299
                ++ PE     + +  SD++S+GVVL E+ + G +P    G ++Q+ V        
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--CGYSNQDVV-------- 240
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG 353
            M +NR       QV+          +A + E C +    +RP  +++   L  
Sbjct: 241 EMIRNR-------QVLPCPDDCPAWVYALMIE-CWNEFPSRRPRFKDIHSRLRA 286

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 82
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 83  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 137
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 138 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEY 190
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 191 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 226

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 76  NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNV 133
            +++G G  G VY+ +L D G ++A+KK         + + + F N E+ I+ +++H N+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKK---------VLQGKAFKNRELQIMRKLDHCNI 75
Query: 134 VKLL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           V+L       G   +  +  LV +++P        H     +  P+ +   +    ++  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 133
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-Y 188
Query: 247 LDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    ++  T   DV+S G VL ELL G +PIF 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G VYK +   G   A+KK +L  +DE +      I EI IL ++ H N+VKL  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                +  +LV+E      L Q L       E  L         +++   +AY H     
Sbjct: 68  VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR-- 120
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QL 257
            + HRD+K  N+L++     K+ADFG ++   +     T +I  T  Y  P+    S + 
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKY 178
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   D++S G +  E++ G  P+F 
Sbjct: 179 STTIDIWSVGCIFAEMVNG-TPLFP 202

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP----HARFYAA-QIV 152
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   L++ H
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLSFCH 120
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 131/294 (44%), Gaps = 43/294 (14%)
Query: 79  LGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           LG+   G VYKG L      E  + +A+K  K   D  E    EEF +E  + +++ H N
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 90
Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR-----------FRV 181
           VV LLG   + +   +++ +  +G L++ L  R  + +   T + R             +
Sbjct: 91  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKI 240
             ++A  + YL   +S  + H+D+ + N+L+ ++   K++D G  + + A D   +    
Sbjct: 151 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 207
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVH 299
                ++ PE     + +  SD++S+GVVL E+ + G +P    G ++Q+ V        
Sbjct: 208 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--CGYSNQDVV-------- 257
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG 353
            M +NR       QV+          +A + E C +    +RP  +++   L  
Sbjct: 258 EMIRNR-------QVLPCPDDCPAWVYALMIE-CWNEFPSRRPRFKDIHSRLRA 303

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 70  TNHFNVNRILGQGGQGTVY------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           ++ +   R+LG+G  G V        G+    ++I+ ++ K   D E L      + E+ 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL------LREVQ 101
Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +L Q++H N++KL     +  +  LV E    G L+  +  R +  E         R+  
Sbjct: 102 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIR 156
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA---KVADFGTSKFIAMDQTHVTTKI 240
           +V   + Y+H    + I HRD+K  N+LL+ + +    ++ DFG S      +  +  KI
Sbjct: 157 QVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKI 212
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            GT  Y+ PE    +   +K DV+S GV+L  LL+G  P
Sbjct: 213 -GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 249

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 12  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 70
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 129
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 130 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 179
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 180 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 234
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F      +   H++                      CL L    RPT EE+
Sbjct: 235 EIIRGQVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 31  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 89
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 90  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 148
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 149 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 198
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 253
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F      +   H++                      CL L    RPT EE+
Sbjct: 254 EIIRGQVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 291

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 24  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 82
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 141
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 142 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 191
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 246
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F      +   H++                      CL L    RPT EE+
Sbjct: 247 EIIRGQVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 284

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 39  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 97
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 156
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 157 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 206
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 207 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 261
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F      +   H++                      CL L    RPT EE+
Sbjct: 262 EIIRGQVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 299

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 70  TNHFNVNRILGQGGQGTVY------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           ++ +   R+LG+G  G V        G+    ++I+ ++ K   D E L      + E+ 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL------LREVQ 102
Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +L Q++H N++KL     +  +  LV E    G L+  +  R +  E         R+  
Sbjct: 103 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIR 157
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQTHVTTKI 240
           +V   + Y+H    + I HRD+K  N+LL+ + +    ++ DFG S      +  +  KI
Sbjct: 158 QVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKI 213
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            GT  Y+ PE    +   +K DV+S GV+L  LL+G  P
Sbjct: 214 -GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 250

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 11  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 69
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 128
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 129 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 178
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 179 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 233
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F      +   H++                      CL L    RPT EE+
Sbjct: 234 EIIRGQVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 271

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF---INEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL+E    +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKEIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E+ P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+++D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 24  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 82
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 141
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 142 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 191
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P        +E
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEE 247
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +    +F                     ++       +L   CL L    RPT EE+
Sbjct: 248 IIGGQVFF---------------------RQRVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E+ P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+++D++   KV DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G VYK +   G   A+KK +L  +DE +      I EI IL ++ H N+VKL  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                +  +LV+E      L Q L       E  L         +++   +AY H     
Sbjct: 68  VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR-- 120
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QL 257
            + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  P+    S + 
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   D++S G +  E++ G  P+F 
Sbjct: 179 STTIDIWSVGCIFAEMVNG-APLFP 202

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 25  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 83
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 142
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 143 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 192
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 247
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F      +   H++                      CL L    RPT EE+
Sbjct: 248 EIIGGQVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 25  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 83
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 142
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 143 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 192
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P        +E
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEE 248
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +    +F                     ++       +L   CL L    RPT EE+
Sbjct: 249 IIGGQVFF---------------------RQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 71
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 72  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 123
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 124 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 70
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 71  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 122
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 123 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 34/251 (13%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           +E D       +  ++G+G  G VY GR      +A++   +  D+E+  +L+ F  E+ 
Sbjct: 26  QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNED--QLKAFKREVM 81
Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
              Q  H NVV  +G C+      ++       TLY  + D     +  L      ++A 
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQ 137
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG---TSKFIAMDQTHVTTKI 240
           E+   + YLH+     I H+D+KS N+  D   +  + DFG    S  +   +     +I
Sbjct: 138 EIVKGMGYLHAKG---ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 241 Q-GTFGYLDPE-YHQSSQLTDK--------SDVYSFGVVLVELLTGKKP---------IF 281
           Q G   +L PE   Q S  T++        SDV++ G +  EL   + P         I+
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253
Query: 282 STGNTSQENVS 292
             G   + N+S
Sbjct: 254 QMGTGMKPNLS 264

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 24  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 82
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 141
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 142 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 191
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 246
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F      +   H++                      CL L    RPT EE+
Sbjct: 247 EIIGGQVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 284

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 25  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 83
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 142
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 143 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 192
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P        +E
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEE 248
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +    +F                     ++       +L   CL L    RPT EE+
Sbjct: 249 IIGGQVFF---------------------RQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G VYK +   G   A+KK +L  +DE +      I EI IL ++ H N+VKL  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASS 198
                +  +LV+E      L Q L       E  L         +++   +AY H     
Sbjct: 68  VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR-- 120
Query: 199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QL 257
            + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  P+    S + 
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 258 TDKSDVYSFGVVLVELLTGKKPIFS 282
           +   D++S G +  E++ G  P+F 
Sbjct: 179 STTIDIWSVGCIFAEMVNG-TPLFP 202

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 96  RIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFI 153
           +I+ V   +L+   E+L ++ E    E  IL Q+  H +++ L+     + F  LV++ +
Sbjct: 125 KIMEVTAERLS--PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182
Query: 154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD 213
             G L+ +L      E+  L+ +    +   +  A+++LH+     I HRD+K  NILLD
Sbjct: 183 RKGELFDYL-----TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLD 234
Query: 214 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ------LTDKSDVYSFG 267
           +  + +++DFG S    ++      ++ GT GYL PE  + S          + D+++ G
Sbjct: 235 DNMQIRLSDFGFS--CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
Query: 268 VVLVELLTGKKPIF 281
           V+L  LL G  P +
Sbjct: 293 VILFTLLAGSPPFW 306

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 24  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 82
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 141
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 142 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 191
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 192 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 246
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F      +   H++                      CL L    RPT EE+
Sbjct: 247 EIIGGQVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 284

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 25  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 83
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 142
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 143 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 192
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 193 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 247
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F      +   H++                      CL L    RPT EE+
Sbjct: 248 EIIGGQVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 285

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 70
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 71  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 122
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 123 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 68  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 175
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 69
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 70  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 121
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 122 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 69
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 70  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 121
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 122 SHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 71
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 72  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 123
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 124 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 71
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 72  D-VIHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 123
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 124 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E+ P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+++D++   KV DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 68  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 175
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 11  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 69
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 128
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 129 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 178
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 179 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 233
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F          H++                      CL L    RPT EE+
Sbjct: 234 EIIRGQVFFRQRVSXECQHLI--------------------RWCLALRPSDRPTFEEI 271

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 72
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 73  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 124
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 125 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 180
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+ K +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+ K +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 68  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 119
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE   
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 68
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 69  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 120
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 44  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 102
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 103 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 161
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 162 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 211
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P        +E
Sbjct: 212 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEE 267
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +    +F                     ++       +L   CL L    RPT EE+
Sbjct: 268 IIRGQVFF---------------------RQRVSXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 12  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 70
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 129
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 130 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 179
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 180 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 234
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F          H++                      CL L    RPT EE+
Sbjct: 235 EIIRGQVFFRQRVSXECQHLI--------------------RWCLALRPSDRPTFEEI 272

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 70
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 71  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 122
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 123 SHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 12  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 70
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 129
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 130 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 179
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 180 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 234
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F          H++                      CL L    RPT EE+
Sbjct: 235 EIIRGQVFFRQRVSXECQHLI--------------------RWCLALRPXDRPTFEEI 272

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 69
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLH---DRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
              + TE  L LV+EF     L+Q L    D       PL     +    ++   LA+ H
Sbjct: 70  D-VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCH 121
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
           S     + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE   
Sbjct: 122 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 254 SSQLTDKS-DVYSFGVVLVELLT 275
             +    + D++S G +  E++T
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 56  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E++P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 167
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+L+D++   +V DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 224 ALGVLIYEMAAGYPPFFA 241

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 76  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 135
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E++P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 136 NLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 187
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+L+D++   +V DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 188 LKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 244 ALGVLIYEMAAGYPPFFA 261

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 46/298 (15%)
Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYK 114
           KL   KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL  
Sbjct: 39  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPN 97
Query: 115 LEEFINEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEY 171
                 E+ +L +++     V++LL      + F L++    P   L+  + +R   +E 
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE- 156
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               E+      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A
Sbjct: 157 ----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---A 206
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +  V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E
Sbjct: 207 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDE 261
Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +     F          H++                      CL L    RPT EE+
Sbjct: 262 EIIRGQVFFRQRVSXECQHLI--------------------RWCLALRPSDRPTFEEI 299

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 48  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 107
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E++P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 108 NLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 159
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+L+D++   +V DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 160 LKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 215
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 216 ALGVLIYEMAAGYPPFFA 233

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 56  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E++P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 167
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+L+D++   +V DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 224 ALGVLIYEMAAGYPPFFA 241

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 55  GRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS 114
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E++P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 166
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+L+D++   +V DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 223 ALGVLIYEMAAGYPPFFA 240

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 55  GRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS 114
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E++P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 166
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+L+D++   +V DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 223 ALGVLIYEMAAGYPPFFA 240

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 55  GRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS 114
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E++P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 166
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+L+D++   +V DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 223 ALGVLIYEMAAGYPPFFA 240

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 56  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E++P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 167
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+L+D++   +V DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 224 ALGVLIYEMAAGYPPFFA 241

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 67  DKATNHFNVNRILGQGGQGTVYKGRLEDG-RIIAVKKSKLAVDDEELYKLEEFINEIFIL 125
           D  ++ F V   LG+G    VY+ + +   +  A+K  K  VD + +        EI +L
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR------TEIGVL 102
Query: 126 SQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            +++H N++KL     ET   + LV E +  G L+  + ++    E      ++     +
Sbjct: 103 LRLSHPNIIKLKEI-FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK-----Q 156
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           +  A+AYLH      I HRD+K  N+L          K+ADFG SK +  +   +   + 
Sbjct: 157 ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVC 211
Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           GT GY  PE  +      + D++S G++   LL G +P +
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   R LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  I  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRIQQ 97
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E+ P G ++ HL    +  E       RF  A ++ 
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 152
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   KVADFG +K +       T  + GT  Y
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEY 205
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 69
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
              + TE  L LV+EF+      +   D       PL     +    ++   LA+ HS  
Sbjct: 70  D-VIHTENKLYLVFEFL--SMDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSHR 124
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE     +
Sbjct: 125 ---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 180
Query: 257 LTDKS-DVYSFGVVLVELLT 275
               + D++S G +  E++T
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 71
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
              + TE  L LV+EF+      +   D       PL     +    ++   LA+ HS  
Sbjct: 72  D-VIHTENKLYLVFEFL--SMDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSHR 126
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE     +
Sbjct: 127 ---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 182
Query: 257 LTDKS-DVYSFGVVLVELLT 275
               + D++S G +  E++T
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 71
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
              + TE  L LV+EF+      +   D       PL     +    ++   LA+ HS  
Sbjct: 72  D-VIHTENKLYLVFEFL--SMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSHR 126
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE     +
Sbjct: 127 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 182
Query: 257 LTDKS-DVYSFGVVLVELLT 275
               + D++S G +  E++T
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT 202

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 48  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 107
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E++P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 108 NLYMVMEYVPGGEMFSHLRRIGRFXEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 159
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+L+D++   +V DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 160 LKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 215
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 216 ALGVLIYEMAAGYPPFFA 233

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFI 119
           KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL       
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVP 59
Query: 120 NEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
            E+ +L +++     V++LL      + F L++    P   L+  + +R   +E     E
Sbjct: 60  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQE-----E 114
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH 235
           +      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  
Sbjct: 115 LARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDT 168
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E +   
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRG 223
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             F      +   H++                      CL L    RPT EE+
Sbjct: 224 QVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 256

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           N F   R+LG+GG G V   ++   G++ A KK +     +   +    +NE  IL ++N
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVN 242
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
            R VV L       +   LV   +  G L  H++   Q   +P    + +  A E+   L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFY--AAEICCGL 299
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
             LH      I +RD+K  NILLD+    +++D G +  +   QT +  ++ GT GY+ P
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAP 354
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
           E  ++ + T   D ++ G +L E++ G+ P 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 70
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
              + TE  L LV+EF+      +   D       PL     +    ++   LA+ HS  
Sbjct: 71  D-VIHTENKLYLVFEFL--SMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSHR 125
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE     +
Sbjct: 126 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 181
Query: 257 LTDKS-DVYSFGVVLVELLT 275
               + D++S G +  E++T
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT 201

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 10/211 (4%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           N F   R+LG+GG G V   ++   G++ A KK +     +   +    +NE  IL ++N
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVN 242
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
            R VV L       +   LV   +  G L  H++   Q   +P    + +  A E+   L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFY--AAEICCGL 299
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
             LH      I +RD+K  NILLD+    +++D G +  +   QT +  ++ GT GY+ P
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAP 354
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
           E  ++ + T   D ++ G +L E++ G+ P 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGRII----AVKK-SKLAVDDEELYKLEEFINEIFILSQ 127
           +N+  +LG+G  G V K +    RI     AVK  +K +  +++   +   + E+ +L +
Sbjct: 24  YNIVCMLGKGSFGEVLKCK---DRITQQEYAVKVINKASAKNKDTSTI---LREVELLKK 77
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           ++H N++KL     ++    +V E    G L+  +  R +  E+        R+  +V  
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----RIIKQVFS 132
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQTHVTTKIQGTF 244
            + Y+H      I HRD+K  NILL+ + +    K+ DFG S     + T +  +I GT 
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
            Y+ PE  + +   +K DV+S GV+L  LL+G  P +
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY 223

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 73  FNVNRILGQGGQGTVYKGR----LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           +N+  +LG+G  G V K +     ++  +  + K+     D         + E+ +L ++
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-----ILREVELLKKL 78
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           +H N++KL     ++    +V E    G L+  +  R +  E+        R+  +V   
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----RIIKQVFSG 133
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQTHVTTKIQGTFG 245
           + Y+H      I HRD+K  NILL+ + +    K+ DFG S     + T +  +I GT  
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAY 188
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           Y+ PE  + +   +K DV+S GV+L  LL+G  P +
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY 223

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 73  FNVNRILGQGGQGTVYKGR----LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           +N+  +LG+G  G V K +     ++  +  + K+     D         + E+ +L ++
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-----ILREVELLKKL 78
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           +H N++KL     ++    +V E    G L+  +  R +  E+        R+  +V   
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----RIIKQVFSG 133
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQTHVTTKIQGTFG 245
           + Y+H      I HRD+K  NILL+ + +    K+ DFG S     + T +  +I GT  
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAY 188
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           Y+ PE  + +   +K DV+S GV+L  LL+G  P +
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY 223

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 77  RILGQGGQGTVYK----GRLEDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQI-N 129
           ++LG G  G V      G  + G  I  AVK  K   D  E    E  ++E+ +++Q+ +
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER---EALMSELKMMTQLGS 107
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE-----EYP------------ 172
           H N+V LLG C  +    L++E+   G L  +L  + +       EY             
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 173 -LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT+E     A +VA  + +L   +     HRD+ + N+L+      K+ DFG ++ I  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 232 DQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
           D  +V     +    ++ PE       T KSDV+S+G++L E       IFS G      
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE-------IFSLGVNPYPG 277
Query: 291 VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS 348
           + + A F + + +N       DQ     ++  I+      + C   + +KRP+   ++
Sbjct: 278 IPVDANF-YKLIQNGFKM---DQPFYATEEIYII-----MQSCWAFDSRKRPSFPNLT 326

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 22/182 (12%)
Query: 110 EELYKLEEF-INEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
           EE+ +L E  + E+ IL +++ H N+++L        F  LV++ +  G L+ +L ++  
Sbjct: 48  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 107
Query: 168 NEEYPLTWEMR--FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT 225
             E     E R   R  +EV  AL  L+      I HRD+K  NILLD+    K+ DFG 
Sbjct: 108 LSEK----ETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 157
Query: 226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS------DVYSFGVVLVELLTGKKP 279
           S    +D      ++ GT  YL PE  + S   +        D++S GV++  LL G  P
Sbjct: 158 S--CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215
Query: 280 IF 281
            +
Sbjct: 216 FW 217

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 73  FNVNRILGQGG-QGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFI-NEIFILSQINH 130
           F     LG G     V       G++ AVK     +  + L   E  I NEI +L +I H
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVK----CIPKKALKGKESSIENEIAVLRKIKH 79
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+V L           LV + +  G L+  + ++    E   +  +R     +V  A+ 
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR-----QVLDAVY 134
Query: 191 YLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           YLH      I HRD+K  N+L    DE  +  ++DFG SK     +  V +   GT GY+
Sbjct: 135 YLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG--KGDVMSTACGTPGYV 189
Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
            PE       +   D +S GV+   LL G  P +   ++
Sbjct: 190 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDS 228

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 95  GRIIAVKKSKLA-------VDDEELYKL---EEFINEIFILSQINHRNVVKLLGCCLETE 144
           GR++ VK  +         +D +++ KL   E  +NE  IL  +N   +VKL     +  
Sbjct: 56  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 115
Query: 145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD 204
              +V E+ P G ++ HL    +  E       RF  A ++     YLHS     + +RD
Sbjct: 116 NLYMVMEYAPGGEMFSHLRRIGRFSEP----HARFYAA-QIVLTFEYLHS---LDLIYRD 167
Query: 205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY 264
           +K  N+++D++   KV DFG +K +       T  + GT  YL PE   S       D +
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 265 SFGVVLVELLTGKKPIFS 282
           + GV++ E+  G  P F+
Sbjct: 224 ALGVLIYEMAAGYPPFFA 241

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   + KL     +     +V E+ P G ++ HL    +  E       RF  A ++ 
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 152
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+++D++   KV DFG +K +       T  + GT  Y
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E+ P G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+++D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   + KL     +     +V E+ P G ++ HL    +  E       RF  A ++ 
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP----HARFYAA-QIV 152
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+++D++   KV DFG +K +       T  + GT  Y
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 22/182 (12%)
Query: 110 EELYKLEEF-INEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
           EE+ +L E  + E+ IL +++ H N+++L        F  LV++ +  G L+ +L ++  
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120
Query: 168 NEEYPLTWEMR--FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT 225
             E     E R   R  +EV  AL  L+      I HRD+K  NILLD+    K+ DFG 
Sbjct: 121 LSEK----ETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS------DVYSFGVVLVELLTGKKP 279
           S    +D      ++ GT  YL PE  + S   +        D++S GV++  LL G  P
Sbjct: 171 S--CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 280 IF 281
            +
Sbjct: 229 FW 230

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 67
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLH-------DRHQNEEYPLTWEMRFRVAIEVAGALA 190
              + TE  L +        +++H+H       D       PL     +    ++   LA
Sbjct: 68  DV-IHTENKLYL--------VFEHVHQDLKTFMDASALTGIPLPLIKSY--LFQLLQGLA 116
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           + HS     + HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  PE
Sbjct: 117 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 172
Query: 251 YHQSSQLTDKS-DVYSFGVVLVELLT 275
                +    + D++S G +  E++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   + KL     +     +V E+ P G ++ HL    +  E       RF  A ++ 
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP----HARFYAA-QIV 152
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+++D++   KV DFG +K +       T  + GT  Y
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+  ++LG+G  G V   R +  GR  A+K   K  +   DE    +   + E  +L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 60
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L       +    V E+   G L+ HL  +R   EE       RF  A E+
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA-EI 114
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS     + +RDIK  N++LD+    K+ DFG  K    D   + T   GT  
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPE 170
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+  ++LG+G  G V   R +  GR  A+K   K  +   DE    +   + E  +L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 60
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L       +    V E+   G L+ HL  +R   EE       RF  A E+
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA-EI 114
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS     + +RDIK  N++LD+    K+ DFG  K    D   + T   GT  
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPE 170
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 110 EELYKLEEF-INEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
           EE+ +L E  + E+ IL +++ H N+++L        F  LV++ +  G L+ +L ++  
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120
Query: 168 NEEYPLTWEMR--FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT 225
             E     E R   R  +EV  AL  L+      I HRD+K  NILLD+    K+ DFG 
Sbjct: 121 LSEK----ETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS------DVYSFGVVLVELLTGKKP 279
           S    +D       + GT  YL PE  + S   +        D++S GV++  LL G  P
Sbjct: 171 S--CQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 280 IF 281
            +
Sbjct: 229 FW 230

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFI 119
           KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL       
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVP 59
Query: 120 NEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
            E+ +L +++     V++LL      + F L++    P   L+  + +R   +E     E
Sbjct: 60  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-----E 114
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH 235
           +      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  
Sbjct: 115 LARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDT 168
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E +   
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRG 223
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             F      +   H++                      CL L    RPT EE+
Sbjct: 224 QVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 256

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 105/243 (43%), Gaps = 52/243 (21%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKL 136
           LG+G  G V+K      G ++AVKK   A  +      +    EI IL++++ H N+V L
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST--DAQRTFREIMILTELSGHENIVNL 74
Query: 137 LGC--CLETEFPLLVYEFIPN-------GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           L            LV++++           + + +H ++              V  ++  
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY--------------VVYQLIK 120
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FIAM--------------- 231
            + YLHSG    + HRD+K +NILL+     KVADFG S+ F+ +               
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 232 ----DQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
               D   + T    T  Y  PE    S++ T   D++S G +L E+L G KPIF   +T
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSST 236
Query: 287 SQE 289
             +
Sbjct: 237 MNQ 239

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFI 119
           KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL       
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVP 60
Query: 120 NEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
            E+ +L +++     V++LL      + F L++    P   L+  + +R   +E     E
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-----E 115
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH 235
           +      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  
Sbjct: 116 LARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDT 169
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRG 224
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             F      +   H++                      CL L    RPT EE+
Sbjct: 225 QVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 257

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+  ++LG+G  G V   R +  GR  A+K   K  +   DE    +   + E  +L 
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 63
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L       +    V E+   G L+ HL  +R   EE       RF  A E+
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA-EI 117
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS     + +RDIK  N++LD+    K+ DFG  K    D   + T   GT  
Sbjct: 118 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPE 173
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFI 119
           KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL       
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVP 60
Query: 120 NEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
            E+ +L +++     V++LL      + F L++    P   L+  + +R   +E     E
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-----E 115
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH 235
           +      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  
Sbjct: 116 LARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDT 169
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRG 224
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             F      +   H++                      CL L    RPT EE+
Sbjct: 225 QVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 257

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFI 119
           KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL       
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVP 60
Query: 120 NEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
            E+ +L +++     V++LL      + F L++    P   L+  + +R   +E     E
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-----E 115
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH 235
           +      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  
Sbjct: 116 LARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDT 169
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRG 224
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             F      +   H++                      CL L    RPT EE+
Sbjct: 225 QVFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 257

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 73  FNVNRILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           FN   +LG+G  G V     KG  E   +  +KK  +  DD+    +E  + E  +L+  
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----VECTMVEKRVLALP 77
Query: 129 NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +  L  C +T   L  V E++  G L  H+    + +E    +      A E+A 
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-----YAAEIAI 132
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGY 246
            L +L S     I +RD+K  N++LD     K+ADFG  K    D   VTTK   GT  Y
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDY 187
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
           + PE           D ++FGV+L E+L G+ P 
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 83
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 138
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+DE+   +V DFG +K +       T  + GT  Y
Sbjct: 139 LTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 191
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 192 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 227

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 70  TNHFNVNRILGQGGQGTVY------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           ++ +   R+LG+G  G V        G+    ++I+ ++ K   D E L      + E+ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL------LREVQ 78
Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +L Q++H N+ KL     +  +  LV E    G L+  +  R +  E         R+  
Sbjct: 79  LLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----RIIR 133
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA---KVADFGTSKFIAMDQTHVTTKI 240
           +V   + Y H    + I HRD+K  N+LL+ + +    ++ DFG S      +     KI
Sbjct: 134 QVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KXKDKI 189
Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            GT  Y+ PE    +   +K DV+S GV+L  LL+G  P F+  N
Sbjct: 190 -GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGAN 231

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           L +   G ++KGR + G  I VK   L V D    K  +F  E   L   +H NV+ +LG
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKV--LKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 139 CC--LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            C       P L+  ++P G+LY  L   H+   + +      + A+++A  +A+LH+  
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALDMARGMAFLHT-- 129
Query: 197 SSPIYHRD-IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF---GYLDPEYH 252
             P+  R  + S ++++DE   A+         I+M     + +  G      ++ PE  
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTAR---------ISMADVKFSFQSPGRMYAPAWVAPEAL 180
Query: 253 Q-SSQLTDK--SDVYSFGVVLVELLTGKKPIFSTGN 285
           Q   + T++  +D++SF V+L EL+T + P     N
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 43/225 (19%)
Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE--IFILSQINHRNVVK 135
           ++G+G  G VYKG L D R +AVK    A         + FINE  I+ +  + H N+ +
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEKNIYRVPLMEHDNIAR 71
Query: 136 LL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
            +            E+ LLV E+ PNG+L ++L   H ++     W    R+A  V   L
Sbjct: 72  FIVGDERVTADGRMEY-LLVMEYYPNGSLXKYL-SLHTSD-----WVSSCRLAHSVTRGL 124
Query: 190 AYLHSGAS------SPIYHRDIKSTNILLDERYRAKVADFGTSKFI-------AMDQTHV 236
           AYLH+           I HRD+ S N+L+       ++DFG S  +         ++ + 
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 237 TTKIQGTFGYLDPEYHQSS-QLTD------KSDVYSFGVVLVELL 274
                GT  Y+ PE  + +  L D      + D+Y+ G++  E+ 
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLXGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 117
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E       RF  A ++ 
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAA-QIV 172
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEY 225
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 52/291 (17%)
Query: 73  FNVNRILGQGGQGTVYKG-RLEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQIN 129
           + +  +LG+GG GTV+ G RL D   +A+K       +    L        E+ +L ++ 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 130 ----HRNVVKLLGCCLETE--FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
               H  V++LL    ET+  F L++   +P   L+ ++ ++    E P     R     
Sbjct: 93  AGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP----SRCFFG- 146
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +V  A+ + HS     + HRDIK  NIL+D  R  AK+ DFG+   +  D+ +  T   G
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPY--TDFDG 200
Query: 243 TFGYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
           T  Y  PE+   HQ   L   + V+S G++L +++ G  P        QE +    +F  
Sbjct: 201 TRVYSPPEWISRHQYHAL--PATVWSLGILLYDMVCGDIPF----ERDQEILEAELHFP- 253
Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
                   H+  D                L  RCL      RP++EE+ ++
Sbjct: 254 -------AHVSPD-------------CCALIRRCLAPKPSSRPSLEEILLD 284

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 46/293 (15%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFI 119
           KE +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL       
Sbjct: 24  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVP 82
Query: 120 NEIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
            E+ +L +++     V++LL      + F L++    P   L+  + +R   +E     E
Sbjct: 83  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-----E 137
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH 235
           +      +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  
Sbjct: 138 LARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDT 191
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           V T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P        +E +   
Sbjct: 192 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQ 247
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            +F                     ++       +L   CL L    RPT EE+
Sbjct: 248 VFF---------------------RQRVSXECQHLIRWCLALRPSDRPTFEEI 279

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLAGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 73  FNVNRILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           FN   +LG+G  G V     KG  E   +  +KK  +  DD+    +E  + E  +L+  
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----VECTMVEKRVLALP 398
Query: 129 NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +  L  C +T   L  V E++  G L  H+    + +E    +      A E+A 
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-----YAAEIAI 453
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGY 246
            L +L S     I +RD+K  N++LD     K+ADFG  K    D   VTTK   GT  Y
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTPDY 508
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
           + PE           D ++FGV+L E+L G+ P 
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F   + LG G  G V   + +E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY----RAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 27/235 (11%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            +  F + R   Q G G  Y  +        +KK +L+     + + EE   E+ IL +I
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKF-------IKKRRLSSSRRGVSR-EEIEREVNILREI 65
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N++ L          +L+ E +  G L+  L ++       LT +   +   ++   
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-----LTEDEATQFLKQILDG 120
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERY----RAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           + YLHS     I H D+K  NI+L ++     R K+ DFG +  I  +  +    I GT 
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTP 175
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
            ++ PE      L  ++D++S GV+   LL+G  P    G T QE   N+S   Y
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GETKQETLTNISAVNY 228

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 24/227 (10%)
Query: 66  LDKATNHFNVNRILGQGGQGTVYKGR--LEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           L +A   +     +G+G  G V+K R     GR +A+K+ ++   +E +      I E+ 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--STIREVA 63
Query: 124 ILSQIN---HRNVVKLLGCCL------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLT 174
           +L  +    H NVV+L   C       ET+   LV+E + +  L  +L D+      P  
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHV-DQDLTTYL-DKVPEPGVPT- 119
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            E    +  ++   L +LHS     + HRD+K  NIL+    + K+ADFG ++  +    
Sbjct: 120 -ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
              T +  T  Y  PE    S      D++S G +  E+   +KP+F
Sbjct: 176 --LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 24/227 (10%)
Query: 66  LDKATNHFNVNRILGQGGQGTVYKGR--LEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           L +A   +     +G+G  G V+K R     GR +A+K+ ++   +E +      I E+ 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--STIREVA 63
Query: 124 ILSQIN---HRNVVKLLGCCL------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLT 174
           +L  +    H NVV+L   C       ET+   LV+E + +  L  +L D+      P  
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHV-DQDLTTYL-DKVPEPGVPT- 119
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            E    +  ++   L +LHS     + HRD+K  NIL+    + K+ADFG ++  +    
Sbjct: 120 -ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
              T +  T  Y  PE    S      D++S G +  E+   +KP+F
Sbjct: 176 --LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF 219

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 24/227 (10%)
Query: 66  LDKATNHFNVNRILGQGGQGTVYKGR--LEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           L +A   +     +G+G  G V+K R     GR +A+K+ ++   +E +      I E+ 
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--STIREVA 63
Query: 124 ILSQIN---HRNVVKLLGCCL------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLT 174
           +L  +    H NVV+L   C       ET+   LV+E + +  L  +L D+      P  
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHV-DQDLTTYL-DKVPEPGVPT- 119
Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            E    +  ++   L +LHS     + HRD+K  NIL+    + K+ADFG ++  +    
Sbjct: 120 -ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
              T +  T  Y  PE    S      D++S G +  E+   +KP+F
Sbjct: 176 --LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF 219

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 79  LGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G VYK R +  G ++A+KK +L  + E +      I EI +L ++NH N+VKLL
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 71
Query: 138 GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
              + TE  L LV+E +      +   D       PL     +    ++   LA+ HS  
Sbjct: 72  DV-IHTENKLYLVFEHVDQD--LKKFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSHR 126
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+L++     K+ADFG ++   +       ++  T  Y  PE     +
Sbjct: 127 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 182
Query: 257 LTDKS-DVYSFGVVLVELLT 275
               + D++S G +  E++T
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT 202

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 152
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 153 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 112
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 113 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 167
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 225
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 226 ANVSAVNY 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 21/219 (9%)
Query: 70  TNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
           T+ + +   +G+G    V +  +L  G   A K     KL+  D +  KLE    E  I 
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ--KLE---REARIC 57
Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
             + H N+V+L     E  F  LV++ +  G L++ +  R    E   +         ++
Sbjct: 58  RLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-----HCIQQI 112
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRA---KVADFGTSKFIAMDQTHVTTKIQG 242
             A+ + H      + HRD+K  N+LL  + +    K+ADFG +  +  DQ        G
Sbjct: 113 LEAVLHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGFAG 168
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           T GYL PE  +        D+++ GV+L  LL G  P +
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFW 207

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 112
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 113 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 167
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 225
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 226 ANVSAVNY 233

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+  ++LG+G  G V   R +  GR  A+K   K  +   DE    +   + E  +L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 60
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L       +    V E+   G L+ HL  +R   EE       RF  A E+
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA-EI 114
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS     + +RDIK  N++LD+    K+ DFG  K   +          GT  
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 27/235 (11%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            +  F + R   Q G G  Y  +        +KK +L+     + + EE   E+ IL +I
Sbjct: 21  GSGQFAIVRKCRQKGTGKEYAAKF-------IKKRRLSSSRRGVSR-EEIEREVNILREI 72
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N++ L          +L+ E +  G L+  L ++       LT +   +   ++   
Sbjct: 73  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-----LTEDEATQFLKQILDG 127
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           + YLHS     I H D+K  NI+L ++     R K+ DFG +  I  +  +    I GT 
Sbjct: 128 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTP 182
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
            ++ PE      L  ++D++S GV+   LL+G  P    G T QE   N+S   Y
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GETKQETLTNISAVNY 235

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+  ++LG+G  G V   R +  GR  A+K   K  +   DE    +   + E  +L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 60
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L       +    V E+   G L+ HL  +R   EE       RF  A E+
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA-EI 114
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS     + +RDIK  N++LD+    K+ DFG  K   +          GT  
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 76  NRILGQGGQGTVYKGRLEDGRII----AVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
            R LG+GG    Y+    D + +     V KS L     + ++ E+   EI I   +++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLL----KPHQKEKMSTEIAIHKSLDNP 102
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +VV   G   + +F  +V E     +L + LH R +    P   E R+ +   + G + Y
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEP---EARYFMRQTIQG-VQY 157
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH+     + HRD+K  N+ L++    K+ DFG +  I  D     T + GT  Y+ PE 
Sbjct: 158 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEV 213
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
                 + + D++S G +L  LL GK P
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+  ++LG+G  G V   R +  GR  A+K   K  +   DE    +   + E  +L 
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 65
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L       +    V E+   G L+ HL  +R   EE       RF  A E+
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA-EI 119
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS     + +RDIK  N++LD+    K+ DFG  K   +          GT  
Sbjct: 120 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 175
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 212

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+  ++LG+G  G V   R +  GR  A+K   K  +   DE    +   + E  +L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 60
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L       +    V E+   G L+ HL  +R   EE       RF  A E+
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA-EI 114
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS     + +RDIK  N++LD+    K+ DFG  K   +          GT  
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 117
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E       RF  A ++ 
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP----HARFYAA-QIV 172
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 173 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 225
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 91
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE-P---HARFYAA-QIV 146
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 147 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 199
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 200 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 235

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
             + + LG G  G V+         +AVK  K          +E F+ E  ++  + H  
Sbjct: 184 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDK 238
Query: 133 VVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +VKL      T+ P+ ++ EF+  G+L   L     +++ PL   + F  + ++A  +A+
Sbjct: 239 LVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDF--SAQIAEGMAF 293
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           +         HRD+++ NIL+      K+ADFG ++  A          +    +  PE 
Sbjct: 294 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVGA----------KFPIKWTAPEA 340
Query: 252 HQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN 285
                 T KSDV+SFG++L+E++T G+ P     N
Sbjct: 341 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 375

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 46/292 (15%)
Query: 65  ELDKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFIN 120
           E +   + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL        
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVPM 59
Query: 121 EIFILSQINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM 177
           E+ +L +++     V++LL      + F L++    P   L+  + +R   +E     E+
Sbjct: 60  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-----EL 114
Query: 178 RFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHV 236
                 +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  V
Sbjct: 115 ARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTV 168
Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            T   GT  Y  PE+ +  +   +S  V+S G++L +++ G  P         E +    
Sbjct: 169 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQ 223
Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            F      +   H++                      CL L    RPT EE+
Sbjct: 224 VFFRQRVSSECQHLI--------------------RWCLALRPSDRPTFEEI 255

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           E+   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES-----LTE 113
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
           E       ++   + YLHS     I H D+K  NI+L +R     R K+ DFG +  I  
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-- 168
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-- 289
           D  +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE  
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETL 226
Query: 290 -NVSLAAY 296
            NVS   Y
Sbjct: 227 ANVSAVNY 234

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 27/235 (11%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            +  F + R   Q G G  Y  +        +KK +L      + + EE   E+ IL +I
Sbjct: 35  GSGQFAIVRKCRQKGTGKEYAAKF-------IKKRRLXSSRRGVSR-EEIEREVNILREI 86
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N++ L          +L+ E +  G L+  L ++       LT +   +   ++   
Sbjct: 87  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-----LTEDEATQFLKQILDG 141
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERY----RAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           + YLHS     I H D+K  NI+L ++     R K+ DFG +  I  +  +    I GT 
Sbjct: 142 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTP 196
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
            ++ PE      L  ++D++S GV+   LL+G  P    G T QE   N+S   Y
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GETKQETLTNISAVNY 249

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 70  TNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
           T+ + +   LG+G    V +  ++  G+  A K     KL+  D +  KLE    E  I 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ--KLE---REARIC 57
Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
             + H N+V+L     E  F  LV++ +  G L++ +  R    E   +         ++
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-----HCIQQI 112
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRA---KVADFGTSKFIAMDQTHVTTKIQG 242
             ++ + H      I HRD+K  N+LL  + +    K+ADFG +  +  DQ        G
Sbjct: 113 LESVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAG 168
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           T GYL PE  +        D+++ GV+L  LL G  P +
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFW 207

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 46/286 (16%)
Query: 71  NHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL        E+ +L 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVPMEVVLLK 62
Query: 127 QINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +++     V++LL      + F L++    P   L+  + +R   +E     E+      
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-----ELARSFFW 117
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  V T   G
Sbjct: 118 QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDG 171
Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
           T  Y  PE+ +  +   +S  V+S G++L +++ G  P         E +     F    
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQR 226
Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             +   H++                      CL L    RPT EE+
Sbjct: 227 VSSECQHLI--------------------RWCLALRPSDRPTFEEI 252

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM 177
            ++E+ +L Q++H N++KL     +     LV E    G L+  +  R +  E      M
Sbjct: 51  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM 110
Query: 178 RFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQT 234
           +     +V     YLH      I HRD+K  N+LL+ + R    K+ DFG S        
Sbjct: 111 K-----QVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF----- 157
Query: 235 HVTTKIQ---GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            V  K++   GT  Y+ PE  +  +  +K DV+S GV+L  LL G  P    G T QE
Sbjct: 158 EVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPF--GGQTDQE 212

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 16/228 (7%)
Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVD-DEELYKLEEFINEIFILSQINHR 131
           F   R LG G  G V+   L + R   +++    ++ D     +E+   EI +L  ++H 
Sbjct: 24  FIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           N++K+     +     +V E    G L + +    Q     L+      +  ++  ALAY
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA-QARGKALSEGYVAELMKQMMNALAY 139
Query: 192 LHSGASSPIYHRDIKSTNILLDE---RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
            HS     + H+D+K  NIL  +       K+ DFG ++    D+   +T   GT  Y+ 
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMA 194
Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY 296
           PE  +   +T K D++S GVV+  LLTG  P   TG + +E    A Y
Sbjct: 195 PEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF--TGTSLEEVQQKATY 239

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 70  TNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
           T+ + +   LG+G    V +  ++  G+  A K     KL+  D +  KLE    E  I 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ--KLE---REARIC 57
Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
             + H N+V+L     E  F  LV++ +  G L++ +  R    E   +         ++
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-----HCIQQI 112
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRA---KVADFGTSKFIAMDQTHVTTKIQG 242
             ++ + H      I HRD+K  N+LL  + +    K+ADFG +  +  DQ        G
Sbjct: 113 LESVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAG 168
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           T GYL PE  +        D+++ GV+L  LL G  P +
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFW 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 34/227 (14%)
Query: 73  FNVNRILGQGGQGTVY--KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           F   + LG+GG G V+  K +++D    A+K+ +L   + EL + E+ + E+  L+++ H
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNY-AIKRIRLP--NRELAR-EKVMREVKALAKLEH 62
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPL----TWEMRFR----- 180
             +V+     LE      +    P   LY  +   R +N +  +    T E R R     
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH----V 236
           + +++A A+ +LHS     + HRD+K +NI        KV DFG     AMDQ      V
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL--VTAMDQDEEEQTV 177
Query: 237 TTKIQ---------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 274
            T +          GT  Y+ PE    +  + K D++S G++L ELL
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ ++  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFA 240

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 46/286 (16%)
Query: 71  NHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL        E+ +L 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVPMEVVLLK 62
Query: 127 QINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +++     V++LL      + F L++    P   L+  + +R   +E     E+      
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-----ELARSFFW 117
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  V T   G
Sbjct: 118 QVLEAVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDG 171
Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
           T  Y  PE+ +  +   +S  V+S G++L +++ G  P        +E +    +F    
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFF---- 223
Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                            ++       +L   CL L    RPT EE+
Sbjct: 224 -----------------RQRVSXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL--YKLEEFINEIFILSQINHRNVVKL 136
           LG+GG    ++  + D     V   K+      L  ++ E+   EI I   + H++VV  
Sbjct: 25  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            G   + +F  +V E     +L + LH R +    P   E R+ +   V G   YLH   
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP---EARYYLRQIVLGC-QYLHRNR 137
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+ L+E    K+ DFG +  +  D     T + GT  Y+ PE      
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 193
Query: 257 LTDKSDVYSFGVVLVELLTGKKP 279
            + + DV+S G ++  LL GK P
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM 177
            ++E+ +L Q++H N++KL     +     LV E    G L+  +  R +  E      M
Sbjct: 68  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM 127
Query: 178 RFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQT 234
           +     +V     YLH      I HRD+K  N+LL+ + R    K+ DFG S        
Sbjct: 128 K-----QVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF----- 174
Query: 235 HVTTKIQ---GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            V  K++   GT  Y+ PE  +  +  +K DV+S GV+L  LL G  P    G T QE
Sbjct: 175 EVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPF--GGQTDQE 229

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL--YKLEEFINEIFILSQINHRNVVKL 136
           LG+GG    ++  + D     V   K+      L  ++ E+   EI I   + H++VV  
Sbjct: 25  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            G   + +F  +V E     +L + LH R +    P   E R+ +   V G   YLH   
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP---EARYYLRQIVLGC-QYLHRNR 137
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+ L+E    K+ DFG +  +  D     T + GT  Y+ PE      
Sbjct: 138 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 193
Query: 257 LTDKSDVYSFGVVLVELLTGKKP 279
            + + DV+S G ++  LL GK P
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL--YKLEEFINEIFILSQINHRNVVKL 136
           LG+GG    ++  + D     V   K+      L  ++ E+   EI I   + H++VV  
Sbjct: 29  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            G   + +F  +V E     +L + LH R +    P   E R+ +   V G   YLH   
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP---EARYYLRQIVLGC-QYLHRNR 141
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+ L+E    K+ DFG +  +  D     T + GT  Y+ PE      
Sbjct: 142 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKG 197
Query: 257 LTDKSDVYSFGVVLVELLTGKKP 279
            + + DV+S G ++  LL GK P
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+++D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 46/286 (16%)
Query: 71  NHFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           + + V  +LG GG G+VY G R+ D   +A+K   K +++ D  EL        E+ +L 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS-DWGELPNGTRVPMEVVLLK 62
Query: 127 QINH--RNVVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +++     V++LL      + F L++    P   L+  + +R   +E     E+      
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-----ELARSFFW 117
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+    A+ +  V T   G
Sbjct: 118 QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDG 171
Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
           T  Y  PE+ +  +   +S  V+S G++L +++ G  P         E +     F    
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQR 226
Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             +   H++                      CL L    RPT EE+
Sbjct: 227 VSSECQHLI--------------------RWCLALRPSDRPTFEEI 252

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 76  NRILGQGGQGTVYKGRLEDGRII----AVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
            R LG+GG    Y+    D + +     V KS L     + ++ E+   EI I   +++ 
Sbjct: 31  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLL----KPHQKEKMSTEIAIHKSLDNP 86
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +VV   G   + +F  +V E     +L + LH R +    P   E R+ +   + G + Y
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEP---EARYFMRQTIQG-VQY 141
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH+     + HRD+K  N+ L++    K+ DFG +  I  D       + GT  Y+ PE 
Sbjct: 142 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEV 197
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
                 + + D++S G +L  LL GK P
Sbjct: 198 LCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 127/291 (43%), Gaps = 42/291 (14%)
Query: 76  NRILGQGGQGTVYKG-RLEDGRIIAVKKSKL---AVDDEELYKLEEFINEIFILSQINHR 131
           N  LGQG    ++KG R E G    + ++++    +D       E F     ++S+++H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           ++V   G C+  +  +LV EF+  G+L  +L  +       + W  +  VA ++A A+ +
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILW--KLEVAKQLAAAMHF 128
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI------QGTFG 245
           L       + H ++ + NILL    R +    G   FI +    ++  +      Q    
Sbjct: 129 LEENT---LIHGNVCAKNILL---IREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 246 YLDPEYHQSSQ-LTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK 303
           ++ PE  ++ + L   +D +SFG  L E+ + G KP+ +               + S RK
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA---------------LDSQRK 227
Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
            + Y   D   +   K  ++   ANL   C+D     RP+   +  +LN +
Sbjct: 228 LQFYE--DRHQLPAPKAAEL---ANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 76  NRILGQGGQGTVYKGRLEDGRII----AVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
            R LG+GG    Y+    D + +     V KS L     + ++ E+   EI I   +++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLL----KPHQKEKMSTEIAIHKSLDNP 102
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +VV   G   + +F  +V E     +L + LH R +    P   E R+ +   + G + Y
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEP---EARYFMRQTIQG-VQY 157
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH+     + HRD+K  N+ L++    K+ DFG +  I  D       + GT  Y+ PE 
Sbjct: 158 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNYIAPEV 213
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
                 + + D++S G +L  LL GK P
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 76  NRILGQGGQGTVYKGRLEDGRII----AVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
            R LG+GG    Y+    D + +     V KS L     + ++ E+   EI I   +++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLL----KPHQKEKMSTEIAIHKSLDNP 102
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +VV   G   + +F  +V E     +L + LH R +    P   E R+ +   + G + Y
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEP---EARYFMRQTIQG-VQY 157
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH+     + HRD+K  N+ L++    K+ DFG +  I  D       + GT  Y+ PE 
Sbjct: 158 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEV 213
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
                 + + D++S G +L  LL GK P
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFIN-EIFILSQINHRNVVK 135
           +++G G  G V++ +L +   +A+KK         + + + F N E+ I+  + H NVV 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKK---------VLQDKRFKNRELQIMRIVKHPNVVD 96
Query: 136 LL------GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           L       G   +  F  LV E++P        H     +  P+     +    ++  +L
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLY--MYQLLRSL 154
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           AY+HS     I HRDIK  N+LLD      K+ DFG++K +   + +V+  I   + Y  
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX-ICSRY-YRA 209
Query: 249 PEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           PE    ++  T   D++S G V+ EL+ G +P+F 
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFP 243

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           AT+ +     +G G  GTVYK R    G  +A+K  ++   +E L      + E+ +L +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRR 59
Query: 128 IN---HRNVVKLLGCCLETEFP-----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           +    H NVV+L+  C  +         LV+E + +  L  +L D+      P   E   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPA--ETIK 115
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF----IAMDQTH 235
            +  +    L +LH+     I HRD+K  NIL+      K+ADFG ++     +A+D   
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVV 172
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           V      T  Y  PE    S      D++S G +  E+   +KP+F  GN+  + +
Sbjct: 173 V------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF-CGNSEADQL 220

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 118/314 (37%), Gaps = 83/314 (26%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 10  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 69
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLVY------------------EFIP- 154
           L   ++E+ IL  I H  NVV LLG C +   PL+V                   EF+P 
Sbjct: 70  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 126
Query: 155 --NGTLYQHLHD----------------------------------RHQNEEYP------ 172
              G  ++   D                                    + EE P      
Sbjct: 127 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 186
Query: 173 -LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+ DFG ++ I  
Sbjct: 187 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 243
Query: 232 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
           D  +V     +    ++ PE       T +SDV+SFGV+L E       IFS G +    
Sbjct: 244 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPG 296
Query: 291 VSLAAYFVHSMRKN 304
           V +   F   +++ 
Sbjct: 297 VKIDEEFCRRLKEG 310

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E P     RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-P---HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT  Y
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L P    S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 22/232 (9%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           AT+ +     +G G  GTVYK R    G  +A+K  ++   +E L      + E+ +L +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRR 59
Query: 128 IN---HRNVVKLLGCCLETEFP-----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           +    H NVV+L+  C  +         LV+E + +  L  +L D+      P   E   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPA--ETIK 115
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
            +  +    L +LH+     I HRD+K  NIL+      K+ADFG ++  +         
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVV 172
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           +  T  Y  PE    S      D++S G +  E+   +KP+F  GN+  + +
Sbjct: 173 V--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF-CGNSEADQL 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 118/314 (37%), Gaps = 83/314 (26%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLVY------------------EFIP- 154
           L   ++E+ IL  I H  NVV LLG C +   PL+V                   EF+P 
Sbjct: 77  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 155 --NGTLYQHLHD----------------------------------RHQNEEYP------ 172
              G  ++   D                                    + EE P      
Sbjct: 134 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 193
Query: 173 -LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+ DFG ++ I  
Sbjct: 194 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 250
Query: 232 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
           D  +V     +    ++ PE       T +SDV+SFGV+L E       IFS G +    
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPG 303
Query: 291 VSLAAYFVHSMRKN 304
           V +   F   +++ 
Sbjct: 304 VKIDEEFCRRLKEG 317

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 118/314 (37%), Gaps = 83/314 (26%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 12  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLVY------------------EFIP- 154
           L   ++E+ IL  I H  NVV LLG C +   PL+V                   EF+P 
Sbjct: 72  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
Query: 155 --NGTLYQHLHD----------------------------------RHQNEEYP------ 172
              G  ++   D                                    + EE P      
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
Query: 173 -LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+ DFG ++ I  
Sbjct: 189 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 232 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
           D  +V     +    ++ PE       T +SDV+SFGV+L E       IFS G +    
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPG 298
Query: 291 VSLAAYFVHSMRKN 304
           V +   F   +++ 
Sbjct: 299 VKIDEEFCRRLKEG 312

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 118/314 (37%), Gaps = 83/314 (26%)
Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKG------RLEDGRIIAVKKSKLAVDDEELYK 114
           + + + +   +   + + LG+G  G V +       +    R +AVK  K      E   
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 115 LEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLVY------------------EFIP- 154
           L   ++E+ IL  I H  NVV LLG C +   PL+V                   EF+P 
Sbjct: 79  L---MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 135
Query: 155 --NGTLYQHLHD----------------------------------RHQNEEYP------ 172
              G  ++   D                                    + EE P      
Sbjct: 136 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 195
Query: 173 -LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+ DFG ++ I  
Sbjct: 196 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 252
Query: 232 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
           D  +V     +    ++ PE       T +SDV+SFGV+L E       IFS G +    
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-------IFSLGASPYPG 305
Query: 291 VSLAAYFVHSMRKN 304
           V +   F   +++ 
Sbjct: 306 VKIDEEFCRRLKEG 319

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 127/291 (43%), Gaps = 42/291 (14%)
Query: 76  NRILGQGGQGTVYKG-RLEDGRIIAVKKSKL---AVDDEELYKLEEFINEIFILSQINHR 131
           N  LGQG    ++KG R E G    + ++++    +D       E F     ++S+++H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           ++V   G C   +  +LV EF+  G+L  +L  +       + W++   VA ++A A+ +
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKL--EVAKQLAWAMHF 128
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI------QGTFG 245
           L       + H ++ + NILL    R +    G   FI +    ++  +      Q    
Sbjct: 129 LEENT---LIHGNVCAKNILL---IREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 246 YLDPEYHQSSQ-LTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK 303
           ++ PE  ++ + L   +D +SFG  L E+ + G KP+ +               + S RK
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA---------------LDSQRK 227
Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
            + Y   D   +   K  ++   ANL   C+D     RP+   +  +LN +
Sbjct: 228 LQFYE--DRHQLPAPKAAEL---ANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G+V K      G+I+AVK+ +  VD++E  +L   ++   ++   +   +V+  
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL--LMDLDVVMRSSDCPYIVQFY 87
Query: 138 GCCLETEFPLLVYEFIPNG--TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           G         +  E +       Y++++    +    +  E+  ++ +    AL +L   
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDV---IPEEILGKITLATVKALNHLKEN 144
Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE---YH 252
               I HRDIK +NILLD     K+ DFG S  +    +   T+  G   Y+ PE     
Sbjct: 145 LK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPS 200
Query: 253 QSSQLTD-KSDVYSFGVVLVELLTGKKP 279
            S Q  D +SDV+S G+ L EL TG+ P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F   ++LG+G  G V   + +  GR  A+K   K  +   DE  + L     E  +L 
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL----TENRVLQ 206
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L       +    V E+   G L+ HL  +R  +E+       RF  A E+
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGA-EI 260
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS  +  + +RD+K  N++LD+    K+ DFG  K    D   + T   GT  
Sbjct: 261 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPE 317
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 318 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 354

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 21/233 (9%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLE-EFINEIFILS 126
           AT+ +     +G G  GTVYK R    G  +A+K  ++         L    + E+ +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 127 QIN---HRNVVKLLGCCLETEFP-----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           ++    H NVV+L+  C  +         LV+E + +  L  +L D+      P   E  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPA--ETI 122
Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
             +  +    L +LH+     I HRD+K  NIL+      K+ADFG ++  +       T
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LT 177
Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
            +  T  Y  PE    S      D++S G +  E+   +KP+F  GN+  + +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF-CGNSEADQL 228

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F   ++LG+G  G V   + +  GR  A+K   K  +   DE  + L     E  +L 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL----TENRVLQ 203
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L       +    V E+   G L+ HL  +R  +E+       RF  A E+
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGA-EI 257
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS  +  + +RD+K  N++LD+    K+ DFG  K    D   + T   GT  
Sbjct: 258 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPE 314
Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 37/242 (15%)
Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFIN 120
           S KE+D+    F V R+ GQG  GTV  G+ +  G  +A+KK    + D      E  I 
Sbjct: 18  SRKEMDR----FQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPRFRNRELQIM 70
Query: 121 EIFILSQINHRNVVKL------LGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPL 173
           +   L+ ++H N+V+L      LG     +  L +V E++P+ TL++   + ++ +  P 
Sbjct: 71  Q--DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP 127
Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMD 232
              ++  +  ++  ++  LH  + + + HRDIK  N+L++E     K+ DFG++K ++  
Sbjct: 128 PILIKVFL-FQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 233 QTHVTTKIQGTFGYLDPEYHQSSQL-------TDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           + +V         Y+   Y+++ +L       T   D++S G +  E++ G +PIF   N
Sbjct: 186 EPNV--------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDN 236
Query: 286 TS 287
           ++
Sbjct: 237 SA 238

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 22/232 (9%)
Query: 69  ATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           AT+ +     +G G  GTVYK R    G  +A+K  ++   +E L      + E+ +L +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRR 59
Query: 128 IN---HRNVVKLLGCCLETEFP-----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           +    H NVV+L+  C  +         LV+E + +  L  +L D+      P   E   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPA--ETIK 115
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
            +  +    L +LH+     I HRD+K  NIL+      K+ADFG ++  +         
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVV 172
Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           +  T  Y  PE    S      D++S G +  E+   +KP+F  GN+  + +
Sbjct: 173 V--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF-CGNSEADQL 220

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 79  LGQGGQGTVYKGR--LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           LG+G   TVYKG+  L D  ++A+K+ +L  + EE       I E+ +L  + H N+V L
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRL--EHEEGAPCTA-IREVSLLKDLKHANIVTL 65
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHD-----RHQNEEYPLTWEMRFRVAIEVAGALAY 191
                  +   LV+E++ +  L Q+L D        N +  L   +R          LAY
Sbjct: 66  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLR---------GLAY 115
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE- 250
            H      + HRD+K  N+L++ER   K+ADFG ++  ++       ++  T  Y  P+ 
Sbjct: 116 CHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171
Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
              S+  + + D++  G +  E+ TG +P+F  G+T +E +
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATG-RPLFP-GSTVEEQL 210

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 25/236 (10%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  G V+K R  + G+ +A+KK  L  +++E + +   + EI IL  + H NVV L+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITA-LREIKILQLLKHENVVNLI 83
Query: 138 GCCLETEFPL--------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
             C     P         LV++F  +      L     N     T     RV   +   L
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-----DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGY 246
            Y+H      I HRD+K+ N+L+      K+ADFG ++  ++ +     +      T  Y
Sbjct: 139 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 247 LDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
             PE     +      D++  G ++ E+ T + PI   GNT Q  ++L +    S+
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQ-GNTEQHQLALISQLCGSI 249

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 25/236 (10%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  G V+K R  + G+ +A+KK  L  +++E + +   + EI IL  + H NVV L+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITA-LREIKILQLLKHENVVNLI 82
Query: 138 GCCLETEFPL--------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
             C     P         LV++F  +      L     N     T     RV   +   L
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHD-----LAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGY 246
            Y+H      I HRD+K+ N+L+      K+ADFG ++  ++ +     +      T  Y
Sbjct: 138 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 247 LDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
             PE     +      D++  G ++ E+ T + PI   GNT Q  ++L +    S+
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQ-GNTEQHQLALISQLCGSI 248

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 25/236 (10%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  G V+K R  + G+ +A+KK  L  +++E + +   + EI IL  + H NVV L+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITA-LREIKILQLLKHENVVNLI 83
Query: 138 GCCLETEFPL--------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
             C     P         LV++F  +      L     N     T     RV   +   L
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEH-----DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGY 246
            Y+H      I HRD+K+ N+L+      K+ADFG ++  ++ +     +      T  Y
Sbjct: 139 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 247 LDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
             PE     +      D++  G ++ E+ T + PI   GNT Q  ++L +    S+
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQ-GNTEQHQLALISQLCGSI 249

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 85  GTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGC----- 139
           G V+K +L +   +AVK     + D++ ++ E    E++ L  + H N+++ +G      
Sbjct: 38  GCVWKAQLLN-EYVAVKI--FPIQDKQSWQNE---YEVYSLPGMKHENILQFIGAEKRGT 91
Query: 140 CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS----- 194
            ++ +   L+  F   G+L   L      +   ++W     +A  +A  LAYLH      
Sbjct: 92  SVDVDL-WLITAFHEKGSLSDFL------KANVVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 195 --GASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHVTTKIQGTFGYLDPEY 251
             G    I HRDIKS N+LL     A +ADFG + KF A      T    GT  Y+ PE 
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 252 HQSSQLTDKS-----DVYSFGVVLVELLT 275
            + +    +      D+Y+ G+VL EL +
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 25/236 (10%)
Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +GQG  G V+K R  + G+ +A+KK  L  +++E + +   + EI IL  + H NVV L+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITA-LREIKILQLLKHENVVNLI 83
Query: 138 GCCLETEFPL--------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
             C     P         LV++F  +      L     N     T     RV   +   L
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEH-----DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGY 246
            Y+H      I HRD+K+ N+L+      K+ADFG ++  ++ +     +      T  Y
Sbjct: 139 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 247 LDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
             PE     +      D++  G ++ E+ T + PI   GNT Q  ++L +    S+
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQ-GNTEQHQLALISQLCGSI 249

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL--YKLEEFINEIFILSQINHRNVVKL 136
           LG+GG    ++  + D     V   K+      L  ++ E+   EI I   + H++VV  
Sbjct: 23  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            G   + +F  +V E     +L + LH R +    P   E R+ +   V G   YLH   
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP---EARYYLRQIVLGC-QYLHRNR 135
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+ L+E    K+ DFG +  +  D       + GT  Y+ PE      
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191
Query: 257 LTDKSDVYSFGVVLVELLTGKKP 279
            + + DV+S G ++  LL GK P
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL--YKLEEFINEIFILSQINHRNVVKL 136
           LG+GG    ++  + D     V   K+      L  ++ E+   EI I   + H++VV  
Sbjct: 47  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            G   + +F  +V E     +L + LH R +    P   E R+ +   V G   YLH   
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP---EARYYLRQIVLGC-QYLHRNR 159
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+ L+E    K+ DFG +  +  D       + GT  Y+ PE      
Sbjct: 160 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 215
Query: 257 LTDKSDVYSFGVVLVELLTGKKP 279
            + + DV+S G ++  LL GK P
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL--YKLEEFINEIFILSQINHRNVVKL 136
           LG+GG    ++  + D     V   K+      L  ++ E+   EI I   + H++VV  
Sbjct: 49  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            G   + +F  +V E     +L + LH R +    P   E R+ +   V G   YLH   
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP---EARYYLRQIVLGC-QYLHRNR 161
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              + HRD+K  N+ L+E    K+ DFG +  +  D       + GT  Y+ PE      
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 217
Query: 257 LTDKSDVYSFGVVLVELLTGKKP 279
            + + DV+S G ++  LL GK P
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL---EEFINEIFILS 126
           + F+  + LG G  G V   +  E G   A+K     +D +++ KL   E  +NE  IL 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +N   +VKL     +     +V E++  G ++ HL    +  E       RF  A ++ 
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAA-QIV 151
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLHS     + +RD+K  N+L+D++   +V DFG +K +       T  + GT   
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEA 204
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLE---EFINEIFILS 126
            H+ +   LG G  G V  G  +  G  +AVK     ++ +++  L+   +   EI  L 
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK----ILNRQKIRSLDVVGKIKREIQNLK 66
Query: 127 QINHRNVVKLLGC-CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
              H +++KL       T+F  +V E++  G L+ ++    + EE     E R R+  ++
Sbjct: 67  LFRHPHIIKLYQVISTPTDF-FMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQI 120
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             A+ Y H      + HRD+K  N+LLD    AK+ADFG S  ++ D   + T   G+  
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSC-GSPN 175
Query: 246 YLDPEYHQSSQL--TDKSDVYSFGVVLVELLTGKKP 279
           Y  PE   S +L    + D++S GV+L  LL G  P
Sbjct: 176 YAAPEV-ISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 16/176 (9%)
Query: 117 EFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           + + E+ +L  ++H N++KL     +     LV E    G L+  +  R +  E      
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI 141
Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQ 233
           ++     +V   + YLH      I HRD+K  N+LL+ + +    K+ DFG S     +Q
Sbjct: 142 IK-----QVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQ 192
Query: 234 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
             +  ++ GT  Y+ PE  +  +  +K DV+S GV+L  LL G  P    G T QE
Sbjct: 193 KKMKERL-GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPF--GGQTDQE 244

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 20/224 (8%)
Query: 70  TNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           ++ F +  +LG+G  G V     +  G I+A+KK  +   D+ L+ L   + EI IL   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--IEPFDKPLFALRT-LREIKILKHF 66
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N++ +        F      +I    +   LH     +   L+ +       +   A
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHIQYFIYQTLRA 124
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGTFG 245
           +  LH    S + HRD+K +N+L++     KV DFG ++ I   A D +  T +  G   
Sbjct: 125 VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 246 YLDPEYHQSSQLTDKS-------DVYSFGVVLVELLTGKKPIFS 282
           Y+   ++++ ++   S       DV+S G +L EL   ++PIF 
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 127/297 (42%), Gaps = 50/297 (16%)
Query: 77  RILGQGGQGT-VYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +ILG G  GT V++G  + GR +AVK+  +   D  L +++       +    +H NV++
Sbjct: 21  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIK------LLTESDDHPNVIR 73
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-QNEEYPLTWEMR-FRVAIEVAGALAYLH 193
              C   T+  L +   + N  L   +  ++  +E   L  E     +  ++A  +A+LH
Sbjct: 74  YY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 194 SGASSPIYHRDIKSTNILLD-------------ERYRAKVADFGTSKFIAMDQTHVTTKI 240
           S     I HRD+K  NIL+              E  R  ++DFG  K +   Q+   T +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 241 Q---GTFGYLDPEYHQSS-------QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
               GT G+  PE  + S       +LT   D++S G V   +L+  K  F    + + N
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 291 VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +    + +             D++  L  ++ I    +L  + +D +  KRPT  +V
Sbjct: 250 IIRGIFSL-------------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 95  GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP 154
            +II  KK  L+  D +  KLE    E  I   + H N+V+L     E  F  LV++ + 
Sbjct: 61  AKIINTKK--LSARDHQ--KLE---REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVT 113
Query: 155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE 214
            G L++ +  R    E   +         ++  ++ ++H      I HRD+K  N+LL  
Sbjct: 114 GGELFEDIVAREYYSEADAS-----HCIHQILESVNHIHQ---HDIVHRDLKPENLLLAS 165
Query: 215 RYRA---KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLV 271
           + +    K+ADFG +  +  +Q        GT GYL PE  +        D+++ GV+L 
Sbjct: 166 KCKGAAVKLADFGLAIEVQGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILY 224
Query: 272 ELLTGKKPIF 281
            LL G  P +
Sbjct: 225 ILLVGYPPFW 234

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           ILG G  G V+K    +     +K +   +    +   EE  NEI +++Q++H N+++L 
Sbjct: 96  ILGGGRFGQVHKC---EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                    +LV E++  G L+    DR  +E Y LT         ++   + ++H    
Sbjct: 153 DAFESKNDIVLVMEYVDGGELF----DRIIDESYNLTELDTILFMKQICEGIRHMHQMY- 207
Query: 198 SPIYHRDIKSTNILLDER--YRAKVADFGTSKFIAMDQTHVTTKIQGTFG---YLDPEYH 252
             I H D+K  NIL   R   + K+ DFG ++     +     K++  FG   +L PE  
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLAR-----RYKPREKLKVNFGTPEFLAPEVV 260
Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
               ++  +D++S GV+   LL+G  P     +    N  LA  +
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 15/228 (6%)
Query: 70  TNHFNVNRILGQGGQGTVY----KGRLEDGRIIAVKKSKLAVDDE-ELYKLEEFINEIFI 124
           +  ++    LG G  G V+    K + ++  +  +KK K+  D   E  KL +   EI I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           LS++ H N++K+L       F  LV E   +G       DRH   + PL     FR   +
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA-SYIFR---Q 138
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  A+ YL       I HRDIK  NI++ E +  K+ DFG++ ++   +   T    GT 
Sbjct: 139 LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTI 193
Query: 245 GYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
            Y  PE    +       +++S GV L  L+  + P      T +  +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI 241

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 23/174 (13%)
Query: 121 EIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           E+ +L Q   HRNV++L+    E +   LV+E +  G++  H+H R    E   +     
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----- 114
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAM--DQT 234
            V  +VA AL +LH+     I HRD+K  NIL +   +    K+ DFG    I +  D +
Sbjct: 115 VVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCS 171
Query: 235 HVTTK----IQGTFGYLDPE----YHQSSQLTDK-SDVYSFGVVLVELLTGKKP 279
            ++T       G+  Y+ PE    + + + + DK  D++S GV+L  LL+G  P
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 20/224 (8%)
Query: 70  TNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           ++ F +  +LG+G  G V     +  G I+A+KK  +   D+ L+ L   + EI IL   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--IEPFDKPLFALRT-LREIKILKHF 66
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N++ +        F      +I    +   LH     +   L+ +       +   A
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHIQYFIYQTLRA 124
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVTTKIQGTFG 245
           +  LH    S + HRD+K +N+L++     KV DFG ++ I   A D +  T +  G   
Sbjct: 125 VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 246 YLDPEYHQSSQLTDKS-------DVYSFGVVLVELLTGKKPIFS 282
           ++   ++++ ++   S       DV+S G +L EL   ++PIF 
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 71  NHFNVNRILGQGGQGTVY------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           N F   ++LG+G  G V        GR    +I+  KK  +   DE  + L E  N +  
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL--KKEVIVAKDEVAHTLTE--NRVL- 62
Query: 125 LSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVA 182
             Q +    +  L    +T   L  V E+   G L+ HL  +R  +E+       RF  A
Sbjct: 63  --QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGA 115
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+  AL YLHS  +  + +RD+K  N++LD+    K+ DFG  K    D         G
Sbjct: 116 -EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCG 171
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           T  YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 211

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLE---EFINEIFILS 126
            H+ +   LG G  G V  G  +  G  +AVK     ++ +++  L+   +   EI  L 
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK----ILNRQKIRSLDVVGKIKREIQNLK 66
Query: 127 QINHRNVVKLLGC-CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
              H +++KL       T+F  +V E++  G L+ ++    + EE     E R R+  ++
Sbjct: 67  LFRHPHIIKLYQVISTPTDF-FMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQI 120
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             A+ Y H      + HRD+K  N+LLD    AK+ADFG S    M          G+  
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRDSCGSPN 175
Query: 246 YLDPEYHQSSQL--TDKSDVYSFGVVLVELLTGKKP 279
           Y  PE   S +L    + D++S GV+L  LL G  P
Sbjct: 176 YAAPEV-ISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 40/306 (13%)
Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           I  +G  G V+K +L +   +AVK     + D++ ++ E    EIF    + H N+++ +
Sbjct: 22  IKARGRFGCVWKAQLMND-FVAVKI--FPLQDKQSWQSE---REIFSTPGMKHENLLQFI 75
Query: 138 -----GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
                G  LE E   L+  F   G+L  +L          +TW     VA  ++  L+YL
Sbjct: 76  AAEKRGSNLEVEL-WLITAFHDKGSLTDYLKGN------IITWNELCHVAETMSRGLSYL 128
Query: 193 HS--------GASSPIYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHVTTKIQGT 243
           H         G    I HRD KS N+LL     A +ADFG + +F        T    GT
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGT 188
Query: 244 FGYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV 298
             Y+ PE  + +    +      D+Y+ G+VL EL++  K   + G   +  +       
Sbjct: 189 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKA--ADGPVDEYMLPFEEEIG 246
Query: 299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLA------ERCLDLNGKKRPTMEEVSMELN 352
                  L  ++  + M+   K+  +    LA      E C D + + R +   V   ++
Sbjct: 247 QHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVS 306
Query: 353 GIRGSI 358
            IR S+
Sbjct: 307 LIRRSV 312

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 20/224 (8%)
Query: 70  TNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           ++ F +  +LG+G  G V     +  G I+A+KK  +   D+ L+ L   + EI IL   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--IEPFDKPLFALRT-LREIKILKHF 66
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N++ +        F      +I    +   LH     +   L+ +       +   A
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHIQYFIYQTLRA 124
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVT------TK 239
           +  LH    S + HRD+K +N+L++     KV DFG ++ I   A D +  T      T+
Sbjct: 125 VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 240 IQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
              T  Y  PE    S++ +   DV+S G +L EL   ++PIF 
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 71  NHFNVNRILGQGGQGTVY------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           N F   ++LG+G  G V        GR    +I+  KK  +   DE  + L E  N +  
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL--KKEVIVAKDEVAHTLTE--NRVL- 63
Query: 125 LSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVA 182
             Q +    +  L    +T   L  V E+   G L+ HL  +R  +E+       RF  A
Sbjct: 64  --QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGA 116
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+  AL YLHS  +  + +RD+K  N++LD+    K+ DFG  K    D         G
Sbjct: 117 -EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCG 172
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           T  YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 212

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 71  NHFNVNRILGQGGQGTVY------KGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           N F   ++LG+G  G V        GR    +I+  KK  +   DE  + L E  N +  
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL--KKEVIVAKDEVAHTLTE--NRVL- 64
Query: 125 LSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVA 182
             Q +    +  L    +T   L  V E+   G L+ HL  +R  +E+       RF  A
Sbjct: 65  --QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGA 117
Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+  AL YLHS  +  + +RD+K  N++LD+    K+ DFG  K    D         G
Sbjct: 118 -EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCG 173
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           T  YL PE  + +      D +  GVV+ E++ G+ P ++
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 213

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 77  RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           R+LG+GG G V+  +++  G++ A KK       ++    +  + E  IL++++ R +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-KKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIEVAGALAYLH 193
           L     ET+  L +   I NG   ++ H  + +E+ P   E R  F  A  V+G L +LH
Sbjct: 250 L-AYAFETKTDLCLVMTIMNGGDIRY-HIYNVDEDNPGFQEPRAIFYTAQIVSG-LEHLH 306
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
                 I +RD+K  N+LLD+    +++D G +  +   QT  T    GT G++ PE   
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
             +     D ++ GV L E++  + P  + G 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEI---------FILSQIN 129
           +G+G  G V++G L  G  +AVK    + D++  ++  E  N +         FI S + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS-SRDEQSWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
            RN    L          L+  +  +G+LY  L  R   E +     +  R+A+  A  L
Sbjct: 74  SRNSSTQL---------WLITHYHEHGSLYDFLQ-RQTLEPH-----LALRLAVSAACGL 118
Query: 190 AYLH-----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV---TTKIQ 241
           A+LH     +     I HRD KS N+L+    +  +AD G +   +    ++        
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV 178
Query: 242 GTFGYLDPEYHQSSQLTD------KSDVYSFGVVLVEL 273
           GT  Y+ PE       TD       +D+++FG+VL E+
Sbjct: 179 GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 77  RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           R+LG+GG G V+  +++  G++ A KK       ++    +  + E  IL++++ R +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-KKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIEVAGALAYLH 193
           L     ET+  L +   I NG   ++ H  + +E+ P   E R  F  A  V+G L +LH
Sbjct: 250 L-AYAFETKTDLCLVMTIMNGGDIRY-HIYNVDEDNPGFQEPRAIFYTAQIVSG-LEHLH 306
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
                 I +RD+K  N+LLD+    +++D G +  +   QT  T    GT G++ PE   
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
             +     D ++ GV L E++  + P  + G 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 77  RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           R+LG+GG G V+  +++  G++ A KK       ++    +  + E  IL++++ R +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-KKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIEVAGALAYLH 193
           L     ET+  L +   I NG   ++ H  + +E+ P   E R  F  A  V+G L +LH
Sbjct: 250 L-AYAFETKTDLCLVMTIMNGGDIRY-HIYNVDEDNPGFQEPRAIFYTAQIVSG-LEHLH 306
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
                 I +RD+K  N+LLD+    +++D G +  +   QT  T    GT G++ PE   
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
             +     D ++ GV L E++  + P  + G 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 77  RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           R+LG+GG G V+  +++  G++ A KK       ++    +  + E  IL++++ R +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-KKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIEVAGALAYLH 193
           L     ET+  L +   I NG   ++ H  + +E+ P   E R  F  A  V+G L +LH
Sbjct: 250 L-AYAFETKTDLCLVMTIMNGGDIRY-HIYNVDEDNPGFQEPRAIFYTAQIVSG-LEHLH 306
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
                 I +RD+K  N+LLD+    +++D G +  +   QT  T    GT G++ PE   
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLL 362
Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
             +     D ++ GV L E++  + P  + G 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK--- 135
           +G+G  G V     +  R   V   K++  + + Y  +  + EI IL +  H NV+    
Sbjct: 51  IGEGAYGMVSSA-YDHVRKTRVAIKKISPFEHQTY-CQRTLREIQILLRFRHENVIGIRD 108
Query: 136 -LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
            L    LE    + + + +    LY+ L  +  + ++   +        ++   L Y+HS
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYF------LYQILRGLKYIHS 162
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI--AMDQTHVTTKIQGTFGYLDPEYH 252
                + HRD+K +N+L++     K+ DFG ++      D T   T+   T  Y  PE  
Sbjct: 163 AN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 253 QSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAYF 297
            +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++     
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNC---- 274
Query: 298 VHSMRKNRLYHILDDQV----MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           + +M+       L  +      KL  K+   A  +L +R L  N  KR T+EE 
Sbjct: 275 IINMKARNYLQSLPSKTKVAWAKLFPKSDSKAL-DLLDRMLTFNPNKRITVEEA 327

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 77  RILGQGGQGT-VYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +ILG G  GT V++G  + GR +AVK+  +   D  L +++       +    +H NV++
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIK------LLTESDDHPNVIR 91
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRH--------QNEEYPLTWEMRFRVAIEVAG 187
              C   T+  L +   + N  L   +  ++        Q E  P++      +  ++A 
Sbjct: 92  YY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIAS 144
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLD-------------ERYRAKVADFGTSKFIAMDQT 234
            +A+LHS     I HRD+K  NIL+              E  R  ++DFG  K +   Q 
Sbjct: 145 GVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 201
Query: 235 HVTTKIQ---GTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
                +    GT G+  PE  + S   +LT   D++S G V   +L+  K  F    + +
Sbjct: 202 XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 261
Query: 289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            N+    + +             D++  L  ++ I    +L  + +D +  KRPT  +V
Sbjct: 262 SNIIRGIFSL-------------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 77  RILGQGGQGT-VYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +ILG G  GT V++G  + GR +AVK+  +   D  L +++       +    +H NV++
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIK------LLTESDDHPNVIR 91
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRH--------QNEEYPLTWEMRFRVAIEVAG 187
              C   T+  L +   + N  L   +  ++        Q E  P++      +  ++A 
Sbjct: 92  YY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIAS 144
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLD-------------ERYRAKVADFGTSKFIAMDQT 234
            +A+LHS     I HRD+K  NIL+              E  R  ++DFG  K +   Q 
Sbjct: 145 GVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 201
Query: 235 HVTTKIQ---GTFGYLDPEYHQSS---QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
                +    GT G+  PE  + S   +LT   D++S G V   +L+  K  F    + +
Sbjct: 202 XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 261
Query: 289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            N+    + +             D++  L  ++ I    +L  + +D +  KRPT  +V
Sbjct: 262 SNIIRGIFSL-------------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 79  LGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEE-FINEIFILSQINHRNVVKL 136
           LG+G   TVYK R ++  +I+A+KK KL    E    +    + EI +L +++H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
           L          LV++F     +   L    ++    LT        +     L YLH   
Sbjct: 78  LDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ 256
              I HRD+K  N+LLDE    K+ADFG +K           ++  T  Y  PE    ++
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGAR 188
Query: 257 LTDKS-DVYSFGVVLVELL 274
           +     D+++ G +L ELL
Sbjct: 189 MYGVGVDMWAVGCILAELL 207

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           L +   G ++KGR + G  I VK   L V D    K  +F  E   L   +H NV+ +LG
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKV--LKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 139 CC--LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
            C       P L+  + P G+LY  L   H+   + +      + A++ A   A+LH+  
Sbjct: 75  ACQSPPAPHPTLITHWXPYGSLYNVL---HEGTNFVVDQSQAVKFALDXARGXAFLHT-- 129
Query: 197 SSPIYHRD-IKSTNILLDERYRAKV--ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
             P+  R  + S ++ +DE   A++  AD   S F +  + +          ++ PE  Q
Sbjct: 130 LEPLIPRHALNSRSVXIDEDXTARISXADVKFS-FQSPGRXYAP-------AWVAPEALQ 181
Query: 254 -SSQLTDK--SDVYSFGVVLVELLTGKKPIFSTGN 285
              + T++  +D +SF V+L EL+T + P     N
Sbjct: 182 KKPEDTNRRSADXWSFAVLLWELVTREVPFADLSN 216

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 87
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 141
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 257
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 258 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 292

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 107/242 (44%), Gaps = 47/242 (19%)
Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
            EI IL ++NH  ++K+     + E   +V E +  G L+  +    + +E   T ++ F
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE--ATCKLYF 120
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHV 236
               ++  A+ YLH      I HRD+K  N+LL   +E    K+ DFG SK +   +T +
Sbjct: 121 ---YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 237 TTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
              + GT  YL PE   S   +      D +S GV+L   L+G  P FS   T    VS 
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRT---QVS- 227
Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIV-AFANLAERCLDL-------NGKKRPTME 345
                           L DQ+   GK N I   +A ++E+ LDL       + K R T E
Sbjct: 228 ----------------LKDQITS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270
Query: 346 EV 347
           E 
Sbjct: 271 EA 272

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 107/241 (44%), Gaps = 47/241 (19%)
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           EI IL ++NH  ++K+     + E   +V E +  G L+  +    + +E   T ++ F 
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE--ATCKLYF- 259
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVT 237
              ++  A+ YLH      I HRD+K  N+LL   +E    K+ DFG SK +   +T + 
Sbjct: 260 --YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLM 312
Query: 238 TKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
             + GT  YL PE   S   +      D +S GV+L   L+G  P FS   T    VSL 
Sbjct: 313 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRT---QVSLK 368
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIV-AFANLAERCLDL-------NGKKRPTMEE 346
                            DQ+   GK N I   +A ++E+ LDL       + K R T EE
Sbjct: 369 -----------------DQITS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 410
Query: 347 V 347
Sbjct: 411 A 411

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 107/242 (44%), Gaps = 47/242 (19%)
Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
            EI IL ++NH  ++K+     + E   +V E +  G L+  +    + +E   T ++ F
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE--ATCKLYF 119
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHV 236
               ++  A+ YLH      I HRD+K  N+LL   +E    K+ DFG SK +   +T +
Sbjct: 120 ---YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 171
Query: 237 TTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
              + GT  YL PE   S   +      D +S GV+L   L+G  P FS   T    VS 
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRT---QVS- 226
Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIV-AFANLAERCLDL-------NGKKRPTME 345
                           L DQ+   GK N I   +A ++E+ LDL       + K R T E
Sbjct: 227 ----------------LKDQITS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 269
Query: 346 EV 347
           E 
Sbjct: 270 EA 271

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 107/242 (44%), Gaps = 47/242 (19%)
Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
            EI IL ++NH  ++K+     + E   +V E +  G L+  +    + +E   T ++ F
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE--ATCKLYF 120
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHV 236
               ++  A+ YLH      I HRD+K  N+LL   +E    K+ DFG SK +   +T +
Sbjct: 121 ---YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 237 TTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
              + GT  YL PE   S   +      D +S GV+L   L+G  P FS   T    VS 
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRT---QVS- 227
Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIV-AFANLAERCLDL-------NGKKRPTME 345
                           L DQ+   GK N I   +A ++E+ LDL       + K R T E
Sbjct: 228 ----------------LKDQITS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270
Query: 346 EV 347
           E 
Sbjct: 271 EA 272

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 126/276 (45%), Gaps = 29/276 (10%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 87
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 141
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
             +S+   KS D++S G +L E+L+  +PIF  G    + ++     + S  +  L  I+
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP-GKHYLDQLNHILGILGSPSQEDLNXII 256
Query: 311 D----DQVMKLGKKNQIVA---FANLAERCLDLNGK 339
           +    + ++ L  KN++     F N   + LDL  K
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 292

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 124/292 (42%), Gaps = 53/292 (18%)
Query: 73  FNVNRILGQGGQGT-VYKGRLEDGRIIAVKK---SKLAVDDEELYKLEEFINEIFILSQI 128
           F    +LG G +GT VY+G   D R +AVK+      +  D E+  L E           
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRE---------SD 75
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR---HQNEEYPLTWEMRFRVAIEV 185
            H NV++      + +F  +  E     TL +++  +   H   E P+T      +  + 
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE-PIT------LLQQT 127
Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLD-----ERYRAKVADFGTSKFIAMDQTHVTTK- 239
              LA+LHS     I HRD+K  NIL+       + +A ++DFG  K +A+ +   + + 
Sbjct: 128 TSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 240 -IQGTFGYLDPEYHQSSQLTDKS---DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            + GT G++ PE        + +   D++S G V   +++     F      Q N+ L A
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244
Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             +  +                 +K++ V    L E+ + ++ +KRP+ + V
Sbjct: 245 CSLDCLHP---------------EKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 87
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 141
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 257
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 258 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 292

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 89
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 143
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 144 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 259
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 260 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 294

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 107/242 (44%), Gaps = 47/242 (19%)
Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
            EI IL ++NH  ++K+     + E   +V E +  G L+  +    + +E   T ++ F
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE--ATCKLYF 120
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHV 236
               ++  A+ YLH      I HRD+K  N+LL   +E    K+ DFG SK +   +T +
Sbjct: 121 ---YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 172
Query: 237 TTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
              + GT  YL PE   S   +      D +S GV+L   L+G  P FS   T    VS 
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRT---QVS- 227
Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIV-AFANLAERCLDL-------NGKKRPTME 345
                           L DQ+   GK N I   +A ++E+ LDL       + K R T E
Sbjct: 228 ----------------LKDQITS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270
Query: 346 EV 347
           E 
Sbjct: 271 EA 272

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 107/241 (44%), Gaps = 47/241 (19%)
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           EI IL ++NH  ++K+     + E   +V E +  G L+  +    + +E   T ++ F 
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE--ATCKLYF- 245
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVT 237
              ++  A+ YLH      I HRD+K  N+LL   +E    K+ DFG SK +   +T + 
Sbjct: 246 --YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLM 298
Query: 238 TKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
             + GT  YL PE   S   +      D +S GV+L   L+G  P FS   T    VSL 
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRT---QVSLK 354
Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIV-AFANLAERCLDL-------NGKKRPTMEE 346
                            DQ+   GK N I   +A ++E+ LDL       + K R T EE
Sbjct: 355 -----------------DQITS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 347 V 347
Sbjct: 397 A 397

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 35/173 (20%)
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQ 241
           ++   L Y+HS     + HRD+K +N+LL+     K+ DFG ++    D  H    T+  
Sbjct: 134 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNT 286
            T  Y  PE   +S+   KS D++S G +L E+L+  +PIF                G+ 
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSP 249
Query: 287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDL 336
           SQE+++          K R Y      ++ L  KN++     F N   + LDL
Sbjct: 250 SQEDLNCGINL-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDL 291

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 107/242 (44%), Gaps = 47/242 (19%)
Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
            EI IL ++NH  ++K+     + E   +V E +  G L+  +    + +E   T ++ F
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE--ATCKLYF 126
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHV 236
               ++  A+ YLH      I HRD+K  N+LL   +E    K+ DFG SK +   +T +
Sbjct: 127 ---YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL 178
Query: 237 TTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
              + GT  YL PE   S   +      D +S GV+L   L+G  P FS   T    VS 
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRT---QVS- 233
Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIV-AFANLAERCLDL-------NGKKRPTME 345
                           L DQ+   GK N I   +A ++E+ LDL       + K R T E
Sbjct: 234 ----------------LKDQITS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 276
Query: 346 EV 347
           E 
Sbjct: 277 EA 278

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 124/283 (43%), Gaps = 49/283 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 107
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 161
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 162 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDL 336
                 K R Y      ++ L  KN++     F N   + LDL
Sbjct: 278 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDL 309

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 49/283 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 107
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + +   +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 161
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 162 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDL 336
                 K R Y      ++ L  KN++     F N   + LDL
Sbjct: 278 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDL 309

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 95
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 149
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 150 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 265
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 266 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 300

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 87
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 141
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 257
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 258 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 292

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 85
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 139
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 140 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 255
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 256 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 290

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYX-QRTLREIKILLRFRHENIIGIN 91
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 145
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 262 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 296

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 78/177 (44%), Gaps = 24/177 (13%)
Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
           P+T E     + +VA  + +L   +S    HRD+ + NILL E    K+ DFG ++ I  
Sbjct: 195 PITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 232 DQTHVTT-KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
           +  +V     +    ++ PE       + KSDV+S+GV+L E       IFS G +    
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWE-------IFSLGGSPYPG 304
Query: 291 VSLAAYFVHSMRKN-----------RLYHILDDQVMKLGKKNQIVAFANLAERCLDL 336
           V +   F   +R+             +Y I+ D   +  K+     FA L E+  DL
Sbjct: 305 VQMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERP--RFAELVEKLGDL 359

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 91
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 145
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 262 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 296

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 87
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 141
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 142 SAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNXIIN 257
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 258 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 292

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 19/198 (9%)
Query: 87  VYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP 146
           V  G+    +II  KK  L+  D +  KLE    E  I   + H N+V+L     E    
Sbjct: 44  VLAGQEYAAKIINTKK--LSARDHQ--KLE---REARICRLLKHPNIVRLHDSISEEGHH 96
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
            L+++ +  G L++ +  R    E   +         ++  A+ + H      + HRD+K
Sbjct: 97  YLIFDLVTGGELFEDIVAREYYSEADAS-----HCIQQILEAVLHCHQMG---VVHRDLK 148
Query: 207 STNILLDERYRA---KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+LL  + +    K+ADFG +  +  +Q        GT GYL PE  +        D+
Sbjct: 149 PENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDL 207
Query: 264 YSFGVVLVELLTGKKPIF 281
           ++ GV+L  LL G  P +
Sbjct: 208 WACGVILYILLVGYPPFW 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 35/176 (19%)
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQ 241
           ++   L Y+HS     + HRD+K +N+LL+     K+ DFG ++    D  H    T+  
Sbjct: 136 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNT 286
            T  Y  PE   +S+   KS D++S G +L E+L+  +PIF                G+ 
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSP 251
Query: 287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
           SQE+++          K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 252 SQEDLNCIINL-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 296

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 92
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 146
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 147 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 262
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 263 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 297

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 93
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 147
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 148 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 263
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 264 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 298

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 84
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 138
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 139 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 254
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 255 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 289

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 91
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 145
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y  PE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 262 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 296

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H N+VKL     +     LV E +  G L++ +  +    E   ++ MR     ++  A+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-----KLVSAV 119
Query: 190 AYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           +++H      + HRD+K  N+L    ++    K+ DFG ++    D   + T    T  Y
Sbjct: 120 SHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHY 175
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
             PE    +   +  D++S GV+L  +L+G+ P  S
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 72  HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLE---EFINEIFILSQ 127
           H+ +   LG G  G V  G+ E  G  +AVK     ++ +++  L+   +   EI  L  
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVK----ILNRQKIRSLDVVGKIRREIQNLKL 72
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
             H +++KL           +V E++  G L+ ++    + +E     E R R+  ++  
Sbjct: 73  FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESR-RLFQQILS 127
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
            + Y H      + HRD+K  N+LLD    AK+ADFG S    M          G+  Y 
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRXSCGSPNYA 182
Query: 248 DPEYHQSSQL--TDKSDVYSFGVVLVELLTGKKP 279
            PE   S +L    + D++S GV+L  LL G  P
Sbjct: 183 APEV-ISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQ 241
           ++   L Y+HS     + HRD+K +N+LL+     K+ DFG ++    D  H    T+  
Sbjct: 130 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS 282
            T  Y  PE   +S+   KS D++S G +L E+L+  +PIF 
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFP 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 35/176 (19%)
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQ 241
           ++   L Y+HS     + HRD+K +N+LL+     K+ DFG ++    D  H    T+  
Sbjct: 136 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNT 286
            T  Y  PE   +S+   KS D++S G +L E+L+  +PIF                G+ 
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSP 251
Query: 287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
           SQE+++          K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 252 SQEDLNCIINL-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 296

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 35/176 (19%)
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQ 241
           ++   L Y+HS     + HRD+K +N+LL+     K+ DFG ++    D  H    T+  
Sbjct: 134 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNT 286
            T  Y  PE   +S+   KS D++S G +L E+L+  +PIF                G+ 
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSP 249
Query: 287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
           SQE+++          K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 250 SQEDLNCIINL-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 294

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 62/303 (20%)
Query: 77  RILGQGGQGT-VYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +ILG G  GT V++G  + GR +AVK+  +   D  L +++       +    +H NV++
Sbjct: 21  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIK------LLTESDDHPNVIR 73
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRH--------QNEEYPLTWEMRFRVAIEVAG 187
              C   T+  L +   + N  L   +  ++        Q E  P++      +  ++A 
Sbjct: 74  YY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIAS 126
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLD-------------ERYRAKVADFGTSKFIAMDQT 234
            +A+LHS     I HRD+K  NIL+              E  R  ++DFG  K +   Q 
Sbjct: 127 GVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 183
Query: 235 HVTTKIQ---GTFGYLDPEYHQSS-------QLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
                +    GT G+  PE  + S       +LT   D++S G V   +L+  K  F   
Sbjct: 184 XFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM 344
            + + N+    + +             D++  L  ++ I    +L  + +D +  KRPT 
Sbjct: 244 YSRESNIIRGIFSL-------------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290
Query: 345 EEV 347
            +V
Sbjct: 291 MKV 293

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 115 LEEFINEIFILSQINHRNVVKLLGCCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
           +E+   EI IL +++H NVVKL+    +   +   +V+E +  G + +    +  +E+  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD 232
              + RF     + G + YLH      I HRDIK +N+L+ E    K+ADFG S      
Sbjct: 138 ---QARFYFQDLIKG-IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 233 QTHVTTKIQGTFGYLDPEYHQSSQ--LTDKS-DVYSFGVVLVELLTGKKP 279
              ++  + GT  ++ PE    ++   + K+ DV++ GV L   + G+ P
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 20/238 (8%)
Query: 49  SYDGSVIDRCKLFSSKEL----DKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSK 104
           +YD  V D  K +  + +    D   +H++++  LG G  G V+  R+ +        +K
Sbjct: 25  NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH--RVTERATGNNFAAK 82
Query: 105 LAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD 164
             +   E  K E    EI  +S + H  +V L     +    +++YEF+  G L++ + D
Sbjct: 83  FVMTPHESDK-ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 141
Query: 165 RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY--RAKVAD 222
            H      ++ +       +V   L ++H        H D+K  NI+   +     K+ D
Sbjct: 142 EHNK----MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLID 194
Query: 223 FGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           FG +  +   Q+  VTT   GT  +  PE  +   +   +D++S GV+   LL+G  P
Sbjct: 195 FGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           EE   E+ IL Q+ H NV+ L          +L+ E +  G L+  L  +    E   T 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
            ++     ++   + YLH+     I H D+K  NI+L ++       K+ DFG +  I  
Sbjct: 120 FIK-----QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169
Query: 232 DQTHVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE- 289
            +  V  K I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE 
Sbjct: 170 -EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQET 226
Query: 290 --NVSLAAY 296
             N++  +Y
Sbjct: 227 LANITAVSY 235

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           EE   E+ IL Q+ H NV+ L          +L+ E +  G L+  L  +    E   T 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
            ++     ++   + YLH+     I H D+K  NI+L ++       K+ DFG +  I  
Sbjct: 120 FIK-----QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169
Query: 232 DQTHVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE- 289
            +  V  K I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE 
Sbjct: 170 -EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQET 226
Query: 290 --NVSLAAY 296
             N++  +Y
Sbjct: 227 LANITAVSY 235

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 86/174 (49%), Gaps = 23/174 (13%)
Query: 121 EIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           E+ +L Q   HRNV++L+    E +   LV+E +  G++  H+H R    E   +     
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----- 114
Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAM--DQT 234
            V  +VA AL +LH+     I HRD+K  NIL +   +    K+ DF     I +  D +
Sbjct: 115 VVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 235 HVTTK----IQGTFGYLDPE----YHQSSQLTDK-SDVYSFGVVLVELLTGKKP 279
            ++T       G+  Y+ PE    + + + + DK  D++S GV+L  LL+G  P
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 29/229 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           + + +   +G G  G V   R    G+ +A+KK   A D   +   +  + E+ IL    
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD--VVTNAKRTLRELKILKHFK 111
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNG---TLYQHL----HDRHQ--NEEYPLTWEMRFR 180
           H N++ +      T         +P G   ++Y  L     D HQ  +   PLT E    
Sbjct: 112 HDNIIAIKDILRPT---------VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRY 162
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVT 237
              ++   L Y+HS     + HRD+K +N+L++E    K+ DFG ++ +     +  +  
Sbjct: 163 FLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219
Query: 238 TKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
           T+   T  Y  PE   S  + T   D++S G +  E+L  ++ +F   N
Sbjct: 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML-ARRQLFPGKN 267

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 38/217 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V++G  + G  +AVK    + D++  ++  E  N + +     H N++  + 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS-SRDEKSWFRETELYNTVML----RHENILGFIA 69
Query: 139 CCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH- 193
             + +        L+  +   G+LY +L     +    L      R+ + +A  LA+LH 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL------RIVLSIASGLAHLHI 123
Query: 194 ----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-------G 242
               +     I HRD+KS NIL+ +  +  +AD G    +A+  +  T ++        G
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG----LAVMHSQSTNQLDVGNNPRVG 179
Query: 243 TFGYLDPEYHQSSQLTD------KSDVYSFGVVLVEL 273
           T  Y+ PE    +   D      + D+++FG+VL E+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           EI  L  + H +++KL          ++V E+   G L+ ++ ++ +     +T +   R
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR-----MTEDEGRR 112
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
              ++  A+ Y H      I HRD+K  N+LLD+    K+ADFG S  I  D   + T  
Sbjct: 113 FFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSC 168
Query: 241 QGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKP 279
            G+  Y  PE          + DV+S G+VL  +L G+ P
Sbjct: 169 -GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 36/225 (16%)
Query: 75  VNRILGQGG----QGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN- 129
            + +LG+G     QG V    L++G+  AVK     ++ +  +       E+  L Q   
Sbjct: 17  TSELLGEGAYAKVQGAV---SLQNGKEYAVK----IIEKQAGHSRSRVFREVETLYQCQG 69
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRVAIEVAGA 188
           ++N+++L+    +     LV+E +  G++  H+   +H NE          RV  +VA A
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNER------EASRVVRDVAAA 123
Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRA---KVADF--GTSKFIAMDQTHVTTK---- 239
           L +LH+     I HRD+K  NIL +   +    K+ DF  G+   +    T +TT     
Sbjct: 124 LDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTT 180
Query: 240 IQGTFGYLDPEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKP 279
             G+  Y+ PE       Q++    + D++S GVVL  +L+G  P
Sbjct: 181 PCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 20/238 (8%)
Query: 49  SYDGSVIDRCKLFSSKEL----DKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSK 104
           +YD  V D  K +  + +    D   +H++++  LG G  G V+  R+ +        +K
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH--RVTERATGNNFAAK 188
Query: 105 LAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD 164
             +   E  K E    EI  +S + H  +V L     +    +++YEF+  G L++ + D
Sbjct: 189 FVMTPHESDK-ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 247
Query: 165 RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY--RAKVAD 222
            H      ++ +       +V   L ++H        H D+K  NI+   +     K+ D
Sbjct: 248 EHNK----MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLID 300
Query: 223 FGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           FG +  +   Q+  VTT   GT  +  PE  +   +   +D++S GV+   LL+G  P
Sbjct: 301 FGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 38/217 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V++G  + G  +AVK    + D++  ++  E  N + +     H N++  + 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS-SRDEKSWFRETELYNTVML----RHENILGFIA 69
Query: 139 CCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH- 193
             + +        L+  +   G+LY +L     +    L      R+ + +A  LA+LH 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL------RIVLSIASGLAHLHI 123
Query: 194 ----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-------G 242
               +     I HRD+KS NIL+ +  +  +AD G    +A+  +  T ++        G
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG----LAVMHSQSTNQLDVGNNPRVG 179
Query: 243 TFGYLDPEYHQSSQLTD------KSDVYSFGVVLVEL 273
           T  Y+ PE    +   D      + D+++FG+VL E+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 38/217 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V++G  + G  +AVK    + D++  ++  E  N + +     H N++  + 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFS-SRDEKSWFRETELYNTVML----RHENILGFIA 98
Query: 139 CCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH- 193
             + +        L+  +   G+LY +L     +    L      R+ + +A  LA+LH 
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL------RIVLSIASGLAHLHI 152
Query: 194 ----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-------G 242
               +     I HRD+KS NIL+ +  +  +AD G    +A+  +  T ++        G
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG----LAVMHSQSTNQLDVGNNPRVG 208
Query: 243 TFGYLDPEYHQSSQLTD------KSDVYSFGVVLVEL 273
           T  Y+ PE    +   D      + D+++FG+VL E+
Sbjct: 209 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           + + +   +G G  G V   R    G+ +A+KK   A D   +   +  + E+ IL    
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD--VVTNAKRTLRELKILKHFK 112
Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNG---TLYQHL----HDRHQ--NEEYPLTWEMRFR 180
           H N++ +      T         +P G   ++Y  L     D HQ  +   PLT E    
Sbjct: 113 HDNIIAIKDILRPT---------VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRY 163
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTHVT 237
              ++   L Y+HS     + HRD+K +N+L++E    K+ DFG ++ +     +  +  
Sbjct: 164 FLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 220
Query: 238 TKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKK 278
           T+   T  Y  PE   S  + T   D++S G +  E+L  ++
Sbjct: 221 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 202 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQ 256
           HRDIK  NIL+D     ++ADFG+   +  D T  ++   GT  Y+ PE  Q+      +
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 257 LTDKSDVYSFGVVLVELLTGKKPIFS 282
              + D +S GV + E+L G+ P ++
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYA 283

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 18/182 (9%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           EE   E+ IL Q+ H NV+ L          +L+ E +  G L+  L  +    E   T 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
            ++     ++   + YLH+     I H D+K  NI+L ++       K+ DFG +  I  
Sbjct: 120 FIK-----QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169
Query: 232 DQTHVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
            +  V  K I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE 
Sbjct: 170 -EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQET 226
Query: 291 VS 292
           ++
Sbjct: 227 LA 228

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 18/182 (9%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           EE   E+ IL Q+ H NV+ L          +L+ E +  G L+  L  +    E   T 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
            ++     ++   + YLH+     I H D+K  NI+L ++       K+ DFG +  I  
Sbjct: 120 FIK-----QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169
Query: 232 DQTHVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
            +  V  K I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE 
Sbjct: 170 -EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQET 226
Query: 291 VS 292
           ++
Sbjct: 227 LA 228

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 18/182 (9%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           EE   E+ IL Q+ H NV+ L          +L+ E +  G L+  L  +    E   T 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
            ++     ++   + YLH+     I H D+K  NI+L ++       K+ DFG +  I  
Sbjct: 120 FIK-----QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169
Query: 232 DQTHVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
            +  V  K I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE 
Sbjct: 170 -EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQET 226
Query: 291 VS 292
           ++
Sbjct: 227 LA 228

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 72  HFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
           ++ + + LG+G  G V        G+ +A+K   K  LA  D +  ++E    EI  L  
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GRIER---EISYLRL 60
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           + H +++KL       +  ++V E+  N  L+ ++  R +  E     E R R   ++  
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQ----EAR-RFFQQIIS 114
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           A+ Y H      I HRD+K  N+LLDE    K+ADFG S  I  D   + T   G+  Y 
Sbjct: 115 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSC-GSPNYA 169
Query: 248 DPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKP 279
            PE          + DV+S GV+L  +L  + P
Sbjct: 170 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 72  HFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
           ++ + + LG+G  G V        G+ +A+K   K  LA  D +  ++E    EI  L  
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GRIER---EISYLRL 69
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           + H +++KL       +  ++V E+  N  L+ ++  R +  E     E R R   ++  
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQ----EAR-RFFQQIIS 123
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           A+ Y H      I HRD+K  N+LLDE    K+ADFG S  I  D   + T   G+  Y 
Sbjct: 124 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSC-GSPNYA 178
Query: 248 DPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKP 279
            PE          + DV+S GV+L  +L  + P
Sbjct: 179 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 72  HFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
           ++ + + LG+G  G V        G+ +A+K   K  LA  D +  ++E    EI  L  
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GRIER---EISYLRL 70
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           + H +++KL       +  ++V E+  N  L+ ++  R +  E     E R R   ++  
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQ----EAR-RFFQQIIS 124
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           A+ Y H      I HRD+K  N+LLDE    K+ADFG S  I  D   + T   G+  Y 
Sbjct: 125 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSC-GSPNYA 179
Query: 248 DPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKP 279
            PE          + DV+S GV+L  +L  + P
Sbjct: 180 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 31/236 (13%)
Query: 72  HFNVNRILGQGGQGTV--YKGRLEDGRIIAVKKSKL-AVDDEELYKLEEFINEIFILSQI 128
           H+   + LG+GG   V   +G L DG   A+K+       D E  + E  ++ +F     
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLF----- 83
Query: 129 NHRNVVKLLGCCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           NH N+++L+  CL          L+  F   GTL+  + +R +++   LT +    + + 
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLG 142
Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT--SKFIAMDQTHVTTKIQG 242
           +   L  +H+   +   HRD+K TNILL +  +  + D G+     I ++ +     +Q 
Sbjct: 143 ICRGLEAIHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 243 ------TFGYLDPEYH--QSSQLTD-KSDVYSFGVVLVELLTGKKP---IFSTGNT 286
                 T  Y  PE    QS  + D ++DV+S G VL  ++ G+ P   +F  G++
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V++G+   G  +AVK   +    EE     E   EI+    + H N++  + 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFRE--AEIYQTVMLRHENILGFIA 70
Query: 139 C-----CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                    T+   LV ++  +G+L+ +L+       Y +T E   ++A+  A  LA+LH
Sbjct: 71  ADNKDNGTWTQL-WLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLH 123
Query: 194 -----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-----GT 243
                +     I HRD+KS NIL+ +     +AD G +  +  D    T  I      GT
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGT 181
Query: 244 FGYLDPEYHQSS------QLTDKSDVYSFGVVLVEL 273
             Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V++G+   G  +AVK   +    EE     E   EI+    + H N++  + 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFRE--AEIYQTVMLRHENILGFIA 64
Query: 139 C-----CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                    T+   LV ++  +G+L+ +L+       Y +T E   ++A+  A  LA+LH
Sbjct: 65  ADNKDNGTWTQL-WLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLH 117
Query: 194 -----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-----GT 243
                +     I HRD+KS NIL+ +     +AD G +  +  D    T  I      GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGT 175
Query: 244 FGYLDPEYHQSS------QLTDKSDVYSFGVVLVEL 273
             Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V++G+   G  +AVK   +    EE     E   EI+    + H N++  + 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFRE--AEIYQTVMLRHENILGFIA 67
Query: 139 C-----CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                    T+   LV ++  +G+L+ +L+       Y +T E   ++A+  A  LA+LH
Sbjct: 68  ADNKDNGTWTQL-WLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLH 120
Query: 194 -----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-----GT 243
                +     I HRD+KS NIL+ +     +AD G +  +  D    T  I      GT
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGT 178
Query: 244 FGYLDPEYHQSS------QLTDKSDVYSFGVVLVEL 273
             Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 72  HFNVNRILGQGGQGTVYKG-RLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
           ++ + + LG+G  G V        G+ +A+K   K  LA  D +  ++E    EI  L  
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GRIER---EISYLRL 64
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           + H +++KL       +  ++V E+  N  L+ ++  R +  E     E R R   ++  
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQ----EAR-RFFQQIIS 118
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           A+ Y H      I HRD+K  N+LLDE    K+ADFG S  I  D   + T   G+  Y 
Sbjct: 119 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSC-GSPNYA 173
Query: 248 DPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKP 279
            PE          + DV+S GV+L  +L  + P
Sbjct: 174 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V++G+   G  +AVK   +    EE     E   EI+    + H N++  + 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFRE--AEIYQTVMLRHENILGFIA 65
Query: 139 C-----CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                    T+   LV ++  +G+L+ +L+       Y +T E   ++A+  A  LA+LH
Sbjct: 66  ADNKDNGTWTQL-WLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLH 118
Query: 194 -----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-----GT 243
                +     I HRD+KS NIL+ +     +AD G +  +  D    T  I      GT
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGT 176
Query: 244 FGYLDPEYHQSS------QLTDKSDVYSFGVVLVEL 273
             Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           EE   E+ IL Q+ H N++ L          +L+ E +  G L+  L  +    E   T 
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAM 231
            ++     ++   + YLH+     I H D+K  NI+L ++       K+ DFG +  I  
Sbjct: 120 FIK-----QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169
Query: 232 DQTHVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE- 289
            +  V  K I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE 
Sbjct: 170 -EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQET 226
Query: 290 --NVSLAAY 296
             N++  +Y
Sbjct: 227 LANITAVSY 235

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 202 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQ 256
           HRDIK  N+LLD     ++ADFG+   +  D T  ++   GT  Y+ PE  Q+      +
Sbjct: 198 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGK 257
Query: 257 LTDKSDVYSFGVVLVELLTGKKPIFS 282
              + D +S GV + E+L G+ P ++
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYA 283

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V++G+   G  +AVK   +    EE     E   EI+    + H N++  + 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFRE--AEIYQTVMLRHENILGFIA 103
Query: 139 C-----CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                    T+   LV ++  +G+L+ +L+       Y +T E   ++A+  A  LA+LH
Sbjct: 104 ADNKDNGTWTQL-WLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLH 156
Query: 194 -----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-----GT 243
                +     I HRD+KS NIL+ +     +AD G +  +  D    T  I      GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGT 214
Query: 244 FGYLDPEYHQSS------QLTDKSDVYSFGVVLVEL 273
             Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V++G+   G  +AVK   +    EE     E   EI+    + H N++  + 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFRE--AEIYQTVMLRHENILGFIA 90
Query: 139 C-----CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                    T+   LV ++  +G+L+ +L+       Y +T E   ++A+  A  LA+LH
Sbjct: 91  ADNKDNGTWTQL-WLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLH 143
Query: 194 -----SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-----GT 243
                +     I HRD+KS NIL+ +     +AD G +  +  D    T  I      GT
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGT 201
Query: 244 FGYLDPEYHQSS------QLTDKSDVYSFGVVLVEL 273
             Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 202 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-----SQ 256
           HRDIK  N+LLD     ++ADFG+   +  D T  ++   GT  Y+ PE  Q+      +
Sbjct: 214 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGK 273
Query: 257 LTDKSDVYSFGVVLVELLTGKKPIFS 282
              + D +S GV + E+L G+ P ++
Sbjct: 274 YGPECDWWSLGVCMYEMLYGETPFYA 299

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 91
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 145
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H     +   T  Y  PE 
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 262 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 296

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 49/286 (17%)
Query: 79  LGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL- 136
           +G+G  G V        ++ +A+KK  ++  + + Y  +  + EI IL +  H N++ + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTY-CQRTLREIKILLRFRHENIIGIN 92
Query: 137 ---LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                  +E    + + + +    LY+ L  +H + ++   +        ++   L Y+H
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF------LYQILRGLKYIH 146
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQGTFGYLDPEY 251
           S     + HRD+K +N+LL+     K+ DFG ++    D  H     +   T  Y  PE 
Sbjct: 147 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNTSQENVSLAAY 296
             +S+   KS D++S G +L E+L+  +PIF                G+ SQE+++    
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 262
Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVA---FANLAERCLDLNGK 339
                 K R Y      ++ L  KN++     F N   + LDL  K
Sbjct: 263 L-----KARNY------LLSLPHKNKVPWNRLFPNADSKALDLLDK 297

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 25/202 (12%)
Query: 79  LGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG G  G V+K R  EDGR+ AVK+S        +       +    L+++     V   
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRS--------MSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 138 GCCLETEFP------LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            CC+  E        L +   +   +L QH      +      W       +    ALA+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLL----ALAH 172
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     + H D+K  NI L  R R K+ DFG    + +         +G   Y+ PE 
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPEL 227
Query: 252 HQSSQLTDKSDVYSFGVVLVEL 273
            Q S  T  +DV+S G+ ++E+
Sbjct: 228 LQGSYGT-AADVFSLGLTILEV 248

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           EI     + H N+V+     L      ++ E+   G LY+ + +  +  E     E RF 
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED----EARFF 121
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIAMDQTHVTT 238
               ++G ++Y HS     I HRD+K  N LLD     R K+ DFG SK   +     +T
Sbjct: 122 FQQLLSG-VSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177
Query: 239 KIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKP 279
              GT  Y+ PE     +   K +DV+S GV L  +L G  P
Sbjct: 178 V--GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+L+D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 38/226 (16%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEE--FINEIFILSQINHRNVVKL 136
           +G+G   TVYKG L+    + V   +L   D +L K E   F  E   L  + H N+V+ 
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 137 LGCCLET----EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV---------AI 183
                 T    +  +LV E   +GTL  +L               RF+V           
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLK--------------RFKVXKIKVLRSWCR 136
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           ++   L +LH+  + PI HRD+K  NI +       K+ D G +    + +      + G
Sbjct: 137 QILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIG 192
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           T  +  PE ++  +  +  DVY+FG   +E  T + P     N +Q
Sbjct: 193 TPEFXAPEXYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQ 237

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 87/170 (51%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N++KL+    +  ++ P LV+E+I N     LYQ L D          +++RF +  E+ 
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTD----------FDIRFYM-YELL 147
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D ++ + ++ D+G ++F    Q +   ++   + 
Sbjct: 148 KALDYCHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY- 202
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q+ D S D++S G +L  ++  ++P F   +   + V +A
Sbjct: 203 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIA 252

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 87/170 (51%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N++KL+    +  ++ P LV+E+I N     LYQ L D          +++RF +  E+ 
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTD----------FDIRFYM-YELL 142
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D ++ + ++ D+G ++F    Q +   ++   + 
Sbjct: 143 KALDYCHSKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY- 197
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q+ D S D++S G +L  ++  ++P F   +   + V +A
Sbjct: 198 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIA 247

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 17/185 (9%)
Query: 100 VKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLY 159
           +   KL+  D +  KLE    E  I   + H N+V+L     E     L+++ +  G L+
Sbjct: 44  INTKKLSARDHQ--KLE---REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF 98
Query: 160 QHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA- 218
           + +  R    E   +         ++  A+ + H      + HR++K  N+LL  + +  
Sbjct: 99  EDIVAREYYSEADAS-----HCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGA 150
Query: 219 --KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG 276
             K+ADFG +  +  +Q        GT GYL PE  +        D+++ GV+L  LL G
Sbjct: 151 AVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
Query: 277 KKPIF 281
             P +
Sbjct: 210 YPPFW 214

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 108 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 153
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 211
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 212 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 108 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 153
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 211
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 212 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 107 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 152
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 210
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 211 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 24/225 (10%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+G  G V++       +    K  K+   D+ L K      EI IL+   HRN++ L 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK-----KEISILNIARHRNILHLH 67
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                 E  ++++EFI    ++    +R     + L          +V  AL +LHS   
Sbjct: 68  ESFESMEELVMIFEFISGLDIF----ERINTSAFELNEREIVSYVHQVCEALQFLHS--- 120
Query: 198 SPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFG---YLDPEYH 252
             I H DI+  NI+   R  +  K+ +FG ++     Q       +  F    Y  PE H
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-----QLKPGDNFRLLFTAPEYYAPEVH 175
Query: 253 QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS-QENVSLAAY 296
           Q   ++  +D++S G ++  LL+G  P  +  N    EN+  A Y
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG 138
           +G+G  G V+ G+   G  +AVK   +    EE     E   EI+    + H N++  + 
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVK---VFFTTEEASWFRE--TEIYQTVLMRHENILGFIA 98
Query: 139 CCLE-----TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
             ++     T+   L+ ++  NG+LY +L     + +  L      ++A      L +LH
Sbjct: 99  ADIKGTGSWTQL-YLITDYHENGSLYDYLKSTTLDAKSML------KLAYSSVSGLCHLH 151
Query: 194 ----SGASSP-IYHRDIKSTNILLDERYRAKVADFGTS-KFIAMDQTHV----TTKIQGT 243
               S    P I HRD+KS NIL+ +     +AD G + KFI+ D   V     T++ GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS-DTNEVDIPPNTRV-GT 209
Query: 244 FGYLDPEYHQSS------QLTDKSDVYSFGVVLVEL 273
             Y+ PE    S      Q    +D+YSFG++L E+
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 109 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 154
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 212
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 146 PLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH 202
           P LV+E + N     LYQ L D          +++RF +  E+  AL Y HS     I H
Sbjct: 114 PALVFEHVNNTDFKQLYQTLTD----------YDIRFYM-YEILKALDYCHSMG---IMH 159
Query: 203 RDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           RD+K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S
Sbjct: 160 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYS 217
Query: 262 -DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
            D++S G +L  ++  K+P F   +   + V +A
Sbjct: 218 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 251

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 71  NHFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFI--NEIFILSQ 127
           +++++   LG G  G V++      GR+   K           Y L+++   NEI I++Q
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP------YPLDKYTVKNEISIMNQ 104
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           ++H  ++ L     +    +L+ EF+  G L+    DR   E+Y ++         +   
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELF----DRIAAEDYKMSEAEVINYMRQACE 160
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQ-THVTTKIQGTF 244
            L ++H  +   I H DIK  NI+ + +  +  K+ DFG +  +  D+   VTT    T 
Sbjct: 161 GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATA 214
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            +  PE      +   +D+++ GV+   LL+G  P
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 104/234 (44%), Gaps = 38/234 (16%)
Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-H 130
             V R+L +GG   VY+ + +  GR  A+K+  L  ++EE  K    I E+  + +++ H
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKR--LLSNEEE--KNRAIIQEVCFMKKLSGH 85
Query: 131 RNVVKLLGCCL---------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
            N+V+               + EF LL+ E    G L + L  +      PL+ +   ++
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEF-LLLTELC-KGQLVEFL--KKMESRGPLSCDTVLKI 141
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI------------ 229
             +   A+ ++H     PI HRD+K  N+LL  +   K+ DFG++  I            
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 230 -AMDQTHVTTKIQGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            A+ +  +T     T  Y  PE    + +  + +K D+++ G +L  L   + P
Sbjct: 201 RALVEEEITRNT--TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           EI     + H N+V+     L      +V E+   G L++ + +  +  E     E RF 
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED----EARFF 120
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIAMDQTHVTT 238
               ++G ++Y H+     + HRD+K  N LLD     R K+ADFG SK   +   H   
Sbjct: 121 FQQLISG-VSYAHAMQ---VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVL---HSQP 173
Query: 239 KIQ-GTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKP 279
           K   GT  Y+ PE     +   K +DV+S GV L  +L G  P
Sbjct: 174 KSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 14/170 (8%)
Query: 114 KLEEFIN-EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
           K++E +  EI     + H N+V+     L      +V E+   G L++ + +  +  E  
Sbjct: 56  KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED- 114
Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIA 230
              E RF     ++G ++Y H+     + HRD+K  N LLD     R K+ DFG SK   
Sbjct: 115 ---EARFFFQQLISG-VSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 167
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKP 279
           +     +T   GT  Y+ PE     +   K +DV+S GV L  +L G  P
Sbjct: 168 LHSQPKSTV--GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           EI     + H N+V+     L      +V E+   G L++ + +  +  E     E RF 
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED----EARFF 120
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIAMDQTHVTT 238
               ++G ++Y H+     + HRD+K  N LLD     R K+ DFG SK   +     +T
Sbjct: 121 FQQLISG-VSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 176
Query: 239 KIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKP 279
              GT  Y+ PE     +   K +DV+S GV L  +L G  P
Sbjct: 177 V--GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 18/107 (16%)
Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH----V 236
           + I++A A+ +LHS     + HRD+K +NI        KV DFG     AMDQ      V
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL--VTAMDQDEEEQTV 223
Query: 237 TTKIQ---------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELL 274
            T +          GT  Y+ PE    +  + K D++S G++L ELL
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDI 205
           P LV+E + N T ++ L  R    +Y    ++RF +  E+  AL Y HS     I HRD+
Sbjct: 109 PALVFEHV-NNTDFKQL--RQTLTDY----DIRFYM-YEILKALDYCHSMG---IMHRDV 157
Query: 206 KSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS-DV 263
           K  N+++D  +R  ++ D+G ++F    Q +   ++   + +  PE     Q+ D S D+
Sbjct: 158 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDM 215
Query: 264 YSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +S G +L  ++  K+P F   +   + V +A
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 188
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 246
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 247 WSLGVIMYILLCGYPPFYS 265

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 144
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 202
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 203 WSLGVIMYILLCGYPPFYS 221

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 194
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 195 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 252
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 253 WSLGVIMYILLCGYPPFYS 271

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 158
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 159 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 216
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 217 WSLGVIMYILLCGYPPFYS 235

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 202 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------- 254
           HRDIK  NILLD     ++ADFG+   +  D T  +    GT  YL PE  Q+       
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 255 SQLTDKSDVYSFGVVLVELLTGKKPIFS 282
                + D ++ GV   E+  G+ P ++
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYA 272

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 143
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 144 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 201
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 202 WSLGVIMYILLCGYPPFYS 220

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 142
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 200
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 201 WSLGVIMYILLCGYPPFYS 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 150
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 151 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 208
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 209 WSLGVIMYILLCGYPPFYS 227

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 149
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 150 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 207
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 208 WSLGVIMYILLCGYPPFYS 226

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 144
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 202
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 203 WSLGVIMYILLCGYPPFYS 221

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 148
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D+
Sbjct: 149 PENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDM 206
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 207 WSLGVIMYILLCGYPPFYS 225

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 44/79 (55%), Gaps = 6/79 (7%)
Query: 200 IYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
           I H D+K  NILL ++ R+  KV DFG+S +   +   V T IQ  F Y  PE    ++ 
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTXIQSRF-YRAPEVILGARY 276
Query: 258 TDKSDVYSFGVVLVELLTG 276
               D++S G +L ELLTG
Sbjct: 277 GMPIDMWSLGCILAELLTG 295

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V        G  +A+KK       E   K      E+ +L  + H NV+ LL
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK--RAYRELLLLKHMQHENVIGLL 107
Query: 138 GCCLETEFPLLVYEF---IP-NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                       Y+F   +P   T  Q +     +EE     ++++ V   + G L Y+H
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEE-----KIQYLVYQMLKG-LKYIH 161
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYH 252
           S     + HRD+K  N+ ++E    K+ DFG ++    + T +V T+      Y  PE  
Sbjct: 162 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 213
Query: 253 QSSQLTDKS-DVYSFGVVLVELLTGK 277
            S    +++ D++S G ++ E+LTGK
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 44/79 (55%), Gaps = 6/79 (7%)
Query: 200 IYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
           I H D+K  NILL ++ R+  KV DFG+S +   +   V T IQ  F Y  PE    ++ 
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTXIQSRF-YRAPEVILGARY 276
Query: 258 TDKSDVYSFGVVLVELLTG 276
               D++S G +L ELLTG
Sbjct: 277 GMPIDMWSLGCILAELLTG 295

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 37/78 (47%)
Query: 202 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKS 261
           HRD+K  NIL+     A + DFG +     ++        GT  Y  PE    S  T ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 262 DVYSFGVVLVELLTGKKP 279
           D+Y+   VL E LTG  P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 95  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQ 253
                I HRD+K +N+ ++E    K+ DFG ++  A + T +V T+      Y  PE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIML 202
Query: 254 SSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 95  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQ 253
                I HRD+K +N+ ++E    K+ DFG ++  A + T +V T+      Y  PE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIML 202
Query: 254 SSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 95  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQ 253
                I HRD+K +N+ ++E    K+ DFG ++  A + T +V T+      Y  PE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPEIML 202
Query: 254 SSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 30/234 (12%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKG--RLEDGRI-IAVKKSKLAVDDEELYKLEEFIN 120
           K  +K  + + ++ ++G+G  G V K   R+E   + I + K+K A        L +   
Sbjct: 47  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-------LNQAQI 99
Query: 121 EIFILSQIN-HRNVVKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEY-PL 173
           E+ +L  +N H   +K     L+  F       LV+E      L  +L+D  +N  +  +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGV 154
Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL--DERYRAKVADFGTSKFIAM 231
           +  +  + A ++  AL +L +   S I H D+K  NILL   +R   K+ DFG+S  +  
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRXAIKIVDFGSSCQLG- 212
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
               +   IQ  F Y  PE           D++S G +LVE+ TG +P+FS  N
Sbjct: 213 --QRIYQXIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGAN 262

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 14/170 (8%)
Query: 114 KLEEFIN-EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
           K++E +  EI     + H N+V+     L      +V E+   G L++ + +  +  E  
Sbjct: 57  KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED- 115
Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIA 230
              E RF     ++G ++Y H+     + HRD+K  N LLD     R K+  FG SK   
Sbjct: 116 ---EARFFFQQLISG-VSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSV 168
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKP 279
           +     +T   GT  Y+ PE     +   K +DV+S GV L  +L G  P
Sbjct: 169 LHSQPKSTV--GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 121 EIFILSQINHRNVVKLLGCCL--ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           EI +L ++ H+NV++L+      E +   +V E+   G   Q + D    + +P+     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFPVCQAHG 113
Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI---AMDQTH 235
           +    ++   L YLHS     I H+DIK  N+LL      K++  G ++ +   A D T 
Sbjct: 114 Y--FCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 236 VTTKIQGTFGYLDPEYHQSSQLTD--KSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENV 291
            T+  QG+  +  PE           K D++S GV L  + TG  P F   N  +  EN+
Sbjct: 169 RTS--QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGDNIYKLFENI 225
Query: 292 SLAAYFV 298
              +Y +
Sbjct: 226 GKGSYAI 232

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V        G  +A+KK       E   K      E+ +L  + H NV+ LL
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK--RAYRELLLLKHMQHENVIGLL 89
Query: 138 GCCLETEFPLLVYEF---IP-NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
                       Y+F   +P   T  Q +     +EE     ++++ V   + G L Y+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE-----KIQYLVYQMLKG-LKYIH 143
Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYH 252
           S     + HRD+K  N+ ++E    K+ DFG ++    + T +V T+      Y  PE  
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 195
Query: 253 QSSQLTDKS-DVYSFGVVLVELLTGK 277
            S    +++ D++S G ++ E+LTGK
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 50/112 (44%), Gaps = 12/112 (10%)
Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGTSKFIAMDQTH 235
            R+  ++   + YLH      I H D+K  NILL   Y     K+ DFG S+ I     H
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG----H 186
Query: 236 VTT--KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
                +I GT  YL PE      +T  +D+++ G++   LLT   P     N
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 30/234 (12%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKG--RLEDGRI-IAVKKSKLAVDDEELYKLEEFIN 120
           K  +K  + + ++ ++G+G  G V K   R+E   + I + K+K A        L +   
Sbjct: 47  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-------LNQAQI 99
Query: 121 EIFILSQIN-HRNVVKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEY-PL 173
           E+ +L  +N H   +K     L+  F       LV+E      L  +L+D  +N  +  +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGV 154
Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL--DERYRAKVADFGTSKFIAM 231
           +  +  + A ++  AL +L +   S I H D+K  NILL   +R   K+ DFG+S  +  
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG- 212
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
               +   IQ  F Y  PE           D++S G +LVE+ TG +P+FS  N
Sbjct: 213 --QRIYQXIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGAN 262

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 77  RILGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           R +G G  G+V   Y  RL     +AVKK  L+   + L        E+ +L  + H NV
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQK--VAVKK--LSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 134 VKLL-----GCCLE--TEFPL---LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           + LL        +E  +E  L   L+   + N    Q L D H          ++F V  
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEH----------VQFLV-Y 130
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++   L Y+HS     I HRD+K +N+ ++E    ++ DFG    +A       T    T
Sbjct: 131 QLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG----LARQADEEMTGYVAT 183
Query: 244 FGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGK 277
             Y  PE   +    +++ D++S G ++ ELL GK
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 30/234 (12%)
Query: 64  KELDKATNHFNVNRILGQGGQGTVYKG--RLEDGRI-IAVKKSKLAVDDEELYKLEEFIN 120
           K  +K  + + ++ ++G+G  G V K   R+E   + I + K+K A        L +   
Sbjct: 28  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-------LNQAQI 80
Query: 121 EIFILSQIN-HRNVVKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEY-PL 173
           E+ +L  +N H   +K     L+  F       LV+E      L  +L+D  +N  +  +
Sbjct: 81  EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGV 135
Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL--DERYRAKVADFGTSKFIAM 231
           +  +  + A ++  AL +L +   S I H D+K  NILL   +R   K+ DFG+S  +  
Sbjct: 136 SLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 194
Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
               +   IQ  F Y  PE           D++S G +LVE+ TG +P+FS  N
Sbjct: 195 ---RIYQXIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGAN 243

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 77  RILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           + LG GG G V+     D  + +A+KK  + + D +   ++  + EI I+ +++H N+VK
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQ--SVKHALREIKIIRRLDHDNIVK 72
Query: 136 L--------------LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
           +              +G   E     +V E++            +  E+ PL  E     
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDL-------ANVLEQGPLLEEHARLF 125
Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKI 240
             ++   L Y+HS     + HRD+K  N+ ++ E    K+ DFG ++ +    +H     
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 241 QG--TFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGK 277
           +G  T  Y  P    S +  T   D+++ G +  E+LTGK
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSIN---IAHRDVK 142
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K      +   T+   T  Y+ PE     +     D+
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTEPCYTPYYVAPEVLGPEKYDKSCDM 200
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV++  LL G  P +S
Sbjct: 201 WSLGVIMYILLCGYPPFYS 219

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 77  RILGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           R +G G  G+V   Y  RL   + +AVKK  L+   + L        E+ +L  + H NV
Sbjct: 34  RPVGSGAYGSVCSAYDARLR--QKVAVKK--LSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 134 VKLL-----GCCLE--TEFPL---LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           + LL        +E  +E  L   L+   + N    Q L D H          ++F V  
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEH----------VQFLV-Y 138
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++   L Y+HS     I HRD+K +N+ ++E    ++ DFG    +A       T    T
Sbjct: 139 QLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFG----LARQADEEMTGYVAT 191
Query: 244 FGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGK 277
             Y  PE   +    +++ D++S G ++ ELL GK
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 12/217 (5%)
Query: 73  FNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLA-VDDEELYKLEEFINEIFILSQINH 130
           + +  ++G+G    V +    E G+  AVK   +A          E+   E  I   + H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            ++V+LL          +V+EF+    L   +  R  +  +  +  +      ++  AL 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR-ADAGFVYSEAVASHYMRQILEALR 144
Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRA---KVADFGTSKFIAMDQTHVTTKIQ-GTFGY 246
           Y H      I HRD+K  N+LL  +  +   K+ DFG +  I + ++ +    + GT  +
Sbjct: 145 YCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHF 199
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 283
           + PE  +        DV+  GV+L  LL+G  P + T
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             ++   +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 77  RILGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           R +G G  G+V   Y  RL     +AVKK  L+   + L        E+ +L  + H NV
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQK--VAVKK--LSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 134 VKLL-----GCCLE--TEFPL---LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           + LL        +E  +E  L   L+   + N    Q L D H          ++F V  
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEH----------VQFLV-Y 138
Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++   L Y+HS     I HRD+K +N+ ++E    ++ DFG    +A       T    T
Sbjct: 139 QLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFG----LARQADEEMTGYVAT 191
Query: 244 FGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGK 277
             Y  PE   +    +++ D++S G ++ ELL GK
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 72  HFNVNRI-LGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           H+  +++ LG+G  G V+  R+ED   G   AVKK +L     E+++ EE +      + 
Sbjct: 93  HWATHQLRLGRGSFGEVH--RMEDKQTGFQCAVKKVRL-----EVFRAEELM----ACAG 141
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           +    +V L G   E  +  +  E +  G+L Q +      E+  L  +       +   
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALYYLGQALE 196
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMD---QTHVTTK-IQG 242
            L YLHS     I H D+K+ N+LL  +   A + DFG +  +  D   ++ +T   I G
Sbjct: 197 GLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG 253
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           T  ++ PE         K DV+S   +++ +L G  P
Sbjct: 254 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 18/219 (8%)
Query: 77  RILGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           + +G G QG V   Y   LE  R +A+KK      ++   K      E+ ++  +NH+N+
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAK--RAYRELVLMKVVNHKNI 85
Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE--EYPLTWEMRFRVAIEVAGALAY 191
           + LL        P    E   +  +   L D + ++  +  L  E    +  ++   + +
Sbjct: 86  IGLLNVFT----PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKH 141
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     I HRD+K +NI++      K+ DFG ++      + + T    T  Y  PE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
                  +  D++S GV++ E++ G      T +  Q N
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWN 235

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 84  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS 139
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 189
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 65/145 (44%), Gaps = 14/145 (9%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L++ E +  G L+  + +R        T      +  ++  A+ +LHS     I HRD+K
Sbjct: 102 LIIMECMEGGELFSRIQERGDQA---FTEREAAEIMRDIGTAIQFLHSHN---IAHRDVK 155
Query: 207 STNILLDERYR---AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   + +    K+ DFG +K     Q  + T     + Y+ PE     +     D+
Sbjct: 156 PENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDM 212
Query: 264 YSFGVVLVELLTGKKPIFSTGNTSQ 288
           +S GV++  LL G  P +S  NT Q
Sbjct: 213 WSLGVIMYILLCGFPPFYS--NTGQ 235

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 84  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEI 189
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 14/170 (8%)
Query: 114 KLEEFIN-EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
           K++E +  EI     + H N+V+     L      +V E+   G L++ + +  +  E  
Sbjct: 57  KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED- 115
Query: 173 LTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIA 230
              E RF     ++G ++Y H+     + HRD+K  N LLD     R K+  FG SK   
Sbjct: 116 ---EARFFFQQLISG-VSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSV 168
Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKP 279
           +      T   GT  Y+ PE     +   K +DV+S GV L  +L G  P
Sbjct: 169 LHSQPKDTV--GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           LG+G  G VYK         +A+K+ +L  ++E +      I E+ +L ++ HRN+++L 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA--IREVSLLKELQHRNIIELK 99
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                     L++E+  N         ++ ++   ++  +      ++   + + HS   
Sbjct: 100 SVIHHNHRLHLIFEYAENDL------KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 198 SPIYHRDIKSTNILL-----DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
               HRD+K  N+LL      E    K+ DFG ++   +     T +I  T  Y  PE  
Sbjct: 154 ---LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEIL 209
Query: 253 QSSQLTDKS-DVYSFGVVLVELLTGKKPIFS 282
             S+    S D++S   +  E+L  K P+F 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLM-KTPLFP 239

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 18/219 (8%)
Query: 77  RILGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           + +G G QG V   Y   LE  R +A+KK      ++   K      E+ ++  +NH+N+
Sbjct: 30  KPIGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAK--RAYRELVLMKVVNHKNI 85
Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE--EYPLTWEMRFRVAIEVAGALAY 191
           + LL        P    E   +  +   L D + ++  +  L  E    +  ++   + +
Sbjct: 86  IGLLNVFT----PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKH 141
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     I HRD+K +NI++      K+ DFG ++      + + T    T  Y  PE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
                  +  D++S GV++ E++ G      T +  Q N
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWN 235

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 135
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 136 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 190
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L+V E +  G L+  + DR        T      +   +  A+ YLHS     I HRD+K
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQA---FTEREASEIXKSIGEAIQYLHSIN---IAHRDVK 188
Query: 207 STNIL-LDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   +R  A  K+ DFG +K        +TT     + Y+ PE     +     D 
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDX 246
Query: 264 YSFGVVLVELLTGKKPIFS 282
           +S GV+   LL G  P +S
Sbjct: 247 WSLGVIXYILLCGYPPFYS 265

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 135
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 136 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 190
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 136
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 137 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 191
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 108 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 164 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRAPEI 213
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 251

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 137
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 138 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 192
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 193 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 136
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 137 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 191
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 135
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 136 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 190
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 65/145 (44%), Gaps = 14/145 (9%)
Query: 147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK 206
           L++ E +  G L+  + +R        T      +  ++  A+ +LHS     I HRD+K
Sbjct: 83  LIIMECMEGGELFSRIQERGDQA---FTEREAAEIMRDIGTAIQFLHSHN---IAHRDVK 136
Query: 207 STNILLDERYR---AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDV 263
             N+L   + +    K+ DFG +K     Q  + T     + Y+ PE     +     D+
Sbjct: 137 PENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDM 193
Query: 264 YSFGVVLVELLTGKKPIFSTGNTSQ 288
           +S GV++  LL G  P +S  NT Q
Sbjct: 194 WSLGVIMYILLCGFPPFYS--NTGQ 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 84  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 189
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 135
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 136 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 190
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 135
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 136 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 190
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 156
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 157 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 211
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 212 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 261

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 132 NVVKLLGCCLE--TEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           N+VKLL    +  ++ P L++E++ N     LY  L D          +++R+ +  E+ 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTD----------YDIRYYI-YELL 135
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D   R  ++ D+G ++F    + +   ++   + 
Sbjct: 136 KALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY- 190
Query: 246 YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
           +  PE     Q  D S D++S G +   ++  K+P F   +   + V +A
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 79  LGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           LG+G  G V+  R++D   G   AVKK +L     E++++EE +      + ++   +V 
Sbjct: 80  LGRGSFGEVH--RMKDKQTGFQCAVKKVRL-----EVFRVEELV----ACAGLSSPRIVP 128
Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ-NEEYPLTWEMRFRVAIEVAGALAYLHS 194
           L G   E  +  +  E +  G+L Q +       E+  L +      A+E    L YLH+
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY---LGQALE---GLEYLHT 182
Query: 195 GASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMD---QTHVTTK-IQGTFGYLDP 249
                I H D+K+ N+LL  +  RA + DFG +  +  D   ++ +T   I GT  ++ P
Sbjct: 183 ---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 239
Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           E         K D++S   +++ +L G  P
Sbjct: 240 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRI--IAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            ++ +   +G+G  G V     +  RI   A K  K  V+D     ++ F  EI I+  +
Sbjct: 26  QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-----VDRFKQEIEIMKSL 80
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQH-LHDRHQNEEYPLTWEMRFRVAIEVAG 187
           +H N+++L     +     LV E    G L++  +H R   E          R+  +V  
Sbjct: 81  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA------RIMKDVLS 134
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           A+AY H      + HRD+K  N L          K+ DFG +      +  + TK+ GT 
Sbjct: 135 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTP 189
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Y+ P+  +      + D +S GV++  LL G  P
Sbjct: 190 YYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 223

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 72  HFNVNRI-LGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           H+  +++ LG+G  G V+  R+ED   G   AVKK +L     E+++ EE +      + 
Sbjct: 74  HWATHQLRLGRGSFGEVH--RMEDKQTGFQCAVKKVRL-----EVFRAEELM----ACAG 122
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           +    +V L G   E  +  +  E +  G+L Q +      E+  L  +       +   
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALYYLGQALE 177
Query: 188 ALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH----VTTKIQG 242
            L YLHS     I H D+K+ N+LL  +   A + DFG +  +  D           I G
Sbjct: 178 GLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPG 234
Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           T  ++ PE         K DV+S   +++ +L G  P
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V     ++ G  IAVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 117 DVFT----PATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 173 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 222
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    + + D++S G ++ ELLTG+     T + +Q
Sbjct: 223 MLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQ 260

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 107 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 163 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 212
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 250

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 108 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 164 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 213
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 251

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 93  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 149 AD---IIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 198
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 236

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 94  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 150 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 199
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 237

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRI--IAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            ++ +   +G+G  G V     +  RI   A K  K  V+D     ++ F  EI I+  +
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-----VDRFKQEIEIMKSL 63
Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQH-LHDRHQNEEYPLTWEMRFRVAIEVAG 187
           +H N+++L     +     LV E    G L++  +H R   E          R+  +V  
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA------RIMKDVLS 117
Query: 188 ALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           A+AY H      + HRD+K  N L          K+ DFG +      +  + TK+ GT 
Sbjct: 118 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTP 172
Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Y+ P+  +      + D +S GV++  LL G  P
Sbjct: 173 YYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 98  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 153
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 154 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 203
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 204 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 241

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 43/79 (54%), Gaps = 6/79 (7%)
Query: 200 IYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
           I H D+K  NILL ++ R+  KV DFG+S +   +   V   IQ  F Y  PE    ++ 
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYXXIQSRF-YRAPEVILGARY 276
Query: 258 TDKSDVYSFGVVLVELLTG 276
               D++S G +L ELLTG
Sbjct: 277 GMPIDMWSLGCILAELLTG 295

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG  +       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDSELKILDFGLCR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 109/267 (40%), Gaps = 70/267 (26%)
Query: 70  TNHFNVNRILGQGGQGTVYKG--RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
            + + +  ++G G  G V +   +LE  R++A+KK     +D  L   +  + EI IL++
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLE-KRVVAIKKILRVFED--LIDCKRILREIAILNR 108
Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           +NH +VVK+L   +    P  V +F     LY  L      E     ++  FR  + +  
Sbjct: 109 LNHDHVVKVLDIVI----PKDVEKF---DELYVVL------EIADSDFKKLFRTPVYLTE 155
Query: 188 ------------ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ-- 233
                        + Y+HS     I HRD+K  N L+++    KV DFG ++ +   +  
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 234 ------------------THVTTKIQGTFGYLDPEYHQSSQL-------TDKSDVYSFGV 268
                              H     +   G++   ++++ +L       T+  DV+S G 
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 269 VLVELLTGKKPIFSTGNTSQENVSLAA 295
           +  ELL          N  +ENV+  A
Sbjct: 273 IFAELL----------NMIKENVAYHA 289

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGXVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 28/224 (12%)
Query: 77  RILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           + +G G QG V        G  +AVKK      ++   K      E+ +L  +NH+N++ 
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK--RAYRELVLLKCVNHKNIIS 85
Query: 136 LLGC-----CLETEFP--LLVYEFIPNGTLYQ--HLHDRHQNEEYPLTWEMRFRVAIEVA 186
           LL        LE EF    LV E + +  L Q  H+   H+   Y L          ++ 
Sbjct: 86  LLNVFTPQKTLE-EFQDVYLVMELM-DANLCQVIHMELDHERMSYLL---------YQML 134
Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
             + +LHS     I HRD+K +NI++      K+ DFG ++  + +   + T    T  Y
Sbjct: 135 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTN--FMMTPYVVTRYY 189
Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
             PE        +  D++S G ++ EL+ G      T +  Q N
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 233

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 93  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 149 AD---IIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 198
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 236

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 93  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 149 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 198
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 236

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 84  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 189
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 99  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 155 AD---IIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 204
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 242

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 18/219 (8%)
Query: 77  RILGQGGQGTV---YKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
           + +G G QG V   Y   LE  R +A+KK      ++   K      E+ ++  +NH+N+
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAK--RAYRELVLMKCVNHKNI 85
Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE--EYPLTWEMRFRVAIEVAGALAY 191
           + LL        P    E   +  +   L D + ++  +  L  E    +  ++   + +
Sbjct: 86  IGLLNVFT----PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS     I HRD+K +NI++      K+ DFG ++      + + T    T  Y  PE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
                  +  D++S G ++ E++ G      T +  Q N
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 100 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 156 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 205
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 243

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKK--LSKPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 100 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 156 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 205
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 243

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 100 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 156 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 205
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 243

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 93  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 149 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 198
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 236

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 87  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 142
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 143 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 192
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 193 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 230

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 111 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 167 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 216
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 254

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 85  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 141 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 190
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 228

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 88  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 231

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 111 DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 167 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRWYRAPEI 216
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 254

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 95  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 200
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 86  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 141
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 142 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 191
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 229

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 107 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 163 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 212
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 250

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 90  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 146 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 195
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 233

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
                   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 90  DVFT----PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 146 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 195
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 233

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 108 ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 164 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 213
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 251

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 85  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 141 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 190
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 228

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 105/249 (42%), Gaps = 28/249 (11%)
Query: 52  GSVIDRCKLFSSKELDKA----TNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLA 106
           GS+      F  +EL+K        +     +G G  G+V      + G  +AVKK  L+
Sbjct: 1   GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK--LS 58
Query: 107 VDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH 166
              + +   +    E+ +L  + H NV+ LL        P    E   +  L  HL    
Sbjct: 59  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT----PARSLEEFNDVYLVTHLMGAD 114
Query: 167 QN---EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF 223
            N   +   LT +    +  ++   L Y+HS     I HRD+K +N+ ++E    K+ DF
Sbjct: 115 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDF 171
Query: 224 GTSKFIAMDQTHVTTKIQG---TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           G ++       H   ++ G   T  Y  PE   +    +++ D++S G ++ ELLTG+  
Sbjct: 172 GLAR-------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 224
Query: 280 IFSTGNTSQ 288
              T +  Q
Sbjct: 225 FPGTDHIDQ 233

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 79  LGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G G  G+V      + G  +AVKK  L+   + +   +    E+ +L  + H NV+ LL
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTWEMRFRVAIEVAGALAYLHS 194
               +   P    E   +  L  HL     N   +   LT +    +  ++   L Y+HS
Sbjct: 99  ----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG---TFGYLDPEY 251
                I HRD+K +N+ ++E    K+ DFG ++       H   ++ G   T  Y  PE 
Sbjct: 155 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 204
Query: 252 HQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
             +    +++ D++S G ++ ELLTG+     T +  Q
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 242
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	360
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-122
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-114
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-110
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-77
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-72
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-71
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-70
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-70
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-66
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-62
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-61
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-53
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-43
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-40
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-40
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-35
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-35
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-33
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-32
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-27
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-25
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-16
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-15
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-12
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  353 bits (909), Expect = e-122
 Identities = 115/308 (37%), Positives = 169/308 (54%), Gaps = 11/308 (3%)

Query: 48  NSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAV 107
            S    V          +L++ATN+F+   ++G G  G VYKG L DG  +A+K+     
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR---- 71

Query: 108 DDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
             E    +EEF  EI  LS   H ++V L+G C E    +L+Y+++ NG L +HL+    
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131

Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK 227
                ++WE R  + I  A  L YLH+     I HRD+KS NILLDE +  K+ DFG SK
Sbjct: 132 PTM-SMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 228 -FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
               +DQTH++T ++GT GY+DPEY    +LT+KSDVYSFGVVL E+L  +  I  +   
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL-- 245

Query: 287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
            +E V+LA + V S    +L  I+D  +    +   +  F + A +CL L+ + RP+M +
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305

Query: 347 VSMELNGI 354
           V  +L   
Sbjct: 306 VLWKLEYA 313

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  333 bits (855), Expect = e-114
 Identities = 105/289 (36%), Positives = 172/289 (59%), Gaps = 4/289 (1%)

Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEF 118
           K FS +EL  A+++F+   ILG+GG G VYKGRL DG ++AVK+  L  +  +  +L+ F
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR--LKEERTQGGELQ-F 74

Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
             E+ ++S   HRN+++L G C+     LLVY ++ NG++   L +R +++  PL W  R
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PLDWPKR 133

Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
            R+A+  A  LAYLH      I HRD+K+ NILLDE + A V DFG +K +    THVTT
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV 298
            ++GT G++ PEY  + + ++K+DV+ +GV+L+EL+TG++        + ++V L  +  
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

Query: 299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             +++ +L  ++D  +    K  ++     +A  C   +  +RP M EV
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  322 bits (827), Expect = e-110
 Identities = 102/308 (33%), Positives = 156/308 (50%), Gaps = 18/308 (5%)

Query: 57  RCKLFSSKELDKATNHFN------VNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDE 110
           R   FS  EL   TN+F+          +G+GG G VYKG + +   +AVKK    VD  
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 111 ELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE 170
                ++F  EI ++++  H N+V+LLG   + +   LVY ++PNG+L   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP- 128

Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK-FI 229
            PL+W MR ++A   A  + +LH        HRDIKS NILLDE + AK++DFG ++   
Sbjct: 129 -PLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASE 184

Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
              QT +T++I GT  Y+ PE     ++T KSD+YSFGVVL+E++TG   +    +  +E
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV----DEHRE 239

Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM 349
              L         + +      D+ M       + A  ++A +CL     KRP +++V  
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299

Query: 350 ELNGIRGS 357
            L  +  S
Sbjct: 300 LLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  239 bits (611), Expect = 4e-77
 Identities = 65/315 (20%), Positives = 119/315 (37%), Gaps = 33/315 (10%)

Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFIN 120
             ++ L   +    +  +  +G  G V+K +L     +AVK     + D++ +   +   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKI--FPIQDKQSW---QNEY 67

Query: 121 EIFILSQINHRNVVKLLGCCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           E++ L  + H N+++ +G             L+  F   G+L   L          ++W 
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWN 121

Query: 177 MRFRVAIEVAGALAYLHSGASS-------PIYHRDIKSTNILLDERYRAKVADFGTSKFI 229
               +A  +A  LAYLH             I HRDIKS N+LL     A +ADFG +   
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181

Query: 230 AMDQTHVTTKIQ-GTFGYLDPEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 283
              ++   T  Q GT  Y+ PE      +       + D+Y+ G+VL EL +        
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 284 GNTSQ---ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIV-AFANLAERCLDLNGK 339
            +      E        +  M++  ++      +    +K+  +       E C D + +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 340 KRPTMEEVSMELNGI 354
            R +   V   +  +
Sbjct: 302 ARLSAGCVGERITQM 316

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  224 bits (574), Expect = 9e-72
 Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 36/301 (11%)

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           S   +D       V  ++G+G  G V K +    + +A+K+  +  + E     + FI E
Sbjct: 1   SLHMIDY--KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESER----KAFIVE 51

Query: 122 IFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           +  LS++NH N+VKL G CL    P+ LV E+   G+LY  LH          T      
Sbjct: 52  LRQLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPY--YTAAHAMS 106

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR-AKVADFGTSKFIAMDQTHVTTK 239
             ++ +  +AYLHS     + HRD+K  N+LL       K+ DFGT+     D     T 
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTN 162

Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
            +G+  ++ PE  + S  ++K DV+S+G++L E++T +KP F         +  A +   
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP-FDEIGGPAFRIMWAVH--- 218

Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK 359
                R    L   + K           +L  RC   +  +RP+MEE+   +  +     
Sbjct: 219 --NGTRP--PLIKNLPK--------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266

Query: 360 N 360
            
Sbjct: 267 G 267

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  222 bits (568), Expect = 4e-71
 Identities = 88/295 (29%), Positives = 143/295 (48%), Gaps = 37/295 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKK---SKLAVDDEELYKLEEFINEIFILS 126
           N     + +G+GG G V+KGR ++D  ++A+K         + E + K +EF  E+FI+S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            +NH N+VKL G       P +V EF+P G LY  L D+      P+ W ++ R+ +++A
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIA 132

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDER-----YRAKVADFGTSKFIAMDQTHVTTKIQ 241
             + Y+ +  + PI HRD++S NI L          AKVADFG S+       H  + + 
Sbjct: 133 LGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLL 187

Query: 242 GTFGYLDPE--YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
           G F ++ PE    +    T+K+D YSF ++L  +LTG+ P F   +  +       +   
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGK-----IKFINM 241

Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
              +     I +D   +L          N+ E C   + KKRP    +  EL+ +
Sbjct: 242 IREEGLRPTIPEDCPPRL---------RNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  221 bits (565), Expect = 2e-70
 Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 24/284 (8%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
              N+   +G G  GTV++     G  +AVK   L   D    ++ EF+ E+ I+ ++ H
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKI--LMEQDFHAERVNEFLREVAIMKRLRH 93

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+V  +G   +     +V E++  G+LY+ LH         L    R  +A +VA  + 
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMN 151

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YLH+  + PI HR++KS N+L+D++Y  KV DFG S+  A       +   GT  ++ PE
Sbjct: 152 YLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPE 209

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
             +     +KSDVYSFGV+L EL T ++P +   N +Q         V   +  RL   +
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP-WGNLNPAQ-----VVAAV-GFKCKRL--EI 260

Query: 311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
              +            A + E C      KRP+   +   L  +
Sbjct: 261 PRNLNP--------QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  219 bits (559), Expect = 5e-70
 Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 45/297 (15%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
               +  I+G GG G VY+     G  +AVK ++   D++    +E    E  + + + H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N++ L G CL+     LV EF   G L + L  +       +  ++    A+++A  + 
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMN 119

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYR--------AKVADFGTSKFIAMDQTHVTTKIQG 242
           YLH  A  PI HRD+KS+NIL+ ++           K+ DFG ++     +T   +   G
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAA-G 176

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
            + ++ PE  ++S  +  SDV+S+GV+L ELLTG+ P F   +         AY V +M 
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP-FRGIDGLA-----VAYGV-AMN 229

Query: 303 KNRLYHILDDQVMKLGKKNQI-----VAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
           K  L                I       FA L E C + +   RP+   +  +L  I
Sbjct: 230 KLAL---------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  209 bits (533), Expect = 6e-66
 Identities = 59/290 (20%), Positives = 111/290 (38%), Gaps = 35/290 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
              N    L +   G ++KGR   G  I VK  K+        K  +F  E   L   +H
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTR--KSRDFNEECPRLRIFSH 66

Query: 131 RNVVKLLGCCLETEFPLL--VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            NV+ +LG C     P    +  ++P G+LY  LH+      + +      + A+++A  
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARG 123

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           +A+LH+     I    + S ++++DE   A+++                        ++ 
Sbjct: 124 MAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVA 176

Query: 249 PE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           PE             +D++SF V+L EL+T + P F+  +  +         V ++   R
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVP-FADLSNME-----IGMKV-ALEGLR 229

Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
              I                 + L + C++ +  KRP  + +   L  ++
Sbjct: 230 P-TI---------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  200 bits (511), Expect = 3e-62
 Identities = 61/293 (20%), Positives = 108/293 (36%), Gaps = 42/293 (14%)

Query: 75  VNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV 134
           +  ++G+G  G VY GR   G + A++   +  D+E+   L+ F  E+    Q  H NVV
Sbjct: 37  IGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQ--LKAFKREVMAYRQTRHENVV 92

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
             +G C+      ++       TLY  + D        L      ++A E+   + YLH 
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLH- 147

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA----MDQTHVTTKIQGTFGYLDPE 250
             +  I H+D+KS N+  D   +  + DFG            +        G   +L PE
Sbjct: 148 --AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204

Query: 251 YHQSSQL---------TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
             +             +  SDV++ G +  EL   + P F T            + + + 
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-FKTQPAEA-----IIWQMGTG 258

Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
            K             L +       +++   C     ++RPT  ++   L  +
Sbjct: 259 MK-----------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  196 bits (501), Expect = 5e-61
 Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 35/285 (12%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           + +G G  GTVYKG+      +AVK   +     +   L+ F NE+ +L +  H N++  
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLF 85

Query: 137 LGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           +G    T   L +V ++    +LY HLH      E     +    +A + A  + YLH+ 
Sbjct: 86  MGYS--TAPQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHA- 138

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLDPE---Y 251
               I HRD+KS NI L E    K+ DFG +   +    +H   ++ G+  ++ PE    
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV--HSMRKNRLYHI 309
             S+  + +SDVY+FG+VL EL+TG+ P +S  N            +         L  +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRD-----QIIEMVGRGSLSPDLSKV 250

Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
             +   ++           L   CL     +RP+   +  E+  +
Sbjct: 251 RSNCPKRM---------KRLMAECLKKKRDERPSFPRILAEIEEL 286

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  196 bits (500), Expect = 2e-60
 Identities = 68/328 (20%), Positives = 124/328 (37%), Gaps = 48/328 (14%)

Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFIN 120
            ++ E     ++  +  ++G+G  G VYKG L D R +AVK    +  + +      FIN
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV--FSFANRQ-----NFIN 54

Query: 121 E--IFILSQINHRNVVKLLGCCLETEFP-----LLVYEFIPNGTLYQHLHDRHQNEEYPL 173
           E  I+ +  + H N+ + +              LLV E+ PNG+L ++L           
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TS 108

Query: 174 TWEMRFRVAIEVAGALAYLHSGASS------PIYHRDIKSTNILLDERYRAKVADFGTSK 227
            W    R+A  V   LAYLH+           I HRD+ S N+L+       ++DFG S 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

Query: 228 FIA-------MDQTHVTTKIQGTFGYLDPEY-------HQSSQLTDKSDVYSFGVVLVEL 273
            +         ++ +      GT  Y+ PE                + D+Y+ G++  E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 274 LTGKKPIFSTGNTSQENVSLAAYF-----VHSMRKNRLYHILDDQVMKLGKKNQIV--AF 326
                 +F   +  +  ++             M+          +  +  K+N +   + 
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 327 ANLAERCLDLNGKKRPTMEEVSMELNGI 354
               E C D + + R T +     +  +
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAEL 316

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  191 bits (486), Expect = 2e-58
 Identities = 67/296 (22%), Positives = 115/296 (38%), Gaps = 39/296 (13%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
            +LG+G  G   K    +   + V K  +  D+E       F+ E+ ++  + H NV+K 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNVLKF 72

Query: 137 LGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA 196
           +G   + +    + E+I  GTL   +            W  R   A ++A  +AYLH   
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLH--- 125

Query: 197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-------------GT 243
           S  I HRD+ S N L+ E     VADFG ++ +  ++T                    G 
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
             ++ PE        +K DV+SFG+VL E++               +  L       + +
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFGLN--VRGFLDR 242

Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK 359
               +                +F  +  RC DL+ +KRP+  ++   L  +R  + 
Sbjct: 243 YCPPNCPP-------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  184 bits (469), Expect = 4e-56
 Identities = 62/309 (20%), Positives = 110/309 (35%), Gaps = 53/309 (17%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
             +G+G  G V++G    G  +AVK    +  DE+ +  E    E++    + H N++  
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKI--FSSRDEKSWFRE---TELYNTVMLRHENILGF 67

Query: 137 LGCCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +   + +        L+  +   G+LY +L          L      R+ + +A  LA+L
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHL 121

Query: 193 HSGASS-----PIYHRDIKSTNILLDERYRAKVADFGTSKFIA----MDQTHVTTKIQGT 243
           H           I HRD+KS NIL+ +  +  +AD G +   +            ++ GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 180

Query: 244 FGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPI---------FSTGNTSQ 288
             Y+ PE               + D+++FG+VL E+                F     + 
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240

Query: 289 ENVSLAAYFVHSMRKNRLY---HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME 345
            +       V  + + R         D  +         + A L + C   N   R T  
Sbjct: 241 PSFEDMRKVV-CVDQQRPNIPNRWFSDPTLT--------SLAKLMKECWYQNPSARLTAL 291

Query: 346 EVSMELNGI 354
            +   L  I
Sbjct: 292 RIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  184 bits (469), Expect = 1e-55
 Identities = 63/307 (20%), Positives = 109/307 (35%), Gaps = 49/307 (15%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
           + +G+G  G V+ G+   G  +AVK       +E  +  E    EI+    + H N++  
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKV--FFTTEEASWFRE---TEIYQTVLMRHENILGF 96

Query: 137 LGCCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +   ++         L+ ++  NG+LY +L          L  +   ++A      L +L
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHL 150

Query: 193 HSGASS-----PIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTF 244
           H+   S      I HRD+KS NIL+ +     +AD G +        +         GT 
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 245 GYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST-------GNTSQENV 291
            Y+ PE           Q    +D+YSFG++L E+                  +    + 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270

Query: 292 SLAA-YFVHSMRKNRL---YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           S      +  ++K R         D+ ++            L   C   N   R T   V
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLR--------QMGKLMTECWAHNPASRLTALRV 322

Query: 348 SMELNGI 354
              L  +
Sbjct: 323 KKTLAKM 329

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (450), Expect = 7e-53
 Identities = 65/309 (21%), Positives = 115/309 (37%), Gaps = 55/309 (17%)

Query: 78  ILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
            +G+G  G V++G+   G  +AVK    +  +E  +  E    EI+    + H N++  +
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKI--FSSREERSWFRE---AEIYQTVMLRHENILGFI 102

Query: 138 GCCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
               +         LV ++  +G+L+ +L+       Y +T E   ++A+  A  LA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLH 156

Query: 194 SGASS-----PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI---QGTFG 245
                      I HRD+KS NIL+ +     +AD G +         +        GT  
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 246 YLDPE--------YHQSSQLTDKSDVYSFGVVLVELLTGKKPI---------FSTGNTSQ 288
           Y+ PE         H  S    ++D+Y+ G+V  E+                +     S 
Sbjct: 217 YMAPEVLDDSINMKHFES--FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274

Query: 289 ENVSLAAYFVHSMRKNRLY---HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME 345
            +V      V   +K R          + ++          A +   C   NG  R T  
Sbjct: 275 PSVEEMRKVV-CEQKLRPNIPNRWQSCEALR--------VMAKIMRECWYANGAARLTAL 325

Query: 346 EVSMELNGI 354
            +   L+ +
Sbjct: 326 RIKKTLSQL 334

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  151 bits (384), Expect = 2e-43
 Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 32/283 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLA--VDDEELYKLEEFINEIFILSQ 127
            +F + + +G+G    VY+   L DG  +A+KK ++   +D +      + I EI +L Q
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQ 88

Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY---PLTWEMRFRVAIE 184
           +NH NV+K     +E     +V E    G L + +    + +        W    +  ++
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQ 144

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  AL ++HS     + HRDIK  N+ +      K+ D G  +F +   T   + + GT 
Sbjct: 145 LCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 200

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
            Y+ PE    +    KSD++S G +L E+   + P F     +  ++             
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP-FYGDKMNLYSL------------- 246

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
               I       L   +       L   C++ + +KRP +  V
Sbjct: 247 -CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  146 bits (370), Expect = 1e-41
 Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 39/288 (13%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLA-VDDEELYKLEEFINEIFILSQI 128
             + V   +G G  G   K R   DG+I+  K+     + + E    +  ++E+ +L ++
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK---QMLVSEVNLLREL 62

Query: 129 NHRNVVKLLGCCLETEFPLL--VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            H N+V+     ++     L  V E+   G L   +    +  +Y L  E   RV  ++ 
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLT 121

Query: 187 GALAYLHS--GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
            AL   H        + HRD+K  N+ LD +   K+ DFG ++ +  D +   T + GT 
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTP 180

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
            Y+ PE        +KSD++S G +L EL     P F+  +  +                
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKE---------------- 223

Query: 305 RLYHILDDQVMKLGKKNQI-----VAFANLAERCLDLNGKKRPTMEEV 347
                L  ++ + GK  +I          +  R L+L    RP++EE+
Sbjct: 224 -----LAGKIRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  145 bits (368), Expect = 2e-41
 Identities = 66/294 (22%), Positives = 114/294 (38%), Gaps = 56/294 (19%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
             F    ++G GG G V+K +   DG+   +K+ K        Y  E+   E+  L++++
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAEREVKALAKLD 62

Query: 130 HRNVVKLLGCCLETEFPL----------------LVYEFIPNGTLYQHLHDRHQNEEYPL 173
           H N+V   GC    ++                  +  EF   GTL Q +  R       L
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KL 119

Query: 174 TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ 233
              +   +  ++   + Y+HS     + +RD+K +NI L +  + K+ DFG     ++  
Sbjct: 120 DKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKN 174

Query: 234 THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL 293
               T+ +GT  Y+ PE   S     + D+Y+ G++L ELL      F T          
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-------- 226

Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              F   +R   +  I D +               L ++ L    + RP   E+
Sbjct: 227 ---FFTDLRDGIISDIFDKK------------EKTLLQKLLSKKPEDRPNTSEI 265

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  145 bits (367), Expect = 1e-40
 Identities = 63/292 (21%), Positives = 120/292 (41%), Gaps = 40/292 (13%)

Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLA-VDDEELYKLEEF 118
              + ++K    +   + +G+G  G     +  EDGR   +K+  ++ +  +E    EE 
Sbjct: 18  LYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER---EES 70

Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---EEYPLTW 175
             E+ +L+ + H N+V+      E     +V ++   G L++ ++ +      E+  L W
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
                  +++  AL ++H      I HRDIKS NI L +    ++ DFG ++ +      
Sbjct: 131 ------FVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
               I GT  YL PE  ++    +KSD+++ G VL EL T K   F  G+          
Sbjct: 182 ARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA-FEAGSMKN------- 232

Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             +     +  +  +                 +L  +    N + RP++  +
Sbjct: 233 --LVLKIISGSFPPVSLHYSY--------DLRSLVSQLFKRNPRDRPSVNSI 274

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  143 bits (363), Expect = 2e-40
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 75  VNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQINHR 131
           +   LG GG  TVY          +A+K        + EE   L+ F  E+   SQ++H+
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEET--LKRFEREVHNSSQLSHQ 71

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           N+V ++    E +   LV E+I   TL +++         PL+ +       ++   + +
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKH 126

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGYLDP 249
            H      I HRDIK  NIL+D     K+ DFG +K  A+ +T +T    + GT  Y  P
Sbjct: 127 AHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSP 181

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           E  +     + +D+YS G+VL E+L G+ P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  143 bits (362), Expect = 3e-40
 Identities = 63/316 (19%), Positives = 119/316 (37%), Gaps = 40/316 (12%)

Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFI 119
           F    +     H+   + LG+GG   V     L DG   A+K+  +   +++    EE  
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR--ILCHEQQ--DREEAQ 74

Query: 120 NEIFILSQINHRNVVKLLGCCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
            E  +    NH N+++L+  CL          L+  F   GTL+  +        + LT 
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTE 133

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
           +    + + +   L  +H+       HRD+K TNILL +  +  + D G+     +    
Sbjct: 134 DQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 236 VTTKIQ--------GTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
               +          T  Y  PE         + +++DV+S G VL  ++ G+ P +   
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-YDMV 249

Query: 285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM 344
               ++V+LA        +N+L      +           A   L    + ++  +RP +
Sbjct: 250 FQKGDSVALA-------VQNQLSIPQSPRHSS--------ALWQLLNSMMTVDPHQRPHI 294

Query: 345 EEVSMELNGIRGSIKN 360
             +  +L  ++     
Sbjct: 295 PLLLSQLEALQPPAPG 310

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  146 bits (369), Expect = 4e-39
 Identities = 45/214 (21%), Positives = 82/214 (38%), Gaps = 31/214 (14%)

Query: 75  VNRILGQGGQGTVYKG---RLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           V   +  GG G +Y      + +GR + +K    + D E        + E   L+++ H 
Sbjct: 84  VKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQ---AMAMAERQFLAEVVHP 139

Query: 132 NVVKLL-----GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           ++V++                +V E++   +L +            L         +E+ 
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEIL 192

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
            AL+YLHS     + + D+K  NI+L E  + K+ D G      ++       + GT G+
Sbjct: 193 PALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY---LYGTPGF 243

Query: 247 LDPEYHQ-SSQLTDKSDVYSFGVVLVELLTGKKP 279
             PE     +  T  +D+Y+ G  L  L      
Sbjct: 244 QAPE--IVRTGPTVATDIYTVGRTLAALTLDLPT 275

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  139 bits (352), Expect = 6e-39
 Identities = 62/301 (20%), Positives = 113/301 (37%), Gaps = 52/301 (17%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
             F   + LG+GG G V++ +   D    A+K+ +L   +      E+ + E+  L+++ 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKALAKLE 61

Query: 130 HRNVVKLLGCCLE---------TEFPLLVY---EFIPNGTLYQHLHDRHQNEEYPLTWEM 177
           H  +V+     LE         +   + +Y   +      L   ++ R   EE      +
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSV 119

Query: 178 RFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 237
              + +++A A+ +LHS     + HRD+K +NI        KV DFG    +  D+   T
Sbjct: 120 CLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 238 TKIQ-----------GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT 286
                          GT  Y+ PE    +  + K D++S G++L ELL      FST   
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----PFSTQ-- 230

Query: 287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
                         M + R    + +         +      + +  L  +  +RP    
Sbjct: 231 --------------MERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAIN 276

Query: 347 V 347
           +
Sbjct: 277 I 277

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  139 bits (351), Expect = 7e-39
 Identities = 63/280 (22%), Positives = 115/280 (41%), Gaps = 40/280 (14%)

Query: 76  NRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYK--LEEFINEIFILSQINHRN 132
           +  +G+G   TVYKG   E    +A  +    + D +L K   + F  E  +L  + H N
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCE----LQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 133 VVKLLGCCLETEFP----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           +V+       T       +LV E + +GTL  +L  R +     +  ++      ++   
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFK----VMKIKVLRSWCRQILKG 141

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           L +LH+  + PI HRD+K  NI +       K+ D G +             + GT  ++
Sbjct: 142 LQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFM 197

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE ++  +  +  DVY+FG+ ++E+ T + P     N +Q                 +Y
Sbjct: 198 APEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----------------IY 239

Query: 308 HILDDQVMKLG-KKNQIVAFANLAERCLDLNGKKRPTMEE 346
             +   V      K  I     + E C+  N  +R ++++
Sbjct: 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (351), Expect = 9e-39
 Identities = 78/310 (25%), Positives = 126/310 (40%), Gaps = 65/310 (20%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            + F    +LGQG  G V K R   D R  A+KK +   +          ++E+ +L+ +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-----TILSEVMLLASL 59

Query: 129 NHRNVVKLLGCCLETEFPL-------------LVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           NH+ VV+     LE    +             +  E+  NGTLY  +H  + N++    W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI------ 229
            + FR   ++  AL+Y+HS     I HRD+K  NI +DE    K+ DFG +K +      
Sbjct: 120 RL-FR---QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 230 --------AMDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
                        ++T+ I GT  Y+  E    +    +K D+YS G++  E++      
Sbjct: 173 LKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---- 227

Query: 281 FSTGNTSQE---NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLN 337
           FSTG         +   +               DD  MK+ KK        +    +D +
Sbjct: 228 FSTGMERVNILKKLRSVSI--------EFPPDFDDNKMKVEKK--------IIRLLIDHD 271

Query: 338 GKKRPTMEEV 347
             KRP    +
Sbjct: 272 PNKRPGARTL 281

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  137 bits (348), Expect = 3e-38
 Identities = 63/278 (22%), Positives = 98/278 (35%), Gaps = 35/278 (12%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-N 129
            F     LG G  G V+K R  EDGR+ AVK+S       +       + E+    ++  
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQ 115

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H   V+L     E     L  E     +L QH     +     L     +    +   AL
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTLLAL 170

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
           A+LHS     + H D+K  NI L  R R K+ DFG      +         +G   Y+ P
Sbjct: 171 AHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRYMAP 225

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
           E  Q       +DV+S G+ ++E+    +     G                +R+  L   
Sbjct: 226 ELLQ-GSYGTAADVFSLGLTILEVACNMEL-PHGGEG-----------WQQLRQGYLPPE 272

Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
               +             ++    L+ + K R T E +
Sbjct: 273 FTAGLSS--------ELRSVLVMMLEPDPKLRATAEAL 302

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  137 bits (348), Expect = 4e-38
 Identities = 54/212 (25%), Positives = 82/212 (38%), Gaps = 22/212 (10%)

Query: 75  VNRILGQGGQGTVYKGRLED---GRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQIN 129
           + R++G+GG G VY+    D    RI+A+K     L+  D           E     ++ 
Sbjct: 38  LRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLS-SDPVF--RTRMQREARTAGRLQ 92

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
             +VV +           +    I    L   L       + PL       +  ++  AL
Sbjct: 93  EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR-----RQGPLAPPRAVAIVRQIGSAL 147

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGTFGYL 247
              H+       HRD+K  NIL+     A + DFG +   A     +T      GT  Y+
Sbjct: 148 DAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYM 202

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            PE    S  T ++D+Y+   VL E LTG  P
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPP 234

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  137 bits (347), Expect = 5e-38
 Identities = 68/216 (31%), Positives = 96/216 (44%), Gaps = 24/216 (11%)

Query: 75  VNRILGQGGQGTVYKG---RLEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQIN 129
           +  ILG GG   V+     R    R +AVK  ++ LA  D        F  E    + +N
Sbjct: 16  LGEILGFGGMSEVHLARDLRD--HRDVAVKVLRADLA-RDPSF--YLRFRREAQNAAALN 70

Query: 130 HRNVVKLL--GCCLETEFPL--LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           H  +V +   G       PL  +V E++   TL   +H        P+T +    V  + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADA 125

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT--KIQGT 243
             AL + H      I HRD+K  NI++      KV DFG ++ IA     VT    + GT
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
             YL PE  +   +  +SDVYS G VL E+LTG+ P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  134 bits (339), Expect = 4e-37
 Identities = 71/283 (25%), Positives = 113/283 (39%), Gaps = 48/283 (16%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
            +LG+G  G VY GR L +   IA+K+     D      L E   EI +   + H+N+V+
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHE---EIALHKHLKHKNIVQ 83

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV-AIEVAGALAYLHS 194
            LG   E  F  +  E +P G+L   L  +    +     E        ++   L YLH 
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIGFYTKQILEGLKYLH- 139

Query: 195 GASSPIYHRDIKSTNILLDERY-RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE--Y 251
              + I HRDIK  N+L++      K++DFGTSK +A       T   GT  Y+ PE   
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIID 196

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI-- 309
                    +D++S G  ++E+ TGK P +  G         AA          ++ +  
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAA----------MFKVGM 240

Query: 310 ------LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
                 + + +    K            +C + +  KR    +
Sbjct: 241 FKVHPEIPESMSAEAK--------AFILKCFEPDPDKRACAND 275

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  136 bits (345), Expect = 4e-37
 Identities = 62/268 (23%), Positives = 112/268 (41%), Gaps = 29/268 (10%)

Query: 28  IRLKEKFFKQNGGLL--LQQMLNSY----------DGSVIDRCKLFSSKELDKATNHFNV 75
           I+  +  ++  G     +  +++             G V+ R        L+       +
Sbjct: 61  IQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNH--EDLVL 118

Query: 76  NRILGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVV 134
              +G+G  G V+ GRL      +AVK  +  +  +      +F+ E  IL Q +H N+V
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK---AKFLQEARILKQYSHPNIV 175

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
           +L+G C + +   +V E +  G     L    + E   L  +   ++  + A  + YL  
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLE- 230

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LDPEYH 252
             S    HRD+ + N L+ E+   K++DFG S+  A D  +  +            PE  
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEAL 287

Query: 253 QSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              + + +SDV+SFG++L E  + G  P
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP 315

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  134 bits (340), Expect = 5e-37
 Identities = 62/292 (21%), Positives = 116/292 (39%), Gaps = 44/292 (15%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
             +++ + +G GG   V++   E  +I A+K  +    D++    L+ + NEI  L+++ 
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQ 84

Query: 130 HRN--VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
             +  +++L    +  ++  +V E   N  L   L  +       +    R      +  
Sbjct: 85  QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLE 138

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGY 246
           A+  +H      I H D+K  N L+ +    K+ DFG +  +  D T V    Q GT  Y
Sbjct: 139 AVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194

Query: 247 LDPE-----------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
           + PE               S+++ KSDV+S G +L  +  GK P F              
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQQIINQIS------ 247

Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                    +L+ I+D                ++ + CL  + K+R ++ E+
Sbjct: 248 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  135 bits (341), Expect = 5e-37
 Identities = 62/318 (19%), Positives = 106/318 (33%), Gaps = 55/318 (17%)

Query: 37  QNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDG 95
            N G+LL + L   D    +     + +              +G+G  G V++ +  + G
Sbjct: 36  DNEGVLLTEKLKPVDYEYREEVHWMTHQPR------------VGRGSFGEVHRMKDKQTG 83

Query: 96  RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPN 155
              AVKK +L V   E         E+   + ++   +V L G   E  +  +  E +  
Sbjct: 84  FQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134

Query: 156 GTLYQHLHDRHQNEEYPLTWEMRFRV-AIEVAGALAYLHSGASSPIYHRDIKSTNILLDE 214
           G+L Q +      ++     E R      +    L YLH   +  I H D+K+ N+LL  
Sbjct: 135 GSLGQLI------KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSS 185

Query: 215 R-YRAKVADFGTSKFIAMDQTHVTTK----IQGTFGYLDPEYHQSSQLTDKSDVYSFGVV 269
              RA + DFG +  +  D    +      I GT  ++ PE         K D++S   +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245

Query: 270 LVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQI-VAFAN 328
           ++ +L G  P                             I  +               A 
Sbjct: 246 MLHMLNGCHPWTQ---------------YFRGPL--CLKIASEPPPIREIPPSCAPLTAQ 288

Query: 329 LAERCLDLNGKKRPTMEE 346
             +  L      R +  E
Sbjct: 289 AIQEGLRKEPVHRASAME 306

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  137 bits (346), Expect = 1e-36
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 15/217 (6%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIF 123
           E+++      +   LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 268

Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           ++ +I H N+V+LLG C       ++ EF+  G L  +L +        ++  +   +A 
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMAT 325

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           +++ A+ YL         HR++ + N L+ E +  KVADFG S+ +  D        +  
Sbjct: 326 QISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 382

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             +  PE    ++ + KSDV++FGV+L E+ T G  P
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  133 bits (338), Expect = 1e-36
 Identities = 55/212 (25%), Positives = 104/212 (49%), Gaps = 22/212 (10%)

Query: 77  RILGQGGQGTVYKGRL----EDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           ++LG G  GTVYKG      E  +I +A+K+ + A   +     +E ++E ++++ +++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMASVDNP 77

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +V +LLG CL +    L+ + +P G L  ++ +   N              +++A  + Y
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW----CVQIAKGMNY 132

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT---FGYLD 248
           L       + HRD+ + N+L+      K+ DFG +K +  ++       +G      ++ 
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMA 187

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            E       T +SDV+S+GV + EL+T G KP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (338), Expect = 2e-36
 Identities = 62/292 (21%), Positives = 115/292 (39%), Gaps = 44/292 (15%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
             +++ + +G GG   V++   E  +I A+K  +    D++    L+ + NEI  L+++ 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQ 65

Query: 130 H--RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +++L    +  ++  +V E   N  L   L  +       +    R      +  
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLE 119

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGY 246
           A+  +H      I H D+K  N L+ +    K+ DFG +  +  D T V    Q GT  Y
Sbjct: 120 AVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175

Query: 247 LDPE-----------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
           + PE               S+++ KSDV+S G +L  +  GK P F              
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQQIINQIS------ 228

Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                    +L+ I+D                ++ + CL  + K+R ++ E+
Sbjct: 229 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  132 bits (333), Expect = 4e-36
 Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 52/306 (16%)

Query: 77  RILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + LG+G  G+V   R +      G ++AVKK + + ++     L +F  EI IL  + H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSLQHD 71

Query: 132 NVVKLLGCCLET-EFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+VK  G C       L L+ E++P G+L  +L    +  ++    +       ++   +
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----TSQICKGM 127

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 247
            YL +       HRD+ + NIL++   R K+ DFG +K +  D+     K  G     + 
Sbjct: 128 EYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE    S+ +  SDV+SFGVVL EL T  +   S        +         M    L 
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QMIVFHLI 242

Query: 308 HILDD---------------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
            +L +                +M                 C + N  +RP+  ++++ ++
Sbjct: 243 ELLKNNGRLPRPDGCPDEIYMIMT---------------ECWNNNVNQRPSFRDLALRVD 287

Query: 353 GIRGSI 358
            IR ++
Sbjct: 288 QIRDNM 293

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  134 bits (338), Expect = 4e-36
 Identities = 61/292 (20%), Positives = 112/292 (38%), Gaps = 44/292 (15%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQIN 129
             +++ + +G GG   V++   E  +I A+K  +    D++ L       NEI  L+++ 
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYR---NEIAYLNKLQ 112

Query: 130 H--RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
                +++L    +  ++  +V E   N  L   L  +       +    R      +  
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLE 166

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-GTFGY 246
           A+  +H      I H D+K  N L+ +    K+ DFG +  +  D T V    Q G   Y
Sbjct: 167 AVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222

Query: 247 LDPE-----------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
           + PE               S+++ KSDV+S G +L  +  GK P F              
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-FQQIINQIS------ 275

Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                    +L+ I+D                ++ + CL  + K+R ++ E+
Sbjct: 276 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  131 bits (331), Expect = 9e-36
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 29/223 (13%)

Query: 75  VNRILGQGGQGTVYKGRLEDGR----IIAVK--KSKLAVDDEELYKLEEFINEIFILSQI 128
           + +ILG+G  G+V +G L+        +AVK  K   +   E    +EEF++E   +   
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE----IEEFLSEAACMKDF 93

Query: 129 NHRNVVKLLGCCLETE-----FPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVA 182
           +H NV++LLG C+E        P+++  F+  G L+ +L + R +     +  +   +  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
           +++A  + YL   ++    HRD+ + N +L +     VADFG SK I     +     QG
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QG 206

Query: 243 TFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
               +       E       T KSDV++FGV + E+ T G  P
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  131 bits (332), Expect = 9e-36
 Identities = 73/307 (23%), Positives = 127/307 (41%), Gaps = 52/307 (16%)

Query: 77  RILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + LG+G  G+V   R +      G ++AVKK + + ++     L +F  EI IL  + H 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----LRDFEREIEILKSLQHD 102

Query: 132 NVVKLLGCCLET-EFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+VK  G C       L L+ E++P G+L  +L    +  ++    +       ++   +
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY----TSQICKGM 158

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 247
            YL    +    HRD+ + NIL++   R K+ DFG +K +  D+ +   K  G     + 
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE    S+ +  SDV+SFGVVL EL T  +   S        +         M    L 
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QMIVFHLI 273

Query: 308 HILDD---------------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
            +L +                +M                 C + N  +RP+  ++++ ++
Sbjct: 274 ELLKNNGRLPRPDGCPDEIYMIMT---------------ECWNNNVNQRPSFRDLALRVD 318

Query: 353 GIRGSIK 359
            IR  + 
Sbjct: 319 QIRDQMA 325

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  132 bits (333), Expect = 1e-35
 Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 23/214 (10%)

Query: 77  RILGQGGQGTVYKGRLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
            ++G+G  G VY G L D        AVK      D  E+    +F+ E  I+   +H N
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKDFSHPN 151

Query: 133 VVKLLGCCLETEFPLL-VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           V+ LLG CL +E   L V  ++ +G L   +    +NE +  T +      ++VA  + +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKF 207

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL---- 247
           L   AS    HRD+ + N +LDE++  KVADFG ++ +   +         T   L    
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKW 262

Query: 248 -DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              E  Q+ + T KSDV+SFGV+L EL+T G  P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  130 bits (328), Expect = 2e-35
 Identities = 71/276 (25%), Positives = 126/276 (45%), Gaps = 33/276 (11%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           +     +GQG  GTVY    +  G+ +A+++  L    ++    E  INEI ++ +  + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----ELIINEILVMRENKNP 77

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           N+V  L   L  +   +V E++  G+L   + +   +E           V  E   AL +
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEF 131

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LHS   + + HRDIKS NILL      K+ DFG    I  +Q+  +T + GT  ++ PE 
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEV 187

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD 311
                   K D++S G++ +E++ G+ P  +                + +R   LY I  
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN---------------ENPLRA--LYLIAT 230

Query: 312 DQVMKLGKKNQI-VAFANLAERCLDLNGKKRPTMEE 346
           +   +L    ++   F +   RCL+++ +KR + +E
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  130 bits (330), Expect = 2e-35
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 26/222 (11%)

Query: 75  VNRILGQGGQGTVYKGRLEDG----RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           + R+LG+G  G+V + +L+        +AVK  K  +       +EEF+ E   + + +H
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDH 84

Query: 131 RNVVKLLGCCLETE------FPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAI 183
            +V KL+G  L +        P+++  F+ +G L+  L   R     + L  +   R  +
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++A  + YL   +S    HRD+ + N +L E     VADFG S+ I     +     QG 
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGC 197

Query: 244 FGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              L       E    +  T  SDV++FGV + E++T G+ P
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  129 bits (327), Expect = 2e-35
 Identities = 57/300 (19%), Positives = 112/300 (37%), Gaps = 54/300 (18%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           T  F+    +G G  G+V+K     DG I A+K+SK  +        +  + E++  + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV--DEQNALREVYAHAVL 67

Query: 129 -NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
             H +VV+      E +  L+  E+   G+L   + + ++             + ++V  
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFKEAELKDLLLQVGR 126

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDE-------------------RYRAKVADFGTSKF 228
            L Y+HS     + H DIK +NI +                     +   K+ D G    
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 229 IAMDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS 287
           I+  Q        G   +L  E   ++     K+D+++  + +V      +P+   G+  
Sbjct: 184 ISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-EPLPRNGDQ- 236

Query: 288 QENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                      H +R+ RL  I       L +      F  L +  +  + ++RP+   +
Sbjct: 237 ----------WHEIRQGRLPRIPQ----VLSQ-----EFTELLKVMIHPDPERRPSAMAL 277

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (328), Expect = 2e-35
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 23/214 (10%)

Query: 77  RILGQGGQGTVYKGRLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
            ++G+G  G VY G L D        AVK      D  E+    +F+ E  I+   +H N
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKDFSHPN 87

Query: 133 VVKLLGCCLETEFPLL-VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           V+ LLG CL +E   L V  ++ +G L   +    +NE +  T +      ++VA  + Y
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKY 143

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL---- 247
           L   AS    HRD+ + N +LDE++  KVADFG ++ +        +    T   L    
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKW 198

Query: 248 -DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              E  Q+ + T KSDV+SFGV+L EL+T G  P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  130 bits (328), Expect = 2e-35
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 38/279 (13%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
            F     +G+G  G V+KG      +++A+K   L   ++E+   E+   EI +LSQ + 
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI---EDIQQEITVLSQCDS 79

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI---EVAG 187
             V K  G  L+     ++ E++  G+    L     +E           +A    E+  
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---------IATILREILK 130

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
            L YLHS       HRDIK+ N+LL E    K+ADFG +  +   Q    T + GT  ++
Sbjct: 131 GLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 186

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE  + S    K+D++S G+  +EL  G+ P                  +H M+   L+
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSE---------------LHPMKV--LF 229

Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
            I  +    L + N         E CL+     RPT +E
Sbjct: 230 LIPKNNPPTL-EGNYSKPLKEFVEACLNKEPSFRPTAKE 267

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  132 bits (334), Expect = 3e-35
 Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 41/286 (14%)

Query: 73  FNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HR 131
           F    +LG G +GT+    + D R +AVK+                  E+ +L + + H 
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE-------CFSFADREVQLLRESDEHP 78

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           NV++      + +F  +  E     T    L +  + +++         +  +    LA+
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-AT----LQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133

Query: 192 LHSGASSPIYHRDIKSTNILLDE-----RYRAKVADFGTSKFIAMDQ--THVTTKIQGTF 244
           LH   S  I HRD+K  NIL+       + +A ++DFG  K +A+ +      + + GT 
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 245 GYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
           G++ PE          T   D++S G V   +++     F      Q N+         +
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---------L 241

Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                   L        +K++ V    L E+ + ++ +KRP+ + V
Sbjct: 242 LGACSLDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  132 bits (334), Expect = 3e-35
 Identities = 68/303 (22%), Positives = 121/303 (39%), Gaps = 50/303 (16%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-N 129
           N     +ILG G  GTV       GR +AVK+  +          +  + EI +L++  +
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDD 67

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI--EVAG 187
           H NV++         F  +  E   N  L   +  ++ ++E     +    +++  ++A 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLD-------------ERYRAKVADFGTSKFIAMDQT 234
            +A+LH   S  I HRD+K  NIL+              E  R  ++DFG  K +   Q+
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 235 HVTTKIQ---GTFGYLDPE-------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
              T +    GT G+  PE            +LT   D++S G V   +L+  K  F   
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM 344
            + + N+    +       + +  + D  ++            +L  + +D +  KRPT 
Sbjct: 244 YSRESNIIRGIF-----SLDEMKCLHDRSLIAEAT--------DLISQMIDHDPLKRPTA 290

Query: 345 EEV 347
            +V
Sbjct: 291 MKV 293

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  129 bits (326), Expect = 7e-35
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 27/221 (12%)

Query: 76  NRILGQGGQGTVYKGRLEDGR------IIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           +R LGQG  G VY+G  +          +A+K    A    E     EF+NE  ++ + N
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASVMKEFN 86

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-----HQNEEYPLTWEMRFRVAIE 184
             +VV+LLG   + +  L++ E +  G L  +L        +     P +     ++A E
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +A  +AYL    ++   HRD+ + N ++ E +  K+ DFG ++ I     +     +G  
Sbjct: 147 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGK 199

Query: 245 GYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           G L      PE  +    T  SDV+SFGVVL E+ T  ++P
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (323), Expect = 1e-34
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)

Query: 77  RILGQGGQGTVYKGRLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           R++G+G  G VY G   D        A+K      + +++   E F+ E  ++  +NH N
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV---EAFLREGLLMRGLNHPN 83

Query: 133 VVKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           V+ L+G  L  E  P ++  ++ +G L Q +    ++ +   T +      ++VA  + Y
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEY 139

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL---- 247
           L   A     HRD+ + N +LDE +  KVADFG ++ I        +  Q     L    
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKW 194

Query: 248 -DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              E  Q+ + T KSDV+SFGV+L ELLT G  P
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  128 bits (324), Expect = 2e-34
 Identities = 51/225 (22%), Positives = 98/225 (43%), Gaps = 24/225 (10%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRL----EDGRI-IAVKKSKLAVDDEELYKLEEF 118
           +   +        ++LG G  GTV+KG      E  +I + +K  +     +     +  
Sbjct: 8   RIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF---QAV 62

Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
            + +  +  ++H ++V+LLG C       LV +++P G+L  H+          L     
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW- 120

Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
               +++A  + YL       + HR++ + N+LL    + +VADFG +  +  D   +  
Sbjct: 121 ---GVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174

Query: 239 KIQGT---FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                     ++  E     + T +SDV+S+GV + EL+T G +P
Sbjct: 175 --SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  128 bits (323), Expect = 2e-34
 Identities = 55/212 (25%), Positives = 104/212 (49%), Gaps = 22/212 (10%)

Query: 77  RILGQGGQGTVYKGRL----EDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           ++LG G  GTVYKG      E  +I +A+K+ + A   +     +E ++E ++++ +++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMASVDNP 77

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +V +LLG CL +    L+ + +P G L  ++ +   N              +++A  + Y
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW----CVQIAKGMNY 132

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT---FGYLD 248
           L       + HRD+ + N+L+      K+ DFG +K +  ++       +G      ++ 
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMA 187

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            E       T +SDV+S+GV + EL+T G KP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  128 bits (323), Expect = 2e-34
 Identities = 75/270 (27%), Positives = 118/270 (43%), Gaps = 33/270 (12%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V   R    GR +AVK   L          E   NE+ I+    H NVV++ 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR----ELLFNEVVIMRDYQHFNVVEMY 108

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
              L  E   ++ EF+  G L   +     NEE   T      V   V  ALAYLH+   
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT------VCEAVLQALAYLHA--- 159

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             + HRDIKS +ILL    R K++DFG    I+ D     + + GT  ++ PE    S  
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLY 218

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKL 317
             + D++S G++++E++ G+ P FS                  ++   +  + D    KL
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFS---------------DSPVQA--MKRLRDSPPPKL 261

Query: 318 GKKNQI-VAFANLAERCLDLNGKKRPTMEE 346
              +++     +  ER L  + ++R T +E
Sbjct: 262 KNSHKVSPVLRDFLERMLVRDPQERATAQE 291

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  131 bits (332), Expect = 2e-34
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 17/217 (7%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           E+ +      +   LGQG  G V+ G       +A+K  K      E      F+ E  +
Sbjct: 263 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-----AFLQEAQV 315

Query: 125 LSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           + ++ H  +V+L      +E P+ +V E++  G+L   L          L       +A 
Sbjct: 316 MKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAA 370

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++A  +AY+         HRD+++ NIL+ E    KVADFG ++ I  ++       +  
Sbjct: 371 QIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             +  PE     + T KSDV+SFG++L EL T G+ P
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  127 bits (321), Expect = 2e-34
 Identities = 71/303 (23%), Positives = 120/303 (39%), Gaps = 54/303 (17%)

Query: 77  RILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           R LG+G  G V   R +      G  +AVK  K       +    +   EI IL  + H 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLYHE 83

Query: 132 NVVKLLGCCLETEFP--LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+VK  G C E       L+ EF+P+G+L ++L       +  +  + + + A+++   +
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGM 139

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 247
            YL    S    HRD+ + N+L++  ++ K+ DFG +K I  D+ + T K        + 
Sbjct: 140 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
            PE    S+    SDV+SFGV L ELLT          +     + +       M   RL
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSD----SSPMALFLKMIGPTHGQMTVTRL 252

Query: 307 YHILDD---------------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
            + L +               Q+M+               +C +     R + + +    
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLMR---------------KCWEFQPSNRTSFQNLIEGF 297

Query: 352 NGI 354
             +
Sbjct: 298 EAL 300

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  127 bits (322), Expect = 2e-34
 Identities = 63/254 (24%), Positives = 99/254 (38%), Gaps = 35/254 (13%)

Query: 36  KQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLED- 94
             + G L        D +V  +              +    R LG+G  G V     +  
Sbjct: 9   HHHHGALEVLFQGPGDPTVFHK-------------RYLKKIRDLGEGHFGKVSLYCYDPT 55

Query: 95  ----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP--LL 148
               G ++AVK  K     +       +  EI IL  + H +++K  GCC +       L
Sbjct: 56  NDGTGEMVAVKALKADAGPQHR---SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112

Query: 149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKST 208
           V E++P G+L  +L          +        A ++   +AYLH   +    HRD+ + 
Sbjct: 113 VMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAAR 163

Query: 209 NILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDPEYHQSSQLTDKSDVYSF 266
           N+LLD     K+ DFG +K +     +   +  G     +  PE  +  +    SDV+SF
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223

Query: 267 GVVLVELLT-GKKP 279
           GV L ELLT     
Sbjct: 224 GVTLYELLTHCDSS 237

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  129 bits (324), Expect = 2e-34
 Identities = 37/314 (11%), Positives = 77/314 (24%), Gaps = 50/314 (15%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIF 123
            L +      +   L  G +  V+  R +E     A+K   +  ++    +LE      F
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS-ELERLHEATF 114

Query: 124 ILSQINHRNVVKLLGCC-LETEFPLLVYEFIPN------------------------GTL 158
             +++   +  +      L      +  +  P                           L
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174

Query: 159 YQ--HLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDER 215
                  D                +  ++    A L S G    + H      N+ +   
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPD 230

Query: 216 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY--HQSSQLTDKSDVYSFGVVLVEL 273
            R  + D                       Y   E+    ++  T   + +  G+ +  +
Sbjct: 231 GRLMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286

Query: 274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERC 333
                P F       +          S ++  L     D +              L  R 
Sbjct: 287 WCLFLP-FGLVTPGIK---------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336

Query: 334 LDLNGKKRPTMEEV 347
           L+ + ++R    E 
Sbjct: 337 LNFDRRRRLLPLEA 350

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  126 bits (319), Expect = 3e-34
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 23/221 (10%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRI-IAVKKSKLAVDDEELYKLEEFINEIF 123
           E+++      +   LG G  G VY+G  +   + +AVK  K     E+  ++EEF+ E  
Sbjct: 9   EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 61

Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           ++ +I H N+V+LLG C       ++ EF+  G L  +L +        ++  +   +A 
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMAT 118

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK---- 239
           +++ A+ YL         HRD+ + N L+ E +  KVADFG S+ +  D           
Sbjct: 119 QISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175

Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           I+ T     PE    ++ + KSDV++FGV+L E+ T G  P
Sbjct: 176 IKWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  127 bits (320), Expect = 4e-34
 Identities = 64/310 (20%), Positives = 118/310 (38%), Gaps = 51/310 (16%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           + + ++ ILGQG    V++GR  + G + A+K           +          E  +L 
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM------REFEVLK 62

Query: 127 QINHRNVVKLLGC--CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI- 183
           ++NH+N+VKL        T   +L+ EF P G+LY  L +       P   E  F + + 
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLR 119

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTK 239
           +V G + +L     + I HR+IK  NI+     D +   K+ DFG ++   ++       
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVS 174

Query: 240 IQGTFGYLDPEYHQSSQLTD--------KSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           + GT  YL P+ ++ + L            D++S GV      TG  P F      + N 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-FRPFEGPRRNK 233

Query: 292 SL--------------AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLN 337
            +                    +   +    +     +  G +  +     +    L+ +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT---PVLANILEAD 290

Query: 338 GKKRPTMEEV 347
            +K    ++ 
Sbjct: 291 QEKCWGFDQF 300

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  125 bits (317), Expect = 4e-34
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 23/220 (10%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           EL +      + + LG G  G V  G+ +    +AVK  K     E+     EF  E   
Sbjct: 4   ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-----EFFQEAQT 56

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           + +++H  +VK  G C +     +V E+I NG L  +L    ++    L       +  +
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYD 112

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--I 240
           V   +A+L    S    HRD+ + N L+D     KV+DFG ++++  DQ  + V TK  +
Sbjct: 113 VCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           + +     PE     + + KSDV++FG+++ E+ + GK P
Sbjct: 170 KWS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  127 bits (320), Expect = 5e-34
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 19/223 (8%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFI 119
           +E++   +  ++ +I+G G  G V  GRL    +    +A+K  K    + +     +F+
Sbjct: 44  REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFL 98

Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           +E  I+ Q +H N+++L G        ++V E++ NG+L   L    +  +   T     
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLV 154

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
            +   V   + YL   +     HRD+ + N+L+D     KV+DFG S+ +  D     T 
Sbjct: 155 GMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211

Query: 240 IQGTFGYL--DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             G        PE       +  SDV+SFGVV+ E+L  G++P
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  127 bits (320), Expect = 5e-34
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 77  RILGQGGQGTVYKGRLEDGR------IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           R LG G  G VY+G++           +AVK       +++     +F+ E  I+S+ NH
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNH 92

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL--HDRHQNEEYPLTWEMRFRVAIEVAGA 188
           +N+V+ +G  L++    ++ E +  G L   L       ++   L       VA ++A  
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 189 LAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             YL     +   HRDI + N LL        AK+ DFG ++ I     +     +G   
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR----KGGCA 205

Query: 246 YL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            L      PE       T K+D +SFGV+L E+ + G  P
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  125 bits (317), Expect = 6e-34
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 21/219 (9%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           E+ +      +   LG G  G V+ G       +AVK  K      +      F+ E  +
Sbjct: 9   EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-----AFLAEANL 61

Query: 125 LSQINHRNVVKLLGCCLETEFPLL-VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           + Q+ H+ +V+L      T+ P+  + E++ NG+L   L          LT      +A 
Sbjct: 62  MKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAA 116

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++A  +A++         HRD+++ NIL+ +    K+ADFG ++ I  ++   T +    
Sbjct: 117 QIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAK 171

Query: 244 FGY--LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           F      PE       T KSDV+SFG++L E++T G+ P
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  127 bits (322), Expect = 6e-34
 Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 19/223 (8%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFI 119
           KELD    + ++++++G G  G V  GRL    +    +A+K  K+   +++     +F+
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFL 94

Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
            E  I+ Q +H N+++L G   +++  ++V E++ NG+L   L    +  +   T     
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLV 150

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
            +   +A  + YL   +     HRD+ + NIL++     KV+DFG  + +  D     T 
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207

Query: 240 IQGTFGYL--DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             G        PE     + T  SDV+S+G+VL E+++ G++P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  125 bits (316), Expect = 7e-34
 Identities = 80/285 (28%), Positives = 120/285 (42%), Gaps = 50/285 (17%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQI 128
           F + R LG+G  G VY  R  +   I+A+K   K++L    E+     +   E+ I S +
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL----EKAGVEHQLRREVEIQSHL 66

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N+++L G   +     L+ E+ P GT+Y+ L    + +E          +  E+A A
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYIT-ELANA 121

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L+Y HS     + HRDIK  N+LL      K+ADFG S   A           GT  YL 
Sbjct: 122 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLP 175

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAY----FVHSMR 302
           PE  +     +K D++S GV+  E L GK P F      +  + +S   +    FV    
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRVEFTFPDFVTEGA 234

Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +                        +L  R L  N  +RP + EV
Sbjct: 235 R------------------------DLISRLLKHNPSQRPMLREV 255

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  126 bits (319), Expect = 7e-34
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 33/225 (14%)

Query: 77  RILGQGGQGTVYKGRLEDGR------IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
             LG+G  G V+     +        ++AVK  K A +       ++F  E  +L+ + H
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTMLQH 102

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL----------HDRHQNEEYPLTWEMRFR 180
           +++V+  G C E    L+V+E++ +G L + L                   PL       
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
           VA +VA  + YL   A     HRD+ + N L+ +    K+ DFG S+ I    +    ++
Sbjct: 163 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRV 216

Query: 241 QGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            G    L      PE     + T +SDV+SFGVVL E+ T GK+P
Sbjct: 217 GGR-TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  129 bits (325), Expect = 7e-34
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 17/217 (7%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           E+ +      +   LGQG  G V+ G       +A+K  K      E      F+ E  +
Sbjct: 180 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-----AFLQEAQV 232

Query: 125 LSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           + ++ H  +V+L      +E P+ +V E++  G+L   L          L       +A 
Sbjct: 233 MKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAA 287

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++A  +AY+         HRD+++ NIL+ E    KVADFG ++ I  ++       +  
Sbjct: 288 QIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             +  PE     + T KSDV+SFG++L EL T G+ P
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  126 bits (319), Expect = 8e-34
 Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 20/224 (8%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRI-----IAVKKSKLAVDDEELYKLEEF 118
            E+    +     +++G G  G VYKG L+         +A+K  K    +++     +F
Sbjct: 39  TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDF 93

Query: 119 INEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR 178
           + E  I+ Q +H N+++L G   + +  +++ E++ NG L + L    + ++   +    
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQL 149

Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
             +   +A  + YL   A+    HRD+ + NIL++     KV+DFG S+ +  D     T
Sbjct: 150 VGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206

Query: 239 KIQGTFGY--LDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              G        PE     + T  SDV+SFG+V+ E++T G++P
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  129 bits (325), Expect = 8e-34
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
            L+       + + +G+G  G V  G    G  +AVK  K           + F+ E  +
Sbjct: 189 ALNM--KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK------NDATAQAFLAEASV 239

Query: 125 LSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           ++Q+ H N+V+LLG  +E +  L +V E++  G+L  +L  R       L  +   + ++
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSL 296

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQ 241
           +V  A+ YL     +   HRD+ + N+L+ E   AKV+DFG +K      T  T K  ++
Sbjct: 297 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVK 351

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            T     PE  +  + + KSDV+SFG++L E+ + G+ P
Sbjct: 352 WT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  125 bits (316), Expect = 9e-34
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)

Query: 77  RILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
             LG G  G V +G      G+ +  AVK  K  V  +     ++FI E+  +  ++HRN
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDHRN 82

Query: 133 VVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +++L G  L    P+ +V E  P G+L   L     +             A++VA  + Y
Sbjct: 83  LIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY----AVQVAEGMGY 136

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LDP 249
           L    S    HRD+ + N+LL  R   K+ DFG  + +  +  H   +      +    P
Sbjct: 137 L---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           E  ++   +  SD + FGV L E+ T G++P
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  125 bits (315), Expect = 1e-33
 Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 23/220 (10%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           E+D         + LG G  G V  G+      +A+K  K     E+     EFI E  +
Sbjct: 20  EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKV 72

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           +  ++H  +V+L G C +     ++ E++ NG L  +L    +   +    +    +  +
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKD 128

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--I 240
           V  A+ YL    S    HRD+ + N L++++   KV+DFG S+++  D+  + V +K  +
Sbjct: 129 VCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           + +     PE    S+ + KSD+++FGV++ E+ + GK P
Sbjct: 186 RWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  125 bits (317), Expect = 1e-33
 Identities = 70/303 (23%), Positives = 123/303 (40%), Gaps = 55/303 (18%)

Query: 77  RILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
             LG+G  G+V   R        G ++AVK+ + +  D++     +F  EI IL  ++  
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ----RDFQREIQILKALHSD 84

Query: 132 NVVKLLGCCLET-EFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
            +VK  G         L LV E++P+G L   L       +           + ++   +
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY----SSQICKGM 140

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYL 247
            YL    S    HRD+ + NIL++     K+ADFG +K + +D+ +   +  G     + 
Sbjct: 141 EYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
            PE    +  + +SDV+SFGVVL EL T   K      + S E + +          +RL
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC----SPSAEFLRMMGCERDVPALSRL 253

Query: 307 YHILDD---------------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
             +L++               ++MK                C   + + RP+   +  +L
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMK---------------LCWAPSPQDRPSFSALGPQL 298

Query: 352 NGI 354
           + +
Sbjct: 299 DML 301

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  126 bits (318), Expect = 1e-33
 Identities = 62/307 (20%), Positives = 125/307 (40%), Gaps = 29/307 (9%)

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVK---KSKLAVDDEELYKLEEF 118
             KE DK  N + + R L QG    +     +D +  A+K   KS L    +      + 
Sbjct: 22  YVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 119 I----------NEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDR-- 165
           I          NE+ I++ I +   +   G  +     + ++YE++ N ++ +       
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFV 139

Query: 166 -HQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG 224
             +N    +  ++   +   V  + +Y+H+  +  I HRD+K +NIL+D+  R K++DFG
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG 197

Query: 225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD--KSDVYSFGVVLVELLTGKKPIFS 282
            S+++           +GT+ ++ PE+  +    +  K D++S G+ L  +     P   
Sbjct: 198 ESEYM---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

Query: 283 TGNTSQ--ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKK 340
             +  +   N+          R + LY + + +              +  +  L  N  +
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED-IDFLKLFLRKNPAE 313

Query: 341 RPTMEEV 347
           R T E+ 
Sbjct: 314 RITSEDA 320

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  128 bits (323), Expect = 2e-33
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 17/217 (7%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           E+ +      + + LG G  G V+         +AVK  K      E      F+ E  +
Sbjct: 184 EIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-----AFLAEANV 236

Query: 125 LSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           +  + H  +VKL      T+ P+ ++ EF+  G+L   L      E            + 
Sbjct: 237 MKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSA 291

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++A  +A++         HRD+++ NIL+      K+ADFG ++ I  ++       +  
Sbjct: 292 QIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
             +  PE       T KSDV+SFG++L+E++T G+ P
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  125 bits (315), Expect = 2e-33
 Identities = 65/246 (26%), Positives = 100/246 (40%), Gaps = 65/246 (26%)

Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           + LG+G  G V K              +AVK  K      EL    + ++E  +L Q+NH
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL---RDLLSEFNVLKQVNH 85

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-------------------HDRHQNEEY 171
            +V+KL G C +    LL+ E+   G+L   L                         +E 
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT       A +++  + YL   A   + HRD+ + NIL+ E  + K++DFG S+ +  
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV-- 200

Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELL 274
                         Y +  Y + SQ            L D     +SDV+SFGV+L E++
Sbjct: 201 --------------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

Query: 275 T-GKKP 279
           T G  P
Sbjct: 247 TLGGNP 252

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  124 bits (313), Expect = 3e-33
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 17/211 (8%)

Query: 75  VNRILGQGGQGTVYKGRLEDGRI---IAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
            ++ LG G  GTV KG  +  ++   +AVK  K   +D      +E + E  ++ Q+++ 
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA--LKDELLAEANVMQQLDNP 78

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +V+++G C   E  +LV E    G L ++L          +  +    +  +V+  + Y
Sbjct: 79  YIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKY 132

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDP 249
           L     S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +  G +   +  P
Sbjct: 133 L---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           E     + + KSDV+SFGV++ E  + G+KP
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  125 bits (317), Expect = 3e-33
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 27/220 (12%)

Query: 77  RILGQGGQGTVYKGRLEDGR------IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           R LG G  G VY+G++           +AVK       +++     +F+ E  I+S+ NH
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNH 133

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR--HQNEEYPLTWEMRFRVAIEVAGA 188
           +N+V+ +G  L++    ++ E +  G L   L +     ++   L       VA ++A  
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 189 LAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             YL     +   HRDI + N LL        AK+ DFG ++ I     +     +G   
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGCA 246

Query: 246 YL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            L      PE       T K+D +SFGV+L E+ + G  P
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  125 bits (315), Expect = 3e-33
 Identities = 67/283 (23%), Positives = 108/283 (38%), Gaps = 42/283 (14%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
            +   R LG+GG    ++    +   + A K   KS L    +     E+   EI I   
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR----EKMSMEISIHRS 97

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           + H++VV   G   E    + +V E     +L +    R    E     E R     ++ 
Sbjct: 98  LAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEAR-YYLRQIV 151

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLH    + + HRD+K  N+ L+E    K+ DFG +  +  D       + GT  Y
Sbjct: 152 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNY 207

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAYFVHSMRKN 304
           + PE       + + DV+S G ++  LL GK P F T    +    +    Y +      
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPK---- 262

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              HI                 A+L ++ L  +   RPT+ E+
Sbjct: 263 ---HINPVA-------------ASLIQKMLQTDPTARPTINEL 289

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  123 bits (311), Expect = 3e-33
 Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 23/220 (10%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
            +D   +     + +G G  G V+ G   +   +A+K  +     EE     +FI E  +
Sbjct: 4   VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEV 56

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           + +++H  +V+L G CLE     LV EF+ +G L  +L    + +      E    + ++
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLD 112

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--THVTTK--I 240
           V   +AYL     + + HRD+ + N L+ E    KV+DFG ++F+  DQ  +   TK  +
Sbjct: 113 VCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +       PE    S+ + KSDV+SFGV++ E+ + GK P
Sbjct: 170 KWA----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (317), Expect = 4e-33
 Identities = 66/314 (21%), Positives = 120/314 (38%), Gaps = 45/314 (14%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           + + ++ ILGQG    V++GR  + G + A+K           +   +      E  +L 
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR------EFEVLK 62

Query: 127 QINHRNVVKLLGC--CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI- 183
           ++NH+N+VKL        T   +L+ EF P G+LY  L +       P   E  F + + 
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLR 119

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTK 239
           +V G + +L     + I HR+IK  NI+     D +   K+ DFG ++   ++       
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVS 174

Query: 240 IQGTFGYLDPEYHQSSQLTD--------KSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
           + GT  YL P+ ++ + L            D++S GV      TG  P F      + N 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP-FRPFEGPRRNK 233

Query: 292 SL------AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFA-----NLAERCLDLNGKK 340
            +                 +  +   D    +     +          +    L+ + +K
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293

Query: 341 RPTMEEVSMELNGI 354
               ++   E + I
Sbjct: 294 CWGFDQFFAETSDI 307

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  124 bits (313), Expect = 4e-33
 Identities = 70/246 (28%), Positives = 102/246 (41%), Gaps = 59/246 (23%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           +   + + LG+G  G V +            R +AVK  K      E       ++E+ I
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKI 83

Query: 125 LSQI-NHRNVVKLLGCCLETEFPLLV-YEFIPNGTLYQHL-HDRHQNEEY---------- 171
           L  I +H NVV LLG C +   PL+V  EF   G L  +L   R++   Y          
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT E     + +VA  + +L   AS    HRD+ + NILL E+   K+ DFG ++ I  
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-- 198

Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQ-----------------LTDKSDVYSFGVVLVELL 274
                         Y DP+Y +                     T +SDV+SFGV+L E+ 
Sbjct: 199 --------------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

Query: 275 T-GKKP 279
           + G  P
Sbjct: 245 SLGASP 250

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  123 bits (310), Expect = 5e-33
 Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 25/219 (11%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
            L+       + + +G+G  G V  G    G  +AVK  K           + F+ E  +
Sbjct: 17  ALNM--KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK------NDATAQAFLAEASV 67

Query: 125 LSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           ++Q+ H N+V+LLG  +E +  L +V E++  G+L  +L  R       L  +   + ++
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSL 124

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK--IQ 241
           +V  A+ YL     +   HRD+ + N+L+ E   AKV+DFG +K  +   T  T K  ++
Sbjct: 125 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVK 179

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            T     PE  +  + + KSDV+SFG++L E+ + G+ P
Sbjct: 180 WT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  123 bits (311), Expect = 5e-33
 Identities = 67/283 (23%), Positives = 108/283 (38%), Gaps = 42/283 (14%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
            +   R LG+GG    ++    +   + A K   KS L    +     E+   EI I   
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR----EKMSMEISIHRS 71

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           + H++VV   G   E    + +V E     +L +    R    E     E R     ++ 
Sbjct: 72  LAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEAR-YYLRQIV 125

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
               YLH    + + HRD+K  N+ L+E    K+ DFG +  +  D       + GT  Y
Sbjct: 126 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNY 181

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAYFVHSMRKN 304
           + PE       + + DV+S G ++  LL GK P F T    +    +    Y +      
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPK---- 236

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              HI                 A+L ++ L  +   RPT+ E+
Sbjct: 237 ---HINPVA-------------ASLIQKMLQTDPTARPTINEL 263

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  125 bits (315), Expect = 5e-33
 Identities = 46/268 (17%), Positives = 86/268 (32%), Gaps = 31/268 (11%)

Query: 42  LLQQM---LNSYDGSVIDRCKLFSSK---ELDKATNHFNVNRILGQGGQGTVYKGR---- 91
           LL  +   ++SY  +   +CKL + K   E    +    V+ +LG+G    VY+      
Sbjct: 30  LLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89

Query: 92  --LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV 149
              ++ +   +K  K        ++       +  L        +K     L     +LV
Sbjct: 90  NDAKNKQKFVLKVQK----PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145

Query: 150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN 209
            E    GTL   ++      E  +   +    A+ +   +  +H      I H DIK  N
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDN 202

Query: 210 ILLDERYRA-----------KVADFGTSKFI-AMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
            +L   +              + D G S  +    +  + T    T G+   E   +   
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGN 285
             + D +     +  +L G         
Sbjct: 263 NYQIDYFGVAATVYCMLFGTYMKVKNEG 290

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  123 bits (311), Expect = 6e-33
 Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 36/284 (12%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              + +   LG G  G VYK +  E G + A K  +   ++E    LE++I EI IL+  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYIVEIEILATC 73

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           +H  +VKLLG         ++ EF P G +           +  LT      V  ++  A
Sbjct: 74  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L +LHS     I HRD+K+ N+L+      ++ADFG S           + I GT  ++ 
Sbjct: 130 LNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMA 185

Query: 249 PE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
           PE       + +    K+D++S G+ L+E+   + P                  ++ MR 
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE---------------LNPMRV 230

Query: 304 NRLYHILDDQVMKLGKKNQI-VAFANLAERCLDLNGKKRPTMEE 346
             L  I       L   ++  V F +  +  LD N + RP+  +
Sbjct: 231 --LLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  124 bits (313), Expect = 6e-33
 Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 35/281 (12%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              F+  R +G G  G VY  R + +  ++A+KK   +       K ++ I E+  L ++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFLQKL 111

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N ++  GC L      LV E+           D  +  + PL       V       
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSAS-----DLLEVHKKPLQEVEIAAVTHGALQG 166

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           LAYLHS     + HRD+K+ NILL E    K+ DFG++  +A   + V     GT  ++ 
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMA 218

Query: 249 PE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           PE        Q   K DV+S G+  +EL   K P+F+               +++M    
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN---------------MNAMSA-- 261

Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           LYHI  ++   L   +    F N  + CL    + RPT E 
Sbjct: 262 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  123 bits (310), Expect = 7e-33
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFIN-EIFIL 125
           + F++ R LG+G  G VY  R  ++  I+A+K   KS+L     E   +E  +  EI I 
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-----EKEGVEHQLRREIEIQ 68

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           S + H N++++     + +   L+ EF P G LY+ L    + +E          +  E+
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSATFME-EL 123

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
           A AL Y H      + HRDIK  N+L+  +   K+ADFG S      +        GT  
Sbjct: 124 ADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLD 177

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           YL PE  +     +K D++  GV+  E L G  P
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  122 bits (309), Expect = 8e-33
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 18/220 (8%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFIN 120
           E+ +      + R +G+G  G V++G     +   +  A+K  K    D      E+F+ 
Sbjct: 11  EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR---EKFLQ 65

Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E   + Q +H ++VKL+G   E     ++ E    G L   L    Q  +Y L       
Sbjct: 66  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLASLIL 120

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
            A +++ ALAYL    S    HRDI + N+L+      K+ DFG S+++     +  +K 
Sbjct: 121 YAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           +    ++ PE     + T  SDV+ FGV + E+L  G KP
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  122 bits (309), Expect = 9e-33
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 34/226 (15%)

Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           R LG+G  G V+          +D  ++AVK  K           ++F  E  +L+ + H
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR----KDFQREAELLTNLQH 76

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-----------HQNEEYPLTWEMRF 179
            ++VK  G C + +  ++V+E++ +G L + L               +  +  L      
Sbjct: 77  EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
            +A ++A  + YL   AS    HRD+ + N L+      K+ DFG S+ +     +   +
Sbjct: 137 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---R 190

Query: 240 IQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           + G    L      PE     + T +SDV+SFGV+L E+ T GK+P
Sbjct: 191 VGGH-TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (308), Expect = 1e-32
 Identities = 73/285 (25%), Positives = 117/285 (41%), Gaps = 43/285 (15%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
             F V  +LG+G    VY+   +  G  +A+K   K  +          +   NE+ I  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV----QRVQNEVKIHC 66

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLT-WEMRFRVAIE 184
           Q+ H ++++L     E    + LV E   NG + ++L +R +    P +  E R  +  +
Sbjct: 67  QLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMH-Q 120

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +   + YLHS     I HRD+  +N+LL      K+ADFG +  + M      T + GT 
Sbjct: 121 IITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTP 176

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAYFVHSMR 302
            Y+ PE    S    +SDV+S G +   LL G+ P F T         V LA Y + S  
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP-FDTDTVKNTLNKVVLADYEMPS-- 233

Query: 303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                 +  +               +L  + L  N   R ++  V
Sbjct: 234 -----FLSIEA-------------KDLIHQLLRRNPADRLSLSSV 260

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  122 bits (308), Expect = 1e-32
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 17/211 (8%)

Query: 75  VNRILGQGGQGTVYKGRL--EDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
            +  LG G  G+V +G       +I +A+K  K   +  +    EE + E  I+ Q+++ 
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNP 70

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
            +V+L+G C   E  +LV E    G L++ L      +   +       +  +V+  + Y
Sbjct: 71  YIVRLIGVCQA-EALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKY 125

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF--GYLDP 249
           L         HRD+ + N+LL  R+ AK++DFG SK +  D ++ T +  G +   +  P
Sbjct: 126 L---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           E     + + +SDV+S+GV + E L+ G+KP
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (310), Expect = 2e-32
 Identities = 56/241 (23%), Positives = 103/241 (42%), Gaps = 60/241 (24%)

Query: 77  RILGQGGQGTVYKGRL--------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + LG+G  G V             ++   +AVK  K    +++L    + ++E+ ++  I
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL---SDLVSEMEMMKMI 97

Query: 129 -NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L           +D ++  E  +T++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                  ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I       
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI------- 207

Query: 237 TTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKK 278
                         Y +++             L D     +SDV+SFGV++ E+ T G  
Sbjct: 208 ---------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258

Query: 279 P 279
           P
Sbjct: 259 P 259

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  124 bits (312), Expect = 2e-32
 Identities = 37/307 (12%), Positives = 75/307 (24%), Gaps = 65/307 (21%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVK----KSKLAVDDEELYKLEEFINEIF-------- 123
            +LGQ       +    E G    V       +   +  +  K E     +         
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 124 ------------ILSQINHRNVVKLLGC----CLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
                       ++     + ++++        + + F L         T  + L     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTS 226
             +  L    R ++ ++V   LA LH  G    + H  ++  +I+LD+R    +  F   
Sbjct: 204 THK-SLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 227 KFIAMDQTHVTTKIQGTFGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
                       +                 H  + +T   D ++ G+ +  +     P  
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP-- 316

Query: 282 STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQI-VAFANLAERCLDLNGKK 340
                                      I             I      L E  L    + 
Sbjct: 317 ---------------NTDDAALGGSEWIFRSCK-------NIPQPVRALLEGFLRYPKED 354

Query: 341 RPTMEEV 347
           R    + 
Sbjct: 355 RLLPLQA 361

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  122 bits (307), Expect = 3e-32
 Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 33/276 (11%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           F+V   LG+G  G+VYK    E G+I+A+K+    V  E    L+E I EI I+ Q +  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ----VPVES--DLQEIIKEISIMQQCDSP 84

Query: 132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +VVK  G   +     +V E+   G++     D  +     LT +    +       L Y
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGLEY 140

Query: 192 LHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY 251
           LH        HRDIK+ NILL+    AK+ADFG +  +        T I GT  ++ PE 
Sbjct: 141 LHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196

Query: 252 HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILD 311
            Q       +D++S G+  +E+  GK P                  +H MR   ++ I  
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYAD---------------IHPMRA--IFMIPT 239

Query: 312 DQVMKL-GKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           +        +     F +  ++CL  + ++R T  +
Sbjct: 240 NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  122 bits (307), Expect = 3e-32
 Identities = 81/296 (27%), Positives = 125/296 (42%), Gaps = 54/296 (18%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              F +  ++G G  G VYKGR ++ G++ A+K   +  D+EE     E   EI +L + 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-----EIKQEINMLKKY 77

Query: 129 -NHRNVVKLLGCCLETEFPL------LVYEFIPNGT---LYQHLHDRHQNEEYPLTWEMR 178
            +HRN+    G  ++   P       LV EF   G+   L ++       EE+       
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW------- 130

Query: 179 FRVAI---EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
             +A    E+   L++LH      + HRDIK  N+LL E    K+ DFG S  +      
Sbjct: 131 --IAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
             T I GT  ++ PE     +  D     KSD++S G+  +E+  G  P+          
Sbjct: 186 RNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-------- 236

Query: 291 VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
                  +H MR   L+ I  +   +L  K     F +  E CL  N  +RP  E+
Sbjct: 237 -------MHPMRA--LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  120 bits (304), Expect = 4e-32
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 16/208 (7%)

Query: 77  RILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           RILG+G  G VY+G      G  I  AVK  K     +     E+F++E  I+  ++H +
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVIMKNLDHPH 74

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +VKL+G   E E   ++ E  P G L  +L    +  +  L        ++++  A+AYL
Sbjct: 75  IVKLIGIIEE-EPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYL 129

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH 252
               S    HRDI   NIL+      K+ DFG S++I  +  +  +  +    ++ PE  
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 186

Query: 253 QSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              + T  SDV+ F V + E+L+ GK+P
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  125 bits (316), Expect = 4e-32
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 17/207 (8%)

Query: 79  LGQGGQGTVYKGRL--EDGRI-IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           LG G  G+V +G       +I +A+K  K   +  +    EE + E  I+ Q+++  +V+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---EEMMREAQIMHQLDNPYIVR 400

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG 195
           L+G C   E  +LV E    G L++ L      +   +       +  +V+  + YL   
Sbjct: 401 LIGVCQA-EALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYL--- 452

Query: 196 ASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY--LDPEYHQ 253
                 HR++ + N+LL  R+ AK++DFG SK +  D ++ T +  G +      PE   
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512

Query: 254 SSQLTDKSDVYSFGVVLVELLT-GKKP 279
             + + +SDV+S+GV + E L+ G+KP
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  122 bits (309), Expect = 5e-32
 Identities = 56/241 (23%), Positives = 103/241 (42%), Gaps = 60/241 (24%)

Query: 77  RILGQGGQGTVYKGRL--------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           + LG+G  G V             ++   +AVK  K    +++L    + ++E+ ++  I
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL---SDLVSEMEMMKMI 143

Query: 129 -NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEEYPLTWE 176
             H+N++ LLG C +     ++ E+   G L ++L           +D ++  E  +T++
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                  ++A  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I       
Sbjct: 204 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI------- 253

Query: 237 TTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKK 278
                         Y +++             L D     +SDV+SFGV++ E+ T G  
Sbjct: 254 ---------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304

Query: 279 P 279
           P
Sbjct: 305 P 305

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  120 bits (304), Expect = 6e-32
 Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 36/291 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           + + +  ++G G    V           +A+K+  L      +   +E + EI  +SQ +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---DELLKEIQAMSQCH 71

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           H N+V      +  +   LV + +  G    + +H+  + +++   L       +  EV 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF-G 245
             L YLH        HRD+K+ NILL E    ++ADFG S F+A        K++ TF G
Sbjct: 132 EGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 246 ---YLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
              ++ PE   Q      K+D++SFG+  +EL TG  P                     M
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK---------------YPPM 233

Query: 302 R------KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           +      +N    +      K   K    +F  +   CL  + +KRPT  E
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (315), Expect = 8e-32
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 24/233 (10%)

Query: 68  KATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           +    + +   LG GG G V +    + G  +A+K+ +  +  +   +      EI I+ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC---LEIQIMK 67

Query: 127 QINHRNVVKLLGCCLETE-------FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           ++NH NVV       +          PLL  E+   G L ++L+            E   
Sbjct: 68  KLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK---EGPI 123

Query: 180 R-VAIEVAGALAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFGTSKFIAMDQTH 235
           R +  +++ AL YLH    + I HRD+K  NI+L    +R   K+ D G +K   +DQ  
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGE 178

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           + T+  GT  YL PE  +  + T   D +SFG +  E +TG +P        Q
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (304), Expect = 1e-31
 Identities = 67/320 (20%), Positives = 126/320 (39%), Gaps = 51/320 (15%)

Query: 61  FSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFI 119
           F  + ++       V R+L +GG   VY+ + +  GR  A+K+  L  ++EE  K    I
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR--LLSNEEE--KNRAII 73

Query: 120 NEIFILSQI-NHRNVVKLLGCCL-------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEY 171
            E+  + ++  H N+V+               +   L+   +  G L + L         
Sbjct: 74  QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG-- 131

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
           PL+ +   ++  +   A+ ++H     PI HRD+K  N+LL  +   K+ DFG++  I+ 
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190

Query: 232 DQTHVTTKIQ-----------GTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGK 277
              +  +  +            T  Y  PE    + +  + +K D+++ G +L  L   +
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

Query: 278 KPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLN 337
            P F      ++   L          N  Y I                F +L    L +N
Sbjct: 251 HP-F------EDGAKLRI-------VNGKYSIPPHDTQYT-------VFHSLIRAMLQVN 289

Query: 338 GKKRPTMEEVSMELNGIRGS 357
            ++R ++ EV  +L  I  +
Sbjct: 290 PEERLSIAEVVHQLQEIAAA 309

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  124 bits (312), Expect = 2e-31
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 18/221 (8%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRL--EDGRII--AVKKSKLAVDDEELYKLEEFI 119
            E+ +      + R +G+G  G V++G     +   +  A+K  K    D      E+F+
Sbjct: 385 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR---EKFL 439

Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
            E   + Q +H ++VKL+G   E     ++ E    G L   L    Q  ++ L      
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLI 494

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
             A +++ ALAYL    S    HRDI + N+L+      K+ DFG S+++     +  +K
Sbjct: 495 LYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551

Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
            +    ++ PE     + T  SDV+ FGV + E+L  G KP
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  119 bits (300), Expect = 2e-31
 Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)

Query: 77  RILGQGGQGTVYKGRLEDGR------IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
             LG+   G VYKG L           +A+K  K   +       EEF +E  + +++ H
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR---EEFRHEAMLRARLQH 71

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-----------HQNEEYPLTWEMRF 179
            NVV LLG   + +   +++ +  +G L++ L  R            +  +  L      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
            +  ++A  + YL   +S  + H+D+ + N+L+ ++   K++D G  + +         K
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYK 185

Query: 240 IQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
           + G    L      PE     + +  SD++S+GVVL E+ + G +P
Sbjct: 186 LLGN-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  120 bits (302), Expect = 3e-31
 Identities = 43/323 (13%), Positives = 87/323 (26%), Gaps = 72/323 (22%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEE--- 117
           EL +         +LGQ       +    E G    V     ++    +      EE   
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126

Query: 118 ------------------FINEIFILSQINHRNVVKLLGCCLETEFPLLVYEF-IPNGTL 158
                             FI    ++     + ++++     +       + +      L
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 159 YQHLHD--RHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDER 215
                    H +    L    R ++ ++V   LA LH  G    + H  ++  +I+LD+R
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQR 242

Query: 216 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-----------TDKSDVY 264
               +  F                   + G+  PE                  T   D +
Sbjct: 243 GGVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297

Query: 265 SFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIV 324
           + G+V+  +     P       +++     + ++    KN     +   V          
Sbjct: 298 ALGLVIYWIWCADLP-I-----TKDAALGGSEWIFRSCKN-----IPQPVR--------- 337

Query: 325 AFANLAERCLDLNGKKRPTMEEV 347
               L E  L    + R    + 
Sbjct: 338 ---ALLEGFLRYPKEDRLLPLQA 357

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  119 bits (300), Expect = 4e-31
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 34/224 (15%)

Query: 77  RILGQGGQGTVYKGRLEDG---RIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRN 132
            ++G+G  G V K R++        A+K+ K     ++     +F  E+ +L ++ +H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPN 87

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP-----------LTWEMRFRV 181
           ++ LLG C    +  L  E+ P+G L   L      E  P           L+ +     
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A +VA  + YL   +     HRD+ + NIL+ E Y AK+ADFG S+    +     T   
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--EVYVKKTM-- 200

Query: 242 GTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              G L       E    S  T  SDV+S+GV+L E+++ G  P
Sbjct: 201 ---GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  119 bits (301), Expect = 4e-31
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 41/234 (17%)

Query: 77  RILGQGGQGTVYKGRLEDGR------IIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           R +G+G  G V++ R           ++AVK  K     +      +F  E  ++++ ++
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ---ADFQREAALMAEFDN 109

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-------------------HQNEEY 171
            N+VKLLG C   +   L++E++  G L + L                            
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
           PL+   +  +A +VA  +AYL   +     HRD+ + N L+ E    K+ADFG S+ I  
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 232 DQTHVTTKIQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              +           +      PE    ++ T +SDV+++GVVL E+ + G +P
Sbjct: 227 ADYYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  118 bits (299), Expect = 5e-31
 Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 36/229 (15%)

Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-N 129
           + LG G  G V +         +    +AVK  K +    E    E  ++E+ +LS + N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER---EALMSELKVLSYLGN 85

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-------------HQNEEYPLTWE 176
           H N+V LLG C      L++ E+   G L   L  +              +++E  L  E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
                + +VA  +A+L   AS    HRD+ + NILL      K+ DFG ++ I  D  +V
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 237 TTKIQGTFGYL-----DPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                     L      PE   +   T +SDV+S+G+ L EL + G  P
Sbjct: 203 ----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  119 bits (301), Expect = 7e-31
 Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 60/242 (24%)

Query: 76  NRILGQGGQGTVYKGRL--------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
            + LG+G  G V                  +AVK  K    +++L    + I+E+ ++  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---SDLISEMEMMKM 130

Query: 128 I-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-----------HDRHQNEEYPLTW 175
           I  H+N++ LLG C +     ++ E+   G L ++L           ++   N E  L+ 
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
           +     A +VA  + YL   AS    HRD+ + N+L+ E    K+ADFG ++ I      
Sbjct: 191 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI------ 241

Query: 236 VTTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GK 277
                     +    Y +++             L D     +SDV+SFGV+L E+ T G 
Sbjct: 242 ----------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291

Query: 278 KP 279
            P
Sbjct: 292 SP 293

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (299), Expect = 8e-31
 Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 39/311 (12%)

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFIN 120
             K  +   + F     LG G  G V+K      G ++A K   L +         + I 
Sbjct: 24  KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR---NQIIR 80

Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
           E+ +L + N   +V   G         +  E +  G+L Q L    +  E  L      +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----K 135

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
           V+I V   L YL       I HRD+K +NIL++ R   K+ DFG S    +  +   + +
Sbjct: 136 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV 191

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
            GT  Y+ PE  Q +  + +SD++S G+ LVE+  G+ PI        E +        +
Sbjct: 192 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250

Query: 301 MRKNR-------------------------LYHILDDQVMKLGKKNQIVAFANLAERCLD 335
                                         L +I+++   KL      + F +   +CL 
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 310

Query: 336 LNGKKRPTMEE 346
            N  +R  +++
Sbjct: 311 KNPAERADLKQ 321

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  118 bits (297), Expect = 1e-30
 Identities = 64/300 (21%), Positives = 110/300 (36%), Gaps = 71/300 (23%)

Query: 16  ILFRIIRKKRMDIRLK--EKFFKQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKATNHF 73
           + ++  +K +  +R K  E +   +   +    L   +     R  L             
Sbjct: 2   VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNL------------- 48

Query: 74  NVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
              + LG G  G V +         +    +AVK  K     +E    E  ++E+ I+S 
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSH 105

Query: 128 I-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY---------PLTWEM 177
           +  H N+V LLG C      L++ E+   G L   L  + +  E            +   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 178 RFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 237
               + +VA  +A+L   AS    HRD+ + N+LL   + AK+ DFG ++ I        
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-------- 214

Query: 238 TKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELLT-GKKP 279
                     D  Y                 + D     +SDV+S+G++L E+ + G  P
Sbjct: 215 --------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  117 bits (294), Expect = 3e-30
 Identities = 56/246 (22%), Positives = 94/246 (38%), Gaps = 65/246 (26%)

Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-N 129
           ++LG G  G V                +AVK  K   D  E    E  ++E+ +++Q+ +
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER---EALMSELKMMTQLGS 107

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR------------------HQNEEY 171
           H N+V LLG C  +    L++E+   G L  +L  +                   + +  
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT+E     A +VA  + +L         HRD+ + N+L+      K+ DFG ++ I  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI-- 222

Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQ------------LTD-----KSDVYSFGVVLVELL 274
                           D  Y                 L +     KSDV+S+G++L E+ 
Sbjct: 223 --------------MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

Query: 275 T-GKKP 279
           + G  P
Sbjct: 269 SLGVNP 274

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  115 bits (289), Expect = 7e-30
 Identities = 50/236 (21%), Positives = 95/236 (40%), Gaps = 42/236 (17%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAV---DDEELYKLEEFIN 120
           ++         N  LGQG    ++KG   + G    + ++++ +   D       E F  
Sbjct: 4   KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61

Query: 121 EIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
              ++S+++H+++V   G C+  +  +LV EF+  G+L  +L    +  +  +    +  
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLE 117

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR--------AKVADFGTSKFIAMD 232
           VA ++A A+ +L     + + H ++ + NILL              K++D G S  +   
Sbjct: 118 VAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174

Query: 233 QTHVTTKIQGTFGYLD-------PE-YHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
                         L        PE       L   +D +SFG  L E+ + G KP
Sbjct: 175 D------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  118 bits (298), Expect = 8e-30
 Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 25/248 (10%)

Query: 49  SYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSK 104
            + G +     +F + +    +  +   + LG G  G V   R        A+K   K+ 
Sbjct: 15  YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74

Query: 105 LAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD 164
           ++          + + E+ +L  ++H N++KL     +     LV E    G L+  +  
Sbjct: 75  VSTSSNS-----KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129

Query: 165 RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVA 221
           R +  E          +  +V   + YLH      I HRD+K  N+LL   ++    K+ 
Sbjct: 130 RMKFNE-----VDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIV 181

Query: 222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           DFG S     +      +  GT  Y+ PE  +     +K DV+S GV+L  LL G  P  
Sbjct: 182 DFGLSAVF--ENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFG 238

Query: 282 STGNTSQE 289
             G T QE
Sbjct: 239 --GQTDQE 244

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (289), Expect = 1e-29
 Identities = 65/294 (22%), Positives = 118/294 (40%), Gaps = 33/294 (11%)

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFIN 120
             +  D           +G+G  G+V K      G+I+AVK+ +  VD++E    ++ + 
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ---KQLLM 69

Query: 121 EI-FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           ++  ++   +   +V+  G         +  E + + +  +     +   +  +  E+  
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG 128

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
           ++ +    AL +L       I HRDIK +NILLD     K+ DFG S    +  +   T+
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ--LVDSIAKTR 184

Query: 240 IQGTFGYLDPEYHQSSQLTD----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
             G   Y+ PE    S        +SDV+S G+ L EL TG+ P                
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK------------- 231

Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIV---AFANLAERCLDLNGKKRPTMEE 346
              +S+   +L  ++     +L    +     +F N    CL  +  KRP  +E
Sbjct: 232 --WNSVFD-QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  116 bits (292), Expect = 4e-29
 Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 24/238 (10%)

Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYK 114
            +F        ++ +   R+LG+G  G V   +    G+  AVK   K ++    ++   
Sbjct: 14  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK--- 70

Query: 115 LEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLT 174
            E  + E+ +L Q++H N++KL     +  +  LV E    G L+  +  R +  E    
Sbjct: 71  -ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE---- 125

Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAM 231
                R+  +V   + Y+H      I HRD+K  N+LL    +    ++ DFG S     
Sbjct: 126 -VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-- 179

Query: 232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           + +       GT  Y+ PE    +   +K DV+S GV+L  LL+G  P F  G    +
Sbjct: 180 EASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP-F-NGANEYD 234

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  115 bits (288), Expect = 4e-29
 Identities = 54/318 (16%), Positives = 97/318 (30%), Gaps = 52/318 (16%)

Query: 70  TNHFNVNRILGQGGQ--GTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
              + +  ++G+G +   TV   R    G  + V++  L     E   +     E+ +  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE--MVTFLQGELHVSK 81

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI--- 183
             NH N+V      +      +V  F+  G+  + L   H  +           +A    
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELA-----IAYILQ 135

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-- 241
            V  AL Y+H        HR +K+++IL+    +  ++   ++  +              
Sbjct: 136 GVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 242 ----GTFGYLDPEYHQSSQL--TDKSDVYSFGVVLVELLTGKKPIF-------------- 281
                   +L PE  Q +      KSD+YS G+   EL  G  P                
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252

Query: 282 -------------STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFAN 328
                             S       +    S+  +       D       +     F +
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312

Query: 329 LAERCLDLNGKKRPTMEE 346
             E+CL  N   RP+   
Sbjct: 313 FVEQCLQRNPDARPSAST 330

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  115 bits (291), Expect = 7e-29
 Identities = 80/303 (26%), Positives = 121/303 (39%), Gaps = 43/303 (14%)

Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELY-- 113
           ++  K+  K    +   R LG G  G V   +        A+K   KS+           
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84

Query: 114 ----KLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNE 169
                 EE  NEI +L  ++H N++KL     + ++  LV EF   G L++ + +RH+ +
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144

Query: 170 EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTS 226
           E          +  ++   + YLH      I HRDIK  NILL   +     K+ DFG S
Sbjct: 145 E-----CDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196

Query: 227 KFIAMDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGN 285
            F    + +      GT  Y+ PE   +     +K DV+S GV++  LL G  P F  G 
Sbjct: 197 SFF--SKDYKLRDRLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPP-F-GGQ 250

Query: 286 TSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFA-NLAERCLDLNGKKRPTM 344
             Q+        +  + K +     D    K      I   A  L +  L  +  KR T 
Sbjct: 251 NDQD-------IIKKVEKGKY--YFDFNDWK-----NISDEAKELIKLMLTYDYNKRCTA 296

Query: 345 EEV 347
           EE 
Sbjct: 297 EEA 299

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  114 bits (288), Expect = 7e-29
 Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 44/293 (15%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAV-DDEELYKLEEFINEIFI 124
            + + +++ LG G  G V      +  + +A++   K K A+    E         EI I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAI 183
           L ++NH  ++K+     + E   +V E +  G L+  +       E        +     
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 246

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKI 240
           ++  A+ YLH    + I HRD+K  N+LL   +E    K+ DFG SK   + +T +   +
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTL 301

Query: 241 QGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ---ENVSLA 294
            GT  YL PE      ++      D +S GV+L   L+G  P FS   T     + ++  
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRTQVSLKDQITSG 360

Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            Y             +  +V +           +L ++ L ++ K R T EE 
Sbjct: 361 KY--------NFIPEVWAEVSEKAL--------DLVKKLLVVDPKARFTTEEA 397

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  113 bits (283), Expect = 9e-29
 Identities = 64/344 (18%), Positives = 114/344 (33%), Gaps = 93/344 (27%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
             F   + +G+GG G V++ +   D    A+K+ +L   +    K+     E+  L+++ 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM---REVKALAKLE 62

Query: 130 HRNVVKLLGCCLETEFPLL----------------------------------------- 148
           H  +V+     LET                                              
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 149 ----VYEFIPNGTLY--------QHLHD--RHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
               +    P   LY        ++L D    +         +   + I++A A+ +LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH- 181

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ-----------GT 243
             S  + HRD+K +NI        KV DFG    +  D+   T               GT
Sbjct: 182 --SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
             Y+ PE    +  + K D++S G++L ELL      FST                 M +
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS----FSTQ----------------MER 279

Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            R+   + +    L    +      + +  L  +  +RP   ++
Sbjct: 280 VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  111 bits (280), Expect = 1e-28
 Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 37/277 (13%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEI-FILSQINHRNVVKL 136
           LG+G  G V K R +  G+I+AVK+ +  V+ +E    +  + ++   +  ++    V  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ---KRLLMDLDISMRTVDCPFTVTF 71

Query: 137 LGCCLETEFPLLVYEFIPNGT--LYQHLHDRHQN-EEYPLTWEMRFRVAIEVAGALAYLH 193
            G         +  E +       Y+ + D+ Q   E  L      ++A+ +  AL +LH
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKALEHLH 126

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE--- 250
           S  S  + HRD+K +N+L++   + K+ DFG S +  +          G   Y+ PE   
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPERIN 182

Query: 251 -YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
                   + KSD++S G+ ++EL   + P  S G                 ++  L  +
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG--------------TPFQQ--LKQV 226

Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           +++   +L        F +   +CL  N K+RPT  E
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  111 bits (279), Expect = 2e-28
 Identities = 35/278 (12%), Positives = 80/278 (28%), Gaps = 64/278 (23%)

Query: 79  LGQGGQGTVYKGRLED---GRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQINHRNV 133
            G       ++    D    R +A+     +  + D+ L   +E ++    LS+I+   V
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVL---QETLSRTLRLSRIDKPGV 93

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
            ++L         L+V E+I  G+L +             +     R    +A A    H
Sbjct: 94  ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH 146

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ 253
               + +       + + +       +A                         +      
Sbjct: 147 R---AGVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA--- 179

Query: 254 SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQ 313
                 + D+   G  L  LL  + P        +  ++ A                  Q
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWP-LP-EAGVRSGLAPA------------ERDTAGQ 221

Query: 314 VMKLGKKNQIV--AFANLAERCLDLNGKKRPTMEEVSM 349
            ++    ++ +    + +A R +  +G  R     +++
Sbjct: 222 PIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNL 259

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  112 bits (281), Expect = 1e-27
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 37/233 (15%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
              +N+  +LG+G  G V K +     +  AVK   K+     D         + E+ +L
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-----TSTILREVELL 75

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAIE 184
            +++H N++KL     ++    +V E    G L+  +  R   +E          R+  +
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------RIIKQ 129

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           V   + Y+H      I HRD+K  NILL   ++    K+ DFG S      Q        
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRI 184

Query: 242 GTFGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
           GT  Y+ PE     Y       +K DV+S GV+L  LL+G  P F  G    +
Sbjct: 185 GTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP-F-YGKNEYD 229

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  109 bits (274), Expect = 2e-27
 Identities = 64/293 (21%), Positives = 112/293 (38%), Gaps = 36/293 (12%)

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFIN 120
             +      N       +G G  G V+K R  + G +IAVK+ + + + EE    +  + 
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN---KRILM 72

Query: 121 EIFIL-SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
           ++ ++    +   +V+  G  +      +  E +           +    E  L      
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG----- 127

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
           ++ + +  AL YL       + HRD+K +NILLDER + K+ DFG S    +       +
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR--LVDDKAKDR 183

Query: 240 IQGTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA 294
             G   Y+ PE       T      ++DV+S G+ LVEL TG+ P  +            
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--------- 234

Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQI-VAFANLAERCLDLNGKKRPTMEE 346
                      L  +L ++   L         F +  + CL  + +KRP   +
Sbjct: 235 -----DFEV--LTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  109 bits (275), Expect = 4e-27
 Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 27/231 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           + F + +++G+G    V   +++  G++ A+K   K  +    E    +  F  E  +L 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE----VSCFREERDVLV 116

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEM-RFRVAIE 184
             + R + +L     + E  L LV E+   G L   L          +  EM RF +A E
Sbjct: 117 NGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFYLA-E 170

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  A+  +H        HRDIK  NILLD     ++ADFG+   +  D T  +    GT 
Sbjct: 171 IVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 245 GYLDPEYHQSSQLTDKSDVY-------SFGVVLVELLTGKKPIFSTGNTSQ 288
            YL PE  Q+      +  Y       + GV   E+  G+ P F   +T++
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP-FYADSTAE 277

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (268), Expect = 9e-27
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 20/222 (9%)

Query: 73  FNVNRILGQGGQGTVYKGRL-EDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQI 128
           F   +ILG+G   TV   R     R  A+K   K  +  +++  Y       E  ++S++
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT----RERDVMSRL 87

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEVAG 187
           +H   VKL     + E       +  NG L +++      +E        RF  A E+  
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVS 141

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK-IQGTFGY 246
           AL YLH      I HRD+K  NILL+E    ++ DFGT+K ++ +          GT  Y
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           + PE          SD+++ G ++ +L+ G  P F  GN   
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYL 239

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (267), Expect = 2e-26
 Identities = 59/280 (21%), Positives = 103/280 (36%), Gaps = 51/280 (18%)

Query: 46  MLNSYDGSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--- 101
           M + +  S       F    L +    +++   +GQG  G V      +   I A+K   
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 102 KSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQH 161
           K+K+   + +   +E    E+ ++ +++H N+ +L     + ++  LV E    G L   
Sbjct: 61  KNKIRQINPK--DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK 118

Query: 162 LHDRHQNEEYPLTWEMRF-----------------------------------RVAIEVA 186
           L+    +       ++                                      +  ++ 
Sbjct: 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178

Query: 187 GALAYLHSGASSPIYHRDIKSTNILL--DERYRAKVADFGTSKFIA---MDQTHVTTKIQ 241
            AL YLH+     I HRDIK  N L   ++ +  K+ DFG SK        + +  T   
Sbjct: 179 SALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235

Query: 242 GTFGYLDPE--YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           GT  ++ PE     +     K D +S GV+L  LL G  P
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  108 bits (272), Expect = 2e-26
 Identities = 56/230 (24%), Positives = 102/230 (44%), Gaps = 16/230 (6%)

Query: 56  DRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDE 110
            R   +   E      + F   R+LG+GG G V+  +++  G++ A K   K +L     
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228

Query: 111 ELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNE 169
                +  + E  IL++++ R +V L     ET+  L LV   +  G +  H+++  ++ 
Sbjct: 229 Y----QGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283

Query: 170 EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 229
                    F  A ++   L +LH      I +RD+K  N+LLD+    +++D G +  +
Sbjct: 284 PGFQEPRAIFYTA-QIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
              QT       GT G++ PE     +     D ++ GV L E++  + P
Sbjct: 340 KAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  109 bits (273), Expect = 2e-26
 Identities = 70/246 (28%), Positives = 107/246 (43%), Gaps = 20/246 (8%)

Query: 51  DGSVIDRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKL 105
           D    +R   +   E    T N F   R+LG+GG G V   ++   G++ A K   K ++
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 222

Query: 106 AVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHD 164
                E   L    NE  IL ++N R VV L     ET+  L LV   +  G L  H++ 
Sbjct: 223 KKRKGEAMAL----NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY- 276

Query: 165 RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG 224
                 +P      F  A E+   L  LH      I +RD+K  NILLD+    +++D G
Sbjct: 277 HMGQAGFPEA-RAVFYAA-EICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLG 331

Query: 225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
            +  +   QT       GT GY+ PE  ++ + T   D ++ G +L E++ G+ P F   
Sbjct: 332 LAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP-FQQR 388

Query: 285 NTSQEN 290
               + 
Sbjct: 389 KKKIKR 394

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  105 bits (263), Expect = 5e-26
 Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 25/232 (10%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAV-DDEELYKLEEFINEIFI 124
            + + +++ LG G  G V      +  + +A+K   K K A+    E         EI I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAI 183
           L ++NH  ++K+     + E   +V E +  G L+  +       E        +     
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 121

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKI 240
           ++  A+ YLH    + I HRD+K  N+LL   +E    K+ DFG SK   + +T +   +
Sbjct: 122 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTL 176

Query: 241 QGTFGYLDPE---YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            GT  YL PE      ++      D +S GV+L   L+G  P FS   T   
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-FSEHRTQVS 227

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  104 bits (261), Expect = 6e-26
 Identities = 63/287 (21%), Positives = 112/287 (39%), Gaps = 40/287 (13%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
            + F   R LG G  G V+       G    +K   K +  V  E++        EI +L
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE------AEIEVL 74

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
             ++H N++K+     +     +V E    G L + +       +  L+      +  ++
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEGYVAELMKQM 133

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
             ALAY H   S  + H+D+K  NIL          K+ DFG ++         +T   G
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAG 188

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAYFVHS 300
           T  Y+ PE  +   +T K D++S GVV+  LLTG  P F+  +  +  +  +        
Sbjct: 189 TALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP-FTGTSLEEVQQKATYKEPNYAV 246

Query: 301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             +          +             +L ++ L  + ++RP+  +V
Sbjct: 247 ECRP---------LTPQAV--------DLLKQMLTKDPERRPSAAQV 276

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  107 bits (269), Expect = 6e-26
 Identities = 52/236 (22%), Positives = 94/236 (39%), Gaps = 27/236 (11%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
            +H++++  LG G  G V++      G   A K       +         E    EI  +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-------DKETVRKEIQTM 208

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           S + H  +V L     +    +++YEF+  G L+    ++  +E   ++ +       +V
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF----EKVADEHNKMSEDEAVEYMRQV 264

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDER--YRAKVADFGTSKFIAMDQTHVTTKIQGT 243
              L ++H    +   H D+K  NI+   +     K+ DFG +  +  D         GT
Sbjct: 265 CKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGT 319

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
             +  PE  +   +   +D++S GV+   LL+G  P F  G    E   NV    +
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-F-GGENDDETLRNVKSCDW 373

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  105 bits (265), Expect = 7e-26
 Identities = 58/267 (21%), Positives = 106/267 (39%), Gaps = 33/267 (12%)

Query: 44  QQMLNSYDGSVIDRCKLFSSKELDKAT----NHFNVNRILGQGGQGTVYKGR-LEDGRII 98
              +N YD    D  K +  + ++       +++++   LG G  G V++      GR+ 
Sbjct: 20  GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 79

Query: 99  AVK---KSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPN 155
             K                     NEI I++Q++H  ++ L     +    +L+ EF+  
Sbjct: 80  VAKFINTPYPL-------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132

Query: 156 GTLYQHLHDRHQNEEYPLTWEMRFRVAI-EVAGALAYLHSGASSPIYHRDIKSTNILL-- 212
           G L+    DR   E+Y ++ E      + +    L ++H      I H DIK  NI+   
Sbjct: 133 GELF----DRIAAEDYKMS-EAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCET 184

Query: 213 DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVE 272
            +    K+ DFG +  +  +   +      T  +  PE      +   +D+++ GV+   
Sbjct: 185 KKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242

Query: 273 LLTGKKPIFSTGNTSQE---NVSLAAY 296
           LL+G  P F+ G    E   NV    +
Sbjct: 243 LLSGLSP-FA-GEDDLETLQNVKRCDW 267

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  104 bits (262), Expect = 1e-25
 Identities = 63/292 (21%), Positives = 107/292 (36%), Gaps = 44/292 (15%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
            + + +  ++G+G    V +    E G+  AVK    +K           E+   E  I 
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT--SSPGLSTEDLKREASIC 80

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAIE 184
             + H ++V+LL          +V+EF+    L   +  R      Y    E    VA  
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS---E---AVASH 134

Query: 185 ----VAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVT 237
               +  AL Y H    + I HRD+K   +LL   +     K+  FG +  +        
Sbjct: 135 YMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191

Query: 238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
            ++ GT  ++ PE  +        DV+  GV+L  LL+G  P + T     E +    Y 
Sbjct: 192 GRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK 250

Query: 298 VHSMRKNRLYHILD--DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           ++                + +  K        +L  R L L+  +R T+ E 
Sbjct: 251 MNP----------RQWSHISESAK--------DLVRRMLMLDPAERITVYEA 284

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  105 bits (263), Expect = 1e-25
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 25/228 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           +HF + R +G+G  G V   +  D  ++ A+K   K K    +E    +     E+ I+ 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE----VRNVFKELQIMQ 70

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIE 184
            + H  +V L     + E  + +V + +  G L  HL  + H  EE      ++  +  E
Sbjct: 71  GLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-----TVKLFIC-E 123

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  AL YL +     I HRD+K  NILLDE     + DF  +  +  +    T  + GT 
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTK 178

Query: 245 GYLDPEYHQSSQLT--DKS-DVYSFGVVLVELLTGKKPIFSTGNTSQE 289
            Y+ PE   S +      + D +S GV   ELL G++P     +TS +
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  106 bits (267), Expect = 2e-25
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+V+RI+G+GG G VY  R  D G++ A+K   K ++ +   E   L    NE  +LS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL----NERIMLS 244

Query: 127 QIN---HRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            ++      +V +      T   L  + + +  G L+ HL       E     +MRF  A
Sbjct: 245 LVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA 299

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+   L ++H+     + +RD+K  NILLDE    +++D G +   +  + H +    G
Sbjct: 300 -EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---G 352

Query: 243 TFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
           T GY+ PE  Q     D S D +S G +L +LL G  P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (259), Expect = 2e-25
 Identities = 63/238 (26%), Positives = 99/238 (41%), Gaps = 24/238 (10%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
            + +++   LG G    V K R    G   A K   K +           EE   E+ IL
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQS-RASRRGVSREEIEREVSIL 69

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            Q+ H NV+ L          +L+ E +  G L+  L  +    E   T  ++     ++
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI 124

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
              + YLH   +  I H D+K  NI+L          K+ DFG +  I  +       I 
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF 179

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
           GT  ++ PE      L  ++D++S GV+   LL+G  P F  G+T QE   N++  +Y
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FL-GDTKQETLANITSVSY 235

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  102 bits (256), Expect = 3e-25
 Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 33/222 (14%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
              +N+  +LG+G  G V K +     +  AVK   K+     D         + E+ +L
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-----TILREVELL 75

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            +++H N++KL     ++    +V E    G L+    D     +   +     R+  +V
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF----DEIIKRKR-FSEHDAARIIKQV 130

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
              + Y+H      I HRD+K  NILL   ++    K+ DFG S      Q        G
Sbjct: 131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIG 185

Query: 243 TFGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           T  Y+ PE     Y       +K DV+S GV+L  LL+G  P
Sbjct: 186 TAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  103 bits (258), Expect = 4e-25
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 24/238 (10%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
            + +++   LG G    V K R    G   A K   K +       + + EE   E+ IL
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR-EEIEREVSIL 69

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            Q+ H N++ L          +L+ E +  G L+  L  +    E   T  ++     ++
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI 124

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
              + YLH   +  I H D+K  NI+L          K+ DFG +  I  +       I 
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF 179

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
           GT  ++ PE      L  ++D++S GV+   LL+G  P F  G+T QE   N++  +Y
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FL-GDTKQETLANITAVSY 235

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  102 bits (257), Expect = 4e-25
 Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 59/301 (19%)

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEE 117
           S  +      ++ + + +G+G    V   R +  GR +A+K   K++L  +   L KL  
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLF- 62

Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
              E+ I+  +NH N+VKL    +ETE  L L+ E+   G ++ +L    + +E     E
Sbjct: 63  --REVRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----E 115

Query: 177 MR--FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
            R  FR   ++  A+ Y H      I HRD+K+ N+LLD     K+ADFG S    +   
Sbjct: 116 ARSKFR---QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169

Query: 235 HVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
                  G   Y  PE      Y        + DV+S GV+L  L++G  P F   N  +
Sbjct: 170 LDAF--CGAPPYAAPELFQGKKYDGP-----EVDVWSLGVILYTLVSGSLP-FDGQNLKE 221

Query: 289 --ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
             E V    Y +        +++  D               NL +R L LN  KR T+E+
Sbjct: 222 LRERVLRGKYRIP-------FYMSTDC-------------ENLLKRFLVLNPIKRGTLEQ 261

Query: 347 V 347
           +
Sbjct: 262 I 262

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  104 bits (260), Expect = 6e-25
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 25/229 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
             F + +++G+G  G V   +L++  ++ A+K   K ++    E       F  E  +L 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE----TACFREERDVLV 129

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEM-RFRVAIE 184
             + + +  L     + +  L LV ++   G L   L       E  L  EM RF +A E
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLA-E 183

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  A+  +H        HRDIK  NIL+D     ++ADFG+   +  D T  ++   GT 
Sbjct: 184 MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 245 GYLDPEYHQSSQLTDKS-----DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            Y+ PE  Q+ +          D +S GV + E+L G+ P F   +  +
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP-FYAESLVE 288

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  100 bits (252), Expect = 9e-25
 Identities = 67/238 (28%), Positives = 105/238 (44%), Gaps = 24/238 (10%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
            +H+ +   LG G    V K R    G+  A K   K +L+     + + EE   E+ IL
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR-EEIEREVNIL 62

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            +I H N++ L          +L+ E +  G L+  L ++    E   T  ++     ++
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-----QI 117

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
              + YLH   S  I H D+K  NI+L        R K+ DFG +  I  +  +    I 
Sbjct: 118 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF 172

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
           GT  ++ PE      L  ++D++S GV+   LL+G  P F  G T QE   N+S   Y
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FL-GETKQETLTNISAVNY 228

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  100 bits (252), Expect = 1e-24
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 22/217 (10%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
           +++++V   LG+G    V +      G   A K     KL+  D +     +   E  I 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-----KLEREARIC 59

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            ++ H N+V+L     E  F  LV++ +  G L++ +  R    E   +  ++     ++
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-----QI 114

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
             ++AY H   S+ I HR++K  N+LL    +    K+ADFG +  +  + +       G
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAG 169

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           T GYL PE  +    +   D+++ GV+L  LL G  P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  102 bits (257), Expect = 2e-24
 Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 20/259 (7%)

Query: 36  KQNGGLLLQQMLNSYDGSVIDRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKGRLED 94
           KQ    +  +  +  D S  +  ++  +K   + T N F   ++LG+G  G V   + + 
Sbjct: 112 KQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA 171

Query: 95  -GRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL-LV 149
            GR  A+K   K  +   DE    +   + E  +L    H  +  L     +T   L  V
Sbjct: 172 TGRYYAMKILKKEVIVAKDE----VAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFV 226

Query: 150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN 209
            E+   G L+ HL       E       RF  A E+  AL YLHS  +  + +RD+K  N
Sbjct: 227 MEYANGGELFFHLSRERVFSED----RARFYGA-EIVSALDYLHSEKN--VVYRDLKLEN 279

Query: 210 ILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVV 269
           ++LD+    K+ DFG  K   +          GT  YL PE  + +      D +  GVV
Sbjct: 280 LMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 338

Query: 270 LVELLTGKKPIFSTGNTSQ 288
           + E++ G+ P F   +  +
Sbjct: 339 MYEMMCGRLP-FYNQDHEK 356

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (252), Expect = 2e-24
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 22/233 (9%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              + +   LG+G  G V++       +    K  K+   D+          EI IL+  
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-----LVKKEISILNIA 58

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            HRN++ L       E  ++++EFI    ++    +R     + L          +V  A
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIF----ERINTSAFELNEREIVSYVHQVCEA 114

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           L +LH   S  I H DI+  NI+   R  +  K+ +FG ++ +          +     Y
Sbjct: 115 LQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEY 169

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
             PE HQ   ++  +D++S G ++  LL+G  P F    T+Q+   N+  A Y
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-FL-AETNQQIIENIMNAEY 220

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  101 bits (253), Expect = 2e-24
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 25/236 (10%)

Query: 70  TNHFNVNR--ILGQGGQGTVYKGR-LEDGRIIAVKK-SKLAVDDEELYKLEEFINEIFIL 125
            + + V++  ILG G  G V+K      G  +A K      + D+E     E  NEI ++
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-----EVKNEISVM 140

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           +Q++H N+++L          +LV E++  G L+    DR  +E Y LT         ++
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF----DRIIDESYNLTELDTILFMKQI 196

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRA--KVADFGTSKFIAMDQTHVTTKIQGT 243
              + ++H      I H D+K  NIL   R     K+ DFG ++              GT
Sbjct: 197 CEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGT 251

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
             +L PE      ++  +D++S GV+   LL+G  P F  G+   E   N+    +
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP-F-LGDNDAETLNNILACRW 305

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (255), Expect = 2e-24
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 22/226 (9%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
             + V +++G+G  G V   R +   ++ A+K   K ++    +       F  E  I++
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD----SAFFWEERDIMA 124

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
             N   VV+L     +  +  +V E++P G L   + +    E+       RF  A EV 
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-----WARFYTA-EVV 178

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
            AL  +HS       HRD+K  N+LLD+    K+ADFGT   +  +         GT  Y
Sbjct: 179 LALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235

Query: 247 LDPEYHQSSQLT---DKS-DVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           + PE  +S        +  D +S GV L E+L G  P F   +   
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP-FYADSLVG 280

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  101 bits (253), Expect = 3e-24
 Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 30/239 (12%)

Query: 52  GSVIDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAV 107
           G  + R   F      K +++++V   LG+G    V +      G   A K     KL+ 
Sbjct: 10  GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA 69

Query: 108 DDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
            D +     +   E  I  ++ H N+V+L     E  F  LV++ +  G L++ +  R  
Sbjct: 70  RDFQ-----KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124

Query: 168 NEEYPLTWEMRFRVAIE----VAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKV 220
             E           A      +  ++AY H   S+ I HR++K  N+LL    +    K+
Sbjct: 125 YSE---------ADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKL 172

Query: 221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           ADFG +  +  + +       GT GYL PE  +    +   D+++ GV+L  LL G  P
Sbjct: 173 ADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 24/238 (10%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
            ++++    LG G    V K R    G   A K   K +           E+   E+ IL
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSIL 68

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            +I H NV+ L          +L+ E +  G L+  L ++    E   T  ++     ++
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-----QI 123

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
              + YLH   S  I H D+K  NI+L      + R K+ DFG +  I  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---NVSLAAY 296
           GT  ++ PE      L  ++D++S GV+   LL+G  P F  G+T QE   NVS   Y
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-F-LGDTKQETLANVSAVNY 234

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 99.2 bits (248), Expect = 7e-24
 Identities = 73/226 (32%), Positives = 110/226 (48%), Gaps = 24/226 (10%)

Query: 71  NHFNVNRILGQGGQGTVY----KGRLEDGRIIAVK---KSKLAVDDEELYKLEEFINEIF 123
           + F + ++LGQG  G V+        +  ++ A+K   K+ L V D           E  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-----RTKMERD 78

Query: 124 ILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
           IL ++NH  +VKL     +TE  L L+ +F+  G L+  L       E     +++F +A
Sbjct: 79  ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE----DVKFYLA 133

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            E+A AL +LHS     I +RD+K  NILLDE    K+ DFG SK  ++D         G
Sbjct: 134 -ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCG 188

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           T  Y+ PE       T  +D +SFGV++ E+LTG  P F   +  +
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKE 233

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 98.5 bits (246), Expect = 8e-24
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 27/225 (12%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK-----KSKLAVDDEELYKLEEFINEIF 123
             ++    ILG+G    V +       +  AVK            +E     E  + E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 124 ILSQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRV 181
           IL +++ H N+++L        F  LV++ +  G L+ +L ++   +E+     E R ++
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR-KI 129

Query: 182 AIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
              +   +  LH       I HRD+K  NILLD+    K+ DFG S  +  D      ++
Sbjct: 130 MRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREV 183

Query: 241 QGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            GT  YL PE               + D++S GV++  LL G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 97.7 bits (244), Expect = 1e-23
 Identities = 70/290 (24%), Positives = 111/290 (38%), Gaps = 52/290 (17%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
            +++ + LG+G  G V           +AVK     +     E + K      EI I   
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK------EICINKM 61

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIE 184
           +NH NVVK  G          L  E+   G L+  +       E     + +  F   + 
Sbjct: 62  LNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLM- 115

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGT 243
               + YLH      I HRDIK  N+LLDER   K++DFG +      ++  +  K+ GT
Sbjct: 116 --AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 244 FGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
             Y+ PE      +H         DV+S G+VL  +L G+ P     ++ QE      Y 
Sbjct: 171 LPYVAPELLKRREFHAE-----PVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YS 219

Query: 298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                K +  ++   + +             L  + L  N   R T+ ++
Sbjct: 220 ---DWKEKKTYLNPWKKIDSAPL-------ALLHKILVENPSARITIPDI 259

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.0 bits (245), Expect = 1e-23
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 23/216 (10%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQ 127
              F    +LG G    V+  +    G++ A+K   K     +         NEI +L +
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-----SLENEIAVLKK 62

Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAIEVA 186
           I H N+V L      T    LV + +  G L+  + +R    E+          V  +V 
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS------LVIQQVL 116

Query: 187 GALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
            A+ YLH    + I HRD+K  N+L    +E  +  + DFG SK     Q  + +   GT
Sbjct: 117 SAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGT 170

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            GY+ PE       +   D +S GV+   LL G  P
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 76/303 (25%), Positives = 119/303 (39%), Gaps = 62/303 (20%)

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEE 117
             KE +   + + V  +LG GG G+VY G  + D   +A+K   K ++  D  EL     
Sbjct: 34  PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI-SDWGELPNGTR 92

Query: 118 FINEIFILSQINHR--NVVKLLGCCLETEFPL-LVYEFI-PNGTLYQHLHDRHQNEEYPL 173
              E+ +L +++     V++LL    E      L+ E   P   L+  + +R   +E   
Sbjct: 93  VPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE-- 149

Query: 174 TWEMR--FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIA 230
               R  F    +V  A+ + H+     + HRDIK  NIL+D  R   K+ DFG+     
Sbjct: 150 --LARSFFW---QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL-- 199

Query: 231 MDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
           +  T  T    GT  Y  PE      YH        + V+S G++L +++ G  P F   
Sbjct: 200 LKDTVYTD-FDGTRVYSPPEWIRYHRYHGR-----SAAVWSLGILLYDMVCGDIP-FE-- 250

Query: 285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM 344
               E +     F           +  +               +L   CL L    RPT 
Sbjct: 251 --HDEEIIRGQVFFR-------QRVSSE-------------CQHLIRWCLALRPSDRPTF 288

Query: 345 EEV 347
           EE+
Sbjct: 289 EEI 291

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 33/223 (14%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVD-DEELYKLEEFINEIFILS 126
            ++    LG G  G V+     E  + + VK   K K+  D   E  KL +   EI ILS
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGT-LYQHLHDRHQNEEYPLTWEMR--FRVA 182
           ++ H N++K+L    E +    LV E   +G  L+  +    + +E          FR  
Sbjct: 85  RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LASYIFR-- 137

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            ++  A+ YL       I HRDIK  NI++ E +  K+ DFG++ ++   +   T    G
Sbjct: 138 -QLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CG 191

Query: 243 TFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           T  Y  PE      Y        + +++S GV L  L+  + P
Sbjct: 192 TIEYCAPEVLMGNPYRGP-----ELEMWSLGVTLYTLVFEENP 229

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 26/224 (11%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFI-NEIFI 124
              ++   ++G+G    V +      G   AVK    +   +  E+L ++ E    E  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 125 LSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVA 182
           L Q+  H +++ L+     + F  LV++ +  G L+ +L ++   +E+     E R  + 
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETR-SIM 206

Query: 183 IEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
             +  A+++LH+      I HRD+K  NILLD+  + +++DFG S    ++      ++ 
Sbjct: 207 RSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELC 260

Query: 242 GTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           GT GYL PE               + D+++ GV+L  LL G  P
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 96.5 bits (241), Expect = 3e-23
 Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 33/221 (14%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQ 127
             ++ +   +G+G  G V            A KK  K  V+D +      F  EI I+  
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-----RFKQEIEIMKS 62

Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAIEVA 186
           ++H N+++L     +     LV E    G L++ +  +    E          R+  +V 
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA------RIMKDVL 116

Query: 187 GALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
            A+AY H      + HRD+K  N L          K+ DFG +         +     GT
Sbjct: 117 SAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGT 171

Query: 244 FGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
             Y+ P+     Y        + D +S GV++  LL G  P
Sbjct: 172 PYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP 206

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 96.6 bits (241), Expect = 5e-23
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 31/223 (13%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
            + +  +LG+G  G V +    E     AVK   K KL         ++    EI +L +
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRR 62

Query: 128 INHRNVVKLLG-CCLETEFPL-LVYEFIPNGT--LYQHLHDRHQNEEYPLTWEMR--FRV 181
           + H+NV++L+     E +  + +V E+   G   +   + ++          +    F  
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV-----CQAHGYFCQ 117

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS---KFIAMDQTHVTT 238
            I+    L YLHS     I H+DIK  N+LL      K++  G +      A D T  T+
Sbjct: 118 LID---GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171

Query: 239 KIQGTFGYLDPEYHQSSQLTD--KSDVYSFGVVLVELLTGKKP 279
             QG+  +  PE           K D++S GV L  + TG  P
Sbjct: 172 --QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.1 bits (245), Expect = 7e-23
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 31/222 (13%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
           T  + +   LG+G    V +   +  G+  A       KL+  D +     +   E  I 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-----KLEREARIC 64

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAIE 184
             + H N+V+L     E     L+++ +  G L++ +  R + +E            A  
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE----------ADASH 114

Query: 185 ----VAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVT 237
               +  A+ + H      + HR++K  N+LL    +    K+ADFG +  +  +Q    
Sbjct: 115 CIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAW 170

Query: 238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
               GT GYL PE  +        D+++ GV+L  LL G  P
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 70/290 (24%), Positives = 111/290 (38%), Gaps = 52/290 (17%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
            +++ + LG+G  G V           +AVK     +     E + K      EI I   
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK------EICINKM 61

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIE 184
           +NH NVVK  G          L  E+   G L+  +       E     + +  F   + 
Sbjct: 62  LNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLM- 115

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM-DQTHVTTKIQGT 243
               + YLH      I HRDIK  N+LLDER   K++DFG +      ++  +  K+ GT
Sbjct: 116 --AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 244 FGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
             Y+ PE      +H         DV+S G+VL  +L G+ P     ++ QE      Y 
Sbjct: 171 LPYVAPELLKRREFHAE-----PVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YS 219

Query: 298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                K +  ++   + +             L  + L  N   R T+ ++
Sbjct: 220 ---DWKEKKTYLNPWKKIDSAPL-------ALLHKILVENPSARITIPDI 259

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 60/251 (23%), Positives = 97/251 (38%), Gaps = 29/251 (11%)

Query: 59  KLFSSKELDKATNHFNVN-RILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELY 113
           +    + ++   N + +  + LG+G    V +      G+  A K   K +   D     
Sbjct: 16  ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA-- 73

Query: 114 KLEEFINEIFILSQINHR-NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP 172
              E ++EI +L        V+ L      T   +L+ E+   G ++         E   
Sbjct: 74  ---EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVS 129

Query: 173 LTWEMRFRVAI-EVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKF 228
              E      I ++   + YLH    + I H D+K  NILL         K+ DFG S+ 
Sbjct: 130 ---ENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183

Query: 229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           I         +I GT  YL PE      +T  +D+++ G++   LLT   P F  G  +Q
Sbjct: 184 I--GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-FV-GEDNQ 239

Query: 289 E---NVSLAAY 296
           E   N+S    
Sbjct: 240 ETYLNISQVNV 250

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 59/258 (22%), Positives = 110/258 (42%), Gaps = 54/258 (20%)

Query: 51  DGSVIDRCKLFSSKELD-KATNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVD 108
            GS++      ++ E   K  + F V R+ GQG  GTV  G+    G  +A+KK    V 
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VI 57

Query: 109 DEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE-------FPLLVYEFIPNGTLYQH 161
            +  ++  E +  +  L+ ++H N+V+L               +  +V E++P+ TL++ 
Sbjct: 58  QDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRC 115

Query: 162 LHDRHQNEEYPLTWEMR-------FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE 214
               +   +      +         R       ++  LH   S  + HRDIK  N+L++E
Sbjct: 116 C-RNYYRRQVAPPPILIKVFLFQLIR-------SIGCLHL-PSVNVCHRDIKPHNVLVNE 166

Query: 215 R-YRAKVADFGTSKFIAMDQTH---VTTK-------IQGTFGYLDPEYHQSSQLTDKSDV 263
                K+ DFG++K ++  + +   + ++       I G   Y           T   D+
Sbjct: 167 ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHY-----------TTAVDI 215

Query: 264 YSFGVVLVELLTGKKPIF 281
           +S G +  E++ G +PIF
Sbjct: 216 WSVGCIFAEMMLG-EPIF 232

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 20/223 (8%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+  ++LG+G  G V   R +  GR  A+K   K  +   DE    +   + E  +L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQ 60

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  L     +T   L  V E+   G L+ HL       E       RF  A E+
Sbjct: 61  NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----RARFYGA-EI 114

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL YLHS     + +RDIK  N++LD+    K+ DFG  K   +          GT  
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           YL PE  + +      D +  GVV+ E++ G+ P F   +  +
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHER 212

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 74/307 (24%), Positives = 122/307 (39%), Gaps = 68/307 (22%)

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLA--VDDEELYKL 115
             K+ +     + +  +LG+GG GTV+ G  L D   +A+K   ++++       +    
Sbjct: 22  GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81

Query: 116 EEFINEIFILSQIN----HRNVVKLLGCCLETEFPL-LVYEF-IPNGTLYQHLHDRHQNE 169
                E+ +L ++     H  V++LL    ET+    LV E  +P   L+ ++ ++    
Sbjct: 82  P---LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLG 137

Query: 170 EYPLTWEMR--FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTS 226
           E       R  F    +V  A+ + HS     + HRDIK  NIL+D  R  AK+ DFG+ 
Sbjct: 138 EG----PSRCFFG---QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG 187

Query: 227 KFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
               +     T    GT  Y  PE      YH        + V+S G++L +++ G  P 
Sbjct: 188 AL--LHDEPYTD-FDGTRVYSPPEWISRHQYHAL-----PATVWSLGILLYDMVCGDIP- 238

Query: 281 FSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKK 340
           F       + +  A             H+  D                L  RCL      
Sbjct: 239 FE----RDQEILEAELHFP-------AHVSPD-------------CCALIRRCLAPKPSS 274

Query: 341 RPTMEEV 347
           RP++EE+
Sbjct: 275 RPSLEEI 281

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 24/227 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL----EDGRIIAVK---KSKLAVDDEELYKLEEFINEIF 123
             F + R+LG+GG G V++ R       G+I A+K   K+ +  + ++         E  
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT---AHTKAERN 73

Query: 124 ILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLH-DRHQNEEYPLTWEMRFRV 181
           IL ++ H  +V L+    +T   L L+ E++  G L+  L  +    E+        F +
Sbjct: 74  ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-----TACFYL 127

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
           A E++ AL +LH      I +RD+K  NI+L+ +   K+ DFG  K  ++    VT    
Sbjct: 128 A-EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFC 182

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           GT  Y+ PE    S      D +S G ++ ++LTG  P F+  N  +
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKK 228

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 44/238 (18%)

Query: 62  SSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
             K  ++    +   +++G G  G V++ +L +   +A+KK    V  ++ +K      E
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK----VLQDKRFKNR----E 82

Query: 122 IFILSQINHRNVVKLLGCCLET-----EFPL-LVYEFIPNGTLYQHL-HDRHQNEEYPL- 173
           + I+  + H NVV L            E  L LV E++P  T+Y+   H     +  P+ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPML 141

Query: 174 -----TWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-YRAKVADFGTSK 227
                 +++  R       +LAY+HS     I HRDIK  N+LLD      K+ DFG++K
Sbjct: 142 LIKLYMYQL-LR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190

Query: 228 FIAMDQ--TH-VTTKIQGTFGYLDPE-YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
            +   +     + ++      Y  PE    ++  T   D++S G V+ EL+ G +P+F
Sbjct: 191 ILIAGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLF 242

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 45/231 (19%)

Query: 70  TNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              +   +++G G  G VY+ +L + G ++A+KK    V  ++ +K  E    + I+ ++
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRE----LQIMRKL 104

Query: 129 NHRNVVKLLGCCLET-----EFPL-LVYEFIPNGTLYQHL-HDRHQNEEYPL------TW 175
           +H N+V+L      +     E  L LV +++P  T+Y+   H     +  P+       +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-YRAKVADFGTSKFIAMDQ- 233
           ++ FR       +LAY+HS     I HRDIK  N+LLD      K+ DFG++K +   + 
Sbjct: 164 QL-FR-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query: 234 -TH-VTTKIQGTFGYLDPEY-HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
               + ++      Y  PE    ++  T   DV+S G VL ELL G +PIF
Sbjct: 213 NVSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIF 257

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 21/232 (9%)

Query: 56  DRCKLFSSKELDKAT-NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDE 110
           D  K + +   + A  + F+  + LG G  G V   + ++ G   A+K   K K+    +
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84

Query: 111 ELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEE 170
               +E  +NE  IL  +N   +VKL     +     +V E++  G ++ HL    +  E
Sbjct: 85  ----IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140

Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
                  RF  A ++     YLHS     + +RD+K  N+L+D++   +V DFG +K + 
Sbjct: 141 P----HARFYAA-QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191

Query: 231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
                 T  + GT   L PE   S       D ++ GV++ E+  G  P F+
Sbjct: 192 ---KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 72/308 (23%), Positives = 118/308 (38%), Gaps = 61/308 (19%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKL-------------------AV 107
           N + +   +G+G  G V       D    A+K   K KL                     
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 108 DDEELYKLEEFINEIFILSQINHRNVVKL---LGCCLETEFPLLVYEFIPNGTLYQHLHD 164
             +    +E+   EI IL +++H NVVKL   L    E     +V+E +  G + +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTL 131

Query: 165 RHQNEEYPLTWEMR--FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD 222
           +  +E+     + R  F+   ++   + YLH      I HRDIK +N+L+ E    K+AD
Sbjct: 132 KPLSED-----QARFYFQ---DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIAD 180

Query: 223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT---DKSDVYSFGVVLVELLTGKKP 279
           FG S         + +   GT  ++ PE    ++        DV++ GV L   + G+ P
Sbjct: 181 FGVSNEF-KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

Query: 280 IFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGK 339
            F                +HS  K++     D   +    K       +L  R LD N +
Sbjct: 240 -FMDERIMC---------LHSKIKSQALEFPDQPDIAEDLK-------DLITRMLDKNPE 282

Query: 340 KRPTMEEV 347
            R  + E+
Sbjct: 283 SRIVVPEI 290

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 30/225 (13%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
              D  ++ F V   LG+G    VY+ +     +  A+K  K  VD + +        EI
Sbjct: 46  SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR------TEI 99

Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRV 181
            +L +++H N++KL           LV E +  G L+  + ++ + +E          R 
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE----------RD 149

Query: 182 AIE----VAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQT 234
           A +    +  A+AYLH    + I HRD+K  N+L          K+ADFG SK +  +  
Sbjct: 150 AADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQ 204

Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            +   + GT GY  PE  +      + D++S G++   LL G +P
Sbjct: 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 91.1 bits (227), Expect = 3e-21
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
           H+ +   LG G  G V  G     G  +AVK   + K+    + + K++    EI  L  
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIK---REIQNLKL 67

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIE 184
             H +++KL    + T     +V E++  G L+ ++    + EE     E R  F+   +
Sbjct: 68  FRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQ---Q 119

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  A+ Y H      + HRD+K  N+LLD    AK+ADFG S  ++  +   T+   G+ 
Sbjct: 120 ILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSP 174

Query: 245 GYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Y  PE      Y        + D++S GV+L  LL G  P
Sbjct: 175 NYAAPEVISGRLYAGP-----EVDIWSCGVILYALLCGTLP 210

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 24/231 (10%)

Query: 61  FSSKELDKAT-NHFNVNRILGQGGQGTVY----KGRLEDGRIIAVK---KSKLAVDDEEL 112
             +   +K    +F + ++LG G  G V+        + G++ A+K   K+ +    +  
Sbjct: 43  NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 102

Query: 113 YKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHL-HDRHQNEE 170
              E    E  +L  I     +  L    +TE  L L+ ++I  G L+ HL       E 
Sbjct: 103 ---EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH 159

Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
                E++  V  E+  AL +LH      I +RDIK  NILLD      + DFG SK   
Sbjct: 160 -----EVQIYVG-EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210

Query: 231 MDQTHVTTKIQGTFGYLDPE-YHQSSQLTDKS-DVYSFGVVLVELLTGKKP 279
            D+T       GT  Y+ P+         DK+ D +S GV++ ELLTG  P
Sbjct: 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 92.8 bits (230), Expect = 8e-21
 Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 19/223 (8%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
             FN   +LG+G  G V     +    + AVK   K  +  DD+    +E  + E  +L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----VECTMVEKRVLA 396

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
                  +  L  C +T   L  V E++  G L  H+    + +E        F  A E+
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAA-EI 451

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
           A  L +L S     I +RD+K  N++LD     K+ADFG  K   +     T    GT  
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPD 507

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           Y+ PE           D ++FGV+L E+L G+ P F   +  +
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDE 549

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 72/298 (24%), Positives = 120/298 (40%), Gaps = 52/298 (17%)

Query: 78  ILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVK 135
           +LG+G    V     L   +  AVK     ++ +  +       E+ +L Q   HRNV++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKI----IEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
           L+    E +   LV+E +  G++  H+H R H NE      E    V  +VA AL +LH+
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVASALDFLHN 129

Query: 195 -GASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQ------GTF 244
            G    I HRD+K  NIL    ++    K+ DF     I ++               G+ 
Sbjct: 130 KG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 245 GYLDPE----YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
            Y+ PE    + + + + DK  D++S GV+L  LL+G  P F  G    +          
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP-FV-GRCGSDCGWDRGEACP 243

Query: 300 SMRKNRLYHILD----------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           + +      I +            +    K        +L  + L  + K+R +  +V
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAK--------DLISKLLVRDAKQRLSAAQV 293

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 19/223 (8%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL-EDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           + F+  +++G+G  G V   R   +    AVK   K  +    EE + + E    + + +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE--RNVLLKN 95

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            + H  +V L     +T   L  V ++I  G L+ HL       E       RF  A E+
Sbjct: 96  -VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAA-EI 148

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
           A AL YLHS     I +RD+K  NILLD +    + DFG  K   ++    T+   GT  
Sbjct: 149 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           YL PE           D +  G VL E+L G  P F + NT++
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP-FYSRNTAE 246

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 20/215 (9%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
             F++ R++G+G    V   RL+   RI A+K   K  +  D++    ++    E  +  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED----IDWVQTEKHVFE 64

Query: 127 QI-NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           Q  NH  +V L   C +TE  L  V E++  G L  H+  + +  E       RF  A E
Sbjct: 65  QASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSA-E 118

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           ++ AL YLH      I +RD+K  N+LLD     K+ D+G  K   +     T+   GT 
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTP 174

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Y+ PE  +        D ++ GV++ E++ G+ P
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 73/224 (32%), Positives = 104/224 (46%), Gaps = 21/224 (9%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           ++F   R+LG+G  G V   R+++ G + AVK   K  +  DD+    +E  + E  ILS
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD----VECTMTEKRILS 78

Query: 127 QI-NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
              NH  + +L  CC +T   L  V EF+  G L  H+    + +E       RF  A E
Sbjct: 79  LARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARFYAA-E 132

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  AL +LH      I +RD+K  N+LLD     K+ADFG  K   +     T    GT 
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTP 188

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
            Y+ PE  Q        D ++ GV+L E+L G  P F   N   
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDD 231

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 20/215 (9%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
             F++ R++G+G    V   RL+   RI A++   K  +  D++    ++    E  +  
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED----IDWVQTEKHVFE 107

Query: 127 QI-NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           Q  NH  +V L   C +TE  L  V E++  G L  H+  + +  E       RF  A E
Sbjct: 108 QASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSA-E 161

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           ++ AL YLH      I +RD+K  N+LLD     K+ D+G  K   +     T+   GT 
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTP 217

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Y+ PE  +        D ++ GV++ E++ G+ P
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
             FN   +LG+G  G V     +    + AVK   K  +  DD+    +E  + E  +L+
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----VECTMVEKRVLA 75

Query: 127 QI-NHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
                  + +L   C +T   L  V E++  G L  H+    + +E        F  A E
Sbjct: 76  LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAA-E 129

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +A  L +L S     I +RD+K  N++LD     K+ADFG  K   +     T    GT 
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTP 185

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Y+ PE           D ++FGV+L E+L G+ P
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 61/293 (20%)

Query: 76  NRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQI-NH 130
           ++ LG+G      K    +  +  AVK   K                  EI  L     H
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME----------ANTQKEITALKLCEGH 65

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+VKL     +     LV E +  G L++ +  +    E   ++ MR     ++  A++
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-----KLVSAVS 120

Query: 191 YLHS-GASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
           ++H  G    + HRD+K  N+L    ++    K+ DFG ++    D   + T    T  Y
Sbjct: 121 HMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHY 175

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
             PE    +   +  D++S GV+L  +L+G+ P F + + S    S              
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVP-FQSHDRSLTCTSAVEIM--------- 225

Query: 307 YHILDDQVMKLGKKNQIVAFA------------NLAERCLDLNGKKRPTMEEV 347
                 ++ K G      +F             +L +  L ++  KR  M  +
Sbjct: 226 -----KKIKK-GD----FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 29/229 (12%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFIL 125
           T+ + V   +G G      +          AVK   KSK    +E          EI +L
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI---------EI-LL 70

Query: 126 SQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDR-HQNEEYPLTWEMRFRVAIE 184
               H N++ L     + ++  +V E +  G L   +  +   +E      E    V   
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EAS-AVLFT 124

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAMDQTHVTTKI 240
           +   + YLH+     + HRD+K +NIL           ++ DFG +K +  +   + T  
Sbjct: 125 ITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
             T  ++ PE  +        D++S GV+L  +LTG  P  +  + + E
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 58/291 (19%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
           H+ +   LG G  G V  G+    G  +AVK   + K+    + + K+     EI  L  
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-RSLDVVGKIR---REIQNLKL 72

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIE 184
             H +++KL    + T   + +V E++  G L+ ++    + +E     E R  F+   +
Sbjct: 73  FRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESRRLFQ---Q 124

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +   + Y H      + HRD+K  N+LLD    AK+ADFG S  ++  +   T+   G+ 
Sbjct: 125 ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSP 179

Query: 245 GYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAY 296
            Y  PE      Y        + D++S GV+L  LL G  P F   +     + +    +
Sbjct: 180 NYAAPEVISGRLYAGP-----EVDIWSSGVILYALLCGTLP-FDDDHVPTLFKKICDGIF 233

Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +          ++                  +L +  L ++  KR T++++
Sbjct: 234 YTPQ-------YLNPSV-------------ISLLKHMLQVDPMKRATIKDI 264

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 19/223 (8%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
             F ++++LG+G  G V+    +   +  A+K   K  + +DD+    + E    +  L+
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE--KRVLSLA 74

Query: 127 QINHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
              H  +  +  C  +T+  L  V E++  G L  H+   H+ +         F  A E+
Sbjct: 75  -WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS----RATFYAA-EI 127

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
              L +LHS     I +RD+K  NILLD+    K+ADFG  K   M     T    GT  
Sbjct: 128 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPD 183

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ 288
           Y+ PE     +     D +SFGV+L E+L G+ P F   +  +
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEE 225

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.8 bits (216), Expect = 2e-19
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 22/215 (10%)

Query: 73  FNVNRILGQGGQGTVYKGRLED-GRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQI 128
           F + R LG G  G V+  R    GR  A+K   K  +    +    +E   +E  +LS +
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ----VEHTNDERLMLSIV 63

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL-HDRHQNEEYPLTWEMRFRVAIEVAG 187
            H  ++++ G   + +   ++ ++I  G L+  L   +            +F  A EV  
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAA-EVCL 117

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           AL YLHS     I +RD+K  NILLD+    K+ DFG +K++      VT  + GT  Y+
Sbjct: 118 ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYI 170

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
            PE   +       D +SFG+++ E+L G  P + 
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.0 bits (214), Expect = 2e-19
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 29/213 (13%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQINHRNV 133
           +G+G  GTV+K +  E   I+A+K+ +L  DD++    E      + EI +L ++ H+N+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL--DDDD----EGVPSSALREICLLKELKHKNI 63

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           V+L       +   LV+EF     L ++    +      L  E+      ++   L + H
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCH 118

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY-- 251
              S  + HRD+K  N+L++     K+A+FG ++   +     + ++  T  Y  P+   
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174

Query: 252 ---HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
                S+ +    D++S G +  EL    +P+F
Sbjct: 175 GAKLYSTSI----DMWSAGCIFAELANAGRPLF 203

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 14/205 (6%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V K R  + GRI+A+KK   + DD+ + K+   + EI +L Q+ H N+V LL
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQLRHENLVNLL 90

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
             C + +   LV+EF+ + T+   L          L +++  +   ++   + + HS   
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS--- 142

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
             I HRDIK  NIL+ +    K+ DFG ++ +A        ++  T  Y  PE       
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVK 201

Query: 258 TDKS-DVYSFGVVLVELLTGKKPIF 281
             K+ DV++ G ++ E+  G +P+F
Sbjct: 202 YGKAVDVWAIGCLVTEMFMG-EPLF 225

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 70/297 (23%), Positives = 108/297 (36%), Gaps = 66/297 (22%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
            ++  + +G G  G     R      ++AVK   +      DE + +      EI     
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQR------EIINHRS 72

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIE 184
           + H N+V+     + T   L ++ E+   G LY+ + +  +  E     E R  F+  + 
Sbjct: 73  LRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSED----EARFFFQQLL- 126

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERY--RAKVADFGTSKFIAMDQTHVTTKIQG 242
               ++Y HS     I HRD+K  N LLD     R K+ DFG SK   +     +T   G
Sbjct: 127 --SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 179

Query: 243 TFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY 296
           T  Y+ PE      Y         +DV+S GV L  +L G  P F               
Sbjct: 180 TPAYIAPEVLLRQEYDGK-----IADVWSCGVTLYVMLVGAYP-FEDPEEP--------- 224

Query: 297 FVHSMRKNRL------YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                RK         Y I DD  +            +L  R    +   R ++ E+
Sbjct: 225 --RDYRKTIQRILSVKYSIPDDIRISPECC-------HLISRIFVADPATRISIPEI 272

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 29/212 (13%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQINHRNVV 134
           +G+G  G VYK +   GRI+A+K+ +L  D E+    E      I EI +L +++H N+V
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRL--DAED----EGIPSTAIREISLLKELHHPNIV 82

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
            L+          LV+EF+    L + L +        L          ++   +A+ H 
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKD-LKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCH- 136

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY--- 251
                I HRD+K  N+L++     K+ADFG ++   +     T ++  T  Y  P+    
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMG 193

Query: 252 --HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
               S+ +    D++S G +  E++TG KP+F
Sbjct: 194 SKKYSTSV----DIWSIGCIFAEMITG-KPLF 220

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.9 bits (211), Expect = 8e-19
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLL 137
           +G+G  G V+K R  + G+I+A+KK   + DD  + K+   + EI +L Q+ H N+V LL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHPNLVNLL 68

Query: 138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS 197
                     LV+E+  + T+   L    +     +   +   +  +   A+ + H    
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN- 122

Query: 198 SPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL 257
               HRD+K  NIL+ +    K+ DFG ++ +     +   ++  T  Y  PE       
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQ 179

Query: 258 TDKS-DVYSFGVVLVELLTGKKPIF 281
                DV++ G V  ELL+G  P++
Sbjct: 180 YGPPVDVWAIGCVFAELLSG-VPLW 203

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 73/298 (24%), Positives = 125/298 (41%), Gaps = 50/298 (16%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQINHRNV 133
           LG G   TVYKG     G  +A+K+ KL   D E    E      I EI ++ ++ H N+
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKL---DSE----EGTPSTAIREISLMKELKHENI 65

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-QNEEYPLTWEMRFRVAIEVAGALAYL 192
           V+L           LV+EF+ N  L +++  R   N    L   +      ++   LA+ 
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY- 251
           H      I HRD+K  N+L+++R + K+ DFG ++   +     ++++  T  Y  P+  
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVL 180

Query: 252 ----HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE------------------ 289
                 S+ +    D++S G +L E++TG KP+F  G   +E                  
Sbjct: 181 MGSRTYSTSI----DIWSCGCILAEMITG-KPLF-PGTNDEEQLKLIFDIMGTPNESLWP 234

Query: 290 NVS-LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           +V+ L  Y  +   + R    L   +    K+       +     L LN   R + ++
Sbjct: 235 SVTKLPKY--NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 38/224 (16%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            + + + R LG+G    V++   + +   + VK  K  V  +++ +      EI IL  +
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKR------EIKILENL 87

Query: 129 -NHRNVVKLLGCCL--ETEFPLLVYEFIPNG---TLYQHLHDRHQNEEYPLTWEMRFRVA 182
               N++ L        +  P LV+E + N     LYQ L D            +RF + 
Sbjct: 88  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD----------IRFYM- 136

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA-KVADFGTSKFIAMDQT---HVTT 238
            E+  AL Y HS     I HRD+K  N+++D  +R  ++ D+G ++F    Q     V +
Sbjct: 137 YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193

Query: 239 KIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF 281
           +      +  PE     Q+ D S D++S G +L  ++  K+P F
Sbjct: 194 RY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 83.3 bits (207), Expect = 2e-18
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 79  LGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQINHRNVV 134
           +G+G  G VYK +   G   A+KK +L  + E+    E      I EI IL ++ H N+V
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL--EKED----EGIPSTTIREISILKELKHSNIV 63

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
           KL       +  +LV+E +    L + L          L         +++   +AY H 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCH- 117

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE---- 250
                + HRD+K  N+L++     K+ADFG ++   +     T +I  T  Y  P+    
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMG 174

Query: 251 -YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
               S+ +    D++S G +  E++ G  P+F
Sbjct: 175 SKKYSTTI----DIWSVGCIFAEMVNG-TPLF 201

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 60/312 (19%), Positives = 112/312 (35%), Gaps = 55/312 (17%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              +   + +G G QG V         R +A+KK      ++   K      E+ ++  +
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK--RAYRELVLMKCV 81

Query: 129 NHRNVVKLLGCCL----ETEFP--LLVYEFIP---NGTLYQHL-HDRHQNEEYPLTWEMR 178
           NH+N++ LL          EF    +V E +       +   L H+R     Y +     
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM----- 136

Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
                     + +LHS     I HRD+K +NI++      K+ DFG ++      + + T
Sbjct: 137 LC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 184

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS--------------TG 284
               T  Y  PE        +  D++S G ++ E++ G   +F                G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLG 243

Query: 285 NTSQENV----SLAAYFVHSMRK------NRLYHILDDQVMKLGKKNQIVAFANLAERCL 334
               E +         +V +  K       +L+  +         K +     +L  + L
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303

Query: 335 DLNGKKRPTMEE 346
            ++  KR +++E
Sbjct: 304 VIDASKRISVDE 315

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 59/305 (19%), Positives = 113/305 (37%), Gaps = 41/305 (13%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              +   + +G G QG V         R +A+KK      ++   K      E+ ++  +
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK--RAYRELVLMKCV 118

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHL--HDRHQNEEYPLTWE-MRFRVAIEV 185
           NH+N++ LL        P    E   +  L   L   +  Q  +  L  E M + +  ++
Sbjct: 119 NHKNIISLL----NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL-YQM 173

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
              + +LHS     I HRD+K +NI++      K+ DFG ++      + + T    T  
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 228

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS--------------TGNTSQENV 291
           Y  PE        +  D++S G ++ E++   K +F                G    E +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFM 287

Query: 292 ----SLAAYFVHSMRK------NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKR 341
                    +V +  K       +L+            K +     +L  + L ++  KR
Sbjct: 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347

Query: 342 PTMEE 346
            ++++
Sbjct: 348 ISVDD 352

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 82.3 bits (204), Expect = 9e-18
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 34/232 (14%)

Query: 75  VNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQIN 129
           + +I GQG  G V+K R  + G+ +A+KK  +  ++E+    E F    + EI IL  + 
Sbjct: 22  LAKI-GQGTFGEVFKARHRKTGQKVALKKVLM--ENEK----EGFPITALREIKILQLLK 74

Query: 130 HRNVVKLLGCCLETEFPL--------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
           H NVV L+  C     P         LV++F  +  L   L +         T     RV
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV----KFTLSEIKRV 129

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
              +   L Y+H    + I HRD+K+ N+L+      K+ADFG ++  ++ +     +  
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186

Query: 242 G---TFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
               T  Y  PE            D++  G ++ E+ T + PI   GNT Q 
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIM-QGNTEQH 236

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 36/221 (16%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILSQ 127
            + +   LG+G  G V      +  + +A+K   +  L    +   ++E    EI  L  
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-KKSDMHMRVE---REISYLKL 65

Query: 128 INHRNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR--FRVAIE 184
           + H +++KL    + T   + +V E+   G L+ ++ ++ +  E     E R  F+   +
Sbjct: 66  LRHPHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED----EGRRFFQ---Q 116

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +  A+ Y H      I HRD+K  N+LLD+    K+ADFG S  +       T+   G+ 
Sbjct: 117 IICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSP 171

Query: 245 GYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            Y  PE      Y        + DV+S G+VL  +L G+ P
Sbjct: 172 NYAAPEVINGKLYAGP-----EVDVWSCGIVLYVMLVGRLP 207

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 35/223 (15%)

Query: 79  LGQGGQGTVYKGR---LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK 135
           +G+G  G VYK +    +D +  A+K+    ++   +        EI +L ++ H NV+ 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQ----IEGTGI--SMSACREIALLRELKHPNVIS 82

Query: 136 LLGCCLE-TEFPL-LVYEFIPN---GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
           L    L   +  + L++++  +     +  H   +   +   L   M   +  ++   + 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 191 YLHSGASSPIYHRDIKSTNILL----DERYRAKVADFGTSKFIAM---DQTHVTTKIQGT 243
           YLH   ++ + HRD+K  NIL+     ER R K+AD G ++           +   +  T
Sbjct: 143 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 198

Query: 244 FGYLDPE-----YHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           F Y  PE      H +  +    D+++ G +  ELLT  +PIF
Sbjct: 199 FWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT-SEPIF 236

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 66/275 (24%), Positives = 95/275 (34%), Gaps = 79/275 (28%)

Query: 77  RILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-N 129
           + LG+G  G V +            R +AVK  K      E       ++E+ IL  I +
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKILIHIGH 84

Query: 130 HRNVVKLLGCCLETEFPLLV-YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           H NVV LLG C +   PL+V  EF   G L  +L  +        T   RFR   +  GA
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144

Query: 189 L-----AYLHSGASSPI-----------------------YHRDIKSTNILL-------- 212
           +       L S  SS                          ++D  +   L+        
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204

Query: 213 ----------------------DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD-- 248
                                  E+   K+ DFG ++ I  D  +V    +     L   
Sbjct: 205 GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----RKGDARLPLK 260

Query: 249 ---PEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP 279
              PE       T +SDV+SFGV+L E+ + G  P
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 50/152 (32%), Positives = 70/152 (46%), Gaps = 18/152 (11%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFIN-----EIFILSQINHRN 132
           LG+G   TVYK R     +I+A+KK KL    E     ++ IN     EI +L +++H N
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----KDGINRTALREIKLLQELSHPN 73

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           ++ LL          LV++F+    L   + D        LT        +     L YL
Sbjct: 74  IIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYL 128

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFG 224
           H      I HRD+K  N+LLDE    K+ADFG
Sbjct: 129 H---QHWILHRDLKPNNLLLDENGVLKLADFG 157

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 31/213 (14%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQINHRNV 133
           LG+G   TVYKG+      ++A+K+ +L  + EE           I E+ +L  + H N+
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRL--EHEE-----GAPCTAIREVSLLKDLKHANI 62

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           V L       +   LV+E++    L Q+L D        +          ++   LAY H
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCH 117

Query: 194 SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEY-- 251
                 + HRD+K  N+L++ER   K+ADFG ++  ++       ++  T  Y  P+   
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILL 173

Query: 252 ---HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
                S+Q+    D++  G +  E+ TG +P+F
Sbjct: 174 GSTDYSTQI----DMWGVGCIFYEMATG-RPLF 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 79.9 bits (198), Expect = 4e-17
 Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 31/222 (13%)

Query: 75  VNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQIN 129
           V  I G G  GTVYK R    G  +A+K  ++                 + E+ +L ++ 
Sbjct: 14  VAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGG---GGGLPISTVREVALLRRLE 69

Query: 130 ---HRNVVKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
              H NVV+L+  C  +         LV+E +    L  +L          L  E    +
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP---GLPAETIKDL 125

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTTK 239
             +    L +LH   ++ I HRD+K  NIL+      K+ADFG ++     M  T V   
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV- 181

Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
              T  Y  PE    S      D++S G +  E+   +KP+F
Sbjct: 182 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF 219

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 36/218 (16%)

Query: 79  LGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQINHRNV 133
           LG+G  G VYK         +A+K+ +L  + EE    E      I E+ +L ++ HRN+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRL--EHEE----EGVPGTAIREVSLLKELQHRNI 95

Query: 134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH 193
           ++L           L++E+  N  L +++ D++      ++  +      ++   + + H
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNP----DVSMRVIKSFLYQLINGVNFCH 149

Query: 194 SGASSPIYHRDIKSTNILLDERYRA-----KVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           S       HRD+K  N+LL     +     K+ DFG ++   +     T +I  T  Y  
Sbjct: 150 SRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRP 205

Query: 249 PEY-----HQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
           PE      H S+ +    D++S   +  E+L    P+F
Sbjct: 206 PEILLGSRHYSTSV----DIWSIACIWAEMLMK-TPLF 238

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 58/267 (21%), Positives = 108/267 (40%), Gaps = 77/267 (28%)

Query: 66  LDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           L+ ++  +++ + LG G  G V +   +E G+  A+KK    V  +  YK  E    + I
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK----VLQDPRYKNRE----LDI 53

Query: 125 LSQINHRNVVKLLGCCLETEFPL------------------------------------- 147
           +  ++H N++KL+     T                                         
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 148 -LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR-------FRVAIEVAGALAYLHSGASSP 199
            ++ E++P+ TL++ L          +   +        FR       A+ ++HS     
Sbjct: 114 NVIMEYVPD-TLHKVLK-SFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLG--- 161

Query: 200 IYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLDPE-YHQS 254
           I HRDIK  N+L++ +    K+ DFG++K +   +     + ++      Y  PE    +
Sbjct: 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGA 216

Query: 255 SQLTDKSDVYSFGVVLVELLTGKKPIF 281
           ++ T   D++S G V  EL+ G KP+F
Sbjct: 217 TEYTPSIDLWSIGCVFGELILG-KPLF 242

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 61/317 (19%), Positives = 112/317 (35%), Gaps = 64/317 (20%)

Query: 70  TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFIN--------- 120
            + + V R +  G  G V  G   +G  +A+K+  +     +   +    +         
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKR--VFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 121 EIFILSQINHRNVVKLLGCCLETEFPL-----LVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           EI +L+  +H N++ L    +  E P      LV E +    L Q +HD+       ++ 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI----VIS- 132

Query: 176 EMRFRVAI-EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
               +  +  +   L  LH      + HRD+   NILL +     + DF  ++    D  
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189

Query: 235 ---HVTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF--------- 281
              +VT +      Y  PE     +   K  D++S G V+ E+    K +F         
Sbjct: 190 KTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQL 243

Query: 282 -----STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKN--QIVAFAN-----L 329
                  G    E        V           L + +  +  +    +V  A+     L
Sbjct: 244 NKIVEVVGTPKIE-------DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296

Query: 330 AERCLDLNGKKRPTMEE 346
             + L+ N ++R + E+
Sbjct: 297 IAKMLEFNPQRRISTEQ 313

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 50/212 (23%), Positives = 83/212 (39%), Gaps = 29/212 (13%)

Query: 78  ILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVK 135
           +LG G  G V +      G+  A+K          LY   +   E+    Q     ++V 
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKL---------LYDSPKARQEVDHHWQASGGPHIVC 86

Query: 136 LLGCC----LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAY 191
           +L             L++ E +  G L+  + +R        T      +  ++  A+ +
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ---AFTEREAAEIMRDIGTAIQF 143

Query: 192 LHS-GASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
           LHS      I HRD+K  N+L    ++    K+ DFG +K     Q  + T    T  Y+
Sbjct: 144 LHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYYV 196

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            PE     +     D++S GV++  LL G  P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 53/237 (22%), Positives = 86/237 (36%), Gaps = 54/237 (22%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVV 134
           ++LG G  G V +          A+K          L    +   E+ +  +     ++V
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKM---------LQDCPKARREVELHWRASQCPHIV 118

Query: 135 KLLG----CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF------RVAIE 184
           +++          +  L+V E +  G L+  + DR             F       +   
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---------AFTEREASEIMKS 169

Query: 185 VAGALAYLHS-GASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVTTKI 240
           +  A+ YLHS      I HRD+K  N+L          K+ DFG +K      +  T   
Sbjct: 170 IGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--P 223

Query: 241 QGTFGYLDPE------YHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
             T  Y+ PE      Y       DKS D++S GV++  LL G  P +S    +   
Sbjct: 224 CYTPYYVAPEVLGPEKY-------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 67/314 (21%), Positives = 111/314 (35%), Gaps = 71/314 (22%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              +     +G G  G+V        G  +A+KK       E   K      E+ +L  +
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK--RAYRELLLLKHM 80

Query: 129 NHRNVVKLLGCCLETEFPL------LVYEFIP---NGTLYQHLHDRH-QNEEYPLTWEMR 178
            H NV+ LL                LV  F+       +     +   Q   Y +     
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM----- 135

Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VT 237
            +        L Y+HS     + HRD+K  N+ ++E    K+ DFG ++    + T  V 
Sbjct: 136 LK-------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185

Query: 238 TKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS-------------- 282
           T+      Y  PE   S    +++ D++S G ++ E+LTG K +F               
Sbjct: 186 TRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQLTQILKV 239

Query: 283 TGNTSQENVSL-----AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFAN-----LAER 332
           TG    E V       A  ++ S+ +                  Q+   A+     L E+
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-----------TQLFPRASPQAADLLEK 288

Query: 333 CLDLNGKKRPTMEE 346
            L+L+  KR T  +
Sbjct: 289 MLELDVDKRLTAAQ 302

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 59/338 (17%), Positives = 122/338 (36%), Gaps = 96/338 (28%)

Query: 75  VNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQIN-- 129
           + R LG G   TV+  + + +   +A+K  +        ++Y  E   +EI +L ++N  
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYT-EAAEDEIKLLQRVNDA 75

Query: 130 ---------HRNVVKLLGC-----------CLETEFPLL---VYEFIPNGTLYQHLHDRH 166
                      +++KLL              +  E  +L   +   I           ++
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALI----------KKY 123

Query: 167 QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA------KV 220
           ++   PL +  +   + ++   L Y+H      I H DIK  N+L++           K+
Sbjct: 124 EHRGIPLIYVKQI--SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKI 179

Query: 221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI 280
           AD G + +      H T  IQ    Y  PE    +     +D++S   ++ EL+TG   +
Sbjct: 180 ADLGNACW---YDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITG-DFL 234

Query: 281 F---STGNTSQENVSLA---------------------AYF--------VHSMRKNRLYH 308
           F      + ++++  +A                      +F        +  ++   L  
Sbjct: 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294

Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
           +L ++      K++    ++     L L+ +KR     
Sbjct: 295 VLTEKYK--FSKDEAKEISDFLSPMLQLDPRKRADAGG 330

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 74/348 (21%), Positives = 123/348 (35%), Gaps = 103/348 (29%)

Query: 67  DKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIF 123
           D     + V +++G+G  G V K    +  + +A+K  +++            +   EI 
Sbjct: 93  DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-------HRQAAEEIR 145

Query: 124 ILSQINHR------NVVKLLGC-------CLETEFPLL---VYEFIPNGTLYQHLHDRHQ 167
           IL  +  +      NV+ +L         C+  E  LL   +YE I             +
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELI------------KK 191

Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA--KVADFGT 225
           N+    +  +  + A  +   L  LH    + I H D+K  NILL ++ R+  KV DFG+
Sbjct: 192 NKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGS 248

Query: 226 SKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           S +   +   V T IQ  F Y  PE      Y          D++S G +L ELLTG  P
Sbjct: 249 SCY---EHQRVYTYIQSRF-YRAPEVILGARYGMPI------DMWSLGCILAELLTG-YP 297

Query: 280 IFSTGNTSQ-----------------ENVSLAAYFVHSM--------------------- 301
           +    +                    +    A  FV S                      
Sbjct: 298 LLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGG 357

Query: 302 --RKNRLYHILDDQVM-KLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
             R+ +L    + +      K      F +  ++CL+ +   R T  +
Sbjct: 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 35/223 (15%)

Query: 75  VNRILGQGGQGTVYKGR--LEDGRIIAVKKSKLAVDDEELYKLEEF----INEIFILSQI 128
           V  I G+G  G V+K R     GR +A+K+ ++     E    E      I E+ +L  +
Sbjct: 16  VAEI-GEGAYGKVFKARDLKNGGRFVALKRVRV--QTGE----EGMPLSTIREVAVLRHL 68

Query: 129 N---HRNVVKLL----GCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFR 180
               H NVV+L         + E  L LV+E +    L  +L    +     +  E    
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP---GVPTETIKD 124

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF--IAMDQTHVTT 238
           +  ++   L +LH   S  + HRD+K  NIL+    + K+ADFG ++     M  T V  
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF 281
               T  Y  PE    S      D++S G +  E+   +KP+F
Sbjct: 182 ----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF 219

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 72/353 (20%), Positives = 123/353 (34%), Gaps = 106/353 (30%)

Query: 67  DKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIF 123
           +K  + + ++ ++G+G  G V K     +   +A+K  K+K A  ++          E+ 
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ-------IEVR 102

Query: 124 ILSQINHR------NVVKLLGC-------CLETEFPLL---VYEFIPNGTLYQHLHDRHQ 167
           +L  +N         +V L          CL  E  +L   +Y+ +              
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLL------------RN 148

Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA--KVADFGT 225
                ++  +  + A ++  AL +L +   S I H D+K  NILL    R+  K+ DFG+
Sbjct: 149 TNFRGVSLNLTRKFAQQMCTALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDFGS 207

Query: 226 SKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           S         +   IQ  F Y  PE      Y  +       D++S G +LVE+ TG +P
Sbjct: 208 SCQ---LGQRIYQYIQSRF-YRSPEVLLGMPYDLAI------DMWSLGCILVEMHTG-EP 256

Query: 280 IFSTGNTSQ-----------------ENVSLAAYFVHS--------------------MR 302
           +FS  N                    +    A  F                         
Sbjct: 257 LFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPG 316

Query: 303 KNRLYHILDDQVMKLGKKNQ---------IVAFANLAERCLDLNGKKRPTMEE 346
             +L++IL  +    G +            + F +L  R LD + K R     
Sbjct: 317 TRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 66/310 (21%), Positives = 116/310 (37%), Gaps = 62/310 (20%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              +   + +G G  G V        G  +A+KK       E   K      E+ +L  +
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK--RAYRELRLLKHM 81

Query: 129 NHRNVVKLLGCCLETEFPL------LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            H NV+ LL      E         LV  F+    L + +  +H+     L  +    + 
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM--KHE----KLGEDRIQFLV 134

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQ 241
            ++   L Y+H+     I HRD+K  N+ ++E    K+ DFG ++    + T +V T+  
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW- 190

Query: 242 GTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS--------------TGNT 286
               Y  PE   +     ++ D++S G ++ E++TG K +F               TG  
Sbjct: 191 ----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTP 245

Query: 287 SQENVSL-----AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFAN-----LAERCLDL 336
             E V       A  ++  + +                   I+  A+     L E+ L L
Sbjct: 246 PAEFVQRLQSDEAKNYMKGLPELEKKDF-----------ASILTNASPLAVNLLEKMLVL 294

Query: 337 NGKKRPTMEE 346
           + ++R T  E
Sbjct: 295 DAEQRVTAGE 304

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 73/316 (23%), Positives = 114/316 (36%), Gaps = 74/316 (23%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              +     +G G  G+V      + G  +AVKK           K      E+ +L  +
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK--RTYRELRLLKHM 85

Query: 129 NHRNVVKLLGCCLETEFPL------LVYEFIPNGTLY-----QHLHDRH-QNEEYPLTWE 176
            H NV+ LL                LV   +    L      Q L D H Q   Y +   
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQI--- 141

Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-H 235
              R        L Y+HS     I HRD+K +N+ ++E    K+ DFG ++  A + T +
Sbjct: 142 --LR-------GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFS------------ 282
           V T+      Y  PE   +    +++ D++S G ++ ELLTG + +F             
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLIL 243

Query: 283 --TGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKK-----NQIVAFAN-----LA 330
              G    E +      + S    R Y      +  L +        +   AN     L 
Sbjct: 244 RLVGTPGAELLK----KISS-ESARNY------IQSLTQMPKMNFANVFIGANPLAVDLL 292

Query: 331 ERCLDLNGKKRPTMEE 346
           E+ L L+  KR T  +
Sbjct: 293 EKMLVLDSDKRITAAQ 308

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 78/338 (23%), Positives = 122/338 (36%), Gaps = 81/338 (23%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              + + + LG+G  G V+K      G ++AVKK   A  +    +      EI IL+++
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ--RTFREIMILTEL 65

Query: 129 N-HRNVVKLLGCCLETEFP--LLVYEFIPNGT-LY-----QHLHDRH-QNEEYPLTWEMR 178
           + H N+V LL            LV++++   T L+       L   H Q   Y L   ++
Sbjct: 66  SGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQL---IK 120

Query: 179 FRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTT 238
                     + YLHSG    + HRD+K +NILL+     KVADFG S+     +     
Sbjct: 121 ---------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 239 KIQGTFGYLDPEYHQSSQLTD---------------------KSDVYSFGVVLVELLTGK 277
                    +        LTD                       D++S G +L E+L G 
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG- 227

Query: 278 KPIF--------------STGNTSQENVS-----LAAYFVHSM---RKNRLYHILDDQVM 315
           KPIF                   S E+V       A   + S+    + R  +  D    
Sbjct: 228 KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287

Query: 316 KLGKKNQIVAFAN-------LAERCLDLNGKKRPTMEE 346
                 +I   A+       L ++ L  N  KR +  +
Sbjct: 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 67/333 (20%), Positives = 122/333 (36%), Gaps = 96/333 (28%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            + +   + LG GG G V+     +  + +A+KK  + + D +  K    + EI I+ ++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSVK--HALREIKIIRRL 65

Query: 129 NHRNVVKLL------------GCCLETEFP--LLVYEF--------IPNGTLYQHLHDRH 166
           +H N+VK+                  TE     +V E+        +  G L   L +  
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL---LEEHA 122

Query: 167 QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGT 225
           +   Y L      R        L Y+HS     + HRD+K  N+ ++ E    K+ DFG 
Sbjct: 123 RLFMYQL-----LR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGL 167

Query: 226 SKFIAMDQTH-------VTTKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGK 277
           ++ +    +H       + TK      Y  P    S     K+ D+++ G +  E+LTG 
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG- 221

Query: 278 KPIF--------------STGNTSQENV----SLAAYFVHSMRK------NRLYHILDDQ 313
           K +F              S     +E+     S+   ++ +          +L   +  +
Sbjct: 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE 281

Query: 314 VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
            +            +  E+ L  +   R T EE
Sbjct: 282 AV------------DFLEQILTFSPMDRLTAEE 302

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 65/361 (18%), Positives = 117/361 (32%), Gaps = 103/361 (28%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            + + +  ++G G  G V +     + R++A+KK     +D    K    + EI IL+++
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK--RILREIAILNRL 109

Query: 129 NHRNVVKLLGCCLETEFPL-----LVYEFIPNGT-LY------QHLHDRH-QNEEYPLTW 175
           NH +VVK+L   +  +        +V E     +          +L + H +   Y L  
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNL-- 165

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG------TSKFI 229
                        + Y+HS     I HRD+K  N L+++    KV DFG        +  
Sbjct: 166 ---LV-------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTD--------------------KS-DVYSFGV 268
                    +            +   QLT                     ++ DV+S G 
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 269 VLVELLT----------GKKPIF----STGNTSQENVSLAAYFVHSMRKNRLYHILD--- 311
           +  ELL            + P+F        +  +       F     +++L  I +   
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG 332

Query: 312 ----------------DQVMKLGKK-----NQIVAFAN-----LAERCLDLNGKKRPTME 345
                             +    K+      +    ++     L +R L  N  KR T+ 
Sbjct: 333 TPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITIN 392

Query: 346 E 346
           E
Sbjct: 393 E 393

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 64/354 (18%), Positives = 120/354 (33%), Gaps = 97/354 (27%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
            +++ +  ++G+G  G VY        + +A+KK     +D    K    + EI IL+++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK--RILREITILNRL 82

Query: 129 NHRNVVKLLGCCLETEFPL-----LVYEFIPNGT-LY------QHLHDRH-QNEEYPLTW 175
               +++L    +  +        +V E     + L         L + H +   Y L  
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNL-- 138

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ-T 234
                          ++H      I HRD+K  N LL++    KV DFG ++ I  ++ T
Sbjct: 139 ---LL-------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTD--------------------KS-DVYSFGVVLVEL 273
           ++   ++          +   QLT                     KS D++S G +  EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 274 LTG----------KKPIFSTGNTSQENVSLAAYFVHSMR--KNRLYHILD-------DQV 314
           L            + P+F  G++               +  +++L  I +       D +
Sbjct: 246 LNMLQSHINDPTNRFPLF-PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL 304

Query: 315 MKLGKKN-----------------QIVAFAN-----LAERCLDLNGKKRPTMEE 346
             + K                   Q     +     L E  L  N  KR T+++
Sbjct: 305 KNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQ 358

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 74/317 (23%), Positives = 127/317 (40%), Gaps = 72/317 (22%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              +     +G+G  G V       +   +A+KK     + +   +    + EI IL + 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQ--RTLREIKILLRF 82

Query: 129 NHRNVVKLLGCCLETEFPL-----LVYEFIPNGT-LY-----QHLHDRH-QNEEYPLTWE 176
            H N++ +                +V + +   T LY     QHL + H     Y +   
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLYQI--- 137

Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV 236
              R        L Y+HS     + HRD+K +N+LL+     K+ DFG ++    D  H 
Sbjct: 138 --LR-------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 237 T--TKIQGTFGYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIF------------ 281
              T+   T  Y  PE   +S+   KS D++S G +L E+L+  +PIF            
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHI 244

Query: 282 --STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKK-----NQIVAFAN-----L 329
               G+ SQE+++     + ++ K R Y      ++ L  K     N++   A+     L
Sbjct: 245 LGILGSPSQEDLN----CIINL-KARNY------LLSLPHKNKVPWNRLFPNADSKALDL 293

Query: 330 AERCLDLNGKKRPTMEE 346
            ++ L  N  KR  +E+
Sbjct: 294 LDKMLTFNPHKRIEVEQ 310

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 74/333 (22%), Positives = 114/333 (34%), Gaps = 96/333 (28%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFIN-------- 120
           ++ F +  +LG+G  G V        G I+A+KK            +E F          
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK------------IEPFDKPLFALRTL 57

Query: 121 -EIFILSQINHRNVVKLLGCCLETEFPL-----LVYEFIPNGT-LY-----QHLHDRH-Q 167
            EI IL    H N++ +        F       ++ E +   T L+     Q L D H Q
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQ 115

Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK 227
              Y        R       A+  LH      + HRD+K +N+L++     KV DFG ++
Sbjct: 116 YFIYQT-----LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160

Query: 228 FIAMDQTHVTTKIQGTFG---------YLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGK 277
            I       +       G         Y  PE   +S    ++ DV+S G +L EL    
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR- 219

Query: 278 KPIFS--------------TGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKK--- 320
           +PIF                G    +N       + S  + R Y      +  L      
Sbjct: 220 RPIFPGRDYRHQLLLIFGIIGTPHSDNDL---RCIESP-RAREY------IKSLPMYPAA 269

Query: 321 --NQIVAFAN-----LAERCLDLNGKKRPTMEE 346
              ++    N     L +R L  +  KR T +E
Sbjct: 270 PLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 77/360 (21%), Positives = 112/360 (31%), Gaps = 118/360 (32%)

Query: 67  DKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIF 123
               N F V R +G G  G V   + +++ +  AVK  ++       + Y     I E  
Sbjct: 31  MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------KKYTRSAKI-EAD 83

Query: 124 ILSQINHR-----NVVKLLGC-------CLETEFPLL---VYEFIPNGTLYQHLHDRHQN 168
           IL +I +      N+VK  G        CL  E   L   +YE I             +N
Sbjct: 84  ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEII------------TRN 129

Query: 169 EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-------------- 214
                  E      IE+  AL YL       + H D+K  NILLD+              
Sbjct: 130 NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVT 186

Query: 215 -----------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQL 257
                          K+ DFG + F      +  + I     Y  PE      +  SS  
Sbjct: 187 DGKKIQIYRTKSTGIKLIDFGCATF---KSDYHGSIINTRQ-YRAPEVILNLGWDVSS-- 240

Query: 258 TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA----------AYFVHSMRKNRLY 307
               D++SFG VL EL TG   +F T         LA             ++   K    
Sbjct: 241 ----DMWSFGCVLAELYTG-SLLFRTHE---HMEHLAMMESIIQPIPKNMLYEATKTNGS 292

Query: 308 HILDDQVMKLGKKNQIV---------------------AFANLAERCLDLNGKKRPTMEE 346
             ++   +KL                             F +     L ++   RP+  E
Sbjct: 293 KYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 67/349 (19%), Positives = 110/349 (31%), Gaps = 108/349 (30%)

Query: 70  TNHFNVNRILGQGGQGTVYKG--RLEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFIL 125
              + +   LG+G  G V +          +A+K  ++         Y+    + EI +L
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARL-EINVL 70

Query: 126 SQINHR------NVVKLLGC-------CLETEFPLL---VYEFIPNGTLYQHLHDRHQNE 169
            +I  +        V +          C+  E  LL    +EF+             +N 
Sbjct: 71  KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFL------------KENN 116

Query: 170 EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA----------- 218
             P        +A ++  AL +LH    + + H D+K  NIL                  
Sbjct: 117 FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173

Query: 219 --------KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKSDVY 264
                   +VADFG++ F   D  H TT +     Y  PE      + Q        DV+
Sbjct: 174 KSVKNTSIRVADFGSATF---DHEHHTTIVATRH-YRPPEVILELGWAQPC------DVW 223

Query: 265 SFGVVLVELLTGKKPIFSTGNTSQ-----------------ENVSLAAYFVHSMRKNRLY 307
           S G +L E   G   +F T    +                        YF          
Sbjct: 224 SIGCILFEYYRG-FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG-GLVWDE 281

Query: 308 HILDDQVMKLGKKN----------QIVAFANLAERCLDLNGKKRPTMEE 346
           +  D + +K   K           + V   +L  R L+ +  +R T+ E
Sbjct: 282 NSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 27/221 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           N F + R +G G  G +Y G  ++    +A+K   +     +L      + E  I   + 
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL------LYESKIYRILQ 60

Query: 130 -HRNVVKLLGCCLETEFPLLVYEFI-PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
               +  +    +E ++ +LV + + P+      L D        L+ +    +A ++  
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLLGPS------LEDLFNFCSRKLSLKTVLMLADQMIN 114

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAK---VADFGTSKFIAMDQTHV------TT 238
            + ++HS +     HRDIK  N L+    RA    + DFG +K      TH         
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            + GT  Y     H   + + + D+ S G VL+  L G  P
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 69/351 (19%), Positives = 121/351 (34%), Gaps = 106/351 (30%)

Query: 67  DKATNHFNVNRILGQGGQGTVYKG--RLEDGRIIAVK--KSKLAVDDEELYKLEEFINEI 122
           D  +  + +   LG+G  G V +       GR +AVK  K+     +          +EI
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR-------SEI 62

Query: 123 FILSQINHR------NVVKLLGC-------CLETEFPLL---VYEFIPNGTLYQHLHDRH 166
            +L  +N          V++L         C+  E  LL    Y+FI             
Sbjct: 63  QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFI------------K 108

Query: 167 QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA-------- 218
           +N   P   +   ++A ++  ++ +LHS   + + H D+K  NIL  +            
Sbjct: 109 ENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIK 165

Query: 219 -----------KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE------YHQSSQLTDKS 261
                      KV DFG++ +   D  H +T +     Y  PE      + Q        
Sbjct: 166 RDERTLINPDIKVVDFGSATY---DDEHHSTLVSTRH-YRAPEVILALGWSQPC------ 215

Query: 262 DVYSFGVVLVELLTGKKPIFSTGNTSQ-----------------ENVSLAAYFVH----- 299
           DV+S G +L+E   G   +F T ++ +                 +      YF H     
Sbjct: 216 DVWSIGCILIEYYLG-FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW 274

Query: 300 ----SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
               S  +         +   L +  +     +L ++ L+ +  KR T+ E
Sbjct: 275 DEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 62/285 (21%), Positives = 94/285 (32%), Gaps = 90/285 (31%)

Query: 67  DKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFIL 125
           D     ++V R LG G   TV+    ++  + +A+K  K A         E  ++EI +L
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY-----TETALDEIRLL 87

Query: 126 SQI--------NHRNVVKLLGCCLETEFPL---------LVYEFIPNGTLYQHLHD-RHQ 167
             +        N   VV+LL       F +         +V+E      L  HL     +
Sbjct: 88  KSVRNSDPNDPNREMVVQLLDD-----FKISGVNGTHICMVFEV-----LGHHLLKWIIK 137

Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL--------------- 212
           +    L      ++  +V   L YLH+     I H DIK  NILL               
Sbjct: 138 SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEAT 195

Query: 213 ----------------------------------DERYRAKVADFGTSKFIAMDQTHVTT 238
                                              E+ + K+AD G + +      H T 
Sbjct: 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTE 252

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 283
            IQ T  Y   E    S     +D++S   +  EL TG   +F  
Sbjct: 253 DIQ-TRQYRSLEVLIGSGYNTPADIWSTACMAFELATG-DYLFEP 295

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 47/221 (21%), Positives = 84/221 (38%), Gaps = 27/221 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           N + + R +G G  G +Y G  +  G  +A+K   +     +L        E  I   + 
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL------HIESKIYKMMQ 62

Query: 130 H-RNVVKLLGCCLETEFPLLVYEFI-PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
               +  +  C  E ++ ++V E + P+      L D         + +    +A ++  
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGPS------LEDLFNFCSRKFSLKTVLLLADQMIS 116

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAK---VADFGTSKFIAMDQTHV------TT 238
            + Y+H   S    HRD+K  N L+    +     + DFG +K     +TH         
Sbjct: 117 RIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
            + GT  Y     H   + + + D+ S G VL+    G  P
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 49/233 (21%), Positives = 85/233 (36%), Gaps = 55/233 (23%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI- 128
           ++   +++LG G  G V +          A+K          L    +   E+ +  +  
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM---------LQDCPKARREVELHWRAS 68

Query: 129 NHRNVVKLLGCCLETEFP-----LLVYEFIPNGTLYQHLHDRHQNE--EYPLTWEMRFRV 181
              ++V+++    E  +      L+V E +  G L+  + DR      E   +  M+   
Sbjct: 69  QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK--- 124

Query: 182 AIEVAGALAYLHS-GASSPIYHRDIKSTNILL---DERYRAKVADFGTSKFIAMDQTHVT 237
              +  A+ YLHS      I HRD+K  N+L          K+ DFG +K         T
Sbjct: 125 --SIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETT 171

Query: 238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
            +      Y D             D++S GV++  LL G  P +S    +   
Sbjct: 172 GE-----KY-DKS----------CDMWSLGVIMYILLCGYPPFYSNHGLAISP 208

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 44/223 (19%), Positives = 81/223 (36%), Gaps = 29/223 (13%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI- 128
            H+ V R +G+G  G +++G  L + + +A+K      D  +L       +E      + 
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL------RDEYRTYKLLA 63

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFI-PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
               +  +     E    +LV + + P+      L D         + +     A ++  
Sbjct: 64  GCTGIPNVYYFGQEGLHNVLVIDLLGPS------LEDLLDLCGRKFSVKTVAMAAKQMLA 117

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAK-----VADFGTSKFIAMDQTHV------ 236
            +  +H  +   + +RDIK  N L+            V DFG  KF     T        
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174

Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
              + GT  Y+    H   + + + D+ + G V +  L G  P
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.4 bits (140), Expect = 9e-10
 Identities = 30/215 (13%), Positives = 59/215 (27%), Gaps = 52/215 (24%)

Query: 69  ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD----EELYKLEEFINEIFI 124
            T        +G+G  G V++    D   +A+K   +   D          EE + EI I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 125 LSQI---------NHRNVVKLLGCCL------------------------------ETEF 145
             ++              + L                                   + + 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDI 205
             +V EF   G   + +  +        +      +  ++  +LA   +       HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL------SSLATAKSILHQLTASLAVAEASLR--FEHRDL 188

Query: 206 KSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKI 240
              N+LL +    K+      K   +    +   I
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 46/236 (19%), Positives = 86/236 (36%), Gaps = 32/236 (13%)

Query: 67  DKATNHFNVNRILGQGGQGTVYKG-RLEDGRIIAVKKSKLAVDDE-------ELYKL--- 115
           D   N + + + +G GG G +Y           A    K+   +        + Y+    
Sbjct: 33  DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK 92

Query: 116 EEFINEIFILSQINHRNVVKLLGC----CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY 171
           ++ I +     Q+++  +    G          +  +V E +  G   Q +  ++     
Sbjct: 93  KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT--- 147

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV--ADFGTSKFI 229
                   ++ I +   L Y+H    +   H DIK+ N+LL  +   +V  AD+G S   
Sbjct: 148 -FKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

Query: 230 AMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
             +  H            GT  +   + H+   L+ +SDV   G  ++  L GK P
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 40/238 (16%), Positives = 87/238 (36%), Gaps = 33/238 (13%)

Query: 67  DKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVK----------KSKLAVDDEELYKL- 115
           D A   + V   +GQGG G +Y   +     +              +     + + Y+  
Sbjct: 31  DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90

Query: 116 --EEFINEIFILSQINHRNVVKLLGC----CLETEFPLLVYEFIPNGTLYQHLHDRHQNE 169
              E I +     ++ +  V K  G          +  ++ +    G+  Q +++ +   
Sbjct: 91  AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKR 148

Query: 170 EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV--ADFGTSK 227
               + +   ++++ +   L Y+H        H DIK++N+LL+ +   +V   D+G + 
Sbjct: 149 ---FSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Query: 228 FIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
               +  H            GT  +   + H     + + D+   G  +++ LTG  P
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 40/242 (16%), Positives = 83/242 (34%), Gaps = 41/242 (16%)

Query: 67  DKATNHFNVNRILGQGGQGTVYKGR---------LEDGRIIAVK----KSKLAVDDEELY 113
           DK+   + +     +  QG +Y+               +  ++K      +L  +     
Sbjct: 38  DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97

Query: 114 KL--EEFINEIFILSQINHRNVVKLLGC-CLETEFPLLVYEFIPNGTLYQHLHDRHQNEE 170
           +      +N+   L       +   +G    + ++  LV   +  G   Q   D      
Sbjct: 98  RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHV 155

Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV--ADFGTSKF 228
                    +VA  +  AL +LH    +   H ++ + NI +D   +++V  A +G +  
Sbjct: 156 LSE--RSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210

Query: 229 IAMDQTHV------TTKIQGTFGYLDPEY-----HQSSQLTDKSDVYSFGVVLVELLTGK 277
                 HV       +  +G       E+     H+    + +SD+ S G  +++ L G 
Sbjct: 211 YCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

Query: 278 KP 279
            P
Sbjct: 266 LP 267

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 40/223 (17%), Positives = 84/223 (37%), Gaps = 29/223 (13%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI- 128
            +F V + +G G  G +  G+ L     +A+K   +     +L+       E     Q+ 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLH------LEYRFYKQLG 62

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFI-PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           +   + ++       ++  +V E + P+      L D     +   + +    +AI++  
Sbjct: 63  SGDGIPQVYYFGPCGKYNAMVLELLGPS------LEDLFDLCDRTFSLKTVLMIAIQLIS 116

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAK-----VADFGTSKFIAMDQTHV------ 236
            + Y+HS     + +RD+K  N L+            + DF  +K     +T        
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173

Query: 237 TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
              + GT  Y+    H   + + + D+ + G + +  L G  P
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 3e-04
 Identities = 58/377 (15%), Positives = 117/377 (31%), Gaps = 94/377 (24%)

Query: 20  IIRKKRMDIRLKEKFF--KQNGGLLLQQMLNSYDGS-----VIDRCKLFSSKELDKATNH 72
           + R +    +L++     +    +L+  +L    GS      +D C    S ++    + 
Sbjct: 131 VSRLQPYL-KLRQALLELRPAKNVLIDGVL----GSGKTWVALDVCL---SYKVQCKMD- 181

Query: 73  FNV------------------NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYK 114
           F +                   ++L Q      +  R +    I ++   +  +   L K
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQKLLYQIDPN--WTSRSDHSSNIKLRIHSIQAELRRLLK 239

Query: 115 LEEFINEIFILSQINHRNVVKL--LGC-CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY 171
            + + N + +L  + +        L C  L T     V +F+   T     H    +   
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT---HISLDHHSM 296

Query: 172 PLTWEMRFRVAIEVAGALA-YLHSGASS-PIYHRDIKSTNILL----DERYRAKVADFGT 225
            LT +       EV   L  YL       P   R++ +TN        E  R  +A +  
Sbjct: 297 TLTPD-------EVKSLLLKYLDCRPQDLP---REVLTTNPRRLSIIAESIRDGLATWDN 346

Query: 226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY-SFGV----------VLVELL 274
            K +  D+  +TT I+ +   L+P  ++         ++    V          +L  L+
Sbjct: 347 WKHVNCDK--LTTIIESSLNVLEPAEYR--------KMFDRLSVFPPSAHIPTILL-SLI 395

Query: 275 TGKKPIFSTGNTSQE--NVSLAA-------YFVHSMRKNRLYHILDDQVMKLGKKNQIVA 325
                         +    SL           + S+       + ++  +       IV 
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL----HRSIVD 451

Query: 326 FANLAERCLDLNGKKRP 342
             N+  +  D +    P
Sbjct: 452 HYNIP-KTFDSDDLIPP 467

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	360
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.16
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.16
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.03
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.97
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.87
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.78
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.73
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.69
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.29
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.24
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.21
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.13
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.02
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.0
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.9
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.59
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.87
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.21
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	94.19
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.51
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	92.57
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.3
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.02
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	83.84
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	81.46
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	80.98
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.88

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.5e-61  Score=424.11  Aligned_cols=262  Identities=26%  Similarity=0.418  Sum_probs=214.4

Q ss_pred             cCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++....    ...++|.+|+.++++++|||||+++|++.+.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~----~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD----NARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH----HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh----HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            56888899999999999999864      467899999875321    34567899999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhc--------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRH--------QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY  216 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~  216 (360)
                      ..++|||||++|+|.++|....        ......+++..++.++.|++.||+|||+++   |+||||||+|||+++++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCC
Confidence            9999999999999999997643        123346999999999999999999999999   99999999999999999


Q ss_pred             cEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchH
Q 040763          217 RAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       217 ~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~  294 (360)
                      .+||+|||+|+......... .....||+.|||||++.++.++.++|||||||++|||+| |+.||.+...     .   
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~---  237 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----N---  237 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----H---
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H---
Confidence            99999999998765443332 233568999999999999999999999999999999999 8999965431     0   


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      + ....+..+.         ....|..+++++.+|+.+||+.||++|||+.+|.+.|+++.+.
T Consensus       238 ~-~~~~i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          238 E-VIECITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             H-HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-HHHHHHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1 111111111         1123445667899999999999999999999999999988653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.3e-61  Score=425.11  Aligned_cols=261  Identities=22%  Similarity=0.346  Sum_probs=214.0

Q ss_pred             cCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .++++.+.||+|+||+||+|.+.      +++.||||.++.....   ...++|.+|+.++.+++|||||+++|++.+.+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~---~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG---PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh---HHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            44677889999999999999863      4678999998764433   34567899999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      ..++|||||++|+|.++|..+...           ....+++..++.++.|+|.||+|||+++   |+||||||+||||+
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence            999999999999999999764321           1246899999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCccccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENV  291 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~  291 (360)
                      +++.+||+|||+++....... .......||+.|||||++.++.++.++|||||||++|||+| |..||.+...      
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------  253 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------  253 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence            999999999999987644332 22345679999999999999999999999999999999999 8999965431      


Q ss_pred             chHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                         ......+..+.         ..+.+..+++++.+|+.+||+.||++|||+.||++.|++..
T Consensus       254 ---~~~~~~i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          254 ---QDVVEMIRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             ---HHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ---HHHHHHHHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence               11112222221         12234556778999999999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-60  Score=418.29  Aligned_cols=264  Identities=26%  Similarity=0.414  Sum_probs=208.0

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .+++.+.+.||+|+||+||+|.+++  .||||+++......  ...+.|.+|+.++++++|||||+++|++.. +..++|
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTP--EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            4678889999999999999998753  58999987544332  346789999999999999999999998765 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||||++|+|.+++....    .++++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+..
T Consensus       110 mEy~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EECCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            99999999999997532    26999999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCC-ceeeecccccCCccchhhhcc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          230 AMDQ-THVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       230 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      .... .......+||+.|||||++.+   +.++.++|||||||++|||+||+.||.+....        ...........
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--------~~~~~~~~~~~  254 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--------DQIIFMVGRGY  254 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------HHHHHHHHTTC
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcCC
Confidence            5432 223445679999999999864   45899999999999999999999999654310        01111111111


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      ..     ......+..+++++.+|+.+||+.||++|||+.||++.|+.++..+
T Consensus       255 ~~-----p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          255 AS-----PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             CC-----CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             CC-----CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            00     0011233456678999999999999999999999999999988664

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-60  Score=425.14  Aligned_cols=262  Identities=26%  Similarity=0.428  Sum_probs=208.7

Q ss_pred             cCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .+|.+.+.||+|+||.||+|.++      ++..||||+++... .   ...++|.+|+.++.+++|||||+++|+|.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-E---SARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-H---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-H---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            45778889999999999999864      46789999987532 1   34567899999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQN----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE  214 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~  214 (360)
                      ..++|||||++|+|.+++......          ...++++..++.++.|++.||+|||+++   |+||||||+||||++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence            999999999999999999765322          2346999999999999999999999999   999999999999999


Q ss_pred             CCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccc
Q 040763          215 RYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVS  292 (360)
Q Consensus       215 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~  292 (360)
                      ++.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+...     . 
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~-  267 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----T-  267 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----H-
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----H-
Confidence            99999999999987654332 23345679999999999999999999999999999999999 8999965431     0 


Q ss_pred             hHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          293 LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                        + ....+..+.         ..+.+..+++++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus       268 --~-~~~~i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          268 --E-AIDCITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             --H-HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --H-HHHHHHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence              1 111111111         1223445667899999999999999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6e-60  Score=421.04  Aligned_cols=252  Identities=21%  Similarity=0.333  Sum_probs=204.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||+|.++ +|+.||||++.......  ...+.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS--KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH--HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            68999999999999999999986 68999999987644332  3456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||||++|+|.+++....   ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus       102 mEy~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EECCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceee
Confidence            99999999999997632   235789999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+...        ...+.... ....   
T Consensus       176 ~~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~-~~~~---  242 (350)
T 4b9d_A          176 NST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKII-SGSF---  242 (350)
T ss_dssp             CHH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH-HTCC---
T ss_pred             cCC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHH-cCCC---
Confidence            432 1223446799999999999999999999999999999999999999965431        11111111 1111   


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ...+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       243 ------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 ------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  1123345678999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.3e-59  Score=412.26  Aligned_cols=255  Identities=21%  Similarity=0.252  Sum_probs=208.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +.|++.++||+|+||.||+|.++ +|+.||||+++.....         .+|+.+++.++|||||++++++.+.+..|+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~---------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR---------VEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH---------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45788889999999999999986 6899999998753221         3699999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cEEEeecCCccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADFGTSKF  228 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~  228 (360)
                      ||||++|+|.+++....     ++++..+..++.|++.||+|||+++   |+||||||+||||+.++ .+||+|||+|+.
T Consensus       129 mEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             EeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence            99999999999997654     5899999999999999999999999   99999999999999987 699999999987


Q ss_pred             cCCCCce----eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          229 IAMDQTH----VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       229 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      .......    .....+||+.|||||++.+..++.++|||||||++|||+||+.||.+.....     +...+..   ..
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~i~~---~~  272 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----LCLKIAS---EP  272 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----CHHHHHH---SC
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HHHHHHc---CC
Confidence            6543221    1233579999999999999999999999999999999999999997543211     1111111   10


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                              ......++.+++++.+|+.+||+.||++|||+.|+++.|......+
T Consensus       273 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          273 --------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             --------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             --------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence                    0011234556778999999999999999999999999887766543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.6e-59  Score=408.21  Aligned_cols=250  Identities=26%  Similarity=0.334  Sum_probs=209.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||++.++ +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            56999999999999999999986 6889999998653211 113456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||||+||+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+
T Consensus       111 mEy~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~  182 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL  182 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence            99999999999998654     5899999999999999999999999   999999999999999999999999999887


Q ss_pred             CCCC-ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      .... .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+...        ...+... ....   
T Consensus       183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i-~~~~---  250 (311)
T 4aw0_A          183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKI-IKLE---  250 (311)
T ss_dssp             CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HHTC---
T ss_pred             CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HcCC---
Confidence            5433 3334567899999999999999999999999999999999999999965431        1111111 1111   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                             ...+...++++.+|+.+||+.||++|||+.|++
T Consensus       251 -------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 -------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                   112334566899999999999999999999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.5e-58  Score=410.01  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=206.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..|+..+.||+|+||+||+|.++ +|+.||||++......    ..+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            56999999999999999999986 6899999998654322    234567899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||||++|+|.+++...      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus       150 mEy~~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~  220 (346)
T 4fih_A          150 MEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV  220 (346)
T ss_dssp             ECCCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence            9999999999998652      4899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+...     .   ..+ ..+....... 
T Consensus       221 ~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~---~~~-~~i~~~~~~~-  289 (346)
T 4fih_A          221 SKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----L---KAM-KMIRDNLPPR-  289 (346)
T ss_dssp             CSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H---HHH-HHHHHSSCCC-
T ss_pred             CCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----H---HHH-HHHHcCCCCC-
Confidence            5432 234456899999999999999999999999999999999999999965431     0   111 1111111000 


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            .......++++.+|+.+||+.||++|||+.|+++
T Consensus       290 ------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          290 ------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  1112345668999999999999999999999874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-58  Score=416.14  Aligned_cols=271  Identities=25%  Similarity=0.360  Sum_probs=218.9

Q ss_pred             hHHHHHHhcCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC-CCcee
Q 040763           63 SKELDKATNHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH-RNVVK  135 (360)
Q Consensus        63 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~  135 (360)
                      ..+.+...++|++.+.||+|+||.||+|.+..      ++.||+|.+......   ...+.+.+|+.++.+++| ||||+
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~---~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh---HHHHHHHHHHHHHHHcCCCCcEEE
Confidence            34445556789999999999999999998653      357999998765443   335678899999999965 99999


Q ss_pred             eeeEEeeC-CcceEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 040763          136 LLGCCLET-EFPLLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHR  203 (360)
Q Consensus       136 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~  203 (360)
                      ++|+|... ...++|||||++|+|.++|......           ....+++..++.++.|+|.||+|||+++   |+||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence            99998764 5689999999999999999764321           1335899999999999999999999999   9999


Q ss_pred             CCCCCCeEEcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCC
Q 040763          204 DIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIF  281 (360)
Q Consensus       204 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~  281 (360)
                      ||||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987654433 33445679999999999999999999999999999999998 999997


Q ss_pred             CCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          282 STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      +.....        .+...+..+         .....+..+++++.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus       290 ~~~~~~--------~~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          290 GVKIDE--------EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             TCCCSH--------HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHH--------HHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            543211        111111111         1122344566789999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-58  Score=402.01  Aligned_cols=248  Identities=22%  Similarity=0.329  Sum_probs=198.9

Q ss_pred             CccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee----CCcceE
Q 040763           74 NVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE----TEFPLL  148 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~~~~~l  148 (360)
                      ++.+.||+|+||+||+|.+. ++..||+|.+.......  ...+.+.+|+.++++++|||||++++++.+    ....|+
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            56678999999999999986 58899999976543332  345678999999999999999999999865    345799


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~  227 (360)
                      |||||++|+|.+++....     ++++..+..++.|++.||+|||+++ ++|+||||||+||||++ ++.+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            999999999999997654     5899999999999999999999976 45999999999999984 7999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .....   .....+||+.|||||++.+ .++.++|||||||++|||+||+.||.+...       ... .......... 
T Consensus       181 ~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~-~~~~i~~~~~-  247 (290)
T 3fpq_A          181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQ-IYRRVTSGVK-  247 (290)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHH-HHHHHTTTCC-
T ss_pred             eCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHH-HHHHHHcCCC-
Confidence            64332   2345689999999998865 699999999999999999999999965331       111 1111111111 


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             +...+...++++.+|+.+||+.||++|||+.|+++
T Consensus       248 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 -------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   11122234557999999999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.6e-58  Score=395.11  Aligned_cols=248  Identities=24%  Similarity=0.329  Sum_probs=192.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||+|.++ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            67999999999999999999976 68999999986543222 23355788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+ +|+|.+++..+.     ++++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus        92 mEy~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             EECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             EeCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence            9999 789999997643     5899999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCceeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ....  .....+||+.|+|||++.+..+ +.++||||+||++|+|+||+.||.+...        ...+. .+....   
T Consensus       163 ~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~-~i~~~~---  228 (275)
T 3hyh_A          163 TDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFK-NISNGV---  228 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHTC---
T ss_pred             CCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHH-HHHcCC---
Confidence            4322  2344689999999999998876 5799999999999999999999965321        11111 111111   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             ...+...++++.+|+.+||+.||++|||+.|+++
T Consensus       229 -------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 -------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                   1123345668999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-57  Score=411.80  Aligned_cols=249  Identities=25%  Similarity=0.390  Sum_probs=207.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +.|++.+.||+|+||.||+|.++ +|+.||||++......    ..+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS----SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh----HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            56999999999999999999986 6899999998654322    234577999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||||+||+|.+++...      .+++..+..++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+|..+
T Consensus       227 mEy~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~  297 (423)
T 4fie_A          227 MEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV  297 (423)
T ss_dssp             EECCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred             EeCCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence            9999999999998642      4889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+...     ...    ...+....... 
T Consensus       298 ~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~----~~~i~~~~~~~-  366 (423)
T 4fie_A          298 SKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKA----MKMIRDNLPPR-  366 (423)
T ss_dssp             CSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHH----HHHHHHSCCCC-
T ss_pred             CCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHH----HHHHHcCCCCC-
Confidence            5432 234456899999999999999999999999999999999999999965431     001    11111111000 


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            .......++++.+|+.+||+.||++|||+.|+++
T Consensus       367 ------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          367 ------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  0112335668999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3e-56  Score=394.16  Aligned_cols=272  Identities=21%  Similarity=0.282  Sum_probs=200.9

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----cc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----FP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----~~  146 (360)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||++......     ......|+..+.+++||||+++++++...+    ..
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4578889999999999999988 4889999998643211     112234666667889999999999998654    46


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA-----SSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                      ++|||||++|+|.+++...      ++++..+..++.|++.||+|||++.     .++|+||||||+||||+.++.+||+
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence            8999999999999999753      4889999999999999999999871     2239999999999999999999999


Q ss_pred             ecCCccccCCCCcee---eecccccCCccchhhhccC------CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc---
Q 040763          222 DFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---  289 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~---  289 (360)
                      |||+++.........   ....+||+.|||||++.+.      .++.++|||||||++|||+||..||.........   
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            999998765433222   2345799999999998764      3677999999999999999998887543221110   


Q ss_pred             ---ccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          290 ---NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       290 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                         ....................+..   ...+.+.++.+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccccchHHHHHHHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence               00011111111111111100000   111234567899999999999999999999999999998753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.1e-58  Score=400.83  Aligned_cols=244  Identities=28%  Similarity=0.291  Sum_probs=195.2

Q ss_pred             cCCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ++|++.+.||+|+||+||+|+..    +++.||+|+++......  .....+.+|+.++++++||||+++++++.+.+..
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            67999999999999999999863    46789999986543221  1123567899999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      |+|||||+||+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             EEEEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccc
Confidence            99999999999999997654     5899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      +...... ......+||+.|||||++.+..++.++||||+||++|||+||+.||.+...        ...... +.... 
T Consensus       174 ~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~-i~~~~-  242 (304)
T 3ubd_A          174 KESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTM-ILKAK-  242 (304)
T ss_dssp             EC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHHCC-
T ss_pred             eeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHH-HHcCC-
Confidence            8654322 223456899999999999999999999999999999999999999965431        111111 11111 


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                               ...+...++++.+|+.+||+.||++|||+
T Consensus       243 ---------~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 ---------LGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                     11234456789999999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.7e-56  Score=392.68  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=190.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC-----
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE-----  144 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----  144 (360)
                      ++|++.+.||+|+||.||+|.++ +++.||+|+++.....   ...+.+.+|+.++++++|||||++++++.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            45899999999999999999986 6889999998764433   34467889999999999999999999987544     


Q ss_pred             -------cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc
Q 040763          145 -------FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR  217 (360)
Q Consensus       145 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~  217 (360)
                             ..|++||||++|+|.+++..+....  ..++..++.++.|++.||+|||+++   |+||||||+|||++.++.
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~--~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~  156 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE--ERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDV  156 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGG--GSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCC--hhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCc
Confidence                   3689999999999999997653222  3566778899999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccCCCCce-----------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 040763          218 AKVADFGTSKFIAMDQTH-----------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT  286 (360)
Q Consensus       218 ~kl~Dfg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~  286 (360)
                      +||+|||+|+........           .....+||+.|||||++.+..|+.++|||||||++|||++   ||....  
T Consensus       157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--  231 (299)
T 4g31_A          157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--  231 (299)
T ss_dssp             EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--
Confidence            999999999876543221           1234579999999999999999999999999999999996   774311  


Q ss_pred             cccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        +   .... .........         .......++++.+|+.+||+.||++|||+.|+++
T Consensus       232 --~---~~~~-~~~~~~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 --E---RVRT-LTDVRNLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --H---HHHH-HHHHHTTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --H---HHHH-HHHHhcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0   0000 111111111         0112334456789999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-53  Score=384.70  Aligned_cols=263  Identities=21%  Similarity=0.297  Sum_probs=202.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee------C
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE------T  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------~  143 (360)
                      ++|++.+.||+|+||+||+|.++ +|+.||||+++......  ...+.+.+|+.+|+.++||||+++++++..      .
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV--TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch--HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            57999999999999999999986 68999999987654332  334577899999999999999999998764      3


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...|+|||||+ |+|.+++....     ++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred             CEEEEEEeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeec
Confidence            56799999995 78999996532     6999999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCC---ceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          224 GTSKFIAMDQ---THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       224 g~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |+++.+....   .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....     .....+..
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-----~~l~~I~~  277 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-----HQLQLIMM  277 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHH
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-----HHHHHHHH
Confidence            9998764322   2234456899999999998875 5689999999999999999999999764321     11111111


Q ss_pred             Hhhccccccc--cc-h---HH-----------hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRKNRLYHI--LD-D---QV-----------MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~~~~~~~--~~-~---~~-----------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..........  .. .   ..           .....+..++++.+|+.+||+.||++|||+.|+++
T Consensus       278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1111100000  00 0   00           00011234568999999999999999999999874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.4e-53  Score=381.97  Aligned_cols=200  Identities=22%  Similarity=0.371  Sum_probs=170.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEee
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLE  142 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~  142 (360)
                      ...++|++.+.||+|+||+||+|.++    +++.||+|.+.....      ...+.+|+.++..+ +||||+++++++.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH------PIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC------HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC------HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            34578999999999999999999864    467899998765322      23567899999988 79999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC-CcEEEe
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-YRAKVA  221 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~  221 (360)
                      .+..|+||||+++|+|.+++.        .+++..+..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~  160 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALV  160 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCEEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEEC
Confidence            999999999999999999984        3889999999999999999999999   9999999999999876 799999


Q ss_pred             ecCCccccCCCCc---------------------------eeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHH
Q 040763          222 DFGTSKFIAMDQT---------------------------HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVEL  273 (360)
Q Consensus       222 Dfg~~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el  273 (360)
                      |||+|+.......                           ......+||+.|+|||++.+. .++.++||||+||++|||
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el  240 (361)
T 4f9c_A          161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL  240 (361)
T ss_dssp             CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred             cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence            9999976533211                           112345799999999999875 589999999999999999


Q ss_pred             HhCCCCCCCCC
Q 040763          274 LTGKKPIFSTG  284 (360)
Q Consensus       274 ~tg~~p~~~~~  284 (360)
                      ++|+.||....
T Consensus       241 l~G~~Pf~~~~  251 (361)
T 4f9c_A          241 LSGRYPFYKAS  251 (361)
T ss_dssp             HHTCSSSSCCS
T ss_pred             HHCCCCCCCCC
Confidence            99999997544

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.3e-52  Score=373.92  Aligned_cols=292  Identities=36%  Similarity=0.622  Sum_probs=245.2

Q ss_pred             CcccccChHHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCcee
Q 040763           56 DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK  135 (360)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~  135 (360)
                      ...+.++..++....++|++.+.||+|+||.||+|...+++.||+|++.......   ....+.+|+.++..++||||++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~   91 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG---GELQFQTEVEMISMAVHRNLLR   91 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch---HHHHHHHHHHHHHhccCCCccc
Confidence            4457789999999999999999999999999999998889999999987643321   2225778999999999999999


Q ss_pred             eeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeEecCCCCCCeEE
Q 040763          136 LLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG---ASSPIYHRDIKSTNILL  212 (360)
Q Consensus       136 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~~i~H~dlk~~Nill  212 (360)
                      +++++......++||||+++++|.+++..... ...++++..+..++.|++.||.|||++   +   ++||||||+||++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~  167 (326)
T 3uim_A           92 LRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILL  167 (326)
T ss_dssp             CCEEECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEE
T ss_pred             eEEEEecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEE
Confidence            99999999999999999999999999976542 334689999999999999999999999   7   9999999999999


Q ss_pred             cCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 040763          213 DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS  292 (360)
Q Consensus       213 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~  292 (360)
                      +.++.+||+|||++...............||+.|+|||.+.+..++.++||||||+++|+|++|..||............
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM  247 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred             CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence            99999999999999877655555555567999999999999989999999999999999999999999533222223333


Q ss_pred             hHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          293 LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      ...+..............+.......+...++++.+++.+||+.||++|||+.++++.|++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            44444444445556666666667777888999999999999999999999999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.2e-52  Score=393.77  Aligned_cols=251  Identities=23%  Similarity=0.257  Sum_probs=200.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChH--HHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDE--ELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ++|++.+.||+|+||.||++.++ +|+.||+|++.......  ..........++.++..++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999986 68999999876432111  0111222234567777889999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +|||||+||+|.+++....     .+++..+..++.||+.||.|||+++   |+||||||+||||+.+|++||+|||+|+
T Consensus       269 lVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence            9999999999999998654     5899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ......   ....+||+.|||||++.+ ..|+.++|+|||||++|||++|..||.+.....     .......... .  
T Consensus       341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~-~--  409 (689)
T 3v5w_A          341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLT-M--  409 (689)
T ss_dssp             ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHH-C--
T ss_pred             ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcC-C--
Confidence            765432   344689999999999975 578999999999999999999999996543211     1111111111 1  


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVS  348 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~  348 (360)
                              ....+...++++.+|+.+||+.||++|++     +.||+
T Consensus       410 --------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          410 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             --------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence                    11223445678999999999999999998     56664

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-50  Score=362.14  Aligned_cols=288  Identities=39%  Similarity=0.620  Sum_probs=237.4

Q ss_pred             ccChHHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeE
Q 040763           60 LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGC  139 (360)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~  139 (360)
                      .++..++....++|++.+.||+|+||.||+|.+++++.||+|+.......    ..+.+.+|+.++..++||||++++++
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~  103 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ----GIEEFETEIETLSFCRHPHLVSLIGF  103 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS----HHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34455566677899999999999999999999888999999987654332    35567899999999999999999999


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEE
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAK  219 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~k  219 (360)
                      +...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+|
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          104 CDERNEMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             CCCTTCCEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEE
T ss_pred             EcCCCeEEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEE
Confidence            9999999999999999999999965432 2336899999999999999999999999   99999999999999999999


Q ss_pred             EeecCCccccCCCC-ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          220 VADFGTSKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       220 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      |+|||++....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......  .......+..
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~  257 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAV  257 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTH
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhh
Confidence            99999997654322 22233446899999999999999999999999999999999999999765432  2222333333


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .......+...++.......+...++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            33444455556666666667788899999999999999999999999999999988754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.3e-51  Score=391.00  Aligned_cols=252  Identities=20%  Similarity=0.305  Sum_probs=207.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|.+.....    ...+.+.+|+.+|+.++||||+++++++.+....|+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch----hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            367999999999999999999986 689999998865432    234567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC--CcEEEeecCCc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER--YRAKVADFGTS  226 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~  226 (360)
                      |||||+||+|.+++....    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||++
T Consensus       232 v~E~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a  304 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT  304 (573)
T ss_dssp             EEECCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred             EEeecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence            999999999999996432    25899999999999999999999999   9999999999999854  89999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      +.+....  .....+||+.|||||++.+..|+.++||||+||++|||++|..||.+...        ...+.. +.....
T Consensus       305 ~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~-i~~~~~  373 (573)
T 3uto_A          305 AHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRN-VKSCDW  373 (573)
T ss_dssp             EECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH-HHTTCC
T ss_pred             eEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHH-HHhCCC
Confidence            8875433  23445899999999999999999999999999999999999999975431        011111 111110


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       .     .........++++.+|+.+||+.||++|||+.|+++
T Consensus       374 -~-----~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          374 -N-----MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -C-----CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -C-----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0     011112334668999999999999999999999975

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-49  Score=360.77  Aligned_cols=266  Identities=24%  Similarity=0.379  Sum_probs=215.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec--------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE--------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCC  140 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~  140 (360)
                      .++|.+.+.||+|+||.||+|.+.        ++..||+|.++.....   ...+.+.+|+.++..+ +||||+++++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH---HHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH---HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            367899999999999999999863        3457999998765433   3456788999999999 899999999999


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN  209 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~N  209 (360)
                      ...+..++||||+++|+|.+++......           ....+++..++.++.|++.||.|||+++   |+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence            9999999999999999999999875421           2335889999999999999999999999   9999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCc
Q 040763          210 ILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTS  287 (360)
Q Consensus       210 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~  287 (360)
                      ||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...  
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--  311 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  311 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            9999999999999999986654322 12233457889999999999999999999999999999999 9999865431  


Q ss_pred             ccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          288 QENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      .   ..    ........         ....+..+++++.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       312 ~---~~----~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          312 E---EL----FKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             G---GH----HHHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H---HH----HHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            0   01    11111111         112234456689999999999999999999999999999876544

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-48  Score=346.45  Aligned_cols=262  Identities=25%  Similarity=0.385  Sum_probs=213.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||+||++.+. +++.+|+|.+.... .   ...+.+.+|+.++..++||||+++++++.+....++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-E---ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-H---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-H---HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence            367899999999999999999986 58899999875421 1   345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++....    ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        85 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  157 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL  157 (310)
T ss_dssp             EEECCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence            999999999999997632    25899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCcee-------------eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          229 IAMDQTHV-------------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       229 ~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      ........             .....||+.|+|||++.+..++.++||||||+++|+|++|..||...............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~  237 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR  237 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence            64432211             11456999999999999999999999999999999999999998654322211111111


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                                      .......+..+++++.+++.+||+.||++|||+.++++.|+.++..+
T Consensus       238 ----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          238 ----------------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             ----------------HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----------------ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                            11112223444557999999999999999999999999999998654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=353.01  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=211.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++.....   ...+.+.+|+.++..++||||+++++++.+...
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE---RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            467899999999999999999975    3446999998765433   345678899999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++||||+++++|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             cEEEeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCc
Confidence            999999999999999996532    25899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCce--eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          226 SKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       226 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      +.........  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....        .. ......
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~-~~~~~~  268 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RD-VISSVE  268 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HH-HHHHHH
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HH-HHHHHH
Confidence            9876543222  2223346788999999999999999999999999999999 9999965431        00 111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      ..         .....+..+++++.+++.+||+.||++|||+.++++.|+.+.++.
T Consensus       269 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          269 EG---------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             cC---------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            11         111123345668999999999999999999999999999988654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-47  Score=341.64  Aligned_cols=287  Identities=33%  Similarity=0.527  Sum_probs=227.9

Q ss_pred             ccccChHHHHHHhcCCCcc------ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCC
Q 040763           58 CKLFSSKELDKATNHFNVN------RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR  131 (360)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~  131 (360)
                      ...|+..++...+++|...      +.||+|+||.||+|.. +++.+|+|++............+.+.+|+.++..++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4678899999999888777      8999999999999987 57889999876543322223456788999999999999


Q ss_pred             CceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 040763          132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNIL  211 (360)
Q Consensus       132 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nil  211 (360)
                      ||+++++++...+..+++|||+++++|.+++.....  ..++++..++.++.|++.||.|||+++   ++||||||+||+
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil  165 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL  165 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            999999999999999999999999999999975432  236899999999999999999999999   999999999999


Q ss_pred             EcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 040763          212 LDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN  290 (360)
Q Consensus       212 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~  290 (360)
                      ++.++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||......... 
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-  243 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-  243 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-
Confidence            99999999999999987654322 22334568999999998865 5789999999999999999999999765432111 


Q ss_pred             cchHHHHHHHhh-ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          291 VSLAAYFVHSMR-KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       291 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                         ......... ...+...++.. ....+...++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       244 ---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          244 ---LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             ---THHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             ---HHHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence               111111111 11112222221 123456778899999999999999999999999999999865

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.8e-49  Score=362.82  Aligned_cols=263  Identities=26%  Similarity=0.388  Sum_probs=214.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ...++|.+.+.||+|+||.||+|.+. +++.||+|.++.....   ...+.+.+|+.+++.++||||+++++++...+..
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP---DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH---HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            34567899999999999999999987 6889999998754332   2345678899999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++|+|.+++.....    .+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s  260 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS  260 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCc
Confidence            999999999999999976432    4889999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceee-ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          227 KFIAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       227 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ........... ....+++.|+|||.+.++.++.++||||||+++|||++ |..||.....         ..........
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------~~~~~~~~~~  331 (377)
T 3cbl_A          261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTREFVEKG  331 (377)
T ss_dssp             EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------HHHHHHHHTT
T ss_pred             eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcC
Confidence            76543221111 11235778999999999999999999999999999998 9999865431         0011111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      .         ....+..+++++.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus       332 ~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          332 G---------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence            1         11223345668999999999999999999999999999998653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6e-49  Score=342.95  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=214.2

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|+||.||++.++++..+|+|.+......     .+.+.+|+.++..++||||+++++++......++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            4679999999999999999999988889999998764332     34577899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++.....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        82 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             EECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             EEccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceec
Confidence            999999999999976532    4889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....        ... ........   
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~-~~~~~~~~---  222 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEV-VLKVSQGH---  222 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHH-HHHHHTTC---
T ss_pred             chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHH-HHHHHcCC---
Confidence            6554444444557788999999999899999999999999999999 9999864431        001 11111110   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                            ....+...++++.+++.+||+.||++|||+.++++.|+.++..
T Consensus       223 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 ------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                  0111222355799999999999999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-49  Score=344.90  Aligned_cols=257  Identities=26%  Similarity=0.423  Sum_probs=213.2

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|+||.||++.+.+++.||+|++......     .+.+.+|+.++.+++||||+++++++.+....++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence            3678999999999999999999988899999998764333     24577899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        84 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             EECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             EEeCCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccc
Confidence            99999999999996532    25899999999999999999999999   999999999999999999999999999866


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....        .. ........    
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~-~~~~~~~~----  223 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SE-VVEDISTG----  223 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH-HHHHHHTT----
T ss_pred             cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HH-HHHHHhcC----
Confidence            5433333334457788999999999999999999999999999999 9999865331        01 11111111    


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                           .....+...++++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          224 -----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                 0111223345679999999999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-48  Score=345.12  Aligned_cols=264  Identities=25%  Similarity=0.391  Sum_probs=209.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+....... ....+.+.+|+.++..++||||+++++++...+..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK-EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc-HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            467999999999999999999976 68899999875543322 2345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++....     ++++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        89 v~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred             EEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence            999999999999997653     5899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      .............||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+...        .......... ..  
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~-~~--  229 (294)
T 4eqm_A          161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQD-SV--  229 (294)
T ss_dssp             C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSS-CC--
T ss_pred             cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhc-cC--
Confidence            654443444456799999999999999999999999999999999999999965431        0001111111 00  


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHhHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-TMEEVSMELNGIRG  356 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ei~~~L~~l~~  356 (360)
                         ...........++.+.+++.+||+.||++|| +++++.+.|+.+..
T Consensus       230 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          230 ---PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             ---CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             ---CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence               1111223344566899999999999999998 99999999987653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3e-49  Score=351.67  Aligned_cols=270  Identities=30%  Similarity=0.422  Sum_probs=207.7

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           64 KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        64 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      ........+|++.+.||+|+||+||++.. +++.+|+|++.......  ...+.+.+|+.++.+++||||+++++++...
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA--ERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            33344457899999999999999999987 47889999977544332  3456788999999999999999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...++||||+++++|.+++.....  ...+++..++.++.|++.||+|||+++ ++++||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999999976321  113889999999999999999999987 45999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      |++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....        ..........
T Consensus       184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~~~~~  254 (309)
T 3p86_A          184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFK  254 (309)
T ss_dssp             C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHHS
T ss_pred             CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc
Confidence            9997544322 223345689999999999999999999999999999999999999965431        0011111000


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..         ....+...++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       255 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          255 CK---------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00         1122344566899999999999999999999999999988754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.2e-48  Score=343.27  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=205.7

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||+||++.+. +++.||+|.+......    ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            367999999999999999999874 6889999987654332    24567789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++...      .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        95 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (297)
T ss_dssp             EEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEECCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence            99999999999999753      4889999999999999999999999   99999999999999999999999999877


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......        .......... .. 
T Consensus       166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~-~~-  234 (297)
T 3fxz_A          166 ITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNG-TP-  234 (297)
T ss_dssp             CCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHC-SC-
T ss_pred             cCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-CC-
Confidence            654332 234457999999999999999999999999999999999999999654310        0001111000 00 


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ....+...++.+.+++.+||+.||++|||+.|+++
T Consensus       235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  01113345567999999999999999999999975

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-48  Score=348.84  Aligned_cols=250  Identities=25%  Similarity=0.351  Sum_probs=207.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP--TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            3468999999999999999999984 78999999986543332  34567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus        91 lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             EEEECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            9999999999999997653     4889999999999999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ......  .....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+...        ... ........ 
T Consensus       163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~-~~~i~~~~-  230 (328)
T 3fe3_A          163 EFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KEL-RERVLRGK-  230 (328)
T ss_dssp             GGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH-HHHHHHCC-
T ss_pred             ecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHH-HHHHHhCC-
Confidence            654332  23445799999999999988775 789999999999999999999965431        111 11111111 


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                               ...+...++++.+|+.+||+.||.+|||+.|+++
T Consensus       231 ---------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 ---------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ---------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                     0122334567999999999999999999999974

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4e-48  Score=346.68  Aligned_cols=272  Identities=23%  Similarity=0.320  Sum_probs=210.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc---
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF---  145 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~---  145 (360)
                      ..++|++.+.||+|+||+||+|.+. ++.||+|++.....     .......|+.++..++||||+++++++.....   
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            3478999999999999999999876 78999999865321     22344568889999999999999999987554   


Q ss_pred             -ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCCeEEcC
Q 040763          146 -PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG----------ASSPIYHRDIKSTNILLDE  214 (360)
Q Consensus       146 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----------~~~~i~H~dlk~~Nill~~  214 (360)
                       .++||||+++|+|.+++...      .+++..+..++.|++.||.|||+.          +   ++||||||+|||++.
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKN  166 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECT
T ss_pred             eEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECC
Confidence             59999999999999999653      488999999999999999999998          8   999999999999999


Q ss_pred             CCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcc
Q 040763          215 RYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSS-----QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ  288 (360)
Q Consensus       215 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~  288 (360)
                      ++.+||+|||++......... ......||+.|+|||++.+.     .++.++||||||+++|||+||+.||.+......
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~  246 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM  246 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred             CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence            999999999999776543322 23335789999999998873     456788999999999999999999976543221


Q ss_pred             cccc-------hHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          289 ENVS-------LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       289 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      ....       .....................   ......++++.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cchhhhhccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1110       011111111111111111111   112345678999999999999999999999999999998643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-48  Score=355.67  Aligned_cols=260  Identities=24%  Similarity=0.422  Sum_probs=201.0

Q ss_pred             hcCCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ..+|++.+.||+|+||.||+|.++    ++..||+|.++.....   ...+.+.+|+.++.+++||||+++++++.....
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE---KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            357999999999999999999875    4678999998765433   345678899999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++||||+++++|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             eEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcc
Confidence            999999999999999997532    25899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          226 SKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       226 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      +..........  .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....         ........
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---------~~~~~~i~  264 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAVD  264 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---------HHHHHHHH
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHH
Confidence            98765432221  122235778999999999999999999999999999998 9999965431         00111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..         .....+..++.++.+++.+||+.||++|||+.++++.|+.+.++
T Consensus       265 ~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          265 EG---------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             TT---------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cC---------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            11         11112234556799999999999999999999999999998754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-48  Score=347.34  Aligned_cols=269  Identities=26%  Similarity=0.376  Sum_probs=217.1

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeE
Q 040763           66 LDKATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGC  139 (360)
Q Consensus        66 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~  139 (360)
                      .....++|.+.+.||+|+||.||++.+.      ++..||+|.+......   ...+.+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP---SELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH---HHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            3344578999999999999999999862      3578999998754433   345678899999999999999999999


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQN-------------------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPI  200 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i  200 (360)
                      +...+..++||||+++++|.+++......                   ....+++..++.++.|++.||.|||+++   +
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i  171 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---L  171 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence            99999999999999999999999865321                   1234789999999999999999999999   9


Q ss_pred             EecCCCCCCeEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCC
Q 040763          201 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKK  278 (360)
Q Consensus       201 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~  278 (360)
                      +||||||+||+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998765433222 233457888999999999889999999999999999999 999


Q ss_pred             CCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          279 PIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       279 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      ||.+....     ..    ........         ....+..+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       252 p~~~~~~~-----~~----~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  313 (314)
T 2ivs_A          252 PYPGIPPE-----RL----FNLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR  313 (314)
T ss_dssp             SSTTCCGG-----GH----HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCCHH-----HH----HHHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence            99654321     11    11111111         11123345668999999999999999999999999999987653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-48  Score=353.77  Aligned_cols=268  Identities=25%  Similarity=0.360  Sum_probs=217.4

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec--------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeee
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE--------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLG  138 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~  138 (360)
                      ...++|.+.+.||+|+||.||+|.+.        .+..||+|+++.....   .....+.+|+.++..+ +||||+++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH---HHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            34578999999999999999999863        2357999998765433   3456788999999999 9999999999


Q ss_pred             EEeeCCcceEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 040763          139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKS  207 (360)
Q Consensus       139 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~  207 (360)
                      ++...+..++||||+++++|.+++......           ....+++..++.++.|++.||.|||+++   |+||||||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp  219 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA  219 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCc
Confidence            999999999999999999999999875421           1246899999999999999999999999   99999999


Q ss_pred             CCeEEcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCC
Q 040763          208 TNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGN  285 (360)
Q Consensus       208 ~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~  285 (360)
                      +|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986654322 22333457889999999999999999999999999999999 9999865431


Q ss_pred             CcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          286 TSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                               ......+....         ....+..+++++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       300 ---------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          300 ---------EELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             ---------HHHHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             ---------HHHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                     01111111111         111223345689999999999999999999999999999876543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-48  Score=341.85  Aligned_cols=259  Identities=22%  Similarity=0.375  Sum_probs=210.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..++|++.+.||+|+||.||++.+.++..||+|++......     .+.+.+|+.++..++||||+++++++.+....++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            45679999999999999999999998889999998764333     3457789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++.....    .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        97 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             EECCCTTCBHHHHHHCGGG----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             EEeccCCCcHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccc
Confidence            9999999999999976322    5899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....        .. ........   
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~-~~~~~~~~---  237 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SE-TAEHIAQG---  237 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HH-HHHHHHTT---
T ss_pred             ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hH-HHHHHhcc---
Confidence            65433333333456788999999999899999999999999999998 9999865331        00 11111111   


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                            .....+...++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       238 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          238 ------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                  01111223345799999999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.1e-49  Score=367.75  Aligned_cols=264  Identities=23%  Similarity=0.385  Sum_probs=214.8

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           64 KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        64 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      +......++|.+.+.||+|+||.||+|.++++..||+|.++....     ..+.+.+|+.+++.++||||+++++++. .
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            334455678999999999999999999998888999999875432     3567889999999999999999999986 5


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      +..++||||+++|+|.+++.....   ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECST
T ss_pred             CccEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeC
Confidence            678999999999999999975421   14788899999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      |++...............+|..|+|||++..+.++.++||||||+++|||+| |+.||.+...        .. ....+.
T Consensus       329 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~-~~~~i~  399 (454)
T 1qcf_A          329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PE-VIRALE  399 (454)
T ss_dssp             TGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH-HHHHHH
T ss_pred             CCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHH
Confidence            9998764432222233446788999999999999999999999999999999 9999965331        01 111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..         .....+..+++++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       400 ~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          400 RG---------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             cC---------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            11         11122344567899999999999999999999999999988654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.6e-48  Score=339.72  Aligned_cols=260  Identities=26%  Similarity=0.405  Sum_probs=199.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      ..++|++.+.||+|+||.||+|.+..    +..+|+|........   ...+.+.+|+.++..++||||+++++++. .+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence            34779999999999999999998753    456999987764332   34567889999999999999999999984 46


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..++||||+++++|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred             ccEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccc
Confidence            7899999999999999997642    25889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.....     ..    ..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~~----~~i~~  232 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VI----GRIEN  232 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HH----HHHHT
T ss_pred             cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----HH----HHHHc
Confidence            998765443333334457889999999999999999999999999999997 999996543211     11    11111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..         ....+..+++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       233 ~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          233 GE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11         1112334566899999999999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.4e-48  Score=343.93  Aligned_cols=270  Identities=25%  Similarity=0.417  Sum_probs=207.5

Q ss_pred             hcCCCccceecccCcEEEEEEEe-----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--  142 (360)
                      .++|++.+.||+|+||+||++.+     .+++.||+|++.....    ...+.+.+|+.++..++||||+++++++..  
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH----HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            47799999999999999999984     3578999999875321    345678899999999999999999999865  


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                      ....++||||+++++|.+++.....    .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D  157 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD  157 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence            3458999999999999999976432    4889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCce--eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc-------ccccch
Q 040763          223 FGTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS-------QENVSL  293 (360)
Q Consensus       223 fg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~-------~~~~~~  293 (360)
                      ||++.........  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+.......       ......
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  237 (295)
T ss_dssp             CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred             CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence            9999876543221  1223457778999999999999999999999999999999999975431100       000000


Q ss_pred             HHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      ........         ........+..+++++.+++.+||+.||++|||+.++++.|+.+.+++.
T Consensus       238 ~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          238 VFHLIELL---------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHHHHH---------HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHHHH---------hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            00001111         1111122344566789999999999999999999999999999988763

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.6e-48  Score=337.83  Aligned_cols=258  Identities=29%  Similarity=0.464  Sum_probs=197.8

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|+||.||++.+. ++.+|+|.++...........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367899999999999999999985 7899999987654443334456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC--------CCcEEEe
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE--------RYRAKVA  221 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~--------~~~~kl~  221 (360)
                      |||+++++|.+++...      .+++..+..++.|++.||.|||+++..+++||||||+||+++.        ++.+||+
T Consensus        85 ~e~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EECCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEcCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            9999999999998532      5889999999999999999999998555889999999999986        7789999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      |||++.......   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+....        ...... 
T Consensus       159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~-  226 (271)
T 3dtc_A          159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AVAYGV-  226 (271)
T ss_dssp             CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHH-
T ss_pred             cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHhh-
Confidence            999997654322   22346899999999999999999999999999999999999999654310        000111 


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      ....        .....+..+++++.+++.+||+.||++|||+.++++.|+.+
T Consensus       227 ~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 AMNK--------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HTSC--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hcCC--------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1111        11112334456899999999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.1e-48  Score=344.07  Aligned_cols=271  Identities=27%  Similarity=0.406  Sum_probs=218.1

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEe------cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeE
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGC  139 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~  139 (360)
                      ....++|++.+.||+|+||.||+|.+      .+++.||+|.+......   ...+.+.+|+.++.++ +||||++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH---HHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            34457899999999999999999985      24678999998765433   3356788999999999 99999999999


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQN-------------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK  206 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  206 (360)
                      +...+..++||||+++++|.+++......             ....+++..++.++.|++.||.|||+++   ++|||||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk  172 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA  172 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence            99999999999999999999999865321             1235899999999999999999999999   9999999


Q ss_pred             CCCeEEcCCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 040763          207 STNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG  284 (360)
Q Consensus       207 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~  284 (360)
                      |+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99999999999999999999876554332 2233457889999999999999999999999999999999 999986543


Q ss_pred             CCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhccC
Q 040763          285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIKN  360 (360)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~~  360 (360)
                      ....        ........         .....+...++++.+++.+||+.||++|||+.++++.|+.+..+..|
T Consensus       253 ~~~~--------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          253 VDSK--------FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             SSHH--------HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             chhH--------HHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence            2110        11111111         11112233456899999999999999999999999999998876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.4e-48  Score=360.00  Aligned_cols=260  Identities=22%  Similarity=0.255  Sum_probs=207.5

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      ++....++|++.+.||+|+||+||++..+ +++.+|+|++....... ......+.+|..++..++||||+++++++.+.
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            33445578999999999999999999987 47889999876421111 11223367899999999999999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      +..|+||||+++|+|.+++....    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999997632    25899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      |++..............+||+.|+|||++.     ...++.++|||||||++|||++|+.||.+...        ...+.
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------~~~~~  291 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYG  291 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--------hHHHH
Confidence            999876655544455568999999999987     45789999999999999999999999975431        01111


Q ss_pred             HHhhccccccccchHHhhhcc---HHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 040763          299 HSMRKNRLYHILDDQVMKLGK---KNQIVAFANLAERCLDLNGKK--RPTMEEVSM  349 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~--Rpt~~ei~~  349 (360)
                      ....         .......+   ...++++.+|+.+||+.+|++  ||+++|+++
T Consensus       292 ~i~~---------~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          292 KIMN---------HKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHT---------HHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hhhh---------ccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1110         00000111   224567999999999998888  999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.3e-47  Score=349.02  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=202.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||++..+ +++.+|+|+++....... ...+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~-~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-HHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            467999999999999999999986 578899999875432211 2334567888888887 8999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       130 lV~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence            9999999999999997653     5899999999999999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....................+....  
T Consensus       202 ~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--  278 (396)
T 4dc2_A          202 EGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--  278 (396)
T ss_dssp             CCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred             ecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence            53322 223445679999999999999999999999999999999999999997543222111111111111111111  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                              ...+...++++.+|+.+||+.||++||++
T Consensus       279 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 --------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             --------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                    11234456689999999999999999996

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.7e-47  Score=338.69  Aligned_cols=265  Identities=22%  Similarity=0.308  Sum_probs=204.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..++|++.+.||+|+||+||++.+.+++.+|+|++.......  .....+.+|+.+++.++||||+++++++.+....++
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE--GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc--hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            347899999999999999999999889999999987543322  234567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||++ ++|.+++....    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        97 v~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           97 VFEFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA  168 (311)
T ss_dssp             EEECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEcCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCcee
Confidence            999997 58888886532    25889999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc--
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR--  305 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  305 (360)
                      ..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+......     ............  
T Consensus       169 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~~~~~~~~  242 (311)
T 3niz_A          169 FGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-----LPKIFSILGTPNPR  242 (311)
T ss_dssp             TTSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-----HHHHHHHHCCCCTT
T ss_pred             cCCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHHCCCChH
Confidence            64332 22334568999999999876 5689999999999999999999999976543221     111111111110  


Q ss_pred             -cc-------------cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 -LY-------------HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 -~~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       +.             ............+..++++.+|+.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             00             000111111122334568999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.7e-48  Score=365.11  Aligned_cols=259  Identities=25%  Similarity=0.402  Sum_probs=214.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ...+|++.+.||+|+||.||+|.++. +..||+|.++....     ..+.+.+|+.++.+++||||+++++++......+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            34668889999999999999999874 78999999875432     2457889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||+++|+|.+++....   ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       293 lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             EEEEccCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccce
Confidence            9999999999999997632   235889999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ..............++..|+|||++.+..++.++||||||+++|||++ |..||.+....     ...    ..+..   
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----~~~----~~~~~---  434 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVY----ELLEK---  434 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHH----HHHHT---
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----HHH----HHHHc---
Confidence            765443333334456789999999999999999999999999999999 99998654311     111    11111   


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                            ......+..+++++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       435 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          435 ------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                  11112344456689999999999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-48  Score=348.70  Aligned_cols=267  Identities=25%  Similarity=0.394  Sum_probs=214.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL  141 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~  141 (360)
                      ...++|++.+.||+|+||.||++.+.+      ++.||+|.++.....   ...+.+.+|+.++..++||||+++++++.
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            345789999999999999999998753      478999998764433   34567889999999999999999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQNE-------------------EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH  202 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  202 (360)
                      ..+..++||||+++++|.+++.......                   ...+++..++.++.|++.||.|||+++   ++|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            9999999999999999999998643211                   146899999999999999999999999   999


Q ss_pred             cCCCCCCeEEcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCC
Q 040763          203 RDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPI  280 (360)
Q Consensus       203 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~  280 (360)
                      |||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999976543322 22233467899999999999999999999999999999999 99999


Q ss_pred             CCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          281 FSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      .+...         .............         ..+..+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       278 ~~~~~---------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          278 YGMAH---------EEVIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TTSCH---------HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CCCCh---------HHHHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            65331         0111111111111         123345568999999999999999999999999999987654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.9e-48  Score=352.83  Aligned_cols=274  Identities=25%  Similarity=0.364  Sum_probs=217.3

Q ss_pred             cChHHHHHHhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCc
Q 040763           61 FSSKELDKATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNV  133 (360)
Q Consensus        61 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~ni  133 (360)
                      +.....+...++|++.+.||+|+||.||+|.+.      +++.||+|.++.....   ...+.+.+|+.++..+ +||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH---HHHHHHHHHHHHHHhhcCCcce
Confidence            344455566788999999999999999999742      4578999998764433   3356788999999999 79999


Q ss_pred             eeeeeEEeeCC-cceEEEEecCCCChhHHhhhhccCC-------------------------------------------
Q 040763          134 VKLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNE-------------------------------------------  169 (360)
Q Consensus       134 v~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~-------------------------------------------  169 (360)
                      +++++++...+ ..++||||+++|+|.+++.......                                           
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            99999988755 4899999999999999997653210                                           


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          170 ------------------EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       170 ------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                                        ...+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              122889999999999999999999999   99999999999999999999999999986644


Q ss_pred             CCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          232 DQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       232 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++ |..||.+.....        ..........    
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~----  313 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------EFCRRLKEGT----  313 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--------HHHHHHHHTC----
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--------HHHHHHHcCC----
Confidence            332 23344568999999999999999999999999999999998 999996543211        0111111111    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                           ....+...++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       314 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          314 -----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                 1112333456799999999999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-47  Score=338.31  Aligned_cols=260  Identities=23%  Similarity=0.359  Sum_probs=201.1

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhh--cCCCCceeeeeEEeeC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ--INHRNVVKLLGCCLET----  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~--l~h~niv~~~~~~~~~----  143 (360)
                      .++|++.+.||+|+||+||+|.+ +++.||+|++...       ....+..|.+++..  ++||||+++++++...    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            46799999999999999999988 5889999997643       12334456666665  7999999999986543    


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeEEcCC
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH--------SGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dlk~~Nill~~~  215 (360)
                      ...++||||+++|+|.+++...      .+++..++.++.|++.||.|||        +++   ++||||||+|||++.+
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKN  149 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTT
T ss_pred             ceeEEehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCC
Confidence            4578999999999999999542      5889999999999999999999        878   9999999999999999


Q ss_pred             CcEEEeecCCccccCCCCcee---eecccccCCccchhhhccC------CCCCccchhhhHHHHHHHHhC----------
Q 040763          216 YRAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTG----------  276 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg----------  276 (360)
                      +.+||+|||++..........   .....||+.|+|||++.+.      .++.++||||||+++|||++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            999999999997665433322   2234799999999999876      455799999999999999999          


Q ss_pred             CCCCCCCCCCcccccchHHHHHHHhhcc-ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          277 KKPIFSTGNTSQENVSLAAYFVHSMRKN-RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       277 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      ..||.........   .. ......... ......    ....+...++++.+++.+||+.||++|||+.++++.|+.+
T Consensus       230 ~~pf~~~~~~~~~---~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          230 KPPFYDVVPNDPS---FE-DMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCTTTTTSCSSCC---HH-HHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccCCCCcc---hh-hhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            7777554321111   11 111111111 111111    1112345678899999999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.5e-48  Score=336.11  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=212.3

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|+||.||++.+.+++.+|+|.+......     .+.+.+|+.++..++||||+++++++...+..+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            3678999999999999999999988889999998764332     24677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....    ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++...
T Consensus        82 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             ECCCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             EeCCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccc
Confidence            99999999999997642    25889999999999999999999999   999999999999999999999999999766


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ............+++.|+|||++.+..++.++||||||+++|+|++ |..||.....        .. .........   
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~-~~~~i~~~~---  222 (267)
T 3t9t_A          155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SE-VVEDISTGF---  222 (267)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH-HHHHHHTTC---
T ss_pred             ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HH-HHHHHhcCC---
Confidence            4432222233457788999999998899999999999999999999 8999865321        01 111111110   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                            ....+...++++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       223 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          223 ------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                  111223345679999999999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=336.53  Aligned_cols=273  Identities=24%  Similarity=0.357  Sum_probs=213.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC--cc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE--FP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~  146 (360)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++......   ...+.+.+|+.++..++||||+++++++....  ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            367999999999999999999987 4889999998754322   23456778999999999999999999988765  67


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----cCCCcEEEee
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVAD  222 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~D  222 (360)
                      ++||||+++++|.+++.....  ...+++..++.++.|++.||.|||+++   |+||||||+||++    +.++.+||+|
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             EEEEeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEcc
Confidence            999999999999999986532  224899999999999999999999999   9999999999999    7888899999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhc--------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ--------SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~  294 (360)
                      ||++........  .....||+.|+|||++.        +..++.++|||||||++|||++|+.||.......... ...
T Consensus       160 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~  236 (319)
T 4euu_A          160 FGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVM  236 (319)
T ss_dssp             CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHH
T ss_pred             CCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHH
Confidence            999987654332  23456899999999886        5678999999999999999999999996543222111 111


Q ss_pred             HHHHHHhhcccccccc-----------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 040763          295 AYFVHSMRKNRLYHIL-----------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNG  353 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~  353 (360)
                      .......+...+....           .-..........++.+.+++.+||+.||++|||+.|+++..++
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            1111111111111000           0011223557788899999999999999999999999988775

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-48  Score=352.75  Aligned_cols=264  Identities=24%  Similarity=0.346  Sum_probs=211.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      .++|++.+.||+|+||.||+|...      ++..||+|.++.....   .....+.+|+.++..++||||+++++++...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE---QDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh---hhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            467899999999999999999843      4668999998754333   2344678899999999999999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC---cE
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY---RA  218 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~---~~  218 (360)
                      ...++||||+++|+|.+++......  ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++   .+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceE
Confidence            9999999999999999999876432  2235899999999999999999999999   99999999999999554   59


Q ss_pred             EEeecCCccccCCCC-ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHH
Q 040763          219 KVADFGTSKFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  296 (360)
                      ||+|||++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.....        .. 
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~-  294 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QE-  294 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH-
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HH-
Confidence            999999997543221 122233457899999999999999999999999999999998 9999865431        01 


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .........         ....+..+++++.+|+.+||+.||++|||+.++++.|+.+.++
T Consensus       295 ~~~~i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          295 VLEFVTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            111111111         1112334456799999999999999999999999999988764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.4e-48  Score=345.00  Aligned_cols=258  Identities=23%  Similarity=0.433  Sum_probs=202.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ++|++.+.||+|+||+||+|.+. +++    .+|+|.+......   ...+.+.+|+.++..++||||+++++++.... 
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            66899999999999999999865 344    3588876543222   34567889999999999999999999998755 


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++++++.+|+|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             eEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcc
Confidence            689999999999999997643    25899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.....     ..    .....
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~----~~~~~  234 (327)
T 3poz_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----IS----SILEK  234 (327)
T ss_dssp             HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HH----HHHHT
T ss_pred             eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----HH----HHHHc
Confidence            9876543322 2233457889999999999999999999999999999999 999996543211     11    11111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .         .....+..++.++.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       235 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          235 G---------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             T---------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             C---------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            1         11112333456799999999999999999999999999988654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.6e-48  Score=337.29  Aligned_cols=260  Identities=24%  Similarity=0.397  Sum_probs=212.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..++|++.+.||+|+||.||+|...++..+|+|.+......     .+.+.+|+.++..++||||+++++++.. +..++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc-----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            44779999999999999999999988889999988754322     3567789999999999999999999864 56899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|||+++++|.+++.....   ..+++..++.++.|++.||.|||+++   ++||||||+||++++++.+||+|||++..
T Consensus        85 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            9999999999999975321   14889999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...        .. .........  
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~-~~~~~~~~~--  227 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PE-VIQNLERGY--  227 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH-HHHHHHTTC--
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HH-HHHHHhccc--
Confidence            65544333344457889999999998889999999999999999999 8999865331        01 111111110  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                             ....+...++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       228 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          228 -------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                   11122344568999999999999999999999999999987654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-47  Score=342.84  Aligned_cols=251  Identities=26%  Similarity=0.317  Sum_probs=205.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++..+ +++.||+|.++..... .......+.+|+.++..++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            367999999999999999999986 6889999998653211 11234567789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        83 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            999999999999997643     5889999999999999999999999   99999999999999999999999999975


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ..... ......+||+.|+|||++.+..++.++|+||||+++|||++|..||.+...        ..... .+....   
T Consensus       155 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~-~i~~~~---  221 (337)
T 1o6l_A          155 GISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFE-LILMEE---  221 (337)
T ss_dssp             SCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHCC---
T ss_pred             cccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHH-HHHcCC---
Confidence            43222 223445799999999999999999999999999999999999999965321        01111 111111   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                             ...+...++++.+|+.+||+.||++||     ++.++++
T Consensus       222 -------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 -------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                   112334566899999999999999999     8888864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.8e-47  Score=342.65  Aligned_cols=266  Identities=26%  Similarity=0.411  Sum_probs=197.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEecCCc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLEDGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      ..++|++.+.||+|+||.||+|.+..+.    .||+|.++......  ...+.+.+|+.+++.++||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS--SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C--HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH--HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3468999999999999999999876432    79999987543222  34567889999999999999999999998776


Q ss_pred             cc------eEEEEecCCCChhHHhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc
Q 040763          145 FP------LLVYEFIPNGTLYQHLHDRHQN-EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR  217 (360)
Q Consensus       145 ~~------~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~  217 (360)
                      ..      +++|||+++++|.+++...... ....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            55      8999999999999999765422 2235899999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHH
Q 040763          218 AKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       218 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~  295 (360)
                      +||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.....     .. 
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~-  249 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----IY-  249 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HH-
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----HH-
Confidence            999999999776443322 2223456788999999999999999999999999999999 899986543211     11 


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                         .......         ....+...++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       250 ---~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          250 ---NYLIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             ---HHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---HHHhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               1111111         1112334556899999999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3e-47  Score=355.74  Aligned_cols=252  Identities=27%  Similarity=0.427  Sum_probs=207.4

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC-cceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE-FPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~l  148 (360)
                      .++|++.+.||+|+||.||+|... ++.||+|.++...      ..+.+.+|+.++.+++||||+++++++.... ..++
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            467889999999999999999886 7799999987542      2456789999999999999999999987665 7899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++.....   ..+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++..
T Consensus       265 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            9999999999999987532   24789999999999999999999999   99999999999999999999999999975


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ....    .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.......     ..    .....+   
T Consensus       339 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~----~~i~~~---  402 (450)
T 1k9a_A          339 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VV----PRVEKG---  402 (450)
T ss_dssp             CC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----HH----HHHHTT---
T ss_pred             cccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH----HHHHcC---
Confidence            4322    122357889999999999999999999999999999998 999996543211     11    111111   


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                            .....+..+++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       403 ------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          403 ------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                  1122344556789999999999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.1e-48  Score=360.20  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=208.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      +...++|++.+.||+|+||.||+|.++++..||+|.++.....     .+.+.+|+.++++++||||+++++++.. +..
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            3445678899999999999999999988888999998764322     3567899999999999999999999876 678


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++|+|.+++.....   ..+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccc
Confidence            999999999999999975321   24889999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ...............+|..|+|||.+.++.++.++||||||+++|||++ |..||.+...        .. .......+ 
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~-~~~~i~~~-  397 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------RE-VLDQVERG-  397 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH-HHHHHHTT-
T ss_pred             eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcC-
Confidence            8765433333333457889999999999999999999999999999999 9999865431        01 11111111 


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                              .....+..+++++.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus       398 --------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          398 --------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                    111223455678999999999999999999999999999886543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-46  Score=340.35  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=205.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH--HHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE--LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      .++|++.+.||+|+||.||++.++ +|+.+|+|.+........  ....+.+.+|+.++..++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999986 588999998775433211  01245678999999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC----cEEEee
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY----RAKVAD  222 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~D  222 (360)
                      ++||||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+||+++.++    .+||+|
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            99999999999999996532     5899999999999999999999999   99999999999998877    799999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...        .... ..+.
T Consensus       163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~-~~i~  231 (361)
T 2yab_A          163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETL-ANIT  231 (361)
T ss_dssp             CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHH-HHHH
T ss_pred             cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHH
Confidence            99998765432  23345799999999999999999999999999999999999999965431        0111 1111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .... . ....    .....++++.+|+.+||+.||++|||+.|+++
T Consensus       232 ~~~~-~-~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          232 AVSY-D-FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TTCC-C-CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCC-C-CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1110 0 0111    11234567999999999999999999999874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.5e-47  Score=340.58  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=202.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~l  148 (360)
                      ++|++.+.||+|+||.||++.++ +++.+|+|++....... ....+.+.+|..++..+ +||||+++++++.+....|+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            57999999999999999999986 58899999987543221 13455677899999888 89999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        88 v~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence            999999999999997643     4889999999999999999999999   99999999999999999999999999975


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+................+....   
T Consensus       160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---  235 (345)
T 3a8x_A          160 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---  235 (345)
T ss_dssp             SCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---
T ss_pred             ccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---
Confidence            33221 22344579999999999999999999999999999999999999997543221111111111111111111   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                             ...+...++++.+|+.+||+.||++||++
T Consensus       236 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                   11233456689999999999999999996

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.6e-47  Score=337.42  Aligned_cols=260  Identities=26%  Similarity=0.401  Sum_probs=216.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||+|.+. ++..+|+|.+.....     ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            4577999999999999999999987 478899999875332     3456789999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||+++++|.+++....   ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.
T Consensus        86 ~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             EEEEcCCCCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999999997632   235899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ..............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......     ...    ......  
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----~~~----~~~~~~--  228 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVY----ELLEKD--  228 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHH----HHHHTT--
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH----HHHhcc--
Confidence            776555444555567889999999999999999999999999999999 99998654311     111    111111  


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                             .....+..+++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       229 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          229 -------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                   11122334556899999999999999999999999999988754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.1e-47  Score=334.17  Aligned_cols=265  Identities=17%  Similarity=0.215  Sum_probs=212.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+......      +.+.+|+.++..+ +|+|++++++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc------HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            467999999999999999999974 6889999987643222      2456789999999 8999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc-----EEEee
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR-----AKVAD  222 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~-----~kl~D  222 (360)
                      ++|||+ +++|.+++....    .++++..+..++.|++.||.|||+++   ++||||||+||+++.++.     +||+|
T Consensus        83 lv~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             EEEEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence            999999 999999997642    25899999999999999999999999   999999999999987776     99999


Q ss_pred             cCCccccCCCCce------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 040763          223 FGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       223 fg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  296 (360)
                      ||++.........      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+........  ....
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~~~~  232 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYER  232 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHH
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH--HHHH
Confidence            9999876543321      2334569999999999999999999999999999999999999997654221111  0111


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      .........         .......+++++.+++.+||+.||++|||+.+|++.|+.+.+.++
T Consensus       233 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          233 IGEKKQSTP---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHHHHSC---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHhhccCcc---------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            111100000         011122345689999999999999999999999999999987654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-47  Score=342.71  Aligned_cols=253  Identities=27%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.+. +++.||+|++......   ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            367999999999999999999986 6889999987654322   223457789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  154 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV  154 (323)
T ss_dssp             EEECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccce
Confidence            999999999999986532     4889999999999999999999999   99999999999999999999999999976


Q ss_pred             cCCCCc-eeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          229 IAMDQT-HVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       229 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.........       +.........
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~  227 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTY  227 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-------HHHHHTTCTT
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhccccc
Confidence            543222 22334579999999999988765 77899999999999999999999754422111       1111111100


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                               .......++++.+|+.+||+.||++|||+.|+++
T Consensus       228 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          228 ---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                     0011234557889999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-46  Score=334.92  Aligned_cols=261  Identities=28%  Similarity=0.400  Sum_probs=209.4

Q ss_pred             cccChHHHHHHhcC----------CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhh
Q 040763           59 KLFSSKELDKATNH----------FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ  127 (360)
Q Consensus        59 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~  127 (360)
                      ..++.+++....+.          |...+.||+|+||.||+|... +|+.||+|++......    ..+.+.+|+.++..
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~   98 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ----RRELLFNEVVIMRD   98 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----SHHHHHHHHHHHTT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh----HHHHHHHHHHHHHh
Confidence            34566666655543          667789999999999999987 6899999997654322    34567799999999


Q ss_pred             cCCCCceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 040763          128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKS  207 (360)
Q Consensus       128 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~  207 (360)
                      ++||||+++++++...+..++||||+++++|.+++...      .+++..+..++.|++.||.|||+++   ++||||||
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp  169 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS  169 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence            99999999999999999999999999999999998642      4899999999999999999999999   99999999


Q ss_pred             CCeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 040763          208 TNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS  287 (360)
Q Consensus       208 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~  287 (360)
                      +||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....  
T Consensus       170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--  246 (321)
T 2c30_A          170 DSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--  246 (321)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--
T ss_pred             HHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence            999999999999999999977654322 23345799999999999999999999999999999999999999965431  


Q ss_pred             ccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          288 QENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ... ...+........       ......++++.+++.+||+.||++|||+.++++
T Consensus       247 ------~~~-~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 ------VQA-MKRLRDSPPPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ------HHH-HHHHHHSSCCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------HHH-HHHHhcCCCCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  011 111111111110       012234557999999999999999999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-47  Score=338.02  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=204.5

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|.+....     .....+.+|+.++..++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            467999999999999999999986 57889999876532     223457789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC--CCcEEEeecCCc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE--RYRAKVADFGTS  226 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~  226 (360)
                      ||||+++++|.+++...    ...+++..+..++.|++.||.|||+++   ++||||||+||+++.  ++.+||+|||++
T Consensus        79 v~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a  151 (321)
T 1tki_A           79 IFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             EECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             EEEeCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence            99999999999999653    235899999999999999999999999   999999999999987  789999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...        ........ ....
T Consensus       152 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~-~~~~  220 (321)
T 1tki_A          152 RQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIM-NAEY  220 (321)
T ss_dssp             EECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-HTCC
T ss_pred             eECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHH-cCCC
Confidence            8765433  23345689999999999998889999999999999999999999965431        01111111 1110


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .  ....    .....++++.+|+.+||+.||++|||+.|+++
T Consensus       221 ~--~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          221 T--FDEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             C--CCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--CChh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0  0010    11234567999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.3e-47  Score=341.18  Aligned_cols=266  Identities=24%  Similarity=0.374  Sum_probs=214.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEec--------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeE
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE--------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGC  139 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~  139 (360)
                      ..++|.+.+.||+|+||.||+|.+.        ++..||+|.+......   ...+.+.+|+.++..+ +||||++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH---HHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            3578999999999999999999863        4678999998765433   3456788999999999 89999999999


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKST  208 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~  208 (360)
                      +...+..++||||+++++|.+++......           ....+++..++.++.|++.||.|||+++   ++||||||+
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~  186 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR  186 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence            99999999999999999999999865421           1235889999999999999999999999   999999999


Q ss_pred             CeEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCC
Q 040763          209 NILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT  286 (360)
Q Consensus       209 Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~  286 (360)
                      ||+++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+... 
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-  265 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  265 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-
Confidence            9999999999999999998765433222 233457888999999998889999999999999999999 9999865421 


Q ss_pred             cccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                             .. .........         ....+..+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       266 -------~~-~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          266 -------EE-LFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             -------HH-HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------HH-HHHHHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                   01 111111111         11123345567999999999999999999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-47  Score=345.37  Aligned_cols=269  Identities=23%  Similarity=0.366  Sum_probs=211.7

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeE
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGC  139 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~  139 (360)
                      +...++|.+.+.||+|+||.||+|.+.      ++..||+|.+......   ...+.+.+|+.++.++ +||||++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH---HHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            344578999999999999999999862      3568999998754322   3345788999999999 89999999999


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQN------------------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIY  201 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~  201 (360)
                      +...+..++||||+++|+|.+++......                  ....+++..++.++.|++.||.|||+++   ++
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv  194 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV  194 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            99999999999999999999999764321                  0124789999999999999999999999   99


Q ss_pred             ecCCCCCCeEEcCCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCC
Q 040763          202 HRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKP  279 (360)
Q Consensus       202 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p  279 (360)
                      ||||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|+|+| |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999999876543322 2334457889999999999999999999999999999998 9999


Q ss_pred             CCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          280 IFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      |.+.....        .........         .....+...++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       275 ~~~~~~~~--------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          275 YPGIPVDA--------NFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             STTCCCSH--------HHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cccCCcHH--------HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            96543211        111111111         111123334568999999999999999999999999999887653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5e-47  Score=333.11  Aligned_cols=259  Identities=28%  Similarity=0.413  Sum_probs=206.0

Q ss_pred             hcCCCccceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .++|.+.+.||+|+||.||+|.+.+    +..||+|.+......   ...+.+.+|+.+++.++||||+++++++.+ +.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL---DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH---HHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc---hHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            4679999999999999999998643    235999998765333   345678899999999999999999999865 45


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+++++|.+++.....    .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             CEEEEecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCC
Confidence            6899999999999999976432    5889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      +...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......     .....    ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~----~~~~  230 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGV----LEKG  230 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHH----HHHT
T ss_pred             CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHH----HhcC
Confidence            98765443333344457889999999998899999999999999999998 99999654321     11111    1111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .         ....+...++.+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       231 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          231 D---------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            0         0111233456799999999999999999999999999988754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=339.72  Aligned_cols=255  Identities=26%  Similarity=0.339  Sum_probs=205.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH--HHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE--LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|.+........  ....+.+.+|+.++..++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356999999999999999999986 588999998765433211  01345678999999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC----cEEEee
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY----RAKVAD  222 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~D  222 (360)
                      ++||||+++++|.+++...     ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++    .+||+|
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            9999999999999999653     25899999999999999999999999   99999999999999887    899999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...        ...... ..
T Consensus       162 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~-~~  230 (326)
T 2y0a_A          162 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLAN-VS  230 (326)
T ss_dssp             CTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH-HH
T ss_pred             CCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHH-HH
Confidence            99998764332  22345699999999999999999999999999999999999999965431        000111 11


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .... . ...    ......++++.+|+.+||+.||++|||+.++++
T Consensus       231 ~~~~-~-~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          231 AVNY-E-FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HTCC-C-CCH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hcCC-C-cCc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1000 0 001    111233557899999999999999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=347.91  Aligned_cols=255  Identities=21%  Similarity=0.290  Sum_probs=205.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||++.+. +++.+|+|.+.......  ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA--RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH--HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            3467999999999999999999875 68899999877644332  33556889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc---CCCcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg  224 (360)
                      +||||+++|+|.+.+....     .+++..+..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||
T Consensus        87 lv~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            9999999999999997643     5889999999999999999999999   99999999999998   56889999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++....... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+...        .. ....+...
T Consensus       159 ~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~-~~~~i~~~  228 (444)
T 3soa_A          159 LAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HR-LYQQIKAG  228 (444)
T ss_dssp             SCBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HH-HHHHHHHT
T ss_pred             eeEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HH-HHHHHHhC
Confidence            997765432 223345799999999999999999999999999999999999999965331        01 11111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .. ...     .......++++.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~-~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          229 AY-DFP-----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CC-CCC-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC-CCC-----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11 000     0011234567999999999999999999999975

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-47  Score=342.59  Aligned_cols=249  Identities=22%  Similarity=0.294  Sum_probs=203.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.+....... ......+.+|+.+++.++||||+++++++.+....++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            367999999999999999999974 68899999876432111 1223467789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+ +|+|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||++..
T Consensus        87 v~E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             EEECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecccee
Confidence            99999 789999987653     5889999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .....  .....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........                
T Consensus       158 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------------  219 (336)
T 3h4j_B          158 MTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------  219 (336)
T ss_dssp             TTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------
T ss_pred             ccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------
Confidence            64432  2234579999999999988776 6899999999999999999999975432111100                


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        ... .....+...++++.+|+.+||+.||.+|||+.|+++
T Consensus       220 --i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          220 --VNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             --CCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             --HHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              000 001123345567999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-47  Score=352.84  Aligned_cols=256  Identities=24%  Similarity=0.293  Sum_probs=205.8

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ....++|++.+.||+|+||.||++.++ +++.+|+|++....... ....+.+.+|..++..++||||+++++++.+...
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            334578999999999999999999987 57899999876421111 1112346789999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .|+||||+++|+|.+++...      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++++||+|||+
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            99999999999999998652      4889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCC----CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ----LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      +..............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+...        ...+....
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~  286 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIM  286 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHHHHH
Confidence            9876655444445678999999999998765    78899999999999999999999975431        11111111


Q ss_pred             hccccccccchHHhhhc--cHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHH
Q 040763          302 RKNRLYHILDDQVMKLG--KKNQIVAFANLAERCLDLNGKK--RPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~--Rpt~~ei~~  349 (360)
                      .         .......  ....++++.+|+.+||+.+|.+  ||++.|+++
T Consensus       287 ~---------~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          287 N---------HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             T---------HHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             h---------ccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            1         1000011  1234568999999999999988  999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.2e-46  Score=344.09  Aligned_cols=272  Identities=19%  Similarity=0.240  Sum_probs=205.5

Q ss_pred             hcCCCccceeccc--CcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           70 TNHFNVNRILGQG--GQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      .++|++.+.||+|  +||+||++.+. +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN--EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh--HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            4779999999999  99999999987 68999999987654332  3456778899999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++++|.+++....   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccc
Confidence            99999999999999997642   225899999999999999999999999   999999999999999999999999988


Q ss_pred             cccCCCCce------eeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          227 KFIAMDQTH------VTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       227 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      .........      ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+................
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            654322111      1122368999999999987  57899999999999999999999999765432221111100000


Q ss_pred             HHhhc-----c-------------ccccc---------cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          299 HSMRK-----N-------------RLYHI---------LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       299 ~~~~~-----~-------------~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .....     .             .....         .........+...++++.+|+.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00000     0             00000         0000011233445678999999999999999999999974

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-46  Score=337.61  Aligned_cols=263  Identities=16%  Similarity=0.216  Sum_probs=209.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+......      +.+.+|+.++..+ +||||+++++++...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            467999999999999999999974 6889999987654322      2466899999999 9999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc-----EEEee
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR-----AKVAD  222 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~-----~kl~D  222 (360)
                      +||||+ +++|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.     +||+|
T Consensus        82 lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~D  153 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIID  153 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred             EEEEeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEE
Confidence            999999 999999997642    26899999999999999999999999   999999999999999887     99999


Q ss_pred             cCCccccCCCCce------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 040763          223 FGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       223 fg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  296 (360)
                      ||++.........      ......||+.|+|||++.+..++.++||||||+++|||++|..||.+.......  .....
T Consensus       154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~--~~~~~  231 (330)
T 2izr_A          154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK--ERYQK  231 (330)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH--HHHHH
T ss_pred             cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH--HHHHH
Confidence            9999876443221      123457999999999999999999999999999999999999999765321110  00000


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      +.........         .......+ ++.+++..||+.||.+||++.+|.+.|+.+....
T Consensus       232 i~~~~~~~~~---------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          232 IGDTKRATPI---------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHHSCH---------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhhhccCCH---------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            1000000000         00011123 7999999999999999999999999999887654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=344.37  Aligned_cols=247  Identities=27%  Similarity=0.343  Sum_probs=198.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      ..++|++.+.||+|+||.||++.++ +++.||+|+++..... .....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            3478999999999999999999986 5889999998753221 113445677899999988 799999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      |+||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccce
Confidence            99999999999999997653     4889999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      +..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...        ...+.... ... 
T Consensus       172 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~-~~~-  240 (353)
T 3txo_A          172 KEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAIL-NDE-  240 (353)
T ss_dssp             BCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCC-
T ss_pred             eecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHH-cCC-
Confidence            753322 2233446799999999999999999999999999999999999999965431        11111111 111 


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                               ...+...++++.+|+.+||+.||++||++
T Consensus       241 ---------~~~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          241 ---------VVYPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence                     11223345679999999999999999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.7e-47  Score=342.03  Aligned_cols=272  Identities=27%  Similarity=0.368  Sum_probs=210.8

Q ss_pred             CCccceecccCcEEEEEEEec-----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--Cc
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EF  145 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~  145 (360)
                      |++.+.||+|+||+||++.++     +++.||+|++......   ...+.+.+|+.+++.++||||+++++++.+.  ..
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP---QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh---HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            489999999999999988642     5788999998765333   3456788999999999999999999999874  56


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++||||+++++|.+++...      .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence            78999999999999999653      3889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCce--eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +.........  ......+|..|+|||.+.+..++.++||||||+++|+|++|..||..............   ......
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~~  257 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA---QGQMTV  257 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC---CHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccc---ccchhH
Confidence            9876554322  22334578889999999998999999999999999999999999854321000000000   000000


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      ...............+..+++++.+|+.+||+.||++|||+.++++.|+.+.+.+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            00111111111222344566789999999999999999999999999999987654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-46  Score=331.56  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=200.0

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ++|++.+.||+|+||+||++...+++.+|+|++.......  ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE--GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG--CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc--ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            5789999999999999999999889999999986543321  22356778999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++ +|.+++....    ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus        80 e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             ECCSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             EecCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            99964 9999886532    25889999999999999999999999   9999999999999999999999999997654


Q ss_pred             CCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc---c
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR---L  306 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~  306 (360)
                      ... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....     ..............   +
T Consensus       152 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~  225 (288)
T 1ob3_A          152 IPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-----DQLMRIFRILGTPNSKNW  225 (288)
T ss_dssp             C----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTS
T ss_pred             ccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHHCCCChhhc
Confidence            322 12233468999999999876 45899999999999999999999999654311     01111111111100   0


Q ss_pred             ccc-----cch-------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHI-----LDD-------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~-----~~~-------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...     .+.       ..........++++.+|+.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000     000       0001112234568899999999999999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-46  Score=338.80  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=198.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      .++|++.+.||+|+||.||+|.++ +++.||+|+++.....   ...+.+.+|+.+++.++||||+++++++.+..    
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT---THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            356899999999999999999987 7899999998754332   23467889999999999999999999986543    


Q ss_pred             -----------------------------------------------------cceEEEEecCCCChhHHhhhhccCCCC
Q 040763          145 -----------------------------------------------------FPLLVYEFIPNGTLYQHLHDRHQNEEY  171 (360)
Q Consensus       145 -----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~  171 (360)
                                                                           ..+++|||+++++|.+++......  .
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~  159 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--E  159 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--G
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--c
Confidence                                                                 268999999999999999875432  2


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc-----------eeeecc
Q 040763          172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-----------HVTTKI  240 (360)
Q Consensus       172 ~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~  240 (360)
                      ..++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++........           ......
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence            4567788999999999999999999   99999999999999999999999999987654321           112334


Q ss_pred             cccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccH
Q 040763          241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKK  320 (360)
Q Consensus       241 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (360)
                      .||+.|+|||.+.+..++.++||||||+++|+|++|..|+...           ...........         ......
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----------~~~~~~~~~~~---------~~~~~~  296 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----------VRIITDVRNLK---------FPLLFT  296 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----------HHHHHHHHTTC---------CCHHHH
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----------HHHHHHhhccC---------CCcccc
Confidence            6999999999999999999999999999999999987764110           00011111110         011123


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          321 NQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       321 ~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..++++.+++.+||+.||++|||+.|+++
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            45567899999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.9e-47  Score=340.28  Aligned_cols=274  Identities=26%  Similarity=0.376  Sum_probs=218.5

Q ss_pred             ccccChHHHHHHhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCC
Q 040763           58 CKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR  131 (360)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~  131 (360)
                      ...+..++.....++|++.+.||+|+||.||+|.+.      ++..||+|.+......   .....+.+|+.+++.++||
T Consensus        12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~   88 (322)
T 1p4o_A           12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCH   88 (322)
T ss_dssp             CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH---HHHHHHHHHHHHGGGCCCT
T ss_pred             ccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH---HHHHHHHHHHHHHHhcCCC
Confidence            344555566667789999999999999999999764      3678999998754333   3345688999999999999


Q ss_pred             CceeeeeEEeeCCcceEEEEecCCCChhHHhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 040763          132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ-----NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIK  206 (360)
Q Consensus       132 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  206 (360)
                      ||+++++++.+.+..++||||+++++|.+++.....     ....++++..++.++.|++.||.|||+++   ++|||||
T Consensus        89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dik  165 (322)
T 1p4o_A           89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLA  165 (322)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCS
T ss_pred             CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCc
Confidence            999999999999999999999999999999976431     11235789999999999999999999999   9999999


Q ss_pred             CCCeEEcCCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 040763          207 STNILLDERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTG  284 (360)
Q Consensus       207 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~  284 (360)
                      |+||+++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus       166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  245 (322)
T 1p4o_A          166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  245 (322)
T ss_dssp             GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence            999999999999999999997654432222 223356889999999999999999999999999999999 888986532


Q ss_pred             CCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      .        .. ..........         ...+...++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       246 ~--------~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          246 N--------EQ-VLRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             H--------HH-HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             H--------HH-HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            1        01 1111111111         1123345567999999999999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.3e-46  Score=340.16  Aligned_cols=254  Identities=23%  Similarity=0.353  Sum_probs=205.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||++.++ +++.+|+|.+.......  ...+.+.+|+.++..++||||+++++++.+.+..+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3467999999999999999999986 58899999987543322  34567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC---CcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER---YRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg  224 (360)
                      +||||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.+   +.+||+|||
T Consensus       105 lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecC
Confidence            9999999999999986532     5889999999999999999999999   9999999999999865   459999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...        .. ....+...
T Consensus       177 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~-~~~~i~~~  245 (362)
T 2bdw_A          177 LAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HR-LYAQIKAG  245 (362)
T ss_dssp             TCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHT
T ss_pred             cceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HH-HHHHHHhC
Confidence            998765332  22345799999999999999999999999999999999999999965431        01 11111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ... ..     .......++++.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~-~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          246 AYD-YP-----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCC-CC-----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCC-CC-----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            100 00     0011234567999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.3e-47  Score=333.80  Aligned_cols=263  Identities=27%  Similarity=0.460  Sum_probs=198.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..++|++.+.||+|+||+||+|...  ..+|+|.++......  ...+.+.+|+.+++.++||||++++++. .....++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCH--HHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            4578999999999999999999865  359999887654432  3456788999999999999999999965 5566899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        97 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             EEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             EEEecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccc
Confidence            999999999999996532    35899999999999999999999999   99999999999999999999999999976


Q ss_pred             cCCCC-ceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          229 IAMDQ-THVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       229 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ..... ........||+.|+|||.+.   +..++.++||||||+++|+|++|+.||.......        .........
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~  241 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--------QIIEMVGRG  241 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--------HHHHHHHHT
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--------HHHHHhccc
Confidence            54322 22233456899999999986   5677889999999999999999999996543211        111111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      .....     .......+++++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       242 ~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          242 SLSPD-----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SCCCC-----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccCcc-----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11100     011123445689999999999999999999999999998754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.6e-47  Score=344.46  Aligned_cols=274  Identities=18%  Similarity=0.230  Sum_probs=206.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEecC------CcEEEEEecccccChHHH--H-----hHHHHHHHHHHHhhcCCCCcee
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEEL--Y-----KLEEFINEIFILSQINHRNVVK  135 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~~~--~-----~~~~~~~e~~~~~~l~h~niv~  135 (360)
                      ..++|++.+.||+|+||.||+|.+..      ++.||+|.+.........  .     .......|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998764      368999987654321100  0     0112345666778889999999


Q ss_pred             eeeEEeeC----CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 040763          136 LLGCCLET----EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNIL  211 (360)
Q Consensus       136 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nil  211 (360)
                      +++++...    ...++||||+ +++|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+|||
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil  184 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL  184 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence            99998765    4579999999 999999997632    26899999999999999999999999   999999999999


Q ss_pred             Ec--CCCcEEEeecCCccccCCCCcee------eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 040763          212 LD--ERYRAKVADFGTSKFIAMDQTHV------TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST  283 (360)
Q Consensus       212 l~--~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~  283 (360)
                      ++  .++.+||+|||++..........      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.+.
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99  88999999999997764432111      12345999999999999999999999999999999999999999753


Q ss_pred             CCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          284 GNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      .....    ......... ...+..+.+..+.   ...+++++.+++..||+.||++|||+.+|++.|+.+...+
T Consensus       265 ~~~~~----~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          265 LKDPK----YVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             TTCHH----HHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccCHH----HHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            32111    111011111 1111122221110   1234568999999999999999999999999999987654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=331.63  Aligned_cols=259  Identities=24%  Similarity=0.361  Sum_probs=210.1

Q ss_pred             cCCCccc-eecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNR-ILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|.++.....   ...+.+.+|+.++..++||||+++++++ ..+..
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~   84 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL   84 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence            4566666 8999999999999864   5778999998765333   3456788999999999999999999999 55668


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++++|.+++...    ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccce
Confidence            9999999999999999643    235899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          227 KFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       227 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ..........  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......        . .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~-~~~~i~~  228 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------E-VMAFIEQ  228 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------H-HHHHHHT
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------H-HHHHHhc
Confidence            8765433322  222346889999999998889999999999999999998 99999654320        0 1111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      ..         ....+..+++++.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus       229 ~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          229 GK---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC---------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            11         11223445668999999999999999999999999999987653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.7e-47  Score=330.29  Aligned_cols=257  Identities=23%  Similarity=0.341  Sum_probs=207.8

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--Ccce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--EFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~  147 (360)
                      .++|++.+.||+|+||.||+|.++ ++.+|+|.+.......  ...+.+.+|+.++..++||||+++++++.+.  ...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWST--RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCH--HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            367999999999999999999986 7889999987654332  3456788999999999999999999999877  7789


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++|||+++++|.+++....   ...+++..++.++.|++.||.|||+++ .+++||||||+||+++.++.++|+|||++.
T Consensus        86 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             eeecccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEecccee
Confidence            9999999999999997632   235899999999999999999999976 459999999999999999999999999875


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCC---ccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTD---KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ....      ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||.+...        ...........
T Consensus       162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~  227 (271)
T 3kmu_A          162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVALEG  227 (271)
T ss_dssp             TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHHHHSC
T ss_pred             eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHHHhcC
Confidence            4322      2235799999999998765554   79999999999999999999965431        01111111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                               .....+...++++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          228 ---------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     1112233456689999999999999999999999999998864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.5e-48  Score=341.17  Aligned_cols=267  Identities=25%  Similarity=0.373  Sum_probs=208.3

Q ss_pred             hcCCCccceecccCcEEEEEEEe-----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC-
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-  143 (360)
                      .++|++.+.||+|+||.||++.+     .+++.||+|.+......   ...+.+.+|+.++..++||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG---NHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc---hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            35689999999999999999983     36889999998754322   3446778999999999999999999999876 


Q ss_pred             -CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          144 -EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       144 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                       ...+++|||+++++|.+++.....    .+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECc
Confidence             667999999999999999965432    5899999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCce--eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC------cccccchH
Q 040763          223 FGTSKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT------SQENVSLA  294 (360)
Q Consensus       223 fg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~------~~~~~~~~  294 (360)
                      ||++.........  ......||..|+|||.+.+..++.++||||||+++|+|++|..|+......      ........
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence            9999876554332  233456888899999999999999999999999999999999886422100      00000000


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      ........         .......+..+++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       250 ~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          250 TRLVNTLK---------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHh---------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00111111         11112233455678999999999999999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-46  Score=340.79  Aligned_cols=259  Identities=22%  Similarity=0.322  Sum_probs=204.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChH-HHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDE-ELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||++.++ +++.||+|++....... .....+.+.+|+.++..++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999876 68899999875422110 0012456789999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc---EEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg  224 (360)
                      +||||+++++|.+++..... ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||
T Consensus       103 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988876432 2335889999999999999999999999   999999999999986654   9999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...         ... ......
T Consensus       179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~-~~i~~~  247 (351)
T 3c0i_A          179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLF-EGIIKG  247 (351)
T ss_dssp             TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHH-HHHHHT
T ss_pred             ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHH-HHHHcC
Confidence            9987654322 23345799999999999999999999999999999999999999965320         111 111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...  .....    ....++++.+|+.+||+.||++|||+.++++
T Consensus       248 ~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          248 KYK--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            100  00100    1123567999999999999999999999974

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-46  Score=331.91  Aligned_cols=259  Identities=32%  Similarity=0.573  Sum_probs=205.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHh---HHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYK---LEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~---~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .++|++.+.||+|+||.||++.+. +++.||+|.+...........   .+.+.+|+.++..++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            377999999999999999999975 688999999865443322221   257889999999999999999999986554 


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc-----EEE
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR-----AKV  220 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~-----~kl  220 (360)
                       ++||||+++++|.+++....    ..+++..++.++.|++.||.|||+++ .+++||||||+||+++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence             79999999999999886532    26899999999999999999999986 45999999999999988776     999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhc--cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ--SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      +|||++.....    ......||+.|+|||++.  ...++.++||||||+++|+|++|+.||........      .. .
T Consensus       171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~-~  239 (287)
T 4f0f_A          171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------KF-I  239 (287)
T ss_dssp             CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH------HH-H
T ss_pred             CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH------HH-H
Confidence            99999875432    233457899999999984  45578899999999999999999999965432111      00 1


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      .......        .....+..+++++.+++.+||+.||++|||+.++++.|+.+
T Consensus       240 ~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 NMIREEG--------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHSC--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHhccC--------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111111        11122334566899999999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=333.11  Aligned_cols=272  Identities=23%  Similarity=0.322  Sum_probs=205.0

Q ss_pred             hHHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhh--cCCCCceeeeeEE
Q 040763           63 SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ--INHRNVVKLLGCC  140 (360)
Q Consensus        63 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~--l~h~niv~~~~~~  140 (360)
                      ........++|++.+.||+|+||.||+|.+. ++.||+|++....       ......|.+++..  ++||||+++++++
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            3344455678999999999999999999886 8899999875421       1223345555554  4999999999999


Q ss_pred             eeC----CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEecCCCCC
Q 040763          141 LET----EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG--------ASSPIYHRDIKST  208 (360)
Q Consensus       141 ~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--------~~~~i~H~dlk~~  208 (360)
                      ...    ...++||||+++++|.+++...      .+++..++.++.|++.||.|||++        +   ++||||||+
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~  171 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSK  171 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGG
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchH
Confidence            877    6789999999999999999653      488999999999999999999998        7   999999999


Q ss_pred             CeEEcCCCcEEEeecCCccccCCCCcee---eecccccCCccchhhhccCCCCCc------cchhhhHHHHHHHHhC---
Q 040763          209 NILLDERYRAKVADFGTSKFIAMDQTHV---TTKIQGTFGYLDPEYHQSSQLTDK------SDVYSFGVVLVELLTG---  276 (360)
Q Consensus       209 Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~el~tg---  276 (360)
                      ||+++.++.+||+|||++..........   .....||+.|+|||++.+...+.+      +||||||+++|||++|   
T Consensus       172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~  251 (337)
T 3mdy_A          172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS  251 (337)
T ss_dssp             GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence            9999999999999999997654432221   124469999999999988766665      9999999999999999   


Q ss_pred             -------CCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          277 -------KKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       277 -------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             ..||.........    ..................   .......+++++.+++.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          252 GGIVEEYQLPYHDLVPSDPS----YEDMREIVCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             TTBCCCCCCTTTTTSCSSCC----HHHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccccccccHhhhcCCCCc----hhhhHHHHhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence                   5555432211111    111111111111111111   11123467788999999999999999999999999


Q ss_pred             HHHHhHhhc
Q 040763          350 ELNGIRGSI  358 (360)
Q Consensus       350 ~L~~l~~~~  358 (360)
                      .|+.+.++.
T Consensus       325 ~L~~l~~~~  333 (337)
T 3mdy_A          325 TLAKMSESQ  333 (337)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHHhhc
Confidence            999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.9e-47  Score=344.04  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=203.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++... +++.||+|.+...... .......+.+|+.++..++||||+++++++.+....++
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            367999999999999999999976 5788999987643211 12235677899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+.+|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        93 v~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             EECCCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeee
Confidence            999999999999997532     5899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhcc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ....  ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||........     .... ...... 
T Consensus       165 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~-~~~~~~-  235 (384)
T 4fr4_A          165 LPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----KEIV-HTFETT-  235 (384)
T ss_dssp             CCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----HHHH-HHHHHC-
T ss_pred             ccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----HHHH-HHHhhc-
Confidence            6433  22345679999999999874   4588999999999999999999999975432111     1111 111111 


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-HHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-MEEVS  348 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~ei~  348 (360)
                               ....+..+++++.+|+.+||+.||++||+ +.++.
T Consensus       236 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          236 ---------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             ---------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence                     11123345668999999999999999998 66654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=335.20  Aligned_cols=248  Identities=25%  Similarity=0.268  Sum_probs=195.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++.......  ........|+..+..+ +||||+++++++.+....
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh--HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            3467999999999999999999987 68999999876543332  2233445566655555 999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+ +++|.+++.....    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             EEEEecc-CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceee
Confidence            9999999 7799999876532    5899999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      .......  ......||+.|+|||++.+ .++.++||||||+++|||++|..|+....            ....+.... 
T Consensus       205 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------------~~~~~~~~~-  268 (311)
T 3p1a_A          205 VELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------------GWQQLRQGY-  268 (311)
T ss_dssp             EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------------HHHHHTTTC-
T ss_pred             eecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------------HHHHHhccC-
Confidence            7664332  2334468999999998876 78999999999999999999977764321            011111111 


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         ..    ...+...++++.+++.+||+.||++|||+.|+++
T Consensus       269 ---~~----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          269 ---LP----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---CC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---CC----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               11    1112234568999999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.6e-47  Score=342.16  Aligned_cols=270  Identities=24%  Similarity=0.361  Sum_probs=215.2

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEecC-C-----cEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeee
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLED-G-----RIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLL  137 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~  137 (360)
                      ..+...++|.+.+.||+|+||.||+|.+.. +     ..+|+|.+......   ...+.+.+|+.++..+ +||||++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA---DEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh---HHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            444556889999999999999999998753 2     37999998765433   3456788999999999 899999999


Q ss_pred             eEEeeCCcceEEEEecCCCChhHHhhhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040763          138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQN---------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKST  208 (360)
Q Consensus       138 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~  208 (360)
                      +++...+..++||||+++|+|.+++......         ....+++..++.++.|++.||.|||+++   ++||||||+
T Consensus       117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~  193 (333)
T 2i1m_A          117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAAR  193 (333)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccc
Confidence            9999999999999999999999999764311         1235789999999999999999999999   999999999


Q ss_pred             CeEEcCCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCC
Q 040763          209 NILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNT  286 (360)
Q Consensus       209 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~  286 (360)
                      ||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|+| |..||.+....
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            999999999999999999866443322 2233457889999999999999999999999999999999 99998654321


Q ss_pred             cccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..        ........         .....+...++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       274 ~~--------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          274 SK--------FYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HH--------HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH--------HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            10        11111111         01111223355799999999999999999999999999987654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.9e-46  Score=333.81  Aligned_cols=267  Identities=23%  Similarity=0.328  Sum_probs=192.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||+|.++ +++.||+|.++.....   ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            467999999999999999999876 5889999988654322   223456789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQN-EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ||||++ ++|.+++...... ....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccce
Confidence            999997 6999999765322 2235889999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc-
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR-  305 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  305 (360)
                      ....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....     .............. 
T Consensus       157 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~  230 (317)
T 2pmi_A          157 AFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-----EQLKLIFDIMGTPNE  230 (317)
T ss_dssp             ETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCT
T ss_pred             ecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCh
Confidence            7643322 2233468999999999876 46899999999999999999999999654321     11111111111000 


Q ss_pred             --ccc-----------------ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 --LYH-----------------ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 --~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        +..                 .+............++++.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence              000                 00011111122234568999999999999999999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-46  Score=330.43  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=204.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++..+ +++.+|+|+++..... .....+.+.+|..++..++||||+++++++.+....++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            367999999999999999999986 6889999987653211 11234567789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        84 v~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCccee
Confidence            999999999999997643     5889999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ....    ....+||+.|+|||++.+..++.++|+||||+++|||++|..||.+...        ...+...... .   
T Consensus       156 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~-~---  219 (318)
T 1fot_A          156 VPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNA-E---  219 (318)
T ss_dssp             CSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHC-C---
T ss_pred             cCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-C---
Confidence            5432    2345799999999999999999999999999999999999999965431        1111111111 1   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                             ...+...++++.+++.+||+.||++||     ++.++++
T Consensus       220 -------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 -------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                   012334456899999999999999999     8888763

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-47  Score=342.89  Aligned_cols=258  Identities=22%  Similarity=0.405  Sum_probs=202.1

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcE----EEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRI----IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ++|++.+.||+|+||.||+|.+. +++.    +++|.+......   .....+.+|+.++..++||||+++++++. ...
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC---SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            57899999999999999999875 3443    777776443222   12234567899999999999999999886 456


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++||||+++++|.+++....    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             cEEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCc
Confidence            799999999999999997532    25788899999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+.....         .......
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------~~~~~~~  232 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---------VPDLLEK  232 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---------HHHHHHT
T ss_pred             ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---------HHHHHHc
Confidence            9876544322 2334567889999999999999999999999999999999 999997543211         1111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..         ....+..++.++.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       233 ~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          233 GE---------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             TC---------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CC---------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11         1111222344688999999999999999999999999987643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.1e-46  Score=337.46  Aligned_cols=247  Identities=23%  Similarity=0.313  Sum_probs=204.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++.++ +++.||+|++...... .....+.+.+|+.++..++||||+++++++.+....|+|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            67999999999999999999986 6889999987643211 112356678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       120 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence            99999999999998653     4889999999999999999999999   999999999999999999999999999866


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...    ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+...        ...+ ..+.....   
T Consensus       192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~-~~i~~~~~---  255 (350)
T 1rdq_E          192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIY-EKIVSGKV---  255 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHHHCCC---
T ss_pred             cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHH-HHHHcCCC---
Confidence            432    2335789999999999999999999999999999999999999965431        1111 11111111   


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~~  349 (360)
                             ..+...++++.+++.+||+.||++||+     +.++++
T Consensus       256 -------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 -------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                   123345668999999999999999998     777753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-46  Score=336.62  Aligned_cols=252  Identities=26%  Similarity=0.339  Sum_probs=194.8

Q ss_pred             hcCCCccceecccCcEEEEEEEe----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .++|++.+.||+|+||.||++..    .+++.+|+|+++.............+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999987    46889999998764332222334567789999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++||||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence            999999999999999997643     4788999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      +....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...        ......... ..
T Consensus       168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~-~~  237 (327)
T 3a62_A          168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILK-CK  237 (327)
T ss_dssp             C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH-TC
T ss_pred             ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh-CC
Confidence            87543221 223345799999999999999999999999999999999999999965431        011111111 10


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                                ...+...++++.+++.+||+.||++||     ++.++++
T Consensus       238 ----------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ----------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                      112233456899999999999999999     6667654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-46  Score=331.33  Aligned_cols=262  Identities=26%  Similarity=0.378  Sum_probs=207.3

Q ss_pred             cCCCccceecccCcEEEEEEEecC-C---cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-G---RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ..|...+.||+|+||+||+|.+.+ +   ..+|+|.+......   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM---QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            346667899999999999998642 2   26999988754333   3456788999999999999999999999876655


Q ss_pred             -eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          147 -LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       147 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                       +++|||+.+++|.+++....    ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             cEEEEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCC
Confidence             99999999999999997532    25889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCc---eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          226 SKFIAMDQT---HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       226 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      +........   .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+......    .....    ...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~~----~~~  242 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTH----FLA  242 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHHH----HHH
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHHH----Hhh
Confidence            976543221   1223345789999999999999999999999999999999966665433211    11111    111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      ...         ....+...++++.+++.+||+.||++|||+.++++.|+.+.+.+.
T Consensus       243 ~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          243 QGR---------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             cCC---------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            111         111233345679999999999999999999999999999987663

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-47  Score=349.46  Aligned_cols=262  Identities=22%  Similarity=0.280  Sum_probs=205.8

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      +.....++|++.+.||+|+||.||++..+ +++.||+|++...... .....+.+.+|..++..++||||+++++++.+.
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            33445678999999999999999999986 6899999998642211 112234467899999999999999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      +..|+||||+++|+|.+++.....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++++||+||
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGE----RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            999999999999999999976432    5889999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhc-------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-------SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  296 (360)
                      |++..............+||+.|+|||++.       ...++.++|||||||++|||++|+.||.+...        ...
T Consensus       207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~  278 (412)
T 2vd5_A          207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AET  278 (412)
T ss_dssp             TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH
T ss_pred             hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HHH
Confidence            999876654444444568999999999987       35689999999999999999999999965431        011


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHH
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKR---PTMEEVSM  349 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt~~ei~~  349 (360)
                      +...........      ....+...++++.+|+.+||+ +|++|   |++.|+++
T Consensus       279 ~~~i~~~~~~~~------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          279 YGKIVHYKEHLS------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHHTHHHHCC------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHHhcccCcC------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            111110000000      000123456689999999999 99998   58888763

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=339.17  Aligned_cols=259  Identities=23%  Similarity=0.435  Sum_probs=200.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcE----EEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRI----IAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .++|++.+.||+|+||.||+|.+. +++.    +++|.+......   ...+.+.+|+.++..++||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC---CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            367999999999999999999875 3443    577766543322   23567789999999999999999999998765


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                       .+++++++.+++|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG  162 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             -ceEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCc
Confidence             789999999999999997643    25889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          225 TSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       225 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.....     ..    ....
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~----~~~~  233 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----IS----SILE  233 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HH----HHHH
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HH----HHHH
Confidence            99876443222 2233456888999999999999999999999999999999 999996543211     11    1111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..         .....+..+++++.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       234 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          234 KG---------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             cC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            11         11112333556799999999999999999999999999988753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=337.41  Aligned_cols=261  Identities=24%  Similarity=0.395  Sum_probs=204.6

Q ss_pred             hcCCCccceecccCcEEEEEEEecC-----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED-----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      ..+|...+.||+|+||.||+|....     +..||+|.+......   .....+.+|+.++..++||||+++++++...+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            3668888999999999999998653     235999998764433   33456889999999999999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..++||||+++++|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             CcEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCC
Confidence            9999999999999999997632    25899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCce--eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 040763          225 TSKFIAMDQTH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       225 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ++.........  ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....        .. ....+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~-~~~~~  263 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HE-VMKAI  263 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH-HHHHH
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HH-HHHHH
Confidence            99876543221  1222346788999999999999999999999999999999 9999965331        01 11111


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      ....         ....+..+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       264 ~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          264 NDGF---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             HTTC---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HCCC---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            1110         11112334567999999999999999999999999999887543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.3e-46  Score=328.98  Aligned_cols=264  Identities=21%  Similarity=0.310  Sum_probs=202.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++.......  .....+.+|+.++..++||||+++++++.+.+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST--THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC--CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            57899999999999999999986 58899999987544332  2345677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++ ++.+++....    ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++...
T Consensus        80 ~e~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EECCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EecCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999965 6666665422    25899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc---
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR---  305 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  305 (360)
                      .... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.......    ..............   
T Consensus       152 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~----~~~~~i~~~~~~~~~~~  226 (292)
T 3o0g_A          152 GIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH----HHHHHHHHHHCCCCTTT
T ss_pred             CCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHHhCCCChhh
Confidence            4332 2233456899999999988765 7999999999999999999988875433211    11111111111110   


Q ss_pred             cccccc------------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILD------------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +.....            ...........++++.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000000            00001112335668899999999999999999999975

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.2e-46  Score=331.72  Aligned_cols=261  Identities=28%  Similarity=0.431  Sum_probs=205.1

Q ss_pred             hcCCCccceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe-eCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL-ETE  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~  144 (360)
                      ..+|++.+.||+|+||+||+|.+.+    ...+|+|.+......   ...+.+.+|+.++++++||||+++++++. ...
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH---HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            3568899999999999999998643    235899987754333   34567889999999999999999999864 556


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..+++|||+++++|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             ceEEEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccc
Confidence            7899999999999999996532    35789999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCc---eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhC-CCCCCCCCCCcccccchHHHHHHH
Q 040763          225 TSKFIAMDQT---HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG-KKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       225 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      ++........   .......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||.......     ...    .
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----~~~----~  244 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITV----Y  244 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----HHH----H
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----HHH----H
Confidence            9986654322   122334578899999999999999999999999999999994 55554332111     111    0


Q ss_pred             hhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      .....         ....+..+++++.+++.+||+.||++|||+.++++.|+.+.+.+
T Consensus       245 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          245 LLQGR---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             HhcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11110         11112334557999999999999999999999999999998765

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-47  Score=344.04  Aligned_cols=261  Identities=28%  Similarity=0.448  Sum_probs=197.8

Q ss_pred             cCCCccceecccCcEEEEEEEecC--C--cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe-eCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED--G--RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL-ETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~  145 (360)
                      ..|.+.+.||+|+||.||+|...+  +  ..+|+|.++.....   ...+.+.+|+.+++.++||||+++++++. ..+.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS---HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            346778899999999999998642  2  36899987654333   34567889999999999999999999865 4567


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++||||+++++|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~  238 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL  238 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             eEEEEECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccc
Confidence            899999999999999997532    25788999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCce---eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 040763          226 SKFIAMDQTH---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       226 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      +.........   ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......     ....    .
T Consensus       239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~~----~  309 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVY----L  309 (373)
T ss_dssp             -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHHH----H
T ss_pred             cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHHH----H
Confidence            9765433211   1223457889999999999999999999999999999999 667775443211     1111    1


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      ....         ....+..+++++.+++.+||+.||++|||+.++++.|+.+...+.
T Consensus       310 ~~~~---------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          310 LQGR---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            1111         011123345679999999999999999999999999999987653

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-46  Score=334.20  Aligned_cols=269  Identities=25%  Similarity=0.394  Sum_probs=203.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      ...++|.+.+.||+|+||.||+|...    ++..||+|.+.......  ...+.+.+|+.++..++||||+++++++...
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ--REIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch--hHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            34577999999999999999999764    24479999987654332  3456788999999999999999999998765


Q ss_pred             C-----cceEEEEecCCCChhHHhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc
Q 040763          144 E-----FPLLVYEFIPNGTLYQHLHDRHQ-NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR  217 (360)
Q Consensus       144 ~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~  217 (360)
                      .     ..+++|||+++++|.+++..... .....+++..++.++.|++.||.|||+++   ++||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence            5     34999999999999999864322 23346899999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHH
Q 040763          218 AKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       218 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~  295 (360)
                      +||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......     ... 
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~-  259 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-----EMY-  259 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHH-
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHH-
Confidence            999999999766443222 1223457889999999999999999999999999999999 88898654321     111 


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                         .......         ....+..+++++.+++.+||+.||++|||+.++++.|+.+.+.+.
T Consensus       260 ---~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          260 ---DYLLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             ---HHHHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ---HHHHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence               1111111         111233455679999999999999999999999999999987764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.2e-47  Score=341.50  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=203.4

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCC
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETE  144 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~  144 (360)
                      ....++|.+.+.||+|+||.||++.++ +++.||+|.++...... ....+....|..++..+ +||||+++++++.+.+
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            345578999999999999999999986 58899999886532111 12344567888888877 9999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..|+||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence            9999999999999999997643     4889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++....... ......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+...        ...+ ..+...
T Consensus       164 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~-~~i~~~  233 (345)
T 1xjd_A          164 MCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELF-HSIRMD  233 (345)
T ss_dssp             TCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-HHHHHC
T ss_pred             hhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHH-HHHHhC
Confidence            997543222 223456799999999999999999999999999999999999999965431        0111 111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME-EVS  348 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ei~  348 (360)
                      .          ...+...++++.+|+.+||+.||++||++. +++
T Consensus       234 ~----------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 N----------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             C----------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             C----------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            1          112233456899999999999999999997 553

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-46  Score=332.75  Aligned_cols=261  Identities=25%  Similarity=0.367  Sum_probs=208.2

Q ss_pred             HhcCCCccc-eecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           69 ATNHFNVNR-ILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        69 ~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      ...+|.+.+ .||+|+||.||+|.+.   +++.+|+|.+......  ....+.+.+|+.++..++||||+++++++ ..+
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            346788888 9999999999999643   4678999998754322  23356788999999999999999999999 566


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..++||||+++++|.+++....     .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCC
Confidence            7899999999999999997632     4889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCceee--ecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 040763          225 TSKFIAMDQTHVT--TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       225 ~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ++...........  ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+...         .......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~  233 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAML  233 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHH
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHH
Confidence            9987655433222  22346788999999998889999999999999999999 9999965431         0011111


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      ....         ....+..+++++.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus       234 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          234 EKGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            1111         11123345668999999999999999999999999999987653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=339.90  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=197.2

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC--CCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH--RNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h--~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||++...+++.||+|++.......  ...+.+.+|+.++..++|  |||+++++++......+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch--HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            46799999999999999999999889999999987544332  345678899999999976  99999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||| +.+++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++ ++.+||+|||++.
T Consensus        86 lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             EEEC-CCSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             EEEe-CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccc
Confidence            9999 56889999997643     5889999999999999999999999   99999999999997 5789999999998


Q ss_pred             ccCCCCce-eeecccccCCccchhhhcc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          228 FIAMDQTH-VTTKIQGTFGYLDPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       228 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      ........ ......||+.|+|||++.+           ..++.++||||||+++|+|++|+.||.....       ...
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~  228 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QIS  228 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHH
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHH
Confidence            76543322 2334579999999999865           6788899999999999999999999964321       111


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .......         .......+...++++.+|+.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          229 KLHAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHHHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhc---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            1111111         11111122223457899999999999999999999974

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.9e-46  Score=327.74  Aligned_cols=265  Identities=19%  Similarity=0.276  Sum_probs=204.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEE-eeCCcc
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCC-LETEFP  146 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-~~~~~~  146 (360)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|........      +.+.+|+.++..++|++++..+..+ ...+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            4578999999999999999999974 6889999975543222      2456799999999887777666655 667778


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---cCCCcEEEeec
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADF  223 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Df  223 (360)
                      +++|||+ +++|.+++....    ..+++..+..++.|++.||.|||+++   ++||||||+||++   +.++.+||+||
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Df  152 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecC
Confidence            9999999 999999997532    25899999999999999999999999   9999999999999   78899999999


Q ss_pred             CCccccCCCCce------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 040763          224 GTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       224 g~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      |++.........      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........  ....
T Consensus       153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~  230 (296)
T 4hgt_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YERI  230 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH--HHHH
T ss_pred             ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh--hhhh
Confidence            999876543321      12345689999999999999999999999999999999999999976543222111  1111


Q ss_pred             HHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      ........         .......+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       231 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          231 SEKKMSTP---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHHSC---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hcccccch---------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            11100000         00011223568999999999999999999999999999988754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-46  Score=341.38  Aligned_cols=252  Identities=19%  Similarity=0.286  Sum_probs=204.5

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||+|.++ +++.+|+|.+.....    .....+.+|+.++..++||||+++++++.+....++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch----hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            467999999999999999999986 688999998765432    223467799999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC--CCcEEEeecCCc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE--RYRAKVADFGTS  226 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~  226 (360)
                      ||||+++++|.+++...    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.  ++.+||+|||++
T Consensus       126 v~E~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a  198 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA  198 (387)
T ss_dssp             EEECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred             EEEcCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccc
Confidence            99999999999998653    235899999999999999999999999   999999999999974  578999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...        ..... .+....+
T Consensus       199 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~-~i~~~~~  267 (387)
T 1kob_A          199 TKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQ-NVKRCDW  267 (387)
T ss_dssp             EECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH-HHHHCCC
T ss_pred             eecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHH-HHHhCCC
Confidence            87654332  2334689999999999999999999999999999999999999965431        01111 1111110


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .      .........++++.+|+.+||+.||++|||+.++++
T Consensus       268 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          268 E------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             C------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             C------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0      011112234568999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.8e-47  Score=362.11  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=213.0

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           66 LDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        66 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .+...++|++.+.||+|+||.||+|.++++..||+|.++....     ..+.+.+|+.+++.++||||+++++++.. ..
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            3344567889999999999999999998888899999876432     23568899999999999999999999876 67


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++||||+++|+|.+++.....   ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~  409 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL  409 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred             ceEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccc
Confidence            8999999999999999975321   24889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      +...............++..|+|||++.+..++.++||||||+++|||++ |..||.+...        .. ....+...
T Consensus       410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~-~~~~i~~~  480 (535)
T 2h8h_A          410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------RE-VLDQVERG  480 (535)
T ss_dssp             TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HH-HHHHHHTT
T ss_pred             ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcC
Confidence            98664322222233456788999999999999999999999999999999 9999865421        01 11111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                               .....+..+++++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       481 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          481 ---------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                     11122344566899999999999999999999999999987654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=362.01  Aligned_cols=258  Identities=24%  Similarity=0.349  Sum_probs=204.4

Q ss_pred             CCccc-eecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           73 FNVNR-ILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        73 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      +.+.+ .||+|+||.||+|.++   ++..||+|.++.....   ...+.+.+|+.++..++||||+++++++.. +..++
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS---TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            33344 7999999999999864   4567999998765332   245678899999999999999999999876 56899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++...    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       413 v~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEECCTTCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             EEEeCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            99999999999999653    235899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          229 IAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       229 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ........  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+....     .    ....+..+.
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~----~~~~i~~~~  556 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----E----VMAFIEQGK  556 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-----H----HHHHHHTTC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----H----HHHHHHcCC
Confidence            65432221  122345689999999999999999999999999999998 99999754321     0    111111111


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                               ....+..+++++.+|+.+||+.||++|||+.++++.|+.+..++.
T Consensus       557 ---------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          557 ---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence                     112344566789999999999999999999999999999876653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=332.03  Aligned_cols=254  Identities=30%  Similarity=0.474  Sum_probs=199.2

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ++|++.+.||+|+||.||++... ++.+|+|.+...      ...+.+.+|+.++..++||||+++++++.  +..++||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence            57889999999999999999885 688999998642      23456789999999999999999999887  4579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeEecCCCCCCeEEcCCCc-EEEeecCCc
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS---GASSPIYHRDIKSTNILLDERYR-AKVADFGTS  226 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~  226 (360)
                      ||+++++|.+++.....  ...++...++.++.|++.||.|||+   ++   ++||||||+||+++.++. +||+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             ECCTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             EcCCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccc
Confidence            99999999999976432  2247888999999999999999999   66   999999999999998886 799999998


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||........      .... .......
T Consensus       154 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~~~~~~  222 (307)
T 2eva_A          154 CDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------RIMW-AVHNGTR  222 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH------HHHH-HHHTTCC
T ss_pred             cccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH------HHHH-HHhcCCC
Confidence            754322    2234589999999999999999999999999999999999999965432110      0001 1111111


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                               ...+...++.+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       223 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          223 ---------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             ---------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             ---------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence                     1122334557999999999999999999999999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=333.01  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=195.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH----------------------HHhHHHHHHHHHHHh
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE----------------------LYKLEEFINEIFILS  126 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~----------------------~~~~~~~~~e~~~~~  126 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++........                      ....+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            368999999999999999999875 688999998765432110                      112356789999999


Q ss_pred             hcCCCCceeeeeEEee--CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 040763          127 QINHRNVVKLLGCCLE--TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD  204 (360)
Q Consensus       127 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~d  204 (360)
                      .++||||+++++++.+  ....++||||+++++|.+++..      .++++..+..++.|++.||.|||+++   ++|||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence            9999999999999986  5678999999999999876532      25899999999999999999999999   99999


Q ss_pred             CCCCCeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCC---CCCccchhhhHHHHHHHHhCCCCCC
Q 040763          205 IKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIF  281 (360)
Q Consensus       205 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~p~~  281 (360)
                      |||+||+++.++.+||+|||++........ ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999999987654322 233457999999999988765   3678999999999999999999996


Q ss_pred             CCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          282 STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +...        .. ...........        .......++++.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~--------~~-~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          242 DERI--------MC-LHSKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CSSH--------HH-HHHHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CccH--------HH-HHHHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            5321        01 11111111100        0011234557999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-46  Score=335.35  Aligned_cols=273  Identities=25%  Similarity=0.363  Sum_probs=216.0

Q ss_pred             ChHHHHHHhcCCCccceecccCcEEEEEEEe------cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCce
Q 040763           62 SSKELDKATNHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVV  134 (360)
Q Consensus        62 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv  134 (360)
                      .........++|++.+.||+|+||.||+|.+      .+++.||+|.+......   ...+.+.+|+.++..+ +||||+
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv   94 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVV   94 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc---HHHHHHHHHHHHHHhcccCCCee
Confidence            3344455568899999999999999999974      24678999998765433   3345678999999999 799999


Q ss_pred             eeeeEEeeCC-cceEEEEecCCCChhHHhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 040763          135 KLLGCCLETE-FPLLVYEFIPNGTLYQHLHDRHQNE-----------EYPLTWEMRFRVAIEVAGALAYLHSGASSPIYH  202 (360)
Q Consensus       135 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H  202 (360)
                      ++++++...+ ..+++|||+++++|.+++.......           ...+++..++.++.|++.||.|||+++   ++|
T Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H  171 (316)
T 2xir_A           95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH  171 (316)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence            9999987654 5899999999999999997643210           123789999999999999999999999   999


Q ss_pred             cCCCCCCeEEcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCC
Q 040763          203 RDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPI  280 (360)
Q Consensus       203 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~  280 (360)
                      |||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987654332 22334567899999999999999999999999999999998 99998


Q ss_pred             CCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          281 FSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .+.....        ...........         ...+...++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       252 ~~~~~~~--------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          252 PGVKIDE--------EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             TTCCCSH--------HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccchhH--------HHHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            6543211        01111111111         112233456799999999999999999999999999988754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-45  Score=325.65  Aligned_cols=264  Identities=19%  Similarity=0.279  Sum_probs=207.5

Q ss_pred             hcCCCccceecccCcEEEEEEEe-cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEE-eeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCC-LETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|.+......      +.+.+|+.++..++|++++..+..+ ......+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch------hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            47899999999999999999997 47899999987654322      2466899999999988776666555 5667789


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---cCCCcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg  224 (360)
                      ++|||+ +++|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||++   +.++.+||+|||
T Consensus        82 lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             EEEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            999999 999999997532    25899999999999999999999999   9999999999999   488899999999


Q ss_pred             CccccCCCCce------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          225 TSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       225 ~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      ++.........      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..........  ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~  231 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ--KYERIS  231 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS--HHHHHH
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh--hhhhhc
Confidence            99876543321      1234569999999999999999999999999999999999999997644222111  111111


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      .......         .......+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       232 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          232 EKKMSTP---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHSC---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccccCCc---------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            1100000         00112234567999999999999999999999999999987654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=339.20  Aligned_cols=270  Identities=24%  Similarity=0.398  Sum_probs=199.5

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHH--HHHHHhhcCCCCceeeeeEEee-----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFIN--EIFILSQINHRNVVKLLGCCLE-----  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~--e~~~~~~l~h~niv~~~~~~~~-----  142 (360)
                      .++|++.+.||+|+||.||+|.. +++.||+|++.....       ..+..  ++..+..++||||+++++.+..     
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch-------hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            47899999999999999999977 578999999864321       22223  3444455899999999986542     


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCCeEEc
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG---------ASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---------~~~~i~H~dlk~~Nill~  213 (360)
                      ....++||||+++|+|.+++...      ..++..+..++.|++.||.|||+.         +   |+||||||+|||++
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~  154 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVK  154 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEEC
T ss_pred             CceEEEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEc
Confidence            23568999999999999999653      357888999999999999999998         7   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCc-------eeeecccccCCccchhhhcc-------CCCCCccchhhhHHHHHHHHhCCCC
Q 040763          214 ERYRAKVADFGTSKFIAMDQT-------HVTTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLTGKKP  279 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~p  279 (360)
                      .++.+||+|||++........       .......||+.|+|||++.+       ..++.++|||||||++|||++|..|
T Consensus       155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            999999999999987654221       11223469999999999887       3566789999999999999999888


Q ss_pred             CCCCCCCcccccchHH---------HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          280 IFSTGNTSQENVSLAA---------YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       280 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                      |...............         ..............+..  ........++++.+|+.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            7654432221111110         00111111110000000  011123467789999999999999999999999999


Q ss_pred             HHHhHhhc
Q 040763          351 LNGIRGSI  358 (360)
Q Consensus       351 L~~l~~~~  358 (360)
                      |+.+....
T Consensus       313 L~~ll~~~  320 (336)
T 3g2f_A          313 MAELMMIW  320 (336)
T ss_dssp             HHHHHHCC
T ss_pred             HHHHHHHH
Confidence            99988654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-46  Score=336.08  Aligned_cols=263  Identities=27%  Similarity=0.422  Sum_probs=207.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcE--EEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRI--IAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      ++|++.+.||+|+||.||++.+. ++..  +++|.+......   ...+.+.+|+.++..+ +||||+++++++...+..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch---HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            67999999999999999999876 4554  488887643222   2345678899999999 899999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQ-----------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~  215 (360)
                      ++||||+++++|.+++.....           .....+++..++.++.|++.||.|||+++   ++||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCC
Confidence            999999999999999976431           12346899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchH
Q 040763          216 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~  294 (360)
                      +.+||+|||++......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+...        .
T Consensus       179 ~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~  248 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------A  248 (327)
T ss_dssp             GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------H
T ss_pred             CeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------H
Confidence            99999999998743221  11223356889999999998889999999999999999998 9999965431        0


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      . ....+...         .....+...++++.+++.+||+.||++|||+.++++.|+.+....+
T Consensus       249 ~-~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          249 E-LYEKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             H-HHHHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             H-HHHHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            1 11111111         1111233445679999999999999999999999999999876543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-46  Score=341.91  Aligned_cols=276  Identities=24%  Similarity=0.349  Sum_probs=214.2

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC--cc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE--FP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~  146 (360)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++......   ...+.+.+|+.+++.++||||+++++++....  ..
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            467999999999999999999987 4889999998753322   23456778999999999999999999988755  67


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----cCCCcEEEee
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL----DERYRAKVAD  222 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~D  222 (360)
                      ++||||+++++|.+++.....  ...+++..++.++.|++.||.|||+++   |+||||||+||++    +.++.+||+|
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             EEEEecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEec
Confidence            999999999999999976432  224899999999999999999999999   9999999999999    7888899999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhcc--------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~  294 (360)
                      ||++.......  ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||........... ..
T Consensus       160 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~-~~  236 (396)
T 4eut_A          160 FGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE-VM  236 (396)
T ss_dssp             GGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH-HH
T ss_pred             CCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH-HH
Confidence            99998764432  2233568999999998875        5677899999999999999999999975432221111 11


Q ss_pred             HHHHHHhhcccccccc-----------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          295 AYFVHSMRKNRLYHIL-----------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      .......+...+....           ............++.+.+++.+||+.||++|||+.++++.++.+.+
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            1111111111110000           0011223457788899999999999999999999999999988764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.7e-46  Score=338.08  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=193.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||+||++.+. +++.||+|++......     .+.+.+|+.+++.++||||+++++++.+....++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            478999999999999999999987 6889999998654322     2356689999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc--EEEeecCCc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR--AKVADFGTS  226 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~  226 (360)
                      ||||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.  +||+|||++
T Consensus        94 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           94 IMEYASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS  165 (361)
T ss_dssp             EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred             EEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence            999999999999997643     4899999999999999999999999   999999999999987765  999999998


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDK-SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ......  .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......    .............
T Consensus       166 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~~  239 (361)
T 3uc3_A          166 KSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSVKY  239 (361)
T ss_dssp             -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTTCC
T ss_pred             cccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcCCC
Confidence            743322  22234469999999999988887665 8999999999999999999975432111    1111111111100


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                               ........++++.+|+.+||+.||++|||+.|+++
T Consensus       240 ---------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          240 ---------SIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ---------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ---------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                     00011123567999999999999999999999975

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.6e-45  Score=331.20  Aligned_cols=275  Identities=21%  Similarity=0.318  Sum_probs=212.6

Q ss_pred             ccChHHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhh--cCCCCceeee
Q 040763           60 LFSSKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ--INHRNVVKLL  137 (360)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~--l~h~niv~~~  137 (360)
                      ..+........++|.+.+.||+|+||.||++.+. ++.||+|.+...       ....+.+|.+++..  ++||||++++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~  102 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFI  102 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence            3444455566788999999999999999999984 889999997642       23455678888877  7899999999


Q ss_pred             eEEeeCC----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCC
Q 040763          138 GCCLETE----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH--------SGASSPIYHRDI  205 (360)
Q Consensus       138 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--------~~~~~~i~H~dl  205 (360)
                      +++....    ..++||||+++++|.+++...      .+++..++.++.|++.||.|||        +.+   ++||||
T Consensus       103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dl  173 (342)
T 1b6c_B          103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDL  173 (342)
T ss_dssp             EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCC
T ss_pred             eeecccCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCC
Confidence            9998776    789999999999999999653      4889999999999999999999        778   999999


Q ss_pred             CCCCeEEcCCCcEEEeecCCccccCCCCce---eeecccccCCccchhhhccCC------CCCccchhhhHHHHHHHHhC
Q 040763          206 KSTNILLDERYRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSSQ------LTDKSDVYSFGVVLVELLTG  276 (360)
Q Consensus       206 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg  276 (360)
                      ||+||+++.++.+||+|||++.........   ......||+.|+|||++.+..      ++.++||||||+++|||++|
T Consensus       174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999999999999999999776544322   123456899999999988752      33689999999999999999


Q ss_pred             ----------CCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 040763          277 ----------KKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE  346 (360)
Q Consensus       277 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e  346 (360)
                                ..||.........   . ...................   ......++.+.+|+.+||+.||++|||+.+
T Consensus       254 ~~~~~~~~~~~~p~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          254 CSIGGIHEDYQLPYYDLVPSDPS---V-EEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCC---H-HHHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cCcCCcccccccCccccCcCccc---H-HHHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence                      6777554321111   1 1111111111111111110   112356778999999999999999999999


Q ss_pred             HHHHHHHhHhhc
Q 040763          347 VSMELNGIRGSI  358 (360)
Q Consensus       347 i~~~L~~l~~~~  358 (360)
                      +++.|+.+.+..
T Consensus       327 i~~~L~~i~~~~  338 (342)
T 1b6c_B          327 IKKTLSQLSQQE  338 (342)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHh
Confidence            999999987653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.8e-46  Score=333.17  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=198.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc--
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP--  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~--  146 (360)
                      .++|++.+.||+|+||.||++.+. +++.||+|++....... ......+.+|+.++..++||||+++++++......  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS-HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC-HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            478999999999999999999974 68899999987643322 23456788999999999999999999998876554  


Q ss_pred             --eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          147 --LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       147 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                        ++||||+++++|.+++....     ++++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             ccEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeecc
Confidence              99999999999999997643     5889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCc--eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          225 TSKFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       225 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ++........  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...        .........
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~  233 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVR  233 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhc
Confidence            9976644322  222345689999999999999999999999999999999999999965431        011111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHH-HHHHHHHh
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE-VSMELNGI  354 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e-i~~~L~~l  354 (360)
                      .....       ........++++.+++.+||+.||++||++.+ +...|..+
T Consensus       234 ~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          234 EDPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCCCC-------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCCC-------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            11100       01112234567999999999999999996555 44555443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-45  Score=326.55  Aligned_cols=264  Identities=22%  Similarity=0.272  Sum_probs=202.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||++.+. +++.||+|.+....... ....+.+.+|+.++..++||||+++++++...+..+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC-HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            3478999999999999999999976 68899999987543322 234567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++|||+++++|.+++....     ++++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.
T Consensus       111 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             EEEEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            9999999999999997643     5889999999999999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..............||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....         .......... ..
T Consensus       183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~-~~  252 (309)
T 2h34_A          183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQA-IP  252 (309)
T ss_dssp             --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSC-CC
T ss_pred             cccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccC-CC
Confidence            7654433334445689999999999999999999999999999999999999964321         0111111111 00


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHhHhh
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-TMEEVSMELNGIRGS  357 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ei~~~L~~l~~~  357 (360)
                            .....+...++++.+++.+||+.||++|| |++++++.|+.+...
T Consensus       253 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          253 ------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             ------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             ------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence                  01112334556799999999999999999 999999999877544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.1e-46  Score=337.45  Aligned_cols=248  Identities=30%  Similarity=0.430  Sum_probs=200.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..|+..+.||+|+||+||+|... +++.||+|++....... ....+.+.+|+.++..++||||+++++++...+..++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            45889999999999999999974 78899999986543322 23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+. |+|.+++....    .++++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++...
T Consensus       133 ~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             EECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence            99996 68888886532    25899999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ...     ....||+.|+|||++.   ++.++.++||||||+++|||++|+.||.....        ......... ...
T Consensus       205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~~-~~~  270 (348)
T 1u5q_A          205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ-NES  270 (348)
T ss_dssp             SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH-SCC
T ss_pred             CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHh-cCC
Confidence            432     2346899999999885   56789999999999999999999999965431        011111111 111


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .        ...+..+++.+.+++.+||+.||++|||+.++++
T Consensus       271 ~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          271 P--------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            0        1112234567999999999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.2e-46  Score=342.55  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=197.5

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC--CCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN--HRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~~~~~  147 (360)
                      ..+|++.+.||+|+||.||++...+++.||+|++.......  ...+.+.+|+.++..++  ||||+++++++...+..+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH--HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            35699999999999999999998889999999986543322  34567889999999996  599999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||| +.+++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++ ++.+||+|||++.
T Consensus       133 lv~E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             EEEe-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            9999 56899999997643     5788899999999999999999999   99999999999996 5799999999998


Q ss_pred             ccCCCCce-eeecccccCCccchhhhcc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          228 FIAMDQTH-VTTKIQGTFGYLDPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       228 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      ........ .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....       ...
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~  275 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QIS  275 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHH
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHH
Confidence            76543322 2344579999999999875           3688899999999999999999999965321       011


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .........         .....+...++++.+|+.+||+.||++|||+.++++
T Consensus       276 ~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          276 KLHAIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCcc---------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            111111111         111112222457899999999999999999999974

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.7e-47  Score=339.53  Aligned_cols=267  Identities=24%  Similarity=0.355  Sum_probs=209.8

Q ss_pred             cCCCccceecccCcEEEEEEEe-----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe--eC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL--ET  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~--~~  143 (360)
                      ++|++.+.||+|+||.||++.+     .+++.||+|.+.....    ...+.+.+|+.+++.++||||+++++++.  ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP----DQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH----HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH----HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            6799999999999999999984     3578999999875422    23456889999999999999999999886  45


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...++||||+++++|.+++.....    .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCG
T ss_pred             ceEEEEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccc
Confidence            568899999999999999976432    4899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc------ccchHH
Q 040763          224 GTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE------NVSLAA  295 (360)
Q Consensus       224 g~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~------~~~~~~  295 (360)
                      |++..........  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.........      ......
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS  251 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence            9998765433222  23345788899999999998999999999999999999999998543210000      000000


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ......         ........+..+++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       252 ~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          252 RLLELL---------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHHHh---------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            011111         11111223445667899999999999999999999999999998764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-45  Score=324.18  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=205.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.+. +++.+|+|++.......  ...+.+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH--HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            478999999999999999999876 58899999976544332  345667899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc---EEEeecCC
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADFGT  225 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~  225 (360)
                      +|||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.   +||+|||+
T Consensus        83 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            999999999999987653     4889999999999999999999999   999999999999986655   99999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      +.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+...     .   . .........
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~---~-~~~~~~~~~  223 (284)
T 3kk8_A          155 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----H---R-LYAQIKAGA  223 (284)
T ss_dssp             CEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---H-HHHHHHHTC
T ss_pred             eEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----h---H-HHHHHHhcc
Confidence            97665432  22345689999999999999999999999999999999999999965331     0   0 111111111


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .. .     ........++++.+++.+||+.||++|||+.++++
T Consensus       224 ~~-~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          224 YD-Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CC-C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc-C-----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            10 0     00111234567999999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.7e-46  Score=336.98  Aligned_cols=247  Identities=25%  Similarity=0.295  Sum_probs=200.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      ..++|++.+.||+|+||.||++..+ +++.||+|+++..... .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            3478999999999999999999987 4788999987653211 112345677899999887 899999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      |+||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            99999999999999997643     4889999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ....... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...        ...+..... .. 
T Consensus       169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~-~~-  237 (353)
T 2i0e_A          169 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIME-HN-  237 (353)
T ss_dssp             BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CC-
T ss_pred             cccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-CC-
Confidence            7543222 223446799999999999999999999999999999999999999965331        111111111 11 


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                               ...+...++++.+|+.+||+.||++||++
T Consensus       238 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          238 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                     11233456689999999999999999964

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3e-46  Score=361.72  Aligned_cols=255  Identities=26%  Similarity=0.372  Sum_probs=204.2

Q ss_pred             ceecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           77 RILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      +.||+|+||.||+|.+.   .++.||+|+++......  ...+++.+|+.++..++||||+++++++.. +..++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP--ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG--GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence            47999999999999653   45789999987643322  345678899999999999999999999864 5578999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      ++|+|.+++....     .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus       452 ~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          452 ELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             TTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             CCCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            9999999997532     5889999999999999999999999   9999999999999999999999999998765433


Q ss_pred             ce--eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          234 TH--VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       234 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+....         .....+....     
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---------~~~~~i~~~~-----  589 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTAMLEKGE-----  589 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---------HHHHHHHTTC-----
T ss_pred             cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHHcCC-----
Confidence            21  2223346788999999999999999999999999999998 99999654310         0111111111     


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhccC
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIKN  360 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~~  360 (360)
                          ....+..+++++.+|+.+||+.||++|||+.++++.|+.+..++-|
T Consensus       590 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~n  635 (635)
T 4fl3_A          590 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  635 (635)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHCC
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhcC
Confidence                1122344567899999999999999999999999999999988765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-46  Score=331.75  Aligned_cols=252  Identities=23%  Similarity=0.364  Sum_probs=201.6

Q ss_pred             hcCCCccceecccCcEEEEEEEecC-C-------cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED-G-------RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL  141 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~  141 (360)
                      .++|.+.+.||+|+||+||+|.+.. +       ..+|+|.+.....    ...+.+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR----NYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG----GGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            3678999999999999999998753 3       4699998765322    23467889999999999999999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc----
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR----  217 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~----  217 (360)
                      ..+..++||||+++++|.+++.....    .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.    
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~  155 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG  155 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGT
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccc
Confidence            99999999999999999999976432    4889999999999999999999999   999999999999998887    


Q ss_pred             ----EEEeecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 040763          218 ----AKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS  292 (360)
Q Consensus       218 ----~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~  292 (360)
                          +||+|||++......     ....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+......      
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------  224 (289)
T 4fvq_A          156 NPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------  224 (289)
T ss_dssp             BCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------
T ss_pred             ccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------
Confidence                999999998654321     23457899999999987 67899999999999999999965554332210      


Q ss_pred             hHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          293 LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                       .. ........           ...+...++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       225 -~~-~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          225 -QR-KLQFYEDR-----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             -HH-HHHHHHTT-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             -HH-HHHHhhcc-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             00 01111110           01112224468899999999999999999999999998764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-45  Score=339.57  Aligned_cols=264  Identities=25%  Similarity=0.354  Sum_probs=191.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCC--
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETE--  144 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~--  144 (360)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.......  .....+.+|+.++..+. ||||+++++++...+  
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS--TDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH--HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh--HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            4578999999999999999999875 68899999876543332  34456778999999996 999999999997544  


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..|+||||++ ++|.+++...      .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG  154 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFG  154 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCc
Confidence            6799999996 6899988652      4888999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCC--------------------CceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCC
Q 040763          225 TSKFIAMD--------------------QTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFST  283 (360)
Q Consensus       225 ~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~  283 (360)
                      ++......                    ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99765321                    1112334579999999999887 67899999999999999999999999764


Q ss_pred             CCCcccccchHHHHHHHhhcccc-----------------------------ccccc---hH-HhhhccHHHHHHHHHHH
Q 040763          284 GNTSQENVSLAAYFVHSMRKNRL-----------------------------YHILD---DQ-VMKLGKKNQIVAFANLA  330 (360)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~---~~-~~~~~~~~~~~~l~~li  330 (360)
                      ....     ....+.........                             .....   .. .........++++.+|+
T Consensus       235 ~~~~-----~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  309 (388)
T 3oz6_A          235 STMN-----QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL  309 (388)
T ss_dssp             SHHH-----HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred             CHHH-----HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence            3211     11111111110000                             00000   00 00000113456899999


Q ss_pred             HHhhcCCCCCCCCHHHHHH
Q 040763          331 ERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       331 ~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .+||+.||++|||+.|+++
T Consensus       310 ~~~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          310 DKLLQFNPNKRISANDALK  328 (388)
T ss_dssp             HHHCCSSGGGSCCHHHHTT
T ss_pred             HHhhccCcccCCCHHHHhC
Confidence            9999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-45  Score=327.04  Aligned_cols=268  Identities=22%  Similarity=0.363  Sum_probs=203.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ...+|++.+.||+|+||.||++... +++.+|+|.+....... ....+.+.+|+.++..++||||+++++++...+..+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            4467999999999999999999875 68899999887532221 234567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++|||+++++|.+++..... ....+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.
T Consensus       109 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             EEEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            99999999999999976432 2236889999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+....      ... ...........
T Consensus       185 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~  256 (310)
T 2wqm_A          185 FFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYS-LCKKIEQCDYP  256 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHH-HHHHHHTTCSC
T ss_pred             eecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHH-HHHHhhcccCC
Confidence            654322 1223346899999999999999999999999999999999999999654311      111 11111111111


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .        ......++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       257 ~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          257 P--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             C--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            1        11123456799999999999999999999999999998764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-45  Score=344.70  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=205.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++...... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            367999999999999999999986 7899999997653211 11234567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        94 v~E~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEECCSSEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhh
Confidence            999999999999996532     5899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .....  .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+...        .... ..+..... 
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~-~~i~~~~~-  233 (476)
T 2y94_A          166 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLF-KKICDGIF-  233 (476)
T ss_dssp             CCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHH-HHHHTTCC-
T ss_pred             ccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHH-HHHhcCCc-
Confidence            65432  2334579999999999988765 6799999999999999999999965431        0111 11111110 


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                               ..+...++++.+|+.+||+.||++|||+.++++
T Consensus       234 ---------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 ---------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                     112234557999999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.1e-46  Score=327.50  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=200.6

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC-CcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-EFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~l  148 (360)
                      .++|++.+.||+|+||.||++... ++.+|+|.+....      ..+.+.+|+.++..++||||+++++++... +..++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            467999999999999999999875 7899999987532      245677899999999999999999997554 47899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|||+++++|.+++.....   ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        93 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             EEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccc
Confidence            9999999999999976431   13788899999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .....    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......     ..    .......   
T Consensus       167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~----~~~~~~~---  230 (278)
T 1byg_A          167 ASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DV----VPRVEKG---  230 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GH----HHHHTTT---
T ss_pred             ccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HH----HHHHhcC---
Confidence            43321    22357889999999999999999999999999999998 99998654310     00    1111111   


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                            .....+...++++.+++.+||+.||++|||+.++++.|+.++..
T Consensus       231 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 ------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                  11122334566899999999999999999999999999998753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.4e-45  Score=342.54  Aligned_cols=260  Identities=20%  Similarity=0.268  Sum_probs=195.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      .++|++.+.||+|+||.||++.+. +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++....    
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh--HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            478999999999999999999876 58899999987543222  34567889999999999999999999997654    


Q ss_pred             --cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          145 --FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       145 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                        ..|+||||+++ +|.+.+..       .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEE
Confidence              45999999965 56666643       3889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ||++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....     ....+.....
T Consensus       208 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-----~~~~i~~~lg  280 (464)
T 3ttj_A          208 FGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-----QWNKVIEQLG  280 (464)
T ss_dssp             CCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHC
T ss_pred             EEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcC
Confidence            9999765432  22344679999999999999999999999999999999999999997543111     1111111110


Q ss_pred             cc-------------------c-ccc-----ccchHH---hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KN-------------------R-LYH-----ILDDQV---MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~-------------------~-~~~-----~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..                   . ...     ......   ........++++.+|+.+||+.||++|||+.|+++
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00                   0 000     000000   00111233678999999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=329.31  Aligned_cols=266  Identities=24%  Similarity=0.330  Sum_probs=199.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||++.+. +++.+|+|++.......  ...+.+.+|+.++..++||||+++++++...+..++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP--VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            67999999999999999999986 58899999876644332  3355678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        81 ~e~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             EECCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            99999999988876432     5889999999999999999999999   999999999999999999999999999776


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH--------HHHH
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY--------FVHS  300 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~  300 (360)
                      ..... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+......  ......        ....
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          153 TGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             C-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHH
T ss_pred             cCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhcccccccccc
Confidence            53322 2234468999999999876 6679999999999999999999999965432110  000000        0000


Q ss_pred             hhcccccc---ccch---HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          301 MRKNRLYH---ILDD---QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       301 ~~~~~~~~---~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ........   ..+.   ..........++++.+|+.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000000   0000   0000011235667999999999999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-45  Score=331.04  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=178.4

Q ss_pred             cceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcceEEEEec
Q 040763           76 NRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      .+.||+|+||.||++.++ +++.||+|.+...       ....+.+|+.++..+. ||||+++++++.+....++||||+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~   88 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL   88 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence            378999999999999986 6889999997642       2345568999999996 999999999999999999999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC---cEEEeecCCccccC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY---RAKVADFGTSKFIA  230 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~~~  230 (360)
                      ++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+||+++.++   .+||+|||++....
T Consensus        89 ~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           89 NGGELFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             CSCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            9999999997643     5899999999999999999999999   99999999999997665   89999999998654


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..... ....+...... . 
T Consensus       161 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-~~~~i~~~~~~-~-  235 (325)
T 3kn6_A          161 PDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVE-IMKKIKKGDFS-F-  235 (325)
T ss_dssp             C-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHH-HHHHHTTTCCC-C-
T ss_pred             CCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHH-HHHHHHcCCCC-C-
Confidence            332 2233456899999999999999999999999999999999999999764421111 11111 11111111110 0 


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                          ........++++.+|+.+||+.||++|||+.+++
T Consensus       236 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          236 ----EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             ----CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             ----CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence                0111123466899999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=337.07  Aligned_cols=268  Identities=19%  Similarity=0.242  Sum_probs=200.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHH-------hHHHHHHHHHHHhhcCCCCceeeee
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELY-------KLEEFINEIFILSQINHRNVVKLLG  138 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~-------~~~~~~~e~~~~~~l~h~niv~~~~  138 (360)
                      .++|.+.+.||+|+||.||+|.+.    ++..+|+|...........+       ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999986    46789999876543221100       1123567888999999999999999


Q ss_pred             EEee----CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC
Q 040763          139 CCLE----TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE  214 (360)
Q Consensus       139 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~  214 (360)
                      ++..    ....++||||+ +++|.+++....     .+++..++.++.|++.||.|||+++   |+||||||+||+++.
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEES
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEcc
Confidence            9987    67889999999 999999997643     5899999999999999999999999   999999999999998


Q ss_pred             CC--cEEEeecCCccccCCCCce------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 040763          215 RY--RAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT  286 (360)
Q Consensus       215 ~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~  286 (360)
                      ++  .+||+|||++.........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            77  9999999999776432211      113346899999999999999999999999999999999999999543211


Q ss_pred             cccccchHHHHHHHhhccccccccchHHhhh-ccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKL-GKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      ...    ...........     ........ .....++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       267 ~~~----~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          267 PVA----VQTAKTNLLDE-----LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHH----HHHHHHHHHHT-----TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cHH----HHHHHHhhccc-----ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111    00011111000     00111000 01145568999999999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=331.32  Aligned_cols=270  Identities=25%  Similarity=0.403  Sum_probs=211.5

Q ss_pred             hcCCCccceecccCcEEEEEEEe-----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~  144 (360)
                      .++|++.+.||+|+||.||++..     .+++.||+|.+.....    ...+.+.+|+.+++.++||||+++++++...+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS----HHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            46789999999999999999983     3688999999876432    34567889999999999999999999987644


Q ss_pred             --cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          145 --FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       145 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                        ..++||||+++++|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence              7899999999999999997642    25889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCc-------ccccch
Q 040763          223 FGTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS-------QENVSL  293 (360)
Q Consensus       223 fg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~-------~~~~~~  293 (360)
                      ||++..........  .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......       ......
T Consensus       189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  268 (326)
T ss_dssp             CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred             CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence            99998765543222  222346778999999999889999999999999999999999875321000       000000


Q ss_pred             HHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      ..........         ......+..+++++.+++.+||+.||++|||+.++++.|+.+.+.+.
T Consensus       269 ~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          269 VFHLIELLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhc---------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            0000111111         11112234456789999999999999999999999999999988764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=327.89  Aligned_cols=267  Identities=23%  Similarity=0.280  Sum_probs=197.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHH-HhHHHHHHHHHHHhhc---CCCCceeeeeEEeeC
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEEL-YKLEEFINEIFILSQI---NHRNVVKLLGCCLET  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~-~~~~~~~~e~~~~~~l---~h~niv~~~~~~~~~  143 (360)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|.+......... .....+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4578999999999999999999975 6889999987643321100 0112344566666655   599999999999875


Q ss_pred             C-----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcE
Q 040763          144 E-----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA  218 (360)
Q Consensus       144 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~  218 (360)
                      .     ..+++||++. ++|.+++....   ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence            5     4789999996 69999997643   224899999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          219 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      ||+|||++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....     .......
T Consensus       160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~  232 (308)
T 3g33_A          160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQLGKIF  232 (308)
T ss_dssp             EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-----HHHHHHH
T ss_pred             EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH
Confidence            99999999765432  2234457899999999999999999999999999999999999999654321     1111111


Q ss_pred             HHhhccc---ccccc---ch-------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          299 HSMRKNR---LYHIL---DD-------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       299 ~~~~~~~---~~~~~---~~-------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .......   +....   ..       ..........++++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111110   00000   00       0001112234568999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.5e-46  Score=326.32  Aligned_cols=252  Identities=27%  Similarity=0.416  Sum_probs=205.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee-----
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE-----  142 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----  142 (360)
                      ...+|++.+.||+|+||.||++.+. +++.+|+|.+....        +.+.+|+.++..++||||+++++++..     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            3467999999999999999999986 78999999886532        134579999999999999999998854     


Q ss_pred             -----------CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 040763          143 -----------TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNIL  211 (360)
Q Consensus       143 -----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nil  211 (360)
                                 ....+++|||+++++|.+++....   ...+++..++.++.|++.||.|||+++   ++|+||||+||+
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil  154 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIF  154 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEE
Confidence                       345789999999999999997642   225889999999999999999999999   999999999999


Q ss_pred             EcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccc
Q 040763          212 LDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV  291 (360)
Q Consensus       212 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~  291 (360)
                      ++.++.+||+|||++.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|..|+....       
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------  225 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------  225 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------
T ss_pred             EcCCCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------
Confidence            9999999999999998765432  2233468999999999999999999999999999999999998863210       


Q ss_pred             chHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                          ..........            .+...++++.+++.+||+.||++|||+.++++.|..+.++.+
T Consensus       226 ----~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          226 ----KFFTDLRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             ----HHHHHHHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ----HHHHHhhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence                0111111111            122344578899999999999999999999999999887653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-45  Score=324.17  Aligned_cols=249  Identities=29%  Similarity=0.397  Sum_probs=201.0

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+...... .......+.+|+.++..++||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            467999999999999999999876 5678999987643211 11234567889999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|||+++++|.+++....     .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        87 v~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence            999999999999997653     4889999999999999999999999   99999999999999999999999999865


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ....   ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....        ..... .+...    
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~-~~~~~----  222 (279)
T 3fdn_A          159 APSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYK-RISRV----  222 (279)
T ss_dssp             C-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH-HHHHT----
T ss_pred             CCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHH-HHHhC----
Confidence            4322   22344689999999999999999999999999999999999999964321        01111 11110    


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       223 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          223 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                  11123334567899999999999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.2e-45  Score=334.09  Aligned_cols=210  Identities=30%  Similarity=0.312  Sum_probs=180.5

Q ss_pred             ccccChHHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-----CC
Q 040763           58 CKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-----HR  131 (360)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-----h~  131 (360)
                      ...++..+.....++|.+.+.||+|+||+||+|.+. +++.||+|++....     .....+..|+.++..++     ||
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~h~   96 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-----KYTRSAKIEADILKKIQNDDINNN   96 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-----HHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-----hhhhhhHHHHHHHHHhcccCCCCC
Confidence            445566666677789999999999999999999985 68899999986421     22345567888998886     99


Q ss_pred             CceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 040763          132 NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNIL  211 (360)
Q Consensus       132 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nil  211 (360)
                      ||+++++++...+..++||||+ +++|.+++.....   ..+++..+..++.|++.||+|||+++   |+||||||+|||
T Consensus        97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  169 (360)
T 3llt_A           97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENIL  169 (360)
T ss_dssp             GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEE
Confidence            9999999999999999999999 9999999986432   25889999999999999999999999   999999999999


Q ss_pred             EcC-------------------------CCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhh
Q 040763          212 LDE-------------------------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSF  266 (360)
Q Consensus       212 l~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  266 (360)
                      ++.                         ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||
T Consensus       170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  245 (360)
T 3llt_A          170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSF  245 (360)
T ss_dssp             ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred             EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence            975                         789999999999764432    234568999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCC
Q 040763          267 GVVLVELLTGKKPIFST  283 (360)
Q Consensus       267 G~il~el~tg~~p~~~~  283 (360)
                      ||++|+|++|+.||...
T Consensus       246 G~il~ell~g~~pf~~~  262 (360)
T 3llt_A          246 GCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHHHHHSSCSCCCS
T ss_pred             HHHHHHHHHCCCCCCCC
Confidence            99999999999999654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-46  Score=339.53  Aligned_cols=257  Identities=28%  Similarity=0.338  Sum_probs=203.2

Q ss_pred             hcCCCccceecccCcEEEEEEEe----cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETE  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~  144 (360)
                      .++|++.+.||+|+||.||++..    .+++.||+|+++...........+.+.+|+.++..+ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999987    368899999876532211111223455789999999 7999999999999999


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ..++||||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence            9999999999999999997653     5889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ++...............||+.|+|||++.+  ..++.++||||||+++|||++|+.||........    ..........
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~  280 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILK  280 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHH
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhc
Confidence            998665443333445679999999999986  3478899999999999999999999975442211    1111111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                      .           ....+...++.+.+|+.+||+.||++||     |+.++++
T Consensus       281 ~-----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          281 S-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             C-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             c-----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            1           1112334556789999999999999999     8999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.7e-46  Score=336.46  Aligned_cols=267  Identities=22%  Similarity=0.268  Sum_probs=203.1

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccCh-HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDD-EELYKLEEFINEIFILSQINHRNVVKLLGCCLE  142 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~  142 (360)
                      .+....++|++.+.||+|+||.||++.+. ++..+|+|.+...... ......+.+.+|+.++..++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            45566788999999999999999999875 6788999987643211 012345678899999999999999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCC-----------------------------------CCCCCHHHHHHHHHHHHH
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNE-----------------------------------EYPLTWEMRFRVAIEVAG  187 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------------------------------~~~~~~~~~~~i~~~i~~  187 (360)
                      .+..++||||+++++|.+++.......                                   ...+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999996321110                                   112356778889999999


Q ss_pred             HHHHHHhCCCCCeEecCCCCCCeEEcCCC--cEEEeecCCccccCCCC---ceeeecccccCCccchhhhcc--CCCCCc
Q 040763          188 ALAYLHSGASSPIYHRDIKSTNILLDERY--RAKVADFGTSKFIAMDQ---THVTTKIQGTFGYLDPEYHQS--SQLTDK  260 (360)
Q Consensus       188 ~l~~lh~~~~~~i~H~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~  260 (360)
                      ||+|||+++   ++||||||+||+++.++  .+||+|||++.......   ........||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999999   99999999999998776  89999999998654322   122344569999999999875  678899


Q ss_pred             cchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCC
Q 040763          261 SDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKK  340 (360)
Q Consensus       261 ~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  340 (360)
                      +||||||+++|+|++|+.||.+...        ..............       ........++++.+|+.+||+.||++
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhH
Confidence            9999999999999999999965431        11111111111100       01111224567999999999999999


Q ss_pred             CCCHHHHHH
Q 040763          341 RPTMEEVSM  349 (360)
Q Consensus       341 Rpt~~ei~~  349 (360)
                      |||+.++++
T Consensus       322 Rps~~~~l~  330 (345)
T 3hko_A          322 RFDAMRALQ  330 (345)
T ss_dssp             SCCHHHHHH
T ss_pred             CCCHHHHhc
Confidence            999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.8e-46  Score=332.99  Aligned_cols=265  Identities=24%  Similarity=0.344  Sum_probs=207.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEe------cCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE  142 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~  142 (360)
                      ..++|++.+.||+|+||.||+|.+      .++..||+|.+......   .....+.+|+.++..++||||+++++++..
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE---QDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch---hhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            347899999999999999999984      24678999998754333   234567889999999999999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCc
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQN--EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYR  217 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~  217 (360)
                      ....++||||+++++|.+++......  ....+++..++.++.|++.||.|||+++   ++||||||+||+++.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence            99999999999999999999875422  1235889999999999999999999999   999999999999984   456


Q ss_pred             EEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHH
Q 040763          218 AKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       218 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~  295 (360)
                      +||+|||++........ .......||+.|+|||.+.+..++.++||||||+++|+|++ |..||.....         .
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------~  252 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---------Q  252 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------H
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---------H
Confidence            99999999876543322 22233467899999999999999999999999999999998 9999865321         0


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ...........         ...+..+++.+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       253 ~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          253 EVLEFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            01111111111         112233456799999999999999999999999999988653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-45  Score=349.68  Aligned_cols=256  Identities=25%  Similarity=0.304  Sum_probs=207.0

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.++ +|+.||+|++...... .......+.+|+.++..++||||+++++++.+.+..++
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            467999999999999999999986 6899999987653211 11234567789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++....   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       262 VmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence            999999999999997532   224899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ......  ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+......    ... ........    
T Consensus       336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~-i~~~i~~~----  404 (576)
T 2acx_A          336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REE-VERLVKEV----  404 (576)
T ss_dssp             CCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHH-HHHHHHHC----
T ss_pred             cccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHH-HHHHhhcc----
Confidence            654322  2345799999999999999999999999999999999999999976432111    111 11111111    


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                            ....+...++++.+|+.+||+.||++||     ++.|+++
T Consensus       405 ------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 ------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                  1112334566899999999999999999     6777763

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=333.73  Aligned_cols=260  Identities=17%  Similarity=0.211  Sum_probs=207.5

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEE------ecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC---CCCce
Q 040763           64 KELDKATNHFNVNRILGQGGQGTVYKGR------LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN---HRNVV  134 (360)
Q Consensus        64 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~---h~niv  134 (360)
                      .++....++|.+.+.||+|+||+||+|.      ..+++.||+|++....       ..++..|+.++..++   |+||+
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv  130 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFM  130 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhh
Confidence            3344456789999999999999999994      3468899999987532       234556777777775   99999


Q ss_pred             eeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC
Q 040763          135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE  214 (360)
Q Consensus       135 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~  214 (360)
                      ++++++...+..++||||+++|+|.+++..........+++..++.++.|++.||+|||+++   |+||||||+|||++.
T Consensus       131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~  207 (365)
T 3e7e_A          131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGN  207 (365)
T ss_dssp             CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECG
T ss_pred             hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecc
Confidence            99999999999999999999999999998755444557999999999999999999999999   999999999999998


Q ss_pred             -----------CCcEEEeecCCccccCC-CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 040763          215 -----------RYRAKVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS  282 (360)
Q Consensus       215 -----------~~~~kl~Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~  282 (360)
                                 ++.+||+|||++..... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                       89999999999976532 223344556799999999999999999999999999999999999999854


Q ss_pred             CCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCC-CCHHHHHHHHHHhHh
Q 040763          283 TGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKR-PTMEEVSMELNGIRG  356 (360)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-pt~~ei~~~L~~l~~  356 (360)
                      .......                ......    . .  ..++.+.+++..||+.+|.+| |+++++.+.|+.+..
T Consensus       288 ~~~~~~~----------------~~~~~~----~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          288 NEGGECK----------------PEGLFR----R-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             EETTEEE----------------ECSCCT----T-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCCcee----------------echhcc----c-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            3211100                000000    0 0  124467789999999999999 688888888877654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=332.71  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=190.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|.+....      ..+.+.+|+.++..++||||+++++++......
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  123 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI  123 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence            34577999999999999999999987 57889999987532      234567899999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEEEeec
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAKVADF  223 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Df  223 (360)
                      ++||||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.   ++.+||+||
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccC
Confidence            99999999999999996532     5889999999999999999999999   999999999999975   889999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      |++.......  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......       . ....+..
T Consensus       196 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~-~~~~i~~  265 (349)
T 2w4o_A          196 GLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------F-MFRRILN  265 (349)
T ss_dssp             C------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------H-HHHHHHT
T ss_pred             ccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------H-HHHHHHh
Confidence            9997654322  2234568999999999999999999999999999999999999996543210       0 1111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .... .     ........+.++.+|+.+||+.||++|||+.++++
T Consensus       266 ~~~~-~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          266 CEYY-F-----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TCCC-C-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCc-c-----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1100 0     01111234567999999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.4e-46  Score=348.61  Aligned_cols=251  Identities=24%  Similarity=0.304  Sum_probs=196.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.+. +++.||+|++...... .......+.+|+.++..++||||+++++++...+..++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            467999999999999999999976 6889999987643211 11234456789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ||||+++++|.+++....     .+++..+..++.|++.||+|||+ ++   |+||||||+|||++.++.+||+|||++.
T Consensus       226 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EEeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence            999999999999997643     58899999999999999999998 88   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...        ..... .+....  
T Consensus       298 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~-~i~~~~--  365 (446)
T 4ejn_A          298 EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFE-LILMEE--  365 (446)
T ss_dssp             TTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHCC--
T ss_pred             eccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHH-HHHhCC--
Confidence            54332 2223446799999999999999999999999999999999999999965431        01111 111111  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                              ...+...++++.+|+.+||+.||++||     |+.|+++
T Consensus       366 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 --------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                    012333456899999999999999999     9999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=329.99  Aligned_cols=265  Identities=22%  Similarity=0.322  Sum_probs=204.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee----C
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE----T  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~  143 (360)
                      ..++|++.+.||+|+||.||++... +++.||+|.+.....    ...+.+.+|+.+++.++||||+++++++..    .
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ----QDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH----HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH----HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            3578999999999999999999974 788999998764321    345677899999999999999999999873    3


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+||
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEec
Confidence            467899999999999999976432 2346899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCce--------eeecccccCCccchhhhccCC---CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc
Q 040763          224 GTSKFIAMDQTH--------VTTKIQGTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS  292 (360)
Q Consensus       224 g~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~  292 (360)
                      |++.........        ......||+.|+|||.+.+..   ++.++||||||+++|+|++|+.||.......   ..
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~  255 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DS  255 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SC
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---ch
Confidence            998754321110        011234799999999987654   6889999999999999999999984311000   00


Q ss_pred             hHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          293 LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ...    ....         ......+...++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       256 ~~~----~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          256 VAL----AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHH----HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hhH----Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            000    0000         011111233456899999999999999999999999999988653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5e-46  Score=338.40  Aligned_cols=252  Identities=27%  Similarity=0.332  Sum_probs=195.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHH-HhhcCCCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFI-LSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~-~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||++..+ +++.+|+|++........ .....+..|..+ +..++||||+++++++.+.+..|
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            467999999999999999999987 578899999865432211 223445566666 46689999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++++||+|||+++
T Consensus       116 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            9999999999999997643     4788999999999999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..... .......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+...        ...+..... ..  
T Consensus       188 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~-~~--  255 (373)
T 2r5t_A          188 ENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILN-KP--  255 (373)
T ss_dssp             GGBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHH-SC--
T ss_pred             ccccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-cc--
Confidence            64322 2223456799999999999999999999999999999999999999965321        111111111 11  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME  350 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~  350 (360)
                              ...+...+.++.+|+.+||+.||++||++.+.+++
T Consensus       256 --------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          256 --------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             --------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             --------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence                    01123345679999999999999999998644433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-45  Score=344.19  Aligned_cols=196  Identities=26%  Similarity=0.398  Sum_probs=155.0

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC-----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-----  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----  143 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.......  ...+.+.+|+.++..++||||+++++++...     
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL--IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH--HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            478999999999999999999876 68899999886543332  3456788999999999999999999998543     


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...|+||||+ +++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          130 DELYVVLEIA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             CCEEEEECCC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred             ceEEEEEecc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccc
Confidence            5689999998 679999986532     5899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCc--------------------------eeeecccccCCccchhhh-ccCCCCCccchhhhHHHHHHHHhC
Q 040763          224 GTSKFIAMDQT--------------------------HVTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTG  276 (360)
Q Consensus       224 g~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg  276 (360)
                      |++........                          ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            99987643211                          123345789999999976 456799999999999999999993

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.9e-45  Score=325.56  Aligned_cols=255  Identities=24%  Similarity=0.318  Sum_probs=205.2

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH--HHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE--LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      .++|++.+.||+|+||.||++.+. +++.+|+|.+........  ....+.+.+|+.++..++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            466999999999999999999986 588999998765433211  01245678999999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC----cEEEee
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY----RAKVAD  222 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~D  222 (360)
                      ++||||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++    .+||+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence            99999999999999997532     5889999999999999999999999   99999999999999888    799999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...        .... ..+.
T Consensus       163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~-~~i~  231 (321)
T 2a2a_A          163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETL-ANIT  231 (321)
T ss_dssp             CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHH-HHHH
T ss_pred             CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHH-HHHH
Confidence            99998765432  22344689999999999999999999999999999999999999965431        0111 1111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....  .....    .....++.+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~--~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          232 SVSY--DFDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TTCC--CCCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hccc--ccChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1100  00111    11234557999999999999999999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.8e-45  Score=347.96  Aligned_cols=253  Identities=22%  Similarity=0.295  Sum_probs=204.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|.+.+.||+|+||.||++.++ +++.||+|++...... .....+.+.+|+.++..++||||+++++++.+....|+|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            67888999999999999999986 6899999997653221 112345678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++..... ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       264 mE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             ECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            999999999999976432 2336899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......    .......... ..    
T Consensus       340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~-~~----  409 (543)
T 3c4z_A          340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLE-QA----  409 (543)
T ss_dssp             CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHH-CC----
T ss_pred             cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhh-cc----
Confidence            54322 23345799999999999999999999999999999999999999976532111    1111111111 11    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                            ...+...++++.+|+.+||+.||++||++
T Consensus       410 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 ------VTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             ------cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                  11233456689999999999999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-45  Score=321.86  Aligned_cols=254  Identities=25%  Similarity=0.347  Sum_probs=197.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||.||++... ++..+|+|.+......   ...+.+.+|+.++..++||||+++++++.+....++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ---VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc---hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            367999999999999999999976 5889999987654332   234567889999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---cCCCcEEEeecCC
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFGT  225 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~  225 (360)
                      ||||+++++|.+++..... ....+++..+..++.|++.||.|||+++   ++||||||+||++   +.++.+||+|||+
T Consensus        98 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             EEEeCCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            9999999999999865422 1236899999999999999999999999   9999999999999   5568899999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      +.......  ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||.+...        ............
T Consensus       174 a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~  242 (285)
T 3is5_A          174 AELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQKATYKEP  242 (285)
T ss_dssp             CCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC
T ss_pred             ceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhhhccCCc
Confidence            97654322  233456899999999886 4688999999999999999999999965431        011111111110


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....        .....++++.+|+.+||+.||++|||+.|+++
T Consensus       243 ~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 NYAV--------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCC----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccc--------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000        01113457899999999999999999999974

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=333.84  Aligned_cols=262  Identities=22%  Similarity=0.323  Sum_probs=195.3

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|.+.+.||+|+||+||+|.+. +++.||+|.+.......   ....+.+|+.+++.++||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc---cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            57899999999999999999986 68899999886543221   112344789999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||++ ++|.+++....    ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++...
T Consensus        79 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             EECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             ecccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence            99996 69999887643    25889999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc---c
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN---R  305 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  305 (360)
                      .... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....     .............   .
T Consensus       151 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~  224 (324)
T 3mtl_A          151 SIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-----EQLHFIFRILGTPTEET  224 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTT
T ss_pred             cCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHh
Confidence            4322 22233468999999999876 56899999999999999999999999654311     1111111111111   1


Q ss_pred             cccccchHH-------------hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQV-------------MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +........             ........++++.+|+.+||+.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            111111000             00112234567899999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3e-45  Score=340.61  Aligned_cols=201  Identities=23%  Similarity=0.345  Sum_probs=167.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC-----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-----  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----  143 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++...     
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL--IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcCh--HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            478999999999999999999976 57889999987543332  3456788999999999999999999998766     


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...|+||||++ ++|.+++....     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             CeEEEEEecCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccC
Confidence            56899999985 69999996532     5899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCce---------------------eeecccccCCccchhhh-ccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 040763          224 GTSKFIAMDQTH---------------------VTTKIQGTFGYLDPEYH-QSSQLTDKSDVYSFGVVLVELLTGKKPIF  281 (360)
Q Consensus       224 g~~~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~p~~  281 (360)
                      |++.........                     .....+||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            999876543211                     23456799999999986 55678999999999999999998655543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.5e-45  Score=319.98  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=202.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||+|.+. ++..+|+|.+......    ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            3467999999999999999999986 4678999987654332    3456788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---cCCCcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg  224 (360)
                      +||||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||++   +.++.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence            9999999999999987643     4889999999999999999999999   9999999999999   788999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++.......  ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||.....        .. ........
T Consensus       155 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~-~~~~~~~~  222 (277)
T 3f3z_A          155 LAARFKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SE-VMLKIREG  222 (277)
T ss_dssp             TCEECCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHC
T ss_pred             cceeccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HH-HHHHHHhC
Confidence            997665432  22334689999999988764 89999999999999999999999965431        01 11111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ... . ...    .....++++.+++.+||+.||++|||+.++++
T Consensus       223 ~~~-~-~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          223 TFT-F-PEK----DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCC-C-CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCC-C-Cch----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            100 0 000    00124567999999999999999999999974

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=335.05  Aligned_cols=246  Identities=24%  Similarity=0.326  Sum_probs=201.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH----HHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE----LYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~----~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      ..++|++.+.||+|+||.||++.+. +++.||+|.+........    ......+.+|+.++..++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3467999999999999999999875 688999998776432111    01223456799999999999999999999999


Q ss_pred             CcceEEEEecCCC-ChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          144 EFPLLVYEFIPNG-TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       144 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                      +..++||||+.+| +|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence            9999999998766 9999997543     5899999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||++........  .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||........             
T Consensus       174 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------  238 (335)
T 3dls_A          174 FGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------  238 (335)
T ss_dssp             CTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------
T ss_pred             cccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------
Confidence            999987654332  233568999999999988776 7899999999999999999999964221000             


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ..      ...+...++++.+|+.+||+.||++|||+.++++
T Consensus       239 ------~~------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          239 ------AA------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             ------TC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------hc------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  00      0012224557999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3e-46  Score=341.68  Aligned_cols=254  Identities=17%  Similarity=0.197  Sum_probs=193.0

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHH---HHhhcCCCCceeee-------e
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIF---ILSQINHRNVVKLL-------G  138 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~---~~~~l~h~niv~~~-------~  138 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....... ....+.+.+|+.   .+..++||||++++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            467888999999999999999974 68999999986432211 123566788994   55556899999998       5


Q ss_pred             EEeeCC-----------------cceEEEEecCCCChhHHhhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 040763          139 CCLETE-----------------FPLLVYEFIPNGTLYQHLHDRHQNEE--YPLTWEMRFRVAIEVAGALAYLHSGASSP  199 (360)
Q Consensus       139 ~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~  199 (360)
                      ++...+                 ..+++|||+ +|+|.+++........  ..+++..++.++.|++.||+|||+++   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            555443                 278999999 6899999986532211  23446888899999999999999999   


Q ss_pred             eEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccC-----------CCCCccchhhhHH
Q 040763          200 IYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-----------QLTDKSDVYSFGV  268 (360)
Q Consensus       200 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~  268 (360)
                      |+||||||+|||++.++.+||+|||++.....    ......| +.|+|||++.+.           .++.++|||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            99999999999999999999999999975332    2334567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          269 VLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       269 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                      ++|||++|+.||.+........                 .+..      .....++++.+|+.+||+.||++|||+.+++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~-----------------~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSE-----------------WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             HHHHHHHSSCCC------CCSG-----------------GGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             HHHHHHHCCCCCcccccccchh-----------------hhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            9999999999996543211100                 0000      0123345799999999999999999999998


Q ss_pred             H--HHHHhHh
Q 040763          349 M--ELNGIRG  356 (360)
Q Consensus       349 ~--~L~~l~~  356 (360)
                      +  .++++..
T Consensus       359 ~hp~f~~~~~  368 (377)
T 3byv_A          359 ETPEYEQLRT  368 (377)
T ss_dssp             TSHHHHHHHH
T ss_pred             hChHHHHHHH
Confidence            5  4555443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-45  Score=321.93  Aligned_cols=253  Identities=27%  Similarity=0.382  Sum_probs=204.0

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++... +++.+|+|.+......   ...+.+.+|+.++..++||||+++++++.+....++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT---THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch---hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            467999999999999999999986 6889999987654332   234567889999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++...     ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            99999999999998643     25889999999999999999999999   99999999999999999999999999976


Q ss_pred             cCCCCc-eeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          229 IAMDQT-HVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       229 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ...... .......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.........       ..........
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~  227 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTY  227 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-------HHHHHTTCTT
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHhhhcccc
Confidence            543221 12334568999999999988765 77899999999999999999999764421110       1111111000


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                               .......++++.+++.+||+.||++|||+.++++
T Consensus       228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 ---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                     0011234557899999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.5e-45  Score=327.71  Aligned_cols=262  Identities=24%  Similarity=0.334  Sum_probs=197.0

Q ss_pred             hcCCCcc-ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           70 TNHFNVN-RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        70 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      .+.|++. +.||+|+||+||++.+. +++.||+|++.....    ...+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~   86 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF   86 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            3568875 78999999999999865 688999999865432    2345677899999885 799999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc---EEEeec
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKVADF  223 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Df  223 (360)
                      ++||||+++++|.+++....     .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.   +||+||
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             EEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence            99999999999999997653     5889999999999999999999999   999999999999998776   999999


Q ss_pred             CCccccCCCCc------eeeecccccCCccchhhhcc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccc-
Q 040763          224 GTSKFIAMDQT------HVTTKIQGTFGYLDPEYHQS-----SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV-  291 (360)
Q Consensus       224 g~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~-  291 (360)
                      |++........      .......||+.|+|||++.+     ..++.++||||||+++|+|++|+.||.+......... 
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence            99876532211      11223458999999999875     5578999999999999999999999976543221000 


Q ss_pred             --ch---HHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          292 --SL---AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       292 --~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        ..   ............. .....     .....++++.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~i~~~~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          239 GEACPACQNMLFESIQEGKY-EFPDK-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             --CCHHHHHHHHHHHHHCCC-CCCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccchhHHHHHHHHHhccCc-ccCch-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              00   0011111111110 00000     01124567999999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=322.53  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=184.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++... +++.||+|.+...... .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            367999999999999999999974 6889999987643211 11234567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|||+++++|.+++....    .++++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            999999999999997532    36899999999999999999999999   99999999999999999999999999976


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..........         .....   .
T Consensus       162 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------~~~~~---~  228 (278)
T 3cok_A          162 LKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------KVVLA---D  228 (278)
T ss_dssp             CC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------CCSS---C
T ss_pred             ccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------HHhhc---c
Confidence            543222 1223468999999999999889999999999999999999999996543211100         00000   0


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             ...+...+.++.+++.+||+.||++|||+.++++
T Consensus       229 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 -------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                   0112334567899999999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.1e-45  Score=329.99  Aligned_cols=266  Identities=18%  Similarity=0.248  Sum_probs=195.4

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ....++|++.+.||+|+||+||++.+. +++.||+|+++......  ...+.+.+|+.+++.++||||+++++++.....
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE--GVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc--ccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            344578999999999999999999875 68899999987653322  234566789999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE-----cCCCcEEE
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL-----DERYRAKV  220 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill-----~~~~~~kl  220 (360)
                      .++||||++ ++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||+     +.++.+||
T Consensus       108 ~~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl  178 (329)
T 3gbz_A          108 LHLIFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI  178 (329)
T ss_dssp             EEEEEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred             EEEEEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence            999999996 59999997643     4889999999999999999999999   9999999999999     45556999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      +|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....     ........
T Consensus       179 ~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~  252 (329)
T 3gbz_A          179 GDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-----DQLFKIFE  252 (329)
T ss_dssp             CCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH
T ss_pred             CcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-----HHHHHHHH
Confidence            9999998764332 223344689999999998874 4899999999999999999999999654311     01111111


Q ss_pred             Hhhccc----------------cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRKNR----------------LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......                .............+...++++.+|+.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            111000                00001111111122234568999999999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=334.91  Aligned_cols=266  Identities=14%  Similarity=0.221  Sum_probs=205.5

Q ss_pred             hcCCCccceecccCcEEEEEEEecC---------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCcee-----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED---------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVK-----  135 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~-----  135 (360)
                      .++|.+.+.||+|+||.||+|.+..         ++.||+|.+...         +.+.+|+.++..++||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence            4689999999999999999999764         788999987643         24568999999999999987     


Q ss_pred             ----------eeeEEee-CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 040763          136 ----------LLGCCLE-TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD  204 (360)
Q Consensus       136 ----------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~d  204 (360)
                                +++++.. ....++||||+ +++|.+++....   ...+++..++.++.|++.||.|||+++   ++|||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~D  184 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGN  184 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSC
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence                      5666665 67789999999 999999998641   236899999999999999999999999   99999


Q ss_pred             CCCCCeEEcCCC--cEEEeecCCccccCCCCce------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhC
Q 040763          205 IKSTNILLDERY--RAKVADFGTSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG  276 (360)
Q Consensus       205 lk~~Nill~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg  276 (360)
                      |||+||+++.++  .+||+|||++.........      ......||+.|+|||.+.+..++.++||||||+++|||++|
T Consensus       185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999998  9999999999776543211      11334689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          277 KKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       277 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      +.||.........   ........ .. ....+.....   .....++++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       265 ~~pf~~~~~~~~~---~~~~~~~~-~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          265 FLPWTNCLPNTED---IMKQKQKF-VD-KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             CCTTGGGTTCHHH---HHHHHHHH-HH-SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCcccCCcCHHH---HHHHHHhc-cC-Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            9999654311111   11111111 10 1111111000   011234579999999999999999999999999999886


Q ss_pred             hcc
Q 040763          357 SIK  359 (360)
Q Consensus       357 ~~~  359 (360)
                      ..+
T Consensus       337 ~~~  339 (352)
T 2jii_A          337 DLR  339 (352)
T ss_dssp             HTT
T ss_pred             hcC
Confidence            643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.3e-45  Score=336.02  Aligned_cols=251  Identities=22%  Similarity=0.278  Sum_probs=189.9

Q ss_pred             cCCCcc-ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhh-cCCCCceeeeeEEee----C
Q 040763           71 NHFNVN-RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ-INHRNVVKLLGCCLE----T  143 (360)
Q Consensus        71 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~-l~h~niv~~~~~~~~----~  143 (360)
                      ++|.+. +.||+|+||+||++.++ +++.||+|++...         ..+.+|+.++.+ .+||||+++++++..    .
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~  131 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR  131 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence            456665 68999999999999986 6889999987532         234467777644 589999999999875    5


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEEE
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAKV  220 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~kl  220 (360)
                      ...++||||+++|+|.+++....   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||
T Consensus       132 ~~~~lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          132 KCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             EEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEE
T ss_pred             cEEEEEEEeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEE
Confidence            67899999999999999997632   235899999999999999999999999   999999999999997   789999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      +|||++.......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......... ...+   
T Consensus       206 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~i---  279 (400)
T 1nxk_A          206 TDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRI---  279 (400)
T ss_dssp             CCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH-HHHH---
T ss_pred             EecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH-HHHH---
Confidence            9999998654322  233457899999999999999999999999999999999999999765432211111 1111   


Q ss_pred             hhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       ..... ...     .......++++.+|+.+||+.||++|||+.++++
T Consensus       280 -~~~~~-~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          280 -RMGQY-EFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             -HHTCC-CCC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HcCcc-cCC-----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             11100 000     0011234567999999999999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=332.27  Aligned_cols=246  Identities=24%  Similarity=0.290  Sum_probs=194.4

Q ss_pred             cceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEecC
Q 040763           76 NRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      .+.||+|+||.||+|... +++.||+|+++....    ...+.+.+|+.++..++||||+++++++...+..++||||++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM----KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            567999999999999875 688999999875422    234578899999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE--cCCCcEEEeecCCccccCCC
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL--DERYRAKVADFGTSKFIAMD  232 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~  232 (360)
                      +++|.+++....    ..+++..+..++.|++.||.|||+++   |+||||||+|||+  +.++.+||+|||++......
T Consensus       170 ~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          170 GGELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             TCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            999999886532    25889999999999999999999999   9999999999999  67789999999999876543


Q ss_pred             CceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccch
Q 040763          233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDD  312 (360)
Q Consensus       233 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (360)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|..||.+....        ......... .+ ...  
T Consensus       243 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~-~~-~~~--  308 (373)
T 2x4f_A          243 EK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNNILAC-RW-DLE--  308 (373)
T ss_dssp             CB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHT-CC-CSC--
T ss_pred             cc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhc-cC-CCC--
Confidence            22  23346999999999999989999999999999999999999999654310        111111111 00 000  


Q ss_pred             HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          313 QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       313 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         .......++++.+|+.+||+.||++|||+.|+++
T Consensus       309 ---~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 ---DEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ---SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0111234568999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-45  Score=332.04  Aligned_cols=259  Identities=23%  Similarity=0.282  Sum_probs=196.2

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++.......  ...+.+.+|+.+++.++||||+++++++....    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH--HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            478999999999999999999985 68999999986544332  34567889999999999999999999997654    


Q ss_pred             --cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          145 --FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       145 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                        ..|+||||+ +++|.+++...      .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             CceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEe
Confidence              359999999 88999998652      4889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||++......    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.....     .........
T Consensus       172 fg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~l~~i~~~~  242 (367)
T 1cm8_A          172 FGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-----QLKEIMKVT  242 (367)
T ss_dssp             CTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHH
T ss_pred             eecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhc
Confidence            9999865432    234568999999999887 678999999999999999999999997543211     111111111


Q ss_pred             hccc---cccccch--------------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNR---LYHILDD--------------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~---~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....   +..+...              ..........++++.+|+.+||+.||++|||+.++++
T Consensus       243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            0000   0000000              0001112334668999999999999999999999976

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.5e-45  Score=330.51  Aligned_cols=266  Identities=26%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+......   ...+.+.+|+.++..++||||+++++++...+..++
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH---HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH---HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            367999999999999999999986 6889999998765333   345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ||||+++++|.+++....     .+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||++.
T Consensus       109 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             EECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            999999999999997653     488999999999999999999996 8   9999999999999999999999999986


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch--------------
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL--------------  293 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~--------------  293 (360)
                      .....   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............              
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          181 QLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             HHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             ccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            54321   2233468999999999999999999999999999999999999996543111000000              


Q ss_pred             -------HHHHHHHhhccccccccchHH----hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          294 -------AAYFVHSMRKNRLYHILDDQV----MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       294 -------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             ..............+..+...    .......+++++.+|+.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                   000000000000000000000    00011224668999999999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-45  Score=357.15  Aligned_cols=264  Identities=25%  Similarity=0.402  Sum_probs=208.9

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEE
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCC  140 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~  140 (360)
                      +.....++|++.+.||+|+||.||+|.+..    +..+|+|..+.....   ...+.+.+|+.++..++||||+++++++
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            334445778999999999999999998743    457999987754333   3456788999999999999999999998


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                      . .+..++||||+++|+|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||
T Consensus       461 ~-~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL  532 (656)
T 2j0j_A          461 T-ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL  532 (656)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred             e-cCceEEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEE
Confidence            5 456899999999999999997532    25889999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      +|||++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....        . ...
T Consensus       533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~-~~~  603 (656)
T 2j0j_A          533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------D-VIG  603 (656)
T ss_dssp             CCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------H-HHH
T ss_pred             EecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------H-HHH
Confidence            9999998765443333344457889999999999999999999999999999997 99998654310        0 111


Q ss_pred             HhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .+....         ....+..+++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       604 ~i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          604 RIENGE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCC---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            111111         1112344566899999999999999999999999999998654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.4e-45  Score=323.31  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=200.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||+||++.+. +++.||+|.+.......  .....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS--HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            467999999999999999999986 78999999977543332  2345677899999999 9999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-------------
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-------------  214 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-------------  214 (360)
                      +||||+++++|.+++..... ....+++..+..++.|++.||.|||+++   ++||||||+||+++.             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------
T ss_pred             EEEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccc
Confidence            99999999999999976532 1135899999999999999999999999   999999999999984             


Q ss_pred             ------CCcEEEeecCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCc
Q 040763          215 ------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTS  287 (360)
Q Consensus       215 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~  287 (360)
                            ...+||+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|+|++|..|+....   
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---  235 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---  235 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred             ccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence                  4479999999998765432     23589999999998876 56689999999999999999987763321   


Q ss_pred             ccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          288 QENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                               ..........         ...+...++++.+++.+||+.||++|||+.++++
T Consensus       236 ---------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 ---------QWHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ---------HHHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------HHHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                     0111111111         1122334567999999999999999999999974

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-45  Score=332.30  Aligned_cols=269  Identities=26%  Similarity=0.375  Sum_probs=200.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.+. +++.||+|++.......  ...+.+.+|+.++..++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK--MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch--HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            367999999999999999999986 58899999876544332  334567789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus       102 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             EEECCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEecCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            999999988888765432     5889999999999999999999999   99999999999999999999999999976


Q ss_pred             cCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH------HHHHHHh
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA------AYFVHSM  301 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~------~~~~~~~  301 (360)
                      ..... .......||+.|+|||++.+. .++.++||||||+++|+|++|+.||..............      .......
T Consensus       174 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          174 LAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             ecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence            54322 222345689999999998875 689999999999999999999999965432110000000      0000000


Q ss_pred             hcc------ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKN------RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...      ...............+..++++.+|+.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000      011111111111112245678999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.6e-45  Score=325.11  Aligned_cols=261  Identities=25%  Similarity=0.409  Sum_probs=198.7

Q ss_pred             hcCCCccceecccCcEEEEEEEec--CCc--EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE--DGR--IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .++|++.+.||+|+||+||+|.+.  +++  .||+|.++...... ....+.+.+|+.++..++||||+++++++.... 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            367999999999999999999864  233  68999877543221 134567889999999999999999999998765 


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+++++|.+++.....    .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ceeeEecccCCCHHHHHHhccC----CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccc
Confidence            7999999999999999976432    5889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          226 SKFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       226 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      +..........  .....+|..|+|||.+.+..++.++||||||+++|+|++ |..||.+...        .........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~  239 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDK  239 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHT
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHc
Confidence            98765433222  223457888999999998889999999999999999999 9999965431        111111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      ...         ....+..+++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       240 ~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          240 EGE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             SCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCC---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            110         011223455689999999999999999999999999998764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.7e-45  Score=324.66  Aligned_cols=248  Identities=28%  Similarity=0.397  Sum_probs=204.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..|++.+.||+|+||.||+|.+. +++.||+|.+......   ...+.+.+|+.++..++||||+++++++......++|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            56899999999999999999875 6889999998654333   2356778999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++..      .++++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++...
T Consensus        99 ~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceec
Confidence            999999999999854      25889999999999999999999999   999999999999999999999999999766


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....        .. .........    
T Consensus       170 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~-~~~~~~~~~----  235 (303)
T 3a7i_A          170 TDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MK-VLFLIPKNN----  235 (303)
T ss_dssp             BTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HH-HHHHHHHSC----
T ss_pred             Cccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HH-HHHHhhcCC----
Confidence            5432 222345689999999999999999999999999999999999999864321        00 011111111    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ....+..+++++.+++.+||+.||++|||+.++++
T Consensus       236 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          236 -----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             -----CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                 11122334557999999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.3e-45  Score=329.79  Aligned_cols=252  Identities=20%  Similarity=0.289  Sum_probs=199.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      ..++|++.+.||+|+||.||++.++ +++.+|+|.+......        ..+|++++.++ +||||+++++++.+....
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD--------PTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC--------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC--------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            3467999999999999999999986 5889999998654322        23577888877 799999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC----CcEEEee
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVAD  222 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~----~~~kl~D  222 (360)
                      |+||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||+.++    +.+||+|
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D  163 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD  163 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence            99999999999999997532     5899999999999999999999999   9999999999998543    3599999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........     .. ....+.
T Consensus       164 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~-~~~~i~  236 (342)
T 2qr7_A          164 FGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-----EE-ILARIG  236 (342)
T ss_dssp             CTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-----HH-HHHHHH
T ss_pred             CCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-----HH-HHHHHc
Confidence            999987644322 23345789999999999988889999999999999999999999965321111     11 111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..... .     ........++++.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~-~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          237 SGKFS-L-----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HCCCC-C-----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCcc-c-----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11110 0     01112334568999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.1e-44  Score=327.59  Aligned_cols=265  Identities=21%  Similarity=0.282  Sum_probs=193.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++....    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh--HHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            478999999999999999999876 68899999987543332  34566789999999999999999999997655    


Q ss_pred             --cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          145 --FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       145 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                        ..++||||++ ++|.+++..       .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A          102 FQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             CCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEE
Confidence              6799999996 578888753       4889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc----------
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS----------  292 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~----------  292 (360)
                      ||++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..........          
T Consensus       171 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          171 FGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  248 (371)
T ss_dssp             CCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHH
T ss_pred             eecccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999765432  1233457899999999999999999999999999999999999999764321000000          


Q ss_pred             ----hHHHHHHHhhccc-cc-----cccchHH---hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          293 ----LAAYFVHSMRKNR-LY-----HILDDQV---MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       293 ----~~~~~~~~~~~~~-~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          +............ ..     .......   ........++++.+|+.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                0000000000000 00     0000000   00112334778999999999999999999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.8e-45  Score=320.75  Aligned_cols=261  Identities=26%  Similarity=0.348  Sum_probs=205.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH--HHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE--LYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      .++|++.+.||+|+||.||++... +++.+|+|.+........  ....+.+.+|+.++..++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356899999999999999999987 688999998765432211  11245678999999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC----cEEEee
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY----RAKVAD  222 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~D  222 (360)
                      +++|||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++    .+||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence            99999999999999997643     5889999999999999999999999   99999999999998877    899999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...        ... .....
T Consensus       156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~-~~~~~  224 (283)
T 3bhy_A          156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QET-LTNIS  224 (283)
T ss_dssp             CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH-HHHHH
T ss_pred             cccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHH-HHHhH
Confidence            99997654322  22334689999999999999999999999999999999999999965431        000 11111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHHhH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM--ELNGIR  355 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~--~L~~l~  355 (360)
                      ....  .....    .....++.+.+++.+||+.||++|||+.++++  .++.++
T Consensus       225 ~~~~--~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          225 AVNY--DFDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             TTCC--CCCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             hccc--CCcch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            1100  00111    11233557899999999999999999999986  455443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-45  Score=324.04  Aligned_cols=260  Identities=24%  Similarity=0.384  Sum_probs=204.7

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--CCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--TEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~  146 (360)
                      .++|++.+.||+|+||.||++... +++.+|+|.+.......  ...+.+.+|+.++..++||||+++++++..  ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            467999999999999999999986 68899999987543332  345678899999999999999999998754  5678


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA--SSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                      ++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+  ..+++||||||+||+++.++.+||+|||
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999999976542 2335899999999999999999999976  2349999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....         ......+...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~i~~~  231 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------KELAGKIREG  231 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHT
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---------HHHHHHHhhc
Confidence            9976543321 12234689999999999998999999999999999999999999865421         0111111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL  351 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L  351 (360)
                      ...         ..+..+++++.+++.+||+.||++|||+.++++.+
T Consensus       232 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          232 KFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             ccc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            111         12334556899999999999999999999998754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-44  Score=325.10  Aligned_cols=255  Identities=22%  Similarity=0.303  Sum_probs=198.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEee--CCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLE--TEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~--~~~~  146 (360)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+...       ..+.+.+|+.++..++ ||||+++++++..  ....
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            67999999999999999999874 6889999998642       2345778999999996 9999999999987  6678


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cEEEeecCC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADFGT  225 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~  225 (360)
                      +++|||+++++|.+++..        ++...+..++.|++.||.|||+++   ++||||||+|||++.++ .+||+|||+
T Consensus       109 ~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            999999999999998853        788899999999999999999999   99999999999999776 899999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      +........  .....||..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........    ...........
T Consensus       178 a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~----l~~~~~~~~~~  251 (330)
T 3nsz_A          178 AEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ----LVRIAKVLGTE  251 (330)
T ss_dssp             CEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH----HHHHHHHHCHH
T ss_pred             ceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH----HHHHHHhcCCc
Confidence            986644322  233468999999999877 67899999999999999999999999654321111    00011110000


Q ss_pred             cccc-----------------------ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYH-----------------------ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~-----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....                       ..........+...++++.+|+.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000                       00000111112235678999999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=327.77  Aligned_cols=268  Identities=24%  Similarity=0.251  Sum_probs=196.4

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHH-HhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEEL-YKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      ...++|++.+.||+|+||.||++.+. +++.||+|.+......... .....+.+|+.++..++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999986 5889999998754322211 112356789999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .++||||+++ +|.+++....    ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             eEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999975 8888886532    25788889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      +....... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+....     .............
T Consensus       159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-----~~~~~i~~~~~~~  232 (346)
T 1ua2_A          159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----DQLTRIFETLGTP  232 (346)
T ss_dssp             GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCC
T ss_pred             ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHHcCCC
Confidence            98764332 223345689999999998764 5789999999999999999999998654311     1111111111111


Q ss_pred             ---ccccccch-----------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 ---RLYHILDD-----------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ---~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         .+......           ..........++++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence               01100000           0000111334568999999999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.7e-45  Score=320.46  Aligned_cols=248  Identities=26%  Similarity=0.343  Sum_probs=203.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||++... ++..+|+|.+....... ....+.+.+|+.++..++||||+++++++.+.+..+++
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            67999999999999999999986 57789999876432111 12245678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        93 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            99999999999997653     4889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ....   .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.....        ..... ......    
T Consensus       165 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~-~~~~~~----  228 (284)
T 2vgo_A          165 PSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHR-RIVNVD----  228 (284)
T ss_dssp             SSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH-HHHTTC----
T ss_pred             cccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHH-HHhccc----
Confidence            4322   2334689999999999999999999999999999999999999965331        00111 111110    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ...+...+.++.+++.+||+.||++|||+.++++
T Consensus       229 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 ------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                  1122334567999999999999999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.5e-45  Score=320.97  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=205.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC-HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            467999999999999999999987 57889999876543221 1345677889999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        93 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  164 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK  164 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence            999999999999987643     5889999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....        ....... ....   
T Consensus       165 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~-~~~~---  231 (294)
T 2rku_A          165 VEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRI-KKNE---  231 (294)
T ss_dssp             CCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH-HTTC---
T ss_pred             cccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-hhcc---
Confidence            543222 22335689999999999998899999999999999999999999965431        1111111 1110   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             ...+...++++.+++.+||+.||++|||+.++++
T Consensus       232 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 -------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                   0112334557899999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-44  Score=341.84  Aligned_cols=256  Identities=30%  Similarity=0.408  Sum_probs=201.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH---------HHhHHHHHHHHHHHhhcCCCCceeee
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE---------LYKLEEFINEIFILSQINHRNVVKLL  137 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~---------~~~~~~~~~e~~~~~~l~h~niv~~~  137 (360)
                      ...++|.+.+.||+|+||+||+|.++ +++.+|+|++........         ....+.+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            45678999999999999999999986 578999998765432210         02245678999999999999999999


Q ss_pred             eEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-
Q 040763          138 GCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-  216 (360)
Q Consensus       138 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-  216 (360)
                      +++.+....++||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++ 
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS  184 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence            99999999999999999999999997653     5899999999999999999999999   99999999999998776 


Q ss_pred             --cEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH
Q 040763          217 --RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       217 --~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~  294 (360)
                        .+||+|||++.......  ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+...        .
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~  253 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND--------Q  253 (504)
T ss_dssp             CSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred             CccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence              69999999998765432  2334569999999998874 689999999999999999999999965431        0


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      . ....+......  ....    .....++++.+|+.+||+.||.+|||+.|+++
T Consensus       254 ~-~~~~i~~~~~~--~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          254 D-IIKKVEKGKYY--FDFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             H-HHHHHHHCCCC--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H-HHHHHHcCCCC--CCcc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1 11111111110  0000    01224567999999999999999999999874

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-44  Score=332.20  Aligned_cols=263  Identities=22%  Similarity=0.289  Sum_probs=199.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC--
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET--  143 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--  143 (360)
                      +...++|++.+.||+|+||.||+|.+. +++.||+|++......        ..+|+.+++.++||||+++++++...  
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCc
Confidence            345678999999999999999999875 6899999987653222        12699999999999999999998543  


Q ss_pred             ------------------------------------CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHH
Q 040763          144 ------------------------------------EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG  187 (360)
Q Consensus       144 ------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~  187 (360)
                                                          ...++||||++ ++|.+.+..... ....+++..+..++.|++.
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~  152 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFR  152 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHH
Confidence                                                33789999997 688888765322 2336899999999999999


Q ss_pred             HHHHHHhCCCCCeEecCCCCCCeEEc-CCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhh
Q 040763          188 ALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYS  265 (360)
Q Consensus       188 ~l~~lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws  265 (360)
                      ||.|||+++   |+||||||+||+++ .++.+||+|||++........  .....||+.|+|||.+.+. .++.++||||
T Consensus       153 aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  227 (383)
T 3eb0_A          153 AVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWS  227 (383)
T ss_dssp             HHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence            999999999   99999999999998 688999999999986644322  2334689999999998775 4899999999


Q ss_pred             hHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc---------------ccccccchHHhhhccHHHHHHHHHHH
Q 040763          266 FGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN---------------RLYHILDDQVMKLGKKNQIVAFANLA  330 (360)
Q Consensus       266 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li  330 (360)
                      +||++|||++|+.||.+.....     ............               .........+....+...++++.+|+
T Consensus       228 lG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  302 (383)
T 3eb0_A          228 IGCVFGELILGKPLFSGETSID-----QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL  302 (383)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence            9999999999999997543211     111111111110               11111122233334455677899999


Q ss_pred             HHhhcCCCCCCCCHHHHHH
Q 040763          331 ERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       331 ~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .+||+.||++|||+.|+++
T Consensus       303 ~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          303 EQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHCCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhhCCCHHHHhc
Confidence            9999999999999999973

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.5e-45  Score=336.15  Aligned_cols=257  Identities=24%  Similarity=0.286  Sum_probs=191.9

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccCh----HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDD----EELYKLEEFINEIFILSQINHRNVVKLLGCCLE  142 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~  142 (360)
                      ...++|.+.+.||+|+||.||+|.+. +++.||+|++......    ........+.+|+.++.+++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34578999999999999999999876 5789999987653211    111122346789999999999999999999754


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC---cEE
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY---RAK  219 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~---~~k  219 (360)
                       +..++||||+++++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++   .+|
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence             45799999999999999886532     5899999999999999999999999   99999999999997544   599


Q ss_pred             EeecCCccccCCCCceeeecccccCCccchhhhcc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 040763          220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  296 (360)
                      |+|||++......  .......||+.|+|||++.+   ..++.++||||||+++|+|++|..||........    ... 
T Consensus       283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~~~-  355 (419)
T 3i6u_A          283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKD-  355 (419)
T ss_dssp             ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----HHH-
T ss_pred             EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----HHH-
Confidence            9999999876432  22344579999999998854   5678899999999999999999999975432111    111 


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         ........ . ..    ......++++.+|+.+||+.||++|||+.++++
T Consensus       356 ---~i~~~~~~-~-~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          356 ---QITSGKYN-F-IP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ---HHHTTCCC-C-CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHhcCCCC-C-Cc----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence               11111110 0 00    011224567999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.5e-45  Score=323.64  Aligned_cols=255  Identities=23%  Similarity=0.357  Sum_probs=188.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||++.+. +++.||+|.+.......  ...+.+.++...++.++||||+++++++...+..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH--HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            467999999999999999999975 68899999987653332  223334455556788899999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ||||++ ++|.+++..... ....+++..+..++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||++.
T Consensus        84 v~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISG  158 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred             EEehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence            999996 588888765322 233689999999999999999999998 8   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhh----ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYH----QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ......  ......||+.|+|||.+    .+..++.++||||||+++|+|++|+.||......       ..........
T Consensus       159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~  229 (290)
T 3fme_A          159 YLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-------FQQLKQVVEE  229 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-------HHHHHHHHHS
T ss_pred             cccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-------HHHHHHHhcc
Confidence            654432  22334689999999996    5567889999999999999999999999643211       0111111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .. .        .......++++.+++.+||+.||++|||+.++++
T Consensus       230 ~~-~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 PS-P--------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CC-C--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC-C--------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            11 1        1112234567999999999999999999999976

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-44  Score=318.61  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=199.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee----CCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE----TEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~~~  145 (360)
                      ..|.+.+.||+|+||+||+|.+. ++..||+|.+.......  ...+.+.+|+.+++.++||||+++++++..    ...
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH--HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            45788889999999999999876 57789999876544332  345678899999999999999999999865    355


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc-CCCcEEEeecC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFG  224 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg  224 (360)
                      .++||||+++++|.+++....     .+++..+..++.|++.||.|||+++ .+++||||||+||+++ .++.+||+|||
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            799999999999999997643     4889999999999999999999976 3499999999999998 78999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++.......   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......       ... .......
T Consensus       178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~-~~~~~~~  245 (290)
T 1t4h_A          178 LATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQI-YRRVTSG  245 (290)
T ss_dssp             GGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHH-HHHHTTT
T ss_pred             Ccccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHH-HHHHhcc
Confidence            997554332   233468999999998864 5899999999999999999999999653321       111 1111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..        ....+...++++.+++.+||+.||++|||+.++++
T Consensus       246 ~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 VK--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CC--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC--------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11        01112223457999999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-44  Score=341.73  Aligned_cols=253  Identities=24%  Similarity=0.356  Sum_probs=201.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||+||++.+. +++.||+|++.......  .....+.+|+.+++.++||||+++++++.+....+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            3467999999999999999999986 68899999875432111  23456789999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc---CCCcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg  224 (360)
                      +||||+++++|.+.+....     .+++..+..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||
T Consensus        98 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECC
Confidence            9999999999999987653     5889999999999999999999999   99999999999995   56679999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++.......  ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+...        .. ....+...
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~-~~~~i~~~  237 (486)
T 3mwu_A          170 LSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YD-ILKRVETG  237 (486)
T ss_dssp             CTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHT
T ss_pred             cCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHhC
Confidence            997654332  2334579999999999876 589999999999999999999999965431        01 11111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....      ..+.....++++.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          238 KYAF------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             CCCS------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCC------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1100      00111234567999999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.7e-45  Score=326.77  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=205.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|.+....... ....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            467999999999999999999986 47889999876543221 1345677889999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +|||+++++|.+++....     .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus       119 v~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  190 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK  190 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence            999999999999987643     5889999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....        ......... ..   
T Consensus       191 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~-~~---  257 (335)
T 2owb_A          191 VEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKK-NE---  257 (335)
T ss_dssp             CCSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-TC---
T ss_pred             cccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHhc-CC---
Confidence            64322 222345689999999999999999999999999999999999999965321        111111111 10   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                             ...+...++++.+++.+||+.||++|||+.++++
T Consensus       258 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 -------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0112234557899999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-43  Score=322.18  Aligned_cols=258  Identities=23%  Similarity=0.402  Sum_probs=204.9

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccCh----HHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE
Q 040763           67 DKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDD----EELYKLEEFINEIFILSQI-NHRNVVKLLGCC  140 (360)
Q Consensus        67 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~  140 (360)
                      .....+|.+.+.||+|+||.||+|.+. +|+.||||++......    ......+.+.+|+.++..+ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            344567999999999999999999986 6899999987654321    1122345678899999999 899999999999


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                      ......++||||+++++|.+++....     .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999997643     5889999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhcc------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~  294 (360)
                      +|||++.......  ......||+.|+|||++.+      ..++.++||||||+++|+|++|..||.....        .
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~  311 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------I  311 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------H
Confidence            9999998765432  2334579999999998864      3578899999999999999999999965321        0


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      . ....+...... . ....    ....++++.+++.+||+.||++|||+.++++
T Consensus       312 ~-~~~~i~~~~~~-~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 L-MLRMIMEGQYQ-F-SSPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             H-HHHHHHHTCCC-C-CHHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H-HHHHHHhCCCC-C-CCcc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0 01111111100 0 0000    0123457999999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.8e-45  Score=325.30  Aligned_cols=267  Identities=25%  Similarity=0.364  Sum_probs=189.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ...++|++.+.||+|+||.||++.+. +++.||+|.+......   ...+.+.+|+.++..++||||+++++++...+..
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ---TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc---hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            44578999999999999999999875 6889999988654322   2345677899999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQ---NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ++||||+++++|.+++.....   .....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEec
Confidence            999999999999999975321   12345899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCc----eeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          224 GTSKFIAMDQT----HVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       224 g~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      |++........    .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........        ..
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~  237 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--------LM  237 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--------HH
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--------HH
Confidence            99876543221    11233468999999999876 5689999999999999999999999965432110        01


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .... ..................+++++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          238 LTLQ-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHT-SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhc-cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1111 1111111111111222334567999999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6e-45  Score=326.73  Aligned_cols=260  Identities=23%  Similarity=0.287  Sum_probs=203.4

Q ss_pred             HHHHHhcCCCcc-ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEe
Q 040763           65 ELDKATNHFNVN-RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCL  141 (360)
Q Consensus        65 ~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~  141 (360)
                      ..+...++|.+. +.||+|+||.||++... +++.||+|.+.......  .....+.+|+.++..+ +||||+++++++.
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ--DCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE--ECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            344555778877 88999999999999886 58899999877644332  2345678899999999 5699999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcE
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRA  218 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~  218 (360)
                      .....++||||+++++|.+++...   ....+++..++.++.|++.||+|||+++   ++||||||+||+++.   ++.+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence            999999999999999999998542   2236899999999999999999999999   999999999999998   7899


Q ss_pred             EEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          219 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      ||+|||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....        .....
T Consensus       174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~  243 (327)
T 3lm5_A          174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QETYL  243 (327)
T ss_dssp             EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH
T ss_pred             EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHH
Confidence            999999998764322  22345789999999999999999999999999999999999999965431        00011


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .. .....      ..........++.+.+++.+||+.||++|||+.++++
T Consensus       244 ~i-~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          244 NI-SQVNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HH-HHTCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HH-Hhccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            11 00000      0011112334567999999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.7e-44  Score=339.92  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=198.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||+||+|.++ ++..+|+|++.......  .....+.+|+.+++.++||||+++++++.+....+
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3467999999999999999999986 67899999877543221  22456789999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg  224 (360)
                      +||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||
T Consensus       113 lv~e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            9999999999999987653     4889999999999999999999999   999999999999976   4559999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++.......  ......||+.|+|||++. +.++.++||||+||++|+|++|..||.+...        .. ....+...
T Consensus       185 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~-~~~~i~~~  252 (494)
T 3lij_A          185 LSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QE-ILRKVEKG  252 (494)
T ss_dssp             TCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHT
T ss_pred             CCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHhC
Confidence            998765432  233457999999999886 4689999999999999999999999965431        01 11111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ... ...     ......++++.+|+.+||+.||++|||+.++++
T Consensus       253 ~~~-~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          253 KYT-FDS-----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCC-CCS-----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC-CCc-----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            110 000     011234567999999999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.7e-44  Score=326.31  Aligned_cols=263  Identities=21%  Similarity=0.277  Sum_probs=201.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC----
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET----  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----  143 (360)
                      ..++|++.+.||+|+||.||++.+. ++..||+|++......   ...+.+.+|+.++..++||||+++++++...    
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ---TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH---HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc---HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence            3468999999999999999999876 6788999998753322   3446778999999999999999999998765    


Q ss_pred             -CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          144 -EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       144 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                       ...+++||+++ ++|.+++...      .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|
T Consensus       102 ~~~~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D  171 (364)
T 3qyz_A          102 MKDVYIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD  171 (364)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             cceEEEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEe
Confidence             36799999996 6999988652      4889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCcee--eecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          223 FGTSKFIAMDQTHV--TTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       223 fg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      ||++..........  .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.....     .......
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~  246 (364)
T 3qyz_A          172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNHILG  246 (364)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-----HHHHHHH
T ss_pred             CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-----HHHHHHH
Confidence            99998765432211  234579999999998665 458999999999999999999999996543211     1111111


Q ss_pred             Hhhcccc---ccccchH--------------HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRKNRL---YHILDDQ--------------VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~~~~---~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .......   .......              .........++++.+|+.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111000   0000000              000111234567999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.2e-44  Score=336.27  Aligned_cols=263  Identities=19%  Similarity=0.281  Sum_probs=206.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC-CCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH-RNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||||+.......      ..+..|+.++..++| +++..+..++...+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            478999999999999999999974 6889999986654332      235679999999976 56666666677788889


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---cCCCcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg  224 (360)
                      +||||+ +++|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||
T Consensus        80 lvme~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             EEEECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCC
Confidence            999999 999999997532    25899999999999999999999999   9999999999999   688999999999


Q ss_pred             CccccCCCCce------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          225 TSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       225 ~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      ++.........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........  ...+.
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~~~i~  229 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK--YEKIS  229 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH--HHHHH
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH--HHHHh
Confidence            99876543321      12245799999999999999999999999999999999999999976543211110  00000


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .......         .......+++++.+++..||+.||++||++.+|++.|+.+...
T Consensus       230 ~~~~~~~---------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          230 EKKVATS---------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHHHHSC---------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hcccccc---------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            0000000         0111223456899999999999999999999999999998654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=330.18  Aligned_cols=264  Identities=23%  Similarity=0.350  Sum_probs=191.2

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEe-
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCL-  141 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~-  141 (360)
                      .++....+|++.+.||+|+||.||++.+. +++.||+|.+.....    ...+.+.+|+.++..+. ||||+++++++. 
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE----EKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH----HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch----HHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            34444568999999999999999999975 688999998754321    34456788999999995 999999999984 


Q ss_pred             -------eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC
Q 040763          142 -------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE  214 (360)
Q Consensus       142 -------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~  214 (360)
                             .....+++|||+. |+|.+++.....  ..++++..++.++.|++.||.|||+++ ++++||||||+|||++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~  173 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSN  173 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECT
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECC
Confidence                   3344789999995 799999876432  235899999999999999999999976 34999999999999999


Q ss_pred             CCcEEEeecCCccccCCCCcee-----------eecccccCCccchhhh---ccCCCCCccchhhhHHHHHHHHhCCCCC
Q 040763          215 RYRAKVADFGTSKFIAMDQTHV-----------TTKIQGTFGYLDPEYH---QSSQLTDKSDVYSFGVVLVELLTGKKPI  280 (360)
Q Consensus       215 ~~~~kl~Dfg~~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~p~  280 (360)
                      ++.+||+|||++..........           .....||+.|+|||++   .+..++.++||||||+++|+|++|+.||
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            9999999999998765432211           1134589999999988   5667889999999999999999999999


Q ss_pred             CCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          281 FSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ........                     .........+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       254 ~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          254 EDGAKLRI---------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ---------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchhHHHh---------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            64321100                     000000011112233588999999999999999999999999988754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.9e-45  Score=333.62  Aligned_cols=257  Identities=12%  Similarity=0.069  Sum_probs=183.2

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc--CCCCceeee-------eE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI--NHRNVVKLL-------GC  139 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l--~h~niv~~~-------~~  139 (360)
                      ..+|.+.+.||+|+||.||+|.+. +++.||+|++....... ....+.+.+|+.++..+  +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS-RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH-HHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc-ccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            355899999999999999999976 68899999988754322 23455667775544444  699988755       44


Q ss_pred             EeeC-----------------CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCC
Q 040763          140 CLET-----------------EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMR------FRVAIEVAGALAYLHSGA  196 (360)
Q Consensus       140 ~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~lh~~~  196 (360)
                      +...                 ...++||||++ ++|.+++.....    .+++..+      ..++.|++.||+|||+++
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKG  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence            4332                 23699999998 899999987532    2344445      678899999999999999


Q ss_pred             CCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHH
Q 040763          197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELL  274 (360)
Q Consensus       197 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~  274 (360)
                         |+||||||+|||++.++.+||+|||++......    .....+|+.|+|||++.+  ..++.++|||||||++|||+
T Consensus       215 ---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell  287 (371)
T 3q60_A          215 ---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW  287 (371)
T ss_dssp             ---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred             ---CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence               999999999999999999999999999865321    223457799999999987  67899999999999999999


Q ss_pred             hCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          275 TGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       275 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +|+.||............          ....................++++.+|+.+||+.||++|||+.++++
T Consensus       288 tg~~Pf~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          288 CLFLPFGLVTPGIKGSWK----------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HSSCSTTBCCTTCTTCCC----------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             hCCCCCCCcCcccccchh----------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999999765321111000          00000000011111112244668999999999999999999999963

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-44  Score=328.54  Aligned_cols=264  Identities=23%  Similarity=0.281  Sum_probs=198.8

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC------
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET------  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~------  143 (360)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.......  .....+.+|+.++..++||||+++++++...      
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            67999999999999999999985 68899999876543332  2234567899999999999999999998873      


Q ss_pred             --CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          144 --EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       144 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                        ...++||||++ ++|.+.+....    ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+
T Consensus        95 ~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           95 CKGSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             --CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             CCceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEc
Confidence              45789999996 47877776532    25899999999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCC---ceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 040763          222 DFGTSKFIAMDQ---THVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       222 Dfg~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      |||++.......   ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+...  ..   .....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~---~~~~i  241 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QH---QLALI  241 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH---HHHHH
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HH---HHHHH
Confidence            999998764322   222334568999999998876 4579999999999999999999999975431  11   11111


Q ss_pred             HHHhhc---cccccccch--------------HHhhh-ccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          298 VHSMRK---NRLYHILDD--------------QVMKL-GKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       298 ~~~~~~---~~~~~~~~~--------------~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......   ..+......              ..... .....++++.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111110   000000000              00000 00112457899999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.4e-44  Score=319.64  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=202.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|.+.+.||+|+||.||++... +++.+|+|.+......    ..+.+.+|+.++..++||||+++++++.+....+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF----RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc----chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            3467999999999999999999986 6889999998754322    2345778999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---cCCCcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg  224 (360)
                      ++|||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||++   +.++.+||+|||
T Consensus        83 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg  154 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG  154 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred             EEEEcCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence            9999999999999997643     5889999999999999999999999   9999999999999   788999999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++......   ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....        .. ....+...
T Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~-~~~~i~~~  222 (304)
T 2jam_A          155 LSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SK-LFEKIKEG  222 (304)
T ss_dssp             TTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HH-HHHHHHHC
T ss_pred             cceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HH-HHHHHHcC
Confidence            98754322   12234689999999999999999999999999999999999999965431        01 11111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .. .     .........++++.+++.+||+.||++|||+.++++
T Consensus       223 ~~-~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          223 YY-E-----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CC-C-----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CC-C-----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            10 0     001112334567999999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.9e-44  Score=326.90  Aligned_cols=271  Identities=21%  Similarity=0.269  Sum_probs=199.9

Q ss_pred             hHHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChH-------HHHhHHHHHHHHHHHhhcCCCCcee
Q 040763           63 SKELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDE-------ELYKLEEFINEIFILSQINHRNVVK  135 (360)
Q Consensus        63 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~  135 (360)
                      ..++....++|.+.+.||+|+||.||+|.+.++..||+|++.......       .....+.+.+|+.++..++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            345667789999999999999999999998889999999876543321       1123467889999999999999999


Q ss_pred             eeeEEeeC-----CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 040763          136 LLGCCLET-----EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNI  210 (360)
Q Consensus       136 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Ni  210 (360)
                      +++++...     ...++||||++ ++|.+++...    ...+++..+..++.|++.||.|||+++   ++||||||+||
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            99998543     35699999996 6888888643    236899999999999999999999999   99999999999


Q ss_pred             EEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 040763          211 LLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE  289 (360)
Q Consensus       211 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~  289 (360)
                      +++.++.+||+|||++.......  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....   
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---  240 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---  240 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred             EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---
Confidence            99999999999999997543322  2334568999999998877 67899999999999999999999999654311   


Q ss_pred             ccchHHHHHHHhhcccc-------------------ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          290 NVSLAAYFVHSMRKNRL-------------------YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       290 ~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        ...............                   ..... ..........++.+.+|+.+||+.||++|||+.++++
T Consensus       241 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          241 --NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA-RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             --HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC-CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh-hhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence              011111111110000                   00000 0011112234567999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.2e-44  Score=330.49  Aligned_cols=264  Identities=23%  Similarity=0.250  Sum_probs=201.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC--------CCCceeeeeEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN--------HRNVVKLLGCC  140 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~--------h~niv~~~~~~  140 (360)
                      .++|++.+.||+|+||+||++.+. +++.||+|++....     ...+.+.+|+.++..++        |+||+++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            478999999999999999999875 57899999986431     23456778999998885        78899999998


Q ss_pred             e----eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCC
Q 040763          141 L----ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       141 ~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~  215 (360)
                      .    .....++||||+ +++|.+++....   ...+++..+..++.|++.||.|||++ +   |+||||||+|||++.+
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~  183 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVN  183 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCC
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEecc
Confidence            7    556789999999 667777775532   23589999999999999999999998 8   9999999999999977


Q ss_pred             C-------------------------------------------------cEEEeecCCccccCCCCceeeecccccCCc
Q 040763          216 Y-------------------------------------------------RAKVADFGTSKFIAMDQTHVTTKIQGTFGY  246 (360)
Q Consensus       216 ~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y  246 (360)
                      +                                                 .+||+|||++......    .....||+.|
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y  259 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGG
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcc
Confidence            5                                                 7999999999865432    2334689999


Q ss_pred             cchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc-ccchHHHHHHHhhcccc---------ccccc-----
Q 040763          247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE-NVSLAAYFVHSMRKNRL---------YHILD-----  311 (360)
Q Consensus       247 ~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~---------~~~~~-----  311 (360)
                      +|||++.+..++.++|||||||++|||++|+.||......... .................         .....     
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            9999999999999999999999999999999999765432211 11111111111110000         00000     


Q ss_pred             ------------hH--HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          312 ------------DQ--VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       312 ------------~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                                  ..  .....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                        00  011235677889999999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.6e-44  Score=332.09  Aligned_cols=200  Identities=25%  Similarity=0.324  Sum_probs=170.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc------CCCCceeeeeEEe
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI------NHRNVVKLLGCCL  141 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l------~h~niv~~~~~~~  141 (360)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|+++...     .....+.+|+.++..+      +|+||+++++++.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            3467999999999999999999876 58899999987532     2234556677777766      5789999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc--EE
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR--AK  219 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~--~k  219 (360)
                      .....+++|||+. ++|.+++....   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.  +|
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vk  242 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIK  242 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEE
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceE
Confidence            9999999999995 79999997643   225899999999999999999999999   999999999999999887  99


Q ss_pred             EeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 040763          220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG  284 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~  284 (360)
                      |+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus       243 L~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          243 VIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             ECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999754322    233578999999999999999999999999999999999999996543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-44  Score=316.87  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=196.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|.+...... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            468999999999999999999986 6889999987653211 11234567899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++..
T Consensus        89 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             EEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccc
Confidence            999999999999997653     4889999999999999999999999   99999999999999999999999999976


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .....  ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.....        .. .........  
T Consensus       161 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~-~~~~~~~~~--  227 (276)
T 2h6d_A          161 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PT-LFKKIRGGV--  227 (276)
T ss_dssp             CCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHCC--
T ss_pred             cCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HH-HHHHhhcCc--
Confidence            54332  1233468999999999988765 6899999999999999999999964321        01 111111111  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                              ...+...+.++.+++.+||+.||++|||+.++++
T Consensus       228 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 --------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                    0112234557899999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-44  Score=341.59  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=203.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3467999999999999999999986 68899999875432211 123556789999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---cCCCcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL---DERYRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg  224 (360)
                      +||||+.+++|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||
T Consensus       103 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            9999999999999997543     5889999999999999999999999   9999999999999   567899999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++.......  ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+...        .. ....+...
T Consensus       175 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~-~~~~i~~~  242 (484)
T 3nyv_A          175 LSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YD-ILKKVEKG  242 (484)
T ss_dssp             HHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHC
T ss_pred             eeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HH-HHHHHHcC
Confidence            997664432  2234569999999999876 689999999999999999999999965431        00 11111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ... .     ..+.....++++.+|+.+||+.||++|||+.++++
T Consensus       243 ~~~-~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          243 KYT-F-----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCC-C-----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC-C-----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            110 0     00111234567999999999999999999999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.6e-45  Score=333.27  Aligned_cols=260  Identities=23%  Similarity=0.306  Sum_probs=195.1

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF----  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~----  145 (360)
                      ..+|.+.+.||+|+||.||+|.+..+..+|+|++......        ..+|+.+++.++||||+++++++.....    
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            4579999999999999999999987777999987543221        1268999999999999999999865443    


Q ss_pred             --ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc-CCCcEEEee
Q 040763          146 --PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVAD  222 (360)
Q Consensus       146 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~D  222 (360)
                        .++||||+++ ++...+..... ....+++..+..++.|++.||.|||+++   |+||||||+|||++ .++.+||+|
T Consensus       111 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~D  185 (394)
T 4e7w_A          111 VFLNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLID  185 (394)
T ss_dssp             EEEEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             eEEEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEee
Confidence              7899999975 44444432211 1236899999999999999999999999   99999999999999 799999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||++........  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....     ....+....
T Consensus       186 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----~l~~i~~~~  258 (394)
T 4e7w_A          186 FGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-----QLVEIIKVL  258 (394)
T ss_dssp             CTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHH
T ss_pred             CCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHh
Confidence            999987643322  2345689999999998764 58999999999999999999999997643211     011111111


Q ss_pred             hc---------------cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RK---------------NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..               ..........+....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            00               0011111111222233345678999999999999999999999975

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=318.36  Aligned_cols=251  Identities=27%  Similarity=0.379  Sum_probs=199.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+.....      .+.+.+|+.++..++||||+++++++......+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            4577999999999999999999986 588999998865422      345778999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||+++++|.+++....    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus       101 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccch
Confidence            9999999999999997432    25899999999999999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....       . .... ........
T Consensus       174 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~-~~~~-~~~~~~~~  243 (314)
T 3com_A          174 QLTDTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------M-RAIF-MIPTNPPP  243 (314)
T ss_dssp             ECBTTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------H-HHHH-HHHHSCCC
T ss_pred             hhhhhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------H-HHHH-HHhcCCCc
Confidence            654332 222344689999999999999999999999999999999999999965331       0 0000 11111100


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..       ..+..++.++.+++.+||+.||++|||+.++++
T Consensus       244 ~~-------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          244 TF-------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CC-------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cc-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00       112334567999999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.7e-45  Score=329.89  Aligned_cols=260  Identities=23%  Similarity=0.287  Sum_probs=184.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC----
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET----  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----  143 (360)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++...    
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            3478999999999999999999875 68899999987643332  3456778999999999999999999998654    


Q ss_pred             --CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          144 --EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       144 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                        ...++++|++ +++|.+++..      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             GCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEe
Confidence              5579999998 7899988854      25899999999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      |||++......    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....     .....+...
T Consensus       175 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~l~~i~~~  245 (367)
T 2fst_X          175 DFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRL  245 (367)
T ss_dssp             C-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHH
T ss_pred             ecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHH
Confidence            99999764322    234578999999999887 67899999999999999999999999654321     111111111


Q ss_pred             hhccc---cccccchHH--------------hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          301 MRKNR---LYHILDDQV--------------MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       301 ~~~~~---~~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .....   +..+.....              ........++++.+|+.+||+.||++|||+.++++
T Consensus       246 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          246 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            11100   000000000              00001123567899999999999999999999974

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=317.58  Aligned_cols=254  Identities=22%  Similarity=0.245  Sum_probs=198.7

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe--eCCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL--ETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~--~~~~~  146 (360)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|.+............+.+.+|+.++..++||||+++++++.  .....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999975 678999999875432221234567889999999999999999999984  45578


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||++++ |.+++....   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence            9999999765 777776532   236899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCC-ceeeecccccCCccchhhhccCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          227 KFIAMDQ-THVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       227 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ....... ........||+.|+|||++.+..  ++.++||||||+++|+|++|..||.+...        .. ....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~-~~~~i~~  227 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YK-LFENIGK  227 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HH-HHHHHHH
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HH-HHHHHhc
Confidence            8764322 22233456899999999988644  37799999999999999999999965321        11 1111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...          ..+..+++++.+++.+||+.||++|||+.++++
T Consensus       228 ~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          228 GSY----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             CCC----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCC----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            110          122334567899999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=333.42  Aligned_cols=269  Identities=23%  Similarity=0.310  Sum_probs=183.4

Q ss_pred             cCCCc-cceecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--CC
Q 040763           71 NHFNV-NRILGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--TE  144 (360)
Q Consensus        71 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~  144 (360)
                      +.|.+ .++||+|+||+||+|.++   +++.||+|.+......      ..+.+|+.+++.++||||+++++++..  ..
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------MSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC------HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC------HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            34555 457999999999999965   4788999998754322      346689999999999999999999954  66


Q ss_pred             cceEEEEecCCCChhHHhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----cCCC
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQ----NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL----DERY  216 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill----~~~~  216 (360)
                      ..++||||+. ++|.+++.....    .....+++..+..++.|++.||.|||+++   |+||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCC
Confidence            7899999995 688888864321    12234899999999999999999999999   9999999999999    7789


Q ss_pred             cEEEeecCCccccCCCCc--eeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccccc--
Q 040763          217 RAKVADFGTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV--  291 (360)
Q Consensus       217 ~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~--  291 (360)
                      .+||+|||++........  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........  
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  249 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  249 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence            999999999987653221  223446789999999998874 589999999999999999999999976543211110  


Q ss_pred             --chHHHHHHHhhccc---ccccc---ch------------------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 040763          292 --SLAAYFVHSMRKNR---LYHIL---DD------------------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTME  345 (360)
Q Consensus       292 --~~~~~~~~~~~~~~---~~~~~---~~------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  345 (360)
                        .....+...+....   +..+.   ..                  ..........++++.+|+.+||+.||++|||+.
T Consensus       250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence              11111111111111   00000   00                  000000001145789999999999999999999


Q ss_pred             HHHH
Q 040763          346 EVSM  349 (360)
Q Consensus       346 ei~~  349 (360)
                      |+++
T Consensus       330 e~L~  333 (405)
T 3rgf_A          330 QAMQ  333 (405)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.6e-44  Score=349.40  Aligned_cols=247  Identities=25%  Similarity=0.296  Sum_probs=202.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      ..++|++.+.||+|+||.||++.++ +++.||+|+++..... .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            4478999999999999999999976 5788999998753211 112345667889999887 799999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      |+||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++++||+|||++
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             EEEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence            99999999999999998653     4889999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      +...... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||.+...        ...+.... ... 
T Consensus       490 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~-~~~-  558 (674)
T 3pfq_A          490 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIM-EHN-  558 (674)
T ss_dssp             EECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-SSC-
T ss_pred             eccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHH-hCC-
Confidence            8643222 224456799999999999999999999999999999999999999975431        11111111 111 


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM  344 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  344 (360)
                               ...+...++++.+|+.+||+.||++||++
T Consensus       559 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          559 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             ---------CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence                     11234456789999999999999999997

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.1e-44  Score=320.08  Aligned_cols=256  Identities=24%  Similarity=0.299  Sum_probs=196.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccCh----HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDD----EELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      ..++|.+.+.||+|+||.||++.+. +++.||+|.+......    ........+.+|+.++..++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999976 5789999987653211    1112233577899999999999999999998765


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc---EEE
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AKV  220 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~---~kl  220 (360)
                      . .++||||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.   +||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence            5 799999999999999986532     5889999999999999999999999   999999999999987654   999


Q ss_pred             eecCCccccCCCCceeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 040763          221 ADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      +|||++.......  ......||+.|+|||++.   ...++.++||||||+++|+|++|..||.......    .+....
T Consensus       159 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~  232 (322)
T 2ycf_A          159 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQI  232 (322)
T ss_dssp             CCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHHHH
T ss_pred             ccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHHHH
Confidence            9999998664322  123346899999999874   4678899999999999999999999996543211    111111


Q ss_pred             HHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ...... . ...    .....++++.+++.+||+.||++|||+.++++
T Consensus       233 ----~~~~~~-~-~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 ----TSGKYN-F-IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ----HHTCCC-C-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----HhCccc-c-Cch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                111110 0 011    11224567999999999999999999999974

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-45  Score=326.02  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=197.7

Q ss_pred             ChHHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeE
Q 040763           62 SSKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGC  139 (360)
Q Consensus        62 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~  139 (360)
                      +..++....++|++.+.||+|+||.||+|.+. +++.||+|.+......     .+.+.+|+.++..+ +||||++++++
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~   89 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-----EEEIKQEINMLKKYSHHRNIATYYGA   89 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-----THHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-----HHHHHHHHHHHHhccCCCCeeeeeeE
Confidence            33344455688999999999999999999985 6889999997654322     34567899999998 89999999999


Q ss_pred             Eee------CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          140 CLE------TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       140 ~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      +..      ....++||||+++++|.+++....   ...+++..+..++.|++.||.|||+++   ++|+||||+||+++
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~  163 (326)
T 2x7f_A           90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT  163 (326)
T ss_dssp             EEECC--CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC
T ss_pred             EeeccCccccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEc
Confidence            976      457899999999999999997642   225889999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcc
Q 040763          214 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ  288 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~  288 (360)
                      .++.+||+|||++....... .......||+.|+|||++.     +..++.++||||||+++|+|++|..||.+...   
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---  239 (326)
T 2x7f_A          164 ENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---  239 (326)
T ss_dssp             TTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---
T ss_pred             CCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---
Confidence            99999999999987654321 1223346899999999987     56688999999999999999999999964331   


Q ss_pred             cccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          289 ENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ..... .........        ..+..+++++.+++.+||+.||++|||+.++++
T Consensus       240 -----~~~~~-~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          240 -----MRALF-LIPRNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             -----HHHHH-HHHHSCCCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -----HHHHH-HhhcCcccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 00001 111111111        112234557999999999999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=315.77  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=197.3

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      +|.....||+|+||.||+|.+. ++..||+|.+.....    ...+.+.+|+.++..++||||+++++++...+..++||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch----HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            3445568999999999999975 678999998765432    23456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEeecCCcccc
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVADFGTSKFI  229 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~  229 (360)
                      ||+++++|.+++....  ....+++..+..++.|++.||.|||+++   ++|+||||+||+++. ++.+||+|||++...
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           99 EQVPGGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             ECCSEEEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EeCCCCCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            9999999999997642  2234678889999999999999999999   999999999999987 899999999999765


Q ss_pred             CCCCceeeecccccCCccchhhhccCC--CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..... ......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.......      ......... .   
T Consensus       174 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-~---  242 (295)
T 2clq_A          174 AGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMF-K---  242 (295)
T ss_dssp             CC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHH-C---
T ss_pred             CCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhccc-c---
Confidence            43221 223446899999999987754  7889999999999999999999996432110      000000000 0   


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            .....+...++++.+++.+||+.||++|||+.++++
T Consensus       243 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 ------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  011223345668999999999999999999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-43  Score=322.59  Aligned_cols=259  Identities=23%  Similarity=0.300  Sum_probs=197.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc-
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP-  146 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~-  146 (360)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++.......  ...+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch--hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            3478999999999999999999876 68899999987644332  3456778999999999999999999999877665 


Q ss_pred             -----eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          147 -----LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       147 -----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                           ++||||+. ++|.+++..       .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred             cceeEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEE
Confidence                 99999996 688887743       4889999999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHH
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS  300 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  300 (360)
                      |||++......    .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.....     ........
T Consensus       187 Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~  257 (371)
T 4exu_A          187 DFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILKV  257 (371)
T ss_dssp             STTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHH
T ss_pred             ecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHH
Confidence            99999754322    234568999999999887 678999999999999999999999996543110     00001100


Q ss_pred             hhccc--cccccchH---------------HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          301 MRKNR--LYHILDDQ---------------VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       301 ~~~~~--~~~~~~~~---------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .....  ....+...               .........++++.+|+.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            00000  00000000               000111234668999999999999999999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.9e-44  Score=314.69  Aligned_cols=256  Identities=24%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccC-----hHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEe
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVD-----DEELYKLEEFINEIFILSQIN-HRNVVKLLGCCL  141 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~-----~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~  141 (360)
                      ..++|++.+.||+|+||.||++.++ +++.||+|.+.....     .......+.+.+|+.++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999986 688999999765431     111233456789999999995 999999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                      .....++||||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence            9999999999999999999997643     5889999999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhc------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHH
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQ------SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA  295 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  295 (360)
                      |||++.......  ......||+.|+|||++.      ...++.++||||||+++|+|++|..||.....        ..
T Consensus       167 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~  236 (298)
T 1phk_A          167 DFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------ML  236 (298)
T ss_dssp             CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH
T ss_pred             cccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------HH
Confidence            999997764332  223456899999999875      45678899999999999999999999965321        00


Q ss_pred             HHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      . .......... .     ........++++.+++.+||+.||++|||+.++++
T Consensus       237 ~-~~~~~~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          237 M-LRMIMSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             H-HHHHHHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H-HHHHhcCCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1 1111111100 0     00111234567999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3e-44  Score=322.28  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=181.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHH-HHhhcCCCCceeeeeEEeeCCcc
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIF-ILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~-~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ..++|++.+.||+|+||.||++..+ +++.||+|.+.......   ....+..|+. +++.++||||+++++++...+..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK---EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH---HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch---HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            3478999999999999999999986 68899999987654332   2334455655 67778999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      ++||||++ ++|.+++..........+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||+
T Consensus        97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence            99999996 5888888654333344689999999999999999999998 8   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhh----ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYH----QSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      +.......  ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||...........        ..
T Consensus       173 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------~~  242 (327)
T 3aln_A          173 SGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT--------QV  242 (327)
T ss_dssp             SCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C--------CC
T ss_pred             ceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH--------HH
Confidence            97654322  12233689999999998    456789999999999999999999999965432110000        00


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......     .........+++++.+|+.+||+.||++|||+.++++
T Consensus       243 ~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000000     0111111234567999999999999999999999965

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-43  Score=315.05  Aligned_cols=253  Identities=26%  Similarity=0.373  Sum_probs=198.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|.+.....    ...+.+.+|+.++..++||||+++++++...+..+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH----HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            3478999999999999999999986 588999998765322    23567788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      +||||+++++|.+++.....    .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.
T Consensus        93 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             EEEEeCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            99999999999999876432    5899999999999999999999999   9999999999999999999999999875


Q ss_pred             ccCCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ..... ........||+.|+|||++.     +..++.++||||||+++|+|++|..||.....        .........
T Consensus       166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~  236 (302)
T 2j7t_A          166 KNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAK  236 (302)
T ss_dssp             HHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH
T ss_pred             ccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhc
Confidence            43211 11122346899999999883     56788999999999999999999999865431        011111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      . .....       ..+..++.++.+++.+||+.||++|||+.++++
T Consensus       237 ~-~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          237 S-DPPTL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             S-CCCCC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             c-CCccc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1 11000       112334567999999999999999999999964

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.4e-43  Score=317.40  Aligned_cols=262  Identities=21%  Similarity=0.269  Sum_probs=198.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC-----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-----  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----  143 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+......   .....+.+|+.++..++||||+++++++...     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP---LFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc---hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            478999999999999999999986 6889999998653322   3345677899999999999999999987654     


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...+++|||+. ++|.+++...      .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+||
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred             ceEEEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEec
Confidence            56799999996 6999988652      4889999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCce---------eeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch
Q 040763          224 GTSKFIAMDQTH---------VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL  293 (360)
Q Consensus       224 g~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~  293 (360)
                      |++.........         ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.....     .
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~  231 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-----Q  231 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----H
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----H
Confidence            999876432211         1223468999999998765 678999999999999999999999996543100     0


Q ss_pred             HHHHHHHhhccc----cccccch--------------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          294 AAYFVHSMRKNR----LYHILDD--------------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       294 ~~~~~~~~~~~~----~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ............    .......              ..........++++.+|+.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000111100000    0000000              0001112245668999999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.5e-44  Score=319.15  Aligned_cols=258  Identities=23%  Similarity=0.330  Sum_probs=198.8

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC--CCCceeeeeEEe
Q 040763           64 KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN--HRNVVKLLGCCL  141 (360)
Q Consensus        64 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~  141 (360)
                      ..+....++|++.+.||+|+||.||++...+++.+|+|.+.......  ...+.+.+|+.++..++  ||||+++++++.
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc--cchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            33444567899999999999999999999889999999986543332  34567889999999996  599999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                      ..+..+++|| +.+++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||++++ +.+||+
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEEC
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEe
Confidence            9999999999 56899999997643     5889999999999999999999999   999999999999965 799999


Q ss_pred             ecCCccccCCCCce-eeecccccCCccchhhhcc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 040763          222 DFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQS-----------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE  289 (360)
Q Consensus       222 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~  289 (360)
                      |||++......... ......||+.|+|||.+.+           ..++.++||||||+++|+|++|..||......   
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---  245 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---  245 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---
Confidence            99999876443222 2234468999999999875           46788999999999999999999999653310   


Q ss_pred             ccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ...........         .....+...++++.+++.+||+.||++|||+.++++
T Consensus       246 ----~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          246 ----ISKLHAIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ----HHHHHHHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHHHhcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                11111111111         111112223457999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-43  Score=328.89  Aligned_cols=259  Identities=25%  Similarity=0.332  Sum_probs=194.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC------
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET------  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~------  143 (360)
                      .+|++.+.||+|+||.||+|.+. +++.||+|++......        ..+|+.+++.++||||+++++++...      
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh--------HHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            46899999999999999999986 5899999987643221        23689999999999999999998542      


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC-CcEEEee
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER-YRAKVAD  222 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~D  222 (360)
                      ...++||||+++ ++.+.+..... ....+++..+..++.|++.||.|||+++   |+||||||+|||++.+ +.+||+|
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEecc
Confidence            235789999964 67776654321 2336899999999999999999999999   9999999999999955 6789999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....     ....+....
T Consensus       201 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-----~l~~i~~~l  273 (420)
T 1j1b_A          201 FGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-----QLVEIIKVL  273 (420)
T ss_dssp             CTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHH
T ss_pred             chhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHh
Confidence            999987543322  2335689999999998764 78999999999999999999999997643111     111111111


Q ss_pred             hcc---------------ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKN---------------RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...               ....+....+....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            000               001111111222233345678999999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-43  Score=317.71  Aligned_cols=265  Identities=23%  Similarity=0.330  Sum_probs=199.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEec--CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc---CCCCceeeeeEEe--
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI---NHRNVVKLLGCCL--  141 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l---~h~niv~~~~~~~--  141 (360)
                      ..++|++.+.||+|+||.||++.+.  +++.||+|.+........  ....+.+|+.+++.+   +||||+++++++.  
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc--CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            4578999999999999999999983  578899998765432211  112344666666665   8999999999987  


Q ss_pred             ---eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcE
Q 040763          142 ---ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA  218 (360)
Q Consensus       142 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~  218 (360)
                         .....++||||++ ++|.+++....   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCE
Confidence               4567899999997 69999997643   224889999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          219 KVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       219 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      ||+|||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....     .......
T Consensus       160 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~  232 (326)
T 1blx_A          160 KLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKIL  232 (326)
T ss_dssp             EECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH
T ss_pred             EEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH
Confidence            999999997654322  223456899999999999999999999999999999999999999754321     1111111


Q ss_pred             HHhhcc---cccccc----------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          299 HSMRKN---RLYHIL----------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       299 ~~~~~~---~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......   .+....          ............++++.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111110   000000          000011122345668999999999999999999999984

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-44  Score=326.95  Aligned_cols=265  Identities=21%  Similarity=0.337  Sum_probs=203.5

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHH-------------HhHHHHHHHHHHHhhcCCCCceee
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEEL-------------YKLEEFINEIFILSQINHRNVVKL  136 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~niv~~  136 (360)
                      .++|.+.+.||+|+||.||++.. +++.||+|.+.........             ...+.+.+|+.++..++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999999999 8999999987653211100             011678899999999999999999


Q ss_pred             eeEEeeCCcceEEEEecCCCChhHHhhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEE
Q 040763          137 LGCCLETEFPLLVYEFIPNGTLYQHLHDR---HQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILL  212 (360)
Q Consensus       137 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill  212 (360)
                      ++++.+.+..++||||+++++|.+++...   .......+++..+..++.|++.||.|||+ ++   ++||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence            99999999999999999999999983211   01113468999999999999999999999 88   9999999999999


Q ss_pred             cCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccC-CCCC-ccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 040763          213 DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQEN  290 (360)
Q Consensus       213 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~el~tg~~p~~~~~~~~~~~  290 (360)
                      +.++.+||+|||++......   ......||+.|+|||.+.+. .++. ++||||||+++|+|++|..||......    
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            99999999999999865433   33445689999999999887 6666 999999999999999999999754321    


Q ss_pred             cchHHHHHHHhhccccccc---------cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          291 VSLAAYFVHSMRKNRLYHI---------LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         .. ....+........         .............++++.+|+.+||+.||++|||+.++++
T Consensus       259 ---~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 ---VE-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ---HH-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HH-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               01 1111111110000         0000001111345668999999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=321.21  Aligned_cols=266  Identities=23%  Similarity=0.393  Sum_probs=201.3

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC
Q 040763           64 KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET  143 (360)
Q Consensus        64 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~  143 (360)
                      .+.....++|++.+.||+|+||.||+|.+.+  .+|+|.+.......  ...+.+.+|+.++..++||||+++++++...
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE--DQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC--CCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH--HHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            3444456889999999999999999998764  48999877543221  1233456799999999999999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...+++|||+++++|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||+++ ++.+||+||
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCC
T ss_pred             CceEEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeec
Confidence            99999999999999999996532    35888999999999999999999999   99999999999998 679999999


Q ss_pred             CCccccCCCC----ceeeecccccCCccchhhhcc---------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 040763          224 GTSKFIAMDQ----THVTTKIQGTFGYLDPEYHQS---------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN  290 (360)
Q Consensus       224 g~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~  290 (360)
                      |++.......    ........||+.|+|||.+.+         ..++.++||||||+++|+|++|..||.....     
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----  248 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----  248 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            9987653211    111223458999999998875         3478899999999999999999999965331     


Q ss_pred             cchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          291 VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                         .. .............        .+...++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       249 ---~~-~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          249 ---EA-IIWQMGTGMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             ---HH-HHHHHHTTCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ---HH-HHHHhccCCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence               00 1111111111111        11123446899999999999999999999999999887653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=319.79  Aligned_cols=258  Identities=22%  Similarity=0.293  Sum_probs=196.5

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc---
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF---  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~---  145 (360)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|.+.......  ...+.+.+|+.++..++||||+++++++.....   
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            467999999999999999999976 68899999987644332  335567899999999999999999999987654   


Q ss_pred             ---ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          146 ---PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       146 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                         .+++|||+. ++|.+++..       .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECS
T ss_pred             ceeEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEee
Confidence               499999996 688877743       4889999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||++......    .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.....     .........
T Consensus       170 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~  240 (353)
T 3coi_A          170 FGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILKVT  240 (353)
T ss_dssp             TTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-----HHHHHHHHH
T ss_pred             cccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHh
Confidence            9999764322    233468999999999887 678999999999999999999999997543110     011111100


Q ss_pred             hccc---cccccch--------------HHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNR---LYHILDD--------------QVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~---~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....   ...+.+.              ..........++++.+|+.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000   0000000              0001112345678999999999999999999999974

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-43  Score=313.67  Aligned_cols=251  Identities=28%  Similarity=0.448  Sum_probs=191.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee------
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE------  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------  142 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+...  .   ...+.+.+|+.++..++||||+++++++..      
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--E---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--H---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--H---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            467999999999999999999975 6889999988542  1   335678899999999999999999998865      


Q ss_pred             -------CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC
Q 040763          143 -------TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       143 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~  215 (360)
                             ....++||||+++++|.+++....    ..+++..++.++.|++.||+|||+++   ++||||||+||+++.+
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~  152 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES  152 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence                   346789999999999999997532    24778899999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCccccCCCC-------------ceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCC
Q 040763          216 YRAKVADFGTSKFIAMDQ-------------THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIF  281 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~  281 (360)
                      +.+||+|||++.......             ........||+.|+|||++.+. .++.++||||||+++|+|++   ||.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence            999999999997654321             1112334689999999998864 68999999999999999998   553


Q ss_pred             CCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          282 STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...    ..    ...........      .......+...++.+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~----~~----~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          230 TGM----ER----VNILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             SHH----HH----HHHHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cch----hH----HHHHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            211    00    00111111110      01112233445567899999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.8e-43  Score=309.30  Aligned_cols=253  Identities=24%  Similarity=0.373  Sum_probs=202.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||++... +++.||+|.+.......  ...+.+.+|+.++++++||||+++++++......+
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch--HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            3467999999999999999999986 68899999876543221  23456789999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC---CcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER---YRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg  224 (360)
                      ++|||+++++|.+++....     .+++..+..++.|++.||.|||+++   ++|+||||+||+++.+   +.+||+|||
T Consensus        98 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             EEEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence            9999999999999987643     4889999999999999999999999   9999999999999754   479999999


Q ss_pred             CccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          225 TSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       225 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      ++........  .....||+.|+|||.+.+. ++.++||||||+++|+|++|..||.+...        .. ........
T Consensus       170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~-~~~~~~~~  237 (287)
T 2wei_A          170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE--------YD-ILKRVETG  237 (287)
T ss_dssp             GGGTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHHHHHC
T ss_pred             cceeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHcC
Confidence            9976543321  2234588999999988764 89999999999999999999999965431        01 11111111


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....  .    .......++++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~--~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          238 KYAF--D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCC--C----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC--C----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            1100  0    0011234567999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.2e-43  Score=318.94  Aligned_cols=271  Identities=21%  Similarity=0.237  Sum_probs=190.3

Q ss_pred             ChHHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEE
Q 040763           62 SSKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCC  140 (360)
Q Consensus        62 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~  140 (360)
                      .........++|++.+.||+|+||.||+|.+. +++.||+|++......     .....+++..+..++||||+++++++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~   88 (360)
T 3e3p_A           14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYF   88 (360)
T ss_dssp             SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhh
Confidence            34456667789999999999999999999986 6889999987543222     22345677888889999999999998


Q ss_pred             eeCCc-------ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCeE
Q 040763          141 LETEF-------PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH--SGASSPIYHRDIKSTNIL  211 (360)
Q Consensus       141 ~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~~i~H~dlk~~Nil  211 (360)
                      .....       .++||||+++ +|...+.... .....+++..+..++.|++.||.|||  +++   |+||||||+|||
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIl  163 (360)
T 3e3p_A           89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVL  163 (360)
T ss_dssp             EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEE
T ss_pred             hccccccccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEE
Confidence            76443       7899999975 6655554322 12336889999999999999999999  888   999999999999


Q ss_pred             EcC-CCcEEEeecCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 040763          212 LDE-RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE  289 (360)
Q Consensus       212 l~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~  289 (360)
                      ++. ++.+||+|||++........  .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.....  
T Consensus       164 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--  239 (360)
T 3e3p_A          164 VNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--  239 (360)
T ss_dssp             EETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             EeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--
Confidence            996 89999999999987654322  2345689999999998765 48999999999999999999999997643211  


Q ss_pred             ccchHHHHHHHhhcc------------ccccc------cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          290 NVSLAAYFVHSMRKN------------RLYHI------LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       290 ~~~~~~~~~~~~~~~------------~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                         ............            .....      .............++++.+|+.+||+.||++|||+.|+++
T Consensus       240 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          240 ---QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             ---HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence               111111110000            00000      0011111122235678999999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.7e-43  Score=313.99  Aligned_cols=259  Identities=22%  Similarity=0.300  Sum_probs=200.6

Q ss_pred             hcCCCccceecccCcEEEEEEEe-c-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCC------CceeeeeEEe
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRL-E-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR------NVVKLLGCCL  141 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~------niv~~~~~~~  141 (360)
                      .++|++.+.||+|+||.||++.+ . +++.||+|+++...     ...+.+.+|+.++..++|+      +++++++++.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            46899999999999999999987 3 67899999986431     2345667888888888655      4999999999


Q ss_pred             eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-------
Q 040763          142 ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-------  214 (360)
Q Consensus       142 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-------  214 (360)
                      ..+..++||||+ +++|.+++....   ..++++..+..++.|++.||+|||+++   ++||||||+||+++.       
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEE
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecccccccc
Confidence            999999999999 899999997643   235889999999999999999999999   999999999999987       


Q ss_pred             ------------CCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 040763          215 ------------RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS  282 (360)
Q Consensus       215 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~  282 (360)
                                  ++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|..||..
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                        678999999999764332    2334689999999999999999999999999999999999999965


Q ss_pred             CCCCcccccchHHHHHHHhhccc-------------------cccccc-----------hHHhhhccHHHHHHHHHHHHH
Q 040763          283 TGNTSQENVSLAAYFVHSMRKNR-------------------LYHILD-----------DQVMKLGKKNQIVAFANLAER  332 (360)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~-----------~~~~~~~~~~~~~~l~~li~~  332 (360)
                      .....     .............                   +.....           .......+...++++.+|+.+
T Consensus       237 ~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  311 (339)
T 1z57_A          237 HDSKE-----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK  311 (339)
T ss_dssp             SCHHH-----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CChHH-----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence            43211     0011111100000                   000000           000011234567789999999


Q ss_pred             hhcCCCCCCCCHHHHHH
Q 040763          333 CLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       333 cl~~dp~~Rpt~~ei~~  349 (360)
                      ||+.||++|||+.|+++
T Consensus       312 ~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          312 MLEYDPAKRITLREALK  328 (339)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HhCcCcccccCHHHHhc
Confidence            99999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.1e-43  Score=321.35  Aligned_cols=264  Identities=21%  Similarity=0.265  Sum_probs=198.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-----------CCCceeee
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-----------HRNVVKLL  137 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-----------h~niv~~~  137 (360)
                      ..+|.+.+.||+|+||.||+|.+. +++.||+|.+....     ...+.+.+|+.++..++           ||||++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-----cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            367999999999999999999975 68899999986421     23445678888888875           89999999


Q ss_pred             eEEeeCC----cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEE
Q 040763          138 GCCLETE----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILL  212 (360)
Q Consensus       138 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill  212 (360)
                      +++....    ..+++||++ +++|.+++....   ...+++..+..++.|++.||.|||++ +   |+||||||+|||+
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll  165 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM  165 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEE
Confidence            9988654    678999999 899999997642   22588999999999999999999998 8   9999999999999


Q ss_pred             c------CCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCC
Q 040763          213 D------ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNT  286 (360)
Q Consensus       213 ~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~  286 (360)
                      +      ..+.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|..||.+....
T Consensus       166 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          166 EIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             eccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence            4      4458999999999765432    23346899999999999999999999999999999999999999754321


Q ss_pred             ccc-ccchHHHHHHHhhccc-------------------cccc-------cch--HHhhhccHHHHHHHHHHHHHhhcCC
Q 040763          287 SQE-NVSLAAYFVHSMRKNR-------------------LYHI-------LDD--QVMKLGKKNQIVAFANLAERCLDLN  337 (360)
Q Consensus       287 ~~~-~~~~~~~~~~~~~~~~-------------------~~~~-------~~~--~~~~~~~~~~~~~l~~li~~cl~~d  337 (360)
                      ... ...............+                   +..+       ...  ......+...++++.+|+.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence            111 0011111111111000                   0000       000  0112245678889999999999999


Q ss_pred             CCCCCCHHHHHH
Q 040763          338 GKKRPTMEEVSM  349 (360)
Q Consensus       338 p~~Rpt~~ei~~  349 (360)
                      |++|||+.|+++
T Consensus       322 P~~Rpt~~ell~  333 (373)
T 1q8y_A          322 PRKRADAGGLVN  333 (373)
T ss_dssp             TTTCBCHHHHHT
T ss_pred             ccccCCHHHHhh
Confidence            999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.4e-43  Score=327.96  Aligned_cols=254  Identities=27%  Similarity=0.361  Sum_probs=187.1

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +.|.+.+.||+|+||+||.+...+|+.||+|++...       ..+.+.+|+.++..+ +||||+++++++.+....++|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            445667889999999998776667999999987642       123456899999876 899999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC------------
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEY--PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER------------  215 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~------------  215 (360)
                      |||+. |+|.+++.........  ..++..++.++.|++.||+|||+++   |+||||||+|||++.+            
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCC
Confidence            99995 6999999764322110  1123345789999999999999999   9999999999999754            


Q ss_pred             -CcEEEeecCCccccCCCCce---eeecccccCCccchhhhcc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 040763          216 -YRAKVADFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQS-------SQLTDKSDVYSFGVVLVELLT-GKKPIFST  283 (360)
Q Consensus       216 -~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~p~~~~  283 (360)
                       +.+||+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             48999999999876543322   1234579999999999876       568899999999999999999 99998543


Q ss_pred             CCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          284 GNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..  .     ........  ...     .......+...++++.+++.+||+.||++|||+.++++
T Consensus       244 ~~--~-----~~~i~~~~--~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          244 YS--R-----ESNIIRGI--FSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TT--H-----HHHHHHTC--CCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hh--h-----HHHHhcCC--CCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            21  0     01111100  000     01112234567789999999999999999999999974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-42  Score=316.09  Aligned_cols=203  Identities=25%  Similarity=0.334  Sum_probs=170.1

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CC-----Cceeeee
Q 040763           66 LDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HR-----NVVKLLG  138 (360)
Q Consensus        66 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~-----niv~~~~  138 (360)
                      .....++|++.+.||+|+||+||+|.+. +++.||+|+++...     .....+..|+.++..++ |+     +++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            3445678999999999999999999876 67889999987431     22345667888887774 44     4999999


Q ss_pred             EEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEecCCCCCCeEEc--C
Q 040763          139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS--GASSPIYHRDIKSTNILLD--E  214 (360)
Q Consensus       139 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~~i~H~dlk~~Nill~--~  214 (360)
                      ++...+..++||||++ ++|.+++....   ...+++..+..++.|++.||.|||+  .+   |+||||||+|||++  .
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPK  196 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTT
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCC
Confidence            9999999999999995 69999997643   2258899999999999999999995  56   99999999999995  5


Q ss_pred             CCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 040763          215 RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG  284 (360)
Q Consensus       215 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~  284 (360)
                      ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus       197 ~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             SCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            788999999999876432    234568999999999999999999999999999999999999997543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.4e-44  Score=320.16  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=199.2

Q ss_pred             cccChHHHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH--HHhHHHHHHHHHHHhhcC--CCCc
Q 040763           59 KLFSSKELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE--LYKLEEFINEIFILSQIN--HRNV  133 (360)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~--~~~~~~~~~e~~~~~~l~--h~ni  133 (360)
                      +..+..+.....++|++.+.||+|+||.||+|.+. +++.||+|.+........  ....+.+.+|+.++..++  |+||
T Consensus        31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           31 KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             ---------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             ccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            44455566667789999999999999999999875 688999998765432210  011123457899999995  5999


Q ss_pred             eeeeeEEeeCCcceEEEEecCC-CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 040763          134 VKLLGCCLETEFPLLVYEFIPN-GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL  212 (360)
Q Consensus       134 v~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill  212 (360)
                      +++++++...+..+++||++.+ ++|.+++....     .+++..+..++.|++.||.|||+++   ++||||||+||++
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll  182 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILI  182 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEE
Confidence            9999999999999999999976 89999997643     5889999999999999999999999   9999999999999


Q ss_pred             c-CCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 040763          213 D-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN  290 (360)
Q Consensus       213 ~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~  290 (360)
                      + +++.+||+|||++.......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....      
T Consensus       183 ~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------  253 (320)
T 3a99_A          183 DLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------  253 (320)
T ss_dssp             ETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred             eCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------
Confidence            9 78999999999998765322   233468999999999887766 678999999999999999999985321      


Q ss_pred             cchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          291 VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                              .... ...          ..+...++++.+++.+||+.||++|||+.++++
T Consensus       254 --------~~~~-~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 --------EIIR-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --------HHHH-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------hhhc-ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    0000 000          012234457999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9e-43  Score=311.49  Aligned_cols=261  Identities=22%  Similarity=0.292  Sum_probs=191.3

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe-------
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL-------  141 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-------  141 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+....    ....+.+.+|+.+++.++||||+++++++.       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC----hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            467999999999999999999987 48899999876532    134567889999999999999999999873       


Q ss_pred             -------eCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc-
Q 040763          142 -------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-  213 (360)
Q Consensus       142 -------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~-  213 (360)
                             .....++||||++ ++|.+++..      .++++..+..++.|++.||.|||+++   ++||||||+||+++ 
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~  155 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINT  155 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEET
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcC
Confidence                   3456799999997 699999854      25889999999999999999999999   99999999999997 


Q ss_pred             CCCcEEEeecCCccccCCCCc--eeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN  290 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~  290 (360)
                      +++.+||+|||++........  .......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.....   
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---  232 (320)
T 2i6l_A          156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---  232 (320)
T ss_dssp             TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred             CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---
Confidence            567999999999987643221  12233457999999998766 678999999999999999999999997543210   


Q ss_pred             cchHHHHHHHhhcc----------ccccccchHH------hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          291 VSLAAYFVHSMRKN----------RLYHILDDQV------MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       291 ~~~~~~~~~~~~~~----------~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                        ............          ..........      ........++++.+++.+||+.||++|||+.++++
T Consensus       233 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          233 --QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             --HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence              011111100000          0000000000      00112235668999999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=313.89  Aligned_cols=249  Identities=27%  Similarity=0.365  Sum_probs=191.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHH--HHhHHHHHHHHHHHhhc----CCCCceeee
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEE--LYKLEEFINEIFILSQI----NHRNVVKLL  137 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~--~~~~~~~~~e~~~~~~l----~h~niv~~~  137 (360)
                      +.....++|++.+.||+|+||.||+|.+. +++.||+|.+........  ......+.+|+.++..+    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34455688999999999999999999875 688999999865432211  01222345688888888    899999999


Q ss_pred             eEEeeCCcceEEEEe-cCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc-CC
Q 040763          138 GCCLETEFPLLVYEF-IPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ER  215 (360)
Q Consensus       138 ~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~-~~  215 (360)
                      +++...+..+++||+ +.+++|.+++....     .+++..++.++.|++.||.|||+++   ++||||||+||+++ .+
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR  176 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence            999999999999999 78999999997643     4889999999999999999999999   99999999999999 88


Q ss_pred             CcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCC-CccchhhhHHHHHHHHhCCCCCCCCCCCcccccchH
Q 040763          216 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLT-DKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLA  294 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~  294 (360)
                      +.+||+|||++.......   .....||..|+|||++.+..+. .++||||||+++|+|++|+.||....          
T Consensus       177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------  243 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------  243 (312)
T ss_dssp             TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred             CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------
Confidence            999999999998765432   2334689999999998877664 58999999999999999999985321          


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          .... ..          ...+...+.++.+++.+||+.||++|||+.++++
T Consensus       244 ----~~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 ----EILE-AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----HHHH-TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----HHhh-hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0000 00          0122334557899999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.8e-43  Score=315.44  Aligned_cols=253  Identities=20%  Similarity=0.259  Sum_probs=172.6

Q ss_pred             HhcCCCccc-eecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee----
Q 040763           69 ATNHFNVNR-ILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE----  142 (360)
Q Consensus        69 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----  142 (360)
                      ..++|.+.+ .||+|+||.||++.++ +++.||+|++....     ....   +....+..++||||+++++++..    
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQ---EVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHH---HHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            347788855 6999999999999987 68999999976421     1111   22233566799999999999876    


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEE
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAK  219 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~k  219 (360)
                      ....++||||+++++|.+++....   ...+++..++.++.|++.||.|||+++   ++||||||+||+++.   ++.+|
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~k  171 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLK  171 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEE
T ss_pred             CceEEEEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEE
Confidence            445799999999999999997642   236899999999999999999999999   999999999999986   45599


Q ss_pred             EeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |+|||++......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||............     ..
T Consensus       172 l~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~~  243 (336)
T 3fhr_A          172 LTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-----KR  243 (336)
T ss_dssp             ECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             Eeccccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-----HH
Confidence            9999999765432   223346899999999998888999999999999999999999999654321110000     00


Q ss_pred             HhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......      ...........++++.+|+.+||+.||++|||+.++++
T Consensus       244 ~~~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          244 RIRLGQ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhccc------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000      00011111234567999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.7e-42  Score=311.24  Aligned_cols=260  Identities=22%  Similarity=0.273  Sum_probs=198.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CC-cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCC------ceeeeeEE
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DG-RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN------VVKLLGCC  140 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~n------iv~~~~~~  140 (360)
                      ..++|++.+.||+|+||+||++.+. ++ +.||+|+++...     ...+.+.+|+.++..++|++      ++.+++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            3578999999999999999999875 34 689999986431     23455678889988887655      89999999


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE--------
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL--------  212 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill--------  212 (360)
                      ......++||||+ ++++.+++....   ...+++..+..++.|++.||.|||+++   |+||||||+|||+        
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEE
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccc
Confidence            9999999999999 677878776532   235899999999999999999999999   9999999999999        


Q ss_pred             -----------cCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 040763          213 -----------DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIF  281 (360)
Q Consensus       213 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~  281 (360)
                                 +.++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|..||.
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                       56789999999999764332    233468999999999999999999999999999999999999996


Q ss_pred             CCCCCcccccchHHHHHHHhhccc-------------------cccccch-----------HHhhhccHHHHHHHHHHHH
Q 040763          282 STGNTSQENVSLAAYFVHSMRKNR-------------------LYHILDD-----------QVMKLGKKNQIVAFANLAE  331 (360)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~-----------~~~~~~~~~~~~~l~~li~  331 (360)
                      ......     .............                   +......           ..........+.++.+|+.
T Consensus       241 ~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          241 THENRE-----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             CSSHHH-----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCHHH-----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence            543210     0011111100000                   0000000           0001122345678999999


Q ss_pred             HhhcCCCCCCCCHHHHHH
Q 040763          332 RCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       332 ~cl~~dp~~Rpt~~ei~~  349 (360)
                      +||+.||++|||+.++++
T Consensus       316 ~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          316 RMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHhcCChhhCcCHHHHhc
Confidence            999999999999999973

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1e-42  Score=333.23  Aligned_cols=276  Identities=24%  Similarity=0.296  Sum_probs=203.5

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee------
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE------  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------  142 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+......   ...+.+.+|+.++..++||||+++++++..      
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP---KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH---HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            378999999999999999999875 6889999998764333   345678899999999999999999998765      


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCc---EE
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYR---AK  219 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~---~k  219 (360)
                      .+..++||||+++++|.+++....  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.   +|
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEE
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEE
Confidence            667899999999999999997643  2235788889999999999999999999   999999999999997665   99


Q ss_pred             EeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |+|||++.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.................
T Consensus       165 L~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          165 IIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE  242 (676)
T ss_dssp             ECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred             Eccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence            99999998765432  2234578999999999999999999999999999999999999996542110000000000000


Q ss_pred             -Hhhcccccc---cc-chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHH-----HHHHHHHhH
Q 040763          300 -SMRKNRLYH---IL-DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE-----VSMELNGIR  355 (360)
Q Consensus       300 -~~~~~~~~~---~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e-----i~~~L~~l~  355 (360)
                       .........   .. ............++.+.+++.+||+.||++|||+.+     +.+.++.+.
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence             000000000   00 001112234557788999999999999999999988     556666554

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=321.67  Aligned_cols=248  Identities=25%  Similarity=0.337  Sum_probs=184.7

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~l  148 (360)
                      ..+|.+.+.||+|+||+|+.....+++.||||++......       .+.+|+.+++.+ +||||+++++++.+....++
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            3568899999999999976555567899999987653222       234789999999 89999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-----CCcEEEeec
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-----RYRAKVADF  223 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Df  223 (360)
                      ||||+. |+|.+++.....    ......+..++.|++.||.|||+++   |+||||||+|||++.     ...+||+||
T Consensus        96 v~E~~~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             EEECCC-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            999995 699999976432    2333445689999999999999999   999999999999953     346889999


Q ss_pred             CCccccCCCCc--eeeecccccCCccchhhhc---cCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHH
Q 040763          224 GTSKFIAMDQT--HVTTKIQGTFGYLDPEYHQ---SSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       224 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      |++........  .......||+.|+|||++.   ...++.++|||||||++|||++ |..||......         ..
T Consensus       168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~  238 (432)
T 3p23_A          168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QA  238 (432)
T ss_dssp             TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HH
T ss_pred             cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HH
Confidence            99987654321  2234457999999999987   4567889999999999999999 88998543210         00


Q ss_pred             HHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                      ......... ...      ......+..+.+|+.+||+.||++|||+.+++
T Consensus       239 ~~~~~~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          239 NILLGACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             HHHTTCCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHhccCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence            011111000 000      11234456788999999999999999999997

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=304.07  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=180.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||.||++.+. +++.||+|.+.......  ...+.+.++..++..++||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH--HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            3467899999999999999999986 68899999987654332  22233444555677889999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      +||||+ ++.+..+.....    ..+++..+..++.|++.||.|||++ +   ++|+||||+||+++.++.+||+|||++
T Consensus       101 lv~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCc
Confidence            999999 555655554322    2588999999999999999999995 8   999999999999999999999999998


Q ss_pred             cccCCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      .......  ......||+.|+|||++.     ...++.++||||||+++|+|++|+.||......       ........
T Consensus       173 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~  243 (318)
T 2dyl_A          173 GRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVL  243 (318)
T ss_dssp             ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHH
T ss_pred             hhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHh
Confidence            7654322  223346899999999984     456788999999999999999999999653210       11111111


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ... .....       .....++++.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~-~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          244 QEE-PPLLP-------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HSC-CCCCC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccC-CCCCC-------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111 10000       01124457999999999999999999999975

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.9e-42  Score=334.02  Aligned_cols=242  Identities=24%  Similarity=0.324  Sum_probs=195.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEec--CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc-
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE--DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF-  145 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~-  145 (360)
                      ..++|++.+.||+|+||.||++.+.  +++.||+|.+......   .....+.+|+.++..++||||+++++++...+. 
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA---EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH---HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH---HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            3478999999999999999999986  5889999987654332   344567899999999999999999999987665 


Q ss_pred             ----ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          146 ----PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       146 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                          .|+||||+++++|.+++..       .+++..++.++.|++.||.|||+++   |+||||||+|||++.+ .+||+
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~  223 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI  223 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence                6999999999999887643       5899999999999999999999999   9999999999999986 99999


Q ss_pred             ecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          222 DFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       222 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      |||++......     ....||+.|+|||++.++. +.++||||||+++|+|++|..||.+.....              
T Consensus       224 DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------  283 (681)
T 2pzi_A          224 DLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------  283 (681)
T ss_dssp             CCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------
T ss_pred             ecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------
Confidence            99999865432     3346899999999987754 889999999999999999988875421100              


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHhH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-TMEEVSMELNGIR  355 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ei~~~L~~l~  355 (360)
                          +   ..    .......++.+.+++.+||+.||++|| +++++...|.++.
T Consensus       284 ----~---~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 ----L---PE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ----C---CT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----c---cc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                0   00    000112345789999999999999999 5777777777664

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-41  Score=298.24  Aligned_cols=236  Identities=14%  Similarity=0.065  Sum_probs=186.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+....... ....+.+.+|+..+..++||||+++++++...+..|+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC-HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            367999999999999999999986 48899999987654432 2345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++++|.+++...       ........++.|++.||.|||+++   |+||||||+|||++.++.+||++++    
T Consensus       109 v~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred             EEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----
Confidence            99999999999998541       345567889999999999999999   9999999999999999999998443    


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                                       |++|       ++.++||||||+++|||++|+.||.+...........          .....
T Consensus       175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----------~~~~~  220 (286)
T 3uqc_A          175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----------RDTAG  220 (286)
T ss_dssp             -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----------BCTTS
T ss_pred             -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----------HHhcc
Confidence                             3333       6789999999999999999999997654321110000          00000


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      .  ...........++++.+++.+||+.||++| |+.++++.|+.+...
T Consensus       221 ~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          221 Q--PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             C--BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             C--CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            0  000111223345679999999999999999 999999999987643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.1e-40  Score=292.38  Aligned_cols=229  Identities=22%  Similarity=0.296  Sum_probs=176.8

Q ss_pred             hcCCCcc-ceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHH-hhcCCCCceeeeeEEee----
Q 040763           70 TNHFNVN-RILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFIL-SQINHRNVVKLLGCCLE----  142 (360)
Q Consensus        70 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~-~~l~h~niv~~~~~~~~----  142 (360)
                      .++|.+. +.||+|+||.||++.+. +++.||+|.+...         ..+.+|+.++ +..+||||+++++++..    
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            3567776 78999999999999975 6889999987532         2345678877 55699999999999876    


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEE
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAK  219 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~k  219 (360)
                      ....++||||+++++|.+++....   ...+++..+..++.|++.||.|||+++   ++||||||+||+++.   ++.+|
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEE
T ss_pred             CceEEEEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEE
Confidence            677899999999999999998642   236899999999999999999999999   999999999999998   78999


Q ss_pred             EeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |+|||++....                       +..++.++||||||+++|+|++|..||.+........         
T Consensus       161 l~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---------  208 (299)
T 3m2w_A          161 LTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---------  208 (299)
T ss_dssp             ECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---------
T ss_pred             Eeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---------
Confidence            99999985432                       2346779999999999999999999996543211100         


Q ss_pred             HhhccccccccchH--HhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRKNRLYHILDDQ--VMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          .....+....  .........++++.+++.+||+.||++|||+.++++
T Consensus       209 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 ----GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ----CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                0000000000  000011234568999999999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-41  Score=312.97  Aligned_cols=246  Identities=16%  Similarity=0.169  Sum_probs=179.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC-CCceeee-----------
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH-RNVVKLL-----------  137 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~-----------  137 (360)
                      .+|...+.||+|+||.||+|.+. +++.||||++....... ....+.+.+|+.++..++| +|.....           
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc-HHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            45778889999999999999965 68999999877433322 2335678899999999977 3221111           


Q ss_pred             ----------eEEee-----CCcceEEEEecCCCChhHHhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 040763          138 ----------GCCLE-----TEFPLLVYEFIPNGTLYQHLHDRH--QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPI  200 (360)
Q Consensus       138 ----------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i  200 (360)
                                ..+..     ....+++|+++ +++|.+++....  ......+++..++.++.|++.||.|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                      11111     12345666654 789999885321  112335778899999999999999999999   9


Q ss_pred             EecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhh----------ccCCCCCccchhhhHHHH
Q 040763          201 YHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYH----------QSSQLTDKSDVYSFGVVL  270 (360)
Q Consensus       201 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~il  270 (360)
                      +||||||+|||++.++.+||+|||++......    ....+| +.|+|||++          .+..++.++|||||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999999999999999998764322    344567 999999998          555688899999999999


Q ss_pred             HHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          271 VELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       271 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      |||++|+.||.........                 ..++.      .....++++.+|+.+||+.||++|||+.++++
T Consensus       308 ~elltg~~Pf~~~~~~~~~-----------------~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGS-----------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCS-----------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCCCCCCCcchhhhH-----------------HHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999999654321110                 00000      01123457999999999999999999877753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-40  Score=300.14  Aligned_cols=245  Identities=16%  Similarity=0.172  Sum_probs=182.8

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccCh----HHHHhHHHHHHHHHHHhhcC---------CCCceee
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD----EELYKLEEFINEIFILSQIN---------HRNVVKL  136 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~~~~e~~~~~~l~---------h~niv~~  136 (360)
                      .++|++.+.||+|+||.||+|.+ +++.||+|++......    ......+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 6799999998764321    11122356778888888775         6666666


Q ss_pred             eeEE-----------------ee-------------CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHH
Q 040763          137 LGCC-----------------LE-------------TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA  186 (360)
Q Consensus       137 ~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~  186 (360)
                      .+++                 .+             ....++||||+++|++.+.+..      ..+++..+..++.|++
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence            6553                 32             6788999999999977776643      2578999999999999


Q ss_pred             HHHHHHH-hCCCCCeEecCCCCCCeEEcCCC--------------------cEEEeecCCccccCCCCceeeecccccCC
Q 040763          187 GALAYLH-SGASSPIYHRDIKSTNILLDERY--------------------RAKVADFGTSKFIAMDQTHVTTKIQGTFG  245 (360)
Q Consensus       187 ~~l~~lh-~~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~  245 (360)
                      .||.||| +++   |+||||||+|||++.++                    .+||+|||+++.....      ...||+.
T Consensus       172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred             HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence            9999999 899   99999999999999887                    8999999999865432      2368999


Q ss_pred             ccchhhhccCCCCCccchhhhHHH-HHHHHhCCCCCCCCCCCcccccchHHHHHHHhh-ccccccccchHHhhhccHHHH
Q 040763          246 YLDPEYHQSSQLTDKSDVYSFGVV-LVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR-KNRLYHILDDQVMKLGKKNQI  323 (360)
Q Consensus       246 y~aPE~~~~~~~~~~~DvwslG~i-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  323 (360)
                      |+|||++.+.. +.++||||+|++ .+++++|..||...        .........+. .....    ...........+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s  309 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLTDKMLKQMTFK----TKCNTPAMKQIK  309 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHHHHHHHTCCCS----SCCCSHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHHHhhhhhhccC----cccchhhhhhcC
Confidence            99999998766 889999998777 77788899997320        00000000110 00000    111122345678


Q ss_pred             HHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          324 VAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       324 ~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                      +++.+|+.+||+.|     |+.|++
T Consensus       310 ~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          310 RKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHHhccC-----CHHHHH
Confidence            89999999999977     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3e-33  Score=267.08  Aligned_cols=187  Identities=20%  Similarity=0.144  Sum_probs=130.2

Q ss_pred             cccCcEEEEEEEe-cCCcEEEEEeccccc------ChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcceEEEE
Q 040763           80 GQGGQGTVYKGRL-EDGRIIAVKKSKLAV------DDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYE  151 (360)
Q Consensus        80 g~G~~g~V~~~~~-~~~~~vaik~~~~~~------~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~lv~e  151 (360)
                      +.|++|.+..++. ..|+.+++|.+....      ........+++.+|+++|+++ +|+||+++++++.++...|||||
T Consensus       243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME  322 (569)
T 4azs_A          243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME  322 (569)
T ss_dssp             C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred             ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4455554443322 247789999876542      122234456799999999999 79999999999999999999999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCC
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM  231 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  231 (360)
                      |++|++|.++|....     +++..   .|+.||+.||+|+|++|   |+||||||+|||+++++.+||+|||+|+....
T Consensus       323 yv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          323 KLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             CCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             cCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999997643     45553   48899999999999999   99999999999999999999999999987654


Q ss_pred             CCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCC
Q 040763          232 DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP  279 (360)
Q Consensus       232 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p  279 (360)
                      .. ......+||+.|+|||++.+. +..++|+||+|++++++.++..|
T Consensus       392 ~~-~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC-SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC-ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            32 233456799999999998764 57789999999998887665544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.6e-29  Score=240.06  Aligned_cols=188  Identities=13%  Similarity=0.187  Sum_probs=145.7

Q ss_pred             CccceecccCcEEEEEEEecCCcEEEEEecccccCh----HHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           74 NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD----EELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ...+.||+|+||.||++.. .+..+++|........    ......+.+.+|+.++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999954 4677888874432211    1122345688999999999999999766666677888999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++++|.+++..             +..++.|++.||.|||+++   |+||||||+|||++.  .+||+|||+++..
T Consensus       418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            999999999999864             3478999999999999999   999999999999999  9999999999877


Q ss_pred             CCCCcee------eecccccCCccchhhhcc--CCCCCccchhhhHHHHHHHHhCCCCC
Q 040763          230 AMDQTHV------TTKIQGTFGYLDPEYHQS--SQLTDKSDVYSFGVVLVELLTGKKPI  280 (360)
Q Consensus       230 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~p~  280 (360)
                      .......      .....||+.|+|||++..  ..|+...|+||..+-..+-+.++.+|
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            5432211      134579999999999987  56788899999999988888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.8e-25  Score=195.18  Aligned_cols=153  Identities=18%  Similarity=0.136  Sum_probs=119.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHH--------------HHhHHHHHHHHHHHhhcCCCCc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEE--------------LYKLEEFINEIFILSQINHRNV  133 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~--------------~~~~~~~~~e~~~~~~l~h~ni  133 (360)
                      .....|.+.+.||+|+||.||+|.+.+|+.+|+|.++.......              ......+.+|+.++..++  | 
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred             hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence            34456677799999999999999997799999999865322110              013456889999999998  4 


Q ss_pred             eeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          134 VKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       134 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      +++.+++.. +..++||||+++++|.+ +..           .....++.|++.||.|||+.+   |+||||||+|||++
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            666665543 56799999999999988 521           113469999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCceeeecccccCCccchhhhcc
Q 040763          214 ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS  254 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  254 (360)
                       ++.+||+|||++..              +..+.|||.+..
T Consensus       228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence             99999999999852              345789998754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=6.3e-21  Score=164.44  Aligned_cols=141  Identities=18%  Similarity=0.163  Sum_probs=105.8

Q ss_pred             CCCccceecccCcEEEEEEEe-cCCcE--EEEEecccccChH--------------------HHHhHHHHHHHHHHHhhc
Q 040763           72 HFNVNRILGQGGQGTVYKGRL-EDGRI--IAVKKSKLAVDDE--------------------ELYKLEEFINEIFILSQI  128 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vaik~~~~~~~~~--------------------~~~~~~~~~~e~~~~~~l  128 (360)
                      -|++.+.||+|+||.||+|.. .+|+.  ||+|+++......                    .......+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367788999999999999998 67888  9999865432110                    001123577899999999


Q ss_pred             CCCCc--eeeeeEEeeCCcceEEEEecCC-C----ChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCe
Q 040763          129 NHRNV--VKLLGCCLETEFPLLVYEFIPN-G----TLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLH-SGASSPI  200 (360)
Q Consensus       129 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i  200 (360)
                      +|+++  ...++.    ...++||||+.+ |    +|.+....        .++.....++.|++.||.||| +.+   |
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---i  192 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---L  192 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence            88754  333332    356899999942 3    66665432        123345678999999999999 988   9


Q ss_pred             EecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          201 YHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       201 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      +||||||+|||+++  .++|+|||++...
T Consensus       193 vHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999999998  9999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=8.2e-19  Score=157.23  Aligned_cols=143  Identities=14%  Similarity=0.121  Sum_probs=100.8

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccCh----------------HHHHhH--HHHHHHHHHHhhcCCCC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD----------------EELYKL--EEFINEIFILSQINHRN  132 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~----------------~~~~~~--~~~~~e~~~~~~l~h~n  132 (360)
                      .-|++.+.||+|++|.||+|...+|+.||||+++.....                ......  -...+|...+.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            348999999999999999999999999999986542110                000000  11235666677765444


Q ss_pred             ceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 040763          133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL  212 (360)
Q Consensus       133 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill  212 (360)
                      +....-+..  ...++||||++|++|..+...           .....++.|++.+|.+||+.|   |+||||||.|||+
T Consensus       175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl  238 (397)
T 4gyi_A          175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILI  238 (397)
T ss_dssp             CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             CCCCeeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence            322111111  234799999999888654321           122457899999999999999   9999999999999


Q ss_pred             cCCC----------cEEEeecCCcccc
Q 040763          213 DERY----------RAKVADFGTSKFI  229 (360)
Q Consensus       213 ~~~~----------~~kl~Dfg~~~~~  229 (360)
                      ++++          .+.|+||+-+...
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             eCCCCcccccccccceEEEEeCCcccC
Confidence            8776          3899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=3.6e-12  Score=109.83  Aligned_cols=145  Identities=15%  Similarity=0.089  Sum_probs=109.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcc
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFP  146 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~  146 (360)
                      .....|.+...++.|+.+.||+.... ++.+++|........    ....+.+|+.+++.+. +..+.++++++...+..
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~----~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC----CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            33456888888888999999998765 678999987643211    1123567888998884 67788999999888889


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA------------------------------  196 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------------------------------  196 (360)
                      |+|||+++|.+|.+.+..          ......++.+++.++..||+..                              
T Consensus        86 ~lv~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             EEEEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            999999999998876421          1112367889999999999811                              


Q ss_pred             --------------------------CCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          197 --------------------------SSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       197 --------------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                                                ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                      1338999999999999876666799999763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.18  E-value=4.7e-11  Score=102.52  Aligned_cols=136  Identities=18%  Similarity=0.158  Sum_probs=96.7

Q ss_pred             CCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCC--ceeeeeEEeeCCcceEE
Q 040763           72 HFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN--VVKLLGCCLETEFPLLV  149 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~n--iv~~~~~~~~~~~~~lv  149 (360)
                      .+.+....+.|..+.||++...+|..+++|......       ...+..|+.+++.+.+.+  +.+++++....+..+++
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            344433334566699999987777889999865431       123457888888885434  55688888877788999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA---------------------------------  196 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---------------------------------  196 (360)
                      |||++|.++.  ...        ...   ..++.+++..+..||+..                                 
T Consensus        94 ~e~i~G~~l~--~~~--------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           94 LGEVPGQDLL--SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EECCSSEETT--TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEecCCcccC--cCc--------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            9999998884  211        111   246677777888887643                                 


Q ss_pred             ----------------------CCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          197 ----------------------SSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       197 ----------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                                            +..++|+|++|.||++++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                  1129999999999999887667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.16  E-value=1.7e-10  Score=104.03  Aligned_cols=143  Identities=14%  Similarity=0.170  Sum_probs=103.8

Q ss_pred             ccceecccCcEEEEEEEecCCcEEEEEecc--cccChHHHHhHHHHHHHHHHHhhcC--CCCceeeeeEEeeC---Ccce
Q 040763           75 VNRILGQGGQGTVYKGRLEDGRIIAVKKSK--LAVDDEELYKLEEFINEIFILSQIN--HRNVVKLLGCCLET---EFPL  147 (360)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~vaik~~~--~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~---~~~~  147 (360)
                      ..+.++.|.++.||+....+ ..+++|+..  .....   .....+.+|..+++.+.  +..+.+++.++.+.   +..+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            45678999999999988764 578888765  32111   12235667999999886  45678888888766   3479


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA-------------------------------  196 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-------------------------------  196 (360)
                      +||||++|.++.+...       ..++......++.+++..|+.||+..                               
T Consensus       118 ~vme~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             EEEECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             EEEEecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            9999999877744211       13667788889999999999999731                               


Q ss_pred             ------------------------CCCeEecCCCCCCeEEcCCCc--EEEeecCCccc
Q 040763          197 ------------------------SSPIYHRDIKSTNILLDERYR--AKVADFGTSKF  228 (360)
Q Consensus       197 ------------------------~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~  228 (360)
                                              ...++|+|++|.||+++.++.  +.|.||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    234999999999999997753  68999998854

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=1.2e-10  Score=102.50  Aligned_cols=184  Identities=21%  Similarity=0.226  Sum_probs=119.4

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCC--ceeeeeEEeeCC---cceEE
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRN--VVKLLGCCLETE---FPLLV  149 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~n--iv~~~~~~~~~~---~~~lv  149 (360)
                      .+.++.|....||+..    ..+++|.....      .....+.+|..+++.+ .+..  +.+.+.......   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568999999998763    45788875432      2344567899999887 3332  344444433333   45899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA---------------------------------  196 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---------------------------------  196 (360)
                      |++++|.++.+....       .++......++.+++..++.||+..                                 
T Consensus        95 m~~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           95 FTKIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             EECCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             EcccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            999999888754322       3566777778888888888888611                                 


Q ss_pred             ----------------------CCCeEecCCCCCCeEEcC--CCcEEEeecCCccccCCCCceeeecccccCCc---cch
Q 040763          197 ----------------------SSPIYHRDIKSTNILLDE--RYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY---LDP  249 (360)
Q Consensus       197 ----------------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y---~aP  249 (360)
                                            ...++|+|++|.||++++  +..+.++||+.+......  ....   ....+   ..|
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~---~~~~~~~~~~~  242 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFI---SLMEDDEEYGM  242 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHH---TTCCTTTSCCH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHH---HHHhhccccCH
Confidence                                  134899999999999998  556789999988643211  1000   01111   233


Q ss_pred             hhhcc-----CCC---------CCccchhhhHHHHHHHHhCCCCCC
Q 040763          250 EYHQS-----SQL---------TDKSDVYSFGVVLVELLTGKKPIF  281 (360)
Q Consensus       250 E~~~~-----~~~---------~~~~DvwslG~il~el~tg~~p~~  281 (360)
                      +....     +..         ..-.+.|++|.++|.+.+|..+|.
T Consensus       243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            32111     111         112589999999999999998863

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=5.1e-07  Score=77.69  Aligned_cols=134  Identities=20%  Similarity=0.188  Sum_probs=93.2

Q ss_pred             eecccCcE-EEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcceEEEEecC
Q 040763           78 ILGQGGQG-TVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPLLVYEFIP  154 (360)
Q Consensus        78 ~lg~G~~g-~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  154 (360)
                      .+..|..+ .||+.... ++..+++|.....       ....+.+|...++.+. +-.+.++++++.+.+..++|||+++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            34445554 68887765 4567888875432       2335667888888874 4457788888888889999999999


Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA--------------------------------------  196 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--------------------------------------  196 (360)
                      |.++.+.....         ......+..+++..|..||+..                                      
T Consensus       104 G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          104 GKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             SEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             CccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            98887765331         1112345556666666666421                                      


Q ss_pred             -----------------CCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          197 -----------------SSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       197 -----------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                                       ...++|+|+.+.||++++++.+-|+||+.+.
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                             1128999999999999988777799999874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=8.8e-07  Score=77.69  Aligned_cols=136  Identities=17%  Similarity=0.164  Sum_probs=89.1

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCC---CceeeeeEEe-eCCcceEEEE
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR---NVVKLLGCCL-ETEFPLLVYE  151 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~---niv~~~~~~~-~~~~~~lv~e  151 (360)
                      .+.++.|....||+.    +..+++|....   .   .....+.+|..++..+.+.   .+.+.+.+.. ..+..+++|+
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---Q---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---H---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---c---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            346788888899987    46678887432   1   2345677899999998642   3556666653 4456789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 040763          152 FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG------------------------------------  195 (360)
Q Consensus       152 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~------------------------------------  195 (360)
                      +++|.++.+..-.       .++......++.+++..|..||+.                                    
T Consensus        94 ~i~G~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           94 KVQGQILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             CCCSEECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             ccCCeECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            9999888663211       123333344444444444444432                                    


Q ss_pred             ---------------------CCCCeEecCCCCCCeEEcC---CCc-EEEeecCCccc
Q 040763          196 ---------------------ASSPIYHRDIKSTNILLDE---RYR-AKVADFGTSKF  228 (360)
Q Consensus       196 ---------------------~~~~i~H~dlk~~Nill~~---~~~-~kl~Dfg~~~~  228 (360)
                                           ....++|+|+.|.||+++.   ++. +.|+||+.+..
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                 2234799999999999997   455 48999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.16  E-value=8.9e-06  Score=72.86  Aligned_cols=83  Identities=6%  Similarity=-0.001  Sum_probs=52.2

Q ss_pred             ccee-cccCcEEEEEEEec-------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-C--CCceeeeeEEeeC-
Q 040763           76 NRIL-GQGGQGTVYKGRLE-------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-H--RNVVKLLGCCLET-  143 (360)
Q Consensus        76 ~~~l-g~G~~g~V~~~~~~-------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h--~niv~~~~~~~~~-  143 (360)
                      .+.| +.|....+|+....       ++..+++|.......... .....+.+|..+++.+. +  ..+.+++.++.+. 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~-~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV-FPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS-SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc-CchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            3567 88888999988654       256788887554220000 00123446777777773 2  3567777776654 


Q ss_pred             --CcceEEEEecCCCChh
Q 040763          144 --EFPLLVYEFIPNGTLY  159 (360)
Q Consensus       144 --~~~~lv~e~~~~~~L~  159 (360)
                        ...+++||+++|.++.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3568999999887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.03  E-value=2.6e-05  Score=70.95  Aligned_cols=79  Identities=16%  Similarity=0.138  Sum_probs=47.6

Q ss_pred             cceecccCcEEEEEEEec-CCcEEEEEecccccC-hHH--HHhHHHHHHHHHHHhhcCC--C-CceeeeeEEeeCCcceE
Q 040763           76 NRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVD-DEE--LYKLEEFINEIFILSQINH--R-NVVKLLGCCLETEFPLL  148 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~-~~~--~~~~~~~~~e~~~~~~l~h--~-niv~~~~~~~~~~~~~l  148 (360)
                      .+.+|.|..+.||++... +++.+++|....... ...  ....+.+..|.+++..+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999764 467899997543211 000  0112345568888877732  3 33455543  3456789


Q ss_pred             EEEecCCC
Q 040763          149 VYEFIPNG  156 (360)
Q Consensus       149 v~e~~~~~  156 (360)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.97  E-value=0.00014  Score=64.36  Aligned_cols=30  Identities=30%  Similarity=0.371  Sum_probs=26.7

Q ss_pred             CCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          198 SPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       198 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            349999999999999888899999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.87  E-value=0.00011  Score=64.29  Aligned_cols=75  Identities=17%  Similarity=0.097  Sum_probs=57.0

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC---CCCceeeeeEEeeCCcceEEEEe
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN---HRNVVKLLGCCLETEFPLLVYEF  152 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~---h~niv~~~~~~~~~~~~~lv~e~  152 (360)
                      .+.|+.|....+|+.... +..+++|.....       ....+..|...++.+.   ...+.+.+.+....+..+++||+
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            456899999999998764 667888875532       2345667888888773   36678888888777889999999


Q ss_pred             cCCCCh
Q 040763          153 IPNGTL  158 (360)
Q Consensus       153 ~~~~~L  158 (360)
                      +++.++
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.78  E-value=0.00022  Score=61.63  Aligned_cols=80  Identities=18%  Similarity=0.142  Sum_probs=54.8

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC---CCceeeeeEEeeCCcce
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH---RNVVKLLGCCLETEFPL  147 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h---~niv~~~~~~~~~~~~~  147 (360)
                      .....++.+|.|..+.||+....+|+.+.+|+.......    ....+..|...|+.+..   --+.+++++    +..+
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~   86 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA----LDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRT   86 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC----CTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc----hhhHHHHHHHHHHHHHhhCCCCcceEEec----cCce
Confidence            345556789999999999999999999999985543211    12235578888888742   234444443    2358


Q ss_pred             EEEEecCCCCh
Q 040763          148 LVYEFIPNGTL  158 (360)
Q Consensus       148 lv~e~~~~~~L  158 (360)
                      ++|||++++..
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            99999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.73  E-value=0.00018  Score=58.42  Aligned_cols=104  Identities=17%  Similarity=0.130  Sum_probs=68.4

Q ss_pred             CCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCc
Q 040763          155 NGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT  234 (360)
Q Consensus       155 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  234 (360)
                      .-+|.+.|..+..    +++++++|.++.|.+.+|.-+-....  -..+=+.|..|++..+|.+...+ +.+.       
T Consensus        32 ~vSL~eIL~~~~~----PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQ----PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             cccHHHHHHHcCC----CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-------
Confidence            3478899977543    89999999999999999887622110  11334567899999999988764 1110       


Q ss_pred             eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCC
Q 040763          235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP  279 (360)
Q Consensus       235 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p  279 (360)
                            .....+.|||... ...+.+.-|||||+++|.-+-...|
T Consensus        98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                  0122466888653 3446788999999999999985555

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.69  E-value=0.00047  Score=63.09  Aligned_cols=75  Identities=12%  Similarity=0.103  Sum_probs=45.6

Q ss_pred             CeEecCCCCCCeEEcCCCcEEEeecCCccccCCCCceeeeccc--ccCCccchhhhccCC---CCCccchhhhHHHHHHH
Q 040763          199 PIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ--GTFGYLDPEYHQSSQ---LTDKSDVYSFGVVLVEL  273 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el  273 (360)
                      .++|+|++|.||+++.++ +.++||+.+..-..  ........  -...|++|+......   .....+..+....+|+.
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p--~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM--GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEECH--HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccCch--HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            399999999999999876 99999998864321  11111111  113466666543211   11234455777778877


Q ss_pred             HhC
Q 040763          274 LTG  276 (360)
Q Consensus       274 ~tg  276 (360)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            665

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.29  E-value=0.0014  Score=57.89  Aligned_cols=31  Identities=32%  Similarity=0.449  Sum_probs=26.9

Q ss_pred             CCeEecCCCCCCeEEcCC----CcEEEeecCCccc
Q 040763          198 SPIYHRDIKSTNILLDER----YRAKVADFGTSKF  228 (360)
Q Consensus       198 ~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~  228 (360)
                      ..++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            349999999999999875    6899999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.24  E-value=0.0013  Score=57.11  Aligned_cols=71  Identities=13%  Similarity=0.131  Sum_probs=41.9

Q ss_pred             cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCc-eeeeeEEeeCCcceEEEEec-
Q 040763           76 NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV-VKLLGCCLETEFPLLVYEFI-  153 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-  153 (360)
                      .+.|+.|....+|+.     ..+++|+.......     .....+|..+++.+...++ .++++.  +.+..++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            567888999999988     45788876542111     0011256766666632222 455544  334458999999 


Q ss_pred             CCCCh
Q 040763          154 PNGTL  158 (360)
Q Consensus       154 ~~~~L  158 (360)
                      ++.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.21  E-value=0.012  Score=51.50  Aligned_cols=160  Identities=13%  Similarity=0.174  Sum_probs=81.2

Q ss_pred             cChHHHHHHhcCCCc-----cceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCC--Cc
Q 040763           61 FSSKELDKATNHFNV-----NRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR--NV  133 (360)
Q Consensus        61 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~--ni  133 (360)
                      ++.+++...-.+|.+     .+.|+.|....+|+....++ .+++|........      +.+..|..++..+...  .+
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~------~~l~~e~~~l~~L~~~g~~v   79 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK------NDLPFFLGLMQHLAAKGLSC   79 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C------CHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH------HHHHHHHHHHHHHHHCCCCC
Confidence            344445444444543     23466788889999887655 5788876642111      1233466666655311  12


Q ss_pred             eeeeeE------EeeCCcceEEEEecCCCChhH-----------H---hhhhc-cCCC---CCC---CHHHHHH------
Q 040763          134 VKLLGC------CLETEFPLLVYEFIPNGTLYQ-----------H---LHDRH-QNEE---YPL---TWEMRFR------  180 (360)
Q Consensus       134 v~~~~~------~~~~~~~~lv~e~~~~~~L~~-----------~---l~~~~-~~~~---~~~---~~~~~~~------  180 (360)
                      .+++..      ....+..+++++|++|.++..           .   +.... ....   ...   .|.....      
T Consensus        80 P~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (322)
T 2ppq_A           80 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  159 (322)
T ss_dssp             CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             CcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence            333321      122355689999998765421           0   11100 0000   001   1211100      


Q ss_pred             ------HHHHHHHHHHHHHhC----CCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          181 ------VAIEVAGALAYLHSG----ASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       181 ------i~~~i~~~l~~lh~~----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                            +...+...+..+...    .+..++|+|+.+.||+++++..+.++||+.+.
T Consensus       160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                  001133445555432    12349999999999999987666899999774

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.13  E-value=0.0066  Score=53.24  Aligned_cols=76  Identities=17%  Similarity=0.118  Sum_probs=45.1

Q ss_pred             ceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC--CCceeeeeE-----EeeCCcceEE
Q 040763           77 RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH--RNVVKLLGC-----CLETEFPLLV  149 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h--~niv~~~~~-----~~~~~~~~lv  149 (360)
                      ..++ |....||+....+|+.+++|........     ...+..|..++..+..  -.+.+++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~-----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT-----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC-----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC-----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3466 7778899887766777899987633211     2234456666666632  223444432     1223455789


Q ss_pred             EEecCCCCh
Q 040763          150 YEFIPNGTL  158 (360)
Q Consensus       150 ~e~~~~~~L  158 (360)
                      |++++|.++
T Consensus       106 ~~~i~G~~~  114 (328)
T 1zyl_A          106 FPSVGGRQF  114 (328)
T ss_dssp             EECCCCEEC
T ss_pred             EEecCCCCC
Confidence            999987543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.02  E-value=0.0024  Score=57.37  Aligned_cols=142  Identities=18%  Similarity=0.207  Sum_probs=78.3

Q ss_pred             ceecccCcEEEEEEEec--------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcce
Q 040763           77 RILGQGGQGTVYKGRLE--------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~--------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~  147 (360)
                      +.+..|-...+|+....        +++.+++++.....     .......+|..+++.+. +.-..++++.+.+    .
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            45666877888988764        24678888753311     12334457888888774 3223566666543    3


Q ss_pred             EEEEecCCCChhH--------------HhhhhccCC---CCCC--CHHHHHHHHHHHHH-------------------HH
Q 040763          148 LVYEFIPNGTLYQ--------------HLHDRHQNE---EYPL--TWEMRFRVAIEVAG-------------------AL  189 (360)
Q Consensus       148 lv~e~~~~~~L~~--------------~l~~~~~~~---~~~~--~~~~~~~i~~~i~~-------------------~l  189 (360)
                      +||||++|.++..              .|.+.+...   ....  .+..+..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            8999998755531              111111110   1111  23344444433321                   22


Q ss_pred             HHH----HhC-CCCCeEecCCCCCCeEEcCC----CcEEEeecCCcc
Q 040763          190 AYL----HSG-ASSPIYHRDIKSTNILLDER----YRAKVADFGTSK  227 (360)
Q Consensus       190 ~~l----h~~-~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~  227 (360)
                      ..|    ... ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            333    222 12349999999999999876    789999999874

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.00  E-value=0.0014  Score=60.05  Aligned_cols=73  Identities=18%  Similarity=0.253  Sum_probs=46.5

Q ss_pred             cceecccCcEEEEEEEecC--------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCc-eeeeeEEeeCCcc
Q 040763           76 NRILGQGGQGTVYKGRLED--------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV-VKLLGCCLETEFP  146 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-v~~~~~~~~~~~~  146 (360)
                      .+.|+.|....+|+....+        ++.+++|+.... ..     .+.+.+|..++..+...++ .++++.+.+    
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            4567888889999998653        467888886431 11     1233468888887743333 566665532    


Q ss_pred             eEEEEecCCCCh
Q 040763          147 LLVYEFIPNGTL  158 (360)
Q Consensus       147 ~lv~e~~~~~~L  158 (360)
                      .+|+||++|.++
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            389999976443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.90  E-value=0.0063  Score=56.10  Aligned_cols=74  Identities=15%  Similarity=0.094  Sum_probs=45.2

Q ss_pred             cceecccCcEEEEEEEecC-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCc-eeeeeEEeeCCcceEEEEec
Q 040763           76 NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV-VKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-v~~~~~~~~~~~~~lv~e~~  153 (360)
                      .+.|+.|-...+|+....+ +..+++|+.......  .  . ...+|..++..+...++ .++++.+.    ...||||+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~--i-dR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I  183 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--I--I-NREREKKISCILYNKNIAKKIYVFFT----NGRIEEFM  183 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--C--S-CHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--h--c-CHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEee
Confidence            3467778889999988764 477888876432111  0  0 01368888888864444 46666663    23599999


Q ss_pred             CCCCh
Q 040763          154 PNGTL  158 (360)
Q Consensus       154 ~~~~L  158 (360)
                      +|.++
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87444

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.76  E-value=0.008  Score=53.10  Aligned_cols=31  Identities=19%  Similarity=0.363  Sum_probs=27.1

Q ss_pred             CCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          198 SPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       198 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ..++|+|+.+.||++++++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3499999999999999888899999987643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.59  E-value=0.0035  Score=56.15  Aligned_cols=73  Identities=15%  Similarity=0.170  Sum_probs=41.2

Q ss_pred             ceecccCcEEEEEEEecC---------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCC-ceeeeeEEeeCCcc
Q 040763           77 RILGQGGQGTVYKGRLED---------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN-VVKLLGCCLETEFP  146 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~---------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~n-iv~~~~~~~~~~~~  146 (360)
                      +.++.|....+|+....+         +..+++|+.......  .   .....|..+++.+...+ ..++++..    ..
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~---~~~~~E~~~l~~L~~~g~~P~~~~~~----~~  109 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--L---YNTISEFEVYKTMSKYKIAPQLLNTF----NG  109 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--T---SCHHHHHHHHHHHHHTTSSCCEEEEE----TT
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--e---ecHHHHHHHHHHHHhcCCCCceEEec----CC
Confidence            457778888899887653         267888876542111  1   11235777777774323 34566544    23


Q ss_pred             eEEEEecCCCCh
Q 040763          147 LLVYEFIPNGTL  158 (360)
Q Consensus       147 ~lv~e~~~~~~L  158 (360)
                      +++|+|++|.++
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            789999987543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.21  E-value=0.39  Score=43.59  Aligned_cols=74  Identities=11%  Similarity=0.045  Sum_probs=45.0

Q ss_pred             cceecccCcEEEEEEEecC--------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcc
Q 040763           76 NRILGQGGQGTVYKGRLED--------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFP  146 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~  146 (360)
                      ++.+..|-...+|+....+        ++.+++++.......     .-...+|..+++.+. +.-..++++.+.    .
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-----~idR~~E~~~l~~L~~~gi~P~l~~~~~----~  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-----FYDSKVELDVFRYLSNINIAPNIIADFP----E  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-----CCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-----hcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence            3557778888899988653        577888875432111     111235777777774 222345554332    3


Q ss_pred             eEEEEecCCCCh
Q 040763          147 LLVYEFIPNGTL  158 (360)
Q Consensus       147 ~lv~e~~~~~~L  158 (360)
                      +.|++|++|.+|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            789999988654

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=94.19  E-value=0.0094  Score=34.44  Aligned_cols=17  Identities=18%  Similarity=0.446  Sum_probs=8.9

Q ss_pred             HHHHHHHHHHHHHhhhh
Q 040763           11 QVIGRILFRIIRKKRMD   27 (360)
Q Consensus        11 l~~~~~~~~~~~~~~~~   27 (360)
                      ++++.++++|+|||+.+
T Consensus        25 vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           25 VVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHhheehhhhh
Confidence            34444445666666544

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.51  E-value=0.018  Score=33.47  Aligned_cols=13  Identities=8%  Similarity=0.066  Sum_probs=6.3

Q ss_pred             HHHHHHHHHhhhh
Q 040763           15 RILFRIIRKKRMD   27 (360)
Q Consensus        15 ~~~~~~~~~~~~~   27 (360)
                      .++++++|||+.+
T Consensus        29 ~~~~~~~RRr~~~   41 (44)
T 2ks1_B           29 LGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHTTTCC
T ss_pred             HHHHHHhhhhHhh
Confidence            3334555555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=92.57  E-value=0.019  Score=33.28  Aligned_cols=13  Identities=15%  Similarity=0.276  Sum_probs=6.5

Q ss_pred             HHHHHHHHHhhhh
Q 040763           15 RILFRIIRKKRMD   27 (360)
Q Consensus        15 ~~~~~~~~~~~~~   27 (360)
                      .++++++|||+++
T Consensus        28 ~~~~~~~RRRr~~   40 (44)
T 2l2t_A           28 LTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHTTCSS
T ss_pred             HHHHHHhhhhhhh
Confidence            3334555555444

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.30  E-value=0.62  Score=37.83  Aligned_cols=83  Identities=10%  Similarity=0.035  Sum_probs=59.2

Q ss_pred             CCCCceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCC
Q 040763          129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA-YLHSGASSPIYHRDIKS  207 (360)
Q Consensus       129 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~-~lh~~~~~~i~H~dlk~  207 (360)
                      .||++  -...-.+.+...+.++.-+++.-...+.        ..+...+++++.+++.... ++++     -.|--+.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P  112 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP  112 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence            57777  3344456666666666554444444443        3778889989988888777 5555     56888999


Q ss_pred             CCeEEcCCCcEEEeecCCc
Q 040763          208 TNILLDERYRAKVADFGTS  226 (360)
Q Consensus       208 ~Nill~~~~~~kl~Dfg~~  226 (360)
                      +|++++.++.+++.-.|+-
T Consensus       113 ~NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             GGEEECTTCCEEESCCEET
T ss_pred             ceEEEeCCCcEEEEEcCCc
Confidence            9999999999999877764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.02  E-value=0.47  Score=38.40  Aligned_cols=115  Identities=7%  Similarity=0.087  Sum_probs=74.8

Q ss_pred             CCCCceeeeeEEeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040763          129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKST  208 (360)
Q Consensus       129 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~  208 (360)
                      .||+.+.. ..-.+.+...+.++.-+++.-...+.        ..+...++.++.+++....++++     -.|--+.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence            57888765 45555565555555433222222333        26788899999999988866665     468889999


Q ss_pred             CeEEcCCCcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchh-hhHHHHHHHHhCCCCCC
Q 040763          209 NILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVY-SFGVVLVELLTGKKPIF  281 (360)
Q Consensus       209 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw-slG~il~el~tg~~p~~  281 (360)
                      |++++.++.+++.--|+...+.+.             =+.+|           |.| .+=+++..+++++..|.
T Consensus       109 NL~f~~~~~p~i~~RGik~~l~P~-------------~~~ee-----------~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVVDPL-------------PVSEA-----------EFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTBSCC-------------CCCHH-----------HHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccCCCCC-------------CCCHH-----------HHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999876654322110             01122           222 45678888999988873

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=83.84  E-value=0.15  Score=29.18  Aligned_cols=9  Identities=0%  Similarity=0.139  Sum_probs=4.0

Q ss_pred             hhHHHHHHH
Q 040763            4 TSLVFLFQV   12 (360)
Q Consensus         4 ~~~~~~~l~   12 (360)
                      +++++++++
T Consensus        19 vv~Gv~ll~   27 (41)
T 2k9y_A           19 VAVGVVLLL   27 (41)
T ss_dssp             HHHHHHHHH
T ss_pred             hhHHHHHHH
Confidence            344444444

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=81.46  E-value=0.2  Score=27.23  Aligned_cols=8  Identities=13%  Similarity=0.380  Sum_probs=4.1

Q ss_pred             HHHHHHHh
Q 040763           17 LFRIIRKK   24 (360)
Q Consensus        17 ~~~~~~~~   24 (360)
                      +..++|||
T Consensus        27 ~~~~iRRr   34 (35)
T 1iij_A           27 VGILIKRR   34 (35)
T ss_dssp             TTHHHHHC
T ss_pred             hheEEeec
Confidence            34555555

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=80.98  E-value=0.78  Score=41.24  Aligned_cols=28  Identities=36%  Similarity=0.528  Sum_probs=24.2

Q ss_pred             eEecCCCCCCeEE------cCCCcEEEeecCCcc
Q 040763          200 IYHRDIKSTNILL------DERYRAKVADFGTSK  227 (360)
Q Consensus       200 i~H~dlk~~Nill------~~~~~~kl~Dfg~~~  227 (360)
                      ++|+|+.+.||++      +++..+.++||-.|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6799999999999      456779999999874

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.88  E-value=0.21  Score=46.05  Aligned_cols=63  Identities=6%  Similarity=-0.025  Sum_probs=17.5

Q ss_pred             CccceecccCcEEEEEEEecC-CcEEEE------EecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEe
Q 040763           74 NVNRILGQGGQGTVYKGRLED-GRIIAV------KKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCL  141 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~-~~~vai------k~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~  141 (360)
                      .+.+.+|   ||.||+|.+.. ..+||+      |..+.....  ......+.+|..++..++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~--~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS--EKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccccc--ccccccccccccccccccccccCCCcceEE
Confidence            3445676   99999998764 356777      544332111  123446778888888899999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	360
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-72
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-68
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-68
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-67
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-64
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-64
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-63
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-59
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-58
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-53
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-53
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-52
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-51
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-49
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-48
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-48
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-47
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-46
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-46
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-44
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-44
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-40
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-39
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-38
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-37
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-35
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 4e-72
 Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 29/292 (9%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
               V + +G G  GTVYKG+      +AVK   +     +  +L+ F NE+ +L +  H
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N++  +G         +V ++    +LY HLH                 +A + A  + 
Sbjct: 64  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMD 118

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA-MDQTHVTTKIQGTFGYLDP 249
           YLH+     I HRD+KS NI L E    K+ DFG +   +    +H   ++ G+  ++ P
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 250 EY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
           E       +  + +SDVY+FG+VL EL+TG+ P          N++     +  + +  L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY--------SNINNRDQIIFMVGRGYL 227

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI 358
              L        K     A   L   CL     +RP   ++   +  +  S+
Sbjct: 228 SPDLSKVRSNCPK-----AMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 2e-68
 Identities = 69/308 (22%), Positives = 119/308 (38%), Gaps = 39/308 (12%)

Query: 66  LDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           ++   + F     LG G  G V+K      G ++A K   L +         + I E+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR---NQIIRELQV 57

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           L + N   +V   G         +  E +  G+L Q L          +  ++  +V+I 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIA 112

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           V   L YL       I HRD+K +NIL++ R   K+ DFG S  +      +     GT 
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTR 167

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST-----------------GNTS 287
            Y+ PE  Q +  + +SD++S G+ LVE+  G+ PI                      T 
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 288 QENVSLAAYFVHSMRKNR--------LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGK 339
               +           +R        L +I+++   KL      + F +   +CL  N  
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 340 KRPTMEEV 347
           +R  ++++
Sbjct: 288 ERADLKQL 295

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 2e-68
 Identities = 59/281 (20%), Positives = 108/281 (38%), Gaps = 29/281 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
               +   LG G  G V+ G       +AVK  K      +      F+ E  ++ Q+ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-----AFLAEANLMKQLQH 67

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
           + +V+L     +     ++ E++ NG+L   L          LT      +A ++A  +A
Sbjct: 68  QRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMA 123

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           ++         HRD+++ NIL+ +    K+ADFG ++ I  ++       +    +  PE
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
                  T KSDV+SFG++L E++T  +  +      +         V    +     + 
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVR 231

Query: 311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
            D   +            L   C     + RPT + +   L
Sbjct: 232 PDNCPE--------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-67
 Identities = 65/287 (22%), Positives = 118/287 (41%), Gaps = 29/287 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +     + +G G  G V+ G   +   +A+K  +     EE     +FI E  ++ +++H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSH 59

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
             +V+L G CLE     LV+EF+ +G L  +L  +          E    + ++V   +A
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMA 115

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YL     + + HRD+ + N L+ E    KV+DFG ++F+  DQ   +T  +    +  PE
Sbjct: 116 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
               S+ + KSDV+SFGV++ E+ +  K                     +   + +   +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI-----------------PYENRSNSEVVEDI 215

Query: 311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
                    +        +   C     + RP    +  +L  I  S
Sbjct: 216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 9e-66
 Identities = 60/277 (21%), Positives = 115/277 (41%), Gaps = 29/277 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
                 + LG G  G V  G+      +A+K  K     E+     EFI E  ++  ++H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSH 58

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
             +V+L G C +     ++ E++ NG L  +L +           +    +  +V  A+ 
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAME 114

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           YL S       HRD+ + N L++++   KV+DFG S+++  D+   +   +    +  PE
Sbjct: 115 YLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
               S+ + KSD+++FGV++ E+ +  K  +     S+     A +    +R  R +   
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIAQGLRLYRPHLAS 227

Query: 311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
           +                 +   C      +RPT + +
Sbjct: 228 EK-------------VYTIMYSCWHEKADERPTFKIL 251

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 5e-65
 Identities = 65/286 (22%), Positives = 126/286 (44%), Gaps = 35/286 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
               + + +G+G  G V  G    G  +AVK     + ++     + F+ E  +++Q+ H
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC----IKNDA--TAQAFLAEASVMTQLRH 59

Query: 131 RNVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
            N+V+LLG  +E +  L +V E++  G+L  +L  R ++    L  +   + +++V  A+
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAM 116

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
            YL     +   HRD+ + N+L+ E   AKV+DFG +K  +  Q       +    +  P
Sbjct: 117 EYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAP 169

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
           E  +  + + KSDV+SFG++L E+ +  +  +                V  + K      
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDA 221

Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
            D     +           + + C  L+   RP+  ++  +L  I+
Sbjct: 222 PDGCPPAV---------YEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 1e-64
 Identities = 63/281 (22%), Positives = 109/281 (38%), Gaps = 29/281 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
               +   LGQG  G V+ G       +A+K  K      E      F+ E  ++ ++ H
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-----AFLQEAQVMKKLRH 71

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
             +V+L       E   +V E++  G+L   L          L       +A ++A  +A
Sbjct: 72  EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMA 127

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           Y+         HRD+++ NIL+ E    KVADFG ++ I  ++       +    +  PE
Sbjct: 128 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
                + T KSDV+SFG++L EL T  +  +      +         V    +       
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPC 235

Query: 311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
             +  +        +  +L  +C     ++RPT E +   L
Sbjct: 236 PPECPE--------SLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (521), Expect = 1e-64
 Identities = 70/291 (24%), Positives = 125/291 (42%), Gaps = 31/291 (10%)

Query: 65  ELDKATNHFNVNRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVDDEELYKLEEFINEIF 123
           E+++      +   LG G  G VY+G  +     +AVK  K     E+  ++EEF+ E  
Sbjct: 13  EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAA 65

Query: 124 ILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           ++ +I H N+V+LLG C       ++ EF+  G L  +L + ++     ++  +   +A 
Sbjct: 66  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMAT 122

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           +++ A+ YL         HRD+ + N L+ E +  KVADFG S+ +  D        +  
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
             +  PE    ++ + KSDV++FGV+L E+ T     +   + SQ               
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------- 224

Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
             +Y +L+        +        L   C   N   RP+  E+      +
Sbjct: 225 --VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (518), Expect = 4e-64
 Identities = 69/317 (21%), Positives = 125/317 (39%), Gaps = 49/317 (15%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEE 117
             L+   N+    R +G+G  G V++ R       E   ++AVK  K     +      +
Sbjct: 6   LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ---AD 62

Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY------ 171
           F  E  ++++ ++ N+VKLLG C   +   L++E++  G L + L     +         
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 172 -------------PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRA 218
                        PL+   +  +A +VA  +AYL         HRD+ + N L+ E    
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVV 179

Query: 219 KVADFGTSKFIAM-DQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK 277
           K+ADFG S+ I   D             ++ PE    ++ T +SDV+++GVVL E+ +  
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 278 KPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLN 337
              +      +                 +Y++ D  ++    +N  +   NL   C    
Sbjct: 240 LQPYYGMAHEE----------------VIYYVRDGNILAC-PENCPLELYNLMRLCWSKL 282

Query: 338 GKKRPTMEEVSMELNGI 354
              RP+   +   L  +
Sbjct: 283 PADRPSFCSIHRILQRM 299

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-63
 Identities = 65/280 (23%), Positives = 112/280 (40%), Gaps = 27/280 (9%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + V   +G G  G   K R   DG+I+  K+       E   + +  ++E+ +L ++ H 
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELKHP 63

Query: 132 NVVKLLGCCLETE--FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           N+V+     ++       +V E+   G L   +  +   E   L  E   RV  ++  AL
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 190 AYLH--SGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYL 247
              H  S     + HRD+K  N+ LD +   K+ DFG ++ +  D +       GT  Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYM 181

Query: 248 DPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
            PE        +KSD++S G +L EL     P                 F    +K    
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-----------------FTAFSQKELAG 224

Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            I + +  ++           +  R L+L    RP++EE+
Sbjct: 225 KIREGKFRRI-PYRYSDELNEIITRMLNLKDYHRPSVEEI 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 64/311 (20%), Positives = 125/311 (40%), Gaps = 44/311 (14%)

Query: 61  FSSKELDKATNHFN---------VNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAV 107
           F+ ++ ++A   F          + +++G G  G V  G L    +    +A+K  K   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 108 DDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQ 167
            +++     +F++E  I+ Q +H NV+ L G   ++   +++ EF+ NG+L   L     
Sbjct: 67  TEKQR---RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123

Query: 168 NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK 227
                 T      +   +A  + YL         HRD+ + NIL++     KV+DFG S+
Sbjct: 124 ----QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 228 FIAMDQTHVTTK----IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFST 283
           F+  D +  T       +    +  PE  Q  + T  SDV+S+G+V+ E+++  +  +  
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-- 234

Query: 284 GNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT 343
                            M    + + ++         +   A   L   C   +   RP 
Sbjct: 235 ---------------WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279

Query: 344 MEEVSMELNGI 354
             ++   L+ +
Sbjct: 280 FGQIVNTLDKM 290

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 1e-62
 Identities = 80/296 (27%), Positives = 121/296 (40%), Gaps = 38/296 (12%)

Query: 56  DRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYK 114
           D  +LF   + +K    F+  R +G G  G VY  R + +  ++A+KK   +       K
Sbjct: 3   DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EK 58

Query: 115 LEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLT 174
            ++ I E+  L ++ H N ++  GC L      LV E+            +      PL 
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQ 113

Query: 175 WEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT 234
                 V       LAYLH   S  + HRD+K+ NILL E    K+ DFG++  +A   +
Sbjct: 114 EVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170

Query: 235 HVTTKIQGTFGYLDPEY---HQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV 291
            V     GT  ++ PE        Q   K DV+S G+  +EL   K P+F+    S    
Sbjct: 171 FV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--- 222

Query: 292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                         LYHI  ++   L   +    F N  + CL    + RPT E +
Sbjct: 223 --------------LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 3e-62
 Identities = 72/321 (22%), Positives = 128/321 (39%), Gaps = 43/321 (13%)

Query: 55  IDRCKLFSSKELDKATNHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVD 108
           ID  +L    + +   N  +  + LG G  G V +         +    +AVK  K +  
Sbjct: 7   IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66

Query: 109 DEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH- 166
             E    E  ++E+ +LS + NH N+V LLG C      L++ E+   G L   L  +  
Sbjct: 67  LTER---EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 167 ------------QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE 214
                       +++E  L  E     + +VA  +A+L    S    HRD+ + NILL  
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180

Query: 215 RYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVEL 273
               K+ DFG ++ I  D  + V    +    ++ PE   +   T +SDV+S+G+ L EL
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

Query: 274 LTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERC 333
            +     +       +                 Y ++ +    L  ++      ++ + C
Sbjct: 241 FSLGSSPYPGMPVDSK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTC 284

Query: 334 LDLNGKKRPTMEEVSMELNGI 354
            D +  KRPT +++   +   
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQ 305

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 7e-62
 Identities = 80/292 (27%), Positives = 131/292 (44%), Gaps = 35/292 (11%)

Query: 74  NVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           + N ++G+G  G VY G L D        AVK      D  E+    +F+ E  I+   +
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKDFS 86

Query: 130 HRNVVKLLGCCLETEF-PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           H NV+ LLG CL +E  PL+V  ++ +G L        +NE +  T +      ++VA  
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGFGLQVAKG 142

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA---MDQTHVTTKIQGTFG 245
           + +L S       HRD+ + N +LDE++  KVADFG ++ +     D  H  T  +    
Sbjct: 143 MKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           ++  E  Q+ + T KSDV+SFGV+L EL+T   P +   NT      +  Y +   R  +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRLLQ 255

Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
             +  D                 +  +C     + RP+  E+   ++ I  +
Sbjct: 256 PEYCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 4e-61
 Identities = 62/299 (20%), Positives = 127/299 (42%), Gaps = 36/299 (12%)

Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGRLEDG-----RIIAVKKSKLAVDDEELYKLEE 117
           + E+    +     +++G G  G VYKG L+         +A+K  K    +++     +
Sbjct: 1   TTEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VD 55

Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM 177
           F+ E  I+ Q +H N+++L G   + +  +++ E++ NG L + L ++        +   
Sbjct: 56  FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQ 111

Query: 178 RFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ--TH 235
              +   +A  + YL +       HRD+ + NIL++     KV+DFG S+ +  D   T+
Sbjct: 112 LVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
            T+  +    +  PE     + T  SDV+SFG+V+ E++T  +  +              
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-------------- 214

Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
                +  + +   ++D        +   A   L  +C      +RP   ++   L+ +
Sbjct: 215 ---WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 4e-61
 Identities = 66/282 (23%), Positives = 119/282 (42%), Gaps = 33/282 (11%)

Query: 76  NRILGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRN 132
           ++ LG G  GTV KG  +     + +AVK  K   +D  L   +E + E  ++ Q+++  
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL--KDELLAEANVMQQLDNPY 69

Query: 133 VVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +V+++G C E E  +LV E    G L ++L          +  +    +  +V+  + YL
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYL 123

Query: 193 HSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ--GTFGYLDPE 250
                S   HRD+ + N+LL  ++ AK++DFG SK +  D+ +   +        +  PE
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL 310
                + + KSDV+SFGV++ E  +  +  +     S+    + A      R        
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGERMGCPAGCP 236

Query: 311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
            +               +L   C   + + RP    V + L 
Sbjct: 237 RE-------------MYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 7e-61
 Identities = 63/300 (21%), Positives = 113/300 (37%), Gaps = 33/300 (11%)

Query: 77  RILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKL 136
             +G+G  G V++G+   G  +AVK      +            EI+    + H N++  
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-----REAEIYQTVMLRHENILGF 62

Query: 137 LGCCLETEFPL----LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYL 192
           +    +         LV ++  +G+L+ +L+       Y +T E   ++A+  A  LA+L
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHL 116

Query: 193 HSGA-----SSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV---TTKIQGTF 244
           H           I HRD+KS NIL+ +     +AD G +         +        GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 245 GYLDPEYHQSS------QLTDKSDVYSFGVVLVELLTGKKP--IFSTGNTSQENVSLAAY 296
            Y+ PE    S      +   ++D+Y+ G+V  E+        I         ++  +  
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQIV-AFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
            V  MRK      L   +    +  + +   A +   C   NG  R T   +   L+ + 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 8e-61
 Identities = 74/278 (26%), Positives = 113/278 (40%), Gaps = 32/278 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
             F + R LG+G  G VY  R  +   I+A+K    A  ++   +  +   E+ I S + 
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLR 64

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H N+++L G   +     L+ E+ P GT+Y+ L             +       E+A AL
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANAL 119

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
           +Y H   S  + HRDIK  N+LL      K+ADFG S      +      + GT  YL P
Sbjct: 120 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPP 173

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
           E  +     +K D++S GV+  E L GK P                 F  +  +     I
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-----------------FEANTYQETYKRI 216

Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              +        +     +L  R L  N  +RP + EV
Sbjct: 217 SRVEFTFPDFVTE--GARDLISRLLKHNPSQRPMLREV 252

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-60
 Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 33/291 (11%)

Query: 59  KLFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEE 117
           KL S   +      +     +GQG  GTVY    +  G+ +A+++  L    ++    E 
Sbjct: 8   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----EL 63

Query: 118 FINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEM 177
            INEI ++ +  + N+V  L   L  +   +V E++  G+L   + +             
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQ 117

Query: 178 RFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT 237
              V  E   AL +LH   S+ + HRDIKS NILL      K+ DFG    I  +Q+  +
Sbjct: 118 IAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174

Query: 238 TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
           T + GT  ++ PE         K D++S G++ +E++ G+ P                 +
Sbjct: 175 TMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-----------------Y 216

Query: 298 VHSMRKNRLYHILDDQVMKLGKKNQI-VAFANLAERCLDLNGKKRPTMEEV 347
           ++      LY I  +   +L    ++   F +   RCLD++ +KR + +E+
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 5e-60
 Identities = 64/301 (21%), Positives = 123/301 (40%), Gaps = 34/301 (11%)

Query: 64  KELDKATNHFNV-NRILGQGGQGTVYKGRL---EDGRIIAVKKSKLAVDDEELYKLEEFI 119
           K+L    ++  + +  LG G  G+V +G     +    +A+K  K   +  +    EE +
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD---TEEMM 57

Query: 120 NEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRF 179
            E  I+ Q+++  +V+L+G C + E  +LV E    G L++ L  + +     +      
Sbjct: 58  REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVA 112

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTK 239
            +  +V+  + YL         HRD+ + N+LL  R+ AK++DFG SK +  D ++ T +
Sbjct: 113 ELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169

Query: 240 --IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF 297
              +    +  PE     + + +SDV+S+GV + E L+  +  +      +    + A+ 
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAFI 225

Query: 298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS 357
               R         +                L   C     + RP    V   +     S
Sbjct: 226 EQGKRMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

Query: 358 I 358
           +
Sbjct: 273 L 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 7e-60
 Identities = 62/308 (20%), Positives = 115/308 (37%), Gaps = 48/308 (15%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLED------GRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
            +    ++LG G  G V                +AVK  K   D  E    E  ++E+ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER---EALMSELKM 93

Query: 125 LSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQN--------------- 168
           ++Q+ +H N+V LLG C  +    L++E+   G L  +L  + +                
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 169 ---EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT 225
              +   LT+E     A +VA  + +L         HRD+ + N+L+      K+ DFG 
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 226 SKFIAMDQTHVT-TKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTG 284
           ++ I  D  +V     +    ++ PE       T KSDV+S+G++L E+ +     +   
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 285 NTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTM 344
                                 Y ++ +                + + C   + +KRP+ 
Sbjct: 271 PVDAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314

Query: 345 EEVSMELN 352
             ++  L 
Sbjct: 315 PNLTSFLG 322

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 9e-60
 Identities = 57/281 (20%), Positives = 111/281 (39%), Gaps = 34/281 (12%)

Query: 73  FNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
              +  +G+G   TVYKG   E    +A  + +     +   + + F  E  +L  + H 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHP 68

Query: 132 NVVKLLGCCLET----EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           N+V+       T    +  +LV E + +GTL  +L          +  ++      ++  
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILK 123

Query: 188 ALAYLHSGASSPIYHRDIKSTNILL-DERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
            L +LH+  + PI HRD+K  NI +       K+ D G +      +      + GT  +
Sbjct: 124 GLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEF 179

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
           + PE ++  +  +  DVY+FG+ ++E+ T + P     N +Q                  
Sbjct: 180 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----------------IY 222

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             +          K  I     + E C+  N  +R +++++
Sbjct: 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-59
 Identities = 70/305 (22%), Positives = 123/305 (40%), Gaps = 40/305 (13%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDG---RIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           N      ++G+G  G V K R++        A+K+ K     ++     +F  E+ +L +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCK 66

Query: 128 I-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYP-----------LTW 175
           + +H N++ LLG C    +  L  E+ P+G L   L      E  P           L+ 
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
           +     A +VA  + YL         HRD+ + NIL+ E Y AK+ADFG S+    +   
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYV 181

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAA 295
             T  +    ++  E    S  T  SDV+S+GV+L E+++     +     ++    L  
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYE 237

Query: 296 YFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR 355
                 R  +  +  D+               +L  +C      +RP+  ++ + LN + 
Sbjct: 238 KLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLNRML 284

Query: 356 GSIKN 360
              K 
Sbjct: 285 EERKT 289

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 3e-59
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 37/292 (12%)

Query: 63  SKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINE 121
           +++L+   + + +   LG G  G VYK +  E   + A K      ++E    LE+++ E
Sbjct: 5   TRDLN-PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LEDYMVE 59

Query: 122 IFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRV 181
           I IL+  +H N+VKLL          ++ EF   G +   + +  +    PLT      V
Sbjct: 60  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVV 115

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
             +   AL YLH    + I HRD+K+ NIL       K+ADFG S           + I 
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI- 171

Query: 242 GTFGYLDPEYHQSSQLTD-----KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY 296
           GT  ++ PE        D     K+DV+S G+ L+E+   + P                 
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----------------- 214

Query: 297 FVHSMRKNRLYHILDDQVMKLGKKNQI-VAFANLAERCLDLNGKKRPTMEEV 347
                    L  I   +   L + ++    F +  ++CL+ N   R T  ++
Sbjct: 215 HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-59
 Identities = 67/280 (23%), Positives = 110/280 (39%), Gaps = 30/280 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
             +++ + LG+G  G V           +AVK   +    +     E    EI I   +N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP---ENIKKEICINKMLN 61

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H NVVK  G   E     L  E+   G L+  +          +      R   ++   +
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGV 116

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTTKIQGTFGYLD 248
            YLH      I HRDIK  N+LLDER   K++DFG +      ++  +  K+ GT  Y+ 
Sbjct: 117 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173

Query: 249 PEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY 307
           PE  +  +   +  DV+S G+VL  +L G+ P     ++ QE            ++ + Y
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------YSDWKEKKTY 225

Query: 308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                ++              L  + L  N   R T+ ++
Sbjct: 226 LNPWKKIDSAPL--------ALLHKILVENPSARITIPDI 257

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-58
 Identities = 67/288 (23%), Positives = 115/288 (39%), Gaps = 32/288 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
               + R +G+G  G V++G           +A+K  K    D      E+F+ E   + 
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR---EKFLQEALTMR 63

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           Q +H ++VKL+G   E     ++ E    G L   L  R     Y L        A +++
Sbjct: 64  QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLS 118

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
            ALAYL S       HRDI + N+L+      K+ DFG S+++     +  +K +    +
Sbjct: 119 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
           + PE     + T  SDV+ FGV + E+L      F     +                  +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----------------I 219

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
             I + + + +   N      +L  +C   +  +RP   E+  +L+ I
Sbjct: 220 GRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  190 bits (483), Expect = 3e-58
 Identities = 62/305 (20%), Positives = 118/305 (38%), Gaps = 35/305 (11%)

Query: 50  YDGSVIDRCKLFSSKEL----DKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSK 104
           YD  V D  K +  + +    D   +H++++  LG G  G V++      G   A K   
Sbjct: 1   YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 60

Query: 105 LAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHD 164
              + ++    E    EI  +S + H  +V L     +    +++YEF+  G L++ + D
Sbjct: 61  TPHESDK----ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 116

Query: 165 RHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILL--DERYRAKVAD 222
            H      ++ +       +V   L ++H        H D+K  NI+         K+ D
Sbjct: 117 EHN----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID 169

Query: 223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFS 282
           FG +  +   Q+   T   GT  +  PE  +   +   +D++S GV+   LL+G  P F 
Sbjct: 170 FGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-FG 226

Query: 283 TGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP 342
             N  +              K+  +++ D     + +        +   + L  +   R 
Sbjct: 227 GENDDE---------TLRNVKSCDWNMDDSAFSGISE-----DGKDFIRKLLLADPNTRM 272

Query: 343 TMEEV 347
           T+ + 
Sbjct: 273 TIHQA 277

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-56
 Identities = 57/288 (19%), Positives = 122/288 (42%), Gaps = 34/288 (11%)

Query: 73  FNVNRILGQGGQGTVYKGRL-----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQ 127
           F   ++LG G  GTVYKG       +    +A+K+ + A   +     +E ++E ++++ 
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMAS 67

Query: 128 INHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAG 187
           +++ +V +LLG CL +    L+ + +P G L  ++ +   N       +      +++A 
Sbjct: 68  VDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAK 122

Query: 188 ALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGY 246
            + YL       + HRD+ + N+L+      K+ DFG +K +  ++  +     +    +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 247 LDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL 306
           +  E       T +SDV+S+GV + EL+T     +                   +  + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----------------DGIPASEI 222

Query: 307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
             IL+            +    +  +C  ++   RP   E+ +E + +
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-56
 Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 31/287 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
               +   LG G  G V +G  +        +AVK  K  V  +    +++FI E+  + 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-EAMDDFIREVNAMH 66

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
            ++HRN+++L G  L      +V E  P G+L   L                 R A++VA
Sbjct: 67  SLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVA 121

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH--VTTKIQGTF 244
             + YL S       HRD+ + N+LL  R   K+ DFG  + +  +  H  +    +  F
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN 304
            +  PE  ++   +  SD + FGV L E+ T  +  +   N SQ                
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------- 223

Query: 305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMEL 351
            L+ I  +       ++      N+  +C     + RPT   +   L
Sbjct: 224 -LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-56
 Identities = 73/296 (24%), Positives = 121/296 (40%), Gaps = 35/296 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL------EDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
               ++R LGQG  G VY+G        E    +A+K    A    E     EF+NE  +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASV 76

Query: 125 LSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEY-----PLTWEMRF 179
           + + N  +VV+LLG   + +  L++ E +  G L  +L              P +     
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 180 RVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI-AMDQTHVTT 238
           ++A E+A  +AYL+   ++   HRD+ + N ++ E +  K+ DFG ++ I   D      
Sbjct: 137 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV 298
           K      ++ PE  +    T  SDV+SFGVVL E+ T  +  +   +  Q         +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VL 245

Query: 299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI 354
             + +  L    D+    L           L   C   N K RP+  E+   +   
Sbjct: 246 RFVMEGGLLDKPDNCPDML---------FELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-54
 Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL--------EDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           +   + + LG+G  G V                  +AVK  K    +++L    + I+E+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---SDLISEM 69

Query: 123 FILSQI-NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRH-----------QNEE 170
            ++  I  H+N++ LLG C +     ++ E+   G L ++L  R             N E
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 171 YPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA 230
             L+ +     A +VA  + YL S       HRD+ + N+L+ E    K+ADFG ++ I 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186

Query: 231 MDQTHVTTK-IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE 289
               +  T   +    ++ PE       T +SDV+SFGV+L E+ T     +      + 
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 245

Query: 290 NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM 349
                           L+ +L +        N       +   C      +RPT +++  
Sbjct: 246 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

Query: 350 ELNGI 354
           +L+ I
Sbjct: 290 DLDRI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-54
 Identities = 68/282 (24%), Positives = 108/282 (38%), Gaps = 30/282 (10%)

Query: 68  KATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
           K    F   +ILG+G   TV   R L   R  A+K  +     +E  K+     E  ++S
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMS 63

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           +++H   VKL     + E       +  NG L +++                     E+ 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIV 118

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMD-QTHVTTKIQGTFG 245
            AL YLH      I HRD+K  NILL+E    ++ DFGT+K ++ + +        GT  
Sbjct: 119 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           Y+ PE          SD+++ G ++ +L+ G  P                 F        
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-----------------FRAGNEYLI 218

Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              I+  +     K        +L E+ L L+  KR   EE+
Sbjct: 219 FQKIIKLEYDFPEKFFP--KARDLVEKLLVLDATKRLGCEEM 258

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 4e-53
 Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 42/304 (13%)

Query: 71  NHFNVNRILGQGGQGTVYKGR------LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFI 124
           +   + + LG+G  G V +            R +AVK  K      E       ++E+ I
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKI 69

Query: 125 LSQINHR-NVVKLLGCCLETEFPL-LVYEFIPNGTLYQHLHDRHQN-----------EEY 171
           L  I H  NVV LLG C +   PL ++ EF   G L  +L  +               + 
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 172 PLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAM 231
            LT E     + +VA  + +L S       HRD+ + NILL E+   K+ DFG ++ I  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 232 DQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN 290
           D  +V     +    ++ PE       T +SDV+SFGV+L E+ +     +      +E 
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245

Query: 291 VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
                 F   +++       D    ++               C      +RPT  E+   
Sbjct: 246 ------FCRRLKEGTRMRAPDYTTPEM---------YQTMLDCWHGEPSQRPTFSELVEH 290

Query: 351 LNGI 354
           L  +
Sbjct: 291 LGNL 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (448), Expect = 5e-53
 Identities = 58/310 (18%), Positives = 112/310 (36%), Gaps = 39/310 (12%)

Query: 47  LNSYDGSVIDRCKLFSSKELDKAT----NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK 101
           +N YD    D  K +  + ++       +++++   LG G  G V++      GR+   K
Sbjct: 1   INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60

Query: 102 KSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQH 161
                ++           NEI I++Q++H  ++ L     +    +L+ EF+  G L+  
Sbjct: 61  F----INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 116

Query: 162 LHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAK 219
           +        Y ++         +    L ++H      I H DIK  NI+ +  +    K
Sbjct: 117 IAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVK 169

Query: 220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKP 279
           + DFG +  +  D+    T    T  +  PE      +   +D+++ GV+   LL+G  P
Sbjct: 170 IIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227

Query: 280 IFSTGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIV--AFANLAERCLDLN 337
                            F        L ++              V     +  +  L   
Sbjct: 228 -----------------FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 270

Query: 338 GKKRPTMEEV 347
            +KR T+ + 
Sbjct: 271 PRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  174 bits (442), Expect = 5e-53
 Identities = 72/296 (24%), Positives = 120/296 (40%), Gaps = 36/296 (12%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
           ++ + +  ILG GG   V+  R L   R +AVK  +  +  +  +    F  E    + +
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF-YLRFRREAQNAAAL 64

Query: 129 NHRNVVKLLGCCLETE----FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
           NH  +V +             P +V E++   TL   +H        P+T +    V  +
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIAD 119

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHV--TTKIQG 242
              AL + H    + I HRD+K  NI++      KV DFG ++ IA     V  T  + G
Sbjct: 120 ACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T  YL PE  +   +  +SDVYS G VL E+LTG+ P                 F     
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----------------FTGDSP 219

Query: 303 KNRLYHILDDQVMKLGKKNQIV--AFANLAERCLDLNGKKRP-TMEEVSMELNGIR 355
            +  Y  + +  +    +++ +      +  + L  N + R  T  E+  +L  + 
Sbjct: 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (444), Expect = 7e-53
 Identities = 58/287 (20%), Positives = 100/287 (34%), Gaps = 30/287 (10%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           K+ +   + ++   +LG G    V         +++A+K       +    K     NEI
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEI 58

Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            +L +I H N+V L           L+ + +  G L+  + ++        T     R+ 
Sbjct: 59  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLI 113

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQG 242
            +V  A+ YLH         +        LDE  +  ++DFG SK    D   V +   G
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACG 171

Query: 243 TFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR 302
           T GY+ PE       +   D +S GV+   LL G  P                 F     
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----------------FYDEND 214

Query: 303 KNRLYHILDDQVMKLGKKNQIV--AFANLAERCLDLNGKKRPTMEEV 347
                 IL  +          +  +  +     ++ + +KR T E+ 
Sbjct: 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-52
 Identities = 60/289 (20%), Positives = 110/289 (38%), Gaps = 39/289 (13%)

Query: 64  KELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEI 122
           KEL      + +   LG+G  G V++       +    K  K+   D+ L        EI
Sbjct: 1   KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-----VKKEI 52

Query: 123 FILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVA 182
            IL+   HRN++ L       E  ++++EFI    +++ ++       + L         
Sbjct: 53  SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYV 108

Query: 183 IEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFGTSKFIAMDQTHVTTKI 240
            +V  AL +LHS     I H DI+  NI+         K+ +FG ++ +           
Sbjct: 109 HQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-- 163

Query: 241 QGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHS 300
                Y  PE HQ   ++  +D++S G ++  LL+G  P                 F+  
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-----------------FLAE 206

Query: 301 MRKNRLYHILDDQVMKLGKKNQIV--AFANLAERCLDLNGKKRPTMEEV 347
             +  + +I++ +     +  + +     +  +R L    K R T  E 
Sbjct: 207 TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  171 bits (433), Expect = 1e-51
 Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 42/291 (14%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYK-----LEEFINEIFIL 125
           ++    ILG+G    V +       +  AVK   +        +      E  + E+ IL
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 126 SQIN-HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIE 184
            +++ H N+++L        F  LV++ +  G L+ +L ++       L+ +   ++   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118

Query: 185 VAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
           +   +  LH      I HRD+K  NILLD+    K+ DFG S  +  D      ++ GT 
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTP 173

Query: 245 GYLDPEYHQSSQL------TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV 298
            YL PE  + S          + D++S GV++  LL G  P                 F 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----------------FW 216

Query: 299 HSMRKNRLYHILDDQVMKLGKKNQIV--AFANLAERCLDLNGKKRPTMEEV 347
           H  +   L  I+         +         +L  R L +  +KR T EE 
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-49
 Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 21/294 (7%)

Query: 68  KATNHFNVNRILGQGGQGTVYKGR--LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFIL 125
           +A   +     +G+G  G V+K R     GR +A+K+ ++   +E        I E+ +L
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVL 61

Query: 126 SQI---NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQ-HLHDRHQNEEYPLTWEMRFRV 181
             +    H NVV+L   C  +         +    + Q       +  E  +  E    +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 182 AIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQ 241
             ++   L +LHS     + HRD+K  NIL+    + K+ADFG ++  +      +    
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-- 176

Query: 242 GTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM 301
            T  Y  PE    S      D++S G +  E+   K     + +  Q    L    +   
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

Query: 302 RKNRLYHILDDQVMKLGKKNQIVAFA--------NLAERCLDLNGKKRPTMEEV 347
                   L  Q         I  F         +L  +CL  N  KR +    
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  162 bits (411), Expect = 2e-48
 Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 20/287 (6%)

Query: 71  NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
             ++    +G+G  G VYK +   G   A+KK +L  +DE +      I EI IL ++ H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKH 59

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+VKL       +  +LV+E +                   L         +++   +A
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIA 114

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           Y H      + HRD+K  N+L++     K+ADFG ++   +     T +I   +      
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ----------ENVSLAAYFVHS 300
              S + +   D++S G +  E++ G           Q           N          
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 301 MRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            + +  + + +    +   K    +  +L  + L L+  +R T ++ 
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 6e-48
 Identities = 65/283 (22%), Positives = 105/283 (37%), Gaps = 21/283 (7%)

Query: 77  RILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEE-FINEIFILSQINHRNVV 134
             LG+G   TVYK R     +I+A+KK KL    E    +    + EI +L +++H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 135 KLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS 194
            LL          LV++F+          +        LT        +     L YLH 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 195 GASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS 254
                I HRD+K  N+LLDE    K+ADFG +K         T ++  T  Y  PE    
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFG 174

Query: 255 SQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQ-ENVSLAAYFVHSMRKNRLYHILDD 312
           +++     D+++ G +L ELL     +    +  Q   +          +   +  + D 
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 313 QVMKLGKKNQIV--------AFANLAERCLDLNGKKRPTMEEV 347
              K      +            +L +     N   R T  + 
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 8e-48
 Identities = 61/289 (21%), Positives = 112/289 (38%), Gaps = 24/289 (8%)

Query: 72  HFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH 130
           +F     +G+G  G VYK R    G ++A+KK +L  + E +      I EI +L ++NH
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--PSTAIREISLLKELNH 60

Query: 131 RNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALA 190
            N+VKLL          LV+EF+              +    +   +      ++   LA
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD----LKKFMDASALTGIPLPLIKSYLFQLLQGLA 116

Query: 191 YLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPE 250
           + HS     + HRD+K  N+L++     K+ADFG ++   +     T ++   +      
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173

Query: 251 YHQSSQLTDKSDVYSFGVVLVELLTGKKP------------IFSTGNTSQENVSLAAYFV 298
                  +   D++S G +  E++T +              IF T  T  E V      +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              + +       D    +   ++     +L  + L  +  KR + +  
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE--DGRSLLSQMLHYDPNKRISAKAA 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-47
 Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 35/295 (11%)

Query: 60  LFSSKELDKATNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLE 116
           +F  + +D   ++++    LG G    V K R    G   A K  K +           E
Sbjct: 2   VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58

Query: 117 EFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWE 176
           +   E+ IL +I H NV+ L          +L+ E +  G L+  L ++       LT E
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEE 113

Query: 177 MRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER----YRAKVADFGTSKFIAMD 232
                  ++   + YLH   S  I H D+K  NI+L +R     R K+ DFG +  I  D
Sbjct: 114 EATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 168

Query: 233 QTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS 292
             +    I GT  ++ PE      L  ++D++S GV+   LL+G  P    G+T QE ++
Sbjct: 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--GDTKQETLA 226

Query: 293 LAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
             +   +        +                   +   R L  + KKR T+++ 
Sbjct: 227 NVSAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDS 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (411), Expect = 2e-47
 Identities = 63/285 (22%), Positives = 112/285 (39%), Gaps = 33/285 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK---KSKLAVDDEELYKLEEFINEIFILS 126
           N F+V+RI+G+GG G VY  R  + G++ A+K   K ++ +   E   L E    + ++S
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 62

Query: 127 QINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
             +   +V +       +    + + +  G L+ HL       E           A E+ 
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-----ADMRFYAAEII 117

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGY 246
             L ++H   +  + +RD+K  NILLDE    +++D G +   +  + H +    GT GY
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 171

Query: 247 LDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           + PE  Q     D  +D +S G +L +LL G  P        +  +      +       
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVE 227

Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
           L      +              +L E  L  +  +R        +
Sbjct: 228 LPDSFSPE------------LRSLLEGLLQRDVNRRLGCLGRGAQ 260

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 4e-47
 Identities = 65/278 (23%), Positives = 105/278 (37%), Gaps = 31/278 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS-QI 128
             F ++++LG+G  G V+     +  +  A+K  K  V   +   +E  + E  +LS   
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAW 60

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H  +  +       E    V E++  G L  H+   H               A E+   
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILG 115

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
           L +LH   S  I +RD+K  NILLD+    K+ADFG  K   +      T   GT  Y+ 
Sbjct: 116 LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIA 171

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE     +     D +SFGV+L E+L G+ P F   +  +       +    M       
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEE------LFHSIRMDNPFYPR 224

Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEE 346
            L+ +              +L  +      +KR  +  
Sbjct: 225 WLEKE------------AKDLLVKLFVREPEKRLGVRG 250

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 7e-47
 Identities = 53/289 (18%), Positives = 110/289 (38%), Gaps = 22/289 (7%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
             +     +G+G  GTV+K +  E   I+A+K+ +L  DDE +      + EI +L ++ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELK 59

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H+N+V+L       +   LV+EF                       E+      ++   L
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGL 114

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
            + HS     + HRD+K  N+L++     K+A+FG ++   +     + ++   +     
Sbjct: 115 GFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ--ENVSLAAYFVHSMRKNRLY 307
               +   +   D++S G +  EL    +P+F   +     + +          +   + 
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 308 HILDDQVMKLGKKNQIV---------AFANLAERCLDLNGKKRPTMEEV 347
            + D +   +      +            +L +  L  N  +R + EE 
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  159 bits (403), Expect = 8e-47
 Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 33/281 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
             F + R LG G  G V+  R   +GR  A+K  K  +      ++E   +E  +LS + 
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVT 62

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H  ++++ G   + +   ++ ++I  G L+  L    +         +    A EV  AL
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAAEVCLAL 117

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
            YLHS     I +RD+K  NILLD+    K+ DFG +K++      +     GT  Y+ P
Sbjct: 118 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAP 170

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
           E   +       D +SFG+++ E+L G  P                 F  S        I
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTP-----------------FYDSNTMKTYEKI 213

Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
           L+ ++      N+     +L  R +  +  +R    +   E
Sbjct: 214 LNAELRFPPFFNE--DVKDLLSRLITRDLSQRLGNLQNGTE 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-46
 Identities = 54/294 (18%), Positives = 106/294 (36%), Gaps = 24/294 (8%)

Query: 70  TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI 128
              +     +G+G  G V       +   +A+KK             +  + EI IL + 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC---QRTLREIKILLRF 63

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
            H N++ +           +   ++    +   L+   + +   L+ +       ++   
Sbjct: 64  RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRG 121

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVT--TKIQGTFGY 246
           L Y+HS   + + HRD+K +N+LL+     K+ DFG ++    D  H    T+   T  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 247 LDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKP------------IFSTGNTSQENVSL 293
             PE   +S+   KS D++S G +L E+L+ +              I     +  +    
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
               + +          +         N      +L ++ L  N  KR  +E+ 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-46
 Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 42/284 (14%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVK--KSKLAVDDEELYKLEEFINEIFILSQ 127
           + + V  +LG GG G+VY G  + D   +A+K  +     D  EL        E+ +L +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 128 IN--HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           ++     V++LL      +  +L+ E                     L  E+      +V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQV 119

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
             A+ + H   +  + HRDIK  NIL+D  R   K+ DFG+   +   +  V T   GT 
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 173

Query: 245 GYLDPEYHQSSQLTDKS-DVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
            Y  PE+ +  +   +S  V+S G++L +++ G  P                 F H    
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----------------FEHDEEI 216

Query: 304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            R       +V             +L   CL L    RPT EE+
Sbjct: 217 IRGQVFFRQRVSS--------ECQHLIRWCLALRPSDRPTFEEI 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-45
 Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 32/293 (10%)

Query: 73  FNVNRILGQGGQGTVYKGRL-EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           +   +++G G  G VY+ +L + G ++A+KK                  E+ I+ +++H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHC 73

Query: 132 NVVKLLGCCLETE------FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
           N+V+L      +       +  LV +++P        H  +   +  L          ++
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 131

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTF 244
             +LAY+HS     I HRDIK  N+LLD +    K+ DFG++K +   + +V+  I   +
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY 187

Query: 245 GYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQ----------ENVSLA 294
                    ++  T   DV+S G VL ELL G+          Q                
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
                +  + +   I      K+ +         L  R L+     R T  E 
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (386), Expect = 1e-44
 Identities = 48/293 (16%), Positives = 93/293 (31%), Gaps = 36/293 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           N + + R +G G  G +Y G  +  G  +A+K   +     +         E  I   + 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ------LHIESKIYKMMQ 60

Query: 130 HRNVVKLLG-CCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
               +  +  C  E ++ ++V E +                    + +    +A ++   
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISR 115

Query: 189 LAYLHSGASSPIYHRDIKSTNIL---LDERYRAKVADFGTSKFIAMDQTHV------TTK 239
           + Y+HS       HRD+K  N L     +     + DFG +K     +TH          
Sbjct: 116 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172

Query: 240 IQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH 299
           + GT  Y     H   + + + D+ S G VL+    G  P       ++           
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK------RQKYE 226

Query: 300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN 352
            + + ++   ++              FA     C  L    +P    +     
Sbjct: 227 RISEKKMSTPIEVLCKGYPS-----EFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 5e-44
 Identities = 54/282 (19%), Positives = 102/282 (36%), Gaps = 37/282 (13%)

Query: 75  VNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRN 132
            +++LG G  G V +          A+K  +            +   E+ +  +     +
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPH 66

Query: 133 VVKLLGCC----LETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           +V+++          +  L+V E +  G L+  + DR        T      +   +  A
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEA 123

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERY---RAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
           + YLHS     I HRD+K  N+L   +      K+ DFG +K      +  T     T  
Sbjct: 124 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPY 178

Query: 246 YLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR 305
           Y+ PE     +     D++S GV++  LL G  P +S    +       +  + +  +  
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------SPGMKTRIRMG 232

Query: 306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
            Y   + +  ++ +         L    L     +R T+ E 
Sbjct: 233 QYEFPNPEWSEVSE-----EVKMLIRNLLKTEPTQRMTITEF 269

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 59/304 (19%), Positives = 111/304 (36%), Gaps = 26/304 (8%)

Query: 61  FSSKELDKAT----NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL 115
           F  +E+ K        +   + +G G  G V        G  +A+KK       E     
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF--A 61

Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           +    E+ +L  + H NV+ LL      E      +F            +    E  L  
Sbjct: 62  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGE 120

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
           +    +  ++   L Y+H   ++ I HRD+K  N+ ++E    K+ DFG ++      + 
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSE 174

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN----- 290
           +T  +   +           + T   D++S G ++ E++TGK     + +  Q       
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234

Query: 291 -VSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIV------AFANLAERCLDLNGKKRPT 343
             +  A FV  ++ +   + +        K    +         NL E+ L L+ ++R T
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294

Query: 344 MEEV 347
             E 
Sbjct: 295 AGEA 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 1e-42
 Identities = 62/298 (20%), Positives = 113/298 (37%), Gaps = 26/298 (8%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           + +     +GQG  G V+K R  + G+ +A+KK  +  + E        + EI IL  + 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF--PITALREIKILQLLK 67

Query: 130 HRNVVKLLGCCLETEFPLLVYE---FIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
           H NVV L+  C     P    +   ++        L     N     T     RV   + 
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQT---HVTTKIQGT 243
             L Y+H    + I HRD+K+ N+L+      K+ADFG ++  ++ +    +  T    T
Sbjct: 128 NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 244 FGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENV------SLAAY 296
             Y  PE     +      D++  G ++ E+ T    +       Q  +      S+   
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 297 FVHSMRKNRLYHILD-------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              ++    LY  L+           +L    +     +L ++ L L+  +R   ++ 
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-42
 Identities = 66/281 (23%), Positives = 105/281 (37%), Gaps = 30/281 (10%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           N F+  ++LG+G  G V   R    GR  A+K  +  V   +  ++   + E  +L    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTR 63

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
           H  +  L       +    V E+   G L+ HL           T E       E+  AL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSAL 118

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDP 249
            YLHS     + +RDIK  N++LD+    K+ DFG  K    D         GT  YL P
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAP 174

Query: 250 EYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI 309
           E  + +      D +  GVV+ E++ G+ P F   +  +       + +  M + R    
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHER------LFELILMEEIRFPRT 227

Query: 310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
           L  +              +L    L  + K+R        +
Sbjct: 228 LSPE------------AKSLLAGLLKKDPKQRLGGGPSDAK 256

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (354), Expect = 8e-40
 Identities = 43/289 (14%), Positives = 90/289 (31%), Gaps = 36/289 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
            H+ V R +G+G  G +++G  L + + +A+K      D  +        +E      + 
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ------LRDEYRTYKLLA 58

Query: 130 HRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGAL 189
               +  +    +     ++   +   +L   L    +      + +     A ++   +
Sbjct: 59  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARV 114

Query: 190 AYLHSGASSPIYHRDIKSTNILLDERYR-----AKVADFGTSKFIAMDQTHV------TT 238
             +H      + +RDIK  N L+            V DFG  KF     T          
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

Query: 239 KIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV 298
            + GT  Y+    H   + + + D+ + G V +  L G  P       + +         
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--------- 222

Query: 299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEV 347
              +  R+        ++         F        +L     P  + +
Sbjct: 223 --QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 73/289 (25%), Positives = 107/289 (37%), Gaps = 34/289 (11%)

Query: 71  NHFNVNRILGQGGQGTVYKGRL----EDGRIIAVKKSKLAVDDEELYKLEEFINEIFILS 126
            +F + ++LG G  G V+  R     + G++ A+K  K A   ++    E    E  +L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 127 QINHR-NVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEV 185
            I     +V L           L+ ++I  G L+ HL  R        T         E+
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEI 138

Query: 186 AGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
             AL +LH      I +RDIK  NILLD      + DFG SK    D+T       GT  
Sbjct: 139 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 246 YLDPEYHQSSQ--LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK 303
           Y+ P+  +          D +S GV++ ELLTG  P                 F     K
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-----------------FTVDGEK 238

Query: 304 NRLYHILDDQVMKLGKKNQIV--AFANLAERCLDLNGKKRPTMEEVSME 350
           N    I    +       Q +     +L +R L  + KKR        +
Sbjct: 239 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (352), Expect = 5e-39
 Identities = 62/282 (21%), Positives = 107/282 (37%), Gaps = 35/282 (12%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKK-SKLAVDDEELYKLEEFINEIFILSQI 128
           + F+  + LG G  G V   +  E G   A+K   K  V   +  ++E  +NE  IL  +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK--QIEHTLNEKRILQAV 98

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
           N   +VKL     +     +V E++  G ++ HL           +       A ++   
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLT 153

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLD 248
             YLH   S  + +RD+K  N+L+D++   +V DFG +K +      +     GT   L 
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALA 206

Query: 249 PEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH 308
           PE   S       D ++ GV++ E+  G  P F+      +        + S +     H
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA------DQPIQIYEKIVSGKVRFPSH 260

Query: 309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSME 350
              D               +L    L ++  KR    +  + 
Sbjct: 261 FSSD-------------LKDLLRNLLQVDLTKRFGNLKNGVN 289

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  138 bits (347), Expect = 1e-38
 Identities = 59/302 (19%), Positives = 110/302 (36%), Gaps = 45/302 (14%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
           + + + R LG+G    V++   + +   + VK  K         K ++   EI IL  + 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLR 87

Query: 130 -HRNVVKLLGCCLE--TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVA 186
              N++ L     +  +  P LV+E + N    Q            LT         E+ 
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEIL 139

Query: 187 GALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTSKFIAMDQTHVTTKIQGTFG 245
            AL Y HS     I HRD+K  N+++D E  + ++ D+G ++F    Q +       +  
Sbjct: 140 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRY 194

Query: 246 YLDPEYHQSSQLTD-KSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF------- 297
           +  PE     Q+ D   D++S G +L  ++  K+P F   +   + V +A          
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254

Query: 298 ------------VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME 345
                        + +         +  V    +        +  ++ L  + + R T  
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

Query: 346 EV 347
           E 
Sbjct: 315 EA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-37
 Identities = 58/304 (19%), Positives = 108/304 (35%), Gaps = 26/304 (8%)

Query: 61  FSSKELDKA----TNHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKL 115
           F  +EL+K        +     +G G  G+V      + G  +AVKK             
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HA 61

Query: 116 EEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTW 175
           +    E+ +L  + H NV+ LL             +      L     +     +     
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121

Query: 176 EMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTH 235
            ++F +  ++   L Y+H   S+ I HRD+K +N+ ++E    K+ DFG ++        
Sbjct: 122 HVQF-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---E 174

Query: 236 VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQEN--VSL 293
           +T  +   +                 D++S G ++ ELLTG+     T +  Q    + L
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

Query: 294 AAYFVHSMRKNRLYHILDDQVMKLGKKNQIV----------AFANLAERCLDLNGKKRPT 343
                  + K        + +  L +  ++              +L E+ L L+  KR T
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

Query: 344 MEEV 347
             + 
Sbjct: 295 AAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 5e-35
 Identities = 53/307 (17%), Positives = 106/307 (34%), Gaps = 45/307 (14%)

Query: 71  NHFNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN 129
             +   + +G G QG V         R +A+KK      ++     +    E+ ++  +N
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVN 74

Query: 130 HRNVVKLLGCCL------ETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAI 183
           H+N++ LL          E +   LV E +          +           E    +  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLY 126

Query: 184 EVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQTHVTTKIQGT 243
           ++   + +LHS   + I HRD+K +NI++      K+ DFG ++      + + T    T
Sbjct: 127 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 181

Query: 244 FGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR- 302
             Y  PE        +  D++S G ++ E++  K          Q N  +          
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241

Query: 303 KNRLYHILDDQVMKLGKKNQIV----------------------AFANLAERCLDLNGKK 340
             +L   + + V    K   +                          +L  + L ++  K
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301

Query: 341 RPTMEEV 347
           R ++++ 
Sbjct: 302 RISVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (287), Expect = 1e-29
 Identities = 57/322 (17%), Positives = 117/322 (36%), Gaps = 58/322 (18%)

Query: 73  FNVNRILGQGGQGTVYKGR-LEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHR 131
           + + R LG G   TV+  + + +   +A+K     V  +++Y  E   +EI +L ++N  
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKI----VRGDKVYT-EAAEDEIKLLQRVNDA 69

Query: 132 NVVKLLGCCLETEFPLLVY--EFIPNGTLYQ---------HLHDRHQNEEYPLTWEMRFR 180
           +  K           LL +     PNG              L    + E   +      +
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 181 VAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER------YRAKVADFGTSKFIAMDQT 234
           ++ ++   L Y+H      I H DIK  N+L++         + K+AD G + +     T
Sbjct: 130 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 235 HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPI--FSTGNTSQENVS 292
           +       T  Y  PE    +     +D++S   ++ EL+TG          + ++++  
Sbjct: 188 NS----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

Query: 293 LA----------AYFVHSMRKNRLYHILDDQVMKLGK-----------------KNQIVA 325
           +A          +Y + + +  R +      +  + K                 K++   
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303

Query: 326 FANLAERCLDLNGKKRPTMEEV 347
            ++     L L+ +KR     +
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 8e-19
 Identities = 28/161 (17%), Positives = 55/161 (34%), Gaps = 18/161 (11%)

Query: 75  VNRILGQGGQGTVYKGRLEDGRIIAVKKSKLA------VDDEELYKLEEFINEIFILSQI 128
           + +++G+G +  V+    E      VK  K+       V ++  Y    F       ++ 
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 129 NHRNVVKLLGCCLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGA 188
             R + KL G  +        Y +  N  L + +  +          +    V   +   
Sbjct: 64  EFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD---EVLDMILEE 115

Query: 189 LAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI 229
           +A  +      I H D+   N+L+ E     + DF  S  +
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	360
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.59
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.11
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.7
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.69
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.03

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-59  Score=403.54  Aligned_cols=258  Identities=25%  Similarity=0.403  Sum_probs=202.7

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++.....     .+++.+|+.++.+++||||++++|++...+..++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            678999999999999999999988889999998754332     356889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++|+|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        80 E~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             ECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             EecCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheecc
Confidence            9999999999986532    36889999999999999999999999   9999999999999999999999999998776


Q ss_pred             CCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ...........||+.|+|||++.+..++.++|||||||++|||+|+..|+.....       ... ........      
T Consensus       153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~-~~~~i~~~------  218 (263)
T d1sm2a_         153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSE-VVEDISTG------  218 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHH-HHHHHHHT------
T ss_pred             CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHH-HHHHHHhc------
Confidence            5444444456789999999999999999999999999999999995444432221       011 11111111      


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                         .....+..+++++.+|+.+||+.||++|||+++|++.|+.+..+
T Consensus       219 ---~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         219 ---FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence               11122344566899999999999999999999999999998753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=401.53  Aligned_cols=264  Identities=27%  Similarity=0.441  Sum_probs=207.9

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|+||+||+|+.+  ..||||+++......  ...+.+.+|+.++.+++||||+++++++.. +..++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT--THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            467999999999999999999865  359999987654332  346688899999999999999999998754 567999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....    ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             EECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence            99999999999997532    25899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCc-eeeecccccCCccchhhhcc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          230 AMDQT-HVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       230 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ..... .......||+.|+|||++.+   +.++.++|||||||++|||+||+.||.+.....        ..........
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--------~~~~~~~~~~  226 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--------QIIFMVGRGY  226 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------HHHHHHHHTS
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--------HHHHHHhcCC
Confidence            54332 23445679999999999865   357889999999999999999999996543110        0111111111


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      ..     ......+..+++++.+|+.+||+.||++|||+.+|++.|+.+.+++
T Consensus       227 ~~-----p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         227 LS-----PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CC-----CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CC-----CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            00     0011233445678999999999999999999999999999998876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.7e-59  Score=406.93  Aligned_cols=260  Identities=25%  Similarity=0.387  Sum_probs=217.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcce
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~  147 (360)
                      ..++|++.+.||+|+||+||+|.++ +++.||||+++....     ..+++.+|+.++++++||||+++++++.+.+..+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            3467899999999999999999986 588999999875433     2456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ++|||+++|+|.+++....   ...+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus        90 iv~E~~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             EEeecccCcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence            9999999999999997632   236899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..............||+.|+|||++.++.++.++|||||||++|||++|..||....+       ... .......    
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~-~~~~i~~----  231 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQ-VYELLEK----  231 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHH-HHHHHHT----
T ss_pred             ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHH-HHHHHhc----
Confidence            8766555555556689999999999999999999999999999999997777654321       011 1111111    


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                           ......+..+++++.+|+.+||+.||++|||+.++++.|+.+.+
T Consensus       232 -----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         232 -----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 11223344566789999999999999999999999999988754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-58  Score=399.07  Aligned_cols=258  Identities=23%  Similarity=0.380  Sum_probs=211.7

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|+||.||+|.+++++.||||+++.....     .+.+.+|+.++.+++||||+++++++.+ +..++|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC-----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            4678999999999999999999988889999998754332     3568899999999999999999998754 567999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++.....   .++++..++.++.|++.||.|||+++   |+||||||+||||++++.+||+|||+++..
T Consensus        86 ~Ey~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             EECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence            999999999998765432   25899999999999999999999999   999999999999999999999999999887


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ............||+.|+|||++.++.++.++|||||||++|||+||..|+......       .. ....+...     
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~-~~~~i~~~-----  226 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PE-VIQNLERG-----  226 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH-HHHHHHTT-----
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHhc-----
Confidence            655444455567899999999999999999999999999999999966665432210       01 11111111     


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                          .....+..+++++.+|+.+||+.||++|||+++|++.|+.+-.
T Consensus       227 ----~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         227 ----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                1122334556689999999999999999999999999988654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-58  Score=397.46  Aligned_cols=252  Identities=27%  Similarity=0.381  Sum_probs=203.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||+|.++ +++.||+|++......   ...+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            56999999999999999999986 6899999998654322   2345678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+..
T Consensus        82 mEy~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             EECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheee
Confidence            99999999999996532     5899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCc-eeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          230 AMDQT-HVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       230 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ..... ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.........       .......... 
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------~~~~~~~~~~-  225 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTY-  225 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-------HHHHHTTCTT-
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-------HHHHhcCCCC-
Confidence            54332 22345679999999999988876 57899999999999999999999754422111       1111111100 


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                              .......++++.+|+.+||+.||++|||+.|+++
T Consensus       226 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 --------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    0112234567899999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-57  Score=400.74  Aligned_cols=259  Identities=24%  Similarity=0.419  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEecC-C---cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-G---RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ++|++.+.||+|+||+||+|.++. +   ..||+|.+......   ...+.+.+|+.++++++||||++++|++...+..
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE---KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            567888999999999999998753 2   25889987654443   3456788999999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++|+|.+++....    ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccc
Confidence            99999999999999887532    25899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCcee----eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHh
Q 040763          227 KFIAMDQTHV----TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       227 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      +.........    .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+...     .   . ....+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~---~-~~~~i  246 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----Q---D-VINAI  246 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H---H-HHHHH
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----H---H-HHHHH
Confidence            8765432221    122457899999999999999999999999999999998 8999865431     0   1 11111


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                      ..+         ...+.+..+++++.+|+.+||+.||++|||+.||++.|+.+.++
T Consensus       247 ~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         247 EQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            111         11123445667899999999999999999999999999987644

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-57  Score=391.15  Aligned_cols=255  Identities=23%  Similarity=0.382  Sum_probs=214.3

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|+||+||+|.+++++.||||.++.....     .+++.+|+.++.+++||||++++|++.+.+..++|
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            3689999999999999999999988889999998764333     34688999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++.....    .+++..++.++.|+++||.|||+++   |+||||||+||++++++.+||+|||++...
T Consensus        78 ~Ey~~~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             EECCTTEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             EEccCCCcHHHhhhcccc----CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheec
Confidence            999999999999765432    5889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ............||+.|+|||.+.+..++.++||||||+++|||+| |+.||.+...  .      . ....+...    
T Consensus       151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~------~-~~~~i~~~----  217 (258)
T d1k2pa_         151 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--S------E-TAEHIAQG----  217 (258)
T ss_dssp             SSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--H------H-HHHHHHTT----
T ss_pred             cCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--H------H-HHHHHHhC----
Confidence            6554444445678999999999999999999999999999999998 8999865431  0      1 11111111    


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                           .....+...++++.+|+.+||+.||++|||++++++.|.++
T Consensus       218 -----~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         218 -----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -----CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                 11122344556899999999999999999999999988643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=391.50  Aligned_cols=248  Identities=29%  Similarity=0.408  Sum_probs=206.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||+|.++ +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999986 6889999987643221 112345678999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        85 mEy~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             EeecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence            99999999999997654     5899999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...        ..... .+....    
T Consensus       157 ~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~-~i~~~~----  220 (263)
T d2j4za1         157 PSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYK-RISRVE----  220 (263)
T ss_dssp             CCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH-HHHTTC----
T ss_pred             CCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHH-HHHcCC----
Confidence            4332   2345799999999999999999999999999999999999999965321        11111 111111    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                            ...+...++++.+|+.+||+.||++|||+.|+++
T Consensus       221 ------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                  1123345668999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-57  Score=394.20  Aligned_cols=259  Identities=24%  Similarity=0.364  Sum_probs=210.8

Q ss_pred             cCCCccce-ecccCcEEEEEEEec---CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRI-LGQGGQGTVYKGRLE---DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||.++.....   ...+++.+|+.++.+++||||++++|++.+ +..
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH---HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            45666664 999999999999764   3457999998765433   345678999999999999999999999865 467


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        84 ~lvmE~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhh
Confidence            9999999999999998543    226899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          227 KFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       227 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +.........  .....||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....        . ....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~-~~~~i~~  227 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------E-VMAFIEQ  227 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------H-HHHHHHT
T ss_pred             hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------H-HHHHHHc
Confidence            8876543322  233468999999999999999999999999999999998 99999654310        0 1111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      +.         ..+.+..+++++.+|+.+||+.||++|||+.+|.+.|+.+..++
T Consensus       228 ~~---------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         228 GK---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC---------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            11         12234456678999999999999999999999999999877554

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-57  Score=392.30  Aligned_cols=249  Identities=27%  Similarity=0.405  Sum_probs=206.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++......    ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            56999999999999999999975 6899999997654322    345688999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++...      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        96 mEy~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             EECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence            9999999999987652      4889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....        ........... .  
T Consensus       167 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~~~~~~~-~--  234 (293)
T d1yhwa1         167 TPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGT-P--  234 (293)
T ss_dssp             CSTT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCS-C--
T ss_pred             cccc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCC-C--
Confidence            5433 2234457999999999999999999999999999999999999999654310        00111111110 0  


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       235 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 -----ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -----CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 01123345668999999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-57  Score=393.87  Aligned_cols=257  Identities=24%  Similarity=0.390  Sum_probs=197.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee--CCcce
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE--TEFPL  147 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~  147 (360)
                      ++|++.+.||+|+||+||+|.++ +|+.||+|.+.......  ...+.+.+|+.++++++||||+++++++.+  ....|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH--HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH--HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            56999999999999999999986 68899999987654332  345678899999999999999999999864  45679


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGAS--SPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      +|||||++|+|.+++..... ....+++..++.++.|++.||.|||+++.  .+|+||||||+|||++.++.+||+|||+
T Consensus        82 ivmEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            99999999999999976432 22369999999999999999999998641  2499999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+...        .. ....+....
T Consensus       161 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~-~~~~i~~~~  230 (269)
T d2java1         161 ARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KE-LAGKIREGK  230 (269)
T ss_dssp             HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HH-HHHHHHHTC
T ss_pred             eeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HH-HHHHHHcCC
Confidence            98765432 223446799999999999999999999999999999999999999965321        01 111111111


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..         ..+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         231 FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11         123445668999999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=391.14  Aligned_cols=259  Identities=23%  Similarity=0.359  Sum_probs=204.0

Q ss_pred             cCCCccceecccCcEEEEEEEecCC-----cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDG-----RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      +.|+..+.||+|+||.||+|.++++     ..||||.+......   ....++.+|+.++.+++||||++++|++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh---HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            5688899999999999999987642     36999998765443   234568899999999999999999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+.++++.+++....    ..+++..++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eEEEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccch
Confidence            999999999999999887643    25899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCc--eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ++.......  .......||+.|+|||++.++.++.++|||||||++|||++|..|+......       .. .......
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~-~~~~i~~  228 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HE-VMKAIND  228 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHHHT
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-------HH-HHHHHhc
Confidence            987654322  2223346899999999999999999999999999999999976665433210       11 1111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                               ....+.+..+++++.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus       229 ---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         229 ---------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ---------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                     11223344456689999999999999999999999999998764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-57  Score=390.19  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=203.0

Q ss_pred             ceecccCcEEEEEEEecC---CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           77 RILGQGGQGTVYKGRLED---GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~---~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      +.||+|+||+||+|.+++   ++.||||+++.....  ....+++.+|+.++++++||||+++++++.. +..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC--HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence            469999999999998653   467999998754332  2345678999999999999999999999865 4578999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      ++|+|.+++....     ++++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        90 ~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          90 ELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             TTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             CCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            9999999997643     5899999999999999999999999   9999999999999999999999999998765543


Q ss_pred             cee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccccc
Q 040763          234 THV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHIL  310 (360)
Q Consensus       234 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (360)
                      ...  .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+...        .+ ....+..+.     
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~-~~~~i~~~~-----  227 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SE-VTAMLEKGE-----  227 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH-HHHHHHTTC-----
T ss_pred             cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HH-HHHHHHcCC-----
Confidence            332  233568999999999999999999999999999999998 8999965431        01 111111111     


Q ss_pred             chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          311 DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                          ....+..+++++.+|+.+||+.||++|||+.+|.+.|+....++
T Consensus       228 ----~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                12234456678999999999999999999999999998876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-57  Score=399.41  Aligned_cols=266  Identities=26%  Similarity=0.389  Sum_probs=205.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .++|++.+.||+|+||+||+|.+. +|+.||+|+++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT---THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            467999999999999999999986 6889999998764333   234577899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSG-ASSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      ||||+++|+|.+++....     .+++..+..++.|++.||.|||++ +   |+||||||+|||+++++.+||+|||+|.
T Consensus        82 VmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             EEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EEEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            999999999999997653     589999999999999999999974 8   9999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH---HHH-----
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY---FVH-----  299 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~-----  299 (360)
                      .....   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+..............   ...     
T Consensus       154 ~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         154 QLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             HHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             ccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence            65432   2234589999999999999999999999999999999999999997654221100000000   000     


Q ss_pred             -------------HhhccccccccchHH----hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 -------------SMRKNRLYHILDDQV----MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 -------------~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                                   ........+......    ........+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                         000000000000000    00011124568999999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=397.71  Aligned_cols=260  Identities=24%  Similarity=0.387  Sum_probs=207.9

Q ss_pred             hcCCCccceecccCcEEEEEEEecCC------cEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEee
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDG------RIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLE  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~------~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~  142 (360)
                      .++|++.+.||+|+||+||+|.+...      ..||+|.+......   .....+.+|+.++.++ +||||+++++++.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH---HHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            36789999999999999999987532      26899987654332   3345678999999998 89999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQN------------------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRD  204 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~d  204 (360)
                      .+..++|||||++|+|.+++..+...                  ....+++..++.++.|++.||+|||+++   |+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence            99999999999999999999764321                  1235889999999999999999999999   99999


Q ss_pred             CCCCCeEEcCCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 040763          205 IKSTNILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFS  282 (360)
Q Consensus       205 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~  282 (360)
                      |||+|||++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544332 3344568999999999999999999999999999999998 8999965


Q ss_pred             CCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 040763          283 TGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELN  352 (360)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~  352 (360)
                      ......        .......+         ...+.+..+++++.+|+.+||+.||++|||++||++.|.
T Consensus       270 ~~~~~~--------~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVDAN--------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCSHH--------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHH--------HHHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            432110        11111111         112234455678999999999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=390.63  Aligned_cols=251  Identities=26%  Similarity=0.360  Sum_probs=204.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      +.|++.+.||+|+||+||+|.++ +++.||+|++......    ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE----ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG----GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence            46899999999999999999986 6889999998654322    345677999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++.....    ++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        88 mEy~~~g~L~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             EECCTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence            999999999999876432    5899999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCceeeecccccCCccchhhhc-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQ-----SSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKN  304 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
                      .... .......||+.|+|||++.     +..++.++|||||||++|||+||+.||.+.....     .   ...... .
T Consensus       161 ~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-----~---~~~i~~-~  230 (288)
T d2jfla1         161 TRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----V---LLKIAK-S  230 (288)
T ss_dssp             HHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----H---HHHHHH-S
T ss_pred             CCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-----H---HHHHHc-C
Confidence            3221 1233457999999999884     4567899999999999999999999996543111     1   111111 1


Q ss_pred             ccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          305 RLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...       ....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 EPP-------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCC-------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC-------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110       01123345668999999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-56  Score=382.62  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=198.3

Q ss_pred             CCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee----CCcce
Q 040763           73 FNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE----TEFPL  147 (360)
Q Consensus        73 ~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~~~~~  147 (360)
                      |+..+.||+|+||+||+|.+. +++.||+|.+.......  ...+.+.+|++++++++||||+++++++.+    ....+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            356678999999999999986 57899999876544332  335678899999999999999999999865    34578


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc-CCCcEEEeecCCc
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD-ERYRAKVADFGTS  226 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~  226 (360)
                      +||||+++|+|.+++....     .+++..+..++.|++.||+|||+++ ++|+||||||+|||++ +++.+||+|||++
T Consensus        89 ivmE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEeCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            9999999999999997654     5889999999999999999999976 4599999999999996 5789999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      +.....   .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+...       ..... ..+..+..
T Consensus       163 ~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~-~~i~~~~~  230 (270)
T d1t4ha_         163 TLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIY-RRVTSGVK  230 (270)
T ss_dssp             GGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHH-HHHTTTCC
T ss_pred             eeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHH-HHHHcCCC
Confidence            765432   2234579999999998865 599999999999999999999999964321       11111 11111111


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                              ....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       231 --------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 --------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                    11122334557999999999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=389.45  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             hcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      .++|++.+.||+|+||.||+|.+++++.||||+++.....     .+.+.+|+.++.+++||||+++++++.+ +..++|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC-----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            4679999999999999999999988889999998754332     3568899999999999999999999854 567999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|..++.....   ..+++..++.++.|++.||+|||+++   |+||||||+||||++++.+||+|||+++..
T Consensus        90 ~Ey~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEecCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhc
Confidence            999999999999876432   25899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ............||+.|+|||++.++.++.++||||||+++|||++|..|+.....       .... ...+...     
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~-~~~i~~~-----  230 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREV-LDQVERG-----  230 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHH-HHHHHTT-----
T ss_pred             cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHH-HHHHHhc-----
Confidence            55444444445789999999999999999999999999999999997666544321       1111 1111111     


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                          ...+.+..+++++.+++.+||+.||++|||+++|++.|+..-.+
T Consensus       231 ----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         231 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ----CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence                11223445567899999999999999999999999999876544

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-56  Score=391.01  Aligned_cols=248  Identities=29%  Similarity=0.414  Sum_probs=202.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ..|+..+.||+|+||+||+|.+. +++.||||++....... ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            34899999999999999999976 68889999987644332 24456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ||||.+|+|..++....     ++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        94 ~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccccc
Confidence            99999999977665432     5899999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCceeeecccccCCccchhhhcc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQS---SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ...     ....||+.|+|||++.+   +.++.++|||||||++|||++|..||.+...        ......... ...
T Consensus       166 ~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~-~~~  231 (309)
T d1u5ra_         166 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ-NES  231 (309)
T ss_dssp             SSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH-SCC
T ss_pred             CCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh-CCC
Confidence            432     33579999999999864   4588999999999999999999999965431        011111111 111


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .        ...+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       232 ~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 P--------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C--------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C--------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1        1112345668999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=389.39  Aligned_cols=250  Identities=26%  Similarity=0.334  Sum_probs=204.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||+|.++ +++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            56999999999999999999986 6889999987643211 123456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus        87 mEy~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence            99999999999987654     5899999999999999999999999   999999999999999999999999999877


Q ss_pred             CCCC-ceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQ-THVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      .... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...        ...... +....   
T Consensus       159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~-i~~~~---  226 (288)
T d1uu3a_         159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQK-IIKLE---  226 (288)
T ss_dssp             C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHTTC---
T ss_pred             ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHH-HHcCC---
Confidence            5433 2233456799999999999999999999999999999999999999965321        011111 11111   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVS  348 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~  348 (360)
                             ...+...++++.+|+.+||+.||++|||++|++
T Consensus       227 -------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 -------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             -------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             -------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence                   112334566899999999999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=383.34  Aligned_cols=258  Identities=26%  Similarity=0.411  Sum_probs=200.0

Q ss_pred             cCCCccceecccCcEEEEEEEecC----CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED----GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ++|++.+.||+|+||.||+|.+..    +..||+|.++.....   ...+.+.+|+.++++++||||+++++++. .+..
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD---SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            579999999999999999998753    346889987654433   34567889999999999999999999986 4678


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++|+|.+++....    ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred             EEEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhh
Confidence            99999999999999886532    25899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      +..............||+.|+|||++.+..++.++|||||||++|||++ |..||.+....     ....    ......
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----~~~~----~i~~~~  226 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIG----RIENGE  226 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHH----HHHTTC
T ss_pred             eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----HHHH----HHHcCC
Confidence            8766544444555678999999999999999999999999999999998 88888654321     1111    111111


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                               ....+..+++++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus       227 ---------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         227 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                     1123445567899999999999999999999999999988654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-56  Score=389.51  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=191.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      .+.|++.+.||+|+||+||+|.++ +++.||+|.+......   .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            467999999999999999999986 6889999998754332   223457789999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc---CCCcEEEeecCC
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFGT  225 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~  225 (360)
                      |||||++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+||++.   +++.+||+|||+
T Consensus        85 vmE~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             EECCCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EEeccCCCcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccce
Confidence            999999999999997533     5899999999999999999999999   99999999999994   578999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      ++......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...        ......... ..
T Consensus       157 a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~-~~  225 (307)
T d1a06a_         157 SKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILK-AE  225 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHT-TC
T ss_pred             eEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-cC
Confidence            98654332  23445799999999999999999999999999999999999999965331        011111111 11


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .      ..........++++.+|+.+||+.||++|||+.|+++
T Consensus       226 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         226 Y------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             C------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0      0111122345668999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-54  Score=386.89  Aligned_cols=252  Identities=20%  Similarity=0.302  Sum_probs=206.5

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      -++|++.+.||+|+||.||+|.++ +|+.||+|++.....    ...+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            367999999999999999999976 689999999865432    234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc--CCCcEEEeecCCc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFGTS  226 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~  226 (360)
                      |||||++|+|.+++....    ..+++..+..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||++
T Consensus       101 vmE~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a  173 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT  173 (350)
T ss_dssp             EECCCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEcCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence            999999999999986432    25899999999999999999999999   99999999999996  4678999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL  306 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (360)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...        ...... +.....
T Consensus       174 ~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~-i~~~~~  242 (350)
T d1koaa2         174 AHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRN-VKSCDW  242 (350)
T ss_dssp             EECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHHTCC
T ss_pred             eecccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHH-HHhCCC
Confidence            87654432  3345799999999999999999999999999999999999999965421        111111 111110


Q ss_pred             ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .      .........++++.+|+.+||+.||++|||+.|+++
T Consensus       243 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         243 N------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             C------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             C------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      011112334568999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-55  Score=385.43  Aligned_cols=258  Identities=23%  Similarity=0.428  Sum_probs=204.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCc----EEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGR----IIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~  145 (360)
                      .+|++.+.||+|+||+||+|.+. +|+    .||+|.++.....   ...+++.+|+.++++++||||++++|++.+. .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP---KANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            46999999999999999999875 343    5888887643322   3456788999999999999999999999865 5


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++++++.+++|.+++....    ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGl  157 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  157 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred             eeEEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccc
Confidence            678889999999999887643    26899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ++......... .....||+.|+|||++.++.++.++|||||||++|||+| |..||.+...     .......    ..
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~~~~~~i----~~  228 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSIL----EK  228 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----GGHHHHH----HH
T ss_pred             ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHH----Hc
Confidence            98875543332 333468999999999999999999999999999999999 7888865431     1111111    11


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                               ......+..+++++.+|+.+||+.||++|||+.||++.|+.+.++
T Consensus       229 ---------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         229 ---------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             ---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---------CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                     111223445567899999999999999999999999999887654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-55  Score=375.45  Aligned_cols=251  Identities=26%  Similarity=0.420  Sum_probs=199.7

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee-CCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE-TEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||+|.++ |..||+|+++...      ..+.+.+|+.++++++||||++++|++.+ .+..++|
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            56888999999999999999985 7789999987532      23567899999999999999999999865 4567999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++.....   ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++..
T Consensus        80 ~ey~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~  153 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  153 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceec
Confidence            999999999999976431   14889999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ...    .....+|..|+|||++.++.++.++||||||+++|||+| |+.||.....  .   ...    .....     
T Consensus       154 ~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~---~~~----~~i~~-----  215 (262)
T d1byga_         154 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--K---DVV----PRVEK-----  215 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--G---GHH----HHHTT-----
T ss_pred             CCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--H---HHH----HHHHc-----
Confidence            432    223457899999999999999999999999999999998 6777754321  1   111    11111     


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                          ....+.+...++++.+|+.+||+.||++|||+.++++.|+.++.
T Consensus       216 ----~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 ----GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                12223344556789999999999999999999999999998874

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=379.56  Aligned_cols=255  Identities=26%  Similarity=0.331  Sum_probs=207.1

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChH--HHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDE--ELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      .++|++.+.||+|+||+||+|.++ +|+.||+|++.......  .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999985 68899999876533221  112356788999999999999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC----cEEEee
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY----RAKVAD  222 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~D  222 (360)
                      |+|||||++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+||+++.++    .+||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence            99999999999999997653     5899999999999999999999999   99999999999998776    599999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      ||++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+...        ..... .+.
T Consensus       161 fG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~-~i~  229 (293)
T d1jksa_         161 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLA-NVS  229 (293)
T ss_dssp             CTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHH
T ss_pred             hhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHH-HHH
Confidence            99998765432  23345789999999999999999999999999999999999999975431        01111 111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....      ......+...++++.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         230 AVNY------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTCC------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hcCC------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1110      0011112234567999999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-54  Score=382.59  Aligned_cols=263  Identities=25%  Similarity=0.389  Sum_probs=211.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee
Q 040763           69 ATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE  142 (360)
Q Consensus        69 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~  142 (360)
                      ..++|++.+.||+|+||+||+|+.+      +++.||||+++.....   ...+++.+|+.+++.++||||+++++++..
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh---HHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3467999999999999999999864      3468999998764433   345678899999999999999999999999


Q ss_pred             CCcceEEEEecCCCChhHHhhhhcc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQ-------------------NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHR  203 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~  203 (360)
                      ....+++|||+++|+|.+++.....                   .....+++..++.++.|++.||+|||+++   ++||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence            9999999999999999999975422                   11235889999999999999999999999   9999


Q ss_pred             CCCCCCeEEcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCC-CCCC
Q 040763          204 DIKSTNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK-KPIF  281 (360)
Q Consensus       204 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~p~~  281 (360)
                      ||||+|||++.++.+||+|||++........ .......||+.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999999999986644332 2233456899999999999999999999999999999999986 5664


Q ss_pred             CCCCCcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          282 STGNTSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                      +...        .+ .......+..         ...+..+++++.+|+.+||+.||++||||.||+++|+.|.
T Consensus       245 ~~~~--------~e-~~~~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAH--------EE-VIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCH--------HH-HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCH--------HH-HHHHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            4321        01 1111222221         1233445668999999999999999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=383.70  Aligned_cols=250  Identities=26%  Similarity=0.311  Sum_probs=208.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||+|.++ +++.||+|+++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            57999999999999999999985 68999999986532211 12456778999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+..
T Consensus        84 ~ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eeccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence            99999999999998754     5889999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+...        ... ........    
T Consensus       156 ~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~-~~~i~~~~----  221 (337)
T d1o6la_         156 ISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERL-FELILMEE----  221 (337)
T ss_dssp             CCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH-HHHHHHCC----
T ss_pred             ccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHH-HHHHhcCC----
Confidence            4332 233456799999999999999999999999999999999999999976431        011 11111111    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~~  349 (360)
                            ...+...++++.+|+.+||+.||++||+     ++|+++
T Consensus       222 ------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 ------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                  1123456678999999999999999995     777764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.8e-54  Score=386.29  Aligned_cols=251  Identities=20%  Similarity=0.292  Sum_probs=206.7

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++......    ..+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL----DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH----HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            57999999999999999999975 6899999997654322    235677899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc--CCCcEEEeecCCcc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD--ERYRAKVADFGTSK  227 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~  227 (360)
                      ||||++|+|.+++...    ..++++..+..++.|++.||.|||+++   |+||||||+|||++  .++.+||+|||++.
T Consensus       105 mE~~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~  177 (352)
T d1koba_         105 LEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT  177 (352)
T ss_dssp             EECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEcCCCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccce
Confidence            9999999999887653    235899999999999999999999999   99999999999998  67899999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .......  .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+...        ..... .+..... 
T Consensus       178 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~-~i~~~~~-  245 (352)
T d1koba_         178 KLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQ-NVKRCDW-  245 (352)
T ss_dssp             ECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH-HHHHCCC-
T ss_pred             ecCCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHH-HHHhCCC-
Confidence            8765432  3345789999999999999999999999999999999999999965431        01111 1111110 


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                           ..........++++.+|+.+||+.||++|||+.|+++
T Consensus       246 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         246 -----EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             -----CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0111122345668999999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-53  Score=370.32  Aligned_cols=262  Identities=26%  Similarity=0.375  Sum_probs=205.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc---
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF---  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~---  145 (360)
                      .++|++.+.||+|+||+||+|.+. +++.||+|+++.....+ ....+.+.+|+.+++.++||||+++++++...+.   
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            467999999999999999999975 68899999987644332 2345678899999999999999999999876543   


Q ss_pred             -ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          146 -PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       146 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                       .|+||||+++++|.+++....     ++++..++.++.|++.||.|||+++   |+||||||+|||++.++..+++|||
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCT
T ss_pred             eEEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhh
Confidence             789999999999999987654     5899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCc--eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          225 TSKFIAMDQT--HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       225 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      .+........  ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+...        .........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~  228 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVR  228 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH
T ss_pred             hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHHh
Confidence            9876543222  233445799999999999999999999999999999999999999965321        111111111


Q ss_pred             ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHhH
Q 040763          303 KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-TMEEVSMELNGIR  355 (360)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~ei~~~L~~l~  355 (360)
                      .....       ........++++.+++.+||+.||++|| |++++++.|..++
T Consensus       229 ~~~~~-------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         229 EDPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCCCC-------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cCCCC-------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            11110       1112234566899999999999999999 8999999998775

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=375.05  Aligned_cols=258  Identities=25%  Similarity=0.399  Sum_probs=198.3

Q ss_pred             cCCCccceecccCcEEEEEEEecC--C--cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED--G--RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ++|++.+.||+|+||.||+|....  +  ..||||+++...... ....+.+.+|+.++.+++||||++++|++.+ ...
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            568999999999999999998642  2  368999887644322 2345678999999999999999999999976 467


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      ++||||+++|++.+++.....    ++++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             heeeeeecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence            899999999999998876432    5899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCcee--eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          227 KFIAMDQTHV--TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       227 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      ..........  .....||..|+|||.+.+..++.++||||||+++|||+| |..||.+...        ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~~~  230 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKE  230 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTS
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHHhC
Confidence            8875543222  233457889999999999999999999999999999998 8999965431        1111111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGI  354 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l  354 (360)
                      +         ...+.+..++.++.+|+.+||+.||++|||+.+|.+.|+..
T Consensus       231 ~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 G---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             C---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1         11122344556899999999999999999999999998865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-54  Score=378.52  Aligned_cols=266  Identities=26%  Similarity=0.347  Sum_probs=201.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCC  140 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~  140 (360)
                      ...++|++.+.||+|+||.||+|.+.      +++.||+|+++.....   ...+.+.+|...+.++ +|+||+.+++++
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc---HHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            33467999999999999999999864      2468999998754443   2345677788888777 789999999998


Q ss_pred             eeC-CcceEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040763          141 LET-EFPLLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKST  208 (360)
Q Consensus       141 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~  208 (360)
                      ... ...+++||||++|+|.+++......           ....+++..+..++.|++.||.|||+++   |+||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence            764 4679999999999999999764321           1235889999999999999999999999   999999999


Q ss_pred             CeEEcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCC-CCCCCCCCC
Q 040763          209 NILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK-KPIFSTGNT  286 (360)
Q Consensus       209 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~p~~~~~~~  286 (360)
                      |||+++++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+||. .||.+....
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654332 2234457999999999999999999999999999999999965 566543211


Q ss_pred             cccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          287 SQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      .        .+......+.         ....+...++++.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus       244 ~--------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         244 E--------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             H--------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--------HHHHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1        1111111111         112334456689999999999999999999999999998754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-54  Score=378.82  Aligned_cols=270  Identities=26%  Similarity=0.376  Sum_probs=217.4

Q ss_pred             HHhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE
Q 040763           68 KATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCC  140 (360)
Q Consensus        68 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~  140 (360)
                      ...++|++.+.||+|+||.||+|++.      ++..||||+++.....   ....++.+|+.++..+ +||||+++++++
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH---HHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            34478999999999999999999852      3568999998765443   3455788999999999 799999999999


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQN-------------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKS  207 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~  207 (360)
                      .+.+..+++||||++|+|.+++......             ....+++..+..++.|++.||+|||+++   ++||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence            9999999999999999999999764321             2346899999999999999999999999   99999999


Q ss_pred             CCeEEcCCCcEEEeecCCccccCCCCc-eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhC-CCCCCCCCC
Q 040763          208 TNILLDERYRAKVADFGTSKFIAMDQT-HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTG-KKPIFSTGN  285 (360)
Q Consensus       208 ~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~p~~~~~~  285 (360)
                      +||+++.++.+|++|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||+|+ .+||.....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987765433 333446789999999999999999999999999999999995 444433321


Q ss_pred             CcccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhccC
Q 040763          286 TSQENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIKN  360 (360)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~~  360 (360)
                       ..       .+....         ........+...++++.+|+.+||+.||++|||+.+|++.|+.+.++-+|
T Consensus       254 -~~-------~~~~~i---------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~~  311 (311)
T d1t46a_         254 -DS-------KFYKMI---------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (311)
T ss_dssp             -SH-------HHHHHH---------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             -HH-------HHHHHH---------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCCC
Confidence             10       011111         11112223344566899999999999999999999999999988776555

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-53  Score=377.17  Aligned_cols=247  Identities=27%  Similarity=0.393  Sum_probs=205.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||+|.++ +|+.||+|+++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            56999999999999999999985 6899999998653221 123456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+++|+|..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        83 mE~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~  154 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV  154 (316)
T ss_dssp             ECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             eeecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence            99999999999987654     4788888999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...        ......... ..    
T Consensus       155 ~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~-~~----  217 (316)
T d1fota_         155 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILN-AE----  217 (316)
T ss_dssp             SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-CC----
T ss_pred             ccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHc-CC----
Confidence            533    2345799999999999999999999999999999999999999965431        111111111 11    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                            ...+...++++.+++.+||+.||++||     |++++++
T Consensus       218 ------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 ------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                  112334556899999999999999996     8888864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=375.26  Aligned_cols=263  Identities=26%  Similarity=0.370  Sum_probs=209.2

Q ss_pred             hcCCCccceecccCcEEEEEEEecC--------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEE
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLED--------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCC  140 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~  140 (360)
                      .++|++.+.||+|+||.||+|+...        +..||+|+++.....   ....++.+|...+.++ +||||+++++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh---HHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            3678999999999999999998642        247999998765544   3456677888888888 899999999999


Q ss_pred             eeCCcceEEEEecCCCChhHHhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 040763          141 LETEFPLLVYEFIPNGTLYQHLHDRHQN-----------EEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTN  209 (360)
Q Consensus       141 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~N  209 (360)
                      .+++..++||||+++|+|.+++..+...           ....+++..++.++.|++.||+|||+++   |+||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence            9999999999999999999999765321           2346899999999999999999999999   9999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCce-eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCCCc
Q 040763          210 ILLDERYRAKVADFGTSKFIAMDQTH-VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLT-GKKPIFSTGNTS  287 (360)
Q Consensus       210 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~p~~~~~~~~  287 (360)
                      ||++.++.+||+|||++......... ......||+.|+|||.+.++.++.++||||||+++|||++ |..||.+...  
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--  243 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  243 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--
Confidence            99999999999999999877554322 2344568999999999999999999999999999999998 6888754321  


Q ss_pred             ccccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          288 QENVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                            .. ....+..+         .....+..+++++.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus       244 ------~~-~~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 ------EE-LFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ------HH-HHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HH-HHHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                  01 11122111         1122334456689999999999999999999999999998864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-54  Score=377.90  Aligned_cols=263  Identities=26%  Similarity=0.401  Sum_probs=207.5

Q ss_pred             cCCCccceecccCcEEEEEEEecC-Cc--EEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLED-GR--IIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~  146 (360)
                      ++|++.+.||+|+||.||+|.+++ +.  .||||.+......   ...+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh---HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            678899999999999999999864 43  4677876543322   2345788999999998 799999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCC
Q 040763          147 LLVYEFIPNGTLYQHLHDRH-----------QNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~  215 (360)
                      ++||||+++|+|.+++....           ......+++..++.++.|++.||.|||+++   ++||||||+|||++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCC
Confidence            99999999999999997542           123346899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCC-CCCCCCCCcccccchH
Q 040763          216 YRAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKK-PIFSTGNTSQENVSLA  294 (360)
Q Consensus       216 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~-p~~~~~~~~~~~~~~~  294 (360)
                      +.+||+|||++.......  ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.+..        ..
T Consensus       164 ~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~  233 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CA  233 (309)
T ss_dssp             GCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH
T ss_pred             CceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------HH
Confidence            999999999997553322  1233468999999999999999999999999999999999765 554322        11


Q ss_pred             HHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhcc
Q 040763          295 AYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSIK  359 (360)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~~  359 (360)
                      . ....+..         ......+..+++++.+|+.+||+.||++|||+.||++.|+.+.+..+
T Consensus       234 ~-~~~~i~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         234 E-LYEKLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             H-HHHHGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             H-HHHHHHh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            1 1111111         11223344566789999999999999999999999999999876543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=372.30  Aligned_cols=256  Identities=29%  Similarity=0.459  Sum_probs=204.3

Q ss_pred             cceecccCcEEEEEEEecCC----cEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC-CcceEEE
Q 040763           76 NRILGQGGQGTVYKGRLEDG----RIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-EFPLLVY  150 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~----~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~lv~  150 (360)
                      .++||+|+||+||+|.+.++    ..||||.++.....   ...+++.+|+.++.+++||||++++|++... ...++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI---GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH---HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            46899999999999987542    25899988754333   3467799999999999999999999998764 5789999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      ||+++++|.+++....    ...++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++....
T Consensus       109 E~~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             ECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EEeecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            9999999999987533    25778899999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCce---eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          231 MDQTH---VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       231 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      .....   ......||+.|+|||.+.++.++.++||||||+++|||+||..||.......+    ....    ...+.  
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~----i~~g~--  251 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVY----LLQGR--  251 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHH----HHTTC--
T ss_pred             ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HHHH----HHcCC--
Confidence            43222   12234689999999999999999999999999999999998888754332111    1111    11111  


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                             ....+..+++++.+|+.+||+.||++|||+.||++.|+++.++.
T Consensus       252 -------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         252 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence                   11123344568999999999999999999999999999998763

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.1e-53  Score=366.20  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=205.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChH-----HHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeC
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDE-----ELYKLEEFINEIFILSQIN-HRNVVKLLGCCLET  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~-----~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~  143 (360)
                      ++|++.+.||+|+||+||+|++. +++.+|+|++.......     .....+.+.+|+.++.+++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67999999999999999999975 68899999976543221     1223456889999999996 99999999999999


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      +..|+||||+++|+|.+++..+.     ++++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence            99999999999999999997654     5899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhcc------CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHH
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS------SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYF  297 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  297 (360)
                      |+++......  ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||.+...        .. .
T Consensus       155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~-~  223 (277)
T d1phka_         155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------ML-M  223 (277)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-H
T ss_pred             hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HH-H
Confidence            9998775432  2344579999999998764      3467899999999999999999999975431        01 1


Q ss_pred             HHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          298 VHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...+......      .........++++.+|+.+||+.||++|||+.|+++
T Consensus       224 ~~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         224 LRMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111111110      011122345678999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.4e-53  Score=377.96  Aligned_cols=247  Identities=23%  Similarity=0.305  Sum_probs=206.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++++.||+|+||.||+|.++ +|+.||+|++...... .....+.+.+|+.+++.++||||+++++++......++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            57999999999999999999986 6899999987643211 123456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+.+|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       120 ~e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            99999999999997654     5899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      ...    .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+...        ..... .+....    
T Consensus       192 ~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~-~i~~~~----  254 (350)
T d1rdqe_         192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYE-KIVSGK----  254 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHCC----
T ss_pred             ccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHH-HHhcCC----
Confidence            532    2345799999999999999999999999999999999999999965321        11111 111111    


Q ss_pred             cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 040763          310 LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRP-----TMEEVSM  349 (360)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~ei~~  349 (360)
                            ...+...++++.+|+.+||+.||++|+     |++++++
T Consensus       255 ------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                  112334566899999999999999994     8999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.1e-53  Score=378.78  Aligned_cols=251  Identities=23%  Similarity=0.264  Sum_probs=199.6

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHH---HHHHHHHhhcCCCCceeeeeEEeeCCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEF---INEIFILSQINHRNVVKLLGCCLETEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~---~~e~~~~~~l~h~niv~~~~~~~~~~~~  146 (360)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++........ .....+   ..++.+++.++||||+++++++.+.+..
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH-TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh-hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            67999999999999999999986 689999998754321111 111222   3457777788999999999999999999


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCc
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTS  226 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~  226 (360)
                      |+||||+++|+|.+++....     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             EEEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence            99999999999999997654     4788999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc
Q 040763          227 KFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR  305 (360)
Q Consensus       227 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (360)
                      +......   .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+......     .. ........ 
T Consensus       155 ~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~-~~~~~~~~-  224 (364)
T d1omwa3         155 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HE-IDRMTLTM-  224 (364)
T ss_dssp             EECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HH-HHHHSSSC-
T ss_pred             eecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HH-HHHhcccC-
Confidence            8765432   334579999999999875 4689999999999999999999999976432111     11 11111110 


Q ss_pred             cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 040763          306 LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVSM  349 (360)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~~  349 (360)
                               ....+...++++.+|+.+||+.||++|||     ++|+++
T Consensus       225 ---------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 ---------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                     11123345668999999999999999999     677763

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=373.27  Aligned_cols=267  Identities=27%  Similarity=0.365  Sum_probs=214.0

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEec------CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeee
Q 040763           65 ELDKATNHFNVNRILGQGGQGTVYKGRLE------DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLG  138 (360)
Q Consensus        65 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~  138 (360)
                      +.+...++|++.+.||+|+||+||+|.+.      ++..||||+++.....   .....+.+|+.++.+++||||+++++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH---HHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh---HHHHHHHHHHHHHHHcCCCCEeeeee
Confidence            33444578999999999999999999864      2568999998754333   34457889999999999999999999


Q ss_pred             EEeeCCcceEEEEecCCCChhHHhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc
Q 040763          139 CCLETEFPLLVYEFIPNGTLYQHLHDRHQ-----NEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD  213 (360)
Q Consensus       139 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~  213 (360)
                      ++......++||||+++|+|.+++.....     .....+++..+..++.|++.||.|||+++   |+||||||+|||++
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld  167 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA  167 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeec
Confidence            99999999999999999999999875421     12235789999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCcee-eecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCC-CCCCCCCCCccccc
Q 040763          214 ERYRAKVADFGTSKFIAMDQTHV-TTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGK-KPIFSTGNTSQENV  291 (360)
Q Consensus       214 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~p~~~~~~~~~~~~  291 (360)
                      .++++||+|||++.......... .....||+.|+|||.+.++.++.++||||||+++|||+||. .||.+...      
T Consensus       168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------  241 (308)
T d1p4oa_         168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------  241 (308)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------
T ss_pred             CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------
Confidence            99999999999998765443322 33346899999999999999999999999999999999985 66643221      


Q ss_pred             chHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhH
Q 040763          292 SLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIR  355 (360)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~  355 (360)
                        ... ...+..+.         ....+..+++++.+++.+||+.||++|||+.+|++.|+...
T Consensus       242 --~~~-~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         242 --EQV-LRFVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             --HHH-HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             --HHH-HHHHHhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence              111 11111111         12233445668999999999999999999999999987753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=374.48  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=203.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHh-hcCCCCceeeeeEEeeCCcceE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILS-QINHRNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~-~l~h~niv~~~~~~~~~~~~~l  148 (360)
                      ++|++.+.||+|+||+||+|.++ +++.||+|+++...... ....+.+..|..++. .++||||+++++++.+.+..|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            57899999999999999999986 68899999986532111 123445666777665 6899999999999999999999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          149 VYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       149 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      ||||+++|+|.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 vmEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence            999999999999997654     4889999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccccc
Q 040763          229 IAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYH  308 (360)
Q Consensus       229 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (360)
                      ..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+...  .      . .........   
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~------~-~~~~i~~~~---  219 (320)
T d1xjda_         153 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--E------E-LFHSIRMDN---  219 (320)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H------H-HHHHHHHCC---
T ss_pred             ccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--H------H-HHHHHHcCC---
Confidence            55432 223445799999999999999999999999999999999999999975431  0      1 111111111   


Q ss_pred             ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 040763          309 ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTME-EVS  348 (360)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-ei~  348 (360)
                             ...+...++++.+|+.+||+.||++|||+. +++
T Consensus       220 -------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         220 -------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                   112334566899999999999999999996 664

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-53  Score=372.50  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=204.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||+|.++ +++.||+|.++.....     ...+.+|+.++..++||||+++++++.+.+..|+|
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-----QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            67999999999999999999986 6889999998764322     23567899999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC--CCcEEEeecCCcc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE--RYRAKVADFGTSK  227 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~  227 (360)
                      ||||++|+|.+++....    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.  ...+||+|||++.
T Consensus        80 mE~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          80 FEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhh
Confidence            99999999999996532    25899999999999999999999999   999999999999985  4589999999998


Q ss_pred             ccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccc
Q 040763          228 FIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLY  307 (360)
Q Consensus       228 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (360)
                      ......  ......+|+.|+|||.+.+..++.++||||+||++|+|++|..||.+...        ...+..... ... 
T Consensus       153 ~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~-~~~-  220 (321)
T d1tkia_         153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMN-AEY-  220 (321)
T ss_dssp             ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-TCC-
T ss_pred             ccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCC-
Confidence            765433  23345689999999999999999999999999999999999999965431        111111111 110 


Q ss_pred             cccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          308 HILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                       .....    .....++++.+|+.+||+.||++|||+.|+++
T Consensus       221 -~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         221 -TFDEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -CCCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCChh----hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00111    11224567999999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=373.27  Aligned_cols=252  Identities=22%  Similarity=0.280  Sum_probs=197.7

Q ss_pred             hcCCCccc-eecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhc-CCCCceeeeeEEee----
Q 040763           70 TNHFNVNR-ILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI-NHRNVVKLLGCCLE----  142 (360)
Q Consensus        70 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~----  142 (360)
                      .++|.+.+ .||+|+||+||+|.+. +++.||+|+++..         ..+.+|+.++.++ +||||+++++++.+    
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            36788775 5999999999999975 6889999997532         2345789887655 89999999999875    


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC---CCcEE
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE---RYRAK  219 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~---~~~~k  219 (360)
                      ....|+|||||++|+|.+++..+.   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.   ++.+|
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~K  154 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK  154 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccc
Confidence            456899999999999999997532   236899999999999999999999999   999999999999985   56799


Q ss_pred             EeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |+|||+++.......  .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.........     ...
T Consensus       155 l~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-----~~~  227 (335)
T d2ozaa1         155 LTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKT  227 (335)
T ss_dssp             ECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------
T ss_pred             ccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-----HHH
Confidence            999999987654332  3445799999999999999999999999999999999999999976432111000     000


Q ss_pred             HhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ......      ...+.......++++.+|+.+||+.||++|||+.|+++
T Consensus       228 ~i~~~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 RIRMGQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CCCSCS------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000000      00111122345678999999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=363.34  Aligned_cols=272  Identities=21%  Similarity=0.269  Sum_probs=200.2

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----cc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----FP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----~~  146 (360)
                      .+|.+.+.||+|+||+||+|+. +|+.||||+++.....     ......|+..+.+++||||+++++++...+    ..
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            5677888999999999999987 5789999988643211     111223555556789999999999998654    46


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeEEcCCCcEEEe
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA-----SSPIYHRDIKSTNILLDERYRAKVA  221 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dlk~~Nill~~~~~~kl~  221 (360)
                      ++||||+++|+|.+++.+.      .+++..++.++.|++.||+|+|+..     ..+|+||||||+||||+.++.+||+
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence            8999999999999999753      4889999999999999999999741     1239999999999999999999999


Q ss_pred             ecCCccccCCCCce---eeecccccCCccchhhhccCC------CCCccchhhhHHHHHHHHhCCCCCCCCCCCccc---
Q 040763          222 DFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSSQ------LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE---  289 (360)
Q Consensus       222 Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~---  289 (360)
                      |||++.........   ......||+.|+|||++.+..      ++.++|||||||++|||+||..||.........   
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            99999876543322   233457999999999987653      567899999999999999999887543321110   


Q ss_pred             ---ccchHHHHHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhh
Q 040763          290 ---NVSLAAYFVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGS  357 (360)
Q Consensus       290 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~  357 (360)
                         ...................-+.   ....+...+.++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCC---GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCC---cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence               0011111122221111110000   0111334566799999999999999999999999999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=365.02  Aligned_cols=260  Identities=24%  Similarity=0.228  Sum_probs=193.9

Q ss_pred             cceecccCcEEEEEEEec-CCcEEEEEecccccChHHH-HhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEEEec
Q 040763           76 NRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEEL-YKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVYEFI  153 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~e~~  153 (360)
                      +++||+|+||+||+|.++ +|+.||+|+++........ ...+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999986 6899999998764332211 11245789999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccCCCC
Q 040763          154 PNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIAMDQ  233 (360)
Q Consensus       154 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  233 (360)
                      .++++..+...     ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            88777665543     225788889999999999999999999   9999999999999999999999999998765433


Q ss_pred             ceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc---
Q 040763          234 THVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI---  309 (360)
Q Consensus       234 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  309 (360)
                      . .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+..+.     .....+............   
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-----~~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----DQLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCCTTTSSST
T ss_pred             c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-----HHHHHHHHhcCCCChhhccch
Confidence            2 23345799999999988754 5799999999999999999999999654321     111111111111100000   


Q ss_pred             cc-----------hHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 LD-----------DQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ..           ...........++++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00           00001111234568999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=364.31  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++.+.||+|+||+||+|.+. +++.||+|+++......  ...+.+.+|+.++++++||||+++++++.+....|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE--GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh--HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            47999999999999999999985 68999999986543221  2345788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      |||+.+ ++.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~e~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EECCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             EeecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceec
Confidence            999964 555555432   2336899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccc---
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNR---  305 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  305 (360)
                      .... .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||.+.....     .............   
T Consensus       153 ~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~  226 (298)
T d1gz8a_         153 GVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-----QLFRIFRTLGTPDEVV  226 (298)
T ss_dssp             CCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTT
T ss_pred             cCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-----HHHHHHHhcCCCchhh
Confidence            5432 2233457999999999877765 4789999999999999999999996543110     0000011100000   


Q ss_pred             ccccc------------chHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          306 LYHIL------------DDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       306 ~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      +....            ............++++.+|+.+||+.||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00000            000000111234568999999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=363.43  Aligned_cols=244  Identities=27%  Similarity=0.411  Sum_probs=196.9

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChH--HHHhHHHHHHHHHHHhhcC--CCCceeeeeEEeeCC
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDE--ELYKLEEFINEIFILSQIN--HRNVVKLLGCCLETE  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~--~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~~  144 (360)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++.......  ......++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999976 68999999876532211  0111223557999999986  899999999999999


Q ss_pred             cceEEEEecCC-CChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-CCcEEEee
Q 040763          145 FPLLVYEFIPN-GTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-RYRAKVAD  222 (360)
Q Consensus       145 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~D  222 (360)
                      ..++||||+.+ +++.+++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++. ++.+||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence            99999999975 67888887643     5899999999999999999999999   999999999999985 57999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQL-TDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||++......   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....              ...
T Consensus       155 FG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~  217 (273)
T d1xwsa_         155 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EII  217 (273)
T ss_dssp             CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHH
T ss_pred             cccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHh
Confidence            9999865432   2334579999999999988765 567899999999999999999995421              001


Q ss_pred             hccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...           ...+...++++.+|+.+||+.||++|||++|+++
T Consensus       218 ~~~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 RGQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HCC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcc-----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            100           0112234568999999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.3e-51  Score=357.44  Aligned_cols=263  Identities=22%  Similarity=0.268  Sum_probs=201.5

Q ss_pred             cCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLVY  150 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv~  150 (360)
                      ++|++.+.||+|+||+||+|.+++|+.||+|+++......  ...+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE--GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG--CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh--HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            5799999999999999999999999999999987653322  23467889999999999999999999999999999999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCccccC
Q 040763          151 EFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFIA  230 (360)
Q Consensus       151 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~  230 (360)
                      |++.++.+..+....     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||.+....
T Consensus        80 e~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             ECCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             EeehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecc
Confidence            999776665555432     36999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhccccccc
Q 040763          231 MDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRLYHI  309 (360)
Q Consensus       231 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (360)
                      .... ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.....     .................
T Consensus       152 ~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~  225 (286)
T d1ob3a_         152 IPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-----QLMRIFRILGTPNSKNW  225 (286)
T ss_dssp             C----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTTS
T ss_pred             cCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-----HHHHHHHhhCCCChhhc
Confidence            4322 23334689999999988764 56899999999999999999999996543111     11111111111100000


Q ss_pred             ---------------cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          310 ---------------LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       310 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                                     .............++++.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                           0000111223345668999999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=358.10  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=196.0

Q ss_pred             hcCCCccceecccCcEEEEEEEec-C-CcEEEEEecccccChHHHHhHHHHHHHHHHHhhc---CCCCceeeeeEEee--
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-D-GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQI---NHRNVVKLLGCCLE--  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l---~h~niv~~~~~~~~--  142 (360)
                      .++|++++.||+|+||+||+|.+. + ++.||+|+++.......  ....+.+|+.+++.+   +||||+++++++..  
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            478999999999999999999974 4 56799999765433221  112344666666655   79999999999853  


Q ss_pred             ---CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEE
Q 040763          143 ---TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAK  219 (360)
Q Consensus       143 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~k  219 (360)
                         ....+++||+++++++......    ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+|
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             cccCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCee
Confidence               3467899999987766544432    2235889999999999999999999999   99999999999999999999


Q ss_pred             EeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHH
Q 040763          220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVH  299 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
                      |+|||++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....     ........
T Consensus       157 l~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~~~~i~~  229 (305)
T d1blxa_         157 LADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILD  229 (305)
T ss_dssp             ECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred             ecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-----HHHHHHHH
Confidence            9999998765432  2234457999999999999999999999999999999999999999654311     11111111


Q ss_pred             Hhhccccccc-------------cchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRKNRLYHI-------------LDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .........+             .............++++.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1111000000             0000111122345668999999999999999999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=352.10  Aligned_cols=262  Identities=21%  Similarity=0.277  Sum_probs=196.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCc---
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEF---  145 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~---  145 (360)
                      +.+|++++.||+|+||+||+|.+. +|+.||||++......   ...+.+.+|+.+++.++||||+++++++.....   
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ---TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH---HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh---HHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            357999999999999999999875 7899999998754332   345678899999999999999999999876542   


Q ss_pred             -ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecC
Q 040763          146 -PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFG  224 (360)
Q Consensus       146 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg  224 (360)
                       .+++++++.+|+|.+++...      .+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG  154 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG  154 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccC
Confidence             34555667799999999653      4899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCce--eeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          225 TSKFIAMDQTH--VTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       225 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ++.........  .....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.......     .......
T Consensus       155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-----~~~~~~~  229 (345)
T d1pmea_         155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-----NHILGIL  229 (345)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHHH
T ss_pred             ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-----HHHhhhc
Confidence            99876443222  2344569999999998855 56788999999999999999999999654321110     0000000


Q ss_pred             hccc------------------cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNR------------------LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....                  ......... .......++++.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPW-NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCChhhhhhhhhhhhhcccccCCccCCCCH-HHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000                  000000000 0011233457999999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-49  Score=346.01  Aligned_cols=262  Identities=19%  Similarity=0.268  Sum_probs=199.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCc-eeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV-VKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-v~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......      +++..|+++++.++|+|+ +.+.++....+..+
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            367999999999999999999975 6889999986654322      245679999999977665 55556667788889


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEc---CCCcEEEeecC
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLD---ERYRAKVADFG  224 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg  224 (360)
                      +||||+ ++++.+.+....    ..+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||
T Consensus        80 ivme~~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          80 MVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EEEEEc-CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccC
Confidence            999998 667777665432    26899999999999999999999999   99999999999986   45679999999


Q ss_pred             CccccCCCCce------eeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHH
Q 040763          225 TSKFIAMDQTH------VTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFV  298 (360)
Q Consensus       225 ~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  298 (360)
                      +++........      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........  .....
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~--~~~~~  229 (299)
T d1ckia_         152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YERIS  229 (299)
T ss_dssp             SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHH
T ss_pred             cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH--HHHhh
Confidence            99876543221      23345799999999999999999999999999999999999999976542221111  00000


Q ss_pred             HHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHh
Q 040763          299 HSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRG  356 (360)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~  356 (360)
                      ......         ........+++++.+++..||+.||++||++.++.+.|+.+..
T Consensus       230 ~~~~~~---------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         230 EKKMST---------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHHHS---------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccCCC---------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            000000         0111123455689999999999999999999999999988754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=351.07  Aligned_cols=265  Identities=23%  Similarity=0.272  Sum_probs=194.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEee------
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLE------  142 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------  142 (360)
                      .++|++++.||+|+||+||+|.+. +|+.||||++.......  ....++.+|+.+++.++|||++++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            378999999999999999999975 78999999976543332  234567799999999999999999999855      


Q ss_pred             --CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEE
Q 040763          143 --TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKV  220 (360)
Q Consensus       143 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl  220 (360)
                        ....+++|||+.++.+......     ...++...+..++.|++.||.|||+++   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl  158 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKL  158 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEE
T ss_pred             ccCceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEe
Confidence              3457899999977666554432     225888999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccCCCCce---eeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 040763          221 ADFGTSKFIAMDQTH---VTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       221 ~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  296 (360)
                      +|||++.........   .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+...  ..   ....
T Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~---~~~~  233 (318)
T d3blha1         159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QH---QLAL  233 (318)
T ss_dssp             CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH---HHHH
T ss_pred             eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HH---HHHH
Confidence            999999776543221   22335699999999998765 689999999999999999999999965321  11   1111


Q ss_pred             HHHHhhc---cccccccc--------------hHHhh-hccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          297 FVHSMRK---NRLYHILD--------------DQVMK-LGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       297 ~~~~~~~---~~~~~~~~--------------~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .......   ........              ..... ......++++.+|+.+||+.||++|||++|+++
T Consensus       234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1111110   00000000              00000 001122457889999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=355.00  Aligned_cols=256  Identities=28%  Similarity=0.335  Sum_probs=204.5

Q ss_pred             cCCCccceecccCcEEEEEEEec----CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC-CCceeeeeEEeeCCc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE----DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH-RNVVKLLGCCLETEF  145 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~  145 (360)
                      ++|++.+.||+|+||+||+|...    +|+.||+|.++......+....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            66999999999999999999852    4789999988654322111223456789999999966 899999999999999


Q ss_pred             ceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCC
Q 040763          146 PLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGT  225 (360)
Q Consensus       146 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~  225 (360)
                      .+++|||+.+|+|.+++....     .++......++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence            999999999999999998754     4678888999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccC--CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhc
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSS--QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRK  303 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  303 (360)
                      +...............|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.+.......    ..........
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~~  251 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKS  251 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHC
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhcccC
Confidence            987655444444556799999999998764  4678999999999999999999999766432211    1111111111


Q ss_pred             cccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 040763          304 NRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPT-----MEEVSM  349 (360)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~ei~~  349 (360)
                                 ....+...++++.+|+.+||+.||++|||     ++|+++
T Consensus       252 -----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                       11123456678999999999999999994     788864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=350.36  Aligned_cols=258  Identities=23%  Similarity=0.278  Sum_probs=194.6

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCC----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETE----  144 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----  144 (360)
                      .++|++++.||+|+||+||+|.++ +|+.||+|+++......  ...+.+.+|+.+++.++||||+++++++...+    
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH--HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh--HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            478999999999999999999976 68999999987644332  34567889999999999999999999997655    


Q ss_pred             --cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEee
Q 040763          145 --FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVAD  222 (360)
Q Consensus       145 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D  222 (360)
                        ..++||||+ +.+|..++...      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+|++|
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             cceEEEEEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccc
Confidence              469999999 66777776532      5899999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHh
Q 040763          223 FGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSM  301 (360)
Q Consensus       223 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  301 (360)
                      ||++......    .+...||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+......     ........
T Consensus       165 fg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-----~~~~~~~~  235 (346)
T d1cm8a_         165 FGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-----LKEIMKVT  235 (346)
T ss_dssp             CTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHHH
T ss_pred             ccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-----HHHHHhcc
Confidence            9999866432    2345789999999998764 568999999999999999999999965432110     00000000


Q ss_pred             hccc------------------cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          302 RKNR------------------LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       302 ~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....                  ....... .........++++.+|+.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         236 GTPPAEFVQRLQSDEAKNYMKGLPELEKK-DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCC-CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCcHHHHhhhcchhhhhhhccCCccccc-chHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000                  0000000 001122334567899999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-48  Score=341.18  Aligned_cols=264  Identities=17%  Similarity=0.213  Sum_probs=207.8

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCC-CCceeeeeEEeeCCcce
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINH-RNVVKLLGCCLETEFPL  147 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~  147 (360)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++......      ..+.+|++.+..++| +|++.+++++......+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            468999999999999999999976 6889999987543222      234578888888865 89999999999999999


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcC-----CCcEEEee
Q 040763          148 LVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDE-----RYRAKVAD  222 (360)
Q Consensus       148 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~-----~~~~kl~D  222 (360)
                      +||||+ +++|.+++....    ..++...+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|
T Consensus        78 ~vme~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~D  149 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD  149 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             EEEEec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcc
Confidence            999998 789999886633    25889999999999999999999999   999999999999974     57899999


Q ss_pred             cCCccccCCCCc------eeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH
Q 040763          223 FGTSKFIAMDQT------HVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY  296 (360)
Q Consensus       223 fg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  296 (360)
                      ||+++.......      .......||+.|+|||++.+..++.++||||||+++|||+||..||.+.........  ...
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~--~~~  227 (293)
T d1csna_         150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--YER  227 (293)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH--HHH
T ss_pred             cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH--HHH
Confidence            999987654321      123345799999999999999999999999999999999999999976543221110  000


Q ss_pred             HHHHhhccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhHhhc
Q 040763          297 FVHSMRKNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSMELNGIRGSI  358 (360)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~~L~~l~~~~  358 (360)
                      .........         ....+..+++++.+++..|+..+|++||+++.+.+.|+.+.+..
T Consensus       228 i~~~~~~~~---------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         228 IGEKKQSTP---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHHSC---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhccCCCC---------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            110000000         11112334568999999999999999999999999988876554

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=354.03  Aligned_cols=263  Identities=24%  Similarity=0.302  Sum_probs=193.1

Q ss_pred             CCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC------C
Q 040763           72 HFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET------E  144 (360)
Q Consensus        72 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~------~  144 (360)
                      +|+..++||+|+||+||+|.+. +|+.||||++......        ..+|+.++++++||||+++++++...      .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            5888899999999999999986 6899999998654322        23699999999999999999998542      3


Q ss_pred             cceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cEEEeec
Q 040763          145 FPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADF  223 (360)
Q Consensus       145 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Df  223 (360)
                      +.++||||++++. .+.+.... .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+||+||
T Consensus        93 ~~~lv~Ey~~~~~-~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          93 YLNLVLDYVPETV-YRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             EEEEEEECCSEEH-HHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCC
T ss_pred             EEEEEEeccCCcc-HHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecc
Confidence            4689999997654 44443221 12336899999999999999999999999   99999999999999775 8999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhcc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccc-------hHH
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQS-SQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVS-------LAA  295 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~-------~~~  295 (360)
                      |++........  .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............       ...
T Consensus       168 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         168 GSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             TTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            99987654332  234579999999998765 56899999999999999999999999654321100000       000


Q ss_pred             HHHHHhh---ccccccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          296 YFVHSMR---KNRLYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       296 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      .+.....   ....................++++.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000   00011111111112223345668999999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-49  Score=344.43  Aligned_cols=264  Identities=21%  Similarity=0.281  Sum_probs=205.5

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeCCcceEE
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLETEFPLLV  149 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~lv  149 (360)
                      ++|++++.||+|+||+||+|.+. +++.||||+++......  ...+.+.+|+.+++.++||||+++++++......+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST--THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh--HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            57999999999999999999985 68899999986544332  3456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeecCCcccc
Q 040763          150 YEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADFGTSKFI  229 (360)
Q Consensus       150 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~  229 (360)
                      ++++.++++..++....     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.+...
T Consensus        80 ~~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eeecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcc
Confidence            99999988888775432     5789999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCCccchhhhccCC-CCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhhcccc--
Q 040763          230 AMDQTHVTTKIQGTFGYLDPEYHQSSQ-LTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMRKNRL--  306 (360)
Q Consensus       230 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  306 (360)
                      ..... ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.......+    ....+.........  
T Consensus       152 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~  226 (292)
T d1unla_         152 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH----HHHHHHHHHCCCCTTT
T ss_pred             cCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH----HHHHHHhhcCCCChhh
Confidence            54332 223345788899999887765 68999999999999999999999865432111    11111111111000  


Q ss_pred             -------------ccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          307 -------------YHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       307 -------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                                   ................++++.+|+.+||+.||.+|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                         0000001111223345668999999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-48  Score=348.63  Aligned_cols=259  Identities=22%  Similarity=0.278  Sum_probs=196.4

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEee--CCcc
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLE--TEFP  146 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~--~~~~  146 (360)
                      ++|++++.||+|+||+||+|.+. +++.||+|+++..       ..+.+.+|+.++..++ ||||+++++++..  ....
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            57999999999999999999985 6899999998653       2345678999999995 9999999999874  4568


Q ss_pred             eEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCC-cEEEeecCC
Q 040763          147 LLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERY-RAKVADFGT  225 (360)
Q Consensus       147 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~  225 (360)
                      ++||||+.+++|..+..        .+++..+..++.|++.||.|||+++   |+||||||+|||++.++ .+||+|||+
T Consensus       108 ~~v~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             EEEEECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             eEEEeecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeeccccc
Confidence            89999999999977642        4889999999999999999999999   99999999999998654 699999999


Q ss_pred             ccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHH-----HHH
Q 040763          226 SKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAY-----FVH  299 (360)
Q Consensus       226 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~  299 (360)
                      +.......  ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....+...........     ...
T Consensus       177 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~  254 (328)
T d3bqca1         177 AEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  254 (328)
T ss_dssp             CEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             ceeccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence            98765432  23445789999999998775 47999999999999999999999997654311110000000     000


Q ss_pred             Hhhc---ccccc-----------ccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          300 SMRK---NRLYH-----------ILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       300 ~~~~---~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ....   .....           ..............++++.+|+.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000   00000           00001111122335678999999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-48  Score=345.84  Aligned_cols=264  Identities=20%  Similarity=0.272  Sum_probs=190.9

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC------
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET------  143 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~------  143 (360)
                      ++|++++.||+|+||+||+|.+. +|+.||||++.......  ...+.+.+|+.++++++||||+++++++...      
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ--THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH--HHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            67999999999999999999986 68999999987654332  3456788999999999999999999998643      


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...|+||||+.++ +.+.+..       .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+|++||
T Consensus        95 ~~~~iv~Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          95 QDVYLVMELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             CEEEEEEECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred             ceeEEEEeccchH-HHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeech
Confidence            5779999999655 4444432       4789999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccch----------
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSL----------  293 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~----------  293 (360)
                      |++......  .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+...........          
T Consensus       164 ~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         164 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             CC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             hhhhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence            998765432  23344578999999999999999999999999999999999999996543111000000          


Q ss_pred             ----HHHHHHHhhccc-c-----ccccchHH---hhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          294 ----AAYFVHSMRKNR-L-----YHILDDQV---MKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       294 ----~~~~~~~~~~~~-~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                          ............ .     ........   ........++++.+|+.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                000000000000 0     00000000   11123446788999999999999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=342.84  Aligned_cols=259  Identities=22%  Similarity=0.263  Sum_probs=195.4

Q ss_pred             hcCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCceeeeeEEeeC-----
Q 040763           70 TNHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNVVKLLGCCLET-----  143 (360)
Q Consensus        70 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----  143 (360)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.......  ...+.+.+|+.+++.++|||++++++++...     
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI--IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH--HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            468999999999999999999975 68999999987654332  3455788999999999999999999998643     


Q ss_pred             CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEEEeec
Q 040763          144 EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAKVADF  223 (360)
Q Consensus       144 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df  223 (360)
                      ...+++++++.+|+|.+++...      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++||
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccccc
Confidence            3346777788899999998542      5899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccCCccchhhhccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCCCcccccchHHHHHHHhh
Q 040763          224 GTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSS-QLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQENVSLAAYFVHSMR  302 (360)
Q Consensus       224 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
                      |++......    .....||+.|+|||...+. .++.++||||+||++|+|++|+.||.+.....     ....+.....
T Consensus       166 g~a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-----~~~~i~~~~~  236 (348)
T d2gfsa1         166 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-----QLKLILRLVG  236 (348)
T ss_dssp             ----CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHC
T ss_pred             chhcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcC
Confidence            998754322    2335689999999987765 46889999999999999999999996543111     1111111100


Q ss_pred             ccc------------------cccccchHHhhhccHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 040763          303 KNR------------------LYHILDDQVMKLGKKNQIVAFANLAERCLDLNGKKRPTMEEVSM  349 (360)
Q Consensus       303 ~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ei~~  349 (360)
                      ...                  ........+ .......++++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         237 TPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCHHHHTTCCCHHHHHHHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChHHhhhccchhhhhhhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            000                  000000000 0011234567899999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.1e-42  Score=310.48  Aligned_cols=265  Identities=20%  Similarity=0.220  Sum_probs=188.0

Q ss_pred             cCCCccceecccCcEEEEEEEec-CCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-----------CCCceeeee
Q 040763           71 NHFNVNRILGQGGQGTVYKGRLE-DGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-----------HRNVVKLLG  138 (360)
Q Consensus        71 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-----------h~niv~~~~  138 (360)
                      ++|++++.||+|+||+||+|++. +|+.||||+++...     ...+.+.+|+.+++.++           |+||+++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            45999999999999999999985 68999999987532     22345567888777764           578999998


Q ss_pred             EEeeC--CcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEEcCC
Q 040763          139 CCLET--EFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHS-GASSPIYHRDIKSTNILLDER  215 (360)
Q Consensus       139 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlk~~Nill~~~  215 (360)
                      ++...  ...+++++++..+.........  .....+++..+..++.|++.||+|||+ .+   |+||||||+|||++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV  162 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred             Eeeeccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeecc
Confidence            87643  4556666666554443333222  233368889999999999999999998 77   9999999999999865


Q ss_pred             C------cEEEeecCCccccCCCCceeeecccccCCccchhhhccCCCCCccchhhhHHHHHHHHhCCCCCCCCCCCccc
Q 040763          216 Y------RAKVADFGTSKFIAMDQTHVTTKIQGTFGYLDPEYHQSSQLTDKSDVYSFGVVLVELLTGKKPIFSTGNTSQE  289 (360)
Q Consensus       216 ~------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~p~~~~~~~~~~  289 (360)
                      +      .++++|||.+......    .....||+.|+|||++.+..++.++||||+||++++|++|+.||.........
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence            5      3999999998754332    23456999999999999999999999999999999999999999754321111


Q ss_pred             c-cchHHHHHHHhhcc----------------------cccccc----ch--HHhhhccHHHHHHHHHHHHHhhcCCCCC
Q 040763          290 N-VSLAAYFVHSMRKN----------------------RLYHIL----DD--QVMKLGKKNQIVAFANLAERCLDLNGKK  340 (360)
Q Consensus       290 ~-~~~~~~~~~~~~~~----------------------~~~~~~----~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~  340 (360)
                      . ..........+...                      .+....    ..  ..........++++.+|+.+||..||++
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence            0 00000001110000                      000000    00  0112234677889999999999999999


Q ss_pred             CCCHHHHHH
Q 040763          341 RPTMEEVSM  349 (360)
Q Consensus       341 Rpt~~ei~~  349 (360)
                      |||++|+++
T Consensus       319 Rpta~e~L~  327 (362)
T d1q8ya_         319 RADAGGLVN  327 (362)
T ss_dssp             CBCHHHHHT
T ss_pred             CcCHHHHhc
Confidence            999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=2.3e-25  Score=181.53  Aligned_cols=168  Identities=19%  Similarity=0.176  Sum_probs=119.9

Q ss_pred             CccceecccCcEEEEEEEecCCcEEEEEecccccCh--------------HHHHhHHHHHHHHHHHhhcCCCCceeeeeE
Q 040763           74 NVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDD--------------EELYKLEEFINEIFILSQINHRNVVKLLGC  139 (360)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~--------------~~~~~~~~~~~e~~~~~~l~h~niv~~~~~  139 (360)
                      .+.+.||+|+||+||+|.+.+|+.||+|+++.....              ...........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            467899999999999999888999999986542111              001112334568888999999999988765


Q ss_pred             EeeCCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEcCCCcEE
Q 040763          140 CLETEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGASSPIYHRDIKSTNILLDERYRAK  219 (360)
Q Consensus       140 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk~~Nill~~~~~~k  219 (360)
                      .    ..+++|||+++..+..            ++......++.|++.+++|||+++   |+||||||+|||++++ .++
T Consensus        83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred             c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence            3    3479999998755432            223334578999999999999999   9999999999999965 589


Q ss_pred             EeecCCccccCCCCceeeecccccCCccch--h---hhccCCCCCccchhhhHHHH
Q 040763          220 VADFGTSKFIAMDQTHVTTKIQGTFGYLDP--E---YHQSSQLTDKSDVYSFGVVL  270 (360)
Q Consensus       220 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DvwslG~il  270 (360)
                      |+|||.|.....+....         |+..  +   ......|+.++|+||+.--+
T Consensus       143 liDFG~a~~~~~~~~~~---------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEGWRE---------ILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTTHHH---------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             EEECCCcccCCCCCcHH---------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999987654332111         1111  1   01135678899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.59  E-value=1.7e-07  Score=78.12  Aligned_cols=149  Identities=16%  Similarity=0.113  Sum_probs=97.6

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEee
Q 040763           64 KELDKATNHFNVNRILGQGGQGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLE  142 (360)
Q Consensus        64 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~  142 (360)
                      .++......|++.+..+-++.+.||+.... ++.+++|+.......    ....+.+|...+..+. +--+.+++.+...
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~   81 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence            445555567777766555566789988654 556777875543221    1223446777777663 4446777888888


Q ss_pred             CCcceEEEEecCCCChhHHhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 040763          143 TEFPLLVYEFIPNGTLYQHLHDRHQNEEYPLTWEMRFRVAIEVAGALAYLHSGA--------------------------  196 (360)
Q Consensus       143 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--------------------------  196 (360)
                      .+..++||++++|.++.+.....       ..   ...++.+++..++.||+..                          
T Consensus        82 ~~~~~lv~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          82 DGWSNLLMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             CCceEEEEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence            88899999999988876554221       11   1224455555556666421                          


Q ss_pred             ------------------------------CCCeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          197 ------------------------------SSPIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       197 ------------------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                                                    ...++|+|+.|.||++++++.+-|.||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                          0117999999999999987767799999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.11  E-value=5.3e-06  Score=68.44  Aligned_cols=74  Identities=18%  Similarity=0.167  Sum_probs=51.0

Q ss_pred             ecccC-cEEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC--CCCceeeeeEEeeCCcceEEEEecCC
Q 040763           79 LGQGG-QGTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN--HRNVVKLLGCCLETEFPLLVYEFIPN  155 (360)
Q Consensus        79 lg~G~-~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~  155 (360)
                      +..|. .+.||+....++..+++|........       .+..|...++.+.  .-.+.+++.+..+.+..+++|++++|
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh-------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            44454 36789998887888888976543221       2345677776663  33466778888888888999999987


Q ss_pred             CChh
Q 040763          156 GTLY  159 (360)
Q Consensus       156 ~~L~  159 (360)
                      .++.
T Consensus        91 ~~~~   94 (255)
T d1nd4a_          91 QDLL   94 (255)
T ss_dssp             EETT
T ss_pred             cccc
Confidence            6653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.70  E-value=0.00011  Score=64.53  Aligned_cols=80  Identities=16%  Similarity=0.170  Sum_probs=46.6

Q ss_pred             cceecccCcEEEEEEEecC-CcEEEEEecccccC---hHHHHhHHHHHHHHHHHhhcC-C--CCceeeeeEEeeCCcceE
Q 040763           76 NRILGQGGQGTVYKGRLED-GRIIAVKKSKLAVD---DEELYKLEEFINEIFILSQIN-H--RNVVKLLGCCLETEFPLL  148 (360)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~-~~~vaik~~~~~~~---~~~~~~~~~~~~e~~~~~~l~-h--~niv~~~~~~~~~~~~~l  148 (360)
                      .+.||.|....||+....+ ++.+++|.......   .......++...|.+.+..+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999998754 66788886432110   000011223446777777662 2  334555543  4556789


Q ss_pred             EEEecCCCC
Q 040763          149 VYEFIPNGT  157 (360)
Q Consensus       149 v~e~~~~~~  157 (360)
                      +||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.69  E-value=0.0072  Score=50.95  Aligned_cols=137  Identities=15%  Similarity=0.116  Sum_probs=74.1

Q ss_pred             EEEEEEEecCCcEEEEEecccccChHHHHhHHHHHHHHHHHhhcCCCCc--eeee-----eEEeeCCcceEEEEecCCCC
Q 040763           85 GTVYKGRLEDGRIIAVKKSKLAVDDEELYKLEEFINEIFILSQINHRNV--VKLL-----GCCLETEFPLLVYEFIPNGT  157 (360)
Q Consensus        85 g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~~~  157 (360)
                      -.||+...++|+.+++|..+.....     .+++..|...+..|...++  +...     ..+......+.++++++|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s-----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWT-----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSC-----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCC-----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            5799999999999999987754322     3345567777766632211  1111     11234556678899887643


Q ss_pred             hhH----Hhhh--------------hccCCCCCCCH----------------------HHHHHHHHHHHHHHHHHH-hCC
Q 040763          158 LYQ----HLHD--------------RHQNEEYPLTW----------------------EMRFRVAIEVAGALAYLH-SGA  196 (360)
Q Consensus       158 L~~----~l~~--------------~~~~~~~~~~~----------------------~~~~~i~~~i~~~l~~lh-~~~  196 (360)
                      +..    .+..              .........+.                      ......+.++...+.-.- +..
T Consensus       111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~  190 (325)
T d1zyla1         111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF  190 (325)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence            321    1100              00000111111                      112223333333333221 222


Q ss_pred             CCCeEecCCCCCCeEEcCCCcEEEeecCCccc
Q 040763          197 SSPIYHRDIKSTNILLDERYRAKVADFGTSKF  228 (360)
Q Consensus       197 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~  228 (360)
                      +..++|+|+.+.|||++++  ..++||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            3348999999999999754  45899998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.50  E-value=0.0039  Score=54.20  Aligned_cols=72  Identities=17%  Similarity=0.209  Sum_probs=44.9

Q ss_pred             ceecccCcEEEEEEEecC--------CcEEEEEecccccChHHHHhHHHHHHHHHHHhhcC-CCCceeeeeEEeeCCcce
Q 040763           77 RILGQGGQGTVYKGRLED--------GRIIAVKKSKLAVDDEELYKLEEFINEIFILSQIN-HRNVVKLLGCCLETEFPL  147 (360)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~  147 (360)
                      +.|+.|-.-.+|+....+        .+.+.+++.-.. ..     .-...+|..+++.+. +.-..++++++..    .
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-----~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch-----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            567778888999988653        245666664421 11     112346888888874 3334467776642    6


Q ss_pred             EEEEecCCCCh
Q 040763          148 LVYEFIPNGTL  158 (360)
Q Consensus       148 lv~e~~~~~~L  158 (360)
                      .|+||++|.++
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            88999976444

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.03  E-value=0.021  Score=47.63  Aligned_cols=29  Identities=17%  Similarity=0.189  Sum_probs=26.2

Q ss_pred             CeEecCCCCCCeEEcCCCcEEEeecCCcc
Q 040763          199 PIYHRDIKSTNILLDERYRAKVADFGTSK  227 (360)
Q Consensus       199 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~  227 (360)
                      .++|+|+.++||+++++...-+.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            49999999999999998777899999874